

  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrobenzaldehyde
C7H5NO3
555-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 C 6.6687 4.6201 0.0 0
M  V30 5 O 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 2 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4-Nitrophenyl)methylene]methanamine
C8H8N2O2
877-80-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 C 6.6685 4.6201 0.0 0
M  V30 5 N 8.0023 3.8501 0.0 0
M  V30 6 C 9.3360 4.6201 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 2.6675 3.8501 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0012 4.6201 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 2 4 5 CFG=2
M  V30 5 1 4 12
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 555-16-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 877-80-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-2375062
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Quantitative Solid-State Reactions of Amines with Carbonyl Compounds and
Isothiocyanates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kaupp, Gerd; Schmeyers, Jens; Boy, Juergen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2000), 56(36), 6899-6911

$RFMT $RIREG SCHEME2 STEP1
$RXN



  2  1
$MOL
Methan-d3-amine
CH2D3N
5581-55-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.3337 0.0 0
M  V30 2 N 0.7700 0.0000 0.0 0
M  V30 3 H 0.0000 1.3337 0.0 0 MASS=2
M  V30 4 H 0.7700 2.6673 0.0 0 MASS=2
M  V30 5 H 3.0800 1.3337 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5,7-dichloropyrazolo[1,5-a]pyrimidine-3-carboxylate
C9H7Cl2N3O2
940284-55-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6519 4.5602 0.0 0
M  V30 2 O 7.6823 5.7048 0.0 0
M  V30 3 O 7.1277 3.0957 0.0 0
M  V30 4 C 9.1887 5.3846 0.0 0
M  V30 5 C 10.2191 6.5290 0.0 0
M  V30 6 Cl 0.0000 4.6200 0.0 0
M  V30 7 Cl 2.6674 0.0000 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 N 2.6674 4.6200 0.0 0
M  V30 10 C 5.1454 4.8804 0.0 0
M  V30 11 N 4.0011 2.3100 0.0 0
M  V30 12 N 2.9876 6.1263 0.0 0
M  V30 13 C 1.3336 3.8500 0.0 0
M  V30 14 C 4.5191 6.2874 0.0 0
M  V30 15 C 2.6674 1.5400 0.0 0
M  V30 16 C 1.3336 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 13
M  V30 7 1 7 15
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 2 12 14
M  V30 16 2 13 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-chloro-7-(methyl-d3-amino)pyrazolo[1,5-a]pyrimidine-3-carboxylate
C10H8ClD3N4O2
2271470-85-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6673 4.6201 0.0 0
M  V30 2 C 1.3337 3.8501 0.0 0
M  V30 3 C 9.3194 4.5603 0.0 0
M  V30 4 O 10.3498 5.7049 0.0 0
M  V30 5 O 9.7952 3.0958 0.0 0
M  V30 6 C 11.8563 5.3847 0.0 0
M  V30 7 C 12.8867 6.5291 0.0 0
M  V30 8 Cl 5.3348 0.0000 0.0 0
M  V30 9 N 5.3348 4.6201 0.0 0
M  V30 10 C 6.6685 3.8501 0.0 0
M  V30 11 C 4.0012 3.8501 0.0 0
M  V30 12 N 5.6550 6.1264 0.0 0
M  V30 13 C 7.8131 4.8805 0.0 0
M  V30 14 N 6.6685 2.3101 0.0 0
M  V30 15 C 4.0012 2.3101 0.0 0
M  V30 16 C 7.1866 6.2875 0.0 0
M  V30 17 C 5.3348 1.5400 0.0 0
M  V30 18 H 1.3337 2.3101 0.0 0 MASS=2
M  V30 19 H 0.0000 3.0801 0.0 0 MASS=2
M  V30 20 H 0.0000 4.6201 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 18
M  V30 4 1 2 19
M  V30 5 1 2 20
M  V30 6 1 3 4
M  V30 7 2 3 5
M  V30 8 1 3 13
M  V30 9 1 4 6
M  V30 10 1 6 7
M  V30 11 1 8 17
M  V30 12 1 9 10
M  V30 13 1 9 11
M  V30 14 1 9 12
M  V30 15 2 10 13
M  V30 16 1 10 14
M  V30 17 2 11 15
M  V30 18 2 12 16
M  V30 19 1 13 16
M  V30 20 2 14 17
M  V30 21 1 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 5581-55-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 940284-55-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2271470-85-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-20912422
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrazolopyrimidines as TYK2 inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Masse, Craig E.; Greenwood, Jeremy Robert; Mondal, Sayan; Cowen, Scott
D.; McLean, Thomas H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019023468 A1 2019-01-31

$RFMT $RIREG SCHEME3 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Aminophthalide
C8H7NO2
57319-65-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.4294 0.0000 0.0 0
M  V30 2 N 6.3710 1.1704 0.0 0
M  V30 3 C 2.3699 1.9404 0.0 0
M  V30 4 C 2.3699 3.4804 0.0 0
M  V30 5 C 0.9052 1.4645 0.0 0
M  V30 6 C 3.7036 1.1704 0.0 0
M  V30 7 C 3.7036 4.2504 0.0 0
M  V30 8 C 0.9052 3.9564 0.0 0
M  V30 9 O 0.0000 2.7104 0.0 0
M  V30 10 C 5.0372 1.9404 0.0 0
M  V30 11 C 5.0372 3.4804 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 9
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Amino-2-(hydroxymethyl)-N-methylbenzamide
C9H12N2O2
2255365-39-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 5.3347 0.0 0
M  V30 2 N 0.7700 5.3347 0.0 0
M  V30 3 O 3.0800 6.6685 0.0 0
M  V30 4 C 0.0000 6.6685 0.0 0
M  V30 5 C 5.3900 5.3347 0.0 0
M  V30 6 O 6.9300 5.3347 0.0 0
M  V30 7 N 2.3100 0.0000 0.0 0
M  V30 8 C 3.0800 4.0011 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 2.3100 2.6674 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 3.0800 1.3338 0.0 0
M  V30 13 C 4.6200 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 9
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 57319-65-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2255365-39-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24661466
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chemical Modification of Linkers Provides Stable Linker-Payloads for the
Generation of Antibody-Drug Conjugates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Poudel, Yam B.; Chowdari, Naidu S.; Cheng, Heng; Iwuagwu, Christiana I.;
King, H. Dalton; Kotapati, Srikanth; Passmore, David; Rampulla, Richard;
Mathur, Arvind; Vite, Gregory; Gangwar, Sanjeev
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2020), 11(11), 2190-2194

$RFMT $RIREG SCHEME3 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Aminophthalide
C8H7NO2
57319-65-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.4294 0.0000 0.0 0
M  V30 2 N 6.3710 1.1704 0.0 0
M  V30 3 C 2.3699 1.9404 0.0 0
M  V30 4 C 2.3699 3.4804 0.0 0
M  V30 5 C 0.9052 1.4645 0.0 0
M  V30 6 C 3.7036 1.1704 0.0 0
M  V30 7 C 3.7036 4.2504 0.0 0
M  V30 8 C 0.9052 3.9564 0.0 0
M  V30 9 O 0.0000 2.7104 0.0 0
M  V30 10 C 5.0372 1.9404 0.0 0
M  V30 11 C 5.0372 3.4804 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 9
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Amino-2-(hydroxymethyl)-N-methylbenzamide
C9H12N2O2
2255365-39-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 5.3347 0.0 0
M  V30 2 N 0.7700 5.3347 0.0 0
M  V30 3 O 3.0800 6.6685 0.0 0
M  V30 4 C 0.0000 6.6685 0.0 0
M  V30 5 C 5.3900 5.3347 0.0 0
M  V30 6 O 6.9300 5.3347 0.0 0
M  V30 7 N 2.3100 0.0000 0.0 0
M  V30 8 C 3.0800 4.0011 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 2.3100 2.6674 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 3.0800 1.3338 0.0 0
M  V30 13 C 4.6200 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 9
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 57319-65-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2255365-39-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-21763906
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Modified self-immolating moieties for use in prodrugs and conjugates and
methods of using and making
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Poudel, Yam B.; Gangwar, Sanjeev
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019231879 A1 2019-12-05

$RFMT $RIREG SCHEME4 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-1,2-dihydro-6-methyl-2-oxo-3-pyridinecarbonitrile
C7H5ClN2O
582300-58-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 N 7.7000 2.6674 0.0 0
M  V30 3 Cl 4.6200 0.0000 0.0 0
M  V30 4 O 4.6200 5.3349 0.0 0
M  V30 5 C 0.0000 2.6674 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.8500 1.3338 0.0 0
M  V30 8 C 3.8500 4.0011 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 N 2.3100 4.0011 0.0 0
M  V30 11 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 6
M  V30 3 1 3 7
M  V30 4 2 4 8
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2-Dihydro-6-methyl-4-(methylamino)-2-oxo-3-pyridinecarbonitrile
C8H9N3O
582300-61-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 1.3338 0.0 0
M  V30 2 C 3.8500 0.0000 0.0 0
M  V30 3 C 6.1600 4.0011 0.0 0
M  V30 4 N 7.7000 4.0011 0.0 0
M  V30 5 O 4.6200 6.6685 0.0 0
M  V30 6 C 0.0000 4.0011 0.0 0
M  V30 7 C 3.8500 2.6674 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 2.3100 2.6674 0.0 0
M  V30 10 C 3.8500 5.3347 0.0 0
M  V30 11 C 1.5400 4.0011 0.0 0
M  V30 12 N 2.3100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 3 3 4
M  V30 4 1 3 8
M  V30 5 2 5 10
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 582300-58-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 582300-61-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8665528
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of indole derivatives as modulators of methyl modifying
enzymes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Albrecht, Brian K.; Audia, James Edmund; Dakin, Les A.; Duplessis,
Martin; Gehling, Victor S.; Harmange, Jean-Christophe; Nasveschuk,
Christopher G.; Vaswani, Rishi G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015023915 A1 2015-02-19

$RFMT $RIREG SCHEME5 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chlorobenzaldehyde
C7H5ClO
587-04-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 O 6.6687 2.3101 0.0 0
M  V30 3 Cl 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Chlorophenyl)methylene]methanamine
C8H8ClN
1081846-83-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0800 0.0 0
M  V30 2 N 6.6686 2.3100 0.0 0
M  V30 3 C 8.0022 3.0800 0.0 0
M  V30 4 Cl 0.0000 3.0800 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6675 3.0800 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 1.3337 2.3100 0.0 0
M  V30 9 C 2.6675 0.0000 0.0 0
M  V30 10 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 587-04-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1081846-83-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-5702814
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of intermediate
[1-(3-chloro-phenyl)-meth-(E)-ylidene]methyl-amine A mixture of
3-chloro-benzoaldehyde (Aldrich, 97%) (4.21 g, 30.0 mmol) and methyl
amine (2.0 M in THF, Aldrich, 22.5 mL, 45.0 mmol) in CH2Cl2 (50 mL) was
stirred at rt overnight. The reaction mixture was concentrated and the
residue was dried under reduced pressure to afford
[[1-(3-chloro-phenyl)-meth-(E)-ylidene]-methyl-amine (4.60 g, 100%) as
colorless oil which was used in the next step without further
purification. [1-(3-chloro-phenyl)-meth-(E)-ylidene]-methyl-amine, yield
(4.60 g, 100%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel N-substituted-pyrrolidines as inhibitors of MDM2-p53 interactions
and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bartkovitz, David Joseph; Chu, Xin-Jie; Liu, Jin-Jun; Morgan Ross, Tina;
Zhang, Zhuming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20110086854 A1 2011-04-14

$RFMT $RIREG SCHEME6 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chlorobenzaldehyde
C7H5ClO
587-04-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 O 6.6687 2.3101 0.0 0
M  V30 3 Cl 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(3-Chlorophenyl)methylene]methanamine
C8H8ClN
90434-25-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0800 0.0 0
M  V30 2 N 6.6686 2.3100 0.0 0
M  V30 3 C 8.0022 3.0800 0.0 0
M  V30 4 Cl 0.0000 3.0800 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6675 3.0800 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 1.3337 2.3100 0.0 0
M  V30 9 C 2.6675 0.0000 0.0 0
M  V30 10 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 587-04-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 90434-25-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-15813456
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7487-88-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Four-Electron Electrocyclic Ring-Opening/Intermolecular [4+2]
Cycloadditions of α-Hydroxycyclobutenones: Stereoselective Synthesis of
Multiple Substituted δ-Lactams
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Song, Peidong; Li, Qing; Wang, Congcong; Wu, Wenfa; Mao, Xu; Wang,
Jiajia; Hu, Xiangdong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2016), 358(8), 1208-1212

$RFMT $RIREG SCHEME7 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-chloro-2-(methylthio)-5-pyrimidinecarboxylate
C8H9ClN2O2S
5909-24-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.6675 0.0 0
M  V30 2 O 2.3100 4.0011 0.0 0
M  V30 3 O 2.3100 1.3338 0.0 0
M  V30 4 C 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 Cl 4.6201 0.0000 0.0 0
M  V30 7 S 9.2401 2.6675 0.0 0
M  V30 8 C 10.0101 4.0011 0.0 0
M  V30 9 C 4.6201 2.6675 0.0 0
M  V30 10 C 5.3901 1.3338 0.0 0
M  V30 11 C 5.3901 4.0011 0.0 0
M  V30 12 N 6.9301 1.3338 0.0 0
M  V30 13 N 6.9301 4.0011 0.0 0
M  V30 14 C 7.7001 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 10
M  V30 7 1 7 8
M  V30 8 1 7 14
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Pyrimidinecarboxylic acid, 4-(methylamino)-2-(methylthio)-, ethyl ester
C9H13N3O2S
76360-82-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3338 0.0 0
M  V30 2 C 5.3901 0.0000 0.0 0
M  V30 3 C 3.0801 4.0012 0.0 0
M  V30 4 O 2.3101 5.3348 0.0 0
M  V30 5 O 2.3101 2.6675 0.0 0
M  V30 6 C 0.7700 5.3348 0.0 0
M  V30 7 C 0.0000 6.6687 0.0 0
M  V30 8 S 9.2402 4.0012 0.0 0
M  V30 9 C 10.0102 5.3348 0.0 0
M  V30 10 C 5.3901 2.6675 0.0 0
M  V30 11 C 4.6201 4.0012 0.0 0
M  V30 12 N 6.9302 2.6675 0.0 0
M  V30 13 C 5.3901 5.3348 0.0 0
M  V30 14 C 7.7002 4.0012 0.0 0
M  V30 15 N 6.9302 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 14
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5909-24-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 76360-82-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-22669165
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Selective, Covalent FGFR4 Inhibitors with Antitumor Activity
in Models of Hepatocellular Carcinoma
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Haibo; Niu, Deqiang; Tham Sjin, Robert Tjin; Dubrovskiy, Alex; Zhu,
Zhendong; McDonald, Joseph J.; Fahnoe, Kelly; Wang, Zhigang; Munson,
Mark; Scholte, Andrew; Barrague, Matthieu; Fitzgerald, Maria; Liu, Jinyu;
Kothe, Michael; Sun, Fangxian; Murtie, Joshua; Ge, Jie; Rocnik, Jennifer;
Harvey, Darren; Ospina, Beatriz; Perron, Keli; Zheng, Gang; Shehu, Elvis;
D'Agostino, Laura Akullian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2020), 11(10), 1899-1904

$RFMT $RIREG SCHEME7 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-chloro-2-(methylthio)-5-pyrimidinecarboxylate
C8H9ClN2O2S
5909-24-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.6675 0.0 0
M  V30 2 O 2.3100 4.0011 0.0 0
M  V30 3 O 2.3100 1.3338 0.0 0
M  V30 4 C 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 Cl 4.6201 0.0000 0.0 0
M  V30 7 S 9.2401 2.6675 0.0 0
M  V30 8 C 10.0101 4.0011 0.0 0
M  V30 9 C 4.6201 2.6675 0.0 0
M  V30 10 C 5.3901 1.3338 0.0 0
M  V30 11 C 5.3901 4.0011 0.0 0
M  V30 12 N 6.9301 1.3338 0.0 0
M  V30 13 N 6.9301 4.0011 0.0 0
M  V30 14 C 7.7001 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 10
M  V30 7 1 7 8
M  V30 8 1 7 14
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Pyrimidinecarboxylic acid, 4-(methylamino)-2-(methylthio)-, ethyl ester
C9H13N3O2S
76360-82-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3338 0.0 0
M  V30 2 C 5.3901 0.0000 0.0 0
M  V30 3 C 3.0801 4.0012 0.0 0
M  V30 4 O 2.3101 5.3348 0.0 0
M  V30 5 O 2.3101 2.6675 0.0 0
M  V30 6 C 0.7700 5.3348 0.0 0
M  V30 7 C 0.0000 6.6687 0.0 0
M  V30 8 S 9.2402 4.0012 0.0 0
M  V30 9 C 10.0102 5.3348 0.0 0
M  V30 10 C 5.3901 2.6675 0.0 0
M  V30 11 C 4.6201 4.0012 0.0 0
M  V30 12 N 6.9302 2.6675 0.0 0
M  V30 13 C 5.3901 5.3348 0.0 0
M  V30 14 C 7.7002 4.0012 0.0 0
M  V30 15 N 6.9302 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 14
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5909-24-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 76360-82-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-5871099
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrido[2,3-d]pyrimidin-5(8H)-one compounds as Wee-1 kinase
inhibitors for treating cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rountree, James Samuel Shane; O'Dowd, Colin Roderick; Burkamp, Frank;
Bell, Mark Peter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015019037 A1 2015-02-12

$RFMT $RIREG SCHEME7 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-chloro-2-(methylthio)-5-pyrimidinecarboxylate
C8H9ClN2O2S
5909-24-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.6675 0.0 0
M  V30 2 O 2.3100 4.0011 0.0 0
M  V30 3 O 2.3100 1.3338 0.0 0
M  V30 4 C 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 Cl 4.6201 0.0000 0.0 0
M  V30 7 S 9.2401 2.6675 0.0 0
M  V30 8 C 10.0101 4.0011 0.0 0
M  V30 9 C 4.6201 2.6675 0.0 0
M  V30 10 C 5.3901 1.3338 0.0 0
M  V30 11 C 5.3901 4.0011 0.0 0
M  V30 12 N 6.9301 1.3338 0.0 0
M  V30 13 N 6.9301 4.0011 0.0 0
M  V30 14 C 7.7001 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 10
M  V30 7 1 7 8
M  V30 8 1 7 14
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Pyrimidinecarboxylic acid, 4-(methylamino)-2-(methylthio)-, ethyl ester
C9H13N3O2S
76360-82-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3338 0.0 0
M  V30 2 C 5.3901 0.0000 0.0 0
M  V30 3 C 3.0801 4.0012 0.0 0
M  V30 4 O 2.3101 5.3348 0.0 0
M  V30 5 O 2.3101 2.6675 0.0 0
M  V30 6 C 0.7700 5.3348 0.0 0
M  V30 7 C 0.0000 6.6687 0.0 0
M  V30 8 S 9.2402 4.0012 0.0 0
M  V30 9 C 10.0102 5.3348 0.0 0
M  V30 10 C 5.3901 2.6675 0.0 0
M  V30 11 C 4.6201 4.0012 0.0 0
M  V30 12 N 6.9302 2.6675 0.0 0
M  V30 13 C 5.3901 5.3348 0.0 0
M  V30 14 C 7.7002 4.0012 0.0 0
M  V30 15 N 6.9302 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 14
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5909-24-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 76360-82-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-3876395
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heteroaryl compounds as inhibitors of protein kinases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM D'Agostino, Laura Akullian; Sjin, Robert Tjin Tham; Niu, Deqiang;
McDonald, Joseph John; Zhu, Zhendong; Liu, Haibo; Mazdiyasni, Hormoz;
Petter, Russell C.; Singh, Juswinder; Barrague, Matthieu; Gross,
Alexandre; Munson, Mark; Harvey, Darren; Scholte, Andrew; Maniar, Sachin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014144737 A1 2014-09-18

$RFMT $RIREG SCHEME8 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxybenzaldehyde
C8H8O2
591-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 3.0801 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 1 3 7
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-N-methylbenzenemethanamine
C9H13NO
41789-95-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 3.0801 0.0 0
M  V30 5 C 0.0000 2.3101 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 591-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 41789-95-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-9095627
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM To a solution of 3-methoxybenzaldehyde (180 g, 1.32 mol) in methanol (1
L) was added a 40% aqueous solution of methylamine (113 ml, 1.31 mol)
followed by 1 hour stirring at 0°C. Sodium borohydride (75 g, 1.98 mol)
was added portionwise at 0°C and the reaction mixture was stirred for 1
hour. The solution was concentrated to a smaller volume then, was diluted
with water (200 mL) and the resulting solution was extracted with
methylene chloride (3 x 500 mL). The combined organic extracts were dried
over sodium sulfate, filtered, and concentrated under reduced pressure to
afford the crude N-methylbenzylamine. clear oil, yield 220 g, 100%. 1H
NMR (CDCl3, 500 MHz) δ.7.23 (t, J = 8.0 Hz, 1H), 6.92-6.88 (m, 2H),
6.81-6.78 (m, 1H), 3.80 (s, 3H), 3.73 (s, 2H), 2.45 (s, 3H), 2.07 (broad
s, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of aryltetrahydroisoquinolines as monoamine reuptake
inhibitors.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Shuang; Molino, Bruce F.; Nacro, Kassoum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010132437 A1 2010-11-18

$RFMT $RIREG SCHEME8 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxybenzaldehyde
C8H8O2
591-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 3.0801 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 1 3 7
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-N-methylbenzenemethanamine
C9H13NO
41789-95-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 3.0801 0.0 0
M  V30 5 C 0.0000 2.3101 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 591-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 41789-95-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-5967705
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step A: To a solution of 3-methoxybenzaldehyde (180 g, 1.32 mol) in
methanol (1 L) was added a 40% aqueous solution of methylamine (113 ml,
1.31 mol) followed by 1 hour stirring at 0 °C. Sodium borohydride (75 g,
1.98 mol) was added portionwise at 0 °C and the reaction mixture was
stirred for 1 hour. The solution was concentrated to a smaller volume
then, was diluted with water (200 mL) and the resulting solution was
extracted with methylene chloride (3 × 500 mL). The combined organic
extracts were dried over sodium sulfate, filtered, and concentrated under
reduced pressure to afford the crude N-methylbenzylamine (220 g,
quantitative) as clear oil, which was used in the next step without
further purification. 1H NMR (CDCl3, 500 MHz) δ.7.23 (t, J = 8.0 Hz, 1H),
6.92-6.88 (m, 2H), 6.81-6.78 (m, 1H), 3.80 (s, 3H), 3.73 (s, 2H), 2.45
(s, 3H), 2.07 (broad s, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 7-([1,2,4,]triazolo[1,5-α]pyridinyl-6-yl)
-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Shuang; Molino, Bruce F.; Nacro, Kassoum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010132442 A1 2010-11-18

$RFMT $RIREG SCHEME8 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxybenzaldehyde
C8H8O2
591-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 3.0801 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 1 3 7
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-N-methylbenzenemethanamine
C9H13NO
41789-95-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 3.0801 0.0 0
M  V30 5 C 0.0000 2.3101 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 591-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 41789-95-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-2547883
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step A: To a solution of 3-methoxybenzaldehyde (180 g, 1.32 mol) in
methanol (1 L) was added a 40% aqueous solution of methylamine (113 ml,
1.31 mol) followed by 1 hour stirring at 0° C. Sodium borohydride (75 g,
1.98 mol) was added portionwise at 0° C. and the reaction mixture was
stirred for 1 hour. The solution was concentrated to a smaller volume
then, was diluted with water (200 mL) and the resulting solution was
extracted with methylene chloride (3×500 mL). The combined organic
extracts were dried over sodium sulfate, filtered, and concentrated under
reduced pressure. The crude N-methylbenzylamine (220 g, quantitative) as
clear oil, which was used in the next step without further purification:
1H NMR (CDCl3, 500 MHz) δ.7.23 (t, J=8.0 Hz, 1H), 6.92-6.88 (m, 2H),
6.81-6.78 (m, 1H), 3.80 (s, 3H), 3.73 (s, 3H), 2.07 (broad s, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Crystalline forms of
(S)-7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorohphenyl)-1,2,3,4-tetrahydroisoquinoline
and use thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wei, Chenkou; Rosso, Victor W.; Gao, Qi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010132487 A1 2010-11-18

$RFMT $RIREG SCHEME8 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxybenzaldehyde
C8H8O2
591-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 3.0801 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 1 3 7
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-N-methylbenzenemethanamine
C9H13NO
41789-95-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 3.0801 0.0 0
M  V30 5 C 0.0000 2.3101 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 591-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 41789-95-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-14915062
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: To a solution of an aldehyde (1 equiv) in
methanol was added an amine derivative (1 equiv). After stirring at room
temperature for 15 min, the solution was cooled to 0 °C prior to the
addition of sodium borohydride (0.5 equiv) portion wise. The resulting
solution was stirred at room temperature for 1 h. After the addition of
water (3 mL), methanol was removed under reduced pressure and the
resulting aqueous phase was extracted with DCM. The combined extracts
were dried over Na2SO4 and concentrated in vacuo to give 5-1 in
quantitative yield. Yield quantitative.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazolylphenyl urea and carbamate compounds and analogs
as kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Feng, Yangbo; Lograsso, Philip; Schroeter, Thomas; Yin, Yan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010036316 A1 2010-04-01

$RFMT $RIREG SCHEME8 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxybenzaldehyde
C8H8O2
591-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 3.0801 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 1 3 7
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-N-methylbenzenemethanamine
C9H13NO
41789-95-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 3.0801 0.0 0
M  V30 5 C 0.0000 2.3101 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 591-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 41789-95-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-11707554
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 19-Preparation of
(+)-(2-methyl-5-phenyl-2,3,4,5-tetrahydro-1H-benzo[c]azepin-8-yl)(morpholino)methanone,
L-tartrate salt [0224] Step A: To a stirred solution of methylamine (40%
in water) (28.2 mL, 327.6 mmol) in methanol (100 mL) at room temperature
was added m-anisaldehyde (20.6 mL, 163.8 mmol) as a solution in methanol
(50 mL) dropwise over 20 minutes. The reaction was stirred at room
temperature under N2 for 15 h, then cooled to 0° C. and sodium
borohydride (6.19 g, 163.8 mmol) was added in portions. After warming to
room temperature, the reaction was stirred for 3 hours. The mixture was
then concentrated under reduced pressure, dissolved in water, and
extracted with methylene chloride (3×). The combined methylene chloride
extracts were extracted with 1N HCl (3×) and the combined HCl extracts
adjusted to pH 10 by addition of 6N NaOH. The aqueous mixture was then
extracted with methylene chloride (3×). The combined methylene chloride
extracts were dried over sodium sulfate, filtered, and concentrated in
vacuo to give the desired amine (25.0 g, quantitative yield) as a light
yellow oil. 1H NMR (300 MHz, CDCl3) δ 7.27-7.22 (m, 1H), 6.91-6.89 (m,
1H), 6.89 (s, 1H), 6.82-6.79 (m, 1H), 3.81 (s, 3H), 3.74 (s, 2H), 2.46
(s, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof
to block reuptake of norepinephrine, dopamine, and serotonin
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Molino, Bruce F.; Liu, Shuang; Sambandam, Aruna; Guzzo, Peter R.; Hu,
Min; Zha, Congxiang; Nacro, Kassoum; Manning, David D.; Isherwood,
Matthew L.; Fleming, Kristen N.; Cui, Wenge; Olson, Richard E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007011820 A2 2007-01-25

$RFMT $RIREG SCHEME9 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
D-Pantolactone
C6H10O3
599-04-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.6527 0.0000 0.0 0
M  V30 2 C 0.0000 3.0715 0.0 0
M  V30 3 C 0.6368 1.1114 0.0 0
M  V30 4 O 5.3632 1.9692 0.0 0
M  V30 5 C 2.6527 1.5400 0.0 0 CFG=1
M  V30 6 C 1.4068 2.4452 0.0 0
M  V30 7 C 3.8987 2.4452 0.0 0
M  V30 8 C 1.8827 3.9098 0.0 0
M  V30 9 O 3.4227 3.9098 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 5 1 CFG=3
M  V30 2 1 2 6
M  V30 3 1 3 6
M  V30 4 2 4 7
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Butanamide, 2,4-dihydroxy-N,3,3-trimethyl-, (R)-
C7H15NO3
88308-84-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.6438 1.5400 0.0 0 CFG=1
M  V30 2 C 2.3100 2.3100 0.0 0
M  V30 3 C 4.9775 2.3100 0.0 0
M  V30 4 O 3.6438 0.0000 0.0 0
M  V30 5 C 1.5400 0.9764 0.0 0
M  V30 6 C 3.0800 3.6437 0.0 0
M  V30 7 C 0.9764 3.0800 0.0 0
M  V30 8 N 6.3111 1.5400 0.0 0
M  V30 9 O 4.9775 3.8500 0.0 0
M  V30 10 O 0.0000 0.9764 0.0 0
M  V30 11 C 7.6450 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 2 7
M  V30 7 1 3 8
M  V30 8 2 3 9
M  V30 9 1 5 10
M  V30 10 1 8 11
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 599-04-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 88308-84-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11943984
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2,4-Dihydroxy-3,3,N-trimethylbutyramide (3) Compound 3 was prepared
according to the literature procedure.S3 To a stirred solution of
Rpantolactone (1.00 g, 7.69 mmol) in methanol (3 ml) 40% aqueous solution
of N-methylamine was added (0.8 ml, 0.32 g, 10.3 mmol). Reaction mixture
was stirred at 25°C for 3 h until completion and then solvents and
unreacted N-methylamine were removed in vacuo yielding pure product 3
(1.24 g, quantitative yield). 2,4-Dihydroxy-3,3,N-trimethylbutyramide
(3), yield 1.24g 1H NMR (500 MHz, CDCl3): δ (ppm) 7.07 (s, 1H), 3,96 (s,
1H), 3.43 (d, J= 11.1 Hz, 1H), 3.39 (d, 11.1 Hz, 1H), 2.77 (d, J= 5.0 Hz,
3H), 0.91 (s, 3H), 0.85 (s, 3H). 13C NMR (125 MHz, CDCl3): δ (ppm) 174.5,
77.2, 70.9, 39.2, 25.7, 21.0, 20.3. IR, νmax (ATR): 3334.1 2961.9, 1539.2
cm-1. HRMS (ES) for C7H16N1O3 (MH+) calcd: 162.1130, found: 162.1125.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Optimization of the Interligand Overhauser Effect for Fragment Linking:
Application to Inhibitor Discovery against Mycobacterium tuberculosis
Pantothenate Synthetase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sledz, Pawel; Silvestre, H. Leonardo; Hung, Alvin W.; Ciulli, Alessio;
Blundell, Tom L.; Abell, Chris
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2010), 132(13), 4544-4545

$RFMT $RIREG SCHEME10 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclopropanecarboxylic acid, 1-[4-(chlorosulfonyl)phenyl]-, methyl ester
C11H11ClO4S
600134-92-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.6584 2.6269 0.0 0
M  V30 2 O 9.1750 2.3594 0.0 0
M  V30 3 O 7.1316 4.0741 0.0 0
M  V30 4 C 10.1649 3.5392 0.0 0
M  V30 5 S 1.3338 4.5271 0.0 0 VAL=6
M  V30 6 Cl 0.0000 5.2971 0.0 0
M  V30 7 O 2.1038 5.8609 0.0 0
M  V30 8 O 0.5638 3.1935 0.0 0
M  V30 9 C 6.6685 1.4471 0.0 0
M  V30 10 C 7.6584 0.2675 0.0 0
M  V30 11 C 6.1418 0.0000 0.0 0
M  V30 12 C 5.3347 2.2171 0.0 0
M  V30 13 C 5.3347 3.7571 0.0 0
M  V30 14 C 4.0011 1.4471 0.0 0
M  V30 15 C 4.0011 4.5271 0.0 0
M  V30 16 C 2.6674 2.2171 0.0 0
M  V30 17 C 2.6674 3.7571 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 5 8
M  V30 8 1 5 17
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1-[4-[(methylamino)sulfonyl]phenyl]cyclopropanecarboxylate
C12H15NO4S
811807-17-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.5065 2.6269 0.0 0
M  V30 2 O 0.9899 2.3594 0.0 0
M  V30 3 O 3.0332 4.0741 0.0 0
M  V30 4 C 0.0000 3.5392 0.0 0
M  V30 5 S 8.8311 4.5271 0.0 0 VAL=6
M  V30 6 N 10.1648 5.2971 0.0 0
M  V30 7 O 9.6011 3.1935 0.0 0
M  V30 8 O 8.0611 5.8609 0.0 0
M  V30 9 C 11.4986 4.5271 0.0 0
M  V30 10 C 3.4964 1.4471 0.0 0
M  V30 11 C 2.5065 0.2675 0.0 0
M  V30 12 C 4.0231 0.0000 0.0 0
M  V30 13 C 4.8301 2.2171 0.0 0
M  V30 14 C 6.1638 1.4471 0.0 0
M  V30 15 C 4.8301 3.7571 0.0 0
M  V30 16 C 7.4975 2.2171 0.0 0
M  V30 17 C 6.1638 4.5271 0.0 0
M  V30 18 C 7.4975 3.7571 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 5 8
M  V30 8 1 5 18
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 600134-92-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 811807-17-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-10081546
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2) Methyl 1-[4-(N-methylsulfamoyl)phenyl]cyclopropane-1-carboxylate To a
solution of methyl 1-(4-chlorosulfonylphenyl)cyclopropane-1-carboxylate
(2.16 g, 7.86 mmol) obtained in 1) in tetrahydrofuran (22 ml) was added
30% solution of methylamine in ethanol (2.44 g, 23.6 mmol) under stirring
and ice-cooling, and the resulting mixture was stirred at room
temperature for 30 minutes. After stirring, ethyl acetate and water were
added to the reaction mixture, and the resulting mixture was partitioned.
The organic layer separated was washed with water, dried over anhydrous
magnesium sulfate and evaporated in vacuo. The solid residue thus
obtained was washed with hexane to afford the title compound (2.13 g,
yield: quantitative) as a white powder. 1H-NMR (500 MHz, CDCl3) δppm:
7.80 (2H, d, J=8 Hz), 7.50 (2H, d, J=8 Hz), 4.35 (1H, quartet, J=5 Hz),
3.64 (3H, s), 2.69 (3H, d, J=5 Hz), 1.70-1.66 (2H, m), 1.24-1.20 (2H, m).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of cyclic tertiary amine compounds that inhibit inflammatory
cytokine production
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kimura, Tomio; Ohkawa, Nobuyuki; Nakao, Akira; Nagasaki, Takayoshi;
Shimozato, Takaichi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20070049620 A1 2007-03-01

$RFMT $RIREG SCHEME11 STEP1
$RXN



  2  1
$MOL
L-Tyrosine
C9H11NO3
60-18-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 3.0800 0.0 0
M  V30 2 C 2.6674 4.6200 0.0 0 CFG=2
M  V30 3 C 1.3336 5.3900 0.0 0
M  V30 4 N 4.0011 5.3900 0.0 0
M  V30 5 O 0.0000 4.6200 0.0 0
M  V30 6 O 1.3336 6.9300 0.0 0
M  V30 7 O 8.0021 0.0000 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 4.0011 0.7700 0.0 0
M  V30 10 C 5.3347 3.0800 0.0 0
M  V30 11 C 5.3347 0.0000 0.0 0
M  V30 12 C 6.6685 2.3100 0.0 0
M  V30 13 C 6.6685 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αS)-α-Amino-4-hydroxy-N-methylbenzenepropanamide
C10H14N2O2
21800-59-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 3.8501 2.6673 0.0 0 CFG=2
M  V30 3 C 2.3101 2.6673 0.0 0
M  V30 4 N 4.6201 4.0010 0.0 0
M  V30 5 N 1.5400 4.0010 0.0 0
M  V30 6 O 1.5400 1.3337 0.0 0
M  V30 7 C 0.0000 4.0010 0.0 0
M  V30 8 O 10.7802 1.3337 0.0 0
M  V30 9 C 6.1601 1.3337 0.0 0
M  V30 10 C 6.9302 0.0000 0.0 0
M  V30 11 C 6.9302 2.6673 0.0 0
M  V30 12 C 8.4702 0.0000 0.0 0
M  V30 13 C 8.4702 2.6673 0.0 0
M  V30 14 C 9.2402 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 60-18-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 21800-59-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-10045783
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cation-π interactions in iminium ion activation: correlating quadrupole
moment & enantioselectivity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Holland, M. C.; Metternich, J. B.; Mueck-Lichtenfeld, C.; Gilmour, R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2015), 51(25),
5322-5325

$RFMT $RIREG SCHEME12 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Buten-1-ol, 4-bromo-, 1-benzoate
C11H11BrO2
60405-65-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 O 5.3348 2.3101 0.0 0
M  V30 3 O 4.0012 4.6201 0.0 0
M  V30 4 C 6.6685 3.0801 0.0 0
M  V30 5 C 8.0022 2.3101 0.0 0
M  V30 6 C 9.3360 3.0801 0.0 0
M  V30 7 C 10.6697 2.3101 0.0 0
M  V30 8 Br 12.0033 3.0801 0.0 0
M  V30 9 C 2.6673 2.3101 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 1.3337 3.0801 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 2.3101 0.0 0
M  V30 14 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 5 6 CFG=2
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Buten-1-ol, 4-(methylamino)-, 1-benzoate
C12H15NO2
852923-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 3.0801 0.0 0
M  V30 2 O 5.3348 2.3101 0.0 0
M  V30 3 O 4.0010 4.6201 0.0 0
M  V30 4 C 6.6685 3.0801 0.0 0
M  V30 5 C 8.0022 2.3101 0.0 0
M  V30 6 C 9.3360 3.0801 0.0 0
M  V30 7 C 10.6697 2.3101 0.0 0
M  V30 8 N 12.0033 3.0801 0.0 0
M  V30 9 C 13.3370 2.3101 0.0 0
M  V30 10 C 2.6673 2.3101 0.0 0
M  V30 11 C 1.3337 3.0801 0.0 0
M  V30 12 C 2.6673 0.7700 0.0 0
M  V30 13 C 0.0000 2.3101 0.0 0
M  V30 14 C 1.3337 0.0000 0.0 0
M  V30 15 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 5 6 CFG=2
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 60405-65-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 852923-33-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-14448440
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Compound 9A can be prepared via a two-step procedure according to the
reference.3 A solution of 9A (6.0 g, 24 mmol) in dry CH2Cl2 (10 mL) was
added below 30 °C to a solution of MeNH2/EtOH (wt 33 %, 15 mL). The
mixture was stirred at room temperature for 0.5 h. Then solvent was
evaporated and the residue was chromatographed on silica gel (CH2Cl2:
EtOH 10:1) to afford 4-methylamino-but-2-enyl benzoate as white solid in
quantitative yield.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium(II)-Catalyzed Enyne Coupling Reaction Initiated by
Acetoxypalladation of Alkynes and Quenched by Protonolysis of the
Carbon-Palladium Bond
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhao, Ligang; Lu, Xiyan; Xu, Wei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2005), 70(10), 4059-4063

$RFMT $RIREG SCHEME13 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3,5,6,8,9,11,12-Octahydro-15-nitro-1,4,7,10,13-benzopentaoxacyclopentadecin
C14H19NO7
60835-69-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.7008 5.0624 0.0 0 VAL=5
M  V30 2 O 10.7008 6.6024 0.0 0
M  V30 3 O 12.0347 4.2923 0.0 0
M  V30 4 C 6.6999 4.2923 0.0 0
M  V30 5 C 6.6999 2.7523 0.0 0
M  V30 6 C 8.0335 5.0624 0.0 0
M  V30 7 O 5.3661 5.0624 0.0 0
M  V30 8 C 8.0335 1.9823 0.0 0
M  V30 9 O 5.3661 1.9823 0.0 0
M  V30 10 C 9.3672 4.2923 0.0 0
M  V30 11 C 5.0459 6.5687 0.0 0
M  V30 12 C 9.3672 2.7523 0.0 0
M  V30 13 C 5.0459 0.4760 0.0 0
M  V30 14 C 3.5813 7.0447 0.0 0
M  V30 15 C 3.5813 0.0000 0.0 0
M  V30 16 O 2.4368 6.0141 0.0 0
M  V30 17 O 2.4368 1.0306 0.0 0
M  V30 18 C 0.9052 6.1752 0.0 0
M  V30 19 C 0.9052 0.8695 0.0 0
M  V30 20 C 0.0000 4.9291 0.0 0
M  V30 21 C 0.0000 2.1155 0.0 0
M  V30 22 O 0.6265 3.5223 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 1 11 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[2-[2-[2-[2-(Methylamino)-5-nitrophenoxy]ethoxy]ethoxy]ethoxy]ethanol
C15H24N2O7
194923-90-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 4.0011 0.0 0
M  V30 2 C 6.9300 5.3347 0.0 0
M  V30 3 C 8.4700 5.3347 0.0 0
M  V30 4 O 9.2400 6.6684 0.0 0
M  V30 5 C 10.7800 6.6684 0.0 0
M  V30 6 C 11.5500 8.0020 0.0 0
M  V30 7 O 13.0900 8.0020 0.0 0
M  V30 8 C 13.8600 9.3358 0.0 0
M  V30 9 C 15.4000 9.3358 0.0 0
M  V30 10 O 16.1700 10.6694 0.0 0
M  V30 11 C 17.7100 10.6694 0.0 0
M  V30 12 C 18.4800 12.0031 0.0 0
M  V30 13 O 20.0200 12.0031 0.0 0
M  V30 14 N 4.6200 1.3336 0.0 0
M  V30 15 C 3.8500 0.0000 0.0 0
M  V30 16 N 1.5400 6.6684 0.0 0 VAL=5
M  V30 17 O 0.0000 6.6684 0.0 0
M  V30 18 O 2.3100 8.0020 0.0 0
M  V30 19 C 4.6200 4.0011 0.0 0
M  V30 20 C 3.8500 2.6673 0.0 0
M  V30 21 C 3.8500 5.3347 0.0 0
M  V30 22 C 2.3100 2.6673 0.0 0
M  V30 23 C 2.3100 5.3347 0.0 0
M  V30 24 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 14 15
M  V30 15 1 14 20
M  V30 16 2 16 17
M  V30 17 2 16 18
M  V30 18 1 16 23
M  V30 19 2 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 21 23
M  V30 23 2 22 24
M  V30 24 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 60835-69-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 194923-90-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-14955754
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Podands 2a-c; General Procedure A mixture of
4'-nitrobenzocrown ether 1a-c (4 mmol) and a 35% solution of MeNH2 in
anhyd EtOH (50 mL) was heated in a sealed tube at 100 °C for 48 h (water
bath). The tube was then opened, the mixture was concentrated in vacuo,
and the residue was purified by column chromatography on silica gel. The
products were eluted successively with a benzene-EtOAc mixture (1:1),
EtOAc, and an EtOAc-EtOH mixture (5:1) for 2a, successively with EtOAc
and an EtOAc-MeOH mixture (5: 1) for 2b, or successively with EtOAc and
an EtOAc-EtOH mixture (5:1) for 2c. Podands 2a-c were isolated as yellow
oils in excellent yields (Tables 1, 2). 2b, yellow ellow oil,
quantitative yield. Rf: 0.58; IR (KBr) (cm-1): 3402 (NH, OH), 1493 (NO2);
Molecular Formula: C15H24N2O7; HRMS m/z Calcd: 344.1583; Found: 344.1571;
1H NMR (CDCl3, 500 MHz, 25 °C) δ 2.92 (d, 3 H, J = 5.0, CH3N), 3.04 (br
s, 1 H, OH), 3.59 (m, 2 H, CH2O), 3.61-3.73 (m, 10 H, 4 CH2O, CH2OH),
3.86 (m, 2 H, CH2CH2OAr), 4.19 (m, 2 H, CH2OAr), 5.72 (br m, 1 H, NH),
6.43 (d, 1 H, J = 8.9, H-3), 7.59 (d, 1 H, J = 1.4, H-6), 7.89 (br d, 1
H, J = 8.9, H-4); 13C NMR (CDCl3, 125 MHz, 25 °C) δ 29.46 (q, J = 136.8,
CH3N), 61.56 (t, J = 141.7, CH2OH), 68.00 (t, J = 144.6, CH2OAr), 69.30
(t, J = 143.2, CH2CH2OAr), 70.05 (t, J = 140.7, CH2O), 70.32 (t, J =
141.0, CH2O), 70.46 (t, J = 141.7, 2 CH2O), 72.47 (t, J = 141.5, CH2O),
105.98 (dd, J = 163.0, 5.1, C-6), 106.09 (dd, J = 161.7, 5.9, C-3);
120.40 (dd, J = 166.9, 4.3, C-4), 136.31 (C-5), 144.12, 145.78 (C-1,
C-2); MS m/z (%): 344 (M+, 100), 256 (22), 212 (22), 168 (72), 167 (30),
89 (98).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A novel ring transformation of nitrobenzocrown ethers as a route to
nitrobenzoazacrown compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gromov, Sergei P.; Dmitrieva, Svetlana N.; Churakova, Marina V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2003), (4), 593-597

$RFMT $RIREG SCHEME14 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Bromomethyl)-1-methoxy-2-nitrobenzene
C8H8BrNO3
61010-34-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 4.6200 0.0 0 VAL=5
M  V30 2 O 0.0000 3.8500 0.0 0
M  V30 3 O 1.3336 6.1600 0.0 0
M  V30 4 O 1.3336 1.5400 0.0 0
M  V30 5 C 1.3336 0.0000 0.0 0
M  V30 6 C 6.6685 4.6200 0.0 0
M  V30 7 Br 8.0021 3.8500 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 C 2.6674 2.3100 0.0 0
M  V30 10 C 4.0011 4.6200 0.0 0
M  V30 11 C 4.0011 1.5400 0.0 0
M  V30 12 C 5.3347 3.8500 0.0 0
M  V30 13 C 5.3347 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 1 6 7
M  V30 7 1 6 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-N-methyl-3-nitrobenzenemethanamine
C9H12N2O3
732976-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 4.6201 0.0 0 VAL=5
M  V30 2 O 0.0000 3.8500 0.0 0
M  V30 3 O 1.3337 6.1601 0.0 0
M  V30 4 O 1.3337 1.5400 0.0 0
M  V30 5 C 1.3337 0.0000 0.0 0
M  V30 6 C 6.6684 4.6201 0.0 0
M  V30 7 N 8.0022 3.8500 0.0 0
M  V30 8 C 9.3359 4.6201 0.0 0
M  V30 9 C 2.6675 3.8500 0.0 0
M  V30 10 C 2.6675 2.3100 0.0 0
M  V30 11 C 4.0011 4.6201 0.0 0
M  V30 12 C 4.0011 1.5400 0.0 0
M  V30 13 C 5.3348 3.8500 0.0 0
M  V30 14 C 5.3348 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 1 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 61010-34-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 732976-89-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-9960068
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 2: Synthesis of 1-(4-methoxy-3-nitrophenyl)-N-methylmethanamine
(46). 4-(bromomethyl)-1-methoxy-2-nitrobenzene (276 mg, 1.122 mmol) was
dissolved in methanamine in EtOH (33% w/w, 8 ml, 64.5 mmol) and stirred
at RT for 1.5 hours. The mixture was evaporated to dryness and diluted
with WATER/brine. The aqueous phase was extracted twice with EtOAc.
NaHCO3 sat. sol. was added until basic pH, and the aqueous phase was
extracted twice with DCM. The combined organic layers were dried and
evaporated under vacuum to give
1-(4-methoxy-3-nitrophenyl)-N-methylmethanamine that was used in the next
step without further purification. Yield 220 mg, 1.121 mmol, 100%.
MS/ESI+ 197.1 [MH]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase
inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Armani, Elisabetta; Amari, Gabriele; Capaldi, Carmelida; Esposito,
Oriana; Peretto, Ilaria
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20130079313 A1 2013-03-28

$RFMT $RIREG SCHEME15 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Nitrophthalide
C8H5NO4
610-93-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.4294 0.3694 0.0 0
M  V30 2 N 6.3708 1.5400 0.0 0 VAL=5
M  V30 3 O 7.7046 2.3100 0.0 0
M  V30 4 O 6.3708 0.0000 0.0 0
M  V30 5 C 2.3699 2.3100 0.0 0
M  V30 6 C 2.3699 3.8500 0.0 0
M  V30 7 C 3.7036 1.5400 0.0 0
M  V30 8 C 0.9052 1.8341 0.0 0
M  V30 9 C 3.7036 4.6200 0.0 0
M  V30 10 C 0.9052 4.3259 0.0 0
M  V30 11 C 5.0372 2.3100 0.0 0
M  V30 12 O 0.0000 3.0800 0.0 0
M  V30 13 C 5.0372 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Hydroxymethyl)-N-methyl-5-nitrobenzamide
C9H10N2O4
2255365-38-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 4.0012 0.0 0
M  V30 2 N 6.9302 5.3348 0.0 0
M  V30 3 O 6.9302 2.6675 0.0 0
M  V30 4 C 8.4702 5.3348 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 O 3.8501 0.0000 0.0 0
M  V30 7 N 1.5400 6.6687 0.0 0 VAL=5
M  V30 8 O 0.0000 6.6687 0.0 0
M  V30 9 O 2.3101 8.0023 0.0 0
M  V30 10 C 4.6201 4.0012 0.0 0
M  V30 11 C 3.8501 2.6675 0.0 0
M  V30 12 C 3.8501 5.3348 0.0 0
M  V30 13 C 2.3101 2.6675 0.0 0
M  V30 14 C 2.3101 5.3348 0.0 0
M  V30 15 C 1.5400 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 14
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 610-93-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2255365-38-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-21003881
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM N-Heteroarylimidazolamines as inhibitors of Alk2 kinase and their
preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kotian, Pravin L.; Babu, Yarlagadda S.; Kumar, V. Satish; Zhang, Weihe;
Lu, Peng-Cheng; Raman, Krishnan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018232094 A1 2018-12-20

$RFMT $RIREG SCHEME16 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dichloronitrobenzene
C6H3Cl2NO2
611-06-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Cl 2.3101 0.0000 0.0 0
M  V30 5 Cl 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-N-methyl-2-nitrobenzenamine
C7H7ClN2O2
35966-84-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Cl 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 611-06-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35966-84-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-542796
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-(methylamino)-4-chloronitrobenzene (Compound E):
2,4-Dichloronitrobenzene (compound D, 61 g, 320 mmol), triethylamine (68
mL, 480 mmol, 1.5 equiv.) and 2M methylamine in THF (500 mL, 1.0 mol, 3.1
equiv.) were mixed in a 3 L round bottom flask equipped with 3 Graham
condensers under Argon. The solution was then heated at 40°C with
stirring and a white solid started to form (HCl salt of Et3N). After
heating for 6 h, an additional two equivalents of the methylamine
solution in THF (330 mL) was added and the mixture was reheated at 40°C
for another 16 h. The reaction mixture was then cooled to RT and the
white solid was removed by filtration and washed with THF. The filtrate
was concentrated under reduced pressure and the residue re-dissolved in
800 mL of dichloromethane, washed with water and brine, and dried over
Na2SO4. The solvents were removed in vacuo. Compound E as an orange solid
(59.5 g, quantitative) which was used directly in the next step.
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of methylamine and THF
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Conformation-Based Restrictions and Scaffold Replacements in the Design
of Hepatitis C Virus Polymerase Inhibitors: Discovery of Deleobuvir (BI
207127)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM LaPlante, Steven R.; Bos, Michael; Brochu, Christian; Chabot, Catherine;
Coulombe, Rene; Gillard, James R.; Jakalian, Araz; Poirier, Martin;
Rancourt, Jean; Stammers, Timothy; Thavonekham, Bounkham; Beaulieu,
Pierre L.; Kukolj, George; Tsantrizos, Youla S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2014), 57(5), 1845-1854

$RFMT $RIREG SCHEME16 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dichloronitrobenzene
C6H3Cl2NO2
611-06-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Cl 2.3101 0.0000 0.0 0
M  V30 5 Cl 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-N-methyl-2-nitrobenzenamine
C7H7ClN2O2
35966-84-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Cl 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 611-06-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35966-84-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-6101680
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 1: 2,4-Dichloronitrobenzene (27-1) (61 g, 0.32 mol), triethylamine
(68 mL, 0.48 mol), and 2.0 M methylamine in THF (500 mL, 1.0 mol) were
mixed in a 3-L round bottom flask equipped with a Graham condenser under
argon pressure. The solution was then heated at 40°C with stirring and a
white solid started to form (Et3NH+Cl-). After heating for ~6 hrs, TLC
(in 20% ethyl acetate in hexane) showed that the reaction was ~60%
complete. Another two equivalents of the methylamine solution in THF (330
mL) was added and the mixture was heated at 40°C with stirring for
another 16 hours. TLC showed that all starting material was consumed. The
reaction mixture was allowed to cool down to room temperature and the
white solid was removed by filtration and washed thoroughly with THF. The
filtrate was concentrated under reduced pressure and re-dissolved in 800
mL of dichloromethane, washed with water and brine, and dried over
Na2SO4. The solvents were removed in vacuo to give compound 27-2 as an
orange solid (59.5 g, quantitative), which was pure enough to use in next
step.
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, incremental addition of methylamine
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of indolylcarbonylaminomethylbenzimidazoles as viral
polymerase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tsantrizos, Youla S.; Chabot, Catherine; Beaulieu, Pierre; Brochu,
Christian; Poirier, Martin; Stammers, Timothy A.; Thavonekham, Bounkham;
Rancourt, Jean
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005080388 A1 2005-09-01

$RFMT $RIREG SCHEME17 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-5-(4-chlorophenyl)-6-(2,4-dichlorophenyl)nicotinonitrile
C18H8Cl4N2
611218-68-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.7800 6.6684 0.0 0
M  V30 2 N 12.3200 6.6684 0.0 0
M  V30 3 Cl 4.6200 9.3358 0.0 0
M  V30 4 Cl 9.2400 9.3358 0.0 0
M  V30 5 Cl 3.8500 0.0000 0.0 0
M  V30 6 Cl 0.0000 6.6684 0.0 0
M  V30 7 C 6.9300 5.3347 0.0 0
M  V30 8 C 6.1600 6.6684 0.0 0
M  V30 9 C 8.4700 5.3347 0.0 0
M  V30 10 N 6.9300 8.0021 0.0 0
M  V30 11 C 9.2400 6.6684 0.0 0
M  V30 12 C 8.4700 8.0021 0.0 0
M  V30 13 C 6.1600 4.0011 0.0 0
M  V30 14 C 4.6200 4.0011 0.0 0
M  V30 15 C 6.9300 2.6674 0.0 0
M  V30 16 C 3.8500 2.6674 0.0 0
M  V30 17 C 6.1600 1.3336 0.0 0
M  V30 18 C 4.6200 1.3336 0.0 0
M  V30 19 C 4.6200 6.6684 0.0 0
M  V30 20 C 3.8500 8.0021 0.0 0
M  V30 21 C 3.8500 5.3347 0.0 0
M  V30 22 C 2.3100 8.0021 0.0 0
M  V30 23 C 2.3100 5.3347 0.0 0
M  V30 24 C 1.5400 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 11
M  V30 3 1 3 20
M  V30 4 1 4 12
M  V30 5 1 5 18
M  V30 6 1 6 24
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 1 8 19
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(4-Chlorophenyl)-6-(2,4-dichlorophenyl)-2-(methylamino)-3-pyridinecarbonitrile
C19H12Cl3N3
852315-01-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.6200 9.3358 0.0 0
M  V30 2 N 9.2400 9.3358 0.0 0
M  V30 3 C 8.4700 10.6694 0.0 0
M  V30 4 C 10.7800 6.6684 0.0 0
M  V30 5 N 12.3200 6.6684 0.0 0
M  V30 6 Cl 0.0000 6.6684 0.0 0
M  V30 7 Cl 3.8500 0.0000 0.0 0
M  V30 8 C 6.1600 6.6684 0.0 0
M  V30 9 C 6.9300 5.3347 0.0 0
M  V30 10 N 6.9300 8.0021 0.0 0
M  V30 11 C 8.4700 5.3347 0.0 0
M  V30 12 C 8.4700 8.0021 0.0 0
M  V30 13 C 9.2400 6.6684 0.0 0
M  V30 14 C 4.6200 6.6684 0.0 0
M  V30 15 C 3.8500 8.0021 0.0 0
M  V30 16 C 3.8500 5.3347 0.0 0
M  V30 17 C 2.3100 8.0021 0.0 0
M  V30 18 C 2.3100 5.3347 0.0 0
M  V30 19 C 1.5400 6.6684 0.0 0
M  V30 20 C 6.1600 4.0011 0.0 0
M  V30 21 C 4.6200 4.0011 0.0 0
M  V30 22 C 6.9300 2.6673 0.0 0
M  V30 23 C 3.8500 2.6673 0.0 0
M  V30 24 C 6.1600 1.3336 0.0 0
M  V30 25 C 4.6200 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 2 3
M  V30 3 1 2 12
M  V30 4 3 4 5
M  V30 5 1 4 13
M  V30 6 1 6 19
M  V30 7 1 7 25
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 14
M  V30 11 1 9 11
M  V30 12 1 9 20
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 611218-68-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 852315-01-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-10064404
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of functionalized 1,8-naphthyridinones and their evaluation as
novel, orally active CB1 receptor inverse agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Debenham, John S.; Madsen-Duggan, Christina B.; Walsh, Thomas F.; Wang,
Junying; Tong, Xinchun; Doss, George A.; Lao, Julie; Fong, Tung M.;
Schaeffer, Marie-Therese; Xiao, Jing Chen; Huang, Cathy R.-R. C.; Shen,
Chun-Pyn; Feng, Yue; Marsh, Donald J.; Stribling, D. Sloan; Shearman,
Lauren P.; Strack, Alison M.; MacIntyre, D. Euan; Van der Ploeg, Lex H.
T.; Goulet, Mark T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2006), 16(3), 681-685

$RFMT $RIREG SCHEME18 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dimethoxybenzaldehyde
C9H10O3
613-45-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 C 0.7700 4.0011 0.0 0
M  V30 4 O 0.0000 5.3349 0.0 0
M  V30 5 O 6.9300 4.0011 0.0 0
M  V30 6 C 7.7000 5.3349 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 1 3 8
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dimethoxy-N-methylbenzenemethanamine
C10H15NO2
102503-23-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 4.0011 0.0 0
M  V30 2 N 7.7000 5.3349 0.0 0
M  V30 3 C 9.2400 5.3349 0.0 0
M  V30 4 O 5.3900 1.3338 0.0 0
M  V30 5 C 4.6200 0.0000 0.0 0
M  V30 6 O 0.7700 4.0011 0.0 0
M  V30 7 C 0.0000 5.3349 0.0 0
M  V30 8 C 5.3900 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 4.6200 5.3349 0.0 0
M  V30 11 C 3.0800 2.6674 0.0 0
M  V30 12 C 3.0800 5.3349 0.0 0
M  V30 13 C 2.3100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 613-45-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 102503-23-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-22945451
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthetic studies to help elucidate the metabolism of the preclinical
candidate TBAJ-876-a less toxic and more potent analogue of bedaquiline
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Choi, Peter J.; Conole, Daniel; Sutherland, Hamish S.; Blaser, Adrian;
Tong, Amy S. T.; Cooper, Christopher B.; Upton, Anna M.; Palmer, Brian
D.; Denny, William A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2020), 25(6), 1423

$RFMT $RIREG SCHEME19 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3-Bromophenyl)-2-(4-morpholinyl)ethanone
C12H14BrNO2
615534-53-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 C 4.0012 2.3101 0.0 0
M  V30 3 O 5.3348 4.6201 0.0 0
M  V30 4 Br 10.6697 3.0801 0.0 0
M  V30 5 C 6.6685 2.3101 0.0 0
M  V30 6 C 8.0023 3.0801 0.0 0
M  V30 7 C 6.6685 0.7700 0.0 0
M  V30 8 C 9.3360 2.3101 0.0 0
M  V30 9 C 8.0023 0.0000 0.0 0
M  V30 10 C 9.3360 0.7700 0.0 0
M  V30 11 N 2.6673 3.0801 0.0 0
M  V30 12 C 2.6673 4.6201 0.0 0
M  V30 13 C 1.3337 2.3101 0.0 0
M  V30 14 C 1.3337 5.3901 0.0 0
M  V30 15 C 0.0000 3.0801 0.0 0
M  V30 16 O 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 2 11
M  V30 5 1 4 8
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-(3-Bromophenyl)-N-methyl-4-morpholineethanamine
C13H19BrN2O
1003878-38-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6674 0.0 0
M  V30 2 C 5.3900 4.0011 0.0 0
M  V30 3 N 5.3900 1.3338 0.0 0
M  V30 4 C 4.6200 0.0000 0.0 0
M  V30 5 Br 0.0000 5.3349 0.0 0
M  V30 6 C 3.0800 2.6674 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 2.3100 1.3338 0.0 0
M  V30 9 C 0.7700 4.0011 0.0 0
M  V30 10 C 0.7700 1.3338 0.0 0
M  V30 11 C 0.0000 2.6674 0.0 0
M  V30 12 N 6.9300 4.0011 0.0 0
M  V30 13 C 7.7000 2.6674 0.0 0
M  V30 14 C 7.7000 5.3349 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 O 10.0100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 2 12
M  V30 5 1 3 4
M  V30 6 1 5 9
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 615534-53-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1003878-38-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-1033226
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM b) [1-(3-bromophenyl)-2-(4-morpholinyl)ethyl]methylamine To a solution of
1-(3-bromophenyl)-2-(4-morpholinyl)ethanone (7.8 g, 27.0 mmol) in THF (50
mL) was added methylamine (100 mL, 200 mmol, 2M solution in THF). After
stirring for 15 min at room temperature, sodium cyanoborohydride (3.40 g,
54 mmol) was added followed by acetic acid (2 mL). The resultant mixture
was stirred at RT for 5 days. The mixture was concentrated under reduced
pressure. The residue was dissolved in ethyl acetate (200 mL) and washed
with 5% NaHCO3 (200 mL) and brine (200 mL). The organic layer was dried
(MgSO4) and concentrated to give
[1-(3-bromophenyl)-2-(4-morpholinyl)ethyl]methylamine as yellow oil (8.10
g, 100%) which solidified after standing at room temperature. MS (ESI):
299.6 [M+H]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-[1-biphenylyl-(morpholinyl- and
pyrrolidinyl)ethyl]glycinamide derivatives as antagonists of urotensin II
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Neeb, Michael J.; Sehon, Clark A.; Viet, Andrew Q.; Goodman, Krista B.;
Wang, Gren Z.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008011551 A1 2008-01-24

$RFMT $RIREG SCHEME20 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Chloromethyl)furan
C5H5ClO
617-88-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 Cl 5.1049 1.8517 0.0 0
M  V30 3 C 2.4374 1.8517 0.0 0
M  V30 4 C 2.2765 0.3202 0.0 0
M  V30 5 O 1.0306 2.4782 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-furanmethanamine
C6H9NO
4753-75-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 N 5.1049 1.8517 0.0 0
M  V30 3 C 6.4386 2.6217 0.0 0
M  V30 4 C 2.4374 1.8517 0.0 0
M  V30 5 C 2.2765 0.3202 0.0 0
M  V30 6 O 1.0306 2.4782 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 617-88-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4753-75-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-6808379
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of highly potent triazole antifungal derivatives by
heterocycle-benzene bioisosteric replacement
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jiang, Zhigan; Wang, Yan; Wang, Wenya; Wang, Shengzheng; Xu, Bo; Fan,
Guorong; Dong, Guoqiang; Liu, Yang; Yao, Jianzhong; Miao, Zhenyuan;
Zhang, Wannian; Sheng, Chunquan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2013), 6416-22

$RFMT $RIREG SCHEME21 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(E)-3-[6-[N-[(Methoxycarbonyl)methyl]amino]pyridin-3-yl]-N-methyl-N-[(2-methy...
C22H24N4O3
620174-36-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 4.6201 0.0 0
M  V30 2 N 7.0870 3.8501 0.0 0
M  V30 3 C 8.4207 4.6201 0.0 0
M  V30 4 C 7.0870 2.3100 0.0 0
M  V30 5 C 9.7545 3.8501 0.0 0
M  V30 6 O 8.4207 6.1601 0.0 0
M  V30 7 C 11.0882 4.6201 0.0 0
M  V30 8 C 5.4032 1.2881 0.0 0
M  V30 9 N 16.4229 1.5400 0.0 0
M  V30 10 C 17.7566 2.3100 0.0 0
M  V30 11 C 19.0903 1.5400 0.0 0
M  V30 12 O 20.4241 2.3100 0.0 0
M  V30 13 O 19.0903 0.0000 0.0 0
M  V30 14 C 21.7577 1.5400 0.0 0
M  V30 15 C 3.0127 4.4765 0.0 0
M  V30 16 C 4.4197 3.8501 0.0 0
M  V30 17 C 1.9823 3.3320 0.0 0
M  V30 18 C 2.5369 5.9411 0.0 0
M  V30 19 C 4.2586 2.3185 0.0 0
M  V30 20 N 2.7523 1.9983 0.0 0
M  V30 21 C 0.4759 3.6523 0.0 0
M  V30 22 C 1.0304 6.2614 0.0 0
M  V30 23 C 0.0000 5.1169 0.0 0
M  V30 24 C 12.4218 3.8501 0.0 0
M  V30 25 C 13.7555 4.6201 0.0 0
M  V30 26 C 12.4218 2.3100 0.0 0
M  V30 27 C 15.0893 3.8501 0.0 0
M  V30 28 N 13.7555 1.5400 0.0 0
M  V30 29 C 15.0893 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 5 7
M  V30 8 1 7 24
M  V30 9 1 8 19
M  V30 10 1 9 10
M  V30 11 1 9 29
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 1 19 20
M  V30 24 1 21 23
M  V30 25 2 22 23
M  V30 26 1 24 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-N-Methyl-3-[6-[[2-(methylamino)-2-oxoethyl]amino]-3-pyridinyl]-N-[(2-met...
C22H25N5O2
620174-38-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 4.6201 0.0 0
M  V30 2 N 7.0870 3.8501 0.0 0
M  V30 3 C 8.4207 4.6201 0.0 0
M  V30 4 C 7.0870 2.3100 0.0 0
M  V30 5 C 9.7545 3.8501 0.0 0
M  V30 6 O 8.4207 6.1601 0.0 0
M  V30 7 C 11.0882 4.6201 0.0 0
M  V30 8 C 5.4032 1.2881 0.0 0
M  V30 9 N 16.4229 1.5400 0.0 0
M  V30 10 C 17.7566 2.3100 0.0 0
M  V30 11 C 19.0903 1.5400 0.0 0
M  V30 12 N 20.4241 2.3100 0.0 0
M  V30 13 O 19.0903 0.0000 0.0 0
M  V30 14 C 21.7577 1.5400 0.0 0
M  V30 15 C 3.0127 4.4765 0.0 0
M  V30 16 C 4.4197 3.8501 0.0 0
M  V30 17 C 1.9823 3.3320 0.0 0
M  V30 18 C 2.5369 5.9411 0.0 0
M  V30 19 C 4.2586 2.3185 0.0 0
M  V30 20 N 2.7523 1.9983 0.0 0
M  V30 21 C 0.4759 3.6523 0.0 0
M  V30 22 C 1.0304 6.2614 0.0 0
M  V30 23 C 0.0000 5.1169 0.0 0
M  V30 24 C 12.4218 3.8501 0.0 0
M  V30 25 C 13.7555 4.6201 0.0 0
M  V30 26 C 12.4218 2.3100 0.0 0
M  V30 27 C 15.0893 3.8501 0.0 0
M  V30 28 N 13.7555 1.5400 0.0 0
M  V30 29 C 15.0893 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 5 7
M  V30 8 1 7 24
M  V30 9 1 8 19
M  V30 10 1 9 10
M  V30 11 1 9 29
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 1 19 20
M  V30 24 1 21 23
M  V30 25 2 22 23
M  V30 26 1 24 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 620174-36-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620174-38-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1631562
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM EXAMPLE 21 Preparation of
(E)-N-methyl-N-(2-methyl-1H-indol-3-ylmethyl)-3-[6-[N-(methy
laminocarbonylmethyl)amino]pyridin-3-yl]acrylamide [1000] To
(E)-3-[6-[N-(methoxycarbonylmethyl)amino]pyridin-3-yl]-N-methyl-N-(2-methyl-1H-indol-3-ylmethyl)acrylamide
(0.7 g, 1.8 mmole) was added a solution of 2.0 M methylamine in MeOH (50
mL). After stirring for 72 h the reaction was concentrated to dryness.
The residue was triturated with Et2O, filtered, and dried under vacuum to
give the title compound (0.703 g, 100%) as an off-white solid. MS (ES)
m/e 392.2 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME21 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(E)-3-[6-[N-[(Methoxycarbonyl)methyl]amino]pyridin-3-yl]-N-methyl-N-[(2-methy...
C22H24N4O3
620174-36-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 4.6201 0.0 0
M  V30 2 N 7.0870 3.8501 0.0 0
M  V30 3 C 8.4207 4.6201 0.0 0
M  V30 4 C 7.0870 2.3100 0.0 0
M  V30 5 C 9.7545 3.8501 0.0 0
M  V30 6 O 8.4207 6.1601 0.0 0
M  V30 7 C 11.0882 4.6201 0.0 0
M  V30 8 C 5.4032 1.2881 0.0 0
M  V30 9 N 16.4229 1.5400 0.0 0
M  V30 10 C 17.7566 2.3100 0.0 0
M  V30 11 C 19.0903 1.5400 0.0 0
M  V30 12 O 20.4241 2.3100 0.0 0
M  V30 13 O 19.0903 0.0000 0.0 0
M  V30 14 C 21.7577 1.5400 0.0 0
M  V30 15 C 3.0127 4.4765 0.0 0
M  V30 16 C 4.4197 3.8501 0.0 0
M  V30 17 C 1.9823 3.3320 0.0 0
M  V30 18 C 2.5369 5.9411 0.0 0
M  V30 19 C 4.2586 2.3185 0.0 0
M  V30 20 N 2.7523 1.9983 0.0 0
M  V30 21 C 0.4759 3.6523 0.0 0
M  V30 22 C 1.0304 6.2614 0.0 0
M  V30 23 C 0.0000 5.1169 0.0 0
M  V30 24 C 12.4218 3.8501 0.0 0
M  V30 25 C 13.7555 4.6201 0.0 0
M  V30 26 C 12.4218 2.3100 0.0 0
M  V30 27 C 15.0893 3.8501 0.0 0
M  V30 28 N 13.7555 1.5400 0.0 0
M  V30 29 C 15.0893 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 5 7
M  V30 8 1 7 24
M  V30 9 1 8 19
M  V30 10 1 9 10
M  V30 11 1 9 29
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 1 19 20
M  V30 24 1 21 23
M  V30 25 2 22 23
M  V30 26 1 24 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-N-Methyl-3-[6-[[2-(methylamino)-2-oxoethyl]amino]-3-pyridinyl]-N-[(2-met...
C22H25N5O2
620174-38-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 4.6201 0.0 0
M  V30 2 N 7.0870 3.8501 0.0 0
M  V30 3 C 8.4207 4.6201 0.0 0
M  V30 4 C 7.0870 2.3100 0.0 0
M  V30 5 C 9.7545 3.8501 0.0 0
M  V30 6 O 8.4207 6.1601 0.0 0
M  V30 7 C 11.0882 4.6201 0.0 0
M  V30 8 C 5.4032 1.2881 0.0 0
M  V30 9 N 16.4229 1.5400 0.0 0
M  V30 10 C 17.7566 2.3100 0.0 0
M  V30 11 C 19.0903 1.5400 0.0 0
M  V30 12 N 20.4241 2.3100 0.0 0
M  V30 13 O 19.0903 0.0000 0.0 0
M  V30 14 C 21.7577 1.5400 0.0 0
M  V30 15 C 3.0127 4.4765 0.0 0
M  V30 16 C 4.4197 3.8501 0.0 0
M  V30 17 C 1.9823 3.3320 0.0 0
M  V30 18 C 2.5369 5.9411 0.0 0
M  V30 19 C 4.2586 2.3185 0.0 0
M  V30 20 N 2.7523 1.9983 0.0 0
M  V30 21 C 0.4759 3.6523 0.0 0
M  V30 22 C 1.0304 6.2614 0.0 0
M  V30 23 C 0.0000 5.1169 0.0 0
M  V30 24 C 12.4218 3.8501 0.0 0
M  V30 25 C 13.7555 4.6201 0.0 0
M  V30 26 C 12.4218 2.3100 0.0 0
M  V30 27 C 15.0893 3.8501 0.0 0
M  V30 28 N 13.7555 1.5400 0.0 0
M  V30 29 C 15.0893 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 5 7
M  V30 8 1 7 24
M  V30 9 1 8 19
M  V30 10 1 9 10
M  V30 11 1 9 29
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 1 19 20
M  V30 24 1 21 23
M  V30 25 2 22 23
M  V30 26 1 24 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 620174-36-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620174-38-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8731458
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004082586 A2 2004-09-30

$RFMT $RIREG SCHEME22 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[5-[(1E)-3-[Methyl[(2-methyl-1H-indol-3-yl)methyl]amino]-3-oxo-1-propen-1-y...
C21H22N4O3
620174-37-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 4.6201 0.0 0
M  V30 2 N 7.0871 3.8501 0.0 0
M  V30 3 C 8.4207 4.6201 0.0 0
M  V30 4 C 7.0871 2.3100 0.0 0
M  V30 5 C 9.7545 3.8501 0.0 0
M  V30 6 O 8.4207 6.1601 0.0 0
M  V30 7 C 11.0882 4.6201 0.0 0
M  V30 8 C 5.4032 1.2881 0.0 0
M  V30 9 N 16.4230 1.5400 0.0 0
M  V30 10 C 17.7567 2.3100 0.0 0
M  V30 11 C 19.0903 1.5400 0.0 0
M  V30 12 O 19.0903 0.0000 0.0 0
M  V30 13 O 20.4242 2.3100 0.0 0
M  V30 14 C 3.0128 4.4766 0.0 0
M  V30 15 C 4.4197 3.8501 0.0 0
M  V30 16 C 1.9823 3.3320 0.0 0
M  V30 17 C 2.5369 5.9411 0.0 0
M  V30 18 C 4.2586 2.3185 0.0 0
M  V30 19 N 2.7523 1.9983 0.0 0
M  V30 20 C 0.4759 3.6523 0.0 0
M  V30 21 C 1.0306 6.2614 0.0 0
M  V30 22 C 0.0000 5.1169 0.0 0
M  V30 23 C 12.4219 3.8501 0.0 0
M  V30 24 C 12.4219 2.3100 0.0 0
M  V30 25 C 13.7555 4.6201 0.0 0
M  V30 26 C 13.7555 1.5400 0.0 0
M  V30 27 N 15.0893 3.8501 0.0 0
M  V30 28 C 15.0893 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 5 7
M  V30 8 1 7 23
M  V30 9 1 8 18
M  V30 10 1 9 10
M  V30 11 1 9 28
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 2 15 18
M  V30 19 1 16 19
M  V30 20 2 16 20
M  V30 21 1 17 21
M  V30 22 1 18 19
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 25 1 23 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-N-Methyl-3-[6-[[2-(methylamino)-2-oxoethyl]amino]-3-pyridinyl]-N-[(2-met...
C22H25N5O2
620174-38-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 4.6201 0.0 0
M  V30 2 N 7.0870 3.8501 0.0 0
M  V30 3 C 8.4207 4.6201 0.0 0
M  V30 4 C 7.0870 2.3100 0.0 0
M  V30 5 C 9.7545 3.8501 0.0 0
M  V30 6 O 8.4207 6.1601 0.0 0
M  V30 7 C 11.0882 4.6201 0.0 0
M  V30 8 C 5.4032 1.2881 0.0 0
M  V30 9 N 16.4229 1.5400 0.0 0
M  V30 10 C 17.7566 2.3100 0.0 0
M  V30 11 C 19.0903 1.5400 0.0 0
M  V30 12 N 20.4241 2.3100 0.0 0
M  V30 13 O 19.0903 0.0000 0.0 0
M  V30 14 C 21.7577 1.5400 0.0 0
M  V30 15 C 3.0127 4.4765 0.0 0
M  V30 16 C 4.4197 3.8501 0.0 0
M  V30 17 C 1.9823 3.3320 0.0 0
M  V30 18 C 2.5369 5.9411 0.0 0
M  V30 19 C 4.2586 2.3185 0.0 0
M  V30 20 N 2.7523 1.9983 0.0 0
M  V30 21 C 0.4759 3.6523 0.0 0
M  V30 22 C 1.0304 6.2614 0.0 0
M  V30 23 C 0.0000 5.1169 0.0 0
M  V30 24 C 12.4218 3.8501 0.0 0
M  V30 25 C 13.7555 4.6201 0.0 0
M  V30 26 C 12.4218 2.3100 0.0 0
M  V30 27 C 15.0893 3.8501 0.0 0
M  V30 28 N 13.7555 1.5400 0.0 0
M  V30 29 C 15.0893 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 5 7
M  V30 8 1 7 24
M  V30 9 1 8 19
M  V30 10 1 9 10
M  V30 11 1 9 29
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 1 19 20
M  V30 24 1 21 23
M  V30 25 2 22 23
M  V30 26 1 24 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 620174-37-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620174-38-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2183490
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-(heteroaryl)methylacrylamides as Fab I inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Burgess, Walter J.; Jakas, Dalia; Huffman, William F.; Miller, William
H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas, Irene N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003088897 A2 2003-10-30

$RFMT $RIREG SCHEME23 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(5-Bromo-2-pyridinyl)glycine methyl ester
C8H9BrN2O2
620175-59-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 2.6673 0.0 0
M  V30 2 C 6.9302 1.3337 0.0 0
M  V30 3 C 8.4702 1.3337 0.0 0
M  V30 4 O 9.2402 0.0000 0.0 0
M  V30 5 O 9.2402 2.6673 0.0 0
M  V30 6 C 10.7802 0.0000 0.0 0
M  V30 7 Br 0.0000 2.6673 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 10 N 3.8501 1.3337 0.0 0
M  V30 11 C 2.3101 4.0010 0.0 0
M  V30 12 C 2.3101 1.3337 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(5-Bromo-2-pyridinyl)amino]-N-methylacetamide
C8H10BrN3O
620175-60-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 2.6673 0.0 0
M  V30 2 C 6.9302 1.3337 0.0 0
M  V30 3 C 8.4702 1.3337 0.0 0
M  V30 4 N 9.2402 0.0000 0.0 0
M  V30 5 O 9.2402 2.6673 0.0 0
M  V30 6 C 10.7802 0.0000 0.0 0
M  V30 7 Br 0.0000 2.6673 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 10 N 3.8501 1.3337 0.0 0
M  V30 11 C 2.3101 4.0010 0.0 0
M  V30 12 C 2.3101 1.3337 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 620175-59-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620175-60-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1031682
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM d) 5-Bromo-2-(methylaminocarbonylmethyl)aminopyridine [0720] A solution
of 2.0 M methylamine in MeOH (75 mL) was added to
5-bromo-2-(methoxycarbonylmethyl)aminopyridine (2.9 g, 12 mmole). The
reaction was stirred for 24 h then was concentrated to dryness. The
residue was triturated with 10% petroleum ether/Et2O (100 mL), then was
collected and dried under vacuum to give the title compound (2.96 g,
100%) as an off-white solid. MS (ES) m/e 244.2 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME23 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(5-Bromo-2-pyridinyl)glycine methyl ester
C8H9BrN2O2
620175-59-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 2.6673 0.0 0
M  V30 2 C 6.9302 1.3337 0.0 0
M  V30 3 C 8.4702 1.3337 0.0 0
M  V30 4 O 9.2402 0.0000 0.0 0
M  V30 5 O 9.2402 2.6673 0.0 0
M  V30 6 C 10.7802 0.0000 0.0 0
M  V30 7 Br 0.0000 2.6673 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 10 N 3.8501 1.3337 0.0 0
M  V30 11 C 2.3101 4.0010 0.0 0
M  V30 12 C 2.3101 1.3337 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(5-Bromo-2-pyridinyl)amino]-N-methylacetamide
C8H10BrN3O
620175-60-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 2.6673 0.0 0
M  V30 2 C 6.9302 1.3337 0.0 0
M  V30 3 C 8.4702 1.3337 0.0 0
M  V30 4 N 9.2402 0.0000 0.0 0
M  V30 5 O 9.2402 2.6673 0.0 0
M  V30 6 C 10.7802 0.0000 0.0 0
M  V30 7 Br 0.0000 2.6673 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 10 N 3.8501 1.3337 0.0 0
M  V30 11 C 2.3101 4.0010 0.0 0
M  V30 12 C 2.3101 1.3337 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 620175-59-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620175-60-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8148249
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004082586 A2 2004-09-30

$RFMT $RIREG SCHEME23 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(5-Bromo-2-pyridinyl)glycine methyl ester
C8H9BrN2O2
620175-59-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 2.6673 0.0 0
M  V30 2 C 6.9302 1.3337 0.0 0
M  V30 3 C 8.4702 1.3337 0.0 0
M  V30 4 O 9.2402 0.0000 0.0 0
M  V30 5 O 9.2402 2.6673 0.0 0
M  V30 6 C 10.7802 0.0000 0.0 0
M  V30 7 Br 0.0000 2.6673 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 10 N 3.8501 1.3337 0.0 0
M  V30 11 C 2.3101 4.0010 0.0 0
M  V30 12 C 2.3101 1.3337 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(5-Bromo-2-pyridinyl)amino]-N-methylacetamide
C8H10BrN3O
620175-60-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 2.6673 0.0 0
M  V30 2 C 6.9302 1.3337 0.0 0
M  V30 3 C 8.4702 1.3337 0.0 0
M  V30 4 N 9.2402 0.0000 0.0 0
M  V30 5 O 9.2402 2.6673 0.0 0
M  V30 6 C 10.7802 0.0000 0.0 0
M  V30 7 Br 0.0000 2.6673 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 10 N 3.8501 1.3337 0.0 0
M  V30 11 C 2.3101 4.0010 0.0 0
M  V30 12 C 2.3101 1.3337 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 620175-59-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620175-60-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1609796
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-(heteroaryl)methylacrylamides as Fab I inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Burgess, Walter J.; Jakas, Dalia; Huffman, William F.; Miller, William
H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas, Irene N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003088897 A2 2003-10-30

$RFMT $RIREG SCHEME24 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzyl isothiocyanate
C8H7NS
622-78-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 N 5.3901 2.6673 0.0 0
M  V30 3 C 6.9301 2.6673 0.0 0
M  V30 4 S 8.4701 2.6673 0.0 0
M  V30 5 C 3.0800 1.3337 0.0 0
M  V30 6 C 2.3100 2.6673 0.0 0
M  V30 7 C 2.3100 0.0000 0.0 0
M  V30 8 C 0.7700 2.6673 0.0 0
M  V30 9 C 0.7700 0.0000 0.0 0
M  V30 10 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 2 3 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Benzyl-3-methyl-2-thiourea
C9H12N2S
2740-94-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 N 5.3348 2.3100 0.0 0
M  V30 3 C 6.6684 1.5400 0.0 0
M  V30 4 N 8.0022 2.3100 0.0 0
M  V30 5 S 6.6684 0.0000 0.0 0
M  V30 6 C 9.3359 1.5400 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 C 2.6675 3.8500 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 1.3337 4.6201 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 622-78-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2740-94-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-316-CAS-17841085
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalytic Asymmetric Synthesis of Quaternary Barbituric Acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM del Pozo, Sandra; Vera, Silvia; Oiarbide, Mikel; Palomo, Claudio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2017), 139(43), 15308-15311

$RFMT $RIREG SCHEME25 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,5-Dibromopyridine
C5H3Br2N
624-28-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 1.3337 0.0 0
M  V30 2 Br 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 N 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methyl-2-pyridinamine
C6H7BrN2
84539-30-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 Br 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 N 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 624-28-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 84539-30-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-1221231
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Intermediate VIII. N-Methyl-5-(tributylstannyl)pyridin-2-amine. Step 1.
5-Bromo-N-mcthylpyridin-2-amine. Intermediate VIII was prepared using
similar methods described in WO2005/023761. 2,5-Dibromopyridine (2.5 g,
10.6 mmol) was treated with a 33% MeNH2 /EtOH (13.2 ml, 106 mmol) at 80°C
for several days. The solvent was evaporated, the residue was dissolved
in 1M HCl and the aqueous solution was washed with DCM. The acidic layer
was basified with 1 M NaOH to pH ∼11 and the milky suspension was
extracted with DCM. The organic layer was dried over MgSO4 and evaporated
to give the target product as a brown solid in quantitative yield.
(Calculated mass: 187.0, observed mass: 188.3).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic naphthalenyl compounds as cytokine inhibitors
useful in treating and preventing cytokine-mediated diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Garrido Montalban, Antonio; Dahl, Russell; Boman, Erik; Ernst, Justin;
Lum, Christopher; Wang, Zhijun; Urban, Jan; Pei, Yazhong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008089034 A2 2008-07-24

$RFMT $RIREG SCHEME26 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl fumarate
C6H8O4
624-49-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3101 0.0 0
M  V30 2 C 4.0012 1.5400 0.0 0
M  V30 3 O 1.3337 1.5400 0.0 0
M  V30 4 O 2.6675 3.8501 0.0 0
M  V30 5 C 5.3348 2.3101 0.0 0
M  V30 6 C 0.0000 2.3101 0.0 0
M  V30 7 C 6.6685 1.5400 0.0 0
M  V30 8 O 8.0023 2.3101 0.0 0
M  V30 9 O 6.6685 0.0000 0.0 0
M  V30 10 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,4-Dimethyl N-methylaspartate
C7H13NO4
144300-47-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.6674 0.0 0
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 C 2.3100 2.6674 0.0 0
M  V30 4 N 4.6200 1.3338 0.0 0
M  V30 5 C 6.1600 4.0011 0.0 0
M  V30 6 O 1.5400 4.0011 0.0 0
M  V30 7 O 1.5400 1.3338 0.0 0
M  V30 8 C 3.8500 0.0000 0.0 0
M  V30 9 O 6.9300 5.3349 0.0 0
M  V30 10 O 6.9300 2.6674 0.0 0
M  V30 11 C 0.0000 4.0011 0.0 0
M  V30 12 C 8.4700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 9 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 624-49-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 144300-47-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-2808029
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-methyl-DL-aspartic acid dimethyl ester 6 Method A: Dimethyl fumarate 5
(28.8 g, 0.2mol) was suspended in 50 ml abs. ethanol, and 25ml of 8M
ethanol solution of methylamine (0.2mol) was added at 0 °C. The reaction
mixture was stirred until complete dissolution of 5, and for three
additional hours. The solvent was evaporated in vacuo to dryness,
yellowish oil of 6 was obtained. For the analytical sample, the oil was
distilled in vacuo. Colorless oil, yield quantitative. bp 68-70 °C at
0.3mmHg (lit. 60-61 °C=0.25 Torr; Stadler and Hofmann, 1962), nD = 1.4378
at 20 °C. 1H-NMR (DMSO-d6, 600MHz): δ = 3.64 (3H, s, OCH3), 3.58 (3H, s,
OCH3), 3.45 (1H, t, 3J1(H,H) = 6.68 Hz, 3J2(H,H) = 7.02 Hz, C-H), 2.65
(1H, d-d, 3J1(H,H) = 6.68 Hz, 2J3(H,H) =15.80Hz, H-CH), 2.55 (1H, d-d,
3J2(H,H) = 7.02 Hz, 2J3(H,H) =15.80Hz, HC-H), 2.23 (3H, s, NCH3) MW =
175.19 ESI-MS m/z: 175.2 [M+H]+ Anal. Calc. for C7H13NO4 C = 43.95% H =
6.18% N = 9.29% Found C = 44.30% H = 6.08% N = 9.39%.
$DTYPE RXN:VAR(1):NOTES
$DATUM Michael addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Methods for syntheses of N-methyl-DL-aspartic acid derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Boros, M.; Koekoesi, J.; Vamos, J.; Koevesdi, I.; Noszal, B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Amino Acids (2007), 33(4), 709-717

$RFMT $RIREG SCHEME27 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-amino-6-[3-[[(phenylmethyl)amino]methyl]phenyl]-2-pyrazinecarboxylate
C20H20N4O2
625470-76-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 3.0801 0.0 0
M  V30 2 O 1.3337 2.3101 0.0 0
M  V30 3 O 2.6675 4.6201 0.0 0
M  V30 4 C 0.0000 3.0801 0.0 0
M  V30 5 C 12.0035 2.3101 0.0 0
M  V30 6 N 13.3372 3.0801 0.0 0
M  V30 7 C 14.6708 2.3101 0.0 0
M  V30 8 N 2.6675 0.0000 0.0 0
M  V30 9 C 6.6685 2.3101 0.0 0
M  V30 10 N 5.3348 3.0801 0.0 0
M  V30 11 C 6.6685 0.7700 0.0 0
M  V30 12 C 4.0012 2.3101 0.0 0
M  V30 13 N 5.3348 0.0000 0.0 0
M  V30 14 C 4.0012 0.7700 0.0 0
M  V30 15 C 8.0023 3.0801 0.0 0
M  V30 16 C 9.3360 2.3101 0.0 0
M  V30 17 C 8.0023 4.6201 0.0 0
M  V30 18 C 10.6697 3.0801 0.0 0
M  V30 19 C 9.3360 5.3901 0.0 0
M  V30 20 C 10.6697 4.6201 0.0 0
M  V30 21 C 16.0045 3.0801 0.0 0
M  V30 22 C 17.3383 2.3101 0.0 0
M  V30 23 C 16.0045 4.6201 0.0 0
M  V30 24 C 18.6720 3.0801 0.0 0
M  V30 25 C 17.3383 5.3901 0.0 0
M  V30 26 C 18.6720 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 18
M  V30 7 1 6 7
M  V30 8 1 7 21
M  V30 9 1 8 14
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 9 15
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-N-methyl-6-[3-[[(phenylmethyl)amino]methyl]phenyl]-2-pyrazinecarboxamide
C20H21N5O
625462-60-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 3.0801 0.0 0
M  V30 2 N 1.3337 2.3101 0.0 0
M  V30 3 O 2.6675 4.6201 0.0 0
M  V30 4 C 0.0000 3.0801 0.0 0
M  V30 5 C 12.0035 2.3101 0.0 0
M  V30 6 N 13.3372 3.0801 0.0 0
M  V30 7 C 14.6708 2.3101 0.0 0
M  V30 8 N 2.6675 0.0000 0.0 0
M  V30 9 C 6.6685 2.3101 0.0 0
M  V30 10 N 5.3348 3.0801 0.0 0
M  V30 11 C 6.6685 0.7700 0.0 0
M  V30 12 C 4.0012 2.3101 0.0 0
M  V30 13 N 5.3348 0.0000 0.0 0
M  V30 14 C 4.0012 0.7700 0.0 0
M  V30 15 C 8.0023 3.0801 0.0 0
M  V30 16 C 9.3360 2.3101 0.0 0
M  V30 17 C 8.0023 4.6201 0.0 0
M  V30 18 C 10.6697 3.0801 0.0 0
M  V30 19 C 9.3360 5.3901 0.0 0
M  V30 20 C 10.6697 4.6201 0.0 0
M  V30 21 C 16.0045 3.0801 0.0 0
M  V30 22 C 17.3383 2.3101 0.0 0
M  V30 23 C 16.0045 4.6201 0.0 0
M  V30 24 C 18.6720 3.0801 0.0 0
M  V30 25 C 17.3383 5.3901 0.0 0
M  V30 26 C 18.6720 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 18
M  V30 7 1 6 7
M  V30 8 1 7 21
M  V30 9 1 8 14
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 9 15
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 625470-76-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 625462-60-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-2727745
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed vessel, methylamine gas used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted pyrazines as protein kinase modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Buhr, Chris A.; Baik, Tae-Gon; Ma, Sunghoon; Tesfai, Zerom; Wang,
Longcheng; Co, Erick Wang; Epshteyn, Sergey; Kennedy, Abigail R.; Chen,
Baili; Dubenko, Larisa; Anand, Neel Kumar; Tsang, Tsze H.; Nuss, John M.;
Peto, Csaba J.; Rice, Kenneth D.; Ibrahim, Mohamed Abdulkader; Schnepp,
Kevin Luke; Shi, Xian; Leahy, James William; Chen, Jeff; Dalrymple, Lisa
Esther; Forsyth, Thimothy Patrick; Huynh, Tai Phat; Mann, Grace; Mann,
Lary Wayne; Takeuchi, Craig Stacy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003093297 A2 2003-11-13

$RFMT $RIREG SCHEME28 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-(4-fluorophenyl)-6-(1-methylethyl)-2-[(phenylmethyl)sulfonyl]-5-pyri...
C22H21FN2O4S
627102-15-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 2.3101 0.0 0
M  V30 2 O 4.0010 0.7700 0.0 0
M  V30 3 O 2.6673 3.0801 0.0 0
M  V30 4 C 2.6673 0.0000 0.0 0
M  V30 5 C 6.6685 0.7700 0.0 0
M  V30 6 C 5.3348 0.0000 0.0 0
M  V30 7 C 8.0022 0.0000 0.0 0
M  V30 8 S 9.3358 5.3901 0.0 0 VAL=6
M  V30 9 C 10.6697 6.1601 0.0 0
M  V30 10 O 10.1059 4.0564 0.0 0
M  V30 11 O 8.5658 6.7238 0.0 0
M  V30 12 F 0.0000 7.7002 0.0 0
M  V30 13 C 5.3348 4.6201 0.0 0
M  V30 14 C 5.3348 3.0801 0.0 0
M  V30 15 N 6.6685 5.3901 0.0 0
M  V30 16 C 6.6685 2.3101 0.0 0
M  V30 17 C 8.0022 4.6201 0.0 0
M  V30 18 N 8.0022 3.0801 0.0 0
M  V30 19 C 4.0010 5.3901 0.0 0
M  V30 20 C 4.0010 6.9302 0.0 0
M  V30 21 C 2.6673 4.6201 0.0 0
M  V30 22 C 2.6673 7.7002 0.0 0
M  V30 23 C 1.3337 5.3901 0.0 0
M  V30 24 C 1.3337 6.9302 0.0 0
M  V30 25 C 12.0033 5.3901 0.0 0
M  V30 26 C 12.0033 3.8501 0.0 0
M  V30 27 C 13.3370 6.1601 0.0 0
M  V30 28 C 13.3370 3.0801 0.0 0
M  V30 29 C 14.6707 5.3901 0.0 0
M  V30 30 C 14.6707 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 16
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 8 11
M  V30 11 1 8 17
M  V30 12 1 9 25
M  V30 13 1 12 24
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 13 19
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-(4-fluorophenyl)-2-(methylamino)-6-(1-methylethyl)-5-pyrimidinecarbo...
C16H18FN3O2
160009-36-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6674 0.0 0
M  V30 2 O 3.8500 1.3336 0.0 0
M  V30 3 O 6.1600 2.6674 0.0 0
M  V30 4 C 4.6200 0.0000 0.0 0
M  V30 5 C 1.5400 2.6674 0.0 0
M  V30 6 C 0.0000 2.6674 0.0 0
M  V30 7 C 2.3100 1.3336 0.0 0
M  V30 8 N 1.5400 8.0021 0.0 0
M  V30 9 C 0.0000 8.0021 0.0 0
M  V30 10 F 10.7800 5.3347 0.0 0
M  V30 11 C 4.6200 5.3347 0.0 0
M  V30 12 C 3.8500 4.0011 0.0 0
M  V30 13 N 3.8500 6.6685 0.0 0
M  V30 14 C 2.3100 4.0011 0.0 0
M  V30 15 C 2.3100 6.6685 0.0 0
M  V30 16 N 1.5400 5.3347 0.0 0
M  V30 17 C 6.1600 5.3347 0.0 0
M  V30 18 C 6.9300 6.6685 0.0 0
M  V30 19 C 6.9300 4.0011 0.0 0
M  V30 20 C 8.4700 6.6685 0.0 0
M  V30 21 C 8.4700 4.0011 0.0 0
M  V30 22 C 9.2400 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 14
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 1 10 22
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 17
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 627102-15-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 160009-36-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-5443637
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for the preparation of rosuvastatin
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kumar, Yatendra; De, Shantanu; Rafeeq, Mohammad; Meeran, Hashim Nizar
Poovanathil Nagoor; Sathyanarayana, Swargam
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003097614 A2 2003-11-27

$RFMT $RIREG SCHEME29 STEP1
$RXN



  2  1
$MOL
3-Bromo-5-nitrobenzoic acid
C7H4BrNO4
6307-83-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3336 4.6200 0.0 0
M  V30 2 O 0.0000 3.8500 0.0 0
M  V30 3 O 1.3336 6.1600 0.0 0
M  V30 4 N 6.6685 4.6200 0.0 0 VAL=5
M  V30 5 O 6.6685 6.1600 0.0 0
M  V30 6 O 8.0021 3.8500 0.0 0
M  V30 7 Br 4.0011 0.0000 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 C 2.6674 2.3100 0.0 0
M  V30 11 C 5.3347 3.8500 0.0 0
M  V30 12 C 4.0011 1.5400 0.0 0
M  V30 13 C 5.3347 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 11
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-N-methyl-5-nitrobenzamide
C8H7BrN2O3
90050-52-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 4.6201 0.0 0
M  V30 2 N 8.0022 3.8500 0.0 0
M  V30 3 O 6.6684 6.1601 0.0 0
M  V30 4 C 9.3359 4.6201 0.0 0
M  V30 5 N 1.3337 4.6201 0.0 0 VAL=5
M  V30 6 O 1.3337 6.1601 0.0 0
M  V30 7 O 0.0000 3.8500 0.0 0
M  V30 8 Br 4.0011 0.0000 0.0 0
M  V30 9 C 5.3348 3.8500 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 5.3348 2.3100 0.0 0
M  V30 12 C 2.6675 3.8500 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 2.6675 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 12
M  V30 8 1 8 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 6307-83-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 90050-52-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2309319
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM From rigid cyclic templates to conformationally stabilized acyclic
scaffolds. Part I: The discovery of CCR3 antagonist development candidate
BMS-639623 with picomolar inhibition potency against eosinophil
chemotaxis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Santella, Joseph B.; Gardner, Daniel S.; Yao, Wenqing; Shi, Chongsheng;
Reddy, Prabhakar; Tebben, Andrew J.; DeLucca, George V.; Wacker, Dean A.;
Watson, Paul S.; Welch, Patricia K.; Wadman, Eric A.; Davies, Paul;
Solomon, Kimberly A.; Graden, Dani M.; Yeleswaram, Swamy; Mandlekar,
Sandhya; Kariv, Ilona; Decicco, Carl P.; Ko, Soo S.; Carter, Percy H.;
Duncia, John V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2008), 18(2), 576-585

$RFMT $RIREG SCHEME30 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Benzyloxy)-4-methoxybenzaldehyde
C15H14O3
6346-05-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 4.0011 0.0 0
M  V30 2 C 6.9300 5.3347 0.0 0
M  V30 3 O 4.6200 1.3338 0.0 0
M  V30 4 C 3.8500 0.0000 0.0 0
M  V30 5 C 1.5400 6.6685 0.0 0
M  V30 6 O 0.0000 6.6685 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 3.8500 2.6674 0.0 0
M  V30 9 C 3.8500 5.3347 0.0 0
M  V30 10 C 2.3100 2.6674 0.0 0
M  V30 11 C 2.3100 5.3347 0.0 0
M  V30 12 C 1.5400 4.0011 0.0 0
M  V30 13 C 8.4700 5.3347 0.0 0
M  V30 14 C 9.2400 6.6685 0.0 0
M  V30 15 C 9.2400 4.0011 0.0 0
M  V30 16 C 10.7800 6.6685 0.0 0
M  V30 17 C 10.7800 4.0011 0.0 0
M  V30 18 C 11.5500 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 13
M  V30 4 1 3 4
M  V30 5 1 3 8
M  V30 6 2 5 6
M  V30 7 1 5 11
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[4-Methoxy-3-(phenylmethoxy)phenyl]methylene]methanamine
C16H17NO2
94707-56-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9300 4.0011 0.0 0
M  V30 2 C 7.7000 5.3347 0.0 0
M  V30 3 O 5.3900 1.3336 0.0 0
M  V30 4 C 4.6200 0.0000 0.0 0
M  V30 5 C 2.3100 6.6685 0.0 0
M  V30 6 N 0.7700 6.6685 0.0 0
M  V30 7 C 0.0000 8.0021 0.0 0
M  V30 8 C 5.3900 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 4.6200 5.3347 0.0 0
M  V30 11 C 3.0800 2.6674 0.0 0
M  V30 12 C 3.0800 5.3347 0.0 0
M  V30 13 C 2.3100 4.0011 0.0 0
M  V30 14 C 9.2400 5.3347 0.0 0
M  V30 15 C 10.0100 4.0011 0.0 0
M  V30 16 C 10.0100 6.6685 0.0 0
M  V30 17 C 11.5500 4.0011 0.0 0
M  V30 18 C 11.5500 6.6685 0.0 0
M  V30 19 C 12.3200 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 14
M  V30 4 1 3 4
M  V30 5 1 3 9
M  V30 6 2 5 6 CFG=2
M  V30 7 1 5 12
M  V30 8 1 6 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6346-05-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 94707-56-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-6923013
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Quantitative Solid-State Reactions of Amines with Carbonyl Compounds and
Isothiocyanates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kaupp, Gerd; Schmeyers, Jens; Boy, Juergen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2000), 56(36), 6899-6911

$RFMT $RIREG SCHEME31 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(Benzyloxycarbonyl)-D-proline
C13H15NO4
6404-31-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.8384 3.7710 0.0 0
M  V30 2 O 6.3784 3.7710 0.0 0
M  V30 3 O 4.0684 5.1048 0.0 0
M  V30 4 C 7.1484 5.1048 0.0 0
M  V30 5 C 1.5063 3.4208 0.0 0
M  V30 6 O 1.9823 4.8855 0.0 0
M  V30 7 O 0.0000 3.1006 0.0 0
M  V30 8 N 4.0684 2.4374 0.0 0
M  V30 9 C 2.5368 2.2764 0.0 0 CFG=1
M  V30 10 C 4.6947 1.0306 0.0 0
M  V30 11 C 2.2167 0.7700 0.0 0
M  V30 12 C 3.5503 0.0000 0.0 0
M  V30 13 C 8.6884 5.1048 0.0 0
M  V30 14 C 9.4584 6.4384 0.0 0
M  V30 15 C 9.4584 3.7710 0.0 0
M  V30 16 C 10.9984 6.4384 0.0 0
M  V30 17 C 10.9984 3.7710 0.0 0
M  V30 18 C 11.7684 5.1048 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 13
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 9 5 CFG=3
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-Pyrrolidinecarboxylic acid, 2-[(methylamino)carbonyl]-, phenylmethyl ester,...
C14H18N2O3
66877-06-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 3.7710 0.0 0
M  V30 2 O 5.3900 3.7710 0.0 0
M  V30 3 O 7.6999 5.1048 0.0 0
M  V30 4 C 4.6200 5.1048 0.0 0
M  V30 5 C 10.2620 3.4208 0.0 0
M  V30 6 N 11.7683 3.1006 0.0 0
M  V30 7 O 9.7862 4.8855 0.0 0
M  V30 8 C 12.7989 4.2450 0.0 0
M  V30 9 N 7.6999 2.4373 0.0 0
M  V30 10 C 9.2316 2.2764 0.0 0 CFG=1
M  V30 11 C 7.0736 1.0306 0.0 0
M  V30 12 C 9.5518 0.7700 0.0 0
M  V30 13 C 8.2180 0.0000 0.0 0
M  V30 14 C 3.0800 5.1048 0.0 0
M  V30 15 C 2.3100 3.7710 0.0 0
M  V30 16 C 2.3100 6.4384 0.0 0
M  V30 17 C 0.7700 3.7710 0.0 0
M  V30 18 C 0.7700 6.4384 0.0 0
M  V30 19 C 0.0000 5.1048 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 10 5 CFG=1
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6404-31-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 66877-06-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2971197
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, characterisation and in vitro cytotoxicity studies of a series
of chiral platinum(II) complexes based on the 2-aminomethylpyrrolidine
ligand: X-ray crystal structure of [PtCl2(R-dimepyrr)] (R-dimepyrr =
N-dimethyl-2(R)-aminomethylpyrrolidine)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Diakos, Connie I.; Zhang, Mei; Beale, Philip J.; Fenton, Ronald R.;
Hambley, Trevor W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2009), 44(7), 2807-2814

$RFMT $RIREG SCHEME32 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Acetylamino)-N-[2-(4-hydroxyphenyl)ethyl]-2-propenamide
C13H16N2O3
646071-98-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 N 8.0022 1.5400 0.0 0
M  V30 4 C 9.3358 2.3101 0.0 0
M  V30 5 C 10.6697 1.5400 0.0 0
M  V30 6 O 9.3358 3.8501 0.0 0
M  V30 7 N 12.0033 2.3101 0.0 0
M  V30 8 C 10.6697 0.0000 0.0 0
M  V30 9 C 13.3370 1.5400 0.0 0
M  V30 10 C 13.3370 0.0000 0.0 0
M  V30 11 O 14.6707 2.3101 0.0 0
M  V30 12 O 0.0000 4.6201 0.0 0
M  V30 13 C 4.0010 2.3101 0.0 0
M  V30 14 C 4.0010 3.8501 0.0 0
M  V30 15 C 2.6673 1.5400 0.0 0
M  V30 16 C 2.6673 4.6201 0.0 0
M  V30 17 C 1.3337 2.3101 0.0 0
M  V30 18 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 12 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Acetylamino)-N-[2-(4-hydroxyphenyl)ethyl]-3-(methylamino)propanamide
C14H21N3O3
646071-52-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 6.6685 0.0 0
M  V30 2 C 6.9300 5.3347 0.0 0
M  V30 3 N 5.3900 5.3347 0.0 0
M  V30 4 C 4.6200 4.0011 0.0 0
M  V30 5 C 3.0800 4.0011 0.0 0
M  V30 6 O 5.3900 2.6674 0.0 0
M  V30 7 N 2.3100 5.3347 0.0 0
M  V30 8 C 2.3100 2.6674 0.0 0
M  V30 9 C 0.7700 5.3347 0.0 0
M  V30 10 N 3.0800 1.3336 0.0 0
M  V30 11 C 0.0000 4.0011 0.0 0
M  V30 12 O 0.0000 6.6685 0.0 0
M  V30 13 C 2.3100 0.0000 0.0 0
M  V30 14 O 13.8600 6.6685 0.0 0
M  V30 15 C 9.2400 6.6685 0.0 0
M  V30 16 C 10.0100 8.0021 0.0 0
M  V30 17 C 10.0100 5.3347 0.0 0
M  V30 18 C 11.5500 8.0021 0.0 0
M  V30 19 C 11.5500 5.3347 0.0 0
M  V30 20 C 12.3200 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 1 14 20
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 646071-98-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 646071-52-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-4077574
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Addition of Amines
to Dehydroalanine Amides (1a-e). A mixture of 1 (0.5 mmol) and amine (5
mmol) in water (5 mL) was stirred at room temperature until the reaction
was complete. The reaction mixture was then freeze-dried. The desired
product 2. Alternatively, the reaction mixture was acidified with aq HCl
(1 N, 5 mL) and purified on a C-18 reverse-phase column using MeOH/water
mixtures. Product-containing fractions were combined, concentrated, and
freeze-dried to give 2.
2-Acetylamino-N-[2-(4-hydroxyphenyl)ethyl]-3-methylaminopropionamide
(2b): white powder (0.1402 g, 100%); 1H NMR (500 MHz, DMSO-d 6) δ 7.98
(1H, t, J = 5.5 Hz), 7.86 (1H, d, J = 7.9 Hz), 6.98 (2H, d, J = 8.6 Hz),
6.66 (2H, d, J = 8.6 Hz), 4.30-4.26 (1H, m), 3.45-3.13 (4H, m), 2.62-2.55
(4H, m), 2.22 (3H, s), 1.84 (3H, m); 13C NMR (125.77 MHz, DMSOd 6) δ
170.6, 169.1, 155.5, 129.4, 129.3, 114.9, 52.8, 52.0, 40.4, 35.4, 34.1,
22.5; HRMS calcd for C14H22N3O3 (M + H) 280.1661, found 280.1663. Anal.
Calcd for C14H21N3O3•0.2H2O•0.1CH3NH2: C, 59.26; H, 7.57; N, 15.18.
Found: C, 59.26; H, 7.51; N, 15.36.
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-solvent, Michael addn. reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Michael addition of amines and thiols to dehydroalanine amides: a
remarkable rate acceleration in water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Naidu, B. Narasimhulu; Sorenson, Margaret E.; Connolly, Timothy P.; Ueda,
Yasutsugu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2003), 68(26), 10098-10102

$RFMT $RIREG SCHEME33 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3aR,8aR)-3,3a,8,8a-Tetrahydro-5-methoxy-3a,8-dimethyl-2H-furo[2,3-b]indo...
C13H15NO3
65131-83-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.5208 5.2023 0.0 0
M  V30 2 C 3.1398 0.0000 0.0 0
M  V30 3 O 9.0814 4.2504 0.0 0
M  V30 4 C 10.4151 3.4804 0.0 0
M  V30 5 O 0.0000 5.6315 0.0 0
M  V30 6 C 5.0803 3.4804 0.0 0
M  V30 7 C 3.6158 3.9564 0.0 0 CFG=2
M  V30 8 C 5.0803 1.9404 0.0 0
M  V30 9 C 6.4140 4.2504 0.0 0
M  V30 10 C 2.7106 2.7104 0.0 0 CFG=1
M  V30 11 C 2.7106 5.2023 0.0 0
M  V30 12 N 3.6156 1.4645 0.0 0
M  V30 13 C 6.4140 1.1704 0.0 0
M  V30 14 C 7.7478 3.4804 0.0 0
M  V30 15 O 1.2459 3.1864 0.0 0
M  V30 16 C 1.2459 4.7264 0.0 0
M  V30 17 C 7.7478 1.9404 0.0 0
M  V30 18 H 1.8054 1.4645 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 7 1 CFG=1
M  V30 2 1 2 12
M  V30 3 1 3 4
M  V30 4 1 3 14
M  V30 5 2 5 16
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 8 13
M  V30 13 1 9 14
M  V30 14 1 10 12
M  V30 15 1 10 15
M  V30 16 1 10 18 CFG=1
M  V30 17 1 11 16
M  V30 18 1 13 17
M  V30 19 2 14 17
M  V30 20 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 7 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(3aR,8aS)-1,2,3,3a,8,8a-Hexahydro-5-methoxy-1,3a,8-trimethylpyrrolo[2,3-b...
C14H20N2O
65131-82-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.5208 5.2024 0.0 0
M  V30 2 C 3.1398 0.0000 0.0 0
M  V30 3 C 0.0000 2.2814 0.0 0
M  V30 4 O 9.0814 4.2506 0.0 0
M  V30 5 C 10.4150 3.4806 0.0 0
M  V30 6 C 3.6158 3.9564 0.0 0 CFG=2
M  V30 7 C 5.0803 3.4806 0.0 0
M  V30 8 C 2.7106 2.7106 0.0 0 CFG=1
M  V30 9 C 2.7106 5.2024 0.0 0
M  V30 10 C 5.0803 1.9406 0.0 0
M  V30 11 C 6.4140 4.2506 0.0 0
M  V30 12 N 3.6158 1.4647 0.0 0
M  V30 13 N 1.2459 3.1864 0.0 0
M  V30 14 C 1.2459 4.7264 0.0 0
M  V30 15 C 6.4140 1.1706 0.0 0
M  V30 16 C 7.7478 3.4806 0.0 0
M  V30 17 C 7.7478 1.9406 0.0 0
M  V30 18 H 1.8053 1.4647 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 6 1 CFG=1
M  V30 2 1 2 12
M  V30 3 1 3 13
M  V30 4 1 4 5
M  V30 5 1 4 16
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 8 13
M  V30 13 1 8 18 CFG=1
M  V30 14 1 9 14
M  V30 15 1 10 12
M  V30 16 2 10 15
M  V30 17 1 11 16
M  V30 18 1 13 14
M  V30 19 1 15 17
M  V30 20 2 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 6 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 65131-83-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 65131-82-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-6696638
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16853-85-3
$DTYPE RXN:VAR(1):NOTES
$DATUM literature prepn.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient formal total synthesis of physostigmine and physovenine:
conformational analysis of key intermediates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Morales-Rios, Martha S.; Santos-Sanchez, Norma F.; Joseph-Nathan, Pedro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Natural Products (2002), 65(2), 136-141

$RFMT $RIREG SCHEME34 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Methoxymethoxy)benzaldehyde
C9H10O3
6515-21-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 C 10.6697 2.3101 0.0 0
M  V30 5 C 1.3337 0.0000 0.0 0
M  V30 6 O 0.0000 0.7700 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[4-(Methoxymethoxy)phenyl]methylene]methanamine
C10H13NO2
911122-88-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0022 3.0801 0.0 0
M  V30 2 C 9.3360 2.3101 0.0 0
M  V30 3 O 10.6697 3.0801 0.0 0
M  V30 4 C 12.0033 2.3101 0.0 0
M  V30 5 C 2.6673 0.0000 0.0 0
M  V30 6 N 1.3337 0.7700 0.0 0
M  V30 7 C 0.0000 0.0000 0.0 0
M  V30 8 C 6.6685 2.3101 0.0 0
M  V30 9 C 5.3348 3.0801 0.0 0
M  V30 10 C 6.6685 0.7700 0.0 0
M  V30 11 C 4.0012 2.3101 0.0 0
M  V30 12 C 5.3348 0.0000 0.0 0
M  V30 13 C 4.0012 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 5 6 CFG=2
M  V30 6 1 5 13
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6515-21-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 911122-88-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-1946746
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7487-88-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM On the mechanism of conversion of
4-carboxy-3,4-dihydro-3-phenyl-1(2H)-isoquinolones to
indeno[1,2-c]isoquinolines by thionyl chloride
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xiao, Xiangshu; Morrell, Andrew; Fanwick, Phillip E.; Cushman, Mark
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2006), 62(41), 9705-9712

$RFMT $RIREG SCHEME35 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Methylthio)thieno[2,3-d]pyrimidine-6-carboxaldehyde
C8H6N2OS2
655253-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 4.0010 0.0 0
M  V30 2 C 0.0000 4.0010 0.0 0
M  V30 3 C 7.6211 3.9554 0.0 0
M  V30 4 O 8.9550 3.1854 0.0 0
M  V30 5 C 3.8501 2.6673 0.0 0
M  V30 6 C 4.6201 1.3337 0.0 0
M  V30 7 C 2.3100 2.6673 0.0 0
M  V30 8 C 4.8807 3.8119 0.0 0
M  V30 9 S 6.1265 1.6538 0.0 0
M  V30 10 N 3.8501 0.0000 0.0 0
M  V30 11 N 1.5400 1.3337 0.0 0
M  V30 12 C 6.2875 3.1854 0.0 0
M  V30 13 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 1 3 12
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[4-(Methylthio)thieno[2,3-d]pyrimidin-6-yl]methylene]methanamine
C9H9N3S2
655253-74-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 4.0010 0.0 0
M  V30 2 C 0.0000 4.0010 0.0 0
M  V30 3 C 7.6212 3.9554 0.0 0
M  V30 4 N 8.9550 3.1854 0.0 0
M  V30 5 C 10.2887 3.9554 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 C 4.6201 1.3337 0.0 0
M  V30 8 C 2.3101 2.6673 0.0 0
M  V30 9 C 4.8807 3.8119 0.0 0
M  V30 10 S 6.1266 1.6538 0.0 0
M  V30 11 N 3.8501 0.0000 0.0 0
M  V30 12 N 1.5400 1.3337 0.0 0
M  V30 13 C 6.2875 3.1854 0.0 0
M  V30 14 C 2.3101 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4 CFG=2
M  V30 4 1 3 13
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 655253-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 655253-74-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-2484542
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM molecular sieves used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel thienopyrimidine and thiazolopyrimidine kinase inhibitors with
activity against Tie-2 in vitro and in vivo
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Luke, Richard W. A.; Ballard, Peter; Buttar, David; Campbell, Leonie;
Curwen, Jon; Emery, Steve C.; Griffen, Alison M.; Hassall, Lorraine;
Hayter, Barry R.; Jones, Cliff D.; McCoull, William; Mellor, Martine;
Swain, Mike L.; Tucker, Julie A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(23), 6670-6674

$RFMT $RIREG SCHEME35 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Methylthio)thieno[2,3-d]pyrimidine-6-carboxaldehyde
C8H6N2OS2
655253-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 4.0010 0.0 0
M  V30 2 C 0.0000 4.0010 0.0 0
M  V30 3 C 7.6211 3.9554 0.0 0
M  V30 4 O 8.9550 3.1854 0.0 0
M  V30 5 C 3.8501 2.6673 0.0 0
M  V30 6 C 4.6201 1.3337 0.0 0
M  V30 7 C 2.3100 2.6673 0.0 0
M  V30 8 C 4.8807 3.8119 0.0 0
M  V30 9 S 6.1265 1.6538 0.0 0
M  V30 10 N 3.8501 0.0000 0.0 0
M  V30 11 N 1.5400 1.3337 0.0 0
M  V30 12 C 6.2875 3.1854 0.0 0
M  V30 13 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 1 3 12
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[4-(Methylthio)thieno[2,3-d]pyrimidin-6-yl]methylene]methanamine
C9H9N3S2
655253-74-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 4.0010 0.0 0
M  V30 2 C 0.0000 4.0010 0.0 0
M  V30 3 C 7.6212 3.9554 0.0 0
M  V30 4 N 8.9550 3.1854 0.0 0
M  V30 5 C 10.2887 3.9554 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 C 4.6201 1.3337 0.0 0
M  V30 8 C 2.3101 2.6673 0.0 0
M  V30 9 C 4.8807 3.8119 0.0 0
M  V30 10 S 6.1266 1.6538 0.0 0
M  V30 11 N 3.8501 0.0000 0.0 0
M  V30 12 N 1.5400 1.3337 0.0 0
M  V30 13 C 6.2875 3.1854 0.0 0
M  V30 14 C 2.3101 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4 CFG=2
M  V30 4 1 3 13
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 655253-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 655253-74-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-7722119
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7487-88-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-[4-(methylthio)thieno[2,3-d]pyrimidin-6-ylmethylidene]methanamine
4-(Methylthio)thieno[2,3-d]pyrimidine-6-carbaldehyde (13 g), methylamine
(33% in EtOH,20.6 mL) and anhydrous MgSO4 (20 g) was stirred in DCM (465
ml) for 2 days at ambient temperature under an inert atmosphere. The
reaction mixture was filtered then concentrated in vacuo to afford the
title compound as a brown solid (13.8 g, 100%); 1H NMR (DMSO-d6) δ 2.70
(s, 3H), 3.45 (s, 3H), 7.82 (s, 1H), 8.62 (s, 1H), 8.89 (s, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted thieno[2,3-d]pyrimidines and
thiazolo[2,3-d]pyrimidines as inhibitors of Tie-2 receptor tyrosine
kinase (TEK)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jones, Clifford David; Luke, Richard William Arthur; Mccoull, William
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005075483 A1 2005-08-18

$RFMT $RIREG SCHEME36 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2,4-Oxadiazole, 3-(chloromethyl)-5-(3-chlorophenyl)-
C9H6Cl2N2O
657423-57-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3038 3.4372 0.0 0
M  V30 2 Cl 10.2089 4.6831 0.0 0
M  V30 3 Cl 0.0000 3.0801 0.0 0
M  V30 4 C 5.3348 3.0801 0.0 0
M  V30 5 N 6.7417 2.4536 0.0 0
M  V30 6 O 5.4958 4.6116 0.0 0
M  V30 7 C 7.7721 3.5981 0.0 0
M  V30 8 N 7.0021 4.9318 0.0 0
M  V30 9 C 4.0010 2.3101 0.0 0
M  V30 10 C 2.6673 3.0801 0.0 0
M  V30 11 C 4.0010 0.7700 0.0 0
M  V30 12 C 1.3337 2.3101 0.0 0
M  V30 13 C 2.6673 0.0000 0.0 0
M  V30 14 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 12
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 9
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(3-Chlorophenyl)-N-methyl-1,2,4-oxadiazole-3-methanamine
C10H10ClN3O
870973-33-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3038 3.4372 0.0 0
M  V30 2 N 10.2090 4.6831 0.0 0
M  V30 3 C 11.7406 4.5221 0.0 0
M  V30 4 Cl 0.0000 3.0801 0.0 0
M  V30 5 C 5.3348 3.0801 0.0 0
M  V30 6 N 6.7416 2.4536 0.0 0
M  V30 7 O 5.4957 4.6116 0.0 0
M  V30 8 C 7.7722 3.5981 0.0 0
M  V30 9 N 7.0022 4.9318 0.0 0
M  V30 10 C 4.0011 2.3100 0.0 0
M  V30 11 C 2.6673 3.0801 0.0 0
M  V30 12 C 4.0011 0.7700 0.0 0
M  V30 13 C 1.3337 2.3100 0.0 0
M  V30 14 C 2.6673 0.0000 0.0 0
M  V30 15 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 13
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 10
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 657423-57-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 870973-33-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-3768865
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 848
1-[5-(3-chlorophenyl)-[1,2,4]oxadiazol-3-yl]-N-methylmethanamine. MeNH2
in EtOH (6 mL, 8 M, 48 mmol) was added to
3-(chloromethyl)-5-(3-chlorophenyl)-1,2,4-oxadiazole (1.5 g, 6.5 mmol) in
EtOH (20 mL). After 20 h the solvent was evaporated and the residue was
dried in vacuum to give 1.47 g (100%) of the title compound. LC-MS
(M++1): 224.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heteropolycyclic compounds and their use as metabotropic
glutamate receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Edwards, Louise; Isaac, Methvin; Johansson, Martin; Kers, Annika;
Malmberg, Johan; McLeod, Donald; Mindis, Alexander; Staaf, Karin; Slassi,
Abdelmalik; Stefanac, Tomislav; Stormann, Thomas; Wensbo, David; Xin,
Tao; Arora, Jalaj
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20050272779 A1 2005-12-08

$RFMT $RIREG SCHEME37 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Tetrahydro-2-[(7-iodoheptyl)oxy]-2H-pyran
C12H23IO2
65785-43-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0010 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 C 8.0022 2.3101 0.0 0
M  V30 5 C 9.3358 3.0801 0.0 0
M  V30 6 C 10.6697 2.3101 0.0 0
M  V30 7 C 12.0033 3.0801 0.0 0
M  V30 8 C 13.3370 2.3101 0.0 0
M  V30 9 I 14.6707 3.0801 0.0 0
M  V30 10 C 2.6673 2.3101 0.0 0
M  V30 11 C 1.3337 3.0801 0.0 0
M  V30 12 O 2.6673 0.7700 0.0 0
M  V30 13 C 0.0000 2.3101 0.0 0
M  V30 14 C 1.3337 0.0000 0.0 0
M  V30 15 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-7-[(tetrahydro-2H-pyran-2-yl)oxy]-1-heptanamine
C13H27NO2
1019975-63-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 6.6687 3.0801 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 C 9.3360 3.0801 0.0 0
M  V30 6 C 10.6698 2.3101 0.0 0
M  V30 7 C 12.0035 3.0801 0.0 0
M  V30 8 C 13.3372 2.3101 0.0 0
M  V30 9 N 14.6708 3.0801 0.0 0
M  V30 10 C 16.0046 2.3101 0.0 0
M  V30 11 C 2.6675 2.3101 0.0 0
M  V30 12 C 1.3338 3.0801 0.0 0
M  V30 13 O 2.6675 0.7700 0.0 0
M  V30 14 C 0.0000 2.3101 0.0 0
M  V30 15 C 1.3338 0.0000 0.0 0
M  V30 16 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 65785-43-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1019975-63-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-8075600
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM The
(2S)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-3-(N-7-hydroxyheptyl-N-methyl-amino)-2-methyl-propanamide
used as starting material was prepared as follows: A solution of
2-(7-iodohept-1-yloxy)tetrahydropyran (0.5 g, 1.53 mmol) in THF (5 mL)
was treated with 40% aqueous methylamine solution (1.19 mL, 15.33 mmol)
and was stirred vigorously for 18 h. The solvent was evaporated and
diethyl ether (15 mL) was added to the residue followed by 2 N aqueous
NaOH solution. The layers were separated, the aqueous extracted with
diethyl ether (15 mL), the combined organics dried (Na2SO4), filtered and
evaporated to give crude
N-methyl-7-(tetrahydropyran-2-yloxy)heptan-1-amine (0.36 g, 103%) NMR
spectrum (CDCl3) 1.38-1.31 (m, 7H), 1.62-1.43 (m, 8H), 1.74-1.68 (m, 1H),
1.87-1.79 (m, 1H), 2.43 (s, 3H), 2.55 (t, 2H), 3.41-3.35 (m, 1H), 3.52-
3.47 (m, 1H), 3.75-3.70 (m, 1H), 3.90-3.84 (m, 1H), 4.58-4.56 (m, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-phenylcarboxamide derivatives for use as antitumor
agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bradbury, Robert Hugh; Hales, Neil James
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008044033 A1 2008-04-17

$RFMT $RIREG SCHEME38 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromobenzaldehyde
C7H5BrO
6630-33-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 O 5.3901 4.0010 0.0 0
M  V30 3 Br 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2-Bromophenyl)methylene]methanamine
C8H8BrN
95547-10-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 C 6.9302 4.0010 0.0 0
M  V30 4 Br 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6630-33-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 95547-10-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-15816682
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7487-88-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Four-Electron Electrocyclic Ring-Opening/Intermolecular [4+2]
Cycloadditions of α-Hydroxycyclobutenones: Stereoselective Synthesis of
Multiple Substituted δ-Lactams
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Song, Peidong; Li, Qing; Wang, Congcong; Wu, Wenfa; Mao, Xu; Wang,
Jiajia; Hu, Xiangdong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2016), 358(8), 1208-1212

$RFMT $RIREG SCHEME39 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenesulfonamide, 3-(trifluoromethyl)-
C7H6F3NO2S
672-58-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 F 0.5637 1.7464 0.0 0
M  V30 3 F 0.0000 3.8501 0.0 0
M  V30 4 F 2.1037 4.4137 0.0 0
M  V30 5 S 6.6687 3.0801 0.0 0 VAL=6
M  V30 6 N 8.0023 3.8501 0.0 0
M  V30 7 O 5.8986 4.4137 0.0 0
M  V30 8 O 7.4387 1.7464 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 4.0012 0.0000 0.0 0
M  V30 14 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 5 8
M  V30 8 1 5 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-(trifluoromethyl)benzenesulfonamide
C8H8F3NO2S
882423-09-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 3.0801 0.0 0 VAL=6
M  V30 2 N 8.0023 3.8501 0.0 0
M  V30 3 O 5.8985 4.4137 0.0 0
M  V30 4 O 7.4385 1.7464 0.0 0
M  V30 5 C 9.3360 3.0801 0.0 0
M  V30 6 C 1.3337 3.0801 0.0 0
M  V30 7 F 2.1037 4.4137 0.0 0
M  V30 8 F 0.0000 3.8501 0.0 0
M  V30 9 F 0.5637 1.7464 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0012 3.0801 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 14 C 4.0012 0.0000 0.0 0
M  V30 15 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 13
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 672-58-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 882423-09-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-1085153
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-Methyl-3-(trifluoromethyl)benzenesulfonamide To
3-(trifluoromethyl)benzenesulfonamide (245 mg, 1.0 mmol) in dioxane (1
ml) was added methylamine (8M in ethanol, 0.38 ml, 3.0 mmol). The slurry
was stirred at ambient temperature for 30 min. The mixture was diluted
with aqueous sulfuric acid (2%) and extracted with dichloromethane (x3).
The organic phase was dried (MgSO4), filtered and the solvent was
evaporated. A solid (297 mg, quant.). 1H NMR (400 MHz, MeOD-d4 ) δ ppm
8.08-8.12 (2 H, m) 7.95 (1 H, d) 7.78-7.83 (1 H, m) 2.55 (3 H, s), ESI-MS
m/z M-H+ 238.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of piperazinyl quinazolines as 5-HT6 modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nordvall, Gunnar; Yngve, Ulrika
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007108743 A2 2007-09-27

$RFMT $RIREG SCHEME40 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-chloro-3-nitropyridine
C5H2BrClN2O2
67443-38-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 Cl 1.3338 4.6201 0.0 0
M  V30 5 Br 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 N 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methyl-3-nitro-2-pyridinamine
C6H6BrN3O2
70232-59-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0 VAL=5
M  V30 2 O 0.7700 1.3338 0.0 0
M  V30 3 O 3.0800 0.0000 0.0 0
M  V30 4 N 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 N 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 67443-38-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 70232-59-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-294733
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 127-19-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step A 5-bromo-N-methyl-3-nitro-2-pyridinamine [00373] A solution of
5-bromo-2-chloro-3-nitropyridine ( 1.00g, 4.21 mmol) in DMA (7.4 mL) was
stirred at 0°C as methylamine (9 mL, of a 2 M solution) was added. The
solution was then allowed to stir at room temperature for one hour. The
solution was then partitioned between EtOAc and NaHC03 solution. The
organic layer was washed with brine, dried with Na2S0 4 filtered and
concentrated to yield 5-bromo-N-methyl-3-nitro-2-pyridinamine. The crude
material was used in the next step without purification.
5-bromo-N-methyl-3-nitro-2-pyridinamine ( 1 .14 g, assume quantitative
yield) 1H NMR (400 MHz, DMSO-d6) δ ppm 8.60 (d, J=2.3 Hz, 1 H) 8.59 -
8.56 (m, 1 H) 8.55 (d, J=2.3 Hz, 1 H) 3.02 (d, J=4.7 Hz, 3 H).
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of aminoquinoline derivatives as antiviral agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Banka, Anna Lindsey; Botyanszki, Janos; Dickerson, Scott Howard; Duan,
Maosheng; Leivers, Martin Robert; Mcfadyen, Robert Blount; Moore,
Christopher Brooks; Redman, Aniko Maria; Shotwell, John Bradford; Tai,
Vincent W.-F.; Tallant, Matthew David; Xue, Jianjun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012037108 A1 2012-03-22

$RFMT $RIREG SCHEME40 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-chloro-3-nitropyridine
C5H2BrClN2O2
67443-38-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 Cl 1.3338 4.6201 0.0 0
M  V30 5 Br 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 N 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methyl-3-nitro-2-pyridinamine
C6H6BrN3O2
70232-59-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0 VAL=5
M  V30 2 O 0.7700 1.3338 0.0 0
M  V30 3 O 3.0800 0.0000 0.0 0
M  V30 4 N 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 N 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 67443-38-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 70232-59-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-10396227
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 63a (3 g, 1.0 eq) is dissolved in THF (13 mL), and then cooled to 0 °C.
Methylamine solution (2M in THF, 20.8 mL, 3.3 eq), is slowly added to the
reaction mixture (exothermic). The reaction mixture is stirred for 30 min
at 0 °C and diluted with EtOAc. Organic layer is washed with sat aq
sodium bicarbonate. The aqueous layer is re-extracted with EtOAc (2x).
The organic phase is washed with brine, dried with MgSO4, filtered and
concentrated under reduced pressure to obtain 63b which dried under high
vacuum for 16 h (2.95 g, quantative yield). 63b, 2.95 g, quantative
yield.
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, exothermic
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Heterocyclic compounds as inhibitors of HIV replication and their
preparation, pharmaceutical compositions and use in the treatment of HIV
infection
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sturino, Claudio; Deroy, Patrick; Duplessis, Martin; Edwards, Paul J.;
Faucher, Anne-Marie; Halmos, Teddy; James, Clint; Lacoste, Jean-Eric;
Malenfant, Eric; Minville, Joannie; Morency, Louis; Morin, Sebastien;
Tremblay, Martin; Yoakim, Christiane
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010115264 A1 2010-10-14

$RFMT $RIREG SCHEME41 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(2-Phenylethyl)-1-oxa-6-azaspiro[2.5]octane
C14H19NO
67685-98-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.9538 2.6673 0.0 0
M  V30 2 C 6.7238 1.3337 0.0 0
M  V30 3 C 1.3337 2.6673 0.0 0
M  V30 4 C 0.0000 1.8973 0.0 0
M  V30 5 O 0.0000 3.4374 0.0 0
M  V30 6 C 2.1037 4.0010 0.0 0
M  V30 7 C 2.1037 1.3337 0.0 0
M  V30 8 C 3.6437 4.0010 0.0 0
M  V30 9 C 3.6437 1.3337 0.0 0
M  V30 10 N 4.4137 2.6673 0.0 0
M  V30 11 C 8.2638 1.3337 0.0 0
M  V30 12 C 9.0338 2.6673 0.0 0
M  V30 13 C 9.0338 0.0000 0.0 0
M  V30 14 C 10.5739 2.6673 0.0 0
M  V30 15 C 10.5739 0.0000 0.0 0
M  V30 16 C 11.3439 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 11
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 4 5
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 1 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(Methylamino)methyl]-1-(2-phenylethyl)-4-piperidinol
C15H24N2O
1497044-76-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.1898 3.6572 0.0 0
M  V30 2 N 12.6368 3.1305 0.0 0
M  V30 3 C 13.8166 4.1204 0.0 0
M  V30 4 O 11.1898 1.6775 0.0 0
M  V30 5 C 5.3900 2.6673 0.0 0
M  V30 6 C 4.6200 1.3336 0.0 0
M  V30 7 C 10.0100 2.6673 0.0 0
M  V30 8 C 9.2400 4.0011 0.0 0
M  V30 9 C 9.2400 1.3336 0.0 0
M  V30 10 C 7.7000 4.0011 0.0 0
M  V30 11 C 7.7000 1.3336 0.0 0
M  V30 12 N 6.9300 2.6673 0.0 0
M  V30 13 C 3.0800 1.3336 0.0 0
M  V30 14 C 2.3100 2.6673 0.0 0
M  V30 15 C 2.3100 0.0000 0.0 0
M  V30 16 C 0.7700 2.6673 0.0 0
M  V30 17 C 0.7700 0.0000 0.0 0
M  V30 18 C 0.0000 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 4 7
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 6 13
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 67685-98-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1497044-76-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-23070301
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of EST73502, a Dual μ-Opioid Receptor Agonist and σ1 Receptor
Antagonist Clinical Candidate for the Treatment of Pain
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Garcia, Monica; Virgili, Marina; Alonso, Monica; Alegret, Carles; Farran,
Joan; Fernandez, Begona; Bordas, Magda; Pascual, Rosalia; Burgueno,
Javier; Vidal-Torres, Alba; Fernandez de Henestrosa, Antonio R.; Ayet,
Eva; Merlos, Manuel; Vela, Jose Miguel; Plata-Salaman, Carlos R.;
Almansa, Carmen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(24), 15508-15526

$RFMT $RIREG SCHEME42 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-2-[(2R,6S)-2,6-Dimethyl-4-morpholinyl]-5-nitrobenzaldehyde
C13H16N2O4
679839-07-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 6.9300 0.0 0
M  V30 2 O 4.0011 8.4700 0.0 0
M  V30 3 C 0.0000 4.6200 0.0 0
M  V30 4 C 2.6673 0.0000 0.0 0
M  V30 5 N 9.3358 6.9300 0.0 0 VAL=5
M  V30 6 O 10.6694 6.1600 0.0 0
M  V30 7 O 9.3358 8.4700 0.0 0
M  V30 8 C 5.3347 4.6200 0.0 0
M  V30 9 C 5.3347 6.1600 0.0 0
M  V30 10 C 6.6684 3.8500 0.0 0
M  V30 11 C 6.6684 6.9300 0.0 0
M  V30 12 C 8.0021 4.6200 0.0 0
M  V30 13 C 8.0021 6.1600 0.0 0
M  V30 14 N 4.0011 3.8500 0.0 0
M  V30 15 C 2.6673 4.6200 0.0 0
M  V30 16 C 4.0011 2.3100 0.0 0
M  V30 17 C 1.3336 3.8500 0.0 0 CFG=2
M  V30 18 C 2.6673 1.5400 0.0 0 CFG=1
M  V30 19 O 1.3336 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 17 3 CFG=1
M  V30 4 1 18 4 CFG=1
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 14
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-2-[(2R,6S)-2,6-Dimethyl-4-morpholinyl]-N-methyl-5-nitrobenzenemethanamine
C14H21N3O3
1799563-58-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 6.9300 0.0 0
M  V30 2 N 4.0011 8.4700 0.0 0
M  V30 3 C 2.6673 9.2400 0.0 0
M  V30 4 C 2.6673 0.0000 0.0 0
M  V30 5 C 0.0000 4.6200 0.0 0
M  V30 6 N 9.3358 6.9300 0.0 0 VAL=5
M  V30 7 O 10.6694 6.1600 0.0 0
M  V30 8 O 9.3358 8.4700 0.0 0
M  V30 9 N 4.0011 3.8500 0.0 0
M  V30 10 C 4.0011 2.3100 0.0 0
M  V30 11 C 2.6673 4.6200 0.0 0
M  V30 12 C 2.6673 1.5400 0.0 0 CFG=2
M  V30 13 C 1.3336 3.8500 0.0 0 CFG=1
M  V30 14 O 1.3336 2.3100 0.0 0
M  V30 15 C 5.3347 4.6200 0.0 0
M  V30 16 C 5.3347 6.1600 0.0 0
M  V30 17 C 6.6684 3.8500 0.0 0
M  V30 18 C 6.6684 6.9300 0.0 0
M  V30 19 C 8.0021 4.6200 0.0 0
M  V30 20 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 12 4 CFG=3
M  V30 5 1 13 5 CFG=3
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 20
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 15
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 12 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 679839-07-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1799563-58-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-7026000
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrimidopyrimidinones useful as Wee-1 kinase inhibitors and their
preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Harrison, Timothy; Trevitt, Graham; Hewitt, Peter Robin; O'Dowd, Colin
Roderick; Burkamp, Frank; Wilkinson, Andrew John; Shepherd, Steven D.;
Miel, Hugues
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015092431 A1 2015-06-25

$RFMT $RIREG SCHEME43 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[2-[[(1,1-Dimethylethoxy)carbonyl]amino]-3-(4-fluorophenyl)-1-oxopropyl]-3-...
C33H40FN3O6
686339-75-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 8.0021 0.0 0
M  V30 2 C 4.6201 6.6684 0.0 0
M  V30 3 O 4.6201 9.3359 0.0 0
M  V30 4 C 3.0800 6.6684 0.0 0
M  V30 5 N 5.3901 5.3348 0.0 0
M  V30 6 C 4.6201 4.0010 0.0 0
M  V30 7 O 5.3901 2.6673 0.0 0
M  V30 8 O 3.0800 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 5.9537 0.5636 0.0 0
M  V30 11 C 3.8500 0.0000 0.0 0
M  V30 12 C 3.2864 2.1037 0.0 0
M  V30 13 C 6.9301 10.6695 0.0 0
M  V30 14 O 7.7001 12.0032 0.0 0
M  V30 15 C 6.9301 13.3369 0.0 0
M  V30 16 C 11.5501 8.0021 0.0 0
M  V30 17 C 12.3201 9.3359 0.0 0
M  V30 18 C 12.3201 6.6684 0.0 0
M  V30 19 O 11.5501 5.3348 0.0 0
M  V30 20 O 13.8602 6.6684 0.0 0
M  V30 21 F 0.0000 12.0032 0.0 0
M  V30 22 N 6.9301 8.0021 0.0 0
M  V30 23 C 7.7001 9.3359 0.0 0
M  V30 24 C 7.7001 6.6684 0.0 0
M  V30 25 C 9.2401 9.3359 0.0 0
M  V30 26 C 9.2401 6.6684 0.0 0
M  V30 27 N 10.0101 8.0021 0.0 0
M  V30 28 C 2.3100 8.0021 0.0 0
M  V30 29 C 0.7700 8.0021 0.0 0
M  V30 30 C 3.0800 9.3359 0.0 0
M  V30 31 C 0.0000 9.3359 0.0 0
M  V30 32 C 2.3100 10.6695 0.0 0
M  V30 33 C 0.7700 10.6695 0.0 0
M  V30 34 C 13.8602 9.3359 0.0 0
M  V30 35 C 14.6302 10.6695 0.0 0
M  V30 36 C 14.6302 8.0021 0.0 0
M  V30 37 C 16.1702 10.6695 0.0 0
M  V30 38 C 16.1702 8.0021 0.0 0
M  V30 39 C 16.9402 9.3359 0.0 0
M  V30 40 C 16.9402 12.0032 0.0 0
M  V30 41 C 18.4802 9.3359 0.0 0
M  V30 42 C 18.4802 12.0032 0.0 0
M  V30 43 C 19.2502 10.6695 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 22
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 4 28
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 13 14
M  V30 15 1 13 23
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 27
M  V30 20 1 17 34
M  V30 21 1 18 19
M  V30 22 2 18 20
M  V30 23 1 21 33
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 36 2 34 35
M  V30 37 1 34 36
M  V30 38 1 35 37
M  V30 39 2 36 38
M  V30 40 2 37 39
M  V30 41 1 37 40
M  V30 42 1 38 39
M  V30 43 1 39 41
M  V30 44 2 40 42
M  V30 45 2 41 43
M  V30 46 1 42 43
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[1-[(4-fluorophenyl)methyl]-2-[2-(methoxymethyl)-4-[2-(me...
C34H43FN4O5
686339-76-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 47 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 8.0020 0.0 0
M  V30 2 C 4.6200 6.6684 0.0 0
M  V30 3 O 4.6200 9.3358 0.0 0
M  V30 4 C 3.0800 6.6684 0.0 0
M  V30 5 N 5.3900 5.3347 0.0 0
M  V30 6 C 4.6200 4.0009 0.0 0
M  V30 7 O 5.3900 2.6673 0.0 0
M  V30 8 O 3.0800 4.0009 0.0 0
M  V30 9 C 4.6200 1.3336 0.0 0
M  V30 10 C 3.2864 2.1036 0.0 0
M  V30 11 C 3.8500 0.0000 0.0 0
M  V30 12 C 5.9536 0.5636 0.0 0
M  V30 13 C 6.9300 10.6694 0.0 0
M  V30 14 O 7.7000 12.0031 0.0 0
M  V30 15 C 6.9300 13.3367 0.0 0
M  V30 16 C 11.5500 8.0020 0.0 0
M  V30 17 C 12.3200 9.3358 0.0 0
M  V30 18 C 12.3200 6.6684 0.0 0
M  V30 19 N 11.5500 5.3347 0.0 0
M  V30 20 O 13.8600 6.6684 0.0 0
M  V30 21 C 12.3200 4.0009 0.0 0
M  V30 22 F 0.0000 12.0031 0.0 0
M  V30 23 N 6.9300 8.0020 0.0 0
M  V30 24 C 7.7000 9.3358 0.0 0
M  V30 25 C 7.7000 6.6684 0.0 0
M  V30 26 C 9.2400 9.3358 0.0 0
M  V30 27 C 9.2400 6.6684 0.0 0
M  V30 28 N 10.0100 8.0020 0.0 0
M  V30 29 C 2.3100 8.0020 0.0 0
M  V30 30 C 3.0800 9.3358 0.0 0
M  V30 31 C 0.7700 8.0020 0.0 0
M  V30 32 C 2.3100 10.6694 0.0 0
M  V30 33 C 0.0000 9.3358 0.0 0
M  V30 34 C 0.7700 10.6694 0.0 0
M  V30 35 C 13.8600 9.3358 0.0 0
M  V30 36 C 14.6300 10.6694 0.0 0
M  V30 37 C 14.6300 8.0020 0.0 0
M  V30 38 C 16.1700 10.6694 0.0 0
M  V30 39 C 16.1700 8.0020 0.0 0
M  V30 40 C 16.9400 9.3358 0.0 0
M  V30 41 C 16.9400 12.0031 0.0 0
M  V30 42 C 18.4800 9.3358 0.0 0
M  V30 43 C 18.4800 12.0031 0.0 0
M  V30 44 C 19.2500 10.6694 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 23
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 4 29
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 13 14
M  V30 15 1 13 24
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 28
M  V30 20 1 17 35
M  V30 21 1 18 19
M  V30 22 2 18 20
M  V30 23 1 19 21
M  V30 24 1 22 34
M  V30 25 1 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 37 2 35 36
M  V30 38 1 35 37
M  V30 39 1 36 38
M  V30 40 2 37 39
M  V30 41 2 38 40
M  V30 42 1 38 41
M  V30 43 1 39 40
M  V30 44 1 40 42
M  V30 45 2 41 43
M  V30 46 2 42 44
M  V30 47 1 43 44
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 686339-75-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 686339-76-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-15292022
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 128625-52-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of piperazine amino acid derivatives and related compounds as
melanocortin receptor ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ebetino, Frank Hallock; Tian, Xinrong; Mazur, Wieslaw Adam; Colson,
Anny-Odile
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004037797 A2 2004-05-06

$RFMT $RIREG SCHEME44 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2,3,4-Tetrahydro-2,4-dioxo-3-(phenylmethyl)-7-quinazolinecarboxylic acid
C16H12N2O4
687580-04-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 0.0000 0.0 0
M  V30 2 C 12.0033 4.6201 0.0 0
M  V30 3 O 12.0033 6.1601 0.0 0
M  V30 4 O 13.3370 3.8501 0.0 0
M  V30 5 O 4.0010 4.6201 0.0 0
M  V30 6 C 4.0010 1.5400 0.0 0
M  V30 7 C 8.0022 3.8501 0.0 0
M  V30 8 C 8.0022 2.3101 0.0 0
M  V30 9 C 9.3360 4.6201 0.0 0
M  V30 10 N 6.6685 4.6201 0.0 0
M  V30 11 C 6.6685 1.5400 0.0 0
M  V30 12 C 9.3360 1.5400 0.0 0
M  V30 13 C 10.6697 3.8501 0.0 0
M  V30 14 C 5.3348 3.8501 0.0 0
M  V30 15 N 5.3348 2.3101 0.0 0
M  V30 16 C 10.6697 2.3101 0.0 0
M  V30 17 C 2.6673 2.3101 0.0 0
M  V30 18 C 2.6673 3.8501 0.0 0
M  V30 19 C 1.3337 1.5400 0.0 0
M  V30 20 C 1.3337 4.6201 0.0 0
M  V30 21 C 0.0000 2.3101 0.0 0
M  V30 22 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 13
M  V30 5 2 5 14
M  V30 6 1 6 15
M  V30 7 1 6 17
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 2 13 16
M  V30 18 1 14 15
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2,3,4-Tetrahydro-N-methyl-2,4-dioxo-3-(phenylmethyl)-7-quinazolinecarboxamide
C17H15N3O3
2390407-66-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 0.0000 0.0 0
M  V30 2 C 4.0010 1.5400 0.0 0
M  V30 3 C 12.0033 4.6201 0.0 0
M  V30 4 N 13.3370 3.8501 0.0 0
M  V30 5 O 12.0033 6.1601 0.0 0
M  V30 6 C 14.6707 4.6201 0.0 0
M  V30 7 O 4.0010 4.6201 0.0 0
M  V30 8 C 8.0022 2.3101 0.0 0
M  V30 9 C 8.0022 3.8501 0.0 0
M  V30 10 C 6.6685 1.5400 0.0 0
M  V30 11 C 9.3358 1.5400 0.0 0
M  V30 12 C 9.3358 4.6201 0.0 0
M  V30 13 N 6.6685 4.6201 0.0 0
M  V30 14 N 5.3348 2.3101 0.0 0
M  V30 15 C 10.6697 2.3101 0.0 0
M  V30 16 C 10.6697 3.8501 0.0 0
M  V30 17 C 5.3348 3.8501 0.0 0
M  V30 18 C 2.6673 2.3101 0.0 0
M  V30 19 C 2.6673 3.8501 0.0 0
M  V30 20 C 1.3337 1.5400 0.0 0
M  V30 21 C 1.3337 4.6201 0.0 0
M  V30 22 C 0.0000 2.3101 0.0 0
M  V30 23 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 14
M  V30 3 1 2 18
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 16
M  V30 7 1 4 6
M  V30 8 2 7 17
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 17
M  V30 19 2 15 16
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 687580-04-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2390407-66-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-22455155
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic and amino acids as MASP-2 inhibitors and
methods of use
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cutshall, Neil S.; Gage, Jennifer Lynn; Gruswitz, Franz A.; Khalaf,
Juhienah; Little, Thomas L.; Metz, Markus; Nguyen, Jeremiah H.; Nollert
von Specht, Peter Kurt; Tsoung, Jennifer; Cicirelli, Michael; Goldstein,
Sara Rebecca; Keshipeddy, Santosh Kumar; Kwon, Do Yeon; Lemus, Robert
Huerta; Vaddela, Sudheer Babu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019231935 A1 2019-12-05

$RFMT $RIREG SCHEME44 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2,3,4-Tetrahydro-2,4-dioxo-3-(phenylmethyl)-7-quinazolinecarboxylic acid
C16H12N2O4
687580-04-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 0.0000 0.0 0
M  V30 2 C 12.0033 4.6201 0.0 0
M  V30 3 O 12.0033 6.1601 0.0 0
M  V30 4 O 13.3370 3.8501 0.0 0
M  V30 5 O 4.0010 4.6201 0.0 0
M  V30 6 C 4.0010 1.5400 0.0 0
M  V30 7 C 8.0022 3.8501 0.0 0
M  V30 8 C 8.0022 2.3101 0.0 0
M  V30 9 C 9.3360 4.6201 0.0 0
M  V30 10 N 6.6685 4.6201 0.0 0
M  V30 11 C 6.6685 1.5400 0.0 0
M  V30 12 C 9.3360 1.5400 0.0 0
M  V30 13 C 10.6697 3.8501 0.0 0
M  V30 14 C 5.3348 3.8501 0.0 0
M  V30 15 N 5.3348 2.3101 0.0 0
M  V30 16 C 10.6697 2.3101 0.0 0
M  V30 17 C 2.6673 2.3101 0.0 0
M  V30 18 C 2.6673 3.8501 0.0 0
M  V30 19 C 1.3337 1.5400 0.0 0
M  V30 20 C 1.3337 4.6201 0.0 0
M  V30 21 C 0.0000 2.3101 0.0 0
M  V30 22 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 13
M  V30 5 2 5 14
M  V30 6 1 6 15
M  V30 7 1 6 17
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 2 13 16
M  V30 18 1 14 15
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2,3,4-Tetrahydro-N-methyl-2,4-dioxo-3-(phenylmethyl)-7-quinazolinecarboxamide
C17H15N3O3
2390407-66-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 0.0000 0.0 0
M  V30 2 C 4.0010 1.5400 0.0 0
M  V30 3 C 12.0033 4.6201 0.0 0
M  V30 4 N 13.3370 3.8501 0.0 0
M  V30 5 O 12.0033 6.1601 0.0 0
M  V30 6 C 14.6707 4.6201 0.0 0
M  V30 7 O 4.0010 4.6201 0.0 0
M  V30 8 C 8.0022 2.3101 0.0 0
M  V30 9 C 8.0022 3.8501 0.0 0
M  V30 10 C 6.6685 1.5400 0.0 0
M  V30 11 C 9.3358 1.5400 0.0 0
M  V30 12 C 9.3358 4.6201 0.0 0
M  V30 13 N 6.6685 4.6201 0.0 0
M  V30 14 N 5.3348 2.3101 0.0 0
M  V30 15 C 10.6697 2.3101 0.0 0
M  V30 16 C 10.6697 3.8501 0.0 0
M  V30 17 C 5.3348 3.8501 0.0 0
M  V30 18 C 2.6673 2.3101 0.0 0
M  V30 19 C 2.6673 3.8501 0.0 0
M  V30 20 C 1.3337 1.5400 0.0 0
M  V30 21 C 1.3337 4.6201 0.0 0
M  V30 22 C 0.0000 2.3101 0.0 0
M  V30 23 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 14
M  V30 3 1 2 18
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 16
M  V30 7 1 4 6
M  V30 8 2 7 17
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 17
M  V30 19 2 15 16
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 687580-04-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2390407-66-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-21795092
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic and amino acids as MASP-2 inhibitors and
methods of use
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Metz, Markus; Goldstein, Sara Rebecca; Keshipeddy, Santosh Kumar; Kwon,
Do Yeon; Lemus, Robert Huerta; Vaddela, Sudheer Babu; Cutshall, Neil S.;
Gage, Jennifer Lynn; Gruswitz, Franz A.; Khalaf, Juhienah; Little, Thomas
L.; Nguyen, Jeremiah H.; Nollert von Specht, Peter Kurt; Tsoung,
Jennifer; Cicirelli, Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019231933 A2 2019-12-05

$RFMT $RIREG SCHEME45 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Tri-2-propen-1-ylborane
C9H15B
688-61-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 B 3.0800 4.0011 0.0 0
M  V30 2 C 2.3100 5.3347 0.0 0
M  V30 3 C 4.6200 4.0011 0.0 0
M  V30 4 C 2.3100 2.6674 0.0 0
M  V30 5 C 0.7700 5.3347 0.0 0
M  V30 6 C 5.3900 5.3347 0.0 0
M  V30 7 C 3.0800 1.3338 0.0 0
M  V30 8 C 0.0000 6.6685 0.0 0
M  V30 9 C 6.9300 5.3347 0.0 0
M  V30 10 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 2 6 9
M  V30 9 2 7 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(T-4)-(Methanamine)tri-2-propen-1-ylboron
C10H20BN
2229897-64-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 B 4.0012 4.0012 0.0 0 CHG=3 VAL=4
M  V30 2 C 2.6675 4.7712 0.0 0 CHG=-1 VAL=4
M  V30 3 C 5.3348 3.2311 0.0 0 CHG=-1 VAL=4
M  V30 4 C 3.2311 2.6675 0.0 0 CHG=-1 VAL=4
M  V30 5 N 4.7712 5.3348 0.0 0 VAL=4
M  V30 6 C 1.3337 4.0012 0.0 0
M  V30 7 C 6.6687 4.0012 0.0 0
M  V30 8 C 4.0012 1.3338 0.0 0
M  V30 9 C 4.0012 6.6687 0.0 0
M  V30 10 C 0.0000 4.7712 0.0 0
M  V30 11 C 8.0023 3.2311 0.0 0
M  V30 12 C 3.2311 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 688-61-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2229897-64-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28888856
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-66-0
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Adducts of Triallylborane with Ammonia and Aliphatic Amines as
Stoichiometric Allylating Agents for Aminoallylation Reaction of Carbonyl
Compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kuznetsov, Nikolai Yu.; Tikhov, Rabdan M.; Strelkova, Tatiana V.; Bubnov,
Yuri N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2018), 20(12), 3549-3552

$RFMT $RIREG SCHEME46 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2-Difluoro-3-nitrobenzene
C6H3F2NO2
6921-22-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 3.0800 0.0 0 VAL=5
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 F 2.6674 4.6200 0.0 0
M  V30 5 F 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-N-methyl-6-nitrobenzenamine
C7H7FN2O2
182551-18-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 4.6201 0.0 0
M  V30 2 C 1.3338 5.3901 0.0 0
M  V30 3 N 5.3348 3.0800 0.0 0 VAL=5
M  V30 4 O 5.3348 4.6201 0.0 0
M  V30 5 O 6.6686 2.3100 0.0 0
M  V30 6 F 0.0000 3.0800 0.0 0
M  V30 7 C 2.6675 3.0800 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 4.0011 0.7700 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6921-22-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 182551-18-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-16323875
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of oxobenzimidazolesulfonamide derivatives as PARG inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM McGonagle, Alison E.; Jordan, Allan M.; Waszkowycz, Bohdan; Hutton, Colin
P.; Waddell, Ian D.; Hitchin, James R.; Smith, Kate M.; Hamilton, Niall
M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016097749 A1 2016-06-23

$RFMT $RIREG SCHEME47 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Oxobutanoic acid
C4H6O3
692-29-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 O 0.0000 2.3100 0.0 0
M  V30 5 O 1.3338 0.0000 0.0 0
M  V30 6 C 5.3348 2.3100 0.0 0
M  V30 7 O 6.6686 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2,4-dichloro-α,γ-dioxobenzenepentanoate
C12H10Cl2O4
883000-41-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 1.5400 0.0 0
M  V30 4 O 6.6685 3.8501 0.0 0
M  V30 5 C 9.3360 2.3101 0.0 0
M  V30 6 C 10.6697 1.5400 0.0 0
M  V30 7 O 9.3360 3.8501 0.0 0
M  V30 8 O 12.0033 2.3101 0.0 0
M  V30 9 O 10.6697 0.0000 0.0 0
M  V30 10 C 13.3370 1.5400 0.0 0
M  V30 11 Cl 2.6673 0.0000 0.0 0
M  V30 12 Cl 0.0000 4.6201 0.0 0
M  V30 13 C 4.0010 2.3101 0.0 0
M  V30 14 C 2.6673 1.5400 0.0 0
M  V30 15 C 4.0010 3.8501 0.0 0
M  V30 16 C 1.3337 2.3101 0.0 0
M  V30 17 C 2.6673 4.6201 0.0 0
M  V30 18 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 8 10
M  V30 11 1 11 14
M  V30 12 1 12 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[2-(2,4-Dichlorophenyl)acetyl]-2,5-dihydro-4-hydroxy-1-methyl-5-oxo-1H-pyrr...
C16H15Cl2NO5
883000-45-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3103 4.0287 0.0 0
M  V30 2 C 7.6440 3.2587 0.0 0
M  V30 3 O 6.3103 5.5688 0.0 0
M  V30 4 C 3.2495 5.3915 0.0 0
M  V30 5 C 1.7849 5.8674 0.0 0
M  V30 6 C 1.4646 7.3737 0.0 0
M  V30 7 O 2.6091 8.4043 0.0 0
M  V30 8 O 0.0000 7.8497 0.0 0
M  V30 9 O 5.9601 0.6966 0.0 0
M  V30 10 C 1.0076 2.9016 0.0 0
M  V30 11 O 2.6829 0.0000 0.0 0
M  V30 12 Cl 10.3115 1.7187 0.0 0
M  V30 13 Cl 12.9788 6.3388 0.0 0
M  V30 14 C 4.9766 3.2587 0.0 0
M  V30 15 C 3.5696 3.8850 0.0 0
M  V30 16 C 4.8155 1.7271 0.0 0
M  V30 17 N 2.5392 2.7406 0.0 0
M  V30 18 C 3.3092 1.4070 0.0 0
M  V30 19 C 8.9776 4.0287 0.0 0
M  V30 20 C 10.3115 3.2587 0.0 0
M  V30 21 C 8.9776 5.5688 0.0 0
M  V30 22 C 11.6451 4.0287 0.0 0
M  V30 23 C 10.3115 6.3388 0.0 0
M  V30 24 C 11.6451 5.5688 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 19
M  V30 5 1 4 5
M  V30 6 1 4 15
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 9 16
M  V30 11 1 10 17
M  V30 12 2 11 18
M  V30 13 1 12 20
M  V30 14 1 13 24
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 692-29-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 883000-41-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 883000-45-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-118-CAS-15005215
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 272 Preparation of P117 [0631]
3-{3-[2-(2,4-Dichloro-phenyl)-acetyl]-4-hydroxy-1-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-yl}-propionic
acid, I-153. A 2.0 M THF solution of methylamine (0.2 mL, 0.4 mmol, 1.1
equiv.) was added to a solution of pyruvate I-149 (100 mg, 0.35 mmol, 1
equiv.) and 15% aqueous succinic semialdehyde (250 mg, 2.42 mmol, 7
equiv.) in AcOH (0.5 mL). The reaction mixture was stirred at 80&#x00B0;
C. for 30 min, then another portion of methylamine (0.1 mL, 0.2 mmol,
0.55 equiv.) was added and the reaction mixture was stirred at 80&#x00B0;
C. for 30 min. The reaction mixture was concentrated, the residue was
dissolved in EtOAc, a solution was washed with water, brine, dried over
MgSO4, filtered and concentrated to afford pyrroledione I-153 (147 mg,
114%) as yellow oil. This oil was converted to a beige solid (104 mg,
81%) by trituration with MTBE-Hexane, 1;1. MS (ESI−): 371 (M−1). 1H-NMR
(500 MHz, DMSO) confirmed the structure.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Sulfonamide peri-substituted bicyclics and their preparation,
pharmaceutical compositions, and prostanoid EP3 inhibitory activity and
use for treatment or prophylaxis of occlusive artery disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Singh, Jasbir; Gurney, Mark E.; Hategan, Georgeta; Yu, Peng; Zembower,
David; Zhou, Nian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060079520 A1 2006-04-13

$RFMT $RIREG SCHEME48 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2E)-4-amino-4-oxo-2-butenoate
C5H7NO3
6971-10-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 O 6.6686 1.5400 0.0 0
M  V30 4 O 5.3348 3.8500 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 8.0022 2.3100 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 N 0.0000 2.3100 0.0 0
M  V30 9 O 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-amino-3-(methylamino)-4-oxobutanoate
C6H12N2O3
1021333-68-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3336 1.5400 0.0 0
M  V30 4 N 2.6674 3.8500 0.0 0
M  V30 5 C 5.3347 2.3100 0.0 0
M  V30 6 N 0.0000 2.3100 0.0 0
M  V30 7 O 1.3336 0.0000 0.0 0
M  V30 8 C 1.3336 4.6200 0.0 0
M  V30 9 O 6.6685 1.5400 0.0 0
M  V30 10 O 5.3347 3.8500 0.0 0
M  V30 11 C 8.0021 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6971-10-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1021333-68-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-4883936
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: N-methyl-DL-isoasparagine-methyl ester 12
1.3ml of 8M ethanol solution of methylamine (0.01mol) was added to an
ethanol solution (8ml) of methyl maleamate 11a or methyl fumaramate 11b
(1.29 g, 0.01mol) [prepared by acid catalyzed esterification of maleamic
10a/fumaramic acid 10b] at 0°C. The reaction mixture was stirred for 12 h
at 0 °C. The solvent was evaporated in vacuo to dryness. oil of 12 was
obtained. N-methyl-DL-isoasparagine-methyl ester 12. Rf (B, a) = 0.84, Rf
(B, b) = 0.85 1H-NMR (DMSO-d6, 500MHz): δ = 7.48 (1H, s, NH), 7.11 (1H,
s, NH), 3.59 (3H, s, OCH3), 3.27 (1H, d-d, 3J1(H,H) = 5.58 Hz, 3J2(H,H) =
8.27 Hz, C-H), 2.57 (1H, d-d, 3J1(H,H) = 5.58 Hz, 2J3(H,H) =15.38Hz,
H-CH), 2.39 (1H, d-d, 3J2(H,H) = 8.27 Hz, 2J3(H,H) =15.38Hz, HC-H), 2.21
(3H, s, NCH3) MW = 160.17 ESI-MS m/z: 160.4 [M+H]+ Anal. Calc. for
C6H12N2O3 C = 44.99% H = 7.55% N = 17.49% Found C = 45.13% H = 7.62% N =
17.41%.
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, Michael addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Methods for syntheses of N-methyl-DL-aspartic acid derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Boros, M.; Koekoesi, J.; Vamos, J.; Koevesdi, I.; Noszal, B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Amino Acids (2007), 33(4), 709-717

$RFMT $RIREG SCHEME49 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,4-Butanediol, 1-(4-methylbenzenesulfonate)
C11H16O4S
6972-09-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3349 1.3338 0.0 0 VAL=6
M  V30 2 O 6.1049 2.6674 0.0 0
M  V30 3 O 4.5649 0.0000 0.0 0
M  V30 4 O 6.6685 0.5638 0.0 0
M  V30 5 C 7.6449 2.6674 0.0 0
M  V30 6 C 8.4149 4.0011 0.0 0
M  V30 7 C 9.9549 4.0011 0.0 0
M  V30 8 C 10.7249 5.3349 0.0 0
M  V30 9 O 12.2649 5.3349 0.0 0
M  V30 10 C 0.0000 4.4138 0.0 0
M  V30 11 C 4.0011 2.1038 0.0 0
M  V30 12 C 4.0011 3.6438 0.0 0
M  V30 13 C 2.6674 1.3338 0.0 0
M  V30 14 C 2.6674 4.4138 0.0 0
M  V30 15 C 1.3338 2.1038 0.0 0
M  V30 16 C 1.3338 3.6438 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 11
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 10 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Methylamino)-1-butanol
C5H13NO
42042-68-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 0.0000 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6675 0.7700 0.0 0
M  V30 4 C 6.6687 0.0000 0.0 0
M  V30 5 N 1.3337 0.0000 0.0 0
M  V30 6 O 8.0023 0.7700 0.0 0
M  V30 7 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6972-09-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 42042-68-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24506952
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterobifunctional molecules useful as TEAD modulators for
treating cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zbieg, Jason Robert; Villemure, Elisia; Rudolph, Joachim; Beroza, Paul
Powell; Crawford, James John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021178339 A1 2021-09-10

$RFMT $RIREG SCHEME50 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-(chlorosulfonyl)-1-methyl-1H-pyrrole-2-carboxylate
C7H8ClNO4S
69812-32-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.4015 2.7104 0.0 0
M  V30 2 O 7.1715 4.0442 0.0 0
M  V30 3 O 7.1715 1.3768 0.0 0
M  V30 4 C 8.7115 4.0442 0.0 0
M  V30 5 C 4.4323 0.0000 0.0 0
M  V30 6 S 1.2459 4.3856 0.0 0 VAL=6
M  V30 7 Cl 0.0000 5.2908 0.0 0
M  V30 8 O 0.3406 3.1398 0.0 0
M  V30 9 O 2.1511 5.6315 0.0 0
M  V30 10 C 4.8615 2.7104 0.0 0
M  V30 11 C 3.9564 3.9564 0.0 0
M  V30 12 N 3.9564 1.4645 0.0 0
M  V30 13 C 2.4917 3.4804 0.0 0
M  V30 14 C 2.4917 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 12
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 6 9
M  V30 9 1 6 13
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1-methyl-4-[(methylamino)sulfonyl]-1H-pyrrole-2-carboxylate
C8H12N2O4S
1060196-42-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.4607 4.0287 0.0 0 VAL=6
M  V30 2 N 8.7944 4.7987 0.0 0
M  V30 3 O 6.6907 5.3624 0.0 0
M  V30 4 O 8.2307 2.6951 0.0 0
M  V30 5 C 10.1282 4.0287 0.0 0
M  V30 6 C 2.1580 2.9016 0.0 0
M  V30 7 O 1.5317 4.3084 0.0 0
M  V30 8 O 1.2528 1.6557 0.0 0
M  V30 9 C 0.0000 4.4695 0.0 0
M  V30 10 C 3.8333 0.0000 0.0 0
M  V30 11 C 6.1270 3.2587 0.0 0
M  V30 12 C 4.7200 3.8850 0.0 0
M  V30 13 C 5.9661 1.7271 0.0 0
M  V30 14 C 3.6896 2.7406 0.0 0
M  V30 15 N 4.4596 1.4068 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 11
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 1 7 9
M  V30 10 1 10 15
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 69812-32-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1060196-42-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-6654
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design of Helicobacter pylori glutamate racemase inhibitors as selective
antibacterial agents: A novel pro-drug approach to increase exposure
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Basarab, Gregory S.; Hill, Pamela J.; Rastagar, Abdullah; Webborn, Peter
J. H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2008), 18(16), 4716-4722

$RFMT $RIREG SCHEME51 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-[4-[1-(4-methoxyphenyl)-3-(trifluoromethyl)-1H-pyrazol-5-yl]phenoxy]a...
C21H19F3N2O4
705936-06-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.8028 1.5316 0.0 0
M  V30 2 F 5.2712 1.3706 0.0 0
M  V30 3 F 6.9637 0.0000 0.0 0
M  V30 4 F 8.3344 1.6925 0.0 0
M  V30 5 O 10.2400 10.8354 0.0 0
M  V30 6 C 11.7800 10.8354 0.0 0
M  V30 7 C 12.5500 12.1690 0.0 0
M  V30 8 O 14.0901 12.1690 0.0 0
M  V30 9 O 11.7800 13.5027 0.0 0
M  V30 10 C 14.8601 13.5027 0.0 0
M  V30 11 C 16.4001 13.5027 0.0 0
M  V30 12 O 1.5065 9.9174 0.0 0
M  V30 13 C 0.0000 9.5972 0.0 0
M  V30 14 C 7.1599 5.5005 0.0 0
M  V30 15 N 5.6284 5.3396 0.0 0
M  V30 16 C 7.7863 4.0936 0.0 0
M  V30 17 N 5.3082 3.8331 0.0 0
M  V30 18 C 6.6419 3.0631 0.0 0
M  V30 19 C 7.9299 6.8342 0.0 0
M  V30 20 C 9.4700 6.8342 0.0 0
M  V30 21 C 7.1599 8.1679 0.0 0
M  V30 22 C 10.2400 8.1679 0.0 0
M  V30 23 C 7.9299 9.5017 0.0 0
M  V30 24 C 9.4700 9.5017 0.0 0
M  V30 25 C 4.5978 6.4840 0.0 0
M  V30 26 C 3.0915 6.1638 0.0 0
M  V30 27 C 5.0738 7.9487 0.0 0
M  V30 28 C 2.0610 7.3082 0.0 0
M  V30 29 C 4.0432 9.0931 0.0 0
M  V30 30 C 2.5369 8.7730 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 18
M  V30 5 1 5 6
M  V30 6 1 5 24
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 12 13
M  V30 13 1 12 30
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 19
M  V30 17 1 15 17
M  V30 18 1 15 25
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[4-[1-(4-Methoxyphenyl)-3-(trifluoromethyl)-1H-pyrazol-5-yl]phenoxy]-N-meth...
C20H18F3N3O3
705936-68-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.2459 9.9241 0.0 0
M  V30 2 F 0.3406 8.6783 0.0 0
M  V30 3 F 0.0000 10.8293 0.0 0
M  V30 4 F 2.1511 11.1700 0.0 0
M  V30 5 O 11.0215 8.2489 0.0 0
M  V30 6 C 11.7915 9.5825 0.0 0
M  V30 7 C 13.3315 9.5825 0.0 0
M  V30 8 N 14.1015 10.9162 0.0 0
M  V30 9 O 14.1015 8.2489 0.0 0
M  V30 10 C 15.6416 10.9162 0.0 0
M  V30 11 O 5.8599 1.1444 0.0 0
M  V30 12 C 4.8295 0.0000 0.0 0
M  V30 13 C 4.8615 8.2489 0.0 0
M  V30 14 N 3.9564 7.0030 0.0 0
M  V30 15 C 3.9564 9.4948 0.0 0
M  V30 16 N 2.4917 7.4789 0.0 0
M  V30 17 C 2.4917 9.0189 0.0 0
M  V30 18 C 6.4015 8.2489 0.0 0
M  V30 19 C 7.1715 9.5825 0.0 0
M  V30 20 C 7.1715 6.9153 0.0 0
M  V30 21 C 8.7115 9.5825 0.0 0
M  V30 22 C 8.7115 6.9153 0.0 0
M  V30 23 C 9.4815 8.2489 0.0 0
M  V30 24 C 4.4323 5.5383 0.0 0
M  V30 25 C 3.4017 4.3940 0.0 0
M  V30 26 C 5.9386 5.2182 0.0 0
M  V30 27 C 3.8777 2.9292 0.0 0
M  V30 28 C 6.4144 3.7536 0.0 0
M  V30 29 C 5.3840 2.6091 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 17
M  V30 5 1 5 6
M  V30 6 1 5 23
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 11 12
M  V30 12 1 11 29
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 13 18
M  V30 16 1 14 16
M  V30 17 1 14 24
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 705936-06-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 705936-68-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-2135243
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazole derivatives useful as COX-1 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shirai, Fumiyuki; Azami, Hidenori; Kayakiri, Natsuko; Okumura, Kazuo;
Nakamura, Katsuya
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004050632 A1 2004-06-17

$RFMT $RIREG SCHEME51 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-[4-[1-(4-methoxyphenyl)-3-(trifluoromethyl)-1H-pyrazol-5-yl]phenoxy]a...
C21H19F3N2O4
705936-06-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.8028 1.5316 0.0 0
M  V30 2 F 5.2712 1.3706 0.0 0
M  V30 3 F 6.9637 0.0000 0.0 0
M  V30 4 F 8.3344 1.6925 0.0 0
M  V30 5 O 10.2400 10.8354 0.0 0
M  V30 6 C 11.7800 10.8354 0.0 0
M  V30 7 C 12.5500 12.1690 0.0 0
M  V30 8 O 14.0901 12.1690 0.0 0
M  V30 9 O 11.7800 13.5027 0.0 0
M  V30 10 C 14.8601 13.5027 0.0 0
M  V30 11 C 16.4001 13.5027 0.0 0
M  V30 12 O 1.5065 9.9174 0.0 0
M  V30 13 C 0.0000 9.5972 0.0 0
M  V30 14 C 7.1599 5.5005 0.0 0
M  V30 15 N 5.6284 5.3396 0.0 0
M  V30 16 C 7.7863 4.0936 0.0 0
M  V30 17 N 5.3082 3.8331 0.0 0
M  V30 18 C 6.6419 3.0631 0.0 0
M  V30 19 C 7.9299 6.8342 0.0 0
M  V30 20 C 9.4700 6.8342 0.0 0
M  V30 21 C 7.1599 8.1679 0.0 0
M  V30 22 C 10.2400 8.1679 0.0 0
M  V30 23 C 7.9299 9.5017 0.0 0
M  V30 24 C 9.4700 9.5017 0.0 0
M  V30 25 C 4.5978 6.4840 0.0 0
M  V30 26 C 3.0915 6.1638 0.0 0
M  V30 27 C 5.0738 7.9487 0.0 0
M  V30 28 C 2.0610 7.3082 0.0 0
M  V30 29 C 4.0432 9.0931 0.0 0
M  V30 30 C 2.5369 8.7730 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 18
M  V30 5 1 5 6
M  V30 6 1 5 24
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 12 13
M  V30 13 1 12 30
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 19
M  V30 17 1 15 17
M  V30 18 1 15 25
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[4-[1-(4-Methoxyphenyl)-3-(trifluoromethyl)-1H-pyrazol-5-yl]phenoxy]-N-meth...
C20H18F3N3O3
705936-68-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.2459 9.9241 0.0 0
M  V30 2 F 0.3406 8.6783 0.0 0
M  V30 3 F 0.0000 10.8293 0.0 0
M  V30 4 F 2.1511 11.1700 0.0 0
M  V30 5 O 11.0215 8.2489 0.0 0
M  V30 6 C 11.7915 9.5825 0.0 0
M  V30 7 C 13.3315 9.5825 0.0 0
M  V30 8 N 14.1015 10.9162 0.0 0
M  V30 9 O 14.1015 8.2489 0.0 0
M  V30 10 C 15.6416 10.9162 0.0 0
M  V30 11 O 5.8599 1.1444 0.0 0
M  V30 12 C 4.8295 0.0000 0.0 0
M  V30 13 C 4.8615 8.2489 0.0 0
M  V30 14 N 3.9564 7.0030 0.0 0
M  V30 15 C 3.9564 9.4948 0.0 0
M  V30 16 N 2.4917 7.4789 0.0 0
M  V30 17 C 2.4917 9.0189 0.0 0
M  V30 18 C 6.4015 8.2489 0.0 0
M  V30 19 C 7.1715 9.5825 0.0 0
M  V30 20 C 7.1715 6.9153 0.0 0
M  V30 21 C 8.7115 9.5825 0.0 0
M  V30 22 C 8.7115 6.9153 0.0 0
M  V30 23 C 9.4815 8.2489 0.0 0
M  V30 24 C 4.4323 5.5383 0.0 0
M  V30 25 C 3.4017 4.3940 0.0 0
M  V30 26 C 5.9386 5.2182 0.0 0
M  V30 27 C 3.8777 2.9292 0.0 0
M  V30 28 C 6.4144 3.7536 0.0 0
M  V30 29 C 5.3840 2.6091 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 17
M  V30 5 1 5 6
M  V30 6 1 5 23
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 11 12
M  V30 12 1 11 29
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 13 18
M  V30 16 1 14 16
M  V30 17 1 14 24
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 705936-06-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 705936-68-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-6516254
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazole derivatives useful as COX-1 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shirai, Fumiyuki; Azami, Hidenori; Kayakiri, Natsuko; Okumura, Kazuo;
Nakamura, Katsuya
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20040116475 A1 2004-06-17

$RFMT $RIREG SCHEME52 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-2-hydroxybenzenecarbothioic acid
C7H5FO2S
705950-02-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 S 5.3347 4.6200 0.0 0
M  V30 4 O 2.6674 4.6200 0.0 0
M  V30 5 F 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-2-hydroxy-N-methylbenzamide
C8H8FNO2
705949-55-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 C 8.0021 3.0800 0.0 0
M  V30 5 O 2.6674 4.6200 0.0 0
M  V30 6 F 0.0000 3.0800 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6674 3.0800 0.0 0
M  V30 9 C 4.0011 0.7700 0.0 0
M  V30 10 C 1.3336 2.3100 0.0 0
M  V30 11 C 2.6674 0.0000 0.0 0
M  V30 12 C 1.3336 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 705950-02-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 705949-55-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11629594
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-41-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM yield depends on reaction conditions
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A short and efficient preparation of methyl[1,2,4]oxadiazolium
derivatives with plant-inducing activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dobler, Markus R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2004), 2(7), 963-964

$RFMT $RIREG SCHEME53 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-2-hydroxybenzenecarbothioic acid
C7H5ClO2S
705950-03-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 S 5.3347 4.6200 0.0 0
M  V30 4 O 2.6674 4.6200 0.0 0
M  V30 5 Cl 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-2-hydroxy-N-methylbenzamide
C8H8ClNO2
705949-56-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 C 8.0021 3.0800 0.0 0
M  V30 5 O 2.6674 4.6200 0.0 0
M  V30 6 Cl 0.0000 3.0800 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6674 3.0800 0.0 0
M  V30 9 C 4.0011 0.7700 0.0 0
M  V30 10 C 1.3336 2.3100 0.0 0
M  V30 11 C 2.6674 0.0000 0.0 0
M  V30 12 C 1.3336 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 705950-03-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 705949-56-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13759745
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-41-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM yield depends on reaction conditions
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A short and efficient preparation of methyl[1,2,4]oxadiazolium
derivatives with plant-inducing activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dobler, Markus R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2004), 2(7), 963-964

$RFMT $RIREG SCHEME54 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-2-hydroxybenzenecarbothioic acid
C7H5BrO2S
705950-04-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 S 5.3347 4.6200 0.0 0
M  V30 4 O 2.6674 4.6200 0.0 0
M  V30 5 Br 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-2-hydroxy-N-methylbenzamide
C8H8BrNO2
705949-57-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 C 8.0021 3.0800 0.0 0
M  V30 5 O 2.6674 4.6200 0.0 0
M  V30 6 Br 0.0000 3.0800 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6674 3.0800 0.0 0
M  V30 9 C 4.0011 0.7700 0.0 0
M  V30 10 C 1.3336 2.3100 0.0 0
M  V30 11 C 2.6674 0.0000 0.0 0
M  V30 12 C 1.3336 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 705950-04-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 705949-57-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-332999
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-41-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM yield depends on reaction conditions
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A short and efficient preparation of methyl[1,2,4]oxadiazolium
derivatives with plant-inducing activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dobler, Markus R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2004), 2(7), 963-964

$RFMT $RIREG SCHEME55 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4Z)-4-[[4-(Acetyloxy)phenyl]methylene]-2-phenyl-5(4H)-oxazolone
C18H13NO4
71198-74-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7854 6.8425 0.0 0
M  V30 2 O 2.7246 8.2053 0.0 0
M  V30 3 O 11.1203 3.7625 0.0 0
M  V30 4 C 12.4539 4.5325 0.0 0
M  V30 5 C 12.4539 6.0725 0.0 0
M  V30 6 O 13.7876 3.7625 0.0 0
M  V30 7 C 2.7844 4.2208 0.0 0
M  V30 8 N 4.2907 4.5409 0.0 0
M  V30 9 O 2.0144 5.5544 0.0 0
M  V30 10 C 4.4516 6.0725 0.0 0
M  V30 11 C 3.0448 6.6988 0.0 0
M  V30 12 C 2.1579 2.8138 0.0 0
M  V30 13 C 3.0631 1.5679 0.0 0
M  V30 14 C 0.6263 2.6529 0.0 0
M  V30 15 C 2.4368 0.1611 0.0 0
M  V30 16 C 0.0000 1.2459 0.0 0
M  V30 17 C 0.9052 0.0000 0.0 0
M  V30 18 C 7.1191 6.0725 0.0 0
M  V30 19 C 7.1191 4.5325 0.0 0
M  V30 20 C 8.4528 6.8425 0.0 0
M  V30 21 C 8.4528 3.7625 0.0 0
M  V30 22 C 9.7865 6.0725 0.0 0
M  V30 23 C 9.7865 4.5325 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 1 18
M  V30 3 2 2 11
M  V30 4 1 3 4
M  V30 5 1 3 23
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 7 12
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 1 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(1Z)-2-(4-Hydroxyphenyl)-1-[(methylamino)carbonyl]ethenyl]benzamide
C17H16N2O3
2036341-13-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 6.6684 0.0 0
M  V30 2 C 4.6200 8.0021 0.0 0
M  V30 3 N 4.6200 5.3347 0.0 0
M  V30 4 C 2.3100 6.6684 0.0 0
M  V30 5 C 3.8500 4.0011 0.0 0
M  V30 6 N 1.5400 8.0021 0.0 0
M  V30 7 O 1.5400 5.3347 0.0 0
M  V30 8 O 2.3100 4.0011 0.0 0
M  V30 9 C 0.0000 8.0021 0.0 0
M  V30 10 O 10.7800 8.0021 0.0 0
M  V30 11 C 6.1600 8.0021 0.0 0
M  V30 12 C 6.9300 9.3358 0.0 0
M  V30 13 C 6.9300 6.6684 0.0 0
M  V30 14 C 8.4700 9.3358 0.0 0
M  V30 15 C 8.4700 6.6684 0.0 0
M  V30 16 C 9.2400 8.0021 0.0 0
M  V30 17 C 4.6200 2.6674 0.0 0
M  V30 18 C 6.1600 2.6674 0.0 0
M  V30 19 C 3.8500 1.3336 0.0 0
M  V30 20 C 6.9300 1.3336 0.0 0
M  V30 21 C 4.6200 0.0000 0.0 0
M  V30 22 C 6.1600 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 2 5 8
M  V30 9 1 5 17
M  V30 10 1 6 9
M  V30 11 1 10 16
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 71198-74-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2036341-13-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-352-CAS-18006735
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Imidazole derivatives as dual emission fluorescent compounds and their
preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Karuso, Peter; Chatterjee, Soumit
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017147646 A1 2017-09-08

$RFMT $RIREG SCHEME55 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4Z)-4-[[4-(Acetyloxy)phenyl]methylene]-2-phenyl-5(4H)-oxazolone
C18H13NO4
71198-74-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7854 6.8425 0.0 0
M  V30 2 O 2.7246 8.2053 0.0 0
M  V30 3 O 11.1203 3.7625 0.0 0
M  V30 4 C 12.4539 4.5325 0.0 0
M  V30 5 C 12.4539 6.0725 0.0 0
M  V30 6 O 13.7876 3.7625 0.0 0
M  V30 7 C 2.7844 4.2208 0.0 0
M  V30 8 N 4.2907 4.5409 0.0 0
M  V30 9 O 2.0144 5.5544 0.0 0
M  V30 10 C 4.4516 6.0725 0.0 0
M  V30 11 C 3.0448 6.6988 0.0 0
M  V30 12 C 2.1579 2.8138 0.0 0
M  V30 13 C 3.0631 1.5679 0.0 0
M  V30 14 C 0.6263 2.6529 0.0 0
M  V30 15 C 2.4368 0.1611 0.0 0
M  V30 16 C 0.0000 1.2459 0.0 0
M  V30 17 C 0.9052 0.0000 0.0 0
M  V30 18 C 7.1191 6.0725 0.0 0
M  V30 19 C 7.1191 4.5325 0.0 0
M  V30 20 C 8.4528 6.8425 0.0 0
M  V30 21 C 8.4528 3.7625 0.0 0
M  V30 22 C 9.7865 6.0725 0.0 0
M  V30 23 C 9.7865 4.5325 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 1 18
M  V30 3 2 2 11
M  V30 4 1 3 4
M  V30 5 1 3 23
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 7 12
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 1 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(1Z)-2-(4-Hydroxyphenyl)-1-[(methylamino)carbonyl]ethenyl]benzamide
C17H16N2O3
2036341-13-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 6.6684 0.0 0
M  V30 2 C 4.6200 8.0021 0.0 0
M  V30 3 N 4.6200 5.3347 0.0 0
M  V30 4 C 2.3100 6.6684 0.0 0
M  V30 5 C 3.8500 4.0011 0.0 0
M  V30 6 N 1.5400 8.0021 0.0 0
M  V30 7 O 1.5400 5.3347 0.0 0
M  V30 8 O 2.3100 4.0011 0.0 0
M  V30 9 C 0.0000 8.0021 0.0 0
M  V30 10 O 10.7800 8.0021 0.0 0
M  V30 11 C 6.1600 8.0021 0.0 0
M  V30 12 C 6.9300 9.3358 0.0 0
M  V30 13 C 6.9300 6.6684 0.0 0
M  V30 14 C 8.4700 9.3358 0.0 0
M  V30 15 C 8.4700 6.6684 0.0 0
M  V30 16 C 9.2400 8.0021 0.0 0
M  V30 17 C 4.6200 2.6674 0.0 0
M  V30 18 C 6.1600 2.6674 0.0 0
M  V30 19 C 3.8500 1.3336 0.0 0
M  V30 20 C 6.9300 1.3336 0.0 0
M  V30 21 C 4.6200 0.0000 0.0 0
M  V30 22 C 6.1600 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 2 5 8
M  V30 9 1 5 17
M  V30 10 1 6 9
M  V30 11 1 10 16
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 71198-74-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2036341-13-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-352-CAS-16404806
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient and concise method to synthesize locked GFP chromophore
analogues
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chatterjee, Soumit; Karuso, Peter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2016), 57(47), 5197-5200

$RFMT $RIREG SCHEME56 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenyl N-cyano-4-[2-[(3-endo)-3-(2-methyl-1H-benzimidazol-1-yl)-8-azabicyclo[...
C36H40N6O
716344-76-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 51 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.0396 4.6088 0.0 0
M  V30 2 C 9.5129 6.0559 0.0 0
M  V30 3 C 15.5572 6.6513 0.0 0
M  V30 4 O 15.5572 8.1913 0.0 0
M  V30 5 N 16.8909 5.8813 0.0 0
M  V30 6 C 16.8909 4.3413 0.0 0
M  V30 7 N 16.8909 2.8013 0.0 0
M  V30 8 C 2.3305 6.0034 0.0 0
M  V30 9 C 11.5562 4.3413 0.0 0
M  V30 10 C 11.5562 5.8813 0.0 0
M  V30 11 C 12.8898 3.5713 0.0 0
M  V30 12 C 12.8898 6.6513 0.0 0
M  V30 13 C 14.2236 4.3413 0.0 0
M  V30 14 N 14.2236 5.8813 0.0 0
M  V30 15 C 11.0295 2.8941 0.0 0
M  V30 16 C 9.5129 2.6268 0.0 0
M  V30 17 C 12.0194 1.7145 0.0 0
M  V30 18 C 8.9862 1.1796 0.0 0
M  V30 19 C 11.4926 0.2673 0.0 0
M  V30 20 C 9.9760 0.0000 0.0 0
M  V30 21 N 7.9963 6.3232 0.0 0
M  V30 22 C 6.8410 7.0192 0.0 0 CFG=1
M  V30 23 C 6.4640 6.0236 0.0 0 CFG=2
M  V30 24 C 6.2436 8.6727 0.0 0
M  V30 25 C 5.8030 5.9757 0.0 0
M  V30 26 C 5.8104 7.7425 0.0 0
M  V30 27 C 5.5535 4.6248 0.0 0
M  V30 28 C 4.7049 8.3673 0.0 0 CFG=1
M  V30 29 C 16.8909 8.9613 0.0 0
M  V30 30 C 18.2245 8.1913 0.0 0
M  V30 31 C 16.8909 10.5013 0.0 0
M  V30 32 C 19.5583 8.9613 0.0 0
M  V30 33 C 18.2245 11.2713 0.0 0
M  V30 34 C 19.5583 10.5013 0.0 0
M  V30 35 N 3.1843 8.6115 0.0 0
M  V30 36 C 2.4882 9.9852 0.0 0
M  V30 37 C 2.0930 7.5251 0.0 0
M  V30 38 C 0.9667 9.7477 0.0 0
M  V30 39 C 3.0432 11.4217 0.0 0
M  V30 40 N 0.7224 8.2271 0.0 0
M  V30 41 C 0.0000 10.9466 0.0 0
M  V30 42 C 2.0767 12.6206 0.0 0
M  V30 43 C 0.5552 12.3831 0.0 0
M  V30 44 H 8.0311 7.9966 0.0 0
M  V30 45 H 7.3252 4.7469 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 21
M  V30 4 1 3 4
M  V30 5 2 3 5 CFG=2
M  V30 6 1 3 14
M  V30 7 1 4 29
M  V30 8 1 5 6
M  V30 9 3 6 7
M  V30 10 1 8 37
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 15
M  V30 14 1 10 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 1 13 14
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 22 25
M  V30 28 1 22 44 CFG=3
M  V30 29 1 23 26
M  V30 30 1 23 27
M  V30 31 1 23 45 CFG=1
M  V30 32 1 24 28
M  V30 33 1 25 27
M  V30 34 1 26 28
M  V30 35 1 28 35 CFG=3
M  V30 36 2 29 30
M  V30 37 1 29 31
M  V30 38 1 30 32
M  V30 39 2 31 33
M  V30 40 2 32 34
M  V30 41 1 33 34
M  V30 42 1 35 36
M  V30 43 1 35 37
M  V30 44 1 36 38
M  V30 45 2 36 39
M  V30 46 2 37 40
M  V30 47 1 38 40
M  V30 48 2 38 41
M  V30 49 1 39 42
M  V30 50 1 41 43
M  V30 51 2 42 43
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 22 23 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-Cyano-N′-methyl-4-[2-[(3-endo)-3-(2-methyl-1H-benzimidazol-1-yl)-8-azabicyc...
C31H39N7
716357-87-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.0396 4.6088 0.0 0
M  V30 2 C 9.5129 6.0559 0.0 0
M  V30 3 C 15.5572 6.6513 0.0 0
M  V30 4 N 16.8909 5.8813 0.0 0
M  V30 5 N 15.5572 8.1913 0.0 0
M  V30 6 C 18.2245 6.6513 0.0 0
M  V30 7 C 16.8909 8.9613 0.0 0
M  V30 8 N 19.5583 7.4213 0.0 0
M  V30 9 C 2.3305 6.0034 0.0 0
M  V30 10 C 11.5562 4.3413 0.0 0
M  V30 11 C 11.5562 5.8813 0.0 0
M  V30 12 C 12.8898 3.5713 0.0 0
M  V30 13 C 12.8898 6.6513 0.0 0
M  V30 14 C 14.2236 4.3413 0.0 0
M  V30 15 N 14.2236 5.8813 0.0 0
M  V30 16 C 11.0295 2.8941 0.0 0
M  V30 17 C 12.0194 1.7145 0.0 0
M  V30 18 C 9.5129 2.6268 0.0 0
M  V30 19 C 11.4926 0.2673 0.0 0
M  V30 20 C 8.9862 1.1796 0.0 0
M  V30 21 C 9.9760 0.0000 0.0 0
M  V30 22 N 7.9963 6.3232 0.0 0
M  V30 23 C 6.8410 7.0192 0.0 0 CFG=1
M  V30 24 C 6.4640 6.0236 0.0 0 CFG=2
M  V30 25 C 6.2436 8.6727 0.0 0
M  V30 26 C 5.8030 5.9757 0.0 0
M  V30 27 C 5.8104 7.7425 0.0 0
M  V30 28 C 5.5535 4.6248 0.0 0
M  V30 29 C 4.7049 8.3673 0.0 0 CFG=1
M  V30 30 N 3.1843 8.6115 0.0 0
M  V30 31 C 2.4882 9.9852 0.0 0
M  V30 32 C 2.0930 7.5251 0.0 0
M  V30 33 C 0.9667 9.7477 0.0 0
M  V30 34 C 3.0432 11.4217 0.0 0
M  V30 35 N 0.7224 8.2271 0.0 0
M  V30 36 C 0.0000 10.9466 0.0 0
M  V30 37 C 2.0767 12.6206 0.0 0
M  V30 38 C 0.5552 12.3831 0.0 0
M  V30 39 H 8.0311 7.9966 0.0 0
M  V30 40 H 7.3252 4.7469 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 22
M  V30 4 2 3 4 CFG=2
M  V30 5 1 3 5
M  V30 6 1 3 15
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 3 6 8
M  V30 10 1 9 32
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 16
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 23 26
M  V30 28 1 23 39 CFG=3
M  V30 29 1 24 27
M  V30 30 1 24 28
M  V30 31 1 24 40 CFG=1
M  V30 32 1 25 29
M  V30 33 1 26 28
M  V30 34 1 27 29
M  V30 35 1 29 30 CFG=3
M  V30 36 1 30 31
M  V30 37 1 30 32
M  V30 38 1 31 33
M  V30 39 2 31 34
M  V30 40 2 32 35
M  V30 41 1 33 35
M  V30 42 2 33 36
M  V30 43 1 34 37
M  V30 44 1 36 38
M  V30 45 2 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 23 24 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 716344-76-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 716357-87-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5544170
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 393A Preparation of
N'-cyano-4-{2-[3-(2-methyl-1H-benzimidazol-1-yl)-8-azabicyclo-[3.2.1]oct-8-yl]ethyl}-4-phenylpiperidine-1-carboximidamide.
Phenyl
N-cyano-4-{2-[3-(2-methyl-1H-benzimidazol-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]ethyl}-4-phenylpiperidine-1-carboximidoate
(100 mg, 0.175 mmol) and a solution of ammonia in methanol (2 mL, 1.4 M)
was stirred at ambient temperature for 20 hours. After evaporation of the
excess ammonia and the solvent, the residue was subject to flash
chromatography (Mega Bond Elut Si, MeOH/EtOAc, 10% to 40%). phenyl
N-cyano-4-{2-[3-(2-methyl-1H-benzimidazol-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]ethyl}-4-phenylpiperidine-1-carboximidoate
(20 mg, 0.035 mmol) and methylamine (0.7 mL, 2 M in EtOH) by the similar
procedure outlined in example 393.
N'-cyano-N-methyl-4-{2-[3-(2-methyl-1H-benzimidazol-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]ethyl}-4-phenylpiperidine-1-carboximidamide
(18 mg, quant.). 1H NMR (CDCl3, 300 MHz) (57.69 (d, J=7.3Hz, 1H),
7.44-7.39 (m, 2H), 7.32-7.25 (m, 4H), 7.22-7.16 (m, 2H), 5.37 (s, 1H),
4.83 (br, 1H), 3.80-3.76 (m, 2H), 3.35-3.24 (m, 4H), 3.03 (d, J=4.6Hz,
3H), 2.63 (s, 3H), 2.56-2.29 (m, 4H), 2.08-1.89 (m, 10H), 1.73-1.71 (m,
2H). HRMS m/z (M+H)+ calcd: 510.3345, obsd: 510.3348.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzimidazolylazabicyclooctylethylpiperidines as Ccr5
antagonists for the treatment of HIV infection
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kazmierski, Wieslaw Mieczyslaw; Aquino, Christopher Joseph; Bifulco,
Neil; Boros, Eric Eugene; Chauder, Brian Andrew; Chong, Pek Yoke; Duan,
Maosheng; Deanda, Felix, Jr.; Koble, Cecilia Suarez; Mclean, Ed Williams;
Peckham, Jennifer Poole; Perkins, Angilique C.; Thompson, James Benjamin;
Vanderwall, Dana
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004054974 A2 2004-07-01

$RFMT $RIREG SCHEME57 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 6-chloro-α-methyl-3-pyridineacetate
C9H10ClNO2
717106-72-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 C 5.3347 0.0000 0.0 0
M  V30 4 O 8.0021 1.5400 0.0 0
M  V30 5 O 6.6684 3.8500 0.0 0
M  V30 6 C 9.3358 2.3100 0.0 0
M  V30 7 Cl 0.0000 4.6200 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 4.0011 3.8500 0.0 0
M  V30 10 C 2.6674 1.5400 0.0 0
M  V30 11 C 2.6674 4.6200 0.0 0
M  V30 12 N 1.3336 2.3100 0.0 0
M  V30 13 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 7 13
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N,α-dimethyl-3-pyridineacetamide
C9H11ClN2O
717106-73-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 C 5.3347 0.0000 0.0 0
M  V30 4 N 8.0021 1.5400 0.0 0
M  V30 5 O 6.6684 3.8500 0.0 0
M  V30 6 C 9.3358 2.3100 0.0 0
M  V30 7 Cl 0.0000 4.6200 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 2.6674 1.5400 0.0 0
M  V30 10 C 4.0011 3.8500 0.0 0
M  V30 11 C 1.3336 2.3100 0.0 0
M  V30 12 N 2.6674 4.6200 0.0 0
M  V30 13 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 7 13
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 717106-72-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 717106-73-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-12236285
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of insecticidal, acaricidal and nematocidal pyridine
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Benko, Zoltan Laszlo; Deamicis, Carl Vincent; Demeter, David Anthony;
Markley, Lowell Dean; Samaritoni, Jack Geno; Schmidt, Carrie Lynn Rau;
Zhu, Yuamning; Erickson, W. Randal; Anzeveno, Peter Biagio; Pechacek,
James Todd; Watson, Gerald Bryan; Deboer, Gerrit Jan; Sheets, Joel Jay;
Zabik, Susan Erhardt; Yerkes, Carla Nanette; Schobert, Christian Thomas;
Dripps, James Edwin; Dintenfass, Leonard Paul; Karr, Laura Lee; Neese,
Paul Allen; Huang, Jim Xinpei; Gifford, James Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004057960 A2 2004-07-15

$RFMT $RIREG SCHEME58 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Iodomethyl)-3-methoxy-2-naphthalenecarbonitrile
C13H10INO
719275-83-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 1.3338 0.0 0
M  V30 2 I 0.7700 1.3338 0.0 0
M  V30 3 O 5.3900 1.3338 0.0 0
M  V30 4 C 4.6200 0.0000 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 N 8.4700 4.0011 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 3.0800 5.3347 0.0 0
M  V30 10 C 0.7700 4.0011 0.0 0
M  V30 11 C 4.6200 2.6674 0.0 0
M  V30 12 C 4.6200 5.3347 0.0 0
M  V30 13 C 2.3100 6.6685 0.0 0
M  V30 14 C 0.0000 5.3347 0.0 0
M  V30 15 C 5.3900 4.0011 0.0 0
M  V30 16 C 0.7700 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 11
M  V30 5 3 5 6
M  V30 6 1 5 15
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 2 12 15
M  V30 16 2 13 16
M  V30 17 1 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-4-[(methylamino)methyl]-2-naphthalenecarbonitrile
C14H14N2O
868151-15-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6674 0.0 0
M  V30 2 N 3.0800 1.3336 0.0 0
M  V30 3 C 2.3100 0.0000 0.0 0
M  V30 4 O 5.3900 2.6674 0.0 0
M  V30 5 C 6.9300 2.6674 0.0 0
M  V30 6 C 6.9300 5.3347 0.0 0
M  V30 7 N 8.4700 5.3347 0.0 0
M  V30 8 C 2.3100 5.3347 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 3.0800 6.6685 0.0 0
M  V30 11 C 0.7700 5.3347 0.0 0
M  V30 12 C 4.6200 4.0011 0.0 0
M  V30 13 C 4.6200 6.6685 0.0 0
M  V30 14 C 2.3100 8.0021 0.0 0
M  V30 15 C 0.0000 6.6685 0.0 0
M  V30 16 C 5.3900 5.3347 0.0 0
M  V30 17 C 0.7700 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 12
M  V30 6 3 6 7
M  V30 7 1 6 16
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 2 13 16
M  V30 17 2 14 17
M  V30 18 1 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 719275-83-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 868151-15-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-15129718
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM The requisite 3-methoxy-4-[(methylamino)methyl]-2-naphthonitrile was
synthesized using the following method. Methylamine (500 mL of a 2.0 M
solution in MeOH) was added to 4-(iodomethyl)-3-methoxy-2-naphthonitrile
(5.00 g, 15.5 mmol). After reacting at RT overnight in a sealed vessel,
the volatiles were removed under reduced pressure. The residue was taken
up in DCM (350 mL) and washed with sat. aq. NaHCO3 (550 mL). The organic
layer was dried over Na2SO4, filtered through though a pad of
diatomaceous earth and the volatiles were removed under reduced pressure.
The title compound as a pale yellow powder (3.50 g, 100%). 1H NMR (300.1
MHz, DMSO) δ 8.53 (s, 1H), 8.26 (d, J = 8.4 Hz, 1H), 8.01 (d, J = 8.4 Hz,
1H), 7.72 (ddd, J = 8.4, 7.0, 1.4 Hz, 1H), 7.62 - 7.56 (m, 1H), 4.06 (s,
2H), 3.94 (s, 3H), 3.31 (s, 1H), 2.38 (s, 3H).
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed vessel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of aryl glycinamides as NK1 antagonists and serotonin
reuptake inhibitors for treatment of depression and anxiety
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bernstein, Peter; Dantzman, Cathy; Palmer, William
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005100325 A1 2005-10-27

$RFMT $RIREG SCHEME59 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl-L-tryptophan methyl ester
C13H16N2O2
724-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 4.0285 0.0 0
M  V30 2 C 7.0870 3.2585 0.0 0 CFG=2
M  V30 3 C 8.4207 4.0285 0.0 0
M  V30 4 N 7.0870 1.7185 0.0 0
M  V30 5 O 9.7545 3.2585 0.0 0
M  V30 6 O 8.4207 5.5686 0.0 0
M  V30 7 C 11.0882 4.0285 0.0 0
M  V30 8 C 2.1258 0.0000 0.0 0
M  V30 9 C 3.0127 3.8850 0.0 0
M  V30 10 C 4.4197 3.2585 0.0 0
M  V30 11 C 1.9823 2.7405 0.0 0
M  V30 12 C 2.5369 5.3496 0.0 0
M  V30 13 C 4.2586 1.7270 0.0 0
M  V30 14 N 2.7523 1.4068 0.0 0
M  V30 15 C 0.4759 3.0606 0.0 0
M  V30 16 C 1.0304 5.6697 0.0 0
M  V30 17 C 0.0000 4.5254 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 8 14
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 13 14
M  V30 17 1 15 17
M  V30 18 2 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αS)-α-Amino-N,1-dimethyl-1H-indole-3-propanamide
C13H17N3O
762222-56-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 4.0285 0.0 0
M  V30 2 C 7.0870 3.2585 0.0 0 CFG=2
M  V30 3 C 8.4207 4.0285 0.0 0
M  V30 4 N 7.0870 1.7185 0.0 0
M  V30 5 N 9.7545 3.2585 0.0 0
M  V30 6 O 8.4207 5.5686 0.0 0
M  V30 7 C 11.0882 4.0285 0.0 0
M  V30 8 C 2.1258 0.0000 0.0 0
M  V30 9 C 3.0127 3.8850 0.0 0
M  V30 10 C 4.4197 3.2585 0.0 0
M  V30 11 C 1.9823 2.7405 0.0 0
M  V30 12 C 2.5369 5.3496 0.0 0
M  V30 13 C 4.2586 1.7270 0.0 0
M  V30 14 N 2.7523 1.4068 0.0 0
M  V30 15 C 0.4759 3.0606 0.0 0
M  V30 16 C 1.0304 5.6697 0.0 0
M  V30 17 C 0.0000 4.5254 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 8 14
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 13 14
M  V30 17 1 15 17
M  V30 18 2 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 724-42-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 762222-56-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-6015128
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Aromatic Interactions in Organocatalyst Design: Augmenting Selectivity
Reversal in Iminium Ion Activation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Holland, Mareike C.; Metternich, Jan Benedikt; Daniliuc, Constantin;
Schweizer, W. Bernd; Gilmour, Ryan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2015), 21(28), 10031-10038

$RFMT $RIREG SCHEME60 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Difluorobenzoyl chloride
C7H3ClF2O
72482-64-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 Cl 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 F 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Difluoro-N-methylbenzamide
C8H7F2NO
948717-18-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 2.6673 0.0 0
M  V30 2 N 1.5400 4.0010 0.0 0
M  V30 3 O 1.5400 1.3337 0.0 0
M  V30 4 C 0.0000 4.0010 0.0 0
M  V30 5 F 3.8501 0.0000 0.0 0
M  V30 6 F 8.4702 2.6673 0.0 0
M  V30 7 C 3.8501 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 6.1601 1.3337 0.0 0
M  V30 11 C 6.1601 4.0010 0.0 0
M  V30 12 C 6.9302 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 72482-64-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 948717-18-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-14347741
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Methyl 2,4-difluorobenzylamide Methylamine 2M in THF (12.4 mL, 1.1 eq) is
added to neat 2,4-difuorobenzoyl chloride (4g, 22.6 mmol). The reaction
mixture is stirred overnight at room temperature. The solvent is
evaporated, ethyl acetate is added to solubilize the residue. The organic
is washed with aqueous NaHCO3, dried with Na2SO4, filtered and evaporated
to afford the quantitatively the desired compound as a white powder. 1H
NMR (500 MHz CDCl3) δ 3.00 (d, J = 4.8 Hz, 3 H), 6.84 (m, J = 2.3; 10.3
Hz, 1H), 6.97 (m, J = 2.3; 8.2 Hz, 1H), 8.08 (td, J = 6.8; 8.9 Hz, 1H)
13C NMR (100 MHz CDCl3) δ 27.0, 104.3 (d, J = 26.0 Hz), 104.6 (d, J =
25.9 Hz), 112.4 (dd, J = 21.2; 3.1 Hz), 118.1 (dd, J = 12.4; 3.8 Hz),
133.7 (dd, J = 10.1; 3.9 Hz), 162.9 (dd, J = 381.1; 12.3 Hz), 163.5.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of thiohydantoins
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ouerfelli, Ouathek; Dilhas, Anna; Yang, Guangbin; Zhao, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008119015 A2 2008-10-02

$RFMT $RIREG SCHEME60 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Difluorobenzoyl chloride
C7H3ClF2O
72482-64-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 Cl 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 F 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Difluoro-N-methylbenzamide
C8H7F2NO
948717-18-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 2.6673 0.0 0
M  V30 2 N 1.5400 4.0010 0.0 0
M  V30 3 O 1.5400 1.3337 0.0 0
M  V30 4 C 0.0000 4.0010 0.0 0
M  V30 5 F 3.8501 0.0000 0.0 0
M  V30 6 F 8.4702 2.6673 0.0 0
M  V30 7 C 3.8501 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 6.1601 1.3337 0.0 0
M  V30 11 C 6.1601 4.0010 0.0 0
M  V30 12 C 6.9302 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 72482-64-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 948717-18-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-4737100
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM A solution of 2,4-difluoro-benzoylchloride D in a solution of methylamine
and tetrahydrofuran (THF) is allowed to react to produce
2,4-difluoro-N-methylbenzamide M (quantitative yield).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of hydantoins as androgen receptor modulators for the
treatment of prostate cancer and other androgen receptor-associated
diseases.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jung, Michael E.; Sawyers, Charles L.; Ouk, Samedy; Tran, Chris;
Wongvipat, John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007126765 A2 2007-11-08

$RFMT $RIREG SCHEME61 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Bromo-1H-pyrrol-2-yl)-2,2,2-trichloroethanone
C6H3BrCl3NO
72652-32-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 O 2.6673 0.0000 0.0 0
M  V30 4 Cl 2.1037 3.6437 0.0 0
M  V30 5 Cl 0.0000 3.0801 0.0 0
M  V30 6 Cl 0.5637 0.9764 0.0 0
M  V30 7 Br 7.9700 2.6672 0.0 0
M  V30 8 C 4.0010 2.3101 0.0 0
M  V30 9 C 5.4080 1.6836 0.0 0
M  V30 10 N 4.1621 3.8416 0.0 0
M  V30 11 C 6.4384 2.8281 0.0 0
M  V30 12 C 5.6684 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 7 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methyl-1H-pyrrole-2-carboxamide
C6H7BrN2O
132911-43-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 1.5400 0.0 0
M  V30 2 N 6.6363 2.3101 0.0 0
M  V30 3 O 5.3026 0.0000 0.0 0
M  V30 4 C 7.9700 1.5400 0.0 0
M  V30 5 Br 0.0000 2.6672 0.0 0
M  V30 6 C 3.9690 2.3101 0.0 0
M  V30 7 C 2.5620 1.6836 0.0 0
M  V30 8 N 3.8079 3.8416 0.0 0
M  V30 9 C 1.5316 2.8281 0.0 0
M  V30 10 C 2.3016 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 72652-32-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 132911-43-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-10676035
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Acid catalyzed halogen dance on deactivated pyrroles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tutino, Federico; Papeo, Gianluca; Quartieri, Francesca
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2010), 47(1), 112-117

$RFMT $RIREG SCHEME62 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-1,3-benzodioxole-4-carboxaldehyde
C8H5BrO3
72744-54-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1456 1.6672 0.0 0
M  V30 2 O 6.4792 2.4373 0.0 0
M  V30 3 Br 5.1456 4.7473 0.0 0
M  V30 4 C 2.4781 1.6672 0.0 0
M  V30 5 C 1.1444 2.4373 0.0 0
M  V30 6 C 3.8119 2.4373 0.0 0
M  V30 7 O 2.1579 0.1609 0.0 0
M  V30 8 C 1.1444 3.9773 0.0 0
M  V30 9 O 0.0000 1.4068 0.0 0
M  V30 10 C 3.8119 3.9773 0.0 0
M  V30 11 C 0.6263 0.0000 0.0 0
M  V30 12 C 2.4781 4.7473 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 10
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methyl-1,3-benzodioxole-4-methanamine
C9H10BrNO2
1622405-53-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1456 1.6672 0.0 0
M  V30 2 N 6.4792 2.4373 0.0 0
M  V30 3 C 7.8129 1.6672 0.0 0
M  V30 4 Br 5.1456 4.7473 0.0 0
M  V30 5 C 2.4781 1.6672 0.0 0
M  V30 6 C 3.8119 2.4373 0.0 0
M  V30 7 C 1.1444 2.4373 0.0 0
M  V30 8 O 2.1579 0.1609 0.0 0
M  V30 9 C 3.8119 3.9773 0.0 0
M  V30 10 C 1.1444 3.9773 0.0 0
M  V30 11 O 0.0000 1.4068 0.0 0
M  V30 12 C 0.6263 0.0000 0.0 0
M  V30 13 C 2.4781 4.7473 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 13
M  V30 14 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 72744-54-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1622405-53-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-14957599
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New methods for the synthesis of naphthyl amines; application to the
synthesis of dihydrosanguinarine, sanguinarine, oxysanguinarine and
(±)-maclekarpines B and C
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tatton, Matthew R.; Simpson, Iain; Donohoe, Timothy J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2014), 50(77),
11314-11316

$RFMT $RIREG SCHEME63 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Thiosalicylic acid
C7H6O2S
7283-41-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 S 0.0000 1.3337 0.0 0
M  V30 4 O 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Hydroxy-N-methylbenzamide
C8H9NO2
1862-88-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 O 5.3901 1.3337 0.0 0
M  V30 4 C 6.9302 4.0010 0.0 0
M  V30 5 O 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 2.3101 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.7700 4.0010 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 7283-41-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1862-88-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-9500324
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-41-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM yield depends on reaction conditions
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A short and efficient preparation of methyl[1,2,4]oxadiazolium
derivatives with plant-inducing activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dobler, Markus R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2004), 2(7), 963-964

$RFMT $RIREG SCHEME64 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(S)-3-Hydroxy-γ-butyrolactone
C4H6O3
7331-52-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 2.6218 0.0 0
M  V30 2 O 5.3026 1.4946 0.0 0
M  V30 3 C 2.7406 2.4782 0.0 0
M  V30 4 C 1.3337 1.8517 0.0 0 CFG=2
M  V30 5 C 3.7711 1.3337 0.0 0
M  V30 6 C 1.4946 0.3202 0.0 0
M  V30 7 O 3.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 4 1 CFG=1
M  V30 2 2 2 5
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3S)-3,4-Dihydroxy-N-methylbutanamide
C5H11NO3
841261-68-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0 CFG=2
M  V30 3 C 2.6675 1.5400 0.0 0
M  V30 4 C 6.6686 2.3100 0.0 0
M  V30 5 O 5.3348 0.0000 0.0 0
M  V30 6 N 1.3337 2.3100 0.0 0
M  V30 7 O 2.6675 0.0000 0.0 0
M  V30 8 O 8.0022 1.5400 0.0 0
M  V30 9 C 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5 CFG=1
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 7331-52-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 841261-68-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10085378
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (S)-3,4-Dihydroxy-N-methylbutyramide (13a).Compounds 13a-c were obtained
by similar methods given in the literature.21 The lactone (20.2 g, 0.20
mol) and methylamine (77.65 g, 1.0 mol, 40 wt % in water) were mixed at
room temperature for 6-8 h. After concentrating on a rotavaporator, the
excess methylamine can be removed by washing with hexane, and the last
trace of solvent and methylamine can be removed on a vacuum pump. The
crude product was obtained as a brown viscous liquid (26.6 g, 0.20 mol,
100%) and was used directly in the second step without further
purification. [α]D 25 = -25.9° (c 1.08, EtOH).1H NMR (D2O, 400 MHz; δ
(ppm)): 3.94 (m, 1H), 3.48 (dd, 1H, J = 11.72, 3.9 Hz), 3.38 (dd, 1H, J =
11.7, 6.8 Hz), 2.61 (s, 3H), 2.32 (dd, J = 14.7, 3.9 Hz), 2.22 (dd, J =
14.7, 8.8 Hz). 13C NMR (CD3OD, D2O, 100 MHz; δ (ppm)): 175.1, 70.1, 69.2,
40.8, 26.9.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New Synthesis of Chiral 1,3-Oxazinan-2-ones from Carbohydrate Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ella-Menye, Jean-Rene; Sharma, Vibha; Wang, Guijun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2005), 70(2), 463-469

$RFMT $RIREG SCHEME65 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,6-Hexanediol, 1-(4-methylbenzenesulfonate)
C13H20O4S
75351-33-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3349 1.3338 0.0 0 VAL=6
M  V30 2 O 6.1049 2.6674 0.0 0
M  V30 3 O 4.5649 0.0000 0.0 0
M  V30 4 O 6.6685 0.5638 0.0 0
M  V30 5 C 7.6449 2.6674 0.0 0
M  V30 6 C 8.4149 4.0011 0.0 0
M  V30 7 C 9.9549 4.0011 0.0 0
M  V30 8 C 10.7249 5.3347 0.0 0
M  V30 9 C 12.2649 5.3347 0.0 0
M  V30 10 C 13.0349 6.6685 0.0 0
M  V30 11 O 14.5749 6.6685 0.0 0
M  V30 12 C 0.0000 4.4138 0.0 0
M  V30 13 C 4.0011 2.1038 0.0 0
M  V30 14 C 4.0011 3.6438 0.0 0
M  V30 15 C 2.6674 1.3338 0.0 0
M  V30 16 C 2.6674 4.4138 0.0 0
M  V30 17 C 1.3338 2.1038 0.0 0
M  V30 18 C 1.3338 3.6438 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 13
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 12 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(Methylamino)-1-hexanol
C7H17NO
50347-17-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 4.0012 0.0000 0.0 0
M  V30 3 C 6.6685 0.0000 0.0 0
M  V30 4 C 2.6673 0.7700 0.0 0
M  V30 5 C 8.0023 0.7700 0.0 0
M  V30 6 C 1.3337 0.0000 0.0 0
M  V30 7 N 9.3360 0.0000 0.0 0
M  V30 8 O 0.0000 0.7700 0.0 0
M  V30 9 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75351-33-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 50347-17-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24506963
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterobifunctional molecules useful as TEAD modulators for
treating cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zbieg, Jason Robert; Villemure, Elisia; Rudolph, Joachim; Beroza, Paul
Powell; Crawford, James John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021178339 A1 2021-09-10

$RFMT $RIREG SCHEME66 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Chloromethyl)thiophene
C5H5ClS
765-50-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 Cl 5.1049 1.8517 0.0 0
M  V30 3 C 2.4374 1.8517 0.0 0
M  V30 4 C 2.2765 0.3202 0.0 0
M  V30 5 S 1.0306 2.4782 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-thiophenemethanamine
C6H9NS
58255-18-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 N 5.1049 1.8517 0.0 0
M  V30 3 C 6.4386 2.6217 0.0 0
M  V30 4 C 2.4374 1.8517 0.0 0
M  V30 5 C 2.2765 0.3202 0.0 0
M  V30 6 S 1.0306 2.4782 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 765-50-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 58255-18-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-4678299
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of highly potent triazole antifungal derivatives by
heterocycle-benzene bioisosteric replacement
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jiang, Zhigan; Wang, Yan; Wang, Wenya; Wang, Shengzheng; Xu, Bo; Fan,
Guorong; Dong, Guoqiang; Liu, Yang; Yao, Jianzhong; Miao, Zhenyuan;
Zhang, Wannian; Sheng, Chunquan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2013), 6416-22

$RFMT $RIREG SCHEME67 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanol, 2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]-, 1-(4-methylbenzenesulfonate)
C15H24O7S
77544-60-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 3.0801 5.3348 0.0 0 VAL=6
M  V30 2 O 4.4139 4.5648 0.0 0
M  V30 3 O 1.7464 6.1048 0.0 0
M  V30 4 O 3.8501 6.6687 0.0 0
M  V30 5 C 5.7476 5.3348 0.0 0
M  V30 6 C 7.0812 4.5648 0.0 0
M  V30 7 O 8.4149 5.3348 0.0 0
M  V30 8 C 9.7487 4.5648 0.0 0
M  V30 9 C 11.0824 5.3348 0.0 0
M  V30 10 O 12.4161 4.5648 0.0 0
M  V30 11 C 13.7497 5.3348 0.0 0
M  V30 12 C 15.0836 4.5648 0.0 0
M  V30 13 O 16.4172 5.3348 0.0 0
M  V30 14 C 17.7509 4.5648 0.0 0
M  V30 15 C 19.0846 5.3348 0.0 0
M  V30 16 O 20.4184 4.5648 0.0 0
M  V30 17 C 0.0000 0.0000 0.0 0
M  V30 18 C 2.3101 4.0012 0.0 0
M  V30 19 C 3.0801 2.6675 0.0 0
M  V30 20 C 0.7700 4.0012 0.0 0
M  V30 21 C 2.3101 1.3338 0.0 0
M  V30 22 C 0.0000 2.6675 0.0 0
M  V30 23 C 0.7700 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 18
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 17 23
M  V30 18 2 18 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 2 20 22
M  V30 22 2 21 23
M  V30 23 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,8,11-Trioxa-2-azatridecan-13-ol
C9H21NO4
90430-59-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 0.0000 0.0 0
M  V30 2 O 8.0023 0.7700 0.0 0
M  V30 3 C 10.6697 0.7700 0.0 0
M  V30 4 C 6.6687 0.0000 0.0 0
M  V30 5 O 12.0035 0.0000 0.0 0
M  V30 6 C 5.3348 0.7700 0.0 0
M  V30 7 C 13.3372 0.7700 0.0 0
M  V30 8 O 4.0012 0.0000 0.0 0
M  V30 9 C 14.6708 0.0000 0.0 0
M  V30 10 C 2.6675 0.7700 0.0 0
M  V30 11 N 16.0045 0.7700 0.0 0
M  V30 12 C 1.3338 0.0000 0.0 0
M  V30 13 C 17.3383 0.0000 0.0 0
M  V30 14 O 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 77544-60-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 90430-59-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24506966
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative reaction conditions gave lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterobifunctional molecules useful as TEAD modulators for
treating cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zbieg, Jason Robert; Villemure, Elisia; Rudolph, Joachim; Beroza, Paul
Powell; Crawford, James John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021178339 A1 2021-09-10

$RFMT $RIREG SCHEME68 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Trifluoromethyl)benzenesulfonyl chloride
C7H4ClF3O2S
777-44-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 F 0.5637 1.7464 0.0 0
M  V30 3 F 0.0000 3.8501 0.0 0
M  V30 4 F 2.1037 4.4137 0.0 0
M  V30 5 S 6.6687 3.0801 0.0 0 VAL=6
M  V30 6 Cl 8.0023 3.8501 0.0 0
M  V30 7 O 5.8986 4.4137 0.0 0
M  V30 8 O 7.4387 1.7464 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 4.0012 0.0000 0.0 0
M  V30 14 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 5 8
M  V30 8 1 5 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-(trifluoromethyl)benzenesulfonamide
C8H8F3NO2S
882423-09-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 3.0801 0.0 0 VAL=6
M  V30 2 N 8.0023 3.8501 0.0 0
M  V30 3 O 5.8985 4.4137 0.0 0
M  V30 4 O 7.4385 1.7464 0.0 0
M  V30 5 C 9.3360 3.0801 0.0 0
M  V30 6 C 1.3337 3.0801 0.0 0
M  V30 7 F 2.1037 4.4137 0.0 0
M  V30 8 F 0.0000 3.8501 0.0 0
M  V30 9 F 0.5637 1.7464 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0012 3.0801 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 14 C 4.0012 0.0000 0.0 0
M  V30 15 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 13
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 777-44-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 882423-09-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-5520186
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Intermediate 2. N- Methyl-3-(trifluoromethyl)benzenesulfonamide. To
3-(trifluoromethyl)benzenesulfonyl chloride (245 mg, 1.0 mmol) in dioxane
(1 ml) was added methylamine (8M in ethanol, 0.38 ml, 3.0 mmol). The
slurry was stirred at ambient temperature for 30 min. The mixture was
diluted with aqueous sulfuric acid (2%) and extracted with
dichloromethane (×3). The organic phase was dried (MgSO4), filtered and
the solvent was evaporated to give a solid (297 mg, quant.). 1HNMR (400
MHz, MeOD-d4) δ ppm 8.08- 8.12 (2 H, m) 7.95 (1 H, d) 7.78-7.83 (1 H, m)
2.55 (3 H, s); MS ESI m/z M-H+ 238.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of piperazinyl quinazolines as 5-HT6 modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nordvall, Gunnar; Yngve, Ulrika
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007108744 A2 2007-09-27

$RFMT $RIREG SCHEME69 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Divinyl sulfone
C4H6O2S
77-77-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.6675 1.3337 0.0 0 VAL=6
M  V30 2 C 1.3338 0.5637 0.0 0
M  V30 3 C 4.0012 2.1037 0.0 0
M  V30 4 O 1.8975 2.6673 0.0 0
M  V30 5 O 3.4375 0.0000 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 5.3350 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 1 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Thiomorpholine, 4-methyl-, 1,1-dioxide
C5H11NO2S
25343-91-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 2.3236 0.0 0
M  V30 2 O 0.0000 0.3437 0.0 0
M  V30 3 C 5.7998 1.3337 0.0 0
M  V30 4 S 1.1797 1.3337 0.0 0 VAL=6
M  V30 5 C 1.9497 2.6673 0.0 0
M  V30 6 C 1.9497 0.0000 0.0 0
M  V30 7 C 3.4897 2.6673 0.0 0
M  V30 8 C 3.4897 0.0000 0.0 0
M  V30 9 N 4.2597 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 4
M  V30 2 2 2 4
M  V30 3 1 3 9
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 77-77-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 25343-91-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-11472812
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Michael addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Bronsted Acid Ionic Liquid as a Solvent-Conserving Catalyst for Organic
Reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Taheri, Amir; Pan, Xiaojuan; Liu, Changhui; Gu, Yanlong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemSusChem (2014), 7(8), 2094-2098

$RFMT $RIREG SCHEME70 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Pyridinemethanol, α-methyl-, 2-methanesulfonate
C8H11NO3S
780802-79-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.8736 0.0 0
M  V30 2 O 5.3900 1.5400 0.0 0
M  V30 3 C 5.3900 4.2073 0.0 0
M  V30 4 S 6.9300 1.5400 0.0 0 VAL=6
M  V30 5 C 6.9300 3.0800 0.0 0
M  V30 6 O 8.4700 1.5400 0.0 0
M  V30 7 O 6.9300 0.0000 0.0 0
M  V30 8 C 3.0800 2.8736 0.0 0
M  V30 9 C 2.3100 4.2073 0.0 0
M  V30 10 N 2.3100 1.5400 0.0 0
M  V30 11 C 0.7700 4.2073 0.0 0
M  V30 12 C 0.7700 1.5400 0.0 0
M  V30 13 C 0.0000 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 2 4 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,α-Dimethyl-2-pyridinemethanamine
C8H12N2
114366-07-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 N 5.3901 2.6673 0.0 0
M  V30 3 C 5.3901 0.0000 0.0 0
M  V30 4 C 6.9302 2.6673 0.0 0
M  V30 5 C 3.0801 1.3337 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 N 2.3101 0.0000 0.0 0
M  V30 8 C 0.7700 2.6673 0.0 0
M  V30 9 C 0.7700 0.0000 0.0 0
M  V30 10 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 5
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 780802-79-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 114366-07-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-3481340
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-Methyl-1-pyridin-2-ylethanamine To 1-pyridin-2-ylethyl methanesulfonate
(Tetrahedron Asymmetry 1994, 5, 1973-78; 800 mg, 4 mmol) was added
methylamine (2.0 M in THF, 10 ml, 20 mmol) and the reaction 5 mixture was
stirred at 50°C overnight. The solvent was removed to give the desired
product as an oil (544 mg, quantitative yield).
N-Methyl-1-pyridin-2-ylethanamine, (544 mg, quantitative yield) 1H NMR
(CDCl3): δ 1.40 (m, 3 H), 2.35 (s, 3 H), 3.75 (m, 1 H), 7.15 (m, 1 H),
7.25 (m, 1 H), 7.63 (m, 1 H), 8.56 (m, 1 H)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazole derivatives as inhibitors of receptor tyrosine
kinases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Block, Michael Howard; Han, Yongxin; Josey, John Anthony; Lee, John W.;
Scott, David; Wang, Bin; Wang, Haixia; Wang, Tao; Yu, Dingwei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005049033 A1 2005-06-02

$RFMT $RIREG SCHEME71 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Isopropyl-1H-pyrazole-3-carboxylic acid ethyl ester
C9H14N2O2
78208-72-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2079 1.5400 0.0 0
M  V30 2 O 7.5415 2.3101 0.0 0
M  V30 3 O 6.2079 0.0000 0.0 0
M  V30 4 C 8.8752 1.5400 0.0 0
M  V30 5 C 10.2089 2.3101 0.0 0
M  V30 6 C 0.9051 2.6672 0.0 0
M  V30 7 C 0.0000 3.9131 0.0 0
M  V30 8 C 0.2787 1.2602 0.0 0
M  V30 9 C 4.8741 2.3101 0.0 0
M  V30 10 C 3.4672 1.6836 0.0 0
M  V30 11 N 4.7131 3.8416 0.0 0
M  V30 12 C 2.4368 2.8281 0.0 0
M  V30 13 N 3.2068 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-5-(1-methylethyl)-1H-pyrazole-3-carboxamide
C8H13N3O
1694600-04-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2079 1.5400 0.0 0
M  V30 2 N 7.5415 2.3100 0.0 0
M  V30 3 O 6.2079 0.0000 0.0 0
M  V30 4 C 8.8752 1.5400 0.0 0
M  V30 5 C 0.9052 2.6672 0.0 0
M  V30 6 C 0.2787 1.2602 0.0 0
M  V30 7 C 0.0000 3.9131 0.0 0
M  V30 8 C 4.8742 2.3100 0.0 0
M  V30 9 C 3.4672 1.6836 0.0 0
M  V30 10 N 4.7131 3.8416 0.0 0
M  V30 11 C 2.4368 2.8281 0.0 0
M  V30 12 N 3.2068 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 11
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 78208-72-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1694600-04-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-2962277
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrrolidine-derived β3-adrenergic receptor agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barr, Kenneth Jay; Scott, Mark E.; Thompson, Christopher F.; Anthony,
Neville; Cammarano, Carolyn Michelle; Bakshi, Raman Kumar; Mohanty,
Subhendu Kumar; Korapala, Chandra Sekhar; Latthe, Prashant R.; Kambam,
Vyjayanthi N.; Sarkar, Sujit Kumar; Thatai, Jayanth Thiruvellore
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015050798 A1 2015-04-09

$RFMT $RIREG SCHEME72 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chloroacetyl chloride
C2H2Cl2O
79-04-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 Cl 1.3337 0.0000 0.0 0
M  V30 4 O 0.0000 2.3101 0.0 0
M  V30 5 Cl 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-methylacetamide
C3H6ClNO
96-30-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 1.5400 0.0 0
M  V30 2 C 1.3338 2.3100 0.0 0
M  V30 3 N 4.0011 2.3100 0.0 0
M  V30 4 O 2.6674 0.0000 0.0 0
M  V30 5 Cl 0.0000 1.5400 0.0 0
M  V30 6 C 5.3349 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 79-04-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 96-30-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-22683068
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 4-Arylthieno[2,3-b]pyridine-2-carboxamides are a new class of
antiplasmodial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schweda, Sandra I.; Alder, Arne; Gilberger, Tim; Kunick, Conrad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2020), 25(14), 3187

$RFMT $RIREG SCHEME73 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl 4-oxopiperidine-1-carboxylate
C10H17NO3
79099-07-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 3.0800 0.0 0
M  V30 8 O 10.0100 2.8736 0.0 0
M  V30 9 N 5.3900 2.8736 0.0 0
M  V30 10 C 6.1600 1.5400 0.0 0
M  V30 11 C 6.1600 4.2073 0.0 0
M  V30 12 C 7.7000 1.5400 0.0 0
M  V30 13 C 7.7000 4.2073 0.0 0
M  V30 14 C 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 14
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Piperidinecarboxylic acid, 4-(methylamino)-, 1,1-dimethylethyl ester
C11H22N2O2
147539-41-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 N 10.0100 2.8736 0.0 0
M  V30 9 C 10.7800 4.2073 0.0 0
M  V30 10 N 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 4.2073 0.0 0
M  V30 12 C 6.1600 1.5400 0.0 0
M  V30 13 C 7.7000 4.2073 0.0 0
M  V30 14 C 7.7000 1.5400 0.0 0
M  V30 15 C 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 79099-07-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 147539-41-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-21680204
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of anthranilamide derivatives
as potent SMO inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ji, Dezhong; Zhang, Wanwan; Xu, Yungen; Zhang, Jing-Jing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2020), 28(6), 115354pp.

$RFMT $RIREG SCHEME74 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(3-Chloropropyl)-3,4-dihydro-1-phenyl-2(1H)-quinolinone
C18H18ClNO
792122-64-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 6.9302 0.0 0
M  V30 2 C 8.0022 5.3901 0.0 0
M  V30 3 C 9.3360 4.6201 0.0 0
M  V30 4 C 10.6697 5.3901 0.0 0
M  V30 5 Cl 12.0033 4.6201 0.0 0
M  V30 6 N 4.0012 4.6201 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 5.3901 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 2.6673 2.3101 0.0 0
M  V30 11 C 6.6685 4.6201 0.0 0
M  V30 12 C 6.6685 3.0801 0.0 0
M  V30 13 C 5.3348 0.7700 0.0 0
M  V30 14 C 2.6673 0.7700 0.0 0
M  V30 15 C 4.0012 0.0000 0.0 0
M  V30 16 C 2.6673 5.3901 0.0 0
M  V30 17 C 1.3337 4.6201 0.0 0
M  V30 18 C 2.6673 6.9302 0.0 0
M  V30 19 C 0.0000 5.3901 0.0 0
M  V30 20 C 1.3337 7.7002 0.0 0
M  V30 21 C 0.0000 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 3
M  V30 3 1 2 11
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 16
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 12
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dihydro-3-[3-(methylamino)propyl]-1-phenyl-2(1H)-quinolinone
C19H22N2O
792122-30-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 6.9302 0.0 0
M  V30 2 C 8.0022 5.3901 0.0 0
M  V30 3 C 9.3360 4.6201 0.0 0
M  V30 4 C 10.6697 5.3901 0.0 0
M  V30 5 N 12.0033 4.6201 0.0 0
M  V30 6 C 13.3370 5.3901 0.0 0
M  V30 7 N 4.0010 4.6201 0.0 0
M  V30 8 C 4.0010 3.0801 0.0 0
M  V30 9 C 5.3348 5.3901 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 6.6685 4.6201 0.0 0
M  V30 13 C 6.6685 3.0801 0.0 0
M  V30 14 C 5.3348 0.7700 0.0 0
M  V30 15 C 2.6673 0.7700 0.0 0
M  V30 16 C 4.0010 0.0000 0.0 0
M  V30 17 C 2.6673 5.3901 0.0 0
M  V30 18 C 2.6673 6.9302 0.0 0
M  V30 19 C 1.3337 4.6201 0.0 0
M  V30 20 C 1.3337 7.7002 0.0 0
M  V30 21 C 0.0000 5.3901 0.0 0
M  V30 22 C 0.0000 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 3
M  V30 3 1 2 12
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 17
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 13
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 792122-64-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 792122-30-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-3063077
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7681-11-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 3-(3-Methylammo-propyl)-1-phenyl-3,4-dihydro-1H-qumolin-2-one (6a). A
soln of (4a) (1.2 g, 4 mmol), potassium iodide (200 mg, 1.2 mmol) and
aqueous 2 5 40% methylamine (12 mL) in ethanol (30 mL) was refluxed at
100°C under nitrogen for 3 h. The reaction mixture was cooled, poured
into water and extracted with ethyl acetate (100 mL). The organic layer
was separated, dried over MgSO4 and concentrated. The product was
purified by preparative LCMS to give the racemate. The racemate was
separated into its individual enantiomers using chiral HPLC. Yield 500
mg. 1H NMR (300 MHz, CDCl3) (racemate & isomer) δ 1.5-1.73 (m, 4H),
1.88-1.97 (m, 1H), 2.43 (s, 3H), 2.62 (t, J = 6.69 Hz, 2H), 2.70-2.79 (m,
1H), 2.84-2.92 (m, 1H), 3.15 (dd, J = 5.45, 5.28 Hz, 1H), 6.33 (d, J =
7.73 Hz, 1H), 6.95-7.06 (m.2H), 7.19-7.22 (m, 3H), 7.38-7.43 (m, 1H),
7.47-7.52 (m, 2H). LCMS (12 minute method) [M+H]+ = 295 @ Rt 4.0 min
(100%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Quinolone derivatives useful as selective norepinephrine reuptake
inhibitors, and their preparation, pharmaceutical compositions, and use
in the treatment of nervous system disorders.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Camp, Nicholas Paul; Penariol, Roberta; Beadle, Christopher David
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004096773 A1 2004-11-11

$RFMT $RIREG SCHEME75 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(3-Chloropropyl)-6-fluoro-3,4-dihydro-1-(4-methylphenyl)-2(1H)-quinolinone
C19H19ClFNO
792122-65-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 8.4702 0.0 0
M  V30 2 C 9.3360 6.9302 0.0 0
M  V30 3 C 10.6697 6.1601 0.0 0
M  V30 4 C 12.0033 6.9302 0.0 0
M  V30 5 Cl 13.3370 6.1601 0.0 0
M  V30 6 F 5.3348 0.0000 0.0 0
M  V30 7 C 0.0000 9.2402 0.0 0
M  V30 8 N 5.3348 6.1601 0.0 0
M  V30 9 C 5.3348 4.6201 0.0 0
M  V30 10 C 6.6685 6.9302 0.0 0
M  V30 11 C 6.6685 3.8501 0.0 0
M  V30 12 C 4.0010 3.8501 0.0 0
M  V30 13 C 8.0022 6.1601 0.0 0
M  V30 14 C 8.0022 4.6201 0.0 0
M  V30 15 C 6.6685 2.3101 0.0 0
M  V30 16 C 4.0010 2.3101 0.0 0
M  V30 17 C 5.3348 1.5400 0.0 0
M  V30 18 C 4.0010 6.9302 0.0 0
M  V30 19 C 2.6673 6.1601 0.0 0
M  V30 20 C 4.0010 8.4702 0.0 0
M  V30 21 C 1.3337 6.9302 0.0 0
M  V30 22 C 2.6673 9.2402 0.0 0
M  V30 23 C 1.3337 8.4702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 3
M  V30 3 1 2 13
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 17
M  V30 7 1 7 23
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 18
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 1 13 14
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Fluoro-3,4-dihydro-3-[3-(methylamino)propyl]-1-(4-methylphenyl)-2(1H)-quino...
C20H23FN2O
792122-31-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 8.4702 0.0 0
M  V30 2 C 9.3358 6.9302 0.0 0
M  V30 3 C 10.6697 6.1601 0.0 0
M  V30 4 C 12.0033 6.9302 0.0 0
M  V30 5 N 13.3370 6.1601 0.0 0
M  V30 6 C 14.6707 6.9302 0.0 0
M  V30 7 F 5.3348 0.0000 0.0 0
M  V30 8 C 0.0000 9.2402 0.0 0
M  V30 9 N 5.3348 6.1601 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 6.6685 6.9302 0.0 0
M  V30 12 C 6.6685 3.8501 0.0 0
M  V30 13 C 4.0010 3.8501 0.0 0
M  V30 14 C 8.0022 6.1601 0.0 0
M  V30 15 C 8.0022 4.6201 0.0 0
M  V30 16 C 6.6685 2.3101 0.0 0
M  V30 17 C 4.0010 2.3101 0.0 0
M  V30 18 C 5.3348 1.5400 0.0 0
M  V30 19 C 4.0010 6.9302 0.0 0
M  V30 20 C 4.0010 8.4702 0.0 0
M  V30 21 C 2.6673 6.1601 0.0 0
M  V30 22 C 2.6673 9.2402 0.0 0
M  V30 23 C 1.3337 6.9302 0.0 0
M  V30 24 C 1.3337 8.4702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 1 2 14
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 18
M  V30 8 1 8 24
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 19
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 15
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 792122-65-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 792122-31-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-5195420
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7681-11-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
3-(3-Methylammo-propyl)-1-phenyl-3,4-dihydro-1H-qumolin-2-one (6a). A
soln of (4a) (1.2 g, 4 mmol), potassium iodide (200 mg, 1.2 mmol) and
aqueous 2 5 40% methylamine (12 mL) in ethanol (30 mL) was refluxed at
100°C under nitrogen for 3 h. The reaction mixture was cooled, poured
into water and extracted with ethyl acetate (100 mL). The organic layer
was separated, dried over MgSO4 and concentrated. The product was
purified by preparative LCMS to give the racemate. The racemate was
separated into its individual enantiomers using chiral HPLC.
6-Fluoro-3-(3-methylamino-propyl)-1-p-tolyl-3,4-dihydro-1H-quinolm-2-one
(6b). This was prepared in an identical manner to (6a) using crude (4b)
(399 mg) to give the crude product, which was purified by preparative
LCMS to give the product (35 mg). 1HNMR (300 MHz, CDCl3) (racemate) δ
1.40-1.70 (m, 3H), 1.75-1.90 (m, 4H), 2.34 (s, 3H), 2.36 (s, 3H),
2.50-2.83 (m, 2H), 3.01-3.08 (m, 1H), 6.21-6.26 (m, 1H), 6.62-6.68 (m,
1H), 6.82-6.86 (m, 1H), 6.99 (d, J = .1 Hz, 2H), 7.22 (d, J = .1 Hz, 2H).
LCMS (12 minute method) [M+H]+ = 327 @ Rt 4.8 min (100%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Quinolone derivatives useful as selective norepinephrine reuptake
inhibitors, and their preparation, pharmaceutical compositions, and use
in the treatment of nervous system disorders.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Camp, Nicholas Paul; Penariol, Roberta; Beadle, Christopher David
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004096773 A1 2004-11-11

$RFMT $RIREG SCHEME76 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(2-Chloroethyl)-3,4-dihydro-1-phenyl-2(1H)-quinolinone
C17H16ClNO
792122-66-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 6.9301 0.0 0
M  V30 2 C 8.0022 5.3901 0.0 0
M  V30 3 C 9.3359 4.6201 0.0 0
M  V30 4 Cl 10.6695 5.3901 0.0 0
M  V30 5 N 4.0011 4.6201 0.0 0
M  V30 6 C 4.0011 3.0800 0.0 0
M  V30 7 C 5.3348 5.3901 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 2.6673 2.3100 0.0 0
M  V30 10 C 6.6684 4.6201 0.0 0
M  V30 11 C 6.6684 3.0800 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 13 C 2.6673 0.7700 0.0 0
M  V30 14 C 4.0011 0.0000 0.0 0
M  V30 15 C 2.6673 5.3901 0.0 0
M  V30 16 C 2.6673 6.9301 0.0 0
M  V30 17 C 1.3337 4.6201 0.0 0
M  V30 18 C 1.3337 7.7001 0.0 0
M  V30 19 C 0.0000 5.3901 0.0 0
M  V30 20 C 0.0000 6.9301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 3
M  V30 3 1 2 10
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 15
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 10 11
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dihydro-3-[2-(methylamino)ethyl]-1-phenyl-2(1H)-quinolinone
C18H20N2O
792122-32-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 6.9302 0.0 0
M  V30 2 C 8.0022 5.3901 0.0 0
M  V30 3 C 9.3360 4.6201 0.0 0
M  V30 4 N 10.6697 5.3901 0.0 0
M  V30 5 C 12.0033 4.6201 0.0 0
M  V30 6 N 4.0012 4.6201 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 5.3901 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 2.6673 2.3101 0.0 0
M  V30 11 C 6.6685 4.6201 0.0 0
M  V30 12 C 6.6685 3.0801 0.0 0
M  V30 13 C 5.3348 0.7700 0.0 0
M  V30 14 C 2.6673 0.7700 0.0 0
M  V30 15 C 4.0012 0.0000 0.0 0
M  V30 16 C 2.6673 5.3901 0.0 0
M  V30 17 C 1.3337 4.6201 0.0 0
M  V30 18 C 2.6673 6.9302 0.0 0
M  V30 19 C 0.0000 5.3901 0.0 0
M  V30 20 C 1.3337 7.7002 0.0 0
M  V30 21 C 0.0000 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 3
M  V30 3 1 2 11
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 16
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 12
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 792122-66-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 792122-32-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-7343579
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7681-11-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
3-(3-Methylammo-propyl)-1-phenyl-3,4-dihydro-1H-qumolin-2-one (6a). A
soln of (4a) (1.2 g, 4 mmol), potassium iodide (200 mg, 1.2 mmol) and
aqueous 2 5 40% methylamine (12 mL) in ethanol (30 mL) was refluxed at
100°C under nitrogen for 3 h. The reaction mixture was cooled, poured
into water and extracted with ethyl acetate (100 mL). The organic layer
was separated, dried over MgSO4 and concentrated. The product was
purified by preparative LCMS to give the racemate. The racemate was
separated into its individual enantiomers using chiral HPLC.
3-(2-Methylamino-ethyl)-1-phenyl-3,4-dihydro-1H-quinolm-2-one (6c) 15
This was prepared in an identical manner to (6a) using crude (4c) (1g) to
give the racemate (80 mg). The racemate was separated into its individual
enantiomers using chiral HPLC. 1H NMR (300 MHz, CDCl3) (racemate &
isomer) δ ppm 1.64-1.76 (m, 1H), 1.79 (br, 1H), 2.03-2.18 (m, 1H), 2.44
(s, 3H), 2.71-2.82 (m, 2H), 2.82- 2.94 (m, 2H), 3.09-3.21 (m, 1H), 6.33
(dd, J = 7.91, 1.32 Hz, 1H), 6.94-7.07 (m, 2H), 7.18-7.24 (m, 3H),
7.37-7.44 (m, 1H), 7.47-7.54 (m, 2H). LCMS (12 minute method) [M+H]+ =
281 @Rt 3.82 min (100%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Quinolone derivatives useful as selective norepinephrine reuptake
inhibitors, and their preparation, pharmaceutical compositions, and use
in the treatment of nervous system disorders.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Camp, Nicholas Paul; Penariol, Roberta; Beadle, Christopher David
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004096773 A1 2004-11-11

$RFMT $RIREG SCHEME77 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(3-Chloropropyl)-3,4-dihydro-3-methyl-1-phenyl-2(1H)-quinolinone
C19H20ClNO
792122-67-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 6.9300 0.0 0
M  V30 2 C 8.1851 4.3527 0.0 0
M  V30 3 C 9.1750 5.5323 0.0 0
M  V30 4 C 10.6916 5.2648 0.0 0
M  V30 5 Cl 11.6815 6.4446 0.0 0
M  V30 6 C 7.1952 6.0671 0.0 0
M  V30 7 N 4.0011 4.6200 0.0 0
M  V30 8 C 4.0011 3.0800 0.0 0
M  V30 9 C 5.3347 5.3900 0.0 0
M  V30 10 C 5.3347 2.3100 0.0 0
M  V30 11 C 2.6674 2.3100 0.0 0
M  V30 12 C 6.6685 4.6200 0.0 0
M  V30 13 C 6.6685 3.0800 0.0 0
M  V30 14 C 5.3347 0.7700 0.0 0
M  V30 15 C 2.6674 0.7700 0.0 0
M  V30 16 C 4.0011 0.0000 0.0 0
M  V30 17 C 2.6674 5.3900 0.0 0
M  V30 18 C 2.6674 6.9300 0.0 0
M  V30 19 C 1.3338 4.6200 0.0 0
M  V30 20 C 1.3338 7.7000 0.0 0
M  V30 21 C 0.0000 5.3900 0.0 0
M  V30 22 C 0.0000 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 3
M  V30 3 1 2 12
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 12
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 17
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 13
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dihydro-3-methyl-3-[3-(methylamino)propyl]-1-phenyl-2(1H)-quinolinone
C20H24N2O
792122-33-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 6.9300 0.0 0
M  V30 2 C 8.1851 4.3527 0.0 0
M  V30 3 C 9.1750 5.5323 0.0 0
M  V30 4 C 10.6916 5.2648 0.0 0
M  V30 5 N 11.6815 6.4446 0.0 0
M  V30 6 C 13.1981 6.1771 0.0 0
M  V30 7 C 7.1952 6.0671 0.0 0
M  V30 8 N 4.0011 4.6200 0.0 0
M  V30 9 C 4.0011 3.0800 0.0 0
M  V30 10 C 5.3347 5.3900 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 2.6674 2.3100 0.0 0
M  V30 13 C 6.6685 4.6200 0.0 0
M  V30 14 C 6.6685 3.0800 0.0 0
M  V30 15 C 5.3347 0.7700 0.0 0
M  V30 16 C 2.6674 0.7700 0.0 0
M  V30 17 C 4.0011 0.0000 0.0 0
M  V30 18 C 2.6674 5.3900 0.0 0
M  V30 19 C 2.6674 6.9300 0.0 0
M  V30 20 C 1.3338 4.6200 0.0 0
M  V30 21 C 1.3338 7.7000 0.0 0
M  V30 22 C 0.0000 5.3900 0.0 0
M  V30 23 C 0.0000 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 3
M  V30 3 1 2 13
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 13
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 18
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 1 13 14
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 792122-67-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 792122-33-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-9481614
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7681-11-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
3-(3-Methylammo-propyl)-1-phenyl-3,4-dihydro-1H-qumolin-2-one (6a). A
soln of (4a) (1.2 g, 4 mmol), potassium iodide (200 mg, 1.2 mmol) and
aqueous 2 5 40% methylamine (12 mL) in ethanol (30 mL) was refluxed at
100°C under nitrogen for 3 h. The reaction mixture was cooled, poured
into water and extracted with ethyl acetate (100 mL). The organic layer
was separated, dried over MgSO4 and concentrated. The product was
purified by preparative LCMS to give the racemate. The racemate was
separated into its individual enantiomers using chiral HPLC.
3-Methyl-3-(3-methylamino-propyl)-1-phenyl-3,4-dihydro-1H-quinolin-2-one
(7a). This was prepared in an identical manner to (6a) using crude (5a)
(650 mg) to give the crude product (198 mg), which was purified by
preparative LCMS. The purified racemate was then separated into its
individual enantiomers using chiral HPLC. 1H NMR (300 MHz, CDCl3)
(isomer) δ ppm 1.27 (s, 3H), 1.43 (br, 1H), 1.53-1.66 (m, 4H), 2.39 (s,
3H), 2.54 (t, J = .12 Hz, 2H), 2.91 (d, J = 5.64 Hz, 1H), 2.98 (d, J
=15.64 Hz, 1H), 6.28 (dd, J = 7.91, 1.32 Hz, 1H), 6.97 (td, J = 7.21,
1.41 Hz, 1H), 7.03 (td, J = 7.68, 1.98 Hz, 1H), 7.14-7.22 (m, 3H),
7.36-7.44 (m, 1H), 7.46-7.53 (m, 2H). LCMS (12 minute method) [M+H]+ =
309 @Rt 4.21 min (100%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Quinolone derivatives useful as selective norepinephrine reuptake
inhibitors, and their preparation, pharmaceutical compositions, and use
in the treatment of nervous system disorders.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Camp, Nicholas Paul; Penariol, Roberta; Beadle, Christopher David
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004096773 A1 2004-11-11

$RFMT $RIREG SCHEME78 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(±)-Pantolactone
C6H10O3
79-50-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6527 0.0000 0.0 0
M  V30 2 C 0.0000 3.0715 0.0 0
M  V30 3 C 0.6368 1.1114 0.0 0
M  V30 4 O 5.3632 1.9692 0.0 0
M  V30 5 C 2.6527 1.5400 0.0 0
M  V30 6 C 1.4068 2.4452 0.0 0
M  V30 7 C 3.8987 2.4452 0.0 0
M  V30 8 C 1.8827 3.9098 0.0 0
M  V30 9 O 3.4227 3.9098 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 1 3 6
M  V30 4 2 4 7
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dihydroxy-N,3,3-trimethylbutanamide
C7H15NO3
79691-41-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.6438 1.5400 0.0 0
M  V30 2 C 2.3100 2.3100 0.0 0
M  V30 3 C 4.9775 2.3100 0.0 0
M  V30 4 O 3.6438 0.0000 0.0 0
M  V30 5 C 1.5400 0.9764 0.0 0
M  V30 6 C 3.0800 3.6437 0.0 0
M  V30 7 C 0.9764 3.0800 0.0 0
M  V30 8 N 6.3111 1.5400 0.0 0
M  V30 9 O 4.9775 3.8500 0.0 0
M  V30 10 O 0.0000 0.9764 0.0 0
M  V30 11 C 7.6450 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 2 7
M  V30 7 1 3 8
M  V30 8 2 3 9
M  V30 9 1 5 10
M  V30 10 1 8 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 79-50-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 79691-41-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-13289114
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM One-pot synthesis of N-substituted pantolactams from pantolactone
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barrios, Ivana; Camps, Pelayo; Comes-Franchini, Mauro; Munoz-Torrero,
Diego; Ricci, Alfredo; Sanchez, Laura
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2003), 59(11), 1971-1979

$RFMT $RIREG SCHEME79 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-6-iodobenzonitrile
C7H3FIN
79544-29-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6674 0.0 0
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 F 3.0800 0.0000 0.0 0
M  V30 4 I 3.0800 5.3349 0.0 0
M  V30 5 C 3.0800 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 0.7700 1.3338 0.0 0
M  V30 9 C 0.7700 4.0011 0.0 0
M  V30 10 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 7
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzonitrile, 2-iodo-6-(methylamino)-
C8H7IN2
1369877-11-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 3.0800 0.0 0
M  V30 2 C 6.6685 3.8500 0.0 0
M  V30 3 C 2.6674 1.5400 0.0 0
M  V30 4 N 2.6674 0.0000 0.0 0
M  V30 5 I 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 5.3900 0.0 0
M  V30 9 C 1.3338 3.8500 0.0 0
M  V30 10 C 2.6674 6.1600 0.0 0
M  V30 11 C 1.3338 5.3900 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 3 3 4
M  V30 4 1 3 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 79544-29-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1369877-11-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-19578524
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Hydrogen Atom Transfer-Mediated Cyclisations of Nitriles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Turner, Oliver J.; Murphy, John A.; Hirst, David J.; Talbot, Eric P. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2018), 24(70), 18658-18662

$RFMT $RIREG SCHEME80 STEP1
$RXN



  2  1
$MOL
4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenone
C16H12Cl2O
79560-19-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.0011 0.0 0
M  V30 2 Cl 9.2400 6.6685 0.0 0
M  V30 3 Cl 10.7800 4.0011 0.0 0
M  V30 4 C 3.8500 2.6674 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 4.6200 1.3338 0.0 0
M  V30 8 C 3.8500 5.3347 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 1.5400 1.3338 0.0 0
M  V30 11 C 3.8500 0.0000 0.0 0
M  V30 12 C 2.3100 5.3347 0.0 0
M  V30 13 C 2.3100 0.0000 0.0 0
M  V30 14 C 6.1600 4.0011 0.0 0
M  V30 15 C 6.9300 5.3347 0.0 0
M  V30 16 C 6.9300 2.6674 0.0 0
M  V30 17 C 8.4700 5.3347 0.0 0
M  V30 18 C 8.4700 2.6674 0.0 0
M  V30 19 C 9.2400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 17
M  V30 3 1 3 19
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 5 14
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 2 11 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenylidene]methanamine
C17H15Cl2N
79560-20-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 4.0011 0.0 0
M  V30 2 C 0.0000 5.3348 0.0 0
M  V30 3 Cl 10.0101 6.6686 0.0 0
M  V30 4 Cl 11.5501 4.0011 0.0 0
M  V30 5 C 4.6201 2.6675 0.0 0
M  V30 6 C 5.3901 4.0011 0.0 0
M  V30 7 C 3.0800 2.6675 0.0 0
M  V30 8 C 5.3901 1.3338 0.0 0
M  V30 9 C 4.6201 5.3348 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 4.6201 0.0000 0.0 0
M  V30 13 C 3.0800 5.3348 0.0 0
M  V30 14 C 3.0800 0.0000 0.0 0
M  V30 15 C 6.9301 4.0011 0.0 0
M  V30 16 C 7.7001 5.3348 0.0 0
M  V30 17 C 7.7001 2.6675 0.0 0
M  V30 18 C 9.2401 5.3348 0.0 0
M  V30 19 C 9.2401 2.6675 0.0 0
M  V30 20 C 10.0101 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 10 CFG=2
M  V30 3 1 3 18
M  V30 4 1 4 20
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 6 15
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 2 12 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 79560-19-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 79560-20-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-14965728
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7550-45-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 1: Preparation of sertraline-1-imine (Schiff base): Sertralone (100
g) was dissolved in toluene (1400 mL) and the solution so obtained was
cooled to 0-5°C. Methyl amine gas (38.7 g) was bubbled through the
solution while maintaining the temperature between 0-5°C. To the above
solution, TiCl4 (20 mL) was added dropwise while maintaining the
temperature below 10°C. The reaction mixture was allowed to warm to room
temperature and then was stirred at room temperature for 3 hours. Upon
completion of the reaction, TiO2 was removed by filtration and the
filtrate was evaporated to dryness. The solid obtained after evaporation
was sertraline-1-imine (101.17 g; yield 100%). sertraline-1-imine, yield
101.17 g; 100%.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel process for preparing (+)-cis-sertraline
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mendelovich, Mariuara; Nidam, Tammy; Pilarsky, Gideon; Gershon, Neomi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001068566 A1 2001-09-20

$RFMT $RIREG SCHEME81 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 5-bromo-2-(bromomethyl)-, methyl ester
C9H8Br2O2
79670-17-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 5.3347 0.0 0
M  V30 2 O 0.7700 5.3347 0.0 0
M  V30 3 O 3.0800 6.6685 0.0 0
M  V30 4 C 0.0000 6.6685 0.0 0
M  V30 5 C 5.3900 5.3347 0.0 0
M  V30 6 Br 6.9300 5.3347 0.0 0
M  V30 7 Br 2.3100 0.0000 0.0 0
M  V30 8 C 3.0800 4.0011 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 2.3100 2.6674 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 3.0800 1.3338 0.0 0
M  V30 13 C 4.6200 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 9
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-2,3-dihydro-2-methyl-1H-isoindol-1-one
C9H8BrNO
1254319-51-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.9416 0.0000 0.0 0
M  V30 2 C 7.9110 2.7104 0.0 0
M  V30 3 Br 0.0000 1.1704 0.0 0
M  V30 4 C 4.0011 1.9404 0.0 0
M  V30 5 C 4.0011 3.4804 0.0 0
M  V30 6 C 5.4658 1.4645 0.0 0
M  V30 7 C 2.6674 1.1704 0.0 0
M  V30 8 C 5.4658 3.9564 0.0 0
M  V30 9 C 2.6674 4.2504 0.0 0
M  V30 10 N 6.3710 2.7104 0.0 0
M  V30 11 C 1.3338 1.9404 0.0 0
M  V30 12 C 1.3338 3.4804 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 10
M  V30 3 1 3 11
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 79670-17-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1254319-51-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-12131071
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 35.1: 6-Bromo-2-methylisoindolin-1-one. To a solution of
5-bromo-2-bromomethyl-benzoic acid methyl ester (1.00 g, 3.25 mmol) in
THF (6.5 mL) was a solution of methylamine in THF (2M, 8.12 mL, 16.24
mmol). The reaction mixture was heated at 50°C for 4 hours and then
concentrated under vacuum. The residue was taken up in EtOAc and the
organic layer was then washed with an aqueous 1M HCl solution, brine,
dried (Na2SO4, filtered, concentrated under vacuum. Yield: (0.73 g, 100%)
as a yellow solid. 1H NMR (400 MHz, CDCl3): δ 3.19 (m, 3H), 4.32 (s, 2H),
7.31 (d, 1H), 7.63 (dd, 1H), 7.96 (d, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of
6-(4-hydroxy-phenyl)-3-styryl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic
acid amide derivatives as kinase inhibitors for treatment of diabetes,
diabetic complications, and other diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Loehn, Matthias; Mendez-Perez, Maria; Pfeiffer-Marek, Stefania; Kannt,
Aimo; Begis, Guillaume; Jeannot, Frederic; Duclos, Olivier
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013037390 A1 2013-03-21

$RFMT $RIREG SCHEME81 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 5-bromo-2-(bromomethyl)-, methyl ester
C9H8Br2O2
79670-17-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 5.3347 0.0 0
M  V30 2 O 0.7700 5.3347 0.0 0
M  V30 3 O 3.0800 6.6685 0.0 0
M  V30 4 C 0.0000 6.6685 0.0 0
M  V30 5 C 5.3900 5.3347 0.0 0
M  V30 6 Br 6.9300 5.3347 0.0 0
M  V30 7 Br 2.3100 0.0000 0.0 0
M  V30 8 C 3.0800 4.0011 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 2.3100 2.6674 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 3.0800 1.3338 0.0 0
M  V30 13 C 4.6200 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 9
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-2,3-dihydro-2-methyl-1H-isoindol-1-one
C9H8BrNO
1254319-51-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.9416 0.0000 0.0 0
M  V30 2 C 7.9110 2.7104 0.0 0
M  V30 3 Br 0.0000 1.1704 0.0 0
M  V30 4 C 4.0011 1.9404 0.0 0
M  V30 5 C 4.0011 3.4804 0.0 0
M  V30 6 C 5.4658 1.4645 0.0 0
M  V30 7 C 2.6674 1.1704 0.0 0
M  V30 8 C 5.4658 3.9564 0.0 0
M  V30 9 C 2.6674 4.2504 0.0 0
M  V30 10 N 6.3710 2.7104 0.0 0
M  V30 11 C 1.3338 1.9404 0.0 0
M  V30 12 C 1.3338 3.4804 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 10
M  V30 3 1 3 11
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 79670-17-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1254319-51-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-12290885
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 35.1: 6-Bromo-2-methylisoindolin-1-one To a solution of
5-bromo-2-bromomethyl-benzoic acid methyl ester (1.00 g, 3.25 mmol) inTHF
(6.5 mL) was a solution ofmethylamine in THF (2M, 8.12 mL, 16.24 mmol).
The reaction mixture was heated at 50°C. for 4 hours and then
concentrated under vacuum. The residue was taken up in EtOAc and the
organic layer was then washed with an aqueous 1M HCl solution, brine,
dried (Na2SO4), filtered, concentrated under vacuum to give the title
compound. Yellow solid, yield 0.73 g, 100%. 1H NMR (400 MHz, CDCl3): δ
3.19 (m, 3H), 4.32 (s, 2H), 7.31 (d, 1H), 7.63 (dd, 1H), 7.96 (d, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of
6-(4-hydroxy-phenyl)-3-styryl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic
acid amide derivatives as kinase inhibitors for treatment of diabetes,
diabetic complications, and other diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Loehn, Matthias; Mendez-Perez, Maria; Pfeiffer-Marek, Stefania; Kannt,
Aimo; Begis, Guillaume; Duclos, Olivier; Jeannot, Federic
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20130065894 A1 2013-03-14

$RFMT $RIREG SCHEME81 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 5-bromo-2-(bromomethyl)-, methyl ester
C9H8Br2O2
79670-17-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 5.3347 0.0 0
M  V30 2 O 0.7700 5.3347 0.0 0
M  V30 3 O 3.0800 6.6685 0.0 0
M  V30 4 C 0.0000 6.6685 0.0 0
M  V30 5 C 5.3900 5.3347 0.0 0
M  V30 6 Br 6.9300 5.3347 0.0 0
M  V30 7 Br 2.3100 0.0000 0.0 0
M  V30 8 C 3.0800 4.0011 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 2.3100 2.6674 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 3.0800 1.3338 0.0 0
M  V30 13 C 4.6200 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 9
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-2,3-dihydro-2-methyl-1H-isoindol-1-one
C9H8BrNO
1254319-51-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.9416 0.0000 0.0 0
M  V30 2 C 7.9110 2.7104 0.0 0
M  V30 3 Br 0.0000 1.1704 0.0 0
M  V30 4 C 4.0011 1.9404 0.0 0
M  V30 5 C 4.0011 3.4804 0.0 0
M  V30 6 C 5.4658 1.4645 0.0 0
M  V30 7 C 2.6674 1.1704 0.0 0
M  V30 8 C 5.4658 3.9564 0.0 0
M  V30 9 C 2.6674 4.2504 0.0 0
M  V30 10 N 6.3710 2.7104 0.0 0
M  V30 11 C 1.3338 1.9404 0.0 0
M  V30 12 C 1.3338 3.4804 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 10
M  V30 3 1 3 11
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 79670-17-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1254319-51-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-23242540
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of
6-(4-hydroxy-phenyl)-3-styryl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic
acid amide derivatives as kinase inhibitors for treatment of diabetes,
diabetic complications, and other diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Loehn, Matthias; Mendez-Perez, Maria; Pfeiffer-Marek, Stefania; Kannt,
Aimo; Begis, Guillaume; Jeannot, Frederic; Duclos, Olivier
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP2567959 A1 2013-03-13

$RFMT $RIREG SCHEME82 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2,6,6-Tetramethyl-1,4-cyclohexanedione
C10H16O2
80560-44-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 2.8503 0.0 0
M  V30 2 C 2.5774 5.7005 0.0 0
M  V30 3 C 0.8629 4.7106 0.0 0
M  V30 4 C 0.8629 0.9899 0.0 0
M  V30 5 C 2.5774 0.0000 0.0 0
M  V30 6 O 6.1600 2.8503 0.0 0
M  V30 7 C 1.5400 2.8503 0.0 0
M  V30 8 C 2.3100 4.1839 0.0 0
M  V30 9 C 2.3100 1.5166 0.0 0
M  V30 10 C 3.8500 4.1839 0.0 0
M  V30 11 C 3.8500 1.5166 0.0 0
M  V30 12 C 4.6200 2.8503 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 8
M  V30 3 1 3 8
M  V30 4 1 4 9
M  V30 5 1 5 9
M  V30 6 2 6 12
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2,6,6-Tetramethyl-4-(methylamino)cyclohexanone
C11H21NO
561307-29-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 2.8503 0.0 0
M  V30 2 C 2.5774 0.0000 0.0 0
M  V30 3 C 0.8629 0.9899 0.0 0
M  V30 4 C 0.8629 4.7106 0.0 0
M  V30 5 C 2.5774 5.7006 0.0 0
M  V30 6 N 6.1601 2.8503 0.0 0
M  V30 7 C 6.9301 4.1839 0.0 0
M  V30 8 C 1.5400 2.8503 0.0 0
M  V30 9 C 2.3100 1.5166 0.0 0
M  V30 10 C 2.3100 4.1839 0.0 0
M  V30 11 C 3.8501 1.5166 0.0 0
M  V30 12 C 3.8501 4.1839 0.0 0
M  V30 13 C 4.6201 2.8503 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 9
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 1 5 10
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 80560-44-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 561307-29-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-3143502
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM To a solution of 2,2,6,6-tetramethyl-cyclohexane-1,4-dione (0.40 g, 2.4
mmol, 1.0 eq.) in THE (8 mL) was added molecular sieves (4 A, 80 mg), 2 M
solution of MeNH2 in THE (1.3 mL, 2.6 mmol, 1.1 eq.), and AcOH (0.17 mL,
3.0 mmol, 1,2 eq.). After 5 minutes of stirring, NaBH(OAc)3 (0.71 g, 3.33
mmol, 1.4 eq.) was added and the resulting mixture was stirred at room
temperature overnight. The reaction was quenched with the addition of
saturated NaHCO3. The mixture was then concentrated and the aqueous layer
was extracted with 3xEtOAc. The combined organic layers were washed once
with saturated NaHCO3, dried over MgSO4, filtered and concentrated to
give a crude pale yellow oil that was crystallized to give 39. White
crystals, yield (0.40 g, >100%).
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, molecular sieves used in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of deazapurines for use in pharmaceutical compositions for
the treatment of reperfusion injuries, osteoporosis and/or bone
metastasis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Daun, Jane; Fields, Scott; Kobayashi, Seiichi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20040186127 A1 2004-09-23

$RFMT $RIREG SCHEME82 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2,6,6-Tetramethyl-1,4-cyclohexanedione
C10H16O2
80560-44-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 2.8503 0.0 0
M  V30 2 C 2.5774 5.7005 0.0 0
M  V30 3 C 0.8629 4.7106 0.0 0
M  V30 4 C 0.8629 0.9899 0.0 0
M  V30 5 C 2.5774 0.0000 0.0 0
M  V30 6 O 6.1600 2.8503 0.0 0
M  V30 7 C 1.5400 2.8503 0.0 0
M  V30 8 C 2.3100 4.1839 0.0 0
M  V30 9 C 2.3100 1.5166 0.0 0
M  V30 10 C 3.8500 4.1839 0.0 0
M  V30 11 C 3.8500 1.5166 0.0 0
M  V30 12 C 4.6200 2.8503 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 8
M  V30 3 1 3 8
M  V30 4 1 4 9
M  V30 5 1 5 9
M  V30 6 2 6 12
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2,6,6-Tetramethyl-4-(methylamino)cyclohexanone
C11H21NO
561307-29-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 2.8503 0.0 0
M  V30 2 C 2.5774 0.0000 0.0 0
M  V30 3 C 0.8629 0.9899 0.0 0
M  V30 4 C 0.8629 4.7106 0.0 0
M  V30 5 C 2.5774 5.7006 0.0 0
M  V30 6 N 6.1601 2.8503 0.0 0
M  V30 7 C 6.9301 4.1839 0.0 0
M  V30 8 C 1.5400 2.8503 0.0 0
M  V30 9 C 2.3100 1.5166 0.0 0
M  V30 10 C 2.3100 4.1839 0.0 0
M  V30 11 C 3.8501 1.5166 0.0 0
M  V30 12 C 3.8501 4.1839 0.0 0
M  V30 13 C 4.6201 2.8503 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 9
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 1 5 10
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 80560-44-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 561307-29-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-13798217
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of deazapurines for use in pharmaceutical compositions for
the treatment of inflammatory, autoimmune and proliferative diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Daun, Jane; Davis, Heather A.; Gusovsky, Fabian; Hishinuma, Ieharu;
Jiang, Yimin; Kaneko, Toshihiko; Kikuchi, Kouichi; Kobayashi, Seiichi;
Lescarbeau, Andre; Li, Xiang-Li; Muramoto, Kenzo; Ohi, Norihito; Pesant,
Marc; Seletsky, Boris M.; Soejima, Motohiko; Yao, Ye; Yokohama,
Hiromitsu; Zhao, Janet Y.; Zheng, Wanjun; Tremblay, Lynda
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003057696 A1 2003-07-17

$RFMT $RIREG SCHEME83 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[5-O-[Bis(4-methoxyphenyl)phenylmethyl]-2-deoxy-3-O-[(1,1-dimethylethyl)dim...
C39H47N5O6Si
80971-34-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  51 56 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 13.5733 7.4776 0.0 0
M  V30 2 O 12.0333 7.4776 0.0 0
M  V30 3 C 11.2633 6.1438 0.0 0
M  V30 4 O 13.5733 13.6376 0.0 0
M  V30 5 C 14.9069 14.4076 0.0 0
M  V30 6 O 19.7333 7.4776 0.0 0
M  V30 7 C 20.5033 6.1438 0.0 0
M  V30 8 O 9.2939 3.4334 0.0 0
M  V30 9 Si 8.2635 2.2889 0.0 0
M  V30 10 C 7.2329 1.1445 0.0 0
M  V30 11 C 7.1190 3.3195 0.0 0
M  V30 12 C 9.4079 1.2585 0.0 0
M  V30 13 C 6.0885 2.1749 0.0 0
M  V30 14 C 6.2025 0.0000 0.0 0
M  V30 15 C 8.3774 0.1140 0.0 0
M  V30 16 O 7.6754 9.9770 0.0 0
M  V30 17 C 2.0479 7.4715 0.0 0
M  V30 18 C 13.5733 9.0176 0.0 0
M  V30 19 C 12.2396 9.7876 0.0 0
M  V30 20 C 14.9069 9.7876 0.0 0
M  V30 21 C 12.2396 11.3276 0.0 0
M  V30 22 C 14.9069 11.3276 0.0 0
M  V30 23 C 13.5733 12.0976 0.0 0
M  V30 24 C 15.1133 7.4776 0.0 0
M  V30 25 C 15.8833 6.1438 0.0 0
M  V30 26 C 15.8833 8.8113 0.0 0
M  V30 27 C 17.4233 6.1438 0.0 0
M  V30 28 C 17.4233 8.8113 0.0 0
M  V30 29 C 18.1933 7.4776 0.0 0
M  V30 30 C 13.5733 5.9376 0.0 0
M  V30 31 C 14.9069 5.1676 0.0 0
M  V30 32 C 12.2396 5.1676 0.0 0
M  V30 33 C 14.9069 3.6276 0.0 0
M  V30 34 C 12.2395 3.6276 0.0 0
M  V30 35 C 13.5733 2.8576 0.0 0
M  V30 36 C 9.7233 6.1438 0.0 0 CFG=1
M  V30 37 C 8.8180 4.8980 0.0 0 CFG=1
M  V30 38 O 8.8180 7.3898 0.0 0
M  V30 39 C 7.3533 5.3738 0.0 0
M  V30 40 C 7.3533 6.9138 0.0 0 CFG=1
M  V30 41 N 6.1075 7.8190 0.0 0
M  V30 42 C 6.2684 9.3506 0.0 0
M  V30 43 C 4.7007 7.1927 0.0 0
M  V30 44 N 5.0226 10.2558 0.0 0
M  V30 45 C 3.4548 8.0979 0.0 0
M  V30 46 C 3.6158 9.6295 0.0 0
M  V30 47 N 2.3699 10.5347 0.0 0
M  V30 48 C 2.3699 12.0747 0.0 0
M  V30 49 N 0.9052 10.0588 0.0 0
M  V30 50 N 0.9052 12.5505 0.0 0
M  V30 51 C 0.0000 11.3047 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 1 24
M  V30 4 1 1 30
M  V30 5 1 2 3
M  V30 6 1 36 3 CFG=3
M  V30 7 1 4 5
M  V30 8 1 4 23
M  V30 9 1 6 7
M  V30 10 1 6 29
M  V30 11 1 8 9
M  V30 12 1 37 8 CFG=1
M  V30 13 1 9 10
M  V30 14 1 9 11
M  V30 15 1 9 12
M  V30 16 1 10 13
M  V30 17 1 10 14
M  V30 18 1 10 15
M  V30 19 2 16 42
M  V30 20 1 17 45
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 39 1 36 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 1 38 40
M  V30 43 1 39 40
M  V30 44 1 40 41 CFG=3
M  V30 45 1 41 42
M  V30 46 1 41 43
M  V30 47 1 42 44
M  V30 48 2 43 45
M  V30 49 2 44 46
M  V30 50 1 45 46
M  V30 51 1 46 47
M  V30 52 1 47 48
M  V30 53 1 47 49
M  V30 54 2 48 50
M  V30 55 2 49 51
M  V30 56 1 50 51
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 36 37 40)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
5′-O-[Bis(4-methoxyphenyl)phenylmethyl]-2′-deoxy-3′-O-[(1,1-dimethylethyl)dim...
C38H49N3O6Si
80971-36-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  48 52 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 12.6101 6.9300 0.0 0
M  V30 2 O 11.0701 6.9300 0.0 0
M  V30 3 C 10.3001 8.2638 0.0 0
M  V30 4 O 12.6101 0.7700 0.0 0
M  V30 5 C 13.9439 0.0000 0.0 0
M  V30 6 O 18.7701 6.9300 0.0 0
M  V30 7 C 19.5401 8.2638 0.0 0
M  V30 8 O 8.3309 10.9742 0.0 0
M  V30 9 Si 7.3004 12.1187 0.0 0
M  V30 10 C 6.2700 13.2631 0.0 0
M  V30 11 C 6.1560 11.0882 0.0 0
M  V30 12 C 8.4449 13.1491 0.0 0
M  V30 13 C 7.4143 14.2937 0.0 0
M  V30 14 C 5.2395 14.4076 0.0 0
M  V30 15 C 5.1256 12.2327 0.0 0
M  V30 16 O 3.5767 8.7464 0.0 0
M  V30 17 C 4.2205 2.6202 0.0 0
M  V30 18 N 1.4068 3.8729 0.0 0
M  V30 19 C 0.0000 4.4994 0.0 0
M  V30 20 C 12.6101 5.3900 0.0 0
M  V30 21 C 13.9439 4.6200 0.0 0
M  V30 22 C 11.2765 4.6200 0.0 0
M  V30 23 C 13.9439 3.0800 0.0 0
M  V30 24 C 11.2765 3.0800 0.0 0
M  V30 25 C 12.6101 2.3100 0.0 0
M  V30 26 C 14.1501 6.9300 0.0 0
M  V30 27 C 14.9201 5.5964 0.0 0
M  V30 28 C 14.9201 8.2638 0.0 0
M  V30 29 C 16.4601 5.5964 0.0 0
M  V30 30 C 16.4601 8.2638 0.0 0
M  V30 31 C 17.2301 6.9300 0.0 0
M  V30 32 C 12.6101 8.4700 0.0 0
M  V30 33 C 11.2765 9.2400 0.0 0
M  V30 34 C 13.9439 9.2400 0.0 0
M  V30 35 C 11.2765 10.7800 0.0 0
M  V30 36 C 13.9439 10.7800 0.0 0
M  V30 37 C 12.6101 11.5500 0.0 0
M  V30 38 C 8.7601 8.2638 0.0 0 CFG=1
M  V30 39 C 7.8549 9.5097 0.0 0 CFG=1
M  V30 40 O 7.8549 7.0178 0.0 0
M  V30 41 C 6.3904 9.0338 0.0 0
M  V30 42 C 6.3904 7.4938 0.0 0 CFG=1
M  V30 43 N 5.1445 6.5886 0.0 0
M  V30 44 C 3.7376 7.2149 0.0 0
M  V30 45 C 5.3055 5.0571 0.0 0
M  V30 46 N 2.4917 6.3097 0.0 0
M  V30 47 C 4.0596 4.1518 0.0 0
M  V30 48 C 2.6527 4.7782 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 1 26
M  V30 4 1 1 32
M  V30 5 1 2 3
M  V30 6 1 38 3 CFG=1
M  V30 7 1 4 5
M  V30 8 1 4 25
M  V30 9 1 6 7
M  V30 10 1 6 31
M  V30 11 1 8 9
M  V30 12 1 39 8 CFG=3
M  V30 13 1 9 10
M  V30 14 1 9 11
M  V30 15 1 9 12
M  V30 16 1 10 13
M  V30 17 1 10 14
M  V30 18 1 10 15
M  V30 19 2 16 44
M  V30 20 1 17 47
M  V30 21 1 18 19
M  V30 22 1 18 48
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 35 2 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 36
M  V30 39 2 35 37
M  V30 40 1 36 37
M  V30 41 1 38 39
M  V30 42 1 38 40
M  V30 43 1 39 41
M  V30 44 1 40 42
M  V30 45 1 41 42
M  V30 46 1 42 43 CFG=1
M  V30 47 1 43 44
M  V30 48 1 43 45
M  V30 49 1 44 46
M  V30 50 2 45 47
M  V30 51 2 46 48
M  V30 52 1 47 48
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 38 39 42)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 80971-34-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 80971-36-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-033-CAS-18066449
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A cyclobutane thymine-N4-methylcytosine dimer is resistant to hydrolysis
but strongly blocks DNA synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yamamoto, Junpei; Oyama, Tomoko; Kunishi, Tomohiro; Masutani, Chikahide;
Hanaoka, Fumio; Iwai, Shigenori
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nucleic Acids Research (2014), 42(3), 2075-2084

$RFMT $RIREG SCHEME84 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2R,4R,5R)-5-Hydroxy-2-phenyl-1,3-dioxane-4-carboxaldehyde
C11H12O4
81577-69-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.3338 0.0 0
M  V30 2 O 2.3100 0.0000 0.0 0
M  V30 3 O 0.0000 4.0011 0.0 0
M  V30 4 C 4.6200 4.0011 0.0 0 CFG=2
M  V30 5 O 3.8500 2.6674 0.0 0
M  V30 6 O 3.8500 5.3349 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0 CFG=1
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0 CFG=2
M  V30 10 C 6.1600 4.0011 0.0 0
M  V30 11 C 6.9300 2.6674 0.0 0
M  V30 12 C 6.9300 5.3349 0.0 0
M  V30 13 C 8.4700 2.6674 0.0 0
M  V30 14 C 8.4700 5.3349 0.0 0
M  V30 15 C 9.2400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 7 1 CFG=1
M  V30 3 1 9 3 CFG=3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10 CFG=1
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 4 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2R,4S,5R)-4-[(Methylimino)methyl]-2-phenyl-1,3-dioxan-5-ol
C12H15NO3
1621988-04-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 3.0800 0.0 0
M  V30 2 N 8.0021 4.6200 0.0 0
M  V30 3 C 9.3358 5.3900 0.0 0
M  V30 4 O 8.0021 0.0000 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0 CFG=2
M  V30 6 O 5.3347 3.0800 0.0 0
M  V30 7 O 4.0011 0.7700 0.0 0
M  V30 8 C 6.6684 2.3100 0.0 0 CFG=1
M  V30 9 C 5.3347 0.0000 0.0 0
M  V30 10 C 6.6684 0.7700 0.0 0 CFG=2
M  V30 11 C 2.6674 3.0800 0.0 0
M  V30 12 C 1.3336 2.3100 0.0 0
M  V30 13 C 2.6674 4.6200 0.0 0
M  V30 14 C 0.0000 3.0800 0.0 0
M  V30 15 C 1.3336 5.3900 0.0 0
M  V30 16 C 0.0000 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 8 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 10 4 CFG=3
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 11 CFG=1
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 5 8 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 81577-69-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1621988-04-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-8724423
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of the Chiral Ligand. The chiral ligand, D-erythrose amino
derivative 3,
(2R,4S,5R)-4-[(N-methylamino)methyl]-2-phenyl-1,3-dioxan-5-ol, was
prepared in two steps from 2,4-O-benzylidene-D-erythrose acetal 1 (Scheme
1). (a) A suspension of aldehyde 1 (0.210 g, 1.00 mmol) in dry THF (2 mL)
was refrigerated at 0 °C, then methylamine was bubbled through for 40
min. The reaction mixture was kept at room temperature for an additional
period of 2.5 h. Volatiles were removed in the rotary evaporator. Imine
2. quantitative yield, white solid. Mp 90-92 °C; [α]D20 = +38.5° (concn
0.93% MeCO2Et); IR νmax (Nujol, cm-1) 3265 s, 1677 m; 1H NMR (400 MHz,
CDCl3) δ 7.87 (1H, t, J = 1.6 Hz, H-1'), 7.54-7.38 (5H, m, H-Ph), 5.57
(1H, s, H-2), 4.37 (1H, dd, J = 5.2, 10.8 Hz, H-6), 4.14 (1H, dt, J =
1.6, 8.8 Hz), 4.02-3.96 (1H, m, H-5), 3.71 (1H, t, J = 10.8 Hz, H-6),
3.35 (3H, s, H-3') ppm; 13C NMR (100.62 MHz, CDCl3) δ 166.4 (C-1'), 137.2
(Cq-Ph), 129.1 (CH-Ph), 128.3 (CH-Ph), 126.1 (CH-Ph), 101.4 (C-2), 79.9
(C-4), 70.2 (H-6), 64.9 (H-5), 47.3 (C-3') ppm; HRMS (ESI) calcd 222.1125
[(C12H16NO3)+], obtained 222.1123.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Norbornene Oxidation by Chiral Complexes Encapsulated in NaY Zeolite
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kuzniarska-Biernacka, I.; Parpot, P.; Oliveira, C.; Silva, A. R.; Alves,
M. J.; Fonseca, A. M.; Neves, I. C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Physical Chemistry C (2014), 118(33), 19042-19050

$RFMT $RIREG SCHEME85 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(Methylthio)methoxy]benzaldehyde
C9H10O2S
828242-88-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 S 9.3360 3.0801 0.0 0
M  V30 4 C 10.6697 2.3101 0.0 0
M  V30 5 C 1.3337 3.0801 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 4.0012 3.0801 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 2.6673 2.3101 0.0 0
M  V30 11 C 4.0012 0.0000 0.0 0
M  V30 12 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 5 6
M  V30 6 1 5 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[3-[(Methylthio)methoxy]phenyl]methylene]methanamine
C10H13NOS
828242-89-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0022 3.0801 0.0 0
M  V30 2 C 9.3360 2.3101 0.0 0
M  V30 3 S 10.6697 3.0801 0.0 0
M  V30 4 C 12.0033 2.3101 0.0 0
M  V30 5 C 2.6673 3.0801 0.0 0
M  V30 6 N 1.3337 2.3101 0.0 0
M  V30 7 C 0.0000 3.0801 0.0 0
M  V30 8 C 6.6685 2.3101 0.0 0
M  V30 9 C 5.3348 3.0801 0.0 0
M  V30 10 C 6.6685 0.7700 0.0 0
M  V30 11 C 4.0012 2.3101 0.0 0
M  V30 12 C 5.3348 0.0000 0.0 0
M  V30 13 C 4.0012 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 5 6 CFG=2
M  V30 6 1 5 11
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 828242-88-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 828242-89-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-1822261
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 2: Methyl-(3-methylsulfanylmethoxy-benzylidene)-amine:
3-Methylsulfanylmeth-oxy-benzaldehyde from step 1 (3.309 g, 18.16 mmol)
was dissolved in EtOH (9 mL). MeNH2 (2.55 mL, 40% in H2O) was added and
the mixture was heated to 40°C for 30 min. Upon cooling, the mixture was
concentrated in vacuo. The aqueous residue was diluted with isopropanol
and then concentrated in vacuo. This was repeated twice more giving 3.55g
(quant) of a pale yellow oil.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A preparation of arylamine-substituted quinazolinones, useful as α1A and
α1B adrenoceptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Connolly, Terrence Joseph; Keitz, Paul Francis; Lee, Eun Kyung; Li, Jim;
Lopez-Tapia, Francisco Javier; Mcgarry, Patrick Finbar; Melville, Chris
Richard; Nitzan, Dov; O'Yang, Counde; Padilla, Fernando; Weinhardt, Klaus
Kurt
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005005395 A2 2005-01-20

$RFMT $RIREG SCHEME86 STEP1
$RXN



  2  1
$MOL
1-(1,1-Dimethylethyl) 4-(3-carboxyphenyl)-1-piperidinecarboxylate
C17H23NO4
828243-30-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 13.3370 3.0801 0.0 0
M  V30 2 O 13.3370 4.6201 0.0 0
M  V30 3 O 14.6707 2.3101 0.0 0
M  V30 4 C 4.0010 5.3901 0.0 0
M  V30 5 O 2.6673 4.6201 0.0 0
M  V30 6 O 4.0010 6.9302 0.0 0
M  V30 7 C 1.3337 5.3901 0.0 0
M  V30 8 C 0.5637 4.0564 0.0 0
M  V30 9 C 0.0000 6.1601 0.0 0
M  V30 10 C 2.1037 6.7238 0.0 0
M  V30 11 C 9.3358 2.3101 0.0 0
M  V30 12 C 10.6697 3.0801 0.0 0
M  V30 13 C 9.3358 0.7700 0.0 0
M  V30 14 C 12.0033 2.3101 0.0 0
M  V30 15 C 10.6697 0.0000 0.0 0
M  V30 16 C 12.0033 0.7700 0.0 0
M  V30 17 C 8.0022 3.0801 0.0 0
M  V30 18 C 8.0022 4.6201 0.0 0
M  V30 19 C 6.6685 2.3101 0.0 0
M  V30 20 C 6.6685 5.3901 0.0 0
M  V30 21 C 5.3348 3.0801 0.0 0
M  V30 22 N 5.3348 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 22
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 11 17
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[3-[(methylamino)carbonyl]phenyl]-1-piperidinecarboxylate
C18H26N2O3
828243-29-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 13.3370 3.0800 0.0 0
M  V30 2 N 14.6707 2.3100 0.0 0
M  V30 3 O 13.3370 4.6201 0.0 0
M  V30 4 C 16.0045 3.0800 0.0 0
M  V30 5 C 4.0011 5.3901 0.0 0
M  V30 6 O 2.6675 4.6201 0.0 0
M  V30 7 O 4.0011 6.9301 0.0 0
M  V30 8 C 1.3338 5.3901 0.0 0
M  V30 9 C 2.1038 6.7237 0.0 0
M  V30 10 C 0.0000 6.1601 0.0 0
M  V30 11 C 0.5638 4.0564 0.0 0
M  V30 12 C 9.3359 2.3100 0.0 0
M  V30 13 C 10.6697 3.0800 0.0 0
M  V30 14 C 9.3359 0.7700 0.0 0
M  V30 15 C 12.0034 2.3100 0.0 0
M  V30 16 C 10.6697 0.0000 0.0 0
M  V30 17 C 12.0034 0.7700 0.0 0
M  V30 18 C 8.0022 3.0800 0.0 0
M  V30 19 C 6.6686 2.3100 0.0 0
M  V30 20 C 8.0022 4.6201 0.0 0
M  V30 21 C 5.3348 3.0800 0.0 0
M  V30 22 C 6.6686 5.3901 0.0 0
M  V30 23 N 5.3348 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 23
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 12 18
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 828243-30-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 828243-29-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-3608259
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 1: 4-(3-Methylcarbamoylphenyl)piperidine-1-methylcarboxamide: To a
solution of 4-(3-carboxyphenyl)piperidine-1-carboxylic acid tert-butyl
ester (1.0 g, 3.27 mmol) in 4 mL of DMF, was added CDI (0.63 g, 3.92
mmol) and the reaction mixture warmed to 60°C for two hours. After that
time, the mixture was cooled to 0-5°C and, a 2 M solution of methylamine
in THF (4.91 mL, 9.82 mmol) was added via syringe and the mixture allowed
to warm to RT overnight. The mixture was poured into a saturated solution
of ammonium chloride, and the product was extracted with ethyl ether
(3x50 mL). Organics were washed with water (3x30 mL) and brine (1x15 L),
then dried with magnesium sulfate and concentrated. The dense liquid,
crude product, was used into the next step without further treatment.
Yield 1.05 g (100%). 1H NMR (CDCl3, 7.26) δ 1.48 (s, 9 H), 1.63 (m, 2 H),
1.75 (m, 2 H), 2.69 (m, 1 H), 2.80 (m, 2 H), 3.01 (d, 3 H), 4.23 (br s,
2H), 6.15 (br s, D2O, 1H), 7.32 (dt, 1H, J = 6.87, 1.71), 7.34 (t, 1H, J
= 6.72), 7.55 (dt, 1H, J = 6.87, 1.71), 7.64 (t, 1H, J = 1.71); MS (ES+)
m/z 319 (M + H), 341.2 (M + Na).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A preparation of arylamine-substituted quinazolinones, useful as α1A and
α1B adrenoceptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Connolly, Terrence Joseph; Keitz, Paul Francis; Lee, Eun Kyung; Li, Jim;
Lopez-Tapia, Francisco Javier; Mcgarry, Patrick Finbar; Melville, Chris
Richard; Nitzan, Dov; O'Yang, Counde; Padilla, Fernando; Weinhardt, Klaus
Kurt
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005005395 A2 2005-01-20

$RFMT $RIREG SCHEME87 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-4-(trifluoromethyl)benzaldehyde
C8H4ClF3O
83279-38-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 2.6673 0.0 0
M  V30 2 F 1.5400 1.1273 0.0 0
M  V30 3 F 0.0000 2.6673 0.0 0
M  V30 4 F 1.5400 4.2073 0.0 0
M  V30 5 Cl 3.0800 0.0000 0.0 0
M  V30 6 C 7.7000 2.6673 0.0 0
M  V30 7 O 8.4700 4.0011 0.0 0
M  V30 8 C 3.0800 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 5.3900 1.3336 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 6.1600 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-N-methyl-4-(trifluoromethyl)benzenemethanamine
C9H9ClF3N
1131740-04-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 2.6673 0.0 0
M  V30 2 F 1.5400 1.1273 0.0 0
M  V30 3 F 0.0000 2.6673 0.0 0
M  V30 4 F 1.5400 4.2073 0.0 0
M  V30 5 Cl 3.0800 0.0000 0.0 0
M  V30 6 C 7.7000 2.6673 0.0 0
M  V30 7 N 8.4700 4.0011 0.0 0
M  V30 8 C 10.0100 4.0011 0.0 0
M  V30 9 C 3.0800 2.6673 0.0 0
M  V30 10 C 3.8500 1.3336 0.0 0
M  V30 11 C 3.8500 4.0011 0.0 0
M  V30 12 C 5.3900 1.3336 0.0 0
M  V30 13 C 5.3900 4.0011 0.0 0
M  V30 14 C 6.1600 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 5 10
M  V30 6 1 6 7
M  V30 7 1 6 14
M  V30 8 1 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 83279-38-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1131740-04-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40490484
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective Defluorination of Trifluoromethyl Substituents by
Conformationally Induced Remote Substitution
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jesani, Mehul H.; Schwarz, Maria; Kim, Shiwhu; Evans, Finlay L.; White,
Alexander; Browning, Alex; Abrams, Roman; Clayden, Jonathan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2024), 63(24), e202403477

$RFMT $RIREG SCHEME88 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl (3-bromopropyl)carbamate
C8H16BrNO2
83948-53-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 2.3101 0.0 0
M  V30 2 C 4.0012 1.5400 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 N 5.3348 2.3101 0.0 0
M  V30 5 O 4.0012 0.0000 0.0 0
M  V30 6 C 2.1037 0.2064 0.0 0
M  V30 7 C 0.0000 0.7700 0.0 0
M  V30 8 C 0.5637 2.8737 0.0 0
M  V30 9 C 6.6685 1.5400 0.0 0
M  V30 10 C 8.0023 2.3101 0.0 0
M  V30 11 C 9.3360 1.5400 0.0 0
M  V30 12 Br 10.6697 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 9 10
M  V30 10 1 10 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[3-(methylamino)propyl]carbamate
C9H20N2O2
442514-22-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 O 2.6673 2.3101 0.0 0
M  V30 4 O 4.0012 0.0000 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 C 8.0022 2.3101 0.0 0
M  V30 8 C 2.1037 0.2064 0.0 0
M  V30 9 C 0.0000 0.7700 0.0 0
M  V30 10 C 0.5637 2.8737 0.0 0
M  V30 11 C 9.3360 1.5400 0.0 0
M  V30 12 N 10.6697 2.3101 0.0 0
M  V30 13 C 12.0033 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 11 12
M  V30 12 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 83948-53-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 442514-22-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-20328785
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a crystalline sulforaphane analog with good solid-state
stability and engagement of the Nrf2 pathway in vitro and in vivo
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Boehm, Jeffrey; Davis, Roderick; Murar, Claudia E.; Li, Tindy; McCleland,
Brent; Dong, Shuping; Yan, Hongxing; Kerns, Jeffrey; Moody, Christopher
J.; Wilson, Anthony J.; Graves, Alan P.; Mentzer, Mary; Qi, Hongwei;
Yonchuk, John; Kou, Jen-Pyng; Foley, Joseph; Sanchez, Yolanda; Podolin,
Patricia L.; Bolognese, Brian; Booth-Genthe, Catherine; Galop, Marc;
Wolfe, Lawrence; Carr, Robin; Callahan, James F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2019), 27(4), 579-588

$RFMT $RIREG SCHEME89 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dimethoxyphenyl isocyanate
C9H9NO3
84370-87-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 4.0012 0.0 0
M  V30 2 C 0.7700 5.3348 0.0 0
M  V30 3 O 0.0000 6.6687 0.0 0
M  V30 4 O 3.0801 1.3338 0.0 0
M  V30 5 C 3.8501 0.0000 0.0 0
M  V30 6 O 7.7002 4.0012 0.0 0
M  V30 7 C 8.4702 5.3348 0.0 0
M  V30 8 C 3.0801 4.0012 0.0 0
M  V30 9 C 3.8501 2.6675 0.0 0
M  V30 10 C 3.8501 5.3348 0.0 0
M  V30 11 C 5.3901 2.6675 0.0 0
M  V30 12 C 5.3901 5.3348 0.0 0
M  V30 13 C 6.1601 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2,4-Dimethoxyphenyl)-N′-methylurea
C10H14N2O3
393057-66-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 4.0011 0.0 0
M  V30 2 C 7.7000 5.3347 0.0 0
M  V30 3 N 9.2400 5.3347 0.0 0
M  V30 4 O 6.9300 6.6685 0.0 0
M  V30 5 C 10.0100 6.6685 0.0 0
M  V30 6 O 5.3900 1.3338 0.0 0
M  V30 7 C 4.6200 0.0000 0.0 0
M  V30 8 O 0.7700 4.0011 0.0 0
M  V30 9 C 0.0000 5.3347 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 2.6674 0.0 0
M  V30 12 C 4.6200 5.3347 0.0 0
M  V30 13 C 3.0800 2.6674 0.0 0
M  V30 14 C 3.0800 5.3347 0.0 0
M  V30 15 C 2.3100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 11
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 84370-87-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 393057-66-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-316-CAS-956291
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Key parameters for carbamate stability in dilute aqueous-organic solution
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vandenabeele-Trambouze, O.; Garrelly, L.; Mion, L.; Boiteau, L.;
Commeyras, A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advances in Environmental Research (2001), 6(1), 67-80

$RFMT $RIREG SCHEME90 STEP1
$RXN



  2  1
$MOL
(2S,4aR,6aS,7R,9S,10aS,10bR)-9-(Acetyloxy)-2-(3-furanyl)octahydro-7-(hydroxym...
C22H28O7
844841-22-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.3193 5.5344 0.0 0
M  V30 2 C 2.6673 7.7002 0.0 0
M  V30 3 O 6.6685 3.8501 0.0 0
M  V30 4 O 8.0022 10.7802 0.0 0
M  V30 5 C 1.3337 6.9302 0.0 0
M  V30 6 O 0.0000 6.1601 0.0 0
M  V30 7 O 4.0010 2.3101 0.0 0
M  V30 8 C 2.6673 1.5400 0.0 0
M  V30 9 C 2.6673 0.0000 0.0 0
M  V30 10 O 1.3337 2.3101 0.0 0
M  V30 11 C 6.6685 6.9302 0.0 0 CFG=2
M  V30 12 C 5.3348 6.1601 0.0 0 CFG=1
M  V30 13 C 6.6685 8.4702 0.0 0 CFG=2
M  V30 14 C 8.0022 6.1601 0.0 0
M  V30 15 C 4.0010 6.9302 0.0 0 CFG=2
M  V30 16 C 5.3348 4.6201 0.0 0
M  V30 17 C 5.3348 9.2402 0.0 0
M  V30 18 C 8.0022 9.2402 0.0 0
M  V30 19 C 9.3358 6.9302 0.0 0 CFG=1
M  V30 20 C 2.6673 6.1601 0.0 0 CFG=2
M  V30 21 C 4.0010 8.4702 0.0 0
M  V30 22 C 4.0010 3.8501 0.0 0 CFG=1
M  V30 23 O 9.3358 8.4702 0.0 0
M  V30 24 C 2.6673 4.6201 0.0 0
M  V30 25 C 10.6697 6.1601 0.0 0
M  V30 26 C 12.0765 6.7865 0.0 0
M  V30 27 C 10.8306 4.6286 0.0 0
M  V30 28 C 13.1069 5.6421 0.0 0
M  V30 29 O 12.3369 4.3084 0.0 0
M  V30 30 H 6.4238 5.0712 0.0 0
M  V30 31 H 6.6685 10.0102 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 11 1 CFG=1
M  V30 2 1 15 2 CFG=1
M  V30 3 2 3 16
M  V30 4 2 4 18
M  V30 5 1 5 6
M  V30 6 1 20 5 CFG=1
M  V30 7 1 7 8
M  V30 8 1 22 7 CFG=1
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 1 12 30 CFG=3
M  V30 17 1 13 17
M  V30 18 1 13 18
M  V30 19 1 13 31 CFG=3
M  V30 20 1 14 19
M  V30 21 1 15 20
M  V30 22 1 15 21
M  V30 23 1 16 22
M  V30 24 1 17 21
M  V30 25 1 18 23
M  V30 26 1 19 23
M  V30 27 1 19 25 CFG=3
M  V30 28 1 20 24
M  V30 29 1 22 24
M  V30 30 1 25 26
M  V30 31 2 25 27
M  V30 32 2 26 28
M  V30 33 1 27 29
M  V30 34 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 11 12 13 15 19 20 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2S,4aR,6aS,7R,9S,10aS,10bR)-9-(Acetyloxy)-2-(3-furanyl)octahydro-6a,10b-dime...
C23H31NO6
910305-43-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7877 5.5344 0.0 0
M  V30 2 C 10.4396 7.7001 0.0 0
M  V30 3 O 6.4385 3.8500 0.0 0
M  V30 4 C 11.7733 6.9301 0.0 0
M  V30 5 N 13.1069 6.1601 0.0 0
M  V30 6 C 14.4407 6.9301 0.0 0
M  V30 7 O 9.1060 2.3100 0.0 0
M  V30 8 C 10.4396 1.5400 0.0 0
M  V30 9 C 10.4396 0.0000 0.0 0
M  V30 10 O 11.7733 2.3100 0.0 0
M  V30 11 O 5.1048 10.7801 0.0 0
M  V30 12 C 7.7721 6.1601 0.0 0 CFG=1
M  V30 13 C 6.4385 6.9301 0.0 0 CFG=2
M  V30 14 C 9.1060 6.9301 0.0 0 CFG=2
M  V30 15 C 7.7721 4.6200 0.0 0
M  V30 16 C 6.4385 8.4701 0.0 0 CFG=2
M  V30 17 C 5.1048 6.1601 0.0 0
M  V30 18 C 10.4396 6.1601 0.0 0 CFG=2
M  V30 19 C 9.1060 8.4701 0.0 0
M  V30 20 C 9.1060 3.8500 0.0 0 CFG=1
M  V30 21 C 7.7721 9.2401 0.0 0
M  V30 22 C 5.1048 9.2401 0.0 0
M  V30 23 C 3.7710 6.9301 0.0 0 CFG=1
M  V30 24 C 10.4396 4.6200 0.0 0
M  V30 25 O 3.7710 8.4701 0.0 0
M  V30 26 C 2.4374 6.1601 0.0 0
M  V30 27 C 2.2764 4.6285 0.0 0
M  V30 28 C 1.0306 6.7864 0.0 0
M  V30 29 C 0.7700 4.3083 0.0 0
M  V30 30 O 0.0000 5.6420 0.0 0
M  V30 31 H 6.6832 5.0711 0.0 0
M  V30 32 H 6.4385 10.0101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 13 1 CFG=3
M  V30 2 1 14 2 CFG=3
M  V30 3 2 3 15
M  V30 4 1 4 5
M  V30 5 1 18 4 CFG=3
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 20 7 CFG=3
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 2 11 22
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 12 31 CFG=1
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 14 19
M  V30 20 1 15 20
M  V30 21 1 16 21
M  V30 22 1 16 22
M  V30 23 1 16 32 CFG=1
M  V30 24 1 17 23
M  V30 25 1 18 24
M  V30 26 1 19 21
M  V30 27 1 20 24
M  V30 28 1 22 25
M  V30 29 1 23 25
M  V30 30 1 23 26 CFG=1
M  V30 31 1 26 27
M  V30 32 2 26 28
M  V30 33 2 27 29
M  V30 34 1 28 30
M  V30 35 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 12 13 14 16 18 20 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 844841-22-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 910305-43-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-15052194
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 358-23-6
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Method E: To a cold (0°C.) solution of 222 (1 equiv) in CH2Cl2 was added
excess pyridine and trifluoromethanesulfonic anhydride. The reaction
solution was stirred at 0°C. for 5 min, quenched with aqueous 1 N HCl (1
mL), washed with brine (1 mL), dried (MgSO4), and evaporated to dryness.
The crude triflate (1 equiv) was taken up in a THF solution of the amine
(excess) and stirred at room temperature (5-10 min). The solution was
concentrated in vacuo, and the residue was purified by column
chromatography (SiO2; CH2Cl2-CH3OH) to obtain the desired product.
Synthesis of 4-(N-methylamino)methyl salvinorin A (224a). Compound 224a
(8.5 mg, quantitative yield) was prepared as an off-white solid from 222a
(8.2 mg, 20 μmol), CH2Cl2 (1 mL), trifluoromethanesulfonic anhydride (25
μL, 150 μmol), pyridine (25 μL, 310 μmol), and CH3NH2 (2.0 N in THF, 500
μL) using method E Rf 0.13 (19:1, CH2Cl2:CH3OH); 1H NMR (CD3OD) δ 0.92
(s, 3H), 1.34- 1.42 (m, 1H), 1.43 (s, 3H), 1.47-1.53 (m, 1H), 1.58-1.68
(m, 1H), 1.73-1.88 (m, 2H), 1.98 (dt, J=12.6, 3.0 Hz, 1H), 2.06-2.12 (m,
1H), 2.11 (s, 3H), 2.32-2.44 (m, 3H), 2.57 (s, 1H), 2.70 (s, 3H), 2.82
(dd, J=12.6, 10.2 Hz, 1H), 3.17 (dd, J=12.6, 2.4 Hz, 1H), 5.21 (dd,
J=12.5, 7.7 Hz, 1H), 5.60 (dd, J=11.7, 5.1 Hz, 1H), 6.50-4.51 (m, 1H),
7.48-7.49 (m, 1H), 7.55-7.56 (m, 1H); 13C NMR (CD3OD) 15.7, 16.3, 19.3,
20.4, 33.3, 34.8, 36.4, 38.3,43.2, 43.7, 46.7, 50.5, 51.6, 64.0, 73.7,
76.8, 109.6, 127.0, 141.3, 145.1, 171.6, 174.1, 204.6 ppm; HRMS (ES+)
calcd for C23H32NO6 [M+H+]: 418.2229, found: 418.2224.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of salvinorin derivatives for treatment of depressive
disorders and mania
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Beguin, Cecile; Carlezon, William A.; Cohen, Bruce M.; He, Minsheng; Lee,
David Yue-Wei; Richards, Michele R.; Liu-Chen, Lee-Yuan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20070213394 A1 2007-09-13

$RFMT $RIREG SCHEME90 STEP1
$RXN



  2  1
$MOL
(2S,4aR,6aS,7R,9S,10aS,10bR)-9-(Acetyloxy)-2-(3-furanyl)octahydro-7-(hydroxym...
C22H28O7
844841-22-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.3193 5.5344 0.0 0
M  V30 2 C 2.6673 7.7002 0.0 0
M  V30 3 O 6.6685 3.8501 0.0 0
M  V30 4 O 8.0022 10.7802 0.0 0
M  V30 5 C 1.3337 6.9302 0.0 0
M  V30 6 O 0.0000 6.1601 0.0 0
M  V30 7 O 4.0010 2.3101 0.0 0
M  V30 8 C 2.6673 1.5400 0.0 0
M  V30 9 C 2.6673 0.0000 0.0 0
M  V30 10 O 1.3337 2.3101 0.0 0
M  V30 11 C 6.6685 6.9302 0.0 0 CFG=2
M  V30 12 C 5.3348 6.1601 0.0 0 CFG=1
M  V30 13 C 6.6685 8.4702 0.0 0 CFG=2
M  V30 14 C 8.0022 6.1601 0.0 0
M  V30 15 C 4.0010 6.9302 0.0 0 CFG=2
M  V30 16 C 5.3348 4.6201 0.0 0
M  V30 17 C 5.3348 9.2402 0.0 0
M  V30 18 C 8.0022 9.2402 0.0 0
M  V30 19 C 9.3358 6.9302 0.0 0 CFG=1
M  V30 20 C 2.6673 6.1601 0.0 0 CFG=2
M  V30 21 C 4.0010 8.4702 0.0 0
M  V30 22 C 4.0010 3.8501 0.0 0 CFG=1
M  V30 23 O 9.3358 8.4702 0.0 0
M  V30 24 C 2.6673 4.6201 0.0 0
M  V30 25 C 10.6697 6.1601 0.0 0
M  V30 26 C 12.0765 6.7865 0.0 0
M  V30 27 C 10.8306 4.6286 0.0 0
M  V30 28 C 13.1069 5.6421 0.0 0
M  V30 29 O 12.3369 4.3084 0.0 0
M  V30 30 H 6.4238 5.0712 0.0 0
M  V30 31 H 6.6685 10.0102 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 11 1 CFG=1
M  V30 2 1 15 2 CFG=1
M  V30 3 2 3 16
M  V30 4 2 4 18
M  V30 5 1 5 6
M  V30 6 1 20 5 CFG=1
M  V30 7 1 7 8
M  V30 8 1 22 7 CFG=1
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 1 12 30 CFG=3
M  V30 17 1 13 17
M  V30 18 1 13 18
M  V30 19 1 13 31 CFG=3
M  V30 20 1 14 19
M  V30 21 1 15 20
M  V30 22 1 15 21
M  V30 23 1 16 22
M  V30 24 1 17 21
M  V30 25 1 18 23
M  V30 26 1 19 23
M  V30 27 1 19 25 CFG=3
M  V30 28 1 20 24
M  V30 29 1 22 24
M  V30 30 1 25 26
M  V30 31 2 25 27
M  V30 32 2 26 28
M  V30 33 1 27 29
M  V30 34 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 11 12 13 15 19 20 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2S,4aR,6aS,7R,9S,10aS,10bR)-9-(Acetyloxy)-2-(3-furanyl)octahydro-6a,10b-dime...
C23H31NO6
910305-43-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7877 5.5344 0.0 0
M  V30 2 C 10.4396 7.7001 0.0 0
M  V30 3 O 6.4385 3.8500 0.0 0
M  V30 4 C 11.7733 6.9301 0.0 0
M  V30 5 N 13.1069 6.1601 0.0 0
M  V30 6 C 14.4407 6.9301 0.0 0
M  V30 7 O 9.1060 2.3100 0.0 0
M  V30 8 C 10.4396 1.5400 0.0 0
M  V30 9 C 10.4396 0.0000 0.0 0
M  V30 10 O 11.7733 2.3100 0.0 0
M  V30 11 O 5.1048 10.7801 0.0 0
M  V30 12 C 7.7721 6.1601 0.0 0 CFG=1
M  V30 13 C 6.4385 6.9301 0.0 0 CFG=2
M  V30 14 C 9.1060 6.9301 0.0 0 CFG=2
M  V30 15 C 7.7721 4.6200 0.0 0
M  V30 16 C 6.4385 8.4701 0.0 0 CFG=2
M  V30 17 C 5.1048 6.1601 0.0 0
M  V30 18 C 10.4396 6.1601 0.0 0 CFG=2
M  V30 19 C 9.1060 8.4701 0.0 0
M  V30 20 C 9.1060 3.8500 0.0 0 CFG=1
M  V30 21 C 7.7721 9.2401 0.0 0
M  V30 22 C 5.1048 9.2401 0.0 0
M  V30 23 C 3.7710 6.9301 0.0 0 CFG=1
M  V30 24 C 10.4396 4.6200 0.0 0
M  V30 25 O 3.7710 8.4701 0.0 0
M  V30 26 C 2.4374 6.1601 0.0 0
M  V30 27 C 2.2764 4.6285 0.0 0
M  V30 28 C 1.0306 6.7864 0.0 0
M  V30 29 C 0.7700 4.3083 0.0 0
M  V30 30 O 0.0000 5.6420 0.0 0
M  V30 31 H 6.6832 5.0711 0.0 0
M  V30 32 H 6.4385 10.0101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 13 1 CFG=3
M  V30 2 1 14 2 CFG=3
M  V30 3 2 3 15
M  V30 4 1 4 5
M  V30 5 1 18 4 CFG=3
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 20 7 CFG=3
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 2 11 22
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 12 31 CFG=1
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 14 19
M  V30 20 1 15 20
M  V30 21 1 16 21
M  V30 22 1 16 22
M  V30 23 1 16 32 CFG=1
M  V30 24 1 17 23
M  V30 25 1 18 24
M  V30 26 1 19 21
M  V30 27 1 20 24
M  V30 28 1 22 25
M  V30 29 1 23 25
M  V30 30 1 23 26 CFG=1
M  V30 31 1 26 27
M  V30 32 2 26 28
M  V30 33 2 27 29
M  V30 34 1 28 30
M  V30 35 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 12 13 14 16 18 20 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 844841-22-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 910305-43-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-14543014
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 358-23-6
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and in vitro evaluation of salvinorin A analogues: Effect of
configuration at C(2) and substitution at C(18)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Beguin, Cecile; Richards, Michele R.; Li, Jian-Guo; Wang, Yulin; Xu, Wei;
Liu-Chen, Lee-Yuan; Carlezon, William A.; Cohen, Bruce M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2006), 16(17), 4679-4685

$RFMT $RIREG SCHEME91 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[(1S)-2-[(2R)-4-benzoyl-2-methyl-1-piperazinyl]-1-methyl-2-oxoethoxy...
C24H25F3N2O6
845655-36-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 2.3100 0.0 0
M  V30 2 C 2.6674 1.5400 0.0 0
M  V30 3 F 2.6674 0.0000 0.0 0
M  V30 4 F 1.3336 0.7700 0.0 0
M  V30 5 F 1.3336 2.3100 0.0 0
M  V30 6 O 6.6684 3.8500 0.0 0
M  V30 7 C 8.0021 4.6200 0.0 0 CFG=1
M  V30 8 C 9.3358 3.8500 0.0 0
M  V30 9 C 8.0021 6.1600 0.0 0
M  V30 10 O 9.3358 2.3100 0.0 0
M  V30 11 C 1.3336 6.9300 0.0 0
M  V30 12 O 1.3336 8.4700 0.0 0
M  V30 13 O 0.0000 6.1600 0.0 0
M  V30 14 C 0.0000 9.2400 0.0 0
M  V30 15 C 12.0032 2.3100 0.0 0
M  V30 16 C 14.6705 6.9300 0.0 0
M  V30 17 O 14.6705 8.4700 0.0 0
M  V30 18 C 4.0011 3.8500 0.0 0
M  V30 19 C 5.3347 4.6200 0.0 0
M  V30 20 C 2.6674 4.6200 0.0 0
M  V30 21 C 5.3347 6.1600 0.0 0
M  V30 22 C 2.6674 6.1600 0.0 0
M  V30 23 C 4.0011 6.9300 0.0 0
M  V30 24 N 10.6694 4.6200 0.0 0
M  V30 25 C 12.0032 3.8500 0.0 0 CFG=2
M  V30 26 C 10.6694 6.1600 0.0 0
M  V30 27 C 13.3369 4.6200 0.0 0
M  V30 28 C 12.0032 6.9300 0.0 0
M  V30 29 N 13.3369 6.1600 0.0 0
M  V30 30 C 16.0041 6.1600 0.0 0
M  V30 31 C 16.0041 4.6200 0.0 0
M  V30 32 C 17.3379 6.9300 0.0 0
M  V30 33 C 17.3379 3.8500 0.0 0
M  V30 34 C 18.6716 6.1600 0.0 0
M  V30 35 C 18.6716 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 1 6 19
M  V30 8 1 7 8
M  V30 9 1 7 9 CFG=1
M  V30 10 2 8 10
M  V30 11 1 8 24
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 22
M  V30 15 1 12 14
M  V30 16 1 25 15 CFG=1
M  V30 17 2 16 17
M  V30 18 1 16 29
M  V30 19 1 16 30
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4-[(1S)-2-[(2R)-4-Benzoyl-2-methyl-1-piperazinyl]-1-methyl-2-oxoethoxy]-N-met...
C24H26F3N3O5
845654-82-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 2.3100 0.0 0
M  V30 2 C 2.6674 1.5400 0.0 0
M  V30 3 F 2.6674 0.0000 0.0 0
M  V30 4 F 1.3336 0.7700 0.0 0
M  V30 5 F 1.3336 2.3100 0.0 0
M  V30 6 O 6.6684 3.8500 0.0 0
M  V30 7 C 8.0021 4.6200 0.0 0 CFG=1
M  V30 8 C 9.3358 3.8500 0.0 0
M  V30 9 C 8.0021 6.1600 0.0 0
M  V30 10 O 9.3358 2.3100 0.0 0
M  V30 11 C 1.3336 6.9300 0.0 0
M  V30 12 N 1.3336 8.4700 0.0 0
M  V30 13 O 0.0000 6.1600 0.0 0
M  V30 14 C 0.0000 9.2400 0.0 0
M  V30 15 C 12.0032 2.3100 0.0 0
M  V30 16 C 14.6705 6.9300 0.0 0
M  V30 17 O 14.6705 8.4700 0.0 0
M  V30 18 C 4.0011 3.8500 0.0 0
M  V30 19 C 5.3347 4.6200 0.0 0
M  V30 20 C 2.6674 4.6200 0.0 0
M  V30 21 C 5.3347 6.1600 0.0 0
M  V30 22 C 2.6674 6.1600 0.0 0
M  V30 23 C 4.0011 6.9300 0.0 0
M  V30 24 N 10.6694 4.6200 0.0 0
M  V30 25 C 12.0032 3.8500 0.0 0 CFG=2
M  V30 26 C 10.6694 6.1600 0.0 0
M  V30 27 C 13.3369 4.6200 0.0 0
M  V30 28 C 12.0032 6.9300 0.0 0
M  V30 29 N 13.3369 6.1600 0.0 0
M  V30 30 C 16.0041 6.1600 0.0 0
M  V30 31 C 17.3379 6.9300 0.0 0
M  V30 32 C 16.0041 4.6200 0.0 0
M  V30 33 C 18.6716 6.1600 0.0 0
M  V30 34 C 17.3379 3.8500 0.0 0
M  V30 35 C 18.6716 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 1 6 19
M  V30 8 1 7 8
M  V30 9 1 7 9 CFG=1
M  V30 10 2 8 10
M  V30 11 1 8 24
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 22
M  V30 15 1 12 14
M  V30 16 1 25 15 CFG=1
M  V30 17 2 16 17
M  V30 18 1 16 29
M  V30 19 1 16 30
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 845655-36-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 845654-82-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-306114
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4-{(1S)-2-[(2R)-4-Benzoyl-2-methyl-piperazin-1-yl]-1-methyl-2-oxo-ethoxy}N-methyl-3-trifluoromethoxy-benzamide
The compound of Preparation 59 (100 mg, 0.2 mmol) and methylamine (33% in
ethanol, 4 mL) were heated at 90° C. in a ReactivialTM for 18 hours. The
solvent was then evaporated under reduced pressure and the residue was
purified by column chromatography on silica gel, eluting with
dichloromethane:methanol, 99:1 to 97:3, to afford the title compound as a
pale orange foam in quantitative yield, 100 mg. LRMS (APCI+): m/z [M+H]+
494
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction was carried out in a Reactivial
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of piperazine derivatives for use in pharmaceutical
compositions for the treatment of HIV infection
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Middleton, Donald Stuart; Mowbray, Charles Eric; Stephenson, Peter
Thomas; Williams, David Howard
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20050043300 A1 2005-02-24

$RFMT $RIREG SCHEME92 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[3-[[[2-Chloro-3-(trifluoromethyl)phenyl]methyl](2,2-diphenylethyl)amino]pr...
C35H32ClF3N2O3
847991-18-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 48 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 12.3201 9.3359 0.0 0
M  V30 2 C 10.7801 9.3359 0.0 0
M  V30 3 C 10.0101 8.0021 0.0 0
M  V30 4 C 8.4701 8.0021 0.0 0
M  V30 5 N 7.7001 6.6684 0.0 0
M  V30 6 C 8.4701 5.3348 0.0 0
M  V30 7 C 6.1600 6.6684 0.0 0
M  V30 8 C 7.7001 4.0010 0.0 0
M  V30 9 C 18.0508 12.7134 0.0 0
M  V30 10 C 19.5155 12.2376 0.0 0
M  V30 11 O 20.6599 13.2680 0.0 0
M  V30 12 O 19.8357 10.7313 0.0 0
M  V30 13 Cl 3.0800 6.6684 0.0 0
M  V30 14 C 1.5400 9.3359 0.0 0
M  V30 15 F 1.5400 10.8759 0.0 0
M  V30 16 F 0.0000 9.3359 0.0 0
M  V30 17 F 1.5400 7.7959 0.0 0
M  V30 18 C 14.6301 10.6695 0.0 0
M  V30 19 C 15.4001 12.0032 0.0 0
M  V30 20 C 13.0901 10.6695 0.0 0
M  V30 21 C 15.6605 9.5250 0.0 0
M  V30 22 N 16.9064 11.6830 0.0 0
M  V30 23 C 14.6301 13.3368 0.0 0
M  V30 24 C 12.3201 12.0032 0.0 0
M  V30 25 C 17.0673 10.1515 0.0 0
M  V30 26 C 13.0901 13.3368 0.0 0
M  V30 27 C 5.3900 8.0021 0.0 0
M  V30 28 C 3.8500 8.0021 0.0 0
M  V30 29 C 6.1600 9.3359 0.0 0
M  V30 30 C 3.0800 9.3359 0.0 0
M  V30 31 C 5.3900 10.6695 0.0 0
M  V30 32 C 3.8500 10.6695 0.0 0
M  V30 33 C 6.1600 4.0010 0.0 0
M  V30 34 C 5.3900 5.3348 0.0 0
M  V30 35 C 5.3900 2.6673 0.0 0
M  V30 36 C 3.8500 5.3348 0.0 0
M  V30 37 C 3.8500 2.6673 0.0 0
M  V30 38 C 3.0800 4.0010 0.0 0
M  V30 39 C 8.4701 2.6673 0.0 0
M  V30 40 C 7.7001 1.3337 0.0 0
M  V30 41 C 10.0101 2.6673 0.0 0
M  V30 42 C 8.4701 0.0000 0.0 0
M  V30 43 C 10.7801 1.3337 0.0 0
M  V30 44 C 10.0101 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 27
M  V30 10 1 8 33
M  V30 11 1 8 39
M  V30 12 1 9 10
M  V30 13 1 9 22
M  V30 14 1 10 11
M  V30 15 2 10 12
M  V30 16 1 13 28
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 14 17
M  V30 20 1 14 30
M  V30 21 1 18 19
M  V30 22 2 18 20
M  V30 23 1 18 21
M  V30 24 1 19 22
M  V30 25 2 19 23
M  V30 26 1 20 24
M  V30 27 2 21 25
M  V30 28 1 22 25
M  V30 29 1 23 26
M  V30 30 2 24 26
M  V30 31 2 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 2 29 31
M  V30 35 2 30 32
M  V30 36 1 31 32
M  V30 37 2 33 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 2 35 37
M  V30 41 2 36 38
M  V30 42 1 37 38
M  V30 43 2 39 40
M  V30 44 1 39 41
M  V30 45 1 40 42
M  V30 46 2 41 43
M  V30 47 2 42 44
M  V30 48 1 43 44
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[3-[[[2-Chloro-3-(trifluoromethyl)phenyl]methyl](2,2-diphenylethyl)amino]pr...
C36H35ClF3N3O2
847990-44-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 49 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 12.3200 9.3358 0.0 0
M  V30 2 C 10.7800 9.3358 0.0 0
M  V30 3 C 10.0100 8.0020 0.0 0
M  V30 4 C 8.4700 8.0020 0.0 0
M  V30 5 N 7.7000 6.6684 0.0 0
M  V30 6 C 8.4700 5.3347 0.0 0
M  V30 7 C 6.1600 6.6684 0.0 0
M  V30 8 C 7.7000 4.0009 0.0 0
M  V30 9 C 18.0508 12.7133 0.0 0
M  V30 10 C 19.5155 12.2375 0.0 0
M  V30 11 N 20.6599 13.2679 0.0 0
M  V30 12 O 19.8357 10.7312 0.0 0
M  V30 13 C 22.1246 12.7920 0.0 0
M  V30 14 Cl 3.0800 6.6684 0.0 0
M  V30 15 C 1.5400 9.3358 0.0 0
M  V30 16 F 1.5400 10.8758 0.0 0
M  V30 17 F 0.0000 9.3358 0.0 0
M  V30 18 F 1.5400 7.7958 0.0 0
M  V30 19 C 14.6300 10.6694 0.0 0
M  V30 20 C 15.4000 12.0031 0.0 0
M  V30 21 C 13.0900 10.6694 0.0 0
M  V30 22 C 15.6606 9.5249 0.0 0
M  V30 23 N 16.9064 11.6829 0.0 0
M  V30 24 C 14.6300 13.3367 0.0 0
M  V30 25 C 12.3200 12.0031 0.0 0
M  V30 26 C 17.0674 10.1514 0.0 0
M  V30 27 C 13.0900 13.3367 0.0 0
M  V30 28 C 5.3900 8.0020 0.0 0
M  V30 29 C 3.8500 8.0020 0.0 0
M  V30 30 C 6.1600 9.3358 0.0 0
M  V30 31 C 3.0800 9.3358 0.0 0
M  V30 32 C 5.3900 10.6694 0.0 0
M  V30 33 C 3.8500 10.6694 0.0 0
M  V30 34 C 6.1600 4.0009 0.0 0
M  V30 35 C 5.3900 5.3347 0.0 0
M  V30 36 C 5.3900 2.6673 0.0 0
M  V30 37 C 3.8500 5.3347 0.0 0
M  V30 38 C 3.8500 2.6673 0.0 0
M  V30 39 C 3.0800 4.0009 0.0 0
M  V30 40 C 8.4700 2.6673 0.0 0
M  V30 41 C 10.0100 2.6673 0.0 0
M  V30 42 C 7.7000 1.3336 0.0 0
M  V30 43 C 10.7800 1.3336 0.0 0
M  V30 44 C 8.4700 0.0000 0.0 0
M  V30 45 C 10.0100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 28
M  V30 10 1 8 34
M  V30 11 1 8 40
M  V30 12 1 9 10
M  V30 13 1 9 23
M  V30 14 1 10 11
M  V30 15 2 10 12
M  V30 16 1 11 13
M  V30 17 1 14 29
M  V30 18 1 15 16
M  V30 19 1 15 17
M  V30 20 1 15 18
M  V30 21 1 15 31
M  V30 22 1 19 20
M  V30 23 2 19 21
M  V30 24 1 19 22
M  V30 25 1 20 23
M  V30 26 2 20 24
M  V30 27 1 21 25
M  V30 28 2 22 26
M  V30 29 1 23 26
M  V30 30 1 24 27
M  V30 31 2 25 27
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 38 2 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 2 36 38
M  V30 42 2 37 39
M  V30 43 1 38 39
M  V30 44 2 40 41
M  V30 45 1 40 42
M  V30 46 1 41 43
M  V30 47 2 42 44
M  V30 48 2 43 45
M  V30 49 1 44 45
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 847991-18-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 847990-44-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-9306864
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 68641-49-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 5.
2-(4-{3-[(2-Chloro-3-trifluoromethyl-benzyl)-2,2-diphenylethyl-amino]-methyl-propoxy}-indol-1-yl)-N-methyl-acetamide.
Following the procedure of Example 2 except substituting methylamine for
thiomorpholine, the title compound was obtained as a clear oil (52 mg,
100%):. MS(ES) m/e 634.4[M+H]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of indole derivatives as modulators of liver X receptors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hoang, Tram H.; Thompson, Scott Kevin; Washburn, David G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005023196 A2 2005-03-17

$RFMT $RIREG SCHEME93 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-2-fluorobenzaldehyde
C7H4ClFO
85070-48-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 O 6.6686 2.3100 0.0 0
M  V30 3 F 2.6675 0.0000 0.0 0
M  V30 4 Cl 0.0000 1.5400 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6675 1.5400 0.0 0
M  V30 7 C 4.0011 3.8500 0.0 0
M  V30 8 C 1.3338 2.3100 0.0 0
M  V30 9 C 2.6675 4.6201 0.0 0
M  V30 10 C 1.3338 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Chloro-2-fluorophenyl)methylene]methanamine
C8H7ClFN
1289570-80-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 C 8.0021 1.5400 0.0 0
M  V30 4 F 2.6674 0.0000 0.0 0
M  V30 5 Cl 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 85070-48-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1289570-80-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-3574718
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of intermediate
[1-(3-chloro-2-fluorophenyl)-meth-(E)-ylidene]-methyl-amine A mixture of
3-chloro-2-fluoro-benzoaldehyde (Oakwood, 97%) (1.59 g, 10.0 mmol) and
methyl amine (2.0 M in THF, Aldrich, 7.5 mL, 15.0 mmol) in CH2Cl2 (20 mL)
was stirred at rt overnight. The reaction mixture was concentrated and
the residue was dried under reduced pressure to afford
[[1-(3-chloro-2-fluoro-phenyl)-meth-(E)-ylidene]-methyl-amine (1.72 g,
100%) as colorless oil which was used in the next step without further
purification.
[[1-(3-chloro-2-fluoro-phenyl)-meth-(E)-ylidene]-methyl-amine, yield
(1.72 g, 100%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel N-substituted-pyrrolidines as inhibitors of MDM2-p53 interactions
and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bartkovitz, David Joseph; Chu, Xin-Jie; Liu, Jin-Jun; Morgan Ross, Tina;
Zhang, Zhuming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20110086854 A1 2011-04-14

$RFMT $RIREG SCHEME94 STEP1
$RXN



  2  1
$MOL
2,3-Dihydro-1-methyl-2-oxo-3-(2-propen-1-yl)-1H-indole-3-acetic acid
C14H15NO3
850833-41-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.6891 2.1580 0.0 0
M  V30 2 C 2.2823 1.5316 0.0 0
M  V30 3 O 1.0363 2.4368 0.0 0
M  V30 4 O 2.1212 0.0000 0.0 0
M  V30 5 C 2.3100 3.6896 0.0 0
M  V30 6 C 1.5400 5.0233 0.0 0
M  V30 7 C 0.0000 5.0233 0.0 0
M  V30 8 O 2.3555 5.9912 0.0 0
M  V30 9 C 5.4163 7.3539 0.0 0
M  V30 10 C 3.8501 3.6896 0.0 0
M  V30 11 C 5.3565 3.3694 0.0 0
M  V30 12 C 3.6891 5.2211 0.0 0
M  V30 13 C 6.1265 4.7031 0.0 0
M  V30 14 C 6.1265 2.0358 0.0 0
M  V30 15 N 5.0959 5.8475 0.0 0
M  V30 16 C 7.6665 4.7031 0.0 0
M  V30 17 C 7.6665 2.0358 0.0 0
M  V30 18 C 8.4366 3.3694 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 2 6 7
M  V30 8 2 8 12
M  V30 9 1 9 15
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 1 16 18
M  V30 19 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-N,1-dimethyl-2-oxo-3-(2-propen-1-yl)-1H-indole-3-acetamide
C15H18N2O2
850833-42-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3632 4.6274 0.0 0
M  V30 2 C 6.6091 3.7222 0.0 0
M  V30 3 N 8.0160 4.3487 0.0 0
M  V30 4 O 6.4482 2.1907 0.0 0
M  V30 5 C 9.2619 3.4435 0.0 0
M  V30 6 C 4.7264 2.6674 0.0 0
M  V30 7 C 3.9564 1.3336 0.0 0
M  V30 8 C 4.7264 0.0000 0.0 0
M  V30 9 O 2.7106 1.5559 0.0 0
M  V30 10 C 0.0000 3.5252 0.0 0
M  V30 11 C 3.9564 4.0011 0.0 0
M  V30 12 C 3.4806 5.4656 0.0 0
M  V30 13 C 2.7106 3.0959 0.0 0
M  V30 14 C 1.9406 5.4656 0.0 0
M  V30 15 C 4.2506 6.7994 0.0 0
M  V30 16 N 1.4645 4.0011 0.0 0
M  V30 17 C 1.1706 6.7994 0.0 0
M  V30 18 C 3.4806 8.1331 0.0 0
M  V30 19 C 1.9406 8.1331 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 11
M  V30 8 2 7 8
M  V30 9 2 9 13
M  V30 10 1 10 16
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 12 15
M  V30 15 1 13 16
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 1 17 19
M  V30 20 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 850833-41-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 850833-42-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-12800266
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 771-61-9
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-(3-Allyl-1-methyl-2-oxoindolin-3-yl)-N-methylacetamide (25). To a
solution of the carboxylic acid 24 (115 mg, 0.47 mmol), pentafluorophenol
(259 mg, 1.4 mmol), and triethylamine (d = 0.73, 130 μL, 0.94 mmol) in
THF (3 mL) was added EDC•HCl (135 mg, 0.70 mmol) at room temperature.
After 5 min, anhydrous methylamine (gas) was conducted into the reaction
mixture for 5 min The resulted mixture was neutralized with 10% aqueous
HCl and extracted with Et2O. The extract was washed with brine, dried
over MgSO4, and concentrated under reduced pressure. The residue was
purified by silica gel column chromatography with AcOEt/hexane (20: 1) as
an eluent to give 25 (121 mg, quantitative yield) as a viscous oil. IR
(CHCl3) 3465, 1698, 1615 cm-1; 1H NMR (CDCl3, 300 MHz) δ 2.53 (dd, 1H, J
= 13.4, 7.6 Hz), 2.59 (dd, 1H, J = 13.4, 7.1 Hz), 2.67 (d, 3H, J = 4.7
Hz), 2.71 (d, 1H, J = 14.9 Hz), 2.85 (d, 1H, J = 14.9 Hz), 3.21 (s, 3H),
4.94 (dq, 1H, J = 10.9, 1.0 Hz), 4.98 (dd, 1H, J = 17.3, 1.8 Hz), 5.39
(dddd, 1H, J = 17.3, 10.9, 7.6, 7.1 Hz), 6.46 (brs, 1H), 6.83 (d, 1H, J =
7.7 Hz), 7.06 (t, 1H, J = 7.7 Hz), 7.23 (d, 1H, J = 7.7 Hz), 7.26 (t, 1H,
J = 7.7 Hz); 13C NMR (CDCl3, 100 MHz) δ 26.38, 26.40, 41.5, 42.4, 50.3,
108.1, 119.4, 122.6, 123.0, 128.1, 130.8, 131.2, 143.1, 169.7, 179.3;
HRMS (EI) m/z calcd for C15H18N2O2 258.1368, found 258.1374.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of diversely functionalized hexahydropyrrolo[2,3-b]indoles
using domino reactions, olefination, isomerization and Claisen
rearrangement followed by reductive cyclization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kawasaki, Tomomi; Ogawa, Atsuyo; Terashima, Romi; Saheki, Toshiko; Ban,
Naoko; Sekiguchi, Hiroko; Sakaguchi, Kenei; Sakamoto, Masanori
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2005), 70(8), 2957-2966

$RFMT $RIREG SCHEME95 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-4-(trifluoromethyl)benzaldehyde
C8H4BrF3O
85118-24-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 2.6673 0.0 0
M  V30 2 F 1.5400 1.1273 0.0 0
M  V30 3 F 0.0000 2.6673 0.0 0
M  V30 4 F 1.5400 4.2073 0.0 0
M  V30 5 Br 6.1600 0.0000 0.0 0
M  V30 6 C 7.7000 2.6673 0.0 0
M  V30 7 O 8.4700 4.0011 0.0 0
M  V30 8 C 3.0800 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 5.3900 1.3336 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 6.1600 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methyl-4-(trifluoromethyl)benzenemethanamine
C9H9BrF3N
1894484-84-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 2.6673 0.0 0
M  V30 2 F 1.5400 4.2073 0.0 0
M  V30 3 F 0.0000 2.6673 0.0 0
M  V30 4 F 1.5400 1.1273 0.0 0
M  V30 5 Br 6.1600 0.0000 0.0 0
M  V30 6 C 7.7000 2.6673 0.0 0
M  V30 7 N 8.4700 4.0011 0.0 0
M  V30 8 C 10.0100 4.0011 0.0 0
M  V30 9 C 3.0800 2.6673 0.0 0
M  V30 10 C 3.8500 1.3336 0.0 0
M  V30 11 C 3.8500 4.0011 0.0 0
M  V30 12 C 5.3900 1.3336 0.0 0
M  V30 13 C 5.3900 4.0011 0.0 0
M  V30 14 C 6.1600 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 5 12
M  V30 6 1 6 7
M  V30 7 1 6 14
M  V30 8 1 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 85118-24-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1894484-84-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40490483
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective Defluorination of Trifluoromethyl Substituents by
Conformationally Induced Remote Substitution
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jesani, Mehul H.; Schwarz, Maria; Kim, Shiwhu; Evans, Finlay L.; White,
Alexander; Browning, Alex; Abrams, Roman; Clayden, Jonathan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2024), 63(24), e202403477

$RFMT $RIREG SCHEME96 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Ethyl-4-[[4-(1-oxopropoxy)phenyl]methylene]-5(4H)-oxazolone
C15H15NO4
851668-70-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1591 1.3628 0.0 0
M  V30 2 O 2.0983 0.0000 0.0 0
M  V30 3 C 1.5317 5.3915 0.0 0
M  V30 4 C 0.0000 5.5524 0.0 0
M  V30 5 O 10.4939 4.4428 0.0 0
M  V30 6 C 11.8275 3.6728 0.0 0
M  V30 7 C 13.1612 4.4428 0.0 0
M  V30 8 O 11.8275 2.1328 0.0 0
M  V30 9 C 14.4950 3.6728 0.0 0
M  V30 10 C 3.8254 2.1328 0.0 0
M  V30 11 N 3.6643 3.6643 0.0 0
M  V30 12 C 2.4185 1.5064 0.0 0
M  V30 13 C 2.1580 3.9845 0.0 0
M  V30 14 O 1.3880 2.6508 0.0 0
M  V30 15 C 6.4927 2.1328 0.0 0
M  V30 16 C 7.8264 1.3628 0.0 0
M  V30 17 C 6.4927 3.6728 0.0 0
M  V30 18 C 9.1602 2.1328 0.0 0
M  V30 19 C 7.8264 4.4428 0.0 0
M  V30 20 C 9.1602 3.6728 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10 CFG=2
M  V30 2 1 1 15
M  V30 3 2 2 12
M  V30 4 1 3 4
M  V30 5 1 3 13
M  V30 6 1 5 6
M  V30 7 1 5 20
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(4-Hydroxyphenyl)-N-methyl-2-[(1-oxopropyl)amino]-2-propenamide
C13H16N2O3
851668-71-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 C 5.3900 5.3347 0.0 0
M  V30 3 N 3.0800 4.0011 0.0 0
M  V30 4 C 5.3900 2.6674 0.0 0
M  V30 5 C 2.3100 5.3347 0.0 0
M  V30 6 N 4.6200 1.3338 0.0 0
M  V30 7 O 6.9300 2.6674 0.0 0
M  V30 8 C 0.7700 5.3347 0.0 0
M  V30 9 O 3.0800 6.6685 0.0 0
M  V30 10 C 5.3900 0.0000 0.0 0
M  V30 11 C 0.0000 6.6685 0.0 0
M  V30 12 O 11.5500 5.3347 0.0 0
M  V30 13 C 6.9300 5.3347 0.0 0
M  V30 14 C 7.7000 6.6685 0.0 0
M  V30 15 C 7.7000 4.0011 0.0 0
M  V30 16 C 9.2400 6.6685 0.0 0
M  V30 17 C 9.2400 4.0011 0.0 0
M  V30 18 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 13
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 12 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 851668-70-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 851668-71-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-352-CAS-2071506
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 3-(p-Hydroxyphenyl)-N-methyl-2-(propionylamino)-2-propenamide (2).
Ethanol (5 mL) and a 40% aqueous methylamine solution (1 mL) were added
to oxazolone 2 (1.37 g, 0.05 mol). The reaction mixture was stirred for
20 min, and then the solvents were removed. The resulting crystalline
solid is practically pure 2. Synthesis of 3 does not require isolation of
2, and it may start directly from 1 as a one-pot procedure.
3-(p-Hydroxyphenyl)-N-methyl-2-(propionylamino)-2-propenamide (2), yield
100% 1H NMR (500 MHz, DMSO-d6) δ 1.27 (t, 3H, CH3), 2.31 (q, 2H, CH2),
2.65 (d, 3H, N-CH3), 6.72 (d, 2H, aromatic), 7.01 (s, 1H, vinylic), 7.36
(d, 2H, aromatic), 7.73 (br m, 1H, NH-Me), 9.10 (s, 1H, NH), 9.72 (s br,
1H, OH).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Properties of the Chromophore of the asFP595 Chromoprotein
from Anemonia sulcata
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yampolsky, Ilia V.; Remington, S. James; Martynov, Vladimir I.; Potapov,
Victor K.; Lukyanov, Sergey; Lukyanov, Konstantin A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Biochemistry (2005), 44(15), 5788-5793

$RFMT $RIREG SCHEME97 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclopropanecarboxaldehyde, 1-[4-(difluoromethoxy)-3-methoxyphenyl]-
C12H12F2O3
853771-76-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.4471 5.5177 0.0 0
M  V30 2 O 0.0000 6.0443 0.0 0
M  V30 3 O 6.3346 1.3338 0.0 0
M  V30 4 C 5.5646 0.0000 0.0 0
M  V30 5 O 7.8746 4.0011 0.0 0
M  V30 6 C 8.6446 5.3347 0.0 0
M  V30 7 F 10.1846 5.3347 0.0 0
M  V30 8 F 7.8746 6.6685 0.0 0
M  V30 9 C 1.7146 4.0011 0.0 0
M  V30 10 C 1.4471 2.4845 0.0 0
M  V30 11 C 0.2675 3.4744 0.0 0
M  V30 12 C 3.2546 4.0011 0.0 0
M  V30 13 C 4.0246 2.6674 0.0 0
M  V30 14 C 4.0246 5.3347 0.0 0
M  V30 15 C 5.5646 2.6674 0.0 0
M  V30 16 C 5.5646 5.3347 0.0 0
M  V30 17 C 6.3346 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 15
M  V30 5 1 5 6
M  V30 6 1 5 17
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1E)-2-[1-[4-(Difluoromethoxy)-3-methoxyphenyl]cyclopropyl]ethenamine
C13H15F2NO2
853771-77-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.7145 5.5177 0.0 0
M  V30 2 C 0.2675 6.0443 0.0 0
M  V30 3 N 0.0000 7.5611 0.0 0
M  V30 4 O 6.6020 1.3338 0.0 0
M  V30 5 C 5.8320 0.0000 0.0 0
M  V30 6 O 8.1420 4.0011 0.0 0
M  V30 7 C 8.9120 5.3347 0.0 0
M  V30 8 F 10.4520 5.3347 0.0 0
M  V30 9 F 8.1420 6.6685 0.0 0
M  V30 10 C 1.9820 4.0011 0.0 0
M  V30 11 C 1.7145 2.4845 0.0 0
M  V30 12 C 0.5348 3.4744 0.0 0
M  V30 13 C 3.5220 4.0011 0.0 0
M  V30 14 C 4.2920 2.6674 0.0 0
M  V30 15 C 4.2920 5.3347 0.0 0
M  V30 16 C 5.8320 2.6674 0.0 0
M  V30 17 C 5.8320 5.3347 0.0 0
M  V30 18 C 6.6020 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 16
M  V30 6 1 6 7
M  V30 7 1 6 18
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 853771-76-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 853771-77-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30319120
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7757-82-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 6: Methylamine (2.0 M in THF, 16.5 mL, 33 mmol) was added to a
suspension of
((1-[4-(difluoromethoxy)-3-methoxyphenyl]cyclopropanecarbaldehyde,
prepared in step 5, (4.01 g, 16.6 mmol) and Na2SO4 (30 g, 211 mmol) in
dry 1,2-dichloroethane. Stirring at rt. for 6 hours gave 60% conversion.
Additional Na2SO4 (10 g) and methylamine (5 mL) were added with continous
stirring 17 hours over night. The mixture was filtered and concentrated.
HNMR of the crude product showed ∼ 15% aldehyde. The crude product was
again dissolved in 1,2-dichloroethane (60 mL) whereafter Na2SO4(10 g) and
methylamine (6 mL) were added. Stirring for 22 hours gave 100% conversion
to imine. The mixture was filtered and the filtrate evaporated to give
the ((1E)-{1-[4-(difluoromethoxy)-3- methoxyphenyl]cyclopropyl}methylene)
methylamine (4.23 g, 100%). 1H NMR (400 MHz, CHLOROFORM-D) ppm 1.13 -
1.18 (m, 2 H) 1.24 - 1.29 (m, 2 H) 3.23 (d, J=1.51 Hz, 2 H) 3.86 (s, 3 H)
6.51 (t, J=75.29 Hz, 1 H) 6.87 (dd, J=8.28, 2.01 Hz, 1 H) 6.91 (d, J=2.01
Hz, 1 H) 7.08 (d, J=8.03 Hz, 1 H) 7.47 (q, J=1.51 Hz, 1 H). GC-MS (EI)
for C13H15F2NO2 m/z 255 (M)+.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, incremental addition of Na2SO4,1,2-dichloroethane and
MeNH2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted urea-octahydroindoles as antagonists of
melanin concentrating hormone receptor 1 (MCH1R)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Browning, Andrew; Nilsson, Jonas; Scobie, Martin; Angbrant, Johan;
Ringom, Rune
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005051381 A1 2005-06-09

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1S,2S)-2-[(1S)-1-[[(1,1-dimethylethoxy)carbonyl]amino]-2-oxo-2-(1-pyr...
C16H26N2O5
856894-48-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.5907 4.6799 0.0 0 CFG=2
M  V30 2 C 4.2569 3.9099 0.0 0
M  V30 3 N 6.9243 3.9099 0.0 0
M  V30 4 O 2.9232 4.6799 0.0 0
M  V30 5 C 8.2579 4.6799 0.0 0
M  V30 6 O 9.5916 3.9099 0.0 0
M  V30 7 O 8.2579 6.2199 0.0 0
M  V30 8 C 10.9254 4.6799 0.0 0
M  V30 9 C 11.6954 3.3461 0.0 0
M  V30 10 C 12.2590 5.4499 0.0 0
M  V30 11 C 10.1554 6.0135 0.0 0
M  V30 12 C 2.6269 5.9606 0.0 0
M  V30 13 O 1.4471 6.9505 0.0 0
M  V30 14 O 2.3594 4.4440 0.0 0
M  V30 15 C 0.0000 6.4238 0.0 0
M  V30 16 C 5.5907 6.2199 0.0 0 CFG=1
M  V30 17 C 4.0739 6.4872 0.0 0 CFG=1
M  V30 18 C 5.0638 7.6670 0.0 0
M  V30 19 N 4.2569 2.3699 0.0 0
M  V30 20 C 5.5027 1.4647 0.0 0
M  V30 21 C 3.0110 1.4647 0.0 0
M  V30 22 C 5.0269 0.0000 0.0 0
M  V30 23 C 3.4869 0.0000 0.0 0
M  V30 24 H 7.1073 6.4872 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 16
M  V30 4 2 2 4
M  V30 5 1 2 19
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 17 12 CFG=1
M  V30 16 1 13 15
M  V30 17 1 16 17
M  V30 18 1 16 18 CFG=3
M  V30 19 1 16 24
M  V30 20 1 17 18
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [(1S)-1-[(1S,2S)-2-[(methylamino)carbonyl]cyclopropyl]-2-oxo-2...
C16H27N3O4
856894-87-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.5907 4.6799 0.0 0 CFG=2
M  V30 2 C 4.2569 3.9099 0.0 0
M  V30 3 N 6.9243 3.9099 0.0 0
M  V30 4 O 2.9232 4.6799 0.0 0
M  V30 5 C 8.2579 4.6799 0.0 0
M  V30 6 O 9.5916 3.9099 0.0 0
M  V30 7 O 8.2579 6.2199 0.0 0
M  V30 8 C 10.9254 4.6799 0.0 0
M  V30 9 C 10.1554 6.0135 0.0 0
M  V30 10 C 12.2590 5.4499 0.0 0
M  V30 11 C 11.6954 3.3461 0.0 0
M  V30 12 C 2.6269 5.9606 0.0 0
M  V30 13 N 1.4471 6.9505 0.0 0
M  V30 14 O 2.3594 4.4440 0.0 0
M  V30 15 C 0.0000 6.4238 0.0 0
M  V30 16 C 5.5907 6.2199 0.0 0 CFG=1
M  V30 17 C 4.0739 6.4872 0.0 0 CFG=1
M  V30 18 C 5.0638 7.6670 0.0 0
M  V30 19 N 4.2569 2.3699 0.0 0
M  V30 20 C 3.0110 1.4647 0.0 0
M  V30 21 C 5.5027 1.4647 0.0 0
M  V30 22 C 3.4869 0.0000 0.0 0
M  V30 23 C 5.0269 0.0000 0.0 0
M  V30 24 H 7.1073 6.4872 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 16
M  V30 4 2 2 4
M  V30 5 1 2 19
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 17 12 CFG=1
M  V30 16 1 13 15
M  V30 17 1 16 17
M  V30 18 1 16 18 CFG=3
M  V30 19 1 16 24
M  V30 20 1 17 18
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 856894-48-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 856894-87-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8517543
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 21.
N1-Methyl-(1S,2S)-2-[(1S)1-amino-2-(pyrrolidin-1-yl)-2-oxoethyl]
cyclopropane-1-carboxamide hydrochloride. Step 1:
N1-Methyl-(1S,2S)-2-[(1S)-1-tert-butyloxycarbonylamino-2-(pyrrolidine-1-yl)-2-oxoethyl]cyclopropane-1-carboxamide:
40 % aqueous methylamine solution (3 ml) was added to a solution
ofIntermediate 16 (0.275 g, 0.843 mmol) in THF (5 ml). The reaction
mixture was stirred at RT for 15 h. The solvent was evaporated under
reduced pressure and the residue was purified by silica gel column
chromatography using 2 % methanol in dichloromethane-to afford 0.276 g
(100 %) of the product as a greenish-yellow solid. IR (KBr) 3337, 2976,
2929, 1709, 1643, 1562, 1453, 1366, 1250, 1167, 1049, 1023 cm-1; 1H NMR
(300 MHz, CDCl3) δ 0.80-0.90 (m, 1H), 1.16-1.26 (m, 1H), 1.42 (s, 9H),
1.43-1.52 (m, 1H), 1.60-1.69 (m, 1H), 1.82-2.02 (m, 4H), 2.79 (d,J= 4.8
Hz, 3H), 3.36-3.65 (m, 4H), 4.45 (dd, J= 7.5,5.1 Hz, 1H), 5.42 (d, J= 8.1
Hz, 1H), 5.69 (br s, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of cyclopropylglycine dipeptides as inhibitors of dipeptidyl
peptidase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Joshi, Hemant Vasant; Gopalan, Balasubramanian; Shah, Daisy Manish;
Thomas, Abraham
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005058849 A1 2005-06-30

$RFMT $RIREG SCHEME99 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3,5-Dinitrobenzoyl)serine methyl ester
C11H11N3O8
86091-68-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 5.3901 0.0 0
M  V30 2 N 8.0021 4.6201 0.0 0
M  V30 3 O 6.6684 6.9301 0.0 0
M  V30 4 C 9.3359 5.3901 0.0 0
M  V30 5 C 10.6695 4.6201 0.0 0
M  V30 6 C 9.3359 6.9301 0.0 0
M  V30 7 O 12.0032 5.3901 0.0 0
M  V30 8 O 10.6695 3.0800 0.0 0
M  V30 9 O 10.6695 7.7001 0.0 0
M  V30 10 C 13.3369 4.6201 0.0 0
M  V30 11 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 12 O 0.0000 4.6201 0.0 0
M  V30 13 O 1.3337 6.9301 0.0 0
M  V30 14 N 4.0010 0.7700 0.0 0 VAL=5
M  V30 15 O 2.6673 0.0000 0.0 0
M  V30 16 O 5.3348 0.0000 0.0 0
M  V30 17 C 5.3348 4.6201 0.0 0
M  V30 18 C 4.0010 5.3901 0.0 0
M  V30 19 C 5.3348 3.0800 0.0 0
M  V30 20 C 2.6673 4.6201 0.0 0
M  V30 21 C 4.0010 2.3100 0.0 0
M  V30 22 C 2.6673 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 2 11 12
M  V30 12 2 11 13
M  V30 13 1 11 20
M  V30 14 2 14 15
M  V30 15 2 14 16
M  V30 16 1 14 21
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[1-(Hydroxymethyl)-2-(methylamino)-2-oxoethyl]-3,5-dinitrobenzamide
C11H12N4O7
2073944-08-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 5.3901 0.0 0
M  V30 2 N 8.0021 4.6201 0.0 0
M  V30 3 O 6.6684 6.9301 0.0 0
M  V30 4 C 9.3359 5.3901 0.0 0
M  V30 5 C 10.6695 4.6201 0.0 0
M  V30 6 C 9.3359 6.9301 0.0 0
M  V30 7 N 12.0032 5.3901 0.0 0
M  V30 8 O 10.6695 3.0800 0.0 0
M  V30 9 O 10.6695 7.7001 0.0 0
M  V30 10 C 13.3369 4.6201 0.0 0
M  V30 11 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 12 O 0.0000 4.6201 0.0 0
M  V30 13 O 1.3337 6.9301 0.0 0
M  V30 14 N 4.0010 0.7700 0.0 0 VAL=5
M  V30 15 O 2.6673 0.0000 0.0 0
M  V30 16 O 5.3348 0.0000 0.0 0
M  V30 17 C 5.3348 4.6201 0.0 0
M  V30 18 C 4.0010 5.3901 0.0 0
M  V30 19 C 5.3348 3.0800 0.0 0
M  V30 20 C 2.6673 4.6201 0.0 0
M  V30 21 C 4.0010 2.3100 0.0 0
M  V30 22 C 2.6673 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 2 11 12
M  V30 12 2 11 13
M  V30 13 1 11 20
M  V30 14 2 14 15
M  V30 15 2 14 16
M  V30 16 1 14 21
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 86091-68-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2073944-08-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-17064580
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM By-design enantioselective self-amplification based on non-covalent
product-catalyst interactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Storch, Golo; Trapp, Oliver
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nature Chemistry (2017), 9(2), 179-187

$RFMT $RIREG SCHEME100 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-(3-fluoro-2-nitrophenoxy)-3,5-dimethoxybenzoate
C16H14FNO7
866082-30-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 2.3101 0.0 0
M  V30 2 O 5.3348 5.3901 0.0 0
M  V30 3 C 5.3348 6.9302 0.0 0
M  V30 4 O 8.0022 0.7700 0.0 0
M  V30 5 C 9.3360 0.0000 0.0 0
M  V30 6 C 10.6697 5.3901 0.0 0
M  V30 7 O 12.0033 4.6201 0.0 0
M  V30 8 O 10.6697 6.9302 0.0 0
M  V30 9 C 13.3370 5.3901 0.0 0
M  V30 10 N 2.6673 0.7700 0.0 0 VAL=5
M  V30 11 O 4.0010 0.0000 0.0 0
M  V30 12 O 1.3337 0.0000 0.0 0
M  V30 13 F 0.0000 2.3101 0.0 0
M  V30 14 C 6.6685 3.0801 0.0 0
M  V30 15 C 6.6685 4.6201 0.0 0
M  V30 16 C 8.0022 2.3101 0.0 0
M  V30 17 C 8.0022 5.3901 0.0 0
M  V30 18 C 9.3360 3.0801 0.0 0
M  V30 19 C 9.3360 4.6201 0.0 0
M  V30 20 C 4.0010 3.0801 0.0 0
M  V30 21 C 2.6673 2.3101 0.0 0
M  V30 22 C 4.0010 4.6201 0.0 0
M  V30 23 C 1.3337 3.0801 0.0 0
M  V30 24 C 2.6673 5.3901 0.0 0
M  V30 25 C 1.3337 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 1 2 15
M  V30 5 1 4 5
M  V30 6 1 4 16
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 19
M  V30 10 1 7 9
M  V30 11 2 10 11
M  V30 12 2 10 12
M  V30 13 1 10 21
M  V30 14 1 13 23
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3,5-dimethoxy-4-[3-(methylamino)-2-nitrophenoxy]benzoate
C17H18N2O7
866082-31-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 2.3100 0.0 0
M  V30 2 O 6.6684 5.3900 0.0 0
M  V30 3 C 6.6684 6.9300 0.0 0
M  V30 4 O 9.3356 0.7700 0.0 0
M  V30 5 C 10.6694 0.0000 0.0 0
M  V30 6 C 12.0031 5.3900 0.0 0
M  V30 7 O 13.3367 4.6200 0.0 0
M  V30 8 O 12.0031 6.9300 0.0 0
M  V30 9 C 14.6703 5.3900 0.0 0
M  V30 10 N 4.0009 0.7700 0.0 0 VAL=5
M  V30 11 O 2.6673 0.0000 0.0 0
M  V30 12 O 5.3347 0.0000 0.0 0
M  V30 13 N 1.3336 2.3100 0.0 0
M  V30 14 C 0.0000 3.0800 0.0 0
M  V30 15 C 8.0020 3.0800 0.0 0
M  V30 16 C 8.0020 4.6200 0.0 0
M  V30 17 C 9.3356 2.3100 0.0 0
M  V30 18 C 9.3356 5.3900 0.0 0
M  V30 19 C 10.6694 3.0800 0.0 0
M  V30 20 C 10.6694 4.6200 0.0 0
M  V30 21 C 5.3347 3.0800 0.0 0
M  V30 22 C 4.0009 2.3100 0.0 0
M  V30 23 C 5.3347 4.6200 0.0 0
M  V30 24 C 2.6673 3.0800 0.0 0
M  V30 25 C 4.0009 5.3900 0.0 0
M  V30 26 C 2.6673 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 1 2 16
M  V30 5 1 4 5
M  V30 6 1 4 17
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 20
M  V30 10 1 7 9
M  V30 11 2 10 11
M  V30 12 2 10 12
M  V30 13 1 10 22
M  V30 14 1 13 14
M  V30 15 1 13 24
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 866082-30-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 866082-31-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-5436629
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 2: [0052] To a solution of 1-1 (1.46 g, 4.16 mmol) in DMF (25 mL)
were added methylamine (2M in MeOH, 9.4 mL, 18.9 mmol) and
diisopropylethylamine (1.64 mL; 9.44 mmol). The mixture was stirred at
room temperature for 48 h. The mixture was then poured into water and
extracted with EtOAc (3X). The combined organic layer was washed with
brine (1X) and dried over MgSO4, filtered and concentrated in vacuo. The
residue obtained was chromatographed on silica gel with n-hexane-EtOAc
(1:1) to give 1.69 g of 1-2 (100%) as a yellowish solid.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzimidazole derivatives as vitronectin receptor
inhibitors for treatment of osteoporosis and other diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Letourneau, Jeffrey John; Paradkar, Vidyadhar; Ohlmeyer, Michael H. J.;
Dillard, Lawrence W.; Baldwin, John J.; Riviello, Christopher Mark; Wong,
Angela; Rong, Yajing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007001249 A1 2007-01-04

$RFMT $RIREG SCHEME100 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-(3-fluoro-2-nitrophenoxy)-3,5-dimethoxybenzoate
C16H14FNO7
866082-30-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 2.3101 0.0 0
M  V30 2 O 5.3348 5.3901 0.0 0
M  V30 3 C 5.3348 6.9302 0.0 0
M  V30 4 O 8.0022 0.7700 0.0 0
M  V30 5 C 9.3360 0.0000 0.0 0
M  V30 6 C 10.6697 5.3901 0.0 0
M  V30 7 O 12.0033 4.6201 0.0 0
M  V30 8 O 10.6697 6.9302 0.0 0
M  V30 9 C 13.3370 5.3901 0.0 0
M  V30 10 N 2.6673 0.7700 0.0 0 VAL=5
M  V30 11 O 4.0010 0.0000 0.0 0
M  V30 12 O 1.3337 0.0000 0.0 0
M  V30 13 F 0.0000 2.3101 0.0 0
M  V30 14 C 6.6685 3.0801 0.0 0
M  V30 15 C 6.6685 4.6201 0.0 0
M  V30 16 C 8.0022 2.3101 0.0 0
M  V30 17 C 8.0022 5.3901 0.0 0
M  V30 18 C 9.3360 3.0801 0.0 0
M  V30 19 C 9.3360 4.6201 0.0 0
M  V30 20 C 4.0010 3.0801 0.0 0
M  V30 21 C 2.6673 2.3101 0.0 0
M  V30 22 C 4.0010 4.6201 0.0 0
M  V30 23 C 1.3337 3.0801 0.0 0
M  V30 24 C 2.6673 5.3901 0.0 0
M  V30 25 C 1.3337 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 1 2 15
M  V30 5 1 4 5
M  V30 6 1 4 16
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 19
M  V30 10 1 7 9
M  V30 11 2 10 11
M  V30 12 2 10 12
M  V30 13 1 10 21
M  V30 14 1 13 23
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3,5-dimethoxy-4-[3-(methylamino)-2-nitrophenoxy]benzoate
C17H18N2O7
866082-31-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 2.3100 0.0 0
M  V30 2 O 6.6684 5.3900 0.0 0
M  V30 3 C 6.6684 6.9300 0.0 0
M  V30 4 O 9.3356 0.7700 0.0 0
M  V30 5 C 10.6694 0.0000 0.0 0
M  V30 6 C 12.0031 5.3900 0.0 0
M  V30 7 O 13.3367 4.6200 0.0 0
M  V30 8 O 12.0031 6.9300 0.0 0
M  V30 9 C 14.6703 5.3900 0.0 0
M  V30 10 N 4.0009 0.7700 0.0 0 VAL=5
M  V30 11 O 2.6673 0.0000 0.0 0
M  V30 12 O 5.3347 0.0000 0.0 0
M  V30 13 N 1.3336 2.3100 0.0 0
M  V30 14 C 0.0000 3.0800 0.0 0
M  V30 15 C 8.0020 3.0800 0.0 0
M  V30 16 C 8.0020 4.6200 0.0 0
M  V30 17 C 9.3356 2.3100 0.0 0
M  V30 18 C 9.3356 5.3900 0.0 0
M  V30 19 C 10.6694 3.0800 0.0 0
M  V30 20 C 10.6694 4.6200 0.0 0
M  V30 21 C 5.3347 3.0800 0.0 0
M  V30 22 C 4.0009 2.3100 0.0 0
M  V30 23 C 5.3347 4.6200 0.0 0
M  V30 24 C 2.6673 3.0800 0.0 0
M  V30 25 C 4.0009 5.3900 0.0 0
M  V30 26 C 2.6673 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 1 2 16
M  V30 5 1 4 5
M  V30 6 1 4 17
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 20
M  V30 10 1 7 9
M  V30 11 2 10 11
M  V30 12 2 10 12
M  V30 13 1 10 22
M  V30 14 1 13 14
M  V30 15 1 13 24
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 866082-30-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 866082-31-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-15158221
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 2: To a solution of 1-1 (1.46 g, 4.16 mmol) in DMF (25 mL) were
added methylamine (2M in MeOH, 9.4 mL, 18.9 mmol) and
diisopropylethylamine (1.64 mL; 9.44 mmol). The mixture was stirred at
room temperature for 48 h. The mixture was then poured into water and
extracted with EtOAc (3x). The combined organic layer was washed with
brine (1x) and dried over MgSO4, filtered and concentrated in vacuo. The
residue obtained was chromatographed on silica gel with n-hexane-EtOAc
(1:1) to give 1.69 g of 1-2 (100%) as a yellowish solid.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of aminobenzimidazoles and related compounds for treatment of
osteoporosis, endometriosis, restenosis, rheumatoid arthritis, cancer,
macular degeneration, and obesity.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Letourneau, Jeffrey John; Paradkar, Vidyahar; Ohlmeyer, Michael H. j.;
Dillard, Lawrence W.; Baldwin, John J.; Riviello, Christopher Mark; Wong,
Angela; Rong, Yaing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20050222203 A1 2005-10-06

$RFMT $RIREG SCHEME101 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-(3-fluoro-2-nitrophenoxy)-1,3-dihydro-1-oxo-2H-isoindole-2-propanoate
C18H15FN2O6
866082-62-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 11.2762 0.0000 0.0 0
M  V30 2 C 13.2455 2.7104 0.0 0
M  V30 3 C 14.0155 4.0442 0.0 0
M  V30 4 C 15.5555 4.0442 0.0 0
M  V30 5 O 16.3255 5.3778 0.0 0
M  V30 6 O 16.3255 2.7104 0.0 0
M  V30 7 C 17.8655 5.3778 0.0 0
M  V30 8 O 5.3347 4.2504 0.0 0
M  V30 9 N 2.6673 5.7904 0.0 0 VAL=5
M  V30 10 O 4.0011 6.5604 0.0 0
M  V30 11 O 1.3336 6.5604 0.0 0
M  V30 12 F 0.0000 4.2504 0.0 0
M  V30 13 C 9.3358 3.4804 0.0 0
M  V30 14 C 9.3358 1.9404 0.0 0
M  V30 15 C 10.8003 3.9564 0.0 0
M  V30 16 C 8.0020 4.2504 0.0 0
M  V30 17 C 10.8003 1.4645 0.0 0
M  V30 18 C 8.0020 1.1704 0.0 0
M  V30 19 N 11.7055 2.7104 0.0 0
M  V30 20 C 6.6684 3.4804 0.0 0
M  V30 21 C 6.6684 1.9404 0.0 0
M  V30 22 C 4.0011 3.4804 0.0 0
M  V30 23 C 2.6673 4.2504 0.0 0
M  V30 24 C 4.0011 1.9404 0.0 0
M  V30 25 C 1.3336 3.4804 0.0 0
M  V30 26 C 2.6673 1.1704 0.0 0
M  V30 27 C 1.3336 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 17
M  V30 2 1 2 3
M  V30 3 1 2 19
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 8 20
M  V30 9 1 8 22
M  V30 10 2 9 10
M  V30 11 2 9 11
M  V30 12 1 9 23
M  V30 13 1 12 25
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 19
M  V30 22 1 18 21
M  V30 23 2 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1,3-dihydro-5-[3-(methylamino)-2-nitrophenoxy]-1-oxo-2H-isoindole-2-pr...
C19H19N3O6
866082-64-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 12.6100 0.0000 0.0 0
M  V30 2 C 14.5792 2.7104 0.0 0
M  V30 3 C 15.3492 4.0442 0.0 0
M  V30 4 C 16.8892 4.0442 0.0 0
M  V30 5 O 17.6592 5.3778 0.0 0
M  V30 6 O 17.6592 2.7104 0.0 0
M  V30 7 C 19.1992 5.3778 0.0 0
M  V30 8 O 6.6684 4.2504 0.0 0
M  V30 9 N 4.0011 5.7904 0.0 0 VAL=5
M  V30 10 O 2.6673 6.5604 0.0 0
M  V30 11 O 5.3347 6.5604 0.0 0
M  V30 12 N 1.3336 4.2504 0.0 0
M  V30 13 C 0.0000 3.4804 0.0 0
M  V30 14 C 10.6694 3.4804 0.0 0
M  V30 15 C 10.6694 1.9404 0.0 0
M  V30 16 C 12.1340 3.9564 0.0 0
M  V30 17 C 9.3358 4.2504 0.0 0
M  V30 18 C 12.1340 1.4645 0.0 0
M  V30 19 C 9.3358 1.1704 0.0 0
M  V30 20 N 13.0392 2.7104 0.0 0
M  V30 21 C 8.0020 3.4804 0.0 0
M  V30 22 C 8.0020 1.9404 0.0 0
M  V30 23 C 5.3347 3.4804 0.0 0
M  V30 24 C 4.0011 4.2504 0.0 0
M  V30 25 C 5.3347 1.9404 0.0 0
M  V30 26 C 2.6673 3.4804 0.0 0
M  V30 27 C 4.0011 1.1704 0.0 0
M  V30 28 C 2.6673 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 18
M  V30 2 1 2 3
M  V30 3 1 2 20
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 8 21
M  V30 9 1 8 23
M  V30 10 2 9 10
M  V30 11 2 9 11
M  V30 12 1 9 24
M  V30 13 1 12 13
M  V30 14 1 12 26
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 18 20
M  V30 23 1 19 22
M  V30 24 2 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 866082-62-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 866082-64-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-13592232
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 4: [0090] To a solution of 8-3 (91 mg; 0.243 mmol) in DMF (2 mL) was
added MeNH2 (2.0 M in MeOH; 0.49 mL; 0.972 mmol). The reaction mixture
was stirred at room temperature for 16 h. The mixture was diluted with
EtOAc (100 mL) and washed with water (1X25 mL) and brine (1X25 mL). The
organic phase was dried (Na2SO4), filtered and concentrated in vacuo. The
desired aniline 8-4 was used crude in the next reaction.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzimidazole derivatives as vitronectin receptor
inhibitors for treatment of osteoporosis and other diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Letourneau, Jeffrey John; Paradkar, Vidyadhar; Ohlmeyer, Michael H. J.;
Dillard, Lawrence W.; Baldwin, John J.; Riviello, Christopher Mark; Wong,
Angela; Rong, Yajing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007001249 A1 2007-01-04

$RFMT $RIREG SCHEME101 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-(3-fluoro-2-nitrophenoxy)-1,3-dihydro-1-oxo-2H-isoindole-2-propanoate
C18H15FN2O6
866082-62-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 11.2762 0.0000 0.0 0
M  V30 2 C 13.2455 2.7104 0.0 0
M  V30 3 C 14.0155 4.0442 0.0 0
M  V30 4 C 15.5555 4.0442 0.0 0
M  V30 5 O 16.3255 5.3778 0.0 0
M  V30 6 O 16.3255 2.7104 0.0 0
M  V30 7 C 17.8655 5.3778 0.0 0
M  V30 8 O 5.3347 4.2504 0.0 0
M  V30 9 N 2.6673 5.7904 0.0 0 VAL=5
M  V30 10 O 4.0011 6.5604 0.0 0
M  V30 11 O 1.3336 6.5604 0.0 0
M  V30 12 F 0.0000 4.2504 0.0 0
M  V30 13 C 9.3358 3.4804 0.0 0
M  V30 14 C 9.3358 1.9404 0.0 0
M  V30 15 C 10.8003 3.9564 0.0 0
M  V30 16 C 8.0020 4.2504 0.0 0
M  V30 17 C 10.8003 1.4645 0.0 0
M  V30 18 C 8.0020 1.1704 0.0 0
M  V30 19 N 11.7055 2.7104 0.0 0
M  V30 20 C 6.6684 3.4804 0.0 0
M  V30 21 C 6.6684 1.9404 0.0 0
M  V30 22 C 4.0011 3.4804 0.0 0
M  V30 23 C 2.6673 4.2504 0.0 0
M  V30 24 C 4.0011 1.9404 0.0 0
M  V30 25 C 1.3336 3.4804 0.0 0
M  V30 26 C 2.6673 1.1704 0.0 0
M  V30 27 C 1.3336 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 17
M  V30 2 1 2 3
M  V30 3 1 2 19
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 8 20
M  V30 9 1 8 22
M  V30 10 2 9 10
M  V30 11 2 9 11
M  V30 12 1 9 23
M  V30 13 1 12 25
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 19
M  V30 22 1 18 21
M  V30 23 2 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1,3-dihydro-5-[3-(methylamino)-2-nitrophenoxy]-1-oxo-2H-isoindole-2-pr...
C19H19N3O6
866082-64-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 12.6100 0.0000 0.0 0
M  V30 2 C 14.5792 2.7104 0.0 0
M  V30 3 C 15.3492 4.0442 0.0 0
M  V30 4 C 16.8892 4.0442 0.0 0
M  V30 5 O 17.6592 5.3778 0.0 0
M  V30 6 O 17.6592 2.7104 0.0 0
M  V30 7 C 19.1992 5.3778 0.0 0
M  V30 8 O 6.6684 4.2504 0.0 0
M  V30 9 N 4.0011 5.7904 0.0 0 VAL=5
M  V30 10 O 2.6673 6.5604 0.0 0
M  V30 11 O 5.3347 6.5604 0.0 0
M  V30 12 N 1.3336 4.2504 0.0 0
M  V30 13 C 0.0000 3.4804 0.0 0
M  V30 14 C 10.6694 3.4804 0.0 0
M  V30 15 C 10.6694 1.9404 0.0 0
M  V30 16 C 12.1340 3.9564 0.0 0
M  V30 17 C 9.3358 4.2504 0.0 0
M  V30 18 C 12.1340 1.4645 0.0 0
M  V30 19 C 9.3358 1.1704 0.0 0
M  V30 20 N 13.0392 2.7104 0.0 0
M  V30 21 C 8.0020 3.4804 0.0 0
M  V30 22 C 8.0020 1.9404 0.0 0
M  V30 23 C 5.3347 3.4804 0.0 0
M  V30 24 C 4.0011 4.2504 0.0 0
M  V30 25 C 5.3347 1.9404 0.0 0
M  V30 26 C 2.6673 3.4804 0.0 0
M  V30 27 C 4.0011 1.1704 0.0 0
M  V30 28 C 2.6673 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 18
M  V30 2 1 2 3
M  V30 3 1 2 20
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 8 21
M  V30 9 1 8 23
M  V30 10 2 9 10
M  V30 11 2 9 11
M  V30 12 1 9 24
M  V30 13 1 12 13
M  V30 14 1 12 26
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 18 20
M  V30 23 1 19 22
M  V30 24 2 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 866082-62-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 866082-64-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-12206878
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 4: To a solution of 8-3 (91 mg; 0.243 mmol) in DMF (2 mL) was added
MeNH2 (2.0 M in MeOH; 0.49 mL; 0.972 mmol). The reaction mixture was
stirred at room temperature for 16 h. The mixture was diluted with EtOAc
(100 mL) and washed with water (1x15 mL) and brine (1x15 mL). The organic
phase was dried (Na2SO4), filtered and concentrated in vacuo. The desired
aniline 8-4 was used crude in the next reaction.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of aminobenzimidazoles and related compounds for treatment of
osteoporosis, endometriosis, restenosis, rheumatoid arthritis, cancer,
macular degeneration, and obesity.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Letourneau, Jeffrey John; Paradkar, Vidyahar; Ohlmeyer, Michael H. j.;
Dillard, Lawrence W.; Baldwin, John J.; Riviello, Christopher Mark; Wong,
Angela; Rong, Yaing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20050222203 A1 2005-10-06

$RFMT $RIREG SCHEME102 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Triethyl phosphonoacetate
C8H17O5P
867-13-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 3.8500 3.8500 0.0 0 VAL=5
M  V30 2 C 5.3900 3.8500 0.0 0
M  V30 3 O 2.3100 3.8500 0.0 0
M  V30 4 O 3.8500 2.3100 0.0 0
M  V30 5 O 3.8500 5.3900 0.0 0
M  V30 6 C 6.1600 5.1836 0.0 0
M  V30 7 C 1.5400 5.1836 0.0 0
M  V30 8 C 2.5164 1.5400 0.0 0
M  V30 9 O 7.7000 5.1836 0.0 0
M  V30 10 O 5.3900 6.5173 0.0 0
M  V30 11 C 0.0000 5.1836 0.0 0
M  V30 12 C 2.5164 0.0000 0.0 0
M  V30 13 C 8.4700 6.5173 0.0 0
M  V30 14 C 10.0100 6.5173 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethyl P-[2-(methylamino)-2-oxoethyl]phosphonate
C7H16NO4P
72563-39-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 4.6201 4.0012 0.0 0 VAL=5
M  V30 2 C 3.8501 5.3348 0.0 0
M  V30 3 O 5.3901 2.6675 0.0 0
M  V30 4 O 5.9538 4.7712 0.0 0
M  V30 5 O 3.2863 3.2311 0.0 0
M  V30 6 C 2.3101 5.3348 0.0 0
M  V30 7 C 4.6201 1.3338 0.0 0
M  V30 8 C 7.2874 4.0012 0.0 0
M  V30 9 N 1.5400 6.6687 0.0 0
M  V30 10 O 1.5400 4.0012 0.0 0
M  V30 11 C 5.3901 0.0000 0.0 0
M  V30 12 C 8.6211 4.7712 0.0 0
M  V30 13 C 0.0000 6.6687 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 867-13-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 72563-39-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9142458
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM diethyl (2-(methylamino)-2-oxoethyl)phosphonate Methylamine (~4 mL) was
condensed into a 100 mL round bottomed flask at -78 ºC. Methanol (8.3 mL)
and triethylphosphonoacetate (5.65 g, 25.2 mmol) were sequentially added,
an empty balloon was fitted onto the rubber septa and the reaction
mixture was gently warmed to room temperature and stirred for 24 h. The
reaction mixture was concentrated. Proton NMR indicated a clean and
quantitative conversion to the desired product. 1H NMR (400 MHz, CDCl3) δ
6.80 (brs, 1H), 4.12 (quintet, J = 7.3 Hz, 4H), 2.83 (d, J = 20.4, 2H),
2.82 (d, J = 4.7 Hz, 3H), 1.32 (t, J = 7.3 Hz, 6H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Exercising Regiocontrol in Palladium-Catalyzed Asymmetric Prenylations
and Geranylation: Unifying Strategy toward Flustramines A and B
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Trost, Barry M.; Malhotra, Sushant; Chan, Walter H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2011), 133(19), 7328-7331

$RFMT $RIREG SCHEME103 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dichloro-N-[(2-fluorophenyl)methyl]-5-pyrimidinamine
C11H8Cl2FN3
867151-50-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3901 4.0011 0.0 0
M  V30 2 C 4.6201 2.6675 0.0 0
M  V30 3 Cl 6.9301 6.6686 0.0 0
M  V30 4 Cl 11.5501 4.0011 0.0 0
M  V30 5 F 3.0800 0.0000 0.0 0
M  V30 6 C 6.9301 4.0011 0.0 0
M  V30 7 C 7.7001 5.3348 0.0 0
M  V30 8 C 7.7001 2.6675 0.0 0
M  V30 9 N 9.2401 5.3348 0.0 0
M  V30 10 N 9.2401 2.6675 0.0 0
M  V30 11 C 10.0101 4.0011 0.0 0
M  V30 12 C 3.0800 2.6675 0.0 0
M  V30 13 C 2.3100 1.3338 0.0 0
M  V30 14 C 2.3100 4.0011 0.0 0
M  V30 15 C 0.7700 1.3338 0.0 0
M  V30 16 C 0.7700 4.0011 0.0 0
M  V30 17 C 0.0000 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 12
M  V30 4 1 3 7
M  V30 5 1 4 11
M  V30 6 1 5 13
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N5-[(2-fluorophenyl)methyl]-N4-methyl-4,5-pyrimidinediamine
C12H12ClFN4
867151-56-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 4.0011 0.0 0
M  V30 2 C 4.6200 5.3347 0.0 0
M  V30 3 N 6.9300 1.3336 0.0 0
M  V30 4 C 7.7000 0.0000 0.0 0
M  V30 5 Cl 11.5500 4.0011 0.0 0
M  V30 6 F 3.0800 8.0021 0.0 0
M  V30 7 C 6.9300 4.0011 0.0 0
M  V30 8 C 7.7000 2.6674 0.0 0
M  V30 9 C 7.7000 5.3347 0.0 0
M  V30 10 N 9.2400 2.6674 0.0 0
M  V30 11 N 9.2400 5.3347 0.0 0
M  V30 12 C 10.0100 4.0011 0.0 0
M  V30 13 C 3.0800 5.3347 0.0 0
M  V30 14 C 2.3100 6.6685 0.0 0
M  V30 15 C 2.3100 4.0011 0.0 0
M  V30 16 C 0.7700 6.6685 0.0 0
M  V30 17 C 0.7700 4.0011 0.0 0
M  V30 18 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 13
M  V30 4 1 3 4
M  V30 5 1 3 8
M  V30 6 1 5 12
M  V30 7 1 6 14
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 867151-50-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 867151-56-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-4509226
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
N5-Benzyl-2-chloro-N4-methylpyrimidine-4,5-diamine (4a); Typical
Procedure To a solution of 3a (200 mg, 0.79 mmol) in EtOH (3 mL) were
added 0.1 M aq HCl (5 mL) and methylamine (33 weight% in EtOH, 1 mL, 7.9
mmol). The mixture was heated at reflux for 1 h and concentrated under
reduced pressure until crystals appeared in the flask (2 mL). The
crystals were collected by filtration and washed with water to afford 4a.
2-Chloro-N5-(2-fluorobenzyl)-N4-methylpyrimidine-4,5-diamine (4d) From 3d
(200 mg, 0.73 mmol) 4d (196 mg, 100%) was obtained as a white solid. 1H
NMR (250 MHz, DMSO-d6): δ = 2.85 (d, J = 4.5 Hz, 3 H, CH3NH), 4.30 (d, J
= 5.4 Hz, 2 H, CH2), 5.39 (t, J = 5.4 Hz, 1 H, NHCH2), 7.15-7.45 (m, 6 H,
H-arom, H-6, NHCH3). 13C NMR (62.5 MHz, DMSO-d6): δ = 27.4 (CH3), 40.2
(CH2), 115.2 (d, JC-F .0 Hz, C-c), 124.3 (d, JC-F 5 Hz, C-e), 125.0 (d,
JC-F .2 Hz, C-a), 126.9 (C-5), 129.2 (d, JC-F 5 Hz, C-d or Cf), 129.9 (d,
JC-F 5 Hz, C-d or C-f), 131.6 (C-6), 147.4 (C-2), 154.3 (C-4), 160.4 (d,
JC-F 4.3 Hz, C-b).
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A general and facile route to new trisubstituted purin-8-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gaulon, Catherine; Dijkstra, Harmen P.; Springer, Caroline J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2005), (13), 2227-2233

$RFMT $RIREG SCHEME104 STEP1
$RXN



  2  1
$MOL
1-(Phenylmethyl) 4-(4-carboxyphenyl)hexahydro-1H-1,4-diazepine-1-carboxylate
C20H22N2O4
868066-30-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 17.4515 3.7903 0.0 0
M  V30 2 O 18.3190 2.5179 0.0 0
M  V30 3 O 18.1197 5.1778 0.0 0
M  V30 4 C 6.6684 1.5400 0.0 0
M  V30 5 O 5.3347 2.3100 0.0 0
M  V30 6 O 6.6684 0.0000 0.0 0
M  V30 7 C 4.0011 1.5400 0.0 0
M  V30 8 C 12.8444 3.4450 0.0 0
M  V30 9 C 13.7119 2.1726 0.0 0
M  V30 10 C 13.5127 4.8325 0.0 0
M  V30 11 C 15.2476 2.2877 0.0 0
M  V30 12 C 15.0484 4.9476 0.0 0
M  V30 13 C 15.9158 3.6752 0.0 0
M  V30 14 N 11.3088 3.3300 0.0 0
M  V30 15 C 10.7460 1.8964 0.0 0
M  V30 16 C 10.5387 4.6636 0.0 0
M  V30 17 C 9.2746 1.4425 0.0 0
M  V30 18 C 9.0160 4.8932 0.0 0
M  V30 19 N 8.0020 2.3100 0.0 0
M  V30 20 C 7.8870 3.8457 0.0 0
M  V30 21 C 2.6673 2.3100 0.0 0
M  V30 22 C 1.3336 1.5400 0.0 0
M  V30 23 C 2.6673 3.8500 0.0 0
M  V30 24 C 0.0000 2.3100 0.0 0
M  V30 25 C 1.3336 4.6200 0.0 0
M  V30 26 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 19
M  V30 7 1 5 7
M  V30 8 1 7 21
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 8 14
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl hexahydro-4-[4-[(methylamino)carbonyl]phenyl]-1H-1,4-diazepine-1...
C21H25N3O3
934744-14-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 17.5133 2.9738 0.0 0
M  V30 2 N 18.2833 4.3076 0.0 0
M  V30 3 O 18.2833 1.6401 0.0 0
M  V30 4 C 19.8233 4.3076 0.0 0
M  V30 5 C 6.5922 1.5357 0.0 0
M  V30 6 O 5.3198 2.4032 0.0 0
M  V30 7 O 6.4771 0.0000 0.0 0
M  V30 8 C 3.9323 1.7350 0.0 0
M  V30 9 C 12.8933 2.9738 0.0 0
M  V30 10 C 13.6633 1.6401 0.0 0
M  V30 11 C 13.6633 4.3076 0.0 0
M  V30 12 C 15.2033 1.6401 0.0 0
M  V30 13 C 15.2033 4.3076 0.0 0
M  V30 14 C 15.9733 2.9738 0.0 0
M  V30 15 N 11.3533 2.9738 0.0 0
M  V30 16 C 10.6850 1.5864 0.0 0
M  V30 17 C 10.6850 4.3613 0.0 0
M  V30 18 C 9.1837 1.2437 0.0 0
M  V30 19 C 9.1837 4.7040 0.0 0
M  V30 20 N 7.9797 2.2038 0.0 0
M  V30 21 C 7.9797 3.7438 0.0 0
M  V30 22 C 2.6599 2.6025 0.0 0
M  V30 23 C 2.7749 4.1382 0.0 0
M  V30 24 C 1.2724 1.9343 0.0 0
M  V30 25 C 1.5026 5.0056 0.0 0
M  V30 26 C 0.0000 2.8019 0.0 0
M  V30 27 C 0.1150 4.3376 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 20
M  V30 8 1 6 8
M  V30 9 1 8 22
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 9 15
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 868066-30-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 934744-14-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-138924
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery and structure-activity relationship of thienopyridine
derivatives as bone anabolic agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Saito, Keiji; Nakao, Akira; Shinozuka, Tsuyoshi; Shimada, Kousei; Matsui,
Satoshi; Oizumi, Kiyoshi; Yano, Kazuki; Ohata, Keiko; Nakai, Daisuke;
Nagai, Yoko; Naito, Satoru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2013), 21(7), 1628-1642

$RFMT $RIREG SCHEME105 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4,5-Trimethoxybenzaldehyde
C10H12O4
86-81-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 2.3100 0.0 0
M  V30 2 C 0.0000 3.0800 0.0 0
M  V30 3 O 4.0011 0.7700 0.0 0
M  V30 4 C 5.3348 0.0000 0.0 0
M  V30 5 O 1.3337 5.3901 0.0 0
M  V30 6 C 1.3337 6.9301 0.0 0
M  V30 7 C 6.6686 5.3901 0.0 0
M  V30 8 O 8.0022 4.6201 0.0 0
M  V30 9 C 2.6675 3.0800 0.0 0
M  V30 10 C 4.0011 2.3100 0.0 0
M  V30 11 C 2.6675 4.6201 0.0 0
M  V30 12 C 5.3348 3.0800 0.0 0
M  V30 13 C 4.0011 5.3901 0.0 0
M  V30 14 C 5.3348 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 2 7 8
M  V30 8 1 7 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4,5-Trimethoxy-N-methylbenzenemethanamine
C11H17NO3
58780-82-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 2.3101 0.0 0
M  V30 2 C 0.0000 3.0801 0.0 0
M  V30 3 O 4.0012 0.7700 0.0 0
M  V30 4 C 5.3348 0.0000 0.0 0
M  V30 5 O 1.3337 5.3901 0.0 0
M  V30 6 C 1.3337 6.9302 0.0 0
M  V30 7 C 6.6685 5.3901 0.0 0
M  V30 8 N 8.0023 4.6201 0.0 0
M  V30 9 C 9.3360 5.3901 0.0 0
M  V30 10 C 2.6675 3.0801 0.0 0
M  V30 11 C 4.0012 2.3101 0.0 0
M  V30 12 C 2.6675 4.6201 0.0 0
M  V30 13 C 5.3348 3.0801 0.0 0
M  V30 14 C 4.0012 5.3901 0.0 0
M  V30 15 C 5.3348 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 1 3 11
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 7 8
M  V30 8 1 7 15
M  V30 9 1 8 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 86-81-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 58780-82-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-17935977
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of a series of
resorcinol-based N-benzyl benzamide derivatives as potent Hsp90
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Park, Sun You; Oh, Yong Jin; Lho, Yunmee; Jeong, Ju Hui; Liu,
Kwang-Hyeon; Song, Jaeyoung; Kim, Soong-Hyun; Ha, Eunyoung; Seo, Young Ho
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2018), 143390-401

$RFMT $RIREG SCHEME106 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Acetylamino)-N-(phenylmethyl)-2-propenamide
C12H14N2O2
86921-49-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 C 8.0022 2.3101 0.0 0
M  V30 5 O 6.6685 0.0000 0.0 0
M  V30 6 N 9.3360 1.5400 0.0 0
M  V30 7 C 8.0022 3.8501 0.0 0
M  V30 8 C 10.6697 2.3101 0.0 0
M  V30 9 C 12.0033 1.5400 0.0 0
M  V30 10 O 10.6697 3.8501 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 2.6673 3.8501 0.0 0
M  V30 13 C 1.3337 1.5400 0.0 0
M  V30 14 C 1.3337 4.6201 0.0 0
M  V30 15 C 0.0000 2.3101 0.0 0
M  V30 16 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Acetylamino)-3-(methylamino)-N-(phenylmethyl)propanamide
C13H19N3O2
172169-81-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 6.6685 0.0 0
M  V30 2 N 5.3900 5.3347 0.0 0
M  V30 3 C 6.9300 5.3347 0.0 0
M  V30 4 C 7.7000 4.0011 0.0 0
M  V30 5 O 7.7000 6.6685 0.0 0
M  V30 6 N 6.9300 2.6674 0.0 0
M  V30 7 C 9.2400 4.0011 0.0 0
M  V30 8 C 7.7000 1.3336 0.0 0
M  V30 9 N 10.0100 5.3347 0.0 0
M  V30 10 C 9.2400 1.3336 0.0 0
M  V30 11 O 6.9300 0.0000 0.0 0
M  V30 12 C 11.5500 5.3347 0.0 0
M  V30 13 C 3.0800 6.6685 0.0 0
M  V30 14 C 2.3100 8.0021 0.0 0
M  V30 15 C 2.3100 5.3347 0.0 0
M  V30 16 C 0.7700 8.0021 0.0 0
M  V30 17 C 0.7700 5.3347 0.0 0
M  V30 18 C 0.0000 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 86921-49-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 172169-81-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-3467562
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General Procedure for the Michael Addition to 1e: To a stirred solution
of 1e (0.109 g, 0.5 mmol) in methanol (2 mL) was added water (3 mL)
followed by the appropriate nucleophile (5 mmol). After the reaction was
complete as judged by LCMS. The reaction mixture was concentrated to
afford the product. 2-Acetylamino-N-benzyl-3-methylamino-propionamide
(3a): 2 White solid (0.1245 g, 100% yield). 1H NMR (500 MHz, CDCl3) δ:
7.23 (1H, s), 7.33-7.23 (5H, m), 6.79 (1H, d, J = 4.9 Hz), 4.48-4.38 (2H,
m), 4.33-4.30 (1H, m), 3.16 (1H, dd, J = 11.6, 3.4 Hz), 2.51 (1H, dd, J =
11.6, 8.2 Hz), 2.40 (3H, s), 2.01 (3H, s). HRMS calcd for C13H18N3O2 (M -
H): 248.1399; found: 248.1405.
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-solvent, Michael addn. reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Michael addition of amines and thiols to dehydroalanine amides: a
remarkable rate acceleration in water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Naidu, B. Narasimhulu; Sorenson, Margaret E.; Connolly, Timothy P.; Ueda,
Yasutsugu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2003), 68(26), 10098-10102

$RFMT $RIREG SCHEME107 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
β-D-Galactopyranoside, 2,4,6-tri-O-acetyl-3-deoxy-3-[4-(methoxycarbonyl)-1H-1...
C32H40N6O18S
869957-51-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  57 60 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 14.4079 6.1600 0.0 0
M  V30 2 C 13.0741 5.3900 0.0 0
M  V30 3 C 13.0741 3.8500 0.0 0
M  V30 4 O 11.7404 6.1600 0.0 0
M  V30 5 O 17.0751 10.7801 0.0 0
M  V30 6 C 17.0751 12.3201 0.0 0
M  V30 7 C 18.4088 13.0901 0.0 0
M  V30 8 O 15.7415 13.0901 0.0 0
M  V30 9 S 11.7404 7.7000 0.0 0
M  V30 10 C 14.4079 12.3201 0.0 0
M  V30 11 O 13.0741 13.0901 0.0 0
M  V30 12 C 13.0741 14.6301 0.0 0
M  V30 13 C 14.4079 15.4001 0.0 0
M  V30 14 O 11.7404 15.4001 0.0 0
M  V30 15 C 21.0441 7.3429 0.0 0
M  V30 16 O 21.9493 6.0970 0.0 0
M  V30 17 O 21.6704 8.7499 0.0 0
M  V30 18 C 23.4808 6.2580 0.0 0
M  V30 19 O 9.0730 9.2400 0.0 0
M  V30 20 C 10.4068 10.0101 0.0 0
M  V30 21 C 10.4068 11.5501 0.0 0
M  V30 22 O 11.7404 9.2400 0.0 0
M  V30 23 C 9.0730 3.0800 0.0 0
M  V30 24 O 10.4068 2.3100 0.0 0
M  V30 25 C 10.4068 0.7700 0.0 0
M  V30 26 C 9.0731 0.0000 0.0 0
M  V30 27 O 11.7404 0.0000 0.0 0
M  V30 28 O 6.4057 4.6200 0.0 0
M  V30 29 C 6.4057 3.0800 0.0 0
M  V30 30 C 7.7393 2.3100 0.0 0
M  V30 31 O 5.0720 2.3100 0.0 0
M  V30 32 C 2.4368 8.0572 0.0 0
M  V30 33 O 1.5315 9.3030 0.0 0
M  V30 34 O 1.8104 6.6502 0.0 0
M  V30 35 C 0.0000 9.1421 0.0 0
M  V30 36 C 15.7415 8.4700 0.0 0 CFG=1
M  V30 37 C 14.4079 7.7000 0.0 0 CFG=1
M  V30 38 C 15.7415 10.0101 0.0 0 CFG=1
M  V30 39 C 13.0741 8.4700 0.0 0 CFG=2
M  V30 40 C 14.4079 10.7801 0.0 0 CFG=1
M  V30 41 O 13.0741 10.0101 0.0 0
M  V30 42 N 17.0751 7.7000 0.0 0
M  V30 43 C 18.4819 8.3264 0.0 0
M  V30 44 N 17.2361 6.1685 0.0 0
M  V30 45 C 19.5125 7.1820 0.0 0
M  V30 46 N 18.7425 5.8483 0.0 0
M  V30 47 C 10.4068 6.9300 0.0 0 CFG=2
M  V30 48 C 9.0730 7.7000 0.0 0 CFG=2
M  V30 49 O 10.4068 5.3900 0.0 0
M  V30 50 C 7.7393 6.9300 0.0 0 CFG=1
M  V30 51 C 9.0730 4.6200 0.0 0 CFG=2
M  V30 52 C 7.7393 5.3900 0.0 0 CFG=1
M  V30 53 N 6.4057 7.7000 0.0 0
M  V30 54 C 4.9989 7.0737 0.0 0
M  V30 55 N 6.2447 9.2316 0.0 0
M  V30 56 C 3.9683 8.2181 0.0 0
M  V30 57 N 4.7383 9.5517 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 37 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 38 5 CFG=3
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 39 9 CFG=3
M  V30 10 1 47 9 CFG=3
M  V30 11 1 10 11
M  V30 12 1 40 10 CFG=3
M  V30 13 1 11 12
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 15 45
M  V30 19 1 16 18
M  V30 20 1 19 20
M  V30 21 1 48 19 CFG=1
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 1 23 24
M  V30 25 1 51 23 CFG=3
M  V30 26 1 24 25
M  V30 27 1 25 26
M  V30 28 2 25 27
M  V30 29 1 28 29
M  V30 30 1 52 28 CFG=3
M  V30 31 1 29 30
M  V30 32 2 29 31
M  V30 33 1 32 33
M  V30 34 2 32 34
M  V30 35 1 32 56
M  V30 36 1 33 35
M  V30 37 1 36 37
M  V30 38 1 36 38
M  V30 39 1 36 42 CFG=3
M  V30 40 1 37 39
M  V30 41 1 38 40
M  V30 42 1 39 41
M  V30 43 1 40 41
M  V30 44 1 42 43
M  V30 45 1 42 44
M  V30 46 2 43 45
M  V30 47 2 44 46
M  V30 48 1 45 46
M  V30 49 1 47 48
M  V30 50 1 47 49
M  V30 51 1 48 50
M  V30 52 1 49 51
M  V30 53 1 50 52
M  V30 54 1 50 53 CFG=3
M  V30 55 1 51 52
M  V30 56 1 53 54
M  V30 57 1 53 55
M  V30 58 2 54 56
M  V30 59 2 55 57
M  V30 60 1 56 57
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 36 37 38 39 40 47 48 50 51 52)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
3-Deoxy-3-[4-[(methylamino)carbonyl]-1H-1,2,3-triazol-1-yl]-β-D-galactopyrano...
C20H30N8O10S
869957-52-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 9.0731 6.9301 0.0 0
M  V30 2 O 6.4057 2.3100 0.0 0
M  V30 3 S 11.7405 5.3901 0.0 0
M  V30 4 C 9.0731 0.7700 0.0 0
M  V30 5 O 7.7394 0.0000 0.0 0
M  V30 6 C 2.4368 5.7472 0.0 0
M  V30 7 N 1.5316 6.9931 0.0 0
M  V30 8 O 1.8105 4.3402 0.0 0
M  V30 9 C 0.0000 6.8322 0.0 0
M  V30 10 O 14.4080 6.9301 0.0 0
M  V30 11 C 14.4080 0.7700 0.0 0
M  V30 12 O 15.7417 0.0000 0.0 0
M  V30 13 O 17.0753 2.3100 0.0 0
M  V30 14 C 21.0443 5.7472 0.0 0
M  V30 15 N 21.9495 6.9931 0.0 0
M  V30 16 O 21.6706 4.3402 0.0 0
M  V30 17 C 23.4811 6.8322 0.0 0
M  V30 18 C 7.7394 4.6201 0.0 0 CFG=1
M  V30 19 C 9.0731 5.3901 0.0 0 CFG=1
M  V30 20 C 7.7394 3.0800 0.0 0 CFG=1
M  V30 21 C 10.4069 4.6201 0.0 0 CFG=2
M  V30 22 C 9.0731 2.3100 0.0 0 CFG=1
M  V30 23 O 10.4069 3.0800 0.0 0
M  V30 24 N 6.4057 5.3901 0.0 0
M  V30 25 C 4.9989 4.7636 0.0 0
M  V30 26 N 6.2448 6.9216 0.0 0
M  V30 27 C 3.9683 5.9081 0.0 0
M  V30 28 N 4.7383 7.2418 0.0 0
M  V30 29 C 13.0742 4.6201 0.0 0 CFG=2
M  V30 30 C 14.4080 5.3901 0.0 0 CFG=2
M  V30 31 O 13.0742 3.0800 0.0 0
M  V30 32 C 15.7417 4.6201 0.0 0 CFG=1
M  V30 33 C 14.4080 2.3100 0.0 0 CFG=2
M  V30 34 C 15.7417 3.0800 0.0 0 CFG=1
M  V30 35 N 17.0753 5.3901 0.0 0
M  V30 36 C 18.4821 4.7636 0.0 0
M  V30 37 N 17.2363 6.9216 0.0 0
M  V30 38 C 19.5127 5.9081 0.0 0
M  V30 39 N 18.7427 7.2418 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 19 1 CFG=1
M  V30 2 1 20 2 CFG=3
M  V30 3 1 21 3 CFG=3
M  V30 4 1 29 3 CFG=1
M  V30 5 1 4 5
M  V30 6 1 22 4 CFG=3
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 27
M  V30 10 1 7 9
M  V30 11 1 30 10 CFG=3
M  V30 12 1 11 12
M  V30 13 1 33 11 CFG=1
M  V30 14 1 34 13 CFG=1
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 14 38
M  V30 18 1 15 17
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 24 CFG=3
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 1 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 1 32 35 CFG=1
M  V30 37 1 33 34
M  V30 38 1 35 36
M  V30 39 1 35 37
M  V30 40 2 36 38
M  V30 41 2 37 39
M  V30 42 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 18 19 20 21 22 29 30 32 33 34)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 869957-51-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 869957-52-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-352-CAS-390908
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 1H-1,2,3-Triazol-1-yl thiodigalactoside derivatives as high affinity
galectin-3 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Salameh, Bader A.; Cumpstey, Ian; Sundin, Anders; Leffler, Hakon;
Nilsson, Ulf J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2010), 18(14), 5367-5378

$RFMT $RIREG SCHEME108 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3aR,7aR)-3a-(3,4-Dimethoxyphenyl)hexahydro-2,6-benzofurandione
C16H18O5
87014-19-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.8959 9.0058 0.0 0
M  V30 2 O 6.8881 0.7700 0.0 0
M  V30 3 C 5.5544 0.0000 0.0 0
M  V30 4 O 0.0000 3.5110 0.0 0
M  V30 5 O 9.5556 2.3101 0.0 0
M  V30 6 C 10.8893 3.0801 0.0 0
M  V30 7 C 4.2208 5.3901 0.0 0 CFG=2
M  V30 8 C 2.9747 6.2954 0.0 0 CFG=1
M  V30 9 C 5.4667 6.2954 0.0 0
M  V30 10 C 4.0597 3.8584 0.0 0
M  V30 11 O 3.4508 7.7599 0.0 0
M  V30 12 C 1.5679 5.6689 0.0 0
M  V30 13 C 4.9908 7.7599 0.0 0
M  V30 14 C 2.6529 3.2321 0.0 0
M  V30 15 C 1.4070 4.1373 0.0 0
M  V30 16 C 5.5544 4.6201 0.0 0
M  V30 17 C 5.5544 3.0801 0.0 0
M  V30 18 C 6.8881 5.3901 0.0 0
M  V30 19 C 6.8881 2.3101 0.0 0
M  V30 20 C 8.2218 4.6201 0.0 0
M  V30 21 C 8.2218 3.0801 0.0 0
M  V30 22 H 1.8303 7.3258 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 1 2 3
M  V30 3 1 2 19
M  V30 4 2 4 15
M  V30 5 1 5 6
M  V30 6 1 5 21
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 16 CFG=3
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 8 22 CFG=3
M  V30 14 1 9 13
M  V30 15 1 10 14
M  V30 16 1 11 13
M  V30 17 1 12 15
M  V30 18 1 14 15
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 7 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(3aR,7aR)-3a-(3,4-Dimethoxyphenyl)hexahydro-1-methyl-1H-indole-2,6-dione
C17H21NO4
21104-34-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.5455 9.0058 0.0 0
M  V30 2 O 5.8959 9.0058 0.0 0
M  V30 3 O 6.8881 0.7700 0.0 0
M  V30 4 C 5.5544 0.0000 0.0 0
M  V30 5 O 0.0000 3.5110 0.0 0
M  V30 6 O 9.5556 2.3101 0.0 0
M  V30 7 C 10.8893 3.0801 0.0 0
M  V30 8 C 4.2208 5.3901 0.0 0 CFG=2
M  V30 9 C 2.9747 6.2954 0.0 0 CFG=1
M  V30 10 C 5.4667 6.2954 0.0 0
M  V30 11 C 4.0597 3.8584 0.0 0
M  V30 12 N 3.4508 7.7599 0.0 0
M  V30 13 C 1.5679 5.6689 0.0 0
M  V30 14 C 4.9908 7.7599 0.0 0
M  V30 15 C 2.6529 3.2321 0.0 0
M  V30 16 C 1.4070 4.1373 0.0 0
M  V30 17 C 5.5544 4.6201 0.0 0
M  V30 18 C 5.5544 3.0801 0.0 0
M  V30 19 C 6.8881 5.3901 0.0 0
M  V30 20 C 6.8881 2.3101 0.0 0
M  V30 21 C 8.2218 4.6201 0.0 0
M  V30 22 C 8.2218 3.0801 0.0 0
M  V30 23 H 1.8303 7.3258 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 2 2 14
M  V30 3 1 3 4
M  V30 4 1 3 20
M  V30 5 2 5 16
M  V30 6 1 6 7
M  V30 7 1 6 22
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 8 17 CFG=3
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 9 23 CFG=3
M  V30 15 1 10 14
M  V30 16 1 11 15
M  V30 17 1 12 14
M  V30 18 1 13 16
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 8 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 87014-19-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 21104-34-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1748538
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Allyl vinyl ethers via Wittig olefination: a short and efficient
synthesis of (±)-mesembrine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kulkarni, Mukund G.; Rasne, Ravindra M.; Davawala, Saryu I.; Doke,
Aniruddha K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2002), 43(12), 2297-2298

$RFMT $RIREG SCHEME109 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Oxocyclohexanecarboxylic acid
C7H10O3
874-61-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 O 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 2 4 10
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-oxocyclohexanecarboxamide
C8H13NO2
925933-44-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 O 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 2 5 11
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 874-61-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 925933-44-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39764828
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Oxoisoindolin-2-ylpiperidine-2,6-dione derivatives as casein kinase 1
alpha degrader and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jo, Hyunsun; Terrett, Nicholas Kenneth; Levy, Daniel Emil; Deninno,
Michael Paul; King-Underwood, John; Chung, Jun-Jae; Mohanty, Sarina;
Park, Jisu; Kim, Purum; Park, Yuna; Jaipuri, Firoz Ali
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024003749 A1 2024-01-04

$RFMT $RIREG SCHEME110 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Phenyl-5-(trifluoromethyl)-2-thiophenecarboxaldehyde
C12H7F3OS
874832-11-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0494 1.4647 0.0 0
M  V30 2 F 6.5139 0.9888 0.0 0
M  V30 3 F 4.5733 0.0000 0.0 0
M  V30 4 F 3.5847 1.9406 0.0 0
M  V30 5 C 8.2358 5.8505 0.0 0
M  V30 6 O 9.6426 5.2240 0.0 0
M  V30 7 C 4.6200 4.1752 0.0 0
M  V30 8 C 5.5252 2.9294 0.0 0
M  V30 9 C 5.5252 5.4211 0.0 0
M  V30 10 S 6.9898 3.4052 0.0 0
M  V30 11 C 6.9898 4.9452 0.0 0
M  V30 12 C 3.0800 4.1752 0.0 0
M  V30 13 C 2.3100 2.8415 0.0 0
M  V30 14 C 2.3100 5.5089 0.0 0
M  V30 15 C 0.7700 2.8415 0.0 0
M  V30 16 C 0.7700 5.5089 0.0 0
M  V30 17 C 0.0000 4.1752 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 2 5 6
M  V30 6 1 5 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 12
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Thiophenemethanamine, N-methyl-4-phenyl-5-(trifluoromethyl)-
C13H12F3NS
3040200-83-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0494 1.4647 0.0 0
M  V30 2 F 6.5139 0.9888 0.0 0
M  V30 3 F 4.5733 0.0000 0.0 0
M  V30 4 F 3.5847 1.9406 0.0 0
M  V30 5 C 8.2356 5.8503 0.0 0
M  V30 6 N 9.6426 5.2240 0.0 0
M  V30 7 C 10.8884 6.1292 0.0 0
M  V30 8 C 4.6200 4.1751 0.0 0
M  V30 9 C 5.5252 2.9292 0.0 0
M  V30 10 C 5.5252 5.4211 0.0 0
M  V30 11 S 6.9898 3.4051 0.0 0
M  V30 12 C 6.9898 4.9451 0.0 0
M  V30 13 C 3.0800 4.1751 0.0 0
M  V30 14 C 2.3100 5.5089 0.0 0
M  V30 15 C 2.3100 2.8415 0.0 0
M  V30 16 C 0.7700 5.5089 0.0 0
M  V30 17 C 0.7700 2.8415 0.0 0
M  V30 18 C 0.0000 4.1751 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 13
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 874832-11-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3040200-83-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40490510
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective Defluorination of Trifluoromethyl Substituents by
Conformationally Induced Remote Substitution
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jesani, Mehul H.; Schwarz, Maria; Kim, Shiwhu; Evans, Finlay L.; White,
Alexander; Browning, Alex; Abrams, Roman; Clayden, Jonathan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2024), 63(24), e202403477

$RFMT $RIREG SCHEME111 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Bromobutoxy)naphthalene
C14H15BrO
87723-22-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 3.0801 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 C 10.6697 2.3101 0.0 0
M  V30 5 C 12.0033 3.0801 0.0 0
M  V30 6 Br 13.3370 2.3101 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 C 2.6673 0.7700 0.0 0
M  V30 9 C 4.0010 3.0801 0.0 0
M  V30 10 C 1.3337 3.0801 0.0 0
M  V30 11 C 4.0010 0.0000 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 C 0.0000 2.3101 0.0 0
M  V30 15 C 5.3348 0.7700 0.0 0
M  V30 16 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-(2-naphthalenyloxy)-1-butanamine
C15H19NO
115600-83-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 3.0801 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3358 3.0801 0.0 0
M  V30 4 C 10.6697 2.3101 0.0 0
M  V30 5 C 12.0033 3.0801 0.0 0
M  V30 6 N 13.3370 2.3101 0.0 0
M  V30 7 C 14.6707 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 2.6673 0.7700 0.0 0
M  V30 10 C 4.0010 3.0801 0.0 0
M  V30 11 C 1.3337 3.0801 0.0 0
M  V30 12 C 4.0010 0.0000 0.0 0
M  V30 13 C 1.3337 0.0000 0.0 0
M  V30 14 C 5.3348 2.3101 0.0 0
M  V30 15 C 0.0000 2.3101 0.0 0
M  V30 16 C 5.3348 0.7700 0.0 0
M  V30 17 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 2 13 17
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 87723-22-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 115600-83-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-20876747
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Medium-Ring-sized Benzolactams by Using Strong Electrophiles
and Quantitative Evaluation of Ring-size Dependency of the Cyclization
Reaction Rate
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kurouchi, Hiroaki; Ohwada, Tomohiko
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2020), 85(2), 876-901

$RFMT $RIREG SCHEME112 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Cyclopropyl-5-thiazolecarboxaldehyde
C7H7NOS
877385-86-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.4894 2.9211 0.0 0
M  V30 2 O 7.8962 2.2948 0.0 0
M  V30 3 C 2.8737 1.2459 0.0 0
M  V30 4 S 3.7789 2.4917 0.0 0
M  V30 5 N 3.7789 0.0000 0.0 0
M  V30 6 C 5.2436 2.0159 0.0 0
M  V30 7 C 5.2436 0.4759 0.0 0
M  V30 8 C 1.3336 1.2459 0.0 0
M  V30 9 C 0.0000 0.4759 0.0 0
M  V30 10 C 0.0000 2.0159 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2-Cyclopropyl-5-thiazolyl)methylene]methanamine
C8H10N2S
1855942-65-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.8428 2.4608 0.0 0
M  V30 2 N 7.7479 3.7067 0.0 0
M  V30 3 C 9.2796 3.5458 0.0 0
M  V30 4 C 2.8739 2.1037 0.0 0
M  V30 5 S 4.2807 1.4774 0.0 0
M  V30 6 N 3.0348 3.6353 0.0 0
M  V30 7 C 5.3111 2.6218 0.0 0
M  V30 8 C 4.5411 3.9554 0.0 0
M  V30 9 C 1.5400 1.3337 0.0 0
M  V30 10 C 0.7700 0.0000 0.0 0
M  V30 11 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 9
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 877385-86-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1855942-65-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-15870223
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for making tetracyclic heterocycle compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Hongming; Yin, Jingjun; Belyk, Kevin M.; Campos, Kevin R.; Chen,
Qinghao; Hyde, Alan M.; Itoh, Tetsuji; Klapars, Artis; Tudge, Mathew
Thomas; Cleator, Edward; Dumas, Aaron M.; Campeau, Louis-Charles; Chen,
Yonggang; Qi, Ji; Xiao, Wensong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016004899 A1 2016-01-14

$RFMT $RIREG SCHEME113 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indole-6-carboxylic acid, 3-cyclohexyl-1-(2,2-dimethoxyethyl)-2-(2-formylp...
C27H31NO5
886041-96-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0494 8.3504 0.0 0
M  V30 2 C 6.0798 9.4947 0.0 0
M  V30 3 O 7.5862 9.1746 0.0 0
M  V30 4 O 5.6039 10.9594 0.0 0
M  V30 5 C 8.6166 10.3190 0.0 0
M  V30 6 C 6.6343 12.1038 0.0 0
M  V30 7 C 3.0800 8.3071 0.0 0
M  V30 8 O 2.3100 9.6409 0.0 0
M  V30 9 C 10.9909 7.1798 0.0 0
M  V30 10 O 12.3247 6.4098 0.0 0
M  V30 11 O 10.9909 8.7198 0.0 0
M  V30 12 C 13.6583 7.1798 0.0 0
M  V30 13 C 4.6200 5.6398 0.0 0
M  V30 14 C 5.5252 4.3939 0.0 0
M  V30 15 N 5.5252 6.8857 0.0 0
M  V30 16 C 6.9899 4.8698 0.0 0
M  V30 17 C 6.9899 6.4098 0.0 0
M  V30 18 C 8.3236 4.0998 0.0 0
M  V30 19 C 8.3236 7.1798 0.0 0
M  V30 20 C 9.6572 4.8698 0.0 0
M  V30 21 C 9.6572 6.4098 0.0 0
M  V30 22 C 3.0800 5.6398 0.0 0
M  V30 23 C 2.3100 6.9734 0.0 0
M  V30 24 C 2.3100 4.3062 0.0 0
M  V30 25 C 0.7700 6.9734 0.0 0
M  V30 26 C 0.7700 4.3062 0.0 0
M  V30 27 C 0.0000 5.6398 0.0 0
M  V30 28 C 5.0494 2.9292 0.0 0
M  V30 29 C 3.5429 2.6091 0.0 0
M  V30 30 C 6.0798 1.7849 0.0 0
M  V30 31 C 3.0671 1.1444 0.0 0
M  V30 32 C 5.6039 0.3202 0.0 0
M  V30 33 C 4.0976 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 7 8
M  V30 8 1 7 23
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 21
M  V30 12 1 10 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 22
M  V30 16 1 14 16
M  V30 17 1 14 28
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 1 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-cyclohexyl-1-(2,2-dimethoxyethyl)-2-[2-[(methylamino)methyl]phenyl]-...
C28H36N2O4
1132679-30-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0494 8.3503 0.0 0
M  V30 2 C 6.0798 9.4947 0.0 0
M  V30 3 O 5.6039 10.9594 0.0 0
M  V30 4 O 7.5862 9.1746 0.0 0
M  V30 5 C 6.6343 12.1038 0.0 0
M  V30 6 C 8.6166 10.3189 0.0 0
M  V30 7 C 3.0800 8.3071 0.0 0
M  V30 8 N 2.3100 9.6409 0.0 0
M  V30 9 C 0.7700 9.6409 0.0 0
M  V30 10 C 10.9908 7.1798 0.0 0
M  V30 11 O 12.3246 6.4098 0.0 0
M  V30 12 O 10.9908 8.7198 0.0 0
M  V30 13 C 13.6583 7.1798 0.0 0
M  V30 14 C 4.6200 5.6398 0.0 0
M  V30 15 C 5.5252 4.3939 0.0 0
M  V30 16 N 5.5252 6.8856 0.0 0
M  V30 17 C 6.9899 4.8698 0.0 0
M  V30 18 C 6.9899 6.4098 0.0 0
M  V30 19 C 8.3235 4.0998 0.0 0
M  V30 20 C 8.3235 7.1798 0.0 0
M  V30 21 C 9.6572 4.8698 0.0 0
M  V30 22 C 9.6572 6.4098 0.0 0
M  V30 23 C 3.0800 5.6398 0.0 0
M  V30 24 C 2.3100 6.9734 0.0 0
M  V30 25 C 2.3100 4.3061 0.0 0
M  V30 26 C 0.7700 6.9734 0.0 0
M  V30 27 C 0.7700 4.3061 0.0 0
M  V30 28 C 0.0000 5.6398 0.0 0
M  V30 29 C 5.0494 2.9292 0.0 0
M  V30 30 C 3.5429 2.6091 0.0 0
M  V30 31 C 6.0798 1.7849 0.0 0
M  V30 32 C 3.0671 1.1444 0.0 0
M  V30 33 C 5.6039 0.3202 0.0 0
M  V30 34 C 4.0975 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 24
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 22
M  V30 13 1 11 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 14 23
M  V30 17 1 15 17
M  V30 18 1 15 29
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 1 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 886041-96-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1132679-30-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-12679723
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM 85-100% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tetracyclic indole inhibitors of hepatitis C virus NS5B-polymerase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Stansfield, Ian; Ercolani, Caterina; Mackay, Angela; Conte, Immacolata;
Pompei, Marco; Koch, Uwe; Gennari, Nadia; Giuliano, Claudio; Rowley,
Michael; Narjes, Frank
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(3), 627-632

$RFMT $RIREG SCHEME114 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-3-fluoro-2-nitrobenzene
C6H3BrFNO2
886762-70-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6675 0.0 0 VAL=5
M  V30 2 O 0.0000 1.3338 0.0 0
M  V30 3 O 0.0000 4.0012 0.0 0
M  V30 4 Br 2.3101 5.3350 0.0 0
M  V30 5 F 2.3101 0.0000 0.0 0
M  V30 6 C 2.3101 2.6675 0.0 0
M  V30 7 C 3.0801 4.0012 0.0 0
M  V30 8 C 3.0801 1.3338 0.0 0
M  V30 9 C 4.6201 4.0012 0.0 0
M  V30 10 C 4.6201 1.3338 0.0 0
M  V30 11 C 5.3901 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 8
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-N-methyl-2-nitrobenzenamine
C7H7BrN2O2
1150617-53-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 4.6201 0.0 0 VAL=5
M  V30 2 O 1.3338 5.3901 0.0 0
M  V30 3 O 4.0012 5.3901 0.0 0
M  V30 4 N 5.3348 3.0801 0.0 0
M  V30 5 C 6.6687 2.3101 0.0 0
M  V30 6 Br 0.0000 3.0801 0.0 0
M  V30 7 C 2.6675 3.0801 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 1.3338 2.3101 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 886762-70-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1150617-53-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35466442
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted pyrazine-2-carboxamides as HPK1 inhibitors for
the treatment of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nilsson Lill, Sten; Giblin, Kathryn; Kettle, Jason Grant; Goldberg,
Frederick Woolf; Grimster, Neil Patrick; Morrill, Lucas; Escobar,
Randolph; Metrano, Anthony; Song, Kun; Sheppeck, James; Ziegler, Robert
Evans; Wu, Ye; Sha, Li; Wu, Dedong; Grebe, Tyler; Mfuh, Adelphe; Balazs,
Amber; Shields, Jason
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023001794 A1 2023-01-26

$RFMT $RIREG SCHEME115 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-(1,3-benzodioxol-5-ylmethyl)-N-(3-bromopropyl)carbamate
C16H22BrNO4
888313-54-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2873 6.6685 0.0 0
M  V30 2 N 7.0574 5.3348 0.0 0
M  V30 3 C 8.5974 5.3348 0.0 0
M  V30 4 C 6.2873 4.0010 0.0 0
M  V30 5 O 9.3674 6.6685 0.0 0
M  V30 6 O 9.3674 4.0010 0.0 0
M  V30 7 C 7.0574 2.6673 0.0 0
M  V30 8 C 10.9074 6.6685 0.0 0
M  V30 9 C 6.2873 1.3337 0.0 0
M  V30 10 C 10.9074 5.1285 0.0 0
M  V30 11 C 12.4475 6.6685 0.0 0
M  V30 12 C 10.9074 8.2085 0.0 0
M  V30 13 Br 7.0574 0.0000 0.0 0
M  V30 14 C 2.4373 8.0022 0.0 0
M  V30 15 C 1.6672 6.6685 0.0 0
M  V30 16 C 3.9773 8.0022 0.0 0
M  V30 17 O 1.4068 9.1466 0.0 0
M  V30 18 C 2.4373 5.3348 0.0 0
M  V30 19 O 0.1609 6.9887 0.0 0
M  V30 20 C 4.7473 6.6685 0.0 0
M  V30 21 C 0.0000 8.5202 0.0 0
M  V30 22 C 3.9773 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 17
M  V30 17 2 15 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-(1,3-benzodioxol-5-ylmethyl)-N-[3-(methylamino)propyl]car...
C17H26N2O4
888313-55-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2873 6.6685 0.0 0
M  V30 2 N 7.0574 5.3348 0.0 0
M  V30 3 C 6.2873 4.0010 0.0 0
M  V30 4 C 8.5974 5.3348 0.0 0
M  V30 5 O 7.0574 2.6673 0.0 0
M  V30 6 O 4.7473 4.0010 0.0 0
M  V30 7 C 9.3674 6.6685 0.0 0
M  V30 8 C 6.2873 1.3337 0.0 0
M  V30 9 C 10.9074 6.6685 0.0 0
M  V30 10 C 7.6212 0.5637 0.0 0
M  V30 11 C 5.5173 0.0000 0.0 0
M  V30 12 C 4.9537 2.1037 0.0 0
M  V30 13 N 11.6775 8.0022 0.0 0
M  V30 14 C 13.2175 8.0022 0.0 0
M  V30 15 C 2.4373 8.0022 0.0 0
M  V30 16 C 1.6672 6.6685 0.0 0
M  V30 17 C 3.9773 8.0022 0.0 0
M  V30 18 O 1.4068 9.1466 0.0 0
M  V30 19 C 2.4373 5.3348 0.0 0
M  V30 20 O 0.1609 6.9887 0.0 0
M  V30 21 C 4.7473 6.6685 0.0 0
M  V30 22 C 0.0000 8.5202 0.0 0
M  V30 23 C 3.9773 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 13 14
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 1 15 18
M  V30 18 2 16 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 888313-54-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 888313-55-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-4795584
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 3. Preparation of compound 2c:
Benzo[1,3]dioxol-5-ylmethyl-(3-methylamino-propyl)-carbamic acid
tert-butyl ester. Methylamine (33 wt. % in EtOH, 30.0 L, 240 mol) was
added over 3 h to a solution of
benzo[1,3]dioxol-5-ylmethyl-(3-bromo-propyl)-carbamic acid tert-butyl
ester (2.93 kg, 7.90 mol) in BtOH (4.00 L) while maintaining an internal
temperature of 14-17 °C. The reaction mixture was warmed to room
temperature and stirried for 14 h. The solution was concentrated under
vacuum (70-15 torr) at 32°C then partitioned between ethyl acetate (5.00
L) and water (3.00 L). The phases were separated and the aqueous layer
back extracted with ethyl acetate (2.00 L). The combined organic layers
were concentrated under vacuum (70-5 torr) at 32°C to give 2.59 kg (100%)
of benzo[1,3]dioxol-5-ylmethyl-(3-methylamino-propyl)-carbamic acid
tert-butyl ester as a clear oil. [M+H]+ 323.70.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of imidazole derivatives as nitric oxide synthase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cowans, Brett A.; Mougin-Andres, Patricia; Wheeler, Patrick E.; Gahman,
Timothy C.; Herbert, Mark R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007062410 A1 2007-05-31

$RFMT $RIREG SCHEME115 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-(1,3-benzodioxol-5-ylmethyl)-N-(3-bromopropyl)carbamate
C16H22BrNO4
888313-54-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2873 6.6685 0.0 0
M  V30 2 N 7.0574 5.3348 0.0 0
M  V30 3 C 8.5974 5.3348 0.0 0
M  V30 4 C 6.2873 4.0010 0.0 0
M  V30 5 O 9.3674 6.6685 0.0 0
M  V30 6 O 9.3674 4.0010 0.0 0
M  V30 7 C 7.0574 2.6673 0.0 0
M  V30 8 C 10.9074 6.6685 0.0 0
M  V30 9 C 6.2873 1.3337 0.0 0
M  V30 10 C 10.9074 5.1285 0.0 0
M  V30 11 C 12.4475 6.6685 0.0 0
M  V30 12 C 10.9074 8.2085 0.0 0
M  V30 13 Br 7.0574 0.0000 0.0 0
M  V30 14 C 2.4373 8.0022 0.0 0
M  V30 15 C 1.6672 6.6685 0.0 0
M  V30 16 C 3.9773 8.0022 0.0 0
M  V30 17 O 1.4068 9.1466 0.0 0
M  V30 18 C 2.4373 5.3348 0.0 0
M  V30 19 O 0.1609 6.9887 0.0 0
M  V30 20 C 4.7473 6.6685 0.0 0
M  V30 21 C 0.0000 8.5202 0.0 0
M  V30 22 C 3.9773 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 17
M  V30 17 2 15 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-(1,3-benzodioxol-5-ylmethyl)-N-[3-(methylamino)propyl]car...
C17H26N2O4
888313-55-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2873 6.6685 0.0 0
M  V30 2 N 7.0574 5.3348 0.0 0
M  V30 3 C 6.2873 4.0010 0.0 0
M  V30 4 C 8.5974 5.3348 0.0 0
M  V30 5 O 7.0574 2.6673 0.0 0
M  V30 6 O 4.7473 4.0010 0.0 0
M  V30 7 C 9.3674 6.6685 0.0 0
M  V30 8 C 6.2873 1.3337 0.0 0
M  V30 9 C 10.9074 6.6685 0.0 0
M  V30 10 C 7.6212 0.5637 0.0 0
M  V30 11 C 5.5173 0.0000 0.0 0
M  V30 12 C 4.9537 2.1037 0.0 0
M  V30 13 N 11.6775 8.0022 0.0 0
M  V30 14 C 13.2175 8.0022 0.0 0
M  V30 15 C 2.4373 8.0022 0.0 0
M  V30 16 C 1.6672 6.6685 0.0 0
M  V30 17 C 3.9773 8.0022 0.0 0
M  V30 18 O 1.4068 9.1466 0.0 0
M  V30 19 C 2.4373 5.3348 0.0 0
M  V30 20 O 0.1609 6.9887 0.0 0
M  V30 21 C 4.7473 6.6685 0.0 0
M  V30 22 C 0.0000 8.5202 0.0 0
M  V30 23 C 3.9773 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 13 14
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 1 15 18
M  V30 18 2 16 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 888313-54-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 888313-55-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-11116948
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 3: Preparation of example 1c:
Benzo[1,3]dioxol-5-ylmethyl-(3-methylamino-propyl)-carbamic acid
tert-butyl ester. Methylamine (33 wt. % in EtOH, 30.0 L, 240 mol) was
added over 3 h to a solution of
benzo[1,3]dioxol-5-ylmethyl-(3-bromo-propyl)-carbamic acid tert-butyl
ester (2.93 kg, 7.90 mol) in EtOH (4.00 L) while maintaining an internal
temperature of 14-17 °C. The reaction mixture was warmed to room
temperature and stirried for 14 h. The solution was concentrated under
vacuum (70-15 torr) at 32°C then partitioned between ethyl acetate (5.00
L) and water (3.00 L). The phases were separated and the aqueous layer
back extracted with ethyl acetate (2.00 L). The combined organic layers
were concentrated under vacuum (70-5 torr) at 32°C to give 2.59 kg (100%)
of benzo[1,3]dioxol-5-ylmethyl-(3-methylamino-propyl)-carbamic acid
tert-butyl ester (1c) as a clear oil. [M+H]+ 323.70.
$DTYPE RXN:VAR(1):NOTES
$DATUM kilogram scale
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for preparation of 3-(imidazol-1-yl)-1,2,4-thiadiazole-5-amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Herbert, Mark R.; Cousins, Russell D.; Lang, Hengyuan; Gahman, Timothy
C.; Noble, Stewart A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007062411 A1 2007-05-31

$RFMT $RIREG SCHEME116 STEP1
$RXN



  2  1
$MOL
1-(Phenylmethoxy)-4-[1-phenyl-1-(2-propen-1-yloxy)-3-buten-1-yl]benzene
C26H26O2
889860-25-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.6200 0.0 0
M  V30 2 O 3.0800 4.6200 0.0 0
M  V30 3 C 4.6200 6.1600 0.0 0
M  V30 4 C 2.3100 5.9536 0.0 0
M  V30 5 C 3.2864 6.9300 0.0 0
M  V30 6 C 0.7700 5.9536 0.0 0
M  V30 7 C 3.2864 8.4700 0.0 0
M  V30 8 C 0.0000 7.2874 0.0 0
M  V30 9 O 10.7800 4.6200 0.0 0
M  V30 10 C 11.5500 5.9536 0.0 0
M  V30 11 C 6.1600 4.6200 0.0 0
M  V30 12 C 6.9300 3.2864 0.0 0
M  V30 13 C 6.9300 5.9536 0.0 0
M  V30 14 C 8.4700 3.2864 0.0 0
M  V30 15 C 8.4700 5.9536 0.0 0
M  V30 16 C 9.2400 4.6200 0.0 0
M  V30 17 C 4.6200 3.0800 0.0 0
M  V30 18 C 3.2864 2.3100 0.0 0
M  V30 19 C 5.9536 2.3100 0.0 0
M  V30 20 C 3.2864 0.7700 0.0 0
M  V30 21 C 5.9536 0.7700 0.0 0
M  V30 22 C 4.6200 0.0000 0.0 0
M  V30 23 C 13.0900 5.9536 0.0 0
M  V30 24 C 13.8600 7.2874 0.0 0
M  V30 25 C 13.8600 4.6200 0.0 0
M  V30 26 C 15.4000 7.2874 0.0 0
M  V30 27 C 15.4000 4.6200 0.0 0
M  V30 28 C 16.1700 5.9536 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 1 17
M  V30 5 1 2 4
M  V30 6 1 3 5
M  V30 7 1 4 6
M  V30 8 2 5 7
M  V30 9 2 6 8
M  V30 10 1 9 10
M  V30 11 1 9 16
M  V30 12 1 10 23
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,6-Dihydro-2-phenyl-2-[4-(phenylmethoxy)phenyl]-2H-pyran
C24H22O2
889860-26-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.7869 4.5498 0.0 0
M  V30 2 C 9.5569 5.8834 0.0 0
M  V30 3 C 2.6269 4.5498 0.0 0
M  V30 4 C 2.8943 6.0664 0.0 0
M  V30 5 O 1.1798 4.0231 0.0 0
M  V30 6 C 1.7146 7.0563 0.0 0
M  V30 7 C 0.0000 5.0130 0.0 0
M  V30 8 C 0.2675 6.5296 0.0 0
M  V30 9 C 4.1669 4.5498 0.0 0
M  V30 10 C 4.9369 3.2161 0.0 0
M  V30 11 C 4.9369 5.8834 0.0 0
M  V30 12 C 6.4769 3.2161 0.0 0
M  V30 13 C 6.4769 5.8834 0.0 0
M  V30 14 C 7.2469 4.5498 0.0 0
M  V30 15 C 2.8943 3.0332 0.0 0
M  V30 16 C 1.7146 2.0433 0.0 0
M  V30 17 C 4.3414 2.5065 0.0 0
M  V30 18 C 1.9820 0.5267 0.0 0
M  V30 19 C 4.6089 0.9899 0.0 0
M  V30 20 C 3.4291 0.0000 0.0 0
M  V30 21 C 11.0969 5.8834 0.0 0
M  V30 22 C 11.8669 7.2171 0.0 0
M  V30 23 C 11.8669 4.5498 0.0 0
M  V30 24 C 13.4069 7.2171 0.0 0
M  V30 25 C 13.4069 4.5498 0.0 0
M  V30 26 C 14.1769 5.8834 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 21
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 9
M  V30 7 1 3 15
M  V30 8 1 4 6
M  V30 9 1 5 7
M  V30 10 2 6 8
M  V30 11 1 7 8
M  V30 12 2 9 10
M  V30 13 1 9 11
M  V30 14 1 10 12
M  V30 15 2 11 13
M  V30 16 2 12 14
M  V30 17 1 13 14
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 889860-25-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 889860-26-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-470-CAS-21095792
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 172222-30-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 25- 2-(4-Benzyloxy-phenyl)2-phenyl-3,6-dihydro-2H-pyran.
1-(1-Allyloxy-1-phenyl-but-3-enyl)-4-benzyloxy-benzene (4.2 g, 10.1 mmol)
was dissolved in dichloromethane (50 mL) and
bis(tricyclohexylphosphine)benzylidene ruthenium (IV) dichloride (25 mg,
0.03 mmol) was added. Stirred at r.1. for 1 h. TLC indicated full
conversion of the starting material. A solution of methylamine in THF (1
M, 1 mL) was added. The solution was eluted through a block of silica.
The silica was washed with a solution of dichloromethane and ethyl
acetate (1: 1, 100 mL). The combined organic phase was concentrated to
slightly coloured syrup (4.1 g, quantitatively). 1H NMR (400 MHz, CDCl3):
7.49-7.24 (m, 12H), 6.95 (d, 2H,J = 8.8 Hz), 6.05-5.98 (m, 1H), 5.72-5.65
(m, 1H), 4.16-4.00 (m, 2H), 2.90-2.76 (m, 2H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 1,1-diphenyl cycloalkane derivatives with activity at
estrogen receptors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Piu, Fabrice; Gil, Daniel W.; Olsson, Roger; Gustafsson, Magnus;
Hyldtoft, Lene; Siemasko, Karyn F.; Stern, Michael E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008033894 A2 2008-03-20

$RFMT $RIREG SCHEME117 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2H-1,3,2-Oxazaphosphorine, tetrahydro-3-[(4-nitrophenyl)sulfonyl]-2-phenyl-, ...
C15H15N2O5PS2
892860-53-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.4864 4.2597 0.0 0
M  V30 2 S 6.1640 3.0801 0.0 0 VAL=6
M  V30 3 O 5.3940 4.4137 0.0 0
M  V30 4 O 6.9340 1.7464 0.0 0
M  V30 5 N 11.4988 6.1601 0.0 0 VAL=5
M  V30 6 O 12.8325 5.3901 0.0 0
M  V30 7 O 11.4988 7.7002 0.0 0
M  V30 8 P 3.4965 3.0801 0.0 0 VAL=5
M  V30 9 N 4.8302 2.3101 0.0 0
M  V30 10 O 2.1628 2.3101 0.0 0
M  V30 11 C 4.8302 0.7700 0.0 0
M  V30 12 C 2.1628 0.7700 0.0 0
M  V30 13 C 3.4965 0.0000 0.0 0
M  V30 14 C 2.5066 4.2597 0.0 0
M  V30 15 C 3.0333 5.7069 0.0 0
M  V30 16 C 0.9899 3.9924 0.0 0
M  V30 17 C 2.0433 6.8867 0.0 0
M  V30 18 C 0.0000 5.1720 0.0 0
M  V30 19 C 0.5267 6.6192 0.0 0
M  V30 20 C 7.4977 3.8501 0.0 0
M  V30 21 C 8.8313 3.0801 0.0 0
M  V30 22 C 7.4977 5.3901 0.0 0
M  V30 23 C 10.1650 3.8501 0.0 0
M  V30 24 C 8.8313 6.1601 0.0 0
M  V30 25 C 10.1650 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 9
M  V30 5 1 2 20
M  V30 6 2 5 6
M  V30 7 2 5 7
M  V30 8 1 5 25
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 14
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
O-[3-[[(4-Nitrophenyl)sulfonyl]amino]propyl] N-methyl-P-phenylphosphonamidoth...
C16H20N3O5PS2
892860-68-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 4.0012 4.6201 0.0 0 VAL=5
M  V30 2 O 5.3348 5.3901 0.0 0
M  V30 3 N 3.2311 5.9538 0.0 0
M  V30 4 S 4.7712 3.2863 0.0 0
M  V30 5 C 6.6685 4.6201 0.0 0
M  V30 6 C 4.0012 7.2874 0.0 0
M  V30 7 C 8.0023 5.3901 0.0 0
M  V30 8 C 9.3360 4.6201 0.0 0
M  V30 9 N 10.6697 5.3901 0.0 0
M  V30 10 S 12.0035 4.6201 0.0 0 VAL=6
M  V30 11 O 11.2335 3.2863 0.0 0
M  V30 12 O 12.7735 5.9538 0.0 0
M  V30 13 N 17.3383 1.5400 0.0 0 VAL=5
M  V30 14 O 17.3383 0.0000 0.0 0
M  V30 15 O 18.6720 2.3101 0.0 0
M  V30 16 C 2.6675 3.8501 0.0 0
M  V30 17 C 2.6675 2.3101 0.0 0
M  V30 18 C 1.3337 4.6201 0.0 0
M  V30 19 C 1.3337 1.5400 0.0 0
M  V30 20 C 0.0000 3.8501 0.0 0
M  V30 21 C 0.0000 2.3101 0.0 0
M  V30 22 C 13.3372 3.8501 0.0 0
M  V30 23 C 14.6708 4.6201 0.0 0
M  V30 24 C 13.3372 2.3101 0.0 0
M  V30 25 C 16.0045 3.8501 0.0 0
M  V30 26 C 14.6708 1.5400 0.0 0
M  V30 27 C 16.0045 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 1 16
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 2 10 11
M  V30 12 2 10 12
M  V30 13 1 10 22
M  V30 14 2 13 14
M  V30 15 2 13 15
M  V30 16 1 13 27
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 892860-53-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 892860-68-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-567-CAS-630080
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The influence of ring size on the selectivity of phosphorus heterocycle
aminolysis in the presence of water or alcohols - case of 2-oxo- or
2-thioxo-3-sulfonyl-1,3,2-oxazaphosphorinanes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dujols, Frederic; Mulliez, Michel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2006), (8), 1959-1964

$RFMT $RIREG SCHEME118 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(5-Bromo-1H-indol-2-yl)ethanone
C10H8BrNO
89671-83-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 C 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 Br 8.9549 4.1617 0.0 0
M  V30 5 C 4.3348 4.1617 0.0 0
M  V30 6 C 5.1048 2.8281 0.0 0
M  V30 7 N 2.8284 3.8416 0.0 0
M  V30 8 C 5.1048 5.4954 0.0 0
M  V30 9 C 4.0743 1.6835 0.0 0
M  V30 10 C 6.6448 2.8281 0.0 0
M  V30 11 C 2.6675 2.3100 0.0 0
M  V30 12 C 6.6448 5.4954 0.0 0
M  V30 13 C 7.4149 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N,α-dimethyl-1H-indole-2-methanamine
C11H13BrN2
1484727-19-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.6211 1.5400 0.0 0
M  V30 2 N 8.9549 2.3100 0.0 0
M  V30 3 C 7.6211 0.0000 0.0 0
M  V30 4 C 10.2886 1.5400 0.0 0
M  V30 5 Br 0.0000 4.1618 0.0 0
M  V30 6 C 4.6201 4.1618 0.0 0
M  V30 7 C 3.8501 2.8281 0.0 0
M  V30 8 N 6.1265 3.8416 0.0 0
M  V30 9 C 3.8501 5.4954 0.0 0
M  V30 10 C 4.8806 1.6836 0.0 0
M  V30 11 C 2.3100 2.8281 0.0 0
M  V30 12 C 6.2875 2.3100 0.0 0
M  V30 13 C 2.3100 5.4954 0.0 0
M  V30 14 C 1.5400 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 89671-83-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1484727-19-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-20821380
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of indolyl ethanamines for the treatment and prophylaxis of
bacterial infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM LaVoie, Edmond J.; Sagong, Hye Yeon; Parhi, Ajit K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019099402 A1 2019-05-23

$RFMT $RIREG SCHEME119 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chlorobenzaldehyde
C7H5ClO
89-98-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 O 5.3901 4.0010 0.0 0
M  V30 3 Cl 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(2-Chlorophenyl)methylene]methanamine
C8H8ClN
1020073-49-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 C 6.9302 4.0010 0.0 0
M  V30 4 Cl 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 89-98-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1020073-49-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-6590714
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7487-88-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General procedure for the synthesis of imines In a typical experiment,
4-fluorobenzaldehyde (124.1 mg, 1 mmol) was added to CH2Cl2 (1 mL)
followed by 70% ethylamine in H2O (A2, 2 mmol) and MgSO4 (2.5 mmol). The
reaction was stirred at room temperature (298K) for 4 h. The reaction
mixture was immediately filtrated, and the supernatant was dried in
vacuo. From the crude product, imine 2-A2 was obtained in quantitative
yield without purification by column chromatography.
(E)-N-(2-chlorobenzylidene)methanamine (1-A1). Quantitative yield.
Colorless oil; 1H-NMR (CDCl3) δ = 8.72 (1H, s), 7.98 (2H, d, J = 7.3 Hz),
7.37 (1H, d, J = 7.9 Hz), 7.33 (1H, brt, J = 7.9 Hz), 7.29 (1H, t, J =
7.3 Hz ), 3.56 (3H, s); 13C-NMR (CDCl3) δ = 159.2, 134.9, 133.3, 131.4,
129.8, 128.1, 127.0, 48.5.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Dynamic Asymmetric Multicomponent Resolution: Lipase-Mediated Amidation
of a Double Dynamic Covalent System
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vongvilai, Pornrapee; Ramstrom, Olof
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2009), 131(40), 14419-14425

$RFMT $RIREG SCHEME120 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Salicylaldehyde
C7H6O2
90-02-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 O 5.3901 4.0010 0.0 0
M  V30 3 O 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(Methylimino)methyl]phenol
C8H9NO
3117-65-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 C 6.9302 4.0010 0.0 0
M  V30 4 O 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 90-02-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3117-65-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-20694727
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Protective groups and methods for protecting benzoxaboroles or oxaboroles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tomsho, John W.; Gamrat, James M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019173814 A1 2019-09-12

$RFMT $RIREG SCHEME120 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Salicylaldehyde
C7H6O2
90-02-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 O 5.3901 4.0010 0.0 0
M  V30 3 O 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(Methylimino)methyl]phenol
C8H9NO
3117-65-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 C 6.9302 4.0010 0.0 0
M  V30 4 O 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 90-02-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3117-65-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-18849731
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Protection of the Benzoxaborole Moiety: Synthesis and Functionalization
of Zwitterionic Benzoxaborole Complexes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gamrat, James M.; Mancini, Giulia; Burke, Sarah J.; Colandrea, Rebecca
C.; Sadowski, Nicholas R.; Figula, Bryan C.; Tomsho, John W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2018), 83(11), 6193-6201

$RFMT $RIREG SCHEME121 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4′-Trifluoromethylbiphenyl-4-carboxaldehyde
C14H9F3O
90035-34-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 F 1.5400 3.0800 0.0 0
M  V30 3 F 0.0000 1.5400 0.0 0
M  V30 4 F 1.5400 0.0000 0.0 0
M  V30 5 C 12.3200 1.5400 0.0 0
M  V30 6 O 13.0900 2.8736 0.0 0
M  V30 7 C 6.1600 1.5400 0.0 0
M  V30 8 C 5.3900 0.2064 0.0 0
M  V30 9 C 5.3900 2.8736 0.0 0
M  V30 10 C 3.8500 0.2064 0.0 0
M  V30 11 C 3.8500 2.8736 0.0 0
M  V30 12 C 3.0800 1.5400 0.0 0
M  V30 13 C 7.7000 1.5400 0.0 0
M  V30 14 C 8.4700 2.8736 0.0 0
M  V30 15 C 8.4700 0.2064 0.0 0
M  V30 16 C 10.0100 2.8736 0.0 0
M  V30 17 C 10.0100 0.2064 0.0 0
M  V30 18 C 10.7800 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 12
M  V30 5 2 5 6
M  V30 6 1 5 18
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4′-(trifluoromethyl)[1,1′-biphenyl]-4-methanamine
C15H14F3N
304694-22-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.3200 1.5400 0.0 0
M  V30 2 N 13.0900 2.8736 0.0 0
M  V30 3 C 14.6300 2.8736 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 F 1.5400 3.0800 0.0 0
M  V30 6 F 0.0000 1.5400 0.0 0
M  V30 7 F 1.5400 0.0000 0.0 0
M  V30 8 C 7.7000 1.5400 0.0 0
M  V30 9 C 8.4700 0.2064 0.0 0
M  V30 10 C 8.4700 2.8736 0.0 0
M  V30 11 C 10.0100 0.2064 0.0 0
M  V30 12 C 10.0100 2.8736 0.0 0
M  V30 13 C 10.7800 1.5400 0.0 0
M  V30 14 C 6.1600 1.5400 0.0 0
M  V30 15 C 5.3900 0.2064 0.0 0
M  V30 16 C 5.3900 2.8736 0.0 0
M  V30 17 C 3.8500 0.2064 0.0 0
M  V30 18 C 3.8500 2.8736 0.0 0
M  V30 19 C 3.0800 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 19
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 14
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 90035-34-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 304694-22-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40490497
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective Defluorination of Trifluoromethyl Substituents by
Conformationally Induced Remote Substitution
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jesani, Mehul H.; Schwarz, Maria; Kim, Shiwhu; Evans, Finlay L.; White,
Alexander; Browning, Alex; Abrams, Roman; Clayden, Jonathan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2024), 63(24), e202403477

$RFMT $RIREG SCHEME122 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-2-pyrazinecarbonyl chloride
C5H2Cl2N2O
90361-99-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 Cl 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Cl 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 N 3.0801 4.0010 0.0 0
M  V30 8 N 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-N-methyl-2-pyrazinecarboxamide
C6H6ClN3O
1350356-42-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 O 5.3901 1.3337 0.0 0
M  V30 4 C 6.9302 4.0010 0.0 0
M  V30 5 Cl 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 N 2.3101 4.0010 0.0 0
M  V30 9 N 0.7700 1.3337 0.0 0
M  V30 10 C 0.7700 4.0010 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 7
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 90361-99-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1350356-42-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-2231909
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM STEP 3. 3-CHLORO-PYRAZINE-2-CARBOXYLIC ACID METHYLAMIDE To a solution of
3-chloropyrazine-2-carboxylic acid chloride (350 mg, 2.0 mmol) in THF (10
mL) was added methylamine (300 mg, 10 mmol) and triethylamine (303 mg,
3.0 mmol). The reaction mixture was stirred at RT for 3h. The reaction
solution was concentrated under reduced pressure to give the desired
compound. Yield 200 mg, 100%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of nitrogen-containing heterocyclic compounds as
phosphodiesterase 10 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Allen, Jennifer R.; Andrews, Kristin L.; Frohn, Michael J.; Harrington,
Paul E.; Pickrell, Alexander J.; Rzasa, Robert M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011143129 A1 2011-11-17

$RFMT $RIREG SCHEME123 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 2-(bromomethyl)-5-nitro-, methyl ester
C9H8BrNO4
90725-68-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 4.0012 0.0 0
M  V30 2 O 6.9302 5.3348 0.0 0
M  V30 3 O 6.9302 2.6675 0.0 0
M  V30 4 C 8.4702 5.3348 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 Br 3.8501 0.0000 0.0 0
M  V30 7 N 1.5400 6.6687 0.0 0 VAL=5
M  V30 8 O 2.3101 8.0023 0.0 0
M  V30 9 O 0.0000 6.6687 0.0 0
M  V30 10 C 4.6201 4.0012 0.0 0
M  V30 11 C 3.8501 2.6675 0.0 0
M  V30 12 C 3.8501 5.3348 0.0 0
M  V30 13 C 2.3101 2.6675 0.0 0
M  V30 14 C 2.3101 5.3348 0.0 0
M  V30 15 C 1.5400 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 14
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-2-methyl-6-nitro-1H-isoindol-1-one
C9H8N2O3
564467-91-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.2753 0.3694 0.0 0
M  V30 2 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 3 O 0.0000 2.3100 0.0 0
M  V30 4 O 1.3338 0.0000 0.0 0
M  V30 5 C 9.2446 3.0800 0.0 0
M  V30 6 C 5.3347 2.3100 0.0 0
M  V30 7 C 5.3347 3.8500 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 6.7994 1.8341 0.0 0
M  V30 10 C 6.7994 4.3259 0.0 0
M  V30 11 C 4.0011 4.6200 0.0 0
M  V30 12 C 2.6674 2.3100 0.0 0
M  V30 13 N 7.7046 3.0800 0.0 0
M  V30 14 C 2.6674 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 12
M  V30 5 1 5 13
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 90725-68-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 564467-91-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-22902503
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted azaindoles as OGA inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bartolome-Nebreda, Jose Manuel; Trabanco-Suarez, Andres Avelino;
Tresadern, Gary John; Martinez Lamenca, Carolina; Leenaerts, Joseph
Elisabeth; Oehlrich, Daniel; Buijnsters, Peter Jacobus Johannes Antonius;
Velter, Adriana Ingrid; Van Roosbroeck, Yves Emiel Maria
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019243535 A1 2019-12-26

$RFMT $RIREG SCHEME124 STEP1
$RXN



  2  1
$MOL
1-(1,1-Dimethylethyl) (2R,4R)-4-[[4-[(3-chloro-2-fluorophenyl)amino]-7-methox...
C26H28ClFN4O6
908294-15-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 5.3347 0.0 0
M  V30 2 O 10.0100 4.0011 0.0 0
M  V30 3 O 11.5500 6.6684 0.0 0
M  V30 4 C 12.3200 8.0021 0.0 0
M  V30 5 F 3.0800 2.6674 0.0 0
M  V30 6 Cl 0.0000 2.6674 0.0 0
M  V30 7 C 14.6300 1.3336 0.0 0
M  V30 8 O 13.8600 0.0000 0.0 0
M  V30 9 O 16.1700 1.3336 0.0 0
M  V30 10 C 16.1700 4.0011 0.0 0
M  V30 11 O 16.9400 5.3347 0.0 0
M  V30 12 O 16.9400 2.6674 0.0 0
M  V30 13 C 18.4800 5.3347 0.0 0
M  V30 14 C 18.4800 3.7947 0.0 0
M  V30 15 C 20.0200 5.3347 0.0 0
M  V30 16 C 18.4800 6.8747 0.0 0
M  V30 17 C 6.9300 6.6684 0.0 0
M  V30 18 C 5.3900 6.6684 0.0 0
M  V30 19 C 7.7000 8.0021 0.0 0
M  V30 20 C 7.7000 5.3347 0.0 0
M  V30 21 N 4.6200 8.0021 0.0 0
M  V30 22 C 9.2400 8.0021 0.0 0
M  V30 23 N 6.9300 9.3358 0.0 0
M  V30 24 C 9.2400 5.3347 0.0 0
M  V30 25 C 5.3900 9.3358 0.0 0
M  V30 26 C 10.0100 6.6684 0.0 0
M  V30 27 C 3.0800 5.3347 0.0 0
M  V30 28 C 2.3100 4.0011 0.0 0
M  V30 29 C 2.3100 6.6684 0.0 0
M  V30 30 C 0.7700 4.0011 0.0 0
M  V30 31 C 0.7700 6.6684 0.0 0
M  V30 32 C 0.0000 5.3347 0.0 0
M  V30 33 C 11.5500 4.0011 0.0 0 CFG=2
M  V30 34 C 12.3200 2.6674 0.0 0
M  V30 35 C 12.3200 5.3347 0.0 0
M  V30 36 C 13.8600 2.6674 0.0 0 CFG=2
M  V30 37 C 13.8600 5.3347 0.0 0
M  V30 38 N 14.6300 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 1 1 27
M  V30 3 1 2 24
M  V30 4 1 33 2 CFG=3
M  V30 5 1 3 4
M  V30 6 1 3 26
M  V30 7 1 5 28
M  V30 8 1 6 30
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 36 7 CFG=1
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 1 10 38
M  V30 15 1 11 13
M  V30 16 1 13 14
M  V30 17 1 13 15
M  V30 18 1 13 16
M  V30 19 1 17 18
M  V30 20 2 17 19
M  V30 21 1 17 20
M  V30 22 2 18 21
M  V30 23 1 19 22
M  V30 24 1 19 23
M  V30 25 2 20 24
M  V30 26 1 21 25
M  V30 27 2 22 26
M  V30 28 2 23 25
M  V30 29 1 24 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 36 1 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 33 36)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2R,4R)-4-[[4-[(3-chloro-2-fluorophenyl)amino]-7-methoxy-6-...
C27H31ClFN5O5
908294-16-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 6.6684 0.0 0
M  V30 2 O 10.0100 5.3347 0.0 0
M  V30 3 O 11.5500 8.0021 0.0 0
M  V30 4 C 12.3200 9.3358 0.0 0
M  V30 5 F 3.0800 4.0011 0.0 0
M  V30 6 Cl 0.0000 4.0011 0.0 0
M  V30 7 C 14.6300 2.6673 0.0 0
M  V30 8 N 13.8600 1.3336 0.0 0
M  V30 9 O 16.1700 2.6673 0.0 0
M  V30 10 C 14.6300 0.0000 0.0 0
M  V30 11 C 16.1700 5.3347 0.0 0
M  V30 12 O 16.9400 6.6684 0.0 0
M  V30 13 O 16.9400 4.0011 0.0 0
M  V30 14 C 18.4800 6.6684 0.0 0
M  V30 15 C 18.4800 5.1284 0.0 0
M  V30 16 C 20.0200 6.6684 0.0 0
M  V30 17 C 18.4800 8.2084 0.0 0
M  V30 18 C 6.9300 8.0021 0.0 0
M  V30 19 C 7.7000 9.3358 0.0 0
M  V30 20 C 5.3900 8.0021 0.0 0
M  V30 21 C 7.7000 6.6684 0.0 0
M  V30 22 C 9.2400 9.3358 0.0 0
M  V30 23 N 6.9300 10.6694 0.0 0
M  V30 24 N 4.6200 9.3358 0.0 0
M  V30 25 C 9.2400 6.6684 0.0 0
M  V30 26 C 10.0100 8.0021 0.0 0
M  V30 27 C 5.3900 10.6694 0.0 0
M  V30 28 C 3.0800 6.6684 0.0 0
M  V30 29 C 2.3100 5.3347 0.0 0
M  V30 30 C 2.3100 8.0021 0.0 0
M  V30 31 C 0.7700 5.3347 0.0 0
M  V30 32 C 0.7700 8.0021 0.0 0
M  V30 33 C 0.0000 6.6684 0.0 0
M  V30 34 C 11.5500 5.3347 0.0 0 CFG=2
M  V30 35 C 12.3200 4.0011 0.0 0
M  V30 36 C 12.3200 6.6684 0.0 0
M  V30 37 C 13.8600 4.0011 0.0 0 CFG=2
M  V30 38 C 13.8600 6.6684 0.0 0
M  V30 39 N 14.6300 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 20
M  V30 2 1 1 28
M  V30 3 1 2 25
M  V30 4 1 34 2 CFG=3
M  V30 5 1 3 4
M  V30 6 1 3 26
M  V30 7 1 5 29
M  V30 8 1 6 31
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 37 7 CFG=1
M  V30 12 1 8 10
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 11 39
M  V30 16 1 12 14
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 14 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 18 21
M  V30 23 1 19 22
M  V30 24 1 19 23
M  V30 25 2 20 24
M  V30 26 2 21 25
M  V30 27 2 22 26
M  V30 28 2 23 27
M  V30 29 1 24 27
M  V30 30 1 25 26
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 37 1 34 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 34 37)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 908294-15-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 908294-16-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-6834059
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 543-27-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM A stirred solution of
(2R,4R)-1-(tert-butoxycarbonyl)-4-({4-[(3-chloro-2-fluorophenyl)amino]-7-methoxyquinazolin-6-yl}oxy)piperidine-2-carboxylic
acid (5.35 g, 9.80 mmol) in THF (50 ml) was cooled to-15°C (acetone/ice).
NMM (1.49 ml, 14.9 mmol) was added to the solution followed by IBCF (2.0
ml, 12.75 mmol). The reaction mixture was held at-15°C (the formation of
the mixed anhydride was monitored by TLC (THF)). After 5-10 minutes, the
reaction mixture was treated with a 2.0M solution of methylamine in THF
(10 ml) at-15°C and allowed to warm to room temperature. The reaction
mixture was diluted with DCM (250 ml), washed with water (2 x 20 ml) and
concentrated to give tert-batyl
(2R,4R)-4-({4-[(3-cMoiO-2-fluorophenyl)amino]-7-methoxyquinazoun-6-yl}oxy)-2-[(methylamino)carbonyl]piperidine-1-carboxylate
(5.94g, 100%) as a pale yellow foam. Mass Spectrum: (M+H)+ 560.1.
$DTYPE RXN:VAR(1):NOTES
$DATUM other procedure gave lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Quinazoline derivatives as tyrosine kinase inhibitors and their
preparation and pharmaceutical compositions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Halsall, Christopher Thomas; Hennequin, Laurent Francois Andre;
Plowright, Alleyn Thomas; Storey, Richard; Lennon, Kieran
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006090163 A1 2006-08-31

$RFMT $RIREG SCHEME125 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl-1H-indole-5-carboxaldehyde
C10H9NO
90923-75-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 3.1885 0.0 0
M  V30 2 C 7.2708 2.4782 0.0 0
M  V30 3 O 8.0408 3.8119 0.0 0
M  V30 4 C 2.6507 2.4782 0.0 0
M  V30 5 C 3.4207 1.1444 0.0 0
M  V30 6 N 1.1444 2.1580 0.0 0
M  V30 7 C 3.4207 3.8119 0.0 0
M  V30 8 C 4.9608 1.1444 0.0 0
M  V30 9 C 2.3903 0.0000 0.0 0
M  V30 10 C 0.9835 0.6263 0.0 0
M  V30 11 C 4.9608 3.8119 0.0 0
M  V30 12 C 5.7308 2.4782 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 2 2 3
M  V30 3 1 2 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 10
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1-Dimethyl-1H-indole-5-methanamine
C11H14N2
709649-73-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 3.1885 0.0 0
M  V30 2 C 7.2707 2.4782 0.0 0
M  V30 3 N 8.0407 3.8118 0.0 0
M  V30 4 C 9.5808 3.8118 0.0 0
M  V30 5 C 3.4207 1.1444 0.0 0
M  V30 6 C 2.6507 2.4782 0.0 0
M  V30 7 C 4.9607 1.1444 0.0 0
M  V30 8 C 2.3903 0.0000 0.0 0
M  V30 9 N 1.1444 2.1580 0.0 0
M  V30 10 C 3.4207 3.8118 0.0 0
M  V30 11 C 5.7307 2.4782 0.0 0
M  V30 12 C 0.9835 0.6263 0.0 0
M  V30 13 C 4.9607 3.8118 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 2 11
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 90923-75-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 709649-73-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-272944
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM b) Methyl-(1-methylindol-5-ylmethyl)amine [0866]
N-Methylindole-5-carbaldehyde (800 mg, 5.1 mmol) was dissolved in
anhydrous methanol (15 mL). Methylamine (7.15 mL of 2M solution in
methanol, 15.3 mmol) was added and the reaction was stirred for 3 hr. The
solution was concentrated to a yellow oil and then dissolved into
anhydrous methanol (15 mL). Sodium borohydride (194 mg, 5.1 mmol) was
added and the mixture was stirred overnight. Water (1 mL) was added and
the solution was concentrated to an orange oil. Sodium hydroxide (5 mL,
1N) was added and the product was extracted with ethyl acetate (3×20 mL),
dried over MgSO4 and concentrated to afford the title compound as an
orange oil (885 mg, 100%). 1H NMR (200 MHz, CDCl3) δ 7.57(s, 1H),
7.35-7.11(m, 3H), 6.51 (d, J=2.9 Hz, 1H), 3.85 (s, 2H), 3.79 (s, 3H),
2.48 (s, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME125 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl-1H-indole-5-carboxaldehyde
C10H9NO
90923-75-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 3.1885 0.0 0
M  V30 2 C 7.2708 2.4782 0.0 0
M  V30 3 O 8.0408 3.8119 0.0 0
M  V30 4 C 2.6507 2.4782 0.0 0
M  V30 5 C 3.4207 1.1444 0.0 0
M  V30 6 N 1.1444 2.1580 0.0 0
M  V30 7 C 3.4207 3.8119 0.0 0
M  V30 8 C 4.9608 1.1444 0.0 0
M  V30 9 C 2.3903 0.0000 0.0 0
M  V30 10 C 0.9835 0.6263 0.0 0
M  V30 11 C 4.9608 3.8119 0.0 0
M  V30 12 C 5.7308 2.4782 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 2 2 3
M  V30 3 1 2 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 10
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1-Dimethyl-1H-indole-5-methanamine
C11H14N2
709649-73-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 3.1885 0.0 0
M  V30 2 C 7.2707 2.4782 0.0 0
M  V30 3 N 8.0407 3.8118 0.0 0
M  V30 4 C 9.5808 3.8118 0.0 0
M  V30 5 C 3.4207 1.1444 0.0 0
M  V30 6 C 2.6507 2.4782 0.0 0
M  V30 7 C 4.9607 1.1444 0.0 0
M  V30 8 C 2.3903 0.0000 0.0 0
M  V30 9 N 1.1444 2.1580 0.0 0
M  V30 10 C 3.4207 3.8118 0.0 0
M  V30 11 C 5.7307 2.4782 0.0 0
M  V30 12 C 0.9835 0.6263 0.0 0
M  V30 13 C 4.9607 3.8118 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 2 11
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 90923-75-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 709649-73-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-14704044
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004082586 A2 2004-09-30

$RFMT $RIREG SCHEME125 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl-1H-indole-5-carboxaldehyde
C10H9NO
90923-75-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 3.1885 0.0 0
M  V30 2 C 7.2708 2.4782 0.0 0
M  V30 3 O 8.0408 3.8119 0.0 0
M  V30 4 C 2.6507 2.4782 0.0 0
M  V30 5 C 3.4207 1.1444 0.0 0
M  V30 6 N 1.1444 2.1580 0.0 0
M  V30 7 C 3.4207 3.8119 0.0 0
M  V30 8 C 4.9608 1.1444 0.0 0
M  V30 9 C 2.3903 0.0000 0.0 0
M  V30 10 C 0.9835 0.6263 0.0 0
M  V30 11 C 4.9608 3.8119 0.0 0
M  V30 12 C 5.7308 2.4782 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 2 2 3
M  V30 3 1 2 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 10
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1-Dimethyl-1H-indole-5-methanamine
C11H14N2
709649-73-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 3.1885 0.0 0
M  V30 2 C 7.2707 2.4782 0.0 0
M  V30 3 N 8.0407 3.8118 0.0 0
M  V30 4 C 9.5808 3.8118 0.0 0
M  V30 5 C 3.4207 1.1444 0.0 0
M  V30 6 C 2.6507 2.4782 0.0 0
M  V30 7 C 4.9607 1.1444 0.0 0
M  V30 8 C 2.3903 0.0000 0.0 0
M  V30 9 N 1.1444 2.1580 0.0 0
M  V30 10 C 3.4207 3.8118 0.0 0
M  V30 11 C 5.7307 2.4782 0.0 0
M  V30 12 C 0.9835 0.6263 0.0 0
M  V30 13 C 4.9607 3.8118 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 2 11
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 90923-75-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 709649-73-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-11963344
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM b) Methyl-(1-methylindol-5-ylmethyl)amine N-Methylindole-5-carbaldehyde
(800 mg, 5.1 mmol) was dissolved in anhydrous methanol (15 mL).
Methylamine (7.15 mL of 2M solution in methanol, 15.3 mmol) was added and
the reaction was stirred for 3 hr. The solution was concentrated to a
yellow oil and then dissolved into anhydrous methanol (15 mL). Sodium
borohydride (194 mg, 5.1 mmol) was added and the mixture was stirred
overnight. Water (1 mL) was added and the solution was concentrated to an
orange oil. Sodium hydroxide (5 mL, 1N) was added and the product was
extracted with ethyl acetate (3 x 20 mL), dried over MgSO4 and
concentrated to afford the title compound as an orange oil.
Methyl-(1-methylindol-5-ylmethyl)amine, yield 885 mg, 100%. 1H NMR (200
MHz, CDCl3) δ 7.57(s, 1H), 7.35-7.11(m, 3H), 6.51 (d, J = 2.9 Hz, 1H),
3.85 (s, 2H), 3.79 (s, 3H), 2.48 (s, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds as antibacterial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd; Sampson, Peter; Pauls, Heinz W.; Ramnauth, Jailall;
Manning, David Douglas; Surman, Matthew David; Xie, Dejian; Decornez,
Helene Yvonne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004052890 A1 2004-06-24

$RFMT $RIREG SCHEME126 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Benzoylpyridine
C12H9NO
91-02-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 O 4.0011 0.0000 0.0 0
M  V30 3 C 5.3347 2.3100 0.0 0
M  V30 4 C 5.3347 3.8500 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 C 6.6685 4.6200 0.0 0
M  V30 7 C 8.0021 2.3100 0.0 0
M  V30 8 C 8.0021 3.8500 0.0 0
M  V30 9 C 2.6674 2.3100 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 N 1.3336 1.5400 0.0 0
M  V30 12 C 1.3336 4.6200 0.0 0
M  V30 13 C 0.0000 2.3100 0.0 0
M  V30 14 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(Phenyl-2-pyridinylmethylene)methanamine
C13H12N2
1182372-35-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0
M  V30 2 N 4.0011 0.7700 0.0 0
M  V30 3 C 2.6674 0.0000 0.0 0
M  V30 4 C 2.6674 3.0800 0.0 0
M  V30 5 C 2.6674 4.6200 0.0 0
M  V30 6 C 1.3336 2.3100 0.0 0
M  V30 7 C 1.3336 5.3900 0.0 0
M  V30 8 C 0.0000 3.0800 0.0 0
M  V30 9 C 0.0000 4.6200 0.0 0
M  V30 10 C 5.3347 3.0800 0.0 0
M  V30 11 C 5.3347 4.6200 0.0 0
M  V30 12 N 6.6685 2.3100 0.0 0
M  V30 13 C 6.6685 5.3900 0.0 0
M  V30 14 C 8.0021 3.0800 0.0 0
M  V30 15 C 8.0021 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 4
M  V30 3 1 1 10
M  V30 4 1 2 3
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 91-02-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1182372-35-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-11040248
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Typical Procedure On one side of an H-tube,
the described ketone was added, and to the other side, aqueous amine
solution or neat amine was added. The tube was sealed immediately with a
rubber seal stopper, and the reaction was monitored by 1H NMR
spectrometry. The excess ammonia or amine gas was removed under reduced
pressure to give the corresponding imine.
N-[Phenyl(pyridin-2-yl)methylene]methanamine (3d) Employing the general
method, imine (3d) was prepared from ketone (1c) (50 mg, 0.27 mmol) and
40% methylamine aq. solution (2 mL). After 17 h, no product was obtained.
Dry methanol (0.5 mL) was added to the ketone and was left to stand at
room temperature for 24 h. After 24 h, the colorless solution changed to
a yellow solution. The excess methylamine and methanol were removed under
reduced pressure to give the title compound (3d) as a yellow oil (53 mg,
100%). 1H NMR (400 MHz, CDCl3) δ 3.26 (s, 3H), 3.34 (s, 3H), 7.16 (m,
3H), 7.21 (m, 4H), 7.40 (m, 8H), 7.54 (m, 2H), 7.69 (dt, J = 1.8, 7.9 Hz,
1H), 7.80 (m, 2H), 8.60 (dd, J = 0.9, 4.9 Hz, 1H), 8.77 (dd, J = 0.9, 4.9
Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 41.48, 42.07, 123.07, 123.43, 123.66,
124.24, 128.28, 128.31, 128.46, 128.73, 128.81, 130.29, 136.12, 136.57,
136.62, 139.12, 149.53, 150.42, 155.91, 157.55, 168.11, 169.89. IR (neat)
νmax 3056w, 1665s, 1632w, 1581m, 1567w, 1466w, 1447m, 1433m, 1319s,
1283s, 1246m, 1162m, 994m, 940m cm-1. Ms calc. (found) for C13H13N2+ (M +
H+): m/z 197.2 (197.2, 60%, 455.5, 100%). HRMS calc. (found) for
C13H13N2+ (M + H+): m/z 197.1073 (197.1074).
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed H-tube used, 100% conversion
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Simplified Ketimine Preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Thienthong, Neeranat; Bergman, Ylva E.; Perlmutter, Patrick
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2009), 39(15), 2683-2693

$RFMT $RIREG SCHEME127 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
D-Phenylalanine-15N methyl ester
C10H13NO2
916152-81-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0 CFG=1
M  V30 3 C 6.6684 1.5400 0.0 0
M  V30 4 N 5.3347 3.8500 0.0 0 MASS=15
M  V30 5 O 8.0021 2.3100 0.0 0
M  V30 6 O 6.6684 0.0000 0.0 0
M  V30 7 C 9.3358 1.5400 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 1.3336 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 1.3336 4.6200 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αR)-α-(Amino-15N)-N-methylbenzenepropanamide
C10H14N2O
916152-82-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0 CFG=1
M  V30 3 C 6.6684 1.5400 0.0 0
M  V30 4 N 5.3347 3.8500 0.0 0 MASS=15
M  V30 5 N 8.0021 2.3100 0.0 0
M  V30 6 O 6.6684 0.0000 0.0 0
M  V30 7 C 9.3358 1.5400 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 1.3336 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 1.3336 4.6200 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 916152-81-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 916152-82-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5596869
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantioselective organocatalytic epoxidation using hypervalent iodine
reagents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lee, Sandra; MacMillan, David W. C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2006), 62(49), 11413-11424

$RFMT $RIREG SCHEME128 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indole-6-carboxylic acid, 3-cyclohexyl-1-(1,3-dioxolan-2-ylmethyl)-2-(2-fo...
C27H29NO5
928341-67-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0494 8.3504 0.0 0
M  V30 2 C 3.0800 8.3073 0.0 0
M  V30 3 O 2.3100 9.6409 0.0 0
M  V30 4 C 10.9909 7.1798 0.0 0
M  V30 5 O 12.3247 6.4098 0.0 0
M  V30 6 O 10.9909 8.7198 0.0 0
M  V30 7 C 13.6583 7.1798 0.0 0
M  V30 8 C 4.6200 5.6398 0.0 0
M  V30 9 C 5.5252 4.3940 0.0 0
M  V30 10 N 5.5252 6.8857 0.0 0
M  V30 11 C 6.9899 4.8698 0.0 0
M  V30 12 C 6.9899 6.4098 0.0 0
M  V30 13 C 8.3236 4.0998 0.0 0
M  V30 14 C 8.3236 7.1798 0.0 0
M  V30 15 C 9.6572 4.8698 0.0 0
M  V30 16 C 9.6572 6.4098 0.0 0
M  V30 17 C 3.0800 5.6398 0.0 0
M  V30 18 C 2.3100 6.9735 0.0 0
M  V30 19 C 2.3100 4.3062 0.0 0
M  V30 20 C 0.7700 6.9735 0.0 0
M  V30 21 C 0.7700 4.3062 0.0 0
M  V30 22 C 0.0000 5.6398 0.0 0
M  V30 23 C 5.0494 2.9292 0.0 0
M  V30 24 C 6.0798 1.7849 0.0 0
M  V30 25 C 3.5429 2.6091 0.0 0
M  V30 26 C 5.6039 0.3202 0.0 0
M  V30 27 C 3.0671 1.1445 0.0 0
M  V30 28 C 4.0975 0.0000 0.0 0
M  V30 29 C 6.0798 9.4948 0.0 0
M  V30 30 O 7.6113 9.3338 0.0 0
M  V30 31 O 5.7596 11.0012 0.0 0
M  V30 32 C 8.2378 10.7406 0.0 0
M  V30 33 C 7.0933 11.7712 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 29
M  V30 3 2 2 3
M  V30 4 1 2 18
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 16
M  V30 8 1 5 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 8 17
M  V30 12 1 9 11
M  V30 13 1 9 23
M  V30 14 1 10 12
M  V30 15 1 11 12
M  V30 16 2 11 13
M  V30 17 2 12 14
M  V30 18 1 13 15
M  V30 19 1 14 16
M  V30 20 2 15 16
M  V30 21 2 17 18
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 2 19 21
M  V30 25 2 20 22
M  V30 26 1 21 22
M  V30 27 1 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 1 27 28
M  V30 33 1 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indole-6-carboxylic acid, 3-cyclohexyl-1-(1,3-dioxolan-2-ylmethyl)-2-[2-[(...
C28H34N2O4
928341-68-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0494 8.3504 0.0 0
M  V30 2 C 3.0800 8.3072 0.0 0
M  V30 3 N 2.3100 9.6409 0.0 0
M  V30 4 C 0.7700 9.6409 0.0 0
M  V30 5 C 10.9909 7.1798 0.0 0
M  V30 6 O 12.3247 6.4098 0.0 0
M  V30 7 O 10.9909 8.7198 0.0 0
M  V30 8 C 13.6583 7.1798 0.0 0
M  V30 9 C 4.6200 5.6398 0.0 0
M  V30 10 C 5.5252 4.3939 0.0 0
M  V30 11 N 5.5252 6.8857 0.0 0
M  V30 12 C 6.9899 4.8698 0.0 0
M  V30 13 C 6.9899 6.4098 0.0 0
M  V30 14 C 8.3236 4.0998 0.0 0
M  V30 15 C 8.3236 7.1798 0.0 0
M  V30 16 C 9.6572 4.8698 0.0 0
M  V30 17 C 9.6572 6.4098 0.0 0
M  V30 18 C 3.0800 5.6398 0.0 0
M  V30 19 C 2.3100 6.9734 0.0 0
M  V30 20 C 2.3100 4.3062 0.0 0
M  V30 21 C 0.7700 6.9734 0.0 0
M  V30 22 C 0.7700 4.3062 0.0 0
M  V30 23 C 0.0000 5.6398 0.0 0
M  V30 24 C 5.0494 2.9292 0.0 0
M  V30 25 C 6.0798 1.7849 0.0 0
M  V30 26 C 3.5429 2.6091 0.0 0
M  V30 27 C 5.6039 0.3202 0.0 0
M  V30 28 C 3.0671 1.1445 0.0 0
M  V30 29 C 4.0975 0.0000 0.0 0
M  V30 30 C 6.0798 9.4947 0.0 0
M  V30 31 O 5.7596 11.0012 0.0 0
M  V30 32 O 7.6113 9.3338 0.0 0
M  V30 33 C 7.0933 11.7712 0.0 0
M  V30 34 C 8.2378 10.7406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 30
M  V30 3 1 2 3
M  V30 4 1 2 19
M  V30 5 1 3 4
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 17
M  V30 9 1 6 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 9 18
M  V30 13 1 10 12
M  V30 14 1 10 24
M  V30 15 1 11 13
M  V30 16 1 12 13
M  V30 17 2 12 14
M  V30 18 2 13 15
M  V30 19 1 14 16
M  V30 20 1 15 17
M  V30 21 2 16 17
M  V30 22 2 18 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 2 20 22
M  V30 26 2 21 23
M  V30 27 1 22 23
M  V30 28 1 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 28 29
M  V30 34 1 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 928341-67-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 928341-68-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-9596787
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 2: Methyl
3-cyclohexyl-1-(1,3-dioxolan-2-ylmethyl)-2-{2-[(methylamino)methyl]phenyl}-1H-indole-6-carboxylate
To a solution of methyl
3-cyclohexyl-1-(1,3-dioxolan-2-ylmethyl)-2-(2-formylphenyl)-1H-indole-6-carboxylate
(from Step 1) in THF (0.15 M), methylamine (10 eq., 2 M solution in THF)
was added and the pH adjusted to pH 6 with acetic acid. The solution was
stirred at RT for 1 h before being concentrated in vacuo. The residue was
taken up in MeOH to give a 0.075 M solution. NaBH3CN (1.5 eq.) was added
and the mixture stirred at RT for 1 h. RP-HPLC analysis of the reaction
mixture showed the complete conversion to the desired amine. The reaction
was quenched with saturated aqueous NaHCO3 and extracted (twice) with
EtOAc. The combined organics were washed with brine before being dried
over Na2SO4, filtered and concentrated in vacuo to give the title
compound as a viscous oil (quantitative). 1H NMR (300 MHz, DMSO-d6, 300
K) [see pdf for image] 1.12-1.29 (m, 4H), 1.60-1.75 (m, 6H), 2.18 (s,
3H), 2.27-2.32 (m, 1H), 3.36 (br s, 2H, partially obscured by water
peak), 3.61-3.81 (m, 5H), 3.87 (s, 3H), 4.14-4.21 (m, 1H), 4.87 (t, J
4.2, 1H), 7.27 (d, J 7.3, 1H), 7.37-7.42 (m, 1H), 7.50-7.55 (m, 1H),
7.65-7.68 (m, 2H), 7.82 (d, J 8.4, 1H), 8.18 (s, 1H); MS (ES+) m/z 463
(M+H)+
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tetracyclic indole derivatives as antiviral agents, their preparation,
pharmaceutical compositions, and use in therapy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Narjes, Frank; Stansfield, Ian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007029029 A2 2007-03-15

$RFMT $RIREG SCHEME129 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3-Chloro-2-quinoxalinyl)(2-fluorophenyl)methanone
C15H8ClFN2O
928790-66-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0801 2.6675 0.0 0
M  V30 2 O 2.3101 1.3338 0.0 0
M  V30 3 Cl 4.6201 0.0000 0.0 0
M  V30 4 F 0.0000 2.6675 0.0 0
M  V30 5 C 4.6201 2.6675 0.0 0
M  V30 6 N 5.3901 4.0012 0.0 0
M  V30 7 C 5.3901 1.3338 0.0 0
M  V30 8 C 6.9302 4.0012 0.0 0
M  V30 9 N 6.9302 1.3338 0.0 0
M  V30 10 C 7.7002 2.6675 0.0 0
M  V30 11 C 7.7002 5.3348 0.0 0
M  V30 12 C 9.2402 2.6675 0.0 0
M  V30 13 C 9.2402 5.3348 0.0 0
M  V30 14 C 10.0102 4.0012 0.0 0
M  V30 15 C 2.3101 4.0012 0.0 0
M  V30 16 C 0.7700 4.0012 0.0 0
M  V30 17 C 3.0801 5.3348 0.0 0
M  V30 18 C 0.0000 5.3348 0.0 0
M  V30 19 C 2.3101 6.6687 0.0 0
M  V30 20 C 0.7700 6.6687 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 1 15
M  V30 4 1 3 7
M  V30 5 1 4 16
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 8 11
M  V30 12 1 9 10
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2-Fluorophenyl)[3-(methylamino)-2-quinoxalinyl]methanone
C16H12FN3O
928790-67-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0
M  V30 2 O 2.3100 2.6674 0.0 0
M  V30 3 N 4.6200 1.3336 0.0 0
M  V30 4 C 5.3900 0.0000 0.0 0
M  V30 5 F 0.0000 4.0011 0.0 0
M  V30 6 C 4.6200 4.0011 0.0 0
M  V30 7 C 5.3900 2.6674 0.0 0
M  V30 8 N 5.3900 5.3347 0.0 0
M  V30 9 N 6.9300 2.6674 0.0 0
M  V30 10 C 6.9300 5.3347 0.0 0
M  V30 11 C 7.7000 4.0011 0.0 0
M  V30 12 C 7.7000 6.6685 0.0 0
M  V30 13 C 9.2400 4.0011 0.0 0
M  V30 14 C 9.2400 6.6685 0.0 0
M  V30 15 C 10.0100 5.3347 0.0 0
M  V30 16 C 2.3100 5.3347 0.0 0
M  V30 17 C 0.7700 5.3347 0.0 0
M  V30 18 C 3.0800 6.6685 0.0 0
M  V30 19 C 0.0000 6.6685 0.0 0
M  V30 20 C 2.3100 8.0021 0.0 0
M  V30 21 C 0.7700 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 1 16
M  V30 4 1 3 4
M  V30 5 1 3 7
M  V30 6 1 5 17
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 928790-66-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 928790-67-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-11333034
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of heterocyclic compounds via nucleophilic aroylation catalyzed
by imidazolidenyl carbene
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Suzuki, Yumiko; Toyota, Tomonori; Miyashita, Akira; Sato, Masayuki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical & Pharmaceutical Bulletin (2006), 54(12), 1653-1658

$RFMT $RIREG SCHEME130 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2S,4R)-4-(3-fluoro-5-nitrophenoxy)-2-[[(methylsulfonyl)oxy...
C17H23FN2O8S
929873-70-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3648 4.0596 0.0 0
M  V30 2 O 6.2700 2.8138 0.0 0
M  V30 3 S 5.6435 1.4068 0.0 0 VAL=6
M  V30 4 C 7.0505 0.7805 0.0 0
M  V30 5 O 5.0172 0.0000 0.0 0
M  V30 6 O 4.2367 2.0333 0.0 0
M  V30 7 C 3.6896 6.9612 0.0 0
M  V30 8 O 3.0632 8.3681 0.0 0
M  V30 9 O 2.7843 5.7153 0.0 0
M  V30 10 C 1.5317 8.5291 0.0 0
M  V30 11 C 1.3706 6.9975 0.0 0
M  V30 12 C 0.0000 8.6900 0.0 0
M  V30 13 C 1.6926 10.0606 0.0 0
M  V30 14 O 8.9921 8.0883 0.0 0
M  V30 15 N 14.3269 8.0883 0.0 0 VAL=5
M  V30 16 O 15.6607 7.3183 0.0 0
M  V30 17 O 14.3269 9.6283 0.0 0
M  V30 18 F 11.6596 3.4683 0.0 0
M  V30 19 C 5.9911 5.4666 0.0 0 CFG=2
M  V30 20 N 5.2211 6.8002 0.0 0
M  V30 21 C 7.4976 5.7868 0.0 0
M  V30 22 C 6.2517 7.9446 0.0 0
M  V30 23 C 7.6585 7.3183 0.0 0 CFG=1
M  V30 24 C 10.3260 7.3183 0.0 0
M  V30 25 C 11.6596 8.0883 0.0 0
M  V30 26 C 10.3260 5.7783 0.0 0
M  V30 27 C 12.9933 7.3183 0.0 0
M  V30 28 C 11.6596 5.0083 0.0 0
M  V30 29 C 12.9933 5.7783 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 19 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 3 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 20
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 23 14 CFG=3
M  V30 15 1 14 24
M  V30 16 2 15 16
M  V30 17 2 15 17
M  V30 18 1 15 27
M  V30 19 1 18 28
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 23
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 2 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 19 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2S,4R)-4-(3-fluoro-5-nitrophenoxy)-2-[(methylamino)methyl]...
C17H24FN3O5
929873-71-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3648 2.6527 0.0 0
M  V30 2 N 6.2700 1.4068 0.0 0
M  V30 3 C 5.6436 0.0000 0.0 0
M  V30 4 C 3.6896 5.5542 0.0 0
M  V30 5 O 3.0633 6.9612 0.0 0
M  V30 6 O 2.7844 4.3084 0.0 0
M  V30 7 C 1.5317 7.1221 0.0 0
M  V30 8 C 1.6926 8.6537 0.0 0
M  V30 9 C 0.0000 7.2831 0.0 0
M  V30 10 C 1.3706 5.5906 0.0 0
M  V30 11 O 8.9922 6.6814 0.0 0
M  V30 12 N 14.3270 6.6814 0.0 0 VAL=5
M  V30 13 O 14.3270 8.2214 0.0 0
M  V30 14 O 15.6608 5.9114 0.0 0
M  V30 15 F 11.6597 2.0613 0.0 0
M  V30 16 C 5.9911 4.0597 0.0 0 CFG=2
M  V30 17 N 5.2211 5.3933 0.0 0
M  V30 18 C 7.4976 4.3798 0.0 0
M  V30 19 C 6.2517 6.5377 0.0 0
M  V30 20 C 7.6585 5.9114 0.0 0 CFG=1
M  V30 21 C 10.3260 5.9114 0.0 0
M  V30 22 C 11.6597 6.6814 0.0 0
M  V30 23 C 10.3260 4.3714 0.0 0
M  V30 24 C 12.9933 5.9114 0.0 0
M  V30 25 C 11.6597 3.6013 0.0 0
M  V30 26 C 12.9933 4.3714 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 16 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 17
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 20 11 CFG=3
M  V30 12 1 11 21
M  V30 13 2 12 13
M  V30 14 2 12 14
M  V30 15 1 12 24
M  V30 16 1 15 25
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 16 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 929873-70-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 929873-71-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-3525120
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (2S,4R)-tert-butyl 4-(3-fluoro-5-nitrophenoxy)-2-((methyl
amino)methyl)pyrrolidine-1-carboxylate. To a solution of
(2S,4R)-tert-butyl 4-(3-fluoro-5-nitrophenoxy)-2-
((methylsulfonyloxy)methyl)pyrrolidine-1-carboxylate (1.0 equiv) in THF
(0.4 M) was added 40% aq. methylamine (90 equiv). The resulting solution
was heated to 55° C. overnight. The reaction mixture was cooled to room
temperature and diluted with EtOAc (20 volume equivalents) and washed
twice with sat. aq. NaHCO3 (10 volume equivalents) and once with brine
(10 volume equivalents). The organic layer was dried over anhydrous
sodium sulfate, filtered and concentrated in vacuo to provide the title
compound as a dark oil with 119% mass balance; the material was used
without further purification.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of (hetero)arylureas as modulators of the cardiac sarcomere
for treatment of heart failure.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Morgan, Bradley P.; Muci, Alex; Kraynack, Erica; Lu, Pu-Ping; Tochimoto,
Todd; Morgans, David J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20070066626 A1 2007-03-22

$RFMT $RIREG SCHEME131 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Difluoro-5-methyl-2-nitrobenzene
C7H5F2NO2
932373-92-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6675 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0011 0.0 0
M  V30 3 O 0.0000 1.3338 0.0 0
M  V30 4 F 2.3100 0.0000 0.0 0
M  V30 5 F 2.3100 5.3349 0.0 0
M  V30 6 C 6.9301 2.6675 0.0 0
M  V30 7 C 2.3100 2.6675 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 4.6201 1.3338 0.0 0
M  V30 11 C 4.6201 4.0011 0.0 0
M  V30 12 C 5.3901 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 9
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-N,5-dimethyl-2-nitrobenzenamine
C8H9FN2O2
1803738-71-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3101 1.3338 0.0 0
M  V30 2 C 3.0801 0.0000 0.0 0
M  V30 3 N 0.7700 4.0012 0.0 0 VAL=5
M  V30 4 O 0.0000 5.3348 0.0 0
M  V30 5 O 0.0000 2.6675 0.0 0
M  V30 6 F 2.3101 6.6687 0.0 0
M  V30 7 C 6.9302 4.0012 0.0 0
M  V30 8 C 3.0801 2.6675 0.0 0
M  V30 9 C 2.3101 4.0012 0.0 0
M  V30 10 C 4.6201 2.6675 0.0 0
M  V30 11 C 3.0801 5.3348 0.0 0
M  V30 12 C 5.3901 4.0012 0.0 0
M  V30 13 C 4.6201 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 9
M  V30 6 1 6 11
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 932373-92-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1803738-71-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35058654
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Small molecules as inhibitors of KRAS G12C mutant and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shibata, Kazuaki; Asakura, Hiroki; Akemoto, Kei; Sakamoto, Toshihiro;
Kondo, Hitomi; Yamamoto, Tomohiro; Miura, Risako; Schoepf, Patrick; Del
Pozo, Juan; Giambusu, George Madalin; Graham, Thomas H.; Han, Yongxin;
Hennessy, Elisabeth T.; Palani, Anandan; Ryan, Michael; Sloman, David L.;
Howard, Steven
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022232318 A1 2022-11-03

$RFMT $RIREG SCHEME132 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (5R)-3-[1-(1-methylpropyl)-1H-indazol-5-yl]-2-oxo-5-oxazolidinecarboxy...
C16H19N3O4
945928-56-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6091 3.9170 0.0 0 CFG=3
M  V30 2 C 1.1445 3.4411 0.0 0
M  V30 3 C 2.9294 5.4234 0.0 0
M  V30 4 C 0.0000 4.4716 0.0 0
M  V30 5 O 10.3093 5.9173 0.0 0
M  V30 6 C 13.4957 1.5315 0.0 0
M  V30 7 O 14.9025 2.1580 0.0 0
M  V30 8 O 13.3348 0.0000 0.0 0
M  V30 9 C 16.1485 1.2528 0.0 0
M  V30 10 C 5.2599 3.2068 0.0 0
M  V30 11 C 6.0299 1.8731 0.0 0
M  V30 12 N 3.7536 2.8866 0.0 0
M  V30 13 C 6.0299 4.5404 0.0 0
M  V30 14 C 7.5699 1.8731 0.0 0
M  V30 15 C 4.9995 0.7286 0.0 0
M  V30 16 N 3.5927 1.3551 0.0 0
M  V30 17 C 7.5699 4.5404 0.0 0
M  V30 18 C 8.3399 3.2068 0.0 0
M  V30 19 N 9.8799 3.2068 0.0 0
M  V30 20 C 10.7851 1.9609 0.0 0
M  V30 21 C 10.7851 4.4526 0.0 0
M  V30 22 C 12.2498 2.4368 0.0 0 CFG=2
M  V30 23 O 12.2498 3.9768 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 2 5 21
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 22 6 CFG=1
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 2 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 18 19
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(5R)-N-Methyl-3-[1-(1-methylpropyl)-1H-indazol-5-yl]-2-oxo-5-oxazolidinecarbo...
C16H20N4O3
945928-35-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6091 3.9170 0.0 0 CFG=3
M  V30 2 C 1.1445 3.4411 0.0 0
M  V30 3 C 2.9294 5.4234 0.0 0
M  V30 4 C 0.0000 4.4717 0.0 0
M  V30 5 O 10.3093 5.9173 0.0 0
M  V30 6 C 13.4957 1.5315 0.0 0
M  V30 7 N 14.9025 2.1580 0.0 0
M  V30 8 O 13.3348 0.0000 0.0 0
M  V30 9 C 16.1485 1.2528 0.0 0
M  V30 10 C 5.2599 3.2068 0.0 0
M  V30 11 C 6.0299 1.8731 0.0 0
M  V30 12 N 3.7536 2.8866 0.0 0
M  V30 13 C 6.0299 4.5404 0.0 0
M  V30 14 C 7.5699 1.8731 0.0 0
M  V30 15 C 4.9995 0.7286 0.0 0
M  V30 16 N 3.5927 1.3551 0.0 0
M  V30 17 C 7.5699 4.5404 0.0 0
M  V30 18 C 8.3399 3.2068 0.0 0
M  V30 19 N 9.8799 3.2068 0.0 0
M  V30 20 C 10.7851 1.9609 0.0 0
M  V30 21 C 10.7851 4.4526 0.0 0
M  V30 22 C 12.2498 2.4368 0.0 0 CFG=2
M  V30 23 O 12.2498 3.9768 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 2 5 21
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 22 6 CFG=1
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 2 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 18 19
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 945928-56-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 945928-35-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-12061508
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 8 Preparation of
(5R)-3-(1-sec-butyl-1H-indazol-5-yl)-N-methyl-2-oxooxazolidine-5-carboxamide
A 2M solution of methylamine in methanol (2.5 mL) is added to (5R)-methyl
3-(1-sec-butyl-1H-indazol-5-yl)-2-oxooxazolidine-5-carboxylate (0.16 g,
0.5 mmol) and stirred at room temperature for an hour /The reaction
mixture is concentrated in vacuo to afford the title compound (0.16 g,
100%). HPLC (SYMMETRY C18 3.5 μM, 4.6 x 30 mm column; gradient elution
2%-98% MeCN with 0.1% TFA over 6 min; 2 mL/min rate): retention time =
2.75 min; 1H NMR (300 MHz, CDCl3) 0.73 (t, J= 9 Hz, 3H), 1.55 (d, J= 6
Hz, 3H), 1.83-2.12 (m, 2H), 2.90 (d, J= 3 Hz, 3H), 4.25-4.35 (m, 2H),
4.48-4.55 (m, 1H), 4.96-5.01 (m, 1H), 6.63 (bs, 1H), 7.43 (d, J= 9 Hz,
1H), 7.60-7.67 (m, 2H), 7.98 (s, 1H); MS for C16H20N4O3 m/z 317.1(M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 5-(2-oxooxazolidine-3-yl)-1H-indazole derivatives as
antibacterial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gordeev, Mikhail Fedorovich; Josyula, Vara Prasad Venkata Nagendra;
Luehr, Gary Wayne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007088478 A1 2007-08-09

$RFMT $RIREG SCHEME133 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-Ethyl (1R,2R,5R,8E)-8-[2-(1,1-dimethylethoxy)-2-oxoethylidene]-1′,2′-dihy...
C26H29NO6
949158-86-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.6022 5.6012 0.0 0
M  V30 2 C 6.4234 4.0011 0.0 0
M  V30 3 C 4.8834 4.0011 0.0 0
M  V30 4 O 4.1134 2.6675 0.0 0
M  V30 5 O 4.1134 5.3347 0.0 0
M  V30 6 C 4.8834 1.3336 0.0 0
M  V30 7 C 6.2170 2.1037 0.0 0
M  V30 8 C 5.6534 0.0000 0.0 0
M  V30 9 C 3.5497 0.5636 0.0 0
M  V30 10 C 2.6590 7.2020 0.0 0
M  V30 11 O 1.3905 8.0752 0.0 0
M  V30 12 C 0.0000 7.4133 0.0 0
M  V30 13 C 11.5273 5.6324 0.0 0
M  V30 14 O 12.6760 6.6581 0.0 0
M  V30 15 O 11.8413 4.1248 0.0 0
M  V30 16 C 14.1387 6.1762 0.0 0
M  V30 17 C 15.2874 7.2020 0.0 0
M  V30 18 C 6.5202 8.1875 0.0 0 CFG=2
M  V30 19 C 7.4028 6.6672 0.0 0 CFG=1
M  V30 20 C 5.8582 9.5779 0.0 0
M  V30 21 C 5.4024 7.1282 0.0 0
M  V30 22 C 7.7433 9.1701 0.0 0
M  V30 23 C 7.1934 5.3347 0.0 0
M  V30 24 C 8.8694 6.7914 0.0 0
M  V30 25 C 4.3313 9.3780 0.0 0
M  V30 26 C 6.4486 11.0003 0.0 0
M  V30 27 N 4.0495 7.8641 0.0 0
M  V30 28 C 7.5112 7.9215 0.0 0
M  V30 29 C 8.4078 6.3159 0.0 0 CFG=1
M  V30 30 C 10.0647 6.1143 0.0 0
M  V30 31 C 3.3946 10.6005 0.0 0
M  V30 32 C 5.5120 12.2228 0.0 0
M  V30 33 C 3.9851 12.0229 0.0 0
M  V30 34 H 5.8892 6.3838 0.0 0
M  V30 35 H 8.8323 4.8356 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 21
M  V30 2 1 2 3
M  V30 3 2 2 23
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 1 10 27
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 13 30
M  V30 16 1 14 16
M  V30 17 1 16 17
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 1 18 21
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 23
M  V30 23 1 19 24
M  V30 24 1 19 34 CFG=3
M  V30 25 1 20 25
M  V30 26 2 20 26
M  V30 27 1 21 27
M  V30 28 2 22 28
M  V30 29 1 23 29
M  V30 30 2 24 30
M  V30 31 1 25 27
M  V30 32 2 25 31
M  V30 33 1 26 32
M  V30 34 1 28 29
M  V30 35 1 29 30
M  V30 36 1 29 35 CFG=1
M  V30 37 1 31 33
M  V30 38 2 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 18 19 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-Ethyl (1R,2R,5S,6R,7R,8Z)-8-[2-(1,1-dimethylethoxy)-2-oxoethylidene]-1′,2...
C27H34N2O6
949158-90-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.6022 5.6011 0.0 0
M  V30 2 C 6.4233 4.0011 0.0 0
M  V30 3 C 4.8833 4.0011 0.0 0
M  V30 4 O 4.1133 2.6674 0.0 0
M  V30 5 O 4.1133 5.3347 0.0 0
M  V30 6 C 4.8833 1.3336 0.0 0
M  V30 7 C 6.2170 2.1036 0.0 0
M  V30 8 C 5.6533 0.0000 0.0 0
M  V30 9 C 3.5497 0.5636 0.0 0
M  V30 10 N 9.1986 8.2958 0.0 0
M  V30 11 C 10.6660 8.7629 0.0 0
M  V30 12 C 2.6590 7.2020 0.0 0
M  V30 13 O 1.3905 8.0751 0.0 0
M  V30 14 C 0.0000 7.4133 0.0 0
M  V30 15 C 11.5272 5.6324 0.0 0
M  V30 16 O 12.6759 6.6580 0.0 0
M  V30 17 O 11.8412 4.1247 0.0 0
M  V30 18 C 14.1386 6.1762 0.0 0
M  V30 19 C 15.2873 7.2020 0.0 0
M  V30 20 C 6.5202 8.1874 0.0 0 CFG=2
M  V30 21 C 7.4028 6.6671 0.0 0 CFG=1
M  V30 22 C 5.8582 9.5779 0.0 0
M  V30 23 C 5.4023 7.1282 0.0 0
M  V30 24 C 7.7433 9.1701 0.0 0
M  V30 25 C 7.1933 5.3347 0.0 0
M  V30 26 C 8.8693 6.7914 0.0 0 CFG=2
M  V30 27 C 4.3313 9.3780 0.0 0
M  V30 28 C 6.4486 11.0002 0.0 0
M  V30 29 N 4.0494 7.8640 0.0 0
M  V30 30 C 7.5112 7.9215 0.0 0
M  V30 31 C 8.4078 6.3158 0.0 0 CFG=1
M  V30 32 C 10.0647 6.1143 0.0 0 CFG=1
M  V30 33 C 3.3946 10.6004 0.0 0
M  V30 34 C 5.5120 12.2227 0.0 0
M  V30 35 C 3.9851 12.0228 0.0 0
M  V30 36 H 5.8891 6.3838 0.0 0
M  V30 37 H 8.8322 4.8356 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 23
M  V30 2 1 2 3
M  V30 3 2 2 25
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 1 26 10 CFG=3
M  V30 12 1 12 13
M  V30 13 1 12 29
M  V30 14 1 13 14
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 1 32 15 CFG=1
M  V30 18 1 16 18
M  V30 19 1 18 19
M  V30 20 1 20 21
M  V30 21 1 20 22
M  V30 22 1 20 23
M  V30 23 1 20 24 CFG=1
M  V30 24 1 21 25
M  V30 25 1 21 26
M  V30 26 1 21 36 CFG=3
M  V30 27 1 22 27
M  V30 28 2 22 28
M  V30 29 1 23 29
M  V30 30 2 24 30
M  V30 31 1 25 31
M  V30 32 1 26 32
M  V30 33 1 27 29
M  V30 34 2 27 33
M  V30 35 1 28 34
M  V30 36 1 30 31
M  V30 37 1 31 32
M  V30 38 1 31 37 CFG=1
M  V30 39 1 33 35
M  V30 40 2 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(5 20 21 26 31 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 949158-86-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 949158-90-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-8170246
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (1S*,2S*,5R*,6S*,7S*,Z)-Ethyl 7-methylamino-8-(2-tert-butyloxylidene)
bicyclo[3.2.1]octa-3-ene-2-(spiro-3-methoxymethyl-2-oxindole)-6-
carboxylate (B). Methylamine (5 mL, 10.0 mmol; 2.0 M in methanol) was
added to 12a (153 mg, 0.339 mmol). The mixture was stirred at rt for 40
min and concentrated directly to give the indicated compound as a white
semi-solid (164 mg, 100%) which was used without purification.
(1S*,2S*,5R*,6S*,7S*,Z)-Ethyl 7-methylamino-8-(2-tert-butyloxylidene)
bicyclo[3.2.1]octa-3-ene-2-(spiro-3-methoxymethyl-2-oxindole)-6-
carboxylate (B), Yield (164 mg, 100%) Rf = 0.32 (60% EtOAc/hex); IR
(neat) 3300 (br), 2960, 2940, 1700 (br) cm-1; 1H NMR (400 MHz, CDCl3) δ
7.58 (d, J = 7.6 Hz, 1H), 7.33 (t, J = 7.6 Hz, 1H), 7.12 (t, J = 7.6 Hz,
1H), 7.07 (d, J = 7.6 Hz, 1H), (dd, J = 6.4, 5.4 Hz, 1H), 5.95 (s, 1H),
5.24 (d, J = 8.0 Hz, 1H), 5.14 (dd, J = 6.2, 1.6 Hz, 1H), 5.02 (dd, J =
6.2, 1.2 Hz, 1H), 4.25 (qd, J = 7.2, 1.6 Hz, 2H), 4.17 (d, J = 5.2 Hz,
1H), 3.90 (s, 1H), 3.38 (m, 1H), 3.35 (s, 3H), 2.71 (t, J = 5.6 Hz, 1H),
2.07 (s, 3H), 1.45 (s, 9H), 1.70 (br s, 1H), 1.33 (dt, J = 6.8, 1.6 Hz,
3H); 13C NMR (100 MHz, CDCl3) δ 175.7, 171.7, 165.8, 156.8, 142.1, 134.6,
129.9, 129.0, 126.4, 126.0, 122.4, 114.5, 109.7, 79.9, 71.8, 61.4, 61.1,
58.7, 57.2, 56.5, 48.4, 45.6, 34.0, 28.2, 14.4; MS (EI) m/z 483 (MH+),
469; HRMS calcd for C27H35N2O6 (MH+): 483.2495 found 483.2492.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Double Conjugate Addition of a Nitropropionate Ester to a Quinone
Monoketal: Synthesis of an Advanced Intermediate to (±)-Gelsemine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Grecian, Scott; Aube, Jeffrey
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2007), 9(16), 3153-3156

$RFMT $RIREG SCHEME134 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,7-Bis(2,4,6-trimethylphenyl)-1H-pyrano[4,3-c]pyridine-1,5(6H)-dione
C26H25NO3
949564-22-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3338 0.0 0
M  V30 2 C 4.6201 6.6687 0.0 0
M  V30 3 O 9.2402 6.6687 0.0 0
M  V30 4 C 0.0000 4.0012 0.0 0
M  V30 5 O 8.4702 0.0000 0.0 0
M  V30 6 C 13.0903 5.3348 0.0 0
M  V30 7 C 13.0903 0.0000 0.0 0
M  V30 8 C 17.7104 2.6675 0.0 0
M  V30 9 C 4.6201 4.0012 0.0 0
M  V30 10 C 3.8501 2.6675 0.0 0
M  V30 11 C 3.8501 5.3348 0.0 0
M  V30 12 C 2.3101 2.6675 0.0 0
M  V30 13 C 2.3101 5.3348 0.0 0
M  V30 14 C 1.5400 4.0012 0.0 0
M  V30 15 C 6.1601 4.0012 0.0 0
M  V30 16 C 6.9302 2.6675 0.0 0
M  V30 17 N 6.9302 5.3348 0.0 0
M  V30 18 C 8.4702 2.6675 0.0 0
M  V30 19 C 8.4702 5.3348 0.0 0
M  V30 20 C 9.2402 4.0012 0.0 0
M  V30 21 C 9.2402 1.3338 0.0 0
M  V30 22 C 10.7802 4.0012 0.0 0
M  V30 23 O 10.7802 1.3338 0.0 0
M  V30 24 C 11.5503 2.6675 0.0 0
M  V30 25 C 13.0903 2.6675 0.0 0
M  V30 26 C 13.8603 4.0012 0.0 0
M  V30 27 C 13.8603 1.3338 0.0 0
M  V30 28 C 15.4003 4.0012 0.0 0
M  V30 29 C 15.4003 1.3338 0.0 0
M  V30 30 C 16.1704 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 11
M  V30 3 2 3 19
M  V30 4 1 4 14
M  V30 5 2 5 21
M  V30 6 1 6 26
M  V30 7 1 7 27
M  V30 8 1 8 30
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 15
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 1 18 21
M  V30 22 1 19 20
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 1 24 25
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2-Dihydro-N-methyl-2-oxo-3-[2-oxo-2-(2,4,6-trimethylphenyl)ethyl]-6-(2,4,6-...
C27H30N2O3
949564-31-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 13.0900 2.6674 0.0 0
M  V30 2 C 13.0900 8.0021 0.0 0
M  V30 3 C 8.4700 2.6674 0.0 0
M  V30 4 N 9.2400 1.3336 0.0 0
M  V30 5 O 6.9300 2.6674 0.0 0
M  V30 6 C 8.4700 0.0000 0.0 0
M  V30 7 O 8.4700 8.0021 0.0 0
M  V30 8 C 17.7100 5.3347 0.0 0
M  V30 9 C 6.9300 5.3347 0.0 0
M  V30 10 C 6.1600 6.6684 0.0 0
M  V30 11 O 6.9300 8.0021 0.0 0
M  V30 12 C 4.6200 9.3358 0.0 0
M  V30 13 C 4.6200 4.0011 0.0 0
M  V30 14 C 0.0000 6.6684 0.0 0
M  V30 15 C 13.0900 5.3347 0.0 0
M  V30 16 C 13.8600 4.0011 0.0 0
M  V30 17 C 13.8600 6.6684 0.0 0
M  V30 18 C 15.4000 4.0011 0.0 0
M  V30 19 C 15.4000 6.6684 0.0 0
M  V30 20 C 16.1700 5.3347 0.0 0
M  V30 21 C 11.5500 5.3347 0.0 0
M  V30 22 C 10.7800 4.0011 0.0 0
M  V30 23 N 10.7800 6.6684 0.0 0
M  V30 24 C 9.2400 4.0011 0.0 0
M  V30 25 C 9.2400 6.6684 0.0 0
M  V30 26 C 8.4700 5.3347 0.0 0
M  V30 27 C 4.6200 6.6684 0.0 0
M  V30 28 C 3.8500 8.0021 0.0 0
M  V30 29 C 3.8500 5.3347 0.0 0
M  V30 30 C 2.3100 8.0021 0.0 0
M  V30 31 C 2.3100 5.3347 0.0 0
M  V30 32 C 1.5400 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 2 17
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 24
M  V30 6 1 4 6
M  V30 7 2 7 25
M  V30 8 1 8 20
M  V30 9 1 9 10
M  V30 10 1 9 26
M  V30 11 2 10 11
M  V30 12 1 10 27
M  V30 13 1 12 28
M  V30 14 1 13 29
M  V30 15 1 14 32
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 15 21
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 949564-22-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 949564-31-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-7973496
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Properties of the keto amides formed by aminolysis of
3,7-diarylpyrano[4,3-c]pyran-1,5-dione derivatives: A solid-state
reaction, crystal structures, and thermal analysis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kawabe, Chika; Kawakita, Keitaro; Morinaga, Masanori; Kondo, Mitsuru;
Irikawa, Hajime
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocycles (2007), 71(9), 1991-2001

$RFMT $RIREG SCHEME135 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Androst-5-en-17-one, 3-[3-[(methylsulfonyl)oxy]propoxy]-, cyclic 1,2-ethanedi...
C25H40O6S
953773-21-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.2309 3.8970 0.0 0
M  V30 2 C 8.2686 3.8006 0.0 0
M  V30 3 O 13.0228 5.3347 0.0 0
M  V30 4 C 13.7928 4.0011 0.0 0
M  V30 5 C 15.3328 4.0011 0.0 0
M  V30 6 C 16.1028 2.6674 0.0 0
M  V30 7 O 17.6428 2.6674 0.0 0
M  V30 8 S 18.4128 1.3336 0.0 0 VAL=6
M  V30 9 C 17.0791 0.5636 0.0 0
M  V30 10 O 19.1828 0.0000 0.0 0
M  V30 11 O 19.7466 2.1036 0.0 0
M  V30 12 C 2.2764 5.6549 0.0 0
M  V30 13 C 3.7827 5.3347 0.0 0 CFG=2
M  V30 14 C 2.1155 7.1864 0.0 0
M  V30 15 O 0.7700 5.9751 0.0 0
M  V30 16 O 2.4374 4.1234 0.0 0
M  V30 17 C 4.5527 6.6684 0.0 0 CFG=2
M  V30 18 C 4.5527 4.0011 0.0 0
M  V30 19 C 3.5223 7.8129 0.0 0
M  V30 20 C 0.0000 4.6414 0.0 0
M  V30 21 C 1.0306 3.4970 0.0 0
M  V30 22 C 6.0927 6.6684 0.0 0 CFG=2
M  V30 23 C 6.0927 4.0011 0.0 0
M  V30 24 C 6.8627 5.3347 0.0 0 CFG=1
M  V30 25 C 6.8627 8.0022 0.0 0
M  V30 26 C 8.4027 5.3347 0.0 0 CFG=2
M  V30 27 C 8.4027 8.0022 0.0 0
M  V30 28 C 9.1727 6.6684 0.0 0
M  V30 29 C 9.1727 4.0011 0.0 0
M  V30 30 C 10.7127 6.6684 0.0 0
M  V30 31 C 10.7127 4.0011 0.0 0
M  V30 32 C 11.4827 5.3347 0.0 0 CFG=1
M  V30 33 H 4.5259 8.2082 0.0 0
M  V30 34 H 5.6942 8.1560 0.0 0
M  V30 35 H 7.2614 3.8472 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 13 1 CFG=1
M  V30 2 1 26 2 CFG=1
M  V30 3 1 3 4
M  V30 4 1 32 3 CFG=1
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 2 8 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 13 18
M  V30 18 1 14 19
M  V30 19 1 15 20
M  V30 20 1 16 21
M  V30 21 1 17 19
M  V30 22 1 17 22
M  V30 23 1 17 33 CFG=3
M  V30 24 1 18 23
M  V30 25 1 20 21
M  V30 26 1 22 24
M  V30 27 1 22 25
M  V30 28 1 22 34 CFG=1
M  V30 29 1 23 24
M  V30 30 1 24 26
M  V30 31 1 24 35 CFG=3
M  V30 32 1 25 27
M  V30 33 1 26 28
M  V30 34 1 26 29
M  V30 35 2 27 28
M  V30 36 1 28 30
M  V30 37 1 29 31
M  V30 38 1 30 32
M  V30 39 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 13 17 22 24 26 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Androst-5-en-17-one, 3-[3-(methylamino)propoxy]-, cyclic 1,2-ethanediyl aceta...
C25H41NO3
953773-22-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.2308 2.5634 0.0 0
M  V30 2 C 8.2685 2.4670 0.0 0
M  V30 3 O 13.0227 4.0011 0.0 0
M  V30 4 C 13.7927 2.6675 0.0 0
M  V30 5 C 15.3327 2.6675 0.0 0
M  V30 6 C 16.1027 1.3338 0.0 0
M  V30 7 N 17.6427 1.3338 0.0 0
M  V30 8 C 18.4128 0.0000 0.0 0
M  V30 9 C 2.2763 4.3213 0.0 0
M  V30 10 C 3.7826 4.0011 0.0 0 CFG=2
M  V30 11 C 2.1154 5.8528 0.0 0
M  V30 12 O 2.4372 2.7897 0.0 0
M  V30 13 O 0.7700 4.6415 0.0 0
M  V30 14 C 4.5526 5.3348 0.0 0 CFG=2
M  V30 15 C 4.5526 2.6675 0.0 0
M  V30 16 C 3.5222 6.4793 0.0 0
M  V30 17 C 1.0304 2.1634 0.0 0
M  V30 18 C 0.0000 3.3078 0.0 0
M  V30 19 C 6.0926 5.3348 0.0 0 CFG=2
M  V30 20 C 6.0926 2.6675 0.0 0
M  V30 21 C 6.8626 4.0011 0.0 0 CFG=1
M  V30 22 C 6.8626 6.6686 0.0 0
M  V30 23 C 8.4026 4.0011 0.0 0 CFG=2
M  V30 24 C 8.4026 6.6686 0.0 0
M  V30 25 C 9.1726 5.3348 0.0 0
M  V30 26 C 9.1726 2.6675 0.0 0
M  V30 27 C 10.7127 5.3348 0.0 0
M  V30 28 C 10.7127 2.6675 0.0 0
M  V30 29 C 11.4827 4.0011 0.0 0 CFG=1
M  V30 30 H 4.5258 6.8746 0.0 0
M  V30 31 H 5.6941 6.8224 0.0 0
M  V30 32 H 6.9969 2.4670 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 10 1 CFG=1
M  V30 2 1 23 2 CFG=1
M  V30 3 1 3 4
M  V30 4 1 29 3 CFG=1
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 10 15
M  V30 15 1 11 16
M  V30 16 1 12 17
M  V30 17 1 13 18
M  V30 18 1 14 16
M  V30 19 1 14 19
M  V30 20 1 14 30 CFG=3
M  V30 21 1 15 20
M  V30 22 1 17 18
M  V30 23 1 19 21
M  V30 24 1 19 22
M  V30 25 1 19 31 CFG=1
M  V30 26 1 20 21
M  V30 27 1 21 23
M  V30 28 1 21 32 CFG=3
M  V30 29 1 22 24
M  V30 30 1 23 25
M  V30 31 1 23 26
M  V30 32 2 24 25
M  V30 33 1 25 27
M  V30 34 1 26 28
M  V30 35 1 27 29
M  V30 36 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 10 14 19 21 23 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 953773-21-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 953773-22-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-9087408
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 3β-(3-Methanesulfonyloxypropoxy)-17-(2-spiro-1,3-dioxolane)androst-5-ene
(1.90 g) was dissolved in a 2.23 M solution of methylamine in MeOH (53
mL) and the solution was heated at 120°C in a steel bomb for 4 hr. After
cooling to room temperature, CHCl3 was added and the mixture washed with
5% NaHCO3, water, brine. The organic layer was dried and evaporated to
dryness to give
3β-(3-N-methylaminopropoxy)-17-(2-spiro-1,3-dioxolane)androst-5-ene (1.60
g, 100%) as a light green residue and used without purification in the
next step. 1H-NMR (300 MHz, DMSO-d6, ppm from TMS): δ 5.30 (1H, m), 3.78
(4H, m), 3.41 (2H, t), 3.05 (1H, m), 2.46 (2H, t), 2.23 (3H, s),
2.33-0.80 (22H, m), 0.93 (3H, s), 0.77 (3H, s).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of amino derivatives of androstanes as medicaments for
cardiovascular disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cerri, Alberto; Torri, Marco; Armaroli, Silvia; Banfi, Leonardo; Bianchi,
Giuseppe; Carzana, Giulio; Ferrari, Patrizia; Micheletti, Rosamaria;
Sputore, Simona; Zappavigna, Maria Pia
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007118832 A2 2007-10-25

$RFMT $RIREG SCHEME136 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dichloro-5-fluoro-6-methylpyrimidine
C5H3Cl2FN2
954220-98-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 0.0000 2.6674 0.0 0
M  V30 2 C 1.5400 0.0000 0.0 0
M  V30 3 Cl 1.5400 5.3349 0.0 0
M  V30 4 Cl 6.1600 2.6674 0.0 0
M  V30 5 C 1.5400 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 N 3.8500 1.3338 0.0 0
M  V30 9 N 3.8500 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 1 3 7
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-5-fluoro-N,6-dimethyl-4-pyrimidinamine
C6H7ClFN3
1883697-71-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 4.6200 0.0 0
M  V30 2 C 6.6685 3.8500 0.0 0
M  V30 3 F 2.6674 6.1600 0.0 0
M  V30 4 C 0.0000 4.6200 0.0 0
M  V30 5 Cl 2.6674 0.0000 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 1.3338 3.8500 0.0 0
M  V30 10 C 2.6674 1.5400 0.0 0
M  V30 11 N 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 7
M  V30 4 1 4 9
M  V30 5 1 5 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 954220-98-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1883697-71-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-14261910
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-Based Design of an Iminoheterocyclic β-Site Amyloid Precursor
Protein Cleaving Enzyme (BACE) Inhibitor that Lowers Central Aβ in
Nonhuman Primates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mandal, Mihirbaran; Wu, Yusheng; Misiaszek, Jeffrey; Li, Guoqing;
Buevich, Alexei; Caldwell, John P.; Liu, Xiaoxiang; Mazzola, Robert D.;
Orth, Peter; Strickland, Corey; Voigt, Johannes; Wang, Hongwu; Zhu,
Zhaoning; Chen, Xia; Grzelak, Michael; Hyde, Lynn A.; Kuvelkar, Reshma;
Leach, Prescott T.; Terracina, Giuseppe; Zhang, Lili; Zhang, Qi;
Michener, Maria S.; Smith, Brad; Cox, Kathleen; Grotz, Diane; Favreau,
Leonard; Mitra, Kaushik; Kazakevich, Irina; McKittrick, Brian A.;
Greenlee, William; Kennedy, Matthew E.; Parker, Eric M.; Cumming, Jared
N.; Stamford, Andrew W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2016), 59(7), 3231-3248

$RFMT $RIREG SCHEME137 STEP1
$RXN



  2  1
$MOL
3-(Cyclopentylthio)benzoic acid
C12H14O2S
956235-61-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 3.7711 1.5400 0.0 0
M  V30 2 C 9.1059 1.5400 0.0 0
M  V30 3 O 9.1059 0.0000 0.0 0
M  V30 4 O 10.4396 2.3101 0.0 0
M  V30 5 C 5.1048 2.3101 0.0 0
M  V30 6 C 6.4384 1.5400 0.0 0
M  V30 7 C 5.1048 3.8501 0.0 0
M  V30 8 C 7.7722 2.3101 0.0 0
M  V30 9 C 6.4384 4.6201 0.0 0
M  V30 10 C 7.7722 3.8501 0.0 0
M  V30 11 C 2.4374 2.3101 0.0 0
M  V30 12 C 1.0304 1.6837 0.0 0
M  V30 13 C 2.2763 3.8416 0.0 0
M  V30 14 C 0.0000 2.8281 0.0 0
M  V30 15 C 0.7700 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 8
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, 3-(cyclopentylthio)-N-methyl-
C13H17NOS
956235-62-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 3.7711 1.5400 0.0 0
M  V30 2 C 9.1059 1.5400 0.0 0
M  V30 3 N 10.4396 2.3101 0.0 0
M  V30 4 O 9.1059 0.0000 0.0 0
M  V30 5 C 11.7733 1.5400 0.0 0
M  V30 6 C 5.1048 2.3101 0.0 0
M  V30 7 C 6.4384 1.5400 0.0 0
M  V30 8 C 5.1048 3.8501 0.0 0
M  V30 9 C 7.7722 2.3101 0.0 0
M  V30 10 C 6.4384 4.6201 0.0 0
M  V30 11 C 7.7722 3.8501 0.0 0
M  V30 12 C 2.4373 2.3101 0.0 0
M  V30 13 C 1.0304 1.6837 0.0 0
M  V30 14 C 2.2763 3.8416 0.0 0
M  V30 15 C 0.0000 2.8281 0.0 0
M  V30 16 C 0.7700 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 9
M  V30 6 1 3 5
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 956235-61-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 956235-62-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11082686
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 3-(Cyclopentylthio)-N-methylbenzamide To a solution of 2.564 g (11.53
mmol) of Intermediate 97 in 100 ml of chloroform (ethanol free), three
drops of anhydrous dimethylformamide were added. The solution was cooled
to 0-5°C and 1.56 ml (18.44 mmol) of oxalyl chloride dissolved in 10 ml
of chloroform (ethanol free) were added. The reaction mixture was stirred
15 minutes at 0-5°C and 2 hours at room temperature. A new amount of
oxalyl chloride (0.50 ml, 5.91 mmol) was added at 0-5°C, and the reaction
mixture was stirred at room temperature for 72 hours. After this reaction
time, solvents were evaporated under reduced pressure. Chloroform
(ethanol free) was added to the residue and concentrated again (x2). The
obtained residue was dissolved in 60 ml of anhydrous tetrahydrofuran and
cooled to -30°C. At this temperature, 40 ml (80 mmol) of commercially
available 2M solution of methyl amine in tetrahydrofuran, diluted with 40
ml of anhydrous tetrahydrofuran, were slowly added. The reaction mixture
was left to warm to room temperature and stirred for 2 hours. The solvent
was evaporated. The obtained residue was dissolved in chloroform and the
solution was washed with water (x2), dried (MgSO4), and concentrated.
Chloroform was added to the residue and concentrated again (x2) to obtain
the title product (2.72 g, 100%). 3-(Cyclopentylthio)-N-methylbenzamide,
yield 2.72 g, 100%
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of oxalyl chloride in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 4-(2-Amino-1-hydroxyethyl)phenol derivatives as agonists of the β2
adrenergic receptor, their preparation, pharmaceutical compositions, and
use in therapy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Puig Duran, Carlos; Prat Quinones, Maria; Perez Crespo, Daniel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007124898 A1 2007-11-08

$RFMT $RIREG SCHEME138 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Isoxazolemethanol, 5-(3-methylphenyl)-, 3-methanesulfonate
C12H13NO4S
956360-01-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3037 3.4370 0.0 0
M  V30 2 O 10.2090 4.6831 0.0 0
M  V30 3 S 11.7405 4.5220 0.0 0 VAL=6
M  V30 4 C 11.9016 6.0535 0.0 0
M  V30 5 O 13.2722 4.3610 0.0 0
M  V30 6 O 11.5796 2.9904 0.0 0
M  V30 7 C 0.0000 3.0800 0.0 0
M  V30 8 C 5.3348 3.0800 0.0 0
M  V30 9 C 6.7418 2.4536 0.0 0
M  V30 10 O 5.4959 4.6116 0.0 0
M  V30 11 C 7.7722 3.5981 0.0 0
M  V30 12 N 7.0022 4.9318 0.0 0
M  V30 13 C 4.0011 2.3100 0.0 0
M  V30 14 C 2.6675 3.0800 0.0 0
M  V30 15 C 4.0011 0.7700 0.0 0
M  V30 16 C 1.3338 2.3100 0.0 0
M  V30 17 C 2.6675 0.0000 0.0 0
M  V30 18 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 3 6
M  V30 7 1 7 16
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 13
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-5-(3-methylphenyl)-3-isoxazolemethanamine
C12H14N2O
893639-32-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3038 3.4372 0.0 0
M  V30 2 N 10.2090 4.6831 0.0 0
M  V30 3 C 11.7406 4.5221 0.0 0
M  V30 4 C 0.0000 3.0801 0.0 0
M  V30 5 C 5.3348 3.0801 0.0 0
M  V30 6 C 6.7416 2.4536 0.0 0
M  V30 7 O 5.4957 4.6116 0.0 0
M  V30 8 C 7.7722 3.5981 0.0 0
M  V30 9 N 7.0022 4.9318 0.0 0
M  V30 10 C 4.0011 2.3100 0.0 0
M  V30 11 C 2.6673 3.0801 0.0 0
M  V30 12 C 4.0011 0.7700 0.0 0
M  V30 13 C 1.3337 2.3100 0.0 0
M  V30 14 C 2.6673 0.0000 0.0 0
M  V30 15 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 13
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 10
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 956360-01-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 893639-32-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-11260191
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 1.1:
N-{[5-(3-Chlorophenyl)isoxazol-3-yl]methyl}cyclopropanamine
[5-(3-Chlorophenyl)isoxazol-3-yl]methyl methanesulfonate (WO 2004/014881)
(1.45 g, 5.04 mmol) was dissolved in THF (30 mL) and cyclopropylamine
(2.0 mL, 25 mmol) was added. The reaction mixture was stirred at rt
overnight. The next day, more cyclopropylamine (2.0 mL, 25 mmol) was
added and the reaction mixture was heated at 40 °C with reflux condenser
for 3 h. The solvent was evaporated and the residue was dissolved in DCM
(80 mL), washed with saturated NaHCO3 solution (50 mL) and dried (MgSO4).
The crude title compound (yield 90%) was used in the next step without
further purification.
N-Methyl-1-[5-(3-methylphenyl)isoxazol-3-yl]methanamine, yield Quant.
0.39 g. 1H NMR (400 MHz, CDCl3): δ 7.62 (s, 1H), 7.59 (d, 1H), 7.36 (t,
1H), 7.27 (m, 1H), 6.53 (s, 1H), 3.89 (s, 2H), 2.53 (s, 3H), 2.43 (s, 3H)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of amino 1,2,4-triazole derivatives as modulators of mGluR5
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Isaac, Methvin; Waallberg, Andreas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009054794 A1 2009-04-30

$RFMT $RIREG SCHEME139 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Fluoro-2-[[3-[(4-fluorophenyl)methyl]-6,8-dihydro-9-[(4-methoxyphenyl)metho...
C36H31F2N3O7S
959406-32-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  49 54 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.8636 7.7000 0.0 0
M  V30 2 C 11.1974 6.9300 0.0 0
M  V30 3 O 6.5893 8.0696 0.0 0
M  V30 4 N 9.8636 13.8601 0.0 0
M  V30 5 S 8.5299 14.6302 0.0 0 VAL=6
M  V30 6 C 11.1974 14.6302 0.0 0
M  V30 7 C 7.1963 15.4002 0.0 0
M  V30 8 O 7.7599 13.2965 0.0 0
M  V30 9 O 9.3000 15.9640 0.0 0
M  V30 10 C 4.6201 10.7801 0.0 0
M  V30 11 C 15.1984 12.3201 0.0 0
M  V30 12 C 1.5400 10.7801 0.0 0
M  V30 13 O 0.0000 10.7801 0.0 0
M  V30 14 O 2.3101 9.4464 0.0 0
M  V30 15 O 11.1974 0.7700 0.0 0
M  V30 16 C 12.5311 0.0000 0.0 0
M  V30 17 F 1.5400 16.1149 0.0 0
M  V30 18 F 20.5333 9.2400 0.0 0
M  V30 19 C 8.5299 10.0101 0.0 0
M  V30 20 C 8.5299 11.5501 0.0 0
M  V30 21 C 9.8636 9.2400 0.0 0
M  V30 22 C 7.0654 9.5342 0.0 0
M  V30 23 C 9.8636 12.3201 0.0 0
M  V30 24 C 7.0654 12.0261 0.0 0
M  V30 25 C 11.1974 10.0101 0.0 0
M  V30 26 N 6.1601 10.7801 0.0 0
M  V30 27 C 11.1974 11.5501 0.0 0
M  V30 28 N 12.5311 9.2400 0.0 0
M  V30 29 C 12.5311 12.3201 0.0 0
M  V30 30 C 13.8648 10.0101 0.0 0
M  V30 31 C 13.8648 11.5501 0.0 0
M  V30 32 C 11.1974 5.3900 0.0 0
M  V30 33 C 9.8636 4.6199 0.0 0
M  V30 34 C 12.5311 4.6199 0.0 0
M  V30 35 C 9.8636 3.0799 0.0 0
M  V30 36 C 12.5311 3.0799 0.0 0
M  V30 37 C 11.1974 2.3099 0.0 0
M  V30 38 C 3.8501 12.1139 0.0 0
M  V30 39 C 2.3101 12.1139 0.0 0
M  V30 40 C 4.6201 13.4476 0.0 0
M  V30 41 C 1.5400 13.4476 0.0 0
M  V30 42 C 3.8501 14.7812 0.0 0
M  V30 43 C 2.3101 14.7812 0.0 0
M  V30 44 C 16.5323 11.5501 0.0 0
M  V30 45 C 16.5323 10.0101 0.0 0
M  V30 46 C 17.8659 12.3201 0.0 0
M  V30 47 C 17.8659 9.2400 0.0 0
M  V30 48 C 19.1996 11.5501 0.0 0
M  V30 49 C 19.1996 10.0101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 32
M  V30 4 2 3 22
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 23
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 2 5 9
M  V30 11 1 10 26
M  V30 12 1 10 38
M  V30 13 1 11 31
M  V30 14 1 11 44
M  V30 15 1 12 13
M  V30 16 2 12 14
M  V30 17 1 12 39
M  V30 18 1 15 16
M  V30 19 1 15 37
M  V30 20 1 17 43
M  V30 21 1 18 49
M  V30 22 1 19 20
M  V30 23 2 19 21
M  V30 24 1 19 22
M  V30 25 2 20 23
M  V30 26 1 20 24
M  V30 27 1 21 25
M  V30 28 1 22 26
M  V30 29 1 23 27
M  V30 30 1 24 26
M  V30 31 1 25 27
M  V30 32 2 25 28
M  V30 33 2 27 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 2 30 31
M  V30 37 2 32 33
M  V30 38 1 32 34
M  V30 39 1 33 35
M  V30 40 2 34 36
M  V30 41 2 35 37
M  V30 42 1 36 37
M  V30 43 2 38 39
M  V30 44 1 38 40
M  V30 45 1 39 41
M  V30 46 2 40 42
M  V30 47 2 41 43
M  V30 48 1 42 43
M  V30 49 2 44 45
M  V30 50 1 44 46
M  V30 51 1 45 47
M  V30 52 2 46 48
M  V30 53 2 47 49
M  V30 54 1 48 49
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Fluoro-2-[[3-[(4-fluorophenyl)methyl]-6,8-dihydro-9-[(4-methoxyphenyl)metho...
C37H34F2N4O6S
959406-33-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  50 55 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.6334 13.8600 0.0 0
M  V30 2 S 9.2998 14.6300 0.0 0 VAL=6
M  V30 3 C 11.9672 14.6300 0.0 0
M  V30 4 C 7.9661 15.4000 0.0 0
M  V30 5 O 10.0698 15.9638 0.0 0
M  V30 6 O 8.5298 13.2964 0.0 0
M  V30 7 O 10.6334 7.7000 0.0 0
M  V30 8 C 11.9672 6.9300 0.0 0
M  V30 9 O 7.3592 8.0696 0.0 0
M  V30 10 C 5.3900 10.7800 0.0 0
M  V30 11 C 15.9681 12.3200 0.0 0
M  V30 12 C 2.3100 10.7800 0.0 0
M  V30 13 N 0.7700 10.7800 0.0 0
M  V30 14 O 3.0800 9.4464 0.0 0
M  V30 15 C 0.0000 9.4464 0.0 0
M  V30 16 F 2.3100 16.1149 0.0 0
M  V30 17 O 11.9672 0.7700 0.0 0
M  V30 18 C 13.3008 0.0000 0.0 0
M  V30 19 F 21.3028 9.2400 0.0 0
M  V30 20 C 9.2998 11.5500 0.0 0
M  V30 21 C 9.2998 10.0100 0.0 0
M  V30 22 C 10.6334 12.3200 0.0 0
M  V30 23 C 7.8351 12.0260 0.0 0
M  V30 24 C 10.6334 9.2400 0.0 0
M  V30 25 C 7.8351 9.5341 0.0 0
M  V30 26 C 11.9672 11.5500 0.0 0
M  V30 27 N 6.9300 10.7800 0.0 0
M  V30 28 C 11.9672 10.0100 0.0 0
M  V30 29 C 13.3008 12.3200 0.0 0
M  V30 30 N 13.3008 9.2400 0.0 0
M  V30 31 C 14.6345 11.5500 0.0 0
M  V30 32 C 14.6345 10.0100 0.0 0
M  V30 33 C 4.6200 12.1138 0.0 0
M  V30 34 C 3.0800 12.1138 0.0 0
M  V30 35 C 5.3900 13.4474 0.0 0
M  V30 36 C 2.3100 13.4474 0.0 0
M  V30 37 C 4.6200 14.7811 0.0 0
M  V30 38 C 3.0800 14.7811 0.0 0
M  V30 39 C 11.9672 5.3900 0.0 0
M  V30 40 C 13.3008 4.6200 0.0 0
M  V30 41 C 10.6334 4.6200 0.0 0
M  V30 42 C 13.3008 3.0800 0.0 0
M  V30 43 C 10.6334 3.0800 0.0 0
M  V30 44 C 11.9672 2.3100 0.0 0
M  V30 45 C 17.3019 11.5500 0.0 0
M  V30 46 C 17.3019 10.0100 0.0 0
M  V30 47 C 18.6355 12.3200 0.0 0
M  V30 48 C 18.6355 9.2400 0.0 0
M  V30 49 C 19.9692 11.5500 0.0 0
M  V30 50 C 19.9692 10.0100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 22
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 2 2 6
M  V30 7 1 7 8
M  V30 8 1 7 24
M  V30 9 1 8 39
M  V30 10 2 9 25
M  V30 11 1 10 27
M  V30 12 1 10 33
M  V30 13 1 11 31
M  V30 14 1 11 45
M  V30 15 1 12 13
M  V30 16 2 12 14
M  V30 17 1 12 34
M  V30 18 1 13 15
M  V30 19 1 16 38
M  V30 20 1 17 18
M  V30 21 1 17 44
M  V30 22 1 19 50
M  V30 23 1 20 21
M  V30 24 2 20 22
M  V30 25 1 20 23
M  V30 26 2 21 24
M  V30 27 1 21 25
M  V30 28 1 22 26
M  V30 29 1 23 27
M  V30 30 1 24 28
M  V30 31 1 25 27
M  V30 32 1 26 28
M  V30 33 2 26 29
M  V30 34 2 28 30
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 2 31 32
M  V30 38 2 33 34
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 2 35 37
M  V30 42 2 36 38
M  V30 43 1 37 38
M  V30 44 2 39 40
M  V30 45 1 39 41
M  V30 46 1 40 42
M  V30 47 2 41 43
M  V30 48 2 42 44
M  V30 49 1 43 44
M  V30 50 2 45 46
M  V30 51 1 45 47
M  V30 52 1 46 48
M  V30 53 2 47 49
M  V30 54 2 48 50
M  V30 55 1 49 50
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 959406-32-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 959406-33-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14404529
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7664-41-7
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: To acid 323 (150 mg, 0.3 mmol, 1 equiv.) was
added DMF (3 mL, 0.1 M) followed by DIPEA (151 μL, 0.8 mmol, 3 equiv.)
and HATU (160 mg, 0.4 mmol, 1.5 equiv.). After 5 minutes, NH3 (2.8 mL,
1.4 mmol, 5 equiv., 0.5 M dioxane) was added. When the reaction was
complete it was quenched with water and diluted with Ethyl Acetate. The
organic layer was washed with water and brine before being dried over
Na2SO4, filtered and concentrated in vacuo. The crude residue was
purified by chromatography on silica gel (4/1-Ethyl acetate/MeOH) to
afford a yellow solid am as the desired product 325. Compound 389, yield
44 mg, 100%. 300 MHz 1H NMR (CDCl3) δ (ppm) 8.93 (s, 1H), 7.87 (s, 1H),
7.6 (d, 2H), 7.44 (m, 1H), 7.24-7.06 (m, 6H), 6.86 (d, 2H), 6.515 (bs,
1H), 5.75 (dd, 2H), 4.91 (dd, 2H), 4.61 (dd, 2H), 4.23 (s, 3H), 3.8 (s,
3H), 3.24 (s, 3H), 2.98 (d, 3H), 2.91 (s, 3H); MS: 701 (M + 1).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrroloquinolinones and related compounds as HIV integrase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cai, Zhenhong R.; Jabri, Salman Y.; Jin, Haolun; Lansdown, Rachael A.;
Metobo, Samuel E.; Mish, Michael L.; Pastor, Richard
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007136714 A2 2007-11-29

$RFMT $RIREG SCHEME140 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(6-Fluoro-3-pyridinyl)-6-methoxybenzoxazole
C13H9FN2O2
960591-40-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 0.0000 1.5400 0.0 0
M  V30 2 O 12.5309 3.0800 0.0 0
M  V30 3 C 13.8647 2.3100 0.0 0
M  V30 4 C 6.1600 1.5400 0.0 0
M  V30 5 O 7.0652 2.7859 0.0 0
M  V30 6 N 7.0652 0.2941 0.0 0
M  V30 7 C 8.5299 2.3100 0.0 0
M  V30 8 C 8.5299 0.7700 0.0 0
M  V30 9 C 9.8636 3.0800 0.0 0
M  V30 10 C 9.8636 0.0000 0.0 0
M  V30 11 C 11.1972 2.3100 0.0 0
M  V30 12 C 11.1972 0.7700 0.0 0
M  V30 13 C 4.6200 1.5400 0.0 0
M  V30 14 C 3.8500 2.8737 0.0 0
M  V30 15 C 3.8500 0.2064 0.0 0
M  V30 16 C 2.3100 2.8737 0.0 0
M  V30 17 N 2.3100 0.2064 0.0 0
M  V30 18 C 1.5400 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 1 2 3
M  V30 3 1 2 11
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 13
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 12
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(6-Methoxy-2-benzoxazolyl)-N-methyl-2-pyridinamine
C14H13N3O2
960591-14-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 1.5400 0.0 0
M  V30 2 C 0.0000 0.2064 0.0 0
M  V30 3 O 13.3009 3.0800 0.0 0
M  V30 4 C 14.6347 2.3100 0.0 0
M  V30 5 C 6.9300 1.5400 0.0 0
M  V30 6 O 7.8353 2.7859 0.0 0
M  V30 7 N 7.8353 0.2941 0.0 0
M  V30 8 C 9.3000 2.3100 0.0 0
M  V30 9 C 9.3000 0.7700 0.0 0
M  V30 10 C 10.6336 3.0800 0.0 0
M  V30 11 C 10.6336 0.0000 0.0 0
M  V30 12 C 11.9672 2.3100 0.0 0
M  V30 13 C 11.9672 0.7700 0.0 0
M  V30 14 C 5.3900 1.5400 0.0 0
M  V30 15 C 4.6200 2.8737 0.0 0
M  V30 16 C 4.6200 0.2064 0.0 0
M  V30 17 C 3.0800 2.8737 0.0 0
M  V30 18 N 3.0800 0.2064 0.0 0
M  V30 19 C 2.3100 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 3 4
M  V30 4 1 3 12
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 960591-40-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 960591-14-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-1956863
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and evaluation of 2-pyridylbenzothiazole, 2-pyridylbenzoxazole
and 2-pyridylbenzofuran derivatives as 11C-PET imaging agents for
β-amyloid plaques
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Swahn, Britt-Marie; Wensbo, David; Sandell, Johan; Sohn, Daniel; Slivo,
Can; Pyring, David; Malmstroem, Jonas; Arzel, Erwan; Vallin, Michaela;
Bergh, Margareta; Jeppsson, Fredrik; Johnson, Allan E.; Jureus, Anders;
Neelissen, Jan; Svensson, Samuel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2010), 20(6), 1976-1980

$RFMT $RIREG SCHEME141 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-3-nitrobenzoic acid
C7H4ClNO4
96-99-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 0.0000 0.0 0
M  V30 4 Cl 1.3336 4.6200 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Methylamino)-3-nitrobenzoic acid
C8H8N2O4
41263-74-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 6.1601 0.0 0 VAL=5
M  V30 2 O 5.3348 6.9302 0.0 0
M  V30 3 O 2.6675 6.9302 0.0 0
M  V30 4 N 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 14 C 4.0012 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 96-99-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 41263-74-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-3767346
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step A: 4-(methylamino)-3-nitrobenzoic acid A solution of
4-chloro-3-nitrobenzoic acid (30 g, 1.0 eq) in 200 mL CH3NH2 (aq) was
stirred at 100 °C for 14 h, cooled, and concentrated in vacuo. The
residue was poured into 200 mL 2N HCl (aq) at °C. The suspension was
filtered and washed with water to give the product. Yellow solid (quant).
1H NMR (400 MHz, DMSO-d6) 8 8.58 (d, J= 2.0 Hz, 1H), 8.51 (d, J= 5.2 Hz,
1H), 7.95 (dd, J= 9.2 Hz, 2.0 Uz, 1H), 7.02 (d, J= 9.2 Hz, 1H), 2.98 (s,
3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of ethylene derivatives as selective estrogen receptor
regulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xiao, Dengming; Zhu, Li; Hu, Yuandong; Yu, Rong; Hu, Wei; Zhao, Na; Peng,
Yong; Luo, Hong; Han, Yongxin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013097773 A1 2013-07-04

$RFMT $RIREG SCHEME142 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-3-nitrobenzoic acid
C7H4ClNO4
96-99-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 0.0000 0.0 0
M  V30 4 Cl 1.3336 4.6200 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Methylamino)-3-nitrobenzoyl chloride
C8H7ClN2O3
82357-48-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 6.1601 0.0 0 VAL=5
M  V30 2 O 5.3348 6.9302 0.0 0
M  V30 3 O 2.6675 6.9302 0.0 0
M  V30 4 N 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 Cl 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 14 C 4.0012 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 96-99-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 82357-48-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9460915
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Molecular modeling studies, synthesis and biological evaluation of
dabigatran analogues as thrombin inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dong, Ming-Hui; Chen, Hai-Feng; Ren, Yu-Jie; Shao, Fang-Ming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2016), 24(2), 73-84

$RFMT $RIREG SCHEME143 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloro-2,4-dinitrobenzene
C6H3ClN2O4
97-00-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 0.0000 0.0 0
M  V30 4 Cl 1.3336 4.6200 0.0 0
M  V30 5 N 6.6685 1.5400 0.0 0 VAL=5
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2,4-dinitroaniline
C7H7N3O4
2044-88-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 6.1601 0.0 0 VAL=5
M  V30 2 O 5.3348 6.9302 0.0 0
M  V30 3 O 2.6675 6.9302 0.0 0
M  V30 4 N 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 14 C 4.0012 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 97-00-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2044-88-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-23239503
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Flavin mimetics: Synthesis and photophysical properties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rasadean, Dora-M.; Machida, Takashi; Sada, Kazuki; Pudney, Christopher
R.; Pantos, G. Dan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2021), 82131925

$RFMT $RIREG SCHEME143 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloro-2,4-dinitrobenzene
C6H3ClN2O4
97-00-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 0.0000 0.0 0
M  V30 4 Cl 1.3336 4.6200 0.0 0
M  V30 5 N 6.6685 1.5400 0.0 0 VAL=5
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2,4-dinitroaniline
C7H7N3O4
2044-88-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 6.1601 0.0 0 VAL=5
M  V30 2 O 5.3348 6.9302 0.0 0
M  V30 3 O 2.6675 6.9302 0.0 0
M  V30 4 N 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 14 C 4.0012 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 97-00-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2044-88-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8489893
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of benzo[1,2-d;3,4-d']diimidazole and
1H-pyrazolo[4,3-b]pyridine as putative A2A receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Piersanti, Giovanni; Giorgi, Luca; Bartoccini, Francesca; Tarzia,
Giorgio; Minetti, Patrizia; Gallo, Grazia; Giorgi, Fabrizio; Castorina,
Massimo; Ghirardi, Orlando; Carminati, Paolo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2007), 5(16), 2567-2571

$RFMT $RIREG SCHEME144 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Furfural
C5H4O2
98-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 O 5.1049 1.8517 0.0 0
M  V30 3 C 2.4374 1.8517 0.0 0
M  V30 4 C 2.2765 0.3202 0.0 0
M  V30 5 O 1.0306 2.4782 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Furanylmethylene)methanamine
C6H7NO
39558-97-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 N 5.1049 1.8517 0.0 0
M  V30 3 C 6.4386 2.6217 0.0 0
M  V30 4 C 2.4374 1.8517 0.0 0
M  V30 5 C 2.2765 0.3202 0.0 0
M  V30 6 O 1.0306 2.4782 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 4
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-01-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 39558-97-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-15919366
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7487-88-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Four-Electron Electrocyclic Ring-Opening/Intermolecular [4+2]
Cycloadditions of α-Hydroxycyclobutenones: Stereoselective Synthesis of
Multiple Substituted δ-Lactams
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Song, Peidong; Li, Qing; Wang, Congcong; Wu, Wenfa; Mao, Xu; Wang,
Jiajia; Hu, Xiangdong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2016), 358(8), 1208-1212

$RFMT $RIREG SCHEME145 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Furfural
C5H4O2
98-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 O 5.1049 1.8517 0.0 0
M  V30 3 C 2.4374 1.8517 0.0 0
M  V30 4 C 2.2765 0.3202 0.0 0
M  V30 5 O 1.0306 2.4782 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-furanmethanamine
C6H9NO
4753-75-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 N 5.1049 1.8517 0.0 0
M  V30 3 C 6.4386 2.6217 0.0 0
M  V30 4 C 2.4374 1.8517 0.0 0
M  V30 5 C 2.2765 0.3202 0.0 0
M  V30 6 O 1.0306 2.4782 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-01-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4753-75-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40172273
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-44-0
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7440-48-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-solvent, catalyst prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chemoenzymatic synthesis of amino-esters as precursors of ammonium
salt-based surfactants from 5-hydroxymethylfurfural (HMF)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Moriana Herraiz, Carlos; Arias, Karen S.; Climent, Maria J.; Iborra,
Sara; Corma, Avelino
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Green Chemistry (2024), 26(16), 9118-9131

$RFMT $RIREG SCHEME146 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Thiophenecarboxaldehyde
C5H4OS
98-03-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 O 5.1049 1.8517 0.0 0
M  V30 3 C 2.4374 1.8517 0.0 0
M  V30 4 C 2.2765 0.3202 0.0 0
M  V30 5 S 1.0306 2.4782 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-(2-Thienylmethylene)methanamine
C6H7NS
142352-11-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 N 5.1049 1.8517 0.0 0
M  V30 3 C 6.4386 2.6217 0.0 0
M  V30 4 C 2.4374 1.8517 0.0 0
M  V30 5 C 2.2765 0.3202 0.0 0
M  V30 6 S 1.0306 2.4782 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-03-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 142352-11-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-16375443
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Hit-to-Lead Studies for the Antimalarial Tetrahydroisoquinolone
Carboxanilides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Floyd, David M.; Stein, Philip; Wang, Zheng; Liu, Jian; Castro, Steve;
Clark, Julie A.; Connelly, Michele; Zhu, Fangyi; Holbrook, Gloria;
Matheny, Amy; Sigal, Martina S.; Min, Jaeki; Dhinakaran, Rajkumar;
Krishnan, Senthil; Bashyum, Sridevi; Knapp, Spencer; Guy, R. Kiplin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2016), 59(17), 7950-7962

$RFMT $RIREG SCHEME147 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 2-(bromomethyl)-3-nitro-, methyl ester
C9H8BrNO4
98475-07-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 4.6201 0.0 0
M  V30 2 Br 2.6675 5.3901 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 O 8.0023 2.3101 0.0 0
M  V30 5 O 6.6685 4.6201 0.0 0
M  V30 6 C 9.3360 3.0801 0.0 0
M  V30 7 N 1.3337 3.0801 0.0 0 VAL=5
M  V30 8 O 1.3337 4.6201 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 2.6675 2.3101 0.0 0
M  V30 13 C 5.3348 0.7700 0.0 0
M  V30 14 C 2.6675 0.7700 0.0 0
M  V30 15 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 4 6
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 12
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-2-methyl-4-nitro-1H-isoindol-1-one
C9H8N2O3
682757-52-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6519 3.0012 0.0 0 VAL=5
M  V30 2 O 6.6519 1.4612 0.0 0
M  V30 3 O 7.9855 3.7712 0.0 0
M  V30 4 O 0.0000 3.0608 0.0 0
M  V30 5 C 1.3627 0.0000 0.0 0
M  V30 6 C 3.9844 3.0012 0.0 0
M  V30 7 C 2.6508 3.7712 0.0 0
M  V30 8 C 5.3181 3.7712 0.0 0
M  V30 9 C 3.6643 1.4947 0.0 0
M  V30 10 C 1.5064 2.7406 0.0 0
M  V30 11 C 2.6508 5.3112 0.0 0
M  V30 12 C 5.3181 5.3112 0.0 0
M  V30 13 N 2.1327 1.3338 0.0 0
M  V30 14 C 3.9844 6.0812 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 2 4 10
M  V30 5 1 5 13
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98475-07-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 682757-52-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-22602750
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient synthesis of dibenzazepine lactams via a sequential
Pd-catalyzed amination and aldol condensation reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Song, Ha-Jeong; Yoon, Eunyoung; Heo, Jung-Nyoung
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2020), 61(9), 151536

$RFMT $RIREG SCHEME148 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromobenzenesulfonyl chloride
C6H4BrClO2S
98-58-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 2 Cl 0.0000 1.5400 0.0 0
M  V30 3 O 1.5400 3.0800 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 Br 7.7000 1.5400 0.0 0
M  V30 6 C 3.0800 1.5400 0.0 0
M  V30 7 C 3.8500 0.2064 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 5.3900 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methylbenzenesulfonamide
C7H8BrNO2S
703-12-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.3100 1.5400 0.0 0 VAL=6
M  V30 2 N 0.7700 1.5400 0.0 0
M  V30 3 O 2.3100 3.0800 0.0 0
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 C 0.0000 2.8736 0.0 0
M  V30 6 Br 8.4700 1.5400 0.0 0
M  V30 7 C 3.8500 1.5400 0.0 0
M  V30 8 C 4.6200 0.2064 0.0 0
M  V30 9 C 4.6200 2.8736 0.0 0
M  V30 10 C 6.1600 0.2064 0.0 0
M  V30 11 C 6.1600 2.8736 0.0 0
M  V30 12 C 6.9300 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 2 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-58-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 703-12-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-14181612
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a potent CDK2 inhibitor with a novel binding mode, using
virtual screening and initial, structure-guided lead scoping
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Richardson, Christine M.; Nunns, Claire L.; Williamson, Douglas S.;
Parratt, Martin J.; Dokurno, Pawel; Howes, Rob; Borgognoni, Jenifer;
Drysdale, Martin J.; Finch, Harry; Hubbard, Roderick E.; Jackson, Philip
S.; Kierstan, Peter; Lentzen, Georg; Moore, Jonathan D.; Murray, James
B.; Simmonite, Heather; Surgenor, Allan E.; Torrance, Christopher J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2007), 17(14), 3880-3885

$RFMT $RIREG SCHEME149 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(1,3-Benzodioxol-5-ylcarbonyl)-L-phenylalanine methyl ester
C18H17NO5
98671-16-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.8500 0.0 0
M  V30 2 N 4.0011 4.6200 0.0 0
M  V30 3 O 5.3347 2.3100 0.0 0
M  V30 4 C 2.6673 3.8500 0.0 0 CFG=2
M  V30 5 C 1.3336 4.6200 0.0 0
M  V30 6 C 2.6673 2.3100 0.0 0
M  V30 7 O 1.3336 1.5400 0.0 0
M  V30 8 O 4.0011 1.5400 0.0 0
M  V30 9 C 1.3336 0.0000 0.0 0
M  V30 10 C 9.3358 4.6200 0.0 0
M  V30 11 C 9.3358 6.1600 0.0 0
M  V30 12 C 8.0020 3.8500 0.0 0
M  V30 13 O 10.8004 4.1442 0.0 0
M  V30 14 C 8.0020 6.9300 0.0 0
M  V30 15 O 10.8004 6.6359 0.0 0
M  V30 16 C 6.6684 4.6200 0.0 0
M  V30 17 C 11.7056 5.3900 0.0 0
M  V30 18 C 6.6684 6.1600 0.0 0
M  V30 19 C 1.3336 6.1600 0.0 0
M  V30 20 C 0.0000 6.9300 0.0 0
M  V30 21 C 2.6673 6.9300 0.0 0
M  V30 22 C 0.0000 8.4700 0.0 0
M  V30 23 C 2.6673 8.4700 0.0 0
M  V30 24 C 1.3336 9.2400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 4 5 CFG=3
M  V30 6 1 4 6
M  V30 7 1 5 19
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 13
M  V30 14 2 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1S)-2-(Methylamino)-2-oxo-1-(phenylmethyl)ethyl]-1,3-benzodioxole-5-carbo...
C18H18N2O4
1809464-26-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.8500 0.0 0
M  V30 2 N 4.0011 4.6200 0.0 0
M  V30 3 O 5.3347 2.3100 0.0 0
M  V30 4 C 2.6673 3.8500 0.0 0 CFG=2
M  V30 5 C 1.3336 4.6200 0.0 0
M  V30 6 C 2.6673 2.3100 0.0 0
M  V30 7 N 1.3336 1.5400 0.0 0
M  V30 8 O 4.0011 1.5400 0.0 0
M  V30 9 C 1.3336 0.0000 0.0 0
M  V30 10 C 9.3358 4.6200 0.0 0
M  V30 11 C 9.3358 6.1600 0.0 0
M  V30 12 C 8.0020 3.8500 0.0 0
M  V30 13 O 10.8004 4.1442 0.0 0
M  V30 14 C 8.0020 6.9300 0.0 0
M  V30 15 O 10.8004 6.6359 0.0 0
M  V30 16 C 6.6684 4.6200 0.0 0
M  V30 17 C 11.7056 5.3900 0.0 0
M  V30 18 C 6.6684 6.1600 0.0 0
M  V30 19 C 1.3336 6.1600 0.0 0
M  V30 20 C 0.0000 6.9300 0.0 0
M  V30 21 C 2.6673 6.9300 0.0 0
M  V30 22 C 0.0000 8.4700 0.0 0
M  V30 23 C 2.6673 8.4700 0.0 0
M  V30 24 C 1.3336 9.2400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 4 5 CFG=3
M  V30 6 1 4 6
M  V30 7 1 5 19
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 13
M  V30 14 2 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98671-16-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1809464-26-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11730988
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 5,5'-Diamino-BIPHEP ligands bearing small selector units for non-covalent
binding of chiral analytes in solution
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Storch, G.; Siebert, M.; Rominger, F.; Trapp, O.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2015), 51(86),
15665-15668

$RFMT $RIREG SCHEME150 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzenesulfonyl chloride
C7H7ClO3S
98-68-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 2 Cl 0.0000 1.5400 0.0 0
M  V30 3 O 1.5400 3.0800 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 O 7.7000 1.5400 0.0 0
M  V30 6 C 8.4700 2.8736 0.0 0
M  V30 7 C 3.0800 1.5400 0.0 0
M  V30 8 C 3.8500 0.2064 0.0 0
M  V30 9 C 3.8500 2.8736 0.0 0
M  V30 10 C 5.3900 0.2064 0.0 0
M  V30 11 C 5.3900 2.8736 0.0 0
M  V30 12 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-N-methylbenzenesulfonamide
C8H11NO3S
7010-86-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.6675 1.3337 0.0 0 VAL=6
M  V30 2 N 1.3337 0.5637 0.0 0
M  V30 3 O 1.8975 2.6673 0.0 0
M  V30 4 O 3.4375 0.0000 0.0 0
M  V30 5 C 0.0000 1.3337 0.0 0
M  V30 6 O 8.0023 4.4137 0.0 0
M  V30 7 C 9.3360 3.6437 0.0 0
M  V30 8 C 4.0012 2.1037 0.0 0
M  V30 9 C 4.0012 3.6437 0.0 0
M  V30 10 C 5.3348 1.3337 0.0 0
M  V30 11 C 5.3348 4.4137 0.0 0
M  V30 12 C 6.6685 2.1037 0.0 0
M  V30 13 C 6.6685 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-68-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 7010-86-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-4747194
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrrolotriazinone derivatives as PI3K inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Erra Sola, Montserrat; Carrascal Riera, Marta; Taltavull Moll, Joan;
Caturla Javaloyes, Juan Francisco; Bernal Anchuela, Francisco Javier;
Pages Santacana, Lluis Miquel; Mir Cepeda, Marta; Casals Coll, Gaspar;
Hernandez Olasagarre, Maria Begona
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014060432 A1 2014-04-24

$RFMT $RIREG SCHEME151 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2S,3S)-(-)-3-tert-Butoxycarbonylamino-1,2-epoxy-4-phenylbutane
C15H21NO3
98737-29-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.8502 0.0 0 CFG=1
M  V30 2 C 3.0800 2.8502 0.0 0
M  V30 3 N 5.3900 4.1839 0.0 0
M  V30 4 C 6.9300 4.1839 0.0 0
M  V30 5 O 7.7000 5.5175 0.0 0
M  V30 6 O 7.7000 2.8502 0.0 0
M  V30 7 C 9.2400 5.5175 0.0 0
M  V30 8 C 9.2400 3.9775 0.0 0
M  V30 9 C 10.7800 5.5175 0.0 0
M  V30 10 C 9.2400 7.0575 0.0 0
M  V30 11 C 5.3900 1.5166 0.0 0 CFG=2
M  V30 12 C 4.2104 0.5267 0.0 0
M  V30 13 O 5.6573 0.0000 0.0 0
M  V30 14 C 2.3100 4.1839 0.0 0
M  V30 15 C 3.0800 5.5175 0.0 0
M  V30 16 C 0.7700 4.1839 0.0 0
M  V30 17 C 2.3100 6.8513 0.0 0
M  V30 18 C 0.0000 5.5175 0.0 0
M  V30 19 C 0.7700 6.8513 0.0 0
M  V30 20 H 6.8371 2.0433 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 14
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 11 12 CFG=1
M  V30 13 1 11 13
M  V30 14 1 11 20
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1S,2R)-2-hydroxy-3-(methylamino)-1-(phenylmethyl)propyl...
C16H26N2O3
160232-54-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.3347 0.0 0 CFG=1
M  V30 2 C 4.6200 6.6684 0.0 0
M  V30 3 N 6.9300 5.3347 0.0 0
M  V30 4 C 4.6200 4.0011 0.0 0 CFG=2
M  V30 5 C 7.7000 6.6684 0.0 0
M  V30 6 C 5.3900 2.6674 0.0 0
M  V30 7 O 3.0800 4.0011 0.0 0
M  V30 8 O 9.2400 6.6684 0.0 0
M  V30 9 O 6.9300 8.0021 0.0 0
M  V30 10 N 4.6200 1.3336 0.0 0
M  V30 11 C 10.0100 8.0021 0.0 0
M  V30 12 C 5.3900 0.0000 0.0 0
M  V30 13 C 8.6764 8.7721 0.0 0
M  V30 14 C 10.7800 9.3358 0.0 0
M  V30 15 C 11.3436 7.2321 0.0 0
M  V30 16 C 3.0800 6.6684 0.0 0
M  V30 17 C 2.3100 8.0021 0.0 0
M  V30 18 C 2.3100 5.3347 0.0 0
M  V30 19 C 0.7700 8.0021 0.0 0
M  V30 20 C 0.7700 5.3347 0.0 0
M  V30 21 C 0.0000 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 16
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7 CFG=1
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 18 20
M  V30 20 2 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98737-29-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 160232-54-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-5165667
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM The following describes the synthetic scheme depicted below. Selection of
particular starting compounds in order to arrive at the desired end
product w be evident to those sked in the art. To 1 equivalent of
commercially available epoxide A (100 mM in 2-propanol) is added 20
equivalents of amine RNH2, and the reaction is refluxed for 18 hours.
Solvent is then removed under reduced pressure providing the adduct B
directly in the case of volatile amines (e.g., Me-NH2,I-Pr-NH2,I-Bu-NH2).
With nonvolatile amines (e.g., PhCH2NH2), the concentrated mixture is
taken up into ethyl acetate and washed with water, 1N HCl, saturated
NaHCO2 solution, and brine. The organic layer is then dried over Na2SO4,
filtered, and concentrated in vacuo to provide adduct B. Yield: 85 to
100%.
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of (hydroxyethyl)ureas as inhibitors of Alzheimer's β-amyloid
production
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wolfe, Michael S.; Selkoe, Dennis J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002014264 A2 2002-02-21

$RFMT $RIREG SCHEME152 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrobenzenesulfonyl chloride
C6H4ClNO4S
98-74-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 1.5400 0.0 0 VAL=6
M  V30 2 Cl 8.4700 1.5400 0.0 0
M  V30 3 O 6.9300 3.0800 0.0 0
M  V30 4 O 6.9300 0.0000 0.0 0
M  V30 5 N 0.7700 1.5400 0.0 0 VAL=5
M  V30 6 O 0.0000 0.2064 0.0 0
M  V30 7 O 0.0000 2.8736 0.0 0
M  V30 8 C 5.3900 1.5400 0.0 0
M  V30 9 C 4.6200 0.2064 0.0 0
M  V30 10 C 4.6200 2.8736 0.0 0
M  V30 11 C 3.0800 0.2064 0.0 0
M  V30 12 C 3.0800 2.8736 0.0 0
M  V30 13 C 2.3100 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-nitrobenzenesulfonamide
C7H8N2O4S
6319-45-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 4.6201 0.0 0 VAL=6
M  V30 2 N 8.0023 5.3901 0.0 0
M  V30 3 O 5.8985 5.9538 0.0 0
M  V30 4 O 7.4385 3.2864 0.0 0
M  V30 5 C 9.3360 4.6201 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 0.0000 2.3101 0.0 0
M  V30 8 O 1.3337 0.0000 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 2.6675 3.8501 0.0 0
M  V30 13 C 4.0012 1.5400 0.0 0
M  V30 14 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 1 2 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-74-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6319-45-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-3569684
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: A. Step 1: Preparation of
Substituted-4-nitro-benzenesulfonamides: To 1 equiv. of
4-nitrobenzenesulfonyl chloride as a 0.1 M solution in CH2Cl2 is added
1.25 eq of i-Pr2NEt, 0.1 equiv. of DMAP and 1.25 equiv. of amine. This
mixture is stirred at 23°C. until judged complete by TLC. After quenching
with sat. NaHCO3 solution and separation of the organic and aqueous
layers, the organic layer is evaporated to yield nearly pure
4-nitrobenzenesulfonamides as off-white to colorless solids. Yield 100%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidine sulfonamide analogs and their use as agonists
of the wnt-β-catenin cellular messaging system for treating cancer, bone
disorders, and Alzheimer's disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hauze, Diane Barbara; Bursavich, Matthew Gregory; Felix, Luciana De
Araujo; Gilbert, Adam Matthew; Pelletier, Jeffrey Claude
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20090048282 A1 2009-02-19

$RFMT $RIREG SCHEME153 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-amino-3-methyl-2-benzofurancarboxylate
C12H13NO3
99245-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0203 5.3182 0.0 0
M  V30 2 N 0.0000 4.0010 0.0 0
M  V30 3 C 6.0811 3.9554 0.0 0
M  V30 4 O 7.4148 3.1854 0.0 0
M  V30 5 O 6.0811 5.4955 0.0 0
M  V30 6 C 8.7486 3.9554 0.0 0
M  V30 7 C 10.0823 3.1854 0.0 0
M  V30 8 C 2.3101 2.6673 0.0 0
M  V30 9 C 3.0801 1.3337 0.0 0
M  V30 10 C 3.3405 3.8119 0.0 0
M  V30 11 C 0.7700 2.6673 0.0 0
M  V30 12 O 4.5865 1.6538 0.0 0
M  V30 13 C 2.3101 0.0000 0.0 0
M  V30 14 C 4.7475 3.1854 0.0 0
M  V30 15 C 0.0000 1.3337 0.0 0
M  V30 16 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 14
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 14
M  V30 16 1 13 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Benzofurancarboxamide, 4-amino-N,3-dimethyl-
C11H12N2O2
2422053-76-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6079 0.3695 0.0 0
M  V30 2 N 1.3337 0.0000 0.0 0
M  V30 3 C 6.5771 3.0800 0.0 0
M  V30 4 N 7.3471 4.4137 0.0 0
M  V30 5 O 7.3471 1.7464 0.0 0
M  V30 6 C 8.8871 4.4137 0.0 0
M  V30 7 C 2.6673 3.8500 0.0 0
M  V30 8 C 2.6673 2.3100 0.0 0
M  V30 9 O 4.1320 4.3259 0.0 0
M  V30 10 C 1.3337 4.6201 0.0 0
M  V30 11 C 4.1320 1.8342 0.0 0
M  V30 12 C 1.3337 1.5400 0.0 0
M  V30 13 C 5.0371 3.0800 0.0 0
M  V30 14 C 0.0000 3.8500 0.0 0
M  V30 15 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 12
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 13
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 13
M  V30 15 1 12 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 99245-00-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2422053-76-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-23050746
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-substituted pyridoazepinyl and pyridodiazepinyl
acrylamides as antibiotics for the treatment of N. gonorrhoeae infections
and related infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gerusz, Vincent; Tatsis, Vasileios; Sunose, Mihiro; Bravo, Juan; Finn,
Terry
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020099341 A1 2020-05-22

$RFMT $RIREG SCHEME154 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Nitrobenzaldehyde
C7H5NO3
99-61-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 C 6.6687 1.5400 0.0 0
M  V30 5 O 8.0023 2.3101 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 2 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(3-Nitrophenyl)methylene]methanamine
C8H8N2O2
121004-44-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 N 1.3337 3.0801 0.0 0 VAL=5
M  V30 5 O 0.0000 2.3101 0.0 0
M  V30 6 O 1.3337 4.6201 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 4.0012 3.0801 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 C 4.0012 0.0000 0.0 0
M  V30 12 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 99-61-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 121004-44-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-5915719
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7487-88-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substituent-Controlled Annuloselectivity and Stereoselectivity in the
Sulfa-Staudinger Cycloadditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Zhanhui; Chen, Ning; Xu, Jiaxi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2015), 80(7), 3611-3620

$RFMT $RIREG SCHEME155 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
p-Chloroacetophenone
C8H7ClO
99-91-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Cl 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[1-(4-Chlorophenyl)ethylidene]methanamine
C9H10ClN
118761-93-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 C 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 Cl 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 6.1601 0.0000 0.0 0
M  V30 10 C 6.1601 2.6673 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 99-91-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 118761-93-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-15410813
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: I. Synthesis of ureas To a stirred solution of
CH3NH2 (8M in EtOH, 4 eq.), the ketone (1 eq.) and M.S. 4Å (250 mg /
mmol) were sequentially added at r.t.. The reaction was stirred for 48h
at r.t. in the case of acetophenone derivatives or at 50°C in the case of
propiophenone derivatives, filtered on celite and washed with CH2Cl2.*
The organic phases were combined and concentrated under reduce pressure
to give the imine (quantitative) as a pale yellow oil.
$DTYPE RXN:VAR(1):NOTES
$DATUM mol. sieves used, alternatively reaction carried out using microwave
reactor at 125 degree Celsius for 30-60 minutes
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tandem β-alkylation-α-arylation of amines by carbolithiation and
rearrangement of N-carbamoyl enamines (vinyl ureas)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Clayden, Jonathan; Donnard, Morgan; Lefranc, Julien; Minassi, Alberto;
Tetlow, Daniel J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2010), 132(19), 6624-6625

$RFMT $RIREG SCHEME155 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
p-Chloroacetophenone
C8H7ClO
99-91-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Cl 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[1-(4-Chlorophenyl)ethylidene]methanamine
C9H10ClN
118761-93-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 C 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 Cl 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 6.1601 0.0000 0.0 0
M  V30 10 C 6.1601 2.6673 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 99-91-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 118761-93-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-7253089
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM I. Synthesis of ureas To a stirred solution of CH3NH2 (8M in EtOH, 4
eq.), the ketone (1 eq.) and M.S. 4Å (250 mg / mmol) were sequentially
added at r.t.. The reaction was stirred for 48h at r.t. in the case of
acetophenone derivatives or at 50°C in the case of propiophenone
derivatives, filtered on celite and washed with CH2Cl2.* The organic
phases were combined and concentrated under reduce pressure to give the
imine (quantitative) as a pale yellow oil.
$DTYPE RXN:VAR(1):NOTES
$DATUM mol. sieves used, alternatively reaction carried out using microwave
reactor at 125 degree Celsius for 30-60 minutes
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tandem β-alkylation-α-arylation of amines by carbolithiation and
rearrangement of N-carbamoyl enamines (vinyl ureas)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Clayden, Jonathan; Donnard, Morgan; Lefranc, Julien; Minassi, Alberto;
Tetlow, Daniel J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2010), 132(19), 6624-6625

$RFMT $RIREG SCHEME156 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(7-Bromo-5-iodo-2-benzothiazolyl)-N′-ethylurea
C10H9BrIN3OS
1000289-36-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 2.6674 0.0000 0.0 0
M  V30 2 N 7.9110 3.0800 0.0 0
M  V30 3 C 8.6810 4.4137 0.0 0
M  V30 4 N 10.2210 4.4137 0.0 0
M  V30 5 O 7.9110 5.7473 0.0 0
M  V30 6 C 10.9910 5.7473 0.0 0
M  V30 7 C 12.5310 5.7473 0.0 0
M  V30 8 I 0.0000 4.6200 0.0 0
M  V30 9 C 4.0011 3.8500 0.0 0
M  V30 10 C 4.0011 2.3100 0.0 0
M  V30 11 N 5.4658 4.3259 0.0 0
M  V30 12 C 2.6674 4.6200 0.0 0
M  V30 13 S 5.4658 1.8341 0.0 0
M  V30 14 C 2.6674 1.5400 0.0 0
M  V30 15 C 6.3710 3.0800 0.0 0
M  V30 16 C 1.3338 3.8500 0.0 0
M  V30 17 C 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 1 2 15
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 16
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 13 15
M  V30 17 1 14 17
M  V30 18 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(7-Bromo-5-iodo-2-benzothiazolyl)-3-ethyltetrahydro-5-methyl-1,3,5-triazin-...
C13H14BrIN4OS
1459771-42-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 9.8635 0.0000 0.0 0
M  V30 2 I 12.5310 4.6200 0.0 0
M  V30 3 O 4.6200 5.7473 0.0 0
M  V30 4 C 1.5400 5.7473 0.0 0
M  V30 5 C 0.0000 5.7473 0.0 0
M  V30 6 C 1.5400 0.4126 0.0 0
M  V30 7 C 8.5299 2.3100 0.0 0
M  V30 8 C 8.5299 3.8500 0.0 0
M  V30 9 S 7.0652 1.8341 0.0 0
M  V30 10 C 9.8635 1.5400 0.0 0
M  V30 11 N 7.0652 4.3259 0.0 0
M  V30 12 C 9.8635 4.6200 0.0 0
M  V30 13 C 6.1600 3.0800 0.0 0
M  V30 14 C 11.1972 2.3100 0.0 0
M  V30 15 C 11.1972 3.8500 0.0 0
M  V30 16 N 4.6200 3.0800 0.0 0
M  V30 17 C 3.8500 4.4136 0.0 0
M  V30 18 C 3.8500 1.7462 0.0 0
M  V30 19 N 2.3100 4.4136 0.0 0
M  V30 20 N 2.3100 1.7462 0.0 0
M  V30 21 C 1.5400 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 15
M  V30 3 2 3 17
M  V30 4 1 4 5
M  V30 5 1 4 19
M  V30 6 1 6 20
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 13
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 2 14 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1000289-36-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1459771-42-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-315-CAS-7245657
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM paraformaldehyde used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery and in vivo evaluation of alcohol-containing benzothiazoles as
potent dual-targeting bacterial DNA supercoiling inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Palmer, James T.; Axford, Lorraine C.; Barker, Stephanie; Bennett, James
M.; Blair, Michael; Collins, Ian; Davies, David T.; Ford, Leigh; Gannon,
Carlie T.; Lancett, Paul; Logan, Alastair; Lunniss, Christopher J.;
Morton, Craig J.; Offermann, Daniel A.; Pitt, Gary R. W.; Rao, B.
Narasinga; Singh, Amit K.; Shukla, Tarun; Srivastava, Anil; Stokes, Neil
R.; Thomaides-Brears, Helena B.; Yadav, Anju; Haydon, David J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2014), 24(17), 4215-4222

$RFMT $RIREG SCHEME157 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Dimethylamino)benzaldehyde
C9H11NO
100-10-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 C 6.6687 4.6201 0.0 0
M  V30 5 O 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 2 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,N-Dimethyl-4-[(methylimino)methyl]benzenamine
C10H14N2
877-79-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0
M  V30 2 C 1.3337 0.0000 0.0 0
M  V30 3 C 0.0000 2.3101 0.0 0
M  V30 4 C 6.6685 4.6201 0.0 0
M  V30 5 N 8.0023 3.8501 0.0 0
M  V30 6 C 9.3360 4.6201 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 2.6675 3.8501 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0012 4.6201 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 7
M  V30 4 2 4 5 CFG=2
M  V30 5 1 4 12
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-10-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 877-79-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-263204
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Syntheses of the various Schiff bases were
carried out according to the literature by combining the given aromatic
aldehyde (1 mmol) with the corresponding amine (1.1 mmol). In cases where
either the aldehyde or the amine was solid, ethanol (∼3 mL) was used to
solubilize the reagents. The reaction was allowed to stir under ambient
conditions for 12 hours. In cases where a precipitate was noted, the
product was isolated by filtration and washed with cold ethanol (∼2 mL)
to afford pure product. When both reagents were initially liquids, the
solvents and excess amine were removed in vacuo. All Schiff base
reactions gave at, or near, quantitative yields (Scheme 2, A). Schiff
base, reactant of compound 7a.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, no solvent or EtOH used for solid reactants
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient synthesis of new 4-arylideneimidazolin-5-ones related to the
GFP chromophore by 2+3 cyclocondensation of arylideneimines with imidate
ylides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baldridge, Anthony; Kowalik, Janusz; Tolbert, Laren M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2010), (14), 2424-2436

$RFMT $RIREG SCHEME158 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-3-nitrobenzonitrile
C7H3FN2O2
1009-35-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 F 1.3337 4.6201 0.0 0
M  V30 5 C 6.6686 1.5400 0.0 0
M  V30 6 N 8.0022 0.7700 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 2.6675 3.8500 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 4.0011 4.6201 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 9
M  V30 5 3 5 6
M  V30 6 1 5 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzonitrile, 4-(methylamino)-3-nitro-
C8H7N3O2
64910-45-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0 VAL=5
M  V30 2 O 0.7700 1.3338 0.0 0
M  V30 3 O 3.0800 0.0000 0.0 0
M  V30 4 N 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 C 6.9300 4.0011 0.0 0
M  V30 7 N 8.4700 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 3 6 7
M  V30 7 1 6 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1009-35-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 64910-45-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38477193
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Leucettinibs, a class of DYRK/CLK kinase inhibitors inspired by the
marine sponge natural product Leucettamine B
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deau, Emmanuel; Lindberg, Mattias F.; Miege, Frederic; Roche, Didier;
George, Nicolas; George, Pascal; Kramer, Andreas; Knapp, Stefan; Meijer,
Laurent
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(15), 10694-10714

$RFMT $RIREG SCHEME159 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indole-6-carboxaldehyde
C9H7NO
1196-70-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 O 7.7047 2.3100 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 C 2.3699 0.7700 0.0 0
M  V30 5 C 3.7036 3.0800 0.0 0
M  V30 6 N 0.9052 2.7859 0.0 0
M  V30 7 C 3.7036 0.0000 0.0 0
M  V30 8 C 0.9052 0.2941 0.0 0
M  V30 9 C 5.0372 2.3100 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 11 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1H-indole-6-methanamine
C10H12N2
3468-21-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 N 7.7047 2.3100 0.0 0
M  V30 3 C 9.0383 3.0800 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 C 2.3699 0.7700 0.0 0
M  V30 6 C 3.7036 3.0800 0.0 0
M  V30 7 N 0.9052 2.7859 0.0 0
M  V30 8 C 3.7036 0.0000 0.0 0
M  V30 9 C 0.9052 0.2941 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 12 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1196-70-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3468-21-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31843856
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-Guided Identification of DNMT3B Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Newton, Ana S.; Faver, John C.; Micevic, Goran; Muthusamy, Viswanathan;
Kudalkar, Shalley N.; Bertoletti, Nicole; Anderson, Karen S.; Bosenberg,
Marcus W.; Jorgensen, William L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2020), 11(5), 971-976

$RFMT $RIREG SCHEME160 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Hydroxybenzaldehyde
C7H6O2
123-08-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 O 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(Methylimino)methyl]phenol
C8H9NO
5766-74-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 1.3337 0.0 0
M  V30 2 N 6.9301 2.6673 0.0 0
M  V30 3 C 8.4701 2.6673 0.0 0
M  V30 4 O 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-08-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5766-74-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-15172471
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Syntheses of the various Schiff bases were
carried out according to the literature by combining the given aromatic
aldehyde (1 mmol) with the corresponding amine (1.1 mmol). In cases where
either the aldehyde or the amine was solid, ethanol (∼3 mL) was used to
solubilize the reagents. The reaction was allowed to stir under ambient
conditions for 12 hours. In cases where a precipitate was noted, the
product was isolated by filtration and washed with cold ethanol (∼2 mL)
to afford pure product. When both reagents were initially liquids, the
solvents and excess amine were removed in vacuo. All Schiff base
reactions gave at, or near, quantitative yields (Scheme 2, A). Schiff
base, reactant of compound 14a.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, no solvent or EtOH used for solid reactants
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient synthesis of new 4-arylideneimidazolin-5-ones related to the
GFP chromophore by 2+3 cyclocondensation of arylideneimines with imidate
ylides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baldridge, Anthony; Kowalik, Janusz; Tolbert, Laren M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2010), (14), 2424-2436

$RFMT $RIREG SCHEME161 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl α-[(2-chloroacetyl)amino]-α-methyl-3-nitrobenzeneacetate
C12H13ClN2O5
1350523-71-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 3.8500 0.0 0
M  V30 2 N 7.7000 3.8500 0.0 0
M  V30 3 C 6.1600 2.3100 0.0 0
M  V30 4 C 6.1600 5.3900 0.0 0
M  V30 5 C 8.4700 5.1836 0.0 0
M  V30 6 O 7.4936 1.5400 0.0 0
M  V30 7 O 4.8264 1.5400 0.0 0
M  V30 8 C 10.0100 5.1836 0.0 0
M  V30 9 O 7.7000 6.5173 0.0 0
M  V30 10 C 7.4936 0.0000 0.0 0
M  V30 11 Cl 10.7800 6.5173 0.0 0
M  V30 12 N 1.5400 6.5173 0.0 0 VAL=5
M  V30 13 O 2.3100 7.8509 0.0 0
M  V30 14 O 0.0000 6.5173 0.0 0
M  V30 15 C 4.6200 3.8500 0.0 0
M  V30 16 C 3.8500 5.1836 0.0 0
M  V30 17 C 3.8500 2.5162 0.0 0
M  V30 18 C 2.3100 5.1836 0.0 0
M  V30 19 C 2.3100 2.5162 0.0 0
M  V30 20 C 1.5400 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 15
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 2 3 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 2 12 13
M  V30 13 2 12 14
M  V30 14 1 12 18
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Dimethyl-3-(3-nitrophenyl)-2,5-piperazinedione
C12H13N3O4
1350523-40-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.8925 5.5397 0.0 0
M  V30 2 O 7.8745 6.0664 0.0 0
M  V30 3 C 10.2339 4.0865 0.0 0
M  V30 4 O 6.8048 0.0000 0.0 0
M  V30 5 N 1.5400 6.6904 0.0 0 VAL=5
M  V30 6 O 0.0000 6.6904 0.0 0
M  V30 7 O 2.3100 8.0240 0.0 0
M  V30 8 C 6.1600 4.0231 0.0 0
M  V30 9 C 7.6071 4.5498 0.0 0
M  V30 10 N 5.8925 2.5065 0.0 0
M  V30 11 N 8.7868 3.5599 0.0 0
M  V30 12 C 7.0723 1.5166 0.0 0
M  V30 13 C 8.5194 2.0433 0.0 0
M  V30 14 C 4.6200 4.0231 0.0 0
M  V30 15 C 3.8500 5.3567 0.0 0
M  V30 16 C 3.8500 2.6893 0.0 0
M  V30 17 C 2.3100 5.3567 0.0 0
M  V30 18 C 2.3100 2.6893 0.0 0
M  V30 19 C 1.5400 4.0231 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 9
M  V30 3 1 3 11
M  V30 4 2 4 12
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 17
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 14
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1350523-71-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1350523-40-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-1430896
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rational design and synthesis of aminopiperazinones as β-secretase (BACE)
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tresadern, Gary; Delgado, Francisca; Delgado, Oscar; Gijsen, Harrie;
Macdonald, Gregor J.; Moechars, Dieder; Rombouts, Frederik; Alexander,
Richard; Spurlino, John; Van Gool, Michiel; Vega, Juan Antonio; Trabanco,
Andres A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2011), 21(24), 7255-7260

$RFMT $RIREG SCHEME162 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl acetoacetate
C6H10O3
141-97-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 O 5.3348 2.3100 0.0 0
M  V30 5 O 4.0011 0.0000 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 6.6686 1.5400 0.0 0
M  V30 9 C 8.0022 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (2Z)-3-(methylamino)-2-butenoate
C7H13NO2
21759-70-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8501 1.3337 0.0 0
M  V30 2 C 4.6201 2.6673 0.0 0
M  V30 3 C 2.3101 1.3337 0.0 0
M  V30 4 O 6.1601 2.6673 0.0 0
M  V30 5 O 3.8501 4.0010 0.0 0
M  V30 6 N 1.5400 2.6673 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 C 6.9302 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 10 C 8.4702 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 141-97-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 21759-70-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-23327876
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Electrochemical Oxidative Cyclization: Synthesis of Polysubstituted
Pyrrole from Enamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Zhiwei; Shi, Guang; Tang, Wei; Sun, Jie; Wang, Wenxing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2021), 2021(6), 951-955

$RFMT $RIREG SCHEME163 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl acetoacetate
C6H10O3
141-97-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 O 5.3348 2.3100 0.0 0
M  V30 5 O 4.0011 0.0000 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 6.6686 1.5400 0.0 0
M  V30 9 C 8.0022 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Butenoic acid, 3-(methylamino)-, ethyl ester
C7H13NO2
870-85-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.3101 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 C 2.6675 1.5400 0.0 0
M  V30 4 O 6.6685 2.3101 0.0 0
M  V30 5 O 5.3348 0.0000 0.0 0
M  V30 6 N 1.3337 2.3101 0.0 0
M  V30 7 C 2.6675 0.0000 0.0 0
M  V30 8 C 8.0023 1.5400 0.0 0
M  V30 9 C 0.0000 1.5400 0.0 0
M  V30 10 C 9.3360 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 141-97-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 870-85-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-3557360
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7631-86-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Synthesis of β -Amino-α , β -Unsaturated
Esters and Ketones; General Procedure Amine 2 (12 mmol, pure amine, or
ammonia or amine in an aqueous solution) was added dropwise to the
suspension of silica gel (100 mg, 10 mg for diketone, Qingdao Ocean
Chemical Industrial Co.) in the dicarbonylic compound 1 (10 mmol) and the
resulting mixture was stirred at room temperature for 10 min-24 hr
(monitored by TLC). For liquid products, crude products were obtained
after removal of silica gel by filtration. Pure liquid products were
obtained by purification on a silica gel column. For solid products,
crude products were obtained after extraction with dichloromethane and
removal of solvent. The purification was performed by column
chromatography on silica gel using hexane /acetone as eluent. Table1. 3g,
yield 99%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A convenient and effective method for synthesizing
β-amino-α,β-unsaturated esters and ketones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gao, Yuanhe; Zhang, Qihan; Xu, Jiaxi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2004), 34(5), 909-916

$RFMT $RIREG SCHEME164 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl acetoacetate
C8H14O3
1694-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 C 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6687 1.3337 0.0 0
M  V30 10 C 8.0023 0.5637 0.0 0
M  V30 11 O 6.6687 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2Z)-3-(methylamino)-2-butenoate
C9H17NO2
1240195-02-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.1037 2.6675 0.0 0
M  V30 2 C 1.3337 4.0012 0.0 0
M  V30 3 C 3.6437 2.6675 0.0 0
M  V30 4 C 2.6673 4.7712 0.0 0
M  V30 5 C 0.5637 5.3350 0.0 0
M  V30 6 C 0.0000 3.2311 0.0 0
M  V30 7 C 4.4137 1.3338 0.0 0
M  V30 8 O 4.4137 4.0012 0.0 0
M  V30 9 C 5.9538 1.3338 0.0 0
M  V30 10 N 6.7238 2.6675 0.0 0
M  V30 11 C 6.7238 0.0000 0.0 0
M  V30 12 C 8.2638 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 2 7 9
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1694-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1240195-02-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-19211762
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, silica gel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted 6-(1H-pyrazol-1-yl)pyrimidin-4-amine
derivatives as Npt2a inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Giese, Anja; Klar, Juergen; Ehrmann, Alexander; Willwacher, Jens; Engel,
David; Dieskau, Andre Philippe; Kahnert, Antje; Gromov, Alexey; Schmeck,
Carsten; Lindner, Niels; Mueller, Thomas; Andreevski, Anna Lena; Dreher,
Jan; Collins, Karl
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018069222 A1 2018-04-19

$RFMT $RIREG SCHEME165 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
O,S-Dimethyl carbonodithioate
C3H6OS2
19708-81-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 1.5400 0.0 0
M  V30 2 O 1.3338 2.3100 0.0 0
M  V30 3 S 4.0011 2.3100 0.0 0
M  V30 4 S 2.6674 0.0000 0.0 0
M  V30 5 C 0.0000 1.5400 0.0 0
M  V30 6 C 5.3349 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
O-Methyl N-methylcarbamothioate
C3H7NOS
14128-35-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 1.5400 0.0 0
M  V30 2 N 1.3338 2.3100 0.0 0
M  V30 3 O 4.0011 2.3100 0.0 0
M  V30 4 S 2.6674 0.0000 0.0 0
M  V30 5 C 0.0000 1.5400 0.0 0
M  V30 6 C 5.3349 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 19708-81-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14128-35-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-10587417
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM O,N-dimethyl thiocarbamate. A 40% methylamine aqueous solution (g 13.95;
moles 0.180) is dropwise added, during 10-15 minutes, into the
O,S-dimethyl dithiocarbonate (g 20.00; moles 0.164) placed into a 100 ml
flask, while stirring. The mixture temperature is maintained at about
20°C by means of a refrigerating bath. The reaction is exothermic and
produces methanthiol, which is absorbed by a sodium hydroxide aqueous
solution. The course of the reaction is monitored through GC and 1H NMR
analysis. After 2 hours the reaction is completed. The reaction mixture
is then extracted with methylene chloride and the gathered organic
extracts are washed in little water, made anhydrous with anhydrous sodium
sulphate and made to evaporate by means of a rotating evaporator. The
residue is constituted by g 17.21 (99.9% yield) of virtually pure (CG,
CG-MS, 1H NMR analysis) O,N-dimethyl thiocarbamate: colourless oil,
O,N-dimethyl thiocarbamate, 17.21g (99.9% yield). b.p. 122-123°C/45 mm
Hg; MS: m/e 105(M+); 1H NMR (CDCl3), eis- and trans- rotamers: δ = 2.81
and 3.03 (2 d, J= 5.12 Hz, 3 H, N-CH3), 3.92 and 4.01 (2 s, 3 H, O-CH3),
6.45 and 7.12 ppm (2 enlarged s, 1H, NH).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for preparing alkylureas from O,S-dimethyl dithiocarbonate
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pallucca, Edoardo; Degani, Jacopo; Serri, Anna Maria; Fochi, Rita;
Gazzetto, Sonia; Fenoglio, Claudia; Ornati, Claudio; Migliaccio, Mara;
Cadamuro, Silvano; Carvoli, Gianni
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP1334965 A1 2003-08-13

$RFMT $RIREG SCHEME166 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2-Dichloro-4-fluoro-5-nitrobenzene
C6H2Cl2FNO2
2339-78-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6675 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0011 0.0 0
M  V30 3 O 0.0000 1.3338 0.0 0
M  V30 4 F 2.3100 0.0000 0.0 0
M  V30 5 Cl 5.3901 5.3349 0.0 0
M  V30 6 Cl 6.9301 2.6675 0.0 0
M  V30 7 C 2.3100 2.6675 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 4.6201 1.3338 0.0 0
M  V30 11 C 4.6201 4.0011 0.0 0
M  V30 12 C 5.3901 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 11
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,5-Dichloro-N-methyl-2-nitrobenzenamine
C7H6Cl2N2O2
107342-18-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 4.0012 0.0 0 VAL=5
M  V30 2 O 0.0000 2.6675 0.0 0
M  V30 3 O 0.0000 5.3348 0.0 0
M  V30 4 N 2.3101 1.3338 0.0 0
M  V30 5 C 3.0801 0.0000 0.0 0
M  V30 6 Cl 5.3901 6.6687 0.0 0
M  V30 7 Cl 6.9302 4.0012 0.0 0
M  V30 8 C 2.3101 4.0012 0.0 0
M  V30 9 C 3.0801 2.6675 0.0 0
M  V30 10 C 3.0801 5.3348 0.0 0
M  V30 11 C 4.6201 2.6675 0.0 0
M  V30 12 C 4.6201 5.3348 0.0 0
M  V30 13 C 5.3901 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 1 6 12
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2339-78-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 107342-18-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-11340674
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (d) 4,5-Dichloro-N-methyl-2-nitroaniline
1,2-Dichloro-4-fluoro-5-nitrobenzene (5.00 g, 23.8 mmol) in DMF (5.0 mL)
was added to methylamine (10% in toluene, 80.0 g, 258 mmol) and stirred
at rt overnight. The reaction mixture was filtered through a pad of ALOX
B, washed with DMF/MeOH and concentrated to give the sub-title compound.
Yield 5.22 g (99%). HPLC-method C: Rt= 2.70 min. MS m/z: 221 [M]+.
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of aminobenzimidazole derivatives for use as
anti-inflammatory agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Priepke, Henning; Kuelzer, Raimund; Mack, Juergen; Pfau, Roland;
Stenkamp, Dirk; Pelcman, Benjamin; Roenn, Robert; Lubriks, Dimitrijs;
Suna, Edgars
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012076672 A1 2012-06-14

$RFMT $RIREG SCHEME167 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[2-fluoro-6-(methoxycarbonyl)-3-pyridinyl]-1-piperazineca...
C16H22FN3O4
2589532-03-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 10.0102 0.0000 0.0 0
M  V30 2 C 14.6303 2.6673 0.0 0
M  V30 3 O 15.4003 4.0010 0.0 0
M  V30 4 O 15.4003 1.3337 0.0 0
M  V30 5 C 16.9404 4.0010 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 O 3.0801 4.0010 0.0 0
M  V30 8 O 3.0801 1.3337 0.0 0
M  V30 9 C 1.5400 4.0010 0.0 0
M  V30 10 C 1.5400 2.4610 0.0 0
M  V30 11 C 0.0000 4.0010 0.0 0
M  V30 12 C 1.5400 5.5410 0.0 0
M  V30 13 C 10.0102 2.6673 0.0 0
M  V30 14 C 10.7802 1.3337 0.0 0
M  V30 15 C 10.7802 4.0010 0.0 0
M  V30 16 N 12.3203 1.3337 0.0 0
M  V30 17 C 12.3203 4.0010 0.0 0
M  V30 18 C 13.0903 2.6673 0.0 0
M  V30 19 N 8.4702 2.6673 0.0 0
M  V30 20 C 7.7002 4.0010 0.0 0
M  V30 21 C 7.7002 1.3337 0.0 0
M  V30 22 C 6.1601 4.0010 0.0 0
M  V30 23 C 6.1601 1.3337 0.0 0
M  V30 24 N 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 24
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[2-fluoro-6-[(methylamino)carbonyl]-3-pyridinyl]-1-pipera...
C16H23FN4O3
2589532-04-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 10.0102 0.0000 0.0 0
M  V30 2 C 14.6303 2.6673 0.0 0
M  V30 3 N 15.4003 4.0010 0.0 0
M  V30 4 O 15.4003 1.3337 0.0 0
M  V30 5 C 16.9404 4.0010 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 O 3.0801 4.0010 0.0 0
M  V30 8 O 3.0801 1.3337 0.0 0
M  V30 9 C 1.5400 4.0010 0.0 0
M  V30 10 C 1.5400 2.4610 0.0 0
M  V30 11 C 0.0000 4.0010 0.0 0
M  V30 12 C 1.5400 5.5410 0.0 0
M  V30 13 C 10.0102 2.6673 0.0 0
M  V30 14 C 10.7802 1.3337 0.0 0
M  V30 15 C 10.7802 4.0010 0.0 0
M  V30 16 N 12.3203 1.3337 0.0 0
M  V30 17 C 12.3203 4.0010 0.0 0
M  V30 18 C 13.0903 2.6673 0.0 0
M  V30 19 N 8.4702 2.6673 0.0 0
M  V30 20 C 7.7002 1.3337 0.0 0
M  V30 21 C 7.7002 4.0010 0.0 0
M  V30 22 C 6.1601 1.3337 0.0 0
M  V30 23 C 6.1601 4.0010 0.0 0
M  V30 24 N 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 24
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2589532-03-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2589532-04-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42578744
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of piperazinyl picolinamide derivatives and methods of use
thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kankanala, Jayakanth; Pettigrew, Jeremy D.; Pham, Son Minh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024178127 A1 2024-08-29

$RFMT $RIREG SCHEME167 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[2-fluoro-6-(methoxycarbonyl)-3-pyridinyl]-1-piperazineca...
C16H22FN3O4
2589532-03-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 10.0102 0.0000 0.0 0
M  V30 2 C 14.6303 2.6673 0.0 0
M  V30 3 O 15.4003 4.0010 0.0 0
M  V30 4 O 15.4003 1.3337 0.0 0
M  V30 5 C 16.9404 4.0010 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 O 3.0801 4.0010 0.0 0
M  V30 8 O 3.0801 1.3337 0.0 0
M  V30 9 C 1.5400 4.0010 0.0 0
M  V30 10 C 1.5400 2.4610 0.0 0
M  V30 11 C 0.0000 4.0010 0.0 0
M  V30 12 C 1.5400 5.5410 0.0 0
M  V30 13 C 10.0102 2.6673 0.0 0
M  V30 14 C 10.7802 1.3337 0.0 0
M  V30 15 C 10.7802 4.0010 0.0 0
M  V30 16 N 12.3203 1.3337 0.0 0
M  V30 17 C 12.3203 4.0010 0.0 0
M  V30 18 C 13.0903 2.6673 0.0 0
M  V30 19 N 8.4702 2.6673 0.0 0
M  V30 20 C 7.7002 4.0010 0.0 0
M  V30 21 C 7.7002 1.3337 0.0 0
M  V30 22 C 6.1601 4.0010 0.0 0
M  V30 23 C 6.1601 1.3337 0.0 0
M  V30 24 N 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 24
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[2-fluoro-6-[(methylamino)carbonyl]-3-pyridinyl]-1-pipera...
C16H23FN4O3
2589532-04-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 10.0102 0.0000 0.0 0
M  V30 2 C 14.6303 2.6673 0.0 0
M  V30 3 N 15.4003 4.0010 0.0 0
M  V30 4 O 15.4003 1.3337 0.0 0
M  V30 5 C 16.9404 4.0010 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 O 3.0801 4.0010 0.0 0
M  V30 8 O 3.0801 1.3337 0.0 0
M  V30 9 C 1.5400 4.0010 0.0 0
M  V30 10 C 1.5400 2.4610 0.0 0
M  V30 11 C 0.0000 4.0010 0.0 0
M  V30 12 C 1.5400 5.5410 0.0 0
M  V30 13 C 10.0102 2.6673 0.0 0
M  V30 14 C 10.7802 1.3337 0.0 0
M  V30 15 C 10.7802 4.0010 0.0 0
M  V30 16 N 12.3203 1.3337 0.0 0
M  V30 17 C 12.3203 4.0010 0.0 0
M  V30 18 C 13.0903 2.6673 0.0 0
M  V30 19 N 8.4702 2.6673 0.0 0
M  V30 20 C 7.7002 1.3337 0.0 0
M  V30 21 C 7.7002 4.0010 0.0 0
M  V30 22 C 6.1601 1.3337 0.0 0
M  V30 23 C 6.1601 4.0010 0.0 0
M  V30 24 N 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 24
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2589532-03-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2589532-04-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42575110
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of piperazinyl picolinamide derivatives as PARP1 modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kankanala, Jayakanth; Pettigrew, Jeremy D.; Pham, Son Minh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024178125 A1 2024-08-29

$RFMT $RIREG SCHEME168 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N,N′-[[4-[11-[[(1,1-dimethylethoxy)carbonyl]amino]-2,3,4,5,6,7...
C35H57N7O8
2676164-76-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  50 51 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 17.9368 11.1789 0.0 0
M  V30 2 C 19.4431 11.4992 0.0 0
M  V30 3 O 20.4735 10.3547 0.0 0
M  V30 4 O 19.9190 12.9637 0.0 0
M  V30 5 C 21.9800 10.6748 0.0 0
M  V30 6 C 21.6598 12.1812 0.0 0
M  V30 7 C 23.4862 10.9950 0.0 0
M  V30 8 C 22.3001 9.1685 0.0 0
M  V30 9 O 15.4000 9.3358 0.0 0
M  V30 10 C 12.3200 9.3358 0.0 0
M  V30 11 C 10.7800 9.3358 0.0 0
M  V30 12 C 10.0100 8.0021 0.0 0
M  V30 13 C 8.4700 8.0021 0.0 0
M  V30 14 N 7.7000 6.6685 0.0 0
M  V30 15 C 6.1600 6.6685 0.0 0
M  V30 16 N 5.3900 8.0021 0.0 0
M  V30 17 N 5.3900 5.3347 0.0 0
M  V30 18 C 3.8500 8.0021 0.0 0
M  V30 19 C 6.1600 4.0011 0.0 0
M  V30 20 O 3.0800 9.3358 0.0 0
M  V30 21 O 3.0800 6.6685 0.0 0
M  V30 22 O 5.3900 2.6674 0.0 0
M  V30 23 O 7.7000 4.0011 0.0 0
M  V30 24 C 1.5400 9.3358 0.0 0
M  V30 25 C 6.1600 1.3338 0.0 0
M  V30 26 C 1.5400 7.7958 0.0 0
M  V30 27 C 0.0000 9.3358 0.0 0
M  V30 28 C 1.5400 10.8758 0.0 0
M  V30 29 C 4.8262 0.5638 0.0 0
M  V30 30 C 6.9300 0.0000 0.0 0
M  V30 31 C 7.4936 2.1038 0.0 0
M  V30 32 C 16.5127 16.4640 0.0 0
M  V30 33 C 15.2668 17.3692 0.0 0
M  V30 34 C 16.3517 14.9325 0.0 0
M  V30 35 C 17.9196 17.0903 0.0 0
M  V30 36 C 15.4277 18.9007 0.0 0
M  V30 37 O 13.8600 16.7429 0.0 0
M  V30 38 N 17.3821 13.7879 0.0 0
M  V30 39 C 18.0805 18.6220 0.0 0
M  V30 40 C 16.8347 19.5272 0.0 0
M  V30 41 C 12.4531 17.3692 0.0 0
M  V30 42 C 16.9063 12.3234 0.0 0
M  V30 43 C 11.2072 16.4640 0.0 0
M  V30 44 N 15.4000 12.0032 0.0 0
M  V30 45 C 11.3681 14.9325 0.0 0
M  V30 46 C 14.6300 10.6696 0.0 0
M  V30 47 C 10.3377 13.7879 0.0 0
M  V30 48 N 13.0900 10.6696 0.0 0
M  V30 49 C 10.8136 12.3234 0.0 0
M  V30 50 C 12.3200 12.0032 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 42
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 2 9 46
M  V30 10 1 10 11
M  V30 11 1 10 48
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 2 14 15
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 18 21
M  V30 22 1 19 22
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 1 22 25
M  V30 26 1 24 26
M  V30 27 1 24 27
M  V30 28 1 24 28
M  V30 29 1 25 29
M  V30 30 1 25 30
M  V30 31 1 25 31
M  V30 32 1 32 33
M  V30 33 1 32 34
M  V30 34 2 32 35
M  V30 35 2 33 36
M  V30 36 1 33 37
M  V30 37 1 34 38
M  V30 38 1 35 39
M  V30 39 1 36 40
M  V30 40 1 37 41
M  V30 41 1 38 42
M  V30 42 2 39 40
M  V30 43 1 41 43
M  V30 44 2 42 44
M  V30 45 1 43 45
M  V30 46 1 44 46
M  V30 47 1 45 47
M  V30 48 1 46 48
M  V30 49 1 47 49
M  V30 50 1 48 50
M  V30 51 1 49 50
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-[8-[4-[[[[(1,1-dimethylethoxy)carbonyl]amino][[(methylamino)...
C32H52N8O7
2676164-80-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  47 48 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.5494 9.8451 0.0 0
M  V30 2 C 4.0431 10.1653 0.0 0
M  V30 3 O 3.0127 9.0209 0.0 0
M  V30 4 O 3.5673 11.6300 0.0 0
M  V30 5 C 1.5063 9.3410 0.0 0
M  V30 6 C 1.1861 7.8348 0.0 0
M  V30 7 C 0.0000 9.6612 0.0 0
M  V30 8 C 1.8264 10.8475 0.0 0
M  V30 9 O 8.0863 8.0020 0.0 0
M  V30 10 C 11.1663 8.0020 0.0 0
M  V30 11 C 12.7063 8.0020 0.0 0
M  V30 12 C 13.4763 6.6684 0.0 0
M  V30 13 C 15.0163 6.6684 0.0 0
M  V30 14 N 15.7863 5.3347 0.0 0
M  V30 15 C 17.3263 5.3347 0.0 0
M  V30 16 N 18.0963 6.6684 0.0 0
M  V30 17 N 18.0963 4.0009 0.0 0
M  V30 18 C 19.6363 6.6684 0.0 0
M  V30 19 C 17.3263 2.6673 0.0 0
M  V30 20 O 20.4063 8.0020 0.0 0
M  V30 21 O 20.4063 5.3347 0.0 0
M  V30 22 N 18.0963 1.3336 0.0 0
M  V30 23 O 15.7863 2.6673 0.0 0
M  V30 24 C 21.9463 8.0020 0.0 0
M  V30 25 C 17.3263 0.0000 0.0 0
M  V30 26 C 21.9463 9.5420 0.0 0
M  V30 27 C 23.4863 8.0020 0.0 0
M  V30 28 C 21.9463 6.4620 0.0 0
M  V30 29 C 6.9736 15.1302 0.0 0
M  V30 30 C 8.2195 16.0354 0.0 0
M  V30 31 C 7.1345 13.5987 0.0 0
M  V30 32 C 5.5667 15.7566 0.0 0
M  V30 33 C 8.0585 17.5670 0.0 0
M  V30 34 O 9.6263 15.4090 0.0 0
M  V30 35 N 6.1041 12.4542 0.0 0
M  V30 36 C 5.4057 17.2882 0.0 0
M  V30 37 C 6.6516 18.1933 0.0 0
M  V30 38 C 11.0332 16.0354 0.0 0
M  V30 39 C 6.5800 10.9896 0.0 0
M  V30 40 C 12.2791 15.1302 0.0 0
M  V30 41 N 8.0863 10.6695 0.0 0
M  V30 42 C 12.1181 13.5987 0.0 0
M  V30 43 C 8.8563 9.3357 0.0 0
M  V30 44 C 13.1486 12.4542 0.0 0
M  V30 45 N 10.3963 9.3357 0.0 0
M  V30 46 C 12.6727 10.9896 0.0 0
M  V30 47 C 11.1663 10.6695 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 39
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 2 9 43
M  V30 10 1 10 11
M  V30 11 1 10 45
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 2 14 15 CFG=2
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 18 21
M  V30 22 1 19 22
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 1 22 25
M  V30 26 1 24 26
M  V30 27 1 24 27
M  V30 28 1 24 28
M  V30 29 1 29 30
M  V30 30 1 29 31
M  V30 31 2 29 32
M  V30 32 2 30 33
M  V30 33 1 30 34
M  V30 34 1 31 35
M  V30 35 1 32 36
M  V30 36 1 33 37
M  V30 37 1 34 38
M  V30 38 1 35 39
M  V30 39 2 36 37
M  V30 40 1 38 40
M  V30 41 2 39 41
M  V30 42 1 40 42
M  V30 43 1 41 43
M  V30 44 1 42 44
M  V30 45 1 43 45
M  V30 46 1 44 46
M  V30 47 1 45 47
M  V30 48 1 46 47
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2676164-76-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2676164-80-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36226471
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery and Optimization of a Novel Macrocyclic Amidinourea Series
Active as Acidic Mammalian Chitinase Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Balestri, Lorenzo Jacopo Ilic; Trivisani, Claudia Immacolata; Orofino,
Francesco; Fiorucci, Diego; Truglio, Giuseppina Ivana; D'Agostino,
Ilaria; Poggialini, Federica; Botta, Lorenzo; Docquier, Jean-Denis;
Dreassi, Elena
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2023), 14(4), 417-424

$RFMT $RIREG SCHEME169 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromobenzenesulfonyl chloride
C6H4BrClO2S
2905-25-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6673 0.0 0 VAL=6
M  V30 2 Cl 6.1600 2.6673 0.0 0
M  V30 3 O 4.6200 4.2073 0.0 0
M  V30 4 O 4.6200 1.1273 0.0 0
M  V30 5 Br 3.0800 0.0000 0.0 0
M  V30 6 C 3.0800 2.6673 0.0 0
M  V30 7 C 2.3100 1.3336 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 0.7700 1.3336 0.0 0
M  V30 10 C 0.7700 4.0011 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methylbenzenesulfonamide
C7H8BrNO2S
98192-14-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6673 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6673 0.0 0
M  V30 3 O 4.6200 4.2073 0.0 0
M  V30 4 O 4.6200 1.1273 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 Br 3.0800 0.0000 0.0 0
M  V30 7 C 3.0800 2.6673 0.0 0
M  V30 8 C 2.3100 1.3336 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 0.7700 1.3336 0.0 0
M  V30 11 C 0.7700 4.0011 0.0 0
M  V30 12 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 2 5
M  V30 6 1 6 8
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2905-25-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 98192-14-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-11869975
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-Bromo-N-methylbenzenesulfonamide (20a); Typical Procedure To a solution
of commercially available 2-bromobenzenesulfonyl chloride (18, 500 mg,
1.96 mmol) in EtOH (20 mL), MeNH2 (0.7 mL, 7.83 mmol) was added and the
mixture was refluxed for 2 h. The residual solvent was evaporated under
reduced pressure and the crude product obtained was purified by column
chromatography (10% EtOAc-PE). 20a 12 (484 mg, 99%) as a white solid. mp
99-101°C; Rf = 0.20 (10% EtOAc-PE).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Regio- and Stereoselective Synthesis of Benzo-δ-sultams by
Palladium-Catalyzed Hydrocarbonation of Alkynes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Debnath, Sudarshan; Mondal, Shovan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2016), 48(5), 710-722

$RFMT $RIREG SCHEME170 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Pyridinecarboxylic acid, 5-bromo-, methyl ester
C7H6BrNO2
29682-15-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 O 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 Br 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 N 4.6201 2.6673 0.0 0
M  V30 9 C 6.1601 0.0000 0.0 0
M  V30 10 C 6.1601 2.6673 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methyl-2-pyridinecarboxamide
C7H7BrN2O
845305-87-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 Br 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 N 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 29682-15-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 845305-87-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34894128
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and in vitro biological evaluation of
3-ethyl-1,5-naphthyridin-2(1H)-one derivatives as potent PARP-1 selective
inhibitors and PARP-1 DNA trappers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ren, Junkang; Quan, Xu; Liu, Ying; Li, Jiani; Zhang, Xiaoyu; Li, Zhiyu;
Zhang, Xiaomeng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2022), 78129046

$RFMT $RIREG SCHEME171 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Hydroxybenzaldehyde
C7H6O2
100-83-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 O 6.6687 2.3101 0.0 0
M  V30 3 O 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(Methylimino)methyl]phenol
C8H9NO
7221-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0800 0.0 0
M  V30 2 N 6.6686 2.3100 0.0 0
M  V30 3 C 8.0022 3.0800 0.0 0
M  V30 4 O 0.0000 3.0800 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6675 3.0800 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 1.3337 2.3100 0.0 0
M  V30 9 C 2.6675 0.0000 0.0 0
M  V30 10 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-83-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 7221-33-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-3580008
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Syntheses of the various Schiff bases were
carried out according to the literature by combining the given aromatic
aldehyde (1 mmol) with the corresponding amine (1.1 mmol). In cases where
either the aldehyde or the amine was solid, ethanol (∼3 mL) was used to
solubilize the reagents. The reaction was allowed to stir under ambient
conditions for 12 hours. In cases where a precipitate was noted, the
product was isolated by filtration and washed with cold ethanol (∼2 mL)
to afford pure product. When both reagents were initially liquids, the
solvents and excess amine were removed in vacuo. All Schiff base
reactions gave at, or near, quantitative yields (Scheme 2, A). Schiff
base, reactant of compound 22a.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, no solvent or EtOH used for solid reactants
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient synthesis of new 4-arylideneimidazolin-5-ones related to the
GFP chromophore by 2+3 cyclocondensation of arylideneimines with imidate
ylides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baldridge, Anthony; Kowalik, Janusz; Tolbert, Laren M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2010), (14), 2424-2436

$RFMT $RIREG SCHEME172 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[(2S)-1-[(Phenylmethoxy)carbonyl]-2-azetidinyl]carbonyl]-L-alanine methyl ...
C16H20N2O5
1013038-61-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.5214 3.6296 0.0 0
M  V30 2 N 11.8550 4.3996 0.0 0
M  V30 3 O 10.5214 2.0895 0.0 0
M  V30 4 C 13.1888 3.6296 0.0 0 CFG=1
M  V30 5 C 14.5225 4.3996 0.0 0
M  V30 6 C 13.1888 2.0895 0.0 0
M  V30 7 O 15.8562 3.6296 0.0 0
M  V30 8 O 14.5225 5.9396 0.0 0
M  V30 9 C 17.1899 4.3996 0.0 0
M  V30 10 C 6.9302 2.6673 0.0 0
M  V30 11 O 5.3901 2.6673 0.0 0
M  V30 12 O 7.7002 1.3337 0.0 0
M  V30 13 C 4.6201 1.3337 0.0 0
M  V30 14 C 9.1877 4.3996 0.0 0 CFG=2
M  V30 15 N 7.7002 4.0010 0.0 0
M  V30 16 C 8.7891 5.8872 0.0 0
M  V30 17 C 7.3015 5.4887 0.0 0
M  V30 18 C 3.0801 1.3337 0.0 0
M  V30 19 C 2.3101 2.6673 0.0 0
M  V30 20 C 2.3101 0.0000 0.0 0
M  V30 21 C 0.7700 2.6673 0.0 0
M  V30 22 C 0.7700 0.0000 0.0 0
M  V30 23 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 14 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6 CFG=3
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 15
M  V30 13 1 11 13
M  V30 14 1 13 18
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Phenylmethyl (2S)-2-[[[(1S)-1-methyl-2-(methylamino)-2-oxoethyl]amino]carbony...
C16H21N3O4
1013038-64-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.5214 3.6296 0.0 0
M  V30 2 N 11.8550 4.3996 0.0 0
M  V30 3 O 10.5214 2.0895 0.0 0
M  V30 4 C 13.1888 3.6296 0.0 0 CFG=1
M  V30 5 C 14.5225 4.3996 0.0 0
M  V30 6 C 13.1888 2.0895 0.0 0
M  V30 7 N 15.8562 3.6296 0.0 0
M  V30 8 O 14.5225 5.9396 0.0 0
M  V30 9 C 17.1899 4.3996 0.0 0
M  V30 10 C 6.9302 2.6673 0.0 0
M  V30 11 O 5.3901 2.6673 0.0 0
M  V30 12 O 7.7002 1.3337 0.0 0
M  V30 13 C 4.6201 1.3337 0.0 0
M  V30 14 C 9.1877 4.3996 0.0 0 CFG=2
M  V30 15 N 7.7002 4.0010 0.0 0
M  V30 16 C 8.7891 5.8872 0.0 0
M  V30 17 C 7.3015 5.4887 0.0 0
M  V30 18 C 3.0801 1.3337 0.0 0
M  V30 19 C 2.3101 2.6673 0.0 0
M  V30 20 C 2.3101 0.0000 0.0 0
M  V30 21 C 0.7700 2.6673 0.0 0
M  V30 22 C 0.7700 0.0000 0.0 0
M  V30 23 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 14 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6 CFG=3
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 15
M  V30 13 1 11 13
M  V30 14 1 13 18
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1013038-61-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1013038-64-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-2739111
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedures for the Preparation of
RCO-Xaa-Ala- NHMe Derivatives. Method A: The corresponding ester (4.22
mmol) was dissolved in MeNH2·EtOH (10 mL, 8M) and reacted over 2-12 h at
room temperature. When necessary, the reaction was purified by flash
chromatography or centrifugal circular thinlayer chromatography, using
the system of eluents indicated in each case. 2(S)-Z-Aze-L-Ala-NHMe (9a):
White solid, 99% yield (from 7a, Method A). (mp 172-174 °C). HPLC: tR =
6.93 min (A:B = 15:85). [α]D -102.25 (c 0.40, CHCl3). 1H NMR (CDCl3): δ
7.26 (m, 6H, NH-Ala, Ph), 6.71 (m, 1H, NH-CH3), 5.07 (d, 1H, J = 12.3 Hz,
CH2-Z), 5.01 (d, 1H, J = 12.3 Hz, CH2-Z), 4.63 (t, 1H, J = 7.7 Hz, H-2),
4.41 (q, 1H, J = 7.0 Hz, α-H, Ala), 3.85 (m, 2H, H-4), 2.65 (d, 3H, J =
4.3 Hz, CH3-NH), 2.35 (m, 2H, H-3), 1.28 (d, 3H, J = 7.0 Hz, β-H, Ala).
1H NMR (DMSO-d6): δ 8.09 (d, 1H, J = 7.2 Hz, NH-Ala), 7.78 (m, 1H,
NH-CH3), 7.32 (m, 5H, Ph), 5.01 (m, 2H, CH2-Z), 4.63 (dd, 1H, J = 8.4,
5.2 Hz, H-2), 4.24 (q, 1H, J = 7.2 Hz, α-H, Ala), 3.87 (m, 2H, H-4), 2.56
(d, 3H, J = 4.6 Hz, CH3-NH), 2.40 (m, 1H, H-3), 2.04 (m, 1H, H-3), 1.15
(m, 3H, β-H, Ala). 13C NMR (CDCl3): δ 172.3 and 170.7 (CON), 157.3
(OCON), 135.7 (C-Ph), 128.4, 128.2, 127.9 (CHPh), 67.2 (CH2-Z), 62.1
(2-C), 48.7 (α-C, Ala), 47.3 (4-C), 25.8 (CH3-NH), 20.2 (3-C), 18.0 (β-C,
Ala). ES-MS: 320.0 [M + 1]+, 342.0 [M + Na]+. Anal. Calcd for C16H21N3O4:
C 60.17, H 6.63, N 13.16. Found: C 60.26, H 6.44, N 13.06.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Azetidine-Derived Amino Acids versus Proline Derivatives. Alternative
Trends in Reverse Turn Induction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baeza, Jose Luis; Gerona-Navarro, Guillermo; Perez de Vega, M. Jesus;
Garcia-Lopez, M. Teresa; Gonzalez-Muniz, Rosario; Martin-Martinez,
Mercedes
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2008), 73(5), 1704-1715

$RFMT $RIREG SCHEME173 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Chlorosulfonyl)benzoic acid
C7H5ClO4S
10130-89-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 1.5400 0.0 0 VAL=6
M  V30 2 Cl 8.4700 1.5400 0.0 0
M  V30 3 O 6.9300 3.0800 0.0 0
M  V30 4 O 6.9300 0.0000 0.0 0
M  V30 5 C 0.7700 1.5400 0.0 0
M  V30 6 O 0.0000 0.2064 0.0 0
M  V30 7 O 0.0000 2.8736 0.0 0
M  V30 8 C 5.3900 1.5400 0.0 0
M  V30 9 C 4.6200 0.2064 0.0 0
M  V30 10 C 4.6200 2.8736 0.0 0
M  V30 11 C 3.0800 0.2064 0.0 0
M  V30 12 C 3.0800 2.8736 0.0 0
M  V30 13 C 2.3100 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(Methylamino)sulfonyl]benzoic acid
C8H9NO4S
10252-63-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 4.6201 0.0 0 VAL=6
M  V30 2 N 8.0023 5.3901 0.0 0
M  V30 3 O 5.8985 5.9538 0.0 0
M  V30 4 O 7.4385 3.2864 0.0 0
M  V30 5 C 9.3360 4.6201 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 O 0.0000 2.3101 0.0 0
M  V30 8 O 1.3337 0.0000 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 2.6675 3.8501 0.0 0
M  V30 13 C 4.0012 1.5400 0.0 0
M  V30 14 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 10130-89-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 10252-63-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-12113199
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 4-(Methylaminosulfonyl)benzoic Acid (2b).
4-Carboxybenzenesulfonyl chloride (1, 1.0 g, 4.5 mmol) was added in
portions to an ice-cooled methylamine solution (40%, 5.0 ml) while
stirring at 5 °C. After 20 minutes, the solution was acidified using
concentrated HCl which were filtered and dried. Yield: 960 mg, 99%, white
solid crystals. m.p.: 228-230 °C. IR (KBr): 3284-2982 (NH, COOH), 1696
(C═O) cm-1. 1H NMR (DMSO-d6): δ = 8.12 (d, 2H, J = 8.4 Hz, Ar), 7.88 (2d,
2H, J = 8.4 Hz, Ar), 7.00 (q, 1H, J = 5 Hz, NH), 2.41 (d, 3H, J = 5 Hz,
CH3) ppm.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and cytotoxicity of 4-sulfonamide substituted
benzamidobenzimidazolones and an acyl benzimidazolone
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Khodarahmi, G. A.; Chen, C. S.; Hakimelahi, G. H.; Tseng, C. T.; Chern,
J. W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the Iranian Chemical Society (2005), 2(2), 124-134

$RFMT $RIREG SCHEME174 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-(2-nitrophenyl)acetamide
C8H7ClN2O3
10147-70-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 4.0011 0.0 0 VAL=5
M  V30 2 O 2.3100 5.3349 0.0 0
M  V30 3 O 0.0000 4.0011 0.0 0
M  V30 4 N 4.6200 4.0011 0.0 0
M  V30 5 C 6.1600 4.0011 0.0 0
M  V30 6 C 6.9300 5.3349 0.0 0
M  V30 7 O 6.9300 2.6674 0.0 0
M  V30 8 Cl 8.4700 5.3349 0.0 0
M  V30 9 C 2.3100 2.6674 0.0 0
M  V30 10 C 3.8500 2.6674 0.0 0
M  V30 11 C 1.5400 1.3338 0.0 0
M  V30 12 C 4.6200 1.3338 0.0 0
M  V30 13 C 2.3100 0.0000 0.0 0
M  V30 14 C 3.8500 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Methylamino)-N-(2-nitrophenyl)acetamide
C9H11N3O3
1152977-15-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 2.3100 0.0 0
M  V30 2 C 5.3347 3.0800 0.0 0
M  V30 3 C 6.6684 2.3100 0.0 0
M  V30 4 O 5.3347 4.6200 0.0 0
M  V30 5 N 8.0021 3.0800 0.0 0
M  V30 6 C 9.3358 2.3100 0.0 0
M  V30 7 N 1.3336 0.7700 0.0 0 VAL=5
M  V30 8 O 0.0000 0.0000 0.0 0
M  V30 9 O 2.6674 0.0000 0.0 0
M  V30 10 C 2.6674 3.0800 0.0 0
M  V30 11 C 1.3336 2.3100 0.0 0
M  V30 12 C 2.6674 4.6200 0.0 0
M  V30 13 C 0.0000 3.0800 0.0 0
M  V30 14 C 1.3336 5.3900 0.0 0
M  V30 15 C 0.0000 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 11
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 10147-70-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1152977-15-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-13096307
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-based design, synthesis, and antifungal activity of new
triazole derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sheng, Chunquan; Che, Xiaoying; Wang, Wenya; Wang, Shengzheng; Cao,
Yongbing; Yao, Jianzhong; Miao, Zhenyuan; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Biology & Drug Design (2011), 78(2), 309-313

$RFMT $RIREG SCHEME175 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-(3-nitrophenyl)acetamide
C8H7ClN2O3
10147-71-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6684 1.5400 0.0 0
M  V30 2 C 8.0022 2.3100 0.0 0
M  V30 3 C 9.3359 1.5400 0.0 0
M  V30 4 O 8.0022 3.8500 0.0 0
M  V30 5 Cl 10.6695 2.3100 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3100 0.0 0
M  V30 9 C 5.3348 2.3100 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 C 5.3348 3.8500 0.0 0
M  V30 12 C 2.6673 2.3100 0.0 0
M  V30 13 C 4.0011 4.6201 0.0 0
M  V30 14 C 2.6673 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Methylamino)-N-(3-nitrophenyl)acetamide
C9H11N3O3
1092306-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 1.5400 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 1.5400 0.0 0
M  V30 4 O 8.0022 3.8501 0.0 0
M  V30 5 N 10.6697 2.3101 0.0 0
M  V30 6 C 12.0033 1.5400 0.0 0
M  V30 7 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 O 1.3337 0.0000 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0012 1.5400 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 4.0012 4.6201 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 13
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 10147-71-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1092306-77-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-10350086
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-based design, synthesis, and antifungal activity of new
triazole derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sheng, Chunquan; Che, Xiaoying; Wang, Wenya; Wang, Shengzheng; Cao,
Yongbing; Yao, Jianzhong; Miao, Zhenyuan; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Biology & Drug Design (2011), 78(2), 309-313

$RFMT $RIREG SCHEME176 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-(1,1-dimethylethyl)-β-oxobenzenepropanoate
C15H20O3
101498-88-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.4137 0.0 0
M  V30 2 C 8.0022 3.6437 0.0 0
M  V30 3 O 6.6685 5.9538 0.0 0
M  V30 4 C 9.3360 4.4137 0.0 0
M  V30 5 O 10.6697 3.6437 0.0 0
M  V30 6 O 9.3358 5.9538 0.0 0
M  V30 7 C 12.0033 4.4137 0.0 0
M  V30 8 C 13.3370 3.6437 0.0 0
M  V30 9 C 1.3337 1.3337 0.0 0
M  V30 10 C 2.1037 0.0000 0.0 0
M  V30 11 C 0.0000 0.5637 0.0 0
M  V30 12 C 0.5637 2.6673 0.0 0
M  V30 13 C 5.3348 3.6437 0.0 0
M  V30 14 C 4.0010 4.4137 0.0 0
M  V30 15 C 5.3348 2.1037 0.0 0
M  V30 16 C 2.6673 3.6437 0.0 0
M  V30 17 C 4.0010 1.3337 0.0 0
M  V30 18 C 2.6673 2.1037 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (2Z)-3-[4-(1,1-dimethylethyl)phenyl]-3-(methylamino)-2-propenoate
C16H23NO2
2614438-02-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.4137 0.0 0
M  V30 2 C 8.0022 3.6437 0.0 0
M  V30 3 N 6.6685 5.9538 0.0 0
M  V30 4 C 9.3360 4.4137 0.0 0
M  V30 5 C 5.3348 6.7238 0.0 0
M  V30 6 O 10.6697 3.6437 0.0 0
M  V30 7 O 9.3360 5.9538 0.0 0
M  V30 8 C 12.0033 4.4137 0.0 0
M  V30 9 C 13.3370 3.6437 0.0 0
M  V30 10 C 1.3337 1.3337 0.0 0
M  V30 11 C 2.1037 0.0000 0.0 0
M  V30 12 C 0.0000 0.5637 0.0 0
M  V30 13 C 0.5637 2.6673 0.0 0
M  V30 14 C 5.3348 3.6437 0.0 0
M  V30 15 C 5.3348 2.1037 0.0 0
M  V30 16 C 4.0010 4.4137 0.0 0
M  V30 17 C 4.0010 1.3337 0.0 0
M  V30 18 C 2.6673 3.6437 0.0 0
M  V30 19 C 2.6673 2.1037 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 19
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 101498-88-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2614438-02-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-23325979
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Electrochemical Oxidative Cyclization: Synthesis of Polysubstituted
Pyrrole from Enamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Zhiwei; Shi, Guang; Tang, Wei; Sun, Jie; Wang, Wenxing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2021), 2021(6), 951-955

$RFMT $RIREG SCHEME177 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-Ethyl (αR,βR)-α-hydroxy-β-[methyl(3-methylphenyl)amino]benzenepropanoate
C19H23NO3
1018836-09-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 4.0011 0.0 0 CFG=1
M  V30 2 N 6.9300 4.0011 0.0 0
M  V30 3 C 4.6200 5.3347 0.0 0 CFG=2
M  V30 4 C 7.7000 2.6674 0.0 0
M  V30 5 C 3.0800 5.3347 0.0 0
M  V30 6 O 5.3900 6.6685 0.0 0
M  V30 7 O 2.3100 6.6685 0.0 0
M  V30 8 O 2.3100 4.0011 0.0 0
M  V30 9 C 0.7700 6.6685 0.0 0
M  V30 10 C 0.0000 8.0021 0.0 0
M  V30 11 C 11.5500 6.6685 0.0 0
M  V30 12 C 4.6200 2.6674 0.0 0
M  V30 13 C 5.3900 1.3336 0.0 0
M  V30 14 C 3.0800 2.6674 0.0 0
M  V30 15 C 4.6200 0.0000 0.0 0
M  V30 16 C 2.3100 1.3336 0.0 0
M  V30 17 C 3.0800 0.0000 0.0 0
M  V30 18 C 7.7000 5.3347 0.0 0
M  V30 19 C 9.2400 5.3347 0.0 0
M  V30 20 C 6.9300 6.6685 0.0 0
M  V30 21 C 10.0100 6.6685 0.0 0
M  V30 22 C 7.7000 8.0021 0.0 0
M  V30 23 C 9.2400 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 2 18
M  V30 6 1 3 5
M  V30 7 1 3 6 CFG=1
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 11 21
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(αR,βR)-α-Hydroxy-N-methyl-β-[methyl(3-methylphenyl)amino]benzenepropanamide
C18H22N2O2
1018836-43-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 4.6201 0.0 0 CFG=1
M  V30 2 N 5.3348 5.3901 0.0 0
M  V30 3 C 4.0012 3.0801 0.0 0 CFG=2
M  V30 4 C 5.3348 6.9302 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 O 5.3348 2.3101 0.0 0
M  V30 7 N 2.6673 0.7700 0.0 0
M  V30 8 O 1.3337 3.0801 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 C 10.6697 5.3901 0.0 0
M  V30 11 C 2.6673 5.3901 0.0 0
M  V30 12 C 1.3337 4.6201 0.0 0
M  V30 13 C 2.6673 6.9302 0.0 0
M  V30 14 C 0.0000 5.3901 0.0 0
M  V30 15 C 1.3337 7.7002 0.0 0
M  V30 16 C 0.0000 6.9302 0.0 0
M  V30 17 C 6.6685 4.6201 0.0 0
M  V30 18 C 8.0023 5.3901 0.0 0
M  V30 19 C 6.6685 3.0801 0.0 0
M  V30 20 C 9.3360 4.6201 0.0 0
M  V30 21 C 8.0023 2.3101 0.0 0
M  V30 22 C 9.3360 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 2 17
M  V30 6 1 3 5
M  V30 7 1 3 6 CFG=3
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 7 9
M  V30 11 1 10 20
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1018836-09-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1018836-43-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8725444
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual
norepinephrine and serotonin reuptake inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vu, An T.; Cohn, Stephen T.; Terefenko, Eugene A.; Moore, William J.;
Zhang, Puwen; Mahaney, Paige E.; Trybulski, Eugene J.; Goljer, Igor;
Dooley, Rebecca; Bray, Jenifer A.; Johnston, Grace H.; Leiter, Jennifer;
Deecher, Darlene C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(9), 2464-2467

$RFMT $RIREG SCHEME178 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-Ethyl (αR,βR)-β-[(2-chlorophenyl)methylamino]-α-hydroxybenzenepropanoate
C18H20ClNO3
1018836-13-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.6200 0.0 0 CFG=1
M  V30 2 N 2.6673 5.3900 0.0 0
M  V30 3 C 5.3347 5.3900 0.0 0 CFG=2
M  V30 4 C 1.3336 4.6200 0.0 0
M  V30 5 C 6.6684 4.6200 0.0 0
M  V30 6 O 5.3347 6.9300 0.0 0
M  V30 7 O 8.0021 5.3900 0.0 0
M  V30 8 O 6.6684 3.0800 0.0 0
M  V30 9 C 9.3358 4.6200 0.0 0
M  V30 10 C 10.6694 5.3900 0.0 0
M  V30 11 Cl 0.0000 6.9300 0.0 0
M  V30 12 C 4.0011 3.0800 0.0 0
M  V30 13 C 2.6673 2.3100 0.0 0
M  V30 14 C 5.3347 2.3100 0.0 0
M  V30 15 C 2.6673 0.7700 0.0 0
M  V30 16 C 5.3347 0.7700 0.0 0
M  V30 17 C 4.0011 0.0000 0.0 0
M  V30 18 C 2.6673 6.9300 0.0 0
M  V30 19 C 1.3336 7.7000 0.0 0
M  V30 20 C 4.0011 7.7000 0.0 0
M  V30 21 C 1.3336 9.2400 0.0 0
M  V30 22 C 4.0011 9.2400 0.0 0
M  V30 23 C 2.6673 10.0100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 2 18
M  V30 6 1 3 5
M  V30 7 1 3 6 CFG=3
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 11 19
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(αR,βR)-β-[(2-Chlorophenyl)methylamino]-α-hydroxy-N-methylbenzenepropanamide
C17H19ClN2O2
1018836-49-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.3347 0.0 0 CFG=1
M  V30 2 N 4.6200 6.6684 0.0 0
M  V30 3 C 4.6200 4.0011 0.0 0 CFG=2
M  V30 4 C 5.3900 8.0021 0.0 0
M  V30 5 C 5.3900 2.6674 0.0 0
M  V30 6 O 3.0800 4.0011 0.0 0
M  V30 7 N 4.6200 1.3336 0.0 0
M  V30 8 O 6.9300 2.6674 0.0 0
M  V30 9 C 5.3900 0.0000 0.0 0
M  V30 10 Cl 3.0800 9.3358 0.0 0
M  V30 11 C 6.9300 5.3347 0.0 0
M  V30 12 C 7.7000 4.0011 0.0 0
M  V30 13 C 7.7000 6.6684 0.0 0
M  V30 14 C 9.2400 4.0011 0.0 0
M  V30 15 C 9.2400 6.6684 0.0 0
M  V30 16 C 10.0100 5.3347 0.0 0
M  V30 17 C 3.0800 6.6684 0.0 0
M  V30 18 C 2.3100 8.0021 0.0 0
M  V30 19 C 2.3100 5.3347 0.0 0
M  V30 20 C 0.7700 8.0021 0.0 0
M  V30 21 C 0.7700 5.3347 0.0 0
M  V30 22 C 0.0000 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 2 17
M  V30 6 1 3 5
M  V30 7 1 3 6 CFG=1
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 7 9
M  V30 11 1 10 18
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1018836-13-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1018836-49-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15114659
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual
norepinephrine and serotonin reuptake inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vu, An T.; Cohn, Stephen T.; Terefenko, Eugene A.; Moore, William J.;
Zhang, Puwen; Mahaney, Paige E.; Trybulski, Eugene J.; Goljer, Igor;
Dooley, Rebecca; Bray, Jenifer A.; Johnston, Grace H.; Leiter, Jennifer;
Deecher, Darlene C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(9), 2464-2467

$RFMT $RIREG SCHEME179 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-Ethyl (αR,βR)-α-hydroxy-β-[(3-methoxyphenyl)methylamino]benzenepropanoate
C19H23NO4
1018836-17-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 4.0011 0.0 0 CFG=1
M  V30 2 N 6.9300 4.0011 0.0 0
M  V30 3 C 4.6200 5.3347 0.0 0 CFG=2
M  V30 4 C 7.7000 2.6674 0.0 0
M  V30 5 C 3.0800 5.3347 0.0 0
M  V30 6 O 5.3900 6.6685 0.0 0
M  V30 7 O 2.3100 6.6685 0.0 0
M  V30 8 O 2.3100 4.0011 0.0 0
M  V30 9 C 0.7700 6.6685 0.0 0
M  V30 10 C 0.0000 8.0021 0.0 0
M  V30 11 O 11.5500 6.6685 0.0 0
M  V30 12 C 12.3200 8.0021 0.0 0
M  V30 13 C 4.6200 2.6674 0.0 0
M  V30 14 C 5.3900 1.3336 0.0 0
M  V30 15 C 3.0800 2.6674 0.0 0
M  V30 16 C 4.6200 0.0000 0.0 0
M  V30 17 C 2.3100 1.3336 0.0 0
M  V30 18 C 3.0800 0.0000 0.0 0
M  V30 19 C 7.7000 5.3347 0.0 0
M  V30 20 C 9.2400 5.3347 0.0 0
M  V30 21 C 6.9300 6.6685 0.0 0
M  V30 22 C 10.0100 6.6685 0.0 0
M  V30 23 C 7.7000 8.0021 0.0 0
M  V30 24 C 9.2400 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 2 19
M  V30 6 1 3 5
M  V30 7 1 3 6 CFG=1
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 22
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(αR,βR)-α-Hydroxy-β-[(3-methoxyphenyl)methylamino]-N-methylbenzenepropana...
C18H22N2O3
1018836-63-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 4.6201 0.0 0 CFG=1
M  V30 2 N 5.3348 5.3901 0.0 0
M  V30 3 C 4.0012 3.0801 0.0 0 CFG=2
M  V30 4 C 5.3348 6.9302 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 O 5.3348 2.3101 0.0 0
M  V30 7 N 2.6673 0.7700 0.0 0
M  V30 8 O 1.3337 3.0801 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 O 10.6697 5.3901 0.0 0
M  V30 11 C 12.0033 4.6201 0.0 0
M  V30 12 C 2.6673 5.3901 0.0 0
M  V30 13 C 2.6673 6.9302 0.0 0
M  V30 14 C 1.3337 4.6201 0.0 0
M  V30 15 C 1.3337 7.7002 0.0 0
M  V30 16 C 0.0000 5.3901 0.0 0
M  V30 17 C 0.0000 6.9302 0.0 0
M  V30 18 C 6.6685 4.6201 0.0 0
M  V30 19 C 8.0022 5.3901 0.0 0
M  V30 20 C 6.6685 3.0801 0.0 0
M  V30 21 C 9.3360 4.6201 0.0 0
M  V30 22 C 8.0022 2.3101 0.0 0
M  V30 23 C 9.3360 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 2 18
M  V30 6 1 3 5
M  V30 7 1 3 6 CFG=3
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 1 10 21
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1018836-17-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1018836-63-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-13824602
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual
norepinephrine and serotonin reuptake inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vu, An T.; Cohn, Stephen T.; Terefenko, Eugene A.; Moore, William J.;
Zhang, Puwen; Mahaney, Paige E.; Trybulski, Eugene J.; Goljer, Igor;
Dooley, Rebecca; Bray, Jenifer A.; Johnston, Grace H.; Leiter, Jennifer;
Deecher, Darlene C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(9), 2464-2467

$RFMT $RIREG SCHEME180 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-Methyl (αR,βR)-α-hydroxy-4-methoxy-β-(methylphenylamino)benzenepropanoate
C18H21NO4
1018836-21-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.3347 0.0 0 CFG=1
M  V30 2 N 4.6200 6.6685 0.0 0
M  V30 3 C 4.6200 4.0011 0.0 0 CFG=2
M  V30 4 C 5.3900 8.0021 0.0 0
M  V30 5 C 5.3900 2.6674 0.0 0
M  V30 6 O 3.0800 4.0011 0.0 0
M  V30 7 O 4.6200 1.3336 0.0 0
M  V30 8 O 6.9300 2.6674 0.0 0
M  V30 9 C 5.3900 0.0000 0.0 0
M  V30 10 O 11.5500 5.3347 0.0 0
M  V30 11 C 12.3200 6.6685 0.0 0
M  V30 12 C 6.9300 5.3347 0.0 0
M  V30 13 C 7.7000 6.6685 0.0 0
M  V30 14 C 7.7000 4.0011 0.0 0
M  V30 15 C 9.2400 6.6685 0.0 0
M  V30 16 C 9.2400 4.0011 0.0 0
M  V30 17 C 10.0100 5.3347 0.0 0
M  V30 18 C 3.0800 6.6685 0.0 0
M  V30 19 C 2.3100 5.3347 0.0 0
M  V30 20 C 2.3100 8.0021 0.0 0
M  V30 21 C 0.7700 5.3347 0.0 0
M  V30 22 C 0.7700 8.0021 0.0 0
M  V30 23 C 0.0000 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 2 18
M  V30 6 1 3 5
M  V30 7 1 3 6 CFG=1
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 1 10 17
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(αR,βR)-α-Hydroxy-4-methoxy-N-methyl-β-(methylphenylamino)benzenepropanamide
C18H22N2O3
1018836-79-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.3347 0.0 0 CFG=1
M  V30 2 N 4.6200 6.6685 0.0 0
M  V30 3 C 4.6200 4.0011 0.0 0 CFG=2
M  V30 4 C 5.3900 8.0021 0.0 0
M  V30 5 C 5.3900 2.6674 0.0 0
M  V30 6 O 3.0800 4.0011 0.0 0
M  V30 7 N 4.6200 1.3336 0.0 0
M  V30 8 O 6.9300 2.6674 0.0 0
M  V30 9 C 5.3900 0.0000 0.0 0
M  V30 10 O 11.5500 5.3347 0.0 0
M  V30 11 C 12.3200 6.6685 0.0 0
M  V30 12 C 6.9300 5.3347 0.0 0
M  V30 13 C 7.7000 6.6685 0.0 0
M  V30 14 C 7.7000 4.0011 0.0 0
M  V30 15 C 9.2400 6.6685 0.0 0
M  V30 16 C 9.2400 4.0011 0.0 0
M  V30 17 C 10.0100 5.3347 0.0 0
M  V30 18 C 3.0800 6.6685 0.0 0
M  V30 19 C 2.3100 8.0021 0.0 0
M  V30 20 C 2.3100 5.3347 0.0 0
M  V30 21 C 0.7700 8.0021 0.0 0
M  V30 22 C 0.7700 5.3347 0.0 0
M  V30 23 C 0.0000 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 2 18
M  V30 6 1 3 5
M  V30 7 1 3 6 CFG=1
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 1 10 17
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1018836-21-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1018836-79-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8947324
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual
norepinephrine and serotonin reuptake inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vu, An T.; Cohn, Stephen T.; Terefenko, Eugene A.; Moore, William J.;
Zhang, Puwen; Mahaney, Paige E.; Trybulski, Eugene J.; Goljer, Igor;
Dooley, Rebecca; Bray, Jenifer A.; Johnston, Grace H.; Leiter, Jennifer;
Deecher, Darlene C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(9), 2464-2467

$RFMT $RIREG SCHEME181 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-Methyl (αR,βR)-3-fluoro-α-hydroxy-β-(methylphenylamino)benzenepropanoate
C17H18FNO3
1018836-29-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.3347 0.0 0 CFG=1
M  V30 2 N 5.3900 6.6685 0.0 0
M  V30 3 C 5.3900 4.0011 0.0 0 CFG=2
M  V30 4 C 4.6200 8.0021 0.0 0
M  V30 5 C 4.6200 2.6674 0.0 0
M  V30 6 O 6.9300 4.0011 0.0 0
M  V30 7 O 5.3900 1.3336 0.0 0
M  V30 8 O 3.0800 2.6674 0.0 0
M  V30 9 C 4.6200 0.0000 0.0 0
M  V30 10 F 0.0000 8.0021 0.0 0
M  V30 11 C 3.0800 5.3347 0.0 0
M  V30 12 C 2.3100 6.6685 0.0 0
M  V30 13 C 2.3100 4.0011 0.0 0
M  V30 14 C 0.7700 6.6685 0.0 0
M  V30 15 C 0.7700 4.0011 0.0 0
M  V30 16 C 0.0000 5.3347 0.0 0
M  V30 17 C 6.9300 6.6685 0.0 0
M  V30 18 C 7.7000 5.3347 0.0 0
M  V30 19 C 7.7000 8.0021 0.0 0
M  V30 20 C 9.2400 5.3347 0.0 0
M  V30 21 C 9.2400 8.0021 0.0 0
M  V30 22 C 10.0100 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 2 17
M  V30 6 1 3 5
M  V30 7 1 3 6 CFG=3
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 7 9
M  V30 11 1 10 14
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(αR,βR)-3-Fluoro-α-hydroxy-N-methyl-β-(methylphenylamino)benzenepropanamide
C17H19FN2O2
1018836-69-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.3347 0.0 0 CFG=1
M  V30 2 N 5.3900 6.6685 0.0 0
M  V30 3 C 5.3900 4.0011 0.0 0 CFG=2
M  V30 4 C 4.6200 8.0021 0.0 0
M  V30 5 C 4.6200 2.6674 0.0 0
M  V30 6 O 6.9300 4.0011 0.0 0
M  V30 7 N 5.3900 1.3336 0.0 0
M  V30 8 O 3.0800 2.6674 0.0 0
M  V30 9 C 4.6200 0.0000 0.0 0
M  V30 10 F 0.0000 8.0021 0.0 0
M  V30 11 C 3.0800 5.3347 0.0 0
M  V30 12 C 2.3100 6.6685 0.0 0
M  V30 13 C 2.3100 4.0011 0.0 0
M  V30 14 C 0.7700 6.6685 0.0 0
M  V30 15 C 0.7700 4.0011 0.0 0
M  V30 16 C 0.0000 5.3347 0.0 0
M  V30 17 C 6.9300 6.6685 0.0 0
M  V30 18 C 7.7000 5.3347 0.0 0
M  V30 19 C 7.7000 8.0021 0.0 0
M  V30 20 C 9.2400 5.3347 0.0 0
M  V30 21 C 9.2400 8.0021 0.0 0
M  V30 22 C 10.0100 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 2 17
M  V30 6 1 3 5
M  V30 7 1 3 6 CFG=3
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 7 9
M  V30 11 1 10 14
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1018836-29-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1018836-69-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-2567636
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual
norepinephrine and serotonin reuptake inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vu, An T.; Cohn, Stephen T.; Terefenko, Eugene A.; Moore, William J.;
Zhang, Puwen; Mahaney, Paige E.; Trybulski, Eugene J.; Goljer, Igor;
Dooley, Rebecca; Bray, Jenifer A.; Johnston, Grace H.; Leiter, Jennifer;
Deecher, Darlene C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(9), 2464-2467

$RFMT $RIREG SCHEME182 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-Ethyl (αR,βS)-α-hydroxy-β-(methylphenylamino)benzenepropanoate
C18H21NO3
1018836-35-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0 CFG=1
M  V30 2 N 3.0800 4.0011 0.0 0
M  V30 3 C 5.3900 5.3347 0.0 0 CFG=1
M  V30 4 C 2.3100 2.6674 0.0 0
M  V30 5 C 6.9300 5.3347 0.0 0
M  V30 6 O 4.6200 6.6685 0.0 0
M  V30 7 O 7.7000 6.6685 0.0 0
M  V30 8 O 7.7000 4.0011 0.0 0
M  V30 9 C 9.2400 6.6685 0.0 0
M  V30 10 C 10.0100 8.0021 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 6.9300 2.6674 0.0 0
M  V30 13 C 4.6200 1.3336 0.0 0
M  V30 14 C 7.7000 1.3336 0.0 0
M  V30 15 C 5.3900 0.0000 0.0 0
M  V30 16 C 6.9300 0.0000 0.0 0
M  V30 17 C 2.3100 5.3347 0.0 0
M  V30 18 C 3.0800 6.6685 0.0 0
M  V30 19 C 0.7700 5.3347 0.0 0
M  V30 20 C 2.3100 8.0021 0.0 0
M  V30 21 C 0.0000 6.6685 0.0 0
M  V30 22 C 0.7700 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 2 17
M  V30 6 1 3 5
M  V30 7 1 3 6 CFG=1
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(αR,βR)-α-[(Methylamino)methyl]-β-(methylphenylamino)benzeneethanol
C17H22N2O
1018834-86-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.3347 0.0 0 CFG=1
M  V30 2 N 4.6200 6.6685 0.0 0
M  V30 3 C 4.6200 4.0011 0.0 0 CFG=1
M  V30 4 C 5.3900 8.0021 0.0 0
M  V30 5 C 5.3900 2.6674 0.0 0
M  V30 6 O 3.0800 4.0011 0.0 0
M  V30 7 N 4.6200 1.3336 0.0 0
M  V30 8 C 5.3900 0.0000 0.0 0
M  V30 9 C 6.9300 5.3347 0.0 0
M  V30 10 C 7.7000 4.0011 0.0 0
M  V30 11 C 7.7000 6.6685 0.0 0
M  V30 12 C 9.2400 4.0011 0.0 0
M  V30 13 C 9.2400 6.6685 0.0 0
M  V30 14 C 10.0100 5.3347 0.0 0
M  V30 15 C 3.0800 6.6685 0.0 0
M  V30 16 C 2.3100 5.3347 0.0 0
M  V30 17 C 2.3100 8.0021 0.0 0
M  V30 18 C 0.7700 5.3347 0.0 0
M  V30 19 C 0.7700 8.0021 0.0 0
M  V30 20 C 0.0000 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 2 15
M  V30 6 1 3 5
M  V30 7 1 3 6 CFG=3
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1018836-35-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1018834-86-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-1573671
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 14044-65-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual
norepinephrine and serotonin reuptake inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vu, An T.; Cohn, Stephen T.; Terefenko, Eugene A.; Moore, William J.;
Zhang, Puwen; Mahaney, Paige E.; Trybulski, Eugene J.; Goljer, Igor;
Dooley, Rebecca; Bray, Jenifer A.; Johnston, Grace H.; Leiter, Jennifer;
Deecher, Darlene C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(9), 2464-2467

$RFMT $RIREG SCHEME183 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-Ethyl (αR,βR)-α-hydroxy-β-[methyl(2-methylphenyl)amino]benzenepropanoate
C19H23NO3
1018836-39-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.6200 0.0 0 CFG=1
M  V30 2 N 2.6673 5.3900 0.0 0
M  V30 3 C 5.3347 5.3900 0.0 0 CFG=2
M  V30 4 C 1.3336 4.6200 0.0 0
M  V30 5 C 6.6684 4.6200 0.0 0
M  V30 6 O 5.3347 6.9300 0.0 0
M  V30 7 O 8.0021 5.3900 0.0 0
M  V30 8 O 6.6684 3.0800 0.0 0
M  V30 9 C 9.3358 4.6200 0.0 0
M  V30 10 C 10.6694 5.3900 0.0 0
M  V30 11 C 0.0000 6.9300 0.0 0
M  V30 12 C 4.0011 3.0800 0.0 0
M  V30 13 C 2.6673 2.3100 0.0 0
M  V30 14 C 5.3347 2.3100 0.0 0
M  V30 15 C 2.6673 0.7700 0.0 0
M  V30 16 C 5.3347 0.7700 0.0 0
M  V30 17 C 4.0011 0.0000 0.0 0
M  V30 18 C 2.6673 6.9300 0.0 0
M  V30 19 C 1.3336 7.7000 0.0 0
M  V30 20 C 4.0011 7.7000 0.0 0
M  V30 21 C 1.3336 9.2400 0.0 0
M  V30 22 C 4.0011 9.2400 0.0 0
M  V30 23 C 2.6673 10.0100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 2 18
M  V30 6 1 3 5
M  V30 7 1 3 6 CFG=3
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 11 19
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(αR,βR)-α-Hydroxy-N-methyl-β-[methyl(2-methylphenyl)amino]benzenepropanamide
C18H22N2O2
1018836-41-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.3347 0.0 0 CFG=1
M  V30 2 N 4.6200 6.6684 0.0 0
M  V30 3 C 4.6200 4.0011 0.0 0 CFG=2
M  V30 4 C 5.3900 8.0021 0.0 0
M  V30 5 C 5.3900 2.6674 0.0 0
M  V30 6 O 3.0800 4.0011 0.0 0
M  V30 7 N 4.6200 1.3336 0.0 0
M  V30 8 O 6.9300 2.6674 0.0 0
M  V30 9 C 5.3900 0.0000 0.0 0
M  V30 10 C 3.0800 9.3358 0.0 0
M  V30 11 C 6.9300 5.3347 0.0 0
M  V30 12 C 7.7000 4.0011 0.0 0
M  V30 13 C 7.7000 6.6684 0.0 0
M  V30 14 C 9.2400 4.0011 0.0 0
M  V30 15 C 9.2400 6.6684 0.0 0
M  V30 16 C 10.0100 5.3347 0.0 0
M  V30 17 C 3.0800 6.6684 0.0 0
M  V30 18 C 2.3100 8.0021 0.0 0
M  V30 19 C 2.3100 5.3347 0.0 0
M  V30 20 C 0.7700 8.0021 0.0 0
M  V30 21 C 0.7700 5.3347 0.0 0
M  V30 22 C 0.0000 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 2 17
M  V30 6 1 3 5
M  V30 7 1 3 6 CFG=1
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 7 9
M  V30 11 1 10 18
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1018836-39-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1018836-41-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-6593209
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual
norepinephrine and serotonin reuptake inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vu, An T.; Cohn, Stephen T.; Terefenko, Eugene A.; Moore, William J.;
Zhang, Puwen; Mahaney, Paige E.; Trybulski, Eugene J.; Goljer, Igor;
Dooley, Rebecca; Bray, Jenifer A.; Johnston, Grace H.; Leiter, Jennifer;
Deecher, Darlene C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(9), 2464-2467

$RFMT $RIREG SCHEME184 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-Ethyl (αR,βR)-α-hydroxy-β-[methyl(4-methylphenyl)amino]benzenepropanoate
C19H23NO3
1018836-45-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 6.6684 0.0 0 CFG=1
M  V30 2 N 5.3900 8.0021 0.0 0
M  V30 3 C 5.3900 5.3347 0.0 0 CFG=2
M  V30 4 C 4.6200 9.3358 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 O 6.9300 5.3347 0.0 0
M  V30 7 O 5.3900 2.6674 0.0 0
M  V30 8 O 3.0800 4.0011 0.0 0
M  V30 9 C 4.6200 1.3336 0.0 0
M  V30 10 C 5.3900 0.0000 0.0 0
M  V30 11 C 11.5500 8.0021 0.0 0
M  V30 12 C 3.0800 6.6684 0.0 0
M  V30 13 C 2.3100 5.3347 0.0 0
M  V30 14 C 2.3100 8.0021 0.0 0
M  V30 15 C 0.7700 5.3347 0.0 0
M  V30 16 C 0.7700 8.0021 0.0 0
M  V30 17 C 0.0000 6.6684 0.0 0
M  V30 18 C 6.9300 8.0021 0.0 0
M  V30 19 C 7.7000 6.6684 0.0 0
M  V30 20 C 7.7000 9.3358 0.0 0
M  V30 21 C 9.2400 6.6684 0.0 0
M  V30 22 C 9.2400 9.3358 0.0 0
M  V30 23 C 10.0100 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 2 18
M  V30 6 1 3 5
M  V30 7 1 3 6 CFG=3
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 11 23
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(αR,βR)-α-Hydroxy-N-methyl-β-[methyl(4-methylphenyl)amino]benzenepropanamide
C18H22N2O2
1018836-47-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.3347 0.0 0 CFG=1
M  V30 2 N 5.3900 6.6685 0.0 0
M  V30 3 C 5.3900 4.0011 0.0 0 CFG=2
M  V30 4 C 4.6200 8.0021 0.0 0
M  V30 5 C 4.6200 2.6674 0.0 0
M  V30 6 O 6.9300 4.0011 0.0 0
M  V30 7 N 5.3900 1.3336 0.0 0
M  V30 8 O 3.0800 2.6674 0.0 0
M  V30 9 C 4.6200 0.0000 0.0 0
M  V30 10 C 11.5500 6.6685 0.0 0
M  V30 11 C 3.0800 5.3347 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 2.3100 6.6685 0.0 0
M  V30 14 C 0.7700 4.0011 0.0 0
M  V30 15 C 0.7700 6.6685 0.0 0
M  V30 16 C 0.0000 5.3347 0.0 0
M  V30 17 C 6.9300 6.6685 0.0 0
M  V30 18 C 7.7000 8.0021 0.0 0
M  V30 19 C 7.7000 5.3347 0.0 0
M  V30 20 C 9.2400 8.0021 0.0 0
M  V30 21 C 9.2400 5.3347 0.0 0
M  V30 22 C 10.0100 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 2 17
M  V30 6 1 3 5
M  V30 7 1 3 6 CFG=3
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 7 9
M  V30 11 1 10 22
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1018836-45-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1018836-47-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10848629
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual
norepinephrine and serotonin reuptake inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vu, An T.; Cohn, Stephen T.; Terefenko, Eugene A.; Moore, William J.;
Zhang, Puwen; Mahaney, Paige E.; Trybulski, Eugene J.; Goljer, Igor;
Dooley, Rebecca; Bray, Jenifer A.; Johnston, Grace H.; Leiter, Jennifer;
Deecher, Darlene C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(9), 2464-2467

$RFMT $RIREG SCHEME185 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-Ethyl (αR,βR)-β-[(3-chlorophenyl)methylamino]-α-hydroxybenzenepropanoate
C18H20ClNO3
1018836-51-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 4.0011 0.0 0 CFG=1
M  V30 2 N 6.9300 4.0011 0.0 0
M  V30 3 C 4.6200 5.3347 0.0 0 CFG=2
M  V30 4 C 7.7000 2.6674 0.0 0
M  V30 5 C 3.0800 5.3347 0.0 0
M  V30 6 O 5.3900 6.6685 0.0 0
M  V30 7 O 2.3100 6.6685 0.0 0
M  V30 8 O 2.3100 4.0011 0.0 0
M  V30 9 C 0.7700 6.6685 0.0 0
M  V30 10 C 0.0000 8.0021 0.0 0
M  V30 11 Cl 11.5500 6.6685 0.0 0
M  V30 12 C 4.6200 2.6674 0.0 0
M  V30 13 C 5.3900 1.3336 0.0 0
M  V30 14 C 3.0800 2.6674 0.0 0
M  V30 15 C 4.6200 0.0000 0.0 0
M  V30 16 C 2.3100 1.3336 0.0 0
M  V30 17 C 3.0800 0.0000 0.0 0
M  V30 18 C 7.7000 5.3347 0.0 0
M  V30 19 C 9.2400 5.3347 0.0 0
M  V30 20 C 6.9300 6.6685 0.0 0
M  V30 21 C 10.0100 6.6685 0.0 0
M  V30 22 C 7.7000 8.0021 0.0 0
M  V30 23 C 9.2400 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 2 18
M  V30 6 1 3 5
M  V30 7 1 3 6 CFG=1
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 11 21
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(αR,βR)-β-[(3-Chlorophenyl)methylamino]-α-hydroxy-N-methylbenzenepropanamide
C17H19ClN2O2
1018836-53-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 4.6201 0.0 0 CFG=1
M  V30 2 N 5.3348 5.3901 0.0 0
M  V30 3 C 4.0012 3.0801 0.0 0 CFG=2
M  V30 4 C 5.3348 6.9302 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 O 5.3348 2.3101 0.0 0
M  V30 7 N 2.6673 0.7700 0.0 0
M  V30 8 O 1.3337 3.0801 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 Cl 10.6697 5.3901 0.0 0
M  V30 11 C 2.6673 5.3901 0.0 0
M  V30 12 C 1.3337 4.6201 0.0 0
M  V30 13 C 2.6673 6.9302 0.0 0
M  V30 14 C 0.0000 5.3901 0.0 0
M  V30 15 C 1.3337 7.7002 0.0 0
M  V30 16 C 0.0000 6.9302 0.0 0
M  V30 17 C 6.6685 4.6201 0.0 0
M  V30 18 C 8.0023 5.3901 0.0 0
M  V30 19 C 6.6685 3.0801 0.0 0
M  V30 20 C 9.3360 4.6201 0.0 0
M  V30 21 C 8.0023 2.3101 0.0 0
M  V30 22 C 9.3360 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 2 17
M  V30 6 1 3 5
M  V30 7 1 3 6 CFG=3
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 7 9
M  V30 11 1 10 20
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1018836-51-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1018836-53-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-7416622
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual
norepinephrine and serotonin reuptake inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vu, An T.; Cohn, Stephen T.; Terefenko, Eugene A.; Moore, William J.;
Zhang, Puwen; Mahaney, Paige E.; Trybulski, Eugene J.; Goljer, Igor;
Dooley, Rebecca; Bray, Jenifer A.; Johnston, Grace H.; Leiter, Jennifer;
Deecher, Darlene C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(9), 2464-2467

$RFMT $RIREG SCHEME186 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-Ethyl (αR,βR)-β-[(4-fluorophenyl)methylamino]-α-hydroxybenzenepropanoate
C18H20FNO3
1018836-55-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 6.6684 0.0 0 CFG=1
M  V30 2 N 5.3900 8.0021 0.0 0
M  V30 3 C 5.3900 5.3347 0.0 0 CFG=2
M  V30 4 C 4.6200 9.3358 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 O 6.9300 5.3347 0.0 0
M  V30 7 O 5.3900 2.6674 0.0 0
M  V30 8 O 3.0800 4.0011 0.0 0
M  V30 9 C 4.6200 1.3336 0.0 0
M  V30 10 C 5.3900 0.0000 0.0 0
M  V30 11 F 11.5500 8.0021 0.0 0
M  V30 12 C 3.0800 6.6684 0.0 0
M  V30 13 C 2.3100 5.3347 0.0 0
M  V30 14 C 2.3100 8.0021 0.0 0
M  V30 15 C 0.7700 5.3347 0.0 0
M  V30 16 C 0.7700 8.0021 0.0 0
M  V30 17 C 0.0000 6.6684 0.0 0
M  V30 18 C 6.9300 8.0021 0.0 0
M  V30 19 C 7.7000 6.6684 0.0 0
M  V30 20 C 7.7000 9.3358 0.0 0
M  V30 21 C 9.2400 6.6684 0.0 0
M  V30 22 C 9.2400 9.3358 0.0 0
M  V30 23 C 10.0100 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 2 18
M  V30 6 1 3 5
M  V30 7 1 3 6 CFG=3
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 11 23
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(αR,βR)-β-[(4-Fluorophenyl)methylamino]-α-hydroxy-N-methylbenzenepropanamide
C17H19FN2O2
1018836-57-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.3347 0.0 0 CFG=1
M  V30 2 N 5.3900 6.6685 0.0 0
M  V30 3 C 5.3900 4.0011 0.0 0 CFG=2
M  V30 4 C 4.6200 8.0021 0.0 0
M  V30 5 C 4.6200 2.6674 0.0 0
M  V30 6 O 6.9300 4.0011 0.0 0
M  V30 7 N 5.3900 1.3336 0.0 0
M  V30 8 O 3.0800 2.6674 0.0 0
M  V30 9 C 4.6200 0.0000 0.0 0
M  V30 10 F 11.5500 6.6685 0.0 0
M  V30 11 C 3.0800 5.3347 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 2.3100 6.6685 0.0 0
M  V30 14 C 0.7700 4.0011 0.0 0
M  V30 15 C 0.7700 6.6685 0.0 0
M  V30 16 C 0.0000 5.3347 0.0 0
M  V30 17 C 6.9300 6.6685 0.0 0
M  V30 18 C 7.7000 8.0021 0.0 0
M  V30 19 C 7.7000 5.3347 0.0 0
M  V30 20 C 9.2400 8.0021 0.0 0
M  V30 21 C 9.2400 5.3347 0.0 0
M  V30 22 C 10.0100 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 2 17
M  V30 6 1 3 5
M  V30 7 1 3 6 CFG=3
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 7 9
M  V30 11 1 10 22
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1018836-55-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1018836-57-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-12983999
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual
norepinephrine and serotonin reuptake inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vu, An T.; Cohn, Stephen T.; Terefenko, Eugene A.; Moore, William J.;
Zhang, Puwen; Mahaney, Paige E.; Trybulski, Eugene J.; Goljer, Igor;
Dooley, Rebecca; Bray, Jenifer A.; Johnston, Grace H.; Leiter, Jennifer;
Deecher, Darlene C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(9), 2464-2467

$RFMT $RIREG SCHEME187 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-Ethyl (αR,βR)-β-[(4-chlorophenyl)methylamino]-α-hydroxybenzenepropanoate
C18H20ClNO3
1018836-59-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 6.6684 0.0 0 CFG=1
M  V30 2 N 5.3900 8.0021 0.0 0
M  V30 3 C 5.3900 5.3347 0.0 0 CFG=2
M  V30 4 C 4.6200 9.3358 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 O 6.9300 5.3347 0.0 0
M  V30 7 O 5.3900 2.6674 0.0 0
M  V30 8 O 3.0800 4.0011 0.0 0
M  V30 9 C 4.6200 1.3336 0.0 0
M  V30 10 C 5.3900 0.0000 0.0 0
M  V30 11 Cl 11.5500 8.0021 0.0 0
M  V30 12 C 3.0800 6.6684 0.0 0
M  V30 13 C 2.3100 5.3347 0.0 0
M  V30 14 C 2.3100 8.0021 0.0 0
M  V30 15 C 0.7700 5.3347 0.0 0
M  V30 16 C 0.7700 8.0021 0.0 0
M  V30 17 C 0.0000 6.6684 0.0 0
M  V30 18 C 6.9300 8.0021 0.0 0
M  V30 19 C 7.7000 6.6684 0.0 0
M  V30 20 C 7.7000 9.3358 0.0 0
M  V30 21 C 9.2400 6.6684 0.0 0
M  V30 22 C 9.2400 9.3358 0.0 0
M  V30 23 C 10.0100 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 2 18
M  V30 6 1 3 5
M  V30 7 1 3 6 CFG=3
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 11 23
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(αR,βR)-β-[(4-Chlorophenyl)methylamino]-α-hydroxy-N-methylbenzenepropanamide
C17H19ClN2O2
1018836-61-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.3347 0.0 0 CFG=1
M  V30 2 N 5.3900 6.6685 0.0 0
M  V30 3 C 5.3900 4.0011 0.0 0 CFG=2
M  V30 4 C 4.6200 8.0021 0.0 0
M  V30 5 C 4.6200 2.6674 0.0 0
M  V30 6 O 6.9300 4.0011 0.0 0
M  V30 7 N 5.3900 1.3336 0.0 0
M  V30 8 O 3.0800 2.6674 0.0 0
M  V30 9 C 4.6200 0.0000 0.0 0
M  V30 10 Cl 11.5500 6.6685 0.0 0
M  V30 11 C 3.0800 5.3347 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 2.3100 6.6685 0.0 0
M  V30 14 C 0.7700 4.0011 0.0 0
M  V30 15 C 0.7700 6.6685 0.0 0
M  V30 16 C 0.0000 5.3347 0.0 0
M  V30 17 C 6.9300 6.6685 0.0 0
M  V30 18 C 7.7000 8.0021 0.0 0
M  V30 19 C 7.7000 5.3347 0.0 0
M  V30 20 C 9.2400 8.0021 0.0 0
M  V30 21 C 9.2400 5.3347 0.0 0
M  V30 22 C 10.0100 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 2 17
M  V30 6 1 3 5
M  V30 7 1 3 6 CFG=3
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 7 9
M  V30 11 1 10 22
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1018836-59-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1018836-61-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9557909
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual
norepinephrine and serotonin reuptake inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vu, An T.; Cohn, Stephen T.; Terefenko, Eugene A.; Moore, William J.;
Zhang, Puwen; Mahaney, Paige E.; Trybulski, Eugene J.; Goljer, Igor;
Dooley, Rebecca; Bray, Jenifer A.; Johnston, Grace H.; Leiter, Jennifer;
Deecher, Darlene C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(9), 2464-2467

$RFMT $RIREG SCHEME188 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-Ethyl (αR,βR)-α-hydroxy-β-[(4-methoxyphenyl)methylamino]benzenepropanoate
C19H23NO4
1018836-65-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 6.6684 0.0 0 CFG=1
M  V30 2 N 5.3900 8.0021 0.0 0
M  V30 3 C 5.3900 5.3347 0.0 0 CFG=2
M  V30 4 C 4.6200 9.3358 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 O 6.9300 5.3347 0.0 0
M  V30 7 O 5.3900 2.6674 0.0 0
M  V30 8 O 3.0800 4.0011 0.0 0
M  V30 9 C 4.6200 1.3336 0.0 0
M  V30 10 C 5.3900 0.0000 0.0 0
M  V30 11 O 11.5500 8.0021 0.0 0
M  V30 12 C 12.3200 9.3358 0.0 0
M  V30 13 C 3.0800 6.6684 0.0 0
M  V30 14 C 2.3100 5.3347 0.0 0
M  V30 15 C 2.3100 8.0021 0.0 0
M  V30 16 C 0.7700 5.3347 0.0 0
M  V30 17 C 0.7700 8.0021 0.0 0
M  V30 18 C 0.0000 6.6684 0.0 0
M  V30 19 C 6.9300 8.0021 0.0 0
M  V30 20 C 7.7000 6.6684 0.0 0
M  V30 21 C 7.7000 9.3358 0.0 0
M  V30 22 C 9.2400 6.6684 0.0 0
M  V30 23 C 9.2400 9.3358 0.0 0
M  V30 24 C 10.0100 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 2 19
M  V30 6 1 3 5
M  V30 7 1 3 6 CFG=3
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 24
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(αR,βR)-α-Hydroxy-β-[(4-methoxyphenyl)methylamino]-N-methylbenzenepropana...
C18H22N2O3
1018836-67-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.3347 0.0 0 CFG=1
M  V30 2 N 5.3900 6.6685 0.0 0
M  V30 3 C 5.3900 4.0011 0.0 0 CFG=2
M  V30 4 C 4.6200 8.0021 0.0 0
M  V30 5 C 4.6200 2.6674 0.0 0
M  V30 6 O 6.9300 4.0011 0.0 0
M  V30 7 N 5.3900 1.3336 0.0 0
M  V30 8 O 3.0800 2.6674 0.0 0
M  V30 9 C 4.6200 0.0000 0.0 0
M  V30 10 O 11.5500 6.6685 0.0 0
M  V30 11 C 12.3200 8.0021 0.0 0
M  V30 12 C 3.0800 5.3347 0.0 0
M  V30 13 C 2.3100 4.0011 0.0 0
M  V30 14 C 2.3100 6.6685 0.0 0
M  V30 15 C 0.7700 4.0011 0.0 0
M  V30 16 C 0.7700 6.6685 0.0 0
M  V30 17 C 0.0000 5.3347 0.0 0
M  V30 18 C 6.9300 6.6685 0.0 0
M  V30 19 C 7.7000 5.3347 0.0 0
M  V30 20 C 7.7000 8.0021 0.0 0
M  V30 21 C 9.2400 5.3347 0.0 0
M  V30 22 C 9.2400 8.0021 0.0 0
M  V30 23 C 10.0100 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 2 18
M  V30 6 1 3 5
M  V30 7 1 3 6 CFG=3
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 1 10 23
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1018836-65-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1018836-67-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-411853
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual
norepinephrine and serotonin reuptake inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vu, An T.; Cohn, Stephen T.; Terefenko, Eugene A.; Moore, William J.;
Zhang, Puwen; Mahaney, Paige E.; Trybulski, Eugene J.; Goljer, Igor;
Dooley, Rebecca; Bray, Jenifer A.; Johnston, Grace H.; Leiter, Jennifer;
Deecher, Darlene C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(9), 2464-2467

$RFMT $RIREG SCHEME189 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-Ethyl (αR,βR)-3-chloro-α-hydroxy-β-(methylphenylamino)benzenepropanoate
C18H20ClNO3
1018836-71-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.3347 0.0 0 CFG=1
M  V30 2 N 3.8500 4.0011 0.0 0
M  V30 3 C 6.1600 5.3347 0.0 0 CFG=2
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 6.9300 6.6684 0.0 0
M  V30 6 O 6.9300 4.0011 0.0 0
M  V30 7 O 8.4700 6.6684 0.0 0
M  V30 8 O 6.1600 8.0021 0.0 0
M  V30 9 C 9.2400 8.0021 0.0 0
M  V30 10 C 10.7800 8.0021 0.0 0
M  V30 11 Cl 0.0000 8.0021 0.0 0
M  V30 12 C 3.8500 6.6684 0.0 0
M  V30 13 C 2.3100 6.6684 0.0 0
M  V30 14 C 4.6200 8.0021 0.0 0
M  V30 15 C 1.5400 8.0021 0.0 0
M  V30 16 C 3.8500 9.3358 0.0 0
M  V30 17 C 2.3100 9.3358 0.0 0
M  V30 18 C 4.6200 2.6674 0.0 0
M  V30 19 C 6.1600 2.6674 0.0 0
M  V30 20 C 3.8500 1.3336 0.0 0
M  V30 21 C 6.9300 1.3336 0.0 0
M  V30 22 C 4.6200 0.0000 0.0 0
M  V30 23 C 6.1600 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 2 18
M  V30 6 1 3 5
M  V30 7 1 3 6 CFG=1
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 11 15
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(αR,βR)-3-Chloro-α-hydroxy-N-methyl-β-(methylphenylamino)benzenepropanamide
C17H19ClN2O2
1018836-73-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.3347 0.0 0 CFG=1
M  V30 2 N 5.3900 6.6685 0.0 0
M  V30 3 C 5.3900 4.0011 0.0 0 CFG=2
M  V30 4 C 4.6200 8.0021 0.0 0
M  V30 5 C 4.6200 2.6674 0.0 0
M  V30 6 O 6.9300 4.0011 0.0 0
M  V30 7 N 5.3900 1.3336 0.0 0
M  V30 8 O 3.0800 2.6674 0.0 0
M  V30 9 C 4.6200 0.0000 0.0 0
M  V30 10 Cl 0.0000 8.0021 0.0 0
M  V30 11 C 3.0800 5.3347 0.0 0
M  V30 12 C 2.3100 6.6685 0.0 0
M  V30 13 C 2.3100 4.0011 0.0 0
M  V30 14 C 0.7700 6.6685 0.0 0
M  V30 15 C 0.7700 4.0011 0.0 0
M  V30 16 C 0.0000 5.3347 0.0 0
M  V30 17 C 6.9300 6.6685 0.0 0
M  V30 18 C 7.7000 5.3347 0.0 0
M  V30 19 C 7.7000 8.0021 0.0 0
M  V30 20 C 9.2400 5.3347 0.0 0
M  V30 21 C 9.2400 8.0021 0.0 0
M  V30 22 C 10.0100 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 2 17
M  V30 6 1 3 5
M  V30 7 1 3 6 CFG=3
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 7 9
M  V30 11 1 10 14
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1018836-71-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1018836-73-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-4696472
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual
norepinephrine and serotonin reuptake inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vu, An T.; Cohn, Stephen T.; Terefenko, Eugene A.; Moore, William J.;
Zhang, Puwen; Mahaney, Paige E.; Trybulski, Eugene J.; Goljer, Igor;
Dooley, Rebecca; Bray, Jenifer A.; Johnston, Grace H.; Leiter, Jennifer;
Deecher, Darlene C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(9), 2464-2467

$RFMT $RIREG SCHEME190 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-Ethyl (αR,βR)-4-chloro-α-hydroxy-β-(methylphenylamino)benzenepropanoate
C18H20ClNO3
1018836-75-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 6.6684 0.0 0 CFG=1
M  V30 2 N 4.6200 8.0021 0.0 0
M  V30 3 C 4.6200 5.3347 0.0 0 CFG=2
M  V30 4 C 5.3900 9.3358 0.0 0
M  V30 5 C 5.3900 4.0011 0.0 0
M  V30 6 O 3.0800 5.3347 0.0 0
M  V30 7 O 4.6200 2.6674 0.0 0
M  V30 8 O 6.9300 4.0011 0.0 0
M  V30 9 C 5.3900 1.3336 0.0 0
M  V30 10 C 4.6200 0.0000 0.0 0
M  V30 11 Cl 11.5500 6.6684 0.0 0
M  V30 12 C 6.9300 6.6684 0.0 0
M  V30 13 C 7.7000 5.3347 0.0 0
M  V30 14 C 7.7000 8.0021 0.0 0
M  V30 15 C 9.2400 5.3347 0.0 0
M  V30 16 C 9.2400 8.0021 0.0 0
M  V30 17 C 10.0100 6.6684 0.0 0
M  V30 18 C 3.0800 8.0021 0.0 0
M  V30 19 C 2.3100 6.6684 0.0 0
M  V30 20 C 2.3100 9.3358 0.0 0
M  V30 21 C 0.7700 6.6684 0.0 0
M  V30 22 C 0.7700 9.3358 0.0 0
M  V30 23 C 0.0000 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 2 18
M  V30 6 1 3 5
M  V30 7 1 3 6 CFG=1
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 11 17
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(αR,βR)-4-Chloro-α-hydroxy-N-methyl-β-(methylphenylamino)benzenepropanamide
C17H19ClN2O2
1018836-77-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.3347 0.0 0 CFG=1
M  V30 2 N 4.6200 6.6685 0.0 0
M  V30 3 C 4.6200 4.0011 0.0 0 CFG=2
M  V30 4 C 5.3900 8.0021 0.0 0
M  V30 5 C 5.3900 2.6674 0.0 0
M  V30 6 O 3.0800 4.0011 0.0 0
M  V30 7 N 4.6200 1.3336 0.0 0
M  V30 8 O 6.9300 2.6674 0.0 0
M  V30 9 C 5.3900 0.0000 0.0 0
M  V30 10 Cl 11.5500 5.3347 0.0 0
M  V30 11 C 6.9300 5.3347 0.0 0
M  V30 12 C 7.7000 4.0011 0.0 0
M  V30 13 C 7.7000 6.6685 0.0 0
M  V30 14 C 9.2400 4.0011 0.0 0
M  V30 15 C 9.2400 6.6685 0.0 0
M  V30 16 C 10.0100 5.3347 0.0 0
M  V30 17 C 3.0800 6.6685 0.0 0
M  V30 18 C 2.3100 5.3347 0.0 0
M  V30 19 C 2.3100 8.0021 0.0 0
M  V30 20 C 0.7700 5.3347 0.0 0
M  V30 21 C 0.7700 8.0021 0.0 0
M  V30 22 C 0.0000 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 2 17
M  V30 6 1 3 5
M  V30 7 1 3 6 CFG=1
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 7 9
M  V30 11 1 10 16
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1018836-75-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1018836-77-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-6827235
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual
norepinephrine and serotonin reuptake inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vu, An T.; Cohn, Stephen T.; Terefenko, Eugene A.; Moore, William J.;
Zhang, Puwen; Mahaney, Paige E.; Trybulski, Eugene J.; Goljer, Igor;
Dooley, Rebecca; Bray, Jenifer A.; Johnston, Grace H.; Leiter, Jennifer;
Deecher, Darlene C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(9), 2464-2467

$RFMT $RIREG SCHEME191 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-Ethyl (αR,βR)-α-hydroxy-β-(methyl-1-naphthalenylamino)benzenepropanoate
C22H23NO3
1018837-04-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 4.0011 0.0 0
M  V30 2 C 5.3900 4.0011 0.0 0 CFG=1
M  V30 3 C 7.7000 2.6674 0.0 0
M  V30 4 C 4.6200 5.3347 0.0 0 CFG=2
M  V30 5 C 3.0800 5.3347 0.0 0
M  V30 6 O 5.3900 6.6685 0.0 0
M  V30 7 O 2.3100 6.6685 0.0 0
M  V30 8 O 2.3100 4.0011 0.0 0
M  V30 9 C 0.7700 6.6685 0.0 0
M  V30 10 C 0.0000 8.0021 0.0 0
M  V30 11 C 7.7000 5.3347 0.0 0
M  V30 12 C 9.2400 5.3347 0.0 0
M  V30 13 C 6.9300 6.6685 0.0 0
M  V30 14 C 10.0100 6.6685 0.0 0
M  V30 15 C 10.0100 4.0011 0.0 0
M  V30 16 C 7.7000 8.0021 0.0 0
M  V30 17 C 9.2400 8.0021 0.0 0
M  V30 18 C 11.5500 6.6685 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 20 C 12.3200 5.3347 0.0 0
M  V30 21 C 4.6200 2.6674 0.0 0
M  V30 22 C 5.3900 1.3336 0.0 0
M  V30 23 C 3.0800 2.6674 0.0 0
M  V30 24 C 4.6200 0.0000 0.0 0
M  V30 25 C 2.3100 1.3336 0.0 0
M  V30 26 C 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 1 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 2 21
M  V30 6 1 4 5
M  V30 7 1 4 6 CFG=1
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 2 15 19
M  V30 20 2 16 17
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 2 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(αR,βR)-α-Hydroxy-N-methyl-β-(methyl-1-naphthalenylamino)benzenepropanamide
C21H22N2O2
1018837-07-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 4.0011 0.0 0
M  V30 2 C 4.6200 4.0011 0.0 0 CFG=1
M  V30 3 C 6.9300 2.6674 0.0 0
M  V30 4 C 3.8500 5.3347 0.0 0 CFG=2
M  V30 5 C 2.3100 5.3347 0.0 0
M  V30 6 O 4.6200 6.6685 0.0 0
M  V30 7 N 1.5400 6.6685 0.0 0
M  V30 8 O 1.5400 4.0011 0.0 0
M  V30 9 C 0.0000 6.6685 0.0 0
M  V30 10 C 6.9300 5.3347 0.0 0
M  V30 11 C 8.4700 5.3347 0.0 0
M  V30 12 C 6.1600 6.6685 0.0 0
M  V30 13 C 9.2400 6.6685 0.0 0
M  V30 14 C 9.2400 4.0011 0.0 0
M  V30 15 C 6.9300 8.0021 0.0 0
M  V30 16 C 8.4700 8.0021 0.0 0
M  V30 17 C 10.7800 6.6685 0.0 0
M  V30 18 C 10.7800 4.0011 0.0 0
M  V30 19 C 11.5500 5.3347 0.0 0
M  V30 20 C 3.8500 2.6674 0.0 0
M  V30 21 C 4.6200 1.3336 0.0 0
M  V30 22 C 2.3100 2.6674 0.0 0
M  V30 23 C 3.8500 0.0000 0.0 0
M  V30 24 C 1.5400 1.3336 0.0 0
M  V30 25 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 1 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 2 20
M  V30 6 1 4 5
M  V30 7 1 4 6 CFG=1
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 2 14 18
M  V30 19 2 15 16
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 2 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1018837-04-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1018837-07-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-12839138
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual
norepinephrine and serotonin reuptake inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vu, An T.; Cohn, Stephen T.; Terefenko, Eugene A.; Moore, William J.;
Zhang, Puwen; Mahaney, Paige E.; Trybulski, Eugene J.; Goljer, Igor;
Dooley, Rebecca; Bray, Jenifer A.; Johnston, Grace H.; Leiter, Jennifer;
Deecher, Darlene C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(9), 2464-2467

$RFMT $RIREG SCHEME192 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(4-chlorophenyl)methyl]-N-(2-oxoethyl)carbamate
C14H18ClNO3
1018909-28-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 4.0011 0.0 0
M  V30 2 C 6.1600 5.3349 0.0 0
M  V30 3 C 3.8500 4.0011 0.0 0
M  V30 4 C 6.1600 2.6674 0.0 0
M  V30 5 O 3.0800 5.3349 0.0 0
M  V30 6 O 3.0800 2.6674 0.0 0
M  V30 7 C 5.3900 1.3338 0.0 0
M  V30 8 C 1.5400 5.3349 0.0 0
M  V30 9 O 6.1600 0.0000 0.0 0
M  V30 10 C 1.5400 3.7949 0.0 0
M  V30 11 C 0.0000 5.3349 0.0 0
M  V30 12 C 1.5400 6.8749 0.0 0
M  V30 13 Cl 12.3200 5.3349 0.0 0
M  V30 14 C 7.7000 5.3349 0.0 0
M  V30 15 C 8.4700 4.0011 0.0 0
M  V30 16 C 8.4700 6.6685 0.0 0
M  V30 17 C 10.0100 4.0011 0.0 0
M  V30 18 C 10.0100 6.6685 0.0 0
M  V30 19 C 10.7800 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 13 19
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(4-chlorophenyl)methyl]-N-[2-(methylamino)ethyl]carbamate
C15H23ClN2O2
1018909-30-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 5.3347 0.0 0
M  V30 2 C 6.1600 6.6685 0.0 0
M  V30 3 C 3.8500 5.3347 0.0 0
M  V30 4 C 6.1600 4.0011 0.0 0
M  V30 5 O 3.0800 6.6685 0.0 0
M  V30 6 O 3.0800 4.0011 0.0 0
M  V30 7 C 5.3900 2.6674 0.0 0
M  V30 8 C 1.5400 6.6685 0.0 0
M  V30 9 N 6.1600 1.3338 0.0 0
M  V30 10 C 1.5400 5.1285 0.0 0
M  V30 11 C 0.0000 6.6685 0.0 0
M  V30 12 C 1.5400 8.2085 0.0 0
M  V30 13 C 5.3900 0.0000 0.0 0
M  V30 14 Cl 12.3200 6.6685 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 8.4700 5.3347 0.0 0
M  V30 17 C 8.4700 8.0021 0.0 0
M  V30 18 C 10.0100 5.3347 0.0 0
M  V30 19 C 10.0100 8.0021 0.0 0
M  V30 20 C 10.7800 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 15
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 14 20
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1018909-28-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1018909-30-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-15048009
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM tert-Butyl 4-Chlorobenzyl[2′-(methylamino)ethyl]carbamate (57a). To a
solution of 56a (0.566 g, 0.002 mol) in MeOH (30 mL) was added MeNH2 (2 M
in MeOH, 2 mL, 0.004 mol) at room temperature under a N2 atmosphere. The
reaction mixture was heated at reflux for 6 h and then cooled to -20 °C.
Then NaBH4 (0.15 g, 0.004 mol) was added in portions. After being stirred
for 1 h at -20 °C, the reaction mixture was stirred for 3 h at room
temperature. The solvent was then evaporated under reduced pressure. The
residue was dissolved in water (20 mL) and extracted with CH2Cl2 (20 mL ×
3). The combined organic layers were washed with brine and dried over
MgSO4. The solvent was evaporated in vacuo, and the residue was purified
by column chromatography (silica gel, CH2Cl2/MeOH = 9:1) to afford a
colorless oil (0.59 g). tert-Butyl
4-Chlorobenzyl[2′-(methylamino)ethyl]carbamate (57a), yield 99%. 1H NMR
(CDCl3, 500 MHz): δ 7.287 (d, 2H), 7.174 (m, 2H), 4.428 (s, 2H),
3.348-3.260 (m, 2H), 2.710 (m, 2H), 2.412 (s, 3H), 1.568-1.444 (s, 9H).
13C NMR (CDCl3, 125.7 MHz): δ 155.993 (1C), 137.216 (1C), 133.076 (1C),
(129.220 + 128.795 + 128.577) (4C), 80.241 (1C), (50.825 + 50.115) (2C),
46.551 (1C), 36.423 (1C), 28.567 (3C). MS (ESI, CH2Cl2): [C15H23ClN2O2]
m/z 299.1 ([M + H]+).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Highly Potent and Selective Inhibitors of Neuronal Nitric
Oxide Synthase by Fragment Hopping
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ji, Haitao; Li, Huiying; Martasek, Pavel; Roman, Linda J.; Poulos, Thomas
L.; Silverman, Richard B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2009), 52(3), 779-797

$RFMT $RIREG SCHEME192 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(4-chlorophenyl)methyl]-N-(2-oxoethyl)carbamate
C14H18ClNO3
1018909-28-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 4.0011 0.0 0
M  V30 2 C 6.1600 5.3349 0.0 0
M  V30 3 C 3.8500 4.0011 0.0 0
M  V30 4 C 6.1600 2.6674 0.0 0
M  V30 5 O 3.0800 5.3349 0.0 0
M  V30 6 O 3.0800 2.6674 0.0 0
M  V30 7 C 5.3900 1.3338 0.0 0
M  V30 8 C 1.5400 5.3349 0.0 0
M  V30 9 O 6.1600 0.0000 0.0 0
M  V30 10 C 1.5400 3.7949 0.0 0
M  V30 11 C 0.0000 5.3349 0.0 0
M  V30 12 C 1.5400 6.8749 0.0 0
M  V30 13 Cl 12.3200 5.3349 0.0 0
M  V30 14 C 7.7000 5.3349 0.0 0
M  V30 15 C 8.4700 4.0011 0.0 0
M  V30 16 C 8.4700 6.6685 0.0 0
M  V30 17 C 10.0100 4.0011 0.0 0
M  V30 18 C 10.0100 6.6685 0.0 0
M  V30 19 C 10.7800 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 13 19
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(4-chlorophenyl)methyl]-N-[2-(methylamino)ethyl]carbamate
C15H23ClN2O2
1018909-30-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 5.3347 0.0 0
M  V30 2 C 6.1600 6.6685 0.0 0
M  V30 3 C 3.8500 5.3347 0.0 0
M  V30 4 C 6.1600 4.0011 0.0 0
M  V30 5 O 3.0800 6.6685 0.0 0
M  V30 6 O 3.0800 4.0011 0.0 0
M  V30 7 C 5.3900 2.6674 0.0 0
M  V30 8 C 1.5400 6.6685 0.0 0
M  V30 9 N 6.1600 1.3338 0.0 0
M  V30 10 C 1.5400 5.1285 0.0 0
M  V30 11 C 0.0000 6.6685 0.0 0
M  V30 12 C 1.5400 8.2085 0.0 0
M  V30 13 C 5.3900 0.0000 0.0 0
M  V30 14 Cl 12.3200 6.6685 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 8.4700 5.3347 0.0 0
M  V30 17 C 8.4700 8.0021 0.0 0
M  V30 18 C 10.0100 5.3347 0.0 0
M  V30 19 C 10.0100 8.0021 0.0 0
M  V30 20 C 10.7800 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 15
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 14 20
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1018909-28-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1018909-30-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-8844833
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of tert-butyl 4-chlorobenzyl[2-(methylamino)ethyl]carbamate
(IV-2) To a solution of IV-1 (0.57 g, 0.002 mol) in MeOH (30 mL) was
added MeNH2 (2M in MeOH, 2 mL, 0.004 mol) at room temperature under N2
atmosphere. The reaction mixture was heated at reflux for 6 h, and then
cooled to -20°C. Then NaBH4 (0.15 g, 0.004 mol) was added in portions.
After stirred 1 h at -20°C, the reaction mixture was continued to stir 3
h at room temperature. The solvent was then evaporated under reduced
pressure. The residue was dissolved in water (20 mL), and extracted with
CH2Cl2 (20 mLX3). The combined organic layers were washed with brine, and
dried over MgSO4. The solvent was evaporated in vacuo, and the residue
was purified by column chromatography (silica gel, CH2Cl2:MeOH = 9:1) to
afford colorless oil (VI-2, 0.59 g, 99%). tert-butyl
4-chlorobenzyl[2-(methylamino)ethyl]carbamate, (0.59 g, 99%) yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Potent and highly selective heteroaromatic inhibitors of neuronal nitric
oxide synthase and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Silverman, Richard B.; Ji, Haitao; Lawton, Graham R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20080108814 A1 2008-05-08

$RFMT $RIREG SCHEME192 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(4-chlorophenyl)methyl]-N-(2-oxoethyl)carbamate
C14H18ClNO3
1018909-28-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 4.0011 0.0 0
M  V30 2 C 6.1600 5.3349 0.0 0
M  V30 3 C 3.8500 4.0011 0.0 0
M  V30 4 C 6.1600 2.6674 0.0 0
M  V30 5 O 3.0800 5.3349 0.0 0
M  V30 6 O 3.0800 2.6674 0.0 0
M  V30 7 C 5.3900 1.3338 0.0 0
M  V30 8 C 1.5400 5.3349 0.0 0
M  V30 9 O 6.1600 0.0000 0.0 0
M  V30 10 C 1.5400 3.7949 0.0 0
M  V30 11 C 0.0000 5.3349 0.0 0
M  V30 12 C 1.5400 6.8749 0.0 0
M  V30 13 Cl 12.3200 5.3349 0.0 0
M  V30 14 C 7.7000 5.3349 0.0 0
M  V30 15 C 8.4700 4.0011 0.0 0
M  V30 16 C 8.4700 6.6685 0.0 0
M  V30 17 C 10.0100 4.0011 0.0 0
M  V30 18 C 10.0100 6.6685 0.0 0
M  V30 19 C 10.7800 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 13 19
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(4-chlorophenyl)methyl]-N-[2-(methylamino)ethyl]carbamate
C15H23ClN2O2
1018909-30-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 5.3347 0.0 0
M  V30 2 C 6.1600 6.6685 0.0 0
M  V30 3 C 3.8500 5.3347 0.0 0
M  V30 4 C 6.1600 4.0011 0.0 0
M  V30 5 O 3.0800 6.6685 0.0 0
M  V30 6 O 3.0800 4.0011 0.0 0
M  V30 7 C 5.3900 2.6674 0.0 0
M  V30 8 C 1.5400 6.6685 0.0 0
M  V30 9 N 6.1600 1.3338 0.0 0
M  V30 10 C 1.5400 5.1285 0.0 0
M  V30 11 C 0.0000 6.6685 0.0 0
M  V30 12 C 1.5400 8.2085 0.0 0
M  V30 13 C 5.3900 0.0000 0.0 0
M  V30 14 Cl 12.3200 6.6685 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 8.4700 5.3347 0.0 0
M  V30 17 C 8.4700 8.0021 0.0 0
M  V30 18 C 10.0100 5.3347 0.0 0
M  V30 19 C 10.0100 8.0021 0.0 0
M  V30 20 C 10.7800 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 15
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 14 20
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1018909-28-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1018909-30-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-868932
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of tert-butyl 4-chlorobenzyl[2-(methylamino)ethyl]carbamate
(IV-2) To a solution of IV-1 (0.57 g, 0.002 mol) in MeOH (30 mL) was
added MeNH2 (2M in MeOH, 2 mL, 0.004 mol) at room temperature under N2
atmosphere. The reaction mixture was heated at reflux for 6 h, and then
cooled to -20 °C. Then NaBH4 (0.15 g, 0.004 mol) was added in portions.
After stirred 1 h at -20 °C, the reaction mixture was continued to stir 3
h at room temperature. The solvent was then evaporated under reduced
pressure. The residue was dissolved in water (20 mL), and extracted with
CH2Cl2 (20 mL x 3). The combined organic layers were washed with brine,
and dried over MgSO4 The solvent was evaporated in vacuo, and the residue
was purified by column chromatography (silica gel, CH2Cl2 : MeOH = 9:1)
to afford colorless oil (VI-2, 0.59 g, 99%). tert-butyl
4-chlorobenzyl[2-(methylamino)ethyl]carbamate (IV-2), yield 0.59 g, 99%
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heteroaromatic compounds as selective neuronal nitric
oxide synthase (nNOS) inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Silverman, Richard B.; Ji, Haitao; Lawton, Graham R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008042353 A1 2008-04-10

$RFMT $RIREG SCHEME193 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2R,4S,7S)-7-cyclohexyl-3,4,6,7,8,9,12,13,14,15,19,20-dodecahydro-23-m...
C32H43N3O8
1021437-85-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 48 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.3122 0.0000 0.0 0
M  V30 2 O 1.1873 6.2131 0.0 0
M  V30 3 C 0.0000 5.2324 0.0 0
M  V30 4 C 12.7207 7.5234 0.0 0
M  V30 5 O 13.7822 6.4077 0.0 0
M  V30 6 O 13.1561 9.0006 0.0 0
M  V30 7 C 15.2791 6.7693 0.0 0
M  V30 8 O 11.6581 10.1633 0.0 0
M  V30 9 C 5.0162 13.5264 0.0 0
M  V30 10 C 3.2671 12.6453 0.0 0
M  V30 11 O 9.1597 14.8091 0.0 0
M  V30 12 C 5.5550 4.5939 0.0 0
M  V30 13 C 6.9903 4.0477 0.0 0
M  V30 14 C 4.3448 3.5980 0.0 0
M  V30 15 C 5.2820 6.1356 0.0 0
M  V30 16 O 8.2967 4.6523 0.0 0
M  V30 17 C 7.2610 2.5088 0.0 0
M  V30 18 C 2.8902 4.1402 0.0 0
M  V30 19 N 4.5964 2.0623 0.0 0
M  V30 20 C 3.8324 6.6658 0.0 0
M  V30 21 C 9.0677 5.8684 0.0 0 CFG=2
M  V30 22 C 6.0577 1.5187 0.0 0
M  V30 23 C 2.6303 5.6751 0.0 0
M  V30 24 C 3.4164 8.1196 0.0 0
M  V30 25 C 8.7104 7.3630 0.0 0
M  V30 26 C 10.6211 5.7215 0.0 0
M  V30 27 C 4.3925 9.3263 0.0 0
M  V30 28 N 10.0319 8.1673 0.0 0 CFG=3
M  V30 29 C 11.2237 7.1620 0.0 0 CFG=1
M  V30 30 C 3.8044 10.7699 0.0 0
M  V30 31 C 10.2062 9.6503 0.0 0
M  V30 32 C 4.6763 12.0245 0.0 0
M  V30 33 C 9.0999 10.7329 0.0 0 CFG=2
M  V30 34 C 6.2326 11.9777 0.0 0
M  V30 35 N 9.5194 12.2338 0.0 0
M  V30 36 O 7.0262 13.3148 0.0 0
M  V30 37 C 8.5458 13.3968 0.0 0
M  V30 38 C 7.7663 9.9629 0.0 0
M  V30 39 C 6.4325 10.7329 0.0 0
M  V30 40 C 7.7663 8.4229 0.0 0
M  V30 41 C 5.0989 9.9629 0.0 0
M  V30 42 C 6.4325 7.6529 0.0 0
M  V30 43 C 5.0989 8.4229 0.0 0
M  V30 44 H 7.5487 6.1216 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 22
M  V30 2 1 2 3
M  V30 3 1 2 23
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 29 4 CFG=3
M  V30 7 1 5 7
M  V30 8 2 8 31
M  V30 9 1 9 32
M  V30 10 1 10 32
M  V30 11 2 11 37
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 2 12 15
M  V30 15 1 13 16
M  V30 16 2 13 17
M  V30 17 2 14 18
M  V30 18 1 14 19
M  V30 19 1 15 20
M  V30 20 1 16 21
M  V30 21 1 17 22
M  V30 22 1 18 23
M  V30 23 1 19 22
M  V30 24 2 20 23
M  V30 25 1 20 24
M  V30 26 1 21 25 CFG=1
M  V30 27 1 21 26
M  V30 28 1 21 44
M  V30 29 1 24 27
M  V30 30 1 25 28
M  V30 31 1 26 29
M  V30 32 1 27 30
M  V30 33 1 28 29
M  V30 34 1 28 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 33 38 CFG=3
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 1 36 37
M  V30 43 1 38 39
M  V30 44 1 38 40
M  V30 45 1 39 41
M  V30 46 1 40 42
M  V30 47 1 41 43
M  V30 48 1 42 43
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 21 29 33)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methyl (2R,4S,7S)-7-cyclohexyl-3,4,6,7,8,9,12,13,14,15-decahydro-23-methoxy-1...
C33H46N4O7
1021438-56-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 49 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 14.8084 8.9664 0.0 0
M  V30 2 C 15.7884 10.1543 0.0 0
M  V30 3 O 8.5958 14.0911 0.0 0
M  V30 4 C 9.5764 15.2784 0.0 0
M  V30 5 C 7.2853 2.5584 0.0 0
M  V30 6 O 8.4010 1.4968 0.0 0
M  V30 7 O 5.8082 2.1229 0.0 0
M  V30 8 C 8.0396 0.0000 0.0 0
M  V30 9 O 4.6458 3.6208 0.0 0
M  V30 10 C 1.2826 10.2624 0.0 0
M  V30 11 C 2.1637 12.0115 0.0 0
M  V30 12 O 0.0000 6.1192 0.0 0
M  V30 13 C 10.2147 9.7236 0.0 0
M  V30 14 C 10.7609 8.2884 0.0 0
M  V30 15 C 11.2107 10.9338 0.0 0
M  V30 16 C 8.6732 9.9967 0.0 0
M  V30 17 O 10.1565 6.9821 0.0 0
M  V30 18 C 12.2999 8.0177 0.0 0
M  V30 19 C 10.6684 12.3883 0.0 0
M  V30 20 N 12.7462 10.6822 0.0 0
M  V30 21 C 8.1431 11.4462 0.0 0
M  V30 22 C 8.9404 6.2111 0.0 0 CFG=2
M  V30 23 C 13.2898 9.2210 0.0 0
M  V30 24 C 9.1337 12.6482 0.0 0
M  V30 25 C 6.6894 11.8621 0.0 0
M  V30 26 C 7.4459 6.5683 0.0 0
M  V30 27 C 9.0872 4.6578 0.0 0
M  V30 28 C 5.4827 10.8861 0.0 0
M  V30 29 N 6.6416 5.2469 0.0 0 CFG=3
M  V30 30 C 7.6469 4.0552 0.0 0 CFG=1
M  V30 31 C 4.0390 11.4742 0.0 0
M  V30 32 C 5.1587 5.0726 0.0 0
M  V30 33 C 2.7846 10.6023 0.0 0
M  V30 34 C 4.0760 6.1789 0.0 0 CFG=2
M  V30 35 C 2.8314 9.0461 0.0 0
M  V30 36 N 2.5752 5.7594 0.0 0
M  V30 37 O 1.4942 8.2525 0.0 0
M  V30 38 C 1.4124 6.7330 0.0 0
M  V30 39 C 4.8460 7.5125 0.0 0
M  V30 40 C 4.0760 8.8462 0.0 0
M  V30 41 C 6.3859 7.5125 0.0 0
M  V30 42 C 4.8460 10.1797 0.0 0
M  V30 43 C 7.1558 8.8462 0.0 0
M  V30 44 C 6.3859 10.1797 0.0 0
M  V30 45 H 8.6871 7.7301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 23
M  V30 3 1 3 4
M  V30 4 1 3 24
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 30 5 CFG=1
M  V30 8 1 6 8
M  V30 9 2 9 32
M  V30 10 1 10 33
M  V30 11 1 11 33
M  V30 12 2 12 38
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 2 15 20
M  V30 20 2 16 21
M  V30 21 1 17 22
M  V30 22 2 18 23
M  V30 23 2 19 24
M  V30 24 1 20 23
M  V30 25 1 21 24
M  V30 26 1 21 25
M  V30 27 1 22 26 CFG=3
M  V30 28 1 22 27
M  V30 29 1 22 45
M  V30 30 1 25 28
M  V30 31 1 26 29
M  V30 32 1 27 30
M  V30 33 1 28 31
M  V30 34 1 29 30
M  V30 35 1 29 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 1 34 39 CFG=1
M  V30 41 1 35 37
M  V30 42 1 36 38
M  V30 43 1 37 38
M  V30 44 1 39 40
M  V30 45 1 39 41
M  V30 46 1 40 42
M  V30 47 1 41 43
M  V30 48 1 42 44
M  V30 49 1 43 44
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 22 30 34)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1021437-85-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1021438-56-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-10031705
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of potent macrocyclic inhibitors of genotype 3a HCV NS3/4A
protease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rudd, Michael T.; McCauley, John A.; Romano, Joseph J.; Butcher, John W.;
Bush, Kimberly; McIntyre, Charles J.; Nguyen, Kevin T.; Gilbert, Kevin
F.; Lyle, Terry A.; Holloway, M. Katharine; Wan, Bang-Lin; Vacca, Joseph
P.; Summa, Vincenzo; Harper, Steven; Rowley, Michael; Carroll, Steven S.;
Burlein, Christine; DiMuzio, Jillian M.; Gates, Adam; Graham, Donald J.;
Huang, Qian; Ludmerer, Steven W.; McClain, Stephanie; McHale, Carolyn;
Stahlhut, Mark; Fandozzi, Christine; Taylor, Anne; Trainor, Nicole;
Olsen, David B.; Liverton, Nigel J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2012), 22(23), 7201-7206

$RFMT $RIREG SCHEME195 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-N-(6-bromo-2-pyridinyl)-N-methyl-2-pyridinamine
C11H9Br2N3
1032745-39-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 1.5400 0.0 0
M  V30 2 C 5.3347 0.0000 0.0 0
M  V30 3 Br 0.0000 1.5400 0.0 0
M  V30 4 Br 10.6694 1.5400 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 N 2.6673 1.5400 0.0 0
M  V30 7 C 4.0011 3.8500 0.0 0
M  V30 8 C 1.3336 2.3100 0.0 0
M  V30 9 C 2.6673 4.6200 0.0 0
M  V30 10 C 1.3336 3.8500 0.0 0
M  V30 11 C 6.6684 2.3100 0.0 0
M  V30 12 N 8.0021 1.5400 0.0 0
M  V30 13 C 6.6684 3.8500 0.0 0
M  V30 14 C 9.3358 2.3100 0.0 0
M  V30 15 C 8.0021 4.6200 0.0 0
M  V30 16 C 9.3358 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 1 11
M  V30 4 1 3 8
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 10
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N2,N6-Dimethyl-N2-[6-(methylamino)-2-pyridinyl]-2,6-pyridinediamine
C13H17N5
957107-88-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 1.5400 0.0 0
M  V30 2 C 6.6685 0.0000 0.0 0
M  V30 3 N 1.3337 1.5400 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 N 12.0033 1.5400 0.0 0
M  V30 6 C 13.3370 2.3101 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 N 4.0010 1.5400 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 2.6673 2.3101 0.0 0
M  V30 11 C 4.0010 4.6201 0.0 0
M  V30 12 C 2.6673 3.8501 0.0 0
M  V30 13 C 8.0022 2.3101 0.0 0
M  V30 14 N 9.3360 1.5400 0.0 0
M  V30 15 C 8.0022 3.8501 0.0 0
M  V30 16 C 10.6697 2.3101 0.0 0
M  V30 17 C 9.3360 4.6201 0.0 0
M  V30 18 C 10.6697 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 1 13
M  V30 4 1 3 4
M  V30 5 1 3 10
M  V30 6 1 5 6
M  V30 7 1 5 16
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1032745-39-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 957107-88-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-2147421
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-Methyl-bis(6-methylaminopyridin-2-yl)amine 4: An autoclave equipped
with a magnetic stir bar was charged with 3 (20.58 g, 60 mmol) and 250 mL
methylamine alcohol solution (27-32%). Then it was heated to 160-170 °C
for 24 h. After the mixture was cooled to room temperature, the solvent
was removed under reduced pressure. The residue was dissolved in
dichloromethane (400 mL) and washed with saturated Na2CO3 solution (100
mL) and brine (3×150 mL). The aqueous phase was re-extracted with
dichloromethane (3×150 mL), and the combined organic phase was dried over
anhydrous Na2SO4. After removal of solvent, the residue was
chromatographed on a silica gel column with a mixture of petroleum ether
and ethyl acetate as the mobile phase to give pure 4 (14.47g, 99%) as a
white solid: mp 100-101 °C;1H NMR (300 MHz, CDCl3, TMS) δ 7 .28 (dd, J
=8.0, 7.94 Hz, 2H), 6.47 (d, J =7.9 Hz, 2H), 5.92 (d, J =8.0 Hz, 2H),
4.46 (brs, 2H), 3.51 (s, 3H); 2.87 (d, J =5.2 Hz , 6H); 13C NMR (75 MHz,
CDCl3, TMS) δ 158.9, 157.1, 138.3, 103.1, 97.6, 35.5, 29.2; IR (KBr) ν
3297, 1602, 1572 cm-1; MS (EI) m/z (%) 244 (14), 243 [M]+ (100), 242
(43), 136 (76). Anal. Calcd for C13H17N5: C, 64.17; H, 7.04; N, 28.78.
Found: C, 64.40; H, 7.09; N, 28.60.
$DTYPE RXN:VAR(1):NOTES
$DATUM autoclave used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of (NH)m(NMe)4-m-Bridged Calix[4]pyridines and the Effect of NH
Bridge on Structure and Properties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, En-Xuan; Wang, De-Xian; Huang, Zhi-Tang; Wang, Mei-Xiang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2009), 74(22), 8595-8603

$RFMT $RIREG SCHEME195 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-N-(6-bromo-2-pyridinyl)-N-methyl-2-pyridinamine
C11H9Br2N3
1032745-39-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 1.5400 0.0 0
M  V30 2 C 5.3347 0.0000 0.0 0
M  V30 3 Br 0.0000 1.5400 0.0 0
M  V30 4 Br 10.6694 1.5400 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 N 2.6673 1.5400 0.0 0
M  V30 7 C 4.0011 3.8500 0.0 0
M  V30 8 C 1.3336 2.3100 0.0 0
M  V30 9 C 2.6673 4.6200 0.0 0
M  V30 10 C 1.3336 3.8500 0.0 0
M  V30 11 C 6.6684 2.3100 0.0 0
M  V30 12 N 8.0021 1.5400 0.0 0
M  V30 13 C 6.6684 3.8500 0.0 0
M  V30 14 C 9.3358 2.3100 0.0 0
M  V30 15 C 8.0021 4.6200 0.0 0
M  V30 16 C 9.3358 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 1 11
M  V30 4 1 3 8
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 10
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N2,N6-Dimethyl-N2-[6-(methylamino)-2-pyridinyl]-2,6-pyridinediamine
C13H17N5
957107-88-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 1.5400 0.0 0
M  V30 2 C 6.6685 0.0000 0.0 0
M  V30 3 N 1.3337 1.5400 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 N 12.0033 1.5400 0.0 0
M  V30 6 C 13.3370 2.3101 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 N 4.0010 1.5400 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 2.6673 2.3101 0.0 0
M  V30 11 C 4.0010 4.6201 0.0 0
M  V30 12 C 2.6673 3.8501 0.0 0
M  V30 13 C 8.0022 2.3101 0.0 0
M  V30 14 N 9.3360 1.5400 0.0 0
M  V30 15 C 8.0022 3.8501 0.0 0
M  V30 16 C 10.6697 2.3101 0.0 0
M  V30 17 C 9.3360 4.6201 0.0 0
M  V30 18 C 10.6697 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 1 13
M  V30 4 1 3 4
M  V30 5 1 3 10
M  V30 6 1 5 6
M  V30 7 1 5 16
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1032745-39-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 957107-88-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-4416240
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM An autoclave equipped with a magnetic stir bar was charged with 1 (20.58
g, 60 mmol) and 250 mL methylamine alcohol solution (27-32%). Then it was
heated to 160-170 °C for 24 h. After cooling to room temperature, the
solvent was removed under reduced pressure. The residue was dissolved in
CH2Cl2 (400 mL) and washed with saturated Na2CO3 solution (100 mL) and
brine (3×150 mL). The aqueous phase was re-extracted with dichloromethane
(3×150 mL), and the combined organic phase was dried over anhydrous
Na2SO4. After removal of solvent, the residue was chromatographed on a
silica gel column (100-200) with a mixture of petroleum ether and ethyl
acetate as the mobile phase to give pure 3 (14.47g, 99%) as a white
solid. mp 100-101 °C; IR (KBr) ν 3297, 2938, 2857, 1949, 1602, 1572,
1469, 1408 cm-1; 1H NMR (300 MHz, CDCl3) δ 6.47 (dd, J = 8.0, 7.94 Hz,
2H), 6.47 (d, J = 7.9 Hz, 2H), 5.92 (d, J = 8.0 Hz, 2H), 4.46 (brs, 2H),
3.51 (s, 3H); 2.87 (d, J = 5.2 Hz , 6H); 13C NMR (75 MHz, CDCl3) δ 158.9,
157.1, 138.3, 103.1, 97.6, 35.5, 29.2; MS (EI) m/z (%) 245 (1), 244 (14),
243 [M]+(100), 242 (43), 136 (76); Anal. Calcd for C13H17N5: C, 64.17; H,
7.04; N, 28.78. Found: C, 64.40; H, 7.09; N, 28.60.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Large Macrocyclic Azacalix[n]pyridines (n = 6 - 9) and Their
Complexation with Fullerenes C60 and C70
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, En-Xuan; Wang, De-Xian; Zheng, Qi-Yu; Wang, Mei-Xiang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2008), 10(12), 2565-2568

$RFMT $RIREG SCHEME196 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-bromo-2-(bromomethyl)-4,5-dimethoxybenzoate
C11H12Br2O4
1042722-41-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 5.3901 0.0 0
M  V30 2 O 8.0023 4.6201 0.0 0
M  V30 3 O 6.6685 6.9302 0.0 0
M  V30 4 C 9.3360 5.3901 0.0 0
M  V30 5 C 4.0012 6.9302 0.0 0
M  V30 6 Br 2.6675 7.7002 0.0 0
M  V30 7 Br 1.3337 5.3901 0.0 0
M  V30 8 O 4.0012 0.7700 0.0 0
M  V30 9 C 5.3348 0.0000 0.0 0
M  V30 10 O 1.3337 2.3101 0.0 0
M  V30 11 C 0.0000 3.0801 0.0 0
M  V30 12 C 5.3348 4.6201 0.0 0
M  V30 13 C 4.0012 5.3901 0.0 0
M  V30 14 C 5.3348 3.0801 0.0 0
M  V30 15 C 2.6675 4.6201 0.0 0
M  V30 16 C 4.0012 2.3101 0.0 0
M  V30 17 C 2.6675 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 13
M  V30 7 1 7 15
M  V30 8 1 8 9
M  V30 9 1 8 16
M  V30 10 1 10 11
M  V30 11 1 10 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2,3-dihydro-5,6-dimethoxy-2-methyl-1H-isoindol-1-one
C11H12BrNO3
1042722-43-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 6.0812 6.6686 0.0 0
M  V30 2 O 0.3504 3.2909 0.0 0
M  V30 3 O 7.6213 4.0011 0.0 0
M  V30 4 C 8.3913 5.3348 0.0 0
M  V30 5 C 0.0000 6.6229 0.0 0
M  V30 6 O 6.0812 1.3338 0.0 0
M  V30 7 C 5.3112 0.0000 0.0 0
M  V30 8 C 3.7712 5.3348 0.0 0
M  V30 9 C 3.0012 4.0011 0.0 0
M  V30 10 C 5.3112 5.3348 0.0 0
M  V30 11 C 2.7406 6.4793 0.0 0
M  V30 12 C 3.7712 2.6675 0.0 0
M  V30 13 C 1.4947 4.3213 0.0 0
M  V30 14 C 6.0812 4.0011 0.0 0
M  V30 15 N 1.3338 5.8529 0.0 0
M  V30 16 C 5.3112 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 2 2 13
M  V30 3 1 3 4
M  V30 4 1 3 14
M  V30 5 1 5 15
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1042722-41-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1042722-43-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-8419238
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM 66-99% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of aristolactam analogues and evaluation of their antitumor
activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Choi, Young Lok; Kim, Joa Kyum; Choi, Sang-Un; Min, Yong-Ki; Bae,
Myung-Ae; Kim, Bum Tae; Heo, Jung-Nyoung
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(11), 3036-3040

$RFMT $RIREG SCHEME197 STEP1
$RXN



  2  1
$MOL
4-Chlorobenzaldehyde
C7H5ClO
104-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-methyl-, compd. with methanamine (1:1)
C2H5NO2.CH5N
65398-48-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 2.6673 3.8501 0.0 0
M  V30 3 O 1.3337 1.5400 0.0 0
M  V30 4 O 0.0000 3.8501 0.0 0
M  V30 5 C 4.0010 3.0800 0.0 0
M  V30 6 C 1.2305 0.0000 0.0 0
M  V30 7 N 2.7705 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanamine, N-[(4-chlorophenyl)methylene]-, (E)-
C8H8ClN
60682-82-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 1.3337 0.0 0
M  V30 2 N 6.9301 2.6673 0.0 0
M  V30 3 C 8.4701 2.6673 0.0 0
M  V30 4 Cl 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 2.3100 0.0000 0.0 0
M  V30 9 C 2.3100 2.6673 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 104-88-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 65398-48-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 60682-82-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-22950011
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Stable carbamate pathway towards organic-inorganic hybrid perovskites and
aromatic imines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lee, Kyu Hyung; Kim, Sun Joo; Park, Hee Sun; Lim, Byung Wook; Lee,
Byeongno; Park, Young Jun; Nam, Wonwoo; Hur, Nam Hwi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2020), 10(62), 38055-38062

$RFMT $RIREG SCHEME198 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chlorobenzaldehyde
C7H5ClO
104-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4-Chlorophenyl)methylene]methanamine
C8H8ClN
13114-22-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 1.3337 0.0 0
M  V30 2 N 6.9301 2.6673 0.0 0
M  V30 3 C 8.4701 2.6673 0.0 0
M  V30 4 Cl 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-88-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 13114-22-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-7846583
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Syntheses of the various Schiff bases were
carried out according to the literature by combining the given aromatic
aldehyde (1 mmol) with the corresponding amine (1.1 mmol). In cases where
either the aldehyde or the amine was solid, ethanol (∼3 mL) was used to
solubilize the reagents. The reaction was allowed to stir under ambient
conditions for 12 hours. In cases where a precipitate was noted, the
product was isolated by filtration and washed with cold ethanol (∼2 mL)
to afford pure product. When both reagents were initially liquids, the
solvents and excess amine were removed in vacuo. All Schiff base
reactions gave at, or near, quantitative yields (Scheme 2, A). Schiff
base, reactant of compound 23a.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, no solvent or EtOH used for solid reactants
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient synthesis of new 4-arylideneimidazolin-5-ones related to the
GFP chromophore by 2+3 cyclocondensation of arylideneimines with imidate
ylides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baldridge, Anthony; Kowalik, Janusz; Tolbert, Laren M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2010), (14), 2424-2436

$RFMT $RIREG SCHEME199 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Cyanobenzaldehyde
C8H5NO
105-07-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9301 1.3337 0.0 0
M  V30 2 N 8.4701 1.3337 0.0 0
M  V30 3 C 0.7700 1.3337 0.0 0
M  V30 4 O 0.0000 2.6673 0.0 0
M  V30 5 C 5.3901 1.3337 0.0 0
M  V30 6 C 4.6201 2.6673 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 3.0800 2.6673 0.0 0
M  V30 9 C 3.0800 0.0000 0.0 0
M  V30 10 C 2.3100 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 2 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(Methylimino)methyl]benzonitrile
C9H8N2
118964-95-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 1.3336 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 C 0.0000 2.6673 0.0 0
M  V30 4 C 8.4700 1.3336 0.0 0
M  V30 5 N 10.0100 1.3336 0.0 0
M  V30 6 C 3.8500 1.3336 0.0 0
M  V30 7 C 4.6200 0.0000 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 6.1600 0.0000 0.0 0
M  V30 10 C 6.1600 2.6673 0.0 0
M  V30 11 C 6.9300 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 3 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 105-07-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 118964-95-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-13423372
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Syntheses of the various Schiff bases were
carried out according to the literature by combining the given aromatic
aldehyde (1 mmol) with the corresponding amine (1.1 mmol). In cases where
either the aldehyde or the amine was solid, ethanol (∼3 mL) was used to
solubilize the reagents. The reaction was allowed to stir under ambient
conditions for 12 hours. In cases where a precipitate was noted, the
product was isolated by filtration and washed with cold ethanol (∼2 mL)
to afford pure product. When both reagents were initially liquids, the
solvents and excess amine were removed in vacuo. All Schiff base
reactions gave at, or near, quantitative yields (Scheme 2, A). Schiff
base, reactant of compound 5a.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, no solvent or EtOH used for solid reactants
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient synthesis of new 4-arylideneimidazolin-5-ones related to the
GFP chromophore by 2+3 cyclocondensation of arylideneimines with imidate
ylides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baldridge, Anthony; Kowalik, Janusz; Tolbert, Laren M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2010), (14), 2424-2436

$RFMT $RIREG SCHEME200 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
β-Alanine, N-(3-methoxy-3-oxopropyl)-N-methyl-, methyl ester
C9H17NO4
105-71-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 8.0022 2.3101 0.0 0
M  V30 4 C 6.6685 0.0000 0.0 0
M  V30 5 C 4.0010 1.5400 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 C 10.6697 2.3101 0.0 0
M  V30 9 O 1.3337 1.5400 0.0 0
M  V30 10 O 2.6673 3.8501 0.0 0
M  V30 11 O 12.0033 1.5400 0.0 0
M  V30 12 O 10.6697 3.8501 0.0 0
M  V30 13 C 0.0000 2.3101 0.0 0
M  V30 14 C 13.3370 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 11 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,3′-(Methylimino)bis[N-methylpropanamide]
C9H19N3O2
888011-54-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 8.0022 2.3101 0.0 0
M  V30 4 C 6.6685 0.0000 0.0 0
M  V30 5 C 4.0010 1.5400 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 C 10.6697 2.3101 0.0 0
M  V30 9 N 1.3337 1.5400 0.0 0
M  V30 10 O 2.6673 3.8501 0.0 0
M  V30 11 N 12.0033 1.5400 0.0 0
M  V30 12 O 10.6697 3.8501 0.0 0
M  V30 13 C 0.0000 2.3101 0.0 0
M  V30 14 C 13.3370 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 11 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 105-71-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 888011-54-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-12454885
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A new stepwise synthesis of a family of propylamines derived from diatom
silaffins and their activity in silicification
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Annenkov, Vadim V.; Patwardhan, Siddharth V.; Belton, David;
Danilovtseva, Elena N.; Perry, Carole C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2006), (14),
1521-1523

$RFMT $RIREG SCHEME201 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl β-oxo-4-(trifluoromethyl)benzenepropanoate
C12H11F3O3
106263-53-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.4137 0.0 0
M  V30 2 C 8.0022 3.6437 0.0 0
M  V30 3 O 6.6685 5.9538 0.0 0
M  V30 4 C 9.3360 4.4137 0.0 0
M  V30 5 O 10.6697 3.6437 0.0 0
M  V30 6 O 9.3360 5.9538 0.0 0
M  V30 7 C 12.0033 4.4137 0.0 0
M  V30 8 C 13.3370 3.6437 0.0 0
M  V30 9 C 1.3337 1.3337 0.0 0
M  V30 10 F 2.1037 0.0000 0.0 0
M  V30 11 F 0.0000 0.5637 0.0 0
M  V30 12 F 0.5637 2.6673 0.0 0
M  V30 13 C 5.3348 3.6437 0.0 0
M  V30 14 C 5.3348 2.1037 0.0 0
M  V30 15 C 4.0010 4.4137 0.0 0
M  V30 16 C 4.0010 1.3337 0.0 0
M  V30 17 C 2.6673 3.6437 0.0 0
M  V30 18 C 2.6673 2.1037 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (2Z)-3-(methylamino)-3-[4-(trifluoromethyl)phenyl]-2-propenoate
C13H14F3NO2
2614438-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.4137 0.0 0
M  V30 2 C 8.0022 3.6437 0.0 0
M  V30 3 N 6.6685 5.9538 0.0 0
M  V30 4 C 9.3360 4.4137 0.0 0
M  V30 5 C 5.3348 6.7238 0.0 0
M  V30 6 O 10.6697 3.6437 0.0 0
M  V30 7 O 9.3360 5.9538 0.0 0
M  V30 8 C 12.0033 4.4137 0.0 0
M  V30 9 C 13.3370 3.6437 0.0 0
M  V30 10 C 1.3337 1.3337 0.0 0
M  V30 11 F 2.1037 0.0000 0.0 0
M  V30 12 F 0.0000 0.5637 0.0 0
M  V30 13 F 0.5637 2.6673 0.0 0
M  V30 14 C 5.3348 3.6437 0.0 0
M  V30 15 C 4.0010 4.4137 0.0 0
M  V30 16 C 5.3348 2.1037 0.0 0
M  V30 17 C 2.6673 3.6437 0.0 0
M  V30 18 C 4.0010 1.3337 0.0 0
M  V30 19 C 2.6673 2.1037 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 19
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106263-53-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2614438-08-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-23326052
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Electrochemical Oxidative Cyclization: Synthesis of Polysubstituted
Pyrrole from Enamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Zhiwei; Shi, Guang; Tang, Wei; Sun, Jie; Wang, Wenxing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2021), 2021(6), 951-955

$RFMT $RIREG SCHEME202 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acrylonitrile
C3H3N
107-13-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 0.0000 0.0 0
M  V30 2 C 1.3337 0.7700 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 3 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Methylamino)propanenitrile
C4H8N2
693-05-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 C 4.0012 0.7700 0.0 0
M  V30 3 C 1.3338 0.7700 0.0 0
M  V30 4 N 5.3348 1.5400 0.0 0
M  V30 5 N 0.0000 0.0000 0.0 0
M  V30 6 C 6.6687 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 3 3 5
M  V30 5 1 4 6
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 107-13-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 693-05-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-15340405
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1298062-16-4
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, ionic liquid catalyst used, Michael addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of a novel ionic liquid with both Lewis and Bronsted acid sites
and its catalytic activities
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liang, Xuezheng; Qi, Chenze
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Catalysis Communications (2011), 12(9), 808-812

$RFMT $RIREG SCHEME202 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acrylonitrile
C3H3N
107-13-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 0.0000 0.0 0
M  V30 2 C 1.3337 0.7700 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 3 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Methylamino)propanenitrile
C4H8N2
693-05-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 C 4.0012 0.7700 0.0 0
M  V30 3 C 1.3338 0.7700 0.0 0
M  V30 4 N 5.3348 1.5400 0.0 0
M  V30 5 N 0.0000 0.0000 0.0 0
M  V30 6 C 6.6687 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 3 3 5
M  V30 5 1 4 6
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 107-13-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 693-05-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-14321662
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1360467-48-6
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, no solvent, Michael addition, mechanism
studied, scalable, ionic liquid used (catalyst), catalyst recyclable
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel ionic liquid with both Lewis and Bronsted acid sites for Michael
addition
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jiang, Xiaoyue; Ye, Weidong; Song, Xiaohua; Ma, Wenxin; Lao, Xuejun;
Shen, Runpu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM International Journal of Molecular Sciences (2011), 127438-7444

$RFMT $RIREG SCHEME203 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Hydroxy-5-methoxybenzaldehyde
C8H8O3
672-13-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 O 6.9300 4.0011 0.0 0
M  V30 3 O 4.6200 0.0000 0.0 0
M  V30 4 O 1.5400 5.3349 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.8500 4.0011 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 2.3100 1.3338 0.0 0
M  V30 11 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 8
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Isopropyl chloroformate
C4H7ClO2
108-23-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6674 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3338 1.5400 0.0 0
M  V30 4 C 5.3349 2.3100 0.0 0
M  V30 5 C 4.0011 0.0000 0.0 0
M  V30 6 Cl 1.3338 0.0000 0.0 0
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methylethyl N-[(2-hydroxy-5-methoxyphenyl)methyl]-N-methylcarbamate
C13H19NO4
1520080-37-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 2.6675 0.0 0
M  V30 2 N 4.6201 4.0012 0.0 0
M  V30 3 C 3.0801 4.0012 0.0 0
M  V30 4 C 5.3901 5.3348 0.0 0
M  V30 5 O 2.3101 5.3348 0.0 0
M  V30 6 O 2.3101 2.6675 0.0 0
M  V30 7 C 0.7700 5.3348 0.0 0
M  V30 8 C 0.0000 4.0012 0.0 0
M  V30 9 C 0.0000 6.6687 0.0 0
M  V30 10 O 6.9302 0.0000 0.0 0
M  V30 11 O 10.0102 5.3348 0.0 0
M  V30 12 C 11.5503 5.3348 0.0 0
M  V30 13 C 6.9302 2.6675 0.0 0
M  V30 14 C 7.7002 4.0012 0.0 0
M  V30 15 C 7.7002 1.3338 0.0 0
M  V30 16 C 9.2402 4.0012 0.0 0
M  V30 17 C 9.2402 1.3338 0.0 0
M  V30 18 C 10.0102 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 10 15
M  V30 11 1 11 12
M  V30 12 1 11 16
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 672-13-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 108-23-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1520080-37-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-4664493
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-64-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedures for Synthesis of
Carbamates: Method B. Preparation of carbamates 5b, 6b, 7b, S1, S4, 10b,
11b, 12b, 13b, 13c, 13f, 13g, 14b, and 14g. To a stirred solution of
aldehyde (2.10 mmol) in MeOH (10.5 mL) was added at rt a 40% MeOH
solution of MeNH2 (0.429 mL, 4.20 mmol). After 1 h at rt, NaBH4 (159 mg,
4.20 mmol) was added at 0°C and the mixture was stirred at rt for 30 min.
The reaction mixture was quenched with acetone (20 mL) at 0°C and the new
mixture was concentrated under reduced pressure. The residual white
solids were used for the next step without purification. To a stirred
solution of the residue in a mixture of 1:1:1 THF-acetone-H2O (10.0 mL)
was added at 0°C ClCO2R (3.78 mmol) or FmocOSu (1.28 g, 3.78 mmol, for
17g and S15). After 2 h at rt, saturated aqueous NaHCO3 (10 mL) was added
at 0°C and the mixture was extracted with EtOAc (10 mL x 3). The extracts
were washed with saturated aqueous NaCl (10 mL), dried over Na2SO4, and
concentrated under reduced pressure. The residue was purified by column
chromatography on silica gel to afford carbamates 5b, 6b, 7b, S1, S4,
10b, 11b, 12b, 13b, 13c, 13f, 13g, 14b, and 14g. From
3-methoxybenzaldehyde. From 2-hydroxy-5-methoxybenzaldehyde. Isopropyl
2-hydroxy-5-methoxybenzyl(methyl)carbamate (S4) as a colorless syrup,
yield 99%. Rf = 0.45 (2:1 hexane-EtOAc); IR (neat, cm-1) 3277, 2982,
1661, 1500, 1405, 1211, 1153, 1110, 1044; 1H NMR (500 MHz, CDCl3) δ 1.25
(6H, d, J = 6.3 Hz), 2.92 (3H, s), 3.76 (3H, s), 4.31 (2H, s), 4.95 (1H,
sept, J = 6.3 Hz), 6.67 (1H, d, J = 2.9 Hz), 6.80 (1H, dd, J = 8.9, 2.9
Hz), 6.88 (1H, d, J = 8.9 Hz), 8.83 (1H, br s); 13C NMR (125 MHz, CDCl3)
δ 22.1, 33.8, 49.7, 55.8, 70.2, 114.7, 116.8, 118.0, 123.1, 149.9, 152.5,
158.2; LRMS (EI) m/z (M)+ 252.8; HRMS (EI) m/z (M)+ calcd for C13H19NO4
253.1314, found 253.1314.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Smooth Isoindolinone Formation from Isopropyl Carbamates via
Bischler-Napieralski-Type Cyclization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Adachi, Satoshi; Onozuka, Masao; Yoshida, Yuko; Ide, Mitsuaki; Saikawa,
Yoko; Nakata, Masaya
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2014), 16(2), 358-361

$RFMT $RIREG SCHEME204 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[7-(3-Bromopropoxy)-2,3-dihydro-2,2-dimethyl-5-benzofuranyl]-5-chloro-3-met...
C22H23BrClNO5S
1089187-78-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 14.0710 4.8479 0.0 0
M  V30 2 C 14.8410 6.1817 0.0 0
M  V30 3 C 16.3810 6.1817 0.0 0
M  V30 4 C 17.1510 7.5154 0.0 0
M  V30 5 Br 18.6910 7.5154 0.0 0
M  V30 6 C 9.9604 0.0000 0.0 0
M  V30 7 C 12.0214 0.0000 0.0 0
M  V30 8 N 9.4510 7.5154 0.0 0
M  V30 9 S 7.9110 7.5154 0.0 0 VAL=6
M  V30 10 O 7.9110 9.0554 0.0 0
M  V30 11 O 7.9110 5.9754 0.0 0
M  V30 12 C 5.9416 10.2259 0.0 0
M  V30 13 Cl 0.0000 9.0554 0.0 0
M  V30 14 C 11.7610 3.5143 0.0 0
M  V30 15 C 10.2210 3.5143 0.0 0
M  V30 16 C 12.5310 4.8479 0.0 0
M  V30 17 O 12.2368 2.0497 0.0 0
M  V30 18 C 9.4510 4.8479 0.0 0
M  V30 19 C 9.7450 2.0497 0.0 0
M  V30 20 C 11.7610 6.1817 0.0 0
M  V30 21 C 10.9910 1.1445 0.0 0
M  V30 22 C 10.2210 6.1817 0.0 0
M  V30 23 C 6.3710 7.5154 0.0 0
M  V30 24 C 5.4658 8.7612 0.0 0
M  V30 25 O 5.4658 6.2695 0.0 0
M  V30 26 C 4.0011 8.2854 0.0 0
M  V30 27 C 4.0011 6.7454 0.0 0
M  V30 28 C 2.6674 9.0554 0.0 0
M  V30 29 C 2.6674 5.9754 0.0 0
M  V30 30 C 1.3338 8.2854 0.0 0
M  V30 31 C 1.3338 6.7454 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 21
M  V30 7 1 7 21
M  V30 8 1 8 9
M  V30 9 1 8 22
M  V30 10 2 9 10
M  V30 11 2 9 11
M  V30 12 1 9 23
M  V30 13 1 12 24
M  V30 14 1 13 30
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 14 17
M  V30 18 2 15 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-N-[2,3-dihydro-2,2-dimethyl-7-[3-(methylamino)propoxy]-5-benzofurany...
C23H27ClN2O5S
1089187-40-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 14.0710 4.8479 0.0 0
M  V30 2 C 14.8410 6.1817 0.0 0
M  V30 3 C 16.3810 6.1817 0.0 0
M  V30 4 C 17.1510 7.5154 0.0 0
M  V30 5 N 18.6910 7.5154 0.0 0
M  V30 6 C 19.4610 8.8490 0.0 0
M  V30 7 C 9.9604 0.0000 0.0 0
M  V30 8 C 12.0214 0.0000 0.0 0
M  V30 9 N 9.4510 7.5154 0.0 0
M  V30 10 S 7.9110 7.5154 0.0 0 VAL=6
M  V30 11 O 7.9110 9.0554 0.0 0
M  V30 12 O 7.9110 5.9754 0.0 0
M  V30 13 C 5.9416 10.2259 0.0 0
M  V30 14 Cl 0.0000 9.0554 0.0 0
M  V30 15 C 11.7610 3.5143 0.0 0
M  V30 16 C 10.2210 3.5143 0.0 0
M  V30 17 C 12.5310 4.8479 0.0 0
M  V30 18 O 12.2368 2.0497 0.0 0
M  V30 19 C 9.4510 4.8479 0.0 0
M  V30 20 C 9.7450 2.0497 0.0 0
M  V30 21 C 11.7610 6.1817 0.0 0
M  V30 22 C 10.9910 1.1445 0.0 0
M  V30 23 C 10.2210 6.1817 0.0 0
M  V30 24 C 6.3710 7.5154 0.0 0
M  V30 25 C 5.4658 8.7612 0.0 0
M  V30 26 O 5.4658 6.2695 0.0 0
M  V30 27 C 4.0011 8.2854 0.0 0
M  V30 28 C 4.0011 6.7454 0.0 0
M  V30 29 C 2.6674 9.0554 0.0 0
M  V30 30 C 2.6674 5.9754 0.0 0
M  V30 31 C 1.3338 8.2854 0.0 0
M  V30 32 C 1.3338 6.7454 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 22
M  V30 8 1 8 22
M  V30 9 1 9 10
M  V30 10 1 9 23
M  V30 11 2 10 11
M  V30 12 2 10 12
M  V30 13 1 10 24
M  V30 14 1 13 25
M  V30 15 1 14 31
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 15 18
M  V30 19 2 16 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1089187-78-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1089187-40-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-6793084
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 5-Chloro-3-methyl-benzofuran-2-sulfonyl-N-[2,3-dihydro-2,2-dimethyl-7-(3-methylamino-propoxy)-benzofuran-5-yl]-amide
To the solution of triethylamine (1.3 ml, 0.95 g, 0.00946 mol) and
dichloromethane (10 ml) under stirring at room temperature an alkoholic
solution of methylamine (12 ml, 33 %) is added, then under stirring and
cooling with tap water
5-chloro-3-methyl-benzofuran-2-sulfonyl-N-{2,3-dihydro-2,2-dimethyl-7-[3-bromo-propoxy]-benzofuran-5-yl}-amide
(2.5 g. 0.00473 mol). Stirring is continued for 3 days, then the reaction
mixture is evaporated until dry in vacuum, the residue is suspended with
ether, then the precipitated crystals are filtered. Thus, 2.25 g (99.4 %)
product are obtained, which is purified on Kieselgel column with an
eluent of cyclohexane - ethylacetate. The suitable fractions are
evaporated and thus, 1.07 g (47.2 %) of the pure crystalline product are
obtained, melting point: 195-198 °C, which is directly suitable for
biological experiments.
5-Chloro-3-methyl-benzofuran-2-sulfonyl-N-[2,3-dihydro-2,2-dimethyl-7-(3-methylamino-propoxy)-benzofuran-5-yl]-amide,
yield 2.25 g (99.4 %). melting point: 195-198 °C; 1H-NMR (DMSO-d6): δ,
ppm 7.78 d (1H), 7.64 d (1H), 7.45 dd (1H), 6.43 d (1H), 6.36 d (1H),
3.79 t (2H), 2.84 s (2H), 2.67 t (2H), 2.37 s (3H), 2.28 s, (2H), 1.78 qi
(2H), 1.33 s (6H).
$DTYPE RXN:VAR(1):NOTES
$DATUM 47.2% isolated yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of (aminoalkoxy)benzofuranamines and their amides and
sulfonamides as selective 5-HT6 receptor inhibitors for the treatment of
cardiovascular and central nervous system disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rivo, Endre; Prauda, Ibolya; Reiter, Jozsef; Barkoczy, Jozsef; Gacsalyi,
Istvan; Kompagne, Hajnalka; Sziray, Nora; Pallagi, Katalin; Egyed,
Andras; Hegedues, Endre; Levay, Gyoergy; Harsing, Laszlo Gabor
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008146063 A1 2008-12-04

$RFMT $RIREG SCHEME205 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1,1-Dimethylethyl) 4-[4-(1-carboxy-1-methylethyl)phenyl]-1-piperazinecarbo...
C19H28N2O4
1095546-00-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.8737 0.0 0
M  V30 2 C 1.5400 4.2073 0.0 0
M  V30 3 C 0.7700 2.8737 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 O 2.3100 5.5410 0.0 0
M  V30 6 O 0.0000 4.2073 0.0 0
M  V30 7 C 13.0901 2.8737 0.0 0
M  V30 8 O 13.8602 1.5400 0.0 0
M  V30 9 O 13.8602 4.2073 0.0 0
M  V30 10 C 15.4002 1.5400 0.0 0
M  V30 11 C 15.4002 3.0800 0.0 0
M  V30 12 C 16.9402 1.5400 0.0 0
M  V30 13 C 15.4002 0.0000 0.0 0
M  V30 14 C 6.9301 2.8737 0.0 0
M  V30 15 C 6.1601 1.5400 0.0 0
M  V30 16 C 6.1601 4.2073 0.0 0
M  V30 17 C 4.6201 1.5400 0.0 0
M  V30 18 C 4.6201 4.2073 0.0 0
M  V30 19 C 3.8500 2.8737 0.0 0
M  V30 20 N 8.4701 2.8737 0.0 0
M  V30 21 C 9.2401 1.5400 0.0 0
M  V30 22 C 9.2401 4.2073 0.0 0
M  V30 23 C 10.7801 1.5400 0.0 0
M  V30 24 C 10.7801 4.2073 0.0 0
M  V30 25 N 11.5501 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 19
M  V30 5 1 2 5
M  V30 6 2 2 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 25
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 14 20
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[4-[1,1-dimethyl-2-(methylamino)-2-oxoethyl]phenyl]-1-pip...
C20H31N3O3
1095540-73-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0801 2.8737 0.0 0
M  V30 2 C 2.3101 4.2074 0.0 0
M  V30 3 C 1.5400 2.8737 0.0 0
M  V30 4 C 2.3101 1.5400 0.0 0
M  V30 5 N 0.7700 4.2074 0.0 0
M  V30 6 O 3.0801 5.5410 0.0 0
M  V30 7 C 0.0000 5.5410 0.0 0
M  V30 8 C 13.8603 2.8737 0.0 0
M  V30 9 O 14.6303 1.5400 0.0 0
M  V30 10 O 14.6303 4.2074 0.0 0
M  V30 11 C 16.1704 1.5400 0.0 0
M  V30 12 C 16.1704 0.0000 0.0 0
M  V30 13 C 17.7104 1.5400 0.0 0
M  V30 14 C 16.1704 3.0801 0.0 0
M  V30 15 C 7.7002 2.8737 0.0 0
M  V30 16 C 6.9302 4.2074 0.0 0
M  V30 17 C 6.9302 1.5400 0.0 0
M  V30 18 C 5.3901 4.2074 0.0 0
M  V30 19 C 5.3901 1.5400 0.0 0
M  V30 20 C 4.6201 2.8737 0.0 0
M  V30 21 N 9.2402 2.8737 0.0 0
M  V30 22 C 10.0102 4.2074 0.0 0
M  V30 23 C 10.0102 1.5400 0.0 0
M  V30 24 C 11.5503 4.2074 0.0 0
M  V30 25 C 11.5503 1.5400 0.0 0
M  V30 26 N 12.3203 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 20
M  V30 5 1 2 5
M  V30 6 2 2 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 26
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 15 21
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 22 1 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1095546-00-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1095540-73-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-7680324
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM tert-butyl
4-(4-(2-methyl-1-(methylamino)-1-oxopropan-2-yl)phenyl)piperazine-1-carboxylate
To a slurry of
2-(4-(4-(tert-butoxycarbonyl)piperazin-1-yl)phenyl)-2-methylpropanoic
acid (266 mg, 0.760 mmol) and HATU (319 mg, 0.84 mmol) in DCM (3.8 mL)
was added N-ethyldiisopropylamine (0.396 ml, 2.29 mmol) followed by
methylamine (1.15 mL, 2.29 mmol) and the reaction stirred for 18 hours.
The mixture was diluted with DCM (50 mL) and washed sequentially with
water (2x50 mL) and saturated NaHCO3 (2x50 mL), dried over MgSO4,
filtered and evaporated to give tert-butyl
4-(4-(2-methyl-1-(methylamino)-oxopropan-2-yl)phenyl)piperazine-1-carboxylate
(274 mg, 99 %) as a yellow solid. tert-butyl
4-(4-(2-methyl-1-(methylamino)-1-oxopropan-2-yl)phenyl)piperazine-1-carboxylate,
Yield 274 mg, 99 % MS (+ve ESI): 362 (M+H)+ 1H NMR (400.132 MHz, CDCl3) δ
6.90 (2H, d), 7.26 (2H, d), 5.16 (1H, s), 3.55 - 3.60 (4H, m), 3.11 -
3.16 (4H, m), 2.70 (3H, d), 1.48 (9H, s), 1.54 (6H, s)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cyanocyclopropylcarboxamides as cathepsin inhibitors and their
preparation and use in the treatment of diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Crawford, James John; Dossetter, Alexander Graham; Finlayson, Jonathan
Erle; Heron, Nicola Murdoch
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009001127 A1 2008-12-31

$RFMT $RIREG SCHEME206 STEP1
$RXN



  2  1
$MOL
4-Bromobenzaldehyde
C7H5BrO
1122-91-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Br 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-methyl-, compd. with methanamine (1:1)
C2H5NO2.CH5N
65398-48-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 2.6673 3.8501 0.0 0
M  V30 3 O 1.3337 1.5400 0.0 0
M  V30 4 O 0.0000 3.8501 0.0 0
M  V30 5 C 4.0010 3.0800 0.0 0
M  V30 6 C 1.2305 0.0000 0.0 0
M  V30 7 N 2.7705 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanamine, N-[(4-bromophenyl)methylene]-, (E)-
C8H8BrN
86402-04-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 1.3337 0.0 0
M  V30 2 N 6.9301 2.6673 0.0 0
M  V30 3 C 8.4701 2.6673 0.0 0
M  V30 4 Br 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 2.3100 0.0000 0.0 0
M  V30 9 C 2.3100 2.6673 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1122-91-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 65398-48-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 86402-04-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-22949668
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Stable carbamate pathway towards organic-inorganic hybrid perovskites and
aromatic imines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lee, Kyu Hyung; Kim, Sun Joo; Park, Hee Sun; Lim, Byung Wook; Lee,
Byeongno; Park, Young Jun; Nam, Wonwoo; Hur, Nam Hwi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2020), 10(62), 38055-38062

$RFMT $RIREG SCHEME207 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromonicotinaldehyde
C6H4BrNO
113118-81-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 O 6.6687 2.3101 0.0 0
M  V30 3 Br 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 N 2.6675 0.0000 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methyl-3-pyridinemethanamine
C7H9BrN2
73335-64-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0800 0.0 0
M  V30 2 N 6.6686 2.3100 0.0 0
M  V30 3 C 8.0022 3.0800 0.0 0
M  V30 4 Br 0.0000 3.0800 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6675 3.0800 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 1.3337 2.3100 0.0 0
M  V30 9 N 2.6675 0.0000 0.0 0
M  V30 10 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 113118-81-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 73335-64-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-20807710
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 1H-indazole-3-carboxamide compounds as glycogen synthase
kinase 3β inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Furlotti, Guido; Cavarischia, Claudia; Buonfiglio, Rosa; Ombrato,
Rosella; Iacoangeli, Tommaso
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019215075 A1 2019-11-14

$RFMT $RIREG SCHEME208 STEP1
$RXN



  2  1
$MOL
5-Methyl-3-phenylisoxazole-4-carboxylic acid
C11H9NO3
1136-45-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.1864 1.1444 0.0 0
M  V30 2 O 2.1559 0.0000 0.0 0
M  V30 3 O 4.6927 0.8242 0.0 0
M  V30 4 C 0.0000 2.1797 0.0 0
M  V30 5 C 3.6156 3.8549 0.0 0
M  V30 6 C 2.7104 2.6091 0.0 0
M  V30 7 N 2.7104 5.1008 0.0 0
M  V30 8 C 1.2459 3.0849 0.0 0
M  V30 9 O 1.2459 4.6250 0.0 0
M  V30 10 C 5.1556 3.8549 0.0 0
M  V30 11 C 5.9256 5.1886 0.0 0
M  V30 12 C 5.9256 2.5213 0.0 0
M  V30 13 C 7.4656 5.1886 0.0 0
M  V30 14 C 7.4656 2.5213 0.0 0
M  V30 15 C 8.2357 3.8549 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 10
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,5-Dimethyl-3-phenyl-4-isoxazolecarboxamide
C12H12N2O2
60986-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.1864 2.6092 0.0 0
M  V30 2 N 2.1559 1.4647 0.0 0
M  V30 3 O 4.6927 2.2889 0.0 0
M  V30 4 C 2.6317 0.0000 0.0 0
M  V30 5 C 0.0000 3.6444 0.0 0
M  V30 6 C 3.6156 5.3196 0.0 0
M  V30 7 C 2.7104 4.0738 0.0 0
M  V30 8 N 2.7104 6.5655 0.0 0
M  V30 9 C 1.2459 4.5496 0.0 0
M  V30 10 O 1.2459 6.0897 0.0 0
M  V30 11 C 5.1556 5.3196 0.0 0
M  V30 12 C 5.9256 6.6534 0.0 0
M  V30 13 C 5.9256 3.9860 0.0 0
M  V30 14 C 7.4656 6.6533 0.0 0
M  V30 15 C 7.4656 3.9860 0.0 0
M  V30 16 C 8.2357 5.3196 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 11
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1136-45-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 60986-88-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2770467
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of isoxazolopyridinones as Nurr1 activators for treating
Parkinson's disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hintermann, Samuel; Hengerer, Bastian; Von Krosigk, Ulrike
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003015780 A2 2003-02-27

$RFMT $RIREG SCHEME209 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-α-(2-chloroethyl)-α-methylbenzenemethanol
C10H12Cl2O
113696-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0801 1.3337 0.0 0
M  V30 2 C 2.3101 2.6673 0.0 0
M  V30 3 C 1.7464 0.5637 0.0 0
M  V30 4 O 3.8501 0.0000 0.0 0
M  V30 5 C 0.7700 2.6673 0.0 0
M  V30 6 Cl 0.0000 4.0012 0.0 0
M  V30 7 Cl 8.4151 4.4137 0.0 0
M  V30 8 C 4.4139 2.1037 0.0 0
M  V30 9 C 4.4139 3.6437 0.0 0
M  V30 10 C 5.7476 1.3337 0.0 0
M  V30 11 C 5.7476 4.4137 0.0 0
M  V30 12 C 7.0812 2.1037 0.0 0
M  V30 13 C 7.0812 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-α-methyl-α-[2-(methylamino)ethyl]benzenemethanol
C11H16ClNO
324752-25-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3349 1.3337 0.0 0
M  V30 2 C 6.1049 2.6673 0.0 0
M  V30 3 C 6.6686 0.5636 0.0 0
M  V30 4 O 4.5649 0.0000 0.0 0
M  V30 5 C 7.6450 2.6673 0.0 0
M  V30 6 N 8.4150 4.0011 0.0 0
M  V30 7 C 9.9550 4.0011 0.0 0
M  V30 8 Cl 0.0000 4.4137 0.0 0
M  V30 9 C 4.0011 2.1037 0.0 0
M  V30 10 C 2.6675 1.3337 0.0 0
M  V30 11 C 4.0011 3.6437 0.0 0
M  V30 12 C 1.3338 2.1037 0.0 0
M  V30 13 C 2.6675 4.4137 0.0 0
M  V30 14 C 1.3338 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 113696-77-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 324752-25-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-14441200
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 3-(4-chlorophenyl)-3-hydroxyl-3-methyl-1-N-methylaminopropane: FIG. 10a A
mixture of 3,3,3-(4-Chlorophenyl)-hydroxylmethyl-1-bromoropane (2, 1.04
g, 4.74 mmol), EtOH (5 mL) and H2NMe in H2O (10 mL, 40% w/w) was heated
at 135 0°C. for 3 hours. The mixture was cooled down to room temperature.
The mixture was extracted with Et2O (5 mLx2), dried over MgSO4 and
concentrated in vauco. Chromatographic purification on silica gel
(CH2Cl2/MeOH/ NH2OH=9/1/0.1) provided 1.01 g
3-(4-chlorophenyl)-3-hydroxyl-3-methyl-1-N-methylaminopropane (3, 99%).
3-(4-chlorophenyl)-3-hydroxyl-3-methyl-1-N-methylaminopropane. Yield 1.01
g(99%). MS m/z: (M+214).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of tricyclic-substituted piperidinols and analogs as
chemokine receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Luly, Jay R.; Nakasato, Yoshisuke; Ohshima, Etsuo; Harriman, Geraldine C.
B.; Carson, Kenneth G.; Ghosh, Shomir; Elder, Amy M.; Mattia, Karen M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20050070549 A1 2005-03-31

$RFMT $RIREG SCHEME209 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-α-(2-chloroethyl)-α-methylbenzenemethanol
C10H12Cl2O
113696-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0801 1.3337 0.0 0
M  V30 2 C 2.3101 2.6673 0.0 0
M  V30 3 C 1.7464 0.5637 0.0 0
M  V30 4 O 3.8501 0.0000 0.0 0
M  V30 5 C 0.7700 2.6673 0.0 0
M  V30 6 Cl 0.0000 4.0012 0.0 0
M  V30 7 Cl 8.4151 4.4137 0.0 0
M  V30 8 C 4.4139 2.1037 0.0 0
M  V30 9 C 4.4139 3.6437 0.0 0
M  V30 10 C 5.7476 1.3337 0.0 0
M  V30 11 C 5.7476 4.4137 0.0 0
M  V30 12 C 7.0812 2.1037 0.0 0
M  V30 13 C 7.0812 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-α-methyl-α-[2-(methylamino)ethyl]benzenemethanol
C11H16ClNO
324752-25-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3349 1.3337 0.0 0
M  V30 2 C 6.1049 2.6673 0.0 0
M  V30 3 C 6.6686 0.5636 0.0 0
M  V30 4 O 4.5649 0.0000 0.0 0
M  V30 5 C 7.6450 2.6673 0.0 0
M  V30 6 N 8.4150 4.0011 0.0 0
M  V30 7 C 9.9550 4.0011 0.0 0
M  V30 8 Cl 0.0000 4.4137 0.0 0
M  V30 9 C 4.0011 2.1037 0.0 0
M  V30 10 C 2.6675 1.3337 0.0 0
M  V30 11 C 4.0011 3.6437 0.0 0
M  V30 12 C 1.3338 2.1037 0.0 0
M  V30 13 C 2.6675 4.4137 0.0 0
M  V30 14 C 1.3338 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 113696-77-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 324752-25-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-1911113
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of tricyclic-substituted piperidinols and analogs as
chemokine receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Luly, Jay R.; Nakasato, Yoshisuke; Ohshima, Etsuo; Sone, Hiroki; Kotera,
Osamu; Harriman, Geraldine C. B.; Carson, Kenneth G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20020169155 A1 2002-11-14

$RFMT $RIREG SCHEME209 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-α-(2-chloroethyl)-α-methylbenzenemethanol
C10H12Cl2O
113696-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0801 1.3337 0.0 0
M  V30 2 C 2.3101 2.6673 0.0 0
M  V30 3 C 1.7464 0.5637 0.0 0
M  V30 4 O 3.8501 0.0000 0.0 0
M  V30 5 C 0.7700 2.6673 0.0 0
M  V30 6 Cl 0.0000 4.0012 0.0 0
M  V30 7 Cl 8.4151 4.4137 0.0 0
M  V30 8 C 4.4139 2.1037 0.0 0
M  V30 9 C 4.4139 3.6437 0.0 0
M  V30 10 C 5.7476 1.3337 0.0 0
M  V30 11 C 5.7476 4.4137 0.0 0
M  V30 12 C 7.0812 2.1037 0.0 0
M  V30 13 C 7.0812 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-α-methyl-α-[2-(methylamino)ethyl]benzenemethanol
C11H16ClNO
324752-25-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3349 1.3337 0.0 0
M  V30 2 C 6.1049 2.6673 0.0 0
M  V30 3 C 6.6686 0.5636 0.0 0
M  V30 4 O 4.5649 0.0000 0.0 0
M  V30 5 C 7.6450 2.6673 0.0 0
M  V30 6 N 8.4150 4.0011 0.0 0
M  V30 7 C 9.9550 4.0011 0.0 0
M  V30 8 Cl 0.0000 4.4137 0.0 0
M  V30 9 C 4.0011 2.1037 0.0 0
M  V30 10 C 2.6675 1.3337 0.0 0
M  V30 11 C 4.0011 3.6437 0.0 0
M  V30 12 C 1.3338 2.1037 0.0 0
M  V30 13 C 2.6675 4.4137 0.0 0
M  V30 14 C 1.3338 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 113696-77-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 324752-25-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-19793678
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted piperidinols as chemokine receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Luly, Jay R.; Nakasato, Yoshisuke; Ohshima, Etsuo; Sone, Hiroki; Kotera,
Osamu; Harriman, Geraldine C. B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20020161005 A1 2002-10-31

$RFMT $RIREG SCHEME210 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Thiophenecarboxaldehyde, 5-[(3-bromophenyl)thio]-4-(2-fluoro-3-pyridinyl)-
C16H9BrFNOS2
1138034-20-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.5626 5.6399 0.0 0
M  V30 2 F 2.0565 2.1049 0.0 0
M  V30 3 C 1.4068 7.3149 0.0 0
M  V30 4 O 0.0000 6.6886 0.0 0
M  V30 5 Br 11.1827 8.3072 0.0 0
M  V30 6 C 4.1174 4.3938 0.0 0
M  V30 7 C 5.0226 5.6399 0.0 0
M  V30 8 C 2.6528 4.8699 0.0 0
M  V30 9 S 4.1174 6.8857 0.0 0
M  V30 10 C 2.6528 6.4099 0.0 0
M  V30 11 C 4.5933 2.9293 0.0 0
M  V30 12 C 3.5628 1.7847 0.0 0
M  V30 13 C 6.0997 2.6091 0.0 0
M  V30 14 N 4.0387 0.3202 0.0 0
M  V30 15 C 6.5756 1.1444 0.0 0
M  V30 16 C 5.5452 0.0000 0.0 0
M  V30 17 C 7.3327 6.9735 0.0 0
M  V30 18 C 8.8727 6.9735 0.0 0
M  V30 19 C 6.5626 8.3072 0.0 0
M  V30 20 C 9.6427 8.3072 0.0 0
M  V30 21 C 7.3327 9.6408 0.0 0
M  V30 22 C 8.8727 9.6408 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 17
M  V30 3 1 2 12
M  V30 4 2 3 4
M  V30 5 1 3 10
M  V30 6 1 5 20
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 6 11
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 12 1 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Di-tert-butyl dicarbonate
C10H18O5
24424-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 O 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6685 1.3337 0.0 0
M  V30 10 O 8.0023 0.5637 0.0 0
M  V30 11 O 6.6685 2.8737 0.0 0
M  V30 12 C 9.3360 1.3337 0.0 0
M  V30 13 C 10.1060 0.0000 0.0 0
M  V30 14 C 10.6697 2.1037 0.0 0
M  V30 15 C 8.5660 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[[5-[(3-bromophenyl)thio]-4-(2-fluoro-3-pyridinyl)-2-thie...
C22H22BrFN2O2S2
1138034-76-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.3159 5.7153 0.0 0
M  V30 2 F 8.4279 1.7288 0.0 0
M  V30 3 C 9.6185 6.8425 0.0 0
M  V30 4 N 10.9522 6.0725 0.0 0
M  V30 5 C 12.2860 6.8425 0.0 0
M  V30 6 C 10.9522 4.5324 0.0 0
M  V30 7 O 13.6196 6.0725 0.0 0
M  V30 8 O 12.2860 8.3825 0.0 0
M  V30 9 C 14.9533 6.8425 0.0 0
M  V30 10 C 14.1833 8.1761 0.0 0
M  V30 11 C 16.2870 7.6125 0.0 0
M  V30 12 C 15.7233 5.5087 0.0 0
M  V30 13 Br 0.0000 8.8510 0.0 0
M  V30 14 C 6.6175 4.2206 0.0 0
M  V30 15 C 5.8475 5.5542 0.0 0
M  V30 16 C 8.1239 4.5408 0.0 0
M  V30 17 S 6.8779 6.6988 0.0 0
M  V30 18 C 8.2849 6.0725 0.0 0
M  V30 19 C 5.9911 2.8138 0.0 0
M  V30 20 C 6.8964 1.5679 0.0 0
M  V30 21 C 4.4594 2.6527 0.0 0
M  V30 22 N 6.2699 0.1609 0.0 0
M  V30 23 C 3.8331 1.2459 0.0 0
M  V30 24 C 4.7383 0.0000 0.0 0
M  V30 25 C 3.6894 7.1221 0.0 0
M  V30 26 C 2.1579 7.2832 0.0 0
M  V30 27 C 4.5947 8.3680 0.0 0
M  V30 28 C 1.5316 8.6900 0.0 0
M  V30 29 C 3.9683 9.7750 0.0 0
M  V30 30 C 2.4368 9.9359 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 1 25
M  V30 3 1 2 20
M  V30 4 1 3 4
M  V30 5 1 3 18
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 13 28
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 14 19
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1138034-20-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 24424-99-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1138034-76-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-4265851
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Reference Example 98 tert-butyl
({5-[(3-bromophenyl)thio]-4-(2-fluoropyridin-3-yl)thiophen-2-yl}methyl)methylcarbamate
5-[(3-Bromophenyl)thio]-4-(2-fluoropyridin-3-yl)thiophene-2-carbaldehyde
(394 mg) was dissolved in a mixed solvent of tetrahydrofuran (3 mL) and
methanol (1 mL), 40% methylamine-methanol solution (1.0 mL) was added,
and the mixture was stirred at room temperature for 3 days. The reaction
mixture was concentrated under reduced pressure, the residue was
dissolved again in methanol (3 mL), and sodium borohydride (22 mg) was
added under ice-cooling. The mixture was stirred at room temperature for
4 hr, and concentrated under reduced pressure. Water was added to the
residue, and the mixture was extracted with ethyl acetate. The extract
was washed with saturated brine, dried over anhydrous sodium sulfate, and
concentrated under reduced pressure. The residue was dissolved in
tetrahydrofuran (3 mL), di-tert-butyl bicarbonate (262 mg) was added, and
the mixture was stirred for 30 min. The reaction mixture was concentrated
under reduced pressure, and the residue was purified by silica gel column
chromatography (eluent: hexane-ethyl acetate=9:1&#x2192;4:1) to give the
title compound as a colorless oil (508 mg, yield 99%). 1H-NMR (CDCl3)
&#x03B4; : 1.49 (9H, s), 2.93 (3H, s), 4.54 (2H, br), 6.95-6.98 (1H, m),
7.05-7.10 (2H, m), 7.16-7.25 (3H, m), 7.76-7.81 (1H, m), 8.17-8.18 (1H,
m).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thiophene and pyrazole derivatives and related analogous
as acid secretion inhibitors and antiulcer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nishida, Haruyuki; Arikawa, Yasuyoshi; Hirase, Keizo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009041705 A2 2009-04-02

$RFMT $RIREG SCHEME211 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 6-[[3-(3-fluorophenyl)-5-methyl-4-isoxazolyl]methoxy]-3-pyridazinecarbo...
C18H16FN3O4
1159251-39-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3104 3.3320 0.0 0
M  V30 2 O 7.6441 2.5620 0.0 0
M  V30 3 C 5.9601 0.0000 0.0 0
M  V30 4 F 0.0000 7.1530 0.0 0
M  V30 5 C 12.9789 5.6420 0.0 0
M  V30 6 O 14.3126 4.8720 0.0 0
M  V30 7 O 12.9789 7.1821 0.0 0
M  V30 8 C 15.6462 5.6420 0.0 0
M  V30 9 C 16.9801 4.8720 0.0 0
M  V30 10 C 3.5698 3.1885 0.0 0
M  V30 11 C 4.9766 2.5620 0.0 0
M  V30 12 N 2.5394 2.0439 0.0 0
M  V30 13 C 4.8157 1.0304 0.0 0
M  V30 14 O 3.3094 0.7103 0.0 0
M  V30 15 C 3.2496 4.6948 0.0 0
M  V30 16 C 1.7849 5.1706 0.0 0
M  V30 17 C 4.3940 5.7254 0.0 0
M  V30 18 C 1.4647 6.6771 0.0 0
M  V30 19 C 4.0738 7.2317 0.0 0
M  V30 20 C 2.6091 7.7075 0.0 0
M  V30 21 C 8.9778 3.3320 0.0 0
M  V30 22 C 8.9778 4.8720 0.0 0
M  V30 23 N 10.3114 2.5620 0.0 0
M  V30 24 C 10.3114 5.6420 0.0 0
M  V30 25 N 11.6452 3.3320 0.0 0
M  V30 26 C 11.6452 4.8720 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 21
M  V30 4 1 3 13
M  V30 5 1 4 18
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 26
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 15
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[[3-(3-Fluorophenyl)-5-methyl-4-isoxazolyl]methoxy]-N-methyl-3-pyridazineca...
C17H15FN4O3
1159251-40-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3103 3.3320 0.0 0
M  V30 2 O 7.6440 2.5620 0.0 0
M  V30 3 C 5.9601 0.0000 0.0 0
M  V30 4 F 0.0000 7.1530 0.0 0
M  V30 5 C 12.9788 5.6421 0.0 0
M  V30 6 N 14.3125 4.8721 0.0 0
M  V30 7 O 12.9788 7.1821 0.0 0
M  V30 8 C 15.6461 5.6421 0.0 0
M  V30 9 C 3.5696 3.1885 0.0 0
M  V30 10 C 4.9765 2.5620 0.0 0
M  V30 11 N 2.5392 2.0439 0.0 0
M  V30 12 C 4.8155 1.0304 0.0 0
M  V30 13 O 3.3092 0.7103 0.0 0
M  V30 14 C 3.2495 4.6948 0.0 0
M  V30 15 C 1.7847 5.1707 0.0 0
M  V30 16 C 4.3939 5.7254 0.0 0
M  V30 17 C 1.4646 6.6771 0.0 0
M  V30 18 C 4.0737 7.2317 0.0 0
M  V30 19 C 2.6091 7.7076 0.0 0
M  V30 20 C 8.9776 3.3320 0.0 0
M  V30 21 C 8.9776 4.8721 0.0 0
M  V30 22 N 10.3113 2.5620 0.0 0
M  V30 23 C 10.3113 5.6421 0.0 0
M  V30 24 N 11.6451 3.3320 0.0 0
M  V30 25 C 11.6451 4.8721 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 20
M  V30 4 1 3 12
M  V30 5 1 4 17
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 25
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 14
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1159251-39-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1159251-40-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-7367197
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-24-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 304-59-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 6-[3-(3-Fluoro-phenyl)-5-methyl-isoxazol-4-ylmethoxy]-pyridazine-3-carboxylic
acid methylamide A solution of trimethylaluminium (2 M in toluene, 800
.quadrature.L, 1.6 mmol) was added dropwise (exothermic) to a solution of
methylamine (2 M in THF, 800 .quadrature.L, 1.6 mmol) in dioxane (10 mL)
and the resulting mixture was stirred at room temperature for 1 h. Then a
solution of
6-[3-(3-fluoro-phenyl)-5-methyl-isoxazol-4-ylmethoxy]-pyridazine-3-carboxylic
acid ethyl ester (143 mg, 0.4 mmol) in dioxane (5 mL) was added. The
resulting mixture was heated at 85-95° C. for 18 h, cooled to room
temperature, poured into a sodium potassium tartrate solution and
extracted with ethyl acetate which was then washed with brine, dried over
sodium sulfate and evaporated. Purification by chromatography (SiO2,
heptane:ethyl acetate=100:0 to 1:1) afforded the title compound which was
obtained as a white solid, yield 122 mg, 99%. MS: m/e=343.3 [M+H]-.
$DTYPE RXN:VAR(1):NOTES
$DATUM exothermic in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of isoxazolo-pyridazine derivatives as modulators of GABA A
α5 receptor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Buettelmann, Bernd; Jakob-Roetne, Roland; Knust, Henner; Thomas, Andrew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20090143385 A1 2009-06-04

$RFMT $RIREG SCHEME212 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-Ethyl (αR,βR)-α-hydroxy-β-[(2-methoxyphenyl)methylamino]benzenepropanoate
C19H23NO4
1160755-21-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.6201 0.0 0 CFG=1
M  V30 2 N 4.0012 5.3901 0.0 0
M  V30 3 C 6.6685 5.3901 0.0 0 CFG=2
M  V30 4 C 2.6673 4.6201 0.0 0
M  V30 5 C 8.0022 4.6201 0.0 0
M  V30 6 O 6.6685 6.9302 0.0 0
M  V30 7 O 9.3360 5.3901 0.0 0
M  V30 8 O 8.0022 3.0801 0.0 0
M  V30 9 C 10.6697 4.6201 0.0 0
M  V30 10 C 12.0033 5.3901 0.0 0
M  V30 11 O 1.3337 6.9302 0.0 0
M  V30 12 C 0.0000 7.7002 0.0 0
M  V30 13 C 5.3348 3.0801 0.0 0
M  V30 14 C 4.0012 2.3101 0.0 0
M  V30 15 C 6.6685 2.3101 0.0 0
M  V30 16 C 4.0012 0.7700 0.0 0
M  V30 17 C 6.6685 0.7700 0.0 0
M  V30 18 C 5.3348 0.0000 0.0 0
M  V30 19 C 4.0012 6.9302 0.0 0
M  V30 20 C 2.6673 7.7002 0.0 0
M  V30 21 C 5.3348 7.7002 0.0 0
M  V30 22 C 2.6673 9.2402 0.0 0
M  V30 23 C 5.3348 9.2402 0.0 0
M  V30 24 C 4.0012 10.0102 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 2 19
M  V30 6 1 3 5
M  V30 7 1 3 6 CFG=3
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 20
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Benzenepropanamide, α-hydroxy-β-[(2-methoxyphenyl)methylamino]-N-methyl-, (R*...
C18H22N2O3
93886-52-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0 CFG=2
M  V30 2 N 6.1600 4.0011 0.0 0
M  V30 3 C 3.8500 5.3347 0.0 0 CFG=1
M  V30 4 C 6.9300 2.6674 0.0 0
M  V30 5 C 2.3100 5.3347 0.0 0
M  V30 6 O 4.6200 6.6685 0.0 0
M  V30 7 N 1.5400 6.6685 0.0 0
M  V30 8 O 1.5400 4.0011 0.0 0
M  V30 9 C 0.0000 6.6685 0.0 0
M  V30 10 O 9.2400 4.0011 0.0 0
M  V30 11 C 10.7800 4.0011 0.0 0
M  V30 12 C 3.8500 2.6674 0.0 0
M  V30 13 C 2.3100 2.6674 0.0 0
M  V30 14 C 4.6200 1.3336 0.0 0
M  V30 15 C 1.5400 1.3336 0.0 0
M  V30 16 C 3.8500 0.0000 0.0 0
M  V30 17 C 2.3100 0.0000 0.0 0
M  V30 18 C 6.9300 5.3347 0.0 0
M  V30 19 C 8.4700 5.3347 0.0 0
M  V30 20 C 6.1600 6.6685 0.0 0
M  V30 21 C 9.2400 6.6685 0.0 0
M  V30 22 C 6.9300 8.0021 0.0 0
M  V30 23 C 8.4700 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 2 18
M  V30 6 1 3 5
M  V30 7 1 3 6 CFG=3
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 1 10 19
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1160755-21-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 93886-52-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11685806
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual
norepinephrine and serotonin reuptake inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vu, An T.; Cohn, Stephen T.; Terefenko, Eugene A.; Moore, William J.;
Zhang, Puwen; Mahaney, Paige E.; Trybulski, Eugene J.; Goljer, Igor;
Dooley, Rebecca; Bray, Jenifer A.; Johnston, Grace H.; Leiter, Jennifer;
Deecher, Darlene C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(9), 2464-2467

$RFMT $RIREG SCHEME213 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Adenosine, 2′-deoxy-, 5′-(phenyl carbonate)
C17H17N5O5
1162656-08-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 0.0000 6.2407 0.0 0
M  V30 2 C 9.9623 2.7106 0.0 0
M  V30 3 O 10.7323 4.0442 0.0 0
M  V30 4 C 12.2723 4.0442 0.0 0
M  V30 5 O 13.0423 5.3779 0.0 0
M  V30 6 O 13.0423 2.7106 0.0 0
M  V30 7 O 7.9929 0.0000 0.0 0
M  V30 8 N 4.8065 4.3858 0.0 0
M  V30 9 C 3.3420 3.9099 0.0 0
M  V30 10 C 4.8065 5.9258 0.0 0
M  V30 11 C 2.4368 5.1558 0.0 0
M  V30 12 N 2.7156 2.5030 0.0 0
M  V30 13 N 3.3420 6.4017 0.0 0
M  V30 14 C 0.9052 4.9949 0.0 0
M  V30 15 C 1.1840 2.3420 0.0 0
M  V30 16 N 0.2787 3.5879 0.0 0
M  V30 17 C 6.0525 3.4806 0.0 0 CFG=1
M  V30 18 O 7.5171 3.9564 0.0 0
M  V30 19 C 6.0525 1.9406 0.0 0
M  V30 20 C 8.4223 2.7106 0.0 0 CFG=2
M  V30 21 C 7.5171 1.4647 0.0 0 CFG=2
M  V30 22 C 14.5823 5.3779 0.0 0
M  V30 23 C 15.3523 6.7117 0.0 0
M  V30 24 C 15.3523 4.0442 0.0 0
M  V30 25 C 16.8923 6.7117 0.0 0
M  V30 26 C 16.8923 4.0442 0.0 0
M  V30 27 C 17.6623 5.3779 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 1 20 2 CFG=3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 22
M  V30 8 1 21 7 CFG=1
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 17 8 CFG=3
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 2 10 13
M  V30 15 1 11 13
M  V30 16 2 11 14
M  V30 17 1 12 15
M  V30 18 1 14 16
M  V30 19 2 15 16
M  V30 20 1 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 17 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Adenosine, 2′-deoxy-, 5′-(N-methylcarbamate)
C12H16N6O4
1162655-72-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 0.0000 7.0420 0.0 0
M  V30 2 C 9.5390 2.4898 0.0 0
M  V30 3 O 10.4442 3.7357 0.0 0
M  V30 4 C 11.9758 3.5747 0.0 0
M  V30 5 N 12.8810 4.8206 0.0 0
M  V30 6 O 12.6021 2.1679 0.0 0
M  V30 7 C 14.4126 4.6597 0.0 0
M  V30 8 O 7.2970 0.0000 0.0 0
M  V30 9 N 4.5865 4.6948 0.0 0
M  V30 10 C 3.0801 4.3746 0.0 0
M  V30 11 C 4.7475 6.2264 0.0 0
M  V30 12 C 2.3101 5.7083 0.0 0
M  V30 13 N 2.3101 3.0410 0.0 0
M  V30 14 N 3.3405 6.8528 0.0 0
M  V30 15 C 0.7700 5.7083 0.0 0
M  V30 16 C 0.7700 3.0410 0.0 0
M  V30 17 N 0.0000 4.3746 0.0 0
M  V30 18 C 5.7309 3.6644 0.0 0 CFG=1
M  V30 19 O 7.2374 3.9845 0.0 0
M  V30 20 C 5.5700 2.1326 0.0 0
M  V30 21 C 8.0074 2.6509 0.0 0 CFG=2
M  V30 22 C 6.9768 1.5063 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 2 3
M  V30 3 1 21 2 CFG=3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 22 8 CFG=1
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 18 9 CFG=3
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 2 11 14
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 18 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1162656-08-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1162655-72-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5769942
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM 72% overall yield for 2 steps
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibition of tRNA-dependent ligase MurM from Streptococcus pneumoniae by
phosphonate and sulfonamide inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cressina, Elena; Lloyd, Adrian J.; De Pascale, Gianfranco; James Mok, B.;
Caddick, Stephen; Roper, David I.; Dowson, Christopher G.; Bugg, Timothy
D. H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2009), 17(9), 3443-3455

$RFMT $RIREG SCHEME214 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Bicyclo[3.1.0]hexane-1-methanol, 2-(acetyloxy)-4-(6-chloro-9H-purin-9-yl)-5-m...
C17H19ClN4O4
1163697-75-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.3420 5.0988 0.0 0
M  V30 2 O 2.4367 6.3446 0.0 0
M  V30 3 C 0.9052 6.1837 0.0 0
M  V30 4 C 0.2789 4.7769 0.0 0
M  V30 5 O 0.0000 7.4296 0.0 0
M  V30 6 C 7.1123 7.2757 0.0 0
M  V30 7 O 4.1632 2.6091 0.0 0
M  V30 8 C 4.6391 1.1444 0.0 0
M  V30 9 C 6.1455 0.8242 0.0 0
M  V30 10 O 3.6087 0.0000 0.0 0
M  V30 11 Cl 14.0035 5.0591 0.0 0
M  V30 12 C 4.8735 5.2599 0.0 0 CFG=2
M  V30 13 C 6.2073 6.0299 0.0 0 CFG=2
M  V30 14 C 5.1936 3.7534 0.0 0 CFG=1
M  V30 15 C 4.8735 6.7999 0.0 0
M  V30 16 C 7.3517 4.9993 0.0 0 CFG=1
M  V30 17 C 6.7253 3.5925 0.0 0
M  V30 18 N 8.8581 5.3195 0.0 0
M  V30 19 C 10.0025 4.2891 0.0 0
M  V30 20 C 9.4844 6.7264 0.0 0
M  V30 21 C 11.3361 5.0591 0.0 0
M  V30 22 N 10.0025 2.7491 0.0 0
M  V30 23 N 11.0159 6.5655 0.0 0
M  V30 24 C 12.6699 4.2891 0.0 0
M  V30 25 C 11.3361 1.9791 0.0 0
M  V30 26 N 12.6699 2.7491 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 13 6 CFG=1
M  V30 7 1 7 8
M  V30 8 1 14 7 CFG=3
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 11 24
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 1 16 17
M  V30 19 1 16 18 CFG=1
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 19 22
M  V30 24 2 20 23
M  V30 25 1 21 23
M  V30 26 2 21 24
M  V30 27 1 22 25
M  V30 28 1 24 26
M  V30 29 2 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 12 13 14 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(1R,2S,4S,5S)-2-Hydroxy-5-methyl-4-[6-(methylamino)-9H-purin-9-yl]bicyclo...
C14H19N5O2
1163697-66-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.9051 3.1197 0.0 0
M  V30 2 O 0.0000 4.3658 0.0 0
M  V30 3 C 4.6756 5.2967 0.0 0
M  V30 4 O 1.7265 0.6300 0.0 0
M  V30 5 N 11.5667 3.0800 0.0 0
M  V30 6 C 12.9003 2.3100 0.0 0
M  V30 7 C 2.4367 3.2808 0.0 0 CFG=1
M  V30 8 C 3.7704 4.0508 0.0 0 CFG=2
M  V30 9 C 2.4367 4.8208 0.0 0
M  V30 10 C 2.7569 1.7744 0.0 0 CFG=1
M  V30 11 C 4.9148 3.0203 0.0 0 CFG=1
M  V30 12 C 4.2884 1.6135 0.0 0
M  V30 13 N 6.4212 3.3404 0.0 0
M  V30 14 C 7.5656 2.3100 0.0 0
M  V30 15 C 7.0475 4.7474 0.0 0
M  V30 16 C 8.8994 3.0800 0.0 0
M  V30 17 N 7.5656 0.7700 0.0 0
M  V30 18 N 8.5791 4.5864 0.0 0
M  V30 19 C 10.2330 2.3100 0.0 0
M  V30 20 C 8.8994 0.0000 0.0 0
M  V30 21 N 10.2330 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 7 1 CFG=1
M  V30 3 1 8 3 CFG=1
M  V30 4 1 10 4 CFG=3
M  V30 5 1 5 6
M  V30 6 1 5 19
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 9
M  V30 11 1 8 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 1 11 13 CFG=1
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 14 17
M  V30 19 2 15 18
M  V30 20 1 16 18
M  V30 21 2 16 19
M  V30 22 1 17 20
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 7 8 10 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1163697-75-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1163697-66-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-2196612
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of methyl-substituted bicyclic carbanucleoside analogs as
potential antiherpetic agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kim, Kyung Ran; Park, Ah-Young; Lee, Hyung-Rock; Kang, Jin-Ah; Kim, Won
Hee; Chun, Pusoon; Bae, Jang Ho; Jeong, Lak Shin; Moon, Hyung Ryong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bulletin of the Korean Chemical Society (2008), 29(10), 1977-1982

$RFMT $RIREG SCHEME215 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-N-[(1R,4S)-4-(6-Chloro-9H-purin-9-yl)-2-cyclopenten-1-yl]benzamide
C17H14ClN5O
1164098-54-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 15.7276 2.7844 0.0 0
M  V30 2 N 5.3348 4.7085 0.0 0
M  V30 3 C 4.0011 3.9385 0.0 0
M  V30 4 O 4.0011 2.3984 0.0 0
M  V30 5 N 10.6374 3.5813 0.0 0
M  V30 6 C 11.6680 2.4368 0.0 0
M  V30 7 C 11.4074 4.9150 0.0 0
M  V30 8 C 13.0748 3.0633 0.0 0
M  V30 9 N 11.5069 0.9052 0.0 0
M  V30 10 N 12.9139 4.5948 0.0 0
M  V30 11 C 14.3207 2.1580 0.0 0
M  V30 12 C 12.7529 0.0000 0.0 0
M  V30 13 N 14.1597 0.6265 0.0 0
M  V30 14 C 9.1058 3.4204 0.0 0 CFG=1
M  V30 15 C 8.0754 4.5648 0.0 0
M  V30 16 C 8.3358 2.0866 0.0 0
M  V30 17 C 6.6684 3.9385 0.0 0 CFG=2
M  V30 18 C 6.8295 2.4067 0.0 0
M  V30 19 C 2.6675 4.7085 0.0 0
M  V30 20 C 2.6675 6.2485 0.0 0
M  V30 21 C 1.3337 3.9385 0.0 0
M  V30 22 C 1.3337 7.0185 0.0 0
M  V30 23 C 0.0000 4.7085 0.0 0
M  V30 24 C 0.0000 6.2485 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 1 17 2 CFG=1
M  V30 4 2 3 4
M  V30 5 1 3 19
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 14 5 CFG=1
M  V30 9 1 6 8
M  V30 10 2 6 9
M  V30 11 2 7 10
M  V30 12 1 8 10
M  V30 13 2 8 11
M  V30 14 1 9 12
M  V30 15 1 11 13
M  V30 16 2 12 13
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 14 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-N-[(1R,4S)-4-[6-(Methylamino)-9H-purin-9-yl]-2-cyclopenten-1-yl]benzamide
C18H18N6O
1164098-56-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 15.7276 4.2341 0.0 0
M  V30 2 C 16.9734 5.1393 0.0 0
M  V30 3 N 5.3348 2.3100 0.0 0
M  V30 4 C 4.0011 3.0800 0.0 0
M  V30 5 O 4.0011 4.6200 0.0 0
M  V30 6 N 10.6373 3.4372 0.0 0
M  V30 7 C 11.6679 4.5817 0.0 0
M  V30 8 C 11.4074 2.1035 0.0 0
M  V30 9 C 13.0747 3.9552 0.0 0
M  V30 10 N 11.5068 6.1132 0.0 0
M  V30 11 N 12.9138 2.4237 0.0 0
M  V30 12 C 14.3206 4.8604 0.0 0
M  V30 13 C 12.7529 7.0185 0.0 0
M  V30 14 N 14.1597 6.3920 0.0 0
M  V30 15 C 9.1058 3.5981 0.0 0 CFG=1
M  V30 16 C 8.0754 2.4537 0.0 0
M  V30 17 C 8.3358 4.9319 0.0 0
M  V30 18 C 6.6684 3.0800 0.0 0 CFG=2
M  V30 19 C 6.8295 4.6117 0.0 0
M  V30 20 C 2.6675 2.3100 0.0 0
M  V30 21 C 1.3337 3.0800 0.0 0
M  V30 22 C 2.6675 0.7700 0.0 0
M  V30 23 C 0.0000 2.3100 0.0 0
M  V30 24 C 1.3337 0.0000 0.0 0
M  V30 25 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 3 4
M  V30 4 1 18 3 CFG=3
M  V30 5 2 4 5
M  V30 6 1 4 20
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 15 6 CFG=3
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 2 8 11
M  V30 13 1 9 11
M  V30 14 2 9 12
M  V30 15 1 10 13
M  V30 16 1 12 14
M  V30 17 2 13 14
M  V30 18 1 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 15 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1164098-54-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1164098-56-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-534761
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed flask used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium(0)-catalyzed syntheses of cyclopentenyl-nucleoside analogs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Quadrelli, Paolo; Mella, Mariella; Martinez, Naiara Vazquez; Piccanello,
Andrea
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ARKIVOC (Gainesville, FL, United States) (2008), (2), 183-200

$RFMT $RIREG SCHEME216 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-4,5-Dimethyl (4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dicarboxylate
C9H14O6
116499-08-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 5.0168 0.0 0
M  V30 2 O 0.7700 5.0168 0.0 0
M  V30 3 O 3.0800 6.3506 0.0 0
M  V30 4 C 0.0000 6.3506 0.0 0
M  V30 5 C 5.6420 4.6666 0.0 0
M  V30 6 O 7.1483 4.3464 0.0 0
M  V30 7 O 5.1662 6.1313 0.0 0
M  V30 8 C 8.1788 5.4910 0.0 0
M  V30 9 C 2.4536 0.2154 0.0 0
M  V30 10 C 4.5032 0.0000 0.0 0
M  V30 11 C 3.0800 3.6832 0.0 0 CFG=2
M  V30 12 C 4.6116 3.5222 0.0 0 CFG=2
M  V30 13 O 2.4536 2.2764 0.0 0
M  V30 14 O 4.9318 2.0158 0.0 0
M  V30 15 C 3.5980 1.2458 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 11 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 12 5 CFG=3
M  V30 8 1 6 8
M  V30 9 1 9 15
M  V30 10 1 10 15
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 11 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(4R,5R)-N4,N5,2,2-Tetramethyl-1,3-dioxolane-4,5-dicarboxamide
C9H16N2O4
1212312-94-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 5.0168 0.0 0
M  V30 2 N 0.7700 5.0168 0.0 0
M  V30 3 O 3.0800 6.3506 0.0 0
M  V30 4 C 0.0000 6.3506 0.0 0
M  V30 5 C 5.6420 4.6666 0.0 0
M  V30 6 N 7.1483 4.3464 0.0 0
M  V30 7 O 5.1662 6.1313 0.0 0
M  V30 8 C 8.1788 5.4910 0.0 0
M  V30 9 C 2.4536 0.2154 0.0 0
M  V30 10 C 4.5032 0.0000 0.0 0
M  V30 11 C 3.0800 3.6832 0.0 0 CFG=1
M  V30 12 C 4.6116 3.5222 0.0 0 CFG=1
M  V30 13 O 2.4536 2.2764 0.0 0
M  V30 14 O 4.9318 2.0158 0.0 0
M  V30 15 C 3.5980 1.2458 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 11 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 12 5 CFG=1
M  V30 8 1 6 8
M  V30 9 1 9 15
M  V30 10 1 10 15
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 11 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 116499-08-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1212312-94-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10232077
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Carbonylation of functionalized diamine diols to cyclic ureas:
application to derivatives of DMP 450
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Darko, Ampofo K.; Curran, F. Chris; Copin, Chloe; McElwee-White, Lisa
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2011), 67(22), 3976-3983

$RFMT $RIREG SCHEME217 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl trans-4-[4-[6-(aminocarbonyl)-3-methyl-2-pyrazinyl]phenyl]c...
C24H31N3O3
1166827-89-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 0.0000 0.0 0
M  V30 2 C 1.3337 3.0801 0.0 0
M  V30 3 N 1.3337 4.6201 0.0 0
M  V30 4 O 0.0000 2.3101 0.0 0
M  V30 5 C 14.6708 7.7002 0.0 0
M  V30 6 C 16.0045 6.9302 0.0 0
M  V30 7 O 17.3382 7.7002 0.0 0
M  V30 8 O 16.0045 5.3901 0.0 0
M  V30 9 C 18.6720 6.9302 0.0 0
M  V30 10 C 17.9020 5.5965 0.0 0
M  V30 11 C 20.0057 6.1601 0.0 0
M  V30 12 C 19.4420 8.2638 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 N 4.0012 3.0801 0.0 0
M  V30 15 C 5.3348 0.7700 0.0 0
M  V30 16 C 2.6675 2.3101 0.0 0
M  V30 17 N 4.0012 0.0000 0.0 0
M  V30 18 C 2.6675 0.7700 0.0 0
M  V30 19 C 6.6685 3.0801 0.0 0
M  V30 20 C 6.6685 4.6201 0.0 0
M  V30 21 C 8.0023 2.3101 0.0 0
M  V30 22 C 8.0023 5.3901 0.0 0
M  V30 23 C 9.3360 3.0801 0.0 0
M  V30 24 C 9.3360 4.6201 0.0 0
M  V30 25 C 10.6697 5.3901 0.0 0 CFG=2
M  V30 26 C 10.6697 6.9302 0.0 0
M  V30 27 C 12.0033 4.6201 0.0 0
M  V30 28 C 12.0033 7.7002 0.0 0
M  V30 29 C 13.3372 5.3901 0.0 0
M  V30 30 C 13.3372 6.9302 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 16
M  V30 5 1 5 6
M  V30 6 1 30 5 CFG=3
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 26 1 25 24 CFG=1
M  V30 27 1 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 25 30)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
trans-4-[4-[3-Methyl-6-[(methylamino)carbonyl]-2-pyrazinyl]phenyl]cyclohexane...
C21H25N3O3
1414867-25-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6697 0.0000 0.0 0
M  V30 2 C 16.0045 3.0801 0.0 0
M  V30 3 N 17.3383 2.3101 0.0 0
M  V30 4 O 16.0045 4.6201 0.0 0
M  V30 5 C 18.6720 3.0801 0.0 0
M  V30 6 C 2.6675 7.7002 0.0 0
M  V30 7 C 1.3337 6.9302 0.0 0
M  V30 8 O 1.3337 5.3901 0.0 0
M  V30 9 O 0.0000 7.7002 0.0 0
M  V30 10 C 12.0035 2.3101 0.0 0
M  V30 11 N 13.3372 3.0801 0.0 0
M  V30 12 C 12.0033 0.7700 0.0 0
M  V30 13 C 14.6708 2.3101 0.0 0
M  V30 14 N 13.3372 0.0000 0.0 0
M  V30 15 C 14.6708 0.7700 0.0 0
M  V30 16 C 10.6697 3.0801 0.0 0
M  V30 17 C 10.6697 4.6201 0.0 0
M  V30 18 C 9.3360 2.3101 0.0 0
M  V30 19 C 9.3360 5.3901 0.0 0
M  V30 20 C 8.0023 3.0801 0.0 0
M  V30 21 C 8.0023 4.6201 0.0 0
M  V30 22 C 6.6685 5.3901 0.0 0 CFG=2
M  V30 23 C 6.6685 6.9302 0.0 0
M  V30 24 C 5.3348 4.6201 0.0 0
M  V30 25 C 5.3348 7.7002 0.0 0
M  V30 26 C 4.0012 5.3901 0.0 0
M  V30 27 C 4.0012 6.9302 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 13
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 27 6 CFG=1
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 16
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 1 22 21 CFG=3
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 22 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1166827-89-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1414867-25-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-352-CAS-6594068
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 125700-67-6
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Step 2. tert-Butyl
{trans-4-[4-(6-carbamoyl-3-methylpyrazin-2-yl)phenyl]cyclohexyl}acetate
To a solution of
6-{4-[trans-4-(2-tert-butoxy-2-oxoethyl)cyclohexyl]phenyl}-5-methylpyrazine-2-carboxylic
acid (41 mg, 0.1 mmol) in (0.5 mL) was added NH4Cl (11 mg, 0.2 mmol),
TBTU (78 mg, 0.15 mmol) and DIPEA (70 μM, 0.4 mmol). The solution was
stirred at rt for 1 h. The mixture was diluted with DCM and washed with
saturated NaHCO3 (aq), 0.5M HCl and water. The organic layer was dried
through a phase separator and concentrated to dryness to give the title
compound as a white amorphous solid (35 mg, 86%). Step 3.
{trans-4-[4-(6-Carbamoyl-3-methylpyrazin-2-yl)phenyl]cyclohexyl} acetic
acid (13) To a solution of tert-butyl
{trans-4-[4-(6-carbamoyl-3-methylpyrazin-2-yl)phenyl]cyclohexyl}acetate
(35 mg, 0.09 mmol) in DCM (1 mL) was added TFA (0.5 mL). The solution was
stirred at rt overnight. The residue was concentrated to dryness,
dissolved in DCM and washed with 0.5M HCl, dried through a phase
separator and concentrated. The crude was dissolved in DCM and put on an
ion exchange column (1 g isolute PE-AX). The column was washed through
with DCM (5 mL), followed by 20% MeOH in DCM (5 mL). The product was
finally eluted with a mixture of 3% AcOH + 20% MeOH in DCM (10 mL). The
solution was concentrated to dryness to afford 13 (16 mg, 53%).
(trans-4-{4-[3-Methyl-6-(methylcarbamoyl)pyrazin-2-yl]phenyl}cyclohexyl)acetic
acid (32) This compound was synthesized using a similar protocol as
described for compound 13, but using methylamine in the amide coupling
(step 2), to afford 32 (24 mg, 99%). 1H NMR (500 MHz, CDCl3) δ 1.17 -
1.32 (m, 2H), 1.52 - 1.65 (m, 2H), 1.87 - 2.05 (m, 5H), 2.3 - 2.38 (m,
2H), 2.54 - 2.65 (m, 1H), 2.73 (s, 3H), 3.04 (d, J = 5.10 Hz, 3H), 7.36
(d, J = 8.15 Hz, 2H), 7.52 (d, J = 8.15 Hz, 2H), 7.84 - 7.95 (m, 1H),
9.22 (s, 1H). ESI-HRMS calculated for C21H25N3O3 (MH+); 368.1974. Found:
368.1964.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and Optimization of Pyrazinecarboxamide-Based Inhibitors of
Diacylglycerol Acyltransferase 1 (DGAT1) Leading to a Clinical Candidate
Dimethylpyrazinecarboxamide Phenylcyclohexylacetic Acid (AZD7687)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barlind, Jonas G.; Bauer, Udo A.; Birch, Alan M.; Birtles, Susan;
Buckett, Linda K.; Butlin, Roger J.; Davies, Robert D. M.; Eriksson, Jan
W.; Hammond, Clare D.; Hovland, Ragnar; Johannesson, Petra; Johansson,
Magnus J.; Kemmitt, Paul D.; Lindmark, Bo T.; Morentin Gutierrez, Pablo;
Noeske, Tobias A.; Nordin, Andreas; O'Donnell, Charles J.; Petersson,
Annika U.; Redzic, Alma; Turnbull, Andrew V.; Vinblad, Johanna
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2012), 55(23), 10610-10629

$RFMT $RIREG SCHEME218 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanol, 2-(2-hydroxyethoxy)-, 1-(4-methylbenzenesulfonate)
C11H16O5S
118591-58-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3349 5.3347 0.0 0 VAL=6
M  V30 2 O 6.1049 4.0011 0.0 0
M  V30 3 O 4.5649 6.6685 0.0 0
M  V30 4 O 6.6685 6.1047 0.0 0
M  V30 5 C 7.6449 4.0011 0.0 0
M  V30 6 C 8.4149 2.6674 0.0 0
M  V30 7 O 9.9549 2.6674 0.0 0
M  V30 8 C 10.7249 1.3338 0.0 0
M  V30 9 C 12.2649 1.3338 0.0 0
M  V30 10 O 13.0349 0.0000 0.0 0
M  V30 11 C 0.0000 2.2547 0.0 0
M  V30 12 C 4.0011 4.5647 0.0 0
M  V30 13 C 4.0011 3.0247 0.0 0
M  V30 14 C 2.6674 5.3347 0.0 0
M  V30 15 C 2.6674 2.2547 0.0 0
M  V30 16 C 1.3338 4.5647 0.0 0
M  V30 17 C 1.3338 3.0247 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 12
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 11 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[2-(Methylamino)ethoxy]ethanol
C5H13NO2
85475-01-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 0.0000 0.0 0
M  V30 2 O 5.3348 0.7700 0.0 0
M  V30 3 C 2.6675 0.7700 0.0 0
M  V30 4 C 6.6685 0.0000 0.0 0
M  V30 5 N 1.3337 0.0000 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 C 0.0000 0.7700 0.0 0
M  V30 8 O 9.3360 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 118591-58-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 85475-01-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-21620288
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bifunctional compounds as modulators of proteolysis useful
for treating cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Crew, Andrew P.; Hornberger, Keith R.; Wang, Jing; Dong, Hanqing; Berlin,
Michael; Crews, Craig M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019195609 A2 2019-10-10

$RFMT $RIREG SCHEME219 STEP1
$RXN



  2  1
$MOL
Anthranilic acid
C7H7NO2
118-92-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 N 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-N-methylbenzamide
C8H10N2O
4141-08-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 O 5.3901 1.3337 0.0 0
M  V30 4 C 6.9302 4.0010 0.0 0
M  V30 5 N 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 2.3101 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.7700 4.0010 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 118-92-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4141-08-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-1378038
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of novel 2-[4-(aminoalkoxy)phenyl]-4(3H)-quinazolinone
derivatives as potent and selective histamine H3 receptor inverse
agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mizutani, Takashi; Nagase, Tsuyoshi; Ito, Sayaka; Miyamoto, Yasuhisa;
Tanaka, Takeshi; Takenaga, Norihiro; Tokita, Shigeru; Sato, Nagaaki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2008), 18(23), 6041-6045

$RFMT $RIREG SCHEME220 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-methyl-1-[(2S)-1-oxo-2-[[(phenylmethoxy)carbonyl]amino]propyl]-2-aze...
C17H22N2O5
1192501-21-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.6697 2.3101 0.0 0
M  V30 2 C 9.3360 3.0801 0.0 0 CFG=2
M  V30 3 O 10.6697 0.7700 0.0 0
M  V30 4 N 8.0023 2.3101 0.0 0
M  V30 5 C 9.3360 4.6201 0.0 0
M  V30 6 C 6.6687 3.0801 0.0 0
M  V30 7 O 5.3348 2.3101 0.0 0
M  V30 8 O 6.6687 4.6201 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 14.9785 2.2829 0.0 0
M  V30 11 O 16.0675 3.3719 0.0 0
M  V30 12 O 15.3771 0.7953 0.0 0
M  V30 13 C 17.5552 2.9732 0.0 0
M  V30 14 C 13.0924 1.1940 0.0 0
M  V30 15 N 12.0035 3.0801 0.0 0
M  V30 16 C 13.4910 2.6815 0.0 0 CFG=3
M  V30 17 C 12.4020 4.5676 0.0 0
M  V30 18 C 13.8896 4.1690 0.0 0
M  V30 19 C 2.6675 2.3101 0.0 0
M  V30 20 C 1.3338 3.0801 0.0 0
M  V30 21 C 2.6675 0.7700 0.0 0
M  V30 22 C 0.0000 2.3101 0.0 0
M  V30 23 C 1.3338 0.0000 0.0 0
M  V30 24 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=1
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 9 19
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 16
M  V30 14 1 11 13
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Phenylmethyl N-[(1S)-1-methyl-2-[(2S)-2-methyl-2-[(methylamino)carbonyl]-1-az...
C17H23N3O4
1192501-41-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.6697 2.3101 0.0 0
M  V30 2 C 9.3360 3.0801 0.0 0 CFG=2
M  V30 3 O 10.6697 0.7700 0.0 0
M  V30 4 N 8.0023 2.3101 0.0 0
M  V30 5 C 9.3360 4.6201 0.0 0
M  V30 6 C 6.6687 3.0801 0.0 0
M  V30 7 O 5.3348 2.3101 0.0 0
M  V30 8 O 6.6687 4.6201 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 14.9785 2.2829 0.0 0
M  V30 11 N 16.0675 3.3719 0.0 0
M  V30 12 O 15.3771 0.7953 0.0 0
M  V30 13 C 17.5552 2.9732 0.0 0
M  V30 14 C 13.0924 1.1940 0.0 0
M  V30 15 N 12.0035 3.0801 0.0 0
M  V30 16 C 13.4910 2.6815 0.0 0 CFG=2
M  V30 17 C 12.4020 4.5676 0.0 0
M  V30 18 C 13.8896 4.1690 0.0 0
M  V30 19 C 2.6675 2.3101 0.0 0
M  V30 20 C 2.6675 0.7700 0.0 0
M  V30 21 C 1.3338 3.0801 0.0 0
M  V30 22 C 1.3338 0.0000 0.0 0
M  V30 23 C 0.0000 2.3101 0.0 0
M  V30 24 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=1
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 9 19
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 16 10 CFG=1
M  V30 14 1 11 13
M  V30 15 1 16 14 CFG=3
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1192501-21-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1192501-41-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-6515823
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Preparation of
Dipeptide Derivatives with C-Terminal Amide Groups. Method A. The
corresponding dipeptide methyl ester (4.22 mmol) was dissolved in MeNH2 •
EtOH (10 mL, 8 M). After 2 h of reaction the solvent was evaporated to
dryness, and when necessary, the residue waspurified by flash
chromatography or centrifugal circular thinlayer chromatography, using
the system of eluents indicated in each case Z-Ala-2(R,S)-MeAze-NHMe
(8b). Syrup, 99% yield [from (R,S)-4b, Method A]. Eluent: EtAcO/hexane
(8:1). HPLC (Chiralpak, hexane/methanol = 95:5): t R = 22.9 min (major
diastereoisomer), 30.5 min (minor diastereoisomer). Diastereoisomers
ratio 1.2:1. 1H NMR(CDCl3): major diastereoisomer δ 7.87 (m, 1H,NH-CH3),
7.35 (m, 5H, Ph), 5.42 (m, 1H, NH-Ala), 5.10 (s, 2H, CH2-Z), 4.21 (q, 1H,
J = 7.1, α-H, Ala), 4.17 (m, 1H, H-4), 3.97 (m, 1H, H-4), 2.88 (m, 1H,
H-3), 2.79 (d, 3H, J = 4.7, CH3-NH), 2.12 (m, 1H, H-3), 1.72 (s, 3H,
2-CH3, 2- MeAze), 1.30 (d, 3H, J = 7.1, β-H, Ala); minor diastereoisomer
δ 7.93 (m, 1H, NH-CH3), 7.35 (m, 5H, Ph), 5.42 (m, 1H, NHAla), 5.10 (s,
2H, CH2-Z), 4.17 (m, 1H, H-4), 4.13 (q, 1H, J = 7.0, α-H, Ala), 3.97 (m,
1H, H-4), 2.88 (m, 1H, H-3), 2.80 (d, 3H, J = 4.5, CH3-NH), 2.12 (m, 1H,
H-3), 1.73 (s, 3H, 2-CH3, 2- MeAze), 1.34 (d, 3H, J = 7.0, β-H, Ala). 1H
NMR(DMSO-d 6): major diastereoisomer δ 7.75 (m, 1H, NH-CH3), 7.59 (d, 1H,
J = 7.0, NH-Ala), 7.33 (m, 5H, Ph), 5.00 (s, 2H, CH2-Z), 4.15 (m, 1H,
H-4), 4.00 (m, 1H, H-4), 3.96 (q, 1H, J = 7.0, α-H, Ala), 2.60 (d, 3H, J
= 4.3,CH3-NH), 2.26 (m, 1H, H-3), 2.01 (m, 1H, H-3), 1.52 (s, 3H, 2-CH3,
2-MeAze), 1.14 (d, 3H, J = 7.0, β-H, Ala); minor diastereoisomer δ
7.67-7.65 (m, 2H, NH-CH3, NH-Ala), 7.33 (m, 5H, Ph), 5.02 (s, 2H,CH2-Z),
4.15 (m, 1H, H- 4), 4.00 (m, 1H, H-4), 3.96 (q, 1H, J = 7.0, α-H, Ala),
2.57 (d, 3H, J = 4.3, CH3-NH), 2.26 (m, 1H, H-3), 2.01 (m, 1H, H-3), 1.52
(s, 3H, 2-CH3, 2-MeAze), 1.15 (d, 3H, J = 7.0, β-H, Ala). 13C NMR
(CDCl3): major diastereoisomer δ 174.4 (CO-Ala), 172.6 (2-CO), 155.6
(CO-Z), 136.2 (C-Ph), 128.5, 128.2, 128.0 (CH-Ph), 72.0 (2-C), 66.9
(CH2-Z), 46.5 (R-C, Ala), 45.8 (4-C), 27.0 (3-C), 26.2 (CH3-NH), 23.4
(2-CH3, 2-MeAze), 18.2 (β-C, Ala); minor diastereoisomer δ 174.0
(CO-Ala), 173.4 (2-CO), 155.6 (CO-Z), 136.2 (C-Ph), 128.5, 128.2, 128.0
(CH-Ph), 71.7 (2-C), 66.9 (CH2-Z), 46.7 (α-C, Ala), 45.7 (4-C), 27.4
(3-C), 26.2 (CH3-NH), 23.2 (2-CH3, 2-MeAze), 17.7 (β-C, Ala). ES-MS:
334.0 [M + 1] + , 356.0 [M + Na] + . Anal. Calcd for C17H23N3O4: C,
61.25; H, 6.95; N, 12.60. Found: C, 61.00; H, 6.71; N, 12.74.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Further Evidence for 2-Alkyl-2-carboxyazetidines as γ-Turn Inducers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baeza, Jose Luis; Gerona-Navarro, Guillermo; Thompson, Kevin; Perez de
Vega, M. Jesus; Infantes, Lourdes; Garcia-Lopez, M. Teresa;
Gonzalez-Muniz, Rosario; Martin-Martinez, Mercedes
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2009), 74(21), 8203-8211

$RFMT $RIREG SCHEME221 STEP1
$RXN



  2  1
$MOL
2-[[(1,1-Dimethylethoxy)carbonyl]amino]-4-pentenoic acid
C10H17NO4
119479-32-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 3.8500 0.0 0
M  V30 2 N 4.0011 4.6201 0.0 0
M  V30 3 C 2.6675 2.3100 0.0 0
M  V30 4 C 1.3337 4.6201 0.0 0
M  V30 5 C 5.3348 3.8500 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 O 1.3337 6.1601 0.0 0
M  V30 8 O 0.0000 3.8500 0.0 0
M  V30 9 O 6.6684 4.6201 0.0 0
M  V30 10 O 5.3348 2.3100 0.0 0
M  V30 11 C 1.3337 0.0000 0.0 0
M  V30 12 C 8.0022 3.8500 0.0 0
M  V30 13 C 8.7722 5.1837 0.0 0
M  V30 14 C 9.3359 3.0800 0.0 0
M  V30 15 C 7.2322 2.5164 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 2 6 11
M  V30 11 1 9 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [1-[(methylamino)carbonyl]-3-butenyl]-, 1,1-dimethylethyl ester
C11H20N2O3
274918-65-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 N 5.3900 5.3347 0.0 0
M  V30 3 C 7.7000 4.0011 0.0 0
M  V30 4 C 5.3900 2.6674 0.0 0
M  V30 5 C 3.8500 5.3347 0.0 0
M  V30 6 N 8.4700 5.3347 0.0 0
M  V30 7 O 8.4700 2.6674 0.0 0
M  V30 8 C 6.1600 1.3338 0.0 0
M  V30 9 O 3.0800 6.6685 0.0 0
M  V30 10 O 3.0800 4.0011 0.0 0
M  V30 11 C 10.0100 5.3347 0.0 0
M  V30 12 C 5.3900 0.0000 0.0 0
M  V30 13 C 1.5400 6.6685 0.0 0
M  V30 14 C 1.5400 5.1285 0.0 0
M  V30 15 C 0.0000 6.6685 0.0 0
M  V30 16 C 1.5400 8.2085 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 119479-32-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 274918-65-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-9167655
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 543-27-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure III (GP-III). N-Alkyl
Amidation of PG-Xaa-OH N-Methyl morpholine (10 mmol) and isobutyl
chloroformate (10 mmol) were successively added to a solution of
Boc-Xaa-OH 2a-g (10 mmol) or PhtN-Xaa-OH 2h-n (10 mmol) in THF (20 mL) at
-20°C. After an activation period of 3 min, 40 % aqueous methylamine
(12-50 mmol) or N-alkyl amine (13 mmol) in THF (5 mL) was added to above
solution, and the resulting solution was stirred for 1 h at -20°C prior
to the addition of 5 % NaHCO3 (20 mL). After 30 min at room temperature,
the aqueous phase was extracted with CH2Cl2 (3×50 mL). The combined
organic layer was washed with 5 % NaHCO3 (2×20 mL) and dried (Na2SO4).
Evaporation of solvents under reduced pressure gave Boc-Xaa-NHMe 3a-g or
PhtN-Xaa-NHR.3h-n The crude products were purified by flash
chromatography (EtOAc/cyclohexane, 1:2) or by crystallization
(EtOAc/pentane or CH2Cl2/pentane). tert-Butyl
1-(methylcarbamoyl)but-3-enylcarbamate (3g) [Boc-Alg-NHMe]. Following
GP-III, from Boc-Alg-OH 2g (2.4 g, 11.2 mmol), title compound 3g was
isolated as a solid which was recrystallized from CH2Cl2/pentane in a
freezer (2.51 g, > 99 %) mp 113°C (CH2Cl2/pentane); δH (300.14 MHz,
CDCl3): 1.44 (3×s, 9 H), 2.38-2.60 (2×m, 2 H), 2.81 (d, 3 H, 3JHH = 4.8
Hz), 4.16 (dd, 1 H, 3JHH = 6.8 Hz, 3JHH = 7.1 Hz), 5.07-5.15 (2×m, 2 H),
5.18 (bs, 1 H), 5.67-5.82 (m, 1 H), 6.45 (bs, 1 H); δC (75.48 MHz,
CDCl3): 26.06 (q), 28.26 (3×q), 36.97 (dd), 53.90/53.95 (2×d), 80.12 (s),
118.65 (dd), 133.23 (d), 155.61 (s), 172.02 (s); MS-ES, m/z: 229.1 [M+H],
251.1 [M+Na]. Anal. Calcd for C11H20N2O3: C, 57.87; H, 8.83; N, 12.27.
Found: C, 57.93; H, 8.78; N, 12.13. Analytical and spectral data was not
given in the literature.8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Highly Efficient Stereoconservative Amidation and Deamidation of α-Amino
Acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shendage, Deepak M.; Froehlich, Roland; Haufe, Guenter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2004), 6(21), 3675-3678

$RFMT $RIREG SCHEME222 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Indole-5-carboxaldehyde
C9H7NO
1196-69-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 O 7.7047 2.3100 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 C 2.3699 0.7700 0.0 0
M  V30 5 C 3.7036 3.0800 0.0 0
M  V30 6 C 0.9052 2.7859 0.0 0
M  V30 7 C 3.7036 0.0000 0.0 0
M  V30 8 N 0.9052 0.2941 0.0 0
M  V30 9 C 5.0372 2.3100 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 11 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1H-indole-5-methanamine
C10H12N2
709649-72-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 N 7.7047 2.3100 0.0 0
M  V30 3 C 9.0383 3.0800 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 C 2.3699 0.7700 0.0 0
M  V30 6 C 3.7036 3.0800 0.0 0
M  V30 7 C 0.9052 2.7859 0.0 0
M  V30 8 C 3.7036 0.0000 0.0 0
M  V30 9 N 0.9052 0.2941 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 12 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1196-69-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 709649-72-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32044183
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-Guided Identification of DNMT3B Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Newton, Ana S.; Faver, John C.; Micevic, Goran; Muthusamy, Viswanathan;
Kudalkar, Shalley N.; Bertoletti, Nicole; Anderson, Karen S.; Bosenberg,
Marcus W.; Jorgensen, William L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2020), 11(5), 971-976

$RFMT $RIREG SCHEME223 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Diethylamino)benzaldehyde
C11H15NO
120-21-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 2.3101 0.0 0
M  V30 2 C 1.3337 3.0801 0.0 0
M  V30 3 C 2.6675 0.7700 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 C 1.3337 0.0000 0.0 0
M  V30 6 C 8.0023 5.3901 0.0 0
M  V30 7 O 9.3360 4.6201 0.0 0
M  V30 8 C 4.0012 3.0801 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 5.3901 0.0 0
M  V30 12 C 6.6685 3.0801 0.0 0
M  V30 13 C 6.6685 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 6 7
M  V30 7 1 6 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,N-Diethyl-4-[(methylimino)methyl]benzenamine
C12H18N2
72617-24-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3337 0.0 0
M  V30 2 C 1.5400 2.6673 0.0 0
M  V30 3 C 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 C 0.0000 0.0000 0.0 0
M  V30 6 C 8.4701 1.3337 0.0 0
M  V30 7 N 9.2401 2.6673 0.0 0
M  V30 8 C 10.7801 2.6673 0.0 0
M  V30 9 C 3.8500 1.3337 0.0 0
M  V30 10 C 4.6201 2.6673 0.0 0
M  V30 11 C 4.6201 0.0000 0.0 0
M  V30 12 C 6.1601 2.6673 0.0 0
M  V30 13 C 6.1601 0.0000 0.0 0
M  V30 14 C 6.9301 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 6 7 CFG=2
M  V30 7 1 6 14
M  V30 8 1 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 120-21-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 72617-24-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-6051
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Syntheses of the various Schiff bases were
carried out according to the literature by combining the given aromatic
aldehyde (1 mmol) with the corresponding amine (1.1 mmol). In cases where
either the aldehyde or the amine was solid, ethanol (∼3 mL) was used to
solubilize the reagents. The reaction was allowed to stir under ambient
conditions for 12 hours. In cases where a precipitate was noted, the
product was isolated by filtration and washed with cold ethanol (∼2 mL)
to afford pure product. When both reagents were initially liquids, the
solvents and excess amine were removed in vacuo. All Schiff base
reactions gave at, or near, quantitative yields (Scheme 2, A). Schiff
base, reactant of compound 6a.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, no solvent or EtOH used for solid reactants
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient synthesis of new 4-arylideneimidazolin-5-ones related to the
GFP chromophore by 2+3 cyclocondensation of arylideneimines with imidate
ylides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baldridge, Anthony; Kowalik, Janusz; Tolbert, Laren M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2010), (14), 2424-2436

$RFMT $RIREG SCHEME224 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,5-Dioxo-1-pyrrolidinyl 2-[[1-[2-[(2S,4S)-1,2,3,4,6,11-hexahydro-2,5,12-trih...
C44H50N2O18
1204819-83-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  67 75 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 13.8821 0.0 0
M  V30 2 O 9.3358 7.7221 0.0 0
M  V30 3 O 6.6684 7.7221 0.0 0
M  V30 4 C 12.1861 11.3046 0.0 0
M  V30 5 C 13.1760 12.4842 0.0 0
M  V30 6 O 12.7128 9.8574 0.0 0
M  V30 7 O 14.6926 12.2169 0.0 0
M  V30 8 O 11.1962 13.0191 0.0 0
M  V30 9 O 4.0009 13.8821 0.0 0
M  V30 10 O 4.0009 7.7221 0.0 0
M  V30 11 C 14.6706 7.7221 0.0 0
M  V30 12 O 1.3336 7.7221 0.0 0
M  V30 13 C 0.0000 6.9521 0.0 0
M  V30 14 O 16.6724 12.2169 0.0 0
M  V30 15 C 18.1890 12.4842 0.0 0
M  V30 16 C 19.1788 11.3046 0.0 0
M  V30 17 O 20.6955 11.5721 0.0 0
M  V30 18 O 18.6521 9.8574 0.0 0
M  V30 19 O 16.0128 1.4068 0.0 0
M  V30 20 C 16.6392 0.0000 0.0 0
M  V30 21 O 24.0377 11.8057 0.0 0
M  V30 22 O 19.8849 8.3211 0.0 0
M  V30 23 C 8.0020 11.5721 0.0 0
M  V30 24 C 8.0020 10.0321 0.0 0
M  V30 25 C 6.6684 12.3421 0.0 0
M  V30 26 C 9.3358 12.3421 0.0 0
M  V30 27 C 9.3358 9.2621 0.0 0 CFG=1
M  V30 28 C 6.6684 9.2621 0.0 0
M  V30 29 C 5.3347 11.5721 0.0 0
M  V30 30 C 10.6695 11.5721 0.0 0 CFG=1
M  V30 31 C 10.6695 10.0321 0.0 0
M  V30 32 C 5.3347 10.0321 0.0 0
M  V30 33 C 4.0009 12.3421 0.0 0
M  V30 34 C 4.0009 9.2621 0.0 0
M  V30 35 C 2.6673 11.5721 0.0 0
M  V30 36 C 2.6673 10.0321 0.0 0
M  V30 37 C 1.3336 12.3421 0.0 0
M  V30 38 C 1.3336 9.2621 0.0 0
M  V30 39 C 0.0000 11.5721 0.0 0
M  V30 40 C 0.0000 10.0321 0.0 0
M  V30 41 C 10.6695 6.9521 0.0 0 CFG=2
M  V30 42 C 10.6695 5.4120 0.0 0
M  V30 43 O 12.0031 7.7221 0.0 0
M  V30 44 C 12.0031 4.6420 0.0 0 CFG=1
M  V30 45 C 13.3368 6.9521 0.0 0 CFG=1
M  V30 46 N 12.3233 3.1356 0.0 0
M  V30 47 C 13.3368 5.4120 0.0 0 CFG=2
M  V30 48 C 13.8548 2.9747 0.0 0 CFG=1
M  V30 49 C 11.4181 1.8897 0.0 0
M  V30 50 O 14.4813 4.3815 0.0 0
M  V30 51 C 14.4813 1.5677 0.0 0 CFG=1
M  V30 52 C 12.0446 0.4828 0.0 0
M  V30 53 O 13.5761 0.3219 0.0 0
M  V30 54 C 15.6825 13.3965 0.0 0
M  V30 55 C 14.3487 14.1665 0.0 0
M  V30 56 C 17.0162 14.1665 0.0 0
M  V30 57 C 14.3487 15.7065 0.0 0
M  V30 58 C 17.0162 15.7065 0.0 0
M  V30 59 C 15.6825 16.4765 0.0 0
M  V30 60 N 21.6853 10.3923 0.0 0
M  V30 61 C 23.2216 10.4998 0.0 0
M  V30 62 C 21.3128 8.8980 0.0 0
M  V30 63 C 23.7985 9.0719 0.0 0
M  V30 64 C 22.6189 8.0820 0.0 0
M  V30 65 H 10.7573 3.7368 0.0 0
M  V30 66 H 14.7437 6.0384 0.0 0
M  V30 67 H 15.3948 2.9747 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 25
M  V30 2 1 27 2 CFG=3
M  V30 3 1 41 2 CFG=3
M  V30 4 1 3 28
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 30 4 CFG=1
M  V30 8 1 5 7
M  V30 9 1 7 54
M  V30 10 1 30 8 CFG=3
M  V30 11 2 9 33
M  V30 12 2 10 34
M  V30 13 1 45 11 CFG=1
M  V30 14 1 12 13
M  V30 15 1 12 38
M  V30 16 1 14 15
M  V30 17 1 14 54
M  V30 18 1 15 16
M  V30 19 1 16 17
M  V30 20 2 16 18
M  V30 21 1 17 60
M  V30 22 1 19 20
M  V30 23 1 51 19 CFG=1
M  V30 24 2 21 61
M  V30 25 2 22 62
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 23 26
M  V30 29 1 24 27
M  V30 30 1 24 28
M  V30 31 2 25 29
M  V30 32 1 26 30
M  V30 33 1 27 31
M  V30 34 2 28 32
M  V30 35 1 29 32
M  V30 36 1 29 33
M  V30 37 1 30 31
M  V30 38 1 32 34
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 1 35 36
M  V30 42 2 35 37
M  V30 43 2 36 38
M  V30 44 1 37 39
M  V30 45 1 38 40
M  V30 46 2 39 40
M  V30 47 1 41 42
M  V30 48 1 41 43
M  V30 49 1 42 44
M  V30 50 1 43 45
M  V30 51 1 44 46
M  V30 52 1 44 47
M  V30 53 1 44 65 CFG=3
M  V30 54 1 45 47
M  V30 55 1 46 48
M  V30 56 1 46 49
M  V30 57 1 47 50
M  V30 58 1 47 66 CFG=3
M  V30 59 1 48 50
M  V30 60 1 48 51
M  V30 61 1 48 67 CFG=1
M  V30 62 1 49 52
M  V30 63 1 51 53
M  V30 64 1 52 53
M  V30 65 1 54 55
M  V30 66 1 54 56
M  V30 67 1 55 57
M  V30 68 1 56 58
M  V30 69 1 57 59
M  V30 70 1 58 59
M  V30 71 1 60 61
M  V30 72 1 60 62
M  V30 73 1 61 63
M  V30 74 1 62 64
M  V30 75 1 63 64
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(8 27 30 41 44 45 47 48 51)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-[[1-[2-[(2S,4S)-1,2,3,4,6,11-Hexahydro-2,5,12-trihydroxy-7-methoxy-4-[[(1S,...
C41H50N2O15
1204819-70-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  61 68 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 13.8821 0.0 0
M  V30 2 O 9.3358 7.7221 0.0 0
M  V30 3 O 6.6684 7.7221 0.0 0
M  V30 4 C 12.1861 11.3046 0.0 0
M  V30 5 C 13.1760 12.4842 0.0 0
M  V30 6 O 12.7128 9.8574 0.0 0
M  V30 7 O 14.6926 12.2169 0.0 0
M  V30 8 O 11.1962 13.0191 0.0 0
M  V30 9 O 4.0011 13.8819 0.0 0
M  V30 10 O 4.0011 7.7221 0.0 0
M  V30 11 C 14.6706 7.7221 0.0 0
M  V30 12 O 1.3336 7.7219 0.0 0
M  V30 13 C 0.0000 6.9519 0.0 0
M  V30 14 O 16.6724 12.2169 0.0 0
M  V30 15 C 18.1890 12.4842 0.0 0
M  V30 16 C 19.1790 11.3046 0.0 0
M  V30 17 N 20.6956 11.5721 0.0 0
M  V30 18 O 18.6523 9.8574 0.0 0
M  V30 19 C 21.6855 10.3923 0.0 0
M  V30 20 O 16.0128 1.4068 0.0 0
M  V30 21 C 16.6393 0.0000 0.0 0
M  V30 22 C 8.0022 11.5721 0.0 0
M  V30 23 C 8.0022 10.0321 0.0 0
M  V30 24 C 6.6684 12.3421 0.0 0
M  V30 25 C 9.3358 12.3421 0.0 0
M  V30 26 C 9.3358 9.2621 0.0 0 CFG=1
M  V30 27 C 6.6684 9.2621 0.0 0
M  V30 28 C 5.3347 11.5719 0.0 0
M  V30 29 C 10.6695 11.5721 0.0 0 CFG=1
M  V30 30 C 10.6695 10.0321 0.0 0
M  V30 31 C 5.3347 10.0319 0.0 0
M  V30 32 C 4.0011 12.3421 0.0 0
M  V30 33 C 4.0011 9.2619 0.0 0
M  V30 34 C 2.6674 11.5719 0.0 0
M  V30 35 C 2.6674 10.0319 0.0 0
M  V30 36 C 1.3336 12.3419 0.0 0
M  V30 37 C 1.3336 9.2619 0.0 0
M  V30 38 C 0.0000 11.5719 0.0 0
M  V30 39 C 0.0000 10.0319 0.0 0
M  V30 40 C 10.6695 6.9521 0.0 0 CFG=2
M  V30 41 C 10.6695 5.4121 0.0 0
M  V30 42 O 12.0031 7.7221 0.0 0
M  V30 43 C 12.0031 4.6420 0.0 0 CFG=1
M  V30 44 C 13.3369 6.9521 0.0 0 CFG=1
M  V30 45 N 12.3235 3.1356 0.0 0
M  V30 46 C 13.3369 5.4121 0.0 0 CFG=2
M  V30 47 C 13.8550 2.9747 0.0 0 CFG=1
M  V30 48 C 11.4182 1.8897 0.0 0
M  V30 49 O 14.4813 4.3815 0.0 0
M  V30 50 C 14.4813 1.5677 0.0 0 CFG=1
M  V30 51 C 12.0446 0.4828 0.0 0
M  V30 52 O 13.5761 0.3219 0.0 0
M  V30 53 C 15.6825 13.3965 0.0 0
M  V30 54 C 17.0162 14.1665 0.0 0
M  V30 55 C 14.3489 14.1665 0.0 0
M  V30 56 C 17.0162 15.7065 0.0 0
M  V30 57 C 14.3489 15.7065 0.0 0
M  V30 58 C 15.6825 16.4765 0.0 0
M  V30 59 H 10.7573 3.7368 0.0 0
M  V30 60 H 14.7437 6.0384 0.0 0
M  V30 61 H 15.3950 2.9747 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 24
M  V30 2 1 26 2 CFG=3
M  V30 3 1 40 2 CFG=3
M  V30 4 1 3 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 29 4 CFG=1
M  V30 8 1 5 7
M  V30 9 1 7 53
M  V30 10 1 29 8 CFG=3
M  V30 11 2 9 32
M  V30 12 2 10 33
M  V30 13 1 44 11 CFG=1
M  V30 14 1 12 13
M  V30 15 1 12 37
M  V30 16 1 14 15
M  V30 17 1 14 53
M  V30 18 1 15 16
M  V30 19 1 16 17
M  V30 20 2 16 18
M  V30 21 1 17 19
M  V30 22 1 20 21
M  V30 23 1 50 20 CFG=1
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 22 25
M  V30 27 1 23 26
M  V30 28 1 23 27
M  V30 29 2 24 28
M  V30 30 1 25 29
M  V30 31 1 26 30
M  V30 32 2 27 31
M  V30 33 1 28 31
M  V30 34 1 28 32
M  V30 35 1 29 30
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 34 35
M  V30 40 2 34 36
M  V30 41 2 35 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 2 38 39
M  V30 45 1 40 41
M  V30 46 1 40 42
M  V30 47 1 41 43
M  V30 48 1 42 44
M  V30 49 1 43 45
M  V30 50 1 43 46
M  V30 51 1 43 59 CFG=3
M  V30 52 1 44 46
M  V30 53 1 45 47
M  V30 54 1 45 48
M  V30 55 1 46 49
M  V30 56 1 46 60 CFG=3
M  V30 57 1 47 49
M  V30 58 1 47 50
M  V30 59 1 47 61 CFG=1
M  V30 60 1 48 51
M  V30 61 1 50 52
M  V30 62 1 51 52
M  V30 63 1 53 54
M  V30 64 1 53 55
M  V30 65 1 54 56
M  V30 66 1 55 57
M  V30 67 1 56 58
M  V30 68 1 57 58
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(8 26 29 40 43 44 46 47 50)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1204819-83-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1204819-70-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1167275
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: To a solution of 47 obtained from step 3 (1
mg, 0.001 mmol) in dry tetrahydrofuran (2 mL), 1 M methylamine in THF
(3μL, 0.003 mmol) were added. The solution was stirred at room
temperature 30 minutes, the solvent evaporated under vacuum and the
residue purified by flash chromatography (dichloromethane/methanol
90:10). title compound 2. yield 0.9 mg (y = 99 %). Red solid. MS (ESI):
811 [M+H]+. Retention time = 6.10 min. Method 2, Retention time = 5.99
min.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anthracycline derivative conjugates, process for their preparation and
their use as antitumor compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Beria, Italo; Caruso, Michele; Flygare, John A.; Lupi, Vittoria; Perego,
Rita; Polakis, Paul; Polson, Andrew; Salsa, Matteo; Spencer, Susan D.;
Valsasina, Barbara
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010009124 A2 2010-01-21

$RFMT $RIREG SCHEME225 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Catechol
C6H6O2
120-80-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6201 2.6673 0.0 0
M  V30 2 O 3.0801 0.0000 0.0 0
M  V30 3 C 3.0801 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 2.3101 4.0010 0.0 0
M  V30 6 C 0.7700 1.3337 0.0 0
M  V30 7 C 0.7700 4.0010 0.0 0
M  V30 8 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 4
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Methylamino)phenol
C7H9NO
611-24-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 4.0010 0.0 0
M  V30 3 O 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 120-80-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 611-24-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28202314
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Polymer-supported metal catalysts for the heterogeneous polymerisation of
lactones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Howard, Ioli C.; Hammond, Ceri; Buchard, Antoine
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polymer Chemistry (2019), 10(43), 5894-5904

$RFMT $RIREG SCHEME226 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 3-fluoro-2-nitro-, methyl ester
C8H6FNO4
1214353-57-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 C 8.0021 3.0800 0.0 0
M  V30 5 N 2.6674 4.6200 0.0 0 VAL=5
M  V30 6 O 4.0011 5.3900 0.0 0
M  V30 7 O 1.3336 5.3900 0.0 0
M  V30 8 F 0.0000 3.0800 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 2.6674 3.0800 0.0 0
M  V30 11 C 4.0011 0.7700 0.0 0
M  V30 12 C 1.3336 2.3100 0.0 0
M  V30 13 C 2.6674 0.0000 0.0 0
M  V30 14 C 1.3336 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 10
M  V30 8 1 8 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-(methylamino)-2-nitrobenzoate
C9H10N2O4
1504570-51-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 O 8.0023 2.3101 0.0 0
M  V30 3 O 6.6685 4.6201 0.0 0
M  V30 4 C 9.3360 3.0801 0.0 0
M  V30 5 N 4.0012 4.6201 0.0 0 VAL=5
M  V30 6 O 5.3348 5.3901 0.0 0
M  V30 7 O 2.6675 5.3901 0.0 0
M  V30 8 N 1.3337 3.0801 0.0 0
M  V30 9 C 0.0000 2.3101 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0012 3.0801 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 14 C 4.0012 0.0000 0.0 0
M  V30 15 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 1 8 9
M  V30 9 1 8 13
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1214353-57-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1504570-51-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36425619
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Molecular flavin catalysts for C-H functionalisation and derivatisation
of dehydroamino acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rehpenn, Andreas; Walter, Alexandra; Storch, Golo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Science (2022), 13(47), 14151-14156

$RFMT $RIREG SCHEME227 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-1-fluoro-3-methyl-2-nitrobenzene
C7H5BrFNO2
1224629-03-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6675 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0011 0.0 0
M  V30 3 O 0.0000 1.3338 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 F 2.3100 5.3349 0.0 0
M  V30 6 Br 6.9301 2.6675 0.0 0
M  V30 7 C 2.3100 2.6675 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 4.6201 1.3338 0.0 0
M  V30 11 C 4.6201 4.0011 0.0 0
M  V30 12 C 5.3901 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 9
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N,3-dimethyl-2-nitrobenzenamine
C8H9BrN2O2
1639116-33-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3101 1.3338 0.0 0
M  V30 2 C 3.0801 0.0000 0.0 0
M  V30 3 N 0.7700 4.0012 0.0 0 VAL=5
M  V30 4 O 0.0000 5.3348 0.0 0
M  V30 5 O 0.0000 2.6675 0.0 0
M  V30 6 C 2.3101 6.6687 0.0 0
M  V30 7 Br 6.9302 4.0012 0.0 0
M  V30 8 C 3.0801 2.6675 0.0 0
M  V30 9 C 2.3101 4.0012 0.0 0
M  V30 10 C 4.6201 2.6675 0.0 0
M  V30 11 C 3.0801 5.3348 0.0 0
M  V30 12 C 5.3901 4.0012 0.0 0
M  V30 13 C 4.6201 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 9
M  V30 6 1 6 11
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1224629-03-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1639116-33-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-4769763
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of imidazopyrrolidinone derivatives as BET protein modulators
useful in treating cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Blank, Jutta; Bold, Guido; Cotesta, Simona; Guagnano, Vito; Rueeger,
Heinrich; Vaupel, Andrea
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014191894 A1 2014-12-04

$RFMT $RIREG SCHEME228 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(Bromomethyl)-1-methyl-3-nitro-1H-pyrazole
C5H6BrN3O2
1227210-47-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.9291 4.0287 0.0 0 VAL=5
M  V30 2 O 7.2628 3.2587 0.0 0
M  V30 3 O 5.9291 5.5688 0.0 0
M  V30 4 C 0.6263 2.9016 0.0 0
M  V30 5 Br 0.0000 4.3086 0.0 0
M  V30 6 C 2.3016 0.0000 0.0 0
M  V30 7 C 4.5953 3.2587 0.0 0
M  V30 8 C 3.1885 3.8850 0.0 0
M  V30 9 N 4.4344 1.7271 0.0 0
M  V30 10 C 2.1580 2.7406 0.0 0
M  V30 11 N 2.9281 1.4070 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1-Dimethyl-3-nitro-1H-pyrazole-5-methanamine
C6H10N4O2
1345510-67-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5626 2.7106 0.0 0
M  V30 2 N 7.3326 4.0442 0.0 0
M  V30 3 C 8.8726 4.0442 0.0 0
M  V30 4 C 4.5932 0.0000 0.0 0
M  V30 5 N 1.4068 4.3858 0.0 0 VAL=5
M  V30 6 O 1.5679 5.9173 0.0 0
M  V30 7 O 0.0000 3.7593 0.0 0
M  V30 8 C 5.0226 2.7106 0.0 0
M  V30 9 C 4.1174 3.9564 0.0 0
M  V30 10 N 4.1174 1.4647 0.0 0
M  V30 11 C 2.6528 3.4806 0.0 0
M  V30 12 N 2.6528 1.9406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1227210-47-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1345510-67-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-8849128
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-64-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 302a N-Methyl(1-methy3-nitro-1H-pyrazo5-yl)methanamine 302a To a
stirred solution of MeNH (30% wt in water) (2.5 g, 20 mmol) in acetone
(10 mL) at 0°C (ice bath) was added K2CO3 (415 mg, 3 mmol), followed by
the dropwise addition of a solution of
5-(bromomethyl)-1-methy3-nitro-1H-pyrazole (220 mg, 1 mmol) in acetone (5
mL). The reaction mixture was then warmed to room temperature and stirred
for 3 h. The solvent was removed and the residue was extracted with
methylene chloride (3 X 15 mL), dried over Na2SO4 and concentrated to
afford 302a, which was used in the next step without additional
purification. Yellow oil, yield (170 mg, 99%). LCMS: (M+H)+ 171
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Heteroarylpyridone and azapyridone compounds as inhibitors of BTK
activity and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Crawford, James John; Ortwine, Daniel Fred; Wei, Binqing; Young, Wendy B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013067274 A1 2013-05-10

$RFMT $RIREG SCHEME228 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(Bromomethyl)-1-methyl-3-nitro-1H-pyrazole
C5H6BrN3O2
1227210-47-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.9291 4.0287 0.0 0 VAL=5
M  V30 2 O 7.2628 3.2587 0.0 0
M  V30 3 O 5.9291 5.5688 0.0 0
M  V30 4 C 0.6263 2.9016 0.0 0
M  V30 5 Br 0.0000 4.3086 0.0 0
M  V30 6 C 2.3016 0.0000 0.0 0
M  V30 7 C 4.5953 3.2587 0.0 0
M  V30 8 C 3.1885 3.8850 0.0 0
M  V30 9 N 4.4344 1.7271 0.0 0
M  V30 10 C 2.1580 2.7406 0.0 0
M  V30 11 N 2.9281 1.4070 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1-Dimethyl-3-nitro-1H-pyrazole-5-methanamine
C6H10N4O2
1345510-67-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5626 2.7106 0.0 0
M  V30 2 N 7.3326 4.0442 0.0 0
M  V30 3 C 8.8726 4.0442 0.0 0
M  V30 4 C 4.5932 0.0000 0.0 0
M  V30 5 N 1.4068 4.3858 0.0 0 VAL=5
M  V30 6 O 1.5679 5.9173 0.0 0
M  V30 7 O 0.0000 3.7593 0.0 0
M  V30 8 C 5.0226 2.7106 0.0 0
M  V30 9 C 4.1174 3.9564 0.0 0
M  V30 10 N 4.1174 1.4647 0.0 0
M  V30 11 C 2.6528 3.4806 0.0 0
M  V30 12 N 2.6528 1.9406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1227210-47-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1345510-67-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-14845164
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-64-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 320a N-Methyl(1-methyl-3-nitro-1H-pyrazol-5-yl)methanamine 320a
To a stirred solution of MeNH2 (30% wt in H2O) (2.5 g, 20 mmol) in
acetone (10 mL) at 0°C (ice bath) was added K2CO3 (415 mg, 3 mmol),
followed by the dropwise addition of a solution of
5-(bromomethyl)-1-methyl-3-nitro-1H-pyrazole (220 mg, 1 mmol) in acetone
(5 mL). The reaction mixture was then warmed to room temperature and
stirred for 3 h. The solvent was removed and the residue was extracted
with methylene chloride (15 mL x 3), dried over Na2SO4 and concentrated
to afford 320a, which was used in the next step without additional
purification. Yield 170 mg, 99%, yellow oil. LCMS: (M+H)+ 171
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyridone and azapyridone compounds as Btk inhibitors for
treating immune disorders, inflammation, cancer, and other Btk-mediated
diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barbosa, Antonio J. M.; Blomgren, Peter A.; Currie, Kevin S.;
Krishnamoorthy, Ravi; Kropf, Jeffrey E.; Lee, Seung H.; Mitchell, Scott
A.; Ortwine, Daniel; Schmitt, Aaron C.; Wang, Xiaojing; Xu, Jianjun;
Young, Wendy; Zhang, Honglu; Zhao, Zhongdong; Zhichkin, Pavel E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011140488 A1 2011-11-10

$RFMT $RIREG SCHEME229 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(7aS,13aR,13bR,13cS)-2,3,6,7,7a,8,13,13a,13b,13c-Decahydro-1H,5H,10H-dipyrido...
C15H22N2S
1227822-66-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 0.0000 0.0 0
M  V30 2 C 2.6674 3.8500 0.0 0 CFG=1
M  V30 3 C 4.0011 4.6200 0.0 0 CFG=2
M  V30 4 C 2.6674 2.3100 0.0 0 CFG=1
M  V30 5 N 1.3336 4.6200 0.0 0
M  V30 6 C 5.3347 3.8500 0.0 0 CFG=1
M  V30 7 C 4.0011 6.1600 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 1.3336 1.5400 0.0 0
M  V30 10 C 1.3338 6.1600 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 12 N 5.3347 2.3100 0.0 0
M  V30 13 C 6.6685 4.6200 0.0 0
M  V30 14 C 2.6674 6.9300 0.0 0
M  V30 15 C 0.0000 2.3100 0.0 0
M  V30 16 C 6.6685 1.5400 0.0 0
M  V30 17 C 8.0021 3.8500 0.0 0
M  V30 18 C 8.0021 2.3100 0.0 0
M  V30 19 H 1.3336 3.0800 0.0 0
M  V30 20 H 4.8844 5.8816 0.0 0
M  V30 21 H 2.6674 0.7700 0.0 0
M  V30 22 H 5.9855 5.2457 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 16
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 19 CFG=1
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 3 20 CFG=1
M  V30 9 1 4 8
M  V30 10 1 4 9
M  V30 11 1 4 21 CFG=1
M  V30 12 1 5 10
M  V30 13 1 5 11
M  V30 14 1 6 12
M  V30 15 1 6 13
M  V30 16 1 6 22 CFG=3
M  V30 17 1 7 14
M  V30 18 1 8 12
M  V30 19 1 9 15
M  V30 20 1 10 14
M  V30 21 1 11 15
M  V30 22 1 12 16
M  V30 23 1 13 17
M  V30 24 1 16 18
M  V30 25 2 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 2 3 4 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(7aS,12S,13aR,13bR,13cS)-Dodecahydro-12-(methylamino)-1H,5H,10H-dipyrido[2,1-...
C16H27N3S
1261068-12-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 6.6684 0.0000 0.0 0
M  V30 2 N 9.3358 4.6200 0.0 0
M  V30 3 C 10.6694 3.8500 0.0 0
M  V30 4 C 2.6673 3.8500 0.0 0 CFG=1
M  V30 5 C 4.0011 4.6200 0.0 0 CFG=2
M  V30 6 C 2.6673 2.3100 0.0 0 CFG=1
M  V30 7 N 1.3336 4.6200 0.0 0
M  V30 8 C 5.3347 3.8500 0.0 0 CFG=1
M  V30 9 C 4.0011 6.1600 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 C 1.3336 1.5400 0.0 0
M  V30 12 C 1.3336 6.1600 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 14 N 5.3347 2.3100 0.0 0
M  V30 15 C 6.6684 4.6200 0.0 0
M  V30 16 C 2.6673 6.9300 0.0 0
M  V30 17 C 0.0000 2.3100 0.0 0
M  V30 18 C 6.6684 1.5400 0.0 0
M  V30 19 C 8.0021 3.8500 0.0 0 CFG=2
M  V30 20 C 8.0021 2.3100 0.0 0
M  V30 21 H 1.3336 3.0800 0.0 0
M  V30 22 H 4.8844 5.8816 0.0 0
M  V30 23 H 2.6673 0.7700 0.0 0
M  V30 24 H 5.9855 5.2457 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 18
M  V30 2 1 2 3
M  V30 3 1 19 2 CFG=3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 21 CFG=1
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 5 22 CFG=1
M  V30 11 1 6 10
M  V30 12 1 6 11
M  V30 13 1 6 23 CFG=1
M  V30 14 1 7 12
M  V30 15 1 7 13
M  V30 16 1 8 14
M  V30 17 1 8 15
M  V30 18 1 8 24 CFG=3
M  V30 19 1 9 16
M  V30 20 1 10 14
M  V30 21 1 11 17
M  V30 22 1 12 16
M  V30 23 1 13 17
M  V30 24 1 14 18
M  V30 25 1 15 19
M  V30 26 1 18 20
M  V30 27 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 4 5 6 8 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1227822-66-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1261068-12-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-239-CAS-13389454
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and in vitro inhibitory activity of matrine derivatives towards
pro-inflammatory cytokines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hu, Honggang; Wang, Shaozhan; Zhang, Chunmei; Wang, Liang; Ding, Li;
Zhang, Junping; Wu, Qiuye
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2010), 20(24), 7537-7539

$RFMT $RIREG SCHEME230 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1′-Bis(1,1-dimethylethyl) 4,4′-[[1-methyl-4-[(methylsulfonyl)oxy]butylidene...
C42H50O9S
1228438-35-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  52 55 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 16.0045 7.7002 0.0 0
M  V30 2 C 16.0045 6.1601 0.0 0
M  V30 3 C 17.3382 6.9302 0.0 0
M  V30 4 C 14.6708 5.3901 0.0 0
M  V30 5 C 14.6708 3.8501 0.0 0
M  V30 6 O 13.3372 3.0801 0.0 0
M  V30 7 S 13.3372 1.5400 0.0 0 VAL=6
M  V30 8 C 11.7971 1.5400 0.0 0
M  V30 9 O 13.3372 0.0000 0.0 0
M  V30 10 O 14.8772 1.5400 0.0 0
M  V30 11 O 21.3393 10.7802 0.0 0
M  V30 12 C 22.6730 10.0102 0.0 0
M  V30 13 O 10.6697 10.7802 0.0 0
M  V30 14 C 9.3360 10.0102 0.0 0
M  V30 15 C 28.0078 13.0903 0.0 0
M  V30 16 O 29.3416 12.3203 0.0 0
M  V30 17 O 28.0078 14.6303 0.0 0
M  V30 18 C 30.6753 13.0903 0.0 0
M  V30 19 C 29.9053 14.4240 0.0 0
M  V30 20 C 32.0090 13.8603 0.0 0
M  V30 21 C 31.4453 11.7566 0.0 0
M  V30 22 C 4.0012 13.0903 0.0 0
M  V30 23 O 2.6673 12.3203 0.0 0
M  V30 24 O 4.0012 14.6303 0.0 0
M  V30 25 C 1.3337 13.0903 0.0 0
M  V30 26 C 0.5637 11.7566 0.0 0
M  V30 27 C 0.0000 13.8603 0.0 0
M  V30 28 C 2.1037 14.4240 0.0 0
M  V30 29 C 17.3382 8.4702 0.0 0
M  V30 30 C 18.6720 7.7002 0.0 0
M  V30 31 C 17.3382 10.0102 0.0 0
M  V30 32 C 20.0057 8.4702 0.0 0
M  V30 33 C 18.6720 10.7802 0.0 0
M  V30 34 C 20.0057 10.0102 0.0 0
M  V30 35 C 14.6708 8.4702 0.0 0
M  V30 36 C 14.6708 10.0102 0.0 0
M  V30 37 C 13.3372 7.7002 0.0 0
M  V30 38 C 13.3372 10.7802 0.0 0
M  V30 39 C 12.0033 8.4702 0.0 0
M  V30 40 C 12.0033 10.0102 0.0 0
M  V30 41 C 24.0068 10.7802 0.0 0
M  V30 42 C 24.0068 12.3203 0.0 0
M  V30 43 C 25.3405 10.0102 0.0 0
M  V30 44 C 25.3405 13.0903 0.0 0
M  V30 45 C 26.6742 10.7802 0.0 0
M  V30 46 C 26.6742 12.3203 0.0 0
M  V30 47 C 8.0022 10.7802 0.0 0
M  V30 48 C 8.0022 12.3203 0.0 0
M  V30 49 C 6.6685 10.0102 0.0 0
M  V30 50 C 6.6685 13.0903 0.0 0
M  V30 51 C 5.3348 10.7802 0.0 0
M  V30 52 C 5.3348 12.3203 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 29
M  V30 4 1 1 35
M  V30 5 1 2 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 2 7 10
M  V30 12 1 11 12
M  V30 13 1 11 34
M  V30 14 1 12 41
M  V30 15 1 13 14
M  V30 16 1 13 40
M  V30 17 1 14 47
M  V30 18 1 15 16
M  V30 19 2 15 17
M  V30 20 1 15 46
M  V30 21 1 16 18
M  V30 22 1 18 19
M  V30 23 1 18 20
M  V30 24 1 18 21
M  V30 25 1 22 23
M  V30 26 2 22 24
M  V30 27 1 22 52
M  V30 28 1 23 25
M  V30 29 1 25 26
M  V30 30 1 25 27
M  V30 31 1 25 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 38 2 35 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 2 37 39
M  V30 42 2 38 40
M  V30 43 1 39 40
M  V30 44 2 41 42
M  V30 45 1 41 43
M  V30 46 1 42 44
M  V30 47 2 43 45
M  V30 48 2 44 46
M  V30 49 1 45 46
M  V30 50 2 47 48
M  V30 51 1 47 49
M  V30 52 1 48 50
M  V30 53 2 49 51
M  V30 54 2 50 52
M  V30 55 1 51 52
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1′-Bis(1,1-dimethylethyl) 4,4′-[[1-methyl-4-(methylamino)butylidene]bis(4,1...
C42H51NO6
1062142-25-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  49 52 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 16.0045 6.1601 0.0 0
M  V30 2 C 16.0045 4.6201 0.0 0
M  V30 3 C 17.3382 5.3901 0.0 0
M  V30 4 C 14.6708 3.8501 0.0 0
M  V30 5 C 14.6708 2.3101 0.0 0
M  V30 6 N 13.3370 1.5400 0.0 0
M  V30 7 C 13.3370 0.0000 0.0 0
M  V30 8 O 21.3393 9.2402 0.0 0
M  V30 9 C 22.6730 8.4702 0.0 0
M  V30 10 O 10.6697 9.2402 0.0 0
M  V30 11 C 9.3360 8.4702 0.0 0
M  V30 12 C 28.0078 11.5503 0.0 0
M  V30 13 O 29.3416 10.7802 0.0 0
M  V30 14 O 28.0078 13.0903 0.0 0
M  V30 15 C 30.6753 11.5503 0.0 0
M  V30 16 C 29.9053 12.8839 0.0 0
M  V30 17 C 32.0090 12.3203 0.0 0
M  V30 18 C 31.4453 10.2166 0.0 0
M  V30 19 C 4.0012 11.5503 0.0 0
M  V30 20 O 2.6673 10.7802 0.0 0
M  V30 21 O 4.0012 13.0903 0.0 0
M  V30 22 C 1.3337 11.5503 0.0 0
M  V30 23 C 0.5637 10.2166 0.0 0
M  V30 24 C 0.0000 12.3203 0.0 0
M  V30 25 C 2.1037 12.8839 0.0 0
M  V30 26 C 17.3382 6.9302 0.0 0
M  V30 27 C 17.3382 8.4702 0.0 0
M  V30 28 C 18.6718 6.1601 0.0 0
M  V30 29 C 18.6718 9.2402 0.0 0
M  V30 30 C 20.0057 6.9302 0.0 0
M  V30 31 C 20.0057 8.4702 0.0 0
M  V30 32 C 14.6708 6.9302 0.0 0
M  V30 33 C 14.6708 8.4702 0.0 0
M  V30 34 C 13.3370 6.1601 0.0 0
M  V30 35 C 13.3370 9.2402 0.0 0
M  V30 36 C 12.0033 6.9302 0.0 0
M  V30 37 C 12.0033 8.4702 0.0 0
M  V30 38 C 24.0068 9.2402 0.0 0
M  V30 39 C 25.3405 8.4702 0.0 0
M  V30 40 C 24.0068 10.7802 0.0 0
M  V30 41 C 26.6742 9.2402 0.0 0
M  V30 42 C 25.3405 11.5503 0.0 0
M  V30 43 C 26.6742 10.7802 0.0 0
M  V30 44 C 8.0022 9.2402 0.0 0
M  V30 45 C 8.0022 10.7802 0.0 0
M  V30 46 C 6.6685 8.4702 0.0 0
M  V30 47 C 6.6685 11.5503 0.0 0
M  V30 48 C 5.3348 9.2402 0.0 0
M  V30 49 C 5.3348 10.7802 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 26
M  V30 4 1 1 32
M  V30 5 1 2 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 31
M  V30 11 1 9 38
M  V30 12 1 10 11
M  V30 13 1 10 37
M  V30 14 1 11 44
M  V30 15 1 12 13
M  V30 16 2 12 14
M  V30 17 1 12 43
M  V30 18 1 13 15
M  V30 19 1 15 16
M  V30 20 1 15 17
M  V30 21 1 15 18
M  V30 22 1 19 20
M  V30 23 2 19 21
M  V30 24 1 19 49
M  V30 25 1 20 22
M  V30 26 1 22 23
M  V30 27 1 22 24
M  V30 28 1 22 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 35 2 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 36
M  V30 39 2 35 37
M  V30 40 1 36 37
M  V30 41 2 38 39
M  V30 42 1 38 40
M  V30 43 1 39 41
M  V30 44 2 40 42
M  V30 45 2 41 43
M  V30 46 1 42 43
M  V30 47 2 44 45
M  V30 48 1 44 46
M  V30 49 1 45 47
M  V30 50 2 46 48
M  V30 51 2 47 49
M  V30 52 1 48 49
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1228438-35-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1062142-25-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-12927391
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Into a sealed tube with a solution of Gn-OMs-benzoic acid tert-butyl
ester (10-12), ca. 0.5-1.0 g in 6 mL of THF, was added methyl amine (40
wt % solution in H2O) (6 mL). The reaction mixture was then heated to
60-70 °C for 5 h.At the end of the reaction as shown by TLC the mixture
was cooled to room temperature, and 20 mL of water was added to quench
the reaction. The solution was extracted with 2 x 20 mL of
dichloromethane. The combined organic layers were dried over Na2SO4.
Dichloromethane was removed under reduced pressure. The amines (13-15),
which were pure enough to be used in the next step without further
purification.
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Dendritically Encapsulated, Water-Soluble Fe4S4: Synthesis and
Electrochemical Properties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sharma, Anil K.; Kim, Namjin; Cameron, Christopher S.; Lyndon, Matthew;
Gorman, Christopher B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Inorganic Chemistry (2010), 49(11), 5072-5078

$RFMT $RIREG SCHEME231 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1′,1′′,1′′′-Tetrakis(1,1-dimethylethyl) 4,4′,4′′,4′′′-[[1-methyl-4-[(methyl...
C100H114O17S
1228438-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  118 127 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 16.9400 24.0063 0.0 0
M  V30 2 C 18.4800 24.0063 0.0 0
M  V30 3 C 17.7100 22.6726 0.0 0
M  V30 4 C 19.2500 22.6726 0.0 0
M  V30 5 C 20.7900 22.6726 0.0 0
M  V30 6 O 21.5600 21.3389 0.0 0
M  V30 7 O 10.7800 24.0063 0.0 0
M  V30 8 C 10.0100 25.3399 0.0 0
M  V30 9 O 20.0200 29.3410 0.0 0
M  V30 10 C 19.2500 30.6746 0.0 0
M  V30 11 C 27.7200 21.3389 0.0 0
M  V30 12 C 26.9500 22.6726 0.0 0
M  V30 13 C 28.4900 22.6726 0.0 0
M  V30 14 C 27.7200 24.0063 0.0 0
M  V30 15 C 26.9500 25.3399 0.0 0
M  V30 16 O 27.7200 26.6736 0.0 0
M  V30 17 S 26.9500 28.0074 0.0 0 VAL=6
M  V30 18 C 25.6164 27.2374 0.0 0
M  V30 19 O 26.1800 29.3410 0.0 0
M  V30 20 O 28.2836 28.7774 0.0 0
M  V30 21 C 3.8500 25.3399 0.0 0
M  V30 22 O 3.0800 26.6736 0.0 0
M  V30 23 O 3.0800 24.0063 0.0 0
M  V30 24 C 1.5400 26.6736 0.0 0
M  V30 25 C 1.5400 28.2136 0.0 0
M  V30 26 C 0.0000 26.6736 0.0 0
M  V30 27 C 1.5400 25.1336 0.0 0
M  V30 28 C 22.3300 36.0094 0.0 0
M  V30 29 O 23.8700 36.0094 0.0 0
M  V30 30 O 21.5600 37.3430 0.0 0
M  V30 31 C 24.6400 37.3430 0.0 0
M  V30 32 C 23.3064 38.1130 0.0 0
M  V30 33 C 25.4100 38.6768 0.0 0
M  V30 34 C 25.9736 36.5730 0.0 0
M  V30 35 O 30.8000 16.0041 0.0 0
M  V30 36 C 32.3400 16.0041 0.0 0
M  V30 37 C 33.1100 14.6705 0.0 0
M  V30 38 C 34.6500 14.6705 0.0 0
M  V30 39 C 35.4200 13.3369 0.0 0
M  V30 40 C 36.1900 14.6705 0.0 0
M  V30 41 O 41.5800 13.3369 0.0 0
M  V30 42 C 42.3500 12.0032 0.0 0
M  V30 43 O 32.3400 8.0021 0.0 0
M  V30 44 C 30.8000 8.0021 0.0 0
M  V30 45 C 48.5100 12.0032 0.0 0
M  V30 46 O 49.2800 13.3369 0.0 0
M  V30 47 O 49.2800 10.6694 0.0 0
M  V30 48 C 50.8200 13.3369 0.0 0
M  V30 49 C 50.8200 11.7969 0.0 0
M  V30 50 C 52.3600 13.3369 0.0 0
M  V30 51 C 50.8200 14.8769 0.0 0
M  V30 52 C 27.7200 2.6674 0.0 0
M  V30 53 O 26.1800 2.6674 0.0 0
M  V30 54 O 28.4900 1.3338 0.0 0
M  V30 55 C 25.4100 1.3338 0.0 0
M  V30 56 C 26.7436 0.5638 0.0 0
M  V30 57 C 24.6400 0.0000 0.0 0
M  V30 58 C 24.0764 2.1038 0.0 0
M  V30 59 C 15.4000 24.0063 0.0 0
M  V30 60 C 14.6300 22.6726 0.0 0
M  V30 61 C 14.6300 25.3399 0.0 0
M  V30 62 C 13.0900 22.6726 0.0 0
M  V30 63 C 13.0900 25.3399 0.0 0
M  V30 64 C 12.3200 24.0063 0.0 0
M  V30 65 C 17.7100 25.3399 0.0 0
M  V30 66 C 19.2500 25.3399 0.0 0
M  V30 67 C 16.9400 26.6736 0.0 0
M  V30 68 C 20.0200 26.6736 0.0 0
M  V30 69 C 17.7100 28.0074 0.0 0
M  V30 70 C 19.2500 28.0074 0.0 0
M  V30 71 C 23.1000 21.3389 0.0 0
M  V30 72 C 23.8700 20.0052 0.0 0
M  V30 73 C 23.8700 22.6726 0.0 0
M  V30 74 C 25.4100 20.0052 0.0 0
M  V30 75 C 25.4100 22.6726 0.0 0
M  V30 76 C 26.1800 21.3389 0.0 0
M  V30 77 C 8.4700 25.3399 0.0 0
M  V30 78 C 7.7000 24.0063 0.0 0
M  V30 79 C 7.7000 26.6736 0.0 0
M  V30 80 C 6.1600 24.0063 0.0 0
M  V30 81 C 6.1600 26.6736 0.0 0
M  V30 82 C 5.3900 25.3399 0.0 0
M  V30 83 C 20.0200 32.0083 0.0 0
M  V30 84 C 21.5600 32.0083 0.0 0
M  V30 85 C 19.2500 33.3421 0.0 0
M  V30 86 C 22.3300 33.3421 0.0 0
M  V30 87 C 20.0200 34.6757 0.0 0
M  V30 88 C 21.5600 34.6757 0.0 0
M  V30 89 C 28.4900 20.0052 0.0 0
M  V30 90 C 27.7200 18.6716 0.0 0
M  V30 91 C 30.0300 20.0052 0.0 0
M  V30 92 C 28.4900 17.3379 0.0 0
M  V30 93 C 30.8000 18.6716 0.0 0
M  V30 94 C 30.0300 17.3379 0.0 0
M  V30 95 C 36.9600 13.3369 0.0 0
M  V30 96 C 37.7300 12.0032 0.0 0
M  V30 97 C 37.7300 14.6705 0.0 0
M  V30 98 C 39.2700 12.0032 0.0 0
M  V30 99 C 39.2700 14.6705 0.0 0
M  V30 100 C 40.0400 13.3369 0.0 0
M  V30 101 C 34.6500 12.0032 0.0 0
M  V30 102 C 33.1100 12.0032 0.0 0
M  V30 103 C 35.4200 10.6694 0.0 0
M  V30 104 C 32.3400 10.6694 0.0 0
M  V30 105 C 34.6500 9.3358 0.0 0
M  V30 106 C 33.1100 9.3358 0.0 0
M  V30 107 C 43.8900 12.0032 0.0 0
M  V30 108 C 44.6600 10.6694 0.0 0
M  V30 109 C 44.6600 13.3369 0.0 0
M  V30 110 C 46.2000 10.6694 0.0 0
M  V30 111 C 46.2000 13.3369 0.0 0
M  V30 112 C 46.9700 12.0032 0.0 0
M  V30 113 C 30.0300 6.6685 0.0 0
M  V30 114 C 30.8000 5.3347 0.0 0
M  V30 115 C 28.4900 6.6685 0.0 0
M  V30 116 C 30.0300 4.0011 0.0 0
M  V30 117 C 27.7200 5.3347 0.0 0
M  V30 118 C 28.4900 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 59
M  V30 4 1 1 65
M  V30 5 1 2 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 6 71
M  V30 9 1 7 8
M  V30 10 1 7 64
M  V30 11 1 8 77
M  V30 12 1 9 10
M  V30 13 1 9 70
M  V30 14 1 10 83
M  V30 15 1 11 12
M  V30 16 1 11 13
M  V30 17 1 11 76
M  V30 18 1 11 89
M  V30 19 1 12 14
M  V30 20 1 14 15
M  V30 21 1 15 16
M  V30 22 1 16 17
M  V30 23 1 17 18
M  V30 24 2 17 19
M  V30 25 2 17 20
M  V30 26 1 21 22
M  V30 27 2 21 23
M  V30 28 1 21 82
M  V30 29 1 22 24
M  V30 30 1 24 25
M  V30 31 1 24 26
M  V30 32 1 24 27
M  V30 33 1 28 29
M  V30 34 2 28 30
M  V30 35 1 28 88
M  V30 36 1 29 31
M  V30 37 1 31 32
M  V30 38 1 31 33
M  V30 39 1 31 34
M  V30 40 1 35 36
M  V30 41 1 35 94
M  V30 42 1 36 37
M  V30 43 1 37 38
M  V30 44 1 38 39
M  V30 45 1 39 40
M  V30 46 1 39 95
M  V30 47 1 39 101
M  V30 48 1 41 42
M  V30 49 1 41 100
M  V30 50 1 42 107
M  V30 51 1 43 44
M  V30 52 1 43 106
M  V30 53 1 44 113
M  V30 54 1 45 46
M  V30 55 2 45 47
M  V30 56 1 45 112
M  V30 57 1 46 48
M  V30 58 1 48 49
M  V30 59 1 48 50
M  V30 60 1 48 51
M  V30 61 1 52 53
M  V30 62 2 52 54
M  V30 63 1 52 118
M  V30 64 1 53 55
M  V30 65 1 55 56
M  V30 66 1 55 57
M  V30 67 1 55 58
M  V30 68 2 59 60
M  V30 69 1 59 61
M  V30 70 1 60 62
M  V30 71 2 61 63
M  V30 72 2 62 64
M  V30 73 1 63 64
M  V30 74 2 65 66
M  V30 75 1 65 67
M  V30 76 1 66 68
M  V30 77 2 67 69
M  V30 78 2 68 70
M  V30 79 1 69 70
M  V30 80 2 71 72
M  V30 81 1 71 73
M  V30 82 1 72 74
M  V30 83 2 73 75
M  V30 84 2 74 76
M  V30 85 1 75 76
M  V30 86 2 77 78
M  V30 87 1 77 79
M  V30 88 1 78 80
M  V30 89 2 79 81
M  V30 90 2 80 82
M  V30 91 1 81 82
M  V30 92 2 83 84
M  V30 93 1 83 85
M  V30 94 1 84 86
M  V30 95 2 85 87
M  V30 96 2 86 88
M  V30 97 1 87 88
M  V30 98 2 89 90
M  V30 99 1 89 91
M  V30 100 1 90 92
M  V30 101 2 91 93
M  V30 102 2 92 94
M  V30 103 1 93 94
M  V30 104 2 95 96
M  V30 105 1 95 97
M  V30 106 1 96 98
M  V30 107 2 97 99
M  V30 108 2 98 100
M  V30 109 1 99 100
M  V30 110 2 101 102
M  V30 111 1 101 103
M  V30 112 1 102 104
M  V30 113 2 103 105
M  V30 114 2 104 106
M  V30 115 1 105 106
M  V30 116 2 107 108
M  V30 117 1 107 109
M  V30 118 1 108 110
M  V30 119 2 109 111
M  V30 120 2 110 112
M  V30 121 1 111 112
M  V30 122 2 113 114
M  V30 123 1 113 115
M  V30 124 1 114 116
M  V30 125 2 115 117
M  V30 126 2 116 118
M  V30 127 1 117 118
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1′,1′′,1′′′-Tetrakis(1,1-dimethylethyl) 4,4′,4′′,4′′′-[[1-methyl-4-(methyla...
C100H115NO14
1228438-38-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  115 124 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 16.9402 13.3370 0.0 0
M  V30 2 C 17.7102 14.6707 0.0 0
M  V30 3 C 16.1702 14.6707 0.0 0
M  V30 4 C 16.9402 16.0043 0.0 0
M  V30 5 C 17.7102 17.3380 0.0 0
M  V30 6 O 19.2502 17.3380 0.0 0
M  V30 7 O 10.7801 13.3370 0.0 0
M  V30 8 C 10.0101 14.6707 0.0 0
M  V30 9 O 20.0202 8.0022 0.0 0
M  V30 10 C 21.5602 8.0022 0.0 0
M  V30 11 C 22.3302 22.6727 0.0 0
M  V30 12 C 23.1003 24.0066 0.0 0
M  V30 13 C 21.5602 24.0066 0.0 0
M  V30 14 C 22.3302 25.3402 0.0 0
M  V30 15 C 23.1003 26.6739 0.0 0
M  V30 16 N 22.3302 28.0077 0.0 0
M  V30 17 C 23.1003 29.3413 0.0 0
M  V30 18 C 3.8500 14.6707 0.0 0
M  V30 19 O 3.0800 16.0043 0.0 0
M  V30 20 O 3.0800 13.3370 0.0 0
M  V30 21 C 1.5400 16.0043 0.0 0
M  V30 22 C 1.5400 14.4643 0.0 0
M  V30 23 C 0.0000 16.0043 0.0 0
M  V30 24 C 1.5400 17.5443 0.0 0
M  V30 25 C 24.6403 2.6675 0.0 0
M  V30 26 O 26.1803 2.6675 0.0 0
M  V30 27 O 23.8703 1.3337 0.0 0
M  V30 28 C 26.9503 1.3337 0.0 0
M  V30 29 C 28.2839 2.1037 0.0 0
M  V30 30 C 27.7203 0.0000 0.0 0
M  V30 31 C 25.6166 0.5636 0.0 0
M  V30 32 O 28.4903 22.6729 0.0 0
M  V30 33 C 29.2603 24.0066 0.0 0
M  V30 34 C 30.8003 24.0066 0.0 0
M  V30 35 C 31.5703 25.3402 0.0 0
M  V30 36 C 33.1104 25.3402 0.0 0
M  V30 37 C 32.3404 24.0066 0.0 0
M  V30 38 O 39.2704 25.3402 0.0 0
M  V30 39 C 40.0404 24.0066 0.0 0
M  V30 40 O 30.0303 30.6750 0.0 0
M  V30 41 C 28.4903 30.6750 0.0 0
M  V30 42 C 46.2005 24.0066 0.0 0
M  V30 43 O 46.9705 25.3402 0.0 0
M  V30 44 O 46.9705 22.6729 0.0 0
M  V30 45 C 48.5105 25.3402 0.0 0
M  V30 46 C 48.5105 23.8002 0.0 0
M  V30 47 C 50.0505 25.3402 0.0 0
M  V30 48 C 48.5105 26.8802 0.0 0
M  V30 49 C 25.4103 36.0098 0.0 0
M  V30 50 O 26.1803 37.3434 0.0 0
M  V30 51 O 23.8703 36.0098 0.0 0
M  V30 52 C 25.4103 38.6772 0.0 0
M  V30 53 C 24.0766 37.9072 0.0 0
M  V30 54 C 24.6403 40.0109 0.0 0
M  V30 55 C 26.7439 39.4472 0.0 0
M  V30 56 C 15.4002 13.3370 0.0 0
M  V30 57 C 14.6302 14.6707 0.0 0
M  V30 58 C 14.6302 12.0032 0.0 0
M  V30 59 C 13.0901 14.6707 0.0 0
M  V30 60 C 13.0901 12.0032 0.0 0
M  V30 61 C 12.3201 13.3370 0.0 0
M  V30 62 C 17.7102 12.0032 0.0 0
M  V30 63 C 16.9402 10.6695 0.0 0
M  V30 64 C 19.2502 12.0032 0.0 0
M  V30 65 C 17.7102 9.3359 0.0 0
M  V30 66 C 20.0202 10.6695 0.0 0
M  V30 67 C 19.2502 9.3359 0.0 0
M  V30 68 C 20.0202 18.6718 0.0 0
M  V30 69 C 19.2502 20.0054 0.0 0
M  V30 70 C 21.5602 18.6718 0.0 0
M  V30 71 C 20.0202 21.3391 0.0 0
M  V30 72 C 22.3302 20.0054 0.0 0
M  V30 73 C 21.5602 21.3391 0.0 0
M  V30 74 C 8.4701 14.6707 0.0 0
M  V30 75 C 7.7001 16.0043 0.0 0
M  V30 76 C 7.7001 13.3370 0.0 0
M  V30 77 C 6.1601 16.0043 0.0 0
M  V30 78 C 6.1601 13.3370 0.0 0
M  V30 79 C 5.3901 14.6707 0.0 0
M  V30 80 C 22.3302 6.6684 0.0 0
M  V30 81 C 23.8703 6.6684 0.0 0
M  V30 82 C 21.5602 5.3348 0.0 0
M  V30 83 C 24.6403 5.3348 0.0 0
M  V30 84 C 22.3302 4.0011 0.0 0
M  V30 85 C 23.8703 4.0011 0.0 0
M  V30 86 C 23.8703 22.6727 0.0 0
M  V30 87 C 24.6403 21.3391 0.0 0
M  V30 88 C 24.6403 24.0066 0.0 0
M  V30 89 C 26.1803 21.3391 0.0 0
M  V30 90 C 26.1803 24.0066 0.0 0
M  V30 91 C 26.9503 22.6729 0.0 0
M  V30 92 C 34.6504 25.3402 0.0 0
M  V30 93 C 35.4204 24.0066 0.0 0
M  V30 94 C 35.4204 26.6739 0.0 0
M  V30 95 C 36.9604 24.0066 0.0 0
M  V30 96 C 36.9604 26.6739 0.0 0
M  V30 97 C 37.7304 25.3402 0.0 0
M  V30 98 C 32.3404 26.6739 0.0 0
M  V30 99 C 33.1104 28.0077 0.0 0
M  V30 100 C 30.8003 26.6739 0.0 0
M  V30 101 C 32.3404 29.3413 0.0 0
M  V30 102 C 30.0303 28.0077 0.0 0
M  V30 103 C 30.8003 29.3413 0.0 0
M  V30 104 C 41.5805 24.0066 0.0 0
M  V30 105 C 42.3505 25.3402 0.0 0
M  V30 106 C 42.3505 22.6729 0.0 0
M  V30 107 C 43.8905 25.3402 0.0 0
M  V30 108 C 43.8905 22.6729 0.0 0
M  V30 109 C 44.6605 24.0066 0.0 0
M  V30 110 C 27.7203 32.0086 0.0 0
M  V30 111 C 28.4903 33.3424 0.0 0
M  V30 112 C 26.1803 32.0086 0.0 0
M  V30 113 C 27.7203 34.6761 0.0 0
M  V30 114 C 25.4103 33.3424 0.0 0
M  V30 115 C 26.1803 34.6761 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 56
M  V30 4 1 1 62
M  V30 5 1 2 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 6 68
M  V30 9 1 7 8
M  V30 10 1 7 61
M  V30 11 1 8 74
M  V30 12 1 9 10
M  V30 13 1 9 67
M  V30 14 1 10 80
M  V30 15 1 11 12
M  V30 16 1 11 13
M  V30 17 1 11 73
M  V30 18 1 11 86
M  V30 19 1 12 14
M  V30 20 1 14 15
M  V30 21 1 15 16
M  V30 22 1 16 17
M  V30 23 1 18 19
M  V30 24 2 18 20
M  V30 25 1 18 79
M  V30 26 1 19 21
M  V30 27 1 21 22
M  V30 28 1 21 23
M  V30 29 1 21 24
M  V30 30 1 25 26
M  V30 31 2 25 27
M  V30 32 1 25 85
M  V30 33 1 26 28
M  V30 34 1 28 29
M  V30 35 1 28 30
M  V30 36 1 28 31
M  V30 37 1 32 33
M  V30 38 1 32 91
M  V30 39 1 33 34
M  V30 40 1 34 35
M  V30 41 1 35 36
M  V30 42 1 36 37
M  V30 43 1 36 92
M  V30 44 1 36 98
M  V30 45 1 38 39
M  V30 46 1 38 97
M  V30 47 1 39 104
M  V30 48 1 40 41
M  V30 49 1 40 103
M  V30 50 1 41 110
M  V30 51 1 42 43
M  V30 52 2 42 44
M  V30 53 1 42 109
M  V30 54 1 43 45
M  V30 55 1 45 46
M  V30 56 1 45 47
M  V30 57 1 45 48
M  V30 58 1 49 50
M  V30 59 2 49 51
M  V30 60 1 49 115
M  V30 61 1 50 52
M  V30 62 1 52 53
M  V30 63 1 52 54
M  V30 64 1 52 55
M  V30 65 2 56 57
M  V30 66 1 56 58
M  V30 67 1 57 59
M  V30 68 2 58 60
M  V30 69 2 59 61
M  V30 70 1 60 61
M  V30 71 2 62 63
M  V30 72 1 62 64
M  V30 73 1 63 65
M  V30 74 2 64 66
M  V30 75 2 65 67
M  V30 76 1 66 67
M  V30 77 2 68 69
M  V30 78 1 68 70
M  V30 79 1 69 71
M  V30 80 2 70 72
M  V30 81 2 71 73
M  V30 82 1 72 73
M  V30 83 2 74 75
M  V30 84 1 74 76
M  V30 85 1 75 77
M  V30 86 2 76 78
M  V30 87 2 77 79
M  V30 88 1 78 79
M  V30 89 2 80 81
M  V30 90 1 80 82
M  V30 91 1 81 83
M  V30 92 2 82 84
M  V30 93 2 83 85
M  V30 94 1 84 85
M  V30 95 2 86 87
M  V30 96 1 86 88
M  V30 97 1 87 89
M  V30 98 2 88 90
M  V30 99 2 89 91
M  V30 100 1 90 91
M  V30 101 2 92 93
M  V30 102 1 92 94
M  V30 103 1 93 95
M  V30 104 2 94 96
M  V30 105 2 95 97
M  V30 106 1 96 97
M  V30 107 2 98 99
M  V30 108 1 98 100
M  V30 109 1 99 101
M  V30 110 2 100 102
M  V30 111 2 101 103
M  V30 112 1 102 103
M  V30 113 2 104 105
M  V30 114 1 104 106
M  V30 115 1 105 107
M  V30 116 2 106 108
M  V30 117 2 107 109
M  V30 118 1 108 109
M  V30 119 2 110 111
M  V30 120 1 110 112
M  V30 121 1 111 113
M  V30 122 2 112 114
M  V30 123 2 113 115
M  V30 124 1 114 115
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1228438-36-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1228438-38-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-15067744
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Into a sealed tube with a solution of
Gn-OMs-benzoic acid tert-butyl ester (10-12), ca. 0.5-1.0 g in 6 mL of
THF, was added methyl amine (40 wt % solution in H2O) (6 mL). The
reaction mixture was then heated to 60-70 °C for 5 h.At the end of the
reaction as shown by TLC the mixture was cooled to room temperature, and
20 mL of water was added to quench the reaction. The solution was
extracted with 2 x 20 mL of dichloromethane. The combined organic layers
were dried over Na2SO4. Dichloromethane was removed under reduced
pressure.
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Dendritically Encapsulated, Water-Soluble Fe4S4: Synthesis and
Electrochemical Properties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sharma, Anil K.; Kim, Namjin; Cameron, Christopher S.; Lyndon, Matthew;
Gorman, Christopher B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Inorganic Chemistry (2010), 49(11), 5072-5078

$RFMT $RIREG SCHEME232 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acetylacetone
C5H8O2
123-54-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3338 1.5400 0.0 0
M  V30 4 C 4.0011 0.0000 0.0 0
M  V30 5 O 5.3349 2.3100 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 O 1.3338 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Methylamino)-3-penten-2-one
C6H11NO
14092-14-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6674 2.3100 0.0 0
M  V30 3 N 5.3347 2.3100 0.0 0
M  V30 4 C 4.0011 0.0000 0.0 0
M  V30 5 C 1.3338 1.5400 0.0 0
M  V30 6 C 6.6685 1.5400 0.0 0
M  V30 7 C 0.0000 2.3100 0.0 0
M  V30 8 O 1.3338 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-54-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14092-14-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-8421336
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7631-86-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Synthesis of β -Amino-α , β -Unsaturated
Esters and Ketones; General Procedure Amine 2 (12 mmol, pure amine, or
ammonia or amine in an aqueous solution) was added dropwise to the
suspension of silica gel (100 mg, 10 mg for diketone, Qingdao Ocean
Chemical Industrial Co.) in the dicarbonylic compound 1 (10 mmol) and the
resulting mixture was stirred at room temperature for 10 min-24 hr
(monitored by TLC). For liquid products, crude products were obtained
after removal of silica gel by filtration. Pure liquid products were
obtained by purification on a silica gel column. For solid products,
crude products were obtained after extraction with dichloromethane and
removal of solvent. The purification was performed by column
chromatography on silica gel using hexane /acetone as eluent. 3b, yield
99%. Mp(°C): 31-33 (37-39)[24]
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A convenient and effective method for synthesizing
β-amino-α,β-unsaturated esters and ketones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gao, Yuanhe; Zhang, Qihan; Xu, Jiaxi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2004), 34(5), 909-916

$RFMT $RIREG SCHEME233 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl β-(acetyloxy)-α-methylenebenzenepropanoate
C13H14O4
124957-36-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.8500 0.0 0
M  V30 2 C 5.3347 4.6200 0.0 0
M  V30 3 O 4.0011 2.3100 0.0 0
M  V30 4 C 6.6684 3.8500 0.0 0
M  V30 5 C 5.3347 6.1600 0.0 0
M  V30 6 C 2.6674 1.5400 0.0 0
M  V30 7 O 8.0021 4.6200 0.0 0
M  V30 8 O 6.6684 2.3100 0.0 0
M  V30 9 C 2.6674 0.0000 0.0 0
M  V30 10 O 1.3336 2.3100 0.0 0
M  V30 11 C 9.3358 3.8500 0.0 0
M  V30 12 C 2.6674 4.6200 0.0 0
M  V30 13 C 1.3336 3.8500 0.0 0
M  V30 14 C 2.6674 6.1600 0.0 0
M  V30 15 C 0.0000 4.6200 0.0 0
M  V30 16 C 1.3336 6.9300 0.0 0
M  V30 17 C 0.0000 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2E)-2-[(methylamino)methyl]-3-phenyl-2-propenoate
C12H15NO2
1021167-64-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 4.0011 0.0 0
M  V30 2 C 4.6200 5.3347 0.0 0
M  V30 3 C 6.9300 4.0011 0.0 0
M  V30 4 C 4.6200 2.6674 0.0 0
M  V30 5 O 7.7000 5.3347 0.0 0
M  V30 6 O 7.7000 2.6674 0.0 0
M  V30 7 N 5.3900 1.3338 0.0 0
M  V30 8 C 9.2400 5.3347 0.0 0
M  V30 9 C 4.6200 0.0000 0.0 0
M  V30 10 C 3.0800 5.3347 0.0 0
M  V30 11 C 2.3100 6.6685 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 0.7700 6.6685 0.0 0
M  V30 14 C 0.7700 4.0011 0.0 0
M  V30 15 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 10
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 124957-36-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1021167-64-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-4635134
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of (E)-methyl-2-((methylamino)methyl)-3-phenylacrylate. The
solution of methyl 2-(acetoxy(phenyl)methyl)acrylate (4.0 g, 15.6 mmol)
in THF (20 mL) was added dropwise to a stirred solution of methylamine
alcohol solution (30%, 20 mL) in THF (80 mL) at 0 °C. The resulting
solution was stirred for 30 min at 0 o C. The volatiles were removed in
vacuo before saturated aqueous NaHCO3 (20 mL) was added. The reaction
mixture was extracted with extracted with EtOAc (3 × 20 mL). The combined
EtOAc layer was dried over MgSO4 and concentrated in vacuo. Purification
by flash column chromatography (Petroleum ether/EtOAc = 1:1, v/v). Yield:
3.16 g (99%). oil. 1H NMR δ 7.83 (s, 1H), 7.48-7.37 (m, 5H), 3.84 (s,
3H), 3.57 (s, 2H), 2.44 (s, 3H), 1.93 (s, 1H); 13C NMR δ 168.5, 142.0,
135.1, 130.6, 129.6, 128.6, 128.9, 52.1, 47.8, 36.2; MS (ESI): m/z 206.0
[M + H+].
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A highly stereocontrolled intramolecular cycloaddition reaction of
azomethine ylide activated by a pyrimidine ring: access to novel
tricyclic hexahydro-1H-pyrrolo[2',3':4,5]pyrido[2,3-d]pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xie, Hongxiang; Xiang, Jinbao; Dang, Qun; Bai, Xu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2012), 23(4), 585-588

$RFMT $RIREG SCHEME234 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 3-(5-methyl-2-pyridinyl)-
C13H11NO2
1255637-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.3338 0.0 0
M  V30 2 O 0.0000 1.3338 0.0 0
M  V30 3 O 2.3100 0.0000 0.0 0
M  V30 4 C 10.7800 4.0011 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 3.8500 5.3349 0.0 0
M  V30 8 C 2.3100 2.6674 0.0 0
M  V30 9 C 2.3100 5.3349 0.0 0
M  V30 10 C 1.5400 4.0011 0.0 0
M  V30 11 C 6.1600 4.0011 0.0 0
M  V30 12 C 6.9300 5.3349 0.0 0
M  V30 13 N 6.9300 2.6674 0.0 0
M  V30 14 C 8.4700 5.3349 0.0 0
M  V30 15 C 8.4700 2.6674 0.0 0
M  V30 16 C 9.2400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 16
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 11
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-(5-methyl-2-pyridinyl)benzamide
C14H14N2O
2760566-11-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 3.0801 0.0 0
M  V30 2 N 10.6697 2.3101 0.0 0
M  V30 3 O 9.3360 4.6201 0.0 0
M  V30 4 C 12.0033 3.0801 0.0 0
M  V30 5 C 0.0000 5.3901 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 6.6685 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 8.0022 2.3101 0.0 0
M  V30 10 C 6.6685 0.0000 0.0 0
M  V30 11 C 8.0022 0.7700 0.0 0
M  V30 12 C 4.0012 3.0801 0.0 0
M  V30 13 C 4.0012 4.6201 0.0 0
M  V30 14 N 2.6673 2.3101 0.0 0
M  V30 15 C 2.6673 5.3901 0.0 0
M  V30 16 C 1.3337 3.0801 0.0 0
M  V30 17 C 1.3337 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 17
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1255637-66-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2760566-11-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31748658
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Piperidin-1-yl-N-pyridin-3-yl-2-oxoacetamide derivatives useful for the
treatment of MTAP-deficient and/or MT-A accumulating cancers and their
preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cottrell, Kevin M.; Maxwell, John P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022026892 A1 2022-02-03

$RFMT $RIREG SCHEME235 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 2,4-difluoro-5-nitro-, methyl ester
C8H5F2NO4
125568-71-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 O 6.9300 2.6674 0.0 0
M  V30 3 O 6.9300 5.3347 0.0 0
M  V30 4 C 8.4700 2.6674 0.0 0
M  V30 5 F 4.6200 6.6685 0.0 0
M  V30 6 N 1.5400 1.3338 0.0 0 VAL=5
M  V30 7 O 2.3100 0.0000 0.0 0
M  V30 8 O 0.0000 1.3338 0.0 0
M  V30 9 F 0.0000 4.0011 0.0 0
M  V30 10 C 4.6200 4.0011 0.0 0
M  V30 11 C 3.8500 2.6674 0.0 0
M  V30 12 C 3.8500 5.3347 0.0 0
M  V30 13 C 2.3100 2.6674 0.0 0
M  V30 14 C 2.3100 5.3347 0.0 0
M  V30 15 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 12
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-fluoro-4-(methylamino)-5-nitrobenzoate
C9H9FN2O4
926648-20-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 2.3101 0.0 0
M  V30 2 C 0.0000 3.0801 0.0 0
M  V30 3 N 4.0012 0.7700 0.0 0 VAL=5
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 O 5.3348 0.0000 0.0 0
M  V30 6 F 4.0012 6.9302 0.0 0
M  V30 7 C 6.6685 5.3901 0.0 0
M  V30 8 O 8.0023 4.6201 0.0 0
M  V30 9 O 6.6685 6.9302 0.0 0
M  V30 10 C 9.3360 5.3901 0.0 0
M  V30 11 C 2.6675 3.0801 0.0 0
M  V30 12 C 4.0012 2.3101 0.0 0
M  V30 13 C 2.6675 4.6201 0.0 0
M  V30 14 C 5.3348 3.0801 0.0 0
M  V30 15 C 4.0012 5.3901 0.0 0
M  V30 16 C 5.3348 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 12
M  V30 6 1 6 15
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 16
M  V30 10 1 8 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 125568-71-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 926648-20-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-3667028
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 4 Step 1: To a cooled solution (0° C.) of ester 3a (Example 3,
step 1) (1.63 g, 7.52 mmol, 1 eq.) in THF (7 mL), was addedtriethylamine
(1.05 mL, 7.52 mmol, 1 eq.) and a solution of methylamine in THF (2N,
5.65 mL, 11.2 mmol, 1.5 eq.). The reaction mixture was allowed to stir
for 1 h at 0° C., then was diluted with EtOAc (100 mL), and washed with
H2O (40 mL) and brine. The organic phase was dried over MgSO4 and
concentrated. The crude material 4a (1.70 g, 99% yield) was used in the
next step without purification.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocycle-fused benzimidazole derivatives as viral
polymerase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tsantrizos, Youla S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007019674 A1 2007-02-22

$RFMT $RIREG SCHEME236 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1R,3R)-1-(2,4-dichlorophenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indo...
C19H16Cl2N2O2
1262447-27-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 O 10.6696 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 Cl 5.3348 9.7102 0.0 0
M  V30 6 Cl 0.0000 9.7102 0.0 0
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 C 6.6685 4.3201 0.0 0
M  V30 9 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 10 N 4.1902 4.0597 0.0 0
M  V30 11 C 6.3483 2.8138 0.0 0
M  V30 12 C 8.0021 5.0901 0.0 0
M  V30 13 N 6.6685 7.4001 0.0 0
M  V30 14 C 4.8167 2.6527 0.0 0
M  V30 15 C 7.2535 1.5679 0.0 0
M  V30 16 C 8.0021 6.6301 0.0 0 CFG=2
M  V30 17 C 4.1902 1.2459 0.0 0
M  V30 18 C 6.6270 0.1609 0.0 0
M  V30 19 C 5.0955 0.0000 0.0 0
M  V30 20 C 4.0011 7.4001 0.0 0
M  V30 21 C 4.0011 8.9401 0.0 0
M  V30 22 C 2.6673 6.6301 0.0 0
M  V30 23 C 2.6673 9.7102 0.0 0
M  V30 24 C 1.3337 7.4001 0.0 0
M  V30 25 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 5 21
M  V30 6 1 6 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=1
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1R,3R)-1-(2,4-Dichlorophenyl)-2,3,4,9-tetrahydro-N-methyl-1H-pyrido[3,4-b]in...
C19H17Cl2N3O
1918182-14-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 N 10.6696 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 Cl 5.3348 9.7102 0.0 0
M  V30 6 Cl 0.0000 9.7102 0.0 0
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 C 6.6685 4.3201 0.0 0
M  V30 9 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 10 N 4.1902 4.0597 0.0 0
M  V30 11 C 6.3483 2.8138 0.0 0
M  V30 12 C 8.0021 5.0901 0.0 0
M  V30 13 N 6.6685 7.4001 0.0 0
M  V30 14 C 4.8167 2.6527 0.0 0
M  V30 15 C 7.2535 1.5679 0.0 0
M  V30 16 C 8.0021 6.6301 0.0 0 CFG=2
M  V30 17 C 4.1902 1.2459 0.0 0
M  V30 18 C 6.6270 0.1609 0.0 0
M  V30 19 C 5.0955 0.0000 0.0 0
M  V30 20 C 4.0011 7.4001 0.0 0
M  V30 21 C 4.0011 8.9401 0.0 0
M  V30 22 C 2.6673 6.6301 0.0 0
M  V30 23 C 2.6673 9.7102 0.0 0
M  V30 24 C 1.3337 7.4001 0.0 0
M  V30 25 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 5 21
M  V30 6 1 6 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=1
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1262447-27-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1918182-14-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15864614
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM closed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions and formulations of methylerthritol phosphate pathway
inhibitors and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Carlier, Paul R.; Cassera, Maria Belen; Merino, Emilio Fernando; Yao,
Zhong-Ke; Ghavami, Maryam
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016069949 A1 2016-05-06

$RFMT $RIREG SCHEME237 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1S,3S)-1-(2,4-dichlorophenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indo...
C19H16Cl2N2O2
1262447-29-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 O 10.6696 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 Cl 5.3348 9.7102 0.0 0
M  V30 6 Cl 0.0000 9.7102 0.0 0
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 C 6.6685 4.3201 0.0 0
M  V30 9 C 5.3348 6.6301 0.0 0 CFG=2
M  V30 10 N 4.1902 4.0597 0.0 0
M  V30 11 C 6.3483 2.8138 0.0 0
M  V30 12 C 8.0021 5.0901 0.0 0
M  V30 13 N 6.6685 7.4001 0.0 0
M  V30 14 C 4.8167 2.6527 0.0 0
M  V30 15 C 7.2535 1.5679 0.0 0
M  V30 16 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 17 C 4.1902 1.2459 0.0 0
M  V30 18 C 6.6270 0.1609 0.0 0
M  V30 19 C 5.0955 0.0000 0.0 0
M  V30 20 C 4.0011 7.4001 0.0 0
M  V30 21 C 4.0011 8.9401 0.0 0
M  V30 22 C 2.6673 6.6301 0.0 0
M  V30 23 C 2.6673 9.7102 0.0 0
M  V30 24 C 1.3337 7.4001 0.0 0
M  V30 25 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 21
M  V30 6 1 6 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=3
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1S,3S)-1-(2,4-Dichlorophenyl)-2,3,4,9-tetrahydro-N-methyl-1H-pyrido[3,4-b]in...
C19H17Cl2N3O
1918182-13-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 N 10.6696 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 Cl 5.3348 9.7102 0.0 0
M  V30 6 Cl 0.0000 9.7102 0.0 0
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 C 6.6685 4.3201 0.0 0
M  V30 9 C 5.3348 6.6301 0.0 0 CFG=2
M  V30 10 N 4.1902 4.0597 0.0 0
M  V30 11 C 6.3483 2.8138 0.0 0
M  V30 12 C 8.0021 5.0901 0.0 0
M  V30 13 N 6.6685 7.4001 0.0 0
M  V30 14 C 4.8167 2.6527 0.0 0
M  V30 15 C 7.2535 1.5679 0.0 0
M  V30 16 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 17 C 4.1902 1.2459 0.0 0
M  V30 18 C 6.6270 0.1609 0.0 0
M  V30 19 C 5.0955 0.0000 0.0 0
M  V30 20 C 4.0011 7.4001 0.0 0
M  V30 21 C 4.0011 8.9401 0.0 0
M  V30 22 C 2.6673 6.6301 0.0 0
M  V30 23 C 2.6673 9.7102 0.0 0
M  V30 24 C 1.3337 7.4001 0.0 0
M  V30 25 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 21
M  V30 6 1 6 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=3
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1262447-29-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1918182-13-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15823388
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM closed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions and formulations of methylerthritol phosphate pathway
inhibitors and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Carlier, Paul R.; Cassera, Maria Belen; Merino, Emilio Fernando; Yao,
Zhong-Ke; Ghavami, Maryam
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016069949 A1 2016-05-06

$RFMT $RIREG SCHEME238 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1R,3S)-1-(2,4-dichlorophenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indo...
C19H16Cl2N2O2
1262447-30-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 O 10.6696 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 Cl 5.3348 9.7102 0.0 0
M  V30 6 Cl 0.0000 9.7102 0.0 0
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 C 6.6685 4.3201 0.0 0
M  V30 9 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 10 N 4.1902 4.0597 0.0 0
M  V30 11 C 6.3483 2.8138 0.0 0
M  V30 12 C 8.0021 5.0901 0.0 0
M  V30 13 N 6.6685 7.4001 0.0 0
M  V30 14 C 4.8167 2.6527 0.0 0
M  V30 15 C 7.2535 1.5679 0.0 0
M  V30 16 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 17 C 4.1902 1.2459 0.0 0
M  V30 18 C 6.6270 0.1609 0.0 0
M  V30 19 C 5.0955 0.0000 0.0 0
M  V30 20 C 4.0011 7.4001 0.0 0
M  V30 21 C 4.0011 8.9401 0.0 0
M  V30 22 C 2.6673 6.6301 0.0 0
M  V30 23 C 2.6673 9.7102 0.0 0
M  V30 24 C 1.3337 7.4001 0.0 0
M  V30 25 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 21
M  V30 6 1 6 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=1
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1R,3S)-1-(2,4-Dichlorophenyl)-2,3,4,9-tetrahydro-N-methyl-1H-pyrido[3,4-b]in...
C19H17Cl2N3O
1679333-90-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 N 10.6696 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 Cl 5.3348 9.7102 0.0 0
M  V30 6 Cl 0.0000 9.7102 0.0 0
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 C 6.6685 4.3201 0.0 0
M  V30 9 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 10 N 4.1902 4.0597 0.0 0
M  V30 11 C 6.3483 2.8138 0.0 0
M  V30 12 C 8.0021 5.0901 0.0 0
M  V30 13 N 6.6685 7.4001 0.0 0
M  V30 14 C 4.8167 2.6527 0.0 0
M  V30 15 C 7.2535 1.5679 0.0 0
M  V30 16 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 17 C 4.1902 1.2459 0.0 0
M  V30 18 C 6.6270 0.1609 0.0 0
M  V30 19 C 5.0955 0.0000 0.0 0
M  V30 20 C 4.0011 7.4001 0.0 0
M  V30 21 C 4.0011 8.9401 0.0 0
M  V30 22 C 2.6673 6.6301 0.0 0
M  V30 23 C 2.6673 9.7102 0.0 0
M  V30 24 C 1.3337 7.4001 0.0 0
M  V30 25 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 21
M  V30 6 1 6 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=1
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1262447-30-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1679333-90-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15838648
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM closed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions and formulations of methylerthritol phosphate pathway
inhibitors and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Carlier, Paul R.; Cassera, Maria Belen; Merino, Emilio Fernando; Yao,
Zhong-Ke; Ghavami, Maryam
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016069949 A1 2016-05-06

$RFMT $RIREG SCHEME238 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1R,3S)-1-(2,4-dichlorophenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indo...
C19H16Cl2N2O2
1262447-30-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 O 10.6696 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 Cl 5.3348 9.7102 0.0 0
M  V30 6 Cl 0.0000 9.7102 0.0 0
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 C 6.6685 4.3201 0.0 0
M  V30 9 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 10 N 4.1902 4.0597 0.0 0
M  V30 11 C 6.3483 2.8138 0.0 0
M  V30 12 C 8.0021 5.0901 0.0 0
M  V30 13 N 6.6685 7.4001 0.0 0
M  V30 14 C 4.8167 2.6527 0.0 0
M  V30 15 C 7.2535 1.5679 0.0 0
M  V30 16 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 17 C 4.1902 1.2459 0.0 0
M  V30 18 C 6.6270 0.1609 0.0 0
M  V30 19 C 5.0955 0.0000 0.0 0
M  V30 20 C 4.0011 7.4001 0.0 0
M  V30 21 C 4.0011 8.9401 0.0 0
M  V30 22 C 2.6673 6.6301 0.0 0
M  V30 23 C 2.6673 9.7102 0.0 0
M  V30 24 C 1.3337 7.4001 0.0 0
M  V30 25 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 21
M  V30 6 1 6 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=1
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1R,3S)-1-(2,4-Dichlorophenyl)-2,3,4,9-tetrahydro-N-methyl-1H-pyrido[3,4-b]in...
C19H17Cl2N3O
1679333-90-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 N 10.6696 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 Cl 5.3348 9.7102 0.0 0
M  V30 6 Cl 0.0000 9.7102 0.0 0
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 C 6.6685 4.3201 0.0 0
M  V30 9 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 10 N 4.1902 4.0597 0.0 0
M  V30 11 C 6.3483 2.8138 0.0 0
M  V30 12 C 8.0021 5.0901 0.0 0
M  V30 13 N 6.6685 7.4001 0.0 0
M  V30 14 C 4.8167 2.6527 0.0 0
M  V30 15 C 7.2535 1.5679 0.0 0
M  V30 16 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 17 C 4.1902 1.2459 0.0 0
M  V30 18 C 6.6270 0.1609 0.0 0
M  V30 19 C 5.0955 0.0000 0.0 0
M  V30 20 C 4.0011 7.4001 0.0 0
M  V30 21 C 4.0011 8.9401 0.0 0
M  V30 22 C 2.6673 6.6301 0.0 0
M  V30 23 C 2.6673 9.7102 0.0 0
M  V30 24 C 1.3337 7.4001 0.0 0
M  V30 25 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 21
M  V30 6 1 6 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=1
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1262447-30-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1679333-90-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-14517528
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM closed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Determination of the active stereoisomer of the MEP pathway-targeting
antimalarial agent MMV008138, and initial structure-activity studies
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yao, Zhong-Ke; Krai, Priscilla M.; Merino, Emilio F.; Simpson, Morgan E.;
Slebodnick, Carla; Cassera, Maria Belen; Carlier, Paul R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2015), 25(7), 1515-1519

$RFMT $RIREG SCHEME239 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1R,3S)-1-(3,4-dichlorophenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indo...
C19H16Cl2N2O2
1262447-34-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 O 10.6695 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 Cl 2.6673 11.2501 0.0 0
M  V30 6 Cl 0.0000 9.7101 0.0 0
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 C 6.6684 4.3200 0.0 0
M  V30 9 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 10 N 4.1902 4.0596 0.0 0
M  V30 11 C 6.3482 2.8138 0.0 0
M  V30 12 C 8.0021 5.0901 0.0 0
M  V30 13 N 6.6684 7.4001 0.0 0
M  V30 14 C 4.8167 2.6527 0.0 0
M  V30 15 C 7.2535 1.5679 0.0 0
M  V30 16 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 17 C 4.1902 1.2459 0.0 0
M  V30 18 C 6.6270 0.1609 0.0 0
M  V30 19 C 5.0954 0.0000 0.0 0
M  V30 20 C 4.0011 7.4001 0.0 0
M  V30 21 C 4.0011 8.9401 0.0 0
M  V30 22 C 2.6673 6.6301 0.0 0
M  V30 23 C 2.6673 9.7101 0.0 0
M  V30 24 C 1.3337 7.4001 0.0 0
M  V30 25 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 23
M  V30 6 1 6 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=1
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1R,3S)-1-(3,4-Dichlorophenyl)-2,3,4,9-tetrahydro-N-methyl-1H-pyrido[3,4-b]in...
C19H17Cl2N3O
1918182-21-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 N 10.6695 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 Cl 2.6673 11.2501 0.0 0
M  V30 6 Cl 0.0000 9.7101 0.0 0
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 C 6.6684 4.3200 0.0 0
M  V30 9 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 10 N 4.1902 4.0596 0.0 0
M  V30 11 C 6.3482 2.8138 0.0 0
M  V30 12 C 8.0021 5.0901 0.0 0
M  V30 13 N 6.6684 7.4001 0.0 0
M  V30 14 C 4.8167 2.6527 0.0 0
M  V30 15 C 7.2535 1.5679 0.0 0
M  V30 16 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 17 C 4.1902 1.2459 0.0 0
M  V30 18 C 6.6270 0.1609 0.0 0
M  V30 19 C 5.0954 0.0000 0.0 0
M  V30 20 C 4.0011 7.4001 0.0 0
M  V30 21 C 4.0011 8.9401 0.0 0
M  V30 22 C 2.6673 6.6301 0.0 0
M  V30 23 C 2.6673 9.7101 0.0 0
M  V30 24 C 1.3337 7.4001 0.0 0
M  V30 25 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 23
M  V30 6 1 6 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=1
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1262447-34-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1918182-21-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15957640
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM closed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions and formulations of methylerthritol phosphate pathway
inhibitors and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Carlier, Paul R.; Cassera, Maria Belen; Merino, Emilio Fernando; Yao,
Zhong-Ke; Ghavami, Maryam
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016069949 A1 2016-05-06

$RFMT $RIREG SCHEME240 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1R,3S)-2-(2-chloroacetyl)-1-(2,4-dichlorophenyl)-2,3,4,9-tetrahydro-1...
C21H17Cl3N2O3
1262447-60-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 8.9401 0.0 0
M  V30 2 C 8.0020 9.7101 0.0 0
M  V30 3 O 5.3347 9.7101 0.0 0
M  V30 4 Cl 8.0020 11.2501 0.0 0
M  V30 5 C 9.3358 7.4000 0.0 0
M  V30 6 O 10.6695 6.6300 0.0 0
M  V30 7 O 9.3358 8.9401 0.0 0
M  V30 8 C 12.0031 7.4000 0.0 0
M  V30 9 Cl 2.6673 5.0900 0.0 0
M  V30 10 Cl 0.0000 9.7101 0.0 0
M  V30 11 C 5.3347 6.6300 0.0 0 CFG=1
M  V30 12 C 5.3347 5.0900 0.0 0
M  V30 13 N 6.6684 7.4000 0.0 0
M  V30 14 C 6.6684 4.3200 0.0 0
M  V30 15 N 4.1902 4.0596 0.0 0
M  V30 16 C 8.0020 6.6300 0.0 0 CFG=2
M  V30 17 C 6.3482 2.8137 0.0 0
M  V30 18 C 8.0020 5.0900 0.0 0
M  V30 19 C 4.8167 2.6527 0.0 0
M  V30 20 C 7.2534 1.5679 0.0 0
M  V30 21 C 4.1902 1.2459 0.0 0
M  V30 22 C 6.6271 0.1609 0.0 0
M  V30 23 C 5.0954 0.0000 0.0 0
M  V30 24 C 4.0011 7.4000 0.0 0
M  V30 25 C 2.6673 6.6300 0.0 0
M  V30 26 C 4.0011 8.9401 0.0 0
M  V30 27 C 1.3336 7.4000 0.0 0
M  V30 28 C 2.6673 9.7101 0.0 0
M  V30 29 C 1.3336 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 16 5 CFG=3
M  V30 8 1 6 8
M  V30 9 1 9 25
M  V30 10 1 10 29
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 24 CFG=1
M  V30 14 2 12 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 17 20
M  V30 23 2 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 11 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(6R,12aS)-6-(2,4-Dichlorophenyl)-2,3,6,7,12,12a-hexahydro-2-methylpyrazino[1′...
C21H17Cl2N3O2
1262447-70-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 8.9160 4.6200 0.0 0
M  V30 2 Cl 6.2486 9.2400 0.0 0
M  V30 3 O 3.5811 1.5400 0.0 0
M  V30 4 C 6.2486 0.0000 0.0 0
M  V30 5 Cl 11.5833 9.2400 0.0 0
M  V30 6 C 6.2486 6.1600 0.0 0 CFG=1
M  V30 7 C 4.9149 6.9300 0.0 0
M  V30 8 N 6.2486 4.6200 0.0 0
M  V30 9 C 3.5811 6.1600 0.0 0
M  V30 10 N 4.5948 8.4363 0.0 0
M  V30 11 C 4.9149 3.8500 0.0 0 CFG=2
M  V30 12 C 7.5822 3.8500 0.0 0
M  V30 13 C 2.4368 7.1905 0.0 0
M  V30 14 C 3.5811 4.6200 0.0 0
M  V30 15 C 3.0631 8.5972 0.0 0
M  V30 16 C 4.9149 2.3100 0.0 0
M  V30 17 C 7.5822 2.3100 0.0 0
M  V30 18 C 0.9052 7.0295 0.0 0
M  V30 19 C 2.1580 9.8431 0.0 0
M  V30 20 N 6.2486 1.5400 0.0 0
M  V30 21 C 0.0000 8.2754 0.0 0
M  V30 22 C 0.6263 9.6822 0.0 0
M  V30 23 C 7.5822 6.9300 0.0 0
M  V30 24 C 7.5822 8.4700 0.0 0
M  V30 25 C 8.9160 6.1600 0.0 0
M  V30 26 C 8.9160 9.2400 0.0 0
M  V30 27 C 10.2497 6.9300 0.0 0
M  V30 28 C 10.2497 8.4700 0.0 0
M  V30 29 H 3.5811 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 2 24
M  V30 3 2 3 16
M  V30 4 1 4 20
M  V30 5 1 5 28
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 23 CFG=1
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14
M  V30 15 1 10 15
M  V30 16 1 11 14
M  V30 17 1 11 16
M  V30 18 1 11 29 CFG=1
M  V30 19 1 12 17
M  V30 20 1 13 15
M  V30 21 2 13 18
M  V30 22 2 15 19
M  V30 23 1 16 20
M  V30 24 1 17 20
M  V30 25 1 18 21
M  V30 26 1 19 22
M  V30 27 2 21 22
M  V30 28 2 23 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 2 25 27
M  V30 32 2 26 28
M  V30 33 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 6 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1262447-60-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1262447-70-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-15814226
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM closed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions and formulations of methylerthritol phosphate pathway
inhibitors and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Carlier, Paul R.; Cassera, Maria Belen; Merino, Emilio Fernando; Yao,
Zhong-Ke; Ghavami, Maryam
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016069949 A1 2016-05-06

$RFMT $RIREG SCHEME241 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Chlorophenyl)-5-fluoro-2-nitrosobenzenamine
C12H8ClFN2O
1264688-59-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 5.3347 0.0 0
M  V30 2 N 1.5400 5.3347 0.0 0
M  V30 3 O 0.0000 5.3347 0.0 0
M  V30 4 F 4.6200 0.0000 0.0 0
M  V30 5 Cl 10.7800 5.3347 0.0 0
M  V30 6 C 3.8500 4.0011 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 1.5400 2.6674 0.0 0
M  V30 10 C 3.8500 1.3338 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 6.1600 5.3347 0.0 0
M  V30 13 C 6.9300 6.6685 0.0 0
M  V30 14 C 6.9300 4.0011 0.0 0
M  V30 15 C 8.4700 6.6685 0.0 0
M  V30 16 C 8.4700 4.0011 0.0 0
M  V30 17 C 9.2400 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 12
M  V30 3 2 2 3
M  V30 4 1 2 7
M  V30 5 1 4 10
M  V30 6 1 5 17
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N3-(4-Chlorophenyl)-N1-methyl-4-nitroso-1,3-benzenediamine
C13H12ClN3O
1447934-38-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 6.6685 0.0 0
M  V30 2 N 1.5400 6.6685 0.0 0
M  V30 3 O 0.0000 6.6685 0.0 0
M  V30 4 N 4.6200 1.3336 0.0 0
M  V30 5 C 3.8500 0.0000 0.0 0
M  V30 6 Cl 10.7800 6.6685 0.0 0
M  V30 7 C 3.8500 5.3347 0.0 0
M  V30 8 C 2.3100 5.3347 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 1.5400 4.0011 0.0 0
M  V30 11 C 3.8500 2.6674 0.0 0
M  V30 12 C 2.3100 2.6674 0.0 0
M  V30 13 C 6.1600 6.6685 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 6.9300 8.0021 0.0 0
M  V30 16 C 8.4700 5.3347 0.0 0
M  V30 17 C 8.4700 8.0021 0.0 0
M  V30 18 C 9.2400 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 13
M  V30 3 2 2 3
M  V30 4 1 2 8
M  V30 5 1 4 5
M  V30 6 1 4 11
M  V30 7 1 6 18
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1264688-59-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1447934-38-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-3465282
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 5-Fluoroor 5-chloro-N-aryl-2-nitrosoaniline
(0.5 mmol) was dissolved (or suspended in case of low solubility) in MeCN
(10 mL), and the appropriate amine (2.5 mmol) was added. The mixture was
stirred at ambient temperature for 2 to 48 h (tlc controlled). After the
reaction was complete the mixture was poured into water and extracted
three times with AcOEt. The combined extracts were washed with water,
brine and the solvent was evaporated. The crude product was purified by
column chromatography (SiO2, hexane/AcOEt).
3-N-(4-Chlorophenyl)-1-N-methyl-4-nitrosobenzene-1,3-diamine: from
N-(4-chlorolphenyl)-5-fluoro-2-nitrosoaniline, yield: 99%; green solid.
mp 178-182 °C. 1H NMR (400 MHz, CDCl3): δ = 2.88 (d, J = 4,5 Hz, 3 H),
5.88 ( d, J = 2.1 Hz, 1 H), 6.34 (dd, J = 9.1, 2.1 Hz, 1 H), 7.21 - 7.25
(m, 2 H), 7.34 - 7.38 (m, 2 H), 8.06 (d, J = 9.1 Hz, 1 H), 13.34 (br s, 1
H). 13C NMR (100 MHz, CDCl3): δ = 29.9, 87.5, 109.6, 126.1, 129.6, 130.0,
131.1, 136.3, 141.3, 151.6, 156.5. MS (EI): m/z 263 (40), 262 (39), 261
(100), 260 (61), 247 (13), 246 (32), 245 (19), 244 (89), 232 (31), 231
917), 230 (82), 229 (11). HRMS (EI): m/z calcd. for C13H12N3OCl:
261.0669; found: 261.0673.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A short preparation of pyrroloquinoxalinones via a cascade reaction of
N-aryl-5-alkylamino-2-nitrosoanilines with methyl 2-cyanoalkanoates:
unexpected direction of nucleophilic substitution of hydrogen
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Krolikiewicz, Magdalena; Cmoch, Piotr; Wrobel, Zbigniew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2013), 24(8), 973-976

$RFMT $RIREG SCHEME242 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-3-carboxylic acid, 5-bromo-1-methyl-, ethyl ester
C7H9BrN2O2
1269293-48-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 4.0287 0.0 0
M  V30 2 O 6.6363 3.2587 0.0 0
M  V30 3 O 5.3026 5.5688 0.0 0
M  V30 4 C 7.9700 4.0287 0.0 0
M  V30 5 C 9.3037 3.2587 0.0 0
M  V30 6 Br 0.0000 2.9016 0.0 0
M  V30 7 C 1.6751 0.0000 0.0 0
M  V30 8 C 3.9688 3.2587 0.0 0
M  V30 9 C 2.5620 3.8850 0.0 0
M  V30 10 N 3.8079 1.7271 0.0 0
M  V30 11 C 1.5316 2.7406 0.0 0
M  V30 12 N 2.3016 1.4070 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 1 7 12
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N,1-dimethyl-1H-pyrazole-3-carboxamide
C6H8BrN3O
2246368-45-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 4.0287 0.0 0
M  V30 2 N 6.6363 3.2587 0.0 0
M  V30 3 O 5.3026 5.5688 0.0 0
M  V30 4 C 7.9700 4.0287 0.0 0
M  V30 5 Br 1.6751 0.0000 0.0 0
M  V30 6 C 0.0000 2.9016 0.0 0
M  V30 7 C 3.9690 3.2587 0.0 0
M  V30 8 C 3.8079 1.7271 0.0 0
M  V30 9 N 2.5620 3.8850 0.0 0
M  V30 10 C 2.3016 1.4070 0.0 0
M  V30 11 N 1.5316 2.7406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1269293-48-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2246368-45-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-20721593
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of isoquinolines as inhibitors of HPK1 useful for treatment
of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chan, Bryan; Drobnick, Joy; Gazzard, Lewis; Heffron, Timothy; Liang, Jun;
Malhotra, Sushant; Mendonca, Rohan; Rajapaksa, Naomi; Stivala, Craig;
Tellis, John; Wang, Weiru; Wei, Binqing; Zhou, Aihe; Cartwright, Matthew
W.; Lainchbury, Michael; Gancia, Emanuela; Seward, Eileen; Madin, Andrew;
Favor, David; Fong, Kin Chiu; Hu, Yonghan; Good, Andrew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018183964 A1 2018-10-04

$RFMT $RIREG SCHEME243 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[1-[(4-Fluorophenyl)methyl]-1,5-dihydro-5-oxo-4H-1,2,4-triazol-4-yl]-1-[(4-...
C21H18FN5O4
1282606-69-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.0494 3.5897 0.0 0
M  V30 2 C 3.0800 6.3003 0.0 0
M  V30 3 C 12.1457 3.8551 0.0 0
M  V30 4 C 10.1763 1.1445 0.0 0
M  V30 5 O 9.1459 0.0000 0.0 0
M  V30 6 O 11.6826 0.8244 0.0 0
M  V30 7 F 0.0000 11.6350 0.0 0
M  V30 8 O 15.2257 9.1898 0.0 0
M  V30 9 C 16.7657 9.1898 0.0 0
M  V30 10 N 6.9899 5.5303 0.0 0
M  V30 11 C 5.5252 5.0543 0.0 0
M  V30 12 C 6.9899 7.0703 0.0 0
M  V30 13 N 4.6200 6.3003 0.0 0
M  V30 14 N 5.5252 7.5462 0.0 0
M  V30 15 C 8.2358 4.6251 0.0 0
M  V30 16 N 9.7005 5.1009 0.0 0
M  V30 17 C 8.2358 3.0851 0.0 0
M  V30 18 N 10.6057 3.8551 0.0 0
M  V30 19 C 9.7005 2.6091 0.0 0
M  V30 20 C 2.3102 7.6339 0.0 0
M  V30 21 C 3.0800 8.9676 0.0 0
M  V30 22 C 0.7700 7.6339 0.0 0
M  V30 23 C 2.3100 10.3012 0.0 0
M  V30 24 C 0.0000 8.9676 0.0 0
M  V30 25 C 0.7702 10.3012 0.0 0
M  V30 26 C 12.9157 5.1887 0.0 0
M  V30 27 C 12.1457 6.5224 0.0 0
M  V30 28 C 14.4557 5.1887 0.0 0
M  V30 29 C 12.9157 7.8560 0.0 0
M  V30 30 C 15.2257 6.5224 0.0 0
M  V30 31 C 14.4557 7.8560 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 13
M  V30 3 1 2 20
M  V30 4 1 3 18
M  V30 5 1 3 26
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 4 19
M  V30 9 1 7 25
M  V30 10 1 8 9
M  V30 11 1 8 31
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 10 15
M  V30 15 1 11 13
M  V30 16 2 12 14
M  V30 17 1 13 14
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[1-[(4-Fluorophenyl)methyl]-1,5-dihydro-5-oxo-4H-1,2,4-triazol-4-yl]-1-[(4-...
C22H21FN6O3
1282606-75-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.0494 5.0543 0.0 0
M  V30 2 C 10.1763 2.6091 0.0 0
M  V30 3 N 9.1459 1.4647 0.0 0
M  V30 4 O 11.6826 2.2889 0.0 0
M  V30 5 C 9.6218 0.0000 0.0 0
M  V30 6 C 12.1457 5.3196 0.0 0
M  V30 7 C 3.0800 7.7648 0.0 0
M  V30 8 O 15.2257 10.6543 0.0 0
M  V30 9 C 16.7657 10.6543 0.0 0
M  V30 10 F 0.0002 13.0995 0.0 0
M  V30 11 C 8.2358 6.0896 0.0 0
M  V30 12 C 8.2358 4.5496 0.0 0
M  V30 13 N 9.7005 6.5655 0.0 0
M  V30 14 C 9.7005 4.0738 0.0 0
M  V30 15 N 10.6057 5.3196 0.0 0
M  V30 16 N 6.9899 6.9948 0.0 0
M  V30 17 C 5.5252 6.5190 0.0 0
M  V30 18 C 6.9899 8.5348 0.0 0
M  V30 19 N 4.6200 7.7648 0.0 0
M  V30 20 N 5.5252 9.0107 0.0 0
M  V30 21 C 12.9157 6.6533 0.0 0
M  V30 22 C 12.1457 7.9869 0.0 0
M  V30 23 C 14.4557 6.6533 0.0 0
M  V30 24 C 12.9157 9.3207 0.0 0
M  V30 25 C 15.2257 7.9869 0.0 0
M  V30 26 C 14.4557 9.3207 0.0 0
M  V30 27 C 2.3100 9.0985 0.0 0
M  V30 28 C 0.7700 9.0985 0.0 0
M  V30 29 C 3.0800 10.4321 0.0 0
M  V30 30 C 0.0000 10.4321 0.0 0
M  V30 31 C 2.3100 11.7659 0.0 0
M  V30 32 C 0.7700 11.7659 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 17
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 6 15
M  V30 7 1 6 21
M  V30 8 1 7 19
M  V30 9 1 7 27
M  V30 10 1 8 9
M  V30 11 1 8 26
M  V30 12 1 10 32
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 11 16
M  V30 16 2 12 14
M  V30 17 1 13 15
M  V30 18 1 14 15
M  V30 19 1 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1282606-69-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1282606-75-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5447196
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 125700-67-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of triazolone derivatives as novel, potent stearoyl-CoA
desaturase-1 (SCD1) inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sun, Shaoyi; Zhang, Zaihui; Pokrovskaia, Natalia; Chowdhury, Sultan; Jia,
Qi; Chang, Elaine; Khakh, Kuldip; Kwan, Rainbow; McLaren, David G.;
Radomski, Chris C.; Ratkay, Leslie G.; Fu, Jianmin; Dales, Natalie A.;
Winther, Michael D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2015), 23(3), 455-465

$RFMT $RIREG SCHEME243 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[1-[(4-Fluorophenyl)methyl]-1,5-dihydro-5-oxo-4H-1,2,4-triazol-4-yl]-1-[(4-...
C21H18FN5O4
1282606-69-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.0494 3.5897 0.0 0
M  V30 2 C 3.0800 6.3003 0.0 0
M  V30 3 C 12.1457 3.8551 0.0 0
M  V30 4 C 10.1763 1.1445 0.0 0
M  V30 5 O 9.1459 0.0000 0.0 0
M  V30 6 O 11.6826 0.8244 0.0 0
M  V30 7 F 0.0000 11.6350 0.0 0
M  V30 8 O 15.2257 9.1898 0.0 0
M  V30 9 C 16.7657 9.1898 0.0 0
M  V30 10 N 6.9899 5.5303 0.0 0
M  V30 11 C 5.5252 5.0543 0.0 0
M  V30 12 C 6.9899 7.0703 0.0 0
M  V30 13 N 4.6200 6.3003 0.0 0
M  V30 14 N 5.5252 7.5462 0.0 0
M  V30 15 C 8.2358 4.6251 0.0 0
M  V30 16 N 9.7005 5.1009 0.0 0
M  V30 17 C 8.2358 3.0851 0.0 0
M  V30 18 N 10.6057 3.8551 0.0 0
M  V30 19 C 9.7005 2.6091 0.0 0
M  V30 20 C 2.3102 7.6339 0.0 0
M  V30 21 C 3.0800 8.9676 0.0 0
M  V30 22 C 0.7700 7.6339 0.0 0
M  V30 23 C 2.3100 10.3012 0.0 0
M  V30 24 C 0.0000 8.9676 0.0 0
M  V30 25 C 0.7702 10.3012 0.0 0
M  V30 26 C 12.9157 5.1887 0.0 0
M  V30 27 C 12.1457 6.5224 0.0 0
M  V30 28 C 14.4557 5.1887 0.0 0
M  V30 29 C 12.9157 7.8560 0.0 0
M  V30 30 C 15.2257 6.5224 0.0 0
M  V30 31 C 14.4557 7.8560 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 13
M  V30 3 1 2 20
M  V30 4 1 3 18
M  V30 5 1 3 26
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 4 19
M  V30 9 1 7 25
M  V30 10 1 8 9
M  V30 11 1 8 31
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 10 15
M  V30 15 1 11 13
M  V30 16 2 12 14
M  V30 17 1 13 14
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[1-[(4-Fluorophenyl)methyl]-1,5-dihydro-5-oxo-4H-1,2,4-triazol-4-yl]-1-[(4-...
C22H21FN6O3
1282606-75-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.0494 5.0543 0.0 0
M  V30 2 C 10.1763 2.6091 0.0 0
M  V30 3 N 9.1459 1.4647 0.0 0
M  V30 4 O 11.6826 2.2889 0.0 0
M  V30 5 C 9.6218 0.0000 0.0 0
M  V30 6 C 12.1457 5.3196 0.0 0
M  V30 7 C 3.0800 7.7648 0.0 0
M  V30 8 O 15.2257 10.6543 0.0 0
M  V30 9 C 16.7657 10.6543 0.0 0
M  V30 10 F 0.0002 13.0995 0.0 0
M  V30 11 C 8.2358 6.0896 0.0 0
M  V30 12 C 8.2358 4.5496 0.0 0
M  V30 13 N 9.7005 6.5655 0.0 0
M  V30 14 C 9.7005 4.0738 0.0 0
M  V30 15 N 10.6057 5.3196 0.0 0
M  V30 16 N 6.9899 6.9948 0.0 0
M  V30 17 C 5.5252 6.5190 0.0 0
M  V30 18 C 6.9899 8.5348 0.0 0
M  V30 19 N 4.6200 7.7648 0.0 0
M  V30 20 N 5.5252 9.0107 0.0 0
M  V30 21 C 12.9157 6.6533 0.0 0
M  V30 22 C 12.1457 7.9869 0.0 0
M  V30 23 C 14.4557 6.6533 0.0 0
M  V30 24 C 12.9157 9.3207 0.0 0
M  V30 25 C 15.2257 7.9869 0.0 0
M  V30 26 C 14.4557 9.3207 0.0 0
M  V30 27 C 2.3100 9.0985 0.0 0
M  V30 28 C 0.7700 9.0985 0.0 0
M  V30 29 C 3.0800 10.4321 0.0 0
M  V30 30 C 0.0000 10.4321 0.0 0
M  V30 31 C 2.3100 11.7659 0.0 0
M  V30 32 C 0.7700 11.7659 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 17
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 6 15
M  V30 7 1 6 21
M  V30 8 1 7 19
M  V30 9 1 7 27
M  V30 10 1 8 9
M  V30 11 1 8 26
M  V30 12 1 10 32
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 11 16
M  V30 16 2 12 14
M  V30 17 1 13 15
M  V30 18 1 14 15
M  V30 19 1 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1282606-69-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1282606-75-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2574270
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 125700-67-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: PREPARATION 8 Preparation of
3-(1-(4-Fluorobenzyl)-5-oxo-1H-1,2,4-triazol-4(5H)-yl)-1-(4-methoxybenzyl)-N-(pyridin-3-ylmethyl)-1H-pyrazole-5-carboxamide
PREPARATION 8.2 Preparation of
3-(1-(4-fluorobenzyl)-5-oxo-1H-1,2,4-triazol-4(5H)-yl)-1-(4-methoxybenzyl)-N-methyl-1H-pyrazole-5-carboxamide
Following the procedure as describe in PREPARATION 8, making variations
as required to replace 3,4-difluorobenzylamine with methylamine to react
with
3-(1-(4-fluorobenzyl)-5-oxo-1H-1,2,4-triazol-4(5H)-yl)-1-(4-methoxybenzyl)-1H-pyrazole-5-carboxylic
acid, the title compound was obtained in 99% yield:. MS (ES+) m/z 437.3
(M+1).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazole derivatives which modulate stearoyl-CoA
desaturase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dales, Natalie; Fu, Jianmin; Jia, Qi; Pokrovskaia, Natalia; Sun, Shaoyi;
Zhang, Zaihui
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011039358 A1 2011-04-07

$RFMT $RIREG SCHEME244 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Methylthio)-2-(trifluoromethyl)benzaldehyde
C9H7F3OS
1289164-55-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 4.6201 0.0 0
M  V30 2 F 0.5637 3.2864 0.0 0
M  V30 3 F 0.0000 5.3901 0.0 0
M  V30 4 F 2.1037 5.9538 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 O 1.3337 0.0000 0.0 0
M  V30 7 S 6.6687 4.6201 0.0 0
M  V30 8 C 8.0023 3.8501 0.0 0
M  V30 9 C 2.6675 3.8501 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 C 4.0012 4.6201 0.0 0
M  V30 12 C 4.0012 1.5400 0.0 0
M  V30 13 C 5.3348 3.8501 0.0 0
M  V30 14 C 5.3348 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 2 5 6
M  V30 6 1 5 10
M  V30 7 1 7 8
M  V30 8 1 7 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-(methylthio)-2-(trifluoromethyl)benzenemethanamine
C10H12F3NS
1542035-75-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 1.3338 0.0 0
M  V30 2 F 2.5164 2.1038 0.0 0
M  V30 3 F 3.0800 0.0000 0.0 0
M  V30 4 F 5.1836 0.5638 0.0 0
M  V30 5 C 2.3100 4.0011 0.0 0
M  V30 6 N 1.5400 5.3349 0.0 0
M  V30 7 C 0.0000 5.3349 0.0 0
M  V30 8 S 8.4700 4.0011 0.0 0
M  V30 9 C 9.2400 5.3349 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 3.8500 4.0011 0.0 0
M  V30 12 C 6.1600 2.6674 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 14 C 6.9300 4.0011 0.0 0
M  V30 15 C 6.1600 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 10
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 14
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1289164-55-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1542035-75-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40490506
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective Defluorination of Trifluoromethyl Substituents by
Conformationally Induced Remote Substitution
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jesani, Mehul H.; Schwarz, Maria; Kim, Shiwhu; Evans, Finlay L.; White,
Alexander; Browning, Alex; Abrams, Roman; Clayden, Jonathan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2024), 63(24), e202403477

$RFMT $RIREG SCHEME245 STEP1
$RXN



  2  1
$MOL
4,6,7,9-Tetrahydro-9,9-dimethyl-4-oxo-3-(phenylmethoxy)pyrimido[2,1-c][1,4]ox...
C17H19N3O4
1289648-91-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 3.4744 0.0 0
M  V30 2 C 1.7145 2.4845 0.0 0
M  V30 3 O 6.0670 6.6685 0.0 0
M  V30 4 C 6.0670 1.3338 0.0 0
M  V30 5 N 7.6070 1.3338 0.0 0
M  V30 6 O 5.2970 0.0000 0.0 0
M  V30 7 O 7.6070 4.0011 0.0 0
M  V30 8 C 8.3770 5.3347 0.0 0
M  V30 9 C 2.9870 4.0011 0.0 0
M  V30 10 N 3.7570 5.3347 0.0 0
M  V30 11 N 3.7570 2.6674 0.0 0
M  V30 12 C 1.4470 4.0011 0.0 0
M  V30 13 C 5.2970 5.3347 0.0 0
M  V30 14 C 2.9870 6.6685 0.0 0
M  V30 15 C 5.2970 2.6674 0.0 0
M  V30 16 O 0.6770 5.3347 0.0 0
M  V30 17 C 6.0670 4.0011 0.0 0
M  V30 18 C 1.4470 6.6685 0.0 0
M  V30 19 C 9.9170 5.3347 0.0 0
M  V30 20 C 10.6870 4.0011 0.0 0
M  V30 21 C 10.6870 6.6685 0.0 0
M  V30 22 C 12.2270 4.0011 0.0 0
M  V30 23 C 12.2270 6.6685 0.0 0
M  V30 24 C 12.9970 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 12
M  V30 3 2 3 13
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 15
M  V30 7 1 7 8
M  V30 8 1 7 17
M  V30 9 1 8 19
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 2 15 17
M  V30 20 1 16 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6,7,9-Tetrahydro-N,9,9-trimethyl-4-oxo-3-(phenylmethoxy)pyrimido[2,1-c][1,4...
C18H21N3O4
1289648-93-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.0670 8.0021 0.0 0
M  V30 2 C 0.0000 4.8080 0.0 0
M  V30 3 C 1.7145 3.8181 0.0 0
M  V30 4 O 7.6070 5.3347 0.0 0
M  V30 5 C 8.3770 6.6685 0.0 0
M  V30 6 C 6.0670 2.6674 0.0 0
M  V30 7 N 5.2970 1.3336 0.0 0
M  V30 8 O 7.6070 2.6674 0.0 0
M  V30 9 C 6.0670 0.0000 0.0 0
M  V30 10 N 3.7570 6.6685 0.0 0
M  V30 11 C 2.9870 5.3347 0.0 0
M  V30 12 C 5.2970 6.6685 0.0 0
M  V30 13 C 2.9870 8.0021 0.0 0
M  V30 14 N 3.7570 4.0011 0.0 0
M  V30 15 C 1.4470 5.3347 0.0 0
M  V30 16 C 6.0670 5.3347 0.0 0
M  V30 17 C 1.4470 8.0021 0.0 0
M  V30 18 C 5.2970 4.0011 0.0 0
M  V30 19 O 0.6770 6.6685 0.0 0
M  V30 20 C 9.9170 6.6685 0.0 0
M  V30 21 C 10.6870 8.0021 0.0 0
M  V30 22 C 10.6870 5.3347 0.0 0
M  V30 23 C 12.2270 8.0021 0.0 0
M  V30 24 C 12.2270 5.3347 0.0 0
M  V30 25 C 12.9970 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 2 15
M  V30 3 1 3 15
M  V30 4 1 4 5
M  V30 5 1 4 16
M  V30 6 1 5 20
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 18
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 2 16 18
M  V30 21 1 17 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1289648-91-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1289648-93-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29118234
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Intermediate 14
3-(Benzyloxy)-N,9,9-trimethyl-4-oxo-4,6,7,9-tetrahydropyrimido[2,1-c][1,4]oxazine-2-carboxamide.
To a slurry of
3-(benzyloxy)-9,9-dimethyl-4-oxo-4,6,7,9-tetrahydropyrimido[2,1-c][1,4]oxazine-2-carboxamide
(0.40 g, 1.21 mmol, 1.0 equiv) in CH2Cl2 (4 mL) was added DMF (1 drop)
followed by oxalyl chloride (0.15 mL, 1.70 mmol, 1.4 equiv). Gas
evolution was observed. After stirring 2 h, the reaction was concentrated
under a stream of nitrogen to provide the acid chloride as a white solid.
The acid chloride was taken up in CH2Cl2 (4 mL) and added slowly to a
solution of MeNH2 (2.42 mL of a 2 M solution in MeOH, 4.84 mmol, 4 equiv)
in CH2Cl2 (3 mL). After stirring 30 min, the reaction was poured into a
saturated aqueous solution of NaHCO3 and extracted with CH2Cl2 (×3). The
combined CH2Cl2 extracts were dried (Na2SO4) and then concentrated in
vacuo to provide the title compound. (0.41 g, 99% yield) as a white
solid. 1H NMR (400 MHz, CDCl3) δ ppm 7.54-7.60 (m, 2H), 7.28-7.40 (m,
3H), 5.27 (s, 2H), 3.97-4.07 (m, 4H), 2.92 (d, J=5.04 Hz, 3H), 1.62 (s,
6H); LCMS (ES+, (M+H)+) m/z 344.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 5-Hydroxypyrimidin-4(3H)-ones as HIV integrase inhibitors and synthesis
and antiviral activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Naidu, B. Narasimhulu; Peese, Kevin; Dicker, Ira B.; Li, Chen; Patel,
Manoj; Meanwell, Nicholas A.; Walker, Michael A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011046873 A1 2011-04-21

$RFMT $RIREG SCHEME246 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,4-Naphthoquinone
C10H6O2
130-15-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.0011 0.0 0
M  V30 2 O 6.1600 4.0011 0.0 0
M  V30 3 C 2.3100 2.6674 0.0 0
M  V30 4 C 3.8500 2.6674 0.0 0
M  V30 5 C 1.5400 4.0011 0.0 0
M  V30 6 C 1.5400 1.3338 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 4.6200 1.3338 0.0 0
M  V30 9 C 2.3100 5.3349 0.0 0
M  V30 10 C 2.3100 0.0000 0.0 0
M  V30 11 C 3.8500 5.3349 0.0 0
M  V30 12 C 3.8500 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 7
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Methylamino)-1,4-naphthoquinone
C11H9NO2
14423-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 6.1600 0.0 0
M  V30 2 O 4.0011 0.0000 0.0 0
M  V30 3 N 6.6685 4.6200 0.0 0
M  V30 4 C 8.0021 3.8500 0.0 0
M  V30 5 C 2.6674 3.8500 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 C 4.0011 4.6200 0.0 0
M  V30 8 C 1.3336 4.6200 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 1.3336 1.5400 0.0 0
M  V30 11 C 5.3347 3.8500 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 13 C 5.3347 2.3100 0.0 0
M  V30 14 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 1 3 4
M  V30 4 1 3 11
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 130-15-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14423-00-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36530529
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM photochemical (blue LED (240 W) bulb used)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Blue Light Irradiated Metal-, Oxidant-, and Base-Free
Cross-Dehydrogenative Coupling of C(sp2)-H and N-H Bonds: Amination of
Naphthoquinones with Amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jha, Raushan Kumar; Batabyal, Monojit; Kumar, Sangit
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2023), 88(11), 7401-7424

$RFMT $RIREG SCHEME247 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-3-nitropyridine
C5H3ClN2O2
13091-23-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Cl 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 N 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-nitro-4-pyridinamine
C6H7N3O2
1633-41-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 1.3338 0.0 0
M  V30 2 C 6.1600 1.3338 0.0 0
M  V30 3 N 1.5400 1.3338 0.0 0 VAL=5
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 O 0.0000 1.3338 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 11 N 2.3100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 7
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13091-23-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1633-41-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-6676564
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-86-4
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-guided design of substituted aza-benzimidazoles as potent
hypoxia inducible factor-1α prolyl hydroxylase-2 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Frohn, Mike; Viswanadhan, Vellarkad; Pickrell, Alexander J.; Golden,
Jennifer E.; Muller, Kristine M.; Buerli, Roland W.; Biddlecome, Gloria;
Yoder, Sean C.; Rogers, Norma; Dao, Jennifer H.; Hungate, Randall; Allen,
Jennifer R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2008), 18(18), 5023-5026

$RFMT $RIREG SCHEME248 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3aR,8aR)-3,3a,8,8a-Tetrahydro-3a,8-bis(4-pyridinylmethyl)-2H-furo[2,3-b]...
C22H19N3O2
1312132-30-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.2477 0.0 0
M  V30 2 C 8.8109 5.6252 0.0 0
M  V30 3 O 2.3890 6.2031 0.0 0
M  V30 4 C 5.3901 3.5813 0.0 0 CFG=2
M  V30 5 C 6.1601 4.9150 0.0 0 CFG=2
M  V30 6 C 6.4205 2.4369 0.0 0
M  V30 7 C 3.8836 3.9015 0.0 0
M  V30 8 N 7.6664 4.5948 0.0 0
M  V30 9 O 5.1295 6.0595 0.0 0
M  V30 10 C 7.8273 3.0633 0.0 0
M  V30 11 C 6.2596 0.9052 0.0 0
M  V30 12 C 3.7227 5.4331 0.0 0
M  V30 13 C 9.0734 2.1580 0.0 0
M  V30 14 C 7.5055 0.0000 0.0 0
M  V30 15 C 8.9123 0.6265 0.0 0
M  V30 16 C 3.0800 2.2477 0.0 0
M  V30 17 C 2.3100 3.5813 0.0 0
M  V30 18 C 2.3100 0.9139 0.0 0
M  V30 19 C 0.7700 3.5813 0.0 0
M  V30 20 C 0.7700 0.9139 0.0 0
M  V30 21 N 0.0000 2.2477 0.0 0
M  V30 22 C 10.2755 5.1494 0.0 0
M  V30 23 C 10.5957 3.6431 0.0 0
M  V30 24 C 11.4200 6.1800 0.0 0
M  V30 25 C 12.0604 3.1672 0.0 0
M  V30 26 C 12.8846 5.7039 0.0 0
M  V30 27 N 13.2048 4.1976 0.0 0
M  V30 28 H 6.9301 6.2488 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 4 1 CFG=1
M  V30 2 1 1 16
M  V30 3 1 2 8
M  V30 4 1 2 22
M  V30 5 2 3 12
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 4 7
M  V30 9 1 5 8
M  V30 10 1 5 9
M  V30 11 1 5 28 CFG=1
M  V30 12 1 6 10
M  V30 13 2 6 11
M  V30 14 1 7 12
M  V30 15 1 8 10
M  V30 16 1 9 12
M  V30 17 2 10 13
M  V30 18 1 11 14
M  V30 19 1 13 15
M  V30 20 2 14 15
M  V30 21 1 16 17
M  V30 22 2 16 18
M  V30 23 2 17 19
M  V30 24 1 18 20
M  V30 25 1 19 21
M  V30 26 2 20 21
M  V30 27 1 22 23
M  V30 28 2 22 24
M  V30 29 2 23 25
M  V30 30 1 24 26
M  V30 31 1 25 27
M  V30 32 2 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 4 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(3aR,8aR)-3,3a,8,8a-Tetrahydro-1-methyl-3a,8-bis(4-pyridinylmethyl)pyrrol...
C23H22N4O
1312132-48-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.3183 0.0 0
M  V30 2 C 8.8108 1.9406 0.0 0
M  V30 3 C 5.4498 0.0000 0.0 0
M  V30 4 O 2.3890 1.3628 0.0 0
M  V30 5 C 5.3900 3.9845 0.0 0 CFG=2
M  V30 6 C 6.1600 2.6508 0.0 0 CFG=2
M  V30 7 C 6.4204 5.1290 0.0 0
M  V30 8 C 3.8836 3.6643 0.0 0
M  V30 9 N 7.6663 2.9710 0.0 0
M  V30 10 N 5.1295 1.5064 0.0 0
M  V30 11 C 7.8272 4.5025 0.0 0
M  V30 12 C 6.2595 6.6605 0.0 0
M  V30 13 C 3.7227 2.1328 0.0 0
M  V30 14 C 9.0733 5.4077 0.0 0
M  V30 15 C 7.5054 7.5658 0.0 0
M  V30 16 C 8.9122 6.9393 0.0 0
M  V30 17 C 3.0800 5.3183 0.0 0
M  V30 18 C 2.3100 3.9845 0.0 0
M  V30 19 C 2.3100 6.6519 0.0 0
M  V30 20 C 0.7700 3.9845 0.0 0
M  V30 21 C 0.7700 6.6519 0.0 0
M  V30 22 N 0.0000 5.3183 0.0 0
M  V30 23 C 10.2754 2.4164 0.0 0
M  V30 24 C 10.5956 3.9229 0.0 0
M  V30 25 C 11.4199 1.3860 0.0 0
M  V30 26 C 12.0603 4.3987 0.0 0
M  V30 27 C 12.8845 1.8619 0.0 0
M  V30 28 N 13.2046 3.3682 0.0 0
M  V30 29 H 6.9300 1.3172 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 5 1 CFG=3
M  V30 2 1 1 17
M  V30 3 1 2 9
M  V30 4 1 2 23
M  V30 5 1 3 10
M  V30 6 2 4 13
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 5 8
M  V30 10 1 6 9
M  V30 11 1 6 10
M  V30 12 1 6 29 CFG=3
M  V30 13 1 7 11
M  V30 14 2 7 12
M  V30 15 1 8 13
M  V30 16 1 9 11
M  V30 17 1 10 13
M  V30 18 2 11 14
M  V30 19 1 12 15
M  V30 20 1 14 16
M  V30 21 2 15 16
M  V30 22 1 17 18
M  V30 23 2 17 19
M  V30 24 2 18 20
M  V30 25 1 19 21
M  V30 26 1 20 22
M  V30 27 2 21 22
M  V30 28 1 23 24
M  V30 29 2 23 25
M  V30 30 2 24 26
M  V30 31 1 25 27
M  V30 32 1 26 28
M  V30 33 2 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 5 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1312132-30-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1312132-48-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-13291331
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of pyrrolidinoindolines from 2-(2-oxo-3-indolyl)acetates: scope
and limitations
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Morales-Rios, Martha S.; Rivera-Becerril, Ernesto; Gonzalez-Juarez,
Daphne E.; Garcia-Vazquez, Juan Benjamin; Trujillo-Serrato, Joel J.;
Hernandez-Barragan, Angelina; Joseph-Nathan, Pedro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Natural Product Communications (2011), 6(4), 457-464

$RFMT $RIREG SCHEME249 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Iodo-2-(2-pyrazinyl)-4(3H)-quinazolinone
C12H7IN4O
1313911-27-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.7000 0.0000 0.0 0
M  V30 2 I 11.5500 4.0011 0.0 0
M  V30 3 C 6.9300 4.0011 0.0 0
M  V30 4 C 7.7000 2.6674 0.0 0
M  V30 5 N 5.3900 4.0011 0.0 0
M  V30 6 C 7.7000 5.3349 0.0 0
M  V30 7 C 6.9300 1.3338 0.0 0
M  V30 8 C 9.2400 2.6674 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 9.2400 5.3349 0.0 0
M  V30 11 N 5.3900 1.3338 0.0 0
M  V30 12 C 10.0100 4.0011 0.0 0
M  V30 13 C 3.0800 2.6674 0.0 0
M  V30 14 C 2.3100 4.0011 0.0 0
M  V30 15 N 2.3100 1.3338 0.0 0
M  V30 16 N 0.7700 4.0011 0.0 0
M  V30 17 C 0.7700 1.3338 0.0 0
M  V30 18 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 12
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 11
M  V30 13 1 9 13
M  V30 14 2 10 12
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Iodo-N-methyl-2-(2-pyrazinyl)-4-quinazolinamine
C13H10IN5
1313910-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.7000 1.3338 0.0 0
M  V30 2 C 6.9300 0.0000 0.0 0
M  V30 3 I 11.5500 5.3347 0.0 0
M  V30 4 C 7.7000 4.0011 0.0 0
M  V30 5 C 6.9300 5.3347 0.0 0
M  V30 6 C 6.9300 2.6674 0.0 0
M  V30 7 C 9.2400 4.0011 0.0 0
M  V30 8 N 5.3900 5.3347 0.0 0
M  V30 9 C 7.7000 6.6685 0.0 0
M  V30 10 N 5.3900 2.6674 0.0 0
M  V30 11 C 10.0100 5.3347 0.0 0
M  V30 12 C 4.6200 4.0011 0.0 0
M  V30 13 C 9.2400 6.6685 0.0 0
M  V30 14 C 3.0800 4.0011 0.0 0
M  V30 15 C 2.3100 5.3347 0.0 0
M  V30 16 N 2.3100 2.6674 0.0 0
M  V30 17 N 0.7700 5.3347 0.0 0
M  V30 18 C 0.7700 2.6674 0.0 0
M  V30 19 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 11
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1313911-27-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1313910-62-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8505365
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 6674-22-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56602-33-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Quinazoline derivatives as striatal-enriched tyrosine phosphatase
modulators and their preparation and use as as therapeutic compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Suzuki, Masaki; Kondo, Kazumi; Kurimura, Muneaki; Valluru, Krishna Reddy;
Takahashi, Akira; Kuroda, Takeshi; Takahashi, Haruka; Fukushima, Tae;
Miyamura, Shin; Ghosh, Indranath; Dogra, Abhishek; Harriman, Geraldine;
Elder, Amy; Shimizu, Satoshi; Hodgetts, Kevin J.; Newcom, Jason S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011082337 A1 2011-07-07

$RFMT $RIREG SCHEME250 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-2-(3-pyridinyl)-4(3H)-quinazolinone
C13H8BrN3O
1313911-30-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.7000 0.0000 0.0 0
M  V30 2 Br 11.5500 4.0011 0.0 0
M  V30 3 C 6.9300 4.0011 0.0 0
M  V30 4 C 7.7000 2.6674 0.0 0
M  V30 5 N 5.3900 4.0011 0.0 0
M  V30 6 C 7.7000 5.3349 0.0 0
M  V30 7 C 6.9300 1.3338 0.0 0
M  V30 8 C 9.2400 2.6674 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 9.2400 5.3349 0.0 0
M  V30 11 N 5.3900 1.3338 0.0 0
M  V30 12 C 10.0100 4.0011 0.0 0
M  V30 13 C 3.0800 2.6674 0.0 0
M  V30 14 C 2.3100 4.0011 0.0 0
M  V30 15 C 2.3100 1.3338 0.0 0
M  V30 16 C 0.7700 4.0011 0.0 0
M  V30 17 N 0.7700 1.3338 0.0 0
M  V30 18 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 12
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 11
M  V30 13 1 9 13
M  V30 14 2 10 12
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-N-methyl-2-(3-pyridinyl)-4-quinazolinamine
C14H11BrN4
1313910-69-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.7000 1.3338 0.0 0
M  V30 2 C 6.9300 0.0000 0.0 0
M  V30 3 Br 11.5500 5.3347 0.0 0
M  V30 4 C 7.7000 4.0011 0.0 0
M  V30 5 C 6.9300 5.3347 0.0 0
M  V30 6 C 6.9300 2.6674 0.0 0
M  V30 7 C 9.2400 4.0011 0.0 0
M  V30 8 N 5.3900 5.3347 0.0 0
M  V30 9 C 7.7000 6.6685 0.0 0
M  V30 10 N 5.3900 2.6674 0.0 0
M  V30 11 C 10.0100 5.3347 0.0 0
M  V30 12 C 4.6200 4.0011 0.0 0
M  V30 13 C 9.2400 6.6685 0.0 0
M  V30 14 C 3.0800 4.0011 0.0 0
M  V30 15 C 2.3100 5.3347 0.0 0
M  V30 16 C 2.3100 2.6674 0.0 0
M  V30 17 C 0.7700 5.3347 0.0 0
M  V30 18 N 0.7700 2.6674 0.0 0
M  V30 19 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 11
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1313911-30-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1313910-69-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-3890125
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 6674-22-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56602-33-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Quinazoline derivatives as striatal-enriched tyrosine phosphatase
modulators and their preparation and use as as therapeutic compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Suzuki, Masaki; Kondo, Kazumi; Kurimura, Muneaki; Valluru, Krishna Reddy;
Takahashi, Akira; Kuroda, Takeshi; Takahashi, Haruka; Fukushima, Tae;
Miyamura, Shin; Ghosh, Indranath; Dogra, Abhishek; Harriman, Geraldine;
Elder, Amy; Shimizu, Satoshi; Hodgetts, Kevin J.; Newcom, Jason S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011082337 A1 2011-07-07

$RFMT $RIREG SCHEME251 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-1-chloro-3-(1,1-dimethylethyl)-2-nitrobenzene
C10H11BrClNO2
1326310-69-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6674 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0011 0.0 0
M  V30 3 O 0.0000 1.3338 0.0 0
M  V30 4 C 2.3100 5.3347 0.0 0
M  V30 5 C 0.7700 5.3347 0.0 0
M  V30 6 C 1.5400 6.6685 0.0 0
M  V30 7 C 3.0800 6.6685 0.0 0
M  V30 8 Cl 2.3100 0.0000 0.0 0
M  V30 9 Br 6.9300 2.6674 0.0 0
M  V30 10 C 2.3100 2.6674 0.0 0
M  V30 11 C 3.0800 4.0011 0.0 0
M  V30 12 C 3.0800 1.3338 0.0 0
M  V30 13 C 4.6200 4.0011 0.0 0
M  V30 14 C 4.6200 1.3338 0.0 0
M  V30 15 C 5.3900 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 11
M  V30 8 1 8 12
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-3-(1,1-dimethylethyl)-N-methyl-2-nitrobenzenamine
C11H15BrN2O2
1326310-70-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 6.1601 0.0 0 VAL=5
M  V30 2 O 5.3348 6.9302 0.0 0
M  V30 3 O 2.6675 6.9302 0.0 0
M  V30 4 C 1.3337 4.6201 0.0 0
M  V30 5 C 1.3337 6.1601 0.0 0
M  V30 6 C 0.0000 5.3901 0.0 0
M  V30 7 C 0.0000 3.8501 0.0 0
M  V30 8 N 6.6687 4.6201 0.0 0
M  V30 9 C 8.0023 3.8501 0.0 0
M  V30 10 Br 4.0012 0.0000 0.0 0
M  V30 11 C 4.0012 4.6201 0.0 0
M  V30 12 C 2.6675 3.8501 0.0 0
M  V30 13 C 5.3348 3.8501 0.0 0
M  V30 14 C 2.6675 2.3101 0.0 0
M  V30 15 C 5.3348 2.3101 0.0 0
M  V30 16 C 4.0012 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 12
M  V30 8 1 8 9
M  V30 9 1 8 13
M  V30 10 1 10 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1326310-69-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1326310-70-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8718686
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step D. 5-bromo-3-(1,1-dimethylethyl)-N-methyl-2-nitroaniline.
5-bromo-1-chloro-3-(1,1-dimethylethyl)-2-nitrobenzene (2.4 g, 5.9 mmol)
was dissolved in methylamine (2M in tetrahydrofuran) (15 ml, 30 mmol) and
stirred at room temperature for 3 hours. The mixture was concentrated,
the residue dissolved in dichloromethane, and the solution passed through
a silica plug eluting with dichloromethane. Fractions were concentrated
to give the title compound (1.77 g, 99%). 1H NMR (400 MHz, CHLOROFORM-d)
δ ppm 12.28 - 12.53 (m, 1 H), 6.95 (s, 1 H), 6.90 (d, 1 H), 2.87 (d, 3
H), 1.49 - 1.65 (m, 9 H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 1-[(1H-benzimidazol-2-yl)carbonyl]piperazine and
1-[(1H-benzimidazol-2-yl)carbonyl]piperidine derivatives as antiviral
agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Banka, Anna; Catalano, John G.; Fang, Jing; Peat, Andrew James; Tai,
Vincent; Turner, Elizabeth
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011097491 A1 2011-08-11

$RFMT $RIREG SCHEME252 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Ethyl-5-[5-(1-methylethyl)-2,4-bis(phenylmethoxy)phenyl]-3′-[[(methylsulfon...
C34H35N3O8S
1330736-89-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  46 50 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0596 9.0654 0.0 0
M  V30 2 N 2.6528 9.6918 0.0 0
M  V30 3 O 4.2207 7.5338 0.0 0
M  V30 4 C 1.4069 8.7866 0.0 0
M  V30 5 C 0.0000 9.4129 0.0 0
M  V30 6 O 9.2154 13.4080 0.0 0
M  V30 7 C 9.9854 14.7416 0.0 0
M  V30 8 C 6.7701 4.0738 0.0 0
M  V30 9 O 7.8006 2.9292 0.0 0
M  V30 10 S 7.3247 1.4647 0.0 0 VAL=6
M  V30 11 C 8.7894 0.9888 0.0 0
M  V30 12 O 6.8488 0.0000 0.0 0
M  V30 13 O 5.8602 1.9406 0.0 0
M  V30 14 C 12.2954 8.0733 0.0 0
M  V30 15 C 13.8354 8.0733 0.0 0
M  V30 16 C 11.5254 6.7397 0.0 0
M  V30 17 O 13.8354 10.7406 0.0 0
M  V30 18 C 14.6054 12.0744 0.0 0
M  V30 19 C 6.7701 9.4947 0.0 0
M  V30 20 C 7.6754 10.7406 0.0 0
M  V30 21 C 5.3055 9.9706 0.0 0
M  V30 22 O 6.7701 11.9866 0.0 0
M  V30 23 N 5.3055 11.5106 0.0 0
M  V30 24 C 7.2460 8.0302 0.0 0
M  V30 25 C 6.3408 6.7842 0.0 0
M  V30 26 O 8.7107 7.5542 0.0 0
M  V30 27 C 7.2460 5.5383 0.0 0
M  V30 28 N 8.7107 6.0142 0.0 0
M  V30 29 C 9.2154 10.7406 0.0 0
M  V30 30 C 9.9854 12.0744 0.0 0
M  V30 31 C 9.9854 9.4069 0.0 0
M  V30 32 C 11.5254 12.0744 0.0 0
M  V30 33 C 11.5254 9.4069 0.0 0
M  V30 34 C 12.2954 10.7406 0.0 0
M  V30 35 C 9.2154 16.0753 0.0 0
M  V30 36 C 7.6754 16.0753 0.0 0
M  V30 37 C 9.9854 17.4091 0.0 0
M  V30 38 C 6.9054 17.4091 0.0 0
M  V30 39 C 9.2154 18.7427 0.0 0
M  V30 40 C 7.6754 18.7427 0.0 0
M  V30 41 C 16.1454 12.0744 0.0 0
M  V30 42 C 16.9154 10.7406 0.0 0
M  V30 43 C 16.9154 13.4080 0.0 0
M  V30 44 C 18.4554 10.7406 0.0 0
M  V30 45 C 18.4554 13.4080 0.0 0
M  V30 46 C 19.2254 12.0744 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 30
M  V30 8 1 7 35
M  V30 9 1 8 9
M  V30 10 1 8 27
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 2 10 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 33
M  V30 18 1 17 18
M  V30 19 1 17 34
M  V30 20 1 18 41
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 19 24
M  V30 24 1 20 22
M  V30 25 1 20 29
M  V30 26 2 21 23
M  V30 27 1 22 23
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 40
M  V30 45 2 41 42
M  V30 46 1 41 43
M  V30 47 1 42 44
M  V30 48 2 43 45
M  V30 49 2 44 46
M  V30 50 1 45 46
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Ethyl-3′-[(methylamino)methyl]-5-[5-(1-methylethyl)-2,4-bis(phenylmethoxy)p...
C34H36N4O5
1330737-95-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 47 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0596 7.6008 0.0 0
M  V30 2 N 2.6528 8.2273 0.0 0
M  V30 3 O 4.2207 6.0693 0.0 0
M  V30 4 C 1.4069 7.3221 0.0 0
M  V30 5 C 0.0000 7.9484 0.0 0
M  V30 6 O 9.2154 11.9435 0.0 0
M  V30 7 C 9.9854 13.2771 0.0 0
M  V30 8 C 6.7701 2.6091 0.0 0
M  V30 9 N 7.8006 1.4647 0.0 0
M  V30 10 C 7.3247 0.0000 0.0 0
M  V30 11 C 12.2954 6.6088 0.0 0
M  V30 12 C 11.5254 5.2750 0.0 0
M  V30 13 C 13.8354 6.6088 0.0 0
M  V30 14 O 13.8354 9.2760 0.0 0
M  V30 15 C 14.6054 10.6097 0.0 0
M  V30 16 C 6.7701 8.0302 0.0 0
M  V30 17 C 7.6754 9.2760 0.0 0
M  V30 18 C 5.3055 8.5060 0.0 0
M  V30 19 O 6.7701 10.5219 0.0 0
M  V30 20 N 5.3055 10.0460 0.0 0
M  V30 21 C 7.2460 6.5655 0.0 0
M  V30 22 C 6.3408 5.3196 0.0 0
M  V30 23 O 8.7107 6.0896 0.0 0
M  V30 24 C 7.2460 4.0738 0.0 0
M  V30 25 N 8.7107 4.5496 0.0 0
M  V30 26 C 9.2154 9.2760 0.0 0
M  V30 27 C 9.9854 10.6097 0.0 0
M  V30 28 C 9.9854 7.9424 0.0 0
M  V30 29 C 11.5254 10.6097 0.0 0
M  V30 30 C 11.5254 7.9424 0.0 0
M  V30 31 C 12.2954 9.2760 0.0 0
M  V30 32 C 9.2154 14.6108 0.0 0
M  V30 33 C 9.9854 15.9444 0.0 0
M  V30 34 C 7.6754 14.6108 0.0 0
M  V30 35 C 9.2154 17.2782 0.0 0
M  V30 36 C 6.9054 15.9444 0.0 0
M  V30 37 C 7.6754 17.2782 0.0 0
M  V30 38 C 16.1454 10.6097 0.0 0
M  V30 39 C 16.9154 9.2760 0.0 0
M  V30 40 C 16.9154 11.9435 0.0 0
M  V30 41 C 18.4554 9.2760 0.0 0
M  V30 42 C 18.4554 11.9435 0.0 0
M  V30 43 C 19.2254 10.6097 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 27
M  V30 8 1 7 32
M  V30 9 1 8 9
M  V30 10 1 8 24
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 30
M  V30 15 1 14 15
M  V30 16 1 14 31
M  V30 17 1 15 38
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 16 21
M  V30 21 1 17 19
M  V30 22 1 17 26
M  V30 23 2 18 20
M  V30 24 1 19 20
M  V30 25 2 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 25
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 36 2 32 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 36
M  V30 40 2 35 37
M  V30 41 1 36 37
M  V30 42 2 38 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 2 40 42
M  V30 46 2 41 43
M  V30 47 1 42 43
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1330736-89-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1330737-95-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41294318
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of novel heat shock protein (Hsp90) inhibitors based on
luminespib with potent antitumor activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jung, Juyoung; Kwon, Jinsun; Hong, Soojung; Moon, An-Na; Jeong, Jinah;
Kwon, Sungwook; Kim, Jeong-ah; Lee, Myoungjae; Lee, Hongsub; Lee, Jin
Hee; Lee, Jeewoo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2020), 30(12), 127165

$RFMT $RIREG SCHEME252 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Ethyl-5-[5-(1-methylethyl)-2,4-bis(phenylmethoxy)phenyl]-3′-[[(methylsulfon...
C34H35N3O8S
1330736-89-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  46 50 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0596 9.0654 0.0 0
M  V30 2 N 2.6528 9.6918 0.0 0
M  V30 3 O 4.2207 7.5338 0.0 0
M  V30 4 C 1.4069 8.7866 0.0 0
M  V30 5 C 0.0000 9.4129 0.0 0
M  V30 6 O 9.2154 13.4080 0.0 0
M  V30 7 C 9.9854 14.7416 0.0 0
M  V30 8 C 6.7701 4.0738 0.0 0
M  V30 9 O 7.8006 2.9292 0.0 0
M  V30 10 S 7.3247 1.4647 0.0 0 VAL=6
M  V30 11 C 8.7894 0.9888 0.0 0
M  V30 12 O 6.8488 0.0000 0.0 0
M  V30 13 O 5.8602 1.9406 0.0 0
M  V30 14 C 12.2954 8.0733 0.0 0
M  V30 15 C 13.8354 8.0733 0.0 0
M  V30 16 C 11.5254 6.7397 0.0 0
M  V30 17 O 13.8354 10.7406 0.0 0
M  V30 18 C 14.6054 12.0744 0.0 0
M  V30 19 C 6.7701 9.4947 0.0 0
M  V30 20 C 7.6754 10.7406 0.0 0
M  V30 21 C 5.3055 9.9706 0.0 0
M  V30 22 O 6.7701 11.9866 0.0 0
M  V30 23 N 5.3055 11.5106 0.0 0
M  V30 24 C 7.2460 8.0302 0.0 0
M  V30 25 C 6.3408 6.7842 0.0 0
M  V30 26 O 8.7107 7.5542 0.0 0
M  V30 27 C 7.2460 5.5383 0.0 0
M  V30 28 N 8.7107 6.0142 0.0 0
M  V30 29 C 9.2154 10.7406 0.0 0
M  V30 30 C 9.9854 12.0744 0.0 0
M  V30 31 C 9.9854 9.4069 0.0 0
M  V30 32 C 11.5254 12.0744 0.0 0
M  V30 33 C 11.5254 9.4069 0.0 0
M  V30 34 C 12.2954 10.7406 0.0 0
M  V30 35 C 9.2154 16.0753 0.0 0
M  V30 36 C 7.6754 16.0753 0.0 0
M  V30 37 C 9.9854 17.4091 0.0 0
M  V30 38 C 6.9054 17.4091 0.0 0
M  V30 39 C 9.2154 18.7427 0.0 0
M  V30 40 C 7.6754 18.7427 0.0 0
M  V30 41 C 16.1454 12.0744 0.0 0
M  V30 42 C 16.9154 10.7406 0.0 0
M  V30 43 C 16.9154 13.4080 0.0 0
M  V30 44 C 18.4554 10.7406 0.0 0
M  V30 45 C 18.4554 13.4080 0.0 0
M  V30 46 C 19.2254 12.0744 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 30
M  V30 8 1 7 35
M  V30 9 1 8 9
M  V30 10 1 8 27
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 2 10 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 33
M  V30 18 1 17 18
M  V30 19 1 17 34
M  V30 20 1 18 41
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 19 24
M  V30 24 1 20 22
M  V30 25 1 20 29
M  V30 26 2 21 23
M  V30 27 1 22 23
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 40
M  V30 45 2 41 42
M  V30 46 1 41 43
M  V30 47 1 42 44
M  V30 48 2 43 45
M  V30 49 2 44 46
M  V30 50 1 45 46
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Ethyl-3′-[(methylamino)methyl]-5-[5-(1-methylethyl)-2,4-bis(phenylmethoxy)p...
C34H36N4O5
1330737-95-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 47 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0596 7.6008 0.0 0
M  V30 2 N 2.6528 8.2273 0.0 0
M  V30 3 O 4.2207 6.0693 0.0 0
M  V30 4 C 1.4069 7.3221 0.0 0
M  V30 5 C 0.0000 7.9484 0.0 0
M  V30 6 O 9.2154 11.9435 0.0 0
M  V30 7 C 9.9854 13.2771 0.0 0
M  V30 8 C 6.7701 2.6091 0.0 0
M  V30 9 N 7.8006 1.4647 0.0 0
M  V30 10 C 7.3247 0.0000 0.0 0
M  V30 11 C 12.2954 6.6088 0.0 0
M  V30 12 C 11.5254 5.2750 0.0 0
M  V30 13 C 13.8354 6.6088 0.0 0
M  V30 14 O 13.8354 9.2760 0.0 0
M  V30 15 C 14.6054 10.6097 0.0 0
M  V30 16 C 6.7701 8.0302 0.0 0
M  V30 17 C 7.6754 9.2760 0.0 0
M  V30 18 C 5.3055 8.5060 0.0 0
M  V30 19 O 6.7701 10.5219 0.0 0
M  V30 20 N 5.3055 10.0460 0.0 0
M  V30 21 C 7.2460 6.5655 0.0 0
M  V30 22 C 6.3408 5.3196 0.0 0
M  V30 23 O 8.7107 6.0896 0.0 0
M  V30 24 C 7.2460 4.0738 0.0 0
M  V30 25 N 8.7107 4.5496 0.0 0
M  V30 26 C 9.2154 9.2760 0.0 0
M  V30 27 C 9.9854 10.6097 0.0 0
M  V30 28 C 9.9854 7.9424 0.0 0
M  V30 29 C 11.5254 10.6097 0.0 0
M  V30 30 C 11.5254 7.9424 0.0 0
M  V30 31 C 12.2954 9.2760 0.0 0
M  V30 32 C 9.2154 14.6108 0.0 0
M  V30 33 C 9.9854 15.9444 0.0 0
M  V30 34 C 7.6754 14.6108 0.0 0
M  V30 35 C 9.2154 17.2782 0.0 0
M  V30 36 C 6.9054 15.9444 0.0 0
M  V30 37 C 7.6754 17.2782 0.0 0
M  V30 38 C 16.1454 10.6097 0.0 0
M  V30 39 C 16.9154 9.2760 0.0 0
M  V30 40 C 16.9154 11.9435 0.0 0
M  V30 41 C 18.4554 9.2760 0.0 0
M  V30 42 C 18.4554 11.9435 0.0 0
M  V30 43 C 19.2254 10.6097 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 27
M  V30 8 1 7 32
M  V30 9 1 8 9
M  V30 10 1 8 24
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 30
M  V30 15 1 14 15
M  V30 16 1 14 31
M  V30 17 1 15 38
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 16 21
M  V30 21 1 17 19
M  V30 22 1 17 26
M  V30 23 2 18 20
M  V30 24 1 19 20
M  V30 25 2 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 25
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 36 2 32 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 36
M  V30 40 2 35 37
M  V30 41 1 36 37
M  V30 42 2 38 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 2 40 42
M  V30 46 2 41 43
M  V30 47 1 42 43
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1330736-89-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1330737-95-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-11256815
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Step 2:
5-(2,4-bis(benzyloxy)-5-isopropylphenyl)-N-ethyl-3'-(morpholinomethyl)-4,5'-biisoxazole-3-carboxamide.
To a solution of the intermediate compound (Step 1) (866.4mg, 1.34mmol)
in DMF (10.9ml) was added morpholine (458.4μl, 5.36mmol), and the
reaction mixture was left to stir at RT for 2 h. After this time, solvent
was evaporated in vacuo, and the residue was extracted between methylene
chloride and water. The organic phase was dried with magnesium sulfate,
and evaporated in vacuo. The residue was purified by silica gel column
chromatography.
(5-(2,4-bis(benzyloxy)-5-isopropylphenyl)-3-(ethylcarbamoyl)-4,5'-biisoxazol-3'-yl)methyl
methane sulfonate (50.9 mg, 0.08mmol) was reacted with 40% aqueous
methylamine (0.5ml, 0.32mmol) .
5-(2,4-bis(benzyloxy)-5-isopropylphenyl)-N-ethyl-3'-((methylamino)methyl)-4,5'-biisoxazole-3-carboxamide
(45.8 mg, 0.08mmol) in a yield of 99%. 1H-NMR (400 MHz, CDCl3) δ
7.40-7.26 (m, 9H), 7.15 (m, 2H), 6.84 (s, 1H), 6.77 (d, 1H), 6.53 (s,
1H), 5.03 (s, 2H), 4.86 (s, 2H), 3.72 (s, 2H), 3.48 (m, 2H), 3.32 (m,
1H), (2,40 (s, 3H), 1.25 (t, 3H), 1.20 (d, 6H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Five-membered heterocycle derivatives as HSP90 inhibitors and and their
preparation, pharmaceutical compositions and use in the treatment of
cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kang, Jae-Hoon; Lee, Hong-Sub; Kwon, Jin-Sun; Park, Joon-Tae; Hong,
Chang-Sung; Shin, Dong-Hyung; Hong, Soo-Jung; Moon, An-Na; Jeong, Jin-Ah;
Kwon, Sung-Wook
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011102660 A2 2011-08-25

$RFMT $RIREG SCHEME253 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[[[4-Bromo-3-[[(methylsulfonyl)oxy]methyl]phenyl]methyl](methylsulfonyl)ami...
C29H28BrFN2O7S2
1331944-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 16.6111 2.6091 0.0 0
M  V30 2 N 15.5806 1.4645 0.0 0
M  V30 3 O 18.1173 2.2889 0.0 0
M  V30 4 C 16.0565 0.0000 0.0 0
M  V30 5 N 10.6694 6.8595 0.0 0
M  V30 6 C 9.3358 6.0895 0.0 0
M  V30 7 S 10.6694 8.3995 0.0 0 VAL=6
M  V30 8 C 10.6694 9.9395 0.0 0
M  V30 9 O 12.2094 8.3995 0.0 0
M  V30 10 O 9.1294 8.3995 0.0 0
M  V30 11 F 23.2004 5.3195 0.0 0
M  V30 12 C 4.0011 6.0895 0.0 0
M  V30 13 O 2.6674 6.8595 0.0 0
M  V30 14 S 1.3338 6.0895 0.0 0 VAL=6
M  V30 15 C 0.5638 7.4233 0.0 0
M  V30 16 O 0.0000 5.3195 0.0 0
M  V30 17 O 2.1038 4.7558 0.0 0
M  V30 18 Br 4.0011 9.1695 0.0 0
M  V30 19 C 14.6705 4.5495 0.0 0
M  V30 20 C 16.1352 4.0736 0.0 0
M  V30 21 C 14.6705 6.0895 0.0 0
M  V30 22 C 13.3369 3.7795 0.0 0
M  V30 23 C 17.0404 5.3195 0.0 0
M  V30 24 C 13.3369 6.8595 0.0 0
M  V30 25 O 16.1352 6.5655 0.0 0
M  V30 26 C 12.0032 4.5495 0.0 0
M  V30 27 C 12.0032 6.0895 0.0 0
M  V30 28 C 18.5804 5.3195 0.0 0
M  V30 29 C 19.3504 3.9858 0.0 0
M  V30 30 C 19.3504 6.6533 0.0 0
M  V30 31 C 20.8904 3.9858 0.0 0
M  V30 32 C 20.8904 6.6533 0.0 0
M  V30 33 C 21.6604 5.3195 0.0 0
M  V30 34 C 10.6694 3.7795 0.0 0
M  V30 35 C 9.1294 3.7795 0.0 0
M  V30 36 C 9.8994 2.4458 0.0 0
M  V30 37 C 8.0021 6.8595 0.0 0
M  V30 38 C 6.6685 6.0895 0.0 0
M  V30 39 C 8.0021 8.3995 0.0 0
M  V30 40 C 5.3347 6.8595 0.0 0
M  V30 41 C 6.6685 9.1695 0.0 0
M  V30 42 C 5.3347 8.3995 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 27
M  V30 8 1 6 37
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 2 7 10
M  V30 12 1 11 33
M  V30 13 1 12 13
M  V30 14 1 12 40
M  V30 15 1 13 14
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 2 14 17
M  V30 19 1 18 42
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 2 19 22
M  V30 23 2 20 23
M  V30 24 2 21 24
M  V30 25 1 21 25
M  V30 26 1 22 26
M  V30 27 1 23 25
M  V30 28 1 23 28
M  V30 29 1 24 27
M  V30 30 2 26 27
M  V30 31 1 26 34
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 38 1 34 35
M  V30 39 1 34 36
M  V30 40 1 35 36
M  V30 41 2 37 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 2 39 41
M  V30 45 2 40 42
M  V30 46 1 41 42
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[[[4-Bromo-3-[(methylamino)methyl]phenyl]methyl](methylsulfonyl)amino]-5-cy...
C29H29BrFN3O4S
1331944-90-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5892 2.6091 0.0 0
M  V30 2 N 7.6198 1.4645 0.0 0
M  V30 3 O 5.0829 2.2889 0.0 0
M  V30 4 C 7.1438 0.0000 0.0 0
M  V30 5 N 12.5308 6.8595 0.0 0
M  V30 6 C 13.8645 6.0895 0.0 0
M  V30 7 S 12.5308 8.3995 0.0 0 VAL=6
M  V30 8 C 12.5308 9.9395 0.0 0
M  V30 9 O 10.9908 8.3995 0.0 0
M  V30 10 O 14.0708 8.3995 0.0 0
M  V30 11 F 0.0000 5.3195 0.0 0
M  V30 12 C 19.1992 6.0895 0.0 0
M  V30 13 N 20.5328 6.8595 0.0 0
M  V30 14 C 21.8665 6.0895 0.0 0
M  V30 15 Br 19.1992 9.1695 0.0 0
M  V30 16 C 8.5298 4.5495 0.0 0
M  V30 17 C 8.5298 6.0895 0.0 0
M  V30 18 C 7.0651 4.0736 0.0 0
M  V30 19 C 9.8634 3.7795 0.0 0
M  V30 20 C 9.8634 6.8595 0.0 0
M  V30 21 O 7.0651 6.5655 0.0 0
M  V30 22 C 6.1600 5.3195 0.0 0
M  V30 23 C 11.1970 4.5495 0.0 0
M  V30 24 C 11.1970 6.0895 0.0 0
M  V30 25 C 4.6200 5.3195 0.0 0
M  V30 26 C 3.8500 3.9858 0.0 0
M  V30 27 C 3.8500 6.6533 0.0 0
M  V30 28 C 2.3100 3.9858 0.0 0
M  V30 29 C 2.3100 6.6533 0.0 0
M  V30 30 C 1.5400 5.3195 0.0 0
M  V30 31 C 12.5308 3.7795 0.0 0
M  V30 32 C 14.0708 3.7795 0.0 0
M  V30 33 C 13.3008 2.4458 0.0 0
M  V30 34 C 15.1981 6.8595 0.0 0
M  V30 35 C 16.5317 6.0895 0.0 0
M  V30 36 C 15.1981 8.3995 0.0 0
M  V30 37 C 17.8655 6.8595 0.0 0
M  V30 38 C 16.5317 9.1695 0.0 0
M  V30 39 C 17.8655 8.3995 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 24
M  V30 8 1 6 34
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 2 7 10
M  V30 12 1 11 30
M  V30 13 1 12 13
M  V30 14 1 12 37
M  V30 15 1 13 14
M  V30 16 1 15 39
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 2 17 20
M  V30 21 1 17 21
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 1 21 22
M  V30 26 1 22 25
M  V30 27 2 23 24
M  V30 28 1 23 31
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 35 1 31 32
M  V30 36 1 31 33
M  V30 37 1 32 33
M  V30 38 2 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 2 36 38
M  V30 42 2 37 39
M  V30 43 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1331944-88-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1331944-90-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-10607765
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 4:
6-[({4-bromo-3-[(methylamino)methyl]phenyl}methyl)(methylsulfonyl)amino]-5-
cyclopropyl-2-(4-fluorophenyl)-N-methyl-1-benzofuran-3-carboxamide. A
solution of
(2-bromo-5-{[{5-cyclopropyl-2-(4-fluorophenyl)-3-[(methylamino)carbonyl]-1-benzofuran-6-yl}(methylsulfonyl)amino]methyl}phenyl)methyl
methanesulfonate (250 mg, 0.368 mmol) and 2.0M methylamine in THF (4.60
mL, 9.20 mmol) in tetrahydrofuran (4 mL) was maintained with stirring at
room temperature for 1 hour. The mixture was poured into saturated sodium
bicarbonate (aq) and diluted with ethyl acetate. The organic layer was
separated, dried over sodium sulfate, filtered, and taken to a residue
under reduced pressure to afford
6-[({4-bromo-3-[(methylamino)methyl]phenyl}methyl)(methylsulfonyl)amino]-5-cyclopropyl-2-(4-fluorophenyl)-N-methyl-1-benzofuran-3-carboxamide
(224 mg, 0.365 mmol, 99 % yield) as a white solid. LCMS (m/z, ES+) = 615
(M+H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzofuranylaminoalkyl boronic acid derivatives
therapeutic compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Johns, Brian Alvin; Shotwell, John Brad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011103063 A1 2011-08-25

$RFMT $RIREG SCHEME254 STEP1
$RXN



  2  1
$MOL
β-D-Glucopyranoside, 2-(trimethylsilyl)ethyl O-4,7,8,9-tetra-O-acetyl-5-azido...
C65H88N4O25Si
1332865-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  98 104 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 14.6705 12.1414 0.0 0
M  V30 2 C 13.3367 11.3714 0.0 0
M  V30 3 O 14.3952 9.6059 0.0 0
M  V30 4 O 20.0058 12.1420 0.0 0
M  V30 5 C 16.3476 7.8806 0.0 0 CFG=2
M  V30 6 C 16.8744 6.4335 0.0 0 CFG=2
M  V30 7 O 14.8310 8.1478 0.0 0
M  V30 8 C 15.8847 5.2537 0.0 0
M  V30 9 O 18.3910 6.1663 0.0 0
M  V30 10 O 16.4115 3.8067 0.0 0
M  V30 11 C 15.4217 2.6268 0.0 0
M  V30 12 C 15.9487 1.1798 0.0 0
M  V30 13 O 13.9051 2.8941 0.0 0
M  V30 14 C 14.4320 1.4470 0.0 0
M  V30 15 C 14.9590 0.0000 0.0 0
M  V30 16 C 17.4653 0.9126 0.0 0
M  V30 17 C 16.2875 14.6791 0.0 0
M  V30 18 O 15.8891 16.1668 0.0 0
M  V30 19 O 15.1983 13.5904 0.0 0
M  V30 20 C 14.4016 16.5655 0.0 0
M  V30 21 O 10.6694 9.8314 0.0 0
M  V30 22 C 9.3358 9.0614 0.0 0
M  V30 23 O 8.0020 11.3714 0.0 0
M  V30 24 C 6.6684 12.1414 0.0 0
M  V30 25 O 10.6694 15.9914 0.0 0
M  V30 26 C 9.3358 16.7614 0.0 0
M  V30 27 C 9.3358 18.3014 0.0 0
M  V30 28 Si 8.0020 19.0714 0.0 0
M  V30 29 C 6.6684 19.8414 0.0 0
M  V30 30 C 8.7720 20.4050 0.0 0
M  V30 31 C 7.2320 17.7377 0.0 0
M  V30 32 C 23.8466 15.3637 0.0 0 CFG=2
M  V30 33 C 25.1801 14.5935 0.0 0 CFG=2
M  V30 34 O 23.8468 16.9037 0.0 0
M  V30 35 C 26.5139 15.3632 0.0 0
M  V30 36 O 25.1798 13.0535 0.0 0
M  V30 37 C 25.1806 17.6735 0.0 0
M  V30 38 O 27.8475 14.5931 0.0 0
M  V30 39 C 26.5134 12.2832 0.0 0
M  V30 40 C 25.1809 19.2135 0.0 0
M  V30 41 O 26.5142 16.9032 0.0 0
M  V30 42 C 29.1813 15.3627 0.0 0
M  V30 43 C 26.5131 10.7432 0.0 0
M  V30 44 O 27.8472 13.0531 0.0 0
M  V30 45 C 29.1815 16.9027 0.0 0
M  V30 46 O 30.5148 14.5926 0.0 0
M  V30 47 O 19.9433 17.7561 0.0 0
M  V30 48 C 18.4267 18.0237 0.0 0
M  V30 49 C 17.4367 16.8441 0.0 0
M  V30 50 O 17.9002 19.4709 0.0 0
M  V30 51 O 8.0020 14.4514 0.0 0
M  V30 52 C 6.6684 13.6814 0.0 0
M  V30 53 N 22.9764 17.2206 0.0 0
M  V30 54 N 22.4500 18.6679 0.0 0 CHG=1 VAL=4
M  V30 55 N 21.9235 20.1150 0.0 0 CHG=-1
M  V30 56 O 1.3336 16.7614 0.0 0
M  V30 57 C 0.0000 15.9914 0.0 0
M  V30 58 C 16.0042 11.3714 0.0 0 CFG=1
M  V30 59 C 17.3384 12.1423 0.0 0
M  V30 60 O 16.0037 9.8304 0.0 0
M  V30 61 C 16.5664 10.3947 0.0 0
M  V30 62 C 18.6721 11.3723 0.0 0 CFG=2
M  V30 63 C 17.3373 9.0604 0.0 0 CFG=1
M  V30 64 N 17.5445 9.8300 0.0 0
M  V30 65 C 18.6714 9.8314 0.0 0 CFG=1
M  V30 66 C 12.0031 12.1414 0.0 0 CFG=1
M  V30 67 C 10.6694 11.3714 0.0 0 CFG=1
M  V30 68 O 12.0031 13.6814 0.0 0
M  V30 69 C 9.3358 12.1414 0.0 0 CFG=2
M  V30 70 C 10.6694 14.4514 0.0 0 CFG=1
M  V30 71 C 9.3358 13.6814 0.0 0 CFG=1
M  V30 72 C 20.0062 13.6820 0.0 0 CFG=2
M  V30 73 O 21.5226 13.4143 0.0 0
M  V30 74 C 19.4796 15.1293 0.0 0
M  V30 75 C 22.5128 14.5940 0.0 0 CFG=1
M  V30 76 C 20.4697 16.3088 0.0 0 CFG=2
M  V30 77 C 21.9863 16.0411 0.0 0 CFG=2
M  V30 78 C 9.3358 7.5214 0.0 0
M  V30 79 C 8.0020 6.7514 0.0 0
M  V30 80 C 10.6694 6.7514 0.0 0
M  V30 81 C 8.0020 5.2114 0.0 0
M  V30 82 C 10.6694 5.2114 0.0 0
M  V30 83 C 9.3358 4.4414 0.0 0
M  V30 84 C 5.3347 11.3714 0.0 0
M  V30 85 C 4.0011 12.1414 0.0 0
M  V30 86 C 5.3347 9.8314 0.0 0
M  V30 87 C 2.6673 11.3714 0.0 0
M  V30 88 C 4.0011 9.0614 0.0 0
M  V30 89 C 2.6673 9.8314 0.0 0
M  V30 90 C 5.3347 14.4514 0.0 0
M  V30 91 C 5.3347 15.9914 0.0 0
M  V30 92 C 4.0011 13.6814 0.0 0
M  V30 93 C 4.0011 16.7614 0.0 0
M  V30 94 C 2.6673 14.4514 0.0 0
M  V30 95 C 2.6673 15.9914 0.0 0
M  V30 96 H 18.3274 7.8810 0.0 0
M  V30 97 H 20.0052 9.0614 0.0 0
M  V30 98 H 23.5024 13.4140 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 58
M  V30 3 1 66 2 CFG=3
M  V30 4 2 3 61
M  V30 5 1 62 4 CFG=3
M  V30 6 1 72 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 5 7 CFG=1
M  V30 9 1 5 63
M  V30 10 1 6 8
M  V30 11 1 6 9 CFG=3
M  V30 12 1 8 10
M  V30 13 1 10 11
M  V30 14 1 11 12
M  V30 15 2 11 13
M  V30 16 1 12 14
M  V30 17 1 12 15
M  V30 18 1 12 16
M  V30 19 1 17 18
M  V30 20 2 17 19
M  V30 21 1 72 17 CFG=1
M  V30 22 1 18 20
M  V30 23 1 21 22
M  V30 24 1 67 21 CFG=1
M  V30 25 1 22 78
M  V30 26 1 23 24
M  V30 27 1 69 23 CFG=3
M  V30 28 1 24 84
M  V30 29 1 25 26
M  V30 30 1 70 25 CFG=3
M  V30 31 1 26 27
M  V30 32 1 27 28
M  V30 33 1 28 29
M  V30 34 1 28 30
M  V30 35 1 28 31
M  V30 36 1 32 33
M  V30 37 1 32 34 CFG=3
M  V30 38 1 32 75
M  V30 39 1 33 35
M  V30 40 1 33 36 CFG=1
M  V30 41 1 34 37
M  V30 42 1 35 38
M  V30 43 1 36 39
M  V30 44 1 37 40
M  V30 45 2 37 41
M  V30 46 1 38 42
M  V30 47 1 39 43
M  V30 48 2 39 44
M  V30 49 1 42 45
M  V30 50 2 42 46
M  V30 51 1 47 48
M  V30 52 1 76 47 CFG=3
M  V30 53 1 48 49
M  V30 54 2 48 50
M  V30 55 1 51 52
M  V30 56 1 71 51 CFG=1
M  V30 57 1 52 90
M  V30 58 2 53 54
M  V30 59 1 77 53 CFG=1
M  V30 60 2 54 55
M  V30 61 1 56 57
M  V30 62 1 56 95
M  V30 63 1 58 59
M  V30 64 1 58 60
M  V30 65 1 58 61 CFG=1
M  V30 66 1 59 62
M  V30 67 1 60 63
M  V30 68 1 61 64
M  V30 69 1 62 65
M  V30 70 1 63 65
M  V30 71 1 63 96 CFG=1
M  V30 72 1 65 64 CFG=1
M  V30 73 1 65 97
M  V30 74 1 66 67
M  V30 75 1 66 68
M  V30 76 1 67 69
M  V30 77 1 68 70
M  V30 78 1 69 71
M  V30 79 1 70 71
M  V30 80 1 72 73
M  V30 81 1 72 74
M  V30 82 1 73 75
M  V30 83 1 74 76
M  V30 84 1 75 77
M  V30 85 1 75 98 CFG=1
M  V30 86 1 76 77
M  V30 87 2 78 79
M  V30 88 1 78 80
M  V30 89 1 79 81
M  V30 90 2 80 82
M  V30 91 2 81 83
M  V30 92 1 82 83
M  V30 93 2 84 85
M  V30 94 1 84 86
M  V30 95 1 85 87
M  V30 96 2 86 88
M  V30 97 2 87 89
M  V30 98 1 88 89
M  V30 99 2 90 91
M  V30 100 1 90 92
M  V30 101 1 91 93
M  V30 102 2 92 94
M  V30 103 2 93 95
M  V30 104 1 94 95
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(17 5 6 32 33 58 62 63 65 66 67 69 70 71 72 75 76 77)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Hydrazine, acetate (1:1)
C2H4O2.H4N2
7335-65-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.5637 3.8501 0.0 0
M  V30 2 N 2.1037 3.8501 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 O 2.6673 2.3101 0.0 0
M  V30 6 O 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 3 4
M  V30 3 1 3 5
M  V30 4 2 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
β-D-Glucopyranoside, 2-(trimethylsilyl)ethyl O-4,7,8,9-tetra-O-acetyl-5-azido...
C69H92N4O27Si
1332865-62-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  104 110 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 14.5109 10.3162 0.0 0
M  V30 2 C 15.8445 9.5462 0.0 0
M  V30 3 O 14.7861 7.7809 0.0 0
M  V30 4 C 12.8338 6.0555 0.0 0 CFG=2
M  V30 5 C 12.3068 4.6085 0.0 0 CFG=2
M  V30 6 O 14.3504 6.3228 0.0 0
M  V30 7 C 10.7902 4.3411 0.0 0
M  V30 8 O 13.2966 3.4285 0.0 0
M  V30 9 C 15.3402 5.1429 0.0 0
M  V30 10 O 10.2634 2.8941 0.0 0
M  V30 11 C 12.7697 1.9815 0.0 0
M  V30 12 C 14.8133 3.6959 0.0 0
M  V30 13 O 16.8568 5.4102 0.0 0
M  V30 14 C 8.7466 2.6268 0.0 0
M  V30 15 C 11.2531 1.7143 0.0 0
M  V30 16 O 13.7595 0.8017 0.0 0
M  V30 17 C 8.2198 1.1798 0.0 0
M  V30 18 O 7.7569 3.8066 0.0 0
M  V30 19 C 7.2300 2.3596 0.0 0
M  V30 20 C 6.7032 0.9125 0.0 0
M  V30 21 C 9.2095 0.0000 0.0 0
M  V30 22 O 9.1754 10.3170 0.0 0
M  V30 23 C 12.1500 12.6545 0.0 0
M  V30 24 O 12.5484 14.1422 0.0 0
M  V30 25 O 13.2393 11.5658 0.0 0
M  V30 26 C 14.0359 14.5411 0.0 0
M  V30 27 O 18.5118 8.0062 0.0 0
M  V30 28 C 19.8456 7.2362 0.0 0
M  V30 29 O 21.1792 9.5462 0.0 0
M  V30 30 C 22.5129 10.3162 0.0 0
M  V30 31 O 18.5118 14.1662 0.0 0
M  V30 32 C 17.1782 14.9362 0.0 0
M  V30 33 C 17.1782 16.4762 0.0 0
M  V30 34 Si 15.8445 17.2462 0.0 0
M  V30 35 C 14.5109 18.0162 0.0 0
M  V30 36 C 16.6145 18.5799 0.0 0
M  V30 37 C 15.0745 15.9126 0.0 0
M  V30 38 C 5.3347 13.5385 0.0 0 CFG=2
M  V30 39 C 4.0011 12.7683 0.0 0 CFG=2
M  V30 40 O 5.3344 15.0785 0.0 0
M  V30 41 C 4.0014 11.2283 0.0 0
M  V30 42 O 2.6673 13.5380 0.0 0
M  V30 43 C 4.0006 15.8484 0.0 0
M  V30 44 O 2.6679 10.4580 0.0 0
M  V30 45 C 1.3338 12.7679 0.0 0
M  V30 46 C 4.0003 17.3884 0.0 0
M  V30 47 O 2.6671 15.0781 0.0 0
M  V30 48 C 2.6681 8.9180 0.0 0
M  V30 49 C 1.3340 11.2279 0.0 0
M  V30 50 O 0.0000 13.5377 0.0 0
M  V30 51 C 4.0019 8.1483 0.0 0
M  V30 52 O 1.3346 8.1479 0.0 0
M  V30 53 O 9.2380 15.9309 0.0 0
M  V30 54 C 10.7546 16.1986 0.0 0
M  V30 55 C 11.2810 17.6459 0.0 0
M  V30 56 O 11.7447 15.0191 0.0 0
M  V30 57 O 21.1792 12.6262 0.0 0
M  V30 58 C 21.1792 14.1662 0.0 0
M  V30 59 N 6.2048 15.3956 0.0 0
M  V30 60 N 6.7314 16.8427 0.0 0 CHG=1 VAL=4
M  V30 61 N 7.2577 18.2900 0.0 0 CHG=-1
M  V30 62 O 26.5140 17.2462 0.0 0
M  V30 63 C 27.8476 16.4762 0.0 0
M  V30 64 C 13.1771 9.5462 0.0 0 CFG=2
M  V30 65 O 13.1777 8.0053 0.0 0
M  V30 66 C 11.8430 10.3171 0.0 0
M  V30 67 C 12.6148 8.5695 0.0 0
M  V30 68 C 11.8440 7.2353 0.0 0 CFG=1
M  V30 69 C 10.5093 9.5471 0.0 0 CFG=2
M  V30 70 N 11.6368 8.0048 0.0 0
M  V30 71 C 10.5098 8.0062 0.0 0 CFG=2
M  V30 72 C 17.1782 10.3162 0.0 0 CFG=1
M  V30 73 C 18.5118 9.5462 0.0 0 CFG=1
M  V30 74 O 17.1782 11.8562 0.0 0
M  V30 75 C 19.8456 10.3162 0.0 0 CFG=2
M  V30 76 C 18.5118 12.6262 0.0 0 CFG=1
M  V30 77 C 19.8456 11.8562 0.0 0 CFG=1
M  V30 78 C 9.1752 11.8570 0.0 0 CFG=2
M  V30 79 O 7.6586 11.5892 0.0 0
M  V30 80 C 9.7016 13.3041 0.0 0
M  V30 81 C 6.6685 12.7688 0.0 0 CFG=1
M  V30 82 C 8.7115 14.4836 0.0 0 CFG=2
M  V30 83 C 7.1949 14.2160 0.0 0 CFG=2
M  V30 84 C 19.8456 5.6962 0.0 0
M  V30 85 C 21.1792 4.9262 0.0 0
M  V30 86 C 18.5118 4.9262 0.0 0
M  V30 87 C 21.1792 3.3862 0.0 0
M  V30 88 C 18.5118 3.3862 0.0 0
M  V30 89 C 19.8456 2.6162 0.0 0
M  V30 90 C 23.8465 9.5462 0.0 0
M  V30 91 C 23.8465 8.0062 0.0 0
M  V30 92 C 25.1803 10.3162 0.0 0
M  V30 93 C 25.1803 7.2362 0.0 0
M  V30 94 C 26.5140 9.5462 0.0 0
M  V30 95 C 26.5140 8.0062 0.0 0
M  V30 96 C 22.5129 14.9362 0.0 0
M  V30 97 C 22.5129 16.4762 0.0 0
M  V30 98 C 23.8467 14.1662 0.0 0
M  V30 99 C 23.8467 17.2462 0.0 0
M  V30 100 C 25.1803 14.9362 0.0 0
M  V30 101 C 25.1803 16.4762 0.0 0
M  V30 102 H 10.8538 6.0558 0.0 0
M  V30 103 H 9.1761 7.2362 0.0 0
M  V30 104 H 5.6788 11.5889 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 64
M  V30 3 1 72 2 CFG=1
M  V30 4 2 3 67
M  V30 5 1 4 5
M  V30 6 1 4 6 CFG=3
M  V30 7 1 4 68
M  V30 8 1 5 7
M  V30 9 1 5 8 CFG=3
M  V30 10 1 6 9
M  V30 11 1 7 10
M  V30 12 1 8 11
M  V30 13 1 9 12
M  V30 14 2 9 13
M  V30 15 1 10 14
M  V30 16 1 11 15
M  V30 17 2 11 16
M  V30 18 1 14 17
M  V30 19 2 14 18
M  V30 20 1 17 19
M  V30 21 1 17 20
M  V30 22 1 17 21
M  V30 23 1 69 22 CFG=1
M  V30 24 1 78 22 CFG=1
M  V30 25 1 23 24
M  V30 26 2 23 25
M  V30 27 1 78 23 CFG=3
M  V30 28 1 24 26
M  V30 29 1 27 28
M  V30 30 1 73 27 CFG=3
M  V30 31 1 28 84
M  V30 32 1 29 30
M  V30 33 1 75 29 CFG=1
M  V30 34 1 30 90
M  V30 35 1 31 32
M  V30 36 1 76 31 CFG=1
M  V30 37 1 32 33
M  V30 38 1 33 34
M  V30 39 1 34 35
M  V30 40 1 34 36
M  V30 41 1 34 37
M  V30 42 1 38 39
M  V30 43 1 38 40 CFG=1
M  V30 44 1 38 81
M  V30 45 1 39 41
M  V30 46 1 39 42 CFG=1
M  V30 47 1 40 43
M  V30 48 1 41 44
M  V30 49 1 42 45
M  V30 50 1 43 46
M  V30 51 2 43 47
M  V30 52 1 44 48
M  V30 53 1 45 49
M  V30 54 2 45 50
M  V30 55 1 48 51
M  V30 56 2 48 52
M  V30 57 1 53 54
M  V30 58 1 82 53 CFG=1
M  V30 59 1 54 55
M  V30 60 2 54 56
M  V30 61 1 57 58
M  V30 62 1 77 57 CFG=3
M  V30 63 1 58 96
M  V30 64 2 59 60
M  V30 65 1 83 59 CFG=3
M  V30 66 2 60 61
M  V30 67 1 62 63
M  V30 68 1 62 101
M  V30 69 1 64 65
M  V30 70 1 64 66
M  V30 71 1 64 67 CFG=3
M  V30 72 1 65 68
M  V30 73 1 66 69
M  V30 74 1 67 70
M  V30 75 1 68 71
M  V30 76 1 68 102 CFG=3
M  V30 77 1 69 71
M  V30 78 1 71 70 CFG=3
M  V30 79 1 71 103
M  V30 80 1 72 73
M  V30 81 1 72 74
M  V30 82 1 73 75
M  V30 83 1 74 76
M  V30 84 1 75 77
M  V30 85 1 76 77
M  V30 86 1 78 79
M  V30 87 1 78 80
M  V30 88 1 79 81
M  V30 89 1 80 82
M  V30 90 1 81 83
M  V30 91 1 81 104 CFG=3
M  V30 92 1 82 83
M  V30 93 2 84 85
M  V30 94 1 84 86
M  V30 95 1 85 87
M  V30 96 2 86 88
M  V30 97 2 87 89
M  V30 98 1 88 89
M  V30 99 2 90 91
M  V30 100 1 90 92
M  V30 101 1 91 93
M  V30 102 2 92 94
M  V30 103 2 93 95
M  V30 104 1 94 95
M  V30 105 2 96 97
M  V30 106 1 96 98
M  V30 107 1 97 99
M  V30 108 2 98 100
M  V30 109 2 99 101
M  V30 110 1 100 101
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(17 4 5 38 39 64 68 69 71 72 73 75 76 77 78 81 82 83)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1332865-52-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 7335-65-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1332865-62-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-370273
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of the glycan moiety of ganglioside HPG-7 with an unusual
trimer of sialic acid as the inner sugar residue
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Iwayama, Yuki; Ando, Hiromune; Tanaka, Hide-Nori; Ishida, Hideharu; Kiso,
Makoto
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2011), 47(34),
9726-9728

$RFMT $RIREG SCHEME255 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[1-[(2-Bromophenyl)methyl]-1H-pyrrol-2-yl]-2,2,2-trichloroethanone
C13H9BrCl3NO
1333169-29-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9521 3.0176 0.0 0
M  V30 2 C 9.4584 3.3378 0.0 0
M  V30 3 O 7.4762 1.5529 0.0 0
M  V30 4 Cl 9.7785 1.8314 0.0 0
M  V30 5 Cl 10.9648 3.6580 0.0 0
M  V30 6 Cl 9.1382 4.8441 0.0 0
M  V30 7 C 4.6200 2.6674 0.0 0
M  V30 8 Br 3.0800 0.0000 0.0 0
M  V30 9 C 6.9215 4.1620 0.0 0
M  V30 10 N 5.3900 4.0011 0.0 0
M  V30 11 C 7.2418 5.6684 0.0 0
M  V30 12 C 4.7637 5.4079 0.0 0
M  V30 13 C 5.9081 6.4384 0.0 0
M  V30 14 C 3.0800 2.6674 0.0 0
M  V30 15 C 2.3100 1.3336 0.0 0
M  V30 16 C 2.3100 4.0011 0.0 0
M  V30 17 C 0.7700 1.3336 0.0 0
M  V30 18 C 0.7700 4.0011 0.0 0
M  V30 19 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 7 10
M  V30 8 1 7 14
M  V30 9 1 8 15
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(2-Bromophenyl)methyl]-N-methyl-1H-pyrrole-2-carboxamide
C13H13BrN2O
1333169-36-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 3.7710 0.0 0
M  V30 2 C 7.9521 3.4208 0.0 0
M  V30 3 N 9.4584 3.1006 0.0 0
M  V30 4 O 7.4762 4.8855 0.0 0
M  V30 5 C 10.4889 4.2450 0.0 0
M  V30 6 Br 3.0800 6.4384 0.0 0
M  V30 7 N 5.3900 2.4374 0.0 0
M  V30 8 C 6.9217 2.2764 0.0 0
M  V30 9 C 4.7637 1.0306 0.0 0
M  V30 10 C 7.2419 0.7700 0.0 0
M  V30 11 C 5.9081 0.0000 0.0 0
M  V30 12 C 3.0800 3.7710 0.0 0
M  V30 13 C 2.3100 5.1048 0.0 0
M  V30 14 C 2.3100 2.4374 0.0 0
M  V30 15 C 0.7700 5.1048 0.0 0
M  V30 16 C 0.7700 2.4374 0.0 0
M  V30 17 C 0.0000 3.7710 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 8
M  V30 6 1 3 5
M  V30 7 1 6 13
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1333169-29-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1333169-36-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-3785829
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for Conversion of
Trichloroacetyl to Amide. The substrate (0.2 mmol) was treated with 2 M
MeNH2 in THF (0.5 mL) at room temperature for 3-5 h. The reaction mixture
was then concentrated followed by column chromatography purification on
silica gel (hexanes/ethyl acetate) to give the title compound.
(R)-1-(2-Bromobenzyl)-1H-pyrrol-N-methyl-2-carboxamide (1p): white solid;
99% yield. mp 96-98 ºC; IR (KBr, cm-1) 1028, 1260, 1542, 1647, 3020,
3469; 1H NMR(500 MHz, CDCl3) δ 2.90 (d, J=5.0Hz, 3H),5.68 (s, 2H), 5.87
(br, 1H), 6.17 (dd, J = 4.0, 2.5 Hz, 1H), 6.58 (dd, J = 4.0, 1.5 Hz, 1H),
6.62 (dd, J=8.0, 1.0Hz, 1H), 6.77(dd, J = 2.5, 1.5 Hz, 1H), 7.10 (dt, J =
8.0, 2.0Hz, 1H), 7.18 (dt, J = 8.0, 2.0 Hz, 1H), 7.54 (dd, J = 8.0, 1.0
Hz, 1H); 13C NMR(100 MHz, CDCl3) δ 26.2, 52.2, 108.2, 111.9, 122.3,
126.0, 127.3, 127.8, 128.1, 128.8, 132.6, 138.5, 162.5. Anal. Calcd for
C13H13N2OBr: C, 53.26; H, 4.47; N, 9.56. Found: C, 53.14; H, 4.53; N,
9.59.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of fused imidazoles, pyrroles, and indoles with a defined
stereocenter α to nitrogen utilizing Mitsunobu alkylation followed by
palladium-catalyzed cyclization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Laha, Joydev K.; Cuny, Gregory D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2011), 76(20), 8477-8482

$RFMT $RIREG SCHEME256 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(4R,5S)-4-(3-Buten-1-yl)tetrahydro-5-methyl-2H-pyran-2-one
C10H16O2
1341210-96-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.6200 0.0 0
M  V30 2 C 5.3347 3.8500 0.0 0
M  V30 3 C 6.6685 4.6200 0.0 0
M  V30 4 C 8.0021 3.8500 0.0 0
M  V30 5 C 1.3336 6.1600 0.0 0
M  V30 6 O 1.3336 0.0000 0.0 0
M  V30 7 C 2.6674 3.8500 0.0 0 CFG=1
M  V30 8 C 1.3336 4.6200 0.0 0 CFG=1
M  V30 9 C 2.6674 2.3100 0.0 0
M  V30 10 C 0.0000 3.8500 0.0 0
M  V30 11 C 1.3336 1.5400 0.0 0
M  V30 12 O 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 7 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 8 5 CFG=3
M  V30 6 2 6 11
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 7 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(3S)-3-[(1R)-2-Hydroxy-1-methylethyl]-N-methyl-6-heptenamide
C11H21NO2
1341210-97-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0 CFG=1
M  V30 2 C 6.1600 4.0011 0.0 0
M  V30 3 C 3.8500 5.3347 0.0 0
M  V30 4 C 3.8500 2.6674 0.0 0 CFG=1
M  V30 5 C 6.9300 5.3347 0.0 0
M  V30 6 C 2.3100 5.3347 0.0 0
M  V30 7 C 4.6200 1.3338 0.0 0
M  V30 8 C 2.3100 2.6674 0.0 0
M  V30 9 N 8.4700 5.3347 0.0 0
M  V30 10 O 6.1600 6.6685 0.0 0
M  V30 11 C 1.5400 6.6685 0.0 0
M  V30 12 O 3.8500 0.0000 0.0 0
M  V30 13 C 9.2400 6.6685 0.0 0
M  V30 14 C 0.0000 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8 CFG=3
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 9 13
M  V30 13 2 11 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1341210-96-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1341210-97-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-6424739
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM autoclave used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Alkaloid synthesis using 2nd generation palladium-catalyzed
cycloalkenylation. Diastereoselective total synthesis of α-skytanthine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Takeda, Kazutaka; Toyota, Masahiro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2011), 52(44), 5872-5875

$RFMT $RIREG SCHEME257 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-(3-bromopropyl)-N-[(2,3-dihydro-1,4-benzodioxin-6-yl)meth...
C17H24BrNO4
1346696-08-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 6.6684 0.0 0
M  V30 2 N 7.7000 5.3347 0.0 0
M  V30 3 C 9.2400 5.3347 0.0 0
M  V30 4 C 6.9300 4.0011 0.0 0
M  V30 5 O 10.0100 6.6684 0.0 0
M  V30 6 O 10.0100 4.0011 0.0 0
M  V30 7 C 7.7000 2.6674 0.0 0
M  V30 8 C 11.5500 6.6684 0.0 0
M  V30 9 C 6.9300 1.3336 0.0 0
M  V30 10 C 11.5500 8.2084 0.0 0
M  V30 11 C 13.0900 6.6684 0.0 0
M  V30 12 C 11.5500 5.1284 0.0 0
M  V30 13 Br 7.7000 0.0000 0.0 0
M  V30 14 C 3.0800 8.0021 0.0 0
M  V30 15 C 2.3100 6.6684 0.0 0
M  V30 16 C 4.6200 8.0021 0.0 0
M  V30 17 O 2.3100 9.3358 0.0 0
M  V30 18 C 3.0800 5.3347 0.0 0
M  V30 19 O 0.7700 6.6684 0.0 0
M  V30 20 C 5.3900 6.6684 0.0 0
M  V30 21 C 0.7700 9.3358 0.0 0
M  V30 22 C 4.6200 5.3347 0.0 0
M  V30 23 C 0.0000 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 17
M  V30 17 2 15 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 2 20 22
M  V30 24 1 21 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(2,3-dihydro-1,4-benzodioxin-6-yl)methyl]-N-[3-(methylam...
C18H28N2O4
1346695-94-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 6.6684 0.0 0
M  V30 2 N 7.7000 5.3347 0.0 0
M  V30 3 C 6.9300 4.0011 0.0 0
M  V30 4 C 9.2400 5.3347 0.0 0
M  V30 5 O 7.7000 2.6674 0.0 0
M  V30 6 O 5.3900 4.0011 0.0 0
M  V30 7 C 10.0100 6.6684 0.0 0
M  V30 8 C 6.9300 1.3336 0.0 0
M  V30 9 C 11.5500 6.6684 0.0 0
M  V30 10 C 5.5964 2.1036 0.0 0
M  V30 11 C 6.1600 0.0000 0.0 0
M  V30 12 C 8.2636 0.5636 0.0 0
M  V30 13 N 12.3200 8.0021 0.0 0
M  V30 14 C 13.8600 8.0021 0.0 0
M  V30 15 C 3.0800 8.0021 0.0 0
M  V30 16 C 2.3100 6.6684 0.0 0
M  V30 17 C 4.6200 8.0021 0.0 0
M  V30 18 O 2.3100 9.3358 0.0 0
M  V30 19 C 3.0800 5.3347 0.0 0
M  V30 20 O 0.7700 6.6684 0.0 0
M  V30 21 C 5.3900 6.6684 0.0 0
M  V30 22 C 0.7700 9.3358 0.0 0
M  V30 23 C 4.6200 5.3347 0.0 0
M  V30 24 C 0.0000 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 13 14
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 1 15 18
M  V30 18 2 16 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1346696-08-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1346695-94-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-4277711
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification and SAR of selective inducible nitric oxide synthase
(iNOS) dimerization inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gahman, Timothy C.; Herbert, Mark R.; Lang, Henk; Thayer, Angie; Symons,
Kent T.; Nguyen, Phan Manh; Massari, Mark E.; Dozier, Sara; Zhang, Yan;
Sablad, Marciano; Rao, Tadimeti S.; Noble, Stewart A.; Shiau, Andrew K.;
Hassig, Christian A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2011), 21(22), 6888-6894

$RFMT $RIREG SCHEME258 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-(3-bromopropyl)-N-[(4-methoxyphenyl)methyl]carbamate
C16H24BrNO3
1346696-09-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.7000 5.3347 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 C 6.9300 6.6685 0.0 0
M  V30 4 C 9.2400 5.3347 0.0 0
M  V30 5 O 7.7000 2.6674 0.0 0
M  V30 6 O 5.3900 4.0011 0.0 0
M  V30 7 C 10.0100 6.6685 0.0 0
M  V30 8 C 6.9300 1.3336 0.0 0
M  V30 9 C 11.5500 6.6685 0.0 0
M  V30 10 C 8.2636 0.5636 0.0 0
M  V30 11 C 6.1600 0.0000 0.0 0
M  V30 12 C 5.5964 2.1036 0.0 0
M  V30 13 Br 12.3200 8.0021 0.0 0
M  V30 14 O 0.7700 6.6685 0.0 0
M  V30 15 C 0.0000 8.0021 0.0 0
M  V30 16 C 5.3900 6.6685 0.0 0
M  V30 17 C 4.6200 8.0021 0.0 0
M  V30 18 C 4.6200 5.3347 0.0 0
M  V30 19 C 3.0800 8.0021 0.0 0
M  V30 20 C 3.0800 5.3347 0.0 0
M  V30 21 C 2.3100 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 16
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 14 15
M  V30 15 1 14 21
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 18 20
M  V30 20 2 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(4-methoxyphenyl)methyl]-N-[3-(methylamino)propyl]carbamate
C17H28N2O3
1346695-95-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.7000 5.3347 0.0 0
M  V30 2 C 6.9300 6.6685 0.0 0
M  V30 3 C 6.9300 4.0011 0.0 0
M  V30 4 C 9.2400 5.3347 0.0 0
M  V30 5 O 7.7000 2.6674 0.0 0
M  V30 6 O 5.3900 4.0011 0.0 0
M  V30 7 C 10.0100 6.6685 0.0 0
M  V30 8 C 6.9300 1.3336 0.0 0
M  V30 9 C 11.5500 6.6685 0.0 0
M  V30 10 C 5.5964 2.1036 0.0 0
M  V30 11 C 6.1600 0.0000 0.0 0
M  V30 12 C 8.2636 0.5636 0.0 0
M  V30 13 N 12.3200 8.0021 0.0 0
M  V30 14 C 13.8600 8.0021 0.0 0
M  V30 15 O 0.7700 6.6685 0.0 0
M  V30 16 C 0.0000 8.0021 0.0 0
M  V30 17 C 5.3900 6.6685 0.0 0
M  V30 18 C 4.6200 8.0021 0.0 0
M  V30 19 C 4.6200 5.3347 0.0 0
M  V30 20 C 3.0800 8.0021 0.0 0
M  V30 21 C 3.0800 5.3347 0.0 0
M  V30 22 C 2.3100 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 17
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 13 14
M  V30 15 1 15 16
M  V30 16 1 15 22
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1346696-09-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1346695-95-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-6327686
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification and SAR of selective inducible nitric oxide synthase
(iNOS) dimerization inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gahman, Timothy C.; Herbert, Mark R.; Lang, Henk; Thayer, Angie; Symons,
Kent T.; Nguyen, Phan Manh; Massari, Mark E.; Dozier, Sara; Zhang, Yan;
Sablad, Marciano; Rao, Tadimeti S.; Noble, Stewart A.; Shiau, Andrew K.;
Hassig, Christian A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2011), 21(22), 6888-6894

$RFMT $RIREG SCHEME259 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-(3-bromopropyl)-N-[(3,4-dimethoxyphenyl)methyl]carbamate
C17H26BrNO4
1346696-10-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 6.6684 0.0 0
M  V30 2 N 7.7000 5.3347 0.0 0
M  V30 3 C 9.2400 5.3347 0.0 0
M  V30 4 C 6.9300 4.0011 0.0 0
M  V30 5 O 10.0100 6.6684 0.0 0
M  V30 6 O 10.0100 4.0011 0.0 0
M  V30 7 C 7.7000 2.6673 0.0 0
M  V30 8 C 11.5500 6.6684 0.0 0
M  V30 9 C 6.9300 1.3336 0.0 0
M  V30 10 C 11.5500 5.1284 0.0 0
M  V30 11 C 13.0900 6.6684 0.0 0
M  V30 12 C 11.5500 8.2084 0.0 0
M  V30 13 Br 7.7000 0.0000 0.0 0
M  V30 14 O 2.3100 9.3358 0.0 0
M  V30 15 C 3.0800 10.6694 0.0 0
M  V30 16 O 0.7700 6.6684 0.0 0
M  V30 17 C 0.0000 5.3347 0.0 0
M  V30 18 C 5.3900 6.6684 0.0 0
M  V30 19 C 4.6200 8.0021 0.0 0
M  V30 20 C 4.6200 5.3347 0.0 0
M  V30 21 C 3.0800 8.0021 0.0 0
M  V30 22 C 3.0800 5.3347 0.0 0
M  V30 23 C 2.3100 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 14 15
M  V30 15 1 14 21
M  V30 16 1 16 17
M  V30 17 1 16 23
M  V30 18 2 18 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 2 20 22
M  V30 22 2 21 23
M  V30 23 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(3,4-dimethoxyphenyl)methyl]-N-[3-(methylamino)propyl]ca...
C18H30N2O4
1346695-96-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 9.3359 0.0 0
M  V30 2 C 3.0800 10.6695 0.0 0
M  V30 3 O 0.7700 6.6684 0.0 0
M  V30 4 C 0.0000 5.3348 0.0 0
M  V30 5 C 6.9301 6.6684 0.0 0
M  V30 6 N 7.7001 5.3348 0.0 0
M  V30 7 C 6.9301 4.0011 0.0 0
M  V30 8 C 9.2401 5.3348 0.0 0
M  V30 9 O 7.7001 2.6673 0.0 0
M  V30 10 O 5.3901 4.0011 0.0 0
M  V30 11 C 10.0101 6.6684 0.0 0
M  V30 12 C 6.9301 1.3337 0.0 0
M  V30 13 C 11.5501 6.6684 0.0 0
M  V30 14 C 8.2637 0.5636 0.0 0
M  V30 15 C 6.1601 0.0000 0.0 0
M  V30 16 C 5.5964 2.1037 0.0 0
M  V30 17 N 12.3201 8.0022 0.0 0
M  V30 18 C 13.8602 8.0022 0.0 0
M  V30 19 C 3.0800 8.0022 0.0 0
M  V30 20 C 2.3100 6.6684 0.0 0
M  V30 21 C 4.6201 8.0022 0.0 0
M  V30 22 C 3.0800 5.3348 0.0 0
M  V30 23 C 5.3901 6.6684 0.0 0
M  V30 24 C 4.6201 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 3 4
M  V30 4 1 3 20
M  V30 5 1 5 6
M  V30 6 1 5 23
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 17 18
M  V30 19 2 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 21 23
M  V30 23 2 22 24
M  V30 24 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1346696-10-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1346695-96-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-8455751
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification and SAR of selective inducible nitric oxide synthase
(iNOS) dimerization inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gahman, Timothy C.; Herbert, Mark R.; Lang, Henk; Thayer, Angie; Symons,
Kent T.; Nguyen, Phan Manh; Massari, Mark E.; Dozier, Sara; Zhang, Yan;
Sablad, Marciano; Rao, Tadimeti S.; Noble, Stewart A.; Shiau, Andrew K.;
Hassig, Christian A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2011), 21(22), 6888-6894

$RFMT $RIREG SCHEME260 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-(3-bromopropyl)-N-[(3,4-difluorophenyl)methyl]carbamate
C15H20BrF2NO2
1346696-11-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 6.6684 0.0 0
M  V30 2 N 5.3900 5.3347 0.0 0
M  V30 3 C 3.8500 5.3347 0.0 0
M  V30 4 C 6.1600 4.0011 0.0 0
M  V30 5 O 3.0800 6.6684 0.0 0
M  V30 6 O 3.0800 4.0011 0.0 0
M  V30 7 C 5.3900 2.6674 0.0 0
M  V30 8 C 1.5400 6.6684 0.0 0
M  V30 9 C 6.1600 1.3336 0.0 0
M  V30 10 C 1.5400 5.1284 0.0 0
M  V30 11 C 0.0000 6.6684 0.0 0
M  V30 12 C 1.5400 8.2084 0.0 0
M  V30 13 Br 5.3900 0.0000 0.0 0
M  V30 14 F 10.7800 9.3358 0.0 0
M  V30 15 F 12.3200 6.6684 0.0 0
M  V30 16 C 7.7000 6.6684 0.0 0
M  V30 17 C 8.4700 8.0021 0.0 0
M  V30 18 C 8.4700 5.3347 0.0 0
M  V30 19 C 10.0100 8.0021 0.0 0
M  V30 20 C 10.0100 5.3347 0.0 0
M  V30 21 C 10.7800 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 14 19
M  V30 15 1 15 21
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 18 20
M  V30 20 2 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(3,4-difluorophenyl)methyl]-N-[3-(methylamino)propyl]car...
C16H24F2N2O2
1346695-97-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 6.6684 0.0 0
M  V30 2 N 6.9300 5.3347 0.0 0
M  V30 3 C 6.1600 4.0011 0.0 0
M  V30 4 C 8.4700 5.3347 0.0 0
M  V30 5 O 6.9300 2.6674 0.0 0
M  V30 6 O 4.6200 4.0011 0.0 0
M  V30 7 C 9.2400 6.6684 0.0 0
M  V30 8 C 6.1600 1.3336 0.0 0
M  V30 9 C 10.7800 6.6684 0.0 0
M  V30 10 C 4.8264 2.1036 0.0 0
M  V30 11 C 5.3900 0.0000 0.0 0
M  V30 12 C 7.4936 0.5636 0.0 0
M  V30 13 N 11.5500 8.0021 0.0 0
M  V30 14 C 13.0900 8.0021 0.0 0
M  V30 15 F 1.5400 9.3358 0.0 0
M  V30 16 F 0.0000 6.6684 0.0 0
M  V30 17 C 4.6200 6.6684 0.0 0
M  V30 18 C 3.8500 8.0021 0.0 0
M  V30 19 C 3.8500 5.3347 0.0 0
M  V30 20 C 2.3100 8.0021 0.0 0
M  V30 21 C 2.3100 5.3347 0.0 0
M  V30 22 C 1.5400 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 13 14
M  V30 15 1 15 20
M  V30 16 1 16 22
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1346696-11-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1346695-97-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-10585515
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification and SAR of selective inducible nitric oxide synthase
(iNOS) dimerization inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gahman, Timothy C.; Herbert, Mark R.; Lang, Henk; Thayer, Angie; Symons,
Kent T.; Nguyen, Phan Manh; Massari, Mark E.; Dozier, Sara; Zhang, Yan;
Sablad, Marciano; Rao, Tadimeti S.; Noble, Stewart A.; Shiau, Andrew K.;
Hassig, Christian A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2011), 21(22), 6888-6894

$RFMT $RIREG SCHEME261 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-(3-bromopropyl)-N-(4-pyridinylmethyl)carbamate
C14H21BrN2O2
1346696-12-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 5.3347 0.0 0
M  V30 2 C 3.8500 5.3347 0.0 0
M  V30 3 C 6.1600 4.0011 0.0 0
M  V30 4 C 6.1600 6.6685 0.0 0
M  V30 5 O 3.0800 6.6685 0.0 0
M  V30 6 O 3.0800 4.0011 0.0 0
M  V30 7 C 7.7000 6.6685 0.0 0
M  V30 8 C 1.5400 6.6685 0.0 0
M  V30 9 C 8.4700 8.0021 0.0 0
M  V30 10 C 1.5400 8.2085 0.0 0
M  V30 11 C 0.0000 6.6685 0.0 0
M  V30 12 C 1.5400 5.1285 0.0 0
M  V30 13 Br 10.0100 8.0021 0.0 0
M  V30 14 C 5.3900 2.6674 0.0 0
M  V30 15 C 3.8500 2.6674 0.0 0
M  V30 16 C 6.1600 1.3338 0.0 0
M  V30 17 C 3.0800 1.3338 0.0 0
M  V30 18 C 5.3900 0.0000 0.0 0
M  V30 19 N 3.8500 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 14
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[3-(methylamino)propyl]-N-(4-pyridinylmethyl)carbamate
C15H25N3O2
1346695-98-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 5.3347 0.0 0
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 C 4.6200 6.6685 0.0 0
M  V30 4 C 6.9300 5.3347 0.0 0
M  V30 5 O 5.3900 2.6674 0.0 0
M  V30 6 O 3.0800 4.0011 0.0 0
M  V30 7 C 7.7000 6.6685 0.0 0
M  V30 8 C 4.6200 1.3336 0.0 0
M  V30 9 C 9.2400 6.6685 0.0 0
M  V30 10 C 3.2864 2.1036 0.0 0
M  V30 11 C 3.8500 0.0000 0.0 0
M  V30 12 C 5.9536 0.5636 0.0 0
M  V30 13 N 10.0100 8.0021 0.0 0
M  V30 14 C 11.5500 8.0021 0.0 0
M  V30 15 C 3.0800 6.6685 0.0 0
M  V30 16 C 2.3100 8.0021 0.0 0
M  V30 17 C 2.3100 5.3347 0.0 0
M  V30 18 C 0.7700 8.0021 0.0 0
M  V30 19 C 0.7700 5.3347 0.0 0
M  V30 20 N 0.0000 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 15
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 13 14
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1346696-12-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1346695-98-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-12709395
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification and SAR of selective inducible nitric oxide synthase
(iNOS) dimerization inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gahman, Timothy C.; Herbert, Mark R.; Lang, Henk; Thayer, Angie; Symons,
Kent T.; Nguyen, Phan Manh; Massari, Mark E.; Dozier, Sara; Zhang, Yan;
Sablad, Marciano; Rao, Tadimeti S.; Noble, Stewart A.; Shiau, Andrew K.;
Hassig, Christian A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2011), 21(22), 6888-6894

$RFMT $RIREG SCHEME262 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-(3-bromopropyl)-N-(1H-indol-5-ylmethyl)carbamate
C17H23BrN2O2
1346696-13-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2873 6.6685 0.0 0
M  V30 2 N 7.0574 5.3348 0.0 0
M  V30 3 C 8.5974 5.3348 0.0 0
M  V30 4 C 6.2873 4.0010 0.0 0
M  V30 5 O 9.3674 6.6685 0.0 0
M  V30 6 O 9.3674 4.0010 0.0 0
M  V30 7 C 7.0574 2.6673 0.0 0
M  V30 8 C 10.9074 6.6685 0.0 0
M  V30 9 C 6.2873 1.3337 0.0 0
M  V30 10 C 10.9074 5.1285 0.0 0
M  V30 11 C 12.4475 6.6685 0.0 0
M  V30 12 C 10.9074 8.2085 0.0 0
M  V30 13 Br 7.0574 0.0000 0.0 0
M  V30 14 C 2.4373 8.0022 0.0 0
M  V30 15 C 1.6672 6.6685 0.0 0
M  V30 16 C 3.9773 8.0022 0.0 0
M  V30 17 C 1.4068 9.1466 0.0 0
M  V30 18 C 2.4373 5.3348 0.0 0
M  V30 19 N 0.1609 6.9887 0.0 0
M  V30 20 C 4.7473 6.6685 0.0 0
M  V30 21 C 0.0000 8.5202 0.0 0
M  V30 22 C 3.9773 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 17
M  V30 17 2 15 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 2 17 21
M  V30 21 1 18 22
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-(1H-indol-5-ylmethyl)-N-[3-(methylamino)propyl]carbamate
C18H27N3O2
1346695-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2873 6.6685 0.0 0
M  V30 2 N 7.0574 5.3348 0.0 0
M  V30 3 C 6.2873 4.0010 0.0 0
M  V30 4 C 8.5974 5.3348 0.0 0
M  V30 5 O 7.0574 2.6673 0.0 0
M  V30 6 O 4.7473 4.0010 0.0 0
M  V30 7 C 9.3674 6.6685 0.0 0
M  V30 8 C 6.2873 1.3337 0.0 0
M  V30 9 C 10.9074 6.6685 0.0 0
M  V30 10 C 7.6212 0.5637 0.0 0
M  V30 11 C 5.5173 0.0000 0.0 0
M  V30 12 C 4.9537 2.1037 0.0 0
M  V30 13 N 11.6775 8.0022 0.0 0
M  V30 14 C 13.2175 8.0022 0.0 0
M  V30 15 C 2.4373 8.0022 0.0 0
M  V30 16 C 1.6672 6.6685 0.0 0
M  V30 17 C 3.9773 8.0022 0.0 0
M  V30 18 C 1.4068 9.1466 0.0 0
M  V30 19 C 2.4373 5.3348 0.0 0
M  V30 20 N 0.1609 6.9887 0.0 0
M  V30 21 C 4.7473 6.6685 0.0 0
M  V30 22 C 0.0000 8.5202 0.0 0
M  V30 23 C 3.9773 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 13 14
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 1 15 18
M  V30 18 2 16 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 2 18 22
M  V30 22 1 19 23
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1346696-13-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1346695-99-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-14852549
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification and SAR of selective inducible nitric oxide synthase
(iNOS) dimerization inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gahman, Timothy C.; Herbert, Mark R.; Lang, Henk; Thayer, Angie; Symons,
Kent T.; Nguyen, Phan Manh; Massari, Mark E.; Dozier, Sara; Zhang, Yan;
Sablad, Marciano; Rao, Tadimeti S.; Noble, Stewart A.; Shiau, Andrew K.;
Hassig, Christian A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2011), 21(22), 6888-6894

$RFMT $RIREG SCHEME263 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-(1,3-benzodioxol-5-ylcarbonyl)-N-(3-bromopropyl)carbamate
C16H20BrNO5
1346696-14-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2873 6.6685 0.0 0
M  V30 2 N 7.0574 5.3348 0.0 0
M  V30 3 O 7.0574 8.0022 0.0 0
M  V30 4 C 8.5974 5.3348 0.0 0
M  V30 5 C 6.2873 4.0010 0.0 0
M  V30 6 O 9.3674 6.6685 0.0 0
M  V30 7 O 9.3674 4.0010 0.0 0
M  V30 8 C 7.0574 2.6673 0.0 0
M  V30 9 C 10.9074 6.6685 0.0 0
M  V30 10 C 6.2873 1.3337 0.0 0
M  V30 11 C 10.9074 5.1285 0.0 0
M  V30 12 C 12.4475 6.6685 0.0 0
M  V30 13 C 10.9074 8.2085 0.0 0
M  V30 14 Br 7.0574 0.0000 0.0 0
M  V30 15 C 2.4373 8.0022 0.0 0
M  V30 16 C 1.6672 6.6685 0.0 0
M  V30 17 C 3.9773 8.0022 0.0 0
M  V30 18 O 1.4068 9.1466 0.0 0
M  V30 19 C 2.4373 5.3348 0.0 0
M  V30 20 O 0.1609 6.9887 0.0 0
M  V30 21 C 4.7473 6.6685 0.0 0
M  V30 22 C 0.0000 8.5202 0.0 0
M  V30 23 C 3.9773 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 1 15 18
M  V30 18 2 16 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-(1,3-benzodioxol-5-ylcarbonyl)-N-[3-(methylamino)propyl]c...
C17H24N2O5
1346696-00-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2873 6.6685 0.0 0
M  V30 2 N 7.0574 5.3348 0.0 0
M  V30 3 O 7.0574 8.0022 0.0 0
M  V30 4 C 6.2873 4.0010 0.0 0
M  V30 5 C 8.5974 5.3348 0.0 0
M  V30 6 O 7.0574 2.6673 0.0 0
M  V30 7 O 4.7473 4.0010 0.0 0
M  V30 8 C 9.3674 6.6685 0.0 0
M  V30 9 C 6.2873 1.3337 0.0 0
M  V30 10 C 10.9074 6.6685 0.0 0
M  V30 11 C 4.9537 2.1037 0.0 0
M  V30 12 C 5.5173 0.0000 0.0 0
M  V30 13 C 7.6212 0.5637 0.0 0
M  V30 14 N 11.6775 8.0022 0.0 0
M  V30 15 C 13.2175 8.0022 0.0 0
M  V30 16 C 2.4373 8.0022 0.0 0
M  V30 17 C 1.6672 6.6685 0.0 0
M  V30 18 C 3.9773 8.0022 0.0 0
M  V30 19 O 1.4068 9.1466 0.0 0
M  V30 20 C 2.4373 5.3348 0.0 0
M  V30 21 O 0.1609 6.9887 0.0 0
M  V30 22 C 4.7473 6.6685 0.0 0
M  V30 23 C 0.0000 8.5202 0.0 0
M  V30 24 C 3.9773 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 22
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 14 15
M  V30 16 1 16 17
M  V30 17 2 16 18
M  V30 18 1 16 19
M  V30 19 2 17 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1346696-14-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1346696-00-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-1460422
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification and SAR of selective inducible nitric oxide synthase
(iNOS) dimerization inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gahman, Timothy C.; Herbert, Mark R.; Lang, Henk; Thayer, Angie; Symons,
Kent T.; Nguyen, Phan Manh; Massari, Mark E.; Dozier, Sara; Zhang, Yan;
Sablad, Marciano; Rao, Tadimeti S.; Noble, Stewart A.; Shiau, Andrew K.;
Hassig, Christian A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2011), 21(22), 6888-6894

$RFMT $RIREG SCHEME264 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-(3-bromopropyl)-N-[(2,2-difluoro-1,3-benzodioxol-5-yl)met...
C16H20BrF2NO4
1346696-15-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 12.9235 9.9850 0.0 0
M  V30 2 F 13.9539 8.2001 0.0 0
M  V30 3 C 6.1601 6.6685 0.0 0
M  V30 4 N 5.3901 5.3348 0.0 0
M  V30 5 C 3.8501 5.3348 0.0 0
M  V30 6 C 6.1601 4.0012 0.0 0
M  V30 7 O 3.0801 6.6685 0.0 0
M  V30 8 O 3.0801 4.0012 0.0 0
M  V30 9 C 5.3901 2.6673 0.0 0
M  V30 10 C 1.5400 6.6685 0.0 0
M  V30 11 C 6.1601 1.3337 0.0 0
M  V30 12 C 1.5400 8.2085 0.0 0
M  V30 13 C 0.0000 6.6685 0.0 0
M  V30 14 C 1.5400 5.1285 0.0 0
M  V30 15 Br 5.3901 0.0000 0.0 0
M  V30 16 C 10.7802 6.6685 0.0 0
M  V30 17 C 10.0102 8.0022 0.0 0
M  V30 18 O 12.2865 6.9887 0.0 0
M  V30 19 C 10.0102 5.3348 0.0 0
M  V30 20 C 8.4702 8.0022 0.0 0
M  V30 21 O 11.0407 9.1467 0.0 0
M  V30 22 C 12.4476 8.5204 0.0 0
M  V30 23 C 8.4702 5.3348 0.0 0
M  V30 24 C 7.7002 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 22
M  V30 2 1 2 22
M  V30 3 1 3 4
M  V30 4 1 3 24
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 2 16 19
M  V30 19 2 17 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(2,2-difluoro-1,3-benzodioxol-5-yl)methyl]-N-[3-(methyla...
C17H24F2N2O4
1346696-01-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 1.0304 9.9850 0.0 0
M  V30 2 F 0.0000 8.2001 0.0 0
M  V30 3 C 7.7938 6.6685 0.0 0
M  V30 4 N 8.5638 5.3348 0.0 0
M  V30 5 C 7.7938 4.0012 0.0 0
M  V30 6 C 10.1039 5.3348 0.0 0
M  V30 7 O 8.5638 2.6673 0.0 0
M  V30 8 O 6.2538 4.0012 0.0 0
M  V30 9 C 10.8739 6.6685 0.0 0
M  V30 10 C 7.7938 1.3337 0.0 0
M  V30 11 C 12.4139 6.6685 0.0 0
M  V30 12 C 6.4601 2.1037 0.0 0
M  V30 13 C 7.0238 0.0000 0.0 0
M  V30 14 C 9.1275 0.5637 0.0 0
M  V30 15 N 13.1839 8.0022 0.0 0
M  V30 16 C 14.7240 8.0022 0.0 0
M  V30 17 C 3.1737 6.6685 0.0 0
M  V30 18 C 3.9437 8.0022 0.0 0
M  V30 19 O 1.6674 6.9887 0.0 0
M  V30 20 C 3.9437 5.3348 0.0 0
M  V30 21 C 5.4838 8.0022 0.0 0
M  V30 22 O 2.9133 9.1467 0.0 0
M  V30 23 C 1.5063 8.5204 0.0 0
M  V30 24 C 5.4838 5.3348 0.0 0
M  V30 25 C 6.2538 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 23
M  V30 2 1 2 23
M  V30 3 1 3 4
M  V30 4 1 3 25
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 15 16
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 2 17 20
M  V30 20 2 18 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1346696-15-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1346696-01-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-3592794
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification and SAR of selective inducible nitric oxide synthase
(iNOS) dimerization inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gahman, Timothy C.; Herbert, Mark R.; Lang, Henk; Thayer, Angie; Symons,
Kent T.; Nguyen, Phan Manh; Massari, Mark E.; Dozier, Sara; Zhang, Yan;
Sablad, Marciano; Rao, Tadimeti S.; Noble, Stewart A.; Shiau, Andrew K.;
Hassig, Christian A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2011), 21(22), 6888-6894

$RFMT $RIREG SCHEME265 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[2-(1,3-benzodioxol-5-yl)ethyl]-N-(3-bromopropyl)carbamate
C17H24BrNO4
1346696-16-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0
M  V30 2 C 5.3348 5.3901 0.0 0
M  V30 3 N 4.0012 4.6201 0.0 0
M  V30 4 C 2.6673 5.3901 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 O 2.6673 6.9302 0.0 0
M  V30 7 O 1.3337 4.6201 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 7.7002 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 2.1037 9.0338 0.0 0
M  V30 12 C 0.0000 8.4702 0.0 0
M  V30 13 C 0.5637 6.3665 0.0 0
M  V30 14 Br 1.3337 0.0000 0.0 0
M  V30 15 C 10.6697 5.3901 0.0 0
M  V30 16 C 10.6697 6.9302 0.0 0
M  V30 17 C 9.3360 4.6201 0.0 0
M  V30 18 O 12.1342 4.9142 0.0 0
M  V30 19 C 9.3360 7.7002 0.0 0
M  V30 20 O 12.1342 7.4060 0.0 0
M  V30 21 C 8.0022 5.3901 0.0 0
M  V30 22 C 13.0395 6.1601 0.0 0
M  V30 23 C 8.0022 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 1 15 18
M  V30 18 2 16 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[2-(1,3-benzodioxol-5-yl)ethyl]-N-[3-(methylamino)propyl]...
C18H28N2O4
1346696-02-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7002 6.6685 0.0 0
M  V30 2 C 6.9302 5.3348 0.0 0
M  V30 3 N 5.3901 5.3348 0.0 0
M  V30 4 C 4.6201 4.0012 0.0 0
M  V30 5 C 4.6201 6.6685 0.0 0
M  V30 6 O 5.3901 2.6675 0.0 0
M  V30 7 O 3.0801 4.0012 0.0 0
M  V30 8 C 3.0801 6.6685 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 2.3101 8.0023 0.0 0
M  V30 11 C 5.9538 0.5637 0.0 0
M  V30 12 C 3.8501 0.0000 0.0 0
M  V30 13 C 3.2863 2.1037 0.0 0
M  V30 14 N 0.7700 8.0023 0.0 0
M  V30 15 C 0.0000 9.3360 0.0 0
M  V30 16 C 11.5503 8.0023 0.0 0
M  V30 17 C 12.3203 6.6685 0.0 0
M  V30 18 C 10.0102 8.0023 0.0 0
M  V30 19 O 12.5807 9.1467 0.0 0
M  V30 20 C 11.5503 5.3348 0.0 0
M  V30 21 O 13.8266 6.9888 0.0 0
M  V30 22 C 9.2402 6.6685 0.0 0
M  V30 23 C 13.9875 8.5204 0.0 0
M  V30 24 C 10.0102 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 14 15
M  V30 16 1 16 17
M  V30 17 2 16 18
M  V30 18 1 16 19
M  V30 19 2 17 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1346696-16-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1346696-02-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-5717239
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification and SAR of selective inducible nitric oxide synthase
(iNOS) dimerization inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gahman, Timothy C.; Herbert, Mark R.; Lang, Henk; Thayer, Angie; Symons,
Kent T.; Nguyen, Phan Manh; Massari, Mark E.; Dozier, Sara; Zhang, Yan;
Sablad, Marciano; Rao, Tadimeti S.; Noble, Stewart A.; Shiau, Andrew K.;
Hassig, Christian A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2011), 21(22), 6888-6894

$RFMT $RIREG SCHEME266 STEP1
$RXN



  2  1
$MOL
2-Methoxybenzaldehyde
C8H8O2
135-02-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 4.0010 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 4.6201 4.0010 0.0 0
M  V30 4 C 6.1601 4.0010 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 C 1.5400 1.3337 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 2.3101 0.0000 0.0 0
M  V30 10 C 3.8501 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-methyl-, compd. with methanamine (1:1)
C2H5NO2.CH5N
65398-48-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 2.6673 3.8501 0.0 0
M  V30 3 O 1.3337 1.5400 0.0 0
M  V30 4 O 0.0000 3.8501 0.0 0
M  V30 5 C 4.0010 3.0800 0.0 0
M  V30 6 C 1.2305 0.0000 0.0 0
M  V30 7 N 2.7705 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(2-Methoxyphenyl)methylene]methanamine
C9H11NO
1268854-18-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 N 6.1600 4.0011 0.0 0
M  V30 3 C 6.9300 5.3349 0.0 0
M  V30 4 O 1.5400 4.0011 0.0 0
M  V30 5 C 0.0000 4.0011 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 1.3338 0.0 0
M  V30 9 C 1.5400 1.3338 0.0 0
M  V30 10 C 3.8500 0.0000 0.0 0
M  V30 11 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 135-02-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 65398-48-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1268854-18-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-22947242
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Stable carbamate pathway towards organic-inorganic hybrid perovskites and
aromatic imines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lee, Kyu Hyung; Kim, Sun Joo; Park, Hee Sun; Lim, Byung Wook; Lee,
Byeongno; Park, Young Jun; Nam, Wonwoo; Hur, Nam Hwi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2020), 10(62), 38055-38062

$RFMT $RIREG SCHEME267 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl β-oxo-2-thiophenepropanoate
C9H10O3S
13669-10-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6218 0.0 0
M  V30 2 C 5.1048 1.8517 0.0 0
M  V30 3 O 3.7711 4.1618 0.0 0
M  V30 4 C 6.4384 2.6218 0.0 0
M  V30 5 O 7.7722 1.8517 0.0 0
M  V30 6 O 6.4384 4.1618 0.0 0
M  V30 7 C 9.1059 2.6218 0.0 0
M  V30 8 C 10.4396 1.8517 0.0 0
M  V30 9 C 2.4374 1.8517 0.0 0
M  V30 10 C 1.0304 2.4782 0.0 0
M  V30 11 S 2.2763 0.3202 0.0 0
M  V30 12 C 0.0000 1.3337 0.0 0
M  V30 13 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (2Z)-3-(methylamino)-3-(2-thienyl)-2-propenoate
C10H13NO2S
2614438-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.3101 0.0 0
M  V30 2 C 5.1048 3.0801 0.0 0
M  V30 3 N 3.7711 0.7700 0.0 0
M  V30 4 C 6.4384 2.3101 0.0 0
M  V30 5 C 2.4374 0.0000 0.0 0
M  V30 6 O 7.7722 3.0801 0.0 0
M  V30 7 O 6.4384 0.7700 0.0 0
M  V30 8 C 9.1059 2.3101 0.0 0
M  V30 9 C 10.4396 3.0801 0.0 0
M  V30 10 C 2.4374 3.0801 0.0 0
M  V30 11 C 1.0304 2.4536 0.0 0
M  V30 12 S 2.2763 4.6116 0.0 0
M  V30 13 C 0.0000 3.5981 0.0 0
M  V30 14 C 0.7700 4.9318 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13669-10-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2614438-12-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-23322291
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Electrochemical Oxidative Cyclization: Synthesis of Polysubstituted
Pyrrole from Enamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Zhiwei; Shi, Guang; Tang, Wei; Sun, Jie; Wang, Wenxing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2021), 2021(6), 951-955

$RFMT $RIREG SCHEME268 STEP1
$RXN



  2  1
$MOL
(4S)-4-(Diphenylmethyl)-1,3,4,8-tetrahydro-2-(2-methoxyethyl)-1,8-dioxo-9-(ph...
C32H30N2O6
1370248-13-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 44 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 7.7000 0.0 0
M  V30 2 O 10.6696 6.9300 0.0 0
M  V30 3 C 12.0032 7.7000 0.0 0
M  V30 4 O 9.3358 4.6200 0.0 0
M  V30 5 C 8.0021 11.5500 0.0 0
M  V30 6 O 6.6685 12.3200 0.0 0
M  V30 7 O 9.3358 12.3200 0.0 0
M  V30 8 C 6.6685 3.0800 0.0 0
M  V30 9 C 5.3347 2.3100 0.0 0
M  V30 10 O 5.3347 0.7700 0.0 0
M  V30 11 C 4.0011 0.0000 0.0 0
M  V30 12 O 10.6696 10.0100 0.0 0
M  V30 13 N 6.6685 7.7000 0.0 0
M  V30 14 C 5.3347 6.9300 0.0 0 CFG=1
M  V30 15 C 8.0021 6.9300 0.0 0
M  V30 16 C 6.6685 9.2400 0.0 0
M  V30 17 C 5.3347 5.3900 0.0 0
M  V30 18 C 9.3358 7.7000 0.0 0
M  V30 19 C 8.0021 5.3900 0.0 0
M  V30 20 C 8.0021 10.0100 0.0 0
M  V30 21 N 6.6685 4.6200 0.0 0
M  V30 22 C 9.3358 9.2400 0.0 0
M  V30 23 C 4.0011 9.2400 0.0 0
M  V30 24 C 2.6674 10.0100 0.0 0
M  V30 25 C 5.3347 10.0100 0.0 0
M  V30 26 C 2.6674 11.5500 0.0 0
M  V30 27 C 5.3347 11.5500 0.0 0
M  V30 28 C 4.0011 12.3200 0.0 0
M  V30 29 C 2.6674 6.9300 0.0 0
M  V30 30 C 2.6674 5.3900 0.0 0
M  V30 31 C 1.3338 7.7000 0.0 0
M  V30 32 C 1.3338 4.6200 0.0 0
M  V30 33 C 0.0000 6.9300 0.0 0
M  V30 34 C 0.0000 5.3900 0.0 0
M  V30 35 C 13.3369 6.9300 0.0 0
M  V30 36 C 14.6705 7.7000 0.0 0
M  V30 37 C 13.3369 5.3900 0.0 0
M  V30 38 C 16.0043 6.9300 0.0 0
M  V30 39 C 14.6705 4.6200 0.0 0
M  V30 40 C 16.0043 5.3900 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 14 1 CFG=3
M  V30 2 1 1 23
M  V30 3 1 1 29
M  V30 4 1 2 3
M  V30 5 1 2 18
M  V30 6 1 3 35
M  V30 7 2 4 19
M  V30 8 1 5 6
M  V30 9 2 5 7
M  V30 10 1 5 20
M  V30 11 1 8 9
M  V30 12 1 8 21
M  V30 13 1 9 10
M  V30 14 1 10 11
M  V30 15 2 12 22
M  V30 16 1 13 14
M  V30 17 1 13 15
M  V30 18 1 13 16
M  V30 19 1 14 17
M  V30 20 2 15 18
M  V30 21 1 15 19
M  V30 22 2 16 20
M  V30 23 1 17 21
M  V30 24 1 18 22
M  V30 25 1 19 21
M  V30 26 1 20 22
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4S)-4-(Diphenylmethyl)-1,3,4,8-tetrahydro-2-(2-methoxyethyl)-N-methyl-1,8-di...
C33H33N3O5
2375881-32-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 7.7000 0.0 0
M  V30 2 C 6.6685 3.0800 0.0 0
M  V30 3 C 5.3347 2.3100 0.0 0
M  V30 4 O 5.3347 0.7700 0.0 0
M  V30 5 C 4.0011 0.0000 0.0 0
M  V30 6 O 10.6696 6.9300 0.0 0
M  V30 7 C 12.0032 7.7000 0.0 0
M  V30 8 O 9.3358 4.6200 0.0 0
M  V30 9 C 8.0021 11.5500 0.0 0
M  V30 10 N 9.3358 12.3200 0.0 0
M  V30 11 O 6.6685 12.3200 0.0 0
M  V30 12 C 9.3358 13.8600 0.0 0
M  V30 13 O 10.6696 10.0100 0.0 0
M  V30 14 C 5.3347 6.9300 0.0 0 CFG=1
M  V30 15 N 6.6685 7.7000 0.0 0
M  V30 16 C 5.3347 5.3900 0.0 0
M  V30 17 C 8.0021 6.9300 0.0 0
M  V30 18 C 6.6685 9.2400 0.0 0
M  V30 19 N 6.6685 4.6200 0.0 0
M  V30 20 C 9.3358 7.7000 0.0 0
M  V30 21 C 8.0021 5.3900 0.0 0
M  V30 22 C 8.0021 10.0100 0.0 0
M  V30 23 C 9.3358 9.2400 0.0 0
M  V30 24 C 2.6674 6.9300 0.0 0
M  V30 25 C 1.3338 7.7000 0.0 0
M  V30 26 C 2.6674 5.3900 0.0 0
M  V30 27 C 0.0000 6.9300 0.0 0
M  V30 28 C 1.3338 4.6200 0.0 0
M  V30 29 C 0.0000 5.3900 0.0 0
M  V30 30 C 4.0011 9.2400 0.0 0
M  V30 31 C 2.6674 10.0100 0.0 0
M  V30 32 C 5.3347 10.0100 0.0 0
M  V30 33 C 2.6674 11.5500 0.0 0
M  V30 34 C 5.3347 11.5500 0.0 0
M  V30 35 C 4.0011 12.3200 0.0 0
M  V30 36 C 13.3369 6.9300 0.0 0
M  V30 37 C 13.3369 5.3900 0.0 0
M  V30 38 C 14.6705 7.7000 0.0 0
M  V30 39 C 14.6705 4.6200 0.0 0
M  V30 40 C 16.0043 6.9300 0.0 0
M  V30 41 C 16.0043 5.3900 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 14 1 CFG=3
M  V30 2 1 1 24
M  V30 3 1 1 30
M  V30 4 1 2 3
M  V30 5 1 2 19
M  V30 6 1 3 4
M  V30 7 1 4 5
M  V30 8 1 6 7
M  V30 9 1 6 20
M  V30 10 1 7 36
M  V30 11 2 8 21
M  V30 12 1 9 10
M  V30 13 2 9 11
M  V30 14 1 9 22
M  V30 15 1 10 12
M  V30 16 2 13 23
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 1 15 18
M  V30 21 1 16 19
M  V30 22 2 17 20
M  V30 23 1 17 21
M  V30 24 2 18 22
M  V30 25 1 19 21
M  V30 26 1 20 23
M  V30 27 1 22 23
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 35
M  V30 40 2 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 2 38 40
M  V30 44 2 39 41
M  V30 45 1 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1370248-13-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2375881-32-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-20609243
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 541-41-3
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and SAR Study of Carbamoyl Pyridone Bicycle Derivatives as
Potent Inhibitors of Influenza Cap-dependent Endonuclease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Miyagawa, Masayoshi; Akiyama, Toshiyuki; Taoda, Yoshiyuki; Takaya, Kenji;
Takahashi-Kageyama, Chika; Tomita, Kenji; Yasuo, Kazuya; Hattori,
Kazunari; Shano, Shinya; Yoshida, Ryu; Shishido, Takao; Yoshinaga,
Tomokazu; Sato, Akihiko; Kawai, Makoto
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2019), 62(17), 8101-8114

$RFMT $RIREG SCHEME269 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-2-ethenylbenzaldehyde
C9H7ClO
1370529-71-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 4.0011 0.0 0
M  V30 2 O 0.0000 5.3349 0.0 0
M  V30 3 C 2.3100 1.3338 0.0 0
M  V30 4 C 3.0800 0.0000 0.0 0
M  V30 5 Cl 6.9300 4.0011 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 3.0800 5.3349 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 4.6200 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 1 3 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4-Chloro-2-ethenylphenyl)methylene]methanamine
C10H10ClN
2143965-33-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 N 6.9300 5.3349 0.0 0
M  V30 3 C 8.4700 5.3349 0.0 0
M  V30 4 C 4.6200 1.3338 0.0 0
M  V30 5 C 3.8500 0.0000 0.0 0
M  V30 6 Cl 0.0000 4.0011 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 3.8500 2.6674 0.0 0
M  V30 9 C 3.8500 5.3349 0.0 0
M  V30 10 C 2.3100 2.6674 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 12 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 1 4 8
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1370529-71-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2143965-33-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34601457
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7487-88-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Targeting σ2R/TMEM97 with novel aminotetralins
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wood, Michael D.; Sahn, James J.; Martin, Stephen F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2022), 243114696

$RFMT $RIREG SCHEME270 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-methoxy-3-(methoxymethoxy)benzenepropanoate
C14H20O5
1373123-54-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 0.7700 0.0 0
M  V30 2 C 5.3347 0.0000 0.0 0
M  V30 3 C 9.3358 2.3100 0.0 0
M  V30 4 C 10.6696 3.0800 0.0 0
M  V30 5 C 12.0032 2.3100 0.0 0
M  V30 6 O 13.3369 3.0800 0.0 0
M  V30 7 O 12.0032 0.7700 0.0 0
M  V30 8 C 14.6705 2.3100 0.0 0
M  V30 9 C 16.0043 3.0800 0.0 0
M  V30 10 O 4.0011 2.3100 0.0 0
M  V30 11 C 2.6674 3.0800 0.0 0
M  V30 12 O 1.3338 2.3100 0.0 0
M  V30 13 C 0.0000 3.0800 0.0 0
M  V30 14 C 6.6685 2.3100 0.0 0
M  V30 15 C 8.0021 3.0800 0.0 0
M  V30 16 C 5.3347 3.0800 0.0 0
M  V30 17 C 8.0021 4.6200 0.0 0
M  V30 18 C 5.3347 4.6200 0.0 0
M  V30 19 C 6.6685 5.3900 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 3 4
M  V30 4 1 3 15
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 1 10 16
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methoxy-3-(methoxymethoxy)-N-methylbenzenepropanamide
C13H19NO4
1373123-55-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 0.7700 0.0 0
M  V30 2 C 5.3348 0.0000 0.0 0
M  V30 3 C 9.3358 2.3101 0.0 0
M  V30 4 C 10.6697 3.0801 0.0 0
M  V30 5 C 12.0033 2.3101 0.0 0
M  V30 6 N 13.3370 3.0801 0.0 0
M  V30 7 O 12.0033 0.7700 0.0 0
M  V30 8 C 14.6707 2.3101 0.0 0
M  V30 9 O 4.0010 2.3101 0.0 0
M  V30 10 C 2.6673 3.0801 0.0 0
M  V30 11 O 1.3337 2.3101 0.0 0
M  V30 12 C 0.0000 3.0801 0.0 0
M  V30 13 C 6.6685 2.3101 0.0 0
M  V30 14 C 8.0022 3.0801 0.0 0
M  V30 15 C 5.3348 3.0801 0.0 0
M  V30 16 C 8.0022 4.6201 0.0 0
M  V30 17 C 5.3348 4.6201 0.0 0
M  V30 18 C 6.6685 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 3 4
M  V30 4 1 3 14
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 15
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1373123-54-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1373123-55-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9019144
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Compound (9) A solutionof 8 (15.7 g, 58.8 mmol) in a mixture 33 wt%
methylamine in absolute ethanol (30 mL) was stirred at room temperature
for 24 h. The solvent was then removed in vacuo and the residue was
purified by silica gel column chromatography (CH2Cl2/MeOH 10:1) to give
pure amide 9. (14.7 g, 99% yield), white solid. mp 60-62 °C; 1H NMR (400
MHz, CDCl3) δ 7.00 (dd, J = 8.4, 1.6 Hz, 1H), 6.94 (t, J = 7.6 Hz, 1H),
6.83 (dd, J = 7.6, 1.2 Hz, 1H), 5.99 (s, 1H), 5.20 (s, 2H), 3.85 (s, 3H),
3.51 (s, 3H), 2.95 (t, J = 7.6 Hz 2H), 2.75 (d, J = 4.8 Hz 3H), 2.47 (t,
J = 8.0 Hz 2H); 13C NMR (100 MHz, CDCl3) δ 172.91, 150.10, 147.66,
134.85, 123.94, 123.09, 114.72, 94.94, 60.62, 56.06, 37.06, 26.08, 25.96;
IR (KBr) νmax 3304, 2937, 1649, 1477, 1265, 1155, 1041, 1009, 922, 733
cm-1; HRMS (ESIMS) caled for C13H19NNaO4+ [M+ Na]+ 276.1212, found
276.1214.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tandem Oxidative Dearomatization/Intramolecular Diels-Alder Reaction for
Construction of the Tricyclic Core of Palhinine A
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhao, Changgui; Zheng, Huaiji; Jing, Peng; Fang, Bowen; Xie, Xingang;
She, Xuegong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2012), 14(9), 2293-2295

$RFMT $RIREG SCHEME271 STEP1
$RXN



  2  1
$MOL
N-[6-[(2-Carboxyethyl)amino]-2-(2-pyridinyl)-4-pyrimidinyl]-β-alanine 1-ethyl...
C17H21N5O4
1373424-02-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.2402 5.3348 0.0 0
M  V30 2 C 10.0102 6.6685 0.0 0
M  V30 3 C 11.5503 6.6685 0.0 0
M  V30 4 C 12.3203 8.0023 0.0 0
M  V30 5 O 13.8603 8.0023 0.0 0
M  V30 6 O 11.5503 9.3360 0.0 0
M  V30 7 C 14.6303 9.3360 0.0 0
M  V30 8 C 16.1704 9.3360 0.0 0
M  V30 9 N 4.6201 8.0023 0.0 0
M  V30 10 C 3.0801 8.0023 0.0 0
M  V30 11 C 2.3101 9.3360 0.0 0
M  V30 12 C 0.7700 9.3360 0.0 0
M  V30 13 O 0.0000 10.6697 0.0 0
M  V30 14 O 0.0000 8.0023 0.0 0
M  V30 15 C 5.3901 4.0012 0.0 0
M  V30 16 N 6.9302 4.0012 0.0 0
M  V30 17 N 4.6201 5.3348 0.0 0
M  V30 18 C 7.7002 5.3348 0.0 0
M  V30 19 C 5.3901 6.6685 0.0 0
M  V30 20 C 6.9302 6.6685 0.0 0
M  V30 21 C 4.6201 2.6673 0.0 0
M  V30 22 C 3.0801 2.6673 0.0 0
M  V30 23 N 5.3901 1.3337 0.0 0
M  V30 24 C 2.3101 1.3337 0.0 0
M  V30 25 C 4.6201 0.0000 0.0 0
M  V30 26 C 3.0801 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 1 9 19
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 1 15 21
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[6-[[3-(Methylamino)-3-oxopropyl]amino]-2-(2-pyridinyl)-4-pyrimidinyl]-β-al...
C18H24N6O3
1373423-91-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.7801 5.3348 0.0 0
M  V30 2 C 11.5501 6.6684 0.0 0
M  V30 3 C 13.0901 6.6684 0.0 0
M  V30 4 C 13.8602 8.0022 0.0 0
M  V30 5 O 15.4002 8.0022 0.0 0
M  V30 6 O 13.0901 9.3359 0.0 0
M  V30 7 C 16.1702 9.3359 0.0 0
M  V30 8 C 17.7102 9.3359 0.0 0
M  V30 9 N 6.1601 8.0022 0.0 0
M  V30 10 C 4.6201 8.0022 0.0 0
M  V30 11 C 3.8500 9.3359 0.0 0
M  V30 12 C 2.3100 9.3359 0.0 0
M  V30 13 N 1.5400 10.6695 0.0 0
M  V30 14 O 1.5400 8.0022 0.0 0
M  V30 15 C 0.0000 10.6695 0.0 0
M  V30 16 C 6.9301 4.0011 0.0 0
M  V30 17 N 8.4701 4.0011 0.0 0
M  V30 18 N 6.1601 5.3348 0.0 0
M  V30 19 C 9.2401 5.3348 0.0 0
M  V30 20 C 6.9301 6.6684 0.0 0
M  V30 21 C 8.4701 6.6684 0.0 0
M  V30 22 C 6.1601 2.6673 0.0 0
M  V30 23 C 6.9301 1.3337 0.0 0
M  V30 24 N 4.6201 2.6673 0.0 0
M  V30 25 C 6.1601 0.0000 0.0 0
M  V30 26 C 3.8500 1.3337 0.0 0
M  V30 27 C 4.6201 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 1 9 20
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 16 17
M  V30 17 2 16 18
M  V30 18 1 16 22
M  V30 19 2 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1373424-02-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1373423-91-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5544734
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Intermediate 85: ethyl
3-{[6-[(3-{[2-(methylamino)-2-oxoethyl]amino)-3-oxopropyl)amino]-2-(2-pyridinyl)-4-pyrimidinyl]amino}propanoate
HATU (53.3 mg, 0.14 mmol) and DIPEA (0.05 mL, 0.26 mmol) were added to a
solution of
3-{[6-{[3-(ethyloxy)-3-oxopropyl]amino}-2-(2-pyridinyl)-4-pyrimidinyl]amino}propanoic
acid (42.0 mg, 0.12 mmol) in N,N-dimethylformamide (5 mL). After 30 min
of stirring N 1-methylglycinamide hydrochloride (17.5 mg, 0.14 mmol) was
added to the reaction mixture which was then stirred for 3 hr. The
reaction mixture was concentrated under reduced pressure and the residue
purified by column chromatography, eluting with 0-14% methanolic ammonia
(2M) - DCM. Intermediate 86 ethyl
3-{[6-{[3-(methylamino)-3-oxopropyl]amino}-2-(2-pyridinyl)-4-pyrimidinyl]amino}propanoate
Yield 99% LC MS Rt = 0.61 min, MH+ 373.1 (Method A)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-(pyridinyl)pyrimidinyl-β-alanine derivatives for use as
histone demethylase JMJD3 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Atkinson, Stephen John; Barker, Michael David; Campbell, Matthew;
Humphreys, Philip; Liddle, John; Sheppard, Robert John; Wilson, David
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012052390 A1 2012-04-26

$RFMT $RIREG SCHEME272 STEP1
$RXN



  2  1
$MOL
BOC-L-Phenylalanine
C14H19NO4
13734-34-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 2.6675 0.0 0 CFG=1
M  V30 2 C 4.6201 4.0012 0.0 0
M  V30 3 N 6.9302 2.6675 0.0 0
M  V30 4 C 4.6201 1.3338 0.0 0
M  V30 5 C 7.7002 4.0012 0.0 0
M  V30 6 O 3.0801 1.3338 0.0 0
M  V30 7 O 5.3901 0.0000 0.0 0
M  V30 8 O 9.2402 4.0012 0.0 0
M  V30 9 O 6.9302 5.3348 0.0 0
M  V30 10 C 10.0102 5.3348 0.0 0
M  V30 11 C 11.3439 4.5648 0.0 0
M  V30 12 C 10.7802 6.6687 0.0 0
M  V30 13 C 8.6766 6.1048 0.0 0
M  V30 14 C 3.0801 4.0012 0.0 0
M  V30 15 C 2.3101 5.3348 0.0 0
M  V30 16 C 2.3101 2.6675 0.0 0
M  V30 17 C 0.7700 5.3348 0.0 0
M  V30 18 C 0.7700 2.6675 0.0 0
M  V30 19 C 0.0000 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [(1S)-2-(methylamino)-2-oxo-1-(phenylmethyl)ethyl]-, 1,1-dimet...
C15H22N2O3
109522-21-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 4.0011 0.0 0 CFG=1
M  V30 2 C 4.6200 5.3347 0.0 0
M  V30 3 N 6.9300 4.0011 0.0 0
M  V30 4 C 4.6200 2.6674 0.0 0
M  V30 5 C 7.7000 5.3347 0.0 0
M  V30 6 N 5.3900 1.3336 0.0 0
M  V30 7 O 3.0800 2.6674 0.0 0
M  V30 8 O 9.2400 5.3347 0.0 0
M  V30 9 O 6.9300 6.6685 0.0 0
M  V30 10 C 4.6200 0.0000 0.0 0
M  V30 11 C 10.0100 6.6685 0.0 0
M  V30 12 C 8.6764 7.4385 0.0 0
M  V30 13 C 10.7800 8.0021 0.0 0
M  V30 14 C 11.3436 5.8985 0.0 0
M  V30 15 C 3.0800 5.3347 0.0 0
M  V30 16 C 2.3100 4.0011 0.0 0
M  V30 17 C 2.3100 6.6685 0.0 0
M  V30 18 C 0.7700 4.0011 0.0 0
M  V30 19 C 0.7700 6.6685 0.0 0
M  V30 20 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 15
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 13734-34-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 109522-21-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13139864
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 543-27-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure III (GP-III). N-Alkyl
Amidation of PG-Xaa-OH N-Methyl morpholine (10 mmol) and isobutyl
chloroformate (10 mmol) were successively added to a solution of
Boc-Xaa-OH 2a-g (10 mmol) or PhtN-Xaa-OH 2h-n (10 mmol) in THF (20 mL) at
-20°C. After an activation period of 3 min, 40 % aqueous methylamine
(12-50 mmol) or N-alkyl amine (13 mmol) in THF (5 mL) was added to above
solution, and the resulting solution was stirred for 1 h at -20°C prior
to the addition of 5 % NaHCO3 (20 mL). After 30 min at room temperature,
the aqueous phase was extracted with CH2Cl2 (3×50 mL). The combined
organic layer was washed with 5 % NaHCO3 (2×20 mL) and dried (Na2SO4).
Evaporation of solvents under reduced pressure gave Boc-Xaa-NHMe 3a-g or
PhtN-Xaa-NHR.3h-n The crude products were purified by flash
chromatography (EtOAc/cyclohexane, 1:2) or by crystallization
(EtOAc/pentane or CH2Cl2/pentane). tert-Butyl
(S)-1-(methylcarbamoyl)-2-phenylethylcarbamate (3e) [Boc-L-Phe-NHMe].
Following GP-III, from Boc-L-Phe- OH 2e (1.28 g, 4.8 mmol), title
compound 3e was isolated as a white solid (1.32 mg, > 99 %) mp 142-143°C
(EtOAc/pentane); [α]D +12.4 (c 1.0, MeOH); δH (300.14 MHz, CDCl3): 1.38
(3×s, 9 H), 2.71 (d, 3 H, 3JHH = 4.9 Hz), 3.03 (2×dd, overlapped, 2 H),
4.34 (dd, 1 H, 3JHH = 7.6 Hz, 3JHH = 7.2 Hz), 5.22 (d, 1 H, 3JHH = 7.7
Hz), 6.13 (bs, 1 H), 7.14-7.30 (m, 5 H); δC (75.48 MHz, CDCl3): 26.00
(q), 28.21 (3×q), 38.86 (dd), 55.97 (d), 80.01 (s), 126.75 (s), 128.47
(2×d), 128.24 (2×d), 136.89 (s), 155.42 (s), 171.90 (s); MS-ES, m/z:
279.2 [M+H], 301.2 [M+Na], MS-EI, m/z (%): 222 (1) [M-56], 220 (1)
[M-C2H4NO], 205 (1) [M-(H2O+56)], 202 (1) [M-77], 187 (1) [M-91], 176 (1)
[205-CH5N], 161 (5) [M-117], 131 (5) [161- CH5N], 120 (50)
[220-(CO2+56)], 117 (3) [M-161], 103 (12) 91 (58) [C7H7], 87 (28)
[162-77], 77 (12) [C6H5], 65 (15), 56 (39) (C4H8), 44 (90), 41 (100);
ES-EM for [C15H22N2O3+Na]: Calcd, 301.1523; Found, 301.1500. Anal. Calcd
for C14H20N2O3: C, 64.73; H, 7.97; N, 10.06. Found: C, 64.63; H, 7.81; N,
10.03. Analytical and spectral data agree with literature.7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Highly Efficient Stereoconservative Amidation and Deamidation of α-Amino
Acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shendage, Deepak M.; Froehlich, Roland; Haufe, Guenter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2004), 6(21), 3675-3678

$RFMT $RIREG SCHEME273 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-[6-bromo-4-[(3,3,3-trifluoropropyl)amino]-1H-benzimidazol-1-y...
C18H15BrF3N3O2
1401450-52-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 12.2015 4.6201 0.0 0
M  V30 2 C 13.5352 3.8501 0.0 0
M  V30 3 C 14.8690 4.6201 0.0 0
M  V30 4 C 16.2027 3.8501 0.0 0
M  V30 5 F 17.5364 3.0801 0.0 0
M  V30 6 F 16.9727 5.1838 0.0 0
M  V30 7 F 15.4327 2.5164 0.0 0
M  V30 8 Br 9.5342 0.0000 0.0 0
M  V30 9 C 1.9822 6.5291 0.0 0
M  V30 10 C 1.0304 3.5998 0.0 0
M  V30 11 O 0.5546 2.1351 0.0 0
M  V30 12 O 0.0000 4.7442 0.0 0
M  V30 13 C 8.2004 3.8501 0.0 0
M  V30 14 N 7.0560 4.8805 0.0 0
M  V30 15 C 9.5342 4.6201 0.0 0
M  V30 16 C 8.2004 2.3101 0.0 0
M  V30 17 C 7.6823 6.2875 0.0 0
M  V30 18 C 10.8679 3.8501 0.0 0
M  V30 19 N 9.2140 6.1264 0.0 0
M  V30 20 C 9.5342 1.5400 0.0 0
M  V30 21 C 10.8679 2.3101 0.0 0
M  V30 22 C 5.5497 4.5603 0.0 0
M  V30 23 C 4.5191 5.7049 0.0 0
M  V30 24 C 5.0736 3.0958 0.0 0
M  V30 25 C 3.0128 5.3847 0.0 0
M  V30 26 C 3.5673 2.7756 0.0 0
M  V30 27 C 2.5369 3.9200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 20
M  V30 9 1 9 25
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 27
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 2 13 16
M  V30 16 1 14 17
M  V30 17 1 14 22
M  V30 18 2 15 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 2 17 19
M  V30 22 1 18 21
M  V30 23 2 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[6-Bromo-4-[(3,3,3-trifluoropropyl)amino]-1H-benzimidazol-1-yl]-N,2-dimethy...
C19H18BrF3N4O
1401450-54-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 13.1533 4.6201 0.0 0
M  V30 2 C 14.4871 3.8501 0.0 0
M  V30 3 C 15.8208 4.6201 0.0 0
M  V30 4 C 17.1544 3.8501 0.0 0
M  V30 5 F 18.4881 3.0801 0.0 0
M  V30 6 F 17.9245 5.1838 0.0 0
M  V30 7 F 16.3844 2.5164 0.0 0
M  V30 8 Br 10.4859 0.0000 0.0 0
M  V30 9 C 2.9341 6.5291 0.0 0
M  V30 10 C 1.9822 3.5998 0.0 0
M  V30 11 N 1.5063 2.1351 0.0 0
M  V30 12 O 0.9517 4.7442 0.0 0
M  V30 13 C 0.0000 1.8149 0.0 0
M  V30 14 N 8.0077 4.8805 0.0 0
M  V30 15 C 9.1523 3.8501 0.0 0
M  V30 16 C 8.6342 6.2875 0.0 0
M  V30 17 C 10.4859 4.6201 0.0 0
M  V30 18 C 9.1523 2.3101 0.0 0
M  V30 19 N 10.1658 6.1264 0.0 0
M  V30 20 C 11.8196 3.8501 0.0 0
M  V30 21 C 10.4859 1.5400 0.0 0
M  V30 22 C 11.8196 2.3101 0.0 0
M  V30 23 C 6.5014 4.5603 0.0 0
M  V30 24 C 5.4708 5.7049 0.0 0
M  V30 25 C 6.0255 3.0958 0.0 0
M  V30 26 C 3.9645 5.3847 0.0 0
M  V30 27 C 4.5191 2.7756 0.0 0
M  V30 28 C 3.4886 3.9200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 21
M  V30 9 1 9 26
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 28
M  V30 13 1 11 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 23
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 2 16 19
M  V30 20 1 17 19
M  V30 21 2 17 20
M  V30 22 1 18 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1401450-52-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1401450-54-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2880473
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 10:
4-{6-(3-Fluorophenoxy)-4-[(3,3,3-trifluoropropyl)amino]-1H-benzimidazol-1-yl}-N,2-dimethylbenzamide.
A mixture comprising 20 mg (42 μmol)
4-{6-(3-fluorophenoxy)-4-[(3,3,3-trifluoropropyl)amino]-1H-benzimidazol-1-yl}-2-methylbenzoic
acid which was prepared according to intermediate example 10a, 31.7 μL
methanamine solution in tetrahydrofuran (2M), 24.1 mg
N-[(dimethylamino)(3H-[1,2,3]triazolo[4,5-b]pyridin-3-yloxy)methylene]-N-methylmethanaminium
hexafluorophosphate, 7.7 mg N,N-dimethylpyridin-4-amine and 0.5 mL
N,N-dimethylformamide was stirred at 23°C overnight. The solvent was
removed and the residue purified by chromatography.
4-{6-bromo-4-[(3,3,3-trifluoropropyl)amino]-1H-benzimidazol-1-yl}-N,
2-dimethylbenzamide. 550 mg (1.24 mmol)
4-{6-bromo-4-[(3,3,3-trifluoropropyl)amino]-1H-benzimidazol-1-yl}-2-methylbenzoic
acid which was prepared according to intermediate example 66b were
transformed in analogy to example 10 to give after working up and 5
purification 566 mg (99%) of the title compound.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted benzimidazoles for treating hyperproliferative
and angiogenesis disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Klar, Ulrich; Koppitz, Marcus; Nguyen, Duy; Kosemund, Dirk; Neuhaus,
Roland; Siemeister, Gerhard
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012130905 A1 2012-10-04

$RFMT $RIREG SCHEME274 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-[6-bromo-8-[(3,3,3-trifluoropropyl)amino]imidazo[1,2-a]pyridi...
C18H15BrF3N3O2
1402595-66-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 12.2015 4.6201 0.0 0
M  V30 2 C 13.5352 3.8501 0.0 0
M  V30 3 C 14.8690 4.6201 0.0 0
M  V30 4 C 16.2027 3.8501 0.0 0
M  V30 5 F 17.5364 3.0801 0.0 0
M  V30 6 F 16.9727 5.1838 0.0 0
M  V30 7 F 15.4327 2.5164 0.0 0
M  V30 8 Br 9.5342 0.0000 0.0 0
M  V30 9 C 1.9822 6.5291 0.0 0
M  V30 10 C 1.0304 3.5998 0.0 0
M  V30 11 O 0.5546 2.1351 0.0 0
M  V30 12 O 0.0000 4.7442 0.0 0
M  V30 13 N 8.2004 3.8501 0.0 0
M  V30 14 C 7.0560 4.8805 0.0 0
M  V30 15 C 9.5342 4.6201 0.0 0
M  V30 16 C 8.2004 2.3101 0.0 0
M  V30 17 C 7.6823 6.2875 0.0 0
M  V30 18 C 10.8679 3.8501 0.0 0
M  V30 19 N 9.2140 6.1264 0.0 0
M  V30 20 C 9.5342 1.5400 0.0 0
M  V30 21 C 10.8679 2.3101 0.0 0
M  V30 22 C 5.5497 4.5603 0.0 0
M  V30 23 C 4.5191 5.7049 0.0 0
M  V30 24 C 5.0736 3.0958 0.0 0
M  V30 25 C 3.0128 5.3847 0.0 0
M  V30 26 C 3.5673 2.7756 0.0 0
M  V30 27 C 2.5369 3.9200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 20
M  V30 9 1 9 25
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 27
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 2 14 17
M  V30 17 1 14 22
M  V30 18 1 15 18
M  V30 19 2 15 19
M  V30 20 2 16 20
M  V30 21 1 17 19
M  V30 22 2 18 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[6-Bromo-8-[(3,3,3-trifluoropropyl)amino]imidazo[1,2-a]pyridin-3-yl]-N,2-di...
C19H18BrF3N4O
1402596-07-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 13.1533 4.6201 0.0 0
M  V30 2 C 14.4871 3.8501 0.0 0
M  V30 3 C 15.8208 4.6201 0.0 0
M  V30 4 C 17.1544 3.8501 0.0 0
M  V30 5 F 18.4881 3.0801 0.0 0
M  V30 6 F 17.9245 5.1838 0.0 0
M  V30 7 F 16.3844 2.5164 0.0 0
M  V30 8 Br 10.4859 0.0000 0.0 0
M  V30 9 C 2.9341 6.5291 0.0 0
M  V30 10 C 1.9822 3.5998 0.0 0
M  V30 11 N 1.5063 2.1351 0.0 0
M  V30 12 O 0.9517 4.7442 0.0 0
M  V30 13 C 0.0000 1.8149 0.0 0
M  V30 14 C 8.0077 4.8805 0.0 0
M  V30 15 N 9.1523 3.8501 0.0 0
M  V30 16 C 8.6342 6.2875 0.0 0
M  V30 17 C 10.4859 4.6201 0.0 0
M  V30 18 C 9.1523 2.3101 0.0 0
M  V30 19 N 10.1658 6.1264 0.0 0
M  V30 20 C 11.8196 3.8501 0.0 0
M  V30 21 C 10.4859 1.5400 0.0 0
M  V30 22 C 11.8196 2.3101 0.0 0
M  V30 23 C 6.5014 4.5603 0.0 0
M  V30 24 C 5.4708 5.7049 0.0 0
M  V30 25 C 6.0255 3.0958 0.0 0
M  V30 26 C 3.9645 5.3847 0.0 0
M  V30 27 C 4.5191 2.7756 0.0 0
M  V30 28 C 3.4886 3.9200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 21
M  V30 9 1 9 26
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 28
M  V30 13 1 11 13
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 23
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 2 17 19
M  V30 21 1 17 20
M  V30 22 2 18 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1402595-66-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1402596-07-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-3624449
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 8.
4-{6-(3-Fluorophenoxy)-8-[(3,3,3-trifluoropropyl)amino]imidazo[1,2-a]pyridin-3-yl}-N,2-dimethylbenzamide.
A mixture comprising 18 mg (38 μmol)
4-{6-(3-fluorophenoxy)-8-[(3,3,3-trifluoropropyl)amino]imidazo[1,2-a]pyridin-3-yl}-2-methylbenzoic
acid which was prepared according to intermediate example 8a, 28.5 μL
methanamine solution in tetrahydrofuran (2M), 21.7 mg
N-[(dimethylamino)(3H-[1,2,3]triazolo[4,5-b]pyridin-3-yloxy)methylene]-N-methylmethanaminium
hexafluorophosphate, 7.0 mg N,N-dimethylpyridin-4-amine and 0.9 mL
N,N-dimethylformamide was stirred at 23°C overnight. The solvent was
removed and the residue purified by chromatography.
4-{6-Bromo-8-[(3,3,3-trifluoropropyl)amino]imidazo[1,2-a]pyridin-3-yl}-N,2-dimethylbenzamide.
400 mg (904 μmol)
4-{6-bromo-8-[(3,3,3-trifluoropropyl)amino]imidazo[1,2-a]pyridin-3-yl}-2-methylbenzoic
acid which was prepared according to intermediate example 42b were
transformed in analogy to example 8 to give after working up and
purification 409mg (99%) of the title compound.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted imidazopyridines and intermediates thereof and
their use in the treatment of hyperproliferative and angiogenic diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Koppitz, Marcus; Klar, Ulrich; Wengner, Antje; Neuhaus, Roland;
Siemeister, Gerhard
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012136531 A1 2012-10-11

$RFMT $RIREG SCHEME275 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl acrylate
C5H8O2
140-88-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 O 4.0011 2.3100 0.0 0
M  V30 3 C 1.3338 2.3100 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 6.6686 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Ethoxy-3-oxopropyl)-N-methyl-β-alanine ethyl ester
C11H21NO4
6315-60-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.0023 1.5400 0.0 0
M  V30 2 C 6.6687 2.3101 0.0 0
M  V30 3 C 9.3360 2.3101 0.0 0
M  V30 4 C 8.0023 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 C 10.6698 1.5400 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 12.0035 2.3101 0.0 0
M  V30 9 O 2.6675 1.5400 0.0 0
M  V30 10 O 4.0012 3.8501 0.0 0
M  V30 11 O 13.3372 1.5400 0.0 0
M  V30 12 O 12.0035 3.8501 0.0 0
M  V30 13 C 1.3338 2.3101 0.0 0
M  V30 14 C 14.6708 2.3101 0.0 0
M  V30 15 C 0.0000 1.5400 0.0 0
M  V30 16 C 16.0046 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 11 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 140-88-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6315-60-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-9211814
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Synthesis of
N-methyl-N,N-bis[2-(alkoxycarbonyl)ethyl]amine: General Procedure
Reactions were typically carried out as follows: 1.40 mol of alkyl
acrylate was placed in a round-bottom flask equipped with reflux
condenser, magnetic stirrer, dropping funnel and thermometer. Ethanolic
solution of methylamine (0.700 mol) was slowly dropped in at temperature
not exceeded 30 °C (reaction is exothermic). The reaction mixture was
then stored at room temperature for ca. 1 additional day. After
evaporating of the solvent, crude product could be (if necessary)
additionally processed by fractional distillation or crystallization. In
the case of pure methylamine reaction was carried out at room temperature
in a pressure glass reactor. Alkyl acrylate (0.600 mol) and 35 ml of
anhydrous ethyl alcohol or 2-propanol (in the case of octadecyl acrylate
only) were placed in pressure glass reactor equipped with magnetic
stirrer, manometer and inlet tube. The reaction mixture was intensively
stirred and cooled with a water-ice bath to maintain the reaction
temperature at 15-20 °C while gaseous methylamine (0.300 mol) was slowly
introduced through the inlet tube under the layer of alkyl acrylate from
a weighed pressure container. The rate of methylamine addition was
controlled with valve to maintain pressure above reaction mixture not
higher than 0.03 MPa. After completion of amine introduction the reaction
mixture was stored for 24 h at room temperature. The yield of crude
products was almost quantitative and at least 99% of purity. In the case
of octadecyl derivative, it was necessary to evaporate the solvent which
could be reused. Table 1 The aza-Michael reaction of methylamine with
alkyl acrylates Compound 4a Product CH3N(CH2CH2COOCH3)2 Table 1 The
aza-Michael reaction of methylamine with alkyl acrylates Compound 4b
Product CH3N(CH2CH2COOC2H5)2 Yield 99.0 %. Bp [°C/mmHg] or mp 143/15 °C
Refractive index nD20 1.4412 Molecular formula C11H21NO4 Elemental
analysis calcd. (wt%): C, 57.12; H, 9.15; N, 6.06. found (wt%): C, 57.13;
H, 9.12; N, 6.10.
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, green chemistry-solvent, gaseous methylamine in pressure
glass reactor also used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New hydrophobic intermediates of aminodiester-type via a green,
Michael-addition reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Piasecki, Andrzej; Zielinski, Wojciech
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Surfactants and Detergents (2008), 11(1), 21-27

$RFMT $RIREG SCHEME276 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Butyl acrylate
C7H12O2
141-32-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 O 4.0012 2.3101 0.0 0
M  V30 3 C 1.3337 2.3101 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 6.6685 2.3101 0.0 0
M  V30 8 C 8.0023 1.5400 0.0 0
M  V30 9 C 9.3360 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-β-alanine butyl ester
C8H17NO2
1250627-62-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 2.3101 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 C 8.0022 1.5400 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 O 5.3348 0.0000 0.0 0
M  V30 6 C 9.3360 2.3101 0.0 0
M  V30 7 C 2.6673 1.5400 0.0 0
M  V30 8 C 10.6697 1.5400 0.0 0
M  V30 9 N 1.3337 2.3101 0.0 0
M  V30 10 C 12.0033 2.3101 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 141-32-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1250627-62-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-8944824
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1298062-16-4
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, ionic liquid catalyst used, Michael addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of a novel ionic liquid with both Lewis and Bronsted acid sites
and its catalytic activities
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liang, Xuezheng; Qi, Chenze
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Catalysis Communications (2011), 12(9), 808-812

$RFMT $RIREG SCHEME276 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Butyl acrylate
C7H12O2
141-32-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 O 4.0012 2.3101 0.0 0
M  V30 3 C 1.3337 2.3101 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 6.6685 2.3101 0.0 0
M  V30 8 C 8.0023 1.5400 0.0 0
M  V30 9 C 9.3360 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-β-alanine butyl ester
C8H17NO2
1250627-62-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 2.3101 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 C 8.0022 1.5400 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 O 5.3348 0.0000 0.0 0
M  V30 6 C 9.3360 2.3101 0.0 0
M  V30 7 C 2.6673 1.5400 0.0 0
M  V30 8 C 10.6697 1.5400 0.0 0
M  V30 9 N 1.3337 2.3101 0.0 0
M  V30 10 C 12.0033 2.3101 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 141-32-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1250627-62-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-7941394
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1360467-48-6
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, no solvent, Michael addition, mechanism
studied, scalable, ionic liquid used (catalyst), catalyst recycled
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel ionic liquid with both Lewis and Bronsted acid sites for Michael
addition
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jiang, Xiaoyue; Ye, Weidong; Song, Xiaohua; Ma, Wenxin; Lao, Xuejun;
Shen, Runpu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM International Journal of Molecular Sciences (2011), 127438-7444

$RFMT $RIREG SCHEME277 STEP1
$RXN



  2  1
$MOL
(-)-Tetrahydro-2,2-diphenyl-3-furanmethanol
C17H18O2
1418006-98-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.8963 3.1255 0.0 0
M  V30 2 O 8.4363 3.1255 0.0 0
M  V30 3 C 4.5947 4.6201 0.0 0
M  V30 4 C 6.1263 4.4592 0.0 0 CFG=3
M  V30 5 O 4.2745 6.1266 0.0 0
M  V30 6 C 6.7527 5.8660 0.0 0
M  V30 7 C 5.6082 6.8966 0.0 0
M  V30 8 C 4.5947 3.0801 0.0 0
M  V30 9 C 3.2610 2.3101 0.0 0
M  V30 10 C 5.9284 2.3101 0.0 0
M  V30 11 C 3.2610 0.7700 0.0 0
M  V30 12 C 5.9284 0.7700 0.0 0
M  V30 13 C 4.5947 0.0000 0.0 0
M  V30 14 C 3.0631 4.4592 0.0 0
M  V30 15 C 2.4368 3.0523 0.0 0
M  V30 16 C 2.1579 5.7051 0.0 0
M  V30 17 C 0.9051 2.8913 0.0 0
M  V30 18 C 0.6263 5.5441 0.0 0
M  V30 19 C 0.0000 4.1371 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 8
M  V30 6 1 3 14
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 7
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(-)-Tetrahydro-N-methyl-2,2-diphenyl-3-furanmethanamine
C18H21NO
1418006-90-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.8963 3.1255 0.0 0
M  V30 2 N 8.4363 3.1255 0.0 0
M  V30 3 C 9.2063 1.7917 0.0 0
M  V30 4 C 4.5947 4.6201 0.0 0
M  V30 5 C 6.1262 4.4592 0.0 0 CFG=3
M  V30 6 O 4.2745 6.1265 0.0 0
M  V30 7 C 6.7527 5.8660 0.0 0
M  V30 8 C 5.6082 6.8966 0.0 0
M  V30 9 C 3.0631 4.4592 0.0 0
M  V30 10 C 2.1579 5.7050 0.0 0
M  V30 11 C 2.4368 3.0523 0.0 0
M  V30 12 C 0.6263 5.5441 0.0 0
M  V30 13 C 0.9051 2.8913 0.0 0
M  V30 14 C 0.0000 4.1371 0.0 0
M  V30 15 C 4.5947 3.0801 0.0 0
M  V30 16 C 5.9283 2.3100 0.0 0
M  V30 17 C 3.2610 2.3100 0.0 0
M  V30 18 C 5.9283 0.7700 0.0 0
M  V30 19 C 3.2610 0.7700 0.0 0
M  V30 20 C 4.5947 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 9
M  V30 7 1 4 15
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1418006-98-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1418006-90-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-5934307
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-48-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 358-23-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: (-)
1-(2,2-diphenyltetrahydrofuran-3-yl)-N-methylmethanamine [(-)3]. To a
stirred solution of (-) (2,2-diphenyltetrahydrofuran-3-yl)methanol
[(-)151 (740mg, 2.91mmol) in anhydrous CH2Cl2 (37 mL) at -10°C,
2,6-lutidine (0.51mL, 4.36mmol) and trifluoromethanesulfonic anhydride
(0.72mL, 4.36mmol) was added dropwise. After stirring for 1h at -10°C,
the solvent was evaporated and Et2O was added. The organic layer was
washed very quickly with cold water and dried with Na2SO4. Evaporation of
the solvent in vacuo without heating led to the crude triflate [(-)17].
which was dissolved in THF (22mL) at 0°C and a solution of MeNH2 (41% in
water, 22mL) was added with stirring. The reaction mixture was warmed to
room temperature and stirred for 8h. The solvent was then evaporated,
Et2O was added, the organic layer was washed with water and evaporated in
vacuo. The residue was purified by flash column chromatography using a
mixture of CH2Cl2 :MeOH (95:5-90:10) as eluent and the product was
obtained. Yield: (2.89mmol, 99%), white amorphous solid. (aD = -208°, c =
1, CH2Cl2).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of (+)- and
(-)-1-(5,5-diphenyltetrahydrofuran-3-yl)-N,N-dimethylmethanamine, (+)-
and (-)-1-(2,2-diphenyltetrahydrofuran-3-yl)-N,N-dimethylmethanamine and
(+)- and (-)-1-(2,2-diphenyltetrahydrofuran-3-yl)-N-methylmethanamine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wamvakides, Alexandre; Moutsos, Vassilios; Schmitt, Martine
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013008044 A1 2013-01-17

$RFMT $RIREG SCHEME278 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αS,3S)-α-[4-[[(1,1-dimethylethoxy)carbonyl]amino]butyl]-1,2,4,9-tetra...
C26H36N4O5
1422538-37-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 9.1796 6.7116 0.0 0
M  V30 2 C 11.1490 4.0011 0.0 0 CFG=2
M  V30 3 C 11.9190 5.3347 0.0 0
M  V30 4 C 11.9190 2.6674 0.0 0
M  V30 5 C 13.4590 5.3347 0.0 0
M  V30 6 O 11.1490 1.3336 0.0 0
M  V30 7 O 13.4590 2.6674 0.0 0
M  V30 8 C 14.2290 6.6684 0.0 0
M  V30 9 C 11.9190 0.0000 0.0 0
M  V30 10 C 15.7690 6.6684 0.0 0
M  V30 11 N 16.5390 8.0021 0.0 0
M  V30 12 C 18.0790 8.0021 0.0 0
M  V30 13 O 18.8490 9.3358 0.0 0
M  V30 14 O 18.8490 6.6684 0.0 0
M  V30 15 C 20.3890 9.3358 0.0 0
M  V30 16 C 20.3890 10.8758 0.0 0
M  V30 17 C 21.9290 9.3358 0.0 0
M  V30 18 C 20.3890 7.7958 0.0 0
M  V30 19 C 7.2391 4.7711 0.0 0 CFG=1
M  V30 20 C 8.7038 5.2469 0.0 0
M  V30 21 C 5.8323 4.1446 0.0 0
M  V30 22 C 7.2391 3.2311 0.0 0
M  V30 23 N 7.4002 6.3026 0.0 0
M  V30 24 N 9.6090 4.0011 0.0 0
M  V30 25 C 4.5864 5.0498 0.0 0
M  V30 26 C 8.7038 2.7552 0.0 0
M  V30 27 C 6.1541 7.2078 0.0 0
M  V30 28 C 3.0800 4.7296 0.0 0
M  V30 29 C 4.7474 6.5815 0.0 0
M  V30 30 C 2.3100 6.0633 0.0 0
M  V30 31 C 2.3100 3.3960 0.0 0
M  V30 32 N 3.3406 7.2078 0.0 0
M  V30 33 C 0.7700 6.0633 0.0 0
M  V30 34 C 0.7700 3.3960 0.0 0
M  V30 35 C 0.0000 4.7296 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 20
M  V30 2 1 2 3 CFG=1
M  V30 3 1 2 4
M  V30 4 1 2 24
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 1 19 22 CFG=3
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 1 22 26
M  V30 26 1 23 27
M  V30 27 1 24 26
M  V30 28 1 25 28
M  V30 29 2 25 29
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 28 31
M  V30 33 1 29 32
M  V30 34 1 30 32
M  V30 35 2 30 33
M  V30 36 1 31 34
M  V30 37 1 33 35
M  V30 38 2 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(5S)-6-(methylamino)-6-oxo-5-[(3S)-1,2,4,9-tetrahydro-2′...
C26H37N5O4
1422538-38-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 9.1796 6.7116 0.0 0
M  V30 2 C 11.1490 4.0011 0.0 0 CFG=2
M  V30 3 C 11.9190 5.3347 0.0 0
M  V30 4 C 11.9190 2.6674 0.0 0
M  V30 5 C 13.4590 5.3347 0.0 0
M  V30 6 N 11.1490 1.3336 0.0 0
M  V30 7 O 13.4590 2.6674 0.0 0
M  V30 8 C 14.2290 6.6684 0.0 0
M  V30 9 C 11.9190 0.0000 0.0 0
M  V30 10 C 15.7690 6.6684 0.0 0
M  V30 11 N 16.5390 8.0021 0.0 0
M  V30 12 C 18.0790 8.0021 0.0 0
M  V30 13 O 18.8490 9.3358 0.0 0
M  V30 14 O 18.8490 6.6684 0.0 0
M  V30 15 C 20.3890 9.3358 0.0 0
M  V30 16 C 20.3890 10.8758 0.0 0
M  V30 17 C 21.9290 9.3358 0.0 0
M  V30 18 C 20.3890 7.7958 0.0 0
M  V30 19 C 7.2391 4.7711 0.0 0 CFG=1
M  V30 20 C 8.7038 5.2469 0.0 0
M  V30 21 C 5.8323 4.1446 0.0 0
M  V30 22 C 7.2391 3.2311 0.0 0
M  V30 23 N 7.4002 6.3026 0.0 0
M  V30 24 N 9.6090 4.0011 0.0 0
M  V30 25 C 4.5864 5.0498 0.0 0
M  V30 26 C 8.7038 2.7552 0.0 0
M  V30 27 C 6.1541 7.2078 0.0 0
M  V30 28 C 3.0800 4.7296 0.0 0
M  V30 29 C 4.7474 6.5815 0.0 0
M  V30 30 C 2.3100 6.0633 0.0 0
M  V30 31 C 2.3100 3.3960 0.0 0
M  V30 32 N 3.3406 7.2078 0.0 0
M  V30 33 C 0.7700 6.0633 0.0 0
M  V30 34 C 0.7700 3.3960 0.0 0
M  V30 35 C 0.0000 4.7296 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 20
M  V30 2 1 2 3 CFG=1
M  V30 3 1 2 4
M  V30 4 1 2 24
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 1 19 22 CFG=3
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 1 22 26
M  V30 26 1 23 27
M  V30 27 1 24 26
M  V30 28 1 25 28
M  V30 29 2 25 29
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 28 31
M  V30 33 1 29 32
M  V30 34 1 30 32
M  V30 35 2 30 33
M  V30 36 1 31 34
M  V30 37 1 33 35
M  V30 38 2 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1422538-37-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1422538-38-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8269264
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM tert-Butyl
((S)-6-(Methylamino)-6-oxo-5-((S)-2'-oxo-1,2,4,9-tetrahydrospiro[pyrido[3,4-b]indole-3,3'-pyrrolidin]-1'-yl)hexyl)-carbamate,
18. To a solution of 17 (0.210 g, 0.43 mmol) in EtOH (0.5 mL),
methanamine (8 M in EtOH, 3 mL, 24 mmol) was added. After 5 h under
stirring, the mixture was concentrated in vacuo to afford pure 18.
Product 18 as a foam, yield 0.207 g, 99%. Rf 0.32 (7:3, EtOAc/MeOH);
[α]20D +15.9 (c 0.57 MeOH); 1H NMR (400 MHz, DMSOd6) δ 10.71 (s, br, 1H),
7.93 (m, br, 1H), 7.39 (d, J = 7.6 Hz, 1H), 7.28 (d, J = 7.8 Hz 1H), 7.01
(t, br, J = 7.5 Hz, 1H), 6.93 (t, br, J = 7.5 Hz, 1H), 6.78 (m, br, 1H),
4.45 (dd, J = 10.1 and 5.8 Hz, 1H), 4.43 (m, br, 1H), 4.02 (d, J = 16.8
Hz, 1H), 3.90 (d, J = 16.8 Hz, 1H), 3.59 (td, J = 9.1 and 3.2 Hz, 1H),
3.37-3.25 (m, 1H), 2.99-2.89 (m, 2H), 2.71 (d, J = 14.9 Hz, 1H), 2.64 (d,
J = 14.9 Hz, 1H), 2.60 (d, J = 4.5 Hz, 3H), 2.02 (dt, J = 12.4 and 7.9
Hz, 1H), 1.86-1.58 (m, 3H), 1.47-1.34 (m, 2H), 1.37 (s, 9H), 1.31-1.08
(m, 2H); 13C NMR (100 MHz CDCl3) δ 176.7, 170.1, 156.1, 136.1, 131.8,
127.6, 121.8, 119.5, 117.8, 110.9, 106.2, 79.2, 59.9, 55.2, 40.9, 40.3,
39.2, 29.7, 29.5, 28.5 (3C), 28.0, 27.5, 26.3, 23.3; HRMS (EI) calcd for
C26H37N2O4 483.2846, found 483.2861.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tetrahydro-β-carboline-Based Spirocyclic Lactam as Type II' β-Turn:
Application to the Synthesis and Biological Evaluation of Somatostatin
Mimetics
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lesma, Giordano; Cecchi, Roberto; Cagnotto, Alfredo; Gobbi, Marco;
Meneghetti, Fiorella; Musolino, Manuele; Sacchetti, Alessandro; Silvani,
Alessandra
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2013), 78(6), 2600-2610

$RFMT $RIREG SCHEME279 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(SP-4-1)-Bis(benzeneacetonitrile)dichloroplatinum
C16H14Cl2N2Pt
143729-48-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 4.6201 0.0 0
M  V30 2 C 5.3348 3.8501 0.0 0
M  V30 3 N 6.6687 3.0801 0.0 0 VAL=4
M  V30 4 Pt 8.0023 2.3101 0.0 0 CHG=2 VAL=4
M  V30 5 N 9.3360 1.5400 0.0 0 VAL=4
M  V30 6 Cl 7.2323 0.9764 0.0 0 CHG=-1 VAL=1
M  V30 7 Cl 8.7723 3.6437 0.0 0 CHG=-1 VAL=1
M  V30 8 C 10.6698 0.7700 0.0 0
M  V30 9 C 12.0035 0.0000 0.0 0
M  V30 10 C 2.6675 3.8501 0.0 0
M  V30 11 C 1.3338 4.6201 0.0 0
M  V30 12 C 2.6675 2.3101 0.0 0
M  V30 13 C 0.0000 3.8501 0.0 0
M  V30 14 C 1.3338 1.5400 0.0 0
M  V30 15 C 0.0000 2.3101 0.0 0
M  V30 16 C 13.3372 0.7700 0.0 0
M  V30 17 C 14.6708 0.0000 0.0 0
M  V30 18 C 13.3372 2.3101 0.0 0
M  V30 19 C 16.0046 0.7700 0.0 0
M  V30 20 C 14.6708 3.0801 0.0 0
M  V30 21 C 16.0046 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 3 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 3 5 8
M  V30 9 1 8 9
M  V30 10 1 9 16
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(SP-4-1)-Dichlorobis[[C(Z)]-N-methylbenzeneethanimidamide-κN′]platinum
C18H24Cl2N4Pt
1054659-35-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 2.6675 0.0 0
M  V30 2 N 6.9302 2.6675 0.0 0 VAL=4
M  V30 3 C 4.6201 4.0012 0.0 0
M  V30 4 N 4.6201 1.3337 0.0 0
M  V30 5 Pt 7.7002 4.0012 0.0 0 CHG=2 VAL=4
M  V30 6 C 5.3901 0.0000 0.0 0
M  V30 7 N 8.4702 5.3348 0.0 0 VAL=4
M  V30 8 Cl 9.0338 3.2311 0.0 0 CHG=-1 VAL=1
M  V30 9 Cl 6.3665 4.7712 0.0 0 CHG=-1 VAL=1
M  V30 10 C 10.0102 5.3348 0.0 0
M  V30 11 C 10.7802 4.0012 0.0 0
M  V30 12 N 10.7802 6.6687 0.0 0
M  V30 13 C 10.0102 8.0023 0.0 0
M  V30 14 C 3.0801 4.0012 0.0 0
M  V30 15 C 2.3101 2.6675 0.0 0
M  V30 16 C 2.3101 5.3348 0.0 0
M  V30 17 C 0.7700 2.6675 0.0 0
M  V30 18 C 0.7700 5.3348 0.0 0
M  V30 19 C 0.0000 4.0012 0.0 0
M  V30 20 C 12.3203 4.0012 0.0 0
M  V30 21 C 13.0903 2.6675 0.0 0
M  V30 22 C 13.0903 5.3348 0.0 0
M  V30 23 C 14.6303 2.6675 0.0 0
M  V30 24 C 14.6303 5.3348 0.0 0
M  V30 25 C 15.4003 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 14
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 2 7 10 CFG=2
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 20
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 143729-48-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1054659-35-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-317-CAS-1964016
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, 5-fold molar excess of amine used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzylamidine complexes of platinum(II) derived by nucleophilic addition
of primary and secondary amines. X-ray crystal structure of
trans-[PtCl2{Z-N(H)C(NHMe)CH2Ph}2]
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sbovata, Silvia Mazzega; Bettio, Frazia; Marzano, Christine; Mozzon,
Mirto; Bertani, Roberta; Benetollo, Franco; Michelin, Rino A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Inorganica Chimica Acta (2008), 361(11), 3109-3116

$RFMT $RIREG SCHEME280 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[[3-(4-Bromo-2,6-dimethylphenyl)-4-methoxy-2-oxo-3-cyclopenten-1-yl]methyl]...
C22H21BrN2O4S
1439558-86-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 10.2959 1.2459 0.0 0
M  V30 2 C 9.3907 0.0000 0.0 0
M  V30 3 O 9.7294 6.6372 0.0 0
M  V30 4 C 12.2499 1.4946 0.0 0
M  V30 5 C 11.6923 6.8001 0.0 0
M  V30 6 C 6.6686 5.2746 0.0 0
M  V30 7 Br 16.5659 4.6304 0.0 0
M  V30 8 S 1.3338 5.2746 0.0 0 VAL=6
M  V30 9 C 0.0000 6.0446 0.0 0
M  V30 10 O 0.5638 3.9407 0.0 0
M  V30 11 O 2.1038 6.6082 0.0 0
M  V30 12 C 1.3338 2.1945 0.0 0
M  V30 13 N 0.0000 1.4245 0.0 0
M  V30 14 C 10.4396 3.9863 0.0 0
M  V30 15 C 9.6696 2.6527 0.0 0
M  V30 16 C 9.4090 5.1309 0.0 0
M  V30 17 C 8.1632 2.9728 0.0 0
M  V30 18 C 8.0022 4.5045 0.0 0
M  V30 19 C 11.9712 4.1474 0.0 0
M  V30 20 C 12.8764 2.9015 0.0 0
M  V30 21 C 12.5975 5.5542 0.0 0
M  V30 22 C 14.4079 3.0625 0.0 0
M  V30 23 C 14.1292 5.7153 0.0 0
M  V30 24 C 15.0342 4.4693 0.0 0
M  V30 25 C 5.3348 4.5045 0.0 0
M  V30 26 N 4.0011 5.2746 0.0 0
M  V30 27 C 5.3348 2.9645 0.0 0
M  V30 28 C 2.6675 4.5045 0.0 0
M  V30 29 C 4.0011 2.1945 0.0 0
M  V30 30 C 2.6675 2.9645 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 2 3 16
M  V30 4 1 4 20
M  V30 5 1 5 21
M  V30 6 1 6 18
M  V30 7 1 6 25
M  V30 8 1 7 24
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 2 8 11
M  V30 12 1 8 28
M  V30 13 3 12 13
M  V30 14 1 12 30
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 14 19
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 1 25 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[[3-(4-Bromo-2,6-dimethylphenyl)-4-methoxy-2-oxo-3-cyclopenten-1-yl]methyl]...
C22H22BrN3O2
1439558-92-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 10.2959 1.2459 0.0 0
M  V30 2 C 9.3907 0.0000 0.0 0
M  V30 3 O 9.7293 6.6373 0.0 0
M  V30 4 C 11.6922 6.8002 0.0 0
M  V30 5 C 12.2498 1.4947 0.0 0
M  V30 6 C 6.6685 5.2745 0.0 0
M  V30 7 Br 16.5659 4.6303 0.0 0
M  V30 8 N 1.3338 5.2745 0.0 0
M  V30 9 C 1.3338 6.8145 0.0 0
M  V30 10 C 1.3338 2.1945 0.0 0
M  V30 11 N 0.0000 1.4245 0.0 0
M  V30 12 C 10.4396 3.9865 0.0 0
M  V30 13 C 9.6696 2.6528 0.0 0
M  V30 14 C 9.4090 5.1308 0.0 0
M  V30 15 C 8.1631 2.9730 0.0 0
M  V30 16 C 8.0022 4.5045 0.0 0
M  V30 17 C 11.9711 4.1474 0.0 0
M  V30 18 C 12.5974 5.5543 0.0 0
M  V30 19 C 12.8763 2.9015 0.0 0
M  V30 20 C 14.1291 5.7153 0.0 0
M  V30 21 C 14.4079 3.0625 0.0 0
M  V30 22 C 15.0342 4.4694 0.0 0
M  V30 23 C 5.3347 4.5045 0.0 0
M  V30 24 N 4.0011 5.2745 0.0 0
M  V30 25 C 5.3347 2.9645 0.0 0
M  V30 26 C 2.6674 4.5045 0.0 0
M  V30 27 C 4.0011 2.1945 0.0 0
M  V30 28 C 2.6674 2.9645 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 2 3 14
M  V30 4 1 4 18
M  V30 5 1 5 19
M  V30 6 1 6 16
M  V30 7 1 6 23
M  V30 8 1 7 22
M  V30 9 1 8 9
M  V30 10 1 8 26
M  V30 11 3 10 11
M  V30 12 1 10 28
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 12 17
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 1 23 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1439558-86-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1439558-92-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-13919883
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Intermediate 3: Synthesis of
6-[[3-(4-bromo-2,6-dimethyphenyl)-4-methoxy-2-oxo-cyclopent-3-en-1-yl]methyl]-2-(methylamino)pyridine-3-carbonitrile
To
6-[[3-(4-bromo-2,6-dimethyphenyl)-4-methoxy-2-oxo-cyclopent-3-en-1-yl]methyl]-2-methylsulfonypyridine-3-carbonitrile
(2.043 mmol, 1 g) was added a solution of methylamine (5.1 ml of a 2M
solution in tetrahydrofuran, 10.22 mmol). The reaction was stirred at
room temperature for three hours and then concentrated under reduced
pressure to give a brown gum. The crude product was purified by column
chromatography on SiO2 using a hexane: EtOAc gradient to yield the
desired compound. Orange solid, yield 890mg, 99%. 1H NMR (400 MHz, CDCl3)
(diagnostic peaks) δ ppm 7.55 (d, 1H), 7.18 (d, 2H), 6.45 (d, 1H), 3.55
(s, 3H), 3.05 (d, 3H), 2.15 (s, 3H), 2.00 (s, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation and use of substituted phenylcyclopentanedione compounds, and
derivatives thereof, for weed control
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Avery, Alaric James; Phadte, Mangala Mahadev; Scutt, James Nicholas;
Taylor, John Benjamin; Viner, Russell Colin; Wailes, Jeffrey Steven
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013079708 A1 2013-06-06

$RFMT $RIREG SCHEME281 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Bis(1-methylethyl) P-(11-bromo-1,1-difluoroundecyl)phosphonate
C17H34BrF2O3P
1446348-18-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 3.0801 3.0801 0.0 0 VAL=5
M  V30 2 C 4.4139 3.8501 0.0 0
M  V30 3 O 1.7464 2.3101 0.0 0
M  V30 4 O 2.3101 4.4137 0.0 0
M  V30 5 O 3.8501 1.7462 0.0 0
M  V30 6 C 5.7476 4.6201 0.0 0
M  V30 7 F 5.1839 2.5163 0.0 0
M  V30 8 F 3.6439 5.1838 0.0 0
M  V30 9 C 1.7464 0.7700 0.0 0
M  V30 10 C 0.7700 4.4137 0.0 0
M  V30 11 C 7.0812 3.8501 0.0 0
M  V30 12 C 3.0801 0.0000 0.0 0
M  V30 13 C 0.4127 0.0000 0.0 0
M  V30 14 C 0.0000 5.7474 0.0 0
M  V30 15 C 0.0000 3.0801 0.0 0
M  V30 16 C 8.4149 4.6201 0.0 0
M  V30 17 C 9.7487 3.8501 0.0 0
M  V30 18 C 11.0824 4.6201 0.0 0
M  V30 19 C 12.4161 3.8501 0.0 0
M  V30 20 C 13.7499 4.6201 0.0 0
M  V30 21 C 15.0836 3.8501 0.0 0
M  V30 22 C 16.4172 4.6201 0.0 0
M  V30 23 C 17.7509 3.8501 0.0 0
M  V30 24 Br 19.0847 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 1 2 7
M  V30 7 1 2 8
M  V30 8 1 3 9
M  V30 9 1 4 10
M  V30 10 1 6 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 10 15
M  V30 15 1 11 16
M  V30 16 1 16 17
M  V30 17 1 17 18
M  V30 18 1 18 19
M  V30 19 1 19 20
M  V30 20 1 20 21
M  V30 21 1 21 22
M  V30 22 1 22 23
M  V30 23 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Bis(1-methylethyl) P-[1,1-difluoro-11-(methylamino)undecyl]phosphonate
C18H38F2NO3P
1446348-20-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 3.0801 3.0801 0.0 0 VAL=5
M  V30 2 C 4.4139 3.8501 0.0 0
M  V30 3 O 1.7464 2.3101 0.0 0
M  V30 4 O 2.3101 4.4137 0.0 0
M  V30 5 O 3.8501 1.7462 0.0 0
M  V30 6 C 5.7476 4.6201 0.0 0
M  V30 7 F 5.1839 2.5163 0.0 0
M  V30 8 F 3.6439 5.1838 0.0 0
M  V30 9 C 1.7464 0.7700 0.0 0
M  V30 10 C 0.7700 4.4137 0.0 0
M  V30 11 C 7.0812 3.8501 0.0 0
M  V30 12 C 3.0801 0.0000 0.0 0
M  V30 13 C 0.4127 0.0000 0.0 0
M  V30 14 C 0.0000 5.7474 0.0 0
M  V30 15 C 0.0000 3.0801 0.0 0
M  V30 16 C 8.4149 4.6201 0.0 0
M  V30 17 C 9.7487 3.8501 0.0 0
M  V30 18 C 11.0824 4.6201 0.0 0
M  V30 19 C 12.4161 3.8501 0.0 0
M  V30 20 C 13.7497 4.6201 0.0 0
M  V30 21 C 15.0836 3.8501 0.0 0
M  V30 22 C 16.4172 4.6201 0.0 0
M  V30 23 C 17.7509 3.8501 0.0 0
M  V30 24 N 19.0846 4.6201 0.0 0
M  V30 25 C 20.4184 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 1 2 7
M  V30 7 1 2 8
M  V30 8 1 3 9
M  V30 9 1 4 10
M  V30 10 1 6 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 10 15
M  V30 15 1 11 16
M  V30 16 1 16 17
M  V30 17 1 17 18
M  V30 18 1 18 19
M  V30 19 1 19 20
M  V30 20 1 20 21
M  V30 21 1 21 22
M  V30 22 1 22 23
M  V30 23 1 23 24
M  V30 24 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1446348-18-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1446348-20-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-7379910
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Preparation of
Acrylamide Derivatives. The bromoalkanes (1 equiv) were diluted in
absolute EtOH (30 mL), and MeNH2 in CH3OH 33 wt % (20 equiv) was added
dropwise. The mixture was stirred under N2 at 40 °C over 18 h. Then the
solvents were removed under reduced pressure, and H2O (20 mL) was added.
A solution of NaOHaq (10%) was introduced until pH ≥11. The aqueous layer
was extracted with CH2Cl2 twice. Combined organic layers were washed with
brine, dried over MgSO4, filtered, and concentrated under reduced
pressure. The product was then involved in the next step without any
purification. The reaction was placed at 40 °C, and starting from 15f
(870 mg, 2.0 mmol), the corresponding methylamine derivative (767 mg,
99%) was isolated as a yellow oil. 1H NMR (400 MHz, CDCl3) δ 4.77 (dsept,
J = 6.2 Hz, J = 6.2 Hz, 2H), 2.49 (t, J = 7.2 Hz, 2H), 2.36 (s, 3H),
2.02-1.89 (m, 3H), 1.50-1.36 (m, 4H), 1.31 (d, J = 6.1 Hz, 6H), 1.30 (d,
J = 6.1 Hz, 6H), 1.29-1.20 (m, 12H); 19F NMR (376 MHz, CDCl3) δ -112.8
(dt, J = 110.0 Hz, 18.8 Hz, 2F). 31P NMR (161 MHz, CDCl3): δ 5.78 (t, J =
110.0 Hz, 1P); 13C NMR (101 MHz, CDCl3) δ 120.6 (dt, J = 259.4 Hz, 217.7
Hz), 73.2 (d, J = 7.1 Hz), 52.0, 36.3, 33.7 (dt, J = 20.9 Hz, 14.2 Hz),
29.7, 29.6, 29.5, 29.4, 29.3, 29.2, 27.2, 24.0 (d, J = 3.4 Hz), 23.6 (d,
J = 4.8 Hz), 20.5 (q, J = 4.7 Hz); IR: 2977, 2925, 2855, 1467, 1377,
1268, 1178, 1103 988. HRMS (ESI) m/z: calcd for C18H39NO3F2P [M + H]+
386.2636. Found 386.2623.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fluorophosphonylated Monomers for Dental Applications
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Derbanne, Mathieu; Zulauf, Anais; Le Goff, Stephane; Pfund, Emmanuel;
Sadoun, Michael; Pham, Thi-Nhan; Lequeux, Thierry
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2014), 18(8), 1010-1019

$RFMT $RIREG SCHEME282 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-chloro-4,4-difluoro-3-(phenylamino)-2-butenoate
C12H12ClF2NO2
144850-63-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6675 0.0 0
M  V30 2 N 3.0800 2.6675 0.0 0
M  V30 3 C 5.3901 4.0011 0.0 0
M  V30 4 C 5.3901 1.3338 0.0 0
M  V30 5 C 6.9301 4.0011 0.0 0
M  V30 6 Cl 4.0564 0.5638 0.0 0
M  V30 7 F 6.1601 0.0000 0.0 0
M  V30 8 F 6.7237 2.1038 0.0 0
M  V30 9 O 7.7001 5.3348 0.0 0
M  V30 10 O 7.7001 2.6675 0.0 0
M  V30 11 C 9.2401 5.3348 0.0 0
M  V30 12 C 10.0101 6.6686 0.0 0
M  V30 13 C 2.3100 4.0011 0.0 0
M  V30 14 C 3.0800 5.3348 0.0 0
M  V30 15 C 0.7700 4.0011 0.0 0
M  V30 16 C 2.3100 6.6686 0.0 0
M  V30 17 C 0.0000 5.3348 0.0 0
M  V30 18 C 0.7700 6.6686 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 1 4
M  V30 4 1 2 13
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 5 9
M  V30 10 2 5 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-(chlorodifluoromethyl)-1,2,3,6-tetrahydro-1-methyl-3-phenyl-5-pyrimid...
C15H17ClF2N2O2
850338-95-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 6.1600 0.0 0
M  V30 2 Cl 3.7947 6.1600 0.0 0
M  V30 3 F 5.3347 7.7000 0.0 0
M  V30 4 F 6.8747 6.1600 0.0 0
M  V30 5 C 8.0020 4.6200 0.0 0
M  V30 6 O 9.3358 3.8500 0.0 0
M  V30 7 O 8.0020 6.1600 0.0 0
M  V30 8 C 10.6694 4.6200 0.0 0
M  V30 9 C 12.0031 3.8500 0.0 0
M  V30 10 C 5.3347 0.0000 0.0 0
M  V30 11 N 4.0011 3.8500 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 4.0011 2.3100 0.0 0
M  V30 14 C 6.6684 3.8500 0.0 0
M  V30 15 N 5.3347 1.5400 0.0 0
M  V30 16 C 6.6684 2.3100 0.0 0
M  V30 17 C 2.6673 4.6200 0.0 0
M  V30 18 C 1.3336 3.8500 0.0 0
M  V30 19 C 2.6673 6.1600 0.0 0
M  V30 20 C 0.0000 4.6200 0.0 0
M  V30 21 C 1.3336 6.9300 0.0 0
M  V30 22 C 0.0000 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 12
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 10 15
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 17
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 144850-63-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 850338-95-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-315-CAS-8876803
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A novel and efficient synthesis of fluoroalkylated multifunctional
1,2,3,4-tetrahydropyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhao, Fu-Lu; Liu, Jin-Tao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Fluorine Chemistry (2004), 125(12), 1841-1845

$RFMT $RIREG SCHEME283 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Oxa-6-azaspiro[2.5]octane-6-carboxylic acid, 1,1-dimethylethyl ester
C11H19NO3
147804-30-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.9537 2.8737 0.0 0
M  V30 2 O 6.7237 1.5400 0.0 0
M  V30 3 O 6.7237 4.2073 0.0 0
M  V30 4 C 8.2637 1.5400 0.0 0
M  V30 5 C 8.2637 0.0000 0.0 0
M  V30 6 C 9.8037 1.5400 0.0 0
M  V30 7 C 8.2637 3.0800 0.0 0
M  V30 8 C 1.3337 2.8737 0.0 0
M  V30 9 C 0.0000 2.1037 0.0 0
M  V30 10 O 0.0000 3.6437 0.0 0
M  V30 11 C 2.1037 1.5400 0.0 0
M  V30 12 C 2.1037 4.2073 0.0 0
M  V30 13 C 3.6437 1.5400 0.0 0
M  V30 14 C 3.6437 4.2073 0.0 0
M  V30 15 N 4.4137 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 10
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Piperidinecarboxylic acid, 4-hydroxy-4-[(methylamino)methyl]-, 1,1-dimethyl...
C12H24N2O3
1073559-55-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.6498 3.8636 0.0 0
M  V30 2 N 11.0968 3.3369 0.0 0
M  V30 3 C 12.2766 4.3268 0.0 0
M  V30 4 O 9.6498 1.8837 0.0 0
M  V30 5 C 3.8500 2.8736 0.0 0
M  V30 6 O 3.0800 1.5400 0.0 0
M  V30 7 O 3.0800 4.2074 0.0 0
M  V30 8 C 1.5400 1.5400 0.0 0
M  V30 9 C 1.5400 0.0000 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 11 C 1.5400 3.0800 0.0 0
M  V30 12 C 8.4700 2.8736 0.0 0
M  V30 13 C 7.7000 4.2074 0.0 0
M  V30 14 C 7.7000 1.5400 0.0 0
M  V30 15 C 6.1600 4.2074 0.0 0
M  V30 16 C 6.1600 1.5400 0.0 0
M  V30 17 N 5.3900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 4 12
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 17
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 147804-30-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1073559-55-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-23067048
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of EST73502, a Dual μ-Opioid Receptor Agonist and σ1 Receptor
Antagonist Clinical Candidate for the Treatment of Pain
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Garcia, Monica; Virgili, Marina; Alonso, Monica; Alegret, Carles; Farran,
Joan; Fernandez, Begona; Bordas, Magda; Pascual, Rosalia; Burgueno,
Javier; Vidal-Torres, Alba; Fernandez de Henestrosa, Antonio R.; Ayet,
Eva; Merlos, Manuel; Vela, Jose Miguel; Plata-Salaman, Carlos R.;
Almansa, Carmen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(24), 15508-15526

$RFMT $RIREG SCHEME284 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(2R)-2-oxiranylmethyl]carbamate
C8H15NO3
149057-20-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 2.1037 0.0 0
M  V30 2 N 5.3348 1.3337 0.0 0
M  V30 3 C 4.0012 2.1037 0.0 0
M  V30 4 O 2.6675 1.3337 0.0 0
M  V30 5 O 4.0012 3.6437 0.0 0
M  V30 6 C 1.3337 2.1037 0.0 0
M  V30 7 C 2.1037 3.4374 0.0 0
M  V30 8 C 0.0000 2.8737 0.0 0
M  V30 9 C 0.5637 0.7700 0.0 0
M  V30 10 C 8.0023 1.3337 0.0 0 CFG=1
M  V30 11 C 8.7723 0.0000 0.0 0
M  V30 12 O 9.5424 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 10 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(2S)-2-hydroxy-3-(methylamino)propyl]carbamate
C9H20N2O3
1204975-36-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 4.0012 2.3101 0.0 0
M  V30 4 C 8.0022 1.5400 0.0 0 CFG=1
M  V30 5 O 2.6673 1.5400 0.0 0
M  V30 6 O 4.0012 3.8501 0.0 0
M  V30 7 C 9.3360 2.3101 0.0 0
M  V30 8 O 8.0022 0.0000 0.0 0
M  V30 9 C 1.3337 2.3101 0.0 0
M  V30 10 N 10.6697 1.5400 0.0 0
M  V30 11 C 2.1037 3.6437 0.0 0
M  V30 12 C 0.0000 3.0801 0.0 0
M  V30 13 C 0.5637 0.9764 0.0 0
M  V30 14 C 12.0033 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8 CFG=3
M  V30 8 1 5 9
M  V30 9 1 7 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 149057-20-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1204975-36-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-8015630
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chiral 2-endo-Substituted 9-Oxabispidines: Novel Ligands for
Enantioselective Copper(II)-Catalyzed Henry Reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Breuning, Matthias; Hein, David; Steiner, Melanie; Gessner, Viktoria H.;
Strohmann, Carsten
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2009), 15(46), 12764-12769,
S12764/1-S12764/41

$RFMT $RIREG SCHEME285 STEP1
$RXN



  2  1
$MOL
2-Methoxycinnamaldehyde
C10H10O2
1504-74-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 C 6.1600 4.0011 0.0 0
M  V30 3 C 6.9300 5.3349 0.0 0
M  V30 4 O 8.4700 5.3349 0.0 0
M  V30 5 O 1.5400 4.0011 0.0 0
M  V30 6 C 0.0000 4.0011 0.0 0
M  V30 7 C 3.8500 2.6674 0.0 0
M  V30 8 C 2.3100 2.6674 0.0 0
M  V30 9 C 4.6200 1.3338 0.0 0
M  V30 10 C 1.5400 1.3338 0.0 0
M  V30 11 C 3.8500 0.0000 0.0 0
M  V30 12 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 5 6
M  V30 6 1 5 8
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-methyl-, compd. with methanamine (1:1)
C2H5NO2.CH5N
65398-48-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 2.6673 3.8501 0.0 0
M  V30 3 O 1.3337 1.5400 0.0 0
M  V30 4 O 0.0000 3.8501 0.0 0
M  V30 5 C 4.0010 3.0800 0.0 0
M  V30 6 C 1.2305 0.0000 0.0 0
M  V30 7 N 2.7705 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(2E)-3-(2-Methoxyphenyl)-2-propen-1-ylidene]methanamine
C11H13NO
2568117-19-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.3101 0.0 0
M  V30 2 C 5.3348 3.0801 0.0 0
M  V30 3 C 6.6685 2.3101 0.0 0
M  V30 4 N 8.0023 3.0801 0.0 0
M  V30 5 C 9.3360 2.3101 0.0 0
M  V30 6 O 1.3337 0.7700 0.0 0
M  V30 7 C 0.0000 0.0000 0.0 0
M  V30 8 C 2.6675 3.0801 0.0 0
M  V30 9 C 1.3337 2.3101 0.0 0
M  V30 10 C 2.6675 4.6201 0.0 0
M  V30 11 C 0.0000 3.0801 0.0 0
M  V30 12 C 1.3337 5.3901 0.0 0
M  V30 13 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 9
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1504-74-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 65398-48-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2568117-19-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-22949701
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Stable carbamate pathway towards organic-inorganic hybrid perovskites and
aromatic imines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lee, Kyu Hyung; Kim, Sun Joo; Park, Hee Sun; Lim, Byung Wook; Lee,
Byeongno; Park, Young Jun; Nam, Wonwoo; Hur, Nam Hwi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2020), 10(62), 38055-38062

$RFMT $RIREG SCHEME286 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 6-bromo-1H-indole-3-acetate
C11H10BrNO2
152213-63-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2708 3.1884 0.0 0
M  V30 2 C 8.7354 2.7125 0.0 0
M  V30 3 O 9.8798 3.7429 0.0 0
M  V30 4 O 9.0556 1.2061 0.0 0
M  V30 5 C 11.3445 3.2671 0.0 0
M  V30 6 Br 0.0000 2.4782 0.0 0
M  V30 7 C 4.6200 2.4782 0.0 0
M  V30 8 C 3.8500 1.1444 0.0 0
M  V30 9 C 6.1264 2.1580 0.0 0
M  V30 10 C 3.8500 3.8118 0.0 0
M  V30 11 N 4.8805 0.0000 0.0 0
M  V30 12 C 2.3100 1.1444 0.0 0
M  V30 13 C 6.2873 0.6263 0.0 0
M  V30 14 C 2.3100 3.8118 0.0 0
M  V30 15 C 1.5400 2.4782 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 15
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 1 12 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-N-methyl-1H-indole-3-acetamide
C11H11BrN2O
1352956-47-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2708 3.1884 0.0 0
M  V30 2 C 8.7354 2.7125 0.0 0
M  V30 3 N 9.8798 3.7429 0.0 0
M  V30 4 O 9.0556 1.2061 0.0 0
M  V30 5 C 11.3445 3.2671 0.0 0
M  V30 6 Br 0.0000 2.4782 0.0 0
M  V30 7 C 4.6200 2.4782 0.0 0
M  V30 8 C 3.8500 1.1444 0.0 0
M  V30 9 C 6.1264 2.1580 0.0 0
M  V30 10 C 3.8500 3.8118 0.0 0
M  V30 11 N 4.8805 0.0000 0.0 0
M  V30 12 C 2.3100 1.1444 0.0 0
M  V30 13 C 6.2873 0.6263 0.0 0
M  V30 14 C 2.3100 3.8118 0.0 0
M  V30 15 C 1.5400 2.4782 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 15
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 1 12 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 152213-63-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1352956-47-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-16532265
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Concise synthesis of deformylflustrabromine, a marine indole alkaloid,
through a 2-propynyl dicobalt hexacarbonyl complex
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Isaji, Hisaaki; Nakazaki, Atsuo; Isobe, Minoru; Nishikawa, Toshio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry Letters (2011), 40(10), 1079-1081

$RFMT $RIREG SCHEME287 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-tert-Butoxycarbonyl-O-benzylthreonine
C16H23NO5
15260-10-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 2.6674 0.0 0 CFG=1
M  V30 2 C 5.3900 2.6674 0.0 0 CFG=1
M  V30 3 N 7.7000 4.0011 0.0 0
M  V30 4 C 7.7000 1.3336 0.0 0
M  V30 5 O 4.6200 4.0011 0.0 0
M  V30 6 C 4.6200 1.3336 0.0 0
M  V30 7 C 9.2400 4.0011 0.0 0
M  V30 8 O 9.2400 1.3336 0.0 0
M  V30 9 O 6.9300 0.0000 0.0 0
M  V30 10 C 3.0800 4.0011 0.0 0
M  V30 11 O 10.0100 5.3347 0.0 0
M  V30 12 O 10.0100 2.6674 0.0 0
M  V30 13 C 11.5500 5.3347 0.0 0
M  V30 14 C 11.5500 3.7947 0.0 0
M  V30 15 C 13.0900 5.3347 0.0 0
M  V30 16 C 11.5500 6.8747 0.0 0
M  V30 17 C 2.3100 5.3347 0.0 0
M  V30 18 C 3.0800 6.6685 0.0 0
M  V30 19 C 0.7700 5.3347 0.0 0
M  V30 20 C 2.3100 8.0021 0.0 0
M  V30 21 C 0.0000 6.6685 0.0 0
M  V30 22 C 0.7700 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=1
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 1 5 10
M  V30 10 1 7 11
M  V30 11 2 7 12
M  V30 12 1 10 17
M  V30 13 1 11 13
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1S,2R)-1-[(methylamino)carbonyl]-2-(phenylmethoxy)propy...
C17H26N2O4
149639-95-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 4.0011 0.0 0 CFG=1
M  V30 2 C 5.3900 4.0011 0.0 0 CFG=1
M  V30 3 N 7.7000 5.3347 0.0 0
M  V30 4 C 7.7000 2.6674 0.0 0
M  V30 5 O 4.6200 5.3347 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 9.2400 5.3347 0.0 0
M  V30 8 N 6.9300 1.3336 0.0 0
M  V30 9 O 9.2400 2.6674 0.0 0
M  V30 10 C 3.0800 5.3347 0.0 0
M  V30 11 O 10.0100 6.6684 0.0 0
M  V30 12 O 10.0100 4.0011 0.0 0
M  V30 13 C 7.7000 0.0000 0.0 0
M  V30 14 C 11.5500 6.6684 0.0 0
M  V30 15 C 11.5500 5.1284 0.0 0
M  V30 16 C 13.0900 6.6684 0.0 0
M  V30 17 C 11.5500 8.2084 0.0 0
M  V30 18 C 2.3100 6.6684 0.0 0
M  V30 19 C 3.0800 8.0021 0.0 0
M  V30 20 C 0.7700 6.6684 0.0 0
M  V30 21 C 2.3100 9.3358 0.0 0
M  V30 22 C 0.0000 8.0021 0.0 0
M  V30 23 C 0.7700 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=1
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 1 5 10
M  V30 10 1 7 11
M  V30 11 2 7 12
M  V30 12 1 8 13
M  V30 13 1 10 18
M  V30 14 1 11 14
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 2 18 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 2 20 22
M  V30 22 2 21 23
M  V30 23 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 15260-10-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 149639-95-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13044728
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Protected Threonine 5. A solution of N-Boc-O-Benzyl-(L)-threonine (3.00
g, 9.70 mmol) in THF (24 mL) was treated with hydroxybenzotriazole (HOBT)
(1.378 g, 10.2 mmol) and methylamine (2.0 M in THF, 6.00 mL, 10.7 mmol)
and cooled to 0 °C. Dicyclohexycarbodiimide (DCC) (2.105 g, 10.2 mmol)
was added and the solution was allowed to warm to ambient temperature.
After stirring for 16 h, ether (100 mL) was added and a white precipitate
was removed by filtration through celite. The precipitate was washed with
ether, and the filtrate was concentrated. Flash chromatography
(hexanes-EtOAc-MeOH, 40:60:0.5) afforded 3.10 g (99%) of desired 5 as a
white powder: R f = 0.29 (hexane-EtOAc, 33:66).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Bio-orthogonal Affinity Purification of Direct Kinase Substrates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Allen, Jasmina J.; Lazerwith, Scott E.; Shokat, Kevan M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2005), 127(15), 5288-5289

$RFMT $RIREG SCHEME288 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-3-fluoro-2-nitropyridine
C5H2BrFN2O2
1532517-95-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 Br 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 N 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methyl-2-nitro-3-pyridinamine
C6H6BrN3O2
152684-13-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 N 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1532517-95-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 152684-13-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37414427
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substituted imidazopyridinyl compounds useful as inhibitors of tlr9
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yoon, David S.; Liu, Chunjian; Regueiro-Ren, Alicia
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023159154 A1 2023-08-24

$RFMT $RIREG SCHEME289 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(3,4-Dimethoxyphenyl)-3,4-dihydro-7-methoxy-6-(phenylmethoxy)-1(2H)-naphtha...
C26H26O5
154490-77-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9302 2.6675 0.0 0
M  V30 2 O 12.3203 1.3337 0.0 0
M  V30 3 C 11.5503 0.0000 0.0 0
M  V30 4 O 13.8603 4.0012 0.0 0
M  V30 5 C 14.6303 5.3348 0.0 0
M  V30 6 O 2.3101 8.0023 0.0 0
M  V30 7 C 3.0801 9.3360 0.0 0
M  V30 8 O 0.7700 5.3348 0.0 0
M  V30 9 C 0.0000 4.0012 0.0 0
M  V30 10 C 9.2402 4.0012 0.0 0
M  V30 11 C 10.0102 5.3348 0.0 0
M  V30 12 C 7.7002 4.0012 0.0 0
M  V30 13 C 10.0102 2.6675 0.0 0
M  V30 14 C 11.5503 5.3348 0.0 0
M  V30 15 C 9.2402 6.6685 0.0 0
M  V30 16 C 6.9302 5.3348 0.0 0
M  V30 17 C 11.5503 2.6675 0.0 0
M  V30 18 C 12.3203 4.0012 0.0 0
M  V30 19 C 7.7002 6.6685 0.0 0
M  V30 20 C 5.3901 5.3348 0.0 0
M  V30 21 C 4.6201 6.6685 0.0 0
M  V30 22 C 4.6201 4.0012 0.0 0
M  V30 23 C 3.0801 6.6685 0.0 0
M  V30 24 C 3.0801 4.0012 0.0 0
M  V30 25 C 2.3101 5.3348 0.0 0
M  V30 26 C 16.1704 5.3348 0.0 0
M  V30 27 C 16.9404 6.6685 0.0 0
M  V30 28 C 16.9404 4.0012 0.0 0
M  V30 29 C 18.4804 6.6685 0.0 0
M  V30 30 C 18.4804 4.0012 0.0 0
M  V30 31 C 19.2504 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 2 3
M  V30 3 1 2 17
M  V30 4 1 4 5
M  V30 5 1 4 18
M  V30 6 1 5 26
M  V30 7 1 6 7
M  V30 8 1 6 23
M  V30 9 1 8 9
M  V30 10 1 8 25
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 2 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 19
M  V30 21 1 16 20
M  V30 22 2 17 18
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(1R,2S)-2-(3,4-Dimethoxyphenyl)-1,2,3,4-tetrahydro-7-methoxy-N-methyl-6-(...
C27H31NO4
1403560-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9302 2.6675 0.0 0
M  V30 2 C 7.7002 1.3337 0.0 0
M  V30 3 O 12.3203 1.3337 0.0 0
M  V30 4 C 11.5503 0.0000 0.0 0
M  V30 5 O 13.8603 4.0012 0.0 0
M  V30 6 C 14.6303 5.3348 0.0 0
M  V30 7 O 2.3101 8.0023 0.0 0
M  V30 8 C 3.0801 9.3360 0.0 0
M  V30 9 O 0.7700 5.3348 0.0 0
M  V30 10 C 0.0000 4.0012 0.0 0
M  V30 11 C 9.2402 4.0012 0.0 0
M  V30 12 C 7.7002 4.0012 0.0 0 CFG=1
M  V30 13 C 10.0102 5.3348 0.0 0
M  V30 14 C 10.0102 2.6675 0.0 0
M  V30 15 C 6.9302 5.3348 0.0 0 CFG=1
M  V30 16 C 11.5503 5.3348 0.0 0
M  V30 17 C 9.2402 6.6685 0.0 0
M  V30 18 C 11.5503 2.6675 0.0 0
M  V30 19 C 7.7002 6.6685 0.0 0
M  V30 20 C 12.3203 4.0012 0.0 0
M  V30 21 C 5.3901 5.3348 0.0 0
M  V30 22 C 4.6201 6.6685 0.0 0
M  V30 23 C 4.6201 4.0012 0.0 0
M  V30 24 C 3.0801 6.6685 0.0 0
M  V30 25 C 3.0801 4.0012 0.0 0
M  V30 26 C 2.3101 5.3348 0.0 0
M  V30 27 C 16.1704 5.3348 0.0 0
M  V30 28 C 16.9404 4.0012 0.0 0
M  V30 29 C 16.9404 6.6685 0.0 0
M  V30 30 C 18.4804 4.0012 0.0 0
M  V30 31 C 18.4804 6.6685 0.0 0
M  V30 32 C 19.2504 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=1
M  V30 3 1 3 4
M  V30 4 1 3 18
M  V30 5 1 5 6
M  V30 6 1 5 20
M  V30 7 1 6 27
M  V30 8 1 7 8
M  V30 9 1 7 24
M  V30 10 1 9 10
M  V30 11 1 9 26
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 2 13 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 15 21 CFG=1
M  V30 21 1 16 20
M  V30 22 1 17 19
M  V30 23 2 18 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 12 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 154490-77-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1403560-05-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-7629749
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7550-45-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM slow addition of reactant mixture stage 1, portionwise addition of
borohydride stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Benzo[c]phenanthridine Alkaloids by Pd(OAc)2-Induced Direct
Aromatic Carbonylation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kumazawa, Eri; Tokuhashi, Takashi; Horibata, Akiyoshi; Kurono, Nobuhito;
Senboku, Hisanori; Tokuda, Masao; Ohkuma, Takashi; Orito, Kazuhiko
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2012), 2012(24), 4622-4633,
S4622/1-S4622/53

$RFMT $RIREG SCHEME290 STEP1
$RXN



  2  1
$MOL
BOC-L-Proline
C10H17NO4
15761-39-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.5254 2.6218 0.0 0
M  V30 2 O 5.8592 1.8517 0.0 0
M  V30 3 O 4.5254 4.1618 0.0 0
M  V30 4 C 7.1929 2.6218 0.0 0
M  V30 5 C 6.4229 3.9554 0.0 0
M  V30 6 C 8.5266 3.3918 0.0 0
M  V30 7 C 7.9629 1.2881 0.0 0
M  V30 8 C 1.4646 3.9845 0.0 0
M  V30 9 O 2.6091 5.0150 0.0 0
M  V30 10 O 0.0000 4.4604 0.0 0
M  V30 11 N 3.1917 1.8517 0.0 0
M  V30 12 C 1.7849 2.4781 0.0 0 CFG=2
M  V30 13 C 3.0308 0.3202 0.0 0
M  V30 14 C 0.7543 1.3337 0.0 0
M  V30 15 C 1.5243 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 12 8 CFG=1
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2S)-2-[(methylamino)carbonyl]-1-pyrrolidinecarboxylate
C11H20N2O3
74360-79-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.6436 3.7710 0.0 0
M  V30 2 O 2.1036 3.7710 0.0 0
M  V30 3 O 4.4136 5.1048 0.0 0
M  V30 4 C 1.3336 5.1048 0.0 0
M  V30 5 C 2.6674 5.8748 0.0 0
M  V30 6 C 0.5636 6.4384 0.0 0
M  V30 7 C 0.0000 4.3348 0.0 0
M  V30 8 C 6.9757 3.4208 0.0 0
M  V30 9 N 8.4820 3.1006 0.0 0
M  V30 10 O 6.4998 4.8855 0.0 0
M  V30 11 C 9.5125 4.2450 0.0 0
M  V30 12 N 4.4136 2.4373 0.0 0
M  V30 13 C 5.9453 2.2764 0.0 0 CFG=2
M  V30 14 C 3.7873 1.0306 0.0 0
M  V30 15 C 6.2654 0.7700 0.0 0
M  V30 16 C 4.9318 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 13 8 CFG=3
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 15761-39-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 74360-79-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-8886046
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 543-27-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure III (GP-III). N-Alkyl
Amidation of PG-Xaa-OH N-Methyl morpholine (10 mmol) and isobutyl
chloroformate (10 mmol) were successively added to a solution of
Boc-Xaa-OH 2a-g (10 mmol) or PhtN-Xaa-OH 2h-n (10 mmol) in THF (20 mL) at
-20°C. After an activation period of 3 min, 40 % aqueous methylamine
(12-50 mmol) or N-alkyl amine (13 mmol) in THF (5 mL) was added to above
solution, and the resulting solution was stirred for 1 h at -20°C prior
to the addition of 5 % NaHCO3 (20 mL). After 30 min at room temperature,
the aqueous phase was extracted with CH2Cl2 (3×50 mL). The combined
organic layer was washed with 5 % NaHCO3 (2×20 mL) and dried (Na2SO4).
Evaporation of solvents under reduced pressure gave Boc-Xaa-NHMe 3a-g or
PhtN-Xaa-NHR.3h-n The crude products were purified by flash
chromatography (EtOAc/cyclohexane, 1:2) or by crystallization
(EtOAc/pentane or CH2Cl2/pentane). (S)-tert-Butyl
2-(methylcarbamoyl)pyrrolidine-1-carboxylate (3b) [Boc-L-Pro-NHMe].
Following GP-III, from Boc-L-Pro-OH 2b (10.76 g, 50 mmol), title compound
3b was isolated as a white solid (11.4 g, > 99 %) mp 84°C
(CH2Cl2/pentane); [α]D -81.0 (c 1.0, CH2Cl2); NMR shows carbamate
dynamics resulted in 13C NMR signal broadening; δH (300.14 MHz, CDCl3):
1.46 (3×s, 9 H, 3JHH = 7.3 Hz), 1.76-2.45 (2×m, 4 H), 2.81 (d, 3 H, 3JHH
= 4.8 Hz), 2.75-2.83 (bs, 1 H, overlapped under dd at 2.81), 3.42 (m, 2
H), 4.24 (bs, 1 H); δC (75.48 MHz, CDCl3): 18.96 (dd), 23.87/24.19
(2×dd), 26.04 (q), 28.24/28.34 (2×3×s), 47.06 (dd), 60.16/60.71 (2×d),
77.20/80.33 (2×s), 156.24/158.56 (2×s), 172.72/172.89 (2×s); MSES, m/z:
229.2 [M+H], 251.2 [M+Na]. Analytical and spectral data agree with
literature.6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Highly Efficient Stereoconservative Amidation and Deamidation of α-Amino
Acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shendage, Deepak M.; Froehlich, Roland; Haufe, Guenter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2004), 6(21), 3675-3678

$RFMT $RIREG SCHEME291 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromophenyl isocyanate
C7H4BrNO
1592-00-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 O 6.6685 3.0800 0.0 0
M  V30 4 Br 1.3338 0.0000 0.0 0
M  V30 5 C 2.6674 2.3100 0.0 0
M  V30 6 C 1.3338 1.5400 0.0 0
M  V30 7 C 2.6674 3.8500 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 1.3338 4.6200 0.0 0
M  V30 10 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Bromophenyl)-N′-methylurea
C8H9BrN2O
82745-13-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 N 6.6685 1.5400 0.0 0
M  V30 4 O 5.3347 3.8500 0.0 0
M  V30 5 C 8.0021 2.3100 0.0 0
M  V30 6 Br 1.3336 0.0000 0.0 0
M  V30 7 C 2.6674 2.3100 0.0 0
M  V30 8 C 1.3336 1.5400 0.0 0
M  V30 9 C 2.6674 3.8500 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 1.3336 4.6200 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 8
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1592-00-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 82745-13-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-316-CAS-11708992
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 2-substituted benzothiazoles by palladium-catalyzed
intramolecular cyclization of o-bromophenylthioureas and
o-bromophenylthioamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Benedi, Carolina; Bravo, Fernando; Uriz, Pedro; Fernandez, Elena; Claver,
Carmen; Castillon, Sergio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2003), 44(32), 6073-6077

$RFMT $RIREG SCHEME292 STEP1
$RXN



  3  1
$MOL
Disuccinimidyl carbonate
C9H8N2O7
74124-79-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.7711 1.3628 0.0 0
M  V30 2 C 5.1048 2.1328 0.0 0
M  V30 3 O 6.4384 1.3628 0.0 0
M  V30 4 O 5.1048 3.6728 0.0 0
M  V30 5 O 3.4209 4.6949 0.0 0
M  V30 6 O 0.7103 0.0000 0.0 0
M  V30 7 O 6.7886 4.6949 0.0 0
M  V30 8 O 9.4992 0.0000 0.0 0
M  V30 9 N 2.4373 2.1328 0.0 0
M  V30 10 C 2.2763 3.6644 0.0 0
M  V30 11 C 1.0304 1.5065 0.0 0
M  V30 12 C 0.7700 3.9845 0.0 0
M  V30 13 C 0.0000 2.6509 0.0 0
M  V30 14 N 7.7722 2.1328 0.0 0
M  V30 15 C 7.9332 3.6644 0.0 0
M  V30 16 C 9.1791 1.5065 0.0 0
M  V30 17 C 9.4395 3.9845 0.0 0
M  V30 18 C 10.2095 2.6509 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 14
M  V30 6 2 5 10
M  V30 7 2 6 11
M  V30 8 2 7 15
M  V30 9 2 8 16
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
trans-1′-[[5-Chloro-1-[3-(methylsulfonyl)propyl]-1H-benzimidazol-2-yl]methyl]...
C23H24ClN3O4S
1603063-67-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.7819 6.0890 0.0 0
M  V30 2 C 7.4925 8.0582 0.0 0
M  V30 3 O 0.0000 7.3852 0.0 0
M  V30 4 C 10.5534 6.6954 0.0 0
M  V30 5 C 11.8870 5.9254 0.0 0
M  V30 6 C 13.2207 6.6954 0.0 0
M  V30 7 S 14.5544 5.9254 0.0 0 VAL=6
M  V30 8 C 15.8882 5.1554 0.0 0
M  V30 9 O 15.3244 7.2592 0.0 0
M  V30 10 O 13.7843 4.5918 0.0 0
M  V30 11 Cl 7.6310 0.0000 0.0 0
M  V30 12 C 3.5361 8.5341 0.0 0 CFG=1
M  V30 13 C 4.0119 9.9988 0.0 0
M  V30 14 C 4.7819 7.6290 0.0 0
M  V30 15 C 2.1639 9.2332 0.0 0
M  V30 16 C 2.8369 7.1619 0.0 0
M  V30 17 C 5.5520 9.9988 0.0 0
M  V30 18 C 3.2419 11.3325 0.0 0
M  V30 19 N 6.0278 8.5341 0.0 0
M  V30 20 C 1.4647 7.8611 0.0 0 CFG=2
M  V30 21 C 6.3220 11.3325 0.0 0
M  V30 22 C 4.0119 12.6661 0.0 0
M  V30 23 C 5.5520 12.6661 0.0 0
M  V30 24 C 7.8127 6.5519 0.0 0
M  V30 25 N 9.2195 5.9254 0.0 0
M  V30 26 N 6.7823 5.4073 0.0 0
M  V30 27 C 9.0586 4.3939 0.0 0
M  V30 28 C 7.5523 4.0737 0.0 0
M  V30 29 C 10.0890 3.2495 0.0 0
M  V30 30 C 7.0763 2.6091 0.0 0
M  V30 31 C 9.6132 1.7847 0.0 0
M  V30 32 C 8.1069 1.4646 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 14
M  V30 2 1 2 19
M  V30 3 1 2 24
M  V30 4 1 20 3 CFG=1
M  V30 5 1 4 5
M  V30 6 1 4 25
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 2 7 10
M  V30 12 1 11 32
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15 CFG=3
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 2 13 18
M  V30 19 1 14 19
M  V30 20 1 15 20
M  V30 21 1 16 20
M  V30 22 1 17 19
M  V30 23 2 17 21
M  V30 24 1 18 22
M  V30 25 1 21 23
M  V30 26 2 22 23
M  V30 27 1 24 25
M  V30 28 2 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 12 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
trans-1′-[[5-Chloro-1-[3-(methylsulfonyl)propyl]-1H-benzimidazol-2-yl]methyl]...
C25H27ClN4O5S
1603063-69-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 11.1059 6.0889 0.0 0
M  V30 2 C 8.3953 8.0581 0.0 0
M  V30 3 O 15.8877 7.3851 0.0 0
M  V30 4 C 17.0321 8.4155 0.0 0
M  V30 5 N 18.4968 7.9396 0.0 0
M  V30 6 O 16.7120 9.9219 0.0 0
M  V30 7 C 19.6412 8.9702 0.0 0
M  V30 8 C 5.3347 6.6953 0.0 0
M  V30 9 C 4.0009 5.9253 0.0 0
M  V30 10 C 2.6673 6.6953 0.0 0
M  V30 11 S 1.3336 5.9253 0.0 0 VAL=6
M  V30 12 C 0.0000 5.1553 0.0 0
M  V30 13 O 0.5636 7.2591 0.0 0
M  V30 14 O 2.1036 4.5917 0.0 0
M  V30 15 Cl 8.2570 0.0000 0.0 0
M  V30 16 C 12.3517 8.5339 0.0 0 CFG=1
M  V30 17 C 11.8759 9.9986 0.0 0
M  V30 18 C 11.1059 7.6289 0.0 0
M  V30 19 C 13.7239 9.2331 0.0 0
M  V30 20 C 13.0509 7.1618 0.0 0
M  V30 21 C 10.3359 9.9986 0.0 0
M  V30 22 C 12.6459 11.3323 0.0 0
M  V30 23 N 9.8600 8.5339 0.0 0
M  V30 24 C 14.4230 7.8609 0.0 0 CFG=2
M  V30 25 C 9.5659 11.3323 0.0 0
M  V30 26 C 11.8759 12.6659 0.0 0
M  V30 27 C 10.3359 12.6659 0.0 0
M  V30 28 C 8.0752 6.5518 0.0 0
M  V30 29 N 6.6684 5.9253 0.0 0
M  V30 30 N 9.1057 5.4073 0.0 0
M  V30 31 C 6.8293 4.3938 0.0 0
M  V30 32 C 8.3357 4.0736 0.0 0
M  V30 33 C 5.7989 3.2494 0.0 0
M  V30 34 C 8.8116 2.6091 0.0 0
M  V30 35 C 6.2747 1.7847 0.0 0
M  V30 36 C 7.7812 1.4645 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 18
M  V30 2 1 2 23
M  V30 3 1 2 28
M  V30 4 1 3 4
M  V30 5 1 24 3 CFG=3
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 8 9
M  V30 10 1 8 29
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 2 11 14
M  V30 16 1 15 36
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 19 CFG=1
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 2 17 22
M  V30 23 1 18 23
M  V30 24 1 19 24
M  V30 25 1 20 24
M  V30 26 1 21 23
M  V30 27 2 21 25
M  V30 28 1 22 26
M  V30 29 1 25 27
M  V30 30 2 26 27
M  V30 31 1 28 29
M  V30 32 2 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 2 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 16 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74124-79-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1603063-67-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1603063-69-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-357-CAS-7733477
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of indolylmethylspiropiperidinepyrrolopyridinone derivatives
and analogs for use as RSV inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tahri, Abdellah; Vendeville, Sandrine Marie Helene; Jonckers, Tim Hugo
Maria; Raboisson, Pierre Jean-Marie Bernard; Hu, Lili; Demin, Samueel
Dominique; Cooymans, Ludwig Paul
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014060411 A1 2014-04-24

$RFMT $RIREG SCHEME293 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-(2-formylphenyl)-, methyl ester
C9H9NO3
160354-69-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 4.0011 0.0 0
M  V30 2 C 6.1600 4.0011 0.0 0
M  V30 3 O 6.9300 5.3349 0.0 0
M  V30 4 O 6.9300 2.6674 0.0 0
M  V30 5 C 8.4700 5.3349 0.0 0
M  V30 6 C 1.5400 4.0011 0.0 0
M  V30 7 O 0.0000 4.0011 0.0 0
M  V30 8 C 3.8500 2.6674 0.0 0
M  V30 9 C 2.3100 2.6674 0.0 0
M  V30 10 C 4.6200 1.3338 0.0 0
M  V30 11 C 1.5400 1.3338 0.0 0
M  V30 12 C 3.8500 0.0000 0.0 0
M  V30 13 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 2 6 7
M  V30 7 1 6 9
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl N-[2-[(methylimino)methyl]phenyl]carbamate
C10H12N2O2
1257860-66-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 4.0011 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 O 7.7000 5.3349 0.0 0
M  V30 4 O 7.7000 2.6674 0.0 0
M  V30 5 C 9.2400 5.3349 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 N 0.7700 4.0011 0.0 0
M  V30 8 C 0.0000 5.3349 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 2.6674 0.0 0
M  V30 11 C 5.3900 1.3338 0.0 0
M  V30 12 C 2.3100 1.3338 0.0 0
M  V30 13 C 4.6200 0.0000 0.0 0
M  V30 14 C 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 2 6 7 CFG=2
M  V30 7 1 6 10
M  V30 8 1 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 160354-69-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1257860-66-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-523683
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7487-88-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM EXAMPLE. Methyl 2-[(Methylimino)methyl]phenylcarbamate (8). A solution of
methylamine in methanol (2 N, 3.6 mL, 7.2 mmol) and magnesium sulfate (3
g) were added to 7 (1 g, 5.6 mmol), and mixture was stirred for 6 h. Then
precipitate was filtered off and washed with chloroform (3 x 20 mL). The
combined filtrate was concentrated on a rotary evaporator. Pale-yellow
oil (1.08 g, 99%). IR (film) 1733, 1640 cm-1; 1H NMR (500 MHz, CDCl3) δ
12.18 (s, 1 H), 8.41 (d, J = 8.4 Hz, 1 H), 8.28 (d, J = 1.0 Hz, 1 H),
7.41-7.33 (m, 1 H), 7.30-7.24 (m, 1 H), 7.08-6.99 (m, 1 H), 3.77 (s, 3
H), 3.50 (d, J = 1.3 Hz, 3 H); 13C NMR (126 MHz, CDCl3) δ 165.57, 154.76,
140.29, 132.99, 131.32, 121.52, 120.46, 118.05, 52.12, 47.96; EIHRMS m/z
M+ calcd. for C10H12N2O2, 192.0899; found, 192.0897.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of dibenzonaphthyridine derivatives for treatment of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cushman, Mark S.; Kiselev, Evgeny A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012024437 A1 2012-02-23

$RFMT $RIREG SCHEME293 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-(2-formylphenyl)-, methyl ester
C9H9NO3
160354-69-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 4.0011 0.0 0
M  V30 2 C 6.1600 4.0011 0.0 0
M  V30 3 O 6.9300 5.3349 0.0 0
M  V30 4 O 6.9300 2.6674 0.0 0
M  V30 5 C 8.4700 5.3349 0.0 0
M  V30 6 C 1.5400 4.0011 0.0 0
M  V30 7 O 0.0000 4.0011 0.0 0
M  V30 8 C 3.8500 2.6674 0.0 0
M  V30 9 C 2.3100 2.6674 0.0 0
M  V30 10 C 4.6200 1.3338 0.0 0
M  V30 11 C 1.5400 1.3338 0.0 0
M  V30 12 C 3.8500 0.0000 0.0 0
M  V30 13 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 2 6 7
M  V30 7 1 6 9
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl N-[2-[(methylimino)methyl]phenyl]carbamate
C10H12N2O2
1257860-66-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 4.0011 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 O 7.7000 5.3349 0.0 0
M  V30 4 O 7.7000 2.6674 0.0 0
M  V30 5 C 9.2400 5.3349 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 N 0.7700 4.0011 0.0 0
M  V30 8 C 0.0000 5.3349 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 2.6674 0.0 0
M  V30 11 C 5.3900 1.3338 0.0 0
M  V30 12 C 2.3100 1.3338 0.0 0
M  V30 13 C 4.6200 0.0000 0.0 0
M  V30 14 C 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 2 6 7 CFG=2
M  V30 7 1 6 10
M  V30 8 1 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 160354-69-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1257860-66-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-6756451
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7487-88-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Methyl 2-[(Methylimino)methyl]phenylcarbamate (8). A solution of
methylamine in methanol (2 N, 3.6 mL, 7.2 mmol) and magnesium sulfate (3
g, 25 mmol) was added to 7 (1 g, 5.6 mmol), and the mixture was stirred
for 6 h. Then, the precipitate was filtered off and washed with
chloroform (3 x 20 mL). The combined filtrate was concentrated on a
rotary evaporator to afford pale-yellow oil (1.08 g, 99%). Methyl
2-[(Methylimino)methyl]phenylcarbamate (8), yield (1.08 g, 99%). IR
(film) 1733, 1640 cm-1; 1H NMR (500 MHz, CDCl3) δ 12.18 (s, 1 H), 8.41
(d, J = 8.4 Hz, 1 H), 8.28 (d, J = 1.0 Hz, 1 H), 7.41-7.33 (m, 1 H),
7.30-7.24 (m, 1 H), 7.08-6.99 (m, 1 H), 3.77 (s, 3 H), 3.50 (d, J = 1.3
Hz, 3 H); 13C NMR (126 MHz, CDCl3) δ 165.57, 154.76, 140.29, 132.99,
131.32, 121.52, 120.46, 118.05, 52.12, 47.96; EIHRMS m/z M+ calcd. for
C10H12N2O2, 192.0899; found, 192.0897.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Evaluation of Dibenzo[c,h][1,6]naphthyridines as
Topoisomerase I Inhibitors and Potential Anticancer Agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kiselev, Evgeny; Dexheimer, Thomas S.; Pommier, Yves; Cushman, Mark
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2010), 53(24), 8716-8726

$RFMT $RIREG SCHEME294 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3′-Azido-3′-deoxy-5′-thymidylyl)-L-phenylalanine 1-methyl ester
C20H25N6O8P
161006-88-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 15.1936 4.5167 0.0 0
M  V30 2 C 8.4700 4.9995 0.0 0
M  V30 3 O 7.7000 6.3331 0.0 0
M  V30 4 P 6.1600 6.3331 0.0 0 VAL=5
M  V30 5 N 4.6200 6.3331 0.0 0
M  V30 6 O 6.1600 7.8731 0.0 0
M  V30 7 O 6.1600 4.7931 0.0 0
M  V30 8 C 3.8500 7.6669 0.0 0 CFG=2
M  V30 9 C 4.6200 9.0005 0.0 0
M  V30 10 C 2.3100 7.6669 0.0 0
M  V30 11 O 1.5400 6.3331 0.0 0
M  V30 12 O 1.5400 9.0005 0.0 0
M  V30 13 C 0.0000 6.3331 0.0 0
M  V30 14 N 10.4394 2.2889 0.0 0
M  V30 15 N 11.4698 1.1445 0.0 0 CHG=1 VAL=4
M  V30 16 N 12.5003 0.0000 0.0 0 CHG=-1
M  V30 17 C 14.5498 10.6429 0.0 0
M  V30 18 O 17.3635 9.3902 0.0 0
M  V30 19 C 12.3799 5.7695 0.0 0 CFG=1
M  V30 20 O 10.9152 6.2453 0.0 0
M  V30 21 C 12.3799 4.2295 0.0 0
M  V30 22 C 10.0100 4.9995 0.0 0 CFG=2
M  V30 23 C 10.9152 3.7536 0.0 0 CFG=2
M  V30 24 N 13.6258 6.6747 0.0 0
M  V30 25 C 15.0326 6.0484 0.0 0
M  V30 26 C 13.4648 8.2062 0.0 0
M  V30 27 N 16.2786 6.9534 0.0 0
M  V30 28 C 14.7107 9.1114 0.0 0
M  V30 29 C 16.1175 8.4851 0.0 0
M  V30 30 C 3.8500 10.3342 0.0 0
M  V30 31 C 4.6200 11.6678 0.0 0
M  V30 32 C 2.3100 10.3342 0.0 0
M  V30 33 C 3.8500 13.0016 0.0 0
M  V30 34 C 1.5400 11.6678 0.0 0
M  V30 35 C 2.3100 13.0016 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 25
M  V30 2 1 2 3
M  V30 3 1 22 2 CFG=1
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 8 9 CFG=3
M  V30 10 1 8 10
M  V30 11 1 9 30
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 2 14 15
M  V30 16 1 23 14 CFG=3
M  V30 17 2 15 16
M  V30 18 1 17 28
M  V30 19 2 18 29
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=1
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 1 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 8 19 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Thymidine, 3′-azido-3′-deoxy-, 5′-[hydrogen [(1S)-2-(methylamino)-2-oxo-1-(ph...
C20H26N7O7P
244127-78-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 15.1936 4.5167 0.0 0
M  V30 2 C 8.4700 4.9995 0.0 0
M  V30 3 O 7.7000 6.3331 0.0 0
M  V30 4 P 6.1600 6.3331 0.0 0 VAL=5
M  V30 5 N 4.6200 6.3331 0.0 0
M  V30 6 O 6.1600 7.8731 0.0 0
M  V30 7 O 6.1600 4.7931 0.0 0
M  V30 8 C 3.8500 7.6669 0.0 0 CFG=2
M  V30 9 C 4.6200 9.0005 0.0 0
M  V30 10 C 2.3100 7.6669 0.0 0
M  V30 11 N 1.5400 6.3331 0.0 0
M  V30 12 O 1.5400 9.0005 0.0 0
M  V30 13 C 0.0000 6.3331 0.0 0
M  V30 14 N 10.4394 2.2889 0.0 0
M  V30 15 N 11.4698 1.1445 0.0 0 CHG=1 VAL=4
M  V30 16 N 12.5003 0.0000 0.0 0 CHG=-1
M  V30 17 C 14.5498 10.6429 0.0 0
M  V30 18 O 17.3635 9.3902 0.0 0
M  V30 19 C 12.3799 5.7695 0.0 0 CFG=1
M  V30 20 O 10.9152 6.2453 0.0 0
M  V30 21 C 12.3799 4.2295 0.0 0
M  V30 22 C 10.0100 4.9995 0.0 0 CFG=2
M  V30 23 C 10.9152 3.7536 0.0 0 CFG=2
M  V30 24 N 13.6258 6.6747 0.0 0
M  V30 25 C 15.0326 6.0484 0.0 0
M  V30 26 C 13.4648 8.2062 0.0 0
M  V30 27 N 16.2786 6.9534 0.0 0
M  V30 28 C 14.7107 9.1114 0.0 0
M  V30 29 C 16.1175 8.4851 0.0 0
M  V30 30 C 3.8500 10.3342 0.0 0
M  V30 31 C 4.6200 11.6678 0.0 0
M  V30 32 C 2.3100 10.3342 0.0 0
M  V30 33 C 3.8500 13.0016 0.0 0
M  V30 34 C 1.5400 11.6678 0.0 0
M  V30 35 C 2.3100 13.0016 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 25
M  V30 2 1 2 3
M  V30 3 1 22 2 CFG=1
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 8 9 CFG=3
M  V30 10 1 8 10
M  V30 11 1 9 30
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 2 14 15
M  V30 16 1 23 14 CFG=3
M  V30 17 2 15 16
M  V30 18 1 17 28
M  V30 19 2 18 29
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=1
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 1 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 8 19 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 161006-88-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 244127-78-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-16778771
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, in Vitro Anti-Breast Cancer Activity, and Intracellular
Decomposition of Amino Acid Methyl Ester and Alkyl Amide Phosphoramidate
Monoesters of 3'-Azido-3'-deoxythymidine (AZT)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Iyer, Vidhya V.; Griesgraber, George W.; Radmer, Matthew R.; McIntee,
Edward J.; Wagner, Carston R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2000), 43(11), 2266-2274

$RFMT $RIREG SCHEME295 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(T-4)-Diphenyl[3-[2,2,2-trifluoro-1-(imino-κN)ethyl]-2,4-pentanedionato-κO2]b...
C19H17BF3NO2
161043-59-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 3.5713 0.0 0
M  V30 2 F 2.1038 2.2376 0.0 0
M  V30 3 F 0.0000 2.8013 0.0 0
M  V30 4 F 0.5638 4.9051 0.0 0
M  V30 5 C 4.0011 8.1913 0.0 0
M  V30 6 C 1.3338 6.6513 0.0 0
M  V30 7 C 0.0000 5.8813 0.0 0
M  V30 8 O 1.3338 8.1913 0.0 0
M  V30 9 B 5.3347 4.3413 0.0 0 CHG=3 VAL=4
M  V30 10 N 4.0011 3.5713 0.0 0 VAL=4
M  V30 11 O 5.3347 5.8813 0.0 0 VAL=3
M  V30 12 C 2.6674 4.3413 0.0 0
M  V30 13 C 4.0011 6.6513 0.0 0
M  V30 14 C 2.6674 5.8813 0.0 0 CHG=-1
M  V30 15 C 6.8513 4.6088 0.0 0 CHG=-1 VAL=4
M  V30 16 C 7.8412 3.4290 0.0 0
M  V30 17 C 7.3781 6.0559 0.0 0
M  V30 18 C 9.3578 3.6965 0.0 0
M  V30 19 C 8.8947 6.3232 0.0 0
M  V30 20 C 9.8846 5.1436 0.0 0
M  V30 21 C 5.8615 2.8941 0.0 0 CHG=-1 VAL=4
M  V30 22 C 4.8716 1.7145 0.0 0
M  V30 23 C 7.3781 2.6268 0.0 0
M  V30 24 C 5.3983 0.2673 0.0 0
M  V30 25 C 7.9048 1.1796 0.0 0
M  V30 26 C 6.9149 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 12
M  V30 5 1 5 13
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 15
M  V30 12 1 9 21
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 13 14
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Methylamino)-3-(2,2,2-trifluoro-1-iminoethyl)-3-penten-2-one
C8H11F3N2O
1214989-86-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.3101 0.0 0
M  V30 2 C 2.6675 1.5400 0.0 0
M  V30 3 C 5.3348 1.5400 0.0 0
M  V30 4 C 4.0012 3.8501 0.0 0
M  V30 5 C 1.3337 2.3101 0.0 0
M  V30 6 N 2.6675 0.0000 0.0 0
M  V30 7 N 6.6687 2.3101 0.0 0
M  V30 8 C 5.3348 0.0000 0.0 0
M  V30 9 C 2.6675 4.6201 0.0 0
M  V30 10 O 5.3348 4.6201 0.0 0
M  V30 11 F 0.0000 3.0801 0.0 0
M  V30 12 F 2.1037 3.6437 0.0 0
M  V30 13 F 0.5637 0.9764 0.0 0
M  V30 14 C 8.0023 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 2 4 10
M  V30 10 1 5 11
M  V30 11 1 5 12
M  V30 12 1 5 13
M  V30 13 1 7 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 161043-59-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1214989-86-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30577004
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-41-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 141-43-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 4-Amino-3-trifluoroacetimidoylpent-3-en-2-one
(7a). A mixture of chelate 2 (2.22 g, 6.1 mmol) and a solution of NH3 in
THF (0.55 N, 44.5 mL) was kept for 1 h, then, monoethanolamine (0.37 mL)
was added and the solvent was evaporated in vacuo. Diethyl ether (75 mL)
and light petroleum (150 mL) were added to the residue, a precipitate of
8 was filtered off, washed 3 times with a mixture of diethyl ether (5 mL)
and light petroleum (10 mL). The filtrate was concentrated on a rotary
evaporator. 4-Methylamino-3-trifluoroacetimidoylpent-3-en-2-one (7b) was
obtained similarly, only in ethereal solution. Molecular formula:
C8H11F3N2O.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 2-(N-Alkylamino)-1-(trifluoroacetimidoyl)vinyl ketone derivatives as
potential reagents in heterocyclic synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vasil'ev, L. S.; Prezent, M. A.; Ignatenko, A. V.; Dorokhov, V. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Chemical Bulletin (2008), 57(11), 2359-2363

$RFMT $RIREG SCHEME296 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-[4-(trifluoromethoxy)phenyl]acetamide
C9H7ClF3NO2
161290-85-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 0.0000 0.0 0
M  V30 2 C 1.3337 0.7700 0.0 0
M  V30 3 F 0.0000 0.0000 0.0 0
M  V30 4 F 0.0000 1.5400 0.0 0
M  V30 5 F 1.3337 2.3101 0.0 0
M  V30 6 N 8.0022 3.0801 0.0 0
M  V30 7 C 9.3360 2.3101 0.0 0
M  V30 8 C 10.6697 3.0801 0.0 0
M  V30 9 O 9.3360 0.7700 0.0 0
M  V30 10 Cl 12.0033 2.3101 0.0 0
M  V30 11 C 4.0012 0.7700 0.0 0
M  V30 12 C 4.0012 2.3101 0.0 0
M  V30 13 C 5.3348 0.0000 0.0 0
M  V30 14 C 5.3348 3.0801 0.0 0
M  V30 15 C 6.6685 0.7700 0.0 0
M  V30 16 C 6.6685 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Methylamino)-N-[4-(trifluoromethoxy)phenyl]acetamide
C10H11F3N2O2
900640-69-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 0.0000 0.0 0
M  V30 2 C 1.3337 0.7700 0.0 0
M  V30 3 F 0.0000 0.0000 0.0 0
M  V30 4 F 0.0000 1.5400 0.0 0
M  V30 5 F 1.3337 2.3101 0.0 0
M  V30 6 N 8.0022 3.0801 0.0 0
M  V30 7 C 9.3360 2.3101 0.0 0
M  V30 8 C 10.6697 3.0801 0.0 0
M  V30 9 O 9.3360 0.7700 0.0 0
M  V30 10 N 12.0033 2.3101 0.0 0
M  V30 11 C 13.3370 3.0801 0.0 0
M  V30 12 C 4.0010 0.7700 0.0 0
M  V30 13 C 4.0010 2.3101 0.0 0
M  V30 14 C 5.3348 0.0000 0.0 0
M  V30 15 C 5.3348 3.0801 0.0 0
M  V30 16 C 6.6685 0.7700 0.0 0
M  V30 17 C 6.6685 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 1 6 17
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 161290-85-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 900640-69-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-8499070
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-based design, synthesis, and antifungal activity of new
triazole derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sheng, Chunquan; Che, Xiaoying; Wang, Wenya; Wang, Shengzheng; Cao,
Yongbing; Yao, Jianzhong; Miao, Zhenyuan; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Biology & Drug Design (2011), 78(2), 309-313

$RFMT $RIREG SCHEME297 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Thietaneacetic acid, 3-amino-, ethyl ester, 1,1-dioxide
C7H13NO4S
1613239-55-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.7712 1.1273 0.0 0
M  V30 2 C 6.1048 1.8973 0.0 0
M  V30 3 O 7.4385 1.1273 0.0 0
M  V30 4 O 6.1048 3.4374 0.0 0
M  V30 5 C 8.7723 1.8973 0.0 0
M  V30 6 C 10.1060 1.1273 0.0 0
M  V30 7 N 4.2075 3.2311 0.0 0
M  V30 8 O 0.0000 2.1037 0.0 0
M  V30 9 O 0.5637 0.0000 0.0 0
M  V30 10 C 2.6675 0.5637 0.0 0
M  V30 11 C 3.4375 1.8973 0.0 0
M  V30 12 S 1.3337 1.3337 0.0 0 VAL=6
M  V30 13 C 2.1037 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 11
M  V30 8 2 8 12
M  V30 9 2 9 12
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Thietaneacetamide, 3-amino-N-methyl-, 1,1-dioxide
C6H12N2O3S
1613240-08-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.7712 1.1273 0.0 0
M  V30 2 C 6.1048 1.8973 0.0 0
M  V30 3 N 7.4387 1.1273 0.0 0
M  V30 4 O 6.1048 3.4374 0.0 0
M  V30 5 C 8.7723 1.8973 0.0 0
M  V30 6 N 4.2075 3.2311 0.0 0
M  V30 7 O 0.0000 2.1037 0.0 0
M  V30 8 O 0.5637 0.0000 0.0 0
M  V30 9 C 2.6675 0.5637 0.0 0
M  V30 10 C 3.4375 1.8973 0.0 0
M  V30 11 S 1.3337 1.3337 0.0 0 VAL=6
M  V30 12 C 2.1037 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 10
M  V30 7 2 7 11
M  V30 8 2 8 11
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1613239-55-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1613240-08-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8331370
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyridine-2-carboxamides useful as CB2 agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Grether, Uwe; Kimbara, Atsushi; Nettekoven, Matthias; Ricklin, Fabienne;
Roever, Stephan; Rogers-Evans, Mark; Rombach, Didier; Schulz-Gasch,
Tanja; Westphal, Matthias
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014086805 A1 2014-06-12

$RFMT $RIREG SCHEME298 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethoxycarbonyl isothiocyanate
C4H5NO2S
16182-04-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 O 2.6675 2.3101 0.0 0
M  V30 4 O 4.0012 0.0000 0.0 0
M  V30 5 C 6.6687 1.5400 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 S 8.0023 0.7700 0.0 0
M  V30 8 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl N-[(methylamino)thioxomethyl]carbamate
C5H10N2O2S
51863-43-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 2.3101 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 C 2.6675 1.5400 0.0 0
M  V30 4 O 6.6685 2.3101 0.0 0
M  V30 5 O 5.3348 0.0000 0.0 0
M  V30 6 N 1.3337 2.3101 0.0 0
M  V30 7 S 2.6675 0.0000 0.0 0
M  V30 8 C 8.0023 1.5400 0.0 0
M  V30 9 C 0.0000 1.5400 0.0 0
M  V30 10 C 9.3360 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 16182-04-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 51863-43-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-316-CAS-2895280
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of Ethyl Methylcarbamathioylcarbamate 5 (R1 = CH3). Methylamine
(100 mmol) was added to ethoxy isothiocyanate 4 (5.91 mL, 50 mmol) in
anhydrous dichloromethane and stirred for 4 h. The reaction mixture was
washed twice with 10% HCl to remove any nonvolatile amines, followed by
additional washing with brine. The solution was then concentrated and
purified by column chromatography (EtOAc/hexane = 1:3) to obtain 5 as a
white solid in quantitative yield (99%). 1H NMR (CDCl3, 300 MHz): δ 9.61
(s, NH, 1H), 8.91 (s, NH, 1H), 4.10 (q, J = 7.1 Hz, CH 2CH3, 2H), 3.06
(d, J = 4.5, NHCH 3, 3H), 1.18 (t, J = 7.1 Hz, CH2CH 3, 3H,). 13C NMR
(CDCl3, 75 MHz): δ 179.8, 152.6, 62.2, 31.6, 13.7. HRMS (ESI, C5H10N2O2S
&# x2212; H): calcd 161.0385; found 161.0387.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Traceless Solid-Phase Synthesis of 6-Amino- and
6-Hydroxyimino-1,3,5-triazine-2,4-diones and 1,3,5-Triazine-2,4,6-triones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kong, Kah-Hoe; Tan, Chong-Kiat; Lam, Yulin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Combinatorial Chemistry (2009), 11(6), 1050-1060

$RFMT $RIREG SCHEME299 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Chloro-3-nitrobenzoyl)-N-2-pyridinyl-β-alanine ethyl ester
C17H16ClN3O5
1620205-04-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 4.0011 0.0 0
M  V30 2 C 5.3900 4.0011 0.0 0
M  V30 3 C 7.7000 5.3347 0.0 0
M  V30 4 O 4.6200 2.6674 0.0 0
M  V30 5 C 9.2400 5.3347 0.0 0
M  V30 6 C 10.0100 6.6684 0.0 0
M  V30 7 O 11.5500 6.6684 0.0 0
M  V30 8 O 9.2400 8.0021 0.0 0
M  V30 9 C 12.3200 8.0021 0.0 0
M  V30 10 C 13.8600 8.0021 0.0 0
M  V30 11 N 0.7700 6.6684 0.0 0 VAL=5
M  V30 12 O 0.0000 5.3347 0.0 0
M  V30 13 O 0.0000 8.0021 0.0 0
M  V30 14 Cl 2.3100 9.3358 0.0 0
M  V30 15 C 7.7000 2.6674 0.0 0
M  V30 16 C 6.9300 1.3336 0.0 0
M  V30 17 N 9.2400 2.6674 0.0 0
M  V30 18 C 7.7000 0.0000 0.0 0
M  V30 19 C 10.0100 1.3336 0.0 0
M  V30 20 C 9.2400 0.0000 0.0 0
M  V30 21 C 4.6200 5.3347 0.0 0
M  V30 22 C 3.0800 5.3347 0.0 0
M  V30 23 C 5.3900 6.6684 0.0 0
M  V30 24 C 2.3100 6.6684 0.0 0
M  V30 25 C 4.6200 8.0021 0.0 0
M  V30 26 C 3.0800 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 15
M  V30 4 2 2 4
M  V30 5 1 2 21
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 2 11 13
M  V30 14 1 11 24
M  V30 15 1 14 26
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-(Methylamino)-3-nitrobenzoyl]-N-2-pyridinyl-β-alanine ethyl ester
C18H20N4O5
429659-01-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 4.0011 0.0 0
M  V30 2 C 5.3900 4.0011 0.0 0
M  V30 3 C 7.7000 5.3347 0.0 0
M  V30 4 O 4.6200 2.6673 0.0 0
M  V30 5 C 9.2400 5.3347 0.0 0
M  V30 6 C 10.0100 6.6684 0.0 0
M  V30 7 O 11.5500 6.6684 0.0 0
M  V30 8 O 9.2400 8.0021 0.0 0
M  V30 9 C 12.3200 8.0021 0.0 0
M  V30 10 C 13.8600 8.0021 0.0 0
M  V30 11 N 0.7700 6.6684 0.0 0 VAL=5
M  V30 12 O 0.0000 8.0021 0.0 0
M  V30 13 O 0.0000 5.3347 0.0 0
M  V30 14 N 2.3100 9.3358 0.0 0
M  V30 15 C 3.0800 10.6694 0.0 0
M  V30 16 C 7.7000 2.6673 0.0 0
M  V30 17 C 9.2400 2.6673 0.0 0
M  V30 18 N 6.9300 1.3336 0.0 0
M  V30 19 C 10.0100 1.3336 0.0 0
M  V30 20 C 7.7000 0.0000 0.0 0
M  V30 21 C 9.2400 0.0000 0.0 0
M  V30 22 C 4.6200 5.3347 0.0 0
M  V30 23 C 3.0800 5.3347 0.0 0
M  V30 24 C 5.3900 6.6684 0.0 0
M  V30 25 C 2.3100 6.6684 0.0 0
M  V30 26 C 4.6200 8.0021 0.0 0
M  V30 27 C 3.0800 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 16
M  V30 4 2 2 4
M  V30 5 1 2 22
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 2 11 13
M  V30 14 1 11 25
M  V30 15 1 14 15
M  V30 16 1 14 27
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1620205-04-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 429659-01-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-20921665
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM methylamine added after 15 min
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Total Synthesis of Dabigatran Revisited; Synthesis of Amidine-Tosylated
Dabigatran
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jopp, Stefan; Molenda, Ricardo; Seiler, Elisabeth R. D.; Maitz, Manfred
F.; Villinger, Alexander; Ehlers, Peter; Langer, Peter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemistrySelect (2019), 4(47), 13802-13805

$RFMT $RIREG SCHEME300 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4,6-Trichlorophenyl 4-[(2,3-dihydro-5,6-dimethoxy-1-oxo-1H-inden-2-yl)methy...
C24H18Cl3NO5
1620646-59-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0408 3.2908 0.0 0
M  V30 2 C 8.3910 6.6229 0.0 0
M  V30 3 O 2.3100 1.3338 0.0 0
M  V30 4 C 3.0800 0.0000 0.0 0
M  V30 5 O 0.7700 4.0011 0.0 0
M  V30 6 C 0.0000 5.3347 0.0 0
M  V30 7 C 11.0583 8.1629 0.0 0
M  V30 8 O 12.3919 8.9329 0.0 0
M  V30 9 O 11.0583 6.6229 0.0 0
M  V30 10 Cl 12.3919 5.8529 0.0 0
M  V30 11 Cl 15.0594 10.4729 0.0 0
M  V30 12 Cl 17.7266 5.8529 0.0 0
M  V30 13 C 5.3900 4.0011 0.0 0
M  V30 14 C 4.6200 5.3347 0.0 0
M  V30 15 C 6.8963 4.3212 0.0 0
M  V30 16 C 4.6200 2.6674 0.0 0
M  V30 17 C 5.6504 6.4792 0.0 0
M  V30 18 C 3.0800 5.3347 0.0 0
M  V30 19 C 7.0572 5.8529 0.0 0
M  V30 20 C 3.0800 2.6674 0.0 0
M  V30 21 C 2.3100 4.0011 0.0 0
M  V30 22 C 8.3910 8.1629 0.0 0
M  V30 23 C 9.7246 8.9329 0.0 0
M  V30 24 C 7.0572 8.9329 0.0 0
M  V30 25 C 9.7246 10.4729 0.0 0
M  V30 26 C 7.0572 10.4729 0.0 0
M  V30 27 N 8.3910 11.2429 0.0 0
M  V30 28 C 13.7257 8.1629 0.0 0
M  V30 29 C 13.7257 6.6229 0.0 0
M  V30 30 C 15.0594 8.9329 0.0 0
M  V30 31 C 15.0594 5.8529 0.0 0
M  V30 32 C 16.3930 8.1629 0.0 0
M  V30 33 C 16.3930 6.6229 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 15
M  V30 2 1 2 19
M  V30 3 1 2 22
M  V30 4 1 3 4
M  V30 5 1 3 20
M  V30 6 1 5 6
M  V30 7 1 5 21
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 23
M  V30 11 1 8 28
M  V30 12 1 10 29
M  V30 13 1 11 30
M  V30 14 1 12 33
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 2 13 16
M  V30 18 1 14 17
M  V30 19 2 14 18
M  V30 20 1 15 19
M  V30 21 1 16 20
M  V30 22 1 17 19
M  V30 23 1 18 21
M  V30 24 2 20 21
M  V30 25 1 22 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(2,3-Dihydro-5,6-dimethoxy-1-oxo-1H-inden-2-yl)methyl]-N-methyl-3-pyridine...
C19H20N2O4
1620646-60-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0410 3.2909 0.0 0
M  V30 2 C 8.3912 6.6231 0.0 0
M  V30 3 O 0.7700 4.0012 0.0 0
M  V30 4 C 0.0000 5.3348 0.0 0
M  V30 5 O 2.3101 1.3338 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 11.0587 8.1631 0.0 0
M  V30 8 N 12.3923 8.9331 0.0 0
M  V30 9 O 11.0587 6.6231 0.0 0
M  V30 10 C 13.7260 8.1631 0.0 0
M  V30 11 C 4.6201 5.3348 0.0 0
M  V30 12 C 5.3901 4.0012 0.0 0
M  V30 13 C 5.6505 6.4794 0.0 0
M  V30 14 C 3.0801 5.3348 0.0 0
M  V30 15 C 6.8964 4.3213 0.0 0
M  V30 16 C 4.6201 2.6675 0.0 0
M  V30 17 C 7.0575 5.8531 0.0 0
M  V30 18 C 2.3101 4.0012 0.0 0
M  V30 19 C 3.0801 2.6675 0.0 0
M  V30 20 C 8.3912 8.1631 0.0 0
M  V30 21 C 9.7249 8.9331 0.0 0
M  V30 22 C 7.0575 8.9331 0.0 0
M  V30 23 C 9.7249 10.4732 0.0 0
M  V30 24 C 7.0575 10.4732 0.0 0
M  V30 25 N 8.3912 11.2432 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 15
M  V30 2 1 2 17
M  V30 3 1 2 20
M  V30 4 1 3 4
M  V30 5 1 3 18
M  V30 6 1 5 6
M  V30 7 1 5 19
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 21
M  V30 11 1 8 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 17
M  V30 20 1 16 19
M  V30 21 2 18 19
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1620646-59-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1620646-60-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-17395888
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in sealed Shlenk tube with a Teflon cap
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Donepezil-Based Central Acetylcholinesterase Inhibitors by Means of a
"Bio-Oxidizable" Prodrug Strategy: Design, Synthesis, and in Vitro
Biological Evaluation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Peauger, Ludovic; Azzouz, Rabah; Gembus, Vincent; Tintas,
Mihaela-Liliana; Sopkova-de Oliveira Santos, Jana; Bohn, Pierre;
Papamicael, Cyril; Levacher, Vincent
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2017), 60(13), 5909-5926

$RFMT $RIREG SCHEME301 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Bis[(2-hydroxy-5-methylphenyl)methyl]-4-methylphenol
C23H24O3
1620-68-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 4.6201 0.0 0
M  V30 2 O 6.6684 6.1601 0.0 0
M  V30 3 C 9.3359 4.6201 0.0 0
M  V30 4 C 6.6684 0.0000 0.0 0
M  V30 5 O 1.3337 6.1601 0.0 0
M  V30 6 C 1.3337 0.0000 0.0 0
M  V30 7 O 12.0032 6.1601 0.0 0
M  V30 8 C 12.0032 0.0000 0.0 0
M  V30 9 C 5.3348 3.8500 0.0 0
M  V30 10 C 6.6684 4.6201 0.0 0
M  V30 11 C 5.3348 2.3100 0.0 0
M  V30 12 C 8.0021 3.8500 0.0 0
M  V30 13 C 6.6684 1.5400 0.0 0
M  V30 14 C 8.0021 2.3100 0.0 0
M  V30 15 C 2.6673 3.8500 0.0 0
M  V30 16 C 1.3337 4.6201 0.0 0
M  V30 17 C 2.6673 2.3100 0.0 0
M  V30 18 C 0.0000 3.8500 0.0 0
M  V30 19 C 1.3337 1.5400 0.0 0
M  V30 20 C 0.0000 2.3100 0.0 0
M  V30 21 C 10.6695 3.8500 0.0 0
M  V30 22 C 12.0032 4.6201 0.0 0
M  V30 23 C 10.6695 2.3100 0.0 0
M  V30 24 C 13.3369 3.8500 0.0 0
M  V30 25 C 12.0032 1.5400 0.0 0
M  V30 26 C 13.3369 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 15
M  V30 3 1 2 10
M  V30 4 1 3 12
M  V30 5 1 3 21
M  V30 6 1 4 13
M  V30 7 1 5 16
M  V30 8 1 6 19
M  V30 9 1 7 22
M  V30 10 1 8 25
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Bis[(3,4-dihydro-3,6-dimethyl-2H-1,3-benzoxazin-8-yl)methyl]-4-methylphenol
C29H34N2O3
1313015-96-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.0032 4.6200 0.0 0
M  V30 2 C 14.6705 0.0000 0.0 0
M  V30 3 O 9.3358 6.1600 0.0 0
M  V30 4 C 18.6716 6.9300 0.0 0
M  V30 5 C 6.6684 4.6200 0.0 0
M  V30 6 C 9.3358 0.0000 0.0 0
M  V30 7 C 4.0011 0.0000 0.0 0
M  V30 8 C 0.0000 6.9300 0.0 0
M  V30 9 C 13.3369 3.8500 0.0 0
M  V30 10 C 14.6705 4.6200 0.0 0
M  V30 11 C 13.3369 2.3100 0.0 0
M  V30 12 C 16.0041 3.8500 0.0 0
M  V30 13 O 14.6705 6.1600 0.0 0
M  V30 14 C 14.6705 1.5400 0.0 0
M  V30 15 C 16.0041 2.3100 0.0 0
M  V30 16 C 17.3379 4.6200 0.0 0
M  V30 17 C 16.0041 6.9300 0.0 0
M  V30 18 N 17.3379 6.1600 0.0 0
M  V30 19 C 10.6694 3.8500 0.0 0
M  V30 20 C 9.3358 4.6200 0.0 0
M  V30 21 C 10.6694 2.3100 0.0 0
M  V30 22 C 8.0021 3.8500 0.0 0
M  V30 23 C 9.3358 1.5400 0.0 0
M  V30 24 C 8.0021 2.3100 0.0 0
M  V30 25 C 5.3347 3.8500 0.0 0
M  V30 26 C 4.0011 4.6200 0.0 0
M  V30 27 C 5.3347 2.3100 0.0 0
M  V30 28 C 2.6674 3.8500 0.0 0
M  V30 29 O 4.0011 6.1600 0.0 0
M  V30 30 C 4.0011 1.5400 0.0 0
M  V30 31 C 2.6674 2.3100 0.0 0
M  V30 32 C 1.3336 4.6200 0.0 0
M  V30 33 C 2.6674 6.9300 0.0 0
M  V30 34 N 1.3336 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 19
M  V30 3 1 2 14
M  V30 4 1 3 20
M  V30 5 1 4 18
M  V30 6 1 5 22
M  V30 7 1 5 25
M  V30 8 1 6 23
M  V30 9 1 7 30
M  V30 10 1 8 34
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 2 11 14
M  V30 16 2 12 15
M  V30 17 1 12 16
M  V30 18 1 13 17
M  V30 19 1 14 15
M  V30 20 1 16 18
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 26 29
M  V30 32 2 27 30
M  V30 33 2 28 31
M  V30 34 1 28 32
M  V30 35 1 29 33
M  V30 36 1 30 31
M  V30 37 1 32 34
M  V30 38 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1620-68-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1313015-96-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-096-CAS-6666395
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Azacalixarenes through Dihydrobenzoxazine Derivatives of
Phenols
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Takemura, Hiroyuki; Takahashi, Asuka; Suga, Haruka; Fukuda, Mika;
Iwanaga, Tetsuo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2011), (17), 3171-3177,
S3171/1-S3171/32

$RFMT $RIREG SCHEME302 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,5-Di-tert-butyl-4-hydroxybenzaldehyde
C15H22O2
1620-98-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 5.3901 0.0 0
M  V30 2 C 7.4387 4.0564 0.0 0
M  V30 3 C 8.0023 6.1601 0.0 0
M  V30 4 C 5.8986 6.7238 0.0 0
M  V30 5 O 4.0012 6.9302 0.0 0
M  V30 6 C 1.3337 5.3901 0.0 0
M  V30 7 C 0.0000 4.6201 0.0 0
M  V30 8 C 0.0000 6.1601 0.0 0
M  V30 9 C 1.3337 6.9302 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 O 2.6675 0.0000 0.0 0
M  V30 12 C 5.3348 4.6201 0.0 0
M  V30 13 C 4.0012 5.3901 0.0 0
M  V30 14 C 5.3348 3.0801 0.0 0
M  V30 15 C 2.6675 4.6201 0.0 0
M  V30 16 C 4.0012 2.3101 0.0 0
M  V30 17 C 2.6675 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 12
M  V30 5 1 5 13
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 15
M  V30 10 2 10 11
M  V30 11 1 10 16
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Bis(1,1-dimethylethyl)-4-[(methylimino)methyl]phenol
C16H25NO
30829-33-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 3.0801 0.0 0
M  V30 2 C 4.0012 1.5400 0.0 0
M  V30 3 C 2.6675 0.7700 0.0 0
M  V30 4 C 4.0012 0.0000 0.0 0
M  V30 5 C 5.3348 0.7700 0.0 0
M  V30 6 C 1.3337 6.1601 0.0 0
M  V30 7 C 0.5637 4.8265 0.0 0
M  V30 8 C 0.0000 6.9302 0.0 0
M  V30 9 C 2.1037 7.4938 0.0 0
M  V30 10 C 6.6685 6.1601 0.0 0
M  V30 11 N 8.0023 5.3901 0.0 0
M  V30 12 C 9.3360 6.1601 0.0 0
M  V30 13 C 2.6675 3.8501 0.0 0
M  V30 14 C 4.0012 3.0801 0.0 0
M  V30 15 C 2.6675 5.3901 0.0 0
M  V30 16 C 5.3348 3.8501 0.0 0
M  V30 17 C 4.0012 6.1601 0.0 0
M  V30 18 C 5.3348 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 14
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 15
M  V30 10 2 10 11 CFG=2
M  V30 11 1 10 18
M  V30 12 1 11 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1620-98-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 30829-33-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-14845935
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Syntheses of the various Schiff bases were
carried out according to the literature by combining the given aromatic
aldehyde (1 mmol) with the corresponding amine (1.1 mmol). In cases where
either the aldehyde or the amine was solid, ethanol (∼3 mL) was used to
solubilize the reagents. The reaction was allowed to stir under ambient
conditions for 12 hours. In cases where a precipitate was noted, the
product was isolated by filtration and washed with cold ethanol (∼2 mL)
to afford pure product. When both reagents were initially liquids, the
solvents and excess amine were removed in vacuo. All Schiff base
reactions gave at, or near, quantitative yields (Scheme 2, A). Schiff
base, reactant of compound 20a.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, no solvent or EtOH used for solid reactants
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient synthesis of new 4-arylideneimidazolin-5-ones related to the
GFP chromophore by 2+3 cyclocondensation of arylideneimines with imidate
ylides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baldridge, Anthony; Kowalik, Janusz; Tolbert, Laren M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2010), (14), 2424-2436

$RFMT $RIREG SCHEME303 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Dichloro-N4,N8-dipropylpyrimido[5,4-d]pyrimidine-4,8-diamine
C12H16Cl2N6
1629634-83-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0010 3.8501 0.0 0
M  V30 2 C 2.6673 4.6201 0.0 0
M  V30 3 C 1.3337 3.8501 0.0 0
M  V30 4 C 0.0000 4.6201 0.0 0
M  V30 5 N 10.6697 4.6201 0.0 0
M  V30 6 C 12.0033 3.8501 0.0 0
M  V30 7 C 13.3370 4.6201 0.0 0
M  V30 8 C 14.6707 3.8501 0.0 0
M  V30 9 Cl 8.0022 0.0000 0.0 0
M  V30 10 Cl 6.6685 8.4702 0.0 0
M  V30 11 C 6.6685 3.8501 0.0 0
M  V30 12 C 8.0022 4.6201 0.0 0
M  V30 13 C 5.3348 4.6201 0.0 0
M  V30 14 N 6.6685 2.3101 0.0 0
M  V30 15 C 9.3358 3.8501 0.0 0
M  V30 16 N 8.0022 6.1601 0.0 0
M  V30 17 N 5.3348 6.1601 0.0 0
M  V30 18 C 8.0022 1.5400 0.0 0
M  V30 19 N 9.3358 2.3101 0.0 0
M  V30 20 C 6.6685 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 9 18
M  V30 10 1 10 20
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 2 13 17
M  V30 17 2 14 18
M  V30 18 2 15 19
M  V30 19 2 16 20
M  V30 20 1 17 20
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N2-methyl-N4,N8-dipropylpyrimido[5,4-d]pyrimidine-2,4,8-triamine
C13H20ClN7
1629635-01-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.6697 4.6201 0.0 0
M  V30 2 C 12.0033 5.3901 0.0 0
M  V30 3 C 13.3370 4.6201 0.0 0
M  V30 4 C 14.6707 5.3901 0.0 0
M  V30 5 N 4.0010 5.3901 0.0 0
M  V30 6 C 2.6673 4.6201 0.0 0
M  V30 7 C 1.3337 5.3901 0.0 0
M  V30 8 C 0.0000 4.6201 0.0 0
M  V30 9 N 6.6685 0.7700 0.0 0
M  V30 10 C 5.3348 0.0000 0.0 0
M  V30 11 Cl 8.0022 9.2402 0.0 0
M  V30 12 C 8.0022 4.6201 0.0 0
M  V30 13 C 6.6685 5.3901 0.0 0
M  V30 14 C 9.3358 5.3901 0.0 0
M  V30 15 N 8.0022 3.0801 0.0 0
M  V30 16 C 5.3348 4.6201 0.0 0
M  V30 17 N 6.6685 6.9302 0.0 0
M  V30 18 N 9.3358 6.9302 0.0 0
M  V30 19 C 6.6685 2.3101 0.0 0
M  V30 20 N 5.3348 3.0801 0.0 0
M  V30 21 C 8.0022 7.7002 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 16
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 1 9 19
M  V30 11 1 11 21
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 17 2 14 18
M  V30 18 2 15 19
M  V30 19 2 16 20
M  V30 20 2 17 21
M  V30 21 1 18 21
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1629634-83-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1629635-01-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-7286201
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, product further converted into HCl salt with 89% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrimido[5,4-d]pyrimidine derivatives as novel breathing control
modulating compounds for preventing and/or treating respiratory diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dax, Scott; Mencel, James Joseph; Ozola, Vita; Shubin, Kirill; Martjuga,
Marina; Suna, Edgars
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014151462 A1 2014-09-25

$RFMT $RIREG SCHEME304 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1S,2R,4R,6S)-2,4-Bis(phenylmethoxy)-7-oxabicyclo[4.1.0]heptane
C20H22O3
163878-18-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 4.0010 4.4137 0.0 0
M  V30 2 C 4.0010 5.9538 0.0 0
M  V30 3 O 9.3358 4.4137 0.0 0
M  V30 4 C 10.6697 3.6437 0.0 0
M  V30 5 C 5.3348 2.1037 0.0 0 CFG=2
M  V30 6 C 6.6685 1.3337 0.0 0 CFG=2
M  V30 7 C 5.3348 3.6437 0.0 0 CFG=2
M  V30 8 O 5.3348 0.5637 0.0 0
M  V30 9 C 8.0022 2.1037 0.0 0
M  V30 10 C 6.6685 4.4137 0.0 0
M  V30 11 C 8.0022 3.6437 0.0 0 CFG=2
M  V30 12 C 2.6673 6.7238 0.0 0
M  V30 13 C 1.3337 5.9538 0.0 0
M  V30 14 C 2.6673 8.2638 0.0 0
M  V30 15 C 0.0000 6.7238 0.0 0
M  V30 16 C 1.3337 9.0338 0.0 0
M  V30 17 C 0.0000 8.2638 0.0 0
M  V30 18 C 12.0033 4.4137 0.0 0
M  V30 19 C 12.0033 5.9538 0.0 0
M  V30 20 C 13.3370 3.6437 0.0 0
M  V30 21 C 13.3370 6.7238 0.0 0
M  V30 22 C 14.6707 4.4137 0.0 0
M  V30 23 C 14.6707 5.9538 0.0 0
M  V30 24 H 3.7948 2.1037 0.0 0
M  V30 25 H 7.4385 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 7 1 CFG=3
M  V30 3 1 2 12
M  V30 4 1 3 4
M  V30 5 1 11 3 CFG=1
M  V30 6 1 4 18
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 5 8
M  V30 10 1 5 24 CFG=1
M  V30 11 1 6 8
M  V30 12 1 6 9
M  V30 13 1 6 25 CFG=1
M  V30 14 1 7 10
M  V30 15 1 9 11
M  V30 16 1 10 11
M  V30 17 2 12 13
M  V30 18 1 12 14
M  V30 19 1 13 15
M  V30 20 2 14 16
M  V30 21 2 15 17
M  V30 22 1 16 17
M  V30 23 2 18 19
M  V30 24 1 18 20
M  V30 25 1 19 21
M  V30 26 2 20 22
M  V30 27 2 21 23
M  V30 28 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 5 6 7 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1S,2R,4S,6R)-2-(Methylamino)-4,6-bis(phenylmethoxy)cyclohexanol
C21H27NO3
218915-51-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 4.0010 5.3901 0.0 0
M  V30 2 C 4.0010 6.9302 0.0 0
M  V30 3 O 4.0010 2.3101 0.0 0
M  V30 4 O 9.3358 5.3901 0.0 0
M  V30 5 C 10.6697 4.6201 0.0 0
M  V30 6 N 6.6685 0.7700 0.0 0
M  V30 7 C 8.0022 0.0000 0.0 0
M  V30 8 C 5.3348 4.6201 0.0 0 CFG=1
M  V30 9 C 6.6685 5.3901 0.0 0
M  V30 10 C 5.3348 3.0801 0.0 0 CFG=1
M  V30 11 C 8.0022 4.6201 0.0 0 CFG=1
M  V30 12 C 6.6685 2.3101 0.0 0 CFG=2
M  V30 13 C 8.0022 3.0801 0.0 0
M  V30 14 C 2.6673 7.7002 0.0 0
M  V30 15 C 1.3337 6.9302 0.0 0
M  V30 16 C 2.6673 9.2402 0.0 0
M  V30 17 C 0.0000 7.7002 0.0 0
M  V30 18 C 1.3337 10.0102 0.0 0
M  V30 19 C 0.0000 9.2402 0.0 0
M  V30 20 C 12.0033 5.3901 0.0 0
M  V30 21 C 12.0033 6.9302 0.0 0
M  V30 22 C 13.3370 4.6201 0.0 0
M  V30 23 C 13.3370 7.7002 0.0 0
M  V30 24 C 14.6707 5.3901 0.0 0
M  V30 25 C 14.6707 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 8 1 CFG=3
M  V30 3 1 2 14
M  V30 4 1 10 3 CFG=3
M  V30 5 1 4 5
M  V30 6 1 11 4 CFG=1
M  V30 7 1 5 20
M  V30 8 1 6 7
M  V30 9 1 12 6 CFG=1
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 8 10 11 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 163878-18-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 218915-51-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-13604147
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 54761-04-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The 6-OH group of D-inositol 1-phosphate serves as an H-bond donor in the
catalytic hydrolysis of the phosphate ester by inositol monophosphatase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Miller, David J.; Beaton, Martin W.; Wilkie, John; Gani, David
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemBioChem (2000), 1(4), 262-271

$RFMT $RIREG SCHEME305 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-(4-methylphenyl)acetamide
C9H10ClNO
16634-82-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0800 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 C 8.0022 3.0800 0.0 0
M  V30 4 O 6.6684 0.7700 0.0 0
M  V30 5 Cl 9.3359 2.3100 0.0 0
M  V30 6 C 0.0000 0.0000 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6675 3.0800 0.0 0
M  V30 9 C 4.0011 0.7700 0.0 0
M  V30 10 C 1.3337 2.3100 0.0 0
M  V30 11 C 2.6675 0.0000 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acetamide, 2-(methylamino)-N-(4-methylphenyl)-
C10H14N2O
64642-17-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9302 2.6673 0.0 0
M  V30 3 C 8.4702 2.6673 0.0 0
M  V30 4 O 6.1601 4.0010 0.0 0
M  V30 5 N 9.2402 4.0010 0.0 0
M  V30 6 C 10.7802 4.0010 0.0 0
M  V30 7 C 0.0000 1.3337 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 3.8501 0.0000 0.0 0
M  V30 10 C 3.8501 2.6673 0.0 0
M  V30 11 C 2.3101 0.0000 0.0 0
M  V30 12 C 2.3101 2.6673 0.0 0
M  V30 13 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 16634-82-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 64642-17-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-12765122
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-based design, synthesis, and antifungal activity of new
triazole derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sheng, Chunquan; Che, Xiaoying; Wang, Wenya; Wang, Shengzheng; Cao,
Yongbing; Yao, Jianzhong; Miao, Zhenyuan; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Biology & Drug Design (2011), 78(2), 309-313

$RFMT $RIREG SCHEME306 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-3-methylbenzo[b]thiophene-2-sulfonyl chloride
C9H6Cl2O2S2
166964-33-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.5094 0.0000 0.0 0
M  V30 2 S 1.5400 2.7104 0.0 0 VAL=6
M  V30 3 Cl 0.0000 2.7104 0.0 0
M  V30 4 O 1.5400 4.2504 0.0 0
M  V30 5 O 1.5400 1.1704 0.0 0
M  V30 6 Cl 9.4510 1.1704 0.0 0
M  V30 7 C 5.4499 1.9404 0.0 0
M  V30 8 C 5.4499 3.4804 0.0 0
M  V30 9 C 3.9852 1.4645 0.0 0
M  V30 10 C 6.7835 1.1704 0.0 0
M  V30 11 S 3.9852 3.9564 0.0 0
M  V30 12 C 6.7835 4.2504 0.0 0
M  V30 13 C 3.0800 2.7104 0.0 0
M  V30 14 C 8.1172 1.9404 0.0 0
M  V30 15 C 8.1172 3.4804 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 2 2 5
M  V30 5 1 2 13
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 1 12 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-N,3-dimethylbenzo[b]thiophene-2-sulfonamide
C10H10ClNO2S2
752132-75-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7282 5.3182 0.0 0
M  V30 2 S 2.6674 3.9555 0.0 0 VAL=6
M  V30 3 N 1.3336 4.7255 0.0 0
M  V30 4 O 3.4374 5.2891 0.0 0
M  V30 5 O 1.8974 2.6218 0.0 0
M  V30 6 C 0.0000 3.9555 0.0 0
M  V30 7 Cl 10.2884 1.3338 0.0 0
M  V30 8 C 6.4384 2.6674 0.0 0
M  V30 9 C 5.6684 1.3338 0.0 0
M  V30 10 C 5.4079 3.8118 0.0 0
M  V30 11 C 7.9784 2.6674 0.0 0
M  V30 12 S 4.1620 1.6540 0.0 0
M  V30 13 C 6.4384 0.0000 0.0 0
M  V30 14 C 4.0011 3.1855 0.0 0
M  V30 15 C 8.7484 1.3338 0.0 0
M  V30 16 C 7.9784 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 2 2 5
M  V30 5 1 2 14
M  V30 6 1 3 6
M  V30 7 1 7 15
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 14
M  V30 16 1 13 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 166964-33-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 752132-75-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-6758905
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step A 5-Chloro-3-methyl-benzo[b]thiophene-2-sulfonic acid methylamide A
solution of triethylamine (1.38 g. 7.17 mmol) and
5-chloro-3-methyl-benzo[b]thiophene-2-sulfonyl chloride (1.00 g, 3.56
mmol) in THF (10 mL) was treated with a 2 M solution of methylamine in
THF (2.67 mL, 5.35 mmol) and stirred at room temperature under No for 30
minutes. When the reaction was complete by TLC (1/1 hexanes/acetone) the
reaction was quenched with 1 N HCl (14 mL), diluted with water and
extracted with ethyl acetate. The organic layer was dried (Na2SO4) and
the solvent was removed in vacuo to afford that was utilized without
further purification. Yield 0.97 g (99%). Rf = 0.47 (1/1
hexanes/acetone). 1H NMR (400 MHz, CDCl3); MS (ES-) m/z mass calculated
for C10H10O2NS2Cl 275. found 274 and 276 (M-1 and M+1, 100%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of sulfonamide derivatives, in particular
N,N-benzo[b]thiophene sulfonamides, as PPAR modulators, especially PPAR
agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Conner, Scott Eugene; Gossett, Lynn Stacy; Green, Jonathan Edward; Jones,
Winton Dennis, Jr.; Mantlo, Nathan Bryan; Matthews, Donald Paul; Mayhugh,
Daniel Ray; Smith, Daryl Lynn; Vance, Jennifer Ann; Wang, Xiaodong;
Warshawsky, Alan M.; Winneroski, Leonard Larry, Jr.; Xu, Yanping; Zhu,
Guoxin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004073606 A2 2004-09-02

$RFMT $RIREG SCHEME307 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1R,3S)-1-(2-chloro-4-methylphenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b...
C20H19ClN2O2
1679333-60-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 O 10.6696 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 Cl 5.3348 9.7102 0.0 0
M  V30 6 C 0.0000 9.7102 0.0 0
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 C 6.6685 4.3201 0.0 0
M  V30 9 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 10 N 4.1902 4.0597 0.0 0
M  V30 11 C 6.3483 2.8138 0.0 0
M  V30 12 C 8.0021 5.0901 0.0 0
M  V30 13 N 6.6685 7.4001 0.0 0
M  V30 14 C 4.8167 2.6527 0.0 0
M  V30 15 C 7.2535 1.5679 0.0 0
M  V30 16 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 17 C 4.1902 1.2459 0.0 0
M  V30 18 C 6.6270 0.1609 0.0 0
M  V30 19 C 5.0955 0.0000 0.0 0
M  V30 20 C 4.0011 7.4001 0.0 0
M  V30 21 C 4.0011 8.9401 0.0 0
M  V30 22 C 2.6673 6.6301 0.0 0
M  V30 23 C 2.6673 9.7102 0.0 0
M  V30 24 C 1.3337 7.4001 0.0 0
M  V30 25 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 21
M  V30 6 1 6 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=1
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1R,3S)-1-(2-Chloro-4-methylphenyl)-2,3,4,9-tetrahydro-N-methyl-1H-pyrido[3,4...
C20H20ClN3O
1679333-91-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 N 10.6696 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 Cl 5.3348 9.7102 0.0 0
M  V30 6 C 0.0000 9.7102 0.0 0
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 C 6.6685 4.3201 0.0 0
M  V30 9 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 10 N 4.1902 4.0597 0.0 0
M  V30 11 C 6.3483 2.8138 0.0 0
M  V30 12 C 8.0021 5.0901 0.0 0
M  V30 13 N 6.6685 7.4001 0.0 0
M  V30 14 C 4.8167 2.6527 0.0 0
M  V30 15 C 7.2535 1.5679 0.0 0
M  V30 16 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 17 C 4.1902 1.2459 0.0 0
M  V30 18 C 6.6270 0.1609 0.0 0
M  V30 19 C 5.0955 0.0000 0.0 0
M  V30 20 C 4.0011 7.4001 0.0 0
M  V30 21 C 4.0011 8.9401 0.0 0
M  V30 22 C 2.6673 6.6301 0.0 0
M  V30 23 C 2.6673 9.7102 0.0 0
M  V30 24 C 1.3337 7.4001 0.0 0
M  V30 25 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 21
M  V30 6 1 6 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=1
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1679333-60-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1679333-91-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15855491
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM closed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions and formulations of methylerthritol phosphate pathway
inhibitors and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Carlier, Paul R.; Cassera, Maria Belen; Merino, Emilio Fernando; Yao,
Zhong-Ke; Ghavami, Maryam
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016069949 A1 2016-05-06

$RFMT $RIREG SCHEME307 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1R,3S)-1-(2-chloro-4-methylphenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b...
C20H19ClN2O2
1679333-60-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 O 10.6696 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 Cl 5.3348 9.7102 0.0 0
M  V30 6 C 0.0000 9.7102 0.0 0
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 C 6.6685 4.3201 0.0 0
M  V30 9 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 10 N 4.1902 4.0597 0.0 0
M  V30 11 C 6.3483 2.8138 0.0 0
M  V30 12 C 8.0021 5.0901 0.0 0
M  V30 13 N 6.6685 7.4001 0.0 0
M  V30 14 C 4.8167 2.6527 0.0 0
M  V30 15 C 7.2535 1.5679 0.0 0
M  V30 16 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 17 C 4.1902 1.2459 0.0 0
M  V30 18 C 6.6270 0.1609 0.0 0
M  V30 19 C 5.0955 0.0000 0.0 0
M  V30 20 C 4.0011 7.4001 0.0 0
M  V30 21 C 4.0011 8.9401 0.0 0
M  V30 22 C 2.6673 6.6301 0.0 0
M  V30 23 C 2.6673 9.7102 0.0 0
M  V30 24 C 1.3337 7.4001 0.0 0
M  V30 25 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 21
M  V30 6 1 6 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=1
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1R,3S)-1-(2-Chloro-4-methylphenyl)-2,3,4,9-tetrahydro-N-methyl-1H-pyrido[3,4...
C20H20ClN3O
1679333-91-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 N 10.6696 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 Cl 5.3348 9.7102 0.0 0
M  V30 6 C 0.0000 9.7102 0.0 0
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 C 6.6685 4.3201 0.0 0
M  V30 9 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 10 N 4.1902 4.0597 0.0 0
M  V30 11 C 6.3483 2.8138 0.0 0
M  V30 12 C 8.0021 5.0901 0.0 0
M  V30 13 N 6.6685 7.4001 0.0 0
M  V30 14 C 4.8167 2.6527 0.0 0
M  V30 15 C 7.2535 1.5679 0.0 0
M  V30 16 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 17 C 4.1902 1.2459 0.0 0
M  V30 18 C 6.6270 0.1609 0.0 0
M  V30 19 C 5.0955 0.0000 0.0 0
M  V30 20 C 4.0011 7.4001 0.0 0
M  V30 21 C 4.0011 8.9401 0.0 0
M  V30 22 C 2.6673 6.6301 0.0 0
M  V30 23 C 2.6673 9.7102 0.0 0
M  V30 24 C 1.3337 7.4001 0.0 0
M  V30 25 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 21
M  V30 6 1 6 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=1
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1679333-60-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1679333-91-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3547795
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM closed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Determination of the active stereoisomer of the MEP pathway-targeting
antimalarial agent MMV008138, and initial structure-activity studies
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yao, Zhong-Ke; Krai, Priscilla M.; Merino, Emilio F.; Simpson, Morgan E.;
Slebodnick, Carla; Cassera, Maria Belen; Carlier, Paul R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2015), 25(7), 1515-1519

$RFMT $RIREG SCHEME308 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1R,3S)-1-(2,4-dimethylphenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indo...
C21H22N2O2
1679333-67-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 O 10.6696 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 C 5.3348 9.7102 0.0 0
M  V30 6 C 0.0000 9.7102 0.0 0
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 C 6.6685 4.3201 0.0 0
M  V30 9 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 10 N 4.1902 4.0597 0.0 0
M  V30 11 C 6.3483 2.8138 0.0 0
M  V30 12 C 8.0021 5.0901 0.0 0
M  V30 13 N 6.6685 7.4001 0.0 0
M  V30 14 C 4.8167 2.6527 0.0 0
M  V30 15 C 7.2535 1.5679 0.0 0
M  V30 16 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 17 C 4.1902 1.2459 0.0 0
M  V30 18 C 6.6270 0.1609 0.0 0
M  V30 19 C 5.0955 0.0000 0.0 0
M  V30 20 C 4.0011 7.4001 0.0 0
M  V30 21 C 4.0011 8.9401 0.0 0
M  V30 22 C 2.6673 6.6301 0.0 0
M  V30 23 C 2.6673 9.7102 0.0 0
M  V30 24 C 1.3337 7.4001 0.0 0
M  V30 25 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 21
M  V30 6 1 6 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=1
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1R,3S)-1-(2,4-Dimethylphenyl)-2,3,4,9-tetrahydro-N-methyl-1H-pyrido[3,4-b]in...
C21H23N3O
1679333-93-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 N 10.6696 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 C 5.3348 9.7102 0.0 0
M  V30 6 C 0.0000 9.7102 0.0 0
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 C 6.6685 4.3201 0.0 0
M  V30 9 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 10 N 4.1902 4.0597 0.0 0
M  V30 11 C 6.3483 2.8138 0.0 0
M  V30 12 C 8.0021 5.0901 0.0 0
M  V30 13 N 6.6685 7.4001 0.0 0
M  V30 14 C 4.8167 2.6527 0.0 0
M  V30 15 C 7.2535 1.5679 0.0 0
M  V30 16 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 17 C 4.1902 1.2459 0.0 0
M  V30 18 C 6.6270 0.1609 0.0 0
M  V30 19 C 5.0955 0.0000 0.0 0
M  V30 20 C 4.0011 7.4001 0.0 0
M  V30 21 C 4.0011 8.9401 0.0 0
M  V30 22 C 2.6673 6.6301 0.0 0
M  V30 23 C 2.6673 9.7102 0.0 0
M  V30 24 C 1.3337 7.4001 0.0 0
M  V30 25 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 21
M  V30 6 1 6 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=1
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1679333-67-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1679333-93-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15811518
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM closed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions and formulations of methylerthritol phosphate pathway
inhibitors and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Carlier, Paul R.; Cassera, Maria Belen; Merino, Emilio Fernando; Yao,
Zhong-Ke; Ghavami, Maryam
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016069949 A1 2016-05-06

$RFMT $RIREG SCHEME308 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1R,3S)-1-(2,4-dimethylphenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indo...
C21H22N2O2
1679333-67-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 O 10.6696 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 C 5.3348 9.7102 0.0 0
M  V30 6 C 0.0000 9.7102 0.0 0
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 C 6.6685 4.3201 0.0 0
M  V30 9 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 10 N 4.1902 4.0597 0.0 0
M  V30 11 C 6.3483 2.8138 0.0 0
M  V30 12 C 8.0021 5.0901 0.0 0
M  V30 13 N 6.6685 7.4001 0.0 0
M  V30 14 C 4.8167 2.6527 0.0 0
M  V30 15 C 7.2535 1.5679 0.0 0
M  V30 16 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 17 C 4.1902 1.2459 0.0 0
M  V30 18 C 6.6270 0.1609 0.0 0
M  V30 19 C 5.0955 0.0000 0.0 0
M  V30 20 C 4.0011 7.4001 0.0 0
M  V30 21 C 4.0011 8.9401 0.0 0
M  V30 22 C 2.6673 6.6301 0.0 0
M  V30 23 C 2.6673 9.7102 0.0 0
M  V30 24 C 1.3337 7.4001 0.0 0
M  V30 25 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 21
M  V30 6 1 6 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=1
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1R,3S)-1-(2,4-Dimethylphenyl)-2,3,4,9-tetrahydro-N-methyl-1H-pyrido[3,4-b]in...
C21H23N3O
1679333-93-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 N 10.6696 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 C 5.3348 9.7102 0.0 0
M  V30 6 C 0.0000 9.7102 0.0 0
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 C 6.6685 4.3201 0.0 0
M  V30 9 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 10 N 4.1902 4.0597 0.0 0
M  V30 11 C 6.3483 2.8138 0.0 0
M  V30 12 C 8.0021 5.0901 0.0 0
M  V30 13 N 6.6685 7.4001 0.0 0
M  V30 14 C 4.8167 2.6527 0.0 0
M  V30 15 C 7.2535 1.5679 0.0 0
M  V30 16 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 17 C 4.1902 1.2459 0.0 0
M  V30 18 C 6.6270 0.1609 0.0 0
M  V30 19 C 5.0955 0.0000 0.0 0
M  V30 20 C 4.0011 7.4001 0.0 0
M  V30 21 C 4.0011 8.9401 0.0 0
M  V30 22 C 2.6673 6.6301 0.0 0
M  V30 23 C 2.6673 9.7102 0.0 0
M  V30 24 C 1.3337 7.4001 0.0 0
M  V30 25 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 21
M  V30 6 1 6 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=1
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1679333-67-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1679333-93-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-2990334
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM closed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Determination of the active stereoisomer of the MEP pathway-targeting
antimalarial agent MMV008138, and initial structure-activity studies
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yao, Zhong-Ke; Krai, Priscilla M.; Merino, Emilio F.; Simpson, Morgan E.;
Slebodnick, Carla; Cassera, Maria Belen; Carlier, Paul R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2015), 25(7), 1515-1519

$RFMT $RIREG SCHEME309 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1S,3S)-1-(2,4-dimethylphenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indo...
C21H22N2O2
1679333-68-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 O 10.6696 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 C 5.3348 9.7102 0.0 0
M  V30 6 C 0.0000 9.7102 0.0 0
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 C 6.6685 4.3201 0.0 0
M  V30 9 C 5.3348 6.6301 0.0 0 CFG=2
M  V30 10 N 4.1902 4.0597 0.0 0
M  V30 11 C 6.3483 2.8138 0.0 0
M  V30 12 C 8.0021 5.0901 0.0 0
M  V30 13 N 6.6685 7.4001 0.0 0
M  V30 14 C 4.8167 2.6527 0.0 0
M  V30 15 C 7.2535 1.5679 0.0 0
M  V30 16 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 17 C 4.1902 1.2459 0.0 0
M  V30 18 C 6.6270 0.1609 0.0 0
M  V30 19 C 5.0955 0.0000 0.0 0
M  V30 20 C 4.0011 7.4001 0.0 0
M  V30 21 C 4.0011 8.9401 0.0 0
M  V30 22 C 2.6673 6.6301 0.0 0
M  V30 23 C 2.6673 9.7102 0.0 0
M  V30 24 C 1.3337 7.4001 0.0 0
M  V30 25 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 21
M  V30 6 1 6 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=3
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1S,3S)-1-(2,4-Dimethylphenyl)-2,3,4,9-tetrahydro-N-methyl-1H-pyrido[3,4-b]in...
C21H23N3O
1918182-05-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 N 10.6696 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 C 5.3348 9.7102 0.0 0
M  V30 6 C 0.0000 9.7102 0.0 0
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 C 6.6685 4.3201 0.0 0
M  V30 9 C 5.3348 6.6301 0.0 0 CFG=2
M  V30 10 N 4.1902 4.0597 0.0 0
M  V30 11 C 6.3483 2.8138 0.0 0
M  V30 12 C 8.0021 5.0901 0.0 0
M  V30 13 N 6.6685 7.4001 0.0 0
M  V30 14 C 4.8167 2.6527 0.0 0
M  V30 15 C 7.2535 1.5679 0.0 0
M  V30 16 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 17 C 4.1902 1.2459 0.0 0
M  V30 18 C 6.6270 0.1609 0.0 0
M  V30 19 C 5.0955 0.0000 0.0 0
M  V30 20 C 4.0011 7.4001 0.0 0
M  V30 21 C 4.0011 8.9401 0.0 0
M  V30 22 C 2.6673 6.6301 0.0 0
M  V30 23 C 2.6673 9.7102 0.0 0
M  V30 24 C 1.3337 7.4001 0.0 0
M  V30 25 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 21
M  V30 6 1 6 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=3
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1679333-68-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1918182-05-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15920679
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM closed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions and formulations of methylerthritol phosphate pathway
inhibitors and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Carlier, Paul R.; Cassera, Maria Belen; Merino, Emilio Fernando; Yao,
Zhong-Ke; Ghavami, Maryam
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016069949 A1 2016-05-06

$RFMT $RIREG SCHEME310 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1R,3S)-1-(2,4-difluorophenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indo...
C19H16F2N2O2
1679333-69-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 O 10.6696 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 F 5.3348 9.7102 0.0 0
M  V30 6 F 0.0000 9.7102 0.0 0
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 C 6.6685 4.3201 0.0 0
M  V30 9 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 10 N 4.1902 4.0597 0.0 0
M  V30 11 C 6.3483 2.8138 0.0 0
M  V30 12 C 8.0021 5.0901 0.0 0
M  V30 13 N 6.6685 7.4001 0.0 0
M  V30 14 C 4.8167 2.6527 0.0 0
M  V30 15 C 7.2535 1.5679 0.0 0
M  V30 16 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 17 C 4.1902 1.2459 0.0 0
M  V30 18 C 6.6270 0.1609 0.0 0
M  V30 19 C 5.0955 0.0000 0.0 0
M  V30 20 C 4.0011 7.4001 0.0 0
M  V30 21 C 4.0011 8.9401 0.0 0
M  V30 22 C 2.6673 6.6301 0.0 0
M  V30 23 C 2.6673 9.7102 0.0 0
M  V30 24 C 1.3337 7.4001 0.0 0
M  V30 25 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 21
M  V30 6 1 6 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=1
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1R,3S)-1-(2,4-Difluorophenyl)-2,3,4,9-tetrahydro-N-methyl-1H-pyrido[3,4-b]in...
C19H17F2N3O
1679333-94-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 N 10.6696 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 F 5.3348 9.7102 0.0 0
M  V30 6 F 0.0000 9.7102 0.0 0
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 C 6.6685 4.3201 0.0 0
M  V30 9 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 10 N 4.1902 4.0597 0.0 0
M  V30 11 C 6.3483 2.8138 0.0 0
M  V30 12 C 8.0021 5.0901 0.0 0
M  V30 13 N 6.6685 7.4001 0.0 0
M  V30 14 C 4.8167 2.6527 0.0 0
M  V30 15 C 7.2535 1.5679 0.0 0
M  V30 16 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 17 C 4.1902 1.2459 0.0 0
M  V30 18 C 6.6270 0.1609 0.0 0
M  V30 19 C 5.0955 0.0000 0.0 0
M  V30 20 C 4.0011 7.4001 0.0 0
M  V30 21 C 4.0011 8.9401 0.0 0
M  V30 22 C 2.6673 6.6301 0.0 0
M  V30 23 C 2.6673 9.7102 0.0 0
M  V30 24 C 1.3337 7.4001 0.0 0
M  V30 25 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 21
M  V30 6 1 6 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=1
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1679333-69-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1679333-94-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15879523
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM closed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions and formulations of methylerthritol phosphate pathway
inhibitors and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Carlier, Paul R.; Cassera, Maria Belen; Merino, Emilio Fernando; Yao,
Zhong-Ke; Ghavami, Maryam
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016069949 A1 2016-05-06

$RFMT $RIREG SCHEME310 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1R,3S)-1-(2,4-difluorophenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indo...
C19H16F2N2O2
1679333-69-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 O 10.6696 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 F 5.3348 9.7102 0.0 0
M  V30 6 F 0.0000 9.7102 0.0 0
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 C 6.6685 4.3201 0.0 0
M  V30 9 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 10 N 4.1902 4.0597 0.0 0
M  V30 11 C 6.3483 2.8138 0.0 0
M  V30 12 C 8.0021 5.0901 0.0 0
M  V30 13 N 6.6685 7.4001 0.0 0
M  V30 14 C 4.8167 2.6527 0.0 0
M  V30 15 C 7.2535 1.5679 0.0 0
M  V30 16 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 17 C 4.1902 1.2459 0.0 0
M  V30 18 C 6.6270 0.1609 0.0 0
M  V30 19 C 5.0955 0.0000 0.0 0
M  V30 20 C 4.0011 7.4001 0.0 0
M  V30 21 C 4.0011 8.9401 0.0 0
M  V30 22 C 2.6673 6.6301 0.0 0
M  V30 23 C 2.6673 9.7102 0.0 0
M  V30 24 C 1.3337 7.4001 0.0 0
M  V30 25 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 21
M  V30 6 1 6 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=1
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1R,3S)-1-(2,4-Difluorophenyl)-2,3,4,9-tetrahydro-N-methyl-1H-pyrido[3,4-b]in...
C19H17F2N3O
1679333-94-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 N 10.6696 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 F 5.3348 9.7102 0.0 0
M  V30 6 F 0.0000 9.7102 0.0 0
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 C 6.6685 4.3201 0.0 0
M  V30 9 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 10 N 4.1902 4.0597 0.0 0
M  V30 11 C 6.3483 2.8138 0.0 0
M  V30 12 C 8.0021 5.0901 0.0 0
M  V30 13 N 6.6685 7.4001 0.0 0
M  V30 14 C 4.8167 2.6527 0.0 0
M  V30 15 C 7.2535 1.5679 0.0 0
M  V30 16 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 17 C 4.1902 1.2459 0.0 0
M  V30 18 C 6.6270 0.1609 0.0 0
M  V30 19 C 5.0955 0.0000 0.0 0
M  V30 20 C 4.0011 7.4001 0.0 0
M  V30 21 C 4.0011 8.9401 0.0 0
M  V30 22 C 2.6673 6.6301 0.0 0
M  V30 23 C 2.6673 9.7102 0.0 0
M  V30 24 C 1.3337 7.4001 0.0 0
M  V30 25 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 21
M  V30 6 1 6 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=1
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1679333-69-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1679333-94-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15020033
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM closed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Determination of the active stereoisomer of the MEP pathway-targeting
antimalarial agent MMV008138, and initial structure-activity studies
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yao, Zhong-Ke; Krai, Priscilla M.; Merino, Emilio F.; Simpson, Morgan E.;
Slebodnick, Carla; Cassera, Maria Belen; Carlier, Paul R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2015), 25(7), 1515-1519

$RFMT $RIREG SCHEME311 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1S,3S)-1-(2,4-difluorophenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indo...
C19H16F2N2O2
1679333-70-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 O 10.6696 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 F 5.3348 9.7102 0.0 0
M  V30 6 F 0.0000 9.7102 0.0 0
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 C 6.6685 4.3201 0.0 0
M  V30 9 C 5.3348 6.6301 0.0 0 CFG=2
M  V30 10 N 4.1902 4.0597 0.0 0
M  V30 11 C 6.3483 2.8138 0.0 0
M  V30 12 C 8.0021 5.0901 0.0 0
M  V30 13 N 6.6685 7.4001 0.0 0
M  V30 14 C 4.8167 2.6527 0.0 0
M  V30 15 C 7.2535 1.5679 0.0 0
M  V30 16 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 17 C 4.1902 1.2459 0.0 0
M  V30 18 C 6.6270 0.1609 0.0 0
M  V30 19 C 5.0955 0.0000 0.0 0
M  V30 20 C 4.0011 7.4001 0.0 0
M  V30 21 C 4.0011 8.9401 0.0 0
M  V30 22 C 2.6673 6.6301 0.0 0
M  V30 23 C 2.6673 9.7102 0.0 0
M  V30 24 C 1.3337 7.4001 0.0 0
M  V30 25 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 21
M  V30 6 1 6 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=3
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1S,3S)-1-(2,4-Difluorophenyl)-2,3,4,9-tetrahydro-N-methyl-1H-pyrido[3,4-b]in...
C19H17F2N3O
1918182-04-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 N 10.6696 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 F 5.3348 9.7102 0.0 0
M  V30 6 F 0.0000 9.7102 0.0 0
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 C 6.6685 4.3201 0.0 0
M  V30 9 C 5.3348 6.6301 0.0 0 CFG=2
M  V30 10 N 4.1902 4.0597 0.0 0
M  V30 11 C 6.3483 2.8138 0.0 0
M  V30 12 C 8.0021 5.0901 0.0 0
M  V30 13 N 6.6685 7.4001 0.0 0
M  V30 14 C 4.8167 2.6527 0.0 0
M  V30 15 C 7.2535 1.5679 0.0 0
M  V30 16 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 17 C 4.1902 1.2459 0.0 0
M  V30 18 C 6.6270 0.1609 0.0 0
M  V30 19 C 5.0955 0.0000 0.0 0
M  V30 20 C 4.0011 7.4001 0.0 0
M  V30 21 C 4.0011 8.9401 0.0 0
M  V30 22 C 2.6673 6.6301 0.0 0
M  V30 23 C 2.6673 9.7102 0.0 0
M  V30 24 C 1.3337 7.4001 0.0 0
M  V30 25 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 21
M  V30 6 1 6 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=3
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1679333-70-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1918182-04-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15838043
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM closed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions and formulations of methylerthritol phosphate pathway
inhibitors and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Carlier, Paul R.; Cassera, Maria Belen; Merino, Emilio Fernando; Yao,
Zhong-Ke; Ghavami, Maryam
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016069949 A1 2016-05-06

$RFMT $RIREG SCHEME312 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(5-Bromo-3-pyridinyl)-2-propenamide
C8H7BrN2O
1695355-36-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0800 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 C 8.0022 3.0800 0.0 0
M  V30 4 O 6.6684 0.7700 0.0 0
M  V30 5 C 9.3359 2.3100 0.0 0
M  V30 6 Br 0.0000 3.0800 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6675 3.0800 0.0 0
M  V30 9 C 4.0011 0.7700 0.0 0
M  V30 10 C 1.3337 2.3100 0.0 0
M  V30 11 N 2.6675 0.0000 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 3 5
M  V30 6 1 6 10
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(5-Bromo-3-pyridinyl)-3-(methylamino)propanamide
C9H12BrN3O
1696193-09-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 3.0801 0.0 0
M  V30 4 O 6.6685 0.7700 0.0 0
M  V30 5 C 9.3360 2.3101 0.0 0
M  V30 6 N 10.6697 3.0801 0.0 0
M  V30 7 C 12.0033 2.3101 0.0 0
M  V30 8 Br 0.0000 3.0801 0.0 0
M  V30 9 C 4.0012 2.3101 0.0 0
M  V30 10 C 2.6673 3.0801 0.0 0
M  V30 11 C 4.0012 0.7700 0.0 0
M  V30 12 C 1.3337 2.3101 0.0 0
M  V30 13 N 2.6673 0.0000 0.0 0
M  V30 14 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 12
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1695355-36-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1696193-09-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33543186
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrido oxazine derivatives as ALK5 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pala, Daniele; Pizzirani, Daniela; Bruno, Paolo; Biagetti, Matteo;
Ronchi, Paolo; Guariento, Sara; Bertani, Barbara; Rescigno, Donatella
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022136221 A1 2022-06-30

$RFMT $RIREG SCHEME313 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,4-Dimethyl-1H-indole-3-carboxaldehyde
C11H11NO
170489-16-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 4.6948 0.0 0
M  V30 2 O 7.1954 4.2188 0.0 0
M  V30 3 C 3.0800 6.6518 0.0 0
M  V30 4 C 3.0202 0.0000 0.0 0
M  V30 5 C 3.0800 3.9844 0.0 0
M  V30 6 C 2.3100 2.6508 0.0 0
M  V30 7 C 4.5864 3.6643 0.0 0
M  V30 8 C 2.3100 5.3182 0.0 0
M  V30 9 N 3.3405 1.5064 0.0 0
M  V30 10 C 0.7700 2.6508 0.0 0
M  V30 11 C 4.7473 2.1327 0.0 0
M  V30 12 C 0.7700 5.3182 0.0 0
M  V30 13 C 0.0000 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 8
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1,4-Trimethyl-1H-indole-3-methanamine
C12H16N2
620175-48-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7306 4.6948 0.0 0
M  V30 2 N 7.1953 4.2188 0.0 0
M  V30 3 C 8.3397 5.2494 0.0 0
M  V30 4 C 3.0800 6.6519 0.0 0
M  V30 5 C 3.0202 0.0000 0.0 0
M  V30 6 C 3.0800 3.9844 0.0 0
M  V30 7 C 2.3100 2.6508 0.0 0
M  V30 8 C 4.5863 3.6643 0.0 0
M  V30 9 C 2.3100 5.3182 0.0 0
M  V30 10 N 3.3404 1.5064 0.0 0
M  V30 11 C 0.7700 2.6508 0.0 0
M  V30 12 C 4.7472 2.1327 0.0 0
M  V30 13 C 0.7700 5.3182 0.0 0
M  V30 14 C 0.0000 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 9
M  V30 5 1 5 10
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 170489-16-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620175-48-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-5954385
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation 11 Preparation of
1-methyl-3-(methylaminomethyl)-1H-indole (Method B) c)
1,4-Dimethyl-3-(methylaminomethyl)-1H-indole [0698] According to the
procedure of Preparation 11, except substituting
1,4-dimethyl-1H-indole-3-carboxaldehyde for
1,3-dimethyl-1H-indole-1-carboxaldehyde, the title compound (1.9 g, 99%)
was prepared as an oil. MS (ES) m/e 189.0 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME313 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,4-Dimethyl-1H-indole-3-carboxaldehyde
C11H11NO
170489-16-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 4.6948 0.0 0
M  V30 2 O 7.1954 4.2188 0.0 0
M  V30 3 C 3.0800 6.6518 0.0 0
M  V30 4 C 3.0202 0.0000 0.0 0
M  V30 5 C 3.0800 3.9844 0.0 0
M  V30 6 C 2.3100 2.6508 0.0 0
M  V30 7 C 4.5864 3.6643 0.0 0
M  V30 8 C 2.3100 5.3182 0.0 0
M  V30 9 N 3.3405 1.5064 0.0 0
M  V30 10 C 0.7700 2.6508 0.0 0
M  V30 11 C 4.7473 2.1327 0.0 0
M  V30 12 C 0.7700 5.3182 0.0 0
M  V30 13 C 0.0000 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 8
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1,4-Trimethyl-1H-indole-3-methanamine
C12H16N2
620175-48-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7306 4.6948 0.0 0
M  V30 2 N 7.1953 4.2188 0.0 0
M  V30 3 C 8.3397 5.2494 0.0 0
M  V30 4 C 3.0800 6.6519 0.0 0
M  V30 5 C 3.0202 0.0000 0.0 0
M  V30 6 C 3.0800 3.9844 0.0 0
M  V30 7 C 2.3100 2.6508 0.0 0
M  V30 8 C 4.5863 3.6643 0.0 0
M  V30 9 C 2.3100 5.3182 0.0 0
M  V30 10 N 3.3404 1.5064 0.0 0
M  V30 11 C 0.7700 2.6508 0.0 0
M  V30 12 C 4.7472 2.1327 0.0 0
M  V30 13 C 0.7700 5.3182 0.0 0
M  V30 14 C 0.0000 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 9
M  V30 5 1 5 10
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 170489-16-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620175-48-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-13068441
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004082586 A2 2004-09-30

$RFMT $RIREG SCHEME313 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,4-Dimethyl-1H-indole-3-carboxaldehyde
C11H11NO
170489-16-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 4.6948 0.0 0
M  V30 2 O 7.1954 4.2188 0.0 0
M  V30 3 C 3.0800 6.6518 0.0 0
M  V30 4 C 3.0202 0.0000 0.0 0
M  V30 5 C 3.0800 3.9844 0.0 0
M  V30 6 C 2.3100 2.6508 0.0 0
M  V30 7 C 4.5864 3.6643 0.0 0
M  V30 8 C 2.3100 5.3182 0.0 0
M  V30 9 N 3.3405 1.5064 0.0 0
M  V30 10 C 0.7700 2.6508 0.0 0
M  V30 11 C 4.7473 2.1327 0.0 0
M  V30 12 C 0.7700 5.3182 0.0 0
M  V30 13 C 0.0000 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 8
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1,4-Trimethyl-1H-indole-3-methanamine
C12H16N2
620175-48-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7306 4.6948 0.0 0
M  V30 2 N 7.1953 4.2188 0.0 0
M  V30 3 C 8.3397 5.2494 0.0 0
M  V30 4 C 3.0800 6.6519 0.0 0
M  V30 5 C 3.0202 0.0000 0.0 0
M  V30 6 C 3.0800 3.9844 0.0 0
M  V30 7 C 2.3100 2.6508 0.0 0
M  V30 8 C 4.5863 3.6643 0.0 0
M  V30 9 C 2.3100 5.3182 0.0 0
M  V30 10 N 3.3404 1.5064 0.0 0
M  V30 11 C 0.7700 2.6508 0.0 0
M  V30 12 C 4.7472 2.1327 0.0 0
M  V30 13 C 0.7700 5.3182 0.0 0
M  V30 14 C 0.0000 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 9
M  V30 5 1 5 10
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 170489-16-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620175-48-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-6622863
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-(heteroaryl)methylacrylamides as Fab I inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Burgess, Walter J.; Jakas, Dalia; Huffman, William F.; Miller, William
H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas, Irene N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003088897 A2 2003-10-30

$RFMT $RIREG SCHEME314 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Benzyl-3,3-dimethylpiperidin-4-one
C14H19NO
173186-91-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5177 0.6770 0.0 0
M  V30 2 C 0.0000 1.7145 0.0 0
M  V30 3 C 0.9899 0.0000 0.0 0
M  V30 4 O 0.1830 3.7570 0.0 0
M  V30 5 N 4.1840 1.4470 0.0 0
M  V30 6 C 2.8504 0.6770 0.0 0
M  V30 7 C 4.1840 2.9870 0.0 0
M  V30 8 C 1.5166 1.4470 0.0 0
M  V30 9 C 2.8504 3.7570 0.0 0
M  V30 10 C 1.5166 2.9870 0.0 0
M  V30 11 C 6.8513 1.4470 0.0 0
M  V30 12 C 8.1851 0.6770 0.0 0
M  V30 13 C 6.8513 2.9870 0.0 0
M  V30 14 C 9.5187 1.4470 0.0 0
M  V30 15 C 8.1851 3.7570 0.0 0
M  V30 16 C 9.5187 2.9870 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 11
M  V30 3 1 2 8
M  V30 4 1 3 8
M  V30 5 2 4 10
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,3,3-Trimethyl-1-(phenylmethyl)-4-piperidinamine
C15H24N2
473838-38-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.8504 0.0 0
M  V30 2 C 8.3771 0.9899 0.0 0
M  V30 3 C 6.6627 0.0000 0.0 0
M  V30 4 N 9.2400 2.8504 0.0 0
M  V30 5 C 10.0100 4.1840 0.0 0
M  V30 6 N 4.6200 2.8504 0.0 0
M  V30 7 C 5.3900 1.5167 0.0 0
M  V30 8 C 5.3900 4.1840 0.0 0
M  V30 9 C 6.9300 1.5167 0.0 0
M  V30 10 C 6.9300 4.1840 0.0 0
M  V30 11 C 7.7000 2.8504 0.0 0
M  V30 12 C 2.3100 4.1840 0.0 0
M  V30 13 C 0.7700 4.1840 0.0 0
M  V30 14 C 3.0800 5.5177 0.0 0
M  V30 15 C 0.0000 5.5177 0.0 0
M  V30 16 C 2.3100 6.8515 0.0 0
M  V30 17 C 0.7700 6.8515 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 12
M  V30 3 1 2 9
M  V30 4 1 3 9
M  V30 5 1 4 5
M  V30 6 1 4 11
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 173186-91-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 473838-38-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-4974951
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Potassium hydroxide (12.85 g, 230 mmol) was added to the stirred solution
of methylamine hydrochloride (15.5 g, 230.0 mmol) in methanol (100 ml)
and stirring was continued for 30 min at 30 °C.
1-Benzyl-3,3-dimethyl-4-piperidone (5 g, 23.0 mmol), was added to the
resulting mixture and stirred for 6 hr. Sodium cyanoborohydride (1.45 g,
23.0 mmol) was added to it and reaction mixture was stirred for 15 hr.
The reaction mixture was concentrated to dryness, triturated with water,
extracted with chloroform, dried (Na2SO4) and concentrated to give
1-benzyl-4-methylamino-3,3-dimethylpiperidine. Yield 5.3 g (99 %).
1-benzyl-4-methylamino-3,3-dimethylpiperidine, Yield 5.3 g (99 %).
C15H24N2, m/z 233 (M+1), PMR (CDCl3): 0.9 (s, 3H), 1.0 (s, 3H), 1.38 (m,
2H), 1.54 (bs, 1H, D2O exchangeable), 1.68-2.1 (m, 4H), 2.4 (s, SB), 2.86
(m, 1H), 3.4 (dd, 2H), 7.3 (m, 5H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of chiral, broad-spectrum antimicrobial 7-substituted
piperidino-quinolone carboxylic acid derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM De Souza, Noel J.; Patel, Mahesh V.; Deshpande, Prasad K.; Agarwal, Shiv
Kumar; Gupte, Shrikant V.; Upadhyay, Dilip J.; Bhawsar, Satish B.; Beri,
Rupinder K.; Sreenivas, Kandepu; Nair, Sheela C.; Shukla, Milind C.;
Chugh, Y.; Shetty, Nitin; Yeole, Ravindra D.; Reddy, Madhav M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002085886 A2 2002-10-31

$RFMT $RIREG SCHEME315 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2,5-Oxadiazole-3-carboxylic acid, 4-amino-, ethyl ester
C5H7N3O3
17376-63-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6218 0.0 0
M  V30 2 O 5.1048 1.8517 0.0 0
M  V30 3 O 3.7711 4.1618 0.0 0
M  V30 4 C 6.4386 2.6218 0.0 0
M  V30 5 C 7.7722 1.8517 0.0 0
M  V30 6 N 0.7103 3.9845 0.0 0
M  V30 7 C 2.4374 1.8517 0.0 0
M  V30 8 C 1.0304 2.4782 0.0 0
M  V30 9 N 2.2765 0.3202 0.0 0
M  V30 10 N 0.0000 1.3337 0.0 0
M  V30 11 O 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 8
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Amino-N-methyl-1,2,5-oxadiazole-3-carboxamide
C4H6N4O2
30720-84-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 N 5.1049 1.8517 0.0 0
M  V30 3 O 3.7711 4.1618 0.0 0
M  V30 4 C 6.4386 2.6217 0.0 0
M  V30 5 N 0.7103 3.9845 0.0 0
M  V30 6 C 2.4374 1.8517 0.0 0
M  V30 7 C 1.0306 2.4782 0.0 0
M  V30 8 N 2.2765 0.3202 0.0 0
M  V30 9 N 0.0000 1.3337 0.0 0
M  V30 10 O 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 7
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 17376-63-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 30720-84-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-22625263
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Imidazo[1,2-b]pyridazines as IL-17a inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Coates, David Andrew; Frimpong, Kwame; Holloway, William Glen; Jones,
Spencer Brian; Levinson, Adam Marc; Lugar, Charles Willis, III; Richett,
Michael Enrico; Watson, Brian Morgan; Woodman, Michael Edward
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020146194 A1 2020-07-16

$RFMT $RIREG SCHEME316 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-(3-bromopropyl)-N-(phenylmethyl)carbamate
C15H22BrNO2
174311-01-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 5.3347 0.0 0
M  V30 2 C 3.8500 5.3347 0.0 0
M  V30 3 C 6.1600 4.0011 0.0 0
M  V30 4 C 6.1600 6.6685 0.0 0
M  V30 5 O 3.0800 6.6685 0.0 0
M  V30 6 O 3.0800 4.0011 0.0 0
M  V30 7 C 7.7000 6.6685 0.0 0
M  V30 8 C 1.5400 6.6685 0.0 0
M  V30 9 C 8.4700 8.0021 0.0 0
M  V30 10 C 1.5400 8.2085 0.0 0
M  V30 11 C 0.0000 6.6685 0.0 0
M  V30 12 C 1.5400 5.1285 0.0 0
M  V30 13 Br 10.0100 8.0021 0.0 0
M  V30 14 C 5.3900 2.6674 0.0 0
M  V30 15 C 3.8500 2.6674 0.0 0
M  V30 16 C 6.1600 1.3338 0.0 0
M  V30 17 C 3.0800 1.3338 0.0 0
M  V30 18 C 5.3900 0.0000 0.0 0
M  V30 19 C 3.8500 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 14
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[3-(methylamino)propyl]-N-(phenylmethyl)carbamate
C16H26N2O2
1346695-93-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 5.3347 0.0 0
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 C 4.6200 6.6685 0.0 0
M  V30 4 C 6.9300 5.3347 0.0 0
M  V30 5 O 5.3900 2.6674 0.0 0
M  V30 6 O 3.0800 4.0011 0.0 0
M  V30 7 C 7.7000 6.6685 0.0 0
M  V30 8 C 4.6200 1.3336 0.0 0
M  V30 9 C 9.2400 6.6685 0.0 0
M  V30 10 C 3.2864 2.1036 0.0 0
M  V30 11 C 3.8500 0.0000 0.0 0
M  V30 12 C 5.9536 0.5636 0.0 0
M  V30 13 N 10.0100 8.0021 0.0 0
M  V30 14 C 11.5500 8.0021 0.0 0
M  V30 15 C 3.0800 6.6685 0.0 0
M  V30 16 C 2.3100 8.0021 0.0 0
M  V30 17 C 2.3100 5.3347 0.0 0
M  V30 18 C 0.7700 8.0021 0.0 0
M  V30 19 C 0.7700 5.3347 0.0 0
M  V30 20 C 0.0000 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 15
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 13 14
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 174311-01-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1346695-93-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-11889816
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification and SAR of selective inducible nitric oxide synthase
(iNOS) dimerization inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gahman, Timothy C.; Herbert, Mark R.; Lang, Henk; Thayer, Angie; Symons,
Kent T.; Nguyen, Phan Manh; Massari, Mark E.; Dozier, Sara; Zhang, Yan;
Sablad, Marciano; Rao, Tadimeti S.; Noble, Stewart A.; Shiau, Andrew K.;
Hassig, Christian A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2011), 21(22), 6888-6894

$RFMT $RIREG SCHEME317 STEP1
$RXN



  2  1
$MOL
(2E)-3-Phenyl-2-pentenoic acid
C11H12O2
174660-79-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0
M  V30 2 C 5.3347 3.0800 0.0 0
M  V30 3 C 4.0011 0.7700 0.0 0
M  V30 4 C 6.6685 2.3100 0.0 0
M  V30 5 C 2.6674 0.0000 0.0 0
M  V30 6 O 6.6685 0.7700 0.0 0
M  V30 7 O 8.0021 3.0800 0.0 0
M  V30 8 C 2.6674 3.0800 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 0.0000 3.0800 0.0 0
M  V30 12 C 1.3336 5.3900 0.0 0
M  V30 13 C 0.0000 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-N-Methyl-3-phenyl-2-pentenamide
C12H15NO
2581296-88-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0
M  V30 2 C 5.3348 3.0800 0.0 0
M  V30 3 C 4.0011 0.7700 0.0 0
M  V30 4 C 6.6684 2.3100 0.0 0
M  V30 5 C 2.6675 0.0000 0.0 0
M  V30 6 N 8.0022 3.0800 0.0 0
M  V30 7 O 6.6684 0.7700 0.0 0
M  V30 8 C 9.3359 2.3100 0.0 0
M  V30 9 C 2.6675 3.0800 0.0 0
M  V30 10 C 2.6675 4.6201 0.0 0
M  V30 11 C 1.3337 2.3100 0.0 0
M  V30 12 C 1.3337 5.3901 0.0 0
M  V30 13 C 0.0000 3.0800 0.0 0
M  V30 14 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 174660-79-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2581296-88-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23051193
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Contra-thermodynamic E → Z isomerization of cinnamamides via selective
energy transfer catalysis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Becker, Marc R.; Morack, Tobias; Robertson, Jack; Metternich, Jan B.;
Mueck-Lichtenfeld, Christian; Daniliuc, Constantin; Burley, Glenn A.;
Gilmour, Ryan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2020), 76(51), 131198

$RFMT $RIREG SCHEME318 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-(3,5-dimethylphenyl)acetamide
C10H12ClNO
174700-38-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 4.6200 0.0 0
M  V30 2 C 6.6684 3.8500 0.0 0
M  V30 3 C 8.0021 4.6200 0.0 0
M  V30 4 O 6.6684 2.3100 0.0 0
M  V30 5 Cl 9.3358 3.8500 0.0 0
M  V30 6 C 0.0000 4.6200 0.0 0
M  V30 7 C 2.6674 0.0000 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 2.6674 4.6200 0.0 0
M  V30 10 C 4.0011 2.3100 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 12 C 2.6674 1.5400 0.0 0
M  V30 13 C 1.3336 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 11
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3,5-Dimethylphenyl)-2-(methylamino)acetamide
C11H16N2O
1017044-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 4.6201 0.0 0
M  V30 2 C 6.6684 3.8500 0.0 0
M  V30 3 C 8.0022 4.6201 0.0 0
M  V30 4 O 6.6684 2.3100 0.0 0
M  V30 5 N 9.3359 3.8500 0.0 0
M  V30 6 C 10.6695 4.6201 0.0 0
M  V30 7 C 0.0000 4.6201 0.0 0
M  V30 8 C 2.6673 0.0000 0.0 0
M  V30 9 C 4.0011 3.8500 0.0 0
M  V30 10 C 2.6673 4.6201 0.0 0
M  V30 11 C 4.0011 2.3100 0.0 0
M  V30 12 C 1.3337 3.8500 0.0 0
M  V30 13 C 2.6673 1.5400 0.0 0
M  V30 14 C 1.3337 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 12
M  V30 8 1 8 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 174700-38-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1017044-18-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-8217172
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-based design, synthesis, and antifungal activity of new
triazole derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sheng, Chunquan; Che, Xiaoying; Wang, Wenya; Wang, Shengzheng; Cao,
Yongbing; Yao, Jianzhong; Miao, Zhenyuan; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Biology & Drug Design (2011), 78(2), 309-313

$RFMT $RIREG SCHEME319 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4Z)-2-Phenyl-4-(phenylmethylene)-5(4H)-oxazolone
C16H11NO2
17606-70-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.8085 2.7106 0.0 0
M  V30 2 O 5.8391 0.0000 0.0 0
M  V30 3 C 3.8987 3.4806 0.0 0
M  V30 4 N 5.3632 3.9564 0.0 0
M  V30 5 O 3.8987 1.9406 0.0 0
M  V30 6 C 6.2684 2.7106 0.0 0
M  V30 7 C 5.3632 1.4647 0.0 0
M  V30 8 C 2.6528 4.3858 0.0 0
M  V30 9 C 1.2459 3.7593 0.0 0
M  V30 10 C 2.8137 5.9173 0.0 0
M  V30 11 C 0.0000 4.6645 0.0 0
M  V30 12 C 1.5679 6.8225 0.0 0
M  V30 13 C 0.1609 6.1961 0.0 0
M  V30 14 C 8.5785 4.0442 0.0 0
M  V30 15 C 7.8085 5.3779 0.0 0
M  V30 16 C 10.1185 4.0442 0.0 0
M  V30 17 C 8.5785 6.7117 0.0 0
M  V30 18 C 10.8885 5.3779 0.0 0
M  V30 19 C 10.1185 6.7117 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 1 14
M  V30 3 2 2 7
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 3 8
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 7
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, N-[1-[(methylamino)carbonyl]-2-phenylethenyl]-, (Z)-
C17H16N2O2
110465-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 5.3347 0.0 0
M  V30 2 C 2.3100 4.0011 0.0 0
M  V30 3 N 4.6200 5.3347 0.0 0
M  V30 4 C 2.3100 6.6685 0.0 0
M  V30 5 C 5.3900 6.6685 0.0 0
M  V30 6 N 0.7700 6.6685 0.0 0
M  V30 7 O 3.0800 8.0021 0.0 0
M  V30 8 O 4.6200 8.0021 0.0 0
M  V30 9 C 0.0000 8.0021 0.0 0
M  V30 10 C 3.0800 2.6674 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 4.6200 2.6674 0.0 0
M  V30 13 C 3.0800 0.0000 0.0 0
M  V30 14 C 5.3900 1.3336 0.0 0
M  V30 15 C 4.6200 0.0000 0.0 0
M  V30 16 C 6.9300 6.6685 0.0 0
M  V30 17 C 7.7000 8.0021 0.0 0
M  V30 18 C 7.7000 5.3347 0.0 0
M  V30 19 C 9.2400 8.0021 0.0 0
M  V30 20 C 9.2400 5.3347 0.0 0
M  V30 21 C 10.0100 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 10
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 2 5 8
M  V30 9 1 5 16
M  V30 10 1 6 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 17606-70-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 110465-31-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-2134182
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A concise approach to polysubstituted oxazoles from N-acyl-2-bromo
enamides via a copper(I)/amino acid-catalyzed intramolecular C-O bond
formation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Bingjie; Zhang, Yueteng; Huang, Gang; Zhang, Xinting; Niu, Pengfei;
Wu, Jie; Yu, Wenquan; Chang, Junbiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2014), 12(23), 3912-3923

$RFMT $RIREG SCHEME320 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Amino-1,5-dimethyl-2(1H)-pyrimidinone
C6H9N3O
17634-60-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 2.6674 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 3 C 4.6200 5.3349 0.0 0
M  V30 4 O 6.1600 2.6674 0.0 0
M  V30 5 C 1.5400 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 N 3.8500 1.3338 0.0 0
M  V30 9 N 3.8500 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 1 3 9
M  V30 4 2 4 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-3-(methylamino)-N-[(methylamino)carbonyl]-2-propenimidamide
C7H14N4O
1564242-76-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3101 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 N 4.0012 1.5400 0.0 0
M  V30 4 N 5.3348 3.8501 0.0 0
M  V30 5 C 8.0023 2.3101 0.0 0
M  V30 6 C 6.6685 0.0000 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 N 9.3360 1.5400 0.0 0
M  V30 9 N 1.3337 1.5400 0.0 0
M  V30 10 O 2.6673 3.8501 0.0 0
M  V30 11 C 10.6697 2.3101 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 2 5 CFG=2
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 5 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 17634-60-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1564242-76-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26965790
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM photochemical, other products also detected, incremental addition of
agent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Opened-ring adducts of 5-methylcytosine and 1,5-dimethylcytosine with
amines and water and evidence for an opened-ring hydrate of
2'-deoxycytidine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shetlar, Martin D.; Chung, Janet
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Photochemistry and Photobiology (2011), 87(4), 818-832

$RFMT $RIREG SCHEME321 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-(3-methoxyphenyl)acetamide
C9H10ClNO2
17641-08-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 O 8.0023 0.7700 0.0 0
M  V30 5 Cl 10.6697 2.3101 0.0 0
M  V30 6 O 1.3337 3.0801 0.0 0
M  V30 7 C 0.0000 2.3101 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Methoxyphenyl)-2-(methylamino)acetamide
C10H14N2O2
901273-54-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 O 8.0022 0.7700 0.0 0
M  V30 5 N 10.6697 2.3101 0.0 0
M  V30 6 C 12.0033 3.0801 0.0 0
M  V30 7 O 1.3337 3.0801 0.0 0
M  V30 8 C 0.0000 2.3101 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 C 4.0012 0.0000 0.0 0
M  V30 14 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 17641-08-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 901273-54-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-10624342
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-based design, synthesis, and antifungal activity of new
triazole derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sheng, Chunquan; Che, Xiaoying; Wang, Wenya; Wang, Shengzheng; Cao,
Yongbing; Yao, Jianzhong; Miao, Zhenyuan; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Biology & Drug Design (2011), 78(2), 309-313

$RFMT $RIREG SCHEME322 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Diethylamino)-2-hydroxybenzaldehyde
C11H15NO2
17754-90-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 4.6201 0.0 0
M  V30 2 C 1.3337 3.8500 0.0 0
M  V30 3 C 2.6675 6.1601 0.0 0
M  V30 4 C 0.0000 4.6201 0.0 0
M  V30 5 C 1.3337 6.9301 0.0 0
M  V30 6 O 5.3348 0.0000 0.0 0
M  V30 7 C 8.0022 1.5400 0.0 0
M  V30 8 O 9.3359 2.3100 0.0 0
M  V30 9 C 4.0011 3.8500 0.0 0
M  V30 10 C 4.0011 2.3100 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 5.3348 1.5400 0.0 0
M  V30 13 C 6.6684 3.8500 0.0 0
M  V30 14 C 6.6684 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(Diethylamino)-2-[(methylimino)methyl]phenol
C12H18N2O
1246401-47-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3101 2.6673 0.0 0
M  V30 2 C 1.5400 4.0010 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 0.0000 4.0010 0.0 0
M  V30 5 C 0.0000 1.3337 0.0 0
M  V30 6 O 6.9302 0.0000 0.0 0
M  V30 7 C 8.4702 2.6673 0.0 0
M  V30 8 N 9.2402 4.0010 0.0 0
M  V30 9 C 10.7802 4.0010 0.0 0
M  V30 10 C 3.8501 2.6673 0.0 0
M  V30 11 C 4.6201 1.3337 0.0 0
M  V30 12 C 4.6201 4.0010 0.0 0
M  V30 13 C 6.1601 1.3337 0.0 0
M  V30 14 C 6.1601 4.0010 0.0 0
M  V30 15 C 6.9302 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 6 13
M  V30 7 2 7 8 CFG=2
M  V30 8 1 7 15
M  V30 9 1 8 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 17754-90-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1246401-47-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-14942730
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Detection of boronic acid derivatives in cells using a fluorescent sensor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hattori, Yoshihide; Ishimura, Miki; Ohta, Youichirou; Takenaka, Hiroshi;
Watanabe, Tsubasa; Tanaka, Hiroki; Ono, Koji; Kirihata, Mitsunori
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2015), 13(25), 6927-6930

$RFMT $RIREG SCHEME322 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Diethylamino)-2-hydroxybenzaldehyde
C11H15NO2
17754-90-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 4.6201 0.0 0
M  V30 2 C 1.3337 3.8500 0.0 0
M  V30 3 C 2.6675 6.1601 0.0 0
M  V30 4 C 0.0000 4.6201 0.0 0
M  V30 5 C 1.3337 6.9301 0.0 0
M  V30 6 O 5.3348 0.0000 0.0 0
M  V30 7 C 8.0022 1.5400 0.0 0
M  V30 8 O 9.3359 2.3100 0.0 0
M  V30 9 C 4.0011 3.8500 0.0 0
M  V30 10 C 4.0011 2.3100 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 5.3348 1.5400 0.0 0
M  V30 13 C 6.6684 3.8500 0.0 0
M  V30 14 C 6.6684 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(Diethylamino)-2-[(methylimino)methyl]phenol
C12H18N2O
1246401-47-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3101 2.6673 0.0 0
M  V30 2 C 1.5400 4.0010 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 0.0000 4.0010 0.0 0
M  V30 5 C 0.0000 1.3337 0.0 0
M  V30 6 O 6.9302 0.0000 0.0 0
M  V30 7 C 8.4702 2.6673 0.0 0
M  V30 8 N 9.2402 4.0010 0.0 0
M  V30 9 C 10.7802 4.0010 0.0 0
M  V30 10 C 3.8501 2.6673 0.0 0
M  V30 11 C 4.6201 1.3337 0.0 0
M  V30 12 C 4.6201 4.0010 0.0 0
M  V30 13 C 6.1601 1.3337 0.0 0
M  V30 14 C 6.1601 4.0010 0.0 0
M  V30 15 C 6.9302 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 6 13
M  V30 7 2 7 8 CFG=2
M  V30 8 1 7 15
M  V30 9 1 8 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 17754-90-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1246401-47-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-6416080
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Syntheses of the various Schiff bases were
carried out according to the literature by combining the given aromatic
aldehyde (1 mmol) with the corresponding amine (1.1 mmol). In cases where
either the aldehyde or the amine was solid, ethanol (∼3 mL) was used to
solubilize the reagents. The reaction was allowed to stir under ambient
conditions for 12 hours. In cases where a precipitate was noted, the
product was isolated by filtration and washed with cold ethanol (∼2 mL)
to afford pure product. When both reagents were initially liquids, the
solvents and excess amine were removed in vacuo. All Schiff base
reactions gave at, or near, quantitative yields (Scheme 2, A). Schiff
base, reactant of compound 6d.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, no solvent or EtOH used for solid reactants
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient synthesis of new 4-arylideneimidazolin-5-ones related to the
GFP chromophore by 2+3 cyclocondensation of arylideneimines with imidate
ylides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baldridge, Anthony; Kowalik, Janusz; Tolbert, Laren M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2010), (14), 2424-2436

$RFMT $RIREG SCHEME323 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1R)-2-(4-chlorophenyl)-1-[5-fluoro-7-[2-[(1-methyl-1H-p...
C27H27ClFN9O2
1788904-43-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 44 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 6.6684 0.0 0 CFG=2
M  V30 2 C 6.1600 8.0020 0.0 0
M  V30 3 N 6.1600 5.3347 0.0 0
M  V30 4 C 6.9300 4.0011 0.0 0
M  V30 5 O 6.1600 2.6673 0.0 0
M  V30 6 O 8.4700 4.0011 0.0 0
M  V30 7 C 6.9300 1.3336 0.0 0
M  V30 8 C 5.5964 0.5636 0.0 0
M  V30 9 C 7.7000 0.0000 0.0 0
M  V30 10 C 8.2636 2.1036 0.0 0
M  V30 11 F 7.5904 9.8965 0.0 0
M  V30 12 N 16.8823 11.0843 0.0 0
M  V30 13 Cl 0.0000 8.0020 0.0 0
M  V30 14 C 20.1594 10.3878 0.0 0
M  V30 15 N 9.3752 7.9142 0.0 0
M  V30 16 C 8.4700 6.6684 0.0 0
M  V30 17 C 10.8399 7.4384 0.0 0
M  V30 18 C 9.0550 9.4206 0.0 0
M  V30 19 N 9.3752 5.4225 0.0 0
M  V30 20 C 11.9843 8.4688 0.0 0
M  V30 21 N 10.8399 5.8984 0.0 0
M  V30 22 C 10.1994 10.4511 0.0 0
M  V30 23 C 11.6641 9.9752 0.0 0
M  V30 24 C 4.6200 8.0020 0.0 0
M  V30 25 C 3.8500 9.3358 0.0 0
M  V30 26 C 3.8500 6.6684 0.0 0
M  V30 27 C 2.3100 9.3358 0.0 0
M  V30 28 C 2.3100 6.6684 0.0 0
M  V30 29 C 1.5400 8.0020 0.0 0
M  V30 30 C 12.8085 11.0056 0.0 0
M  V30 31 N 14.2732 10.5297 0.0 0
M  V30 32 C 12.4883 12.5120 0.0 0
M  V30 33 C 15.4176 11.5602 0.0 0
M  V30 34 C 13.6328 13.5425 0.0 0
M  V30 35 N 15.0974 13.0666 0.0 0
M  V30 36 C 18.0266 12.1149 0.0 0
M  V30 37 N 19.5331 11.7946 0.0 0
M  V30 38 C 17.8657 13.6464 0.0 0
M  V30 39 N 20.3031 13.1283 0.0 0
M  V30 40 C 19.2726 14.2727 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 16
M  V30 4 1 2 24
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 11 18
M  V30 13 1 12 33
M  V30 14 1 12 36
M  V30 15 1 13 29
M  V30 16 1 14 37
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 2 16 19
M  V30 21 1 17 20
M  V30 22 2 17 21
M  V30 23 2 18 22
M  V30 24 1 19 21
M  V30 25 2 20 23
M  V30 26 1 22 23
M  V30 27 1 23 30
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 35
M  V30 40 1 36 37
M  V30 41 2 36 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 2 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1R)-2-(4-chlorophenyl)-1-[5-(methylamino)-7-[2-[(1-meth...
C28H31ClN10O2
1788904-45-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 6.6684 0.0 0 CFG=2
M  V30 2 C 6.1600 8.0020 0.0 0
M  V30 3 N 6.1600 5.3347 0.0 0
M  V30 4 C 6.9300 4.0011 0.0 0
M  V30 5 O 6.1600 2.6673 0.0 0
M  V30 6 O 8.4700 4.0011 0.0 0
M  V30 7 C 6.9300 1.3336 0.0 0
M  V30 8 C 8.2636 2.1036 0.0 0
M  V30 9 C 7.7000 0.0000 0.0 0
M  V30 10 C 5.5964 0.5636 0.0 0
M  V30 11 N 7.5904 9.8965 0.0 0
M  V30 12 C 7.2702 11.4028 0.0 0
M  V30 13 N 16.8823 11.0843 0.0 0
M  V30 14 Cl 0.0000 8.0020 0.0 0
M  V30 15 C 20.1594 10.3878 0.0 0
M  V30 16 N 9.3752 7.9142 0.0 0
M  V30 17 C 8.4700 6.6684 0.0 0
M  V30 18 C 10.8399 7.4384 0.0 0
M  V30 19 C 9.0550 9.4206 0.0 0
M  V30 20 N 9.3752 5.4225 0.0 0
M  V30 21 C 11.9843 8.4688 0.0 0
M  V30 22 N 10.8399 5.8984 0.0 0
M  V30 23 C 10.1994 10.4511 0.0 0
M  V30 24 C 11.6641 9.9752 0.0 0
M  V30 25 C 4.6200 8.0020 0.0 0
M  V30 26 C 3.8500 6.6684 0.0 0
M  V30 27 C 3.8500 9.3358 0.0 0
M  V30 28 C 2.3100 6.6684 0.0 0
M  V30 29 C 2.3100 9.3358 0.0 0
M  V30 30 C 1.5400 8.0020 0.0 0
M  V30 31 C 12.8085 11.0056 0.0 0
M  V30 32 N 14.2732 10.5297 0.0 0
M  V30 33 C 12.4883 12.5120 0.0 0
M  V30 34 C 15.4176 11.5602 0.0 0
M  V30 35 C 13.6328 13.5425 0.0 0
M  V30 36 N 15.0974 13.0666 0.0 0
M  V30 37 C 18.0266 12.1149 0.0 0
M  V30 38 N 19.5331 11.7946 0.0 0
M  V30 39 C 17.8657 13.6464 0.0 0
M  V30 40 N 20.3031 13.1283 0.0 0
M  V30 41 C 19.2726 14.2727 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 17
M  V30 4 1 2 25
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 11 12
M  V30 13 1 11 19
M  V30 14 1 13 34
M  V30 15 1 13 37
M  V30 16 1 14 30
M  V30 17 1 15 38
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 16 19
M  V30 21 2 17 20
M  V30 22 1 18 21
M  V30 23 2 18 22
M  V30 24 2 19 23
M  V30 25 1 20 22
M  V30 26 2 21 24
M  V30 27 1 23 24
M  V30 28 1 24 31
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 35
M  V30 39 2 34 36
M  V30 40 1 35 36
M  V30 41 1 37 38
M  V30 42 2 37 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 2 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1788904-43-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1788904-45-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-7782047
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of azabenzo[cd]azulene and similar compounds as
serine/threonine kinase inhibitors for treating hyperproliferative
disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kolesnikov, Aleksandr; Do, Steven
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015085007 A1 2015-06-11

$RFMT $RIREG SCHEME324 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,7-Dichloro-2-formyl-8-quinolinyl 1,1-dimethylethyl carbonate
C15H13Cl2NO4
1803402-16-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9300 5.3347 0.0 0
M  V30 2 C 8.4700 5.3347 0.0 0
M  V30 3 O 9.2400 6.6685 0.0 0
M  V30 4 O 9.2400 4.0011 0.0 0
M  V30 5 C 10.7800 6.6685 0.0 0
M  V30 6 C 10.7800 5.1285 0.0 0
M  V30 7 C 12.3200 6.6685 0.0 0
M  V30 8 C 10.7800 8.2085 0.0 0
M  V30 9 Cl 3.8500 0.0000 0.0 0
M  V30 10 Cl 8.4700 2.6674 0.0 0
M  V30 11 C 1.5400 6.6685 0.0 0
M  V30 12 O 0.0000 6.6685 0.0 0
M  V30 13 C 4.6200 4.0011 0.0 0
M  V30 14 C 3.8500 2.6674 0.0 0
M  V30 15 C 6.1600 4.0011 0.0 0
M  V30 16 N 3.8500 5.3347 0.0 0
M  V30 17 C 4.6200 1.3338 0.0 0
M  V30 18 C 2.3100 2.6674 0.0 0
M  V30 19 C 6.9300 2.6674 0.0 0
M  V30 20 C 2.3100 5.3347 0.0 0
M  V30 21 C 6.1600 1.3338 0.0 0
M  V30 22 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 17
M  V30 10 1 10 19
M  V30 11 2 11 12
M  V30 12 1 11 20
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 1 14 18
M  V30 18 2 15 19
M  V30 19 2 16 20
M  V30 20 2 17 21
M  V30 21 2 18 22
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,7-Dichloro-2-[(methylimino)methyl]-8-quinolinol
C11H8Cl2N2O
1803402-19-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 6.1601 0.0 0
M  V30 2 Cl 2.6673 0.0000 0.0 0
M  V30 3 C 8.0023 4.6201 0.0 0
M  V30 4 N 9.3360 3.8501 0.0 0
M  V30 5 C 10.6697 4.6201 0.0 0
M  V30 6 Cl 0.0000 4.6201 0.0 0
M  V30 7 C 4.0012 3.8501 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 N 5.3348 4.6201 0.0 0
M  V30 10 C 2.6673 4.6201 0.0 0
M  V30 11 C 2.6673 1.5400 0.0 0
M  V30 12 C 5.3348 1.5400 0.0 0
M  V30 13 C 6.6685 3.8501 0.0 0
M  V30 14 C 1.3337 3.8501 0.0 0
M  V30 15 C 1.3337 2.3101 0.0 0
M  V30 16 C 6.6685 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 11
M  V30 3 2 3 4 CFG=2
M  V30 4 1 3 13
M  V30 5 1 4 5
M  V30 6 1 6 14
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 1 13 16
M  V30 17 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1803402-16-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1803402-19-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-5194634
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel Fluorinated 8-Hydroxyquinoline Based Metal Ionophores for Exploring
the Metal Hypothesis of Alzheimer's Disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liang, Steven H.; Southon, Adam G.; Fraser, Benjamin H.; Krause-Heuer,
Anwen M.; Zhang, Bo; Shoup, Timothy M.; Lewis, Rebecca; Volitakis, Irene;
Han, Yifeng; Greguric, Ivan; Bush, Ashley I.; Vasdev, Neil
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2015), 6(9), 1025-1029

$RFMT $RIREG SCHEME325 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzene, 1-bromo-2-chloro-3-fluoro-4-nitro-
C6H2BrClFNO2
1804382-22-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 Cl 5.3901 0.0000 0.0 0
M  V30 6 Br 6.9302 2.6673 0.0 0
M  V30 7 C 2.3101 2.6673 0.0 0
M  V30 8 C 3.0801 1.3337 0.0 0
M  V30 9 C 3.0801 4.0010 0.0 0
M  V30 10 C 4.6201 1.3337 0.0 0
M  V30 11 C 4.6201 4.0010 0.0 0
M  V30 12 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 10
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-2-chloro-N-methyl-6-nitrobenzenamine
C7H6BrClN2O2
2054343-83-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Cl 5.3900 1.3338 0.0 0
M  V30 7 Br 6.9300 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 9
M  V30 6 1 6 10
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1804382-22-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2054343-83-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33768476
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocycles as IRAK degraders and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mainolfi, Nello; Ji, Nan; Weiss, Matthew M.; Zheng, Xiaozhang; Zhang, Yi;
Fleming, Paul R.; Zhu, Xiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022147465 A1 2022-07-07

$RFMT $RIREG SCHEME326 STEP1
$RXN



  2  1
$MOL
1,3-Dioxino[5,4-b]furo[2,3-d]pyrrol-7(4H)-one, 5-[(2E)-3-(4-fluorophenyl)-2-p...
C19H22FNO4
1823155-06-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6587 6.1614 0.0 0
M  V30 2 C 8.1987 6.1614 0.0 0
M  V30 3 C 8.9687 7.4950 0.0 0
M  V30 4 C 0.6118 2.4090 0.0 0
M  V30 5 C 0.0000 4.2918 0.0 0
M  V30 6 O 8.5590 0.0000 0.0 0
M  V30 7 F 15.1287 7.4950 0.0 0
M  V30 8 C 4.0370 3.1604 0.0 0 CFG=2
M  V30 9 C 5.3706 2.3904 0.0 0 CFG=1
M  V30 10 C 4.3571 4.6668 0.0 0 CFG=1
M  V30 11 O 2.5723 2.6845 0.0 0
M  V30 12 C 6.5150 3.4208 0.0 0 CFG=1
M  V30 13 O 5.9969 0.9836 0.0 0
M  V30 14 N 5.8887 4.8277 0.0 0
M  V30 15 C 3.2126 5.6972 0.0 0
M  V30 16 C 1.4279 3.7149 0.0 0
M  V30 17 C 7.8488 2.6508 0.0 0
M  V30 18 C 7.5286 1.1445 0.0 0
M  V30 19 O 1.7481 5.2214 0.0 0
M  V30 20 C 10.5087 7.4950 0.0 0
M  V30 21 C 11.2787 8.8288 0.0 0
M  V30 22 C 11.2787 6.1614 0.0 0
M  V30 23 C 12.8187 8.8288 0.0 0
M  V30 24 C 12.8187 6.1614 0.0 0
M  V30 25 C 13.5887 7.4950 0.0 0
M  V30 26 H 3.4850 1.7226 0.0 0
M  V30 27 H 4.7689 0.9728 0.0 0
M  V30 28 H 4.8330 6.1314 0.0 0
M  V30 29 H 7.6595 4.4514 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 2 2 3
M  V30 4 1 3 20
M  V30 5 1 4 16
M  V30 6 1 5 16
M  V30 7 2 6 18
M  V30 8 1 7 25
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 26 CFG=1
M  V30 13 1 9 12
M  V30 14 1 9 13
M  V30 15 1 9 27 CFG=1
M  V30 16 1 10 14
M  V30 17 1 10 15
M  V30 18 1 10 28 CFG=3
M  V30 19 1 11 16
M  V30 20 1 12 14
M  V30 21 1 12 17
M  V30 22 1 12 29 CFG=1
M  V30 23 1 13 18
M  V30 24 1 15 19
M  V30 25 1 16 19
M  V30 26 1 17 18
M  V30 27 2 20 21
M  V30 28 1 20 22
M  V30 29 1 21 23
M  V30 30 2 22 24
M  V30 31 2 23 25
M  V30 32 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 8 9 10 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2R,3S,4R,5R)-1-[3-(4-Fluorophenyl)propyl]-3,4-dihydroxy-5-(hydroxymethyl)-N-...
C17H25FN2O4
1823155-08-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.3752 5.3026 0.0 0
M  V30 2 C 8.9152 5.3026 0.0 0
M  V30 3 C 9.6852 6.6363 0.0 0
M  V30 4 C 4.0432 4.9524 0.0 0
M  V30 5 C 2.5367 4.6322 0.0 0
M  V30 6 N 1.5063 5.7766 0.0 0
M  V30 7 O 2.0609 3.1675 0.0 0
M  V30 8 C 0.0000 5.4565 0.0 0
M  V30 9 C 8.7379 2.2418 0.0 0
M  V30 10 O 9.2138 0.7771 0.0 0
M  V30 11 O 3.3466 1.6751 0.0 0
M  V30 12 O 6.2482 0.0000 0.0 0
M  V30 13 F 15.8453 6.6363 0.0 0
M  V30 14 N 6.6052 3.9689 0.0 0
M  V30 15 C 5.0736 3.8079 0.0 0 CFG=2
M  V30 16 C 7.2316 2.5620 0.0 0 CFG=2
M  V30 17 C 4.7534 2.3016 0.0 0 CFG=2
M  V30 18 C 6.0871 1.5316 0.0 0 CFG=1
M  V30 19 C 11.2252 6.6363 0.0 0
M  V30 20 C 11.9952 5.3026 0.0 0
M  V30 21 C 11.9952 7.9699 0.0 0
M  V30 22 C 13.5353 5.3026 0.0 0
M  V30 23 C 13.5353 7.9699 0.0 0
M  V30 24 C 14.3053 6.6363 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 19
M  V30 5 1 4 5
M  V30 6 1 15 4 CFG=1
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 1 16 9 CFG=3
M  V30 12 1 17 11 CFG=1
M  V30 13 1 18 12 CFG=1
M  V30 14 1 13 24
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 15 16 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1823155-06-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1823155-08-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-006-CAS-1778478
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM H-Cube reactor used (stage 1)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Convenient Approach to Stereoisomeric Iminocyclitols: Generation of
Potent Brain-Permeable OGA Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bergeron-Brlek, Milan; Goodwin-Tindall, Jake; Cekic, Nevena; Roth,
Christian; Zandberg, Wesley F.; Shan, Xiaoyang; Varghese, Vimal; Chan,
Sherry; Davies, Gideon J.; Vocadlo, David J.; Britton, Robert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2015), 54(51), 15429-15433

$RFMT $RIREG SCHEME327 STEP1
$RXN



  2  1
$MOL
3-(Methoxymethoxy)-5-[(methoxymethoxy)phenylmethyl]benzaldehyde
C18H20O5
1830340-36-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 4.6201 0.0 0
M  V30 2 O 4.0010 3.0801 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 O 2.6673 0.7700 0.0 0
M  V30 5 C 1.3337 0.0000 0.0 0
M  V30 6 O 9.3360 4.6201 0.0 0
M  V30 7 C 10.6697 5.3901 0.0 0
M  V30 8 O 12.0033 4.6201 0.0 0
M  V30 9 C 13.3370 5.3901 0.0 0
M  V30 10 C 6.6685 9.2402 0.0 0
M  V30 11 O 8.0022 10.0102 0.0 0
M  V30 12 C 5.3348 5.3901 0.0 0
M  V30 13 C 6.6685 4.6201 0.0 0
M  V30 14 C 5.3348 6.9302 0.0 0
M  V30 15 C 8.0022 5.3901 0.0 0
M  V30 16 C 6.6685 7.7002 0.0 0
M  V30 17 C 8.0022 6.9302 0.0 0
M  V30 18 C 2.6673 5.3901 0.0 0
M  V30 19 C 1.3337 4.6201 0.0 0
M  V30 20 C 2.6673 6.9302 0.0 0
M  V30 21 C 0.0000 5.3901 0.0 0
M  V30 22 C 1.3337 7.7002 0.0 0
M  V30 23 C 0.0000 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 1 18
M  V30 4 1 2 3
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 6 7
M  V30 8 1 6 15
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 16
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Methoxymethoxy)-5-[(methoxymethoxy)phenylmethyl]-N-methylbenzenemethanamine
C19H25NO4
1830340-37-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 6.9302 0.0 0
M  V30 2 O 4.0010 8.4702 0.0 0
M  V30 3 C 2.6673 9.2402 0.0 0
M  V30 4 O 2.6673 10.7802 0.0 0
M  V30 5 C 1.3337 11.5503 0.0 0
M  V30 6 O 9.3360 6.9302 0.0 0
M  V30 7 C 10.6697 6.1601 0.0 0
M  V30 8 O 12.0033 6.9302 0.0 0
M  V30 9 C 13.3370 6.1601 0.0 0
M  V30 10 C 6.6685 2.3101 0.0 0
M  V30 11 N 8.0022 1.5400 0.0 0
M  V30 12 C 8.0022 0.0000 0.0 0
M  V30 13 C 5.3348 6.1601 0.0 0
M  V30 14 C 6.6685 6.9302 0.0 0
M  V30 15 C 5.3348 4.6201 0.0 0
M  V30 16 C 8.0022 6.1601 0.0 0
M  V30 17 C 6.6685 3.8501 0.0 0
M  V30 18 C 8.0022 4.6201 0.0 0
M  V30 19 C 2.6673 6.1601 0.0 0
M  V30 20 C 2.6673 4.6201 0.0 0
M  V30 21 C 1.3337 6.9302 0.0 0
M  V30 22 C 1.3337 3.8501 0.0 0
M  V30 23 C 0.0000 6.1601 0.0 0
M  V30 24 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 1 19
M  V30 4 1 2 3
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 6 7
M  V30 8 1 6 16
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 17
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1830340-36-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1830340-37-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-6609086
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-65-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Aromatic compounds, compositions and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rai, Roopa; Pham, Son Minh; Agarwal, Anil Kumar; Chakravarty, Sarvajit
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015184405 A1 2015-12-03

$RFMT $RIREG SCHEME328 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (3S)-7-fluoro-3,4-dihydro-2H-1,4-benzoxazine-3-acetate
C12H14FNO3
1850385-83-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 3.0801 0.0 0
M  V30 2 C 9.3360 2.3101 0.0 0
M  V30 3 O 10.6697 3.0801 0.0 0
M  V30 4 O 9.3360 0.7700 0.0 0
M  V30 5 C 12.0033 2.3101 0.0 0
M  V30 6 C 13.3370 3.0801 0.0 0
M  V30 7 F 0.0000 0.0000 0.0 0
M  V30 8 C 4.0010 2.3101 0.0 0
M  V30 9 C 4.0010 0.7700 0.0 0
M  V30 10 N 5.3348 3.0801 0.0 0
M  V30 11 C 2.6673 3.0801 0.0 0
M  V30 12 O 5.3348 0.0000 0.0 0
M  V30 13 C 2.6673 0.0000 0.0 0
M  V30 14 C 6.6685 2.3101 0.0 0 CFG=1
M  V30 15 C 1.3337 2.3101 0.0 0
M  V30 16 C 6.6685 0.7700 0.0 0
M  V30 17 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 14 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 17
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3S)-7-Fluoro-3,4-dihydro-N-methyl-2H-1,4-benzoxazine-3-acetamide
C11H13FN2O2
1850385-88-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 3.0801 0.0 0
M  V30 2 C 9.3360 2.3101 0.0 0
M  V30 3 N 10.6697 3.0801 0.0 0
M  V30 4 O 9.3360 0.7700 0.0 0
M  V30 5 C 12.0033 2.3101 0.0 0
M  V30 6 F 0.0000 0.0000 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 4.0012 0.7700 0.0 0
M  V30 9 N 5.3348 3.0801 0.0 0
M  V30 10 C 2.6673 3.0801 0.0 0
M  V30 11 O 5.3348 0.0000 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 6.6685 2.3101 0.0 0 CFG=1
M  V30 14 C 1.3337 2.3101 0.0 0
M  V30 15 C 6.6685 0.7700 0.0 0
M  V30 16 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 13 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 16
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1850385-83-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1850385-88-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1847609
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of reactant (methylamine), alternative preparation
shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzoxazinone amides as mineralocorticoid receptor
modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM O'Mahony, Gavin; Kossenjans, Michael; Edman, Karl; Kajanus, Johan;
Hogner, Karl Anders; Cornwall, Philip; Turner, Andrew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20150376170 A1 2015-12-31

$RFMT $RIREG SCHEME329 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(4-Bromophenyl)methylene]-2-methyl-5(4H)-oxazolone
C11H8BrNO2
186605-19-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.3320 5.3026 0.0 0
M  V30 2 O 0.0000 4.9524 0.0 0
M  V30 3 C 2.2049 0.0000 0.0 0
M  V30 4 Br 9.4921 5.3026 0.0 0
M  V30 5 C 2.5620 3.9690 0.0 0
M  V30 6 N 3.1885 2.5620 0.0 0
M  V30 7 C 1.0304 3.8079 0.0 0
M  V30 8 C 2.0439 1.5316 0.0 0
M  V30 9 O 0.7103 2.3016 0.0 0
M  V30 10 C 4.8720 5.3026 0.0 0
M  V30 11 C 5.6420 6.6363 0.0 0
M  V30 12 C 5.6420 3.9690 0.0 0
M  V30 13 C 7.1821 6.6363 0.0 0
M  V30 14 C 7.1821 3.9690 0.0 0
M  V30 15 C 7.9521 5.3026 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5 CFG=2
M  V30 2 1 1 10
M  V30 3 2 2 7
M  V30 4 1 3 8
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Acetylamino)-3-(4-bromophenyl)-N-methyl-2-propenamide
C12H13BrN2O2
1384247-71-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 4.0011 0.0 0
M  V30 2 C 4.6200 5.3347 0.0 0
M  V30 3 C 4.6200 2.6674 0.0 0
M  V30 4 N 2.3100 4.0011 0.0 0
M  V30 5 N 3.8500 1.3338 0.0 0
M  V30 6 O 6.1600 2.6674 0.0 0
M  V30 7 C 1.5400 5.3347 0.0 0
M  V30 8 C 4.6200 0.0000 0.0 0
M  V30 9 C 2.3100 6.6685 0.0 0
M  V30 10 O 0.0000 5.3347 0.0 0
M  V30 11 Br 10.7800 5.3347 0.0 0
M  V30 12 C 6.1600 5.3347 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 6.9300 6.6685 0.0 0
M  V30 15 C 8.4700 4.0011 0.0 0
M  V30 16 C 8.4700 6.6685 0.0 0
M  V30 17 C 9.2400 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 12
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 11 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 186605-19-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1384247-71-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9762344
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile synthesis of 4-arylidene-5-imidazolinones as synthetic analogs of
fluorescent protein chromophore
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lee, Cheng-Yu; Chen, Yun-Chung; Lin, Hao-Chun; Jhong, Yuandong; Chang,
Chih-Wei; Tsai, Ching-Hua; Kao, Chai-Lin; Chien, Tun-Cheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2012), 68(29), 5898-5907

$RFMT $RIREG SCHEME330 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,5-Furandimethanol
C6H8O3
1883-75-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2079 2.6218 0.0 0
M  V30 2 O 7.5415 1.8517 0.0 0
M  V30 3 C 0.9052 1.4946 0.0 0
M  V30 4 O 0.0000 0.2487 0.0 0
M  V30 5 C 4.8742 1.8517 0.0 0
M  V30 6 O 3.4672 2.4782 0.0 0
M  V30 7 C 4.7131 0.3202 0.0 0
M  V30 8 C 2.4368 1.3337 0.0 0
M  V30 9 C 3.2068 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,N′-(2,5-Furandiyldimethylidyne)bis[methanamine]
C8H10N2O
92259-17-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.6218 0.0 0
M  V30 2 N 1.3337 1.8517 0.0 0
M  V30 3 C 0.0000 2.6218 0.0 0
M  V30 4 C 7.9701 1.4946 0.0 0
M  V30 5 N 8.8754 0.2487 0.0 0
M  V30 6 C 10.4069 0.4096 0.0 0
M  V30 7 C 4.0012 1.8517 0.0 0
M  V30 8 O 5.4080 2.4782 0.0 0
M  V30 9 C 4.1621 0.3202 0.0 0
M  V30 10 C 6.4386 1.3337 0.0 0
M  V30 11 C 5.6686 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 4 5 CFG=2
M  V30 5 1 4 10
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1883-75-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 92259-17-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32425348
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1313-13-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-solvent, reaction conducted in the presence of air,
catalyst prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile One-Pot Synthesis of Furan Double Schiff Base from
5-Hydroxymethylfurfural via an Amination-Oxidation-Amination Strategy in
Water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Jie; Jia, Wenlong; Yu, Xin; Wang, Qian; Sun, Yong; Yang, Shuliang;
Li, Zheng; Tang, Xing; Zeng, Xianhai; Lin, Lu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Sustainable Chemistry & Engineering (2022), 10(20), 6835-6842

$RFMT $RIREG SCHEME331 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1R,3S)-1-(4-fluorophenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3...
C19H17FN2O2
1918182-41-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 O 10.6696 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 F 0.0000 9.7101 0.0 0
M  V30 6 C 5.3348 5.0901 0.0 0
M  V30 7 C 6.6684 4.3201 0.0 0
M  V30 8 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 9 N 4.1902 4.0597 0.0 0
M  V30 10 C 6.3483 2.8138 0.0 0
M  V30 11 C 8.0021 5.0901 0.0 0
M  V30 12 N 6.6684 7.4001 0.0 0
M  V30 13 C 4.8167 2.6527 0.0 0
M  V30 14 C 7.2535 1.5679 0.0 0
M  V30 15 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 16 C 4.1902 1.2459 0.0 0
M  V30 17 C 6.6270 0.1609 0.0 0
M  V30 18 C 5.0955 0.0000 0.0 0
M  V30 19 C 4.0011 7.4001 0.0 0
M  V30 20 C 4.0011 8.9401 0.0 0
M  V30 21 C 2.6673 6.6301 0.0 0
M  V30 22 C 2.6673 9.7101 0.0 0
M  V30 23 C 1.3337 7.4001 0.0 0
M  V30 24 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 15 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 24
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 8 19 CFG=1
M  V30 13 1 9 13
M  V30 14 1 10 13
M  V30 15 2 10 14
M  V30 16 1 11 15
M  V30 17 1 12 15
M  V30 18 2 13 16
M  V30 19 1 14 17
M  V30 20 1 16 18
M  V30 21 2 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 8 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1R,3S)-1-(4-Fluorophenyl)-2,3,4,9-tetrahydro-N-methyl-1H-pyrido[3,4-b]indole...
C19H18FN3O
1918182-19-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 N 10.6696 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 F 0.0000 9.7101 0.0 0
M  V30 6 C 5.3348 5.0901 0.0 0
M  V30 7 C 6.6684 4.3201 0.0 0
M  V30 8 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 9 N 4.1902 4.0597 0.0 0
M  V30 10 C 6.3483 2.8138 0.0 0
M  V30 11 C 8.0021 5.0901 0.0 0
M  V30 12 N 6.6684 7.4001 0.0 0
M  V30 13 C 4.8167 2.6527 0.0 0
M  V30 14 C 7.2535 1.5679 0.0 0
M  V30 15 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 16 C 4.1902 1.2459 0.0 0
M  V30 17 C 6.6270 0.1609 0.0 0
M  V30 18 C 5.0955 0.0000 0.0 0
M  V30 19 C 4.0011 7.4001 0.0 0
M  V30 20 C 2.6673 6.6301 0.0 0
M  V30 21 C 4.0011 8.9401 0.0 0
M  V30 22 C 1.3337 7.4001 0.0 0
M  V30 23 C 2.6673 9.7101 0.0 0
M  V30 24 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 15 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 24
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 8 19 CFG=1
M  V30 13 1 9 13
M  V30 14 1 10 13
M  V30 15 2 10 14
M  V30 16 1 11 15
M  V30 17 1 12 15
M  V30 18 2 13 16
M  V30 19 1 14 17
M  V30 20 1 16 18
M  V30 21 2 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 8 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1918182-41-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1918182-19-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15810545
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM closed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions and formulations of methylerthritol phosphate pathway
inhibitors and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Carlier, Paul R.; Cassera, Maria Belen; Merino, Emilio Fernando; Yao,
Zhong-Ke; Ghavami, Maryam
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016069949 A1 2016-05-06

$RFMT $RIREG SCHEME332 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1R,3S)-1-(4-chloro-2-fluorophenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b...
C19H16ClFN2O2
1918182-51-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 O 10.6696 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 F 5.3348 9.7102 0.0 0
M  V30 6 Cl 0.0000 9.7102 0.0 0
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 C 6.6685 4.3201 0.0 0
M  V30 9 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 10 N 4.1902 4.0597 0.0 0
M  V30 11 C 6.3483 2.8138 0.0 0
M  V30 12 C 8.0021 5.0901 0.0 0
M  V30 13 N 6.6685 7.4001 0.0 0
M  V30 14 C 4.8167 2.6527 0.0 0
M  V30 15 C 7.2535 1.5679 0.0 0
M  V30 16 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 17 C 4.1902 1.2459 0.0 0
M  V30 18 C 6.6270 0.1609 0.0 0
M  V30 19 C 5.0955 0.0000 0.0 0
M  V30 20 C 4.0011 7.4001 0.0 0
M  V30 21 C 4.0011 8.9401 0.0 0
M  V30 22 C 2.6673 6.6301 0.0 0
M  V30 23 C 2.6673 9.7102 0.0 0
M  V30 24 C 1.3337 7.4001 0.0 0
M  V30 25 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 21
M  V30 6 1 6 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=1
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1R,3S)-1-(4-Chloro-2-fluorophenyl)-2,3,4,9-tetrahydro-N-methyl-1H-pyrido[3,4...
C19H17ClFN3O
1918182-32-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 N 10.6696 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 F 5.3348 9.7102 0.0 0
M  V30 6 Cl 0.0000 9.7102 0.0 0
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 C 6.6685 4.3201 0.0 0
M  V30 9 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 10 N 4.1902 4.0597 0.0 0
M  V30 11 C 6.3483 2.8138 0.0 0
M  V30 12 C 8.0021 5.0901 0.0 0
M  V30 13 N 6.6685 7.4001 0.0 0
M  V30 14 C 4.8167 2.6527 0.0 0
M  V30 15 C 7.2535 1.5679 0.0 0
M  V30 16 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 17 C 4.1902 1.2459 0.0 0
M  V30 18 C 6.6270 0.1609 0.0 0
M  V30 19 C 5.0955 0.0000 0.0 0
M  V30 20 C 4.0011 7.4001 0.0 0
M  V30 21 C 4.0011 8.9401 0.0 0
M  V30 22 C 2.6673 6.6301 0.0 0
M  V30 23 C 2.6673 9.7102 0.0 0
M  V30 24 C 1.3337 7.4001 0.0 0
M  V30 25 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 21
M  V30 6 1 6 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=1
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1918182-51-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1918182-32-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15906190
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM closed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions and formulations of methylerthritol phosphate pathway
inhibitors and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Carlier, Paul R.; Cassera, Maria Belen; Merino, Emilio Fernando; Yao,
Zhong-Ke; Ghavami, Maryam
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016069949 A1 2016-05-06

$RFMT $RIREG SCHEME333 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-2-hydroxybenzaldehyde
C7H5ClO2
1927-94-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 O 6.6686 2.3100 0.0 0
M  V30 3 O 2.6675 0.0000 0.0 0
M  V30 4 Cl 0.0000 1.5400 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6675 1.5400 0.0 0
M  V30 7 C 4.0011 3.8500 0.0 0
M  V30 8 C 1.3338 2.3100 0.0 0
M  V30 9 C 2.6675 4.6201 0.0 0
M  V30 10 C 1.3338 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-6-[(methylimino)methyl]phenol
C8H8ClNO
63770-01-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 C 8.0021 1.5400 0.0 0
M  V30 4 O 2.6674 0.0000 0.0 0
M  V30 5 Cl 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1927-94-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 63770-01-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-19397987
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Stable Fe(III) phenoxyimines as selective and robust CO2/epoxide coupling
catalysts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fazekas, Eszter; Nichol, Gary S.; Shaver, Michael P.; Garden, Jennifer A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Dalton Transactions (2018), 47(37), 13106-13112

$RFMT $RIREG SCHEME334 STEP1
$RXN



  2  1
$MOL
3-(4-Methoxyphenyl)propionic acid
C10H12O3
1929-29-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 O 0.0000 2.3101 0.0 0
M  V30 5 O 1.3337 0.0000 0.0 0
M  V30 6 O 9.3360 4.6201 0.0 0
M  V30 7 C 10.6697 3.8501 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 6.6685 1.5400 0.0 0
M  V30 11 C 6.6685 4.6201 0.0 0
M  V30 12 C 8.0022 2.3101 0.0 0
M  V30 13 C 8.0022 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-N-methylbenzenepropanamide
C11H15NO2
178382-72-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 1.5400 0.0 0
M  V30 4 N 10.6697 2.3101 0.0 0
M  V30 5 O 9.3360 0.0000 0.0 0
M  V30 6 C 12.0033 1.5400 0.0 0
M  V30 7 O 1.3337 4.6201 0.0 0
M  V30 8 C 0.0000 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 4.0012 1.5400 0.0 0
M  V30 12 C 4.0012 4.6201 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 2.6673 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1929-29-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 178382-72-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14200844
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM ansa-Ruthenium(II) Complexes of DPEN-SO2N(Me)(CH2)n(η6-aryl) Conjugate
Ligands for Asymmetric Transfer Hydrogenation of Aryl Ketones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kisic, Andrea; Stephan, Michel; Mohar, Barbara
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2014), 356(14-15), 3193-3198

$RFMT $RIREG SCHEME335 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Bromo-1,6-naphthyridine-2-carboxylic acid
C9H5BrN2O2
197507-55-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 1.3336 0.0000 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 O 8.0021 2.3100 0.0 0
M  V30 5 C 2.6674 2.3100 0.0 0
M  V30 6 C 2.6674 3.8500 0.0 0
M  V30 7 N 4.0011 1.5400 0.0 0
M  V30 8 C 1.3336 1.5400 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 C 1.3336 4.6200 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 0.0000 2.3100 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 14 N 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Bromo-N-methyl-1,6-naphthyridine-2-carboxamide
C10H8BrN3O
875514-91-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 1.3337 0.0000 0.0 0
M  V30 2 C 6.6684 1.5400 0.0 0
M  V30 3 N 8.0022 2.3100 0.0 0
M  V30 4 O 6.6684 0.0000 0.0 0
M  V30 5 C 9.3359 1.5400 0.0 0
M  V30 6 C 2.6675 2.3100 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 N 4.0011 1.5400 0.0 0
M  V30 9 C 1.3337 1.5400 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 1.3337 4.6201 0.0 0
M  V30 12 C 5.3348 2.3100 0.0 0
M  V30 13 C 0.0000 2.3100 0.0 0
M  V30 14 C 5.3348 3.8500 0.0 0
M  V30 15 N 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 12
M  V30 5 1 3 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 197507-55-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 875514-91-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31937573
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ergosterol analogs as inhibitors of cyclin dependent kinase 8
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Siapkaras, Petros D.; Solum, Eirik Johansson
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Steroids (2022), 178108965

$RFMT $RIREG SCHEME336 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-fluoro-β-oxobenzenepropanoate
C11H11FO3
1999-00-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 O 5.3348 0.0000 0.0 0
M  V30 4 C 8.0022 1.5400 0.0 0
M  V30 5 O 9.3360 2.3101 0.0 0
M  V30 6 O 8.0022 0.0000 0.0 0
M  V30 7 C 10.6697 1.5400 0.0 0
M  V30 8 C 12.0033 2.3101 0.0 0
M  V30 9 F 0.0000 4.6201 0.0 0
M  V30 10 C 4.0012 2.3101 0.0 0
M  V30 11 C 2.6673 1.5400 0.0 0
M  V30 12 C 4.0012 3.8501 0.0 0
M  V30 13 C 1.3337 2.3101 0.0 0
M  V30 14 C 2.6673 4.6201 0.0 0
M  V30 15 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (2Z)-3-(4-fluorophenyl)-3-(methylamino)-2-propenoate
C12H14FNO2
2614438-07-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3101 0.0 0
M  V30 2 C 6.6685 3.0801 0.0 0
M  V30 3 N 5.3348 0.7700 0.0 0
M  V30 4 C 8.0022 2.3101 0.0 0
M  V30 5 C 4.0012 0.0000 0.0 0
M  V30 6 O 9.3360 3.0801 0.0 0
M  V30 7 O 8.0022 0.7700 0.0 0
M  V30 8 C 10.6697 2.3101 0.0 0
M  V30 9 C 12.0033 3.0801 0.0 0
M  V30 10 F 0.0000 5.3901 0.0 0
M  V30 11 C 4.0012 3.0801 0.0 0
M  V30 12 C 4.0012 4.6201 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 2.6673 5.3901 0.0 0
M  V30 15 C 1.3337 3.0801 0.0 0
M  V30 16 C 1.3337 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 10 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1999-00-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2614438-07-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-23326505
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Electrochemical Oxidative Cyclization: Synthesis of Polysubstituted
Pyrrole from Enamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Zhiwei; Shi, Guang; Tang, Wei; Sun, Jie; Wang, Wenxing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2021), 2021(6), 951-955

$RFMT $RIREG SCHEME337 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-(3,4-dichlorophenyl)acetamide
C8H6Cl3NO
20149-84-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0023 3.0801 0.0 0
M  V30 4 O 6.6685 0.7700 0.0 0
M  V30 5 Cl 9.3360 2.3101 0.0 0
M  V30 6 Cl 0.0000 3.0801 0.0 0
M  V30 7 Cl 0.0000 0.0000 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 2.6675 3.0801 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 11
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3,4-Dichlorophenyl)-2-(methylamino)acetamide
C9H10Cl2N2O
22010-09-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 2.6674 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 C 8.4700 4.0011 0.0 0
M  V30 4 O 6.1600 5.3349 0.0 0
M  V30 5 N 9.2400 5.3349 0.0 0
M  V30 6 C 10.7800 5.3349 0.0 0
M  V30 7 Cl 1.5400 0.0000 0.0 0
M  V30 8 Cl 0.0000 2.6674 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.8500 1.3338 0.0 0
M  V30 11 C 3.8500 4.0011 0.0 0
M  V30 12 C 2.3100 1.3338 0.0 0
M  V30 13 C 2.3100 4.0011 0.0 0
M  V30 14 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 12
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 20149-84-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 22010-09-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-14944411
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-based design, synthesis, and antifungal activity of new
triazole derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sheng, Chunquan; Che, Xiaoying; Wang, Wenya; Wang, Shengzheng; Cao,
Yongbing; Yao, Jianzhong; Miao, Zhenyuan; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Biology & Drug Design (2011), 78(2), 309-313

$RFMT $RIREG SCHEME338 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-[4-(1,1-dimethylethyl)phenyl]acetamide
C12H16ClNO
20330-46-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 2.6673 0.0 0
M  V30 2 C 1.5400 4.2073 0.0 0
M  V30 3 C 0.0000 2.6673 0.0 0
M  V30 4 C 1.5400 1.1273 0.0 0
M  V30 5 N 7.7000 2.6673 0.0 0
M  V30 6 C 8.4700 1.3336 0.0 0
M  V30 7 C 10.0100 1.3336 0.0 0
M  V30 8 O 7.7000 0.0000 0.0 0
M  V30 9 Cl 10.7800 0.0000 0.0 0
M  V30 10 C 3.0800 2.6673 0.0 0
M  V30 11 C 3.8500 4.0011 0.0 0
M  V30 12 C 3.8500 1.3336 0.0 0
M  V30 13 C 5.3900 4.0011 0.0 0
M  V30 14 C 5.3900 1.3336 0.0 0
M  V30 15 C 6.1600 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 10
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-(1,1-Dimethylethyl)phenyl]-2-(methylamino)acetamide
C13H20N2O
1016843-97-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 C 1.5400 3.0800 0.0 0
M  V30 3 C 0.0000 1.5400 0.0 0
M  V30 4 C 1.5400 0.0000 0.0 0
M  V30 5 N 7.7000 1.5400 0.0 0
M  V30 6 C 8.4700 2.8736 0.0 0
M  V30 7 C 10.0100 2.8736 0.0 0
M  V30 8 O 7.7000 4.2073 0.0 0
M  V30 9 N 10.7800 4.2073 0.0 0
M  V30 10 C 12.3200 4.2073 0.0 0
M  V30 11 C 3.0800 1.5400 0.0 0
M  V30 12 C 3.8500 2.8736 0.0 0
M  V30 13 C 3.8500 0.2062 0.0 0
M  V30 14 C 5.3900 2.8736 0.0 0
M  V30 15 C 5.3900 0.2062 0.0 0
M  V30 16 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 11
M  V30 5 1 5 6
M  V30 6 1 5 16
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 20330-46-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1016843-97-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-12804855
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-based design, synthesis, and antifungal activity of new
triazole derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sheng, Chunquan; Che, Xiaoying; Wang, Wenya; Wang, Shengzheng; Cao,
Yongbing; Yao, Jianzhong; Miao, Zhenyuan; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Biology & Drug Design (2011), 78(2), 309-313

$RFMT $RIREG SCHEME339 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenaminium, 4-mercapto-N,N,N-trimethyl-, dibromoargentate(1-) (1:1)
C9H14NS.AgBr2
2034157-70-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 3.0800 0.0 0 CHG=1 VAL=4
M  V30 2 C 0.0000 3.0800 0.0 0
M  V30 3 C 1.5400 1.5400 0.0 0
M  V30 4 C 1.5400 4.6200 0.0 0
M  V30 5 S 7.7000 3.0800 0.0 0
M  V30 6 C 3.0800 3.0800 0.0 0
M  V30 7 C 3.8500 1.7464 0.0 0
M  V30 8 C 3.8500 4.4136 0.0 0
M  V30 9 C 5.3900 1.7464 0.0 0
M  V30 10 C 5.3900 4.4136 0.0 0
M  V30 11 C 6.1600 3.0800 0.0 0
M  V30 12 Ag 3.8500 0.0000 0.0 0 CHG=1 VAL=2
M  V30 13 Br 2.3100 0.0000 0.0 0 CHG=-1 VAL=1
M  V30 14 Br 5.3900 0.0000 0.0 0 CHG=-1 VAL=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 6
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenaminium, 4-mercapto-N,N,N-trimethyl-, dibromoargentate(1-), compd. with...
C9H14NS.CH5N.AgBr2
2034157-72-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 6.1600 0.0 0
M  V30 2 N 4.6200 6.1600 0.0 0
M  V30 3 N 1.5400 3.0800 0.0 0 CHG=1 VAL=4
M  V30 4 C 0.0000 3.0800 0.0 0
M  V30 5 C 1.5400 1.5400 0.0 0
M  V30 6 C 1.5400 4.6200 0.0 0
M  V30 7 S 7.7000 3.0800 0.0 0
M  V30 8 C 3.0800 3.0800 0.0 0
M  V30 9 C 3.8500 1.7464 0.0 0
M  V30 10 C 3.8500 4.4136 0.0 0
M  V30 11 C 5.3900 1.7464 0.0 0
M  V30 12 C 5.3900 4.4136 0.0 0
M  V30 13 C 6.1600 3.0800 0.0 0
M  V30 14 Ag 3.8500 0.0000 0.0 0 CHG=1 VAL=2
M  V30 15 Br 2.3100 0.0000 0.0 0 CHG=-1 VAL=1
M  V30 16 Br 5.3900 0.0000 0.0 0 CHG=-1 VAL=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 3 4
M  V30 3 1 3 5
M  V30 4 1 3 6
M  V30 5 1 3 8
M  V30 6 1 7 13
M  V30 7 2 8 9
M  V30 8 1 8 10
M  V30 9 1 9 11
M  V30 10 2 10 12
M  V30 11 2 11 13
M  V30 12 1 12 13
M  V30 13 1 14 15
M  V30 14 1 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2034157-70-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2034157-72-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30703403
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM One Unique 1D Silver(I)-Bromide-Thiol Coordination Polymer Used for
Highly Efficient Chemiresistive Sensing of Ammonia and Amines in Water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Fan; Wang, Yu-Ting; Yu, Hong; Chen, Jin-Xiang; Gao, Bin-Bin; Lang,
Jian-Ping
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Inorganic Chemistry (2016), 55(18), 9417-9423

$RFMT $RIREG SCHEME340 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[3-[(Methylsulfonyl)oxy]propyl]piperidine-1-carboxylic acid tert-butyl ester
C14H27NO5S
203859-94-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 4.2073 0.0 0
M  V30 2 O 3.0800 5.5409 0.0 0
M  V30 3 O 3.0800 2.8736 0.0 0
M  V30 4 C 1.5400 5.5409 0.0 0
M  V30 5 C 1.5400 7.0809 0.0 0
M  V30 6 C 0.0000 5.5409 0.0 0
M  V30 7 C 1.5400 4.0009 0.0 0
M  V30 8 C 10.0100 4.2073 0.0 0
M  V30 9 C 10.7800 2.8736 0.0 0
M  V30 10 C 12.3200 2.8736 0.0 0
M  V30 11 O 13.0900 1.5400 0.0 0
M  V30 12 S 14.6300 1.5400 0.0 0 VAL=6
M  V30 13 C 14.6300 3.0800 0.0 0
M  V30 14 O 16.1700 1.5400 0.0 0
M  V30 15 O 14.6300 0.0000 0.0 0
M  V30 16 N 5.3900 4.2073 0.0 0
M  V30 17 C 6.1600 5.5409 0.0 0
M  V30 18 C 6.1600 2.8736 0.0 0
M  V30 19 C 7.7000 5.5409 0.0 0
M  V30 20 C 7.7000 2.8736 0.0 0
M  V30 21 C 8.4700 4.2073 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 21
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 2 12 15
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[3-(methylamino)propyl]-1-piperidinecarboxylate
C14H28N2O2
171049-43-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 1.5400 0.0 0
M  V30 2 O 2.6673 2.3101 0.0 0
M  V30 3 O 4.0010 0.0000 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 0.5637 2.8737 0.0 0
M  V30 6 C 0.0000 0.7700 0.0 0
M  V30 7 C 2.1037 0.2064 0.0 0
M  V30 8 C 9.3358 4.6201 0.0 0
M  V30 9 C 10.6697 3.8501 0.0 0
M  V30 10 C 12.0033 4.6201 0.0 0
M  V30 11 N 13.3370 3.8501 0.0 0
M  V30 12 C 14.6707 4.6201 0.0 0
M  V30 13 N 5.3348 2.3101 0.0 0
M  V30 14 C 5.3348 3.8501 0.0 0
M  V30 15 C 6.6685 1.5400 0.0 0
M  V30 16 C 6.6685 4.6201 0.0 0
M  V30 17 C 8.0022 2.3101 0.0 0
M  V30 18 C 8.0022 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 18
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 203859-94-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 171049-43-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-22611346
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bifunctional compounds as IRAK degraders and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mainolfi, Nello; Ji, Nan; Kluge, Arthur F.; Weiss, Matthew M.; Zhang, Yi;
Zheng, Xiaozhang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020113233 A1 2020-06-04

$RFMT $RIREG SCHEME341 STEP1
$RXN



  2  1
$MOL
3-Benzoylpropionic acid
C10H10O3
2051-95-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 O 4.0011 0.0000 0.0 0
M  V30 4 C 6.6684 1.5400 0.0 0
M  V30 5 C 8.0021 2.3100 0.0 0
M  V30 6 O 9.3358 1.5400 0.0 0
M  V30 7 O 8.0021 3.8500 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 2.6674 3.8500 0.0 0
M  V30 10 C 1.3336 1.5400 0.0 0
M  V30 11 C 1.3336 4.6200 0.0 0
M  V30 12 C 0.0000 2.3100 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-γ-oxobenzenebutanamide
C11H13NO2
103859-83-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 4.0012 0.0000 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 8.0023 2.3101 0.0 0
M  V30 6 N 9.3360 1.5400 0.0 0
M  V30 7 O 8.0023 3.8501 0.0 0
M  V30 8 C 10.6697 2.3101 0.0 0
M  V30 9 C 2.6673 2.3101 0.0 0
M  V30 10 C 2.6673 3.8501 0.0 0
M  V30 11 C 1.3337 1.5400 0.0 0
M  V30 12 C 1.3337 4.6201 0.0 0
M  V30 13 C 0.0000 2.3101 0.0 0
M  V30 14 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2051-95-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 103859-83-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13901775
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 541-41-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4-(Methylamino)-1-phenylbutan-1-ol (21). Step 1. 33 A solution of
3-benzoylpropionic acid (3.5 g, 20 mmol) and Et3N (9.6 ml, 69 mmol) in
THF (100 mL) was cooled to -40 °C, treated dropwise with ethyl
chloroformate (2.1 ml, 22 mmol), stirred at -20 °C for 30 minutes,
treated with 40 wt. % methylamine in water (8.5 ml, 98 mmol), stirred at
room temperature over night, concentrated to remove the majority of the
THF and partitioned between 1 M HCl (100 mL) and Et2O (400 mL). The Et2O
layer was washed with brine. On standing before drying with MgSO4, a
solid precipitated. This solid was collected by filtration and washed
with a small amount of Et2O to provide some of the desired product. The
filtrate was dried (MgSO4), filtered and concentrated to provide
additional desired product (total of 3.7 g , 99%). 1H NMR (CDCl3) δ 1.41
(s, 9H), 1.79 (m, 4H), 2.23 (q, J=7.9 Hz, 2H), 2.60 (m, 4H), 2.80 (s,
3H), 2.87 (t, J=6.1 Hz, 2H), 3.14 (dd, J=8.7, 6.7 Hz, 2H), 3.83 (t, J=7.7
Hz, 1H), 4.06 (t, J=6.1 Hz, 2H), 6.83 (d, J=8.7 Hz, 2H), 7.13 (d, J=8.7
Hz, 2H), 7.16-7.32 (m, 5H); MS (DCI/NH3) m/z 192 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Diaryldiamines with Dual Inhibition of the Histamine H3 Receptor and the
Norepinephrine Transporter and the Efficacy of
4-(3-(Methylamino)-1-phenylpropyl)-6-(2-(pyrrolidin-1-yl)ethoxy)naphthalen-1-ol
in Pain
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Altenbach, Robert J.; Black, Lawrence A.; Strakhova, Marina I.; Manelli,
Arlene M.; Carr, Tracy L.; Marsh, Kennan C.; Wetter, Jill M.; Wensink,
Erica J.; Hsieh, Gin C.; Honore, Prisca; Garrison, Tiffany Runyan;
Brioni, Jorge D.; Cowart, Marlon D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2010), 53(21), 7869-7873

$RFMT $RIREG SCHEME342 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-phenoxyacetate
C9H10O3
2065-23-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 1.5400 0.0 0
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 C 6.6684 1.5400 0.0 0
M  V30 4 O 8.0022 2.3100 0.0 0
M  V30 5 O 6.6684 0.0000 0.0 0
M  V30 6 C 9.3359 1.5400 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 C 2.6675 3.8500 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 1.3337 4.6201 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-phenoxyacetamide
C9H11NO2
15422-25-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 1.5400 0.0 0
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 C 6.6684 1.5400 0.0 0
M  V30 4 N 8.0022 2.3100 0.0 0
M  V30 5 O 6.6684 0.0000 0.0 0
M  V30 6 C 9.3359 1.5400 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 C 2.6675 3.8500 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 1.3337 4.6201 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2065-23-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 15422-25-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35498417
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Placing CF2 in the Center: Major Physicochemical Changes Upon a Minor
Structural Alteration in Gem-Difunctional Compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Saphier, Sigal; Katalan, Shahaf; Yacov, Guy; Berliner, Anat; Redy-Keisar,
Orit; Fridkin, Gil; Ghindes-Azaria, Lee; Columbus, Ishay; Pevzner,
Alexander; Drug, Eyal; Prihed, Hagit; Gershonov, Eytan; Eichen, Yoav;
Elias, Shlomi; Parvari, Galit; Zafrani, Yossi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2023), 29(7), e202202939

$RFMT $RIREG SCHEME343 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-bromo-2-fluorobenzoate
C8H6BrFO2
206551-41-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 C 8.0021 3.0800 0.0 0
M  V30 5 F 2.6674 4.6200 0.0 0
M  V30 6 Br 0.0000 3.0800 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6674 3.0800 0.0 0
M  V30 9 C 4.0011 0.7700 0.0 0
M  V30 10 C 1.3336 2.3100 0.0 0
M  V30 11 C 2.6674 0.0000 0.0 0
M  V30 12 C 1.3336 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-bromo-2-(methylamino)benzoate
C9H10BrNO2
1945956-02-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 C 8.0021 3.0800 0.0 0
M  V30 5 N 2.6674 4.6200 0.0 0
M  V30 6 C 1.3336 5.3900 0.0 0
M  V30 7 Br 0.0000 3.0800 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 2.6674 3.0800 0.0 0
M  V30 10 C 4.0011 0.7700 0.0 0
M  V30 11 C 1.3336 2.3100 0.0 0
M  V30 12 C 2.6674 0.0000 0.0 0
M  V30 13 C 1.3336 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 9
M  V30 7 1 7 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 206551-41-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1945956-02-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-16340524
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 2,4-Dioxoquinazoline-6-sulfonamide derivatives as inhibitors of PARG and
their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM McGonagle, Alison E.; Jordan, Allan; Waszkowycz, Bohdan; Hutton, Colin;
Waddell, Ian; Hitchin, James R.; Smith, Kate Mary; Hamilton, Niall M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016092326 A1 2016-06-16

$RFMT $RIREG SCHEME344 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3,4-Dimethoxyphenyl)cyclopropanecarboxaldehyde
C12H14O3
20802-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.4471 5.5177 0.0 0
M  V30 2 O 0.0000 6.0445 0.0 0
M  V30 3 O 6.3346 1.3338 0.0 0
M  V30 4 C 5.5646 0.0000 0.0 0
M  V30 5 O 7.8746 4.0011 0.0 0
M  V30 6 C 8.6446 5.3349 0.0 0
M  V30 7 C 1.7146 4.0011 0.0 0
M  V30 8 C 0.2675 3.4744 0.0 0
M  V30 9 C 1.4471 2.4845 0.0 0
M  V30 10 C 3.2546 4.0011 0.0 0
M  V30 11 C 4.0246 2.6674 0.0 0
M  V30 12 C 4.0246 5.3347 0.0 0
M  V30 13 C 5.5646 2.6674 0.0 0
M  V30 14 C 5.5646 5.3347 0.0 0
M  V30 15 C 6.3346 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[1-(3,4-Dimethoxyphenyl)cyclopropyl]methylene]methanamine
C13H17NO2
20802-17-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.8372 6.1418 0.0 0
M  V30 2 N 8.0169 7.1317 0.0 0
M  V30 3 C 9.4640 6.6050 0.0 0
M  V30 4 O 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3348 0.0 0
M  V30 6 O 2.3100 1.3338 0.0 0
M  V30 7 C 3.0800 0.0000 0.0 0
M  V30 8 C 5.3901 6.6686 0.0 0
M  V30 9 C 5.6574 8.1852 0.0 0
M  V30 10 C 4.2103 7.6584 0.0 0
M  V30 11 C 4.6201 5.3348 0.0 0
M  V30 12 C 3.0800 5.3348 0.0 0
M  V30 13 C 5.3901 4.0011 0.0 0
M  V30 14 C 2.3100 4.0011 0.0 0
M  V30 15 C 4.6201 2.6675 0.0 0
M  V30 16 C 3.0800 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 20802-16-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 20802-17-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41089554
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7487-88-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of mesembrine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Protzko, Ryan Joseph
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024074831 A1 2024-04-11

$RFMT $RIREG SCHEME344 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3,4-Dimethoxyphenyl)cyclopropanecarboxaldehyde
C12H14O3
20802-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.4471 5.5177 0.0 0
M  V30 2 O 0.0000 6.0445 0.0 0
M  V30 3 O 6.3346 1.3338 0.0 0
M  V30 4 C 5.5646 0.0000 0.0 0
M  V30 5 O 7.8746 4.0011 0.0 0
M  V30 6 C 8.6446 5.3349 0.0 0
M  V30 7 C 1.7146 4.0011 0.0 0
M  V30 8 C 0.2675 3.4744 0.0 0
M  V30 9 C 1.4471 2.4845 0.0 0
M  V30 10 C 3.2546 4.0011 0.0 0
M  V30 11 C 4.0246 2.6674 0.0 0
M  V30 12 C 4.0246 5.3347 0.0 0
M  V30 13 C 5.5646 2.6674 0.0 0
M  V30 14 C 5.5646 5.3347 0.0 0
M  V30 15 C 6.3346 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[1-(3,4-Dimethoxyphenyl)cyclopropyl]methylene]methanamine
C13H17NO2
20802-17-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.8372 6.1418 0.0 0
M  V30 2 N 8.0169 7.1317 0.0 0
M  V30 3 C 9.4640 6.6050 0.0 0
M  V30 4 O 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3348 0.0 0
M  V30 6 O 2.3100 1.3338 0.0 0
M  V30 7 C 3.0800 0.0000 0.0 0
M  V30 8 C 5.3901 6.6686 0.0 0
M  V30 9 C 5.6574 8.1852 0.0 0
M  V30 10 C 4.2103 7.6584 0.0 0
M  V30 11 C 4.6201 5.3348 0.0 0
M  V30 12 C 3.0800 5.3348 0.0 0
M  V30 13 C 5.3901 4.0011 0.0 0
M  V30 14 C 2.3100 4.0011 0.0 0
M  V30 15 C 4.6201 2.6675 0.0 0
M  V30 16 C 3.0800 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 20802-16-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 20802-17-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41088260
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7487-88-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of mesembrine, enantioenriched mesembrine, and therapeutic
uses
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Protzko, Ryan Joseph
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United Kingdom, GB2623122 A 2024-04-10

$RFMT $RIREG SCHEME345 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3,4-Dimethoxyphenyl)cyclopropanecarboxaldehyde
C12H14O3
20802-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.4471 5.5177 0.0 0
M  V30 2 O 0.0000 6.0445 0.0 0
M  V30 3 O 6.3346 1.3338 0.0 0
M  V30 4 C 5.5646 0.0000 0.0 0
M  V30 5 O 7.8746 4.0011 0.0 0
M  V30 6 C 8.6446 5.3349 0.0 0
M  V30 7 C 1.7146 4.0011 0.0 0
M  V30 8 C 0.2675 3.4744 0.0 0
M  V30 9 C 1.4471 2.4845 0.0 0
M  V30 10 C 3.2546 4.0011 0.0 0
M  V30 11 C 4.0246 2.6674 0.0 0
M  V30 12 C 4.0246 5.3347 0.0 0
M  V30 13 C 5.5646 2.6674 0.0 0
M  V30 14 C 5.5646 5.3347 0.0 0
M  V30 15 C 6.3346 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanamine, N-[[1-(3,4-dimethoxyphenyl)cyclopropyl]methylene]-, [N(Z)]-
C13H17NO2
3020747-52-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.1975 5.5177 0.0 0
M  V30 2 N 8.6445 6.0445 0.0 0
M  V30 3 C 9.8243 5.0546 0.0 0
M  V30 4 O 2.3100 1.3338 0.0 0
M  V30 5 C 3.0800 0.0000 0.0 0
M  V30 6 O 0.7700 4.0011 0.0 0
M  V30 7 C 0.0000 5.3349 0.0 0
M  V30 8 C 6.9300 4.0011 0.0 0
M  V30 9 C 7.1975 2.4845 0.0 0
M  V30 10 C 8.3771 3.4744 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 2.6674 0.0 0
M  V30 13 C 4.6200 5.3347 0.0 0
M  V30 14 C 3.0800 2.6674 0.0 0
M  V30 15 C 3.0800 5.3349 0.0 0
M  V30 16 C 2.3100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 20802-16-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3020747-52-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42575846
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7757-82-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Solid forms of mesembranol and therapeutic uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Yunmin; Chang, Le
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024173800 A2 2024-08-22

$RFMT $RIREG SCHEME345 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3,4-Dimethoxyphenyl)cyclopropanecarboxaldehyde
C12H14O3
20802-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.4471 5.5177 0.0 0
M  V30 2 O 0.0000 6.0445 0.0 0
M  V30 3 O 6.3346 1.3338 0.0 0
M  V30 4 C 5.5646 0.0000 0.0 0
M  V30 5 O 7.8746 4.0011 0.0 0
M  V30 6 C 8.6446 5.3349 0.0 0
M  V30 7 C 1.7146 4.0011 0.0 0
M  V30 8 C 0.2675 3.4744 0.0 0
M  V30 9 C 1.4471 2.4845 0.0 0
M  V30 10 C 3.2546 4.0011 0.0 0
M  V30 11 C 4.0246 2.6674 0.0 0
M  V30 12 C 4.0246 5.3347 0.0 0
M  V30 13 C 5.5646 2.6674 0.0 0
M  V30 14 C 5.5646 5.3347 0.0 0
M  V30 15 C 6.3346 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanamine, N-[[1-(3,4-dimethoxyphenyl)cyclopropyl]methylene]-, [N(Z)]-
C13H17NO2
3020747-52-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.1975 5.5177 0.0 0
M  V30 2 N 8.6445 6.0445 0.0 0
M  V30 3 C 9.8243 5.0546 0.0 0
M  V30 4 O 2.3100 1.3338 0.0 0
M  V30 5 C 3.0800 0.0000 0.0 0
M  V30 6 O 0.7700 4.0011 0.0 0
M  V30 7 C 0.0000 5.3349 0.0 0
M  V30 8 C 6.9300 4.0011 0.0 0
M  V30 9 C 7.1975 2.4845 0.0 0
M  V30 10 C 8.3771 3.4744 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 2.6674 0.0 0
M  V30 13 C 4.6200 5.3347 0.0 0
M  V30 14 C 3.0800 2.6674 0.0 0
M  V30 15 C 3.0800 5.3349 0.0 0
M  V30 16 C 2.3100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 20802-16-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3020747-52-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40768791
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7757-82-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Delivery of therapeutic alkaloid compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Placzek, Michael S.; Pettit, Simon N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024137898 A1 2024-06-27

$RFMT $RIREG SCHEME345 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3,4-Dimethoxyphenyl)cyclopropanecarboxaldehyde
C12H14O3
20802-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.4471 5.5177 0.0 0
M  V30 2 O 0.0000 6.0445 0.0 0
M  V30 3 O 6.3346 1.3338 0.0 0
M  V30 4 C 5.5646 0.0000 0.0 0
M  V30 5 O 7.8746 4.0011 0.0 0
M  V30 6 C 8.6446 5.3349 0.0 0
M  V30 7 C 1.7146 4.0011 0.0 0
M  V30 8 C 0.2675 3.4744 0.0 0
M  V30 9 C 1.4471 2.4845 0.0 0
M  V30 10 C 3.2546 4.0011 0.0 0
M  V30 11 C 4.0246 2.6674 0.0 0
M  V30 12 C 4.0246 5.3347 0.0 0
M  V30 13 C 5.5646 2.6674 0.0 0
M  V30 14 C 5.5646 5.3347 0.0 0
M  V30 15 C 6.3346 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanamine, N-[[1-(3,4-dimethoxyphenyl)cyclopropyl]methylene]-, [N(Z)]-
C13H17NO2
3020747-52-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.1975 5.5177 0.0 0
M  V30 2 N 8.6445 6.0445 0.0 0
M  V30 3 C 9.8243 5.0546 0.0 0
M  V30 4 O 2.3100 1.3338 0.0 0
M  V30 5 C 3.0800 0.0000 0.0 0
M  V30 6 O 0.7700 4.0011 0.0 0
M  V30 7 C 0.0000 5.3349 0.0 0
M  V30 8 C 6.9300 4.0011 0.0 0
M  V30 9 C 7.1975 2.4845 0.0 0
M  V30 10 C 8.3771 3.4744 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 2.6674 0.0 0
M  V30 13 C 4.6200 5.3347 0.0 0
M  V30 14 C 3.0800 2.6674 0.0 0
M  V30 15 C 3.0800 5.3349 0.0 0
M  V30 16 C 2.3100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 20802-16-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3020747-52-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40751248
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7775-14-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of mesembrine or mesembrenone derivatives for selective
inhibition of PDE4
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hooker, Jacob M.; Placzek, Michael S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024102991 A1 2024-05-16

$RFMT $RIREG SCHEME345 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3,4-Dimethoxyphenyl)cyclopropanecarboxaldehyde
C12H14O3
20802-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.4471 5.5177 0.0 0
M  V30 2 O 0.0000 6.0445 0.0 0
M  V30 3 O 6.3346 1.3338 0.0 0
M  V30 4 C 5.5646 0.0000 0.0 0
M  V30 5 O 7.8746 4.0011 0.0 0
M  V30 6 C 8.6446 5.3349 0.0 0
M  V30 7 C 1.7146 4.0011 0.0 0
M  V30 8 C 0.2675 3.4744 0.0 0
M  V30 9 C 1.4471 2.4845 0.0 0
M  V30 10 C 3.2546 4.0011 0.0 0
M  V30 11 C 4.0246 2.6674 0.0 0
M  V30 12 C 4.0246 5.3347 0.0 0
M  V30 13 C 5.5646 2.6674 0.0 0
M  V30 14 C 5.5646 5.3347 0.0 0
M  V30 15 C 6.3346 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanamine, N-[[1-(3,4-dimethoxyphenyl)cyclopropyl]methylene]-, [N(Z)]-
C13H17NO2
3020747-52-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.1975 5.5177 0.0 0
M  V30 2 N 8.6445 6.0445 0.0 0
M  V30 3 C 9.8243 5.0546 0.0 0
M  V30 4 O 2.3100 1.3338 0.0 0
M  V30 5 C 3.0800 0.0000 0.0 0
M  V30 6 O 0.7700 4.0011 0.0 0
M  V30 7 C 0.0000 5.3349 0.0 0
M  V30 8 C 6.9300 4.0011 0.0 0
M  V30 9 C 7.1975 2.4845 0.0 0
M  V30 10 C 8.3771 3.4744 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 2.6674 0.0 0
M  V30 13 C 4.6200 5.3347 0.0 0
M  V30 14 C 3.0800 2.6674 0.0 0
M  V30 15 C 3.0800 5.3349 0.0 0
M  V30 16 C 2.3100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 20802-16-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3020747-52-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40668627
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7757-82-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of alkyl-substituted derivatives of mesembrine and mesembrenone
for treating mental health disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hooker, Jacob M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024102461 A1 2024-05-16

$RFMT $RIREG SCHEME345 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3,4-Dimethoxyphenyl)cyclopropanecarboxaldehyde
C12H14O3
20802-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.4471 5.5177 0.0 0
M  V30 2 O 0.0000 6.0445 0.0 0
M  V30 3 O 6.3346 1.3338 0.0 0
M  V30 4 C 5.5646 0.0000 0.0 0
M  V30 5 O 7.8746 4.0011 0.0 0
M  V30 6 C 8.6446 5.3349 0.0 0
M  V30 7 C 1.7146 4.0011 0.0 0
M  V30 8 C 0.2675 3.4744 0.0 0
M  V30 9 C 1.4471 2.4845 0.0 0
M  V30 10 C 3.2546 4.0011 0.0 0
M  V30 11 C 4.0246 2.6674 0.0 0
M  V30 12 C 4.0246 5.3347 0.0 0
M  V30 13 C 5.5646 2.6674 0.0 0
M  V30 14 C 5.5646 5.3347 0.0 0
M  V30 15 C 6.3346 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanamine, N-[[1-(3,4-dimethoxyphenyl)cyclopropyl]methylene]-, [N(Z)]-
C13H17NO2
3020747-52-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.1975 5.5177 0.0 0
M  V30 2 N 8.6445 6.0445 0.0 0
M  V30 3 C 9.8243 5.0546 0.0 0
M  V30 4 O 2.3100 1.3338 0.0 0
M  V30 5 C 3.0800 0.0000 0.0 0
M  V30 6 O 0.7700 4.0011 0.0 0
M  V30 7 C 0.0000 5.3349 0.0 0
M  V30 8 C 6.9300 4.0011 0.0 0
M  V30 9 C 7.1975 2.4845 0.0 0
M  V30 10 C 8.3771 3.4744 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 2.6674 0.0 0
M  V30 13 C 4.6200 5.3347 0.0 0
M  V30 14 C 3.0800 2.6674 0.0 0
M  V30 15 C 3.0800 5.3349 0.0 0
M  V30 16 C 2.3100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 20802-16-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3020747-52-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40076686
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7757-82-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Mesembrine derivatives as 5-HTT inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hooker, Jacob M.; Placzek, Michael S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024026059 A2 2024-02-01

$RFMT $RIREG SCHEME345 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3,4-Dimethoxyphenyl)cyclopropanecarboxaldehyde
C12H14O3
20802-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.4471 5.5177 0.0 0
M  V30 2 O 0.0000 6.0445 0.0 0
M  V30 3 O 6.3346 1.3338 0.0 0
M  V30 4 C 5.5646 0.0000 0.0 0
M  V30 5 O 7.8746 4.0011 0.0 0
M  V30 6 C 8.6446 5.3349 0.0 0
M  V30 7 C 1.7146 4.0011 0.0 0
M  V30 8 C 0.2675 3.4744 0.0 0
M  V30 9 C 1.4471 2.4845 0.0 0
M  V30 10 C 3.2546 4.0011 0.0 0
M  V30 11 C 4.0246 2.6674 0.0 0
M  V30 12 C 4.0246 5.3347 0.0 0
M  V30 13 C 5.5646 2.6674 0.0 0
M  V30 14 C 5.5646 5.3347 0.0 0
M  V30 15 C 6.3346 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanamine, N-[[1-(3,4-dimethoxyphenyl)cyclopropyl]methylene]-, [N(Z)]-
C13H17NO2
3020747-52-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.1975 5.5177 0.0 0
M  V30 2 N 8.6445 6.0445 0.0 0
M  V30 3 C 9.8243 5.0546 0.0 0
M  V30 4 O 2.3100 1.3338 0.0 0
M  V30 5 C 3.0800 0.0000 0.0 0
M  V30 6 O 0.7700 4.0011 0.0 0
M  V30 7 C 0.0000 5.3349 0.0 0
M  V30 8 C 6.9300 4.0011 0.0 0
M  V30 9 C 7.1975 2.4845 0.0 0
M  V30 10 C 8.3771 3.4744 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 2.6674 0.0 0
M  V30 13 C 4.6200 5.3347 0.0 0
M  V30 14 C 3.0800 2.6674 0.0 0
M  V30 15 C 3.0800 5.3349 0.0 0
M  V30 16 C 2.3100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 20802-16-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3020747-52-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39768455
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7757-82-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of solid forms of mesembrine and therapeutic uses
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lu, Zhongyi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024015559 A2 2024-01-18

$RFMT $RIREG SCHEME345 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3,4-Dimethoxyphenyl)cyclopropanecarboxaldehyde
C12H14O3
20802-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.4471 5.5177 0.0 0
M  V30 2 O 0.0000 6.0445 0.0 0
M  V30 3 O 6.3346 1.3338 0.0 0
M  V30 4 C 5.5646 0.0000 0.0 0
M  V30 5 O 7.8746 4.0011 0.0 0
M  V30 6 C 8.6446 5.3349 0.0 0
M  V30 7 C 1.7146 4.0011 0.0 0
M  V30 8 C 0.2675 3.4744 0.0 0
M  V30 9 C 1.4471 2.4845 0.0 0
M  V30 10 C 3.2546 4.0011 0.0 0
M  V30 11 C 4.0246 2.6674 0.0 0
M  V30 12 C 4.0246 5.3347 0.0 0
M  V30 13 C 5.5646 2.6674 0.0 0
M  V30 14 C 5.5646 5.3347 0.0 0
M  V30 15 C 6.3346 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanamine, N-[[1-(3,4-dimethoxyphenyl)cyclopropyl]methylene]-, [N(Z)]-
C13H17NO2
3020747-52-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.1975 5.5177 0.0 0
M  V30 2 N 8.6445 6.0445 0.0 0
M  V30 3 C 9.8243 5.0546 0.0 0
M  V30 4 O 2.3100 1.3338 0.0 0
M  V30 5 C 3.0800 0.0000 0.0 0
M  V30 6 O 0.7700 4.0011 0.0 0
M  V30 7 C 0.0000 5.3349 0.0 0
M  V30 8 C 6.9300 4.0011 0.0 0
M  V30 9 C 7.1975 2.4845 0.0 0
M  V30 10 C 8.3771 3.4744 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 2.6674 0.0 0
M  V30 13 C 4.6200 5.3347 0.0 0
M  V30 14 C 3.0800 2.6674 0.0 0
M  V30 15 C 3.0800 5.3349 0.0 0
M  V30 16 C 2.3100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 20802-16-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3020747-52-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39355407
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7757-82-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Solid forms of mesembrine and therapeutic uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lu, Zhongyi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023225773 A1 2023-11-30

$RFMT $RIREG SCHEME345 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3,4-Dimethoxyphenyl)cyclopropanecarboxaldehyde
C12H14O3
20802-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.4471 5.5177 0.0 0
M  V30 2 O 0.0000 6.0445 0.0 0
M  V30 3 O 6.3346 1.3338 0.0 0
M  V30 4 C 5.5646 0.0000 0.0 0
M  V30 5 O 7.8746 4.0011 0.0 0
M  V30 6 C 8.6446 5.3349 0.0 0
M  V30 7 C 1.7146 4.0011 0.0 0
M  V30 8 C 0.2675 3.4744 0.0 0
M  V30 9 C 1.4471 2.4845 0.0 0
M  V30 10 C 3.2546 4.0011 0.0 0
M  V30 11 C 4.0246 2.6674 0.0 0
M  V30 12 C 4.0246 5.3347 0.0 0
M  V30 13 C 5.5646 2.6674 0.0 0
M  V30 14 C 5.5646 5.3347 0.0 0
M  V30 15 C 6.3346 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanamine, N-[[1-(3,4-dimethoxyphenyl)cyclopropyl]methylene]-, [N(Z)]-
C13H17NO2
3020747-52-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.1975 5.5177 0.0 0
M  V30 2 N 8.6445 6.0445 0.0 0
M  V30 3 C 9.8243 5.0546 0.0 0
M  V30 4 O 2.3100 1.3338 0.0 0
M  V30 5 C 3.0800 0.0000 0.0 0
M  V30 6 O 0.7700 4.0011 0.0 0
M  V30 7 C 0.0000 5.3349 0.0 0
M  V30 8 C 6.9300 4.0011 0.0 0
M  V30 9 C 7.1975 2.4845 0.0 0
M  V30 10 C 8.3771 3.4744 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 2.6674 0.0 0
M  V30 13 C 4.6200 5.3347 0.0 0
M  V30 14 C 3.0800 2.6674 0.0 0
M  V30 15 C 3.0800 5.3349 0.0 0
M  V30 16 C 2.3100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 20802-16-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3020747-52-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39529182
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7757-82-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Solid forms of mesembrine and therapeutic uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lu, Zhongyi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023230049 A1 2023-11-30

$RFMT $RIREG SCHEME346 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[4-(Bromomethyl)phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole
C10H6BrF3N2O
2093101-98-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5316 3.4372 0.0 0
M  V30 2 F 1.6925 1.9056 0.0 0
M  V30 3 F 0.0000 3.2763 0.0 0
M  V30 4 F 1.3706 4.9688 0.0 0
M  V30 5 C 10.8354 0.0000 0.0 0
M  V30 6 Br 12.1690 0.7700 0.0 0
M  V30 7 C 5.5005 3.0801 0.0 0
M  V30 8 N 4.0937 2.4537 0.0 0
M  V30 9 N 5.3396 4.6116 0.0 0
M  V30 10 C 3.0631 3.5981 0.0 0
M  V30 11 O 3.8331 4.9318 0.0 0
M  V30 12 C 6.8342 2.3101 0.0 0
M  V30 13 C 8.1679 3.0801 0.0 0
M  V30 14 C 6.8342 0.7700 0.0 0
M  V30 15 C 9.5017 2.3101 0.0 0
M  V30 16 C 8.1679 0.0000 0.0 0
M  V30 17 C 9.5017 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 10
M  V30 5 1 5 6
M  V30 6 1 5 17
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 12
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzenemethanamine
C11H10F3N3O
2093187-66-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5316 1.5316 0.0 0
M  V30 2 F 1.6925 3.0631 0.0 0
M  V30 3 F 0.0000 1.6925 0.0 0
M  V30 4 F 1.3706 0.0000 0.0 0
M  V30 5 C 10.8354 4.9688 0.0 0
M  V30 6 N 12.1690 4.1987 0.0 0
M  V30 7 C 13.5027 4.9688 0.0 0
M  V30 8 C 5.5005 1.8887 0.0 0
M  V30 9 N 4.0936 2.5150 0.0 0
M  V30 10 N 5.3396 0.3571 0.0 0
M  V30 11 C 3.0631 1.3706 0.0 0
M  V30 12 O 3.8331 0.0370 0.0 0
M  V30 13 C 6.8342 2.6587 0.0 0
M  V30 14 C 8.1679 1.8887 0.0 0
M  V30 15 C 6.8342 4.1987 0.0 0
M  V30 16 C 9.5017 2.6587 0.0 0
M  V30 17 C 8.1679 4.9688 0.0 0
M  V30 18 C 9.5017 4.1987 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 11
M  V30 5 1 5 6
M  V30 6 1 5 18
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 13
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2093101-98-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2093187-66-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31663128
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel heterocyclic compounds for combating phytopathogenic fungi
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bhujade, Paras Raybhan; Naik, Maruti N.; Autkar, Santosh Shridhar; Garg,
Ruchi; Klausener, Alexander G. M.; Aswale, Parsaram Dadasaheb;
Ramakrishna, Visannagari; Dengale, Rohit Arvind
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022038500 A1 2022-02-24

$RFMT $RIREG SCHEME347 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[4-(2-Bromoethoxy)phenyl]-1,2,3,4-tetrahydro-6-methoxy-2-phenylnaphthalene
C25H25BrO2
2095106-21-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.5400 10.6697 0.0 0
M  V30 2 C 0.0000 10.6697 0.0 0
M  V30 3 O 10.7802 5.3348 0.0 0
M  V30 4 C 11.5503 6.6685 0.0 0
M  V30 5 C 13.0903 6.6685 0.0 0
M  V30 6 Br 13.8603 8.0023 0.0 0
M  V30 7 C 4.6201 5.3348 0.0 0
M  V30 8 C 3.8501 6.6685 0.0 0
M  V30 9 C 3.8501 4.0012 0.0 0
M  V30 10 C 2.3101 6.6685 0.0 0
M  V30 11 C 4.6201 8.0023 0.0 0
M  V30 12 C 2.3101 4.0012 0.0 0
M  V30 13 C 1.5400 8.0023 0.0 0
M  V30 14 C 1.5400 5.3348 0.0 0
M  V30 15 C 3.8501 9.3360 0.0 0
M  V30 16 C 2.3101 9.3360 0.0 0
M  V30 17 C 6.1601 5.3348 0.0 0
M  V30 18 C 6.9302 6.6685 0.0 0
M  V30 19 C 6.9302 4.0012 0.0 0
M  V30 20 C 8.4702 6.6685 0.0 0
M  V30 21 C 8.4702 4.0012 0.0 0
M  V30 22 C 9.2402 5.3348 0.0 0
M  V30 23 C 4.6201 2.6673 0.0 0
M  V30 24 C 3.8501 1.3337 0.0 0
M  V30 25 C 6.1601 2.6673 0.0 0
M  V30 26 C 4.6201 0.0000 0.0 0
M  V30 27 C 6.9302 1.3337 0.0 0
M  V30 28 C 6.1601 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 3 4
M  V30 4 1 3 22
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 17
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 9 23
M  V30 14 2 10 13
M  V30 15 1 10 14
M  V30 16 1 11 15
M  V30 17 1 12 14
M  V30 18 1 13 16
M  V30 19 2 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-[4-(1,2,3,4-tetrahydro-6-methoxy-2-phenyl-1-naphthalenyl)phenoxy]e...
C26H29NO2
2095104-01-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.5400 10.6695 0.0 0
M  V30 2 C 0.0000 10.6695 0.0 0
M  V30 3 O 10.7801 5.3348 0.0 0
M  V30 4 C 11.5501 6.6684 0.0 0
M  V30 5 C 13.0901 6.6684 0.0 0
M  V30 6 N 13.8602 8.0022 0.0 0
M  V30 7 C 15.4002 8.0022 0.0 0
M  V30 8 C 4.6201 5.3348 0.0 0
M  V30 9 C 3.8500 6.6684 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 6.6684 0.0 0
M  V30 12 C 4.6201 8.0022 0.0 0
M  V30 13 C 2.3100 4.0011 0.0 0
M  V30 14 C 1.5400 8.0022 0.0 0
M  V30 15 C 1.5400 5.3348 0.0 0
M  V30 16 C 3.8500 9.3359 0.0 0
M  V30 17 C 2.3100 9.3359 0.0 0
M  V30 18 C 6.1601 5.3348 0.0 0
M  V30 19 C 6.9301 4.0011 0.0 0
M  V30 20 C 6.9301 6.6684 0.0 0
M  V30 21 C 8.4701 4.0011 0.0 0
M  V30 22 C 8.4701 6.6684 0.0 0
M  V30 23 C 9.2401 5.3348 0.0 0
M  V30 24 C 4.6201 2.6673 0.0 0
M  V30 25 C 6.1601 2.6673 0.0 0
M  V30 26 C 3.8500 1.3337 0.0 0
M  V30 27 C 6.9301 1.3337 0.0 0
M  V30 28 C 4.6201 0.0000 0.0 0
M  V30 29 C 6.1601 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 3 4
M  V30 4 1 3 23
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 18
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 1 10 24
M  V30 15 2 11 14
M  V30 16 1 11 15
M  V30 17 1 12 16
M  V30 18 1 13 15
M  V30 19 1 14 17
M  V30 20 2 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2095106-21-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2095104-01-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-17210410
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM In Vivo Knockdown of Pathogenic Proteins via Specific and Nongenetic
Inhibitor of Apoptosis Protein (IAP)-dependent Protein Erasers (SNIPERs)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ohoka, Nobumichi; Okuhira, Keiichiro; Ito, Masahiro; Nagai, Katsunori;
Shibata, Norihito; Hattori, Takayuki; Ujikawa, Osamu; Shimokawa,
Kenichiro; Sano, Osamu; Koyama, Ryokichi; Fujita, Hisashi; Teratani,
Mika; Matsumoto, Hirokazu; Imaeda, Yasuhiro; Nara, Hiroshi; Cho, Nobuo;
Naito, Mikihiko
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Biological Chemistry (2017), 292(11), 4556-4570

$RFMT $RIREG SCHEME348 STEP1
$RXN



  2  1
$MOL
rel-(5aR,6S,7R,8R,8aS)-5a-(4-Bromophenyl)-3-chloro-5a,7,8,8a-tetrahydro-8,8a-...
C24H19BrClNO6
2098196-09-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.4389 3.8782 0.0 0
M  V30 2 O 8.0156 1.9426 0.0 0
M  V30 3 C 4.7383 1.2459 0.0 0
M  V30 4 O 5.6435 0.0000 0.0 0
M  V30 5 O 3.2068 1.0849 0.0 0
M  V30 6 O 10.3726 4.3153 0.0 0
M  V30 7 C 11.9126 4.3153 0.0 0
M  V30 8 Br 1.5839 9.7800 0.0 0
M  V30 9 Cl 10.3726 9.6500 0.0 0
M  V30 10 C 5.6252 5.1308 0.0 0 CFG=1
M  V30 11 C 7.0321 4.5045 0.0 0 CFG=2
M  V30 12 C 4.5948 3.9865 0.0 0 CFG=2
M  V30 13 O 5.7861 6.6625 0.0 0
M  V30 14 C 8.0626 5.6491 0.0 0
M  V30 15 C 6.8711 2.9730 0.0 0 CFG=2
M  V30 16 C 5.3648 2.6528 0.0 0 CFG=1
M  V30 17 C 7.2926 6.9827 0.0 0
M  V30 18 C 9.6026 5.6491 0.0 0
M  V30 19 C 8.0626 8.3164 0.0 0
M  V30 20 N 10.3726 6.9827 0.0 0
M  V30 21 C 9.6026 8.3164 0.0 0
M  V30 22 C 4.6149 6.2932 0.0 0
M  V30 23 C 3.1031 5.9993 0.0 0
M  V30 24 C 5.1162 7.7493 0.0 0
M  V30 25 C 2.0929 7.1617 0.0 0
M  V30 26 C 4.1060 8.9116 0.0 0
M  V30 27 C 2.5941 8.6177 0.0 0
M  V30 28 C 3.0632 4.1474 0.0 0
M  V30 29 C 2.1580 2.9015 0.0 0
M  V30 30 C 2.4368 5.5543 0.0 0
M  V30 31 C 0.6265 3.0625 0.0 0
M  V30 32 C 0.9052 5.7153 0.0 0
M  V30 33 C 0.0000 4.4694 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 11 1 CFG=1
M  V30 2 1 15 2 CFG=3
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 16 3 CFG=3
M  V30 6 1 6 7
M  V30 7 1 6 18
M  V30 8 1 8 27
M  V30 9 1 9 21
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 22 CFG=1
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 12 28 CFG=1
M  V30 18 1 13 17
M  V30 19 1 14 17
M  V30 20 2 14 18
M  V30 21 1 15 16
M  V30 22 2 17 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 2 20 21
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(5 10 11 12 15 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(5aR,6S,7R,8R,8aS)-5a-(4-Bromophenyl)-3-chloro-5a,7,8,8a-tetrahydro-8,8a-...
C25H22BrClN2O5
2098196-73-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.2879 2.7897 0.0 0
M  V30 2 O 4.3998 2.1885 0.0 0
M  V30 3 C 2.1580 4.6784 0.0 0
M  V30 4 N 1.5315 3.2715 0.0 0
M  V30 5 O 1.2528 5.9243 0.0 0
M  V30 6 C 0.0000 3.1105 0.0 0
M  V30 7 O 7.6332 1.3337 0.0 0
M  V30 8 C 8.4033 0.0000 0.0 0
M  V30 9 Br 7.9714 11.6773 0.0 0
M  V30 10 Cl 12.2533 4.0011 0.0 0
M  V30 11 C 5.9659 5.8528 0.0 0 CFG=1
M  V30 12 C 6.1270 4.3213 0.0 0 CFG=2
M  V30 13 C 4.4596 6.1730 0.0 0 CFG=2
M  V30 14 O 7.3728 6.4793 0.0 0
M  V30 15 C 7.6332 4.0011 0.0 0
M  V30 16 C 4.7200 3.6950 0.0 0 CFG=2
M  V30 17 C 3.6896 4.8393 0.0 0 CFG=1
M  V30 18 C 8.4033 5.3348 0.0 0
M  V30 19 C 8.4033 2.6675 0.0 0
M  V30 20 C 9.9433 5.3348 0.0 0
M  V30 21 N 9.9433 2.6675 0.0 0
M  V30 22 C 10.7133 4.0011 0.0 0
M  V30 23 C 6.4673 7.3089 0.0 0
M  V30 24 C 5.4569 8.4712 0.0 0
M  V30 25 C 7.9790 7.6028 0.0 0
M  V30 26 C 5.9583 9.9274 0.0 0
M  V30 27 C 8.4804 9.0590 0.0 0
M  V30 28 C 7.4700 10.2212 0.0 0
M  V30 29 C 3.8331 7.5800 0.0 0
M  V30 30 C 2.3016 7.7409 0.0 0
M  V30 31 C 4.7383 8.8258 0.0 0
M  V30 32 C 1.6752 9.1477 0.0 0
M  V30 33 C 4.1120 10.2326 0.0 0
M  V30 34 C 2.5805 10.3937 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 12 1 CFG=1
M  V30 2 1 16 2 CFG=3
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 17 3 CFG=3
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 19
M  V30 9 1 9 28
M  V30 10 1 10 22
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 23 CFG=1
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 13 29 CFG=1
M  V30 19 1 14 18
M  V30 20 1 15 18
M  V30 21 2 15 19
M  V30 22 1 16 17
M  V30 23 2 18 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 2 21 22
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(5 11 12 13 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2098196-09-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2098196-73-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-18672933
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Heterocyclic derivatives as eIF4A inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ernst, Justin T.; Reich, Siegfried H.; Sprengeler, Paul A.; Tran, Chinh
Viet; Packard, Garrick Kenneth; Xiang, Alan X.; Nilewski, Christian;
Michels, Theo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20170145026 A1 2017-05-25

$RFMT $RIREG SCHEME349 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloro-2-fluoro-3-nitrobenzene
C6H3ClFNO2
2106-49-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 3.0800 0.0 0 VAL=5
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 F 2.6674 4.6200 0.0 0
M  V30 5 Cl 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-methyl-6-nitrobenzenamine
C7H7ClN2O2
75438-12-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 4.6201 0.0 0
M  V30 2 C 1.3338 5.3901 0.0 0
M  V30 3 N 5.3348 3.0800 0.0 0 VAL=5
M  V30 4 O 5.3348 4.6201 0.0 0
M  V30 5 O 6.6686 2.3100 0.0 0
M  V30 6 Cl 0.0000 3.0800 0.0 0
M  V30 7 C 2.6675 3.0800 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 4.0011 0.7700 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2106-49-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 75438-12-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31868837
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Spiroconjugated Tetraaminospirenes as Donors in Color-Tunable
Charge-Transfer Emitters with Donor-Acceptor Structure
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Grenz, David C.; Rose, Daniel; Wossner, Jan S.; Wilbuer, Jennifer; Adler,
Florin; Hermann, Mathias; Chan, Chin-Yiu; Adachi, Chihaya; Esser, Birgit
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2022), 28(6), e202104150

$RFMT $RIREG SCHEME350 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-[8-[8-[[bis[[(1,1-dimethylethoxy)carbonyl]amino]methylene]am...
C39H65N7O8
2111828-89-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  54 55 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.5494 13.8463 0.0 0
M  V30 2 C 4.0431 14.1665 0.0 0
M  V30 3 O 3.0127 13.0219 0.0 0
M  V30 4 O 3.5673 15.6310 0.0 0
M  V30 5 C 1.5063 13.3421 0.0 0
M  V30 6 C 1.1861 11.8358 0.0 0
M  V30 7 C 0.0000 13.6624 0.0 0
M  V30 8 C 1.8264 14.8485 0.0 0
M  V30 9 O 8.0862 12.0031 0.0 0
M  V30 10 C 11.1662 12.0031 0.0 0
M  V30 11 C 12.7062 12.0031 0.0 0
M  V30 12 C 13.4762 10.6694 0.0 0
M  V30 13 C 15.0162 10.6694 0.0 0
M  V30 14 C 15.7862 9.3358 0.0 0
M  V30 15 C 17.3262 9.3358 0.0 0
M  V30 16 C 18.0962 8.0021 0.0 0
M  V30 17 C 19.6362 8.0021 0.0 0
M  V30 18 N 20.4062 6.6684 0.0 0
M  V30 19 C 21.9462 6.6684 0.0 0
M  V30 20 N 22.7162 8.0021 0.0 0
M  V30 21 N 22.7162 5.3347 0.0 0
M  V30 22 C 24.2562 8.0021 0.0 0
M  V30 23 C 21.9462 4.0011 0.0 0
M  V30 24 O 25.0262 9.3358 0.0 0
M  V30 25 O 25.0262 6.6684 0.0 0
M  V30 26 O 22.7162 2.6674 0.0 0
M  V30 27 O 20.4062 4.0011 0.0 0
M  V30 28 C 26.5662 9.3358 0.0 0
M  V30 29 C 21.9462 1.3336 0.0 0
M  V30 30 C 26.5662 10.8758 0.0 0
M  V30 31 C 28.1062 9.3358 0.0 0
M  V30 32 C 26.5662 7.7958 0.0 0
M  V30 33 C 23.2800 0.5636 0.0 0
M  V30 34 C 21.1762 0.0000 0.0 0
M  V30 35 C 20.6126 2.1036 0.0 0
M  V30 36 C 6.9736 19.1313 0.0 0
M  V30 37 C 8.2194 20.0365 0.0 0
M  V30 38 C 7.1345 17.5997 0.0 0
M  V30 39 C 5.5666 19.7577 0.0 0
M  V30 40 C 8.0585 21.5680 0.0 0
M  V30 41 O 9.6262 19.4102 0.0 0
M  V30 42 N 6.1041 16.4554 0.0 0
M  V30 43 C 5.4057 21.2893 0.0 0
M  V30 44 C 6.6516 22.1945 0.0 0
M  V30 45 C 11.0332 20.0365 0.0 0
M  V30 46 C 6.5800 14.9907 0.0 0
M  V30 47 C 12.2790 19.1313 0.0 0
M  V30 48 N 8.0862 14.6705 0.0 0
M  V30 49 C 12.1181 17.5997 0.0 0
M  V30 50 C 8.8562 13.3369 0.0 0
M  V30 51 C 13.1485 16.4554 0.0 0
M  V30 52 N 10.3962 13.3369 0.0 0
M  V30 53 C 12.6727 14.9907 0.0 0
M  V30 54 C 11.1662 14.6705 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 46
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 2 9 50
M  V30 10 1 10 11
M  V30 11 1 10 52
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 2 18 19
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 22 25
M  V30 26 1 23 26
M  V30 27 2 23 27
M  V30 28 1 24 28
M  V30 29 1 26 29
M  V30 30 1 28 30
M  V30 31 1 28 31
M  V30 32 1 28 32
M  V30 33 1 29 33
M  V30 34 1 29 34
M  V30 35 1 29 35
M  V30 36 1 36 37
M  V30 37 1 36 38
M  V30 38 2 36 39
M  V30 39 2 37 40
M  V30 40 1 37 41
M  V30 41 1 38 42
M  V30 42 1 39 43
M  V30 43 1 40 44
M  V30 44 1 41 45
M  V30 45 1 42 46
M  V30 46 2 43 44
M  V30 47 1 45 47
M  V30 48 2 46 48
M  V30 49 1 47 49
M  V30 50 1 48 50
M  V30 51 1 49 51
M  V30 52 1 50 52
M  V30 53 1 51 53
M  V30 54 1 52 54
M  V30 55 1 53 54
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-[8-[8-[[[[(1,1-dimethylethoxy)carbonyl]amino][[(methylamino)...
C36H60N8O7
2111833-05-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  51 52 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.5494 11.1789 0.0 0
M  V30 2 C 4.0431 11.4992 0.0 0
M  V30 3 O 3.0127 10.3547 0.0 0
M  V30 4 O 3.5673 12.9637 0.0 0
M  V30 5 C 1.5063 10.6748 0.0 0
M  V30 6 C 1.1861 9.1685 0.0 0
M  V30 7 C 0.0000 10.9950 0.0 0
M  V30 8 C 1.8264 12.1812 0.0 0
M  V30 9 O 8.0862 9.3358 0.0 0
M  V30 10 C 11.1662 9.3358 0.0 0
M  V30 11 C 12.7062 9.3358 0.0 0
M  V30 12 C 13.4762 8.0022 0.0 0
M  V30 13 C 15.0162 8.0022 0.0 0
M  V30 14 C 15.7862 6.6685 0.0 0
M  V30 15 C 17.3262 6.6685 0.0 0
M  V30 16 C 18.0962 5.3347 0.0 0
M  V30 17 C 19.6362 5.3347 0.0 0
M  V30 18 N 20.4062 6.6685 0.0 0
M  V30 19 C 21.9462 6.6685 0.0 0
M  V30 20 N 22.7162 5.3347 0.0 0
M  V30 21 N 22.7162 8.0022 0.0 0
M  V30 22 C 21.9462 4.0011 0.0 0
M  V30 23 C 24.2562 8.0022 0.0 0
M  V30 24 O 22.7162 2.6674 0.0 0
M  V30 25 O 20.4062 4.0011 0.0 0
M  V30 26 N 25.0262 9.3358 0.0 0
M  V30 27 O 25.0262 6.6685 0.0 0
M  V30 28 C 21.9462 1.3338 0.0 0
M  V30 29 C 26.5662 9.3358 0.0 0
M  V30 30 C 20.6126 2.1038 0.0 0
M  V30 31 C 21.1762 0.0000 0.0 0
M  V30 32 C 23.2800 0.5638 0.0 0
M  V30 33 C 6.9736 16.4640 0.0 0
M  V30 34 C 8.2194 17.3692 0.0 0
M  V30 35 C 7.1345 14.9325 0.0 0
M  V30 36 C 5.5666 17.0903 0.0 0
M  V30 37 C 8.0585 18.9007 0.0 0
M  V30 38 O 9.6262 16.7429 0.0 0
M  V30 39 N 6.1041 13.7879 0.0 0
M  V30 40 C 5.4057 18.6220 0.0 0
M  V30 41 C 6.6516 19.5272 0.0 0
M  V30 42 C 11.0332 17.3692 0.0 0
M  V30 43 C 6.5800 12.3234 0.0 0
M  V30 44 C 12.2790 16.4640 0.0 0
M  V30 45 N 8.0862 12.0032 0.0 0
M  V30 46 C 12.1181 14.9325 0.0 0
M  V30 47 C 8.8562 10.6694 0.0 0
M  V30 48 C 13.1485 13.7879 0.0 0
M  V30 49 N 10.3962 10.6694 0.0 0
M  V30 50 C 12.6727 12.3234 0.0 0
M  V30 51 C 11.1662 12.0032 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 43
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 2 9 47
M  V30 10 1 10 11
M  V30 11 1 10 49
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 2 18 19 CFG=2
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 22 25
M  V30 26 1 23 26
M  V30 27 2 23 27
M  V30 28 1 24 28
M  V30 29 1 26 29
M  V30 30 1 28 30
M  V30 31 1 28 31
M  V30 32 1 28 32
M  V30 33 1 33 34
M  V30 34 1 33 35
M  V30 35 2 33 36
M  V30 36 2 34 37
M  V30 37 1 34 38
M  V30 38 1 35 39
M  V30 39 1 36 40
M  V30 40 1 37 41
M  V30 41 1 38 42
M  V30 42 1 39 43
M  V30 43 2 40 41
M  V30 44 1 42 44
M  V30 45 2 43 45
M  V30 46 1 44 46
M  V30 47 1 45 47
M  V30 48 1 46 48
M  V30 49 1 47 49
M  V30 50 1 48 50
M  V30 51 1 49 51
M  V30 52 1 50 51
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2111828-89-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2111833-05-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36226480
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used, literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery and Optimization of a Novel Macrocyclic Amidinourea Series
Active as Acidic Mammalian Chitinase Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Balestri, Lorenzo Jacopo Ilic; Trivisani, Claudia Immacolata; Orofino,
Francesco; Fiorucci, Diego; Truglio, Giuseppina Ivana; D'Agostino,
Ilaria; Poggialini, Federica; Botta, Lorenzo; Docquier, Jean-Denis;
Dreassi, Elena
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2023), 14(4), 417-424

$RFMT $RIREG SCHEME351 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Fluoro-2H-1-benzopyran-5-carboxylic acid
C10H7FO3
214823-01-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 4.0011 0.0 0
M  V30 2 O 0.0000 2.6674 0.0 0
M  V30 3 O 0.0000 5.3349 0.0 0
M  V30 4 F 6.9300 4.0011 0.0 0
M  V30 5 C 3.0800 2.6674 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 2.3100 1.3338 0.0 0
M  V30 9 C 5.3900 4.0011 0.0 0
M  V30 10 O 5.3900 1.3338 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 3.0800 0.0000 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 14 C 4.6200 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Fluoro-N-methyl-2H-1-benzopyran-5-carboxamide
C11H10FNO2
843652-57-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 N 6.9300 5.3349 0.0 0
M  V30 3 O 6.9300 2.6674 0.0 0
M  V30 4 C 8.4700 5.3349 0.0 0
M  V30 5 F 0.0000 4.0011 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 4.6200 1.3338 0.0 0
M  V30 10 C 1.5400 4.0011 0.0 0
M  V30 11 O 1.5400 1.3338 0.0 0
M  V30 12 C 3.8500 5.3349 0.0 0
M  V30 13 C 3.8500 0.0000 0.0 0
M  V30 14 C 2.3100 5.3349 0.0 0
M  V30 15 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 214823-01-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 843652-57-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-6323734
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 8-Fluoro-N-methyl-2H-chromene-5-carboxamide (30). To 26a (3.5 g, 0.018
mol) in anhydrous THF (100 mL), under nitrogen at room temperature, was
added 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC,
6.9 g, 0.036 mol), 1-hydroxybenzotriazole hydrate (HOBt, 4.86 g, 0.036
mol), and methylamine (2 M/THF, 36 mL, 0.072 mol). The mixture was
stirred at room temperature overnight. It was concentrated and the
residue taken up in CH2Cl2/H2O. The aqueous layer was extracted one more
time with CH2Cl2, and the organic extracts were treated with brine, dried
over anhydrous MgSO4, filtered, and concentrated. Chromatography (3:1
EtOAc-hexanes) afforded 3.69 g (99%) of 30 as a white solid. white solid:
mp 150-153 °C; 1H NMR (400 MHz, DMSO-d6) δ 2.73 (d, J = 4.6 Hz, 3H),
4.74-4.90 (m, 2H), 5.94-6.08 (m, 1H), 6.70-6.83 (m, 1H), 6.90-7.02 (m,
1H), 7.04-7.18 (m, 1H), 8.19-8.33 (m, 1H); MS (ES) m/z 206.1 ([M - H]-).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Advances toward New Antidepressants with Dual Serotonin Transporter and
5-HT1A Receptor Affinity within a Class of 3-Aminochroman Derivatives.
Part 2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hatzenbuhler, Nicole T.; Baudy, Reinhardt; Evrard, Deborah A.; Failli,
Amedeo; Harrison, Boyd L.; Lenicek, Steven; Mewshaw, Richard E.; Saab,
Annmarie; Shah, Uresh; Sze, Jean; Zhang, Minsheng; Zhou, Dahui; Chlenov,
Michael; Kagan, Michael; Golembieski, Jeannette; Hornby, Geoffrey; Lai,
Margaret; Smith, Deborah L.; Sullivan, Kelly M.; Schechter, Lee E.;
Andree, Terrance H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2008), 51(21), 6980-7004

$RFMT $RIREG SCHEME351 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Fluoro-2H-1-benzopyran-5-carboxylic acid
C10H7FO3
214823-01-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 4.0011 0.0 0
M  V30 2 O 0.0000 2.6674 0.0 0
M  V30 3 O 0.0000 5.3349 0.0 0
M  V30 4 F 6.9300 4.0011 0.0 0
M  V30 5 C 3.0800 2.6674 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 2.3100 1.3338 0.0 0
M  V30 9 C 5.3900 4.0011 0.0 0
M  V30 10 O 5.3900 1.3338 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 3.0800 0.0000 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 14 C 4.6200 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Fluoro-N-methyl-2H-1-benzopyran-5-carboxamide
C11H10FNO2
843652-57-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 N 6.9300 5.3349 0.0 0
M  V30 3 O 6.9300 2.6674 0.0 0
M  V30 4 C 8.4700 5.3349 0.0 0
M  V30 5 F 0.0000 4.0011 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 4.6200 1.3338 0.0 0
M  V30 10 C 1.5400 4.0011 0.0 0
M  V30 11 O 1.5400 1.3338 0.0 0
M  V30 12 C 3.8500 5.3349 0.0 0
M  V30 13 C 3.8500 0.0000 0.0 0
M  V30 14 C 2.3100 5.3349 0.0 0
M  V30 15 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 214823-01-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 843652-57-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14090114
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 29: Intermediate
83c--8-fluoro-N-methyl-2H-chromene-5-carboxamide. To
8-fluoro-2H-chromene-5-carboxylic acid (3.5g, 0.018mol) in anhydrous THF
(100 mL), under nitrogen at room temperature, was added EDC (6.9g,
0.036mol), HOBt (4.86g, 0.036mol) and a 2M solution of methylamine in THF
(36mL, 0.072mol). The reaction mixture was stirred at room temperature
overnight. The reaction mixture was concentrated in vacuo and the residue
taken up in CH2Cl2/H2O. The organic layer was separated and the aqueous
layer extracted one more time with CH2Cl2. The organic extracts were
pooled, dried over anhydrous magnesium sulfate, filtered and
concentrated. Chromatography ((3:1) EtOAc-Hex) afforded 3.69g (99%) of
desired product as a white solid:. mp 150-153 °C;MS (ES) m/z 206.1.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A preparation of 3-aminochroman and 2-aminotetralin derivatives, useful
in the treatment of serotonin-mediated disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hatzenbuhler, Nicole Theriault; Evrard, Deborah Ann; Mewshaw, Richard
Eric; Zhou, Dahui; Shah, Uresh Shantilal; Inghrim, Jennifer Ann; Lenicek,
Steven Edward; Baudy, Reinhardt Bernhard; Butera, John Anthony; Sabb,
Annmarie L.; Failli, Amedeo Arturo; Ramamoorthy, Pudukkaraipudur
Sivaramakrishnan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005012291 A1 2005-02-10

$RFMT $RIREG SCHEME352 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Lauryl acrylate
C15H28O2
2156-97-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 2.3101 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 C 8.0023 1.5400 0.0 0
M  V30 4 O 4.0012 2.3101 0.0 0
M  V30 5 C 9.3360 2.3101 0.0 0
M  V30 6 C 2.6675 1.5400 0.0 0
M  V30 7 C 10.6697 1.5400 0.0 0
M  V30 8 C 1.3337 2.3101 0.0 0
M  V30 9 O 2.6675 0.0000 0.0 0
M  V30 10 C 12.0033 2.3101 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 12 C 13.3372 1.5400 0.0 0
M  V30 13 C 14.6708 2.3101 0.0 0
M  V30 14 C 16.0045 1.5400 0.0 0
M  V30 15 C 17.3382 2.3101 0.0 0
M  V30 16 C 18.6720 1.5400 0.0 0
M  V30 17 C 20.0057 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 14 1 14 15
M  V30 15 1 15 16
M  V30 16 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[3-(Dodecyloxy)-3-oxopropyl]-N-methyl-β-alanine dodecyl ester
C31H61NO4
1123109-58-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 20.0057 2.3101 0.0 0
M  V30 2 N 21.3393 1.5400 0.0 0
M  V30 3 C 18.6718 1.5400 0.0 0
M  V30 4 C 22.6730 2.3101 0.0 0
M  V30 5 C 21.3393 0.0000 0.0 0
M  V30 6 C 17.3382 2.3101 0.0 0
M  V30 7 C 24.0067 1.5400 0.0 0
M  V30 8 O 16.0045 1.5400 0.0 0
M  V30 9 O 17.3382 3.8501 0.0 0
M  V30 10 C 25.3405 2.3101 0.0 0
M  V30 11 C 14.6708 2.3101 0.0 0
M  V30 12 O 26.6742 1.5400 0.0 0
M  V30 13 O 25.3405 3.8501 0.0 0
M  V30 14 C 13.3370 1.5400 0.0 0
M  V30 15 C 28.0078 2.3101 0.0 0
M  V30 16 C 12.0033 2.3101 0.0 0
M  V30 17 C 29.3415 1.5400 0.0 0
M  V30 18 C 10.6697 1.5400 0.0 0
M  V30 19 C 30.6753 2.3101 0.0 0
M  V30 20 C 9.3360 2.3101 0.0 0
M  V30 21 C 32.0090 1.5400 0.0 0
M  V30 22 C 8.0022 1.5400 0.0 0
M  V30 23 C 33.3427 2.3101 0.0 0
M  V30 24 C 6.6685 2.3101 0.0 0
M  V30 25 C 34.6765 1.5400 0.0 0
M  V30 26 C 5.3348 1.5400 0.0 0
M  V30 27 C 36.0101 2.3101 0.0 0
M  V30 28 C 4.0012 2.3101 0.0 0
M  V30 29 C 37.3438 1.5400 0.0 0
M  V30 30 C 2.6673 1.5400 0.0 0
M  V30 31 C 38.6775 2.3101 0.0 0
M  V30 32 C 1.3337 2.3101 0.0 0
M  V30 33 C 40.0113 1.5400 0.0 0
M  V30 34 C 0.0000 1.5400 0.0 0
M  V30 35 C 41.3450 2.3101 0.0 0
M  V30 36 C 42.6786 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 1 26 28
M  V30 28 1 27 29
M  V30 29 1 28 30
M  V30 30 1 29 31
M  V30 31 1 30 32
M  V30 32 1 31 33
M  V30 33 1 32 34
M  V30 34 1 33 35
M  V30 35 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2156-97-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1123109-58-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-9497665
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Synthesis of
N-methyl-N,N-bis[2-(alkoxycarbonyl)ethyl]amine: General Procedure
Reactions were typically carried out as follows: 1.40 mol of alkyl
acrylate was placed in a round-bottom flask equipped with reflux
condenser, magnetic stirrer, dropping funnel and thermometer. Ethanolic
solution of methylamine (0.700 mol) was slowly dropped in at temperature
not exceeded 30 °C (reaction is exothermic). The reaction mixture was
then stored at room temperature for ca. 1 additional day. After
evaporating of the solvent, crude product could be (if necessary)
additionally processed by fractional distillation or crystallization. In
the case of pure methylamine reaction was carried out at room temperature
in a pressure glass reactor. Alkyl acrylate (0.600 mol) and 35 ml of
anhydrous ethyl alcohol or 2-propanol (in the case of octadecyl acrylate
only) were placed in pressure glass reactor equipped with magnetic
stirrer, manometer and inlet tube. The reaction mixture was intensively
stirred and cooled with a water-ice bath to maintain the reaction
temperature at 15-20 °C while gaseous methylamine (0.300 mol) was slowly
introduced through the inlet tube under the layer of alkyl acrylate from
a weighed pressure container. The rate of methylamine addition was
controlled with valve to maintain pressure above reaction mixture not
higher than 0.03 MPa. After completion of amine introduction the reaction
mixture was stored for 24 h at room temperature. The yield of crude
products was almost quantitative and at least 99% of purity. In the case
of octadecyl derivative, it was necessary to evaporate the solvent which
could be reused. Table 1 The aza-Michael reaction of methylamine with
alkyl acrylates Compound 4a Product CH3N(CH2CH2COOCH3)2 Table 1 The
aza-Michael reaction of methylamine with alkyl acrylates Compound 4f
Product CH3N(CH2CH2COOC12H25)2 Yield 99.0 %. Bp [°C/mmHg] or mp 15.7-15.9
°C Refractive index nD20 1.4544 Molecular formula C31H61NO4 Elemental
analysis calcd. (wt%): C, 72.75; H, 12.01; N, 2.74. found (wt%): C,
72.71; H, 12.04; N, 2.70.
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, green chemistry-solvent, gaseous methylamine in pressure
glass reactor also used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New hydrophobic intermediates of aminodiester-type via a green,
Michael-addition reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Piasecki, Andrzej; Zielinski, Wojciech
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Surfactants and Detergents (2008), 11(1), 21-27

$RFMT $RIREG SCHEME353 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (3aS,4S,7aR)-2,3,3a,7a-tetrahydro-4-phenyl-4H-furo[2,3-b]pyran-6-carbo...
C15H16O4
216220-81-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 4.7473 0.0 0
M  V30 2 O 9.3360 3.9773 0.0 0
M  V30 3 O 8.0023 6.2873 0.0 0
M  V30 4 C 10.6697 4.7473 0.0 0
M  V30 5 C 4.0012 3.9773 0.0 0 CFG=1
M  V30 6 C 4.0012 2.4373 0.0 0 CFG=2
M  V30 7 C 5.3348 4.7473 0.0 0
M  V30 8 C 5.3348 1.6672 0.0 0 CFG=2
M  V30 9 C 2.8566 1.4068 0.0 0
M  V30 10 C 6.6685 3.9773 0.0 0
M  V30 11 O 6.6685 2.4373 0.0 0
M  V30 12 O 5.0147 0.1609 0.0 0
M  V30 13 C 3.4831 0.0000 0.0 0
M  V30 14 C 2.6673 4.7473 0.0 0
M  V30 15 C 1.3337 3.9773 0.0 0
M  V30 16 C 2.6673 6.2873 0.0 0
M  V30 17 C 0.0000 4.7473 0.0 0
M  V30 18 C 1.3337 7.0574 0.0 0
M  V30 19 C 0.0000 6.2873 0.0 0
M  V30 20 H 2.5942 3.0637 0.0 0
M  V30 21 H 6.5807 0.7622 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 14 CFG=1
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 6 20 CFG=3
M  V30 11 2 7 10
M  V30 12 1 8 11
M  V30 13 1 8 12
M  V30 14 1 8 21 CFG=3
M  V30 15 1 9 13
M  V30 16 1 10 11
M  V30 17 1 12 13
M  V30 18 2 14 15
M  V30 19 1 14 16
M  V30 20 1 15 17
M  V30 21 2 16 18
M  V30 22 2 17 19
M  V30 23 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 5 6 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3aS,4S,7aR)-2,3,3a,7a-Tetrahydro-N-methyl-4-phenyl-4H-furo[2,3-b]pyran-6-car...
C15H17NO3
2411944-65-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 4.7473 0.0 0
M  V30 2 N 9.3360 3.9773 0.0 0
M  V30 3 O 8.0023 6.2873 0.0 0
M  V30 4 C 10.6697 4.7473 0.0 0
M  V30 5 C 4.0012 3.9773 0.0 0 CFG=1
M  V30 6 C 4.0012 2.4373 0.0 0 CFG=2
M  V30 7 C 5.3348 4.7473 0.0 0
M  V30 8 C 5.3348 1.6672 0.0 0 CFG=2
M  V30 9 C 2.8566 1.4068 0.0 0
M  V30 10 C 6.6685 3.9773 0.0 0
M  V30 11 O 6.6685 2.4373 0.0 0
M  V30 12 O 5.0147 0.1609 0.0 0
M  V30 13 C 3.4831 0.0000 0.0 0
M  V30 14 C 2.6673 4.7473 0.0 0
M  V30 15 C 2.6673 6.2873 0.0 0
M  V30 16 C 1.3337 3.9773 0.0 0
M  V30 17 C 1.3337 7.0574 0.0 0
M  V30 18 C 0.0000 4.7473 0.0 0
M  V30 19 C 0.0000 6.2873 0.0 0
M  V30 20 H 2.5942 3.0637 0.0 0
M  V30 21 H 6.5807 0.7622 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 14 CFG=1
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 6 20 CFG=3
M  V30 11 2 7 10
M  V30 12 1 8 11
M  V30 13 1 8 12
M  V30 14 1 8 21 CFG=3
M  V30 15 1 9 13
M  V30 16 1 10 11
M  V30 17 1 12 13
M  V30 18 2 14 15
M  V30 19 1 14 16
M  V30 20 1 15 17
M  V30 21 2 16 18
M  V30 22 2 17 19
M  V30 23 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 5 6 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 216220-81-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2411944-65-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-22508294
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, ee 93%, dr ration 99:1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Modular Chiral Bisoxalamide-Copper Catalyzed Asymmetric Oxo-Diels-Alder
Reaction: Carbonyl Coordination for High Enantio- and Diastereo-Controls
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Jun-Bo; Xu, Man; Zhang, Jun-Qi; Sun, Bing-Bing; Hu, Jia-Ming; Yu,
Jie-Qiang; Wang, Xing-Wang; Xia, Yuanzhi; Wang, Zheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Catalysis (2020), 10(6), 3556-3563

$RFMT $RIREG SCHEME354 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1-(2-cyclopropylethyl)-3-nitro-1H-pyrazole-5-carboxylate
C10H13N3O4
2170907-69-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5626 5.3196 0.0 0
M  V30 2 C 7.3326 6.6533 0.0 0
M  V30 3 C 4.5932 2.6091 0.0 0
M  V30 4 O 3.5628 1.4647 0.0 0
M  V30 5 O 6.0996 2.2889 0.0 0
M  V30 6 C 4.0387 0.0000 0.0 0
M  V30 7 N 1.4068 6.9949 0.0 0 VAL=5
M  V30 8 O 0.0000 6.3684 0.0 0
M  V30 9 O 1.5679 8.5264 0.0 0
M  V30 10 N 5.0226 5.3196 0.0 0
M  V30 11 C 4.1174 4.0738 0.0 0
M  V30 12 N 4.1174 6.5655 0.0 0
M  V30 13 C 2.6527 4.5496 0.0 0
M  V30 14 C 2.6527 6.0896 0.0 0
M  V30 15 C 8.8726 6.6533 0.0 0
M  V30 16 C 10.2062 7.4233 0.0 0
M  V30 17 C 10.2062 5.8833 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 15
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 11
M  V30 7 1 4 6
M  V30 8 2 7 8
M  V30 9 2 7 9
M  V30 10 1 7 14
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Cyclopropylethyl)-N-methyl-3-nitro-1H-pyrazole-5-carboxamide
C10H14N4O3
2170909-28-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5626 5.3196 0.0 0
M  V30 2 C 7.3326 6.6533 0.0 0
M  V30 3 C 4.5932 2.6091 0.0 0
M  V30 4 N 3.5628 1.4647 0.0 0
M  V30 5 O 6.0996 2.2889 0.0 0
M  V30 6 C 4.0387 0.0000 0.0 0
M  V30 7 N 1.4068 6.9949 0.0 0 VAL=5
M  V30 8 O 1.5679 8.5264 0.0 0
M  V30 9 O 0.0000 6.3684 0.0 0
M  V30 10 N 5.0226 5.3196 0.0 0
M  V30 11 C 4.1174 4.0738 0.0 0
M  V30 12 N 4.1174 6.5655 0.0 0
M  V30 13 C 2.6527 4.5496 0.0 0
M  V30 14 C 2.6527 6.0896 0.0 0
M  V30 15 C 8.8726 6.6533 0.0 0
M  V30 16 C 10.2062 7.4233 0.0 0
M  V30 17 C 10.2062 5.8833 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 15
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 11
M  V30 7 1 4 6
M  V30 8 2 7 8
M  V30 9 2 7 9
M  V30 10 1 7 14
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2170907-69-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2170909-28-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19250168
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed tube,no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Heteroaromatic derivatives as NIK inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Stansfield, Ian; Querolle, Olivier Alexis Georges; Ligny, Yannick Aime
Eddy; Gross, Gerhard Max; Jacoby, Edgar; Meerpoel, Lieven; Green, Simon
Richard; Hynd, George; Kulagowski, Janusz Jozef; MacLeod, Calum; Mann,
Samuel Edward
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018002217 A1 2018-01-04

$RFMT $RIREG SCHEME355 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-chloro-β-oxobenzenepropanoate
C10H9ClO3
22027-53-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 C 3.8501 1.3337 0.0 0
M  V30 3 O 3.8501 4.0010 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 O 1.5400 0.0000 0.0 0
M  V30 6 O 1.5400 2.6673 0.0 0
M  V30 7 C 0.0000 0.0000 0.0 0
M  V30 8 Cl 10.7802 2.6673 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 C 6.9302 4.0010 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 12 C 8.4702 4.0010 0.0 0
M  V30 13 C 8.4702 1.3337 0.0 0
M  V30 14 C 9.2402 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2Z)-3-(4-chlorophenyl)-3-(methylamino)-2-propenoate
C11H12ClNO2
2304416-14-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6674 0.0 0
M  V30 2 C 3.8500 4.0011 0.0 0
M  V30 3 N 3.8500 1.3338 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 4.6200 0.0000 0.0 0
M  V30 6 O 1.5400 5.3349 0.0 0
M  V30 7 O 1.5400 2.6674 0.0 0
M  V30 8 C 0.0000 5.3349 0.0 0
M  V30 9 Cl 10.7800 2.6674 0.0 0
M  V30 10 C 6.1600 2.6674 0.0 0
M  V30 11 C 6.9300 4.0011 0.0 0
M  V30 12 C 6.9300 1.3338 0.0 0
M  V30 13 C 8.4700 4.0011 0.0 0
M  V30 14 C 8.4700 1.3338 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 22027-53-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2304416-14-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-19946806
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Functionalized Imidazolium Salts via Iodine-Mediated
Annulations of Enamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xia, Biao; Chen, Wenjun; Zhao, Qiongli; Yu, Wenquan; Chang, Junbiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2019), 21(8), 2583-2587

$RFMT $RIREG SCHEME356 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-(2,5-dichlorophenyl)acetamide
C8H6Cl3NO
22303-26-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 4.6200 0.0 0
M  V30 2 C 5.3347 3.8500 0.0 0
M  V30 3 C 6.6685 4.6200 0.0 0
M  V30 4 O 5.3347 2.3100 0.0 0
M  V30 5 Cl 8.0021 3.8500 0.0 0
M  V30 6 Cl 1.3336 6.1600 0.0 0
M  V30 7 Cl 1.3336 0.0000 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 C 1.3336 4.6200 0.0 0
M  V30 10 C 2.6674 2.3100 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 12 C 1.3336 1.5400 0.0 0
M  V30 13 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 9
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2,5-Dichlorophenyl)-2-(methylamino)acetamide
C9H10Cl2N2O
688012-14-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 4.6200 0.0 0
M  V30 2 C 5.3347 3.8500 0.0 0
M  V30 3 C 6.6684 4.6200 0.0 0
M  V30 4 O 5.3347 2.3100 0.0 0
M  V30 5 N 8.0021 3.8500 0.0 0
M  V30 6 C 9.3358 4.6200 0.0 0
M  V30 7 Cl 1.3336 6.1600 0.0 0
M  V30 8 Cl 1.3336 0.0000 0.0 0
M  V30 9 C 2.6674 3.8500 0.0 0
M  V30 10 C 1.3336 4.6200 0.0 0
M  V30 11 C 2.6674 2.3100 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 13 C 1.3336 1.5400 0.0 0
M  V30 14 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 10
M  V30 8 1 8 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 22303-26-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 688012-14-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-15225870
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-based design, synthesis, and antifungal activity of new
triazole derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sheng, Chunquan; Che, Xiaoying; Wang, Wenya; Wang, Shengzheng; Cao,
Yongbing; Yao, Jianzhong; Miao, Zhenyuan; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Biology & Drug Design (2011), 78(2), 309-313

$RFMT $RIREG SCHEME357 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Chloro-5-fluorophenyl)-4-methyl[1,2,4]triazolo[4,3-a]quinoxaline-8-carbo...
C17H10ClFN4O2
2246355-10-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.5440 5.8111 0.0 0
M  V30 2 C 1.0740 7.1447 0.0 0
M  V30 3 O 0.3040 5.8111 0.0 0
M  V30 4 O 0.3040 8.4783 0.0 0
M  V30 5 Cl 4.5778 0.0000 0.0 0
M  V30 6 F 0.0000 4.1218 0.0 0
M  V30 7 N 5.6940 4.4773 0.0 0
M  V30 8 C 4.9240 5.8111 0.0 0
M  V30 9 C 5.2181 3.0127 0.0 0
M  V30 10 C 7.2340 4.4773 0.0 0
M  V30 11 C 5.6940 7.1447 0.0 0
M  V30 12 C 3.3840 5.8111 0.0 0
M  V30 13 N 6.4640 2.1075 0.0 0
M  V30 14 C 8.0040 5.8111 0.0 0
M  V30 15 N 7.7099 3.0127 0.0 0
M  V30 16 N 7.2340 7.1447 0.0 0
M  V30 17 C 4.9240 8.4783 0.0 0
M  V30 18 C 2.6140 7.1447 0.0 0
M  V30 19 C 3.3840 8.4783 0.0 0
M  V30 20 C 3.7535 2.5368 0.0 0
M  V30 21 C 3.4333 1.0304 0.0 0
M  V30 22 C 2.6091 3.5673 0.0 0
M  V30 23 C 1.9687 0.5546 0.0 0
M  V30 24 C 1.1444 3.0914 0.0 0
M  V30 25 C 0.8242 1.5850 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 18
M  V30 5 1 5 21
M  V30 6 1 6 24
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 9 20
M  V30 14 1 10 14
M  V30 15 2 10 15
M  V30 16 1 11 16
M  V30 17 2 11 17
M  V30 18 1 12 18
M  V30 19 1 13 15
M  V30 20 2 14 16
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Chloro-5-fluorophenyl)-N,4-dimethyl[1,2,4]triazolo[4,3-a]quinoxaline-8-c...
C18H13ClFN5O
2244979-88-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.7800 5.8110 0.0 0
M  V30 2 C 2.3100 7.1447 0.0 0
M  V30 3 N 1.5400 8.4783 0.0 0
M  V30 4 O 1.5400 5.8110 0.0 0
M  V30 5 C 0.0000 8.4783 0.0 0
M  V30 6 Cl 5.8138 0.0000 0.0 0
M  V30 7 F 1.2360 4.1218 0.0 0
M  V30 8 N 6.9300 4.4772 0.0 0
M  V30 9 C 6.1600 5.8110 0.0 0
M  V30 10 C 6.4541 3.0127 0.0 0
M  V30 11 C 8.4700 4.4772 0.0 0
M  V30 12 C 6.9300 7.1447 0.0 0
M  V30 13 C 4.6200 5.8110 0.0 0
M  V30 14 N 7.7000 2.1075 0.0 0
M  V30 15 C 9.2400 5.8110 0.0 0
M  V30 16 N 8.9459 3.0127 0.0 0
M  V30 17 N 8.4700 7.1447 0.0 0
M  V30 18 C 6.1600 8.4783 0.0 0
M  V30 19 C 3.8500 7.1447 0.0 0
M  V30 20 C 4.6200 8.4783 0.0 0
M  V30 21 C 4.9894 2.5368 0.0 0
M  V30 22 C 4.6693 1.0304 0.0 0
M  V30 23 C 3.8451 3.5673 0.0 0
M  V30 24 C 3.2047 0.5546 0.0 0
M  V30 25 C 2.3804 3.0914 0.0 0
M  V30 26 C 2.0602 1.5850 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 19
M  V30 5 1 3 5
M  V30 6 1 6 22
M  V30 7 1 7 25
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 10 21
M  V30 15 1 11 15
M  V30 16 2 11 16
M  V30 17 1 12 17
M  V30 18 2 12 18
M  V30 19 1 13 19
M  V30 20 1 14 16
M  V30 21 2 15 17
M  V30 22 1 18 20
M  V30 23 2 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2246355-10-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2244979-88-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19362801
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Mathematical and Structural Characterization of Strong Nonadditive
Structure-Activity Relationship Caused by Protein Conformational Changes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gomez, Laurent; Xu, Rui; Sinko, William; Selfridge, Brandon; Vernier,
William; Ly, Kiev; Truong, Richard; Metz, Markus; Marrone, Tami; Sebring,
Kristen; Yan, Yingzhou; Appleton, Brent; Aertgeerts, Kathleen; Massari,
Mark Eben; Breitenbucher, J. Guy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2018), 61(17), 7754-7766

$RFMT $RIREG SCHEME358 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Acetylindole-3-carboxaldehyde
C11H9NO2
22948-94-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5063 1.4647 0.0 0
M  V30 2 C 0.0000 1.7848 0.0 0
M  V30 3 O 1.9823 0.0000 0.0 0
M  V30 4 C 6.2010 4.1752 0.0 0
M  V30 5 O 7.2314 3.0307 0.0 0
M  V30 6 C 2.2166 4.1154 0.0 0
M  V30 7 C 3.5503 4.8854 0.0 0
M  V30 8 N 2.5368 2.6090 0.0 0
M  V30 9 C 0.8829 4.8854 0.0 0
M  V30 10 C 4.6946 3.8549 0.0 0
M  V30 11 C 3.5503 6.4254 0.0 0
M  V30 12 C 4.0683 2.4481 0.0 0
M  V30 13 C 0.8829 6.4254 0.0 0
M  V30 14 C 2.2166 7.1954 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 2 4 5
M  V30 5 1 4 10
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[3-[(Methylamino)methyl]-1H-indol-1-yl]ethanone
C12H14N2O
620175-54-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5064 1.4647 0.0 0
M  V30 2 C 1.9823 0.0000 0.0 0
M  V30 3 O 0.0000 1.7849 0.0 0
M  V30 4 C 6.2012 4.1753 0.0 0
M  V30 5 N 7.2316 3.0307 0.0 0
M  V30 6 C 8.7380 3.3509 0.0 0
M  V30 7 C 2.2167 4.1155 0.0 0
M  V30 8 C 3.5503 4.8855 0.0 0
M  V30 9 N 2.5369 2.6091 0.0 0
M  V30 10 C 0.8830 4.8855 0.0 0
M  V30 11 C 4.6949 3.8550 0.0 0
M  V30 12 C 3.5503 6.4255 0.0 0
M  V30 13 C 4.0684 2.4482 0.0 0
M  V30 14 C 0.8830 6.4255 0.0 0
M  V30 15 C 2.2167 7.1956 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 13
M  V30 15 1 12 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 22948-94-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620175-54-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-5617068
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation 16 Preparation of
3-(methylaminomethyl)-1H-indole a) 3-(Methylaminomethyl)-1H-indole
Preparation 23 Preparation of 1-acetyl-3-(methylaminomethyl)-1H-indole a)
1-Acetyl-3-(methylaminomethyl)indole [0707] According to the procedure of
Preparation 16 (a), except substituting N-acetyl-3-indole carboxaldehyde
(1.33 g, 7.10 mmole), the title compound (1.40 g, 99%) was prepared as a
light yellow oil. MS (ES) m/e 203 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME358 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Acetylindole-3-carboxaldehyde
C11H9NO2
22948-94-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5063 1.4647 0.0 0
M  V30 2 C 0.0000 1.7848 0.0 0
M  V30 3 O 1.9823 0.0000 0.0 0
M  V30 4 C 6.2010 4.1752 0.0 0
M  V30 5 O 7.2314 3.0307 0.0 0
M  V30 6 C 2.2166 4.1154 0.0 0
M  V30 7 C 3.5503 4.8854 0.0 0
M  V30 8 N 2.5368 2.6090 0.0 0
M  V30 9 C 0.8829 4.8854 0.0 0
M  V30 10 C 4.6946 3.8549 0.0 0
M  V30 11 C 3.5503 6.4254 0.0 0
M  V30 12 C 4.0683 2.4481 0.0 0
M  V30 13 C 0.8829 6.4254 0.0 0
M  V30 14 C 2.2166 7.1954 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 2 4 5
M  V30 5 1 4 10
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[3-[(Methylamino)methyl]-1H-indol-1-yl]ethanone
C12H14N2O
620175-54-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5064 1.4647 0.0 0
M  V30 2 C 1.9823 0.0000 0.0 0
M  V30 3 O 0.0000 1.7849 0.0 0
M  V30 4 C 6.2012 4.1753 0.0 0
M  V30 5 N 7.2316 3.0307 0.0 0
M  V30 6 C 8.7380 3.3509 0.0 0
M  V30 7 C 2.2167 4.1155 0.0 0
M  V30 8 C 3.5503 4.8855 0.0 0
M  V30 9 N 2.5369 2.6091 0.0 0
M  V30 10 C 0.8830 4.8855 0.0 0
M  V30 11 C 4.6949 3.8550 0.0 0
M  V30 12 C 3.5503 6.4255 0.0 0
M  V30 13 C 4.0684 2.4482 0.0 0
M  V30 14 C 0.8830 6.4255 0.0 0
M  V30 15 C 2.2167 7.1956 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 13
M  V30 15 1 12 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 22948-94-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620175-54-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-12736540
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004082586 A2 2004-09-30

$RFMT $RIREG SCHEME358 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Acetylindole-3-carboxaldehyde
C11H9NO2
22948-94-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5063 1.4647 0.0 0
M  V30 2 C 0.0000 1.7848 0.0 0
M  V30 3 O 1.9823 0.0000 0.0 0
M  V30 4 C 6.2010 4.1752 0.0 0
M  V30 5 O 7.2314 3.0307 0.0 0
M  V30 6 C 2.2166 4.1154 0.0 0
M  V30 7 C 3.5503 4.8854 0.0 0
M  V30 8 N 2.5368 2.6090 0.0 0
M  V30 9 C 0.8829 4.8854 0.0 0
M  V30 10 C 4.6946 3.8549 0.0 0
M  V30 11 C 3.5503 6.4254 0.0 0
M  V30 12 C 4.0683 2.4481 0.0 0
M  V30 13 C 0.8829 6.4254 0.0 0
M  V30 14 C 2.2166 7.1954 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 2 4 5
M  V30 5 1 4 10
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[3-[(Methylamino)methyl]-1H-indol-1-yl]ethanone
C12H14N2O
620175-54-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5064 1.4647 0.0 0
M  V30 2 C 1.9823 0.0000 0.0 0
M  V30 3 O 0.0000 1.7849 0.0 0
M  V30 4 C 6.2012 4.1753 0.0 0
M  V30 5 N 7.2316 3.0307 0.0 0
M  V30 6 C 8.7380 3.3509 0.0 0
M  V30 7 C 2.2167 4.1155 0.0 0
M  V30 8 C 3.5503 4.8855 0.0 0
M  V30 9 N 2.5369 2.6091 0.0 0
M  V30 10 C 0.8830 4.8855 0.0 0
M  V30 11 C 4.6949 3.8550 0.0 0
M  V30 12 C 3.5503 6.4255 0.0 0
M  V30 13 C 4.0684 2.4482 0.0 0
M  V30 14 C 0.8830 6.4255 0.0 0
M  V30 15 C 2.2167 7.1956 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 13
M  V30 15 1 12 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 22948-94-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620175-54-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-9255737
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-(heteroaryl)methylacrylamides as Fab I inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Burgess, Walter J.; Jakas, Dalia; Huffman, William F.; Miller, William
H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas, Irene N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003088897 A2 2003-10-30

$RFMT $RIREG SCHEME359 STEP1
$RXN



  2  1
$MOL
Methan-d3-amine
CH2D3N
5581-55-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.3337 0.0 0
M  V30 2 N 0.7700 0.0000 0.0 0
M  V30 3 H 0.0000 1.3337 0.0 0 MASS=2
M  V30 4 H 0.7700 2.6673 0.0 0 MASS=2
M  V30 5 H 3.0800 1.3337 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3-bromo-α-hydroxy-4-methyl-α-(trifluoromethyl)benzeneacetate
C12H12BrF3O3
2308544-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3350 2.1037 0.0 0
M  V30 2 C 6.1050 3.4374 0.0 0
M  V30 3 C 6.6687 1.3337 0.0 0
M  V30 4 O 4.5650 0.7700 0.0 0
M  V30 5 O 7.6450 3.4374 0.0 0
M  V30 6 O 5.3350 4.7712 0.0 0
M  V30 7 F 7.4387 2.6673 0.0 0
M  V30 8 F 8.0023 0.5637 0.0 0
M  V30 9 F 5.8986 0.0000 0.0 0
M  V30 10 C 8.4151 4.7712 0.0 0
M  V30 11 C 9.9551 4.7712 0.0 0
M  V30 12 Br 0.0000 2.1037 0.0 0
M  V30 13 C 0.0000 5.1838 0.0 0
M  V30 14 C 4.0012 2.8737 0.0 0
M  V30 15 C 2.6675 2.1037 0.0 0
M  V30 16 C 4.0012 4.4137 0.0 0
M  V30 17 C 1.3338 2.8737 0.0 0
M  V30 18 C 2.6675 5.1838 0.0 0
M  V30 19 C 1.3338 4.4137 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 14
M  V30 5 1 2 5
M  V30 6 2 2 6
M  V30 7 1 3 7
M  V30 8 1 3 8
M  V30 9 1 3 9
M  V30 10 1 5 10
M  V30 11 1 10 11
M  V30 12 1 12 17
M  V30 13 1 13 19
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-α-hydroxy-4-methyl-N-(methyl-d3)-α-(trifluoromethyl)benzeneacetamide
C11H8BrD3F3NO2
2308544-94-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.1038 0.0 0
M  V30 2 C 3.8500 3.4374 0.0 0
M  V30 3 C 3.2864 1.3338 0.0 0
M  V30 4 O 5.3900 0.7700 0.0 0
M  V30 5 N 2.3100 3.4374 0.0 0
M  V30 6 O 4.6200 4.7711 0.0 0
M  V30 7 F 2.5164 2.6674 0.0 0
M  V30 8 F 1.9527 0.5638 0.0 0
M  V30 9 F 4.0564 0.0000 0.0 0
M  V30 10 C 1.5400 4.7711 0.0 0
M  V30 11 Br 9.9549 2.1038 0.0 0
M  V30 12 C 9.9549 5.1838 0.0 0
M  V30 13 C 5.9538 2.8738 0.0 0
M  V30 14 C 7.2874 2.1038 0.0 0
M  V30 15 C 5.9538 4.4138 0.0 0
M  V30 16 C 8.6211 2.8738 0.0 0
M  V30 17 C 7.2874 5.1838 0.0 0
M  V30 18 C 8.6211 4.4138 0.0 0
M  V30 19 H 2.3100 6.1049 0.0 0 MASS=2
M  V30 20 H 0.7700 6.1049 0.0 0 MASS=2
M  V30 21 H 0.0000 4.7711 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 13
M  V30 5 1 2 5
M  V30 6 2 2 6
M  V30 7 1 3 7
M  V30 8 1 3 8
M  V30 9 1 3 9
M  V30 10 1 5 10
M  V30 11 1 10 19
M  V30 12 1 10 20
M  V30 13 1 10 21
M  V30 14 1 11 16
M  V30 15 1 12 18
M  V30 16 2 13 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 5581-55-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2308544-93-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2308544-94-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-20928896
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-24-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of imidazo[1,2-a]pyrazines and related compounds as PI3K-γ
inhibitors useful for treatment of cancer, autoimmune, cardiovascular,
and neurodegenerative diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Douty, Brent; Buesking, Andrew W.; Burns, David M.; Combs, Andrew P.;
Falahatpisheh, Nikoo; Jalluri, Ravi Kumar; Levy, Daniel; Polam, Padmaja;
Shao, Lixin; Shepard, Stacey; Shvartsbart, Artem; Sparks, Richard B.;
Yue, Eddy W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019079469 A1 2019-04-25

$RFMT $RIREG SCHEME360 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-N-[(4-methoxyphenyl)methyl]-3-nitrobenzenesulfonamide
C14H13FN2O5S
2345982-64-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6687 3.0801 0.0 0 VAL=6
M  V30 2 N 8.0023 3.8501 0.0 0
M  V30 3 O 7.4387 1.7464 0.0 0
M  V30 4 O 5.8986 4.4137 0.0 0
M  V30 5 C 9.3360 3.0801 0.0 0
M  V30 6 N 1.3338 3.0801 0.0 0 VAL=5
M  V30 7 O 1.3338 4.6201 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 F 1.3338 0.0000 0.0 0
M  V30 10 O 14.6708 6.1601 0.0 0
M  V30 11 C 16.0046 5.3901 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 4.0012 3.0801 0.0 0
M  V30 14 C 5.3348 0.7700 0.0 0
M  V30 15 C 2.6675 2.3101 0.0 0
M  V30 16 C 4.0012 0.0000 0.0 0
M  V30 17 C 2.6675 0.7700 0.0 0
M  V30 18 C 10.6698 3.8501 0.0 0
M  V30 19 C 12.0035 3.0801 0.0 0
M  V30 20 C 10.6698 5.3901 0.0 0
M  V30 21 C 13.3372 3.8501 0.0 0
M  V30 22 C 12.0035 6.1601 0.0 0
M  V30 23 C 13.3372 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 12
M  V30 5 1 2 5
M  V30 6 1 5 18
M  V30 7 2 6 7
M  V30 8 2 6 8
M  V30 9 1 6 15
M  V30 10 1 9 17
M  V30 11 1 10 11
M  V30 12 1 10 23
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4-Methoxyphenyl)methyl]-4-(methylamino)-3-nitrobenzenesulfonamide
C15H17N3O5S
2763824-56-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6687 4.6201 0.0 0 VAL=6
M  V30 2 N 8.0023 5.3901 0.0 0
M  V30 3 O 5.8986 5.9538 0.0 0
M  V30 4 O 7.4387 3.2864 0.0 0
M  V30 5 C 9.3360 4.6201 0.0 0
M  V30 6 N 1.3338 4.6201 0.0 0 VAL=5
M  V30 7 O 1.3338 6.1601 0.0 0
M  V30 8 O 0.0000 3.8501 0.0 0
M  V30 9 N 1.3338 1.5400 0.0 0
M  V30 10 C 1.3338 0.0000 0.0 0
M  V30 11 O 14.6708 7.7002 0.0 0
M  V30 12 C 16.0046 6.9302 0.0 0
M  V30 13 C 5.3348 3.8501 0.0 0
M  V30 14 C 4.0012 4.6201 0.0 0
M  V30 15 C 5.3348 2.3101 0.0 0
M  V30 16 C 2.6675 3.8501 0.0 0
M  V30 17 C 4.0012 1.5400 0.0 0
M  V30 18 C 2.6675 2.3101 0.0 0
M  V30 19 C 10.6698 5.3901 0.0 0
M  V30 20 C 10.6698 6.9302 0.0 0
M  V30 21 C 12.0035 4.6201 0.0 0
M  V30 22 C 12.0035 7.7002 0.0 0
M  V30 23 C 13.3372 5.3901 0.0 0
M  V30 24 C 13.3372 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 13
M  V30 5 1 2 5
M  V30 6 1 5 19
M  V30 7 2 6 7
M  V30 8 2 6 8
M  V30 9 1 6 16
M  V30 10 1 9 10
M  V30 11 1 9 18
M  V30 12 1 11 12
M  V30 13 1 11 24
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2345982-64-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2763824-56-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31826402
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds as CBP/EP300 bromodomain inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Abbineni, Chandrasekhar; Samajdar, Susanta; S. Senaiar, Ramesh; Aggunda
Renukappa, Girish; Mukherjee, Subhendu; Tatyasaheb Gore, Suraj;
Wohlfahrt, Gerd; Myllymaki, Mikko
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022053967 A1 2022-03-17

$RFMT $RIREG SCHEME361 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C12H23NO6S
2357115-97-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.9628 0.0 0
M  V30 2 C 4.0012 3.1928 0.0 0
M  V30 3 O 2.6673 3.9628 0.0 0
M  V30 4 O 4.0012 1.6528 0.0 0
M  V30 5 C 1.3337 3.1928 0.0 0
M  V30 6 C 2.1037 1.8590 0.0 0
M  V30 7 C 0.0000 2.4228 0.0 0
M  V30 8 C 0.5637 4.5265 0.0 0
M  V30 9 O 9.8884 1.3337 0.0 0
M  V30 10 C 11.2221 2.1037 0.0 0
M  V30 11 C 12.5557 1.3337 0.0 0
M  V30 12 O 13.8896 2.1037 0.0 0
M  V30 13 S 15.2232 1.3337 0.0 0 VAL=6
M  V30 14 C 15.9933 2.6675 0.0 0
M  V30 15 O 16.5569 0.5637 0.0 0
M  V30 16 O 14.4532 0.0000 0.0 0
M  V30 17 C 6.6685 3.1928 0.0 0 CFG=2
M  V30 18 C 7.0671 1.7051 0.0 0
M  V30 19 C 8.1560 3.5914 0.0 0
M  V30 20 C 8.5547 2.1037 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 17 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 20 9 CFG=1
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 2 13 16
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 17 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[trans-3-[2-(methylamino)ethoxy]cyclobutyl]carbamate
C12H24N2O3
2798770-22-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 0.5638 0.0 0
M  V30 2 C 4.0012 1.3338 0.0 0
M  V30 3 O 2.6675 0.5638 0.0 0
M  V30 4 O 4.0012 2.8739 0.0 0
M  V30 5 C 1.3337 1.3338 0.0 0
M  V30 6 C 2.1037 2.6675 0.0 0
M  V30 7 C 0.0000 2.1038 0.0 0
M  V30 8 C 0.5637 0.0000 0.0 0
M  V30 9 O 9.8884 3.1928 0.0 0
M  V30 10 C 11.2221 2.4228 0.0 0
M  V30 11 C 12.5557 3.1928 0.0 0
M  V30 12 N 13.8896 2.4228 0.0 0
M  V30 13 C 15.2232 3.1928 0.0 0
M  V30 14 C 6.6685 1.3338 0.0 0 CFG=1
M  V30 15 C 7.0671 2.8213 0.0 0
M  V30 16 C 8.1562 0.9351 0.0 0
M  V30 17 C 8.5547 2.4228 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 14 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 17 9 CFG=1
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 14 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2357115-97-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2798770-22-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33768725
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocycles as IRAK degraders and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mainolfi, Nello; Ji, Nan; Weiss, Matthew M.; Zheng, Xiaozhang; Zhang, Yi;
Fleming, Paul R.; Zhu, Xiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022147465 A1 2022-07-07

$RFMT $RIREG SCHEME362 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-chloro-5-(2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-2-pyridinecarboxylate
C14H10ClN3O3
2378819-85-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0849 6.4933 0.0 0
M  V30 2 Cl 8.1343 6.4501 0.0 0
M  V30 3 C 9.6743 3.7827 0.0 0
M  V30 4 O 10.4443 2.4491 0.0 0
M  V30 5 O 10.4443 5.1163 0.0 0
M  V30 6 C 11.9843 2.4491 0.0 0
M  V30 7 N 3.5143 3.7827 0.0 0
M  V30 8 C 2.6091 2.5368 0.0 0
M  V30 9 C 2.6091 5.0286 0.0 0
M  V30 10 C 1.1445 3.0127 0.0 0
M  V30 11 C 2.9292 1.0304 0.0 0
M  V30 12 N 1.1445 4.5527 0.0 0
M  V30 13 C 0.0000 1.9823 0.0 0
M  V30 14 C 1.7849 0.0000 0.0 0
M  V30 15 C 0.3202 0.4759 0.0 0
M  V30 16 C 5.0543 3.7827 0.0 0
M  V30 17 C 5.8243 5.1163 0.0 0
M  V30 18 C 5.8243 2.4491 0.0 0
M  V30 19 C 7.3643 5.1163 0.0 0
M  V30 20 N 7.3643 2.4491 0.0 0
M  V30 21 C 8.1343 3.7827 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 19
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 21
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 16
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 1 11 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-5-(2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-N-methyl-2-pyridinecarbox...
C14H11ClN4O2
2378819-82-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0849 6.4933 0.0 0
M  V30 2 Cl 8.1343 6.4501 0.0 0
M  V30 3 C 9.6743 3.7827 0.0 0
M  V30 4 N 10.4443 2.4491 0.0 0
M  V30 5 O 10.4443 5.1163 0.0 0
M  V30 6 C 11.9843 2.4491 0.0 0
M  V30 7 N 3.5143 3.7827 0.0 0
M  V30 8 C 2.6091 2.5368 0.0 0
M  V30 9 C 2.6091 5.0286 0.0 0
M  V30 10 C 1.1445 3.0127 0.0 0
M  V30 11 C 2.9292 1.0304 0.0 0
M  V30 12 N 1.1445 4.5527 0.0 0
M  V30 13 C 0.0000 1.9823 0.0 0
M  V30 14 C 1.7849 0.0000 0.0 0
M  V30 15 C 0.3202 0.4759 0.0 0
M  V30 16 C 5.0543 3.7827 0.0 0
M  V30 17 C 5.8243 5.1163 0.0 0
M  V30 18 C 5.8243 2.4491 0.0 0
M  V30 19 C 7.3643 5.1163 0.0 0
M  V30 20 N 7.3643 2.4491 0.0 0
M  V30 21 C 8.1343 3.7827 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 19
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 21
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 16
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 1 11 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2378819-85-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2378819-82-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-20860493
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused cyclic urea derivatives as CRHR2 antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ohmi, Masashi; Matsushita, Takeshi; Ando, Kazuo; Yamaguchi, Ryuichi;
Fukumoto, Yutaka; Magara, Ryohei; Yamagishi, Tatsuya; Takefuji, Mikito
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019198692 A1 2019-10-17

$RFMT $RIREG SCHEME363 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-(2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-6-methyl-2-pyridinecarboxylate
C15H13N3O3
2378819-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0849 6.4933 0.0 0
M  V30 2 C 5.0543 6.4501 0.0 0
M  V30 3 C 9.6743 3.7827 0.0 0
M  V30 4 O 10.4443 2.4491 0.0 0
M  V30 5 O 10.4443 5.1163 0.0 0
M  V30 6 C 11.9843 2.4491 0.0 0
M  V30 7 N 3.5143 3.7827 0.0 0
M  V30 8 C 2.6091 2.5368 0.0 0
M  V30 9 C 2.6091 5.0286 0.0 0
M  V30 10 C 1.1445 3.0127 0.0 0
M  V30 11 C 2.9292 1.0304 0.0 0
M  V30 12 N 1.1445 4.5527 0.0 0
M  V30 13 C 0.0000 1.9823 0.0 0
M  V30 14 C 1.7849 0.0000 0.0 0
M  V30 15 C 0.3202 0.4759 0.0 0
M  V30 16 C 5.0543 3.7827 0.0 0
M  V30 17 C 5.8243 5.1163 0.0 0
M  V30 18 C 5.8243 2.4491 0.0 0
M  V30 19 N 7.3643 5.1163 0.0 0
M  V30 20 C 7.3643 2.4491 0.0 0
M  V30 21 C 8.1343 3.7827 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 17
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 21
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 16
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 1 11 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(2,3-Dihydro-2-oxo-1H-benzimidazol-1-yl)-N,6-dimethyl-2-pyridinecarboxamide
C15H14N4O2
2378819-86-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0849 6.4933 0.0 0
M  V30 2 C 5.0543 6.4501 0.0 0
M  V30 3 C 9.6743 3.7827 0.0 0
M  V30 4 N 10.4443 2.4491 0.0 0
M  V30 5 O 10.4443 5.1163 0.0 0
M  V30 6 C 11.9843 2.4491 0.0 0
M  V30 7 N 3.5143 3.7827 0.0 0
M  V30 8 C 2.6091 2.5368 0.0 0
M  V30 9 C 2.6091 5.0286 0.0 0
M  V30 10 C 1.1445 3.0127 0.0 0
M  V30 11 C 2.9292 1.0304 0.0 0
M  V30 12 N 1.1445 4.5527 0.0 0
M  V30 13 C 0.0000 1.9823 0.0 0
M  V30 14 C 1.7849 0.0000 0.0 0
M  V30 15 C 0.3202 0.4759 0.0 0
M  V30 16 C 5.0543 3.7827 0.0 0
M  V30 17 C 5.8243 5.1163 0.0 0
M  V30 18 C 5.8243 2.4491 0.0 0
M  V30 19 N 7.3643 5.1163 0.0 0
M  V30 20 C 7.3643 2.4491 0.0 0
M  V30 21 C 8.1343 3.7827 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 17
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 21
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 16
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 1 11 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2378819-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2378819-86-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-20860496
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused cyclic urea derivatives as CRHR2 antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ohmi, Masashi; Matsushita, Takeshi; Ando, Kazuo; Yamaguchi, Ryuichi;
Fukumoto, Yutaka; Magara, Ryohei; Yamagishi, Tatsuya; Takefuji, Mikito
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019198692 A1 2019-10-17

$RFMT $RIREG SCHEME364 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4′-Azido[1,1′-biphenyl]-4-carboxaldehyde
C13H9N3O
2408815-29-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.6697 5.3901 0.0 0
M  V30 2 N 12.0033 4.6201 0.0 0 CHG=1 VAL=4
M  V30 3 N 13.3370 3.8501 0.0 0 CHG=-1
M  V30 4 C 1.3337 0.0000 0.0 0
M  V30 5 O 0.0000 0.7700 0.0 0
M  V30 6 C 6.6685 3.0801 0.0 0
M  V30 7 C 6.6685 4.6201 0.0 0
M  V30 8 C 8.0022 2.3101 0.0 0
M  V30 9 C 8.0022 5.3901 0.0 0
M  V30 10 C 9.3360 3.0801 0.0 0
M  V30 11 C 9.3360 4.6201 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 5.3348 0.7700 0.0 0
M  V30 14 C 4.0010 3.0801 0.0 0
M  V30 15 C 4.0010 0.0000 0.0 0
M  V30 16 C 2.6673 2.3101 0.0 0
M  V30 17 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 11
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 4 17
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[1,1′-Biphenyl]-4-methanamine, 4′-azido-N-methyl-
C14H14N4
2987103-27-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.0033 5.3901 0.0 0
M  V30 2 N 13.3370 4.6201 0.0 0
M  V30 3 C 14.6707 5.3901 0.0 0
M  V30 4 N 2.6673 0.0000 0.0 0
M  V30 5 N 1.3337 0.7700 0.0 0 CHG=1 VAL=4
M  V30 6 N 0.0000 1.5400 0.0 0 CHG=-1
M  V30 7 C 8.0022 3.0801 0.0 0
M  V30 8 C 9.3358 2.3101 0.0 0
M  V30 9 C 8.0022 4.6201 0.0 0
M  V30 10 C 10.6697 3.0801 0.0 0
M  V30 11 C 9.3358 5.3901 0.0 0
M  V30 12 C 10.6697 4.6201 0.0 0
M  V30 13 C 6.6685 2.3101 0.0 0
M  V30 14 C 6.6685 0.7700 0.0 0
M  V30 15 C 5.3348 3.0801 0.0 0
M  V30 16 C 5.3348 0.0000 0.0 0
M  V30 17 C 4.0010 2.3101 0.0 0
M  V30 18 C 4.0010 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 1 4 18
M  V30 6 2 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2408815-29-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2987103-27-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37787815
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 1,2,3-triazoles using Grignard reactions through the
protection of azides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Namioka, Rina; Suzuki, Minori; Yoshida, Suguru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Frontiers in Chemistry (Lausanne, Switzerland) (2023), 111237878

$RFMT $RIREG SCHEME365 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-Ethyl (1R,2R,3R)-5′-bromo-1′,2′-dihydro-3-methyl-2′-oxospiro[cyclopropane...
C14H14BrNO3
2414121-97-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.1588 2.6675 0.0 0
M  V30 2 O 8.9288 1.3338 0.0 0
M  V30 3 O 8.9288 4.0012 0.0 0
M  V30 4 C 10.4688 1.3338 0.0 0
M  V30 5 C 11.2389 0.0000 0.0 0
M  V30 6 C 4.5151 0.5638 0.0 0
M  V30 7 O 7.4179 5.1645 0.0 0
M  V30 8 Br 0.0000 2.0134 0.0 0
M  V30 9 C 5.2851 3.4375 0.0 0 CFG=2
M  V30 10 C 6.6188 2.6675 0.0 0 CFG=2
M  V30 11 C 3.7535 3.5984 0.0 0
M  V30 12 C 5.2851 1.8975 0.0 0 CFG=2
M  V30 13 C 5.9116 4.8443 0.0 0
M  V30 14 C 3.4334 5.1049 0.0 0
M  V30 15 C 2.6091 2.5680 0.0 0
M  V30 16 N 4.7670 5.8749 0.0 0
M  V30 17 C 1.9686 5.5808 0.0 0
M  V30 18 C 1.1444 3.0439 0.0 0
M  V30 19 C 0.8242 4.5502 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 10 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 12 6 CFG=1
M  V30 7 2 7 13
M  V30 8 1 8 18
M  V30 9 1 9 10
M  V30 10 1 9 11 CFG=3
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 1 13 16
M  V30 17 1 14 16
M  V30 18 2 14 17
M  V30 19 1 15 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 9 10 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(1R,2R,3R)-5′-Bromo-1′,2′-dihydro-N,3-dimethyl-2′-oxospiro[cyclopropane-1...
C13H13BrN2O2
2414122-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.1587 2.1038 0.0 0
M  V30 2 N 8.9287 0.7700 0.0 0
M  V30 3 O 8.9287 3.4375 0.0 0
M  V30 4 C 10.4687 0.7700 0.0 0
M  V30 5 C 4.5150 0.0000 0.0 0
M  V30 6 O 7.4178 4.6008 0.0 0
M  V30 7 Br 0.0000 1.4498 0.0 0
M  V30 8 C 5.2850 2.8738 0.0 0 CFG=2
M  V30 9 C 6.6187 2.1038 0.0 0 CFG=2
M  V30 10 C 3.7535 3.0347 0.0 0
M  V30 11 C 5.2850 1.3338 0.0 0 CFG=2
M  V30 12 C 5.9115 4.2806 0.0 0
M  V30 13 C 3.4333 4.5412 0.0 0
M  V30 14 C 2.6091 2.0043 0.0 0
M  V30 15 N 4.7670 5.3112 0.0 0
M  V30 16 C 1.9686 5.0171 0.0 0
M  V30 17 C 1.1444 2.4802 0.0 0
M  V30 18 C 0.8242 3.9865 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 9 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 11 5 CFG=1
M  V30 6 2 6 12
M  V30 7 1 7 17
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 8 12 CFG=1
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 12 15
M  V30 16 1 13 15
M  V30 17 2 13 16
M  V30 18 1 14 17
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 8 9 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2414121-97-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2414122-16-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-21868344
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM DABCO-Catalyzed Michael/Alkylation Cascade Reactions Involving
α-Substituted Ammonium Ylides for the Construction of Spirocyclopropyl
Oxindoles: Access to the Powerful Chemical Leads against HIV-1
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Lin; He, Jin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2020), 85(8), 5203-5219

$RFMT $RIREG SCHEME366 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-6-[methyl(1-methylethyl)amino]-4-[[(methylsulfonyl)oxy]methyl]-1H...
C13H19N3O4S
2421200-99-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 3.7035 0.0 0
M  V30 2 O 7.7000 5.0372 0.0 0
M  V30 3 S 9.2400 5.0372 0.0 0 VAL=6
M  V30 4 C 9.2400 3.4972 0.0 0
M  V30 5 O 10.7800 5.0372 0.0 0
M  V30 6 O 9.2400 6.5772 0.0 0
M  V30 7 O 1.1394 0.4294 0.0 0
M  V30 8 N 2.3100 6.3708 0.0 0
M  V30 9 C 0.7700 6.3708 0.0 0
M  V30 10 C 3.0800 7.7046 0.0 0
M  V30 11 C 0.0000 7.7046 0.0 0
M  V30 12 C 0.0000 5.0372 0.0 0
M  V30 13 C 4.6200 2.3699 0.0 0
M  V30 14 C 3.0800 2.3699 0.0 0
M  V30 15 C 5.3900 3.7035 0.0 0
M  V30 16 C 5.0959 0.9052 0.0 0
M  V30 17 C 2.3100 3.7035 0.0 0
M  V30 18 C 2.6041 0.9052 0.0 0
M  V30 19 N 4.6200 5.0372 0.0 0
M  V30 20 N 3.8500 0.0000 0.0 0
M  V30 21 C 3.0800 5.0372 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 3 6
M  V30 7 2 7 18
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 21
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 13 16
M  V30 16 2 14 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-4-[(methylamino)methyl]-6-[methyl(1-methylethyl)amino]-1H-pyrrolo...
C13H20N4O
2421201-00-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.7308 0.0 0
M  V30 2 N 1.3337 7.2708 0.0 0
M  V30 3 C 0.0000 8.0408 0.0 0
M  V30 4 O 4.7114 0.0000 0.0 0
M  V30 5 N 6.6685 5.7308 0.0 0
M  V30 6 C 8.0023 4.9608 0.0 0
M  V30 7 C 6.6685 7.2708 0.0 0
M  V30 8 C 8.0023 3.4207 0.0 0
M  V30 9 C 9.3360 5.7308 0.0 0
M  V30 10 C 2.6675 3.4207 0.0 0
M  V30 11 C 4.0012 2.6507 0.0 0
M  V30 12 C 2.6675 4.9608 0.0 0
M  V30 13 C 1.5229 2.3903 0.0 0
M  V30 14 C 5.3348 3.4207 0.0 0
M  V30 15 C 3.6810 1.1444 0.0 0
M  V30 16 N 4.0012 5.7308 0.0 0
M  V30 17 N 2.1494 0.9835 0.0 0
M  V30 18 C 5.3348 4.9608 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 4 15
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 18
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 13
M  V30 13 2 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2421200-99-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2421201-00-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24848992
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of azalactam compounds as HPK1 inhibitors for treating cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barber, Joyann; Cho-Schultz, Sujin; Del Bel, Matthew L.; Gallego, Rebecca
Anne; He, Mingying; Jalaie, Mehran; Kania, Robert Steven; Mctigue,
Michele Ann; Nair, Sajiv Krishnan; Schmitt, Anne-Marie Dechert; Tuttle,
Jamison Bryce; Zhou, Dahui; Zhou, Ru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021220185 A1 2021-11-04

$RFMT $RIREG SCHEME366 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-6-[methyl(1-methylethyl)amino]-4-[[(methylsulfonyl)oxy]methyl]-1H...
C13H19N3O4S
2421200-99-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 3.7035 0.0 0
M  V30 2 O 7.7000 5.0372 0.0 0
M  V30 3 S 9.2400 5.0372 0.0 0 VAL=6
M  V30 4 C 9.2400 3.4972 0.0 0
M  V30 5 O 10.7800 5.0372 0.0 0
M  V30 6 O 9.2400 6.5772 0.0 0
M  V30 7 O 1.1394 0.4294 0.0 0
M  V30 8 N 2.3100 6.3708 0.0 0
M  V30 9 C 0.7700 6.3708 0.0 0
M  V30 10 C 3.0800 7.7046 0.0 0
M  V30 11 C 0.0000 7.7046 0.0 0
M  V30 12 C 0.0000 5.0372 0.0 0
M  V30 13 C 4.6200 2.3699 0.0 0
M  V30 14 C 3.0800 2.3699 0.0 0
M  V30 15 C 5.3900 3.7035 0.0 0
M  V30 16 C 5.0959 0.9052 0.0 0
M  V30 17 C 2.3100 3.7035 0.0 0
M  V30 18 C 2.6041 0.9052 0.0 0
M  V30 19 N 4.6200 5.0372 0.0 0
M  V30 20 N 3.8500 0.0000 0.0 0
M  V30 21 C 3.0800 5.0372 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 3 6
M  V30 7 2 7 18
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 21
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 13 16
M  V30 16 2 14 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-4-[(methylamino)methyl]-6-[methyl(1-methylethyl)amino]-1H-pyrrolo...
C13H20N4O
2421201-00-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.7308 0.0 0
M  V30 2 N 1.3337 7.2708 0.0 0
M  V30 3 C 0.0000 8.0408 0.0 0
M  V30 4 O 4.7114 0.0000 0.0 0
M  V30 5 N 6.6685 5.7308 0.0 0
M  V30 6 C 8.0023 4.9608 0.0 0
M  V30 7 C 6.6685 7.2708 0.0 0
M  V30 8 C 8.0023 3.4207 0.0 0
M  V30 9 C 9.3360 5.7308 0.0 0
M  V30 10 C 2.6675 3.4207 0.0 0
M  V30 11 C 4.0012 2.6507 0.0 0
M  V30 12 C 2.6675 4.9608 0.0 0
M  V30 13 C 1.5229 2.3903 0.0 0
M  V30 14 C 5.3348 3.4207 0.0 0
M  V30 15 C 3.6810 1.1444 0.0 0
M  V30 16 N 4.0012 5.7308 0.0 0
M  V30 17 N 2.1494 0.9835 0.0 0
M  V30 18 C 5.3348 4.9608 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 4 15
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 18
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 13
M  V30 13 2 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2421200-99-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2421201-00-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-22490464
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of azalactams as HPK1 inhibitors for the treatment of cancers
and proliferative diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ahmad, Omar Khaled; Del Bel, Matthew; Gallego, Rebecca Anne; He,
Mingying; Jalaie, Mehran; Johnson, Ted William; Kania, Robert Steven;
McTigue, Michele; Nair, Sajiv Krishnan; Tuttle, Jamison Bryce; Zhou, Ru;
Zhou, Dahui
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Canada, CA3061392 A1 2020-05-15

$RFMT $RIREG SCHEME367 STEP1
$RXN



  2  1
$MOL
4,5-Dibromo-2-furancarboxylic acid
C5H2Br2O3
2434-03-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 4.0287 0.0 0
M  V30 2 O 6.6363 3.2587 0.0 0
M  V30 3 O 5.3026 5.5688 0.0 0
M  V30 4 Br 0.0000 2.9016 0.0 0
M  V30 5 Br 1.6752 0.0000 0.0 0
M  V30 6 C 3.9690 3.2587 0.0 0
M  V30 7 C 2.5620 3.8850 0.0 0
M  V30 8 O 3.8079 1.7271 0.0 0
M  V30 9 C 1.5316 2.7406 0.0 0
M  V30 10 C 2.3016 1.4070 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 9
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,5-Dibromo-N-methyl-2-furancarboxamide
C6H5Br2NO2
2411909-61-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 4.0287 0.0 0
M  V30 2 N 6.6363 3.2587 0.0 0
M  V30 3 O 5.3026 5.5688 0.0 0
M  V30 4 C 7.9700 4.0287 0.0 0
M  V30 5 Br 1.6751 0.0000 0.0 0
M  V30 6 Br 0.0000 2.9016 0.0 0
M  V30 7 C 3.9690 3.2587 0.0 0
M  V30 8 C 3.8079 1.7271 0.0 0
M  V30 9 O 2.5620 3.8850 0.0 0
M  V30 10 C 2.3016 1.4070 0.0 0
M  V30 11 C 1.5316 2.7406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2434-03-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2411909-61-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33528355
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate reaction conditions also shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fragment-based Scaffold Hopping: Identification of Potent, Selective, and
Highly Soluble Bromo and Extra Terminal Domain (BET) Second Bromodomain
(BD2) Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Seal, Jonathan T.; Atkinson, Stephen J.; Bamborough, Paul; Bassil, Anna;
Chung, Chun-wa; Foley, James; Gordon, Laurie; Grandi, Paola; Gray, James
R. J.; Harrison, Lee A.; Kruger, Ryan G.; Matteo, Jeanne J.; McCabe,
Michael T.; Messenger, Cassie; Mitchell, Darren; Phillipou, Alex;
Preston, Alex; Prinjha, Rab K.; Rianjongdee, Francesco; Rioja,
Inmaculada; Taylor, Simon; Wall, Ian D.; Watson, Robert J.; Woolven,
James M.; Wyce, Anastasia; Zhang, Xi-Ping; Demont, Emmanuel H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(15), 10772-10805

$RFMT $RIREG SCHEME368 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,5-Difluorobenzaldehyde
C7H4F2O
32085-88-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.6201 0.0 0
M  V30 2 O 6.6686 3.8500 0.0 0
M  V30 3 F 2.6675 0.0000 0.0 0
M  V30 4 F 0.0000 4.6201 0.0 0
M  V30 5 C 4.0011 3.8500 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6675 4.6201 0.0 0
M  V30 8 C 2.6675 1.5400 0.0 0
M  V30 9 C 1.3338 3.8500 0.0 0
M  V30 10 C 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 8
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Di-tert-butyl dicarbonate
C10H18O5
24424-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 O 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6685 1.3337 0.0 0
M  V30 10 O 8.0023 0.5637 0.0 0
M  V30 11 O 6.6685 2.8737 0.0 0
M  V30 12 C 9.3360 1.3337 0.0 0
M  V30 13 C 10.1060 0.0000 0.0 0
M  V30 14 C 10.6697 2.1037 0.0 0
M  V30 15 C 8.5660 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(3,5-difluorophenyl)methyl]-N-methylcarbamate
C13H17F2NO2
2201100-82-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.6201 0.0 0
M  V30 2 N 6.6685 3.8501 0.0 0
M  V30 3 C 8.0022 4.6201 0.0 0
M  V30 4 C 6.6685 2.3101 0.0 0
M  V30 5 O 9.3360 3.8501 0.0 0
M  V30 6 O 8.0022 6.1601 0.0 0
M  V30 7 C 10.6697 4.6201 0.0 0
M  V30 8 C 9.8996 5.9538 0.0 0
M  V30 9 C 12.0033 5.3901 0.0 0
M  V30 10 C 11.4397 3.2864 0.0 0
M  V30 11 F 2.6673 0.0000 0.0 0
M  V30 12 F 0.0000 4.6201 0.0 0
M  V30 13 C 4.0012 3.8501 0.0 0
M  V30 14 C 4.0012 2.3101 0.0 0
M  V30 15 C 2.6673 4.6201 0.0 0
M  V30 16 C 2.6673 1.5400 0.0 0
M  V30 17 C 1.3337 3.8501 0.0 0
M  V30 18 C 1.3337 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 16
M  V30 12 1 12 17
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 32085-88-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 24424-99-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2201100-82-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35121412
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Pyrazolopyridine Derivatives as HPK1 Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ye, Qinda; Liu, Kai; Ye, Hai-Fen; Pan, Jun; Sokolsky, Alexander; Wang,
Anlai; Zhang, Ke; Hummel, Joshua R.; Kong, Ling; Behshad, Elham; He, Xin;
Conlen, Patricia; Stump, Kristine; Ye, Min; Diamond, Sharon; Covington,
Maryanne; Yeleswaram, Swamy; Atasoylu, Onur; Vechorkin, Oleg; Yao,
Wenqing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2023), 14(1), 5-10

$RFMT $RIREG SCHEME368 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,5-Difluorobenzaldehyde
C7H4F2O
32085-88-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.6201 0.0 0
M  V30 2 O 6.6686 3.8500 0.0 0
M  V30 3 F 2.6675 0.0000 0.0 0
M  V30 4 F 0.0000 4.6201 0.0 0
M  V30 5 C 4.0011 3.8500 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6675 4.6201 0.0 0
M  V30 8 C 2.6675 1.5400 0.0 0
M  V30 9 C 1.3338 3.8500 0.0 0
M  V30 10 C 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 8
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Di-tert-butyl dicarbonate
C10H18O5
24424-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 O 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6685 1.3337 0.0 0
M  V30 10 O 8.0023 0.5637 0.0 0
M  V30 11 O 6.6685 2.8737 0.0 0
M  V30 12 C 9.3360 1.3337 0.0 0
M  V30 13 C 10.1060 0.0000 0.0 0
M  V30 14 C 10.6697 2.1037 0.0 0
M  V30 15 C 8.5660 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(3,5-difluorophenyl)methyl]-N-methylcarbamate
C13H17F2NO2
2201100-82-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.6201 0.0 0
M  V30 2 N 6.6685 3.8501 0.0 0
M  V30 3 C 8.0022 4.6201 0.0 0
M  V30 4 C 6.6685 2.3101 0.0 0
M  V30 5 O 9.3360 3.8501 0.0 0
M  V30 6 O 8.0022 6.1601 0.0 0
M  V30 7 C 10.6697 4.6201 0.0 0
M  V30 8 C 9.8996 5.9538 0.0 0
M  V30 9 C 12.0033 5.3901 0.0 0
M  V30 10 C 11.4397 3.2864 0.0 0
M  V30 11 F 2.6673 0.0000 0.0 0
M  V30 12 F 0.0000 4.6201 0.0 0
M  V30 13 C 4.0012 3.8501 0.0 0
M  V30 14 C 4.0012 2.3101 0.0 0
M  V30 15 C 2.6673 4.6201 0.0 0
M  V30 16 C 2.6673 1.5400 0.0 0
M  V30 17 C 1.3337 3.8501 0.0 0
M  V30 18 C 1.3337 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 16
M  V30 12 1 12 17
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 32085-88-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 24424-99-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2201100-82-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-19940144
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazolopyridine derivatives as HPK1 modulators and uses
thereof for the treatment of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ye, Hai-Fen; Vechorkin, Oleg; Pan, Jun; Liu, Kai; Sokolsky, Alexander;
Wang, Anlai; Ye, Qinda; Yao, Wenqing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018049200 A1 2018-03-15

$RFMT $RIREG SCHEME369 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyridine, 5-bromo-2-chloro-, 1-oxide
C5H3BrClNO
889865-43-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.5400 0.0000 0.0 0
M  V30 2 Cl 0.0000 2.6673 0.0 0
M  V30 3 Br 6.1601 2.6673 0.0 0
M  V30 4 N 2.3101 1.3337 0.0 0 VAL=5
M  V30 5 C 1.5400 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 4
M  V30 2 1 2 5
M  V30 3 1 3 8
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Di-tert-butyl dicarbonate
C10H18O5
24424-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 O 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6685 1.3337 0.0 0
M  V30 10 O 8.0023 0.5637 0.0 0
M  V30 11 O 6.6685 2.8737 0.0 0
M  V30 12 C 9.3360 1.3337 0.0 0
M  V30 13 C 10.1060 0.0000 0.0 0
M  V30 14 C 10.6697 2.1037 0.0 0
M  V30 15 C 8.5660 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-(5-bromo-1-oxido-2-pyridinyl)-N-methylcarbamate
C11H15BrN2O3
1801986-35-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 5.3348 0.0000 0.0 0
M  V30 4 O 8.0023 1.5400 0.0 0
M  V30 5 O 6.6685 3.8501 0.0 0
M  V30 6 C 9.3360 2.3101 0.0 0
M  V30 7 C 10.1060 0.9764 0.0 0
M  V30 8 C 10.6697 3.0801 0.0 0
M  V30 9 C 8.5660 3.6437 0.0 0
M  V30 10 O 2.6673 0.0000 0.0 0
M  V30 11 Br 0.0000 4.6201 0.0 0
M  V30 12 C 4.0012 2.3101 0.0 0
M  V30 13 N 2.6673 1.5400 0.0 0 VAL=5
M  V30 14 C 4.0012 3.8501 0.0 0
M  V30 15 C 1.3337 2.3101 0.0 0
M  V30 16 C 2.6673 4.6201 0.0 0
M  V30 17 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 2 10 13
M  V30 11 1 11 17
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 889865-43-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 24424-99-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1801986-35-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-12397592
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile Route to 2-Fluoropyridines via 2-Pyridyltrialkylammonium Salts
Prepared from Pyridine N-Oxides and Application to 18F-Labeling
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xiong, Hui; Hoye, Adam T.; Fan, Kuo-Hsien; Li, Ximin; Clemens, Jennifer;
Horchler, Carey L.; Lim, Nathaniel C.; Attardo, Giorgio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2015), 17(15), 3726-3729

$RFMT $RIREG SCHEME370 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2′,3′-Dihydrospiro[1,3-dioxolane-2,1′-[1H]indene]-5′-carboxaldehyde
C12H12O3
908860-66-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.4027 2.4782 0.0 0
M  V30 2 O 9.1727 3.8119 0.0 0
M  V30 3 C 2.2763 2.1580 0.0 0
M  V30 4 C 3.7826 2.4782 0.0 0
M  V30 5 C 2.1154 0.6265 0.0 0
M  V30 6 O 0.7700 1.8379 0.0 0
M  V30 7 O 2.4373 3.6896 0.0 0
M  V30 8 C 4.5526 1.1446 0.0 0
M  V30 9 C 4.5526 3.8119 0.0 0
M  V30 10 C 3.5222 0.0000 0.0 0
M  V30 11 C 0.0000 3.1715 0.0 0
M  V30 12 C 1.0304 4.3161 0.0 0
M  V30 13 C 6.0927 1.1446 0.0 0
M  V30 14 C 6.0927 3.8119 0.0 0
M  V30 15 C 6.8627 2.4782 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 15
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 8 10
M  V30 13 2 8 13
M  V30 14 1 9 14
M  V30 15 1 11 12
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Di-tert-butyl dicarbonate
C10H18O5
24424-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 O 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6685 1.3337 0.0 0
M  V30 10 O 8.0023 0.5637 0.0 0
M  V30 11 O 6.6685 2.8737 0.0 0
M  V30 12 C 9.3360 1.3337 0.0 0
M  V30 13 C 10.1060 0.0000 0.0 0
M  V30 14 C 10.6697 2.1037 0.0 0
M  V30 15 C 8.5660 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-[(2′,3′-dihydrospiro[1,3-dioxolane-2,1′-[1H]inden]-5′-yl)met...
C18H25NO4
1859112-13-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.4027 4.2074 0.0 0
M  V30 2 N 9.1727 2.8737 0.0 0
M  V30 3 C 10.7128 2.8737 0.0 0
M  V30 4 C 8.4027 1.5400 0.0 0
M  V30 5 O 11.4828 1.5400 0.0 0
M  V30 6 O 11.4828 4.2074 0.0 0
M  V30 7 C 13.0228 1.5400 0.0 0
M  V30 8 C 13.0228 3.0801 0.0 0
M  V30 9 C 14.5629 1.5400 0.0 0
M  V30 10 C 13.0228 0.0000 0.0 0
M  V30 11 C 2.2763 4.5277 0.0 0
M  V30 12 C 3.7826 4.2074 0.0 0
M  V30 13 C 2.1154 6.0593 0.0 0
M  V30 14 O 0.7700 4.8479 0.0 0
M  V30 15 O 2.4373 2.9960 0.0 0
M  V30 16 C 4.5526 5.5412 0.0 0
M  V30 17 C 4.5526 2.8737 0.0 0
M  V30 18 C 3.5222 6.6856 0.0 0
M  V30 19 C 0.0000 3.5140 0.0 0
M  V30 20 C 1.0304 2.3696 0.0 0
M  V30 21 C 6.0927 5.5412 0.0 0
M  V30 22 C 6.0927 2.8737 0.0 0
M  V30 23 C 6.8627 4.2074 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 12 17
M  V30 17 1 13 18
M  V30 18 1 14 19
M  V30 19 1 15 20
M  V30 20 1 16 18
M  V30 21 2 16 21
M  V30 22 1 17 22
M  V30 23 1 19 20
M  V30 24 1 21 23
M  V30 25 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 908860-66-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 24424-99-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1859112-13-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-12122376
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of sodium borohydride (stage 2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Small-Molecule CD4-Mimics: Structure-Based Optimization of HIV-1 Entry
Inhibition
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Melillo, Bruno; Liang, Shuaiyi; Park, Jongwoo; Schon, Arne; Courter, Joel
R.; LaLonde, Judith M.; Wendler, Daniel J.; Princiotto, Amy M.; Seaman,
Michael S.; Freire, Ernesto; Sodroski, Joseph; Madani, Navid;
Hendrickson, Wayne A.; Smith, Amos B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2016), 7(3), 330-334

$RFMT $RIREG SCHEME370 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2′,3′-Dihydrospiro[1,3-dioxolane-2,1′-[1H]indene]-5′-carboxaldehyde
C12H12O3
908860-66-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.4027 2.4782 0.0 0
M  V30 2 O 9.1727 3.8119 0.0 0
M  V30 3 C 2.2763 2.1580 0.0 0
M  V30 4 C 3.7826 2.4782 0.0 0
M  V30 5 C 2.1154 0.6265 0.0 0
M  V30 6 O 0.7700 1.8379 0.0 0
M  V30 7 O 2.4373 3.6896 0.0 0
M  V30 8 C 4.5526 1.1446 0.0 0
M  V30 9 C 4.5526 3.8119 0.0 0
M  V30 10 C 3.5222 0.0000 0.0 0
M  V30 11 C 0.0000 3.1715 0.0 0
M  V30 12 C 1.0304 4.3161 0.0 0
M  V30 13 C 6.0927 1.1446 0.0 0
M  V30 14 C 6.0927 3.8119 0.0 0
M  V30 15 C 6.8627 2.4782 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 15
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 8 10
M  V30 13 2 8 13
M  V30 14 1 9 14
M  V30 15 1 11 12
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Di-tert-butyl dicarbonate
C10H18O5
24424-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 O 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6685 1.3337 0.0 0
M  V30 10 O 8.0023 0.5637 0.0 0
M  V30 11 O 6.6685 2.8737 0.0 0
M  V30 12 C 9.3360 1.3337 0.0 0
M  V30 13 C 10.1060 0.0000 0.0 0
M  V30 14 C 10.6697 2.1037 0.0 0
M  V30 15 C 8.5660 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-[(2′,3′-dihydrospiro[1,3-dioxolane-2,1′-[1H]inden]-5′-yl)met...
C18H25NO4
1859112-13-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.4027 4.2074 0.0 0
M  V30 2 N 9.1727 2.8737 0.0 0
M  V30 3 C 10.7128 2.8737 0.0 0
M  V30 4 C 8.4027 1.5400 0.0 0
M  V30 5 O 11.4828 1.5400 0.0 0
M  V30 6 O 11.4828 4.2074 0.0 0
M  V30 7 C 13.0228 1.5400 0.0 0
M  V30 8 C 13.0228 3.0801 0.0 0
M  V30 9 C 14.5629 1.5400 0.0 0
M  V30 10 C 13.0228 0.0000 0.0 0
M  V30 11 C 2.2763 4.5277 0.0 0
M  V30 12 C 3.7826 4.2074 0.0 0
M  V30 13 C 2.1154 6.0593 0.0 0
M  V30 14 O 0.7700 4.8479 0.0 0
M  V30 15 O 2.4373 2.9960 0.0 0
M  V30 16 C 4.5526 5.5412 0.0 0
M  V30 17 C 4.5526 2.8737 0.0 0
M  V30 18 C 3.5222 6.6856 0.0 0
M  V30 19 C 0.0000 3.5140 0.0 0
M  V30 20 C 1.0304 2.3696 0.0 0
M  V30 21 C 6.0927 5.5412 0.0 0
M  V30 22 C 6.0927 2.8737 0.0 0
M  V30 23 C 6.8627 4.2074 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 12 17
M  V30 17 1 13 18
M  V30 18 1 14 19
M  V30 19 1 15 20
M  V30 20 1 16 18
M  V30 21 2 16 21
M  V30 22 1 17 22
M  V30 23 1 19 20
M  V30 24 1 21 23
M  V30 25 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 908860-66-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 24424-99-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1859112-13-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-15856376
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 1H-indene compounds as CD4-mimetics inhibiting HIV-1 entry
for the treatment of HIV infection
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Smith, Amos B., III; Sodroski, Joseph; Madani, Navid; Melillo, Bruno
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016025681 A1 2016-02-18

$RFMT $RIREG SCHEME371 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-[3-fluoro-4-[(3,4,5-trimethoxyphenyl)methoxy]phenyl]acetamide
C18H19ClFNO5
2442526-25-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 4.0012 0.0 0
M  V30 2 C 0.0000 2.6675 0.0 0
M  V30 3 O 2.3101 6.6687 0.0 0
M  V30 4 C 3.0801 8.0023 0.0 0
M  V30 5 O 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 6.9302 4.0012 0.0 0
M  V30 8 O 7.7002 5.3348 0.0 0
M  V30 9 F 9.2402 8.0023 0.0 0
M  V30 10 N 13.8603 5.3348 0.0 0
M  V30 11 C 14.6303 4.0012 0.0 0
M  V30 12 C 16.1704 4.0012 0.0 0
M  V30 13 O 13.8603 2.6675 0.0 0
M  V30 14 Cl 16.9404 2.6675 0.0 0
M  V30 15 C 2.3101 4.0012 0.0 0
M  V30 16 C 3.0801 5.3348 0.0 0
M  V30 17 C 3.0801 2.6675 0.0 0
M  V30 18 C 4.6201 5.3348 0.0 0
M  V30 19 C 4.6201 2.6675 0.0 0
M  V30 20 C 5.3901 4.0012 0.0 0
M  V30 21 C 9.2402 5.3348 0.0 0
M  V30 22 C 10.0102 6.6687 0.0 0
M  V30 23 C 10.0102 4.0012 0.0 0
M  V30 24 C 11.5503 6.6687 0.0 0
M  V30 25 C 11.5503 4.0012 0.0 0
M  V30 26 C 12.3203 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 3 4
M  V30 4 1 3 16
M  V30 5 1 5 6
M  V30 6 1 5 17
M  V30 7 1 7 8
M  V30 8 1 7 20
M  V30 9 1 8 21
M  V30 10 1 9 22
M  V30 11 1 10 11
M  V30 12 1 10 26
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[3-Fluoro-4-[(3,4,5-trimethoxyphenyl)methoxy]phenyl]-2-(methylamino)acetamide
C19H23FN2O5
2442526-48-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9301 4.0011 0.0 0
M  V30 2 O 7.7001 5.3348 0.0 0
M  V30 3 O 2.3100 6.6686 0.0 0
M  V30 4 C 3.0800 8.0022 0.0 0
M  V30 5 O 2.3100 1.3337 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 O 0.7700 4.0011 0.0 0
M  V30 8 C 0.0000 2.6675 0.0 0
M  V30 9 F 9.2401 8.0022 0.0 0
M  V30 10 N 13.8602 5.3348 0.0 0
M  V30 11 C 14.6302 4.0011 0.0 0
M  V30 12 C 16.1702 4.0011 0.0 0
M  V30 13 O 13.8602 2.6675 0.0 0
M  V30 14 N 16.9402 2.6675 0.0 0
M  V30 15 C 18.4802 2.6675 0.0 0
M  V30 16 C 5.3901 4.0011 0.0 0
M  V30 17 C 4.6201 5.3348 0.0 0
M  V30 18 C 4.6201 2.6675 0.0 0
M  V30 19 C 3.0800 5.3348 0.0 0
M  V30 20 C 3.0800 2.6675 0.0 0
M  V30 21 C 2.3100 4.0011 0.0 0
M  V30 22 C 9.2401 5.3348 0.0 0
M  V30 23 C 10.0101 6.6686 0.0 0
M  V30 24 C 10.0101 4.0011 0.0 0
M  V30 25 C 11.5501 6.6686 0.0 0
M  V30 26 C 11.5501 4.0011 0.0 0
M  V30 27 C 12.3201 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 22
M  V30 4 1 3 4
M  V30 5 1 3 19
M  V30 6 1 5 6
M  V30 7 1 5 20
M  V30 8 1 7 8
M  V30 9 1 7 21
M  V30 10 1 9 23
M  V30 11 1 10 11
M  V30 12 1 10 27
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2442526-25-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2442526-48-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-22746480
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate reaction conditions also shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of tetrazole derivatives as caspase inhibitors for the
treatment of inflammatory, infectious and neoplastic diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Doemling, Alexander Stephan Siegfried; Spanu, Pietro; Ulgheri, Fausta
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP3666769 A1 2020-06-17

$RFMT $RIREG SCHEME372 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (4S)-5-[bis(phenylmethyl)amino]-5-oxo-4-[[(phenylmethoxy)carbonyl]amin...
C28H30N2O5
2445875-74-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 8.4700 0.0 0
M  V30 2 C 5.3347 6.9300 0.0 0
M  V30 3 C 4.0011 9.2400 0.0 0
M  V30 4 C 6.6685 9.2400 0.0 0
M  V30 5 C 6.6685 6.1600 0.0 0 CFG=2
M  V30 6 O 4.0011 6.1600 0.0 0
M  V30 7 N 8.0021 6.9300 0.0 0
M  V30 8 C 6.6685 4.6200 0.0 0
M  V30 9 C 9.3358 6.1600 0.0 0
M  V30 10 C 5.3347 3.8500 0.0 0
M  V30 11 O 10.6696 6.9300 0.0 0
M  V30 12 O 9.3358 4.6200 0.0 0
M  V30 13 C 5.3347 2.3100 0.0 0
M  V30 14 C 12.0032 6.1600 0.0 0
M  V30 15 O 4.0011 1.5400 0.0 0
M  V30 16 O 6.6685 1.5400 0.0 0
M  V30 17 C 4.0011 0.0000 0.0 0
M  V30 18 C 2.6674 8.4700 0.0 0
M  V30 19 C 2.6674 6.9300 0.0 0
M  V30 20 C 1.3338 9.2400 0.0 0
M  V30 21 C 1.3338 6.1600 0.0 0
M  V30 22 C 0.0000 8.4700 0.0 0
M  V30 23 C 0.0000 6.9300 0.0 0
M  V30 24 C 6.6685 10.7800 0.0 0
M  V30 25 C 5.3347 11.5500 0.0 0
M  V30 26 C 8.0021 11.5500 0.0 0
M  V30 27 C 5.3347 13.0900 0.0 0
M  V30 28 C 8.0021 13.0900 0.0 0
M  V30 29 C 6.6685 13.8600 0.0 0
M  V30 30 C 13.3369 6.9300 0.0 0
M  V30 31 C 14.6705 6.1600 0.0 0
M  V30 32 C 13.3369 8.4700 0.0 0
M  V30 33 C 16.0043 6.9300 0.0 0
M  V30 34 C 14.6705 9.2400 0.0 0
M  V30 35 C 16.0043 8.4700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 18
M  V30 7 1 4 24
M  V30 8 1 5 7
M  V30 9 1 5 8 CFG=1
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 1 13 15
M  V30 17 2 13 16
M  V30 18 1 14 30
M  V30 19 1 15 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Phenylmethyl N-[(1S)-1-[[bis(phenylmethyl)amino]carbonyl]-4-(methylamino)-4-o...
C28H31N3O4
2445875-78-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 8.4700 0.0 0
M  V30 2 C 5.3347 6.9300 0.0 0
M  V30 3 C 4.0011 9.2400 0.0 0
M  V30 4 C 6.6685 9.2400 0.0 0
M  V30 5 C 6.6685 6.1600 0.0 0 CFG=2
M  V30 6 O 4.0011 6.1600 0.0 0
M  V30 7 N 8.0021 6.9300 0.0 0
M  V30 8 C 6.6685 4.6200 0.0 0
M  V30 9 C 9.3358 6.1600 0.0 0
M  V30 10 C 5.3347 3.8500 0.0 0
M  V30 11 O 10.6696 6.9300 0.0 0
M  V30 12 O 9.3358 4.6200 0.0 0
M  V30 13 C 5.3347 2.3100 0.0 0
M  V30 14 C 12.0032 6.1600 0.0 0
M  V30 15 N 4.0011 1.5400 0.0 0
M  V30 16 O 6.6685 1.5400 0.0 0
M  V30 17 C 4.0011 0.0000 0.0 0
M  V30 18 C 2.6674 8.4700 0.0 0
M  V30 19 C 2.6674 6.9300 0.0 0
M  V30 20 C 1.3338 9.2400 0.0 0
M  V30 21 C 1.3338 6.1600 0.0 0
M  V30 22 C 0.0000 8.4700 0.0 0
M  V30 23 C 0.0000 6.9300 0.0 0
M  V30 24 C 6.6685 10.7800 0.0 0
M  V30 25 C 5.3347 11.5500 0.0 0
M  V30 26 C 8.0021 11.5500 0.0 0
M  V30 27 C 5.3347 13.0900 0.0 0
M  V30 28 C 8.0021 13.0900 0.0 0
M  V30 29 C 6.6685 13.8600 0.0 0
M  V30 30 C 13.3369 6.9300 0.0 0
M  V30 31 C 14.6705 6.1600 0.0 0
M  V30 32 C 13.3369 8.4700 0.0 0
M  V30 33 C 16.0043 6.9300 0.0 0
M  V30 34 C 14.6705 9.2400 0.0 0
M  V30 35 C 16.0043 8.4700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 18
M  V30 7 1 4 24
M  V30 8 1 5 7
M  V30 9 1 5 8 CFG=1
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 1 13 15
M  V30 17 2 13 16
M  V30 18 1 14 30
M  V30 19 1 15 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2445875-74-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2445875-78-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-22833745
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Syntheses of enantiopure 1,2-ethylenediamines with tethered secondary
amines of the formula H2NCH2CH[(CH2)nNHMe]NH2 (n = 1 - 4) from α-amino
acids: New agents for asymmetric catalysis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kabes, Connor Q.; Gunn, Jack H.; Selbst, Maximilian A.; Lucas, Reagan F.;
Gladysz, John A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2020), 52(21), 3277-3285

$RFMT $RIREG SCHEME373 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-chloropyridine-2-carboxylate
C7H6ClNO2
24484-93-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 0.0000 0.0 0
M  V30 4 C 8.0021 1.5400 0.0 0
M  V30 5 Cl 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 N 4.0011 3.8500 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-methylpicolinamide
C7H7ClN2O
220000-87-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 0.0000 0.0 0
M  V30 4 C 8.0021 1.5400 0.0 0
M  V30 5 Cl 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 N 4.0011 3.8500 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 24484-93-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 220000-87-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-12116347
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4-Chloro-N-methylpicolinamide (D.20): A solution of methyl
4-chloropicolinate (D.19) (1.72 g, 10 mmol) in methanol (10 mL) was
treated with 2 M methylamine in methanol (20 mL) at 0 °C. The mixture was
stirred at 5°C for 3 hr. The reaction mixture was concentrated and the
residue was dissolved in ethyl acetate and washed with brine, dried,
concentrated to give 4-chloro-N-methylpicolinamide (D.20) as colorless
oil (1.70 g, 99%). LCMS-ESI (POS), M/Z, M+1: Found 171.1, Calculated
171.0.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Alkynyl alcohols as kinase inhibitors and their preparation,
pharmaceutical compositions and use in the treatment of inflammation and
inflammatory disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Guoqing; Cushing, Timothy D.; Fisher, Benjamin; He, Xiao; Li,
Kexue; Li, Zhihong; McGee, Lawrence R.; Pattaropong, Vatee; Faulder,
Paul; Seganish, Jennifer L.; Shin, Youngsook
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009158011 A1 2009-12-30

$RFMT $RIREG SCHEME373 STEP1
$RXN



  2  1
$MOL
Methyl 4-chloropyridine-2-carboxylate
C7H6ClNO2
24484-93-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 0.0000 0.0 0
M  V30 4 C 8.0021 1.5400 0.0 0
M  V30 5 Cl 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 N 4.0011 3.8500 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-methylpicolinamide
C7H7ClN2O
220000-87-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 0.0000 0.0 0
M  V30 4 C 8.0021 1.5400 0.0 0
M  V30 5 Cl 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 N 4.0011 3.8500 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 24484-93-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 220000-87-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15207746
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7786-30-3
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 1) Synthesis of (4-Chloropyridine-2-carboxylic acid)-methylamide (2) 13 g
(62.5 mmol) of 1 are dissolved in THF together with 2.98 g (31.2 25 mmol)
of water free magnesium chloride. After 5 min, 110 ml methylamine
solution (2M in THF) are added dropwise within 10 min. This suspension is
stirred for 2 hours at room temperature. The reaction mixture is mixed
with 120 ml water and 63 ml 1N HCl solution and extracted 3 x with ethyl
acetate. The pooled organic phases are washed with saturated NaCl
solution, dried with Na2SO4, filtered and evaporated to dryness. Yield:
10.5 g (98.5 %) of 2, colorless oil
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation and formulations of diacylhydrazine derivatives capable of
inhibiting raf-kinases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Finsinger, Dirk; Buchstaller, Hans-Peter; Burgdorf, Lars; Amendt,
Christiane; Grell, Matthias; Sirrenberg, Christian; Zenke, Frank
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005058832 A1 2005-06-30

$RFMT $RIREG SCHEME373 STEP1
$RXN



  2  1
$MOL
Methyl 4-chloropyridine-2-carboxylate
C7H6ClNO2
24484-93-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 0.0000 0.0 0
M  V30 4 C 8.0021 1.5400 0.0 0
M  V30 5 Cl 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 N 4.0011 3.8500 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-methylpicolinamide
C7H7ClN2O
220000-87-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 0.0000 0.0 0
M  V30 4 C 8.0021 1.5400 0.0 0
M  V30 5 Cl 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 N 4.0011 3.8500 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 24484-93-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 220000-87-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10749743
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7786-30-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 13 g (62.5 mmol) 1 are dissolved together with 2.98 g (31.24 mmol) dry
magnesiumchloride in THF. After 5 min 110 ml methylamin-solution (2M in
THF) are added dropwise within 10 min and the suspension stirred for 2 h
at room temperature. 120 ml water und 63 mL 1M HCl- solution are added
and the mixture is extracted three times with ethyl acetate. The combined
organic phases are washed with brine, dried with Na2SO4, filtered and
evaporated. Yield: 10.5 g (98.5 %) 2, colourless oil. 2, Yield: 10.5 g
(98.5 %)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzimidazole amides as raf kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Buchstaller, Hans-Peter; Finsinger, Dirk; Wiesner, Matthias; Burgdorf,
Lars; Amendt, Christiane; Grell, Matthias; Sirrenberg, Christian; Zenke,
Frank
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005004864 A1 2005-01-20

$RFMT $RIREG SCHEME373 STEP1
$RXN



  2  1
$MOL
Methyl 4-chloropyridine-2-carboxylate
C7H6ClNO2
24484-93-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 0.0000 0.0 0
M  V30 4 C 8.0021 1.5400 0.0 0
M  V30 5 Cl 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 N 4.0011 3.8500 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-methylpicolinamide
C7H7ClN2O
220000-87-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 0.0000 0.0 0
M  V30 4 C 8.0021 1.5400 0.0 0
M  V30 5 Cl 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 N 4.0011 3.8500 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 24484-93-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 220000-87-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3362392
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7786-30-3
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyridinyloxybenzylureas as RAF kinase inhibitors.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Buchstaller, Hans-Peter; Wiesner, Matthias; Schadt, Oliver; Amendt,
Christiane; Zenke, Frank; Sirrenberg, Christian; Grell, Matthias;
Finsinger, Dirk
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004037789 A2 2004-05-06

$RFMT $RIREG SCHEME374 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
D-Tryptophan, N-(3′-azido-3′-deoxy-5′-thymidylyl)-, α-methyl ester
C22H26N7O8P
245321-23-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 15.1936 4.5167 0.0 0
M  V30 2 C 8.4700 4.9995 0.0 0
M  V30 3 O 7.7000 6.3331 0.0 0
M  V30 4 P 6.1600 6.3331 0.0 0 VAL=5
M  V30 5 N 4.6200 6.3331 0.0 0
M  V30 6 O 6.1600 4.7931 0.0 0
M  V30 7 O 6.1600 7.8731 0.0 0
M  V30 8 C 3.8500 7.6669 0.0 0 CFG=1
M  V30 9 C 4.6200 9.0005 0.0 0
M  V30 10 C 2.3100 7.6669 0.0 0
M  V30 11 O 1.5400 6.3331 0.0 0
M  V30 12 O 1.5400 9.0005 0.0 0
M  V30 13 C 0.0000 6.3331 0.0 0
M  V30 14 N 10.4394 2.2889 0.0 0
M  V30 15 N 11.4698 1.1445 0.0 0 CHG=1 VAL=4
M  V30 16 N 12.5003 0.0000 0.0 0 CHG=-1
M  V30 17 C 14.5498 10.6429 0.0 0
M  V30 18 O 17.3635 9.3903 0.0 0
M  V30 19 C 12.3799 5.7695 0.0 0 CFG=1
M  V30 20 O 10.9152 6.2453 0.0 0
M  V30 21 C 12.3799 4.2295 0.0 0
M  V30 22 C 10.0100 4.9995 0.0 0 CFG=2
M  V30 23 C 10.9152 3.7536 0.0 0 CFG=2
M  V30 24 N 13.6258 6.6747 0.0 0
M  V30 25 C 15.0327 6.0484 0.0 0
M  V30 26 C 13.4648 8.2062 0.0 0
M  V30 27 N 16.2786 6.9534 0.0 0
M  V30 28 C 14.7107 9.1114 0.0 0
M  V30 29 C 16.1175 8.4851 0.0 0
M  V30 30 C 3.8500 10.3342 0.0 0
M  V30 31 C 4.4765 11.7411 0.0 0
M  V30 32 C 2.3185 10.4951 0.0 0
M  V30 33 C 3.3319 12.7715 0.0 0
M  V30 34 C 5.9410 12.2170 0.0 0
M  V30 35 N 1.9983 12.0015 0.0 0
M  V30 36 C 3.6521 14.2778 0.0 0
M  V30 37 C 6.2612 13.7232 0.0 0
M  V30 38 C 5.1168 14.7538 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 25
M  V30 2 1 2 3
M  V30 3 1 22 2 CFG=1
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 8 9 CFG=1
M  V30 10 1 8 10
M  V30 11 1 9 30
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 2 14 15
M  V30 16 1 23 14 CFG=3
M  V30 17 2 15 16
M  V30 18 1 17 28
M  V30 19 2 18 29
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=1
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 1 27 29
M  V30 31 1 28 29
M  V30 32 1 30 31
M  V30 33 2 30 32
M  V30 34 1 31 33
M  V30 35 2 31 34
M  V30 36 1 32 35
M  V30 37 1 33 35
M  V30 38 2 33 36
M  V30 39 1 34 37
M  V30 40 1 36 38
M  V30 41 2 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 8 19 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Thymidine, 3′-azido-3′-deoxy-, 5′-[hydrogen [(1R)-1-(1H-indol-3-ylmethyl)-2-(...
C22H27N8O7P
245321-07-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 15.1936 4.5167 0.0 0
M  V30 2 C 8.4700 4.9995 0.0 0
M  V30 3 O 7.7000 6.3331 0.0 0
M  V30 4 P 6.1600 6.3331 0.0 0 VAL=5
M  V30 5 N 4.6200 6.3331 0.0 0
M  V30 6 O 6.1600 7.8731 0.0 0
M  V30 7 O 6.1600 4.7931 0.0 0
M  V30 8 C 3.8500 7.6669 0.0 0 CFG=1
M  V30 9 C 4.6200 9.0005 0.0 0
M  V30 10 C 2.3100 7.6669 0.0 0
M  V30 11 N 1.5400 6.3331 0.0 0
M  V30 12 O 1.5400 9.0005 0.0 0
M  V30 13 C 0.0000 6.3331 0.0 0
M  V30 14 N 10.4394 2.2889 0.0 0
M  V30 15 N 11.4698 1.1445 0.0 0 CHG=1 VAL=4
M  V30 16 N 12.5003 0.0000 0.0 0 CHG=-1
M  V30 17 C 14.5498 10.6429 0.0 0
M  V30 18 O 17.3635 9.3902 0.0 0
M  V30 19 C 12.3799 5.7695 0.0 0 CFG=1
M  V30 20 O 10.9152 6.2453 0.0 0
M  V30 21 C 12.3799 4.2295 0.0 0
M  V30 22 C 10.0100 4.9995 0.0 0 CFG=2
M  V30 23 C 10.9152 3.7536 0.0 0 CFG=2
M  V30 24 N 13.6258 6.6747 0.0 0
M  V30 25 C 15.0326 6.0484 0.0 0
M  V30 26 C 13.4648 8.2062 0.0 0
M  V30 27 N 16.2786 6.9534 0.0 0
M  V30 28 C 14.7107 9.1114 0.0 0
M  V30 29 C 16.1175 8.4851 0.0 0
M  V30 30 C 3.8500 10.3342 0.0 0
M  V30 31 C 4.4765 11.7411 0.0 0
M  V30 32 C 2.3185 10.4951 0.0 0
M  V30 33 C 3.3319 12.7715 0.0 0
M  V30 34 C 5.9410 12.2170 0.0 0
M  V30 35 N 1.9983 12.0015 0.0 0
M  V30 36 C 3.6523 14.2778 0.0 0
M  V30 37 C 6.2613 13.7232 0.0 0
M  V30 38 C 5.1168 14.7538 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 25
M  V30 2 1 2 3
M  V30 3 1 22 2 CFG=1
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 8 9 CFG=1
M  V30 10 1 8 10
M  V30 11 1 9 30
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 2 14 15
M  V30 16 1 23 14 CFG=3
M  V30 17 2 15 16
M  V30 18 1 17 28
M  V30 19 2 18 29
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=1
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 1 27 29
M  V30 31 1 28 29
M  V30 32 1 30 31
M  V30 33 2 30 32
M  V30 34 1 31 33
M  V30 35 2 31 34
M  V30 36 1 32 35
M  V30 37 1 33 35
M  V30 38 2 33 36
M  V30 39 1 34 37
M  V30 40 1 36 38
M  V30 41 2 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 8 19 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 245321-23-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 245321-07-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-16778774
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, in Vitro Anti-Breast Cancer Activity, and Intracellular
Decomposition of Amino Acid Methyl Ester and Alkyl Amide Phosphoramidate
Monoesters of 3'-Azido-3'-deoxythymidine (AZT)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Iyer, Vidhya V.; Griesgraber, George W.; Radmer, Matthew R.; McIntee,
Edward J.; Wagner, Carston R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2000), 43(11), 2266-2274

$RFMT $RIREG SCHEME375 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-tert-Butylsalicylaldehyde
C11H14O2
24623-65-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 C 1.3337 4.6201 0.0 0
M  V30 3 C 0.0000 3.8501 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 O 4.0012 4.6201 0.0 0
M  V30 6 C 6.6687 3.0801 0.0 0
M  V30 7 O 8.0023 2.3101 0.0 0
M  V30 8 C 2.6675 2.3101 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 2.6675 0.7700 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(1,1-Dimethylethyl)-6-[(methylimino)methyl]phenol
C12H17NO
479507-93-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 C 1.3337 4.6201 0.0 0
M  V30 3 C 0.0000 3.8501 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 O 4.0012 4.6201 0.0 0
M  V30 6 C 6.6685 3.0801 0.0 0
M  V30 7 N 8.0023 2.3101 0.0 0
M  V30 8 C 9.3360 3.0801 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 4.0012 0.0000 0.0 0
M  V30 14 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 5 10
M  V30 6 2 6 7 CFG=2
M  V30 7 1 6 12
M  V30 8 1 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 24623-65-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 479507-93-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-19996704
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Zirconium complexes having phenoxy/cycloalkylimine chelate ligands for
production of low molecular weight polyethylenes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ishii, Seiichi; Mitani, Makoto; Saito, Junji; Matsuura, Sadahiko;
Matsukawa, Naoto; Tsuru, Kazutaka; Fujita, Terunori
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP1270603 A2 2003-01-02

$RFMT $RIREG SCHEME376 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Hexyl acrylate
C9H16O2
2499-95-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 O 4.0012 2.3101 0.0 0
M  V30 3 C 6.6685 2.3101 0.0 0
M  V30 4 C 2.6673 1.5400 0.0 0
M  V30 5 C 8.0022 1.5400 0.0 0
M  V30 6 C 1.3337 2.3101 0.0 0
M  V30 7 O 2.6673 0.0000 0.0 0
M  V30 8 C 9.3360 2.3101 0.0 0
M  V30 9 C 0.0000 1.5400 0.0 0
M  V30 10 C 10.6697 1.5400 0.0 0
M  V30 11 C 12.0033 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 8 10
M  V30 10 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[3-(Hexyloxy)-3-oxopropyl]-N-methyl-β-alanine hexyl ester
C19H37NO4
1123109-54-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 13.3372 1.5400 0.0 0
M  V30 2 C 14.6708 2.3101 0.0 0
M  V30 3 C 12.0035 2.3101 0.0 0
M  V30 4 C 13.3372 0.0000 0.0 0
M  V30 5 C 16.0045 1.5400 0.0 0
M  V30 6 C 10.6697 1.5400 0.0 0
M  V30 7 C 17.3383 2.3101 0.0 0
M  V30 8 C 9.3360 2.3101 0.0 0
M  V30 9 O 18.6720 1.5400 0.0 0
M  V30 10 O 17.3383 3.8501 0.0 0
M  V30 11 O 8.0023 1.5400 0.0 0
M  V30 12 O 9.3360 3.8501 0.0 0
M  V30 13 C 20.0057 2.3101 0.0 0
M  V30 14 C 6.6687 2.3101 0.0 0
M  V30 15 C 21.3395 1.5400 0.0 0
M  V30 16 C 5.3348 1.5400 0.0 0
M  V30 17 C 22.6731 2.3101 0.0 0
M  V30 18 C 4.0012 2.3101 0.0 0
M  V30 19 C 24.0068 1.5400 0.0 0
M  V30 20 C 2.6675 1.5400 0.0 0
M  V30 21 C 25.3405 2.3101 0.0 0
M  V30 22 C 1.3338 2.3101 0.0 0
M  V30 23 C 26.6743 1.5400 0.0 0
M  V30 24 C 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 11 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2499-95-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1123109-54-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-5216687
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Synthesis of
N-methyl-N,N-bis[2-(alkoxycarbonyl)ethyl]amine: General Procedure
Reactions were typically carried out as follows: 1.40 mol of alkyl
acrylate was placed in a round-bottom flask equipped with reflux
condenser, magnetic stirrer, dropping funnel and thermometer. Ethanolic
solution of methylamine (0.700 mol) was slowly dropped in at temperature
not exceeded 30 °C (reaction is exothermic). The reaction mixture was
then stored at room temperature for ca. 1 additional day. After
evaporating of the solvent, crude product could be (if necessary)
additionally processed by fractional distillation or crystallization. In
the case of pure methylamine reaction was carried out at room temperature
in a pressure glass reactor. Alkyl acrylate (0.600 mol) and 35 ml of
anhydrous ethyl alcohol or 2-propanol (in the case of octadecyl acrylate
only) were placed in pressure glass reactor equipped with magnetic
stirrer, manometer and inlet tube. The reaction mixture was intensively
stirred and cooled with a water-ice bath to maintain the reaction
temperature at 15-20 °C while gaseous methylamine (0.300 mol) was slowly
introduced through the inlet tube under the layer of alkyl acrylate from
a weighed pressure container. The rate of methylamine addition was
controlled with valve to maintain pressure above reaction mixture not
higher than 0.03 MPa. After completion of amine introduction the reaction
mixture was stored for 24 h at room temperature. The yield of crude
products was almost quantitative and at least 99% of purity. In the case
of octadecyl derivative, it was necessary to evaporate the solvent which
could be reused. Table 1 The aza-Michael reaction of methylamine with
alkyl acrylates Compound 4a Product CH3N(CH2CH2COOCH3)2 Table 1 The
aza-Michael reaction of methylamine with alkyl acrylates Compound 4d
Product CH3N(CH2CH2COOC6H13)2 Yield 99.0 %. Refractive index nD20 1.4477
Molecular formula C19H37NO4 Elemental analysis calcd. (wt%): C, 66.43; H,
10.86; N, 4.08. found (wt%): C, 66.40; H, 10.81; N, 4.03.
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, green chemistry-solvent, gaseous methylamine in pressure
glass reactor also used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New hydrophobic intermediates of aminodiester-type via a green,
Michael-addition reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Piasecki, Andrzej; Zielinski, Wojciech
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Surfactants and Detergents (2008), 11(1), 21-27

$RFMT $RIREG SCHEME377 STEP1
$RXN



  2  1
$MOL
6-[3,5-Difluoro-2-[[(5-fluoro-2-methyl-3-pyridinyl)sulfonyl]amino]-4-pyridiny...
C25H25F4N5O5SSi
2505372-34-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 15.2774 6.5653 0.0 0
M  V30 2 O 16.7837 6.8856 0.0 0
M  V30 3 C 17.2596 8.3502 0.0 0
M  V30 4 C 18.7660 8.6704 0.0 0
M  V30 5 Si 19.2418 10.1350 0.0 0
M  V30 6 C 19.7177 11.5996 0.0 0
M  V30 7 C 17.7771 10.6109 0.0 0
M  V30 8 C 20.7065 9.6592 0.0 0
M  V30 9 F 12.0032 6.9349 0.0 0
M  V30 10 C 15.2774 1.1444 0.0 0
M  V30 11 O 14.2468 0.0000 0.0 0
M  V30 12 O 16.7837 0.8242 0.0 0
M  V30 13 F 8.0021 3.0849 0.0 0
M  V30 14 F 10.6694 7.7049 0.0 0
M  V30 15 N 5.3347 4.6249 0.0 0
M  V30 16 S 4.0011 5.3949 0.0 0 VAL=6
M  V30 17 O 4.7711 6.7286 0.0 0
M  V30 18 O 3.2311 4.0613 0.0 0
M  V30 19 C 1.3338 3.8549 0.0 0
M  V30 20 F 1.3338 10.0149 0.0 0
M  V30 21 C 13.3369 4.6249 0.0 0
M  V30 22 C 13.3369 3.0849 0.0 0
M  V30 23 N 14.8016 5.1008 0.0 0
M  V30 24 C 12.0032 5.3949 0.0 0
M  V30 25 C 14.8016 2.6091 0.0 0
M  V30 26 C 12.0032 2.3149 0.0 0
M  V30 27 N 15.7066 3.8549 0.0 0
M  V30 28 C 10.6694 4.6249 0.0 0
M  V30 29 C 10.6694 3.0849 0.0 0
M  V30 30 C 9.3358 5.3949 0.0 0
M  V30 31 C 8.0021 4.6249 0.0 0
M  V30 32 C 9.3358 6.9349 0.0 0
M  V30 33 C 6.6685 5.3949 0.0 0
M  V30 34 C 8.0021 7.7049 0.0 0
M  V30 35 N 6.6685 6.9349 0.0 0
M  V30 36 C 2.6674 6.1649 0.0 0
M  V30 37 C 1.3338 5.3949 0.0 0
M  V30 38 C 2.6674 7.7049 0.0 0
M  V30 39 N 0.0000 6.1649 0.0 0
M  V30 40 C 1.3338 8.4749 0.0 0
M  V30 41 C 0.0000 7.7049 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 24
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 25
M  V30 13 1 13 31
M  V30 14 1 14 32
M  V30 15 1 15 16
M  V30 16 1 15 33
M  V30 17 2 16 17
M  V30 18 2 16 18
M  V30 19 1 16 36
M  V30 20 1 19 37
M  V30 21 1 20 40
M  V30 22 1 21 22
M  V30 23 1 21 23
M  V30 24 2 21 24
M  V30 25 1 22 25
M  V30 26 2 22 26
M  V30 27 1 23 27
M  V30 28 1 24 28
M  V30 29 2 25 27
M  V30 30 1 26 29
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 30 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 35
M  V30 39 2 36 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 2 38 40
M  V30 43 2 39 41
M  V30 44 1 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[3,5-Difluoro-2-[[(5-fluoro-2-methyl-3-pyridinyl)sulfonyl]amino]-4-pyridiny...
C26H28F4N6O4SSi
2505372-35-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 15.2774 7.2060 0.0 0
M  V30 2 O 16.7837 7.5261 0.0 0
M  V30 3 C 17.2596 8.9907 0.0 0
M  V30 4 C 18.7660 9.3108 0.0 0
M  V30 5 Si 19.2418 10.7755 0.0 0
M  V30 6 C 19.7177 12.2402 0.0 0
M  V30 7 C 20.7065 10.2997 0.0 0
M  V30 8 C 17.7771 11.2514 0.0 0
M  V30 9 F 12.0032 7.5754 0.0 0
M  V30 10 C 15.2774 1.7849 0.0 0
M  V30 11 N 16.7837 1.4647 0.0 0
M  V30 12 O 14.2468 0.6405 0.0 0
M  V30 13 C 17.2596 0.0000 0.0 0
M  V30 14 F 8.0021 3.7254 0.0 0
M  V30 15 F 10.6694 8.3454 0.0 0
M  V30 16 N 5.3347 5.2654 0.0 0
M  V30 17 S 4.0011 6.0354 0.0 0 VAL=6
M  V30 18 O 3.2311 4.7018 0.0 0
M  V30 19 O 4.7711 7.3691 0.0 0
M  V30 20 C 1.3338 4.4954 0.0 0
M  V30 21 F 1.3338 10.6554 0.0 0
M  V30 22 C 13.3369 5.2654 0.0 0
M  V30 23 C 13.3369 3.7254 0.0 0
M  V30 24 N 14.8016 5.7413 0.0 0
M  V30 25 C 12.0032 6.0354 0.0 0
M  V30 26 C 14.8016 3.2496 0.0 0
M  V30 27 C 12.0032 2.9554 0.0 0
M  V30 28 N 15.7066 4.4954 0.0 0
M  V30 29 C 10.6694 5.2654 0.0 0
M  V30 30 C 10.6694 3.7254 0.0 0
M  V30 31 C 9.3358 6.0354 0.0 0
M  V30 32 C 8.0021 5.2654 0.0 0
M  V30 33 C 9.3358 7.5754 0.0 0
M  V30 34 C 6.6685 6.0354 0.0 0
M  V30 35 C 8.0021 8.3454 0.0 0
M  V30 36 N 6.6685 7.5754 0.0 0
M  V30 37 C 2.6674 6.8054 0.0 0
M  V30 38 C 1.3338 6.0354 0.0 0
M  V30 39 C 2.6674 8.3454 0.0 0
M  V30 40 N 0.0000 6.8054 0.0 0
M  V30 41 C 1.3338 9.1154 0.0 0
M  V30 42 C 0.0000 8.3454 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 24
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 25
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 26
M  V30 13 1 11 13
M  V30 14 1 14 32
M  V30 15 1 15 33
M  V30 16 1 16 17
M  V30 17 1 16 34
M  V30 18 2 17 18
M  V30 19 2 17 19
M  V30 20 1 17 37
M  V30 21 1 20 38
M  V30 22 1 21 41
M  V30 23 1 22 23
M  V30 24 1 22 24
M  V30 25 2 22 25
M  V30 26 1 23 26
M  V30 27 2 23 27
M  V30 28 1 24 28
M  V30 29 1 25 29
M  V30 30 2 26 28
M  V30 31 1 27 30
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 31 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 2 35 36
M  V30 40 2 37 38
M  V30 41 1 37 39
M  V30 42 1 38 40
M  V30 43 2 39 41
M  V30 44 2 40 42
M  V30 45 1 41 42
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2505372-34-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2505372-35-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23552865
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of (aza)indazolyl-aryl sulfonamide and related compounds for
inhibiting GCN2 activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ramurthy, Savithri; Mulvihill, Mark J.; Sherborne, Bradley; Talbot, Eric;
Thomson, Chris; Aicher, Thomas Daniel; Padilla, Fernando; Taylor, Clarke
B.; Toogood, Peter L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020210828 A1 2020-10-15

$RFMT $RIREG SCHEME378 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-(2-phenylethyl)[1,2,4]triazolo[4,3-a]quinoxalin-1-amine
C17H14ClN5
2529934-46-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6517 5.3302 0.0 0
M  V30 2 C 7.6823 6.4748 0.0 0
M  V30 3 C 9.1886 6.1546 0.0 0
M  V30 4 Cl 0.0000 5.3900 0.0 0
M  V30 5 N 4.0009 4.6200 0.0 0
M  V30 6 C 4.0009 3.0800 0.0 0
M  V30 7 C 2.6673 5.3900 0.0 0
M  V30 8 C 5.1454 5.6504 0.0 0
M  V30 9 C 2.6673 2.3100 0.0 0
M  V30 10 C 5.3347 2.3100 0.0 0
M  V30 11 C 1.3336 4.6200 0.0 0
M  V30 12 N 2.9874 6.8963 0.0 0
M  V30 13 N 4.5191 7.0574 0.0 0
M  V30 14 N 1.3336 3.0800 0.0 0
M  V30 15 C 2.6673 0.7700 0.0 0
M  V30 16 C 5.3347 0.7700 0.0 0
M  V30 17 C 4.0009 0.0000 0.0 0
M  V30 18 C 10.2190 7.2990 0.0 0
M  V30 19 C 11.7254 6.9788 0.0 0
M  V30 20 C 9.7431 8.7637 0.0 0
M  V30 21 C 12.7558 8.1232 0.0 0
M  V30 22 C 10.7737 9.9081 0.0 0
M  V30 23 C 12.2800 9.5879 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 18
M  V30 5 1 4 11
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 2 7 12
M  V30 13 2 8 13
M  V30 14 1 9 14
M  V30 15 2 9 15
M  V30 16 1 10 16
M  V30 17 2 11 14
M  V30 18 1 12 13
M  V30 19 1 15 17
M  V30 20 2 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N4-Methyl-N1-(2-phenylethyl)[1,2,4]triazolo[4,3-a]quinoxaline-1,4-diamine
C18H18N6
2529934-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.9855 5.3302 0.0 0
M  V30 2 C 9.0159 6.4748 0.0 0
M  V30 3 C 10.5222 6.1546 0.0 0
M  V30 4 N 1.3336 5.3900 0.0 0
M  V30 5 C 0.0000 4.6200 0.0 0
M  V30 6 N 5.3347 4.6200 0.0 0
M  V30 7 C 5.3347 3.0800 0.0 0
M  V30 8 C 4.0009 5.3900 0.0 0
M  V30 9 C 6.4791 5.6504 0.0 0
M  V30 10 C 4.0009 2.3100 0.0 0
M  V30 11 C 6.6684 2.3100 0.0 0
M  V30 12 C 2.6673 4.6200 0.0 0
M  V30 13 N 4.3211 6.8963 0.0 0
M  V30 14 N 5.8528 7.0574 0.0 0
M  V30 15 N 2.6673 3.0800 0.0 0
M  V30 16 C 4.0009 0.7700 0.0 0
M  V30 17 C 6.6684 0.7700 0.0 0
M  V30 18 C 5.3347 0.0000 0.0 0
M  V30 19 C 11.5528 7.2990 0.0 0
M  V30 20 C 11.0768 8.7637 0.0 0
M  V30 21 C 13.0590 6.9788 0.0 0
M  V30 22 C 12.1073 9.9081 0.0 0
M  V30 23 C 14.0895 8.1232 0.0 0
M  V30 24 C 13.6136 9.5879 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 19
M  V30 5 1 4 5
M  V30 6 1 4 12
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 2 8 13
M  V30 14 2 9 14
M  V30 15 1 10 15
M  V30 16 2 10 16
M  V30 17 1 11 17
M  V30 18 2 12 15
M  V30 19 1 13 14
M  V30 20 1 16 18
M  V30 21 2 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2529934-46-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2529934-42-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-22839762
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of [1,2,4]triazolo[4,3-a]quinoxaline-1,3,4-oxadiazole
derivatives as potent antiproliferative agents via a hybrid pharmacophore
approach
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kaneko, Daiki; Ninomiya, Masayuki; Yoshikawa, Rina; Ono, Yukari;
Sonawane, Amol D.; Tanaka, Kaori; Nishina, Atsuyoshi; Koketsu, Mamoru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic Chemistry (2020), 104104293

$RFMT $RIREG SCHEME379 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyphenyl α,α-difluoro-2,3-dihydro-3-(4-methoxyphenyl)-1-methyl-2-oxo-1...
C25H21F2NO5
2529974-64-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3479 7.0316 0.0 0
M  V30 2 C 6.6817 6.2615 0.0 0
M  V30 3 F 5.3479 8.5716 0.0 0
M  V30 4 F 4.5778 5.6977 0.0 0
M  V30 5 O 8.0153 7.0316 0.0 0
M  V30 6 O 6.6817 4.7215 0.0 0
M  V30 7 O 1.6752 5.3044 0.0 0
M  V30 8 C 0.0000 8.2060 0.0 0
M  V30 9 O 4.4519 0.9052 0.0 0
M  V30 10 C 3.2058 0.0000 0.0 0
M  V30 11 O 13.3501 3.9515 0.0 0
M  V30 12 C 14.6837 4.7215 0.0 0
M  V30 13 C 3.8078 7.0316 0.0 0
M  V30 14 C 3.9689 8.5631 0.0 0
M  V30 15 C 2.3016 6.7112 0.0 0
M  V30 16 C 2.5620 9.1894 0.0 0
M  V30 17 C 5.2148 9.4683 0.0 0
M  V30 18 N 1.5315 8.0450 0.0 0
M  V30 19 C 2.4010 10.7210 0.0 0
M  V30 20 C 5.0539 10.9999 0.0 0
M  V30 21 C 3.6469 11.6262 0.0 0
M  V30 22 C 3.9689 5.4999 0.0 0
M  V30 23 C 2.7231 4.5946 0.0 0
M  V30 24 C 5.3757 4.8735 0.0 0
M  V30 25 C 2.8840 3.0631 0.0 0
M  V30 26 C 5.5367 3.3420 0.0 0
M  V30 27 C 4.2908 2.4368 0.0 0
M  V30 28 C 9.3490 6.2615 0.0 0
M  V30 29 C 9.3490 4.7215 0.0 0
M  V30 30 C 10.6826 7.0316 0.0 0
M  V30 31 C 10.6826 3.9515 0.0 0
M  V30 32 C 12.0164 6.2615 0.0 0
M  V30 33 C 12.0164 4.7215 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 13
M  V30 5 1 2 5
M  V30 6 2 2 6
M  V30 7 1 5 28
M  V30 8 2 7 15
M  V30 9 1 8 18
M  V30 10 1 9 10
M  V30 11 1 9 27
M  V30 12 1 11 12
M  V30 13 1 11 33
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 22
M  V30 17 1 14 16
M  V30 18 2 14 17
M  V30 19 1 15 18
M  V30 20 1 16 18
M  V30 21 2 16 19
M  V30 22 1 17 20
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α,α-Difluoro-2,3-dihydro-3-(4-methoxyphenyl)-N,1-dimethyl-2-oxo-1H-indole-3-a...
C19H18F2N2O3
2529974-65-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.7474 3.8987 0.0 0
M  V30 2 C 5.6526 2.6528 0.0 0
M  V30 3 F 3.2158 3.7377 0.0 0
M  V30 4 F 5.9932 4.8039 0.0 0
M  V30 5 N 5.0263 1.2460 0.0 0
M  V30 6 O 7.1841 2.8137 0.0 0
M  V30 7 C 5.9313 0.0000 0.0 0
M  V30 8 O 6.0810 7.7319 0.0 0
M  V30 9 C 3.0202 9.0946 0.0 0
M  V30 10 O 10.7464 5.4302 0.0 0
M  V30 11 C 11.5164 6.7640 0.0 0
M  V30 12 C 4.5864 5.4302 0.0 0
M  V30 13 C 3.0800 5.1100 0.0 0
M  V30 14 C 4.7474 6.9619 0.0 0
M  V30 15 C 2.3100 6.4438 0.0 0
M  V30 16 C 2.3100 3.7764 0.0 0
M  V30 17 N 3.3406 7.5882 0.0 0
M  V30 18 C 0.7700 6.4438 0.0 0
M  V30 19 C 0.7700 3.7764 0.0 0
M  V30 20 C 0.0000 5.1100 0.0 0
M  V30 21 C 6.1264 5.4302 0.0 0
M  V30 22 C 6.8964 6.7640 0.0 0
M  V30 23 C 6.8964 4.0966 0.0 0
M  V30 24 C 8.4364 6.7640 0.0 0
M  V30 25 C 8.4364 4.0966 0.0 0
M  V30 26 C 9.2064 5.4302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 12
M  V30 5 1 2 5
M  V30 6 2 2 6
M  V30 7 1 5 7
M  V30 8 2 8 14
M  V30 9 1 9 17
M  V30 10 1 10 11
M  V30 11 1 10 26
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 21
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 1 15 17
M  V30 19 2 15 18
M  V30 20 1 16 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2529974-64-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2529974-65-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-22809413
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Construction of β-Quaternary α,α-Difluoroketones via Catalytic
Nucleophilic Substitution of Tertiary Alcohols with Difluoroenoxysilanes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hao, Yong-Jia; Gong, Yi; Zhou, Ying; Zhou, Jian; Yu, Jin-Sheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2020), 22(21), 8516-8521

$RFMT $RIREG SCHEME380 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Bromophenyl)-2-chloroacetamide
C8H7BrClNO
2564-02-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0800 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 C 8.0022 3.0800 0.0 0
M  V30 4 O 6.6684 0.7700 0.0 0
M  V30 5 Cl 9.3359 2.3100 0.0 0
M  V30 6 Br 0.0000 0.0000 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6675 3.0800 0.0 0
M  V30 9 C 4.0011 0.7700 0.0 0
M  V30 10 C 1.3337 2.3100 0.0 0
M  V30 11 C 2.6675 0.0000 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Bromophenyl)-2-(methylamino)acetamide
C9H11BrN2O
404913-19-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9302 2.6673 0.0 0
M  V30 3 C 8.4702 2.6673 0.0 0
M  V30 4 O 6.1601 4.0010 0.0 0
M  V30 5 N 9.2402 4.0010 0.0 0
M  V30 6 C 10.7802 4.0010 0.0 0
M  V30 7 Br 0.0000 1.3337 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 3.8501 0.0000 0.0 0
M  V30 10 C 3.8501 2.6673 0.0 0
M  V30 11 C 2.3101 0.0000 0.0 0
M  V30 12 C 2.3101 2.6673 0.0 0
M  V30 13 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2564-02-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 404913-19-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-12476116
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-based design, synthesis, and antifungal activity of new
triazole derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sheng, Chunquan; Che, Xiaoying; Wang, Wenya; Wang, Shengzheng; Cao,
Yongbing; Yao, Jianzhong; Miao, Zhenyuan; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Biology & Drug Design (2011), 78(2), 309-313

$RFMT $RIREG SCHEME381 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-(3,4-dimethylphenyl)acetamide
C10H12ClNO
2564-04-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0023 3.0801 0.0 0
M  V30 4 O 6.6685 0.7700 0.0 0
M  V30 5 Cl 9.3360 2.3101 0.0 0
M  V30 6 C 0.0000 3.0801 0.0 0
M  V30 7 C 0.0000 0.0000 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 2.6675 3.0801 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 11
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3,4-Dimethylphenyl)-2-(methylamino)acetamide
C11H16N2O
1016687-41-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 2.6674 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 C 8.4700 4.0011 0.0 0
M  V30 4 O 6.1600 5.3349 0.0 0
M  V30 5 N 9.2400 5.3349 0.0 0
M  V30 6 C 10.7800 5.3349 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 C 0.0000 2.6674 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.8500 1.3338 0.0 0
M  V30 11 C 3.8500 4.0011 0.0 0
M  V30 12 C 2.3100 1.3338 0.0 0
M  V30 13 C 2.3100 4.0011 0.0 0
M  V30 14 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 12
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2564-04-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1016687-41-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-3968470
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-based design, synthesis, and antifungal activity of new
triazole derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sheng, Chunquan; Che, Xiaoying; Wang, Wenya; Wang, Shengzheng; Cao,
Yongbing; Yao, Jianzhong; Miao, Zhenyuan; Zhang, Wannian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Biology & Drug Design (2011), 78(2), 309-313

$RFMT $RIREG SCHEME382 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Phenylalanine, methyl ester
C10H13NO2
2577-90-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0 CFG=2
M  V30 3 C 6.6684 1.5400 0.0 0
M  V30 4 N 5.3347 3.8500 0.0 0
M  V30 5 O 8.0021 2.3100 0.0 0
M  V30 6 O 6.6684 0.0000 0.0 0
M  V30 7 C 9.3358 1.5400 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 1.3336 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 1.3336 4.6200 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αS)-α-Amino-N-methylbenzenepropanamide
C10H14N2O
35373-92-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0 CFG=2
M  V30 3 C 6.6684 1.5400 0.0 0
M  V30 4 N 5.3347 3.8500 0.0 0
M  V30 5 N 8.0021 2.3100 0.0 0
M  V30 6 O 6.6684 0.0000 0.0 0
M  V30 7 C 9.3358 1.5400 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 1.3336 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 1.3336 4.6200 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2577-90-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35373-92-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-7679486
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of (S)-phenylalanine-N-methylamide (153): (S)-Phenylalanine
methyl ester (3.59 g, 20.0 mmol) was dissolved in an ethanolic solution
of methylamine (12.5 mL, 100 mmol, 5.0 equiv.; 8 M in ethanol), and the
resulting solution was stirred at room temperature overnight (12 hr). The
volatiles were removed in vacuo and (S)-phenylalanine-N-methylamide (153;
white solid; 3.56 g, > 99 % yield) was used in the next step without
further purification.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Organocatalytic Asymmetric Epoxidations and Hydroperoxidations of
α,β-Unsaturated Ketones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Reisinger, Corinna Marie
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM (2010), (D0912-1), No pp.

$RFMT $RIREG SCHEME383 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-3,5-dinitropyridine
C5H2ClN3O4
2578-45-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 0.0000 0.0 0
M  V30 4 Cl 1.3336 4.6200 0.0 0
M  V30 5 N 6.6685 1.5400 0.0 0 VAL=5
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 N 4.0011 4.6200 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3,5-dinitro-2-pyridinamine
C6H6N4O4
19404-40-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 6.1601 0.0 0 VAL=5
M  V30 2 O 5.3348 6.9302 0.0 0
M  V30 3 O 2.6675 6.9302 0.0 0
M  V30 4 N 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 N 5.3348 2.3101 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 14 C 4.0012 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2578-45-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 19404-40-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24254950
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM synthesis of heterocyclic necroptosis inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lessene, Guillaume Laurent; Garnier, Jean-Marc Daniel; Feutrill, John
Thomas; Cuzzupe, Anthony Nicholas; Czabotar, Peter Edward
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021168521 A1 2021-09-02

$RFMT $RIREG SCHEME384 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1,1-Dimethylethyl) 4-[(6-chloro-2-naphthalenyl)sulfonyl]-1,2-piperazinedic...
C20H23ClN2O6S
259809-22-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 10.0100 4.0011 0.0 0 VAL=6
M  V30 2 O 10.0100 5.5411 0.0 0
M  V30 3 O 10.0100 2.4611 0.0 0
M  V30 4 C 5.3900 1.3338 0.0 0
M  V30 5 O 6.1600 0.0000 0.0 0
M  V30 6 O 3.8500 1.3338 0.0 0
M  V30 7 C 3.8500 4.0011 0.0 0
M  V30 8 O 3.0800 5.3349 0.0 0
M  V30 9 O 3.0800 2.6674 0.0 0
M  V30 10 C 1.5400 5.3349 0.0 0
M  V30 11 C 1.5400 6.8749 0.0 0
M  V30 12 C 0.0000 5.3349 0.0 0
M  V30 13 C 1.5400 3.7949 0.0 0
M  V30 14 Cl 18.4800 5.3349 0.0 0
M  V30 15 N 8.4700 4.0011 0.0 0
M  V30 16 C 7.7000 2.6674 0.0 0
M  V30 17 C 7.7000 5.3349 0.0 0
M  V30 18 C 6.1600 2.6674 0.0 0
M  V30 19 C 6.1600 5.3349 0.0 0
M  V30 20 N 5.3900 4.0011 0.0 0
M  V30 21 C 11.5500 4.0011 0.0 0
M  V30 22 C 12.3200 5.3349 0.0 0
M  V30 23 C 12.3200 2.6674 0.0 0
M  V30 24 C 13.8600 5.3349 0.0 0
M  V30 25 C 13.8600 2.6674 0.0 0
M  V30 26 C 14.6300 4.0011 0.0 0
M  V30 27 C 14.6300 6.6685 0.0 0
M  V30 28 C 16.1700 4.0011 0.0 0
M  V30 29 C 16.1700 6.6685 0.0 0
M  V30 30 C 16.9400 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 1 21
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 18
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 20
M  V30 11 1 8 10
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 1 14 30
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 24 27
M  V30 28 1 25 26
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(6-Chloro-2-naphthalenyl)sulfonyl]-N-methyl-2-piperazinecarboxamide
C16H18ClN3O3S
259809-33-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.0023 3.0801 0.0 0 VAL=6
M  V30 2 O 7.2323 1.7464 0.0 0
M  V30 3 O 8.7723 4.4137 0.0 0
M  V30 4 C 13.3372 3.0801 0.0 0
M  V30 5 N 14.6708 2.3101 0.0 0
M  V30 6 O 13.3372 4.6201 0.0 0
M  V30 7 C 16.0046 3.0801 0.0 0
M  V30 8 Cl 0.0000 6.1601 0.0 0
M  V30 9 C 6.6687 3.8501 0.0 0
M  V30 10 C 5.3348 3.0801 0.0 0
M  V30 11 C 6.6687 5.3901 0.0 0
M  V30 12 C 4.0012 3.8501 0.0 0
M  V30 13 C 5.3348 6.1601 0.0 0
M  V30 14 C 4.0012 5.3901 0.0 0
M  V30 15 C 2.6675 3.0801 0.0 0
M  V30 16 C 2.6675 6.1601 0.0 0
M  V30 17 C 1.3338 3.8501 0.0 0
M  V30 18 C 1.3338 5.3901 0.0 0
M  V30 19 N 9.3360 2.3101 0.0 0
M  V30 20 C 10.6698 3.0801 0.0 0
M  V30 21 C 9.3360 0.7700 0.0 0
M  V30 22 C 12.0035 2.3101 0.0 0
M  V30 23 C 10.6698 0.0000 0.0 0
M  V30 24 N 12.0035 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 1 19
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 22
M  V30 8 1 5 7
M  V30 9 1 8 18
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 12 15
M  V30 16 1 13 14
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 259809-22-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 259809-33-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-10359921
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Orally active factor Xa inhibitors:
4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Haginoya, Noriyasu; Kobayashi, Syozo; Komoriya, Satoshi; Hirokawa,
Yumiko; Furugori, Taketoshi; Nagahara, Takayasu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2004), 14(11), 2935-2939

$RFMT $RIREG SCHEME385 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Iodobenzaldehyde
C7H5IO
26260-02-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 O 5.3901 4.0010 0.0 0
M  V30 3 I 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Iodo-N-methylbenzenemethanamine
C8H10IN
113258-86-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 C 6.9302 4.0010 0.0 0
M  V30 4 I 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 26260-02-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 113258-86-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-20899996
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantioselective synthesis of isochromans and tetrahydroisoquinolines by
C-H insertion of donor/donor carbenes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nickerson, Leslie A.; Bergstrom, Benjamin D.; Gao, Mingchun; Shiue,
Yuan-Shin; Laconsay, Croix J.; Culberson, Matthew R.; Knauss, Walker A.;
Fettinger, James C.; Tantillo, Dean J.; Shaw, Jared T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Science (2020), 11(2), 494-498

$RFMT $RIREG SCHEME386 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (αS)-α-[2-[(methylsulfonyl)oxy]ethyl]-α-[[(methylsulfonyl)o...
C17H25NO10S2
2639841-36-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 5.3348 0.0 0 CFG=2
M  V30 2 C 6.6685 6.1048 0.0 0
M  V30 3 C 6.1048 4.0012 0.0 0
M  V30 4 C 4.0012 4.5648 0.0 0
M  V30 5 C 8.0022 5.3348 0.0 0
M  V30 6 O 5.3348 2.6675 0.0 0
M  V30 7 O 7.6449 4.0012 0.0 0
M  V30 8 O 2.6673 5.3348 0.0 0
M  V30 9 O 9.3360 6.1048 0.0 0
M  V30 10 C 6.1048 1.3337 0.0 0
M  V30 11 S 1.3337 4.5648 0.0 0 VAL=6
M  V30 12 S 10.6697 5.3348 0.0 0 VAL=6
M  V30 13 C 4.7712 0.5637 0.0 0
M  V30 14 C 6.8749 0.0000 0.0 0
M  V30 15 C 7.4385 2.1037 0.0 0
M  V30 16 C 0.5637 5.8985 0.0 0
M  V30 17 O 0.0000 3.7948 0.0 0
M  V30 18 O 2.1037 3.2311 0.0 0
M  V30 19 C 9.8996 4.0012 0.0 0
M  V30 20 O 12.0033 4.5648 0.0 0
M  V30 21 O 11.4397 6.6685 0.0 0
M  V30 22 N 6.8749 8.0023 0.0 0 VAL=5
M  V30 23 O 7.6449 9.3360 0.0 0
M  V30 24 O 7.6449 6.6685 0.0 0
M  V30 25 C 4.5648 6.6685 0.0 0
M  V30 26 C 5.3348 8.0023 0.0 0
M  V30 27 C 3.0248 6.6685 0.0 0
M  V30 28 C 4.5648 9.3360 0.0 0
M  V30 29 C 2.2548 8.0023 0.0 0
M  V30 30 C 3.0248 9.3360 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 1 1 25
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 2 3 7
M  V30 8 1 4 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 1 10 15
M  V30 16 1 11 16
M  V30 17 2 11 17
M  V30 18 2 11 18
M  V30 19 1 12 19
M  V30 20 2 12 20
M  V30 21 2 12 21
M  V30 22 2 22 23
M  V30 23 2 22 24
M  V30 24 1 22 26
M  V30 25 2 25 26
M  V30 26 1 25 27
M  V30 27 1 26 28
M  V30 28 2 27 29
M  V30 29 2 28 30
M  V30 30 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (3S)-1-methyl-3-(2-nitrophenyl)-3-pyrrolidinecarboxylate
C16H22N2O4
2639841-35-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.8660 4.7902 0.0 0
M  V30 2 O 7.2729 4.1639 0.0 0
M  V30 3 O 5.7050 6.3218 0.0 0
M  V30 4 C 8.5188 5.0691 0.0 0
M  V30 5 C 9.4240 3.8231 0.0 0
M  V30 6 C 9.7647 5.9742 0.0 0
M  V30 7 C 7.6136 6.3150 0.0 0
M  V30 8 N 1.5400 3.8850 0.0 0 VAL=5
M  V30 9 O 2.3100 2.5514 0.0 0
M  V30 10 O 0.0000 3.8850 0.0 0
M  V30 11 C 5.5070 0.0000 0.0 0
M  V30 12 C 4.6201 3.8850 0.0 0 CFG=1
M  V30 13 C 3.2133 3.2587 0.0 0
M  V30 14 C 5.6505 2.7406 0.0 0
M  V30 15 C 3.3742 1.7271 0.0 0
M  V30 16 N 4.8805 1.4068 0.0 0
M  V30 17 C 3.8501 5.2187 0.0 0
M  V30 18 C 2.3100 5.2187 0.0 0
M  V30 19 C 4.6201 6.5525 0.0 0
M  V30 20 C 1.5400 6.5525 0.0 0
M  V30 21 C 3.8501 7.8862 0.0 0
M  V30 22 C 2.3100 7.8862 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 12 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 18
M  V30 11 1 11 16
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 17 CFG=3
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2639841-36-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2639841-35-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-23590732
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantioselective synthesis of (+)-coerulescine by a phase-transfer
catalytic allylation of diphenylmethyl tert-butyl
α-(2-nitrophenyl)malonate
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lee, Sangki; Yang, Jewon; Yang, Sehun; Lee, Geumwoo; Oh, Daehyun; Ha, Min
Woo; Hong, Suckchang; Park, Hyeung-geun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Frontiers in Chemistry (Lausanne, Switzerland) (2020), 8577371

$RFMT $RIREG SCHEME387 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C13H14O3
2647924-26-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.6731 2.0842 0.0 0
M  V30 2 O 2.6506 0.0000 0.0 0
M  V30 3 C 6.3417 4.0442 0.0 0
M  V30 4 C 7.8817 4.0442 0.0 0
M  V30 5 C 6.9787 2.0842 0.0 0
M  V30 6 C 3.0800 2.7106 0.0 0 CFG=1
M  V30 7 C 3.5559 1.2459 0.0 0
M  V30 8 C 4.3259 3.6158 0.0 0
M  V30 9 O 5.0959 1.2459 0.0 0
M  V30 10 C 5.5717 2.7106 0.0 0 CFG=2
M  V30 11 C 2.3100 4.0442 0.0 0
M  V30 12 C 0.7700 4.0442 0.0 0
M  V30 13 C 3.0800 5.3778 0.0 0
M  V30 14 C 0.0000 5.3778 0.0 0
M  V30 15 C 2.3100 6.7116 0.0 0
M  V30 16 C 0.7700 6.7116 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 6 1 CFG=1
M  V30 2 2 2 7
M  V30 3 2 3 4
M  V30 4 1 10 3 CFG=3
M  V30 5 1 10 5 CFG=1
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 11 CFG=3
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 6 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C13H14O3
2647924-27-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.6731 2.0842 0.0 0
M  V30 2 O 2.6506 0.0000 0.0 0
M  V30 3 C 6.3417 4.0442 0.0 0
M  V30 4 C 7.8817 4.0442 0.0 0
M  V30 5 C 6.9787 2.0842 0.0 0
M  V30 6 C 3.0800 2.7106 0.0 0 CFG=2
M  V30 7 C 3.5559 1.2459 0.0 0
M  V30 8 C 4.3259 3.6158 0.0 0
M  V30 9 O 5.0959 1.2459 0.0 0
M  V30 10 C 5.5717 2.7106 0.0 0 CFG=2
M  V30 11 C 2.3100 4.0442 0.0 0
M  V30 12 C 0.7700 4.0442 0.0 0
M  V30 13 C 3.0800 5.3778 0.0 0
M  V30 14 C 0.0000 5.3778 0.0 0
M  V30 15 C 2.3100 6.7116 0.0 0
M  V30 16 C 0.7700 6.7116 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 6 1 CFG=3
M  V30 2 2 2 7
M  V30 3 2 3 4
M  V30 4 1 10 3 CFG=3
M  V30 5 1 10 5 CFG=1
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 11 CFG=1
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 6 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C14H19NO3
2647924-79-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 3.8500 0.0 0 CFG=2
M  V30 2 C 6.1600 3.8500 0.0 0
M  V30 3 C 4.6200 2.3100 0.0 0
M  V30 4 O 4.6200 5.3900 0.0 0
M  V30 5 C 6.9300 5.1836 0.0 0 CFG=2
M  V30 6 N 5.9536 1.5400 0.0 0
M  V30 7 O 3.2862 1.5400 0.0 0
M  V30 8 C 8.2636 4.4136 0.0 0
M  V30 9 C 7.7000 6.5173 0.0 0
M  V30 10 O 5.5962 5.9536 0.0 0
M  V30 11 C 5.9536 0.0000 0.0 0
M  V30 12 C 9.5973 5.1836 0.0 0
M  V30 13 C 3.0800 3.8500 0.0 0
M  V30 14 C 2.3100 2.5162 0.0 0
M  V30 15 C 2.3100 5.1836 0.0 0
M  V30 16 C 0.7700 2.5162 0.0 0
M  V30 17 C 0.7700 5.1836 0.0 0
M  V30 18 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 1 13
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 2 3 7
M  V30 8 1 5 8
M  V30 9 1 5 9 CFG=3
M  V30 10 1 5 10 CFG=1
M  V30 11 1 6 11
M  V30 12 2 8 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2647924-26-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2647924-27-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2647924-79-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-23766992
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM Schlenk tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Iridium-catalyzed stereoselective [3+2] annulation of α-oxocarboxylic
acids with 1,3-dienes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yabe, Ryota; Ebe, Yusuke; Nishimura, Takahiro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2021), 57(48),
5917-5920

$RFMT $RIREG SCHEME388 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-bromo-β-oxobenzenepropanoate
C11H11BrO3
26510-95-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 O 5.3348 0.0000 0.0 0
M  V30 4 C 8.0022 1.5400 0.0 0
M  V30 5 O 9.3360 2.3101 0.0 0
M  V30 6 O 8.0022 0.0000 0.0 0
M  V30 7 C 10.6697 1.5400 0.0 0
M  V30 8 C 12.0033 2.3101 0.0 0
M  V30 9 Br 0.0000 4.6201 0.0 0
M  V30 10 C 4.0012 2.3101 0.0 0
M  V30 11 C 2.6673 1.5400 0.0 0
M  V30 12 C 4.0012 3.8501 0.0 0
M  V30 13 C 1.3337 2.3101 0.0 0
M  V30 14 C 2.6673 4.6201 0.0 0
M  V30 15 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (2Z)-3-(4-bromophenyl)-3-(methylamino)-2-propenoate
C12H14BrNO2
2614438-04-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3101 0.0 0
M  V30 2 C 6.6685 3.0801 0.0 0
M  V30 3 N 5.3348 0.7700 0.0 0
M  V30 4 C 8.0022 2.3101 0.0 0
M  V30 5 C 4.0012 0.0000 0.0 0
M  V30 6 O 9.3360 3.0801 0.0 0
M  V30 7 O 8.0022 0.7700 0.0 0
M  V30 8 C 10.6697 2.3101 0.0 0
M  V30 9 C 12.0033 3.0801 0.0 0
M  V30 10 Br 0.0000 5.3901 0.0 0
M  V30 11 C 4.0012 3.0801 0.0 0
M  V30 12 C 4.0012 4.6201 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 2.6673 5.3901 0.0 0
M  V30 15 C 1.3337 3.0801 0.0 0
M  V30 16 C 1.3337 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 10 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 26510-95-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2614438-04-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-23322054
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Electrochemical Oxidative Cyclization: Synthesis of Polysubstituted
Pyrrole from Enamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Zhiwei; Shi, Guang; Tang, Wei; Sun, Jie; Wang, Wenxing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2021), 2021(6), 951-955

$RFMT $RIREG SCHEME390 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[5-Bromo-3-(ethylthio)-2-pyridinyl]-4-chloro-5-nitropyrimidine
C11H8BrClN4O2S
2694861-18-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 2.6674 0.0 0
M  V30 2 C 7.7000 1.3336 0.0 0
M  V30 3 C 6.9300 0.0000 0.0 0
M  V30 4 Cl 2.3100 8.0021 0.0 0
M  V30 5 Br 11.5500 5.3347 0.0 0
M  V30 6 N 0.7700 5.3347 0.0 0 VAL=5
M  V30 7 O 0.0000 4.0011 0.0 0
M  V30 8 O 0.0000 6.6685 0.0 0
M  V30 9 C 6.9300 5.3347 0.0 0
M  V30 10 C 7.7000 4.0011 0.0 0
M  V30 11 N 7.7000 6.6685 0.0 0
M  V30 12 C 9.2400 4.0011 0.0 0
M  V30 13 C 9.2400 6.6685 0.0 0
M  V30 14 C 10.0100 5.3347 0.0 0
M  V30 15 C 5.3900 5.3347 0.0 0
M  V30 16 N 4.6200 6.6685 0.0 0
M  V30 17 N 4.6200 4.0011 0.0 0
M  V30 18 C 3.0800 6.6685 0.0 0
M  V30 19 C 3.0800 4.0011 0.0 0
M  V30 20 C 2.3100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 4 18
M  V30 5 1 5 14
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 20
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 15
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[5-Bromo-3-(ethylthio)-2-pyridinyl]-N-methyl-5-nitro-4-pyrimidinamine
C12H12BrN5O2S
2694861-19-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9302 2.6675 0.0 0
M  V30 2 C 7.7002 1.3337 0.0 0
M  V30 3 C 6.9302 0.0000 0.0 0
M  V30 4 N 2.3101 8.0023 0.0 0
M  V30 5 C 3.0801 9.3360 0.0 0
M  V30 6 N 0.7700 5.3348 0.0 0 VAL=5
M  V30 7 O 0.0000 6.6685 0.0 0
M  V30 8 O 0.0000 4.0012 0.0 0
M  V30 9 Br 11.5503 5.3348 0.0 0
M  V30 10 C 5.3901 5.3348 0.0 0
M  V30 11 N 4.6201 6.6685 0.0 0
M  V30 12 N 4.6201 4.0012 0.0 0
M  V30 13 C 3.0801 6.6685 0.0 0
M  V30 14 C 3.0801 4.0012 0.0 0
M  V30 15 C 2.3101 5.3348 0.0 0
M  V30 16 C 6.9302 5.3348 0.0 0
M  V30 17 C 7.7002 4.0012 0.0 0
M  V30 18 N 7.7002 6.6685 0.0 0
M  V30 19 C 9.2402 4.0012 0.0 0
M  V30 20 C 9.2402 6.6685 0.0 0
M  V30 21 C 10.0102 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 13
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 15
M  V30 9 1 9 21
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 16
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2694861-18-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2694861-19-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24254002
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of
5-(3-(ethylsulfonyl)pyridin-2-yl)-pyrazolo[1,5-a]pyrimidine derivatives
and related derivatives as pesticide and insecticide agents for crop
protection
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kukreja, Gagan; Suthar, Suresh Kumar; Singh, Viraj; Cheemala, Narasimha
Murthy; Kape, Sandeep Ashok; Saxena, Rohit; Maity, Chandan; Gade,
Vishwanath; Saragur, Ravikumar Suryanarayana; Klausener, Alexander G. M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021165834 A1 2021-08-26

$RFMT $RIREG SCHEME391 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[4-[[3-Fluoro-5-(trifluoromethyl)phenyl]methyl]-2-pyridinyl]-5-(hydroxymeth...
C19H15F4N3O3
2702994-65-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.1471 2.4873 0.0 0
M  V30 2 O 1.6825 2.0114 0.0 0
M  V30 3 C 0.9052 4.9772 0.0 0
M  V30 4 O 0.0000 6.2231 0.0 0
M  V30 5 O 0.2787 3.5703 0.0 0
M  V30 6 C 2.5805 7.8788 0.0 0
M  V30 7 C 10.2090 4.6201 0.0 0
M  V30 8 C 15.5439 4.6201 0.0 0
M  V30 9 F 14.7739 5.9538 0.0 0
M  V30 10 F 16.8775 5.3901 0.0 0
M  V30 11 F 16.3139 3.2864 0.0 0
M  V30 12 F 12.8764 0.0000 0.0 0
M  V30 13 N 4.8742 4.6201 0.0 0
M  V30 14 C 3.4672 3.9938 0.0 0
M  V30 15 N 4.7131 6.1517 0.0 0
M  V30 16 C 2.4368 5.1382 0.0 0
M  V30 17 C 3.2068 6.4718 0.0 0
M  V30 18 C 6.2079 3.8501 0.0 0
M  V30 19 C 7.5415 4.6201 0.0 0
M  V30 20 N 6.2079 2.3101 0.0 0
M  V30 21 C 8.8754 3.8501 0.0 0
M  V30 22 C 7.5415 1.5400 0.0 0
M  V30 23 C 8.8754 2.3101 0.0 0
M  V30 24 C 11.5427 3.8501 0.0 0
M  V30 25 C 12.8764 4.6201 0.0 0
M  V30 26 C 11.5427 2.3101 0.0 0
M  V30 27 C 14.2102 3.8501 0.0 0
M  V30 28 C 12.8764 1.5400 0.0 0
M  V30 29 C 14.2102 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 16
M  V30 6 1 6 17
M  V30 7 1 7 21
M  V30 8 1 7 24
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 27
M  V30 13 1 12 28
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 18
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[4-[[3-Fluoro-5-(trifluoromethyl)phenyl]methyl]-2-pyridinyl]-5-(hydroxymeth...
C20H18F4N4O2
2702994-27-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 13.7305 2.4873 0.0 0
M  V30 2 O 15.1952 2.0114 0.0 0
M  V30 3 C 15.9725 4.9772 0.0 0
M  V30 4 N 16.8775 6.2231 0.0 0
M  V30 5 O 16.5988 3.5703 0.0 0
M  V30 6 C 18.4093 6.0622 0.0 0
M  V30 7 C 14.2972 7.8788 0.0 0
M  V30 8 C 6.6687 4.6201 0.0 0
M  V30 9 C 1.3338 4.6201 0.0 0
M  V30 10 F 2.1038 5.9538 0.0 0
M  V30 11 F 0.0000 5.3901 0.0 0
M  V30 12 F 0.5638 3.2864 0.0 0
M  V30 13 F 4.0012 0.0000 0.0 0
M  V30 14 N 12.0035 4.6201 0.0 0
M  V30 15 C 13.4103 3.9938 0.0 0
M  V30 16 N 12.1644 6.1517 0.0 0
M  V30 17 C 14.4407 5.1382 0.0 0
M  V30 18 C 13.6707 6.4718 0.0 0
M  V30 19 C 10.6697 3.8501 0.0 0
M  V30 20 C 9.3360 4.6201 0.0 0
M  V30 21 N 10.6697 2.3101 0.0 0
M  V30 22 C 8.0023 3.8501 0.0 0
M  V30 23 C 9.3360 1.5400 0.0 0
M  V30 24 C 8.0023 2.3101 0.0 0
M  V30 25 C 5.3348 3.8501 0.0 0
M  V30 26 C 4.0012 4.6201 0.0 0
M  V30 27 C 5.3348 2.3101 0.0 0
M  V30 28 C 2.6675 3.8501 0.0 0
M  V30 29 C 4.0012 1.5400 0.0 0
M  V30 30 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 17
M  V30 6 1 4 6
M  V30 7 1 7 18
M  V30 8 1 8 22
M  V30 9 1 8 25
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 9 28
M  V30 14 1 13 29
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 19
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2702994-65-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2702994-27-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36368730
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Gpr52 modulator compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Watson, Stephen Paul; Swain, Nigel Alan; O'Brien, Michael Alistair
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023041909 A1 2023-03-23

$RFMT $RIREG SCHEME392 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-tert-Butyl-2-hydroxybenzaldehyde
C11H14O2
2725-53-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0009 0.0 0
M  V30 2 C 6.1600 2.4609 0.0 0
M  V30 3 C 7.7000 4.0009 0.0 0
M  V30 4 C 6.1600 5.5409 0.0 0
M  V30 5 C 1.5400 1.3336 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 O 0.0000 4.0009 0.0 0
M  V30 8 C 4.6200 4.0009 0.0 0
M  V30 9 C 3.8500 2.6673 0.0 0
M  V30 10 C 3.8500 5.3347 0.0 0
M  V30 11 C 2.3100 2.6673 0.0 0
M  V30 12 C 2.3100 5.3347 0.0 0
M  V30 13 C 1.5400 4.0009 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 2 5 6
M  V30 6 1 5 11
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(1,1-Dimethylethyl)-2-[(methylimino)methyl]phenol
C12H17NO
209254-65-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3348 0.0 0
M  V30 2 C 2.6673 6.1048 0.0 0
M  V30 3 C 0.5637 6.6687 0.0 0
M  V30 4 C 0.0000 4.5648 0.0 0
M  V30 5 C 5.9538 2.6675 0.0 0
M  V30 6 N 6.7238 4.0012 0.0 0
M  V30 7 C 8.2638 4.0012 0.0 0
M  V30 8 O 4.4137 0.0000 0.0 0
M  V30 9 C 2.1037 4.0012 0.0 0
M  V30 10 C 3.6437 4.0012 0.0 0
M  V30 11 C 1.3337 2.6675 0.0 0
M  V30 12 C 4.4137 2.6675 0.0 0
M  V30 13 C 2.1037 1.3338 0.0 0
M  V30 14 C 3.6437 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 2 5 6 CFG=2
M  V30 6 1 5 12
M  V30 7 1 6 7
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2725-53-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 209254-65-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41078221
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM (Phenoxyimine)nickel-Catalyzed C(sp2)-C(sp3) Suzuki-Miyaura
Cross-Coupling: Evidence for a Recovering Radical Chain Mechanism
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mills, L. Reginald; Simmons, Eric M.; Lee, Heejun; Nester, Eva; Kim,
Junho; Wisniewski, Steven R.; Pecoraro, Matthew V.; Chirik, Paul J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2024), 146(14), 10124-10141

$RFMT $RIREG SCHEME393 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αE)-2-[[[(E)-(6-bromo-2,3-dihydro-1H-inden-1-ylidene)amino]oxy]methyl...
C21H21BrN2O4
2757243-23-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.0881 3.0801 0.0 0
M  V30 2 C 9.7544 2.3101 0.0 0
M  V30 3 N 12.4219 2.3101 0.0 0
M  V30 4 O 9.7544 0.7700 0.0 0
M  V30 5 O 8.4208 3.0801 0.0 0
M  V30 6 O 13.7556 3.0801 0.0 0
M  V30 7 C 8.4208 0.0000 0.0 0
M  V30 8 C 15.0893 2.3101 0.0 0
M  V30 9 C 8.4208 4.6201 0.0 0
M  V30 10 O 7.0871 5.3901 0.0 0
M  V30 11 N 5.7533 4.6201 0.0 0
M  V30 12 C 8.4208 7.7002 0.0 0
M  V30 13 Br 0.5546 1.5142 0.0 0
M  V30 14 C 11.0881 4.6201 0.0 0
M  V30 15 C 9.7544 5.3901 0.0 0
M  V30 16 C 12.4219 5.3901 0.0 0
M  V30 17 C 9.7544 6.9302 0.0 0
M  V30 18 C 12.4219 6.9302 0.0 0
M  V30 19 C 11.0881 7.7002 0.0 0
M  V30 20 C 4.4196 5.3901 0.0 0
M  V30 21 C 3.0128 4.7638 0.0 0
M  V30 22 C 4.2587 6.9217 0.0 0
M  V30 23 C 1.9822 5.9082 0.0 0
M  V30 24 C 2.5369 3.2991 0.0 0
M  V30 25 C 2.7522 7.2419 0.0 0
M  V30 26 C 0.4759 5.5880 0.0 0
M  V30 27 C 1.0304 2.9789 0.0 0
M  V30 28 C 0.0000 4.1233 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 15
M  V30 11 1 10 11
M  V30 12 2 11 20
M  V30 13 1 12 17
M  V30 14 1 13 27
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 21 24
M  V30 25 1 22 25
M  V30 26 1 23 25
M  V30 27 2 23 26
M  V30 28 1 24 27
M  V30 29 1 26 28
M  V30 30 2 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αE)-2-[[[(E)-(6-Bromo-2,3-dihydro-1H-inden-1-ylidene)amino]oxy]methyl]-α-(me...
C21H22BrN3O3
2757243-34-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.0881 3.0801 0.0 0
M  V30 2 C 9.7544 2.3101 0.0 0
M  V30 3 N 12.4219 2.3101 0.0 0
M  V30 4 N 9.7544 0.7700 0.0 0
M  V30 5 O 8.4208 3.0801 0.0 0
M  V30 6 O 13.7556 3.0801 0.0 0
M  V30 7 C 8.4208 0.0000 0.0 0
M  V30 8 C 15.0893 2.3101 0.0 0
M  V30 9 C 8.4208 4.6201 0.0 0
M  V30 10 O 7.0871 5.3901 0.0 0
M  V30 11 N 5.7533 4.6201 0.0 0
M  V30 12 C 8.4208 7.7002 0.0 0
M  V30 13 Br 0.5546 1.5142 0.0 0
M  V30 14 C 11.0881 4.6201 0.0 0
M  V30 15 C 9.7544 5.3901 0.0 0
M  V30 16 C 12.4219 5.3901 0.0 0
M  V30 17 C 9.7544 6.9302 0.0 0
M  V30 18 C 12.4219 6.9302 0.0 0
M  V30 19 C 11.0881 7.7002 0.0 0
M  V30 20 C 4.4196 5.3901 0.0 0
M  V30 21 C 3.0128 4.7638 0.0 0
M  V30 22 C 4.2587 6.9217 0.0 0
M  V30 23 C 1.9822 5.9082 0.0 0
M  V30 24 C 2.5369 3.2991 0.0 0
M  V30 25 C 2.7522 7.2419 0.0 0
M  V30 26 C 0.4759 5.5880 0.0 0
M  V30 27 C 1.0304 2.9789 0.0 0
M  V30 28 C 0.0000 4.1233 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 15
M  V30 11 1 10 11
M  V30 12 2 11 20
M  V30 13 1 12 17
M  V30 14 1 13 27
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 21 24
M  V30 25 1 22 25
M  V30 26 1 23 25
M  V30 27 2 23 26
M  V30 28 1 24 27
M  V30 29 1 26 28
M  V30 30 2 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2757243-23-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2757243-34-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31148006
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of strobilurin fungicides combating phytopathogenic fungi
containing an amino acid substitution f129l in the mitochondrial
cytochrome b protein conferring resistance to Qo inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kulkarni, Sarang; Dey, Chandan; Poonoth, Manojkumar; Rath, Rakesh; Le
Vezouet, Ronan; Winter, Christian Harald; Koch, Andreas; Fehr, Marcus;
Tegge, Vanessa; Grammenos, Wassilios; Khanna, Smriti
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022008303 A1 2022-01-13

$RFMT $RIREG SCHEME394 STEP1
$RXN



  2  1
$MOL
Methan-d3-amine
CH2D3N
5581-55-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.3337 0.0 0
M  V30 2 N 0.7700 0.0000 0.0 0
M  V30 3 H 0.0000 1.3337 0.0 0 MASS=2
M  V30 4 H 0.7700 2.6673 0.0 0 MASS=2
M  V30 5 H 3.0800 1.3337 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[3-Methyl-4-[(1-methyl-1H-benzimidazol-5-yl)oxy]phenyl]-6-(methylsulfonyl)p...
C22H19N7O3S
2757314-38-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.7239 6.6518 0.0 0
M  V30 2 S 1.3338 5.3182 0.0 0 VAL=6
M  V30 3 C 0.5638 3.9845 0.0 0
M  V30 4 O 2.6675 4.5481 0.0 0
M  V30 5 O 0.0000 6.0882 0.0 0
M  V30 6 C 11.3440 9.3193 0.0 0
M  V30 7 O 12.8840 6.6518 0.0 0
M  V30 8 C 15.9043 0.0000 0.0 0
M  V30 9 C 4.4139 7.9856 0.0 0
M  V30 10 C 5.9539 7.9856 0.0 0
M  V30 11 C 3.6438 9.3193 0.0 0
M  V30 12 N 3.6438 6.6518 0.0 0
M  V30 13 N 6.7239 9.3193 0.0 0
M  V30 14 C 2.1038 9.3193 0.0 0
M  V30 15 N 4.4139 10.6529 0.0 0
M  V30 16 C 2.1038 6.6518 0.0 0
M  V30 17 C 5.9539 10.6529 0.0 0
M  V30 18 N 1.3338 7.9856 0.0 0
M  V30 19 C 8.2639 6.6518 0.0 0
M  V30 20 C 9.0339 7.9856 0.0 0
M  V30 21 C 9.0339 5.3182 0.0 0
M  V30 22 C 10.5739 7.9856 0.0 0
M  V30 23 C 10.5739 5.3182 0.0 0
M  V30 24 C 11.3440 6.6518 0.0 0
M  V30 25 C 13.6540 5.3182 0.0 0
M  V30 26 C 15.1940 5.3182 0.0 0
M  V30 27 C 12.8840 3.9845 0.0 0
M  V30 28 C 15.9640 3.9845 0.0 0
M  V30 29 C 13.6540 2.6508 0.0 0
M  V30 30 C 15.1940 2.6508 0.0 0
M  V30 31 N 17.4703 3.6643 0.0 0
M  V30 32 N 16.2244 1.5063 0.0 0
M  V30 33 C 17.6314 2.1328 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 1 2 16
M  V30 7 1 6 22
M  V30 8 1 7 24
M  V30 9 1 7 25
M  V30 10 1 8 32
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 1 9 12
M  V30 14 2 10 13
M  V30 15 1 11 14
M  V30 16 1 11 15
M  V30 17 2 12 16
M  V30 18 1 13 17
M  V30 19 2 14 18
M  V30 20 2 15 17
M  V30 21 1 16 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 28 31
M  V30 34 2 29 30
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C22H17D3N8O
2757309-21-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.9074 6.6518 0.0 0
M  V30 2 N 16.2975 5.3182 0.0 0
M  V30 3 C 17.8375 5.3182 0.0 0
M  V30 4 C 6.2873 9.3193 0.0 0
M  V30 5 O 4.7473 6.6518 0.0 0
M  V30 6 C 1.7270 0.0000 0.0 0
M  V30 7 C 13.2175 7.9857 0.0 0
M  V30 8 C 11.6774 7.9857 0.0 0
M  V30 9 C 13.9875 9.3193 0.0 0
M  V30 10 N 13.9875 6.6518 0.0 0
M  V30 11 N 10.9074 9.3193 0.0 0
M  V30 12 C 15.5275 9.3193 0.0 0
M  V30 13 N 13.2175 10.6530 0.0 0
M  V30 14 C 15.5275 6.6518 0.0 0
M  V30 15 C 11.6774 10.6530 0.0 0
M  V30 16 N 16.2975 7.9857 0.0 0
M  V30 17 C 9.3674 6.6518 0.0 0
M  V30 18 C 8.5974 7.9857 0.0 0
M  V30 19 C 8.5974 5.3182 0.0 0
M  V30 20 C 7.0573 7.9857 0.0 0
M  V30 21 C 7.0573 5.3182 0.0 0
M  V30 22 C 6.2873 6.6518 0.0 0
M  V30 23 C 3.9773 5.3182 0.0 0
M  V30 24 C 2.4372 5.3182 0.0 0
M  V30 25 C 4.7473 3.9845 0.0 0
M  V30 26 C 1.6672 3.9845 0.0 0
M  V30 27 C 3.9773 2.6509 0.0 0
M  V30 28 C 2.4372 2.6509 0.0 0
M  V30 29 N 0.1609 3.6643 0.0 0
M  V30 30 N 1.4068 1.5063 0.0 0
M  V30 31 C 0.0000 2.1328 0.0 0
M  V30 32 H 18.6076 3.9845 0.0 0 MASS=2
M  V30 33 H 19.3776 5.3182 0.0 0 MASS=2
M  V30 34 H 18.6076 6.6518 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 2 14
M  V30 5 1 3 32
M  V30 6 1 3 33
M  V30 7 1 3 34
M  V30 8 1 4 20
M  V30 9 1 5 22
M  V30 10 1 5 23
M  V30 11 1 6 30
M  V30 12 1 7 8
M  V30 13 2 7 9
M  V30 14 1 7 10
M  V30 15 2 8 11
M  V30 16 1 9 12
M  V30 17 1 9 13
M  V30 18 2 10 14
M  V30 19 1 11 15
M  V30 20 2 12 16
M  V30 21 2 13 15
M  V30 22 1 14 16
M  V30 23 2 17 18
M  V30 24 1 17 19
M  V30 25 1 18 20
M  V30 26 2 19 21
M  V30 27 2 20 22
M  V30 28 1 21 22
M  V30 29 1 23 24
M  V30 30 2 23 25
M  V30 31 2 24 26
M  V30 32 1 25 27
M  V30 33 1 26 28
M  V30 34 1 26 29
M  V30 35 2 27 28
M  V30 36 1 28 30
M  V30 37 2 29 31
M  V30 38 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 5581-55-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2757314-38-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2757309-21-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31352015
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 127-19-5
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in capped vial
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrimido[5,4-d]pyrimidine derivatives as HER2 mutation inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Boys, Mark Laurence; Ellis, Bryan Daniel; Gaudino, John Joseph; Hicken,
Erik James; Laird, Ellen Ruth; Lazzara, Nicholas Charles; Newhouse,
Bradley Jon; Pajk, Spencer Phillip
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022003575 A1 2022-01-06

$RFMT $RIREG SCHEME395 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αE)-2-[[[(E)-[[4-fluoro-2-(trifluoromethyl)phenyl]methylene]amino]oxy...
C20H18F4N2O4
2757706-34-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.0032 3.0800 0.0 0
M  V30 2 C 10.6696 2.3100 0.0 0
M  V30 3 N 13.3369 2.3100 0.0 0
M  V30 4 O 10.6696 0.7700 0.0 0
M  V30 5 O 9.3358 3.0800 0.0 0
M  V30 6 O 14.6705 3.0800 0.0 0
M  V30 7 C 9.3358 0.0000 0.0 0
M  V30 8 C 16.0043 2.3100 0.0 0
M  V30 9 C 9.3358 4.6200 0.0 0
M  V30 10 O 8.0021 5.3900 0.0 0
M  V30 11 N 6.6685 4.6200 0.0 0
M  V30 12 C 5.3347 5.3900 0.0 0
M  V30 13 C 9.3358 7.7000 0.0 0
M  V30 14 C 2.6674 6.9300 0.0 0
M  V30 15 F 1.1274 6.9300 0.0 0
M  V30 16 F 2.6674 8.4700 0.0 0
M  V30 17 F 4.2074 6.9300 0.0 0
M  V30 18 F 0.0000 2.3100 0.0 0
M  V30 19 C 12.0032 4.6200 0.0 0
M  V30 20 C 10.6696 5.3900 0.0 0
M  V30 21 C 13.3369 5.3900 0.0 0
M  V30 22 C 10.6696 6.9300 0.0 0
M  V30 23 C 13.3369 6.9300 0.0 0
M  V30 24 C 12.0032 7.7000 0.0 0
M  V30 25 C 4.0011 4.6200 0.0 0
M  V30 26 C 2.6674 5.3900 0.0 0
M  V30 27 C 4.0011 3.0800 0.0 0
M  V30 28 C 1.3338 4.6200 0.0 0
M  V30 29 C 2.6674 2.3100 0.0 0
M  V30 30 C 1.3338 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 20
M  V30 11 1 10 11
M  V30 12 2 11 12
M  V30 13 1 12 25
M  V30 14 1 13 22
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 14 26
M  V30 19 1 18 30
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 26 2 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 2 27 29
M  V30 30 2 28 30
M  V30 31 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αE)-2-[[[(E)-[[4-Fluoro-2-(trifluoromethyl)phenyl]methylene]amino]oxy]methyl...
C20H19F4N3O3
2757706-35-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.0032 3.0800 0.0 0
M  V30 2 C 10.6696 2.3100 0.0 0
M  V30 3 N 13.3369 2.3100 0.0 0
M  V30 4 N 10.6696 0.7700 0.0 0
M  V30 5 O 9.3358 3.0800 0.0 0
M  V30 6 O 14.6705 3.0800 0.0 0
M  V30 7 C 9.3358 0.0000 0.0 0
M  V30 8 C 16.0043 2.3100 0.0 0
M  V30 9 C 9.3358 4.6200 0.0 0
M  V30 10 O 8.0021 5.3900 0.0 0
M  V30 11 N 6.6685 4.6200 0.0 0
M  V30 12 C 5.3347 5.3900 0.0 0
M  V30 13 C 9.3358 7.7000 0.0 0
M  V30 14 C 2.6674 6.9300 0.0 0
M  V30 15 F 1.1274 6.9300 0.0 0
M  V30 16 F 2.6674 8.4700 0.0 0
M  V30 17 F 4.2074 6.9300 0.0 0
M  V30 18 F 0.0000 2.3100 0.0 0
M  V30 19 C 12.0032 4.6200 0.0 0
M  V30 20 C 10.6696 5.3900 0.0 0
M  V30 21 C 13.3369 5.3900 0.0 0
M  V30 22 C 10.6696 6.9300 0.0 0
M  V30 23 C 13.3369 6.9300 0.0 0
M  V30 24 C 12.0032 7.7000 0.0 0
M  V30 25 C 4.0011 4.6200 0.0 0
M  V30 26 C 2.6674 5.3900 0.0 0
M  V30 27 C 4.0011 3.0800 0.0 0
M  V30 28 C 1.3338 4.6200 0.0 0
M  V30 29 C 2.6674 2.3100 0.0 0
M  V30 30 C 1.3338 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 20
M  V30 11 1 10 11
M  V30 12 2 11 12
M  V30 13 1 12 25
M  V30 14 1 13 22
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 14 26
M  V30 19 1 18 30
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 26 2 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 2 27 29
M  V30 30 2 28 30
M  V30 31 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2757706-34-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2757706-35-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31206256
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Strobilurin type compounds and their use for combating phytopathogenic
fungi
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kulkarni, Sarang; Dey, Chandan; Poonoth, Manojkumar; Rath, Rakesh; Le
Vezouet, Ronan; Khanna, Smriti; Winter, Christian Harald; Fehr, Marcus;
Koch, Andreas; Grammenos, Wassilios; Tegge, Vanessa
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP3939961 A1 2022-01-19

$RFMT $RIREG SCHEME395 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αE)-2-[[[(E)-[[4-fluoro-2-(trifluoromethyl)phenyl]methylene]amino]oxy...
C20H18F4N2O4
2757706-34-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.0032 3.0800 0.0 0
M  V30 2 C 10.6696 2.3100 0.0 0
M  V30 3 N 13.3369 2.3100 0.0 0
M  V30 4 O 10.6696 0.7700 0.0 0
M  V30 5 O 9.3358 3.0800 0.0 0
M  V30 6 O 14.6705 3.0800 0.0 0
M  V30 7 C 9.3358 0.0000 0.0 0
M  V30 8 C 16.0043 2.3100 0.0 0
M  V30 9 C 9.3358 4.6200 0.0 0
M  V30 10 O 8.0021 5.3900 0.0 0
M  V30 11 N 6.6685 4.6200 0.0 0
M  V30 12 C 5.3347 5.3900 0.0 0
M  V30 13 C 9.3358 7.7000 0.0 0
M  V30 14 C 2.6674 6.9300 0.0 0
M  V30 15 F 1.1274 6.9300 0.0 0
M  V30 16 F 2.6674 8.4700 0.0 0
M  V30 17 F 4.2074 6.9300 0.0 0
M  V30 18 F 0.0000 2.3100 0.0 0
M  V30 19 C 12.0032 4.6200 0.0 0
M  V30 20 C 10.6696 5.3900 0.0 0
M  V30 21 C 13.3369 5.3900 0.0 0
M  V30 22 C 10.6696 6.9300 0.0 0
M  V30 23 C 13.3369 6.9300 0.0 0
M  V30 24 C 12.0032 7.7000 0.0 0
M  V30 25 C 4.0011 4.6200 0.0 0
M  V30 26 C 2.6674 5.3900 0.0 0
M  V30 27 C 4.0011 3.0800 0.0 0
M  V30 28 C 1.3338 4.6200 0.0 0
M  V30 29 C 2.6674 2.3100 0.0 0
M  V30 30 C 1.3338 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 20
M  V30 11 1 10 11
M  V30 12 2 11 12
M  V30 13 1 12 25
M  V30 14 1 13 22
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 14 26
M  V30 19 1 18 30
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 26 2 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 2 27 29
M  V30 30 2 28 30
M  V30 31 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αE)-2-[[[(E)-[[4-Fluoro-2-(trifluoromethyl)phenyl]methylene]amino]oxy]methyl...
C20H19F4N3O3
2757706-35-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.0032 3.0800 0.0 0
M  V30 2 C 10.6696 2.3100 0.0 0
M  V30 3 N 13.3369 2.3100 0.0 0
M  V30 4 N 10.6696 0.7700 0.0 0
M  V30 5 O 9.3358 3.0800 0.0 0
M  V30 6 O 14.6705 3.0800 0.0 0
M  V30 7 C 9.3358 0.0000 0.0 0
M  V30 8 C 16.0043 2.3100 0.0 0
M  V30 9 C 9.3358 4.6200 0.0 0
M  V30 10 O 8.0021 5.3900 0.0 0
M  V30 11 N 6.6685 4.6200 0.0 0
M  V30 12 C 5.3347 5.3900 0.0 0
M  V30 13 C 9.3358 7.7000 0.0 0
M  V30 14 C 2.6674 6.9300 0.0 0
M  V30 15 F 1.1274 6.9300 0.0 0
M  V30 16 F 2.6674 8.4700 0.0 0
M  V30 17 F 4.2074 6.9300 0.0 0
M  V30 18 F 0.0000 2.3100 0.0 0
M  V30 19 C 12.0032 4.6200 0.0 0
M  V30 20 C 10.6696 5.3900 0.0 0
M  V30 21 C 13.3369 5.3900 0.0 0
M  V30 22 C 10.6696 6.9300 0.0 0
M  V30 23 C 13.3369 6.9300 0.0 0
M  V30 24 C 12.0032 7.7000 0.0 0
M  V30 25 C 4.0011 4.6200 0.0 0
M  V30 26 C 2.6674 5.3900 0.0 0
M  V30 27 C 4.0011 3.0800 0.0 0
M  V30 28 C 1.3338 4.6200 0.0 0
M  V30 29 C 2.6674 2.3100 0.0 0
M  V30 30 C 1.3338 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 20
M  V30 11 1 10 11
M  V30 12 2 11 12
M  V30 13 1 12 25
M  V30 14 1 13 22
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 14 26
M  V30 19 1 18 30
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 26 2 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 2 27 29
M  V30 30 2 28 30
M  V30 31 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2757706-34-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2757706-35-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31206382
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Strobilurin type compounds and their use for combating phytopathogenic
fungi
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kulkarni, Sarang; Dey, Chandan; Poonoth, Manojkumar; Rath, Rakesh; Le
Vezouet, Ronan; Khanna, Smriti; Winter, Christian Harald; Fehr, Marcus;
Koch, Andreas; Grammenos, Wassilios; Tegge, Vanessa
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022013009 A1 2022-01-20

$RFMT $RIREG SCHEME396 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2,3-dihydro-2-oxo-3-phenyl-1-(phenylmethyl)-1H-indole-3-acetate
C25H23NO3
2757795-97-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.2497 3.9741 0.0 0
M  V30 2 C 10.0428 5.2942 0.0 0
M  V30 3 O 11.5825 5.2673 0.0 0
M  V30 4 O 9.2962 6.6411 0.0 0
M  V30 5 C 12.3758 6.5874 0.0 0
M  V30 6 C 13.9155 6.5606 0.0 0
M  V30 7 O 6.4640 1.5559 0.0 0
M  V30 8 C 3.7535 3.5252 0.0 0
M  V30 9 C 7.7099 4.0011 0.0 0
M  V30 10 C 7.2340 5.4656 0.0 0
M  V30 11 C 6.4640 3.0959 0.0 0
M  V30 12 C 5.6940 5.4656 0.0 0
M  V30 13 C 8.0040 6.7994 0.0 0
M  V30 14 N 5.2181 4.0011 0.0 0
M  V30 15 C 4.9240 6.7994 0.0 0
M  V30 16 C 7.2340 8.1331 0.0 0
M  V30 17 C 5.6940 8.1331 0.0 0
M  V30 18 C 8.4799 2.6674 0.0 0
M  V30 19 C 7.7099 1.3336 0.0 0
M  V30 20 C 10.0199 2.6674 0.0 0
M  V30 21 C 8.4799 0.0000 0.0 0
M  V30 22 C 10.7899 1.3336 0.0 0
M  V30 23 C 10.0199 0.0000 0.0 0
M  V30 24 C 2.6091 4.5556 0.0 0
M  V30 25 C 1.1444 4.0798 0.0 0
M  V30 26 C 2.9292 6.0619 0.0 0
M  V30 27 C 0.0000 5.1102 0.0 0
M  V30 28 C 1.7847 7.0925 0.0 0
M  V30 29 C 0.3202 6.6166 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 2 7 11
M  V30 8 1 8 14
M  V30 9 1 8 24
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 18
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 1 11 14
M  V30 16 1 12 14
M  V30 17 2 12 15
M  V30 18 1 13 16
M  V30 19 1 15 17
M  V30 20 2 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-N-methyl-2-oxo-3-phenyl-1-(phenylmethyl)-1H-indole-3-acetamide
C24H22N2O2
2757796-21-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.1260 3.9741 0.0 0
M  V30 2 C 2.3329 5.2942 0.0 0
M  V30 3 N 0.7931 5.2673 0.0 0
M  V30 4 O 3.0795 6.6411 0.0 0
M  V30 5 C 0.0000 6.5873 0.0 0
M  V30 6 O 5.9118 1.5559 0.0 0
M  V30 7 C 8.6223 3.5252 0.0 0
M  V30 8 C 4.6659 4.0011 0.0 0
M  V30 9 C 5.1418 5.4656 0.0 0
M  V30 10 C 5.9118 3.0959 0.0 0
M  V30 11 C 6.6818 5.4656 0.0 0
M  V30 12 C 4.3718 6.7994 0.0 0
M  V30 13 N 7.1576 4.0011 0.0 0
M  V30 14 C 7.4518 6.7994 0.0 0
M  V30 15 C 5.1418 8.1330 0.0 0
M  V30 16 C 6.6818 8.1330 0.0 0
M  V30 17 C 3.8959 2.6674 0.0 0
M  V30 18 C 4.6659 1.3336 0.0 0
M  V30 19 C 2.3559 2.6674 0.0 0
M  V30 20 C 3.8959 0.0000 0.0 0
M  V30 21 C 1.5859 1.3336 0.0 0
M  V30 22 C 2.3559 0.0000 0.0 0
M  V30 23 C 9.7667 4.5556 0.0 0
M  V30 24 C 9.4465 6.0619 0.0 0
M  V30 25 C 11.2314 4.0798 0.0 0
M  V30 26 C 10.5909 7.0925 0.0 0
M  V30 27 C 12.3757 5.1102 0.0 0
M  V30 28 C 12.0556 6.6166 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 2 6 10
M  V30 7 1 7 13
M  V30 8 1 7 23
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 17
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 11 13
M  V30 16 2 11 14
M  V30 17 1 12 15
M  V30 18 1 14 16
M  V30 19 2 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2757795-97-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2757796-21-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28835783
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-Catalyzed Carbamoyl-Carbamoylation/
Carboxylation/Thioesterification of Alkene-Tethered Carbamoyl Chlorides
Using Mo(CO)6 as the Carbonyl Source
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Chen; Huang, Yujie; Ding, Jie; Liu, Liying; Zhu, Bolin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2022), 364(4), 794-801

$RFMT $RIREG SCHEME397 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C12H14FN3S2
2757913-84-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3358 3.8501 0.0 0
M  V30 2 S 8.0022 3.0801 0.0 0
M  V30 3 C 6.6685 3.8501 0.0 0
M  V30 4 C 5.3348 3.0801 0.0 0
M  V30 5 N 4.0010 3.8501 0.0 0
M  V30 6 C 2.6673 3.0801 0.0 0
M  V30 7 N 2.6673 1.5400 0.0 0
M  V30 8 S 1.3337 3.8501 0.0 0
M  V30 9 C 1.3337 0.7700 0.0 0
M  V30 10 C 1.3337 5.3901 0.0 0
M  V30 11 N 0.0000 0.0000 0.0 0
M  V30 12 F 14.6707 3.8501 0.0 0
M  V30 13 C 10.6697 3.0801 0.0 0
M  V30 14 C 12.0033 3.8501 0.0 0
M  V30 15 C 10.6697 1.5400 0.0 0
M  V30 16 C 13.3370 3.0801 0.0 0
M  V30 17 C 12.0033 0.7700 0.0 0
M  V30 18 C 13.3370 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 5 6 CFG=2
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 3 9 11
M  V30 12 1 12 16
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Cyano-N′-[2-[[(3-fluorophenyl)methyl]thio]ethyl]-N′′-methylguanidine
C12H15FN4S
2738667-39-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3358 3.8501 0.0 0
M  V30 2 S 8.0022 3.0801 0.0 0
M  V30 3 C 6.6685 3.8501 0.0 0
M  V30 4 C 5.3348 3.0801 0.0 0
M  V30 5 N 4.0010 3.8501 0.0 0
M  V30 6 C 2.6673 3.0801 0.0 0
M  V30 7 N 2.6673 1.5400 0.0 0
M  V30 8 N 1.3337 3.8501 0.0 0
M  V30 9 C 1.3337 0.7700 0.0 0
M  V30 10 C 1.3337 5.3901 0.0 0
M  V30 11 N 0.0000 0.0000 0.0 0
M  V30 12 F 14.6707 3.8501 0.0 0
M  V30 13 C 10.6697 3.0801 0.0 0
M  V30 14 C 12.0033 3.8501 0.0 0
M  V30 15 C 10.6697 1.5400 0.0 0
M  V30 16 C 13.3370 3.0801 0.0 0
M  V30 17 C 12.0033 0.7700 0.0 0
M  V30 18 C 13.3370 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 5 6 CFG=2
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 3 9 11
M  V30 12 1 12 16
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2757913-84-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2738667-39-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24543976
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Importance of the azole moiety of cimetidine derivatives for the
inhibition of human multidrug and toxin extrusion transporter 1 (hMATE1)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shinya, Susumu; Kawai, Kentaro; Tarui, Atsushi; Karuo, Yukiko; Sato,
Kazuyuki; Matsuda, Masaya; Kitatani, Kazuyuki; Kobayashi, Naoki; Nabe,
Takeshi; Otsuka, Masato; Omote, Masaaki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical & Pharmaceutical Bulletin (2021), 69(9), 905-912

$RFMT $RIREG SCHEME398 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αE)-2-[[[(E)-[1-[6-ethenyl-4-(trifluoromethyl)-2-pyridinyl]ethylidene...
C22H22F3N3O4
2761370-70-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 13.3372 3.0801 0.0 0
M  V30 2 C 12.0035 2.3101 0.0 0
M  V30 3 N 14.6708 2.3101 0.0 0
M  V30 4 O 12.0035 0.7700 0.0 0
M  V30 5 O 10.6697 3.0801 0.0 0
M  V30 6 O 16.0045 3.0801 0.0 0
M  V30 7 C 10.6697 0.0000 0.0 0
M  V30 8 C 17.3383 2.3101 0.0 0
M  V30 9 C 10.6697 4.6201 0.0 0
M  V30 10 O 9.3360 5.3901 0.0 0
M  V30 11 N 8.0023 4.6201 0.0 0
M  V30 12 C 6.6687 5.3901 0.0 0
M  V30 13 C 6.6687 6.9302 0.0 0
M  V30 14 C 10.6697 7.7002 0.0 0
M  V30 15 C 1.3338 5.3901 0.0 0
M  V30 16 F 2.1038 6.7238 0.0 0
M  V30 17 F 0.0000 6.1601 0.0 0
M  V30 18 F 0.5638 4.0564 0.0 0
M  V30 19 C 4.0012 0.7700 0.0 0
M  V30 20 C 2.6675 0.0000 0.0 0
M  V30 21 C 13.3372 4.6201 0.0 0
M  V30 22 C 12.0035 5.3901 0.0 0
M  V30 23 C 14.6708 5.3901 0.0 0
M  V30 24 C 12.0035 6.9302 0.0 0
M  V30 25 C 14.6708 6.9302 0.0 0
M  V30 26 C 13.3372 7.7002 0.0 0
M  V30 27 C 5.3348 4.6201 0.0 0
M  V30 28 C 4.0012 5.3901 0.0 0
M  V30 29 N 5.3348 3.0801 0.0 0
M  V30 30 C 2.6675 4.6201 0.0 0
M  V30 31 C 4.0012 2.3101 0.0 0
M  V30 32 C 2.6675 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 22
M  V30 11 1 10 11
M  V30 12 2 11 12
M  V30 13 1 12 13
M  V30 14 1 12 27
M  V30 15 1 14 24
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 15 30
M  V30 20 2 19 20
M  V30 21 1 19 31
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 28 2 27 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 2 29 31
M  V30 32 2 30 32
M  V30 33 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C22H23F3N4O3
2761370-90-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 13.3372 3.0801 0.0 0
M  V30 2 C 12.0035 2.3101 0.0 0
M  V30 3 N 14.6708 2.3101 0.0 0
M  V30 4 N 12.0035 0.7700 0.0 0
M  V30 5 O 10.6697 3.0801 0.0 0
M  V30 6 O 16.0045 3.0801 0.0 0
M  V30 7 C 10.6697 0.0000 0.0 0
M  V30 8 C 17.3383 2.3101 0.0 0
M  V30 9 C 10.6697 4.6201 0.0 0
M  V30 10 O 9.3360 5.3901 0.0 0
M  V30 11 N 8.0023 4.6201 0.0 0
M  V30 12 C 6.6687 5.3901 0.0 0
M  V30 13 C 6.6687 6.9302 0.0 0
M  V30 14 C 10.6697 7.7002 0.0 0
M  V30 15 C 1.3338 5.3901 0.0 0
M  V30 16 F 2.1038 6.7238 0.0 0
M  V30 17 F 0.0000 6.1601 0.0 0
M  V30 18 F 0.5638 4.0564 0.0 0
M  V30 19 C 4.0012 0.7700 0.0 0
M  V30 20 C 2.6675 0.0000 0.0 0
M  V30 21 C 13.3372 4.6201 0.0 0
M  V30 22 C 12.0035 5.3901 0.0 0
M  V30 23 C 14.6708 5.3901 0.0 0
M  V30 24 C 12.0035 6.9302 0.0 0
M  V30 25 C 14.6708 6.9302 0.0 0
M  V30 26 C 13.3372 7.7002 0.0 0
M  V30 27 C 5.3348 4.6201 0.0 0
M  V30 28 C 4.0012 5.3901 0.0 0
M  V30 29 N 5.3348 3.0801 0.0 0
M  V30 30 C 2.6675 4.6201 0.0 0
M  V30 31 C 4.0012 2.3101 0.0 0
M  V30 32 C 2.6675 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 22
M  V30 11 1 10 11
M  V30 12 2 11 12
M  V30 13 1 12 13
M  V30 14 1 12 27
M  V30 15 1 14 24
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 15 30
M  V30 20 2 19 20
M  V30 21 1 19 31
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 28 2 27 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 2 29 31
M  V30 32 2 30 32
M  V30 33 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2761370-70-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2761370-90-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31600356
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Use of strobilurin type compounds for combating phytopathogenic fungi
containing an amino acid substitution F129L in the mitochondrial
cytochrome b protein conferring resistance to Qo inhibitors VIII
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Koch, Andreas; Fehr, Marcus; Tegge, Vanessa; Dey, Chandan; Poonoth,
Manojkumar; Kulkarni, Sarang; Le Vezouet, Ronan; Winter, Christian
Harald; Rudolf, Georg Christoph; Rath, Rakesh; Khanna, Smriti; Craig, Ian
Robert; Grammenos, Wassilios; Grote, Thomas; Stammler, Gerd; Mentzel,
Tobias; Haden, Egon; Rheinheimer, Joachim
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022033906 A1 2022-02-17

$RFMT $RIREG SCHEME399 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Amino-5-chloro-3-methylphenyl)-2,2,2-trichloroethanone
C9H7Cl4NO
2763629-89-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 4.6200 0.0 0
M  V30 2 C 1.3336 3.8500 0.0 0
M  V30 3 O 2.6674 6.1600 0.0 0
M  V30 4 Cl 0.5636 5.1836 0.0 0
M  V30 5 Cl 0.0000 3.0800 0.0 0
M  V30 6 Cl 2.1036 2.5164 0.0 0
M  V30 7 N 5.3347 6.1600 0.0 0
M  V30 8 C 8.0021 4.6200 0.0 0
M  V30 9 Cl 5.3347 0.0000 0.0 0
M  V30 10 C 4.0011 3.8500 0.0 0
M  V30 11 C 5.3347 4.6200 0.0 0
M  V30 12 C 4.0011 2.3100 0.0 0
M  V30 13 C 6.6685 3.8500 0.0 0
M  V30 14 C 5.3347 1.5400 0.0 0
M  V30 15 C 6.6685 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 7 11
M  V30 8 1 8 13
M  V30 9 1 9 14
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-chloro-N,3-dimethylbenzamide
C9H11ClN2O
890707-28-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 4.6200 0.0 0
M  V30 2 N 6.6685 3.8500 0.0 0
M  V30 3 O 5.3347 6.1600 0.0 0
M  V30 4 C 8.0021 4.6200 0.0 0
M  V30 5 N 2.6674 6.1600 0.0 0
M  V30 6 C 0.0000 4.6200 0.0 0
M  V30 7 Cl 2.6674 0.0000 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 2.6674 4.6200 0.0 0
M  V30 10 C 4.0011 2.3100 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 12 C 2.6674 1.5400 0.0 0
M  V30 13 C 1.3336 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 1 6 11
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2763629-89-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 890707-28-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39128114
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Concise Approach to the Synthesis of First Generation Anthranilic Diamide
Insecticide, Chlorantraniliprole
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Saikiran, Aita; Banik, Swarnayu; Ajay, Chidrawar; Deepthi, Pulivarthi;
Gopalan, Balasubramanian; Subba Reddy, B. V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemistrySelect (2023), 8(41), e202302076

$RFMT $RIREG SCHEME400 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C12H22ClNO4S
2766125-86-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.0022 3.6437 0.0 0
M  V30 2 C 9.3360 2.8737 0.0 0
M  V30 3 O 10.6697 3.6437 0.0 0
M  V30 4 O 9.3360 1.3337 0.0 0
M  V30 5 C 12.0033 2.8737 0.0 0
M  V30 6 C 11.2333 1.5400 0.0 0
M  V30 7 C 13.3370 2.1037 0.0 0
M  V30 8 C 12.7733 4.2074 0.0 0
M  V30 9 C 2.6673 0.5637 0.0 0
M  V30 10 S 1.3337 1.3337 0.0 0 VAL=6
M  V30 11 Cl 0.0000 2.1037 0.0 0
M  V30 12 O 0.5637 0.0000 0.0 0
M  V30 13 O 2.1037 2.6673 0.0 0
M  V30 14 C 6.6685 2.8737 0.0 0 CFG=2
M  V30 15 C 6.6685 1.3337 0.0 0
M  V30 16 C 5.3348 3.6437 0.0 0
M  V30 17 C 5.3348 0.5637 0.0 0
M  V30 18 C 4.0010 2.8737 0.0 0
M  V30 19 C 4.0010 1.3337 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 14 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 19 9 CFG=3
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 2 10 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 14 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C13H26N2O4S
2766125-87-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6697 0.5637 0.0 0
M  V30 2 S 12.0033 1.3337 0.0 0 VAL=6
M  V30 3 N 13.3370 2.1037 0.0 0
M  V30 4 O 12.7733 0.0000 0.0 0
M  V30 5 O 11.2333 2.6673 0.0 0
M  V30 6 C 14.6707 1.3337 0.0 0
M  V30 7 N 5.3348 3.6437 0.0 0
M  V30 8 C 4.0010 2.8737 0.0 0
M  V30 9 O 2.6673 3.6437 0.0 0
M  V30 10 O 4.0010 1.3337 0.0 0
M  V30 11 C 1.3337 2.8737 0.0 0
M  V30 12 C 0.5637 4.2074 0.0 0
M  V30 13 C 0.0000 2.1037 0.0 0
M  V30 14 C 2.1037 1.5400 0.0 0
M  V30 15 C 9.3358 1.3337 0.0 0 CFG=2
M  V30 16 C 9.3358 2.8737 0.0 0
M  V30 17 C 8.0022 0.5637 0.0 0
M  V30 18 C 8.0022 3.6437 0.0 0
M  V30 19 C 6.6685 1.3337 0.0 0
M  V30 20 C 6.6685 2.8737 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 15 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 7 8
M  V30 8 1 20 7 CFG=1
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 15 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2766125-86-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2766125-87-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31969999
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pharmaceutically active pyrazolo-triazine and/or
pyrazolo-pyrimidine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nam, Kiyean; Kim, Jaeseung; Jeon, Yeejin; Yu, Donghoon; Seo, Mooyoung;
Park, Dongsik; Eickhoff, Jan; Zischinsky, Gunther; Koch, Uwe
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20220098208 A1 2022-03-31

$RFMT $RIREG SCHEME401 STEP1
$RXN



  2  1
$MOL
BOC-Tranexamic acid
C13H23NO4
27687-14-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 C 4.0010 4.6201 0.0 0
M  V30 4 O 2.6673 3.8501 0.0 0
M  V30 5 O 4.0010 6.1601 0.0 0
M  V30 6 C 1.3337 4.6201 0.0 0
M  V30 7 C 0.5637 3.2864 0.0 0
M  V30 8 C 0.0000 5.3901 0.0 0
M  V30 9 C 2.1037 5.9538 0.0 0
M  V30 10 C 12.0033 1.5400 0.0 0
M  V30 11 O 12.0033 0.0000 0.0 0
M  V30 12 O 13.3370 2.3101 0.0 0
M  V30 13 C 8.0022 3.8501 0.0 0 CFG=2
M  V30 14 C 8.0022 2.3101 0.0 0
M  V30 15 C 9.3360 4.6201 0.0 0
M  V30 16 C 9.3360 1.5400 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 10.6697 2.3101 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 13 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 18 10 CFG=1
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 13 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[[trans-4-[(methylamino)carbonyl]cyclohexyl]methyl]carbamate
C14H26N2O3
916210-15-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 C 4.0010 4.6201 0.0 0
M  V30 4 O 2.6673 3.8501 0.0 0
M  V30 5 O 4.0010 6.1601 0.0 0
M  V30 6 C 1.3337 4.6201 0.0 0
M  V30 7 C 2.1037 5.9538 0.0 0
M  V30 8 C 0.0000 5.3901 0.0 0
M  V30 9 C 0.5637 3.2864 0.0 0
M  V30 10 C 12.0033 1.5400 0.0 0
M  V30 11 N 13.3370 2.3101 0.0 0
M  V30 12 O 12.0033 0.0000 0.0 0
M  V30 13 C 14.6707 1.5400 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0 CFG=2
M  V30 15 C 8.0022 2.3101 0.0 0
M  V30 16 C 9.3358 4.6201 0.0 0
M  V30 17 C 9.3358 1.5400 0.0 0
M  V30 18 C 10.6697 3.8501 0.0 0
M  V30 19 C 10.6697 2.3101 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 14 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 19 10 CFG=1
M  V30 13 1 11 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 14 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27687-14-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 916210-15-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-15002598
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparative Example 44 Step A To a solution of
commercially available
trans-4-(tert-butoxycarbonylamino-methyl)-cyclohexanecarboxylic acid (262
mg) in dry THF (5 mL) was added 1,1′-carbonyldiimidazole (243 mg). The
resulting clear colorless solution was stirred at room temperature for 1
h, then a 0.5M solution of NH3 in 1,4-dioxane (20 mL) was added and
stirring at room temperature was continued for 5 h. The mixture was
concentrated and purified by flash chromatography (silica, CH2Cl2/MeOH).
Ex. 51; Yield: 99% [MNa]+ = 293
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of amide containing heterobicyclic metalloprotease inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Steeneck, Christoph; Gege, Christian; Richter, Frank; Kroth, Heiko;
Hochguertel, Matthias; Essers, Michael; Van Veldhuizen, Joshua; Nolte,
Bert; Gallagher, Brian; Feuerstein, Tim; Schneider, Matthias; Arndt,
Torsten; Deng, Hongbo; Biesinger, Ralf; Wu, Xinyuan; Bluhm, Harald;
Sucholeiki, Irving; Taveras, Arthur G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20070155738 A1 2007-07-05

$RFMT $RIREG SCHEME402 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-(2-fluorophenyl)-5,6-dihydro-β-(2-methylpropyl)-2-(methylthio)-7H-py...
C21H26FN3O2S
2768873-60-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.8706 4.0432 0.0 0
M  V30 2 C 10.0151 5.0738 0.0 0
M  V30 3 C 9.1908 2.5369 0.0 0
M  V30 4 C 11.4797 4.5978 0.0 0
M  V30 5 C 8.0464 1.5063 0.0 0
M  V30 6 O 12.6243 5.6284 0.0 0
M  V30 7 O 11.7999 3.0915 0.0 0
M  V30 8 C 8.3665 0.0000 0.0 0
M  V30 9 C 6.5816 1.9823 0.0 0
M  V30 10 C 14.0888 5.1525 0.0 0
M  V30 11 S 7.7002 9.9850 0.0 0
M  V30 12 C 6.9302 11.3186 0.0 0
M  V30 13 F 3.0801 9.9850 0.0 0
M  V30 14 C 5.3901 5.9838 0.0 0
M  V30 15 C 6.9302 5.9838 0.0 0
M  V30 16 C 4.6201 7.3175 0.0 0
M  V30 17 C 4.9141 4.5191 0.0 0
M  V30 18 N 7.4060 4.5191 0.0 0
M  V30 19 N 7.7002 7.3175 0.0 0
M  V30 20 N 5.3901 8.6511 0.0 0
M  V30 21 C 6.1601 3.6140 0.0 0
M  V30 22 C 6.9302 8.6511 0.0 0
M  V30 23 C 3.0801 7.3175 0.0 0
M  V30 24 C 2.3101 8.6513 0.0 0
M  V30 25 C 2.3101 5.9838 0.0 0
M  V30 26 C 0.7700 8.6511 0.0 0
M  V30 27 C 0.7700 5.9838 0.0 0
M  V30 28 C 0.0000 7.3175 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 1 11 12
M  V30 12 1 11 22
M  V30 13 1 13 24
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 17
M  V30 17 1 15 18
M  V30 18 2 15 19
M  V30 19 1 16 20
M  V30 20 1 16 23
M  V30 21 1 17 21
M  V30 22 1 18 21
M  V30 23 1 19 22
M  V30 24 2 20 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(2-Fluorophenyl)-5,6-dihydro-N-methyl-β-(2-methylpropyl)-2-(methylthio)-7H-...
C21H27FN4OS
2768873-61-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.8706 4.0432 0.0 0
M  V30 2 C 10.0151 5.0738 0.0 0
M  V30 3 C 9.1908 2.5369 0.0 0
M  V30 4 C 11.4797 4.5978 0.0 0
M  V30 5 C 8.0464 1.5063 0.0 0
M  V30 6 N 12.6243 5.6284 0.0 0
M  V30 7 O 11.7999 3.0915 0.0 0
M  V30 8 C 8.3665 0.0000 0.0 0
M  V30 9 C 6.5816 1.9823 0.0 0
M  V30 10 C 14.0888 5.1525 0.0 0
M  V30 11 S 7.7002 9.9850 0.0 0
M  V30 12 C 6.9302 11.3186 0.0 0
M  V30 13 F 3.0801 9.9850 0.0 0
M  V30 14 C 5.3901 5.9838 0.0 0
M  V30 15 C 6.9302 5.9838 0.0 0
M  V30 16 C 4.6201 7.3175 0.0 0
M  V30 17 C 4.9141 4.5191 0.0 0
M  V30 18 N 7.4060 4.5191 0.0 0
M  V30 19 N 7.7002 7.3175 0.0 0
M  V30 20 N 5.3901 8.6511 0.0 0
M  V30 21 C 6.1601 3.6140 0.0 0
M  V30 22 C 6.9302 8.6511 0.0 0
M  V30 23 C 3.0801 7.3175 0.0 0
M  V30 24 C 2.3101 8.6513 0.0 0
M  V30 25 C 2.3101 5.9838 0.0 0
M  V30 26 C 0.7700 8.6511 0.0 0
M  V30 27 C 0.7700 5.9838 0.0 0
M  V30 28 C 0.0000 7.3175 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 1 11 12
M  V30 12 1 11 22
M  V30 13 1 13 24
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 17
M  V30 17 1 15 18
M  V30 18 2 15 19
M  V30 19 1 16 20
M  V30 20 1 16 23
M  V30 21 1 17 21
M  V30 22 1 18 21
M  V30 23 1 19 22
M  V30 24 2 20 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2768873-60-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2768873-61-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32324037
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed tube
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic spiro compounds, especially, substituted
2-acryloyl-6-(5,6,7,8-tetrahydroquinazolin-2-yl)-2,6-diazaspiro[3.4]octanes
and related compounds as G12C mutant KRAS protein inhibitors for treating
cancers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lanman, Brian Alan; Banerjee, Abhisek; Chu-Moyer, Margaret; Dai,
Dongcheng; Eshon, Josephine; Huang, David; Kaller, Matthew R.; Lee,
Heejun; Lopez, Patricia; Ma, Vu Van; Manoni, Francesco; Medina, Jose M.;
Pickrell, Alexander J.; Stellwagen, John C.; Sun, Zhen; Tamayo, Nuria A.;
Zhang, Wenhan; Zhu, Kai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022083569 A1 2022-04-28

$RFMT $RIREG SCHEME403 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 6-[4-(2-fluorophenyl)-7-[1-(2-methoxy-2-oxoethyl)-3-methylb...
C31H40FN5O4
2768873-80-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 16.1198 7.8295 0.0 0
M  V30 2 O 17.0251 9.0754 0.0 0
M  V30 3 O 16.7462 6.4227 0.0 0
M  V30 4 C 18.5566 8.9145 0.0 0
M  V30 5 C 18.3957 7.3829 0.0 0
M  V30 6 C 20.0882 8.7536 0.0 0
M  V30 7 C 18.7176 10.4461 0.0 0
M  V30 8 C 4.0432 8.8706 0.0 0
M  V30 9 C 5.0736 10.0151 0.0 0
M  V30 10 C 2.5367 9.1908 0.0 0
M  V30 11 C 4.5978 11.4797 0.0 0
M  V30 12 C 1.5063 8.0464 0.0 0
M  V30 13 O 5.6282 12.6243 0.0 0
M  V30 14 O 3.0915 11.7999 0.0 0
M  V30 15 C 0.0000 8.3665 0.0 0
M  V30 16 C 1.9822 6.5816 0.0 0
M  V30 17 C 5.1523 14.0888 0.0 0
M  V30 18 F 9.9848 3.0801 0.0 0
M  V30 19 C 12.4222 8.2182 0.0 0
M  V30 20 C 11.3918 7.0737 0.0 0
M  V30 21 C 13.3914 7.0213 0.0 0
M  V30 22 C 13.6191 9.1874 0.0 0
M  V30 23 C 11.6522 9.5519 0.0 0
M  V30 24 N 9.9848 7.7002 0.0 0
M  V30 25 N 14.5883 7.9905 0.0 0
M  V30 26 C 10.1459 9.2317 0.0 0
M  V30 27 C 8.6511 6.9302 0.0 0
M  V30 28 N 7.3175 7.7002 0.0 0
M  V30 29 N 8.6511 5.3901 0.0 0
M  V30 30 C 5.9838 6.9302 0.0 0
M  V30 31 C 7.3175 4.6201 0.0 0
M  V30 32 C 5.9838 5.3901 0.0 0
M  V30 33 N 4.5191 7.4060 0.0 0
M  V30 34 C 4.5191 4.9141 0.0 0
M  V30 35 C 3.6138 6.1601 0.0 0
M  V30 36 C 7.3175 3.0801 0.0 0
M  V30 37 C 8.6511 2.3101 0.0 0
M  V30 38 C 5.9838 2.3101 0.0 0
M  V30 39 C 8.6511 0.7700 0.0 0
M  V30 40 C 5.9838 0.7700 0.0 0
M  V30 41 C 7.3175 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 25
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 33
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 18 37
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 1 19 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 1 22 25
M  V30 26 1 23 26
M  V30 27 1 24 26
M  V30 28 1 24 27
M  V30 29 1 27 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 1 30 33
M  V30 35 2 31 32
M  V30 36 1 31 36
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 35
M  V30 40 2 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 2 38 40
M  V30 44 2 39 41
M  V30 45 1 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 6-[4-(2-fluorophenyl)-7-[3-methyl-1-[2-(methylamino)-2-oxoe...
C31H41FN6O3
2768873-81-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 16.1198 7.8295 0.0 0
M  V30 2 O 17.0251 9.0754 0.0 0
M  V30 3 O 16.7462 6.4227 0.0 0
M  V30 4 C 18.5566 8.9145 0.0 0
M  V30 5 C 18.3957 7.3829 0.0 0
M  V30 6 C 20.0882 8.7536 0.0 0
M  V30 7 C 18.7176 10.4461 0.0 0
M  V30 8 C 4.0432 8.8706 0.0 0
M  V30 9 C 5.0736 10.0151 0.0 0
M  V30 10 C 2.5367 9.1908 0.0 0
M  V30 11 C 4.5978 11.4797 0.0 0
M  V30 12 C 1.5063 8.0464 0.0 0
M  V30 13 N 5.6282 12.6243 0.0 0
M  V30 14 O 3.0915 11.7999 0.0 0
M  V30 15 C 0.0000 8.3665 0.0 0
M  V30 16 C 1.9822 6.5816 0.0 0
M  V30 17 C 5.1523 14.0888 0.0 0
M  V30 18 F 9.9848 3.0801 0.0 0
M  V30 19 C 12.4222 8.2182 0.0 0
M  V30 20 C 11.3918 7.0737 0.0 0
M  V30 21 C 13.3914 7.0213 0.0 0
M  V30 22 C 13.6191 9.1874 0.0 0
M  V30 23 C 11.6522 9.5519 0.0 0
M  V30 24 N 9.9848 7.7002 0.0 0
M  V30 25 N 14.5883 7.9905 0.0 0
M  V30 26 C 10.1459 9.2317 0.0 0
M  V30 27 C 8.6511 6.9302 0.0 0
M  V30 28 N 7.3175 7.7002 0.0 0
M  V30 29 N 8.6511 5.3901 0.0 0
M  V30 30 C 5.9838 6.9302 0.0 0
M  V30 31 C 7.3175 4.6201 0.0 0
M  V30 32 C 5.9838 5.3901 0.0 0
M  V30 33 N 4.5191 7.4060 0.0 0
M  V30 34 C 4.5191 4.9141 0.0 0
M  V30 35 C 3.6138 6.1601 0.0 0
M  V30 36 C 7.3175 3.0801 0.0 0
M  V30 37 C 8.6511 2.3101 0.0 0
M  V30 38 C 5.9838 2.3101 0.0 0
M  V30 39 C 8.6511 0.7700 0.0 0
M  V30 40 C 5.9838 0.7700 0.0 0
M  V30 41 C 7.3175 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 25
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 33
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 18 37
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 1 19 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 1 22 25
M  V30 26 1 23 26
M  V30 27 1 24 26
M  V30 28 1 24 27
M  V30 29 1 27 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 1 30 33
M  V30 35 2 31 32
M  V30 36 1 31 36
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 35
M  V30 40 2 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 2 38 40
M  V30 44 2 39 41
M  V30 45 1 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2768873-80-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2768873-81-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32324051
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic spiro compounds, especially, substituted
2-acryloyl-6-(5,6,7,8-tetrahydroquinazolin-2-yl)-2,6-diazaspiro[3.4]octanes
and related compounds as G12C mutant KRAS protein inhibitors for treating
cancers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lanman, Brian Alan; Banerjee, Abhisek; Chu-Moyer, Margaret; Dai,
Dongcheng; Eshon, Josephine; Huang, David; Kaller, Matthew R.; Lee,
Heejun; Lopez, Patricia; Ma, Vu Van; Manoni, Francesco; Medina, Jose M.;
Pickrell, Alexander J.; Stellwagen, John C.; Sun, Zhen; Tamayo, Nuria A.;
Zhang, Wenhan; Zhu, Kai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022083569 A1 2022-04-28

$RFMT $RIREG SCHEME404 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2,2-Trifluoroethyl chloroformate
C3H2ClF3O2
27746-99-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 C 1.3338 2.3101 0.0 0
M  V30 3 O 4.0012 2.3101 0.0 0
M  V30 4 F 0.0000 3.0801 0.0 0
M  V30 5 F 2.1038 3.6437 0.0 0
M  V30 6 F 0.5638 0.9764 0.0 0
M  V30 7 C 5.3348 1.5400 0.0 0
M  V30 8 Cl 6.6687 2.3101 0.0 0
M  V30 9 O 5.3348 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanol, 2,2,2-trifluoro-, methylcarbamate
C4H6F3NO2
878218-01-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 2.3101 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 C 2.6675 1.5400 0.0 0
M  V30 4 N 6.6687 2.3101 0.0 0
M  V30 5 O 5.3348 0.0000 0.0 0
M  V30 6 C 1.3337 2.3101 0.0 0
M  V30 7 C 8.0023 1.5400 0.0 0
M  V30 8 F 0.0000 3.0801 0.0 0
M  V30 9 F 2.1037 3.6437 0.0 0
M  V30 10 F 0.5637 0.9764 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 27746-99-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 878218-01-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-10449659
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A facile synthesis of unsymmetrical ureas
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bogolubsky, Andrey V.; Ryabukhin, Sergey V.; Pipko, Sergey E.; Lukin,
Oleg; Shivanyuk, Alexander; Mykytenko, Dmytro; Tolmachev, Andrey
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2011), 67(20), 3619-3623

$RFMT $RIREG SCHEME405 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenepropanoic acid, 4-methyl-β-oxo-, ethyl ester
C12H14O3
27835-00-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 O 5.3348 0.0000 0.0 0
M  V30 4 C 8.0022 1.5400 0.0 0
M  V30 5 O 9.3360 2.3101 0.0 0
M  V30 6 O 8.0022 0.0000 0.0 0
M  V30 7 C 10.6697 1.5400 0.0 0
M  V30 8 C 12.0033 2.3101 0.0 0
M  V30 9 C 0.0000 4.6201 0.0 0
M  V30 10 C 4.0012 2.3101 0.0 0
M  V30 11 C 2.6673 1.5400 0.0 0
M  V30 12 C 4.0012 3.8501 0.0 0
M  V30 13 C 1.3337 2.3101 0.0 0
M  V30 14 C 2.6673 4.6201 0.0 0
M  V30 15 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (2Z)-3-(methylamino)-3-(4-methylphenyl)-2-propenoate
C13H17NO2
2614438-00-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3101 0.0 0
M  V30 2 C 6.6685 3.0801 0.0 0
M  V30 3 N 5.3348 0.7700 0.0 0
M  V30 4 C 8.0022 2.3101 0.0 0
M  V30 5 C 4.0012 0.0000 0.0 0
M  V30 6 O 9.3360 3.0801 0.0 0
M  V30 7 O 8.0022 0.7700 0.0 0
M  V30 8 C 10.6697 2.3101 0.0 0
M  V30 9 C 12.0033 3.0801 0.0 0
M  V30 10 C 0.0000 5.3901 0.0 0
M  V30 11 C 4.0012 3.0801 0.0 0
M  V30 12 C 4.0012 4.6201 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 2.6673 5.3901 0.0 0
M  V30 15 C 1.3337 3.0801 0.0 0
M  V30 16 C 1.3337 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 10 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 27835-00-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2614438-00-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-23323808
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Electrochemical Oxidative Cyclization: Synthesis of Polysubstituted
Pyrrole from Enamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Zhiwei; Shi, Guang; Tang, Wei; Sun, Jie; Wang, Wenxing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2021), 2021(6), 951-955

$RFMT $RIREG SCHEME406 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2R,4R)-3,4-dihydro-4-phenyl-2-(1H-pyrrol-2-yl)-2H-pyran-6-carboxylate
C17H17NO3
2786780-21-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 6.9899 0.0 0
M  V30 2 O 9.3360 6.2199 0.0 0
M  V30 3 O 8.0023 8.5299 0.0 0
M  V30 4 C 10.6697 6.9899 0.0 0
M  V30 5 C 5.3348 3.9098 0.0 0 CFG=2
M  V30 6 C 4.0012 4.6799 0.0 0
M  V30 7 O 6.6685 4.6799 0.0 0
M  V30 8 C 4.0012 6.2199 0.0 0 CFG=1
M  V30 9 C 6.6685 6.2199 0.0 0
M  V30 10 C 5.3348 6.9899 0.0 0
M  V30 11 C 5.3348 2.3698 0.0 0
M  V30 12 C 4.0889 1.4646 0.0 0
M  V30 13 N 6.5807 1.4646 0.0 0
M  V30 14 C 4.5648 0.0000 0.0 0
M  V30 15 C 6.1048 0.0000 0.0 0
M  V30 16 C 2.6673 6.9899 0.0 0
M  V30 17 C 1.3337 6.2199 0.0 0
M  V30 18 C 2.6673 8.5299 0.0 0
M  V30 19 C 0.0000 6.9899 0.0 0
M  V30 20 C 1.3337 9.3000 0.0 0
M  V30 21 C 0.0000 8.5299 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 11 CFG=1
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 16 CFG=1
M  V30 12 2 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 5 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2R,4R)-3,4-Dihydro-N-methyl-4-phenyl-2-(1H-pyrrol-2-yl)-2H-pyran-6-carboxamide
C17H18N2O2
2786780-44-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 6.9899 0.0 0
M  V30 2 N 9.3360 6.2199 0.0 0
M  V30 3 O 8.0023 8.5299 0.0 0
M  V30 4 C 10.6697 6.9899 0.0 0
M  V30 5 C 5.3348 3.9098 0.0 0 CFG=2
M  V30 6 C 4.0012 4.6799 0.0 0
M  V30 7 O 6.6685 4.6799 0.0 0
M  V30 8 C 4.0012 6.2199 0.0 0 CFG=1
M  V30 9 C 6.6685 6.2199 0.0 0
M  V30 10 C 5.3348 6.9899 0.0 0
M  V30 11 C 5.3348 2.3698 0.0 0
M  V30 12 C 4.0889 1.4646 0.0 0
M  V30 13 N 6.5807 1.4646 0.0 0
M  V30 14 C 4.5648 0.0000 0.0 0
M  V30 15 C 6.1048 0.0000 0.0 0
M  V30 16 C 2.6673 6.9899 0.0 0
M  V30 17 C 1.3337 6.2199 0.0 0
M  V30 18 C 2.6673 8.5299 0.0 0
M  V30 19 C 0.0000 6.9899 0.0 0
M  V30 20 C 1.3337 9.3000 0.0 0
M  V30 21 C 0.0000 8.5299 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 11 CFG=1
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 16 CFG=1
M  V30 12 2 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 5 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2786780-21-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2786780-44-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32584420
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM diastereomeric ratio, >20:1, stereoselective, ee 96%
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Copper-Catalyzed Stereoselective [4 + 2] Cycloaddition of β,γ-Unsaturated
α-Keto Esters and 2-Vinylpyrroles in Water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhao, Shuangshuang; Li, Kuiliang; Sun, Xiang; Zha, Zhenggen; Wang,
Zhiyong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2022), 24(23), 4224-4228

$RFMT $RIREG SCHEME407 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C30H42O4Si2
2803627-99-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 17.3382 6.1601 0.0 0
M  V30 2 O 18.6718 6.9302 0.0 0
M  V30 3 Si 20.0057 6.1601 0.0 0
M  V30 4 C 21.3393 5.3901 0.0 0
M  V30 5 C 19.2356 4.8265 0.0 0
M  V30 6 C 20.7757 7.4938 0.0 0
M  V30 7 C 22.1093 6.7238 0.0 0
M  V30 8 C 22.6730 4.6201 0.0 0
M  V30 9 C 20.5693 4.0564 0.0 0
M  V30 10 C 12.0033 6.1601 0.0 0
M  V30 11 C 10.6697 5.3901 0.0 0
M  V30 12 C 14.6708 10.7802 0.0 0
M  V30 13 O 13.3370 11.5503 0.0 0
M  V30 14 C 5.3348 5.3901 0.0 0
M  V30 15 O 4.0012 4.6201 0.0 0
M  V30 16 Si 2.6673 5.3901 0.0 0
M  V30 17 C 1.3337 6.1601 0.0 0
M  V30 18 C 3.4374 6.7238 0.0 0
M  V30 19 C 1.8973 4.0564 0.0 0
M  V30 20 C 2.1037 7.4938 0.0 0
M  V30 21 C 0.0000 6.9302 0.0 0
M  V30 22 C 0.5637 4.8265 0.0 0
M  V30 23 C 8.0022 0.7700 0.0 0
M  V30 24 O 9.3360 0.0000 0.0 0
M  V30 25 C 16.0045 6.9302 0.0 0
M  V30 26 C 14.6708 6.1601 0.0 0
M  V30 27 C 16.0045 8.4702 0.0 0
M  V30 28 C 13.3370 6.9302 0.0 0
M  V30 29 C 14.6708 9.2402 0.0 0
M  V30 30 C 13.3370 8.4702 0.0 0
M  V30 31 C 9.3360 4.6201 0.0 0
M  V30 32 C 8.0022 5.3901 0.0 0
M  V30 33 C 9.3360 3.0801 0.0 0
M  V30 34 C 6.6685 4.6201 0.0 0
M  V30 35 C 8.0022 2.3101 0.0 0
M  V30 36 C 6.6685 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 25
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 4 9
M  V30 10 3 10 11
M  V30 11 1 10 28
M  V30 12 1 11 31
M  V30 13 2 12 13
M  V30 14 1 12 29
M  V30 15 1 14 15
M  V30 16 1 14 34
M  V30 17 1 15 16
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 16 19
M  V30 21 1 17 20
M  V30 22 1 17 21
M  V30 23 1 17 22
M  V30 24 2 23 24
M  V30 25 1 23 35
M  V30 26 2 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 2 27 29
M  V30 30 2 28 30
M  V30 31 1 29 30
M  V30 32 2 31 32
M  V30 33 1 31 33
M  V30 34 1 32 34
M  V30 35 2 33 35
M  V30 36 2 34 36
M  V30 37 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C32H48N2O2Si2
2803628-00-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 17.3382 7.7002 0.0 0
M  V30 2 O 18.6718 8.4702 0.0 0
M  V30 3 Si 20.0057 7.7002 0.0 0
M  V30 4 C 21.3393 6.9302 0.0 0
M  V30 5 C 20.7757 9.0338 0.0 0
M  V30 6 C 19.2356 6.3665 0.0 0
M  V30 7 C 22.1093 8.2638 0.0 0
M  V30 8 C 22.6730 6.1601 0.0 0
M  V30 9 C 20.5693 5.5965 0.0 0
M  V30 10 C 12.0033 7.7002 0.0 0
M  V30 11 C 10.6697 6.9302 0.0 0
M  V30 12 C 14.6708 12.3203 0.0 0
M  V30 13 N 13.3370 13.0903 0.0 0
M  V30 14 C 13.3370 14.6303 0.0 0
M  V30 15 C 5.3348 6.9302 0.0 0
M  V30 16 O 4.0012 6.1601 0.0 0
M  V30 17 Si 2.6673 6.9302 0.0 0
M  V30 18 C 1.3337 7.7002 0.0 0
M  V30 19 C 1.8973 5.5965 0.0 0
M  V30 20 C 3.4374 8.2638 0.0 0
M  V30 21 C 2.1037 9.0338 0.0 0
M  V30 22 C 0.0000 8.4702 0.0 0
M  V30 23 C 0.5637 6.3665 0.0 0
M  V30 24 C 8.0022 2.3101 0.0 0
M  V30 25 N 9.3360 1.5400 0.0 0
M  V30 26 C 9.3360 0.0000 0.0 0
M  V30 27 C 16.0045 8.4702 0.0 0
M  V30 28 C 14.6708 7.7002 0.0 0
M  V30 29 C 16.0045 10.0102 0.0 0
M  V30 30 C 13.3370 8.4702 0.0 0
M  V30 31 C 14.6708 10.7802 0.0 0
M  V30 32 C 13.3370 10.0102 0.0 0
M  V30 33 C 9.3360 6.1601 0.0 0
M  V30 34 C 8.0022 6.9302 0.0 0
M  V30 35 C 9.3360 4.6201 0.0 0
M  V30 36 C 6.6685 6.1601 0.0 0
M  V30 37 C 8.0022 3.8501 0.0 0
M  V30 38 C 6.6685 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 27
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 4 9
M  V30 10 3 10 11
M  V30 11 1 10 30
M  V30 12 1 11 33
M  V30 13 2 12 13
M  V30 14 1 12 31
M  V30 15 1 13 14
M  V30 16 1 15 16
M  V30 17 1 15 36
M  V30 18 1 16 17
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 17 20
M  V30 22 1 18 21
M  V30 23 1 18 22
M  V30 24 1 18 23
M  V30 25 2 24 25
M  V30 26 1 24 37
M  V30 27 1 25 26
M  V30 28 2 27 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 2 29 31
M  V30 32 2 30 32
M  V30 33 1 31 32
M  V30 34 2 33 34
M  V30 35 1 33 35
M  V30 36 1 34 36
M  V30 37 2 35 37
M  V30 38 2 36 38
M  V30 39 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2803627-99-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2803628-00-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33260939
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tandem Imine Formation and Alkyne Metathesis Enabled by Catalyst Choice
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Greenlee, Andrew J.; Chen, Heyu; Wendell, Chloe I.; Moore, Jeffrey S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2022), 87(13), 8429-8436

$RFMT $RIREG SCHEME408 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 6-(2-chloro-4-pyridinyl)-8-[[[1-[(1,1-dimethylethoxy)carbonyl]-4-piperi...
C26H33ClN6O4
2827007-08-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.1392 7.7002 0.0 0
M  V30 2 C 10.4730 6.9302 0.0 0
M  V30 3 C 2.4873 7.6406 0.0 0
M  V30 4 C 3.8501 10.7012 0.0 0
M  V30 5 O 2.3101 10.7012 0.0 0
M  V30 6 O 4.6201 12.0351 0.0 0
M  V30 7 C 1.5400 12.0351 0.0 0
M  V30 8 C 0.0000 12.0351 0.0 0
M  V30 9 Cl 3.8043 0.0000 0.0 0
M  V30 10 C 15.8078 10.0102 0.0 0
M  V30 11 O 17.1415 9.2402 0.0 0
M  V30 12 O 15.8078 11.5503 0.0 0
M  V30 13 C 18.4752 10.0102 0.0 0
M  V30 14 C 17.7052 11.3440 0.0 0
M  V30 15 C 19.8088 10.7802 0.0 0
M  V30 16 C 19.2452 8.6765 0.0 0
M  V30 17 C 6.4718 7.7002 0.0 0
M  V30 18 N 5.1382 6.9302 0.0 0
M  V30 19 C 7.8055 6.9302 0.0 0
M  V30 20 N 6.1517 9.2066 0.0 0
M  V30 21 C 3.9936 7.9607 0.0 0
M  V30 22 C 5.1382 5.3901 0.0 0
M  V30 23 N 7.8055 5.3901 0.0 0
M  V30 24 C 4.6201 9.3676 0.0 0
M  V30 25 C 6.4718 4.6201 0.0 0
M  V30 26 C 6.4718 3.0801 0.0 0
M  V30 27 C 5.1382 2.3101 0.0 0
M  V30 28 C 7.8055 2.3101 0.0 0
M  V30 29 C 5.1382 0.7700 0.0 0
M  V30 30 C 7.8055 0.7700 0.0 0
M  V30 31 N 6.4718 0.0000 0.0 0
M  V30 32 C 11.8067 7.7002 0.0 0
M  V30 33 C 13.1403 6.9302 0.0 0
M  V30 34 C 11.8067 9.2402 0.0 0
M  V30 35 C 14.4740 7.7002 0.0 0
M  V30 36 C 13.1403 10.0102 0.0 0
M  V30 37 N 14.4740 9.2402 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 32
M  V30 4 1 3 21
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 24
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 9 29
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 37
M  V30 14 1 11 13
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 2 17 20
M  V30 21 1 18 21
M  V30 22 1 18 22
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 2 21 24
M  V30 26 2 22 25
M  V30 27 1 23 25
M  V30 28 1 25 26
M  V30 29 1 26 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 31
M  V30 35 1 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[[[6-(2-chloro-4-pyridinyl)-3-methyl-2-[(methylamino)carb...
C25H32ClN7O3
2827007-09-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.4700 7.5535 0.0 0
M  V30 2 C 9.2400 8.8872 0.0 0
M  V30 3 C 2.6794 4.2794 0.0 0
M  V30 4 C 5.3900 2.3100 0.0 0
M  V30 5 N 4.0564 1.5400 0.0 0
M  V30 6 O 6.7236 1.5400 0.0 0
M  V30 7 C 4.0564 0.0000 0.0 0
M  V30 8 Cl 0.0000 11.5546 0.0 0
M  V30 9 C 15.4000 8.8872 0.0 0
M  V30 10 O 16.1700 10.2208 0.0 0
M  V30 11 O 16.1700 7.5535 0.0 0
M  V30 12 C 17.7100 10.2208 0.0 0
M  V30 13 C 17.7100 8.6808 0.0 0
M  V30 14 C 19.2500 10.2208 0.0 0
M  V30 15 C 17.7100 11.7608 0.0 0
M  V30 16 C 6.1600 6.2199 0.0 0
M  V30 17 N 4.6200 6.2199 0.0 0
M  V30 18 C 6.9300 7.5535 0.0 0
M  V30 19 N 6.6359 4.7552 0.0 0
M  V30 20 C 3.8500 7.5535 0.0 0
M  V30 21 C 4.1441 4.7552 0.0 0
M  V30 22 N 6.1600 8.8872 0.0 0
M  V30 23 C 5.3900 3.8500 0.0 0
M  V30 24 C 4.6200 8.8872 0.0 0
M  V30 25 C 3.8500 10.2208 0.0 0
M  V30 26 C 2.3100 10.2208 0.0 0
M  V30 27 C 4.6200 11.5546 0.0 0
M  V30 28 C 1.5400 11.5546 0.0 0
M  V30 29 C 3.8500 12.8883 0.0 0
M  V30 30 N 2.3100 12.8883 0.0 0
M  V30 31 C 10.7800 8.8872 0.0 0
M  V30 32 C 11.5500 7.5535 0.0 0
M  V30 33 C 11.5500 10.2208 0.0 0
M  V30 34 C 13.0900 7.5535 0.0 0
M  V30 35 C 13.0900 10.2208 0.0 0
M  V30 36 N 13.8600 8.8872 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 31
M  V30 4 1 3 21
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 23
M  V30 8 1 5 7
M  V30 9 1 8 28
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 36
M  V30 13 1 10 12
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 1 17 21
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 2 20 24
M  V30 25 2 21 23
M  V30 26 1 22 24
M  V30 27 1 24 25
M  V30 28 1 25 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 30
M  V30 34 1 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2827007-08-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2827007-09-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35352411
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM pressure tube used, thermal
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Imidazo[1,2-a]pyrazines as inhibitors of haspin and therapeutic uses
thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pastor Fernandez, Joaquin; Martinez Gonzalez, Sonia; Blanco-Aparicio,
Carmen; Gonzalez Cantalapiedra, Esther; Garcia Garcia, Ana Belen; Pastor
Fernandez, Miryam; Hernandez Higueras, Ana Isabel; Albarran Santino,
Maria Isabel; Cebria Gomez, Antonio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP4049726 A1 2022-08-31

$RFMT $RIREG SCHEME409 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 8-[[[1-[(1,1-dimethylethoxy)carbonyl]-4-fluoro-4-piperidinyl]methyl]ami...
C26H33FN6O4
2827007-13-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.1391 7.7000 0.0 0
M  V30 2 C 10.4728 6.9300 0.0 0
M  V30 3 C 2.4873 7.6404 0.0 0
M  V30 4 C 3.8500 10.7010 0.0 0
M  V30 5 O 2.3100 10.7010 0.0 0
M  V30 6 O 4.6200 12.0348 0.0 0
M  V30 7 C 1.5400 12.0348 0.0 0
M  V30 8 C 0.0000 12.0348 0.0 0
M  V30 9 F 10.8167 8.8798 0.0 0
M  V30 10 C 16.3563 6.8978 0.0 0
M  V30 11 O 17.3463 8.0775 0.0 0
M  V30 12 O 16.8830 5.4507 0.0 0
M  V30 13 C 18.8628 7.8101 0.0 0
M  V30 14 C 19.1302 9.3267 0.0 0
M  V30 15 C 20.3794 7.5426 0.0 0
M  V30 16 C 18.5953 6.2935 0.0 0
M  V30 17 C 6.4719 7.7000 0.0 0
M  V30 18 N 5.1381 6.9300 0.0 0
M  V30 19 C 7.8055 6.9300 0.0 0
M  V30 20 N 6.1515 9.2064 0.0 0
M  V30 21 C 5.1381 5.3900 0.0 0
M  V30 22 C 3.9937 7.9606 0.0 0
M  V30 23 N 7.8055 5.3900 0.0 0
M  V30 24 C 4.6200 9.3674 0.0 0
M  V30 25 C 6.4719 4.6200 0.0 0
M  V30 26 C 6.4719 3.0800 0.0 0
M  V30 27 C 7.8055 2.3100 0.0 0
M  V30 28 C 5.1381 2.3100 0.0 0
M  V30 29 C 7.8055 0.7700 0.0 0
M  V30 30 C 5.1381 0.7700 0.0 0
M  V30 31 N 6.4719 0.0000 0.0 0
M  V30 32 C 11.8066 7.7000 0.0 0
M  V30 33 C 12.3332 6.2529 0.0 0
M  V30 34 C 12.7963 8.8798 0.0 0
M  V30 35 C 13.8498 5.9855 0.0 0
M  V30 36 C 14.3129 8.6123 0.0 0
M  V30 37 N 14.8397 7.1652 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 32
M  V30 4 1 3 22
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 24
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 9 32
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 37
M  V30 14 1 11 13
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 2 17 20
M  V30 21 1 18 21
M  V30 22 1 18 22
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 2 21 25
M  V30 26 2 22 24
M  V30 27 1 23 25
M  V30 28 1 25 26
M  V30 29 1 26 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 31
M  V30 35 1 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-fluoro-4-[[[3-methyl-2-[(methylamino)carbonyl]-6-(4-pyrid...
C25H32FN7O3
2827007-14-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.5991 7.7000 0.0 0
M  V30 2 C 8.9328 6.9300 0.0 0
M  V30 3 C 0.9473 7.6404 0.0 0
M  V30 4 C 2.3100 10.7010 0.0 0
M  V30 5 N 0.7700 10.7010 0.0 0
M  V30 6 O 3.0800 12.0348 0.0 0
M  V30 7 C 0.0000 12.0348 0.0 0
M  V30 8 F 9.2767 8.8798 0.0 0
M  V30 9 C 14.8163 6.8978 0.0 0
M  V30 10 O 15.8063 8.0775 0.0 0
M  V30 11 O 15.3430 5.4507 0.0 0
M  V30 12 C 17.3228 7.8101 0.0 0
M  V30 13 C 17.5902 9.3267 0.0 0
M  V30 14 C 18.8394 7.5426 0.0 0
M  V30 15 C 17.0553 6.2935 0.0 0
M  V30 16 C 4.9319 7.7000 0.0 0
M  V30 17 N 3.5981 6.9300 0.0 0
M  V30 18 C 6.2655 6.9300 0.0 0
M  V30 19 N 4.6115 9.2064 0.0 0
M  V30 20 C 3.5981 5.3900 0.0 0
M  V30 21 C 2.4537 7.9606 0.0 0
M  V30 22 N 6.2655 5.3900 0.0 0
M  V30 23 C 3.0800 9.3674 0.0 0
M  V30 24 C 4.9319 4.6200 0.0 0
M  V30 25 C 4.9319 3.0800 0.0 0
M  V30 26 C 3.5981 2.3100 0.0 0
M  V30 27 C 6.2655 2.3100 0.0 0
M  V30 28 C 3.5981 0.7700 0.0 0
M  V30 29 C 6.2655 0.7700 0.0 0
M  V30 30 N 4.9319 0.0000 0.0 0
M  V30 31 C 10.2666 7.7000 0.0 0
M  V30 32 C 10.7932 6.2529 0.0 0
M  V30 33 C 11.2563 8.8798 0.0 0
M  V30 34 C 12.3098 5.9855 0.0 0
M  V30 35 C 12.7729 8.6123 0.0 0
M  V30 36 N 13.2997 7.1652 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 31
M  V30 4 1 3 21
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 23
M  V30 8 1 5 7
M  V30 9 1 8 31
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 36
M  V30 13 1 10 12
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 1 17 21
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 2 20 24
M  V30 25 2 21 23
M  V30 26 1 22 24
M  V30 27 1 24 25
M  V30 28 1 25 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 30
M  V30 34 1 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2827007-13-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2827007-14-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35352419
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM pressure tube used, thermal
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Imidazo[1,2-a]pyrazines as inhibitors of haspin and therapeutic uses
thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pastor Fernandez, Joaquin; Martinez Gonzalez, Sonia; Blanco-Aparicio,
Carmen; Gonzalez Cantalapiedra, Esther; Garcia Garcia, Ana Belen; Pastor
Fernandez, Miryam; Hernandez Higueras, Ana Isabel; Albarran Santino,
Maria Isabel; Cebria Gomez, Antonio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP4049726 A1 2022-08-31

$RFMT $RIREG SCHEME410 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 8-[[[4-cyano-1-[(1,1-dimethylethoxy)carbonyl]-4-piperidinyl]methyl]amin...
C27H33N7O4
2827007-20-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.1391 7.7000 0.0 0
M  V30 2 C 10.4728 6.9300 0.0 0
M  V30 3 C 2.4873 7.6404 0.0 0
M  V30 4 C 3.8500 10.7010 0.0 0
M  V30 5 O 2.3100 10.7010 0.0 0
M  V30 6 O 4.6200 12.0348 0.0 0
M  V30 7 C 1.5400 12.0348 0.0 0
M  V30 8 C 0.0000 12.0348 0.0 0
M  V30 9 C 10.8167 8.8798 0.0 0
M  V30 10 N 9.8267 10.0594 0.0 0
M  V30 11 C 16.3563 6.8978 0.0 0
M  V30 12 O 17.3463 8.0775 0.0 0
M  V30 13 O 16.8830 5.4507 0.0 0
M  V30 14 C 18.8628 7.8101 0.0 0
M  V30 15 C 19.1302 9.3267 0.0 0
M  V30 16 C 20.3794 7.5426 0.0 0
M  V30 17 C 18.5953 6.2935 0.0 0
M  V30 18 C 6.4719 7.7000 0.0 0
M  V30 19 N 5.1381 6.9300 0.0 0
M  V30 20 C 7.8055 6.9300 0.0 0
M  V30 21 N 6.1515 9.2064 0.0 0
M  V30 22 C 5.1381 5.3900 0.0 0
M  V30 23 C 3.9937 7.9606 0.0 0
M  V30 24 N 7.8055 5.3900 0.0 0
M  V30 25 C 4.6200 9.3674 0.0 0
M  V30 26 C 6.4719 4.6200 0.0 0
M  V30 27 C 6.4719 3.0800 0.0 0
M  V30 28 C 5.1381 2.3100 0.0 0
M  V30 29 C 7.8055 2.3100 0.0 0
M  V30 30 C 5.1381 0.7700 0.0 0
M  V30 31 C 7.8055 0.7700 0.0 0
M  V30 32 N 6.4719 0.0000 0.0 0
M  V30 33 C 11.8066 7.7000 0.0 0
M  V30 34 C 12.3332 6.2529 0.0 0
M  V30 35 C 12.7963 8.8798 0.0 0
M  V30 36 C 13.8498 5.9855 0.0 0
M  V30 37 C 14.3129 8.6123 0.0 0
M  V30 38 N 14.8397 7.1652 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 33
M  V30 4 1 3 23
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 25
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 3 9 10
M  V30 11 1 9 33
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 38
M  V30 15 1 12 14
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 14 17
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 2 18 21
M  V30 22 1 19 22
M  V30 23 1 19 23
M  V30 24 2 20 24
M  V30 25 1 21 25
M  V30 26 2 22 26
M  V30 27 2 23 25
M  V30 28 1 24 26
M  V30 29 1 26 27
M  V30 30 1 27 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 32
M  V30 36 1 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-cyano-4-[[[3-methyl-2-[(methylamino)carbonyl]-6-(4-pyridi...
C26H32N8O3
2827007-21-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.5991 7.7000 0.0 0
M  V30 2 C 8.9328 6.9300 0.0 0
M  V30 3 C 0.9473 7.6404 0.0 0
M  V30 4 C 2.3100 10.7010 0.0 0
M  V30 5 N 0.7700 10.7010 0.0 0
M  V30 6 O 3.0800 12.0348 0.0 0
M  V30 7 C 0.0000 12.0348 0.0 0
M  V30 8 C 9.2767 8.8798 0.0 0
M  V30 9 N 8.2867 10.0594 0.0 0
M  V30 10 C 14.8163 6.8978 0.0 0
M  V30 11 O 15.8063 8.0775 0.0 0
M  V30 12 O 15.3430 5.4507 0.0 0
M  V30 13 C 17.3228 7.8101 0.0 0
M  V30 14 C 17.5902 9.3267 0.0 0
M  V30 15 C 18.8394 7.5426 0.0 0
M  V30 16 C 17.0553 6.2935 0.0 0
M  V30 17 C 4.9319 7.7000 0.0 0
M  V30 18 N 3.5981 6.9300 0.0 0
M  V30 19 C 6.2655 6.9300 0.0 0
M  V30 20 N 4.6115 9.2064 0.0 0
M  V30 21 C 3.5981 5.3900 0.0 0
M  V30 22 C 2.4537 7.9606 0.0 0
M  V30 23 N 6.2655 5.3900 0.0 0
M  V30 24 C 3.0800 9.3674 0.0 0
M  V30 25 C 4.9319 4.6200 0.0 0
M  V30 26 C 4.9319 3.0800 0.0 0
M  V30 27 C 3.5981 2.3100 0.0 0
M  V30 28 C 6.2655 2.3100 0.0 0
M  V30 29 C 3.5981 0.7700 0.0 0
M  V30 30 C 6.2655 0.7700 0.0 0
M  V30 31 N 4.9319 0.0000 0.0 0
M  V30 32 C 10.2666 7.7000 0.0 0
M  V30 33 C 10.7932 6.2529 0.0 0
M  V30 34 C 11.2563 8.8798 0.0 0
M  V30 35 C 12.3098 5.9855 0.0 0
M  V30 36 C 12.7729 8.6123 0.0 0
M  V30 37 N 13.2997 7.1652 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 32
M  V30 4 1 3 22
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 24
M  V30 8 1 5 7
M  V30 9 3 8 9
M  V30 10 1 8 32
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 37
M  V30 14 1 11 13
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 2 17 20
M  V30 21 1 18 21
M  V30 22 1 18 22
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 2 21 25
M  V30 26 2 22 24
M  V30 27 1 23 25
M  V30 28 1 25 26
M  V30 29 1 26 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 31
M  V30 35 1 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2827007-20-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2827007-21-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35352418
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM pressure tube used, thermal
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Imidazo[1,2-a]pyrazines as inhibitors of haspin and therapeutic uses
thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pastor Fernandez, Joaquin; Martinez Gonzalez, Sonia; Blanco-Aparicio,
Carmen; Gonzalez Cantalapiedra, Esther; Garcia Garcia, Ana Belen; Pastor
Fernandez, Miryam; Hernandez Higueras, Ana Isabel; Albarran Santino,
Maria Isabel; Cebria Gomez, Antonio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP4049726 A1 2022-08-31

$RFMT $RIREG SCHEME411 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 6-(2-chloro-4-pyridinyl)-8-[[[1-[(1,1-dimethylethoxy)carbonyl]-4-fluoro...
C26H32ClFN6O4
2827007-24-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.1391 7.7000 0.0 0
M  V30 2 C 10.4728 6.9300 0.0 0
M  V30 3 C 2.4873 7.6404 0.0 0
M  V30 4 C 3.8500 10.7010 0.0 0
M  V30 5 O 2.3100 10.7010 0.0 0
M  V30 6 O 4.6200 12.0348 0.0 0
M  V30 7 C 1.5400 12.0348 0.0 0
M  V30 8 C 0.0000 12.0348 0.0 0
M  V30 9 F 10.8167 8.8798 0.0 0
M  V30 10 Cl 3.8044 0.0000 0.0 0
M  V30 11 C 16.3563 6.8978 0.0 0
M  V30 12 O 17.3463 8.0775 0.0 0
M  V30 13 O 16.8830 5.4507 0.0 0
M  V30 14 C 18.8628 7.8101 0.0 0
M  V30 15 C 19.1302 9.3267 0.0 0
M  V30 16 C 20.3794 7.5426 0.0 0
M  V30 17 C 18.5953 6.2935 0.0 0
M  V30 18 C 6.4719 7.7000 0.0 0
M  V30 19 N 5.1381 6.9300 0.0 0
M  V30 20 C 7.8055 6.9300 0.0 0
M  V30 21 N 6.1515 9.2064 0.0 0
M  V30 22 C 5.1381 5.3900 0.0 0
M  V30 23 C 3.9937 7.9606 0.0 0
M  V30 24 N 7.8055 5.3900 0.0 0
M  V30 25 C 4.6200 9.3674 0.0 0
M  V30 26 C 6.4719 4.6200 0.0 0
M  V30 27 C 6.4719 3.0800 0.0 0
M  V30 28 C 5.1381 2.3100 0.0 0
M  V30 29 C 7.8055 2.3100 0.0 0
M  V30 30 C 5.1381 0.7700 0.0 0
M  V30 31 C 7.8055 0.7700 0.0 0
M  V30 32 N 6.4719 0.0000 0.0 0
M  V30 33 C 11.8066 7.7000 0.0 0
M  V30 34 C 12.3332 6.2529 0.0 0
M  V30 35 C 12.7963 8.8798 0.0 0
M  V30 36 C 13.8498 5.9855 0.0 0
M  V30 37 C 14.3129 8.6123 0.0 0
M  V30 38 N 14.8397 7.1652 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 33
M  V30 4 1 3 23
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 25
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 9 33
M  V30 11 1 10 30
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 38
M  V30 15 1 12 14
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 14 17
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 2 18 21
M  V30 22 1 19 22
M  V30 23 1 19 23
M  V30 24 2 20 24
M  V30 25 1 21 25
M  V30 26 2 22 26
M  V30 27 2 23 25
M  V30 28 1 24 26
M  V30 29 1 26 27
M  V30 30 1 27 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 32
M  V30 36 1 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[[[6-(2-chloro-4-pyridinyl)-3-methyl-2-[(methylamino)carb...
C25H31ClFN7O3
2827007-25-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.5991 7.7000 0.0 0
M  V30 2 C 8.9328 6.9300 0.0 0
M  V30 3 C 0.9473 7.6404 0.0 0
M  V30 4 C 2.3100 10.7010 0.0 0
M  V30 5 N 0.7700 10.7010 0.0 0
M  V30 6 O 3.0800 12.0348 0.0 0
M  V30 7 C 0.0000 12.0348 0.0 0
M  V30 8 F 9.2767 8.8798 0.0 0
M  V30 9 Cl 2.2644 0.0000 0.0 0
M  V30 10 C 14.8163 6.8978 0.0 0
M  V30 11 O 15.8063 8.0775 0.0 0
M  V30 12 O 15.3430 5.4507 0.0 0
M  V30 13 C 17.3228 7.8101 0.0 0
M  V30 14 C 17.5902 9.3267 0.0 0
M  V30 15 C 18.8394 7.5426 0.0 0
M  V30 16 C 17.0553 6.2935 0.0 0
M  V30 17 C 4.9319 7.7000 0.0 0
M  V30 18 N 3.5981 6.9300 0.0 0
M  V30 19 C 6.2655 6.9300 0.0 0
M  V30 20 N 4.6115 9.2064 0.0 0
M  V30 21 C 3.5981 5.3900 0.0 0
M  V30 22 C 2.4537 7.9606 0.0 0
M  V30 23 N 6.2655 5.3900 0.0 0
M  V30 24 C 3.0800 9.3674 0.0 0
M  V30 25 C 4.9319 4.6200 0.0 0
M  V30 26 C 4.9319 3.0800 0.0 0
M  V30 27 C 3.5981 2.3100 0.0 0
M  V30 28 C 6.2655 2.3100 0.0 0
M  V30 29 C 3.5981 0.7700 0.0 0
M  V30 30 C 6.2655 0.7700 0.0 0
M  V30 31 N 4.9319 0.0000 0.0 0
M  V30 32 C 10.2666 7.7000 0.0 0
M  V30 33 C 10.7932 6.2529 0.0 0
M  V30 34 C 11.2563 8.8798 0.0 0
M  V30 35 C 12.3098 5.9855 0.0 0
M  V30 36 C 12.7729 8.6123 0.0 0
M  V30 37 N 13.2997 7.1652 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 32
M  V30 4 1 3 22
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 24
M  V30 8 1 5 7
M  V30 9 1 8 32
M  V30 10 1 9 29
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 37
M  V30 14 1 11 13
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 2 17 20
M  V30 21 1 18 21
M  V30 22 1 18 22
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 2 21 25
M  V30 26 2 22 24
M  V30 27 1 23 25
M  V30 28 1 25 26
M  V30 29 1 26 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 31
M  V30 35 1 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2827007-24-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2827007-25-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35352433
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM pressure tube used, thermal
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Imidazo[1,2-a]pyrazines as inhibitors of haspin and therapeutic uses
thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pastor Fernandez, Joaquin; Martinez Gonzalez, Sonia; Blanco-Aparicio,
Carmen; Gonzalez Cantalapiedra, Esther; Garcia Garcia, Ana Belen; Pastor
Fernandez, Miryam; Hernandez Higueras, Ana Isabel; Albarran Santino,
Maria Isabel; Cebria Gomez, Antonio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP4049726 A1 2022-08-31

$RFMT $RIREG SCHEME412 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Imidazo[1,2-a]pyrazine-2-carboxylic acid, 8-[[[1-[(1,1-dimethylethoxy)carbony...
C25H31FN6O4
2827007-32-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.1392 7.7002 0.0 0
M  V30 2 C 10.4730 6.9302 0.0 0
M  V30 3 C 3.8501 10.7012 0.0 0
M  V30 4 O 2.3101 10.7012 0.0 0
M  V30 5 O 4.6201 12.0351 0.0 0
M  V30 6 C 1.5400 12.0351 0.0 0
M  V30 7 C 0.0000 12.0351 0.0 0
M  V30 8 F 3.8043 3.0801 0.0 0
M  V30 9 C 15.8078 10.0102 0.0 0
M  V30 10 O 17.1415 9.2402 0.0 0
M  V30 11 O 15.8078 11.5503 0.0 0
M  V30 12 C 18.4752 10.0102 0.0 0
M  V30 13 C 17.7052 11.3440 0.0 0
M  V30 14 C 19.8088 10.7802 0.0 0
M  V30 15 C 19.2452 8.6765 0.0 0
M  V30 16 C 6.4718 7.7002 0.0 0
M  V30 17 N 5.1382 6.9302 0.0 0
M  V30 18 C 7.8055 6.9302 0.0 0
M  V30 19 N 6.1517 9.2066 0.0 0
M  V30 20 C 5.1382 5.3901 0.0 0
M  V30 21 C 3.9936 7.9607 0.0 0
M  V30 22 N 7.8055 5.3901 0.0 0
M  V30 23 C 4.6201 9.3676 0.0 0
M  V30 24 C 6.4718 4.6201 0.0 0
M  V30 25 C 6.4718 3.0801 0.0 0
M  V30 26 C 5.1382 2.3101 0.0 0
M  V30 27 C 7.8055 2.3101 0.0 0
M  V30 28 C 5.1382 0.7700 0.0 0
M  V30 29 C 7.8055 0.7700 0.0 0
M  V30 30 N 6.4718 0.0000 0.0 0
M  V30 31 C 11.8067 7.7002 0.0 0
M  V30 32 C 13.1403 6.9302 0.0 0
M  V30 33 C 11.8067 9.2402 0.0 0
M  V30 34 C 14.4740 7.7002 0.0 0
M  V30 35 C 13.1403 10.0102 0.0 0
M  V30 36 N 14.4740 9.2402 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 31
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 23
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 8 26
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 36
M  V30 13 1 10 12
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 1 17 21
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 2 20 24
M  V30 25 2 21 23
M  V30 26 1 22 24
M  V30 27 1 24 25
M  V30 28 1 25 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 30
M  V30 34 1 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[[[6-(3-fluoro-4-pyridinyl)-2-[(methylamino)carbonyl]imid...
C24H30FN7O3
2827007-34-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.5991 7.7002 0.0 0
M  V30 2 C 8.9330 6.9302 0.0 0
M  V30 3 C 2.3101 10.7012 0.0 0
M  V30 4 N 0.7700 10.7012 0.0 0
M  V30 5 O 3.0801 12.0351 0.0 0
M  V30 6 C 0.0000 12.0351 0.0 0
M  V30 7 F 2.2643 3.0801 0.0 0
M  V30 8 C 14.2678 10.0102 0.0 0
M  V30 9 O 15.6015 9.2402 0.0 0
M  V30 10 O 14.2678 11.5503 0.0 0
M  V30 11 C 16.9351 10.0102 0.0 0
M  V30 12 C 16.1651 11.3440 0.0 0
M  V30 13 C 18.2688 10.7802 0.0 0
M  V30 14 C 17.7052 8.6765 0.0 0
M  V30 15 C 4.9318 7.7002 0.0 0
M  V30 16 N 3.5981 6.9302 0.0 0
M  V30 17 C 6.2655 6.9302 0.0 0
M  V30 18 N 4.6116 9.2066 0.0 0
M  V30 19 C 3.5981 5.3901 0.0 0
M  V30 20 C 2.4536 7.9607 0.0 0
M  V30 21 N 6.2655 5.3901 0.0 0
M  V30 22 C 3.0801 9.3676 0.0 0
M  V30 23 C 4.9318 4.6201 0.0 0
M  V30 24 C 4.9318 3.0801 0.0 0
M  V30 25 C 3.5981 2.3101 0.0 0
M  V30 26 C 6.2655 2.3101 0.0 0
M  V30 27 C 3.5981 0.7700 0.0 0
M  V30 28 C 6.2655 0.7700 0.0 0
M  V30 29 N 4.9318 0.0000 0.0 0
M  V30 30 C 10.2666 7.7002 0.0 0
M  V30 31 C 10.2666 9.2402 0.0 0
M  V30 32 C 11.6003 6.9302 0.0 0
M  V30 33 C 11.6003 10.0102 0.0 0
M  V30 34 C 12.9340 7.7002 0.0 0
M  V30 35 N 12.9340 9.2402 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 30
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 22
M  V30 7 1 4 6
M  V30 8 1 7 25
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 35
M  V30 12 1 9 11
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 1 16 19
M  V30 20 1 16 20
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 2 19 23
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 23 24
M  V30 27 1 24 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 29
M  V30 33 1 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2827007-32-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2827007-34-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35352434
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM pressure tube used, thermal
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Imidazo[1,2-a]pyrazines as inhibitors of haspin and therapeutic uses
thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pastor Fernandez, Joaquin; Martinez Gonzalez, Sonia; Blanco-Aparicio,
Carmen; Gonzalez Cantalapiedra, Esther; Garcia Garcia, Ana Belen; Pastor
Fernandez, Miryam; Hernandez Higueras, Ana Isabel; Albarran Santino,
Maria Isabel; Cebria Gomez, Antonio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP4049726 A1 2022-08-31

$RFMT $RIREG SCHEME413 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Imidazo[1,2-a]pyrazine-2-carboxylic acid, 8-[[[4-cyano-1-[(1,1-dimethylethoxy...
C26H30FN7O4
2827007-35-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.1391 7.7000 0.0 0
M  V30 2 C 10.4728 6.9300 0.0 0
M  V30 3 C 3.8500 10.7010 0.0 0
M  V30 4 O 2.3100 10.7010 0.0 0
M  V30 5 O 4.6200 12.0348 0.0 0
M  V30 6 C 1.5400 12.0348 0.0 0
M  V30 7 C 0.0000 12.0348 0.0 0
M  V30 8 C 10.8167 8.8798 0.0 0
M  V30 9 N 9.8267 10.0594 0.0 0
M  V30 10 F 3.8044 3.0800 0.0 0
M  V30 11 C 16.3563 6.8978 0.0 0
M  V30 12 O 17.3463 8.0775 0.0 0
M  V30 13 O 16.8830 5.4507 0.0 0
M  V30 14 C 18.8628 7.8101 0.0 0
M  V30 15 C 18.5953 6.2935 0.0 0
M  V30 16 C 20.3794 7.5426 0.0 0
M  V30 17 C 19.1302 9.3267 0.0 0
M  V30 18 C 6.4719 7.7000 0.0 0
M  V30 19 N 5.1381 6.9300 0.0 0
M  V30 20 C 7.8055 6.9300 0.0 0
M  V30 21 N 6.1515 9.2064 0.0 0
M  V30 22 C 5.1381 5.3900 0.0 0
M  V30 23 C 3.9937 7.9606 0.0 0
M  V30 24 N 7.8055 5.3900 0.0 0
M  V30 25 C 4.6200 9.3674 0.0 0
M  V30 26 C 6.4719 4.6200 0.0 0
M  V30 27 C 6.4719 3.0800 0.0 0
M  V30 28 C 5.1381 2.3100 0.0 0
M  V30 29 C 7.8055 2.3100 0.0 0
M  V30 30 C 5.1381 0.7700 0.0 0
M  V30 31 C 7.8055 0.7700 0.0 0
M  V30 32 N 6.4719 0.0000 0.0 0
M  V30 33 C 11.8066 7.7000 0.0 0
M  V30 34 C 12.3332 6.2529 0.0 0
M  V30 35 C 12.7963 8.8798 0.0 0
M  V30 36 C 13.8498 5.9855 0.0 0
M  V30 37 C 14.3131 8.6123 0.0 0
M  V30 38 N 14.8397 7.1652 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 33
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 25
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 3 8 9
M  V30 10 1 8 33
M  V30 11 1 10 28
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 38
M  V30 15 1 12 14
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 14 17
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 2 18 21
M  V30 22 1 19 22
M  V30 23 1 19 23
M  V30 24 2 20 24
M  V30 25 1 21 25
M  V30 26 2 22 26
M  V30 27 2 23 25
M  V30 28 1 24 26
M  V30 29 1 26 27
M  V30 30 1 27 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 32
M  V30 36 1 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-cyano-4-[[[6-(3-fluoro-4-pyridinyl)-2-[(methylamino)carbo...
C25H29FN8O3
2827007-40-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.5991 7.7000 0.0 0
M  V30 2 C 8.9328 6.9300 0.0 0
M  V30 3 C 2.3100 10.7010 0.0 0
M  V30 4 N 0.7700 10.7010 0.0 0
M  V30 5 O 3.0800 12.0348 0.0 0
M  V30 6 C 0.0000 12.0348 0.0 0
M  V30 7 C 9.2767 8.8798 0.0 0
M  V30 8 N 8.2867 10.0594 0.0 0
M  V30 9 F 2.2644 3.0800 0.0 0
M  V30 10 C 14.8163 6.8978 0.0 0
M  V30 11 O 15.8063 8.0775 0.0 0
M  V30 12 O 15.3430 5.4507 0.0 0
M  V30 13 C 17.3228 7.8101 0.0 0
M  V30 14 C 17.5902 9.3267 0.0 0
M  V30 15 C 18.8394 7.5426 0.0 0
M  V30 16 C 17.0553 6.2935 0.0 0
M  V30 17 C 4.9319 7.7000 0.0 0
M  V30 18 N 3.5981 6.9300 0.0 0
M  V30 19 C 6.2655 6.9300 0.0 0
M  V30 20 N 4.6115 9.2064 0.0 0
M  V30 21 C 3.5981 5.3900 0.0 0
M  V30 22 C 2.4537 7.9606 0.0 0
M  V30 23 N 6.2655 5.3900 0.0 0
M  V30 24 C 3.0800 9.3674 0.0 0
M  V30 25 C 4.9319 4.6200 0.0 0
M  V30 26 C 4.9319 3.0800 0.0 0
M  V30 27 C 3.5981 2.3100 0.0 0
M  V30 28 C 6.2655 2.3100 0.0 0
M  V30 29 C 3.5981 0.7700 0.0 0
M  V30 30 C 6.2655 0.7700 0.0 0
M  V30 31 N 4.9319 0.0000 0.0 0
M  V30 32 C 10.2666 7.7000 0.0 0
M  V30 33 C 10.7932 6.2529 0.0 0
M  V30 34 C 11.2563 8.8798 0.0 0
M  V30 35 C 12.3098 5.9855 0.0 0
M  V30 36 C 12.7731 8.6123 0.0 0
M  V30 37 N 13.2997 7.1652 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 32
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 24
M  V30 7 1 4 6
M  V30 8 3 7 8
M  V30 9 1 7 32
M  V30 10 1 9 27
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 37
M  V30 14 1 11 13
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 2 17 20
M  V30 21 1 18 21
M  V30 22 1 18 22
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 2 21 25
M  V30 26 2 22 24
M  V30 27 1 23 25
M  V30 28 1 25 26
M  V30 29 1 26 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 31
M  V30 35 1 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2827007-35-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2827007-40-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35352452
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM pressure tube used, thermal
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Imidazo[1,2-a]pyrazines as inhibitors of haspin and therapeutic uses
thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pastor Fernandez, Joaquin; Martinez Gonzalez, Sonia; Blanco-Aparicio,
Carmen; Gonzalez Cantalapiedra, Esther; Garcia Garcia, Ana Belen; Pastor
Fernandez, Miryam; Hernandez Higueras, Ana Isabel; Albarran Santino,
Maria Isabel; Cebria Gomez, Antonio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP4049726 A1 2022-08-31

$RFMT $RIREG SCHEME414 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 6-(3-chloro-4-pyridinyl)-8-[[[1-[(1,1-dimethylethoxy)carbonyl]-4-piperi...
C25H31ClN6O4
2827007-37-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.1392 7.7002 0.0 0
M  V30 2 C 10.4730 6.9302 0.0 0
M  V30 3 C 3.8501 10.7012 0.0 0
M  V30 4 O 2.3101 10.7012 0.0 0
M  V30 5 O 4.6201 12.0351 0.0 0
M  V30 6 C 1.5400 12.0351 0.0 0
M  V30 7 C 0.0000 12.0351 0.0 0
M  V30 8 Cl 3.8043 3.0801 0.0 0
M  V30 9 C 15.8078 10.0102 0.0 0
M  V30 10 O 17.1415 9.2402 0.0 0
M  V30 11 O 15.8078 11.5503 0.0 0
M  V30 12 C 18.4752 10.0102 0.0 0
M  V30 13 C 17.7052 11.3440 0.0 0
M  V30 14 C 19.8088 10.7802 0.0 0
M  V30 15 C 19.2452 8.6765 0.0 0
M  V30 16 C 6.4718 7.7002 0.0 0
M  V30 17 N 5.1382 6.9302 0.0 0
M  V30 18 C 7.8055 6.9302 0.0 0
M  V30 19 N 6.1517 9.2066 0.0 0
M  V30 20 C 5.1382 5.3901 0.0 0
M  V30 21 C 3.9936 7.9607 0.0 0
M  V30 22 N 7.8055 5.3901 0.0 0
M  V30 23 C 4.6201 9.3676 0.0 0
M  V30 24 C 6.4718 4.6201 0.0 0
M  V30 25 C 6.4718 3.0801 0.0 0
M  V30 26 C 5.1382 2.3101 0.0 0
M  V30 27 C 7.8055 2.3101 0.0 0
M  V30 28 C 5.1382 0.7700 0.0 0
M  V30 29 C 7.8055 0.7700 0.0 0
M  V30 30 N 6.4718 0.0000 0.0 0
M  V30 31 C 11.8067 7.7002 0.0 0
M  V30 32 C 11.8067 9.2402 0.0 0
M  V30 33 C 13.1403 6.9302 0.0 0
M  V30 34 C 13.1403 10.0102 0.0 0
M  V30 35 C 14.4740 7.7002 0.0 0
M  V30 36 N 14.4740 9.2402 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 31
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 23
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 8 26
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 36
M  V30 13 1 10 12
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 1 17 21
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 2 20 24
M  V30 25 2 21 23
M  V30 26 1 22 24
M  V30 27 1 24 25
M  V30 28 1 25 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 30
M  V30 34 1 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[[[6-(3-chloro-4-pyridinyl)-2-[(methylamino)carbonyl]imid...
C24H30ClN7O3
2827007-39-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.5991 7.7002 0.0 0
M  V30 2 C 8.9330 6.9302 0.0 0
M  V30 3 C 2.3101 10.7012 0.0 0
M  V30 4 N 0.7700 10.7012 0.0 0
M  V30 5 O 3.0801 12.0351 0.0 0
M  V30 6 C 0.0000 12.0351 0.0 0
M  V30 7 Cl 2.2643 3.0801 0.0 0
M  V30 8 C 14.2678 10.0102 0.0 0
M  V30 9 O 15.6015 9.2402 0.0 0
M  V30 10 O 14.2678 11.5503 0.0 0
M  V30 11 C 16.9351 10.0102 0.0 0
M  V30 12 C 16.1651 11.3440 0.0 0
M  V30 13 C 18.2688 10.7802 0.0 0
M  V30 14 C 17.7052 8.6765 0.0 0
M  V30 15 C 4.9318 7.7002 0.0 0
M  V30 16 N 3.5981 6.9302 0.0 0
M  V30 17 C 6.2655 6.9302 0.0 0
M  V30 18 N 4.6116 9.2066 0.0 0
M  V30 19 C 3.5981 5.3901 0.0 0
M  V30 20 C 2.4536 7.9607 0.0 0
M  V30 21 N 6.2655 5.3901 0.0 0
M  V30 22 C 3.0801 9.3676 0.0 0
M  V30 23 C 4.9318 4.6201 0.0 0
M  V30 24 C 4.9318 3.0801 0.0 0
M  V30 25 C 3.5981 2.3101 0.0 0
M  V30 26 C 6.2655 2.3101 0.0 0
M  V30 27 C 3.5981 0.7700 0.0 0
M  V30 28 C 6.2655 0.7700 0.0 0
M  V30 29 N 4.9318 0.0000 0.0 0
M  V30 30 C 10.2666 7.7002 0.0 0
M  V30 31 C 10.2666 9.2402 0.0 0
M  V30 32 C 11.6003 6.9302 0.0 0
M  V30 33 C 11.6003 10.0102 0.0 0
M  V30 34 C 12.9340 7.7002 0.0 0
M  V30 35 N 12.9340 9.2402 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 30
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 22
M  V30 7 1 4 6
M  V30 8 1 7 25
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 35
M  V30 12 1 9 11
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 1 16 19
M  V30 20 1 16 20
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 2 19 23
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 23 24
M  V30 27 1 24 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 29
M  V30 33 1 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2827007-37-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2827007-39-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35352431
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM pressure tube used, thermal
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Imidazo[1,2-a]pyrazines as inhibitors of haspin and therapeutic uses
thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pastor Fernandez, Joaquin; Martinez Gonzalez, Sonia; Blanco-Aparicio,
Carmen; Gonzalez Cantalapiedra, Esther; Garcia Garcia, Ana Belen; Pastor
Fernandez, Miryam; Hernandez Higueras, Ana Isabel; Albarran Santino,
Maria Isabel; Cebria Gomez, Antonio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP4049726 A1 2022-08-31

$RFMT $RIREG SCHEME415 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Imidazo[1,2-a]pyrazine-2-carboxylic acid, 8-[[[1-[(1,1-dimethylethoxy)carbony...
C26H33FN6O4
2827007-42-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.1392 7.7002 0.0 0
M  V30 2 C 10.4730 6.9302 0.0 0
M  V30 3 C 2.4873 7.6406 0.0 0
M  V30 4 C 3.8501 10.7012 0.0 0
M  V30 5 O 2.3101 10.7012 0.0 0
M  V30 6 O 4.6201 12.0351 0.0 0
M  V30 7 C 1.5400 12.0351 0.0 0
M  V30 8 C 0.0000 12.0351 0.0 0
M  V30 9 F 3.8043 3.0801 0.0 0
M  V30 10 C 15.8078 10.0102 0.0 0
M  V30 11 O 17.1415 9.2402 0.0 0
M  V30 12 O 15.8078 11.5503 0.0 0
M  V30 13 C 18.4752 10.0102 0.0 0
M  V30 14 C 17.7052 11.3440 0.0 0
M  V30 15 C 19.8088 10.7802 0.0 0
M  V30 16 C 19.2452 8.6765 0.0 0
M  V30 17 C 6.4718 7.7002 0.0 0
M  V30 18 N 5.1382 6.9302 0.0 0
M  V30 19 C 7.8055 6.9302 0.0 0
M  V30 20 N 6.1517 9.2066 0.0 0
M  V30 21 C 5.1382 5.3901 0.0 0
M  V30 22 C 3.9936 7.9607 0.0 0
M  V30 23 N 7.8055 5.3901 0.0 0
M  V30 24 C 4.6201 9.3676 0.0 0
M  V30 25 C 6.4718 4.6201 0.0 0
M  V30 26 C 6.4718 3.0801 0.0 0
M  V30 27 C 5.1382 2.3101 0.0 0
M  V30 28 C 7.8055 2.3101 0.0 0
M  V30 29 C 5.1382 0.7700 0.0 0
M  V30 30 C 7.8055 0.7700 0.0 0
M  V30 31 N 6.4718 0.0000 0.0 0
M  V30 32 C 11.8067 7.7002 0.0 0
M  V30 33 C 13.1403 6.9302 0.0 0
M  V30 34 C 11.8067 9.2402 0.0 0
M  V30 35 C 14.4740 7.7002 0.0 0
M  V30 36 C 13.1403 10.0102 0.0 0
M  V30 37 N 14.4740 9.2402 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 32
M  V30 4 1 3 22
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 24
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 9 27
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 37
M  V30 14 1 11 13
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 2 17 20
M  V30 21 1 18 21
M  V30 22 1 18 22
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 2 21 25
M  V30 26 2 22 24
M  V30 27 1 23 25
M  V30 28 1 25 26
M  V30 29 1 26 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 31
M  V30 35 1 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[[[6-(3-fluoro-4-pyridinyl)-3-methyl-2-[(methylamino)carb...
C25H32FN7O3
2827007-43-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.5991 7.7002 0.0 0
M  V30 2 C 8.9330 6.9302 0.0 0
M  V30 3 C 0.9473 7.6406 0.0 0
M  V30 4 C 2.3101 10.7012 0.0 0
M  V30 5 N 0.7700 10.7012 0.0 0
M  V30 6 O 3.0801 12.0351 0.0 0
M  V30 7 C 0.0000 12.0351 0.0 0
M  V30 8 F 2.2643 3.0801 0.0 0
M  V30 9 C 14.2678 10.0102 0.0 0
M  V30 10 O 15.6015 9.2402 0.0 0
M  V30 11 O 14.2678 11.5503 0.0 0
M  V30 12 C 16.9351 10.0102 0.0 0
M  V30 13 C 16.1651 11.3440 0.0 0
M  V30 14 C 18.2688 10.7802 0.0 0
M  V30 15 C 17.7052 8.6765 0.0 0
M  V30 16 C 4.9318 7.7002 0.0 0
M  V30 17 N 3.5981 6.9302 0.0 0
M  V30 18 C 6.2655 6.9302 0.0 0
M  V30 19 N 4.6116 9.2066 0.0 0
M  V30 20 C 3.5981 5.3901 0.0 0
M  V30 21 C 2.4536 7.9607 0.0 0
M  V30 22 N 6.2655 5.3901 0.0 0
M  V30 23 C 3.0801 9.3676 0.0 0
M  V30 24 C 4.9318 4.6201 0.0 0
M  V30 25 C 4.9318 3.0801 0.0 0
M  V30 26 C 3.5981 2.3101 0.0 0
M  V30 27 C 6.2655 2.3101 0.0 0
M  V30 28 C 3.5981 0.7700 0.0 0
M  V30 29 C 6.2655 0.7700 0.0 0
M  V30 30 N 4.9318 0.0000 0.0 0
M  V30 31 C 10.2666 7.7002 0.0 0
M  V30 32 C 10.2666 9.2402 0.0 0
M  V30 33 C 11.6003 6.9302 0.0 0
M  V30 34 C 11.6003 10.0102 0.0 0
M  V30 35 C 12.9340 7.7002 0.0 0
M  V30 36 N 12.9340 9.2402 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 31
M  V30 4 1 3 21
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 23
M  V30 8 1 5 7
M  V30 9 1 8 26
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 36
M  V30 13 1 10 12
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 1 17 21
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 2 20 24
M  V30 25 2 21 23
M  V30 26 1 22 24
M  V30 27 1 24 25
M  V30 28 1 25 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 30
M  V30 34 1 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2827007-42-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2827007-43-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35352450
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM pressure tube used, thermal
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Imidazo[1,2-a]pyrazines as inhibitors of haspin and therapeutic uses
thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pastor Fernandez, Joaquin; Martinez Gonzalez, Sonia; Blanco-Aparicio,
Carmen; Gonzalez Cantalapiedra, Esther; Garcia Garcia, Ana Belen; Pastor
Fernandez, Miryam; Hernandez Higueras, Ana Isabel; Albarran Santino,
Maria Isabel; Cebria Gomez, Antonio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP4049726 A1 2022-08-31

$RFMT $RIREG SCHEME416 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2R)-2-hydroxy-3-[[(1S)-1-[2-(trifluoromethyl)-5-pyrimidinyl]ethyl]ami...
C11H14F3N3O3
2875172-33-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.3337 0.0 0
M  V30 2 F 0.5637 2.6673 0.0 0
M  V30 3 F 0.0000 0.5637 0.0 0
M  V30 4 F 2.1037 0.0000 0.0 0
M  V30 5 C 6.6685 4.4137 0.0 0 CFG=2
M  V30 6 N 8.0022 3.6437 0.0 0
M  V30 7 C 6.6685 5.9538 0.0 0
M  V30 8 C 9.3358 4.4137 0.0 0
M  V30 9 C 10.6697 3.6437 0.0 0 CFG=1
M  V30 10 C 12.0033 4.4137 0.0 0
M  V30 11 O 10.6697 2.1037 0.0 0
M  V30 12 O 13.3370 3.6437 0.0 0
M  V30 13 O 12.0033 5.9538 0.0 0
M  V30 14 C 14.6707 4.4137 0.0 0
M  V30 15 C 2.6673 2.1037 0.0 0
M  V30 16 N 4.0010 1.3337 0.0 0
M  V30 17 N 2.6673 3.6437 0.0 0
M  V30 18 C 5.3348 2.1037 0.0 0
M  V30 19 C 4.0010 4.4137 0.0 0
M  V30 20 C 5.3348 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 15
M  V30 5 1 5 6
M  V30 6 1 5 7 CFG=3
M  V30 7 1 5 20
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 9 11 CFG=3
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 12 14
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 5 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2R)-2-Hydroxy-N-methyl-3-[[(1S)-1-[2-(trifluoromethyl)-5-pyrimidinyl]ethyl]a...
C11H15F3N4O2
2875172-34-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.3337 0.0 0
M  V30 2 F 0.5637 2.6673 0.0 0
M  V30 3 F 0.0000 0.5637 0.0 0
M  V30 4 F 2.1037 0.0000 0.0 0
M  V30 5 C 6.6685 4.4137 0.0 0 CFG=2
M  V30 6 N 8.0022 3.6437 0.0 0
M  V30 7 C 6.6685 5.9538 0.0 0
M  V30 8 C 9.3358 4.4137 0.0 0
M  V30 9 C 10.6697 3.6437 0.0 0 CFG=1
M  V30 10 C 12.0033 4.4137 0.0 0
M  V30 11 O 10.6697 2.1037 0.0 0
M  V30 12 N 13.3370 3.6437 0.0 0
M  V30 13 O 12.0033 5.9538 0.0 0
M  V30 14 C 14.6707 4.4137 0.0 0
M  V30 15 C 2.6673 2.1037 0.0 0
M  V30 16 N 4.0010 1.3337 0.0 0
M  V30 17 N 2.6673 3.6437 0.0 0
M  V30 18 C 5.3348 2.1037 0.0 0
M  V30 19 C 4.0010 4.4137 0.0 0
M  V30 20 C 5.3348 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 15
M  V30 5 1 5 6
M  V30 6 1 5 7 CFG=3
M  V30 7 1 5 20
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 9 11 CFG=3
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 12 14
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 5 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2875172-33-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2875172-34-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41697250
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed tube
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A crystal form of a fused heterocycle derivative compound
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ng, Alicia Tee Fuay; Zhang, Lijun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024114709 A1 2024-06-06

$RFMT $RIREG SCHEME416 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2R)-2-hydroxy-3-[[(1S)-1-[2-(trifluoromethyl)-5-pyrimidinyl]ethyl]ami...
C11H14F3N3O3
2875172-33-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.3337 0.0 0
M  V30 2 F 0.5637 2.6673 0.0 0
M  V30 3 F 0.0000 0.5637 0.0 0
M  V30 4 F 2.1037 0.0000 0.0 0
M  V30 5 C 6.6685 4.4137 0.0 0 CFG=2
M  V30 6 N 8.0022 3.6437 0.0 0
M  V30 7 C 6.6685 5.9538 0.0 0
M  V30 8 C 9.3358 4.4137 0.0 0
M  V30 9 C 10.6697 3.6437 0.0 0 CFG=1
M  V30 10 C 12.0033 4.4137 0.0 0
M  V30 11 O 10.6697 2.1037 0.0 0
M  V30 12 O 13.3370 3.6437 0.0 0
M  V30 13 O 12.0033 5.9538 0.0 0
M  V30 14 C 14.6707 4.4137 0.0 0
M  V30 15 C 2.6673 2.1037 0.0 0
M  V30 16 N 4.0010 1.3337 0.0 0
M  V30 17 N 2.6673 3.6437 0.0 0
M  V30 18 C 5.3348 2.1037 0.0 0
M  V30 19 C 4.0010 4.4137 0.0 0
M  V30 20 C 5.3348 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 15
M  V30 5 1 5 6
M  V30 6 1 5 7 CFG=3
M  V30 7 1 5 20
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 9 11 CFG=3
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 12 14
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 5 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2R)-2-Hydroxy-N-methyl-3-[[(1S)-1-[2-(trifluoromethyl)-5-pyrimidinyl]ethyl]a...
C11H15F3N4O2
2875172-34-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.3337 0.0 0
M  V30 2 F 0.5637 2.6673 0.0 0
M  V30 3 F 0.0000 0.5637 0.0 0
M  V30 4 F 2.1037 0.0000 0.0 0
M  V30 5 C 6.6685 4.4137 0.0 0 CFG=2
M  V30 6 N 8.0022 3.6437 0.0 0
M  V30 7 C 6.6685 5.9538 0.0 0
M  V30 8 C 9.3358 4.4137 0.0 0
M  V30 9 C 10.6697 3.6437 0.0 0 CFG=1
M  V30 10 C 12.0033 4.4137 0.0 0
M  V30 11 O 10.6697 2.1037 0.0 0
M  V30 12 N 13.3370 3.6437 0.0 0
M  V30 13 O 12.0033 5.9538 0.0 0
M  V30 14 C 14.6707 4.4137 0.0 0
M  V30 15 C 2.6673 2.1037 0.0 0
M  V30 16 N 4.0010 1.3337 0.0 0
M  V30 17 N 2.6673 3.6437 0.0 0
M  V30 18 C 5.3348 2.1037 0.0 0
M  V30 19 C 4.0010 4.4137 0.0 0
M  V30 20 C 5.3348 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 15
M  V30 5 1 5 6
M  V30 6 1 5 7 CFG=3
M  V30 7 1 5 20
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 9 11 CFG=3
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 12 14
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 5 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2875172-33-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2875172-34-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35278320
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed tube
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fused heterocyclic derivatives, their preparation method and application
for treating HBV diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lu, Chunliang; Deng, Gang; Liu, Lianzhu; Li, Xiaoyu; Liu, Zhiguo; Tang,
Bingqing; Cai, Wei; Plunkett, Shane; Pye, Philip James; Deratt, Lindsey
Graham; Raboisson, Pierre Jean-Maria Bernard; Jacoby, Edgar; Grosse,
Sandrine Celine; Cheng, Zhanling; Vandyck, Koen; Jonckers, Tim Hugo
Maria; Kuduk, Scott D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022253255 A1 2022-12-08

$RFMT $RIREG SCHEME417 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-chloro-β-oxobenzenepropanoate
C11H11ClO3
2881-63-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 O 5.3348 0.0000 0.0 0
M  V30 4 C 8.0022 1.5400 0.0 0
M  V30 5 O 9.3360 2.3101 0.0 0
M  V30 6 O 8.0022 0.0000 0.0 0
M  V30 7 C 10.6697 1.5400 0.0 0
M  V30 8 C 12.0033 2.3101 0.0 0
M  V30 9 Cl 0.0000 4.6201 0.0 0
M  V30 10 C 4.0012 2.3101 0.0 0
M  V30 11 C 2.6673 1.5400 0.0 0
M  V30 12 C 4.0012 3.8501 0.0 0
M  V30 13 C 1.3337 2.3101 0.0 0
M  V30 14 C 2.6673 4.6201 0.0 0
M  V30 15 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (2Z)-3-(4-chlorophenyl)-3-(methylamino)-2-propenoate
C12H14ClNO2
2614438-06-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3101 0.0 0
M  V30 2 C 6.6685 3.0801 0.0 0
M  V30 3 N 5.3348 0.7700 0.0 0
M  V30 4 C 8.0022 2.3101 0.0 0
M  V30 5 C 4.0012 0.0000 0.0 0
M  V30 6 O 9.3360 3.0801 0.0 0
M  V30 7 O 8.0022 0.7700 0.0 0
M  V30 8 C 10.6697 2.3101 0.0 0
M  V30 9 C 12.0033 3.0801 0.0 0
M  V30 10 Cl 0.0000 5.3901 0.0 0
M  V30 11 C 4.0012 3.0801 0.0 0
M  V30 12 C 4.0012 4.6201 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 2.6673 5.3901 0.0 0
M  V30 15 C 1.3337 3.0801 0.0 0
M  V30 16 C 1.3337 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 10 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2881-63-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2614438-06-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-23325101
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Electrochemical Oxidative Cyclization: Synthesis of Polysubstituted
Pyrrole from Enamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Zhiwei; Shi, Guang; Tang, Wei; Sun, Jie; Wang, Wenxing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2021), 2021(6), 951-955

$RFMT $RIREG SCHEME418 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3-(4-methoxyphenyl)-3-oxopropanoate
C12H14O4
2881-83-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 C 9.3360 1.5400 0.0 0
M  V30 5 O 10.6697 2.3101 0.0 0
M  V30 6 O 9.3360 0.0000 0.0 0
M  V30 7 C 12.0033 1.5400 0.0 0
M  V30 8 C 13.3370 2.3101 0.0 0
M  V30 9 O 1.3337 4.6201 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 13 C 4.0010 1.5400 0.0 0
M  V30 14 C 4.0010 4.6201 0.0 0
M  V30 15 C 2.6673 2.3101 0.0 0
M  V30 16 C 2.6673 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 1 9 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (2Z)-3-(4-methoxyphenyl)-3-(methylamino)-2-propenoate
C13H17NO3
2614438-03-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 4.0012 0.0 0
M  V30 2 C 4.6201 2.6675 0.0 0
M  V30 3 N 4.6201 5.3348 0.0 0
M  V30 4 C 3.0801 2.6675 0.0 0
M  V30 5 C 5.3901 6.6687 0.0 0
M  V30 6 O 2.3101 1.3338 0.0 0
M  V30 7 O 2.3101 4.0012 0.0 0
M  V30 8 C 0.7700 1.3338 0.0 0
M  V30 9 C 0.0000 0.0000 0.0 0
M  V30 10 O 11.5503 4.0012 0.0 0
M  V30 11 C 12.3203 2.6675 0.0 0
M  V30 12 C 6.9302 4.0012 0.0 0
M  V30 13 C 7.7002 5.3348 0.0 0
M  V30 14 C 7.7002 2.6675 0.0 0
M  V30 15 C 9.2402 5.3348 0.0 0
M  V30 16 C 9.2402 2.6675 0.0 0
M  V30 17 C 10.0102 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 1 10 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2881-83-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2614438-03-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-23324781
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Electrochemical Oxidative Cyclization: Synthesis of Polysubstituted
Pyrrole from Enamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Zhiwei; Shi, Guang; Tang, Wei; Sun, Jie; Wang, Wenxing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2021), 2021(6), 951-955

$RFMT $RIREG SCHEME419 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluorobenzenesulfonyl chloride
C6H4ClFO2S
2905-21-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6673 0.0 0 VAL=6
M  V30 2 Cl 6.1600 2.6673 0.0 0
M  V30 3 O 4.6200 4.2073 0.0 0
M  V30 4 O 4.6200 1.1273 0.0 0
M  V30 5 F 3.0800 0.0000 0.0 0
M  V30 6 C 3.0800 2.6673 0.0 0
M  V30 7 C 2.3100 1.3336 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 0.7700 1.3336 0.0 0
M  V30 10 C 0.7700 4.0011 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-N-methylbenzenesulfonamide
C7H8FNO2S
851169-58-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6673 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6673 0.0 0
M  V30 3 O 4.6200 4.2073 0.0 0
M  V30 4 O 4.6200 1.1273 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 F 3.0800 0.0000 0.0 0
M  V30 7 C 3.0800 2.6673 0.0 0
M  V30 8 C 2.3100 1.3336 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 0.7700 1.3336 0.0 0
M  V30 11 C 0.7700 4.0011 0.0 0
M  V30 12 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 2 5
M  V30 6 1 6 8
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2905-21-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 851169-58-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-9951817
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 1. 2-Fluoro-N-methylbenzenesulfonamide A RBF was charged with
methylamine (0.5 mL, 40%, 14 mmol) in ethanol (2 mL). The mixture was
chilled to 0° C in an ice bath while being stirred under an inert
atmosphere. 2-Fluorobenzenesulfonyl chloride (0.6 mL, 3 mmol) was added
dropwise into the mixture. The resulting mixture was allowed to stir at
0° C for 30 minutes. The mixture was diluted with EtOAc and water. The
aqueous layer was extracted with EtOAc three times, and the combined
organic layers were washed with brine, dried over sodium sulfate,
filtered, and concentrated in vacuo to give
2-fluoro-N-methylbenzenesulfonamide (0.530 g, 99% yield) as a colorless
oil. MS (ESI pos. ion) m/z: 190(MH+). Calculated exact mass for
C7H8FNO2S: 189.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 2-aminobenzothiazole derivatives as phosphoinositide
3-kinase (PI3 kinase) modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Booker, Shon; D'Angelo, Noel; D'Amico, Derin C.; Kim, Tae-Seong; Liu,
Longbin; Meagher, Kristin; Norman, Mark H.; Panter, Kathleen; Schenkel,
Laurie B.; Smith, Adrian L.; Tamayo, Nuria A.; Whittington, Douglas A.;
Xi, Ning; Yang, Kevin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009017822 A2 2009-02-05

$RFMT $RIREG SCHEME420 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromobenzenesulfonyl chloride
C6H4BrClO2S
2905-24-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.3338 3.0801 0.0 0 VAL=6
M  V30 2 Cl 0.0000 3.8501 0.0 0
M  V30 3 O 0.5638 1.7464 0.0 0
M  V30 4 O 2.1038 4.4137 0.0 0
M  V30 5 Br 6.6687 3.0801 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-N-methylbenzenesulfonamide
C7H8BrNO2S
153435-79-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6687 3.8501 0.0 0
M  V30 3 O 6.1048 1.7464 0.0 0
M  V30 4 O 4.5648 4.4137 0.0 0
M  V30 5 C 8.0023 3.0801 0.0 0
M  V30 6 Br 0.0000 3.0801 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 2.6675 3.0801 0.0 0
M  V30 9 C 4.0012 0.7700 0.0 0
M  V30 10 C 1.3337 2.3101 0.0 0
M  V30 11 C 2.6675 0.0000 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 2 5
M  V30 6 1 6 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2905-24-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 153435-79-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-7231225
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM A15. Synthesis of an Aniline via Electrophilic Nitration Followed by
Reduction. Synthesis of 4-(3-Methylsulfamoylphenoxy)aniline. Step 1.
Synthesis of N-methyl-3-bromobenzenesulfonamide. To a solution of
3-bromobenzenesulfonyl chloride (2.5 g, 11.2 mmol) in THF (15 mL) at 0°C.
was added methylamine (2.0 M in THF; 28 mL, 56 mmol). The resulting
solution was allowed to warm to room temp. and was stirred at roomtemp.
overnight. The resulting mixture was separated between EtOAc (25 mL) and
a 1 M HCl solution (25 mL). The aqueous phase was back-extracted with
EtOAc (2×25 mL). The combined organic phases were sequentially washed
with water (2×25 mL) and a saturated NaCl solution (25 mL), dried (MgSO4)
and concentrated under reducedpressure to give
N-methyl-3-bromobenzenesulfonamide as a white solid (2.8 g, 99%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Riedl, Bernd; Dumas, Jacques; Khire, Uday; Lowinger, Timothy B.; Scott,
William J.; Smith, Roger A.; Wood, Jill E.; Monahan, Mary-Katherine;
Natero, Reina; Renick, Joel; Sibley, Robert N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US7235576 B1 2007-06-26

$RFMT $RIREG SCHEME420 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromobenzenesulfonyl chloride
C6H4BrClO2S
2905-24-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.3338 3.0801 0.0 0 VAL=6
M  V30 2 Cl 0.0000 3.8501 0.0 0
M  V30 3 O 0.5638 1.7464 0.0 0
M  V30 4 O 2.1038 4.4137 0.0 0
M  V30 5 Br 6.6687 3.0801 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-N-methylbenzenesulfonamide
C7H8BrNO2S
153435-79-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6687 3.8501 0.0 0
M  V30 3 O 6.1048 1.7464 0.0 0
M  V30 4 O 4.5648 4.4137 0.0 0
M  V30 5 C 8.0023 3.0801 0.0 0
M  V30 6 Br 0.0000 3.0801 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 2.6675 3.0801 0.0 0
M  V30 9 C 4.0012 0.7700 0.0 0
M  V30 10 C 1.3337 2.3101 0.0 0
M  V30 11 C 2.6675 0.0000 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 2 5
M  V30 6 1 6 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2905-24-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 153435-79-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-5248084
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of omega-carboxyaryl substituted diphenyl ureas as raf kinase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Riedl, Bernd; Dumas, Jacques; Khire, Uday; Lowinger, Timothy B.; Scott,
William J.; Smith, Roger A.; Wood, Jill E.; Monahan, Mary-katherine;
Natero, Reina; Renick, Joel; Sibley, Robert N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20030181442 A1 2003-09-25

$RFMT $RIREG SCHEME420 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromobenzenesulfonyl chloride
C6H4BrClO2S
2905-24-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.3338 3.0801 0.0 0 VAL=6
M  V30 2 Cl 0.0000 3.8501 0.0 0
M  V30 3 O 0.5638 1.7464 0.0 0
M  V30 4 O 2.1038 4.4137 0.0 0
M  V30 5 Br 6.6687 3.0801 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-N-methylbenzenesulfonamide
C7H8BrNO2S
153435-79-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6687 3.8501 0.0 0
M  V30 3 O 6.1048 1.7464 0.0 0
M  V30 4 O 4.5648 4.4137 0.0 0
M  V30 5 C 8.0023 3.0801 0.0 0
M  V30 6 Br 0.0000 3.0801 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 2.6675 3.0801 0.0 0
M  V30 9 C 4.0012 0.7700 0.0 0
M  V30 10 C 1.3337 2.3101 0.0 0
M  V30 11 C 2.6675 0.0000 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 2 5
M  V30 6 1 6 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2905-24-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 153435-79-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-10547037
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of diphenylureas as RAF kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Riedl, Bernd; Dumas, Jacques; Khire, Uday; Lowinger, Timothy B.; Scott,
William J.; Smith, Roger A.; Wood, Jill E.; Monahan, Mary-katherine;
Natero, Reina; Renick, Joel; Sibley, Robert N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20030144278 A1 2003-07-31

$RFMT $RIREG SCHEME420 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromobenzenesulfonyl chloride
C6H4BrClO2S
2905-24-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.3338 3.0801 0.0 0 VAL=6
M  V30 2 Cl 0.0000 3.8501 0.0 0
M  V30 3 O 0.5638 1.7464 0.0 0
M  V30 4 O 2.1038 4.4137 0.0 0
M  V30 5 Br 6.6687 3.0801 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-N-methylbenzenesulfonamide
C7H8BrNO2S
153435-79-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6687 3.8501 0.0 0
M  V30 3 O 6.1048 1.7464 0.0 0
M  V30 4 O 4.5648 4.4137 0.0 0
M  V30 5 C 8.0023 3.0801 0.0 0
M  V30 6 Br 0.0000 3.0801 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 2.6675 3.0801 0.0 0
M  V30 9 C 4.0012 0.7700 0.0 0
M  V30 10 C 1.3337 2.3101 0.0 0
M  V30 11 C 2.6675 0.0000 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 2 5
M  V30 6 1 6 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2905-24-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 153435-79-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-15534690
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of quinolyl, isoquinolyl or pyridyl-ureas as inhibitors of
raf kinase for the treatment of tumors and/or cancerous cell growth
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dumas, Jacques; Riedl, Bernd; Khire, Uday; Wood, Jill E.; Robert, Sibley
N.; Monahan, Mary-Katherine; Renick, Joel; Gunn, David E.; Lowinger,
Timothy B.; Scott, William J.; Smith, Roger A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20020165394 A1 2002-11-07

$RFMT $RIREG SCHEME420 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromobenzenesulfonyl chloride
C6H4BrClO2S
2905-24-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.3338 3.0801 0.0 0 VAL=6
M  V30 2 Cl 0.0000 3.8501 0.0 0
M  V30 3 O 0.5638 1.7464 0.0 0
M  V30 4 O 2.1038 4.4137 0.0 0
M  V30 5 Br 6.6687 3.0801 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-N-methylbenzenesulfonamide
C7H8BrNO2S
153435-79-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6687 3.8501 0.0 0
M  V30 3 O 6.1048 1.7464 0.0 0
M  V30 4 O 4.5648 4.4137 0.0 0
M  V30 5 C 8.0023 3.0801 0.0 0
M  V30 6 Br 0.0000 3.0801 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 2.6675 3.0801 0.0 0
M  V30 9 C 4.0012 0.7700 0.0 0
M  V30 10 C 1.3337 2.3101 0.0 0
M  V30 11 C 2.6675 0.0000 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 2 5
M  V30 6 1 6 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2905-24-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 153435-79-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-7475218
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 1. Synthesis of N-methy3-bromobenzenesulfonamide To a solution of
3-bromobenzenesulfonyl chloride (2.5 g, 11.2 mmol) in THF (15 mL) at 0
°C. was added methylamine (2.0M in THF; 28 mL, 56 mmol). The resulting
solution was allowed to warm to room temp. and was stirred at room temp.
overnight. The resulting mixture was separated between EtOAc (25 mL) and
a 1M HCl solution (25 mL). The aqueous phase was back-extracted with
EtOAc (2x25 mL). The combined organic phases were sequentially washed
with water (2x25 mL) and a saturated NaCl solution (25 mL), dried (MgSO4)
and concentrated under reduced pressure to give
N-methy3-bromobenzenesulfonamide. White solid, yield (2.8 g, 99%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-aryl-N'-[(acylphenoxy)phenyl]ureas as raf kinase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dumas, Jacques; Riedl, Bernd; Khire, Uday; Wood, Jill E.; Sibley, Robert
N.; Monahan, Mary-Katherine; Renick, Joel; Gunn, David E.; Lowinger,
Timothy B.; Scott, William J.; Smith, Roger A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002062763 A2 2002-08-15

$RFMT $RIREG SCHEME420 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromobenzenesulfonyl chloride
C6H4BrClO2S
2905-24-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.3338 3.0801 0.0 0 VAL=6
M  V30 2 Cl 0.0000 3.8501 0.0 0
M  V30 3 O 0.5638 1.7464 0.0 0
M  V30 4 O 2.1038 4.4137 0.0 0
M  V30 5 Br 6.6687 3.0801 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-N-methylbenzenesulfonamide
C7H8BrNO2S
153435-79-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6687 3.8501 0.0 0
M  V30 3 O 6.1048 1.7464 0.0 0
M  V30 4 O 4.5648 4.4137 0.0 0
M  V30 5 C 8.0023 3.0801 0.0 0
M  V30 6 Br 0.0000 3.0801 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 2.6675 3.0801 0.0 0
M  V30 9 C 4.0012 0.7700 0.0 0
M  V30 10 C 1.3337 2.3101 0.0 0
M  V30 11 C 2.6675 0.0000 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 2 5
M  V30 6 1 6 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2905-24-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 153435-79-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-17659719
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of ω-carboxy(hetero)aryl substituted diphenyl ureas as raf
kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Riedl, Bernd; Dumas, Jacques; Khire, Uday; Lowinger, Timothy B.; Scott,
William J.; Smith, Roger A.; Wood, Jill E.; Monahan, Mary-Katherine;
Natero, Reina; Renick, Joel; Sibley, Robert N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2000042012 A1 2000-07-20

$RFMT $RIREG SCHEME421 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C28H28F4N6O3
2911640-46-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 46 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.2999 4.0009 0.0 0
M  V30 2 O 8.5299 2.6673 0.0 0
M  V30 3 O 10.8399 4.0009 0.0 0
M  V30 4 C 9.2999 1.3336 0.0 0
M  V30 5 C 8.5299 0.0000 0.0 0
M  V30 6 N 12.7652 10.9269 0.0 0
M  V30 7 C 1.5400 12.1067 0.0 0
M  V30 8 F 1.5400 13.6467 0.0 0
M  V30 9 F 0.0000 12.1067 0.0 0
M  V30 10 F 1.5400 10.5667 0.0 0
M  V30 11 F 3.0800 14.7740 0.0 0
M  V30 12 C 17.4599 13.6373 0.0 0
M  V30 13 O 18.4905 12.4929 0.0 0
M  V30 14 N 7.6915 9.2783 0.0 0
M  V30 15 C 8.0117 7.7719 0.0 0
M  V30 16 C 6.1600 9.4393 0.0 0
M  V30 17 C 6.6781 7.0019 0.0 0
M  V30 18 C 9.1562 6.7415 0.0 0
M  V30 19 N 5.5337 8.0325 0.0 0
M  V30 20 C 6.9982 5.4956 0.0 0
M  V30 21 C 8.5299 5.3347 0.0 0 CFG=3
M  V30 22 C 8.7221 10.4227 0.0 0
M  V30 23 N 10.2284 10.1026 0.0 0
M  V30 24 C 8.2461 11.8874 0.0 0
M  V30 25 C 11.2588 11.2471 0.0 0
M  V30 26 C 9.2767 13.0318 0.0 0
M  V30 27 N 10.7829 12.7116 0.0 0
M  V30 28 C 5.3900 10.7729 0.0 0
M  V30 29 C 3.8500 10.7729 0.0 0
M  V30 30 C 6.1600 12.1067 0.0 0
M  V30 31 C 3.0800 12.1067 0.0 0
M  V30 32 C 5.3900 13.4404 0.0 0
M  V30 33 C 3.8500 13.4404 0.0 0
M  V30 34 C 13.7956 12.0713 0.0 0 CFG=2
M  V30 35 C 15.3272 11.9104 0.0 0
M  V30 36 C 13.4755 13.5777 0.0 0
M  V30 37 N 15.9536 13.3172 0.0 0
M  V30 38 C 14.8091 14.3476 0.0 0
M  V30 39 C 17.9358 15.1020 0.0 0
M  V30 40 C 19.0803 16.1324 0.0 0
M  V30 41 C 17.6156 16.6083 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 25
M  V30 7 1 34 6 CFG=3
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 7 31
M  V30 12 1 11 33
M  V30 13 2 12 13
M  V30 14 1 12 37
M  V30 15 1 12 39
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 14 22
M  V30 19 2 15 17
M  V30 20 1 15 18
M  V30 21 2 16 19
M  V30 22 1 16 28
M  V30 23 1 17 19
M  V30 24 1 17 20
M  V30 25 1 18 21
M  V30 26 1 20 21
M  V30 27 2 22 23
M  V30 28 1 22 24
M  V30 29 1 23 25
M  V30 30 2 24 26
M  V30 31 2 25 27
M  V30 32 1 26 27
M  V30 33 2 28 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 2 30 32
M  V30 37 2 31 33
M  V30 38 1 32 33
M  V30 39 1 34 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 1 36 38
M  V30 43 1 37 38
M  V30 44 1 39 40
M  V30 45 1 39 41
M  V30 46 1 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 34)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C27H27F4N7O2
2911640-54-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.2999 2.6673 0.0 0
M  V30 2 N 8.5299 1.3336 0.0 0
M  V30 3 O 10.8399 2.6673 0.0 0
M  V30 4 C 9.2999 0.0000 0.0 0
M  V30 5 N 12.7652 9.5931 0.0 0
M  V30 6 C 1.5400 10.7731 0.0 0
M  V30 7 F 1.5400 9.2331 0.0 0
M  V30 8 F 0.0000 10.7731 0.0 0
M  V30 9 F 1.5400 12.3131 0.0 0
M  V30 10 F 3.0800 13.4403 0.0 0
M  V30 11 C 17.4599 12.3037 0.0 0
M  V30 12 O 18.4905 11.1593 0.0 0
M  V30 13 N 7.6915 7.9447 0.0 0
M  V30 14 C 8.0117 6.4383 0.0 0
M  V30 15 C 6.1600 8.1056 0.0 0
M  V30 16 C 6.6781 5.6683 0.0 0
M  V30 17 C 9.1562 5.4079 0.0 0
M  V30 18 N 5.5337 6.6988 0.0 0
M  V30 19 C 6.9982 4.1620 0.0 0
M  V30 20 C 8.5299 4.0011 0.0 0 CFG=3
M  V30 21 C 8.7221 9.0891 0.0 0
M  V30 22 N 10.2284 8.7689 0.0 0
M  V30 23 C 8.2461 10.5538 0.0 0
M  V30 24 C 11.2588 9.9134 0.0 0
M  V30 25 C 9.2767 11.6981 0.0 0
M  V30 26 N 10.7829 11.3780 0.0 0
M  V30 27 C 5.3900 9.4393 0.0 0
M  V30 28 C 3.8500 9.4393 0.0 0
M  V30 29 C 6.1600 10.7731 0.0 0
M  V30 30 C 3.0800 10.7731 0.0 0
M  V30 31 C 5.3900 12.1067 0.0 0
M  V30 32 C 3.8500 12.1067 0.0 0
M  V30 33 C 13.7956 10.7377 0.0 0 CFG=2
M  V30 34 C 15.3272 10.5767 0.0 0
M  V30 35 C 13.4755 12.2439 0.0 0
M  V30 36 N 15.9536 11.9835 0.0 0
M  V30 37 C 14.8091 13.0139 0.0 0
M  V30 38 C 17.9358 13.7684 0.0 0
M  V30 39 C 19.0803 14.7988 0.0 0
M  V30 40 C 17.6156 15.2746 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 2 4
M  V30 5 1 5 24
M  V30 6 1 33 5 CFG=3
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 6 30
M  V30 11 1 10 32
M  V30 12 2 11 12
M  V30 13 1 11 36
M  V30 14 1 11 38
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 21
M  V30 18 2 14 16
M  V30 19 1 14 17
M  V30 20 2 15 18
M  V30 21 1 15 27
M  V30 22 1 16 18
M  V30 23 1 16 19
M  V30 24 1 17 20
M  V30 25 1 19 20
M  V30 26 2 21 22
M  V30 27 1 21 23
M  V30 28 1 22 24
M  V30 29 2 23 25
M  V30 30 2 24 26
M  V30 31 1 25 26
M  V30 32 2 27 28
M  V30 33 1 27 29
M  V30 34 1 28 30
M  V30 35 2 29 31
M  V30 36 2 30 32
M  V30 37 1 31 32
M  V30 38 1 33 34
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 1 36 37
M  V30 43 1 38 39
M  V30 44 1 38 40
M  V30 45 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 33)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2911640-46-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2911640-54-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34862265
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel 1,4,5,6-tetrahydrocyclopenta[d]imidazole-5-carboxamide-based JNK3
inhibitors: Design, synthesis, molecular docking, and therapeutic
potential in neurodegenerative diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jun, Joonhong; Baek, Jihyun; Kang, Dahyun; Moon, Hyungwoo; Kim, Hyejin;
Cho, Hyunwook; Hah, Jung-Mi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 245(Part_1), 114917

$RFMT $RIREG SCHEME422 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyridine, 3-bromo-4,6-dichloro-2-methyl-5-nitro-
C6H3BrCl2N2O2
2930866-43-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6674 0.0 0 VAL=5
M  V30 2 O 0.0000 1.3338 0.0 0
M  V30 3 O 0.0000 4.0011 0.0 0
M  V30 4 Cl 2.3100 5.3349 0.0 0
M  V30 5 Cl 2.3100 0.0000 0.0 0
M  V30 6 Br 5.3900 5.3349 0.0 0
M  V30 7 C 6.9300 2.6674 0.0 0
M  V30 8 C 2.3100 2.6674 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 3.0800 1.3338 0.0 0
M  V30 11 C 4.6200 4.0011 0.0 0
M  V30 12 N 4.6200 1.3338 0.0 0
M  V30 13 C 5.3900 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 9
M  V30 5 1 5 10
M  V30 6 1 6 11
M  V30 7 1 7 13
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Pyridinamine, 3-bromo-6-chloro-N,2-dimethyl-5-nitro-
C7H7BrClN3O2
2930866-44-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3101 1.3338 0.0 0
M  V30 2 C 3.0801 0.0000 0.0 0
M  V30 3 N 0.7700 4.0012 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6675 0.0 0
M  V30 5 O 0.0000 5.3348 0.0 0
M  V30 6 Br 5.3901 1.3338 0.0 0
M  V30 7 Cl 2.3101 6.6687 0.0 0
M  V30 8 C 6.9302 4.0012 0.0 0
M  V30 9 C 3.0801 2.6675 0.0 0
M  V30 10 C 2.3101 4.0012 0.0 0
M  V30 11 C 4.6201 2.6675 0.0 0
M  V30 12 C 3.0801 5.3348 0.0 0
M  V30 13 C 5.3901 4.0012 0.0 0
M  V30 14 N 4.6201 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 10
M  V30 6 1 6 11
M  V30 7 1 7 12
M  V30 8 1 8 13
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2930866-43-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2930866-44-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38014918
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Therapeutic heteroaromatic compounds and methods of use in the treatment
of cancer and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zbieg, Jason Robert; Beroza, Paul Powell; Verma, Vishal Anil; Zhu,
Bing-Yan; Beveridge, Ramsay; Zhao, Liang; Leblanc, Melissa; Barton, Lisa
Marie; Chan, Bryan; Bouayad-Gervais, Samir; Dey, Anwesha; Evangelista,
Marie Anne; Smith, Russell Tyler
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023097194 A2 2023-06-01

$RFMT $RIREG SCHEME423 STEP1
$RXN



  2  1
$MOL
Acetic acid, [[(1,1-dimethylethoxy)carbonyl]amino][(1,1-dimethylethyl)dimethy...
C13H27NO4Si
294847-11-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.2074 0.0 0
M  V30 2 N 5.3900 2.8738 0.0 0
M  V30 3 Si 3.0800 4.2074 0.0 0
M  V30 4 C 5.3900 5.5411 0.0 0
M  V30 5 C 6.9300 2.8738 0.0 0
M  V30 6 C 1.5400 4.2074 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 3.0800 5.7474 0.0 0
M  V30 9 O 4.6200 6.8749 0.0 0
M  V30 10 O 6.9300 5.5411 0.0 0
M  V30 11 O 7.7000 1.5400 0.0 0
M  V30 12 O 7.7000 4.2074 0.0 0
M  V30 13 C 1.5400 5.7474 0.0 0
M  V30 14 C 0.0000 4.2074 0.0 0
M  V30 15 C 1.5400 2.6674 0.0 0
M  V30 16 C 9.2400 1.5400 0.0 0
M  V30 17 C 9.2400 3.0800 0.0 0
M  V30 18 C 10.7800 1.5400 0.0 0
M  V30 19 C 9.2400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 2 4 10
M  V30 10 1 5 11
M  V30 11 2 5 12
M  V30 12 1 6 13
M  V30 13 1 6 14
M  V30 14 1 6 15
M  V30 15 1 11 16
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [1-[(1,1-dimethylethyl)dimethylsilyl]-2-(methylamino)-2-oxoeth...
C14H30N2O3Si
847180-77-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 Si 3.0800 4.0011 0.0 0
M  V30 3 N 5.3900 5.3347 0.0 0
M  V30 4 C 5.3900 2.6674 0.0 0
M  V30 5 C 1.5400 4.0011 0.0 0
M  V30 6 C 3.0800 2.4611 0.0 0
M  V30 7 C 3.0800 5.5411 0.0 0
M  V30 8 C 6.9300 5.3347 0.0 0
M  V30 9 N 4.6200 1.3338 0.0 0
M  V30 10 O 6.9300 2.6674 0.0 0
M  V30 11 C 1.5400 5.5411 0.0 0
M  V30 12 C 0.0000 4.0011 0.0 0
M  V30 13 C 1.5400 2.4611 0.0 0
M  V30 14 O 7.7000 6.6685 0.0 0
M  V30 15 O 7.7000 4.0011 0.0 0
M  V30 16 C 5.3900 0.0000 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 9.2400 8.2085 0.0 0
M  V30 19 C 10.7800 6.6685 0.0 0
M  V30 20 C 9.2400 5.1285 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 2 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 2 4 10
M  V30 10 1 5 11
M  V30 11 1 5 12
M  V30 12 1 5 13
M  V30 13 1 8 14
M  V30 14 2 8 15
M  V30 15 1 9 16
M  V30 16 1 14 17
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 17 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 294847-11-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 847180-77-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5698229
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM To a rt solution of 9d (65 mg, 0.22 mmol) in THF (2 mL) was added
carbonyldiimidazole (71 mg, 0.44 mmol). After 1 h, methylamine in THF
(0.33 mL, 0.66 mmol) was added and the resulting mixture was stirred
overnight. Following addition of diethyl ether (10 mL), the mixture was
filtered and concentrated. Flash chromatography (2.5:1:0.02 hexanes/ethyl
acetate/methanol) gave 12 as a colorless solid (67 mg, 99%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM α-Trialkylsilyl Amino Acid Stability
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Guodong; Sieburth, Scott McN.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2005), 7(4), 665-668

$RFMT $RIREG SCHEME424 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,5-Diazabicyclo[4.1.0]heptane-2-carboxylic acid, 5-[2-fluoro-6-(methoxycarbo...
C17H22FN3O4
2960967-33-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8501 2.6673 0.0 0
M  V30 2 O 3.0801 4.0010 0.0 0
M  V30 3 O 3.0801 1.3337 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 C 1.5400 5.5410 0.0 0
M  V30 6 C 0.0000 4.0010 0.0 0
M  V30 7 C 1.5400 2.4610 0.0 0
M  V30 8 F 10.0102 5.3348 0.0 0
M  V30 9 C 14.6303 2.6673 0.0 0
M  V30 10 O 15.4003 1.3337 0.0 0
M  V30 11 O 15.4003 4.0010 0.0 0
M  V30 12 C 16.9404 1.3337 0.0 0
M  V30 13 C 7.7002 1.3337 0.0 0
M  V30 14 C 6.1601 1.3337 0.0 0
M  V30 15 N 8.4702 2.6673 0.0 0
M  V30 16 C 6.9302 0.0000 0.0 0
M  V30 17 N 5.3901 2.6673 0.0 0
M  V30 18 C 7.7002 4.0010 0.0 0
M  V30 19 C 6.1601 4.0010 0.0 0
M  V30 20 C 10.0102 2.6673 0.0 0
M  V30 21 C 10.7802 4.0010 0.0 0
M  V30 22 C 10.7802 1.3337 0.0 0
M  V30 23 N 12.3203 4.0010 0.0 0
M  V30 24 C 12.3203 1.3337 0.0 0
M  V30 25 C 13.0903 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 21
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 25
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 15 18
M  V30 19 1 15 20
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,5-Diazabicyclo[4.1.0]heptane-2-carboxylic acid, 5-[2-fluoro-6-[(methylamino...
C17H23FN4O3
2960967-34-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8501 2.6673 0.0 0
M  V30 2 O 3.0801 4.0010 0.0 0
M  V30 3 O 3.0801 1.3337 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 C 1.5400 5.5410 0.0 0
M  V30 6 C 0.0000 4.0010 0.0 0
M  V30 7 C 1.5400 2.4610 0.0 0
M  V30 8 F 10.0102 5.3348 0.0 0
M  V30 9 C 14.6303 2.6673 0.0 0
M  V30 10 N 15.4003 1.3337 0.0 0
M  V30 11 O 15.4003 4.0010 0.0 0
M  V30 12 C 16.9404 1.3337 0.0 0
M  V30 13 C 7.7002 1.3337 0.0 0
M  V30 14 C 6.1601 1.3337 0.0 0
M  V30 15 N 8.4702 2.6673 0.0 0
M  V30 16 C 6.9302 0.0000 0.0 0
M  V30 17 N 5.3901 2.6673 0.0 0
M  V30 18 C 7.7002 4.0010 0.0 0
M  V30 19 C 6.1601 4.0010 0.0 0
M  V30 20 C 10.0102 2.6673 0.0 0
M  V30 21 C 10.7802 4.0010 0.0 0
M  V30 22 C 10.7802 1.3337 0.0 0
M  V30 23 N 12.3203 4.0010 0.0 0
M  V30 24 C 12.3203 1.3337 0.0 0
M  V30 25 C 13.0903 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 21
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 25
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 15 18
M  V30 19 1 15 20
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2960967-33-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2960967-34-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37652340
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Piperazine derivatives as PARP1 inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hoffman, Robert L.; Va, Porino Jinjo; Pinchman, Joseph Robert; Trzoss,
Lynnie; Dong, Qing; Kaldor, Stephen W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023146960 A1 2023-08-03

$RFMT $RIREG SCHEME425 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Bis (trifluoromethyl)acetophenone
C10H6F6O
30071-93-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3336 6.1600 0.0 0
M  V30 2 F 2.1036 7.4936 0.0 0
M  V30 3 F 0.0000 6.9300 0.0 0
M  V30 4 F 0.5636 4.8264 0.0 0
M  V30 5 C 4.0011 1.5400 0.0 0
M  V30 6 F 2.4611 1.5400 0.0 0
M  V30 7 F 4.0011 0.0000 0.0 0
M  V30 8 F 5.5411 1.5400 0.0 0
M  V30 9 C 6.6685 6.1600 0.0 0
M  V30 10 C 8.0021 5.3900 0.0 0
M  V30 11 O 6.6685 7.7000 0.0 0
M  V30 12 C 2.6674 5.3900 0.0 0
M  V30 13 C 2.6674 3.8500 0.0 0
M  V30 14 C 4.0011 6.1600 0.0 0
M  V30 15 C 4.0011 3.0800 0.0 0
M  V30 16 C 5.3347 5.3900 0.0 0
M  V30 17 C 5.3347 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 12
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 15
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 16
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[1-[3,5-Bis(trifluoromethyl)phenyl]ethylidene]methanamine
C11H9F6N
1441046-90-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 F 5.5411 1.5400 0.0 0
M  V30 3 F 4.0011 0.0000 0.0 0
M  V30 4 F 2.4611 1.5400 0.0 0
M  V30 5 C 1.3337 6.1601 0.0 0
M  V30 6 F 0.5636 4.8264 0.0 0
M  V30 7 F 0.0000 6.9301 0.0 0
M  V30 8 F 2.1037 7.4937 0.0 0
M  V30 9 C 6.6684 6.1601 0.0 0
M  V30 10 N 8.0022 5.3901 0.0 0
M  V30 11 C 6.6684 7.7001 0.0 0
M  V30 12 C 9.3359 6.1601 0.0 0
M  V30 13 C 4.0011 3.0800 0.0 0
M  V30 14 C 2.6675 3.8500 0.0 0
M  V30 15 C 5.3348 3.8500 0.0 0
M  V30 16 C 2.6675 5.3901 0.0 0
M  V30 17 C 5.3348 5.3901 0.0 0
M  V30 18 C 4.0011 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 16
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 17
M  V30 12 1 10 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 30071-93-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1441046-90-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-4515813
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7757-82-6
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 104-15-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM The mixture of ketone (5.12 g, 20 mmol), p-TsOH (380 mg, 2 mmol) and
Na2SO4 (5.68 g, 40 mmol) in 20 mL of MeNH2/MeOH (40 %) was stirred at
room temperature overnight. The solvent was removed by rotary
evaporation. The residue was filtered via a short pad of celite and
washed with petroleum ether (40-60 °C, 150 mL). The filtrate was
concentrated to afford the crude imine. Light yellow oil, yield 5.35 g,
99 %. >95 % purity by 1H NMR.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 1-(azolylcarbonyl)-2-(methoxymethyl)pyrrolidines for use
as catalysts for asymmetric reduction of imines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jones, Simon; Li, Xianfu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013079942 A1 2013-06-06

$RFMT $RIREG SCHEME426 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Bis (trifluoromethyl)acetophenone
C10H6F6O
30071-93-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3336 6.1600 0.0 0
M  V30 2 F 2.1036 7.4936 0.0 0
M  V30 3 F 0.0000 6.9300 0.0 0
M  V30 4 F 0.5636 4.8264 0.0 0
M  V30 5 C 4.0011 1.5400 0.0 0
M  V30 6 F 2.4611 1.5400 0.0 0
M  V30 7 F 4.0011 0.0000 0.0 0
M  V30 8 F 5.5411 1.5400 0.0 0
M  V30 9 C 6.6685 6.1600 0.0 0
M  V30 10 C 8.0021 5.3900 0.0 0
M  V30 11 O 6.6685 7.7000 0.0 0
M  V30 12 C 2.6674 5.3900 0.0 0
M  V30 13 C 2.6674 3.8500 0.0 0
M  V30 14 C 4.0011 6.1600 0.0 0
M  V30 15 C 4.0011 3.0800 0.0 0
M  V30 16 C 5.3347 5.3900 0.0 0
M  V30 17 C 5.3347 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 12
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 15
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 16
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αS)-N,α-Dimethyl-3,5-bis(trifluoromethyl)benzenemethanamine
C11H11F6N
511256-36-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 6.1601 0.0 0
M  V30 2 F 2.1037 7.4937 0.0 0
M  V30 3 F 0.0000 6.9301 0.0 0
M  V30 4 F 0.5636 4.8264 0.0 0
M  V30 5 C 4.0011 1.5400 0.0 0
M  V30 6 F 5.5411 1.5400 0.0 0
M  V30 7 F 4.0011 0.0000 0.0 0
M  V30 8 F 2.4611 1.5400 0.0 0
M  V30 9 C 6.6684 6.1601 0.0 0 CFG=2
M  V30 10 N 8.0022 5.3901 0.0 0
M  V30 11 C 6.6684 7.7001 0.0 0
M  V30 12 C 9.3359 6.1601 0.0 0
M  V30 13 C 2.6675 5.3901 0.0 0
M  V30 14 C 2.6675 3.8500 0.0 0
M  V30 15 C 4.0011 6.1601 0.0 0
M  V30 16 C 4.0011 3.0800 0.0 0
M  V30 17 C 5.3348 5.3901 0.0 0
M  V30 18 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 16
M  V30 9 1 9 10
M  V30 10 1 9 11 CFG=3
M  V30 11 1 9 17
M  V30 12 1 10 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 30071-93-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 511256-36-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-2101785
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7757-82-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 10025-78-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 104-15-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1441045-97-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Synthesis of Imine.The mixture of ketone (5.12
g, 20 mmol), p-TsOH (380 mg, 2 mmol) and Na2SO4 (5.68 g, 40 mmol) in 20
mL of MeNH2/MeOH (40 %) was stirred at room temperature overnight. The
solvent was removed by rotary evaporation. The residue was filtered via a
short pad of celite and washed with petroleum ether (40-60 °C, 150 mL).
The filtrate was concentrated to afford the crude imine as light yellow
oil (5.35 g, 99 % yield). Reduction of Imine. The crude imine (5.35 g)
prepared as described above was dissolved in ethyl acetate (20 mL) and
catalyst (7.5 mg, 0.02 mmol, 0.1% catalyst loading) was added. The
resulting solution was cooled to 0 °C and then HSiCI3 (4 mL, 40 mmol) was
added dropwise. The mixture was stirred for 5 hours at 0 °C. The reaction
mixture was transferred into a 500 mL conical flask, diluted with ethyl
acetate (100 mL) and quenched carefully by addition of water (40 mL) at 0
°C. After addition of Na2SO4 (15 g), the resulting mixture was
neutralized by addition of Na2CO3 (8 g) and ethyl acetate (100 mL) was
added. The mixture was then left overnight and filtered via a short pad
of Celite. The solid was washed with ethyl acetate (400 mL) and the
filtrate was dried over Na2SO4 and concentrated to afford the crude
product. Yellow oil, yield 5.06 g, 93 %. 87 % ee by GC, > 95 % purity by
1H NMR); [a]D +36.7 (c 1.5 in CHCl3); δΗ (400 MHz, CDCl3) 1.39 (d, 3H,
J6.6, CH3), 1.48 (br, s, 1 Η, NH), 2.34 (s, 3H, CH3), 3.82 (q, 1 H, J6.6,
CH), 7.78 (s, 1 H, ArH), 7.83 (s, 2H, ArH); δC (400 MHz, CDCl3) 24.2
(CH3), 34.5 (NCH3), 59.9 (NCH), 120.9 (ArCH), 123.5 (q, J 270, 2 xCF3),
126.9 (ArCH), 131.6 (q, J 33, ArC).
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, ee 91%, alternate step-wise reaction gave lower yield,
catalyst prepared and used in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 1-(azolylcarbonyl)-2-(methoxymethyl)pyrrolidines for use
as catalysts for asymmetric reduction of imines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jones, Simon; Li, Xianfu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013079942 A1 2013-06-06

$RFMT $RIREG SCHEME427 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C14H13BrCl3NO4
3016360-68-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7535 5.2186 0.0 0
M  V30 2 N 7.2935 5.2186 0.0 0
M  V30 3 C 8.0635 6.5524 0.0 0
M  V30 4 O 9.6035 6.5524 0.0 0
M  V30 5 O 7.2935 7.8861 0.0 0
M  V30 6 C 10.3735 7.8861 0.0 0
M  V30 7 C 11.9135 7.8861 0.0 0
M  V30 8 Cl 13.4535 7.8861 0.0 0
M  V30 9 Cl 11.9135 9.4261 0.0 0
M  V30 10 Cl 11.9135 6.3461 0.0 0
M  V30 11 O 4.0967 0.0000 0.0 0
M  V30 12 Br 0.0000 7.5058 0.0 0
M  V30 13 C 4.9835 3.8850 0.0 0 CFG=1
M  V30 14 C 6.3904 3.2587 0.0 0
M  V30 15 O 3.9530 2.7406 0.0 0
M  V30 16 C 6.2295 1.7271 0.0 0
M  V30 17 C 4.7230 1.4068 0.0 0
M  V30 18 C 3.7376 4.7902 0.0 0
M  V30 19 C 3.8985 6.3217 0.0 0
M  V30 20 C 2.3308 4.1639 0.0 0
M  V30 21 C 2.6527 7.2269 0.0 0
M  V30 22 C 1.0849 5.0691 0.0 0
M  V30 23 C 1.2459 6.6006 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 13 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 2 11 17
M  V30 12 1 12 23
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 18 CFG=1
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
5-Oxazolidinepropanamide, 5-(4-bromophenyl)-N-methyl-2-oxo-, (5R)-
C13H15BrN2O3
3016361-01-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.3159 5.3632 0.0 0
M  V30 2 C 2.7843 5.5243 0.0 0
M  V30 3 C 2.1580 6.9311 0.0 0
M  V30 4 N 0.6265 7.0920 0.0 0
M  V30 5 O 3.0632 8.1770 0.0 0
M  V30 6 C 0.0000 8.4990 0.0 0
M  V30 7 O 5.4182 0.0000 0.0 0
M  V30 8 Br 10.2771 7.0364 0.0 0
M  V30 9 C 4.9423 3.9564 0.0 0 CFG=2
M  V30 10 C 3.4776 3.4806 0.0 0
M  V30 11 O 5.8476 2.7106 0.0 0
M  V30 12 N 3.4776 1.9406 0.0 0
M  V30 13 C 4.9423 1.4647 0.0 0
M  V30 14 C 6.2760 4.7264 0.0 0
M  V30 15 C 6.2760 6.2664 0.0 0
M  V30 16 C 7.6096 3.9564 0.0 0
M  V30 17 C 7.6096 7.0364 0.0 0
M  V30 18 C 8.9434 4.7264 0.0 0
M  V30 19 C 8.9434 6.2664 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 9 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 2 7 13
M  V30 8 1 8 19
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 14 CFG=1
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3016360-68-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3016361-01-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38459615
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM ee 93%
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nitrene-Mediated Enantioselective Intramolecular Olefin Oxyamination to
Access Chiral γ-Aminomethyl-γ-Lactones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nie, Xin; Ritter, Clayton W.; Hemming, Marcel; Ivlev, Sergei I.; Xie,
Xiulan; Chen, Shuming; Meggers, Eric
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2023), 62(51), e202314398

$RFMT $RIREG SCHEME428 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolo[2,3-c][1,2,6]selenadiazine-5-carbonitrile, 4,6-dichloro-
C6Cl2N4Se
3036915-11-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7309 1.9571 0.0 0
M  V30 2 N 6.8753 0.9266 0.0 0
M  V30 3 Cl 3.0801 0.0000 0.0 0
M  V30 4 Cl 6.0811 5.2891 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 4.5864 2.9875 0.0 0
M  V30 8 C 2.3101 1.3337 0.0 0
M  V30 9 N 3.3405 5.1456 0.0 0
M  V30 10 N 0.7700 4.0010 0.0 0
M  V30 11 C 4.7475 4.5191 0.0 0
M  V30 12 N 0.7700 1.3337 0.0 0
M  V30 13 Se 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 1 3 8
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 11
M  V30 13 1 10 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolo[2,3-c][1,2,6]selenadiazine-5-carbonitrile, 4-chloro-6-(methylamino)-
C7H4ClN5Se
3036915-16-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0205 1.5063 0.0 0
M  V30 2 N 2.7001 0.0000 0.0 0
M  V30 3 Cl 0.0000 2.8235 0.0 0
M  V30 4 N 6.0811 2.8691 0.0 0
M  V30 5 C 7.4150 3.6391 0.0 0
M  V30 6 C 2.3101 4.1572 0.0 0
M  V30 7 C 3.0801 5.4908 0.0 0
M  V30 8 C 3.3406 3.0126 0.0 0
M  V30 9 C 0.7700 4.1572 0.0 0
M  V30 10 N 4.5865 5.1707 0.0 0
M  V30 11 N 2.3101 6.8245 0.0 0
M  V30 12 C 4.7475 3.6391 0.0 0
M  V30 13 N 0.0000 5.4908 0.0 0
M  V30 14 Se 0.7700 6.8245 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 8
M  V30 3 1 3 9
M  V30 4 1 4 5
M  V30 5 1 4 12
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 2 10 12
M  V30 14 1 11 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3036915-11-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3036915-16-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41348227
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, alternative reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Reaction of tetracyanoethylene with diselenium dichloride: a route to
pyrrolo[2,3-c][1,2,6]selenadiazines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Laurent, Cory; Kourtellaris, Andreas; Koutentis, Panayiotis A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM New Journal of Chemistry (2024), 48(3), 1206-1211

